1	Involvement	Involvement	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	adenylate	adenylate	B-NP	NN	B-protein	4	NMOD
4	cyclase	cyclase	I-NP	NN	I-protein	10	NMOD
5	and	and	O	CC	O	10	NMOD
6	p70	p70	B-NP	NN	B-protein	10	NMOD
7	(	(	O	(	I-protein	10	P
8	S6	S6	B-NP	NN	I-protein	10	NMOD
9	)	)	O	)	I-protein	10	P
10	-kinase	-kinase	B-NP	NN	I-protein	11	NMOD
11	activation	activation	I-NP	NN	O	2	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	IL-10	IL-10	B-NP	NN	B-protein	14	NMOD
14	up-regulation	up-regulation	I-NP	NN	O	12	PMOD
15	in	in	B-PP	IN	O	14	NMOD
16	human	human	B-NP	JJ	B-cell_type	17	NMOD
17	monocytes	monocyte	I-NP	NNS	I-cell_type	15	PMOD
18	by	by	B-PP	IN	O	1	NMOD
19	gp41	gp41	B-NP	NN	B-protein	21	NMOD
20	envelope	envelope	I-NP	NN	I-protein	21	NMOD
21	protein	protein	I-NP	NN	I-protein	18	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	human	human	B-NP	JJ	O	26	NMOD
24	immunodeficiency	immunodeficiency	I-NP	NN	O	26	NMOD
25	virus	virus	I-NP	NN	O	26	NMOD
26	type	type	I-NP	NN	O	22	PMOD
27	1	1	I-NP	CD	O	26	NMOD
28	.	.	O	.	O	1	P

1	Our	Our	B-NP	PRP$	O	3	NMOD
2	previous	previous	I-NP	JJ	O	3	NMOD
3	results	result	I-NP	NNS	O	4	SUB
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	recombinant	recombinant	B-NP	JJ	B-protein	7	NMOD
7	gp41	gp41	I-NP	NN	I-protein	14	NMOD
8	(	(	O	(	O	9	P
9	aa565-647	aa565-647	B-NP	NN	B-protein	7	NMOD
10	)	)	O	)	O	9	P
11	,	,	O	,	O	14	P
12	the	the	B-NP	DT	O	14	NMOD
13	extracellular	extracellular	I-NP	JJ	B-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	20	SUB
15	of	of	B-PP	IN	O	14	NMOD
16	HIV-1	HIV-1	B-NP	NN	B-protein	18	NMOD
17	transmembrane	transmembrane	I-NP	JJ	I-protein	18	NMOD
18	glycoprotein	glycoprotein	I-NP	NN	I-protein	15	PMOD
19	,	,	O	,	O	14	P
20	stimulates	stimulate	B-VP	VBZ	O	5	SBAR
21	interleukin-10	interleukin-10	B-NP	NN	B-protein	25	NMOD
22	(	(	O	(	O	23	P
23	IL-10	IL-10	B-NP	NN	B-protein	21	NMOD
24	)	)	O	)	O	23	P
25	production	production	B-NP	NN	O	20	OBJ
26	in	in	B-PP	IN	O	25	NMOD
27	human	human	B-NP	JJ	B-cell_type	28	NMOD
28	monocytes	monocyte	I-NP	NNS	I-cell_type	26	PMOD
29	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	signal	signal	I-NP	NN	O	3	NMOD
3	cascade	cascade	I-NP	NN	O	7	SUB
4	transducing	transduce	B-VP	VBG	O	3	NMOD
5	this	this	B-NP	DT	O	6	NMOD
6	effect	effect	I-NP	NN	O	4	OBJ
7	is	be	B-VP	VBZ	O	0	ROOT
8	not	not	O	RB	O	7	VMOD
9	yet	yet	B-ADJP	RB	O	7	VMOD
10	clear	clear	I-ADJP	JJ	O	7	PRD
11	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	examined	examine	B-VP	VBD	O	0	ROOT
7	whether	whether	B-SBAR	IN	O	6	VMOD
8	gp41-induced	gp41-induced	B-NP	JJ	O	10	NMOD
9	IL-10	IL-10	I-NP	NN	B-protein	10	NMOD
10	up-regulation	up-regulation	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	7	SBAR
12	mediated	mediate	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	18	NMOD
15	previously	previously	I-NP	RB	O	16	AMOD
16	described	describe	I-NP	VBN	O	18	NMOD
17	synergistic	synergistic	I-NP	JJ	O	18	NMOD
18	activation	activation	I-NP	NN	O	13	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	cAMP	cAMP	B-NP	NN	O	23	NMOD
21	and	and	I-NP	CC	O	23	NMOD
22	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	23	NMOD
23	pathways	pathway	I-NP	NNS	O	19	PMOD
24	.	.	O	.	O	6	P

1	gp41	gp41	B-NP	NN	B-protein	2	SUB
2	induced	induce	B-VP	VBD	O	0	ROOT
3	cAMP	cAMP	B-NP	NN	O	4	NMOD
4	accumulation	accumulation	I-NP	NN	O	2	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	monocytes	monocyte	B-NP	NNS	B-cell_type	5	PMOD
7	in	in	B-PP	IN	O	2	VMOD
8	a	a	B-NP	DT	O	18	NMOD
9	time-	time-	I-NP	NN	O	18	NMOD
10	and	and	O	CC	O	18	NMOD
11	concentration-dependent	concentration-dependent	B-NP	JJ	O	12	NMOD
12	manner	manner	I-NP	NN	O	18	NMOD
13	and	and	O	CC	O	18	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	adenylate	adenylate	I-NP	NN	B-protein	18	NMOD
16	cyclase	cyclase	I-NP	NN	I-protein	18	NMOD
17	inhibitor	inhibitor	I-NP	NN	O	18	NMOD
18	SQ	SQ	I-NP	NN	O	20	SUB
19	22536	22536	I-NP	CD	O	18	NMOD
20	suppressed	suppress	B-VP	VBD	O	7	SBAR
21	gp41-induced	gp41-induced	B-NP	JJ	O	23	NMOD
22	IL-10	IL-10	I-NP	NN	B-protein	23	NMOD
23	production	production	I-NP	NN	O	20	OBJ
24	in	in	B-PP	IN	O	23	NMOD
25	monocytes	monocyte	B-NP	NNS	B-cell_type	24	PMOD
26	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	5	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	gp41	gp41	B-NP	NN	B-protein	5	SUB
5	failed	fail	B-VP	VBD	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	stimulate	stimulate	I-VP	VB	O	5	VMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	O	10	NMOD
10	activity	activity	I-NP	NN	O	7	OBJ
11	in	in	B-PP	IN	O	7	VMOD
12	as	as	B-NP	RB	O	13	NMOD
13	much	much	I-NP	JJ	O	11	PMOD
14	as	as	B-PP	IN	O	7	VMOD
15	no	no	B-NP	DT	O	16	NMOD
16	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	14	PMOD
17	bound	bind	B-VP	VBD	O	5	VMOD
18	to	to	B-PP	TO	O	17	VMOD
19	the	the	B-NP	DT	O	22	NMOD
20	main	main	I-NP	JJ	B-DNA	22	NMOD
21	NF-kappaB-binding	NF-kappaB-binding	I-NP	JJ	I-DNA	22	NMOD
22	site	site	I-NP	NN	I-DNA	18	PMOD
23	2	2	I-NP	CD	O	22	NMOD
24	of	of	B-PP	IN	O	22	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	IL-10	IL-10	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
28	after	after	B-PP	IN	O	17	VMOD
29	addition	addition	B-NP	NN	O	28	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	gp41	gp41	B-NP	NN	B-protein	30	PMOD
32	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	examined	examine	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	involvement	involvement	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	other	other	B-NP	JJ	O	10	NMOD
8	signal	signal	I-NP	NN	O	10	NMOD
9	transduction	transduction	I-NP	NN	O	10	NMOD
10	pathways	pathway	I-NP	NNS	O	6	PMOD
11	.	.	O	.	O	3	P

1	Specific	Specific	B-NP	JJ	O	2	NMOD
2	inhibitors	inhibitor	I-NP	NNS	O	15	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	p70	p70	B-NP	NN	B-protein	8	NMOD
5	(	(	O	(	I-protein	8	P
6	S6	S6	B-NP	NN	I-protein	8	NMOD
7	)	)	O	)	I-protein	8	P
8	-kinase	-kinase	B-NP	NN	I-protein	3	PMOD
9	(	(	O	(	O	10	P
10	rapamycin	rapamycin	B-NP	NN	O	8	NMOD
11	)	)	O	)	O	10	P
12	,	,	O	,	O	15	P
13	and	and	O	CC	O	15	NMOD
14	Gi	Gi	B-NP	NN	B-protein	15	NMOD
15	protein	protein	I-NP	NN	I-protein	21	SUB
16	(	(	O	(	O	18	P
17	pertussis	pertussis	B-NP	NN	B-protein	18	NMOD
18	toxin	toxin	I-NP	NN	I-protein	15	NMOD
19	)	)	O	)	O	18	P
20	,	,	O	,	O	15	P
21	prevented	prevent	B-VP	VBD	O	0	ROOT
22	induction	induction	B-NP	NN	O	21	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	IL-10	IL-10	B-NP	NN	B-protein	25	NMOD
25	production	production	I-NP	NN	O	23	PMOD
26	by	by	B-PP	IN	O	22	NMOD
27	gp41	gp41	B-NP	NN	B-protein	26	PMOD
28	in	in	B-PP	IN	O	22	NMOD
29	monocytes	monocyte	B-NP	NNS	B-cell_type	28	PMOD
30	,	,	O	,	O	21	P
31	while	while	B-SBAR	IN	O	21	VMOD
32	inhibitors	inhibitor	B-NP	NNS	O	56	SUB
33	of	of	B-PP	IN	O	32	NMOD
34	the	the	B-NP	DT	O	36	NMOD
35	phosphatidylinositol	phosphatidylinositol	I-NP	NN	B-protein	36	NMOD
36	3-kinase	3-kinase	I-NP	NN	I-protein	47	NMOD
37	(	(	O	(	O	39	P
38	PI	PI	B-NP	NN	B-protein	39	NMOD
39	3-kinase	3-kinase	I-NP	NN	I-protein	36	NMOD
40	)	)	O	)	O	39	P
41	(	(	O	(	O	42	P
42	wortmannin	wortmannin	B-NP	NN	O	36	NMOD
43	)	)	O	)	O	42	P
44	and	and	O	CC	O	47	NMOD
45	mitogen-activated	mitogen-activated	B-NP	JJ	B-protein	47	NMOD
46	protein	protein	I-NP	NN	I-protein	47	NMOD
47	kinase	kinase	I-NP	NN	I-protein	51	NMOD
48	(	(	O	(	O	49	P
49	MAPK	MAPK	B-NP	NN	B-protein	47	NMOD
50	)	)	O	)	O	49	P
51	pathway	pathway	B-NP	NN	O	33	PMOD
52	(	(	O	(	O	53	P
53	PD	PD	B-NP	NN	O	51	NMOD
54	98059	98059	I-NP	CD	O	53	NMOD
55	)	)	O	)	O	53	P
56	did	do	B-VP	VBD	O	31	SBAR
57	not	not	O	RB	O	56	VMOD
58	.	.	O	.	O	21	P

1	Thus	Thus	B-NP	RB	O	5	NMOD
2	HIV-1	HIV-1	I-NP	NN	O	5	NMOD
3	gp41-induced	gp41-induced	I-NP	JJ	O	5	NMOD
4	IL-10	IL-10	I-NP	NN	B-protein	5	NMOD
5	up-regulation	up-regulation	I-NP	NN	O	8	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	monocytes	monocyte	B-NP	NNS	B-cell_type	6	PMOD
8	may	may	B-VP	MD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	involve	involve	I-VP	VB	O	8	VC
11	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	NMOD
12	,	,	O	,	O	18	P
13	MAPK	MAPK	B-NP	NN	B-protein	18	NMOD
14	,	,	O	,	O	18	P
15	or	or	O	CC	O	18	NMOD
16	PI	PI	B-NP	NN	B-protein	17	NMOD
17	3-kinase	3-kinase	I-NP	NN	I-protein	18	NMOD
18	activation	activation	I-NP	NN	O	10	OBJ
19	,	,	O	,	O	10	P
20	but	but	O	CC	O	10	VMOD
21	rather	rather	B-VP	RB	O	22	VMOD
22	may	may	I-VP	MD	O	10	VMOD
23	operate	operate	I-VP	VB	O	22	VC
24	through	through	B-PP	IN	O	23	VMOD
25	activation	activation	B-NP	NN	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	adenylate	adenylate	B-NP	NN	B-protein	28	NMOD
28	cyclase	cyclase	I-NP	NN	I-protein	32	NMOD
29	and	and	O	CC	O	32	NMOD
30	pertussis-toxin-sensitive	pertussis-toxin-sensitive	B-NP	JJ	B-protein	32	NMOD
31	Gi/Go	Gi/Go	I-NP	NN	I-protein	32	NMOD
32	protein	protein	I-NP	NN	I-protein	26	PMOD
33	to	to	B-PP	TO	O	25	NMOD
34	effect	effect	B-NP	NN	O	39	NMOD
35	p70	p70	I-NP	NN	B-protein	39	NMOD
36	(	(	O	(	I-protein	39	P
37	S6	S6	B-NP	NN	I-protein	39	NMOD
38	)	)	O	)	I-protein	39	P
39	-kinase	-kinase	B-NP	NN	I-protein	40	NMOD
40	activation	activation	I-NP	NN	O	33	PMOD
41	.	.	O	.	O	8	P

1	Constitutive	Constitutive	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	primary	primary	B-NP	JJ	B-cell_type	10	NMOD
7	adult	adult	I-NP	JJ	I-cell_type	10	NMOD
8	T-cell	T-cell	I-NP	NN	I-cell_type	10	NMOD
9	leukemia	leukemia	I-NP	NN	I-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
11	.	.	O	.	O	2	P

1	Human	Human	B-NP	JJ	O	5	NMOD
2	T-cell	T-cell	I-NP	NN	O	5	NMOD
3	leukemia	leukemia	I-NP	NN	O	5	NMOD
4	virus	virus	I-NP	NN	O	5	NMOD
5	type	type	I-NP	NN	O	10	SUB
6	I	I	I-NP	CD	O	5	NMOD
7	(	(	O	(	O	8	P
8	HTLV-I	HTLV-I	B-NP	NN	O	5	NMOD
9	)	)	O	)	O	8	P
10	is	be	B-VP	VBZ	O	0	ROOT
11	an	an	B-NP	DT	O	13	NMOD
12	etiologic	etiologic	I-NP	JJ	O	13	NMOD
13	agent	agent	I-NP	NN	O	10	PRD
14	of	of	B-PP	IN	O	13	NMOD
15	adult	adult	B-NP	JJ	O	17	NMOD
16	T-cell	T-cell	I-NP	NN	O	17	NMOD
17	leukemia	leukemia	I-NP	NN	O	14	PMOD
18	(	(	O	(	O	19	P
19	ATL	ATL	B-NP	NN	O	17	NMOD
20	)	)	O	)	O	19	P
21	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	4	NMOD
2	viral	viral	I-NP	JJ	B-protein	4	NMOD
3	protein	protein	I-NP	NN	I-protein	4	NMOD
4	Tax	Tax	I-NP	NN	B-protein	5	SUB
5	induces	induce	B-VP	VBZ	O	0	ROOT
6	the	the	B-NP	DT	O	10	NMOD
7	activation	activation	I-NP	NN	O	10	NMOD
8	and	and	O	CC	O	10	NMOD
9	nuclear	nuclear	B-NP	JJ	O	10	NMOD
10	translocalization	translocalization	I-NP	NN	O	5	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	transcription	transcription	B-NP	NN	B-protein	13	NMOD
13	factor	factor	I-NP	NN	I-protein	14	NMOD
14	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	11	PMOD
15	,	,	O	,	O	10	P
16	which	which	B-NP	WDT	O	10	NMOD
17	is	be	B-VP	VBZ	O	16	SBAR
18	proposed	propose	I-VP	VBN	O	17	VC
19	to	to	I-VP	TO	O	20	VMOD
20	play	play	I-VP	VB	O	18	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	crucial	crucial	I-NP	JJ	O	23	NMOD
23	role	role	I-NP	NN	O	20	OBJ
24	in	in	B-PP	IN	O	20	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	transformation	transformation	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	T	T	B-NP	NN	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	27	PMOD
30	by	by	B-PP	IN	O	26	NMOD
31	HTLV-I	HTLV-I	B-NP	NN	O	30	PMOD
32	.	.	O	.	O	5	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	5	NMOD
4	HTLV-I	HTLV-I	I-NP	NN	B-DNA	5	NMOD
5	genes	gene	I-NP	NNS	I-DNA	8	SUB
6	including	include	B-PP	VBG	O	5	NMOD
7	Tax	Tax	B-NP	NN	B-protein	6	PMOD
8	are	be	B-VP	VBP	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	expressed	express	I-VP	VBN	O	8	VC
11	significantly	significantly	B-ADVP	RB	O	10	VMOD
12	in	in	B-PP	IN	O	10	VMOD
13	primary	primary	B-NP	JJ	B-cell_type	15	NMOD
14	leukemic	leukemic	I-NP	JJ	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	from	from	B-PP	IN	O	15	NMOD
17	ATL	ATL	B-NP	NN	O	18	NMOD
18	patients	patient	I-NP	NNS	O	16	PMOD
19	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	examined	examine	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	basis	basis	I-NP	NN	O	6	OBJ
9	for	for	B-PP	IN	O	8	NMOD
10	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	NMOD
11	activation	activation	I-NP	NN	O	9	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	freshly	freshly	B-NP	RB	B-cell_type	16	NMOD
14	isolated	isolate	I-NP	VBN	I-cell_type	16	NMOD
15	leukemic	leukemic	I-NP	JJ	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
17	from	from	B-PP	IN	O	16	NMOD
18	ATL	ATL	B-NP	NN	O	19	NMOD
19	patients	patient	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	found	find	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	leukemic	leukemic	B-NP	JJ	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	15	SUB
6	from	from	B-PP	IN	O	5	NMOD
7	ATL	ATL	B-NP	NN	O	8	NMOD
8	patients	patient	I-NP	NNS	O	6	PMOD
9	,	,	O	,	O	5	P
10	like	like	B-PP	IN	O	5	NMOD
11	HTLV-I-infected	HTLV-I-infected	B-NP	JJ	B-cell_line	13	NMOD
12	T-cell	T-cell	I-NP	NN	I-cell_line	13	NMOD
13	lines	line	I-NP	NNS	I-cell_line	10	PMOD
14	,	,	O	,	O	5	P
15	display	display	B-VP	VBP	O	3	SBAR
16	constitutive	constitutive	B-NP	JJ	O	20	NMOD
17	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	20	NMOD
18	DNA	DNA	I-NP	NN	O	20	NMOD
19	binding	binding	I-NP	NN	O	20	NMOD
20	activity	activity	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	increased	increase	B-NP	VBN	O	23	NMOD
23	degradation	degradation	I-NP	NN	O	15	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	28	NMOD
26	(	(	O	(	O	28	P
27	an	an	B-NP	DT	O	28	NMOD
28	inhibitor	inhibitor	I-NP	NN	O	24	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	29	PMOD
31	)	)	O	)	O	28	P
32	.	.	O	.	O	2	P

1	Whereas	Whereas	B-SBAR	IN	O	18	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	5	NMOD
4	binding	binding	I-NP	NN	O	5	NMOD
5	activity	activity	I-NP	NN	O	10	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	Tax-expressing	Tax-expressing	B-NP	JJ	B-cell_line	9	NMOD
8	T-cell	T-cell	I-NP	NN	I-cell_line	9	NMOD
9	lines	line	I-NP	NNS	I-cell_line	6	PMOD
10	consisted	consist	B-VP	VBD	O	1	SBAR
11	mostly	mostly	B-ADVP	RB	O	10	VMOD
12	of	of	B-PP	IN	O	10	VMOD
13	p50/c-Rel	p50/c-Rel	B-NP	NN	B-protein	12	PMOD
14	,	,	O	,	O	18	P
15	fresh	fresh	B-NP	JJ	O	17	NMOD
16	ATL	ATL	I-NP	NN	O	17	NMOD
17	samples	sample	I-NP	NNS	O	18	SUB
18	contained	contain	B-VP	VBD	O	0	ROOT
19	p50/p50	p50/p50	B-NP	NN	B-protein	22	NMOD
20	and	and	I-NP	CC	O	22	NMOD
21	p50/p65	p50/p65	I-NP	NN	B-protein	22	NMOD
22	heterodimers	heterodimer	I-NP	NNS	I-protein	18	OBJ
23	.	.	O	.	O	18	P

1	One	One	B-NP	CD	O	3	NMOD
2	T-cell	T-cell	I-NP	NN	B-cell_line	3	NMOD
3	line	line	I-NP	NN	I-cell_line	10	NMOD
4	derived	derive	B-VP	VBN	O	3	NMOD
5	from	from	B-PP	IN	O	4	VMOD
6	ATL	ATL	B-NP	NN	O	8	NMOD
7	leukemic	leukemic	I-NP	JJ	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
9	,	,	O	,	O	10	P
10	TL-Om1	TL-Om1	B-NP	NN	O	12	SUB
11	,	,	O	,	O	10	P
12	displayed	display	B-VP	VBD	O	0	ROOT
13	constitutive	constitutive	B-NP	JJ	O	15	NMOD
14	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	15	NMOD
15	activity	activity	I-NP	NN	O	21	NMOD
16	,	,	O	,	O	21	P
17	as	as	B-CONJP	RB	O	21	NMOD
18	well	well	I-CONJP	RB	O	17	DEP
19	as	as	I-CONJP	IN	O	17	DEP
20	enhanced	enhance	B-NP	VBN	O	21	NMOD
21	degradation	degradation	I-NP	NN	O	12	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	22	PMOD
24	,	,	O	,	O	12	P
25	despite	despite	B-PP	IN	O	12	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	lack	lack	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	detectable	detectable	B-NP	JJ	O	31	NMOD
30	Tax	Tax	I-NP	NN	B-protein	31	NMOD
31	expression	expression	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	12	P

1	Interestingly	Interestingly	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	the	the	B-NP	DT	O	4	NMOD
4	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	7	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	TL-Om1	TL-Om1	B-NP	NN	O	5	PMOD
7	consists	consist	B-VP	VBZ	O	0	ROOT
8	of	of	B-PP	IN	O	7	VMOD
9	p50/p50	p50/p50	B-NP	NN	B-protein	11	NMOD
10	and	and	O	CC	O	11	NMOD
11	p50/p65	p50/p65	B-NP	NN	B-protein	8	PMOD
12	like	like	B-PP	IN	O	7	VMOD
13	that	that	B-NP	DT	O	12	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	fresh	fresh	B-NP	JJ	O	18	NMOD
16	primary	primary	I-NP	JJ	B-cell_type	18	NMOD
17	leukemic	leukemic	I-NP	JJ	I-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
19	.	.	O	.	O	7	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	activation	activation	B-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	6	PMOD
8	occurs	occur	B-VP	VBZ	O	4	SBAR
9	through	through	B-PP	IN	O	8	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	Tax-independent	Tax-independent	I-NP	JJ	O	12	NMOD
12	mechanism	mechanism	I-NP	NN	O	9	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	leukemic	leukemic	B-NP	JJ	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	ATL	ATL	B-NP	NN	O	18	NMOD
18	patients	patient	I-NP	NNS	O	16	PMOD
19	,	,	O	,	O	8	P
20	possibly	possibly	B-ADVP	RB	O	8	VMOD
21	due	due	B-PP	JJ	O	8	VMOD
22	to	to	B-PP	TO	O	21	AMOD
23	differential	differential	B-NP	JJ	O	26	NMOD
24	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	26	NMOD
25	subunit	subunit	I-NP	NN	I-protein	26	NMOD
26	activation	activation	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	3	P

1	Apoptosis-resistant	Apoptosis-resistant	B-NP	JJ	B-cell_line	3	NMOD
2	T	T	I-NP	NN	I-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	a	a	B-NP	DT	O	6	NMOD
6	deficiency	deficiency	I-NP	NN	O	4	OBJ
7	in	in	B-PP	IN	O	4	VMOD
8	NF-kappaB-mediated	NF-kappaB-mediated	B-NP	JJ	O	9	NMOD
9	induction	induction	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	Fas	Fas	B-NP	NN	B-protein	13	NMOD
12	ligand	ligand	I-NP	NN	I-protein	13	NMOD
13	transcription	transcription	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	4	P

1	Apoptosis	Apoptosis	B-NP	NN	O	10	SUB
2	induced	induce	B-VP	VBN	O	1	NMOD
3	through	through	B-PP	IN	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	TCR	TCR	I-NP	NN	B-protein	3	PMOD
6	in	in	B-PP	IN	O	2	VMOD
7	CD4+	CD4+	B-NP	JJ	B-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	mostly	mostly	I-VP	RB	O	10	VMOD
12	mediated	mediate	I-VP	VBN	O	10	VC
13	by	by	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	inducible	inducible	I-NP	JJ	O	16	NMOD
16	expression	expression	I-NP	NN	O	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	Fas	Fas	B-NP	NN	B-protein	19	NMOD
19	ligand	ligand	I-NP	NN	I-protein	17	PMOD
20	(	(	O	(	O	21	P
21	FasL	FasL	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	as	as	B-PP	IN	O	12	VMOD
24	a	a	B-NP	DT	O	26	NMOD
25	primary	primary	I-NP	JJ	O	26	NMOD
26	event	event	I-NP	NN	O	23	PMOD
27	leading	lead	B-VP	VBG	O	26	NMOD
28	to	to	B-PP	TO	O	27	VMOD
29	the	the	B-NP	DT	O	30	NMOD
30	commitment	commitment	I-NP	NN	O	28	PMOD
31	to	to	B-PP	TO	O	30	NMOD
32	death	death	B-NP	NN	O	31	PMOD
33	.	.	O	.	O	10	P

1	To	To	B-VP	TO	O	2	VMOD
2	gain	gain	I-VP	VB	O	16	VMOD
3	a	a	B-NP	DT	O	5	NMOD
4	better	good	I-NP	JJR	O	5	NMOD
5	understanding	understanding	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD
9	events	event	I-NP	NNS	O	6	PMOD
10	that	that	B-NP	WDT	O	9	NMOD
11	regulate	regulate	B-VP	VBP	O	10	SBAR
12	this	this	B-NP	DT	O	13	NMOD
13	expression	expression	I-NP	NN	O	11	OBJ
14	,	,	O	,	O	16	P
15	we	we	B-NP	PRP	O	16	SUB
16	took	take	B-VP	VBD	O	0	ROOT
17	advantage	advantage	B-NP	NN	O	16	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	our	our	B-NP	PRP$	O	24	NMOD
20	previously	previously	I-NP	RB	O	21	AMOD
21	described	describe	I-NP	VBN	O	24	NMOD
22	mutant	mutant	I-NP	JJ	B-cell_line	24	NMOD
23	Jurkat	Jurkat	I-NP	NN	I-cell_line	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
25	.	.	O	.	O	16	P

1	These	These	B-NP	DT	O	2	NMOD
2	cells	cell	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	deficient	deficient	B-ADJP	JJ	O	3	PRD
5	in	in	B-PP	IN	O	4	AMOD
6	FasL	FasL	B-NP	NN	B-protein	7	NMOD
7	expression	expression	B-NP	NN	O	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	apoptosis	apoptosis	B-NP	NN	O	5	PMOD
10	induced	induce	B-VP	VBN	O	9	NMOD
11	upon	upon	B-PP	IN	O	10	VMOD
12	TCR	TCR	B-NP	NN	B-protein	13	NMOD
13	triggering	triggering	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	3	P
15	although	although	B-SBAR	IN	O	3	VMOD
16	their	their	B-NP	PRP$	O	17	NMOD
17	cytokine	cytokine	I-NP	NN	B-protein	23	NMOD
18	(	(	O	(	O	21	P
19	IL-2	IL-2	B-NP	NN	B-protein	21	NMOD
20	and	and	O	CC	O	21	NMOD
21	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	17	NMOD
22	)	)	O	)	O	21	P
23	production	production	B-NP	NN	O	24	SUB
24	is	be	B-VP	VBZ	O	15	SBAR
25	normal	normal	B-ADJP	JJ	O	24	PRD
26	.	.	O	.	O	3	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	both	both	O	CC	O	13	NMOD
6	a	a	B-NP	DT	O	7	NMOD
7	FasL-	FasL-	I-NP	NN	B-protein	13	NMOD
8	and	and	O	CC	O	13	NMOD
9	a	a	B-NP	DT	O	13	NMOD
10	consensus	consensus	I-NP	NN	B-DNA	13	NMOD
11	NF-kappaB-	NF-kappaB-	I-NP	NN	I-DNA	13	NMOD
12	reporter	reporter	I-NP	NN	I-DNA	13	NMOD
13	construct	construct	I-NP	NN	I-DNA	14	SUB
14	are	be	B-VP	VBP	O	4	SBAR
15	inefficiently	inefficiently	I-VP	RB	O	14	VMOD
16	induced	induce	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	these	these	B-NP	DT	O	19	NMOD
19	cells	cell	I-NP	NNS	O	17	PMOD
20	compared	compare	B-VP	VBN	O	19	NMOD
21	to	to	B-PP	TO	O	20	VMOD
22	wild-type	wild-type	B-NP	JJ	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
24	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	we	we	B-NP	PRP	O	5	SUB
5	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	inducible	inducible	I-NP	JJ	O	10	NMOD
9	transcriptional	transcriptional	I-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	15	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	FasL	FasL	I-NP	NN	B-DNA	14	NMOD
14	reporter	reporter	I-NP	NN	I-DNA	11	PMOD
15	is	be	B-VP	VBZ	O	6	SBAR
16	abolished	abolish	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	specific	specific	B-NP	JJ	O	19	NMOD
19	inhibitors	inhibitor	I-NP	NNS	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	22	NMOD
22	activation	activation	I-NP	NN	O	20	PMOD
23	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	could	could	B-VP	MD	O	0	ROOT
5	trace	trace	I-VP	VB	O	4	VC
6	the	the	B-NP	DT	O	7	NMOD
7	deficit	deficit	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	mutant	mutant	I-NP	JJ	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
12	to	to	B-PP	TO	O	7	NMOD
13	an	an	B-NP	DT	O	16	NMOD
14	inefficient	inefficient	I-NP	JJ	O	16	NMOD
15	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	16	NMOD
16	activation	activation	I-NP	NN	O	12	PMOD
17	,	,	O	,	O	5	P
18	evidencing	evidence	B-VP	VBG	O	5	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	relevant	relevant	I-NP	JJ	O	21	NMOD
21	role	role	I-NP	NN	O	18	OBJ
22	for	for	B-PP	IN	O	21	NMOD
23	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	22	PMOD
24	in	in	B-PP	IN	O	18	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	regulation	regulation	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	FasL	FasL	B-NP	NN	B-protein	29	NMOD
29	expression	expression	I-NP	NN	O	27	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	activated	activate	B-NP	VBN	B-cell_type	33	NMOD
32	T	T	I-NP	NN	I-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	30	PMOD
34	.	.	O	.	O	4	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	our	our	B-NP	PRP$	O	4	NMOD
4	results	result	I-NP	NNS	O	5	SUB
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	induction	induction	I-NP	NN	O	15	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	FasL	FasL	B-NP	NN	B-protein	12	NMOD
11	versus	versus	I-NP	CC	O	12	NMOD
12	cytokine	cytokine	I-NP	NN	B-DNA	14	NMOD
13	gene	gene	I-NP	NN	I-DNA	14	NMOD
14	expression	expression	I-NP	NN	O	9	PMOD
15	is	be	B-VP	VBZ	O	6	SBAR
16	differentially	differentially	B-ADJP	RB	O	17	AMOD
17	sensitive	sensitive	I-ADJP	JJ	O	15	PRD
18	to	to	B-PP	TO	O	17	AMOD
19	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	20	NMOD
20	deprivation	deprivation	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	5	P

1	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	2	SUB
2	regulates	regulate	B-VP	VBZ	O	0	ROOT
3	Fas/APO-1/CD95-	Fas/APO-1/CD95-	B-NP	NN	B-protein	5	NMOD
4	and	and	I-NP	CC	O	5	NMOD
5	TCR-	TCR-	I-NP	NN	B-protein	7	NMOD
6	mediated	mediate	I-NP	VBN	O	7	NMOD
7	apoptosis	apoptosis	I-NP	NN	O	2	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	8	PMOD
11	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	maintenance	maintenance	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	lymphocyte	lymphocyte	B-NP	NN	O	5	NMOD
5	homeostasis	homeostasis	I-NP	NN	O	3	PMOD
6	by	by	B-PP	IN	O	2	NMOD
7	apoptosis	apoptosis	B-NP	NN	O	6	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	12	NMOD
10	critical	critical	I-NP	JJ	O	12	NMOD
11	regulatory	regulatory	I-NP	JJ	O	12	NMOD
12	mechanism	mechanism	I-NP	NN	O	8	PRD
13	in	in	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	17	NMOD
15	normal	normal	I-NP	JJ	O	17	NMOD
16	immune	immune	I-NP	JJ	O	17	NMOD
17	system	system	I-NP	NN	O	13	PMOD
18	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	4	NMOD
2	transcription	transcription	I-NP	NN	B-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	4	NMOD
4	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	5	SUB
5	has	have	B-VP	VBZ	O	0	ROOT
6	been	be	I-VP	VBN	O	5	VC
7	shown	show	I-VP	VBN	O	6	VC
8	to	to	I-VP	TO	O	9	VMOD
9	play	play	I-VP	VB	O	7	VMOD
10	a	a	B-NP	DT	O	11	NMOD
11	role	role	I-NP	NN	O	9	OBJ
12	in	in	B-PP	IN	O	9	VMOD
13	protecting	protect	B-VP	VBG	O	14	NMOD
14	cells	cell	B-NP	NNS	O	12	PMOD
15	against	against	B-PP	IN	O	14	NMOD
16	death	death	B-NP	NN	O	15	PMOD
17	mediated	mediate	B-VP	VBN	O	16	NMOD
18	by	by	B-PP	IN	O	17	VMOD
19	TNF	TNF	B-NP	NN	B-protein	18	PMOD
20	We	We	B-NP	PRP	O	21	SUB
21	show	show	B-VP	VBP	O	19	NMOD
22	here	here	B-ADVP	RB	O	21	VMOD
23	that	that	B-SBAR	IN	O	21	VMOD
24	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	26	SUB
25	also	also	B-ADVP	RB	O	26	VMOD
26	has	have	B-VP	VBZ	O	23	SBAR
27	a	a	B-NP	DT	O	28	NMOD
28	role	role	I-NP	NN	O	26	OBJ
29	in	in	B-PP	IN	O	26	VMOD
30	regulating	regulate	B-VP	VBG	O	29	PMOD
31	Fas/APO-1/CD95-mediated	Fas/APO-1/CD95-mediated	B-NP	JJ	O	32	NMOD
32	death	death	I-NP	NN	O	36	NMOD
33	,	,	O	,	O	36	P
34	a	a	B-NP	DT	O	36	NMOD
35	major	major	I-NP	JJ	O	36	NMOD
36	pathway	pathway	I-NP	NN	O	30	OBJ
37	of	of	B-PP	IN	O	36	NMOD
38	peripheral	peripheral	B-NP	JJ	B-cell_type	41	NMOD
39	T	T	I-NP	NN	I-cell_type	41	NMOD
40	cell	cell	I-NP	NN	I-cell_type	41	NMOD
41	death	death	I-NP	NN	O	37	PMOD
42	.	.	O	.	O	5	P

1	Transfection	Transfection	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Jurkat	Jurkat	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	8	NMOD
8	subunits	subunit	I-NP	NNS	I-protein	11	NMOD
9	p50	p50	I-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	p65	p65	I-NP	NN	B-protein	5	PMOD
12	confers	confer	B-VP	VBZ	O	0	ROOT
13	resistance	resistance	B-NP	NN	O	12	OBJ
14	against	against	B-PP	IN	O	13	NMOD
15	Fas-mediated	Fas-mediated	B-NP	JJ	O	16	NMOD
16	apoptosis	apoptosis	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	12	P

1	Reciprocally	Reciprocally	B-ADVP	RB	O	23	VMOD
2	,	,	O	,	O	23	P
3	inhibition	inhibition	B-NP	NN	O	23	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	6	NMOD
6	activation	activation	I-NP	NN	O	4	PMOD
7	by	by	B-PP	IN	O	3	NMOD
8	a	a	B-NP	DT	O	11	NMOD
9	soluble	soluble	I-NP	JJ	O	11	NMOD
10	peptide	peptide	I-NP	NN	O	11	NMOD
11	inhibitor	inhibitor	I-NP	NN	O	15	NMOD
12	or	or	O	CC	O	15	NMOD
13	a	a	B-NP	DT	O	15	NMOD
14	dominant	dominant	I-NP	JJ	O	15	NMOD
15	form	form	I-NP	NN	O	7	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	19	NMOD
19	inhibitor	inhibitor	I-NP	NN	O	21	NMOD
20	,	,	O	,	O	21	P
21	IkappaB	IkappaB	B-NP	NN	B-protein	16	PMOD
22	,	,	O	,	O	3	P
23	makes	make	B-VP	VBZ	O	0	ROOT
24	the	the	B-NP	DT	O	25	NMOD
25	cells	cell	I-NP	NNS	O	23	OBJ
26	more	more	B-ADJP	RBR	O	27	AMOD
27	susceptible	susceptible	I-ADJP	JJ	O	25	NMOD
28	to	to	B-PP	TO	O	27	AMOD
29	Fas-mediated	Fas-mediated	B-NP	JJ	O	30	NMOD
30	apoptosis	apoptosis	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	23	P

1	Furthermore	Furthermore	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	inhibition	inhibition	B-NP	NN	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	6	NMOD
6	activation	activation	I-NP	NN	O	4	PMOD
7	by	by	B-PP	IN	O	3	NMOD
8	a	a	B-NP	DT	O	11	NMOD
9	soluble	soluble	I-NP	JJ	O	11	NMOD
10	peptide	peptide	I-NP	NN	O	11	NMOD
11	inhibitor	inhibitor	I-NP	NN	O	7	PMOD
12	rendered	render	B-VP	VBD	O	0	ROOT
13	a	a	B-NP	DT	O	16	NMOD
14	T	T	I-NP	NN	B-cell_line	16	NMOD
15	cell	cell	I-NP	NN	I-cell_line	16	NMOD
16	hybridoma	hybridoma	I-NP	NN	I-cell_line	18	AMOD
17	more	more	B-ADJP	RBR	O	18	AMOD
18	susceptible	susceptible	I-ADJP	JJ	O	12	VMOD
19	to	to	B-PP	TO	O	18	AMOD
20	TCR-mediated	TCR-mediated	B-NP	JJ	O	21	NMOD
21	apoptosis	apoptosis	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	12	P

1	Correspondingly	Correspondingly	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	transfection	transfection	B-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	p50	p50	B-NP	NN	B-protein	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	p65	p65	B-NP	NN	B-protein	4	PMOD
8	provided	provide	B-VP	VBD	O	0	ROOT
9	considerable	considerable	B-NP	JJ	O	10	NMOD
10	protection	protection	I-NP	NN	O	8	OBJ
11	from	from	B-PP	IN	O	10	NMOD
12	TCR-mediated	TCR-mediated	B-NP	JJ	O	13	NMOD
13	apoptosis	apoptosis	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	corroborated	corroborate	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	studies	study	B-NP	NNS	O	5	PMOD
7	on	on	B-PP	IN	O	6	NMOD
8	Fas-mediated	Fas-mediated	B-NP	JJ	O	9	NMOD
9	death	death	I-NP	NN	O	7	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	primary	primary	B-NP	JJ	B-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
14	.	.	O	.	O	3	P

1	Concanavalin	Concanavalin	B-NP	NN	O	6	NMOD
2	A-activated	A-activated	I-NP	JJ	O	6	NMOD
3	cycling	cycling	I-NP	NN	O	6	NMOD
4	T	T	I-NP	NN	B-cell_type	6	NMOD
5	cell	cell	I-NP	NN	I-cell_type	6	NMOD
6	blasts	blast	I-NP	NNS	I-cell_type	17	SUB
7	from	from	B-PP	IN	O	6	NMOD
8	mice	mouse	B-NP	NNS	O	7	PMOD
9	that	that	B-NP	WDT	O	6	NMOD
10	are	be	B-VP	VBP	O	9	SBAR
11	transgenic	transgenic	B-ADJP	JJ	O	10	PRD
12	for	for	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	16	NMOD
14	dominant	dominant	I-NP	JJ	B-protein	16	NMOD
15	IkappaB	IkappaB	I-NP	NN	I-protein	16	NMOD
16	molecule	molecule	I-NP	NN	I-protein	12	PMOD
17	have	have	B-VP	VBP	O	0	ROOT
18	increased	increase	I-VP	VBN	O	17	VC
19	sensitivity	sensitivity	B-NP	NN	O	18	OBJ
20	to	to	B-PP	TO	O	19	NMOD
21	Fas-mediated	Fas-mediated	B-NP	JJ	O	22	NMOD
22	apoptosis	apoptosis	I-NP	NN	O	20	PMOD
23	,	,	O	,	O	19	P
24	associated	associate	B-VP	VBN	O	19	NMOD
25	with	with	B-PP	IN	O	24	VMOD
26	a	a	B-NP	DT	O	27	NMOD
27	down-regulation	down-regulation	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	30	NMOD
30	complexes	complex	I-NP	NNS	I-protein	28	PMOD
31	in	in	B-PP	IN	O	27	NMOD
32	the	the	B-NP	DT	O	33	NMOD
33	nucleus	nucleus	I-NP	NN	O	31	PMOD
34	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	17	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	17	P
4	blocking	block	B-VP	VBG	O	17	VMOD
5	TNF	TNF	B-NP	NN	B-protein	4	OBJ
6	,	,	O	,	O	17	P
7	itself	itself	B-NP	PRP	O	10	NMOD
8	a	a	B-NP	DT	O	10	NMOD
9	positive	positive	I-NP	JJ	B-protein	10	NMOD
10	regulator	regulator	I-NP	NN	I-protein	17	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	PMOD
13	,	,	O	,	O	10	P
14	with	with	B-PP	IN	O	10	NMOD
15	neutralizing	neutralize	B-NP	VBG	B-protein	16	NMOD
16	antibodies	antibody	I-NP	NNS	I-protein	14	PMOD
17	renders	render	B-VP	VBZ	O	0	ROOT
18	the	the	B-NP	DT	O	19	NMOD
19	cells	cell	I-NP	NNS	O	17	OBJ
20	more	more	B-ADJP	RBR	O	21	AMOD
21	susceptible	susceptible	I-ADJP	JJ	O	19	NMOD
22	to	to	B-PP	TO	O	21	AMOD
23	anti-Fas-mediated	anti-Fas-mediated	B-NP	JJ	O	24	NMOD
24	apoptosis	apoptosis	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	6	VMOD
2	summary	summary	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	our	our	B-NP	PRP$	O	5	NMOD
5	results	result	I-NP	NNS	O	6	SUB
6	provide	provide	B-VP	VBP	O	0	ROOT
7	compelling	compelling	B-NP	JJ	O	8	NMOD
8	evidence	evidence	I-NP	NN	O	6	OBJ
9	that	that	B-SBAR	IN	O	8	NMOD
10	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	SUB
11	protects	protect	B-VP	VBZ	O	9	SBAR
12	against	against	B-PP	IN	O	11	VMOD
13	Fas-mediated	Fas-mediated	B-NP	JJ	O	14	NMOD
14	death	death	I-NP	NN	O	12	PMOD
15	and	and	O	CC	O	11	VMOD
16	is	be	B-VP	VBZ	O	11	VMOD
17	likely	likely	B-ADJP	JJ	O	16	PRD
18	to	to	B-VP	TO	O	19	VMOD
19	be	be	I-VP	VB	O	17	AMOD
20	an	an	B-NP	DT	O	22	NMOD
21	important	important	I-NP	JJ	O	22	NMOD
22	regulator	regulator	I-NP	NN	O	19	PRD
23	of	of	B-PP	IN	O	22	NMOD
24	T	T	B-NP	NN	O	26	NMOD
25	cell	cell	I-NP	NN	O	26	NMOD
26	homeostasis	homeostasis	I-NP	NN	O	28	NMOD
27	and	and	I-NP	CC	O	28	NMOD
28	tolerance	tolerance	I-NP	NN	O	23	PMOD
29	.	.	O	.	O	6	P

1	Evidence	Evidence	B-NP	NN	O	0	ROOT
2	for	for	B-PP	IN	O	1	NMOD
3	distinct	distinct	B-NP	JJ	O	6	NMOD
4	intracellular	intracellular	I-NP	JJ	O	6	NMOD
5	signaling	signaling	I-NP	NN	O	6	NMOD
6	pathways	pathway	I-NP	NNS	O	2	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	CD34+	CD34+	B-NP	JJ	B-cell_type	9	NMOD
9	progenitor	progenitor	I-NP	NN	I-cell_type	7	PMOD
10	to	to	B-PP	TO	O	9	NMOD
11	dendritic	dendritic	B-NP	JJ	O	13	NMOD
12	cell	cell	I-NP	NN	O	13	NMOD
13	differentiation	differentiation	I-NP	NN	O	10	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	a	a	B-NP	DT	O	19	NMOD
16	human	human	I-NP	JJ	O	19	NMOD
17	cell	cell	I-NP	NN	O	19	NMOD
18	line	line	I-NP	NN	O	19	NMOD
19	model	model	I-NP	NN	O	14	PMOD
20	.	.	O	.	O	1	P

1	Intracellular	Intracellular	B-NP	JJ	O	2	NMOD
2	signals	signal	I-NP	NNS	O	16	SUB
3	that	that	B-NP	WDT	O	2	NMOD
4	mediate	mediate	B-VP	VBP	O	3	SBAR
5	differentiation	differentiation	B-NP	NN	O	4	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	pluripotent	pluripotent	B-NP	JJ	B-cell_type	9	NMOD
8	hemopoietic	hemopoietic	I-NP	JJ	I-cell_type	9	NMOD
9	progenitors	progenitor	I-NP	NNS	I-cell_type	6	PMOD
10	to	to	B-PP	TO	O	5	NMOD
11	dendritic	dendritic	B-NP	JJ	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
13	(	(	O	(	O	14	P
14	DC	DC	B-NP	NNS	B-cell_type	12	NMOD
15	)	)	O	)	O	14	P
16	are	be	B-VP	VBP	O	0	ROOT
17	largely	largely	B-ADJP	RB	O	18	AMOD
18	undefined	undefined	I-ADJP	JJ	O	16	PRD
19	.	.	O	.	O	16	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	previously	previously	I-VP	RB	O	2	VMOD
4	shown	show	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	protein	protein	B-NP	NN	B-protein	8	NMOD
7	kinase	kinase	I-NP	NN	I-protein	8	NMOD
8	C	C	I-NP	NN	I-protein	12	NMOD
9	(	(	O	(	O	10	P
10	PKC	PKC	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	activation	activation	B-NP	NN	O	23	SUB
13	(	(	O	(	O	20	P
14	with	with	B-PP	IN	O	20	AMOD
15	phorbol	phorbol	B-NP	NN	O	16	NMOD
16	ester	ester	I-NP	NN	O	14	PMOD
17	(	(	O	(	O	18	P
18	PMA	PMA	B-NP	NN	O	16	NMOD
19	)	)	O	)	O	18	P
20	alone	alone	B-ADVP	RB	O	12	NMOD
21	)	)	O	)	O	20	P
22	specifically	specifically	B-ADVP	RB	O	23	VMOD
23	induces	induce	B-VP	VBZ	O	5	SBAR
24	differentiation	differentiation	B-NP	NN	O	23	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	primary	primary	B-NP	JJ	B-cell_type	31	NMOD
27	human	human	I-NP	JJ	I-cell_type	31	NMOD
28	CD34+	CD34+	I-NP	JJ	I-cell_type	31	NMOD
29	hemopoietic	hemopoietic	I-NP	JJ	I-cell_type	31	NMOD
30	progenitor	progenitor	I-NP	NN	I-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	25	PMOD
32	(	(	O	(	O	33	P
33	HPC	HPC	B-NP	NN	B-cell_type	31	NMOD
34	)	)	O	)	O	33	P
35	to	to	B-PP	TO	O	24	NMOD
36	mature	mature	B-NP	JJ	B-cell_type	37	NMOD
37	DC	DC	I-NP	NN	I-cell_type	35	PMOD
38	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	find	find	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	cytokine-driven	cytokine-driven	O	JJ	O	17	NMOD
6	(	(	O	(	O	10	P
7	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-protein	8	NMOD
8	CSF	CSF	I-NP	NN	I-protein	10	AMOD
9	and	and	I-NP	CC	O	10	AMOD
10	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	13	NMOD
11	)	)	I-NP	)	O	10	P
12	CD34+	CD34+	I-NP	JJ	O	13	NMOD
13	HPC	HPC	I-NP	NN	B-cell_type	17	NMOD
14	--	--	O	:	O	17	P
15	>	>	O	SYM	O	17	NMOD
16	DC	DC	B-NP	NN	B-cell_type	17	NMOD
17	differentiation	differentiation	I-NP	NN	O	18	SUB
18	is	be	B-VP	VBZ	O	4	SBAR
19	preferentially	preferentially	I-VP	RB	O	18	VMOD
20	blocked	block	I-VP	VBN	O	18	VC
21	by	by	B-PP	IN	O	20	VMOD
22	inhibitors	inhibitor	B-NP	NNS	O	21	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	PKC	PKC	B-NP	NN	B-protein	25	NMOD
25	activation	activation	I-NP	NN	O	23	PMOD
26	.	.	O	.	O	3	P

1	To	To	B-VP	TO	O	3	VMOD
2	further	further	I-VP	RB	O	3	VMOD
3	identify	identify	I-VP	VB	O	18	VMOD
4	intracellular	intracellular	B-NP	JJ	O	5	NMOD
5	signals	signal	I-NP	NNS	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	downstream	downstream	B-NP	JJ	O	8	NMOD
8	events	event	I-NP	NNS	O	3	OBJ
9	important	important	B-ADJP	JJ	O	8	NMOD
10	in	in	B-PP	IN	O	9	AMOD
11	CD34+	CD34+	B-NP	JJ	B-cell_line	12	NMOD
12	HPC	HPC	I-NP	NN	I-cell_line	10	PMOD
13	--	--	O	:	O	16	P
14	>	>	B-NP	SYM	O	16	NMOD
15	DC	DC	I-NP	NN	B-cell_type	16	NMOD
16	differentiation	differentiation	I-NP	NN	O	3	OBJ
17	we	we	B-NP	PRP	O	18	SUB
18	have	have	B-VP	VBP	O	0	ROOT
19	characterized	characterize	I-VP	VBN	O	18	VC
20	a	a	B-NP	DT	O	25	NMOD
21	human	human	I-NP	JJ	B-cell_line	25	NMOD
22	leukemic	leukemic	I-NP	JJ	I-cell_line	25	NMOD
23	cell	cell	I-NP	NN	I-cell_line	25	NMOD
24	line	line	I-NP	NN	I-cell_line	25	NMOD
25	model	model	I-NP	NN	O	19	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	this	this	B-NP	DT	O	28	NMOD
28	process	process	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	6	NMOD
2	CD34+	CD34+	I-NP	JJ	B-cell_line	6	NMOD
3	myelomonocytic	myelomonocytic	I-NP	JJ	I-cell_line	6	NMOD
4	cell	cell	I-NP	NN	I-cell_line	6	NMOD
5	line	line	I-NP	NN	I-cell_line	6	NMOD
6	KG1	KG1	I-NP	NN	B-cell_line	7	SUB
7	differentiates	differentiate	B-VP	VBZ	O	0	ROOT
8	into	into	B-PP	IN	O	7	VMOD
9	dendritic-like	dendritic-like	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	in	in	B-PP	IN	O	7	VMOD
12	response	response	B-NP	NN	O	11	PMOD
13	to	to	B-PP	TO	O	11	PMOD
14	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-protein	17	NMOD
15	CSF	CSF	I-NP	NN	I-protein	17	NMOD
16	plus	plus	I-NP	CC	O	17	NMOD
17	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	20	NMOD
18	,	,	O	,	O	20	P
19	or	or	O	CC	O	20	NMOD
20	PMA	PMA	B-NP	NN	O	11	PMOD
21	(	(	O	(	O	20	P
22	with	with	B-PP	IN	O	20	NMOD
23	or	or	I-PP	CC	O	22	PMOD
24	without	without	I-PP	IN	O	22	PMOD
25	the	the	B-NP	DT	O	28	NMOD
26	calcium	calcium	I-NP	NN	O	28	NMOD
27	ionophore	ionophore	I-NP	NN	O	28	NMOD
28	ionomycin	ionomycin	I-NP	NN	O	22	PMOD
29	,	,	O	,	O	31	P
30	or	or	O	CC	O	31	NMOD
31	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	20	NMOD
32	)	)	O	)	O	31	P
33	,	,	O	,	O	20	P
34	with	with	B-PP	IN	O	20	NMOD
35	different	different	B-NP	JJ	O	36	NMOD
36	stimuli	stimulus	I-NP	NNS	O	34	PMOD
37	mediating	mediate	B-VP	VBG	O	36	NMOD
38	different	different	B-NP	JJ	O	39	NMOD
39	aspects	aspect	I-NP	NNS	O	37	OBJ
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	42	NMOD
42	process	process	I-NP	NN	O	40	PMOD
43	.	.	O	.	O	7	P

1	Phenotypic	Phenotypic	B-NP	JJ	O	3	NMOD
2	DC	DC	I-NP	NN	O	3	NMOD
3	characteristics	characteristic	I-NP	NNS	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	KG1	KG1	B-NP	NN	B-cell_line	7	NMOD
6	dendritic-like	dendritic-like	I-NP	JJ	I-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
8	include	include	B-VP	VBP	O	0	ROOT
9	morphology	morphology	B-NP	NN	O	13	NMOD
10	(	(	O	(	O	13	P
11	loosely	loosely	B-NP	RB	B-cell_type	13	NMOD
12	adherent	adherent	I-NP	JJ	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	32	NMOD
14	with	with	B-PP	IN	O	13	NMOD
15	long	long	B-NP	JJ	O	17	NMOD
16	neurite	neurite	I-NP	NN	O	17	NMOD
17	processes	process	I-NP	NNS	O	14	PMOD
18	)	)	O	)	O	13	P
19	,	,	O	,	O	32	P
20	MHC	MHC	B-NP	NN	B-protein	25	NMOD
21	I+/MHC	I+/MHC	I-NP	NN	I-protein	25	NMOD
22	IIbright/CD83+/CD86+/CD14-	IIbright/CD83+/CD86+/CD14-	I-NP	NN	I-protein	25	NMOD
23	surface	surface	I-NP	NN	I-protein	25	NMOD
24	Ag	Ag	I-NP	NN	I-protein	25	NMOD
25	expression	expression	I-NP	NN	O	32	NMOD
26	,	,	O	,	O	32	P
27	and	and	O	CC	O	32	NMOD
28	RelB	RelB	B-NP	NN	B-protein	32	NMOD
29	and	and	I-NP	CC	O	32	NMOD
30	DC-CK1	DC-CK1	I-NP	NN	O	32	NMOD
31	gene	gene	I-NP	NN	O	32	NMOD
32	expression	expression	I-NP	NN	O	8	OBJ
33	.	.	O	.	O	8	P

1	Functional	Functional	B-NP	JJ	O	3	NMOD
2	DC	DC	I-NP	NN	B-cell_type	3	NMOD
3	characteristics	characteristic	I-NP	NNS	O	4	SUB
4	include	include	B-VP	VBP	O	0	ROOT
5	fluid	fluid	B-NP	NN	O	8	NMOD
6	phase	phase	I-NP	NN	O	8	NMOD
7	macromolecule	macromolecule	I-NP	NN	O	8	NMOD
8	uptake	uptake	I-NP	NN	O	13	NMOD
9	(	(	O	(	O	10	P
10	FITC-dextran	FITC-dextran	B-NP	NN	O	8	NMOD
11	)	)	O	)	O	10	P
12	and	and	O	CC	O	13	NMOD
13	activation	activation	B-NP	NN	O	4	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	resting	rest	B-NP	VBG	B-cell_type	17	NMOD
16	T	T	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
18	.	.	O	.	O	4	P

1	Comparison	Comparison	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	KG1	KG1	B-NP	NN	B-cell_line	2	PMOD
4	to	to	B-PP	TO	O	1	NMOD
5	the	the	B-NP	DT	O	8	NMOD
6	PMA-unresponsive	PMA-unresponsive	I-NP	JJ	B-cell_line	8	NMOD
7	subline	subline	I-NP	NN	I-cell_line	8	NMOD
8	KG1a	KG1a	I-NP	NN	I-cell_line	4	PMOD
9	reveals	reveal	B-VP	VBZ	O	0	ROOT
10	differences	difference	B-NP	NNS	O	34	NMOD
11	in	in	B-PP	IN	O	10	NMOD
12	expression	expression	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	TNF	TNF	B-NP	NN	B-protein	15	NMOD
15	receptors	receptor	I-NP	NNS	I-protein	13	PMOD
16	1	1	B-NP	CD	I-protein	18	NMOD
17	and	and	I-NP	CC	I-protein	18	NMOD
18	2	2	I-NP	CD	I-protein	15	NMOD
19	;	;	O	:	O	34	P
20	PKC	PKC	B-NP	NN	B-protein	22	NMOD
21	isoforms	isoform	I-NP	NNS	I-protein	22	NMOD
22	alpha	alpha	I-NP	NN	I-protein	34	NMOD
23	,	,	O	,	O	34	P
24	beta	beta	B-NP	NN	O	34	NMOD
25	I	I	I-NP	CD	O	24	NMOD
26	,	,	O	,	O	34	P
27	beta	beta	B-NP	NN	B-protein	34	NMOD
28	II	II	I-NP	CD	I-protein	27	NMOD
29	,	,	O	,	O	34	P
30	and	and	O	CC	O	34	NMOD
31	mu	mu	B-NP	NN	O	34	NMOD
32	;	;	O	:	O	34	P
33	and	and	O	CC	O	34	NMOD
34	RelB	RelB	B-NP	NN	B-protein	9	OBJ
35	,	,	O	,	O	9	P
36	suggesting	suggest	B-VP	VBG	O	9	VMOD
37	that	that	B-SBAR	IN	O	36	VMOD
38	these	these	B-NP	DT	O	39	NMOD
39	components/pathways	components/pathway	I-NP	NNS	O	40	SUB
40	are	be	B-VP	VBP	O	37	SBAR
41	important	important	B-ADJP	JJ	O	40	PRD
42	for	for	B-PP	IN	O	41	AMOD
43	DC	DC	B-NP	NN	B-cell_type	44	NMOD
44	differentiation	differentiation	I-NP	NN	O	42	PMOD
45	.	.	O	.	O	9	P

1	Together	Together	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	findings	finding	I-NP	NNS	O	5	SUB
5	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	cytokine	cytokine	B-NP	NN	B-protein	11	NMOD
8	or	or	O	CC	O	11	NMOD
9	phorbol	phorbol	B-NP	NN	O	11	NMOD
10	ester	ester	I-NP	NN	O	11	NMOD
11	stimulation	stimulation	I-NP	NN	O	14	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	KG1	KG1	B-NP	NN	B-cell_line	12	PMOD
14	is	be	B-VP	VBZ	O	6	SBAR
15	a	a	B-NP	DT	O	16	NMOD
16	model	model	I-NP	NN	O	14	PRD
17	of	of	B-PP	IN	O	16	NMOD
18	human	human	B-NP	JJ	B-cell_line	20	NMOD
19	CD34+	CD34+	I-NP	JJ	I-cell_line	20	NMOD
20	HPC	HPC	I-NP	NN	I-cell_line	17	PMOD
21	to	to	B-PP	TO	O	16	NMOD
22	DC	DC	B-NP	NN	B-cell_type	23	NMOD
23	differentiation	differentiation	I-NP	NN	O	21	PMOD
24	and	and	O	CC	O	5	VMOD
25	suggest	suggest	B-VP	VBP	O	5	VMOD
26	that	that	B-SBAR	IN	O	25	VMOD
27	specific	specific	B-NP	JJ	O	30	NMOD
28	intracellular	intracellular	I-NP	JJ	O	30	NMOD
29	signaling	signaling	I-NP	NN	O	30	NMOD
30	pathways	pathway	I-NP	NNS	O	31	SUB
31	mediate	mediate	B-VP	VBP	O	26	SBAR
32	specific	specific	B-NP	JJ	O	33	NMOD
33	events	event	I-NP	NNS	O	31	OBJ
34	in	in	B-PP	IN	O	31	VMOD
35	DC	DC	B-NP	NN	B-cell_type	37	NMOD
36	lineage	lineage	I-NP	NN	O	37	NMOD
37	commitment	commitment	I-NP	NN	O	34	PMOD
38	.	.	O	.	O	5	P

1	IL-2-mediated	IL-2-mediated	B-NP	JJ	O	4	NMOD
2	cell	cell	I-NP	NN	O	4	NMOD
3	cycle	cycle	I-NP	NN	O	4	NMOD
4	progression	progression	I-NP	NN	O	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	inhibition	inhibition	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	apoptosis	apoptosis	B-NP	NN	O	7	PMOD
9	does	do	B-VP	VBZ	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	require	require	I-VP	VB	O	9	VC
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	11	OBJ
14	or	or	O	CC	O	11	VMOD
15	activating	activate	B-VP	VBG	B-protein	11	VMOD
16	protein-1	protein-1	B-NP	NN	I-protein	17	NMOD
17	activation	activation	I-NP	NN	O	15	OBJ
18	in	in	B-PP	IN	O	17	NMOD
19	primary	primary	B-NP	JJ	B-cell_type	22	NMOD
20	human	human	I-NP	JJ	I-cell_type	22	NMOD
21	T	T	I-NP	NN	I-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	18	PMOD
23	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	4	NMOD
2	IL-2	IL-2	I-NP	NN	B-protein	4	NMOD
3	growth	growth	I-NP	NN	O	4	NMOD
4	hormone	hormone	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	the	the	B-NP	DT	O	9	NMOD
7	major	major	I-NP	JJ	O	9	NMOD
8	growth	growth	I-NP	NN	O	9	NMOD
9	factor	factor	I-NP	NN	O	5	PRD
10	of	of	B-PP	IN	O	9	NMOD
11	activated	activate	B-NP	VBN	O	13	NMOD
12	T	T	I-NP	NN	B-cell_type	13	NMOD
13	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD
14	during	during	B-PP	IN	O	9	NMOD
15	a	a	B-NP	DT	O	18	NMOD
16	developing	develop	I-NP	VBG	O	18	NMOD
17	immune	immune	I-NP	JJ	O	18	NMOD
18	response	response	I-NP	NN	O	14	PMOD
19	.	.	O	.	O	5	P

1	IL-2	IL-2	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	required	require	I-VP	VBN	O	2	VC
4	not	not	B-CONJP	RB	O	13	VMOD
5	only	only	I-CONJP	RB	O	4	DEP
6	for	for	B-PP	IN	O	4	PMOD
7	cell	cell	B-NP	NN	O	9	NMOD
8	cycle	cycle	I-NP	NN	O	9	NMOD
9	progression	progression	I-NP	NN	O	6	PMOD
10	but	but	B-CONJP	CC	O	4	PMOD
11	also	also	I-CONJP	RB	O	10	DEP
12	to	to	B-VP	TO	O	13	VMOD
13	protect	protect	I-VP	VB	O	3	VMOD
14	Ag-activated	Ag-activated	B-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	OBJ
17	from	from	B-PP	IN	O	13	VMOD
18	programmed	program	B-NP	VBN	O	20	NMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	death	death	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	16	VMOD
2	several	several	B-NP	JJ	O	4	NMOD
3	cell	cell	I-NP	NN	O	4	NMOD
4	types	type	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	16	P
6	activation	activation	B-NP	NN	O	16	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	12	NMOD
10	and/or	and/or	O	CC	O	12	NMOD
11	activating	activate	B-VP	VBG	B-protein	12	NMOD
12	protein-1	protein-1	B-NP	NN	I-protein	7	PMOD
13	(	(	O	(	O	14	P
14	AP-1	AP-1	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	has	have	B-VP	VBZ	O	0	ROOT
17	been	be	I-VP	VBN	O	16	VC
18	demonstrated	demonstrate	I-VP	VBN	O	17	VC
19	to	to	I-VP	TO	O	20	VMOD
20	be	be	I-VP	VB	O	18	VMOD
21	extremely	extremely	B-ADJP	RB	O	22	AMOD
22	important	important	I-ADJP	JJ	O	20	PRD
23	in	in	B-PP	IN	O	22	AMOD
24	blocking	block	B-VP	VBG	O	23	PMOD
25	apoptosis	apoptosis	B-NP	NN	O	24	OBJ
26	.	.	O	.	O	16	P

1	To	To	B-VP	TO	O	2	VMOD
2	determine	determine	I-VP	VB	O	0	ROOT
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	either	either	B-NP	DT	O	6	NMOD
5	or	or	I-NP	CC	O	6	NMOD
6	both	both	I-NP	DT	O	11	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	10	NMOD
9	transcription	transcription	I-NP	NN	B-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	7	PMOD
11	are	be	B-VP	VBP	O	3	SBAR
12	involved	involve	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	cell	cell	B-NP	NN	O	15	NMOD
15	survival	survival	I-NP	NN	O	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	cell	cell	B-NP	NN	O	19	NMOD
18	cycle	cycle	I-NP	NN	O	19	NMOD
19	progression	progression	I-NP	NN	O	13	PMOD
20	in	in	B-PP	IN	O	12	VMOD
21	response	response	I-PP	NN	O	20	PMOD
22	to	to	I-PP	TO	O	21	NMOD
23	IL-2	IL-2	B-NP	NN	B-protein	28	NMOD
24	,	,	O	,	O	28	P
25	primary	primary	B-NP	JJ	B-cell_type	28	NMOD
26	human	human	I-NP	JJ	I-cell_type	28	NMOD
27	T	T	I-NP	NN	I-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
29	responsive	responsive	B-ADJP	JJ	O	28	NMOD
30	to	to	B-PP	TO	O	29	AMOD
31	the	the	B-NP	DT	O	33	NMOD
32	growth	growth	I-NP	NN	B-protein	33	NMOD
33	factor	factor	I-NP	NN	I-protein	30	PMOD
34	were	be	B-VP	VBD	O	11	VMOD
35	analyzed	analyze	I-VP	VBN	O	34	VC
36	for	for	B-PP	IN	O	35	VMOD
37	NF-kappa	NF-kappa	B-NP	NN	B-protein	38	NMOD
38	B	B	I-NP	NN	I-protein	40	NMOD
39	and	and	O	CC	O	40	NMOD
40	AP-1	AP-1	B-NP	NN	B-protein	41	NMOD
41	activation	activation	B-NP	NN	O	36	PMOD
42	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	current	current	I-NP	JJ	O	3	NMOD
3	study	study	I-NP	NN	O	5	SUB
4	clearly	clearly	B-ADVP	RB	O	5	VMOD
5	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	IL-2	IL-2	B-NP	NN	B-protein	8	SUB
8	does	do	B-VP	VBZ	O	6	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	induce	induce	I-VP	VB	O	8	VC
11	I	I	B-NP	NN	B-protein	14	NMOD
12	kappa	kappa	I-NP	NN	I-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	15	NMOD
15	degradation	degradation	I-NP	NN	O	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	NF-kappa	NF-kappa	B-NP	NN	B-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	activation	activation	I-NP	NN	O	10	OBJ
20	in	in	B-PP	IN	O	19	NMOD
21	primary	primary	B-NP	JJ	B-cell_type	24	NMOD
22	human	human	I-NP	JJ	I-cell_type	24	NMOD
23	T	T	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
25	that	that	B-NP	WDT	O	24	NMOD
26	respond	respond	B-VP	VBP	O	25	SBAR
27	to	to	B-PP	TO	O	26	VMOD
28	IL-2	IL-2	B-NP	NN	B-protein	27	PMOD
29	by	by	B-PP	IN	O	26	VMOD
30	entering	enter	B-VP	VBG	O	29	PMOD
31	the	the	B-NP	DT	O	33	NMOD
32	cell	cell	I-NP	NN	O	33	NMOD
33	cycle	cycle	I-NP	NN	O	30	OBJ
34	and	and	O	CC	O	30	VMOD
35	avoiding	avoid	B-VP	VBG	O	30	VMOD
36	apoptosis	apoptosis	B-NP	NN	O	35	OBJ
37	.	.	O	.	O	5	P

1	Similarly	Similarly	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	IL-2	IL-2	B-NP	NN	B-protein	5	SUB
4	neither	neither	O	CC	O	5	VMOD
5	activates	activate	B-VP	VBZ	O	0	ROOT
6	JNK	JNK	B-NP	NN	B-protein	5	OBJ
7	nor	nor	O	CC	O	5	VMOD
8	increases	increase	B-VP	VBZ	O	5	VMOD
9	AP-1	AP-1	B-NP	NN	B-protein	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	activity	activity	I-NP	NN	O	8	OBJ
12	to	to	B-PP	TO	O	11	NMOD
13	a	a	B-NP	DT	O	21	NMOD
14	consensus	consensus	I-NP	NN	B-DNA	21	NMOD
15	o-tetradecanoylphorbol	o-tetradecanoylphorbol	I-NP	NN	I-DNA	21	NMOD
16	13-acetate	13-acetate	I-NP	NN	I-DNA	21	NMOD
17	(	(	O	(	I-DNA	21	P
18	TPA	TPA	B-NP	NN	I-DNA	21	NMOD
19	)	)	O	)	I-DNA	21	P
20	response	response	B-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	12	PMOD
22	.	.	O	.	O	5	P

1	On	On	B-PP	IN	O	9	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	other	other	I-NP	JJ	O	4	NMOD
4	hand	hand	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	9	P
6	the	the	B-NP	DT	O	8	NMOD
7	growth	growth	I-NP	NN	B-protein	8	NMOD
8	factor	factor	I-NP	NN	I-protein	9	SUB
9	does	do	B-VP	VBZ	O	0	ROOT
10	induce	induce	I-VP	VB	O	9	VC
11	the	the	B-NP	DT	O	12	NMOD
12	activation	activation	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	STAT3	STAT3	B-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	STAT5	STAT5	I-NP	NN	B-protein	13	PMOD
17	in	in	B-PP	IN	O	12	NMOD
18	these	these	B-NP	DT	O	19	NMOD
19	cells	cell	I-NP	NNS	O	17	PMOD
20	,	,	O	,	O	9	P
21	as	as	B-SBAR	IN	O	9	VMOD
22	has	have	B-VP	VBZ	O	21	SBAR
23	been	be	I-VP	VBN	O	22	VC
24	previously	previously	I-VP	RB	O	23	VMOD
25	demonstrated	demonstrate	I-VP	VBN	O	23	VC
26	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	neither	neither	O	CC	O	10	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	9	NMOD
8	nor	nor	O	CC	O	9	NMOD
9	AP-1	AP-1	B-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	4	SBAR
12	required	require	I-VP	VBN	O	11	VC
13	for	for	B-PP	IN	O	12	VMOD
14	IL-2-mediated	IL-2-mediated	B-NP	JJ	O	15	NMOD
15	survival	survival	I-NP	NN	O	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	cell	cell	B-NP	NN	O	19	NMOD
18	cycle	cycle	I-NP	NN	O	19	NMOD
19	progression	progression	I-NP	NN	O	13	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	activated	activate	B-NP	VBN	B-cell_type	25	NMOD
22	primary	primary	I-NP	JJ	I-cell_type	25	NMOD
23	human	human	I-NP	JJ	I-cell_type	25	NMOD
24	T	T	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
26	.	.	O	.	O	3	P

1	Impaired	Impaired	B-NP	JJ	O	4	NMOD
2	fetal	fetal	I-NP	JJ	B-cell_type	4	NMOD
3	thymocyte	thymocyte	I-NP	NN	I-cell_type	4	NMOD
4	development	development	I-NP	NN	O	0	ROOT
5	after	after	B-PP	IN	O	4	NMOD
6	efficient	efficient	B-NP	JJ	O	8	NMOD
7	adenovirus-mediated	adenovirus-mediated	I-NP	JJ	O	8	NMOD
8	inhibition	inhibition	I-NP	NN	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
11	B	B	I-NP	NN	I-protein	12	NMOD
12	activation	activation	I-NP	NN	O	9	PMOD
13	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	introduce	introduce	B-VP	VBP	O	0	ROOT
3	a	a	B-NP	DT	O	6	NMOD
4	new	new	I-NP	JJ	O	6	NMOD
5	experimental	experimental	I-NP	JJ	O	6	NMOD
6	system	system	I-NP	NN	O	2	OBJ
7	combining	combine	B-VP	VBG	O	6	NMOD
8	adenovirus-mediated	adenovirus-mediated	B-NP	JJ	O	10	NMOD
9	gene	gene	I-NP	NN	O	10	NMOD
10	transfer	transfer	I-NP	NN	O	15	NMOD
11	and	and	O	CC	O	15	NMOD
12	fetal	fetal	B-NP	JJ	O	15	NMOD
13	thymic	thymic	I-NP	JJ	O	15	NMOD
14	organ	organ	I-NP	NN	O	15	NMOD
15	culture	culture	I-NP	NN	O	7	OBJ
16	(	(	O	(	O	17	P
17	FTOC	FTOC	B-NP	NN	B-cell_line	15	NMOD
18	)	)	O	)	O	17	P
19	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	2	NMOD
2	system	system	I-NP	NN	O	3	SUB
3	allowed	allow	B-VP	VBD	O	0	ROOT
4	us	us	B-NP	PRP	O	7	SUB
5	to	to	B-VP	TO	O	7	VMOD
6	efficiently	efficiently	I-VP	RB	O	7	VMOD
7	express	express	I-VP	VB	O	3	VMOD
8	in	in	B-PP	IN	O	7	VMOD
9	developing	develop	B-VP	VBG	O	8	PMOD
10	thymocytes	thymocyte	B-NP	NNS	B-cell_type	13	NMOD
11	a	a	B-NP	DT	O	13	NMOD
12	mutant	mutant	I-NP	JJ	O	13	NMOD
13	form	form	I-NP	NN	O	9	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	22	NMOD
16	NF-kappa	NF-kappa	I-NP	NN	B-protein	22	NMOD
17	B	B	I-NP	NN	I-protein	22	NMOD
18	inhibitor	inhibitor	I-NP	NN	O	22	NMOD
19	I	I	I-NP	NN	B-protein	22	NMOD
20	kappa	kappa	I-NP	NN	I-protein	22	NMOD
21	B	B	I-NP	NN	I-protein	22	NMOD
22	alpha	alpha	I-NP	NN	I-protein	14	PMOD
23	(	(	O	(	O	26	P
24	mut-I	mut-I	B-NP	NN	B-protein	26	NMOD
25	kappa	kappa	I-NP	NN	I-protein	26	NMOD
26	B	B	I-NP	NN	I-protein	22	NMOD
27	)	)	O	)	O	26	P
28	and	and	O	CC	O	7	VMOD
29	to	to	B-VP	TO	O	30	VMOD
30	study	study	I-VP	VB	O	7	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	maturation	maturation	I-NP	NN	O	33	NMOD
33	defects	defect	I-NP	NNS	O	30	OBJ
34	occurring	occur	B-VP	VBG	O	33	NMOD
35	when	when	B-ADVP	WRB	O	34	VMOD
36	NF-kappa	NF-kappa	B-NP	NN	B-protein	38	NMOD
37	B	B	I-NP	NN	I-protein	38	NMOD
38	activation	activation	I-NP	NN	O	39	SUB
39	is	be	B-VP	VBZ	O	35	SBAR
40	inhibited	inhibit	I-VP	VBN	O	39	VC
41	during	during	B-PP	IN	O	40	VMOD
42	fetal	fetal	B-NP	JJ	O	43	NMOD
43	development	development	I-NP	NN	O	41	PMOD
44	.	.	O	.	O	3	P

1	Fetal	Fetal	B-NP	JJ	B-cell_type	2	NMOD
2	thymocytes	thymocyte	I-NP	NNS	I-cell_type	10	SUB
3	infected	infect	B-VP	VBN	O	2	NMOD
4	with	with	B-PP	IN	O	3	VMOD
5	adenovirus	adenovirus	B-NP	NN	O	4	PMOD
6	containing	contain	B-VP	VBG	O	5	NMOD
7	mut-I	mut-I	B-NP	NN	B-protein	9	NMOD
8	kappa	kappa	I-NP	NN	I-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	6	OBJ
10	were	be	B-VP	VBD	O	0	ROOT
11	found	find	I-VP	VBN	O	10	VC
12	to	to	I-VP	TO	O	13	VMOD
13	develop	develop	I-VP	VB	O	11	VMOD
14	normally	normally	B-ADVP	RB	O	13	VMOD
15	until	until	B-SBAR	IN	O	13	VMOD
16	the	the	B-NP	DT	O	21	NMOD
17	CD44-CD25+	CD44-CD25+	I-NP	JJ	O	21	NMOD
18	,	,	I-NP	,	O	21	P
19	CD4-CD8-	CD4-CD8-	I-NP	JJ	O	21	NMOD
20	double-negative	double-negative	I-NP	JJ	O	21	NMOD
21	stage	stage	I-NP	NN	O	15	SBAR
22	,	,	O	,	O	21	P
23	while	while	B-SBAR	IN	O	21	VMOD
24	production	production	B-NP	NN	O	32	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	more	more	B-NP	RBR	O	27	AMOD
27	mature	mature	I-NP	JJ	O	31	NMOD
28	double-positive	double-positive	I-NP	JJ	O	30	AMOD
29	and	and	I-NP	CC	O	30	AMOD
30	single-positive	single-positive	I-NP	JJ	O	31	NMOD
31	populations	population	I-NP	NNS	O	25	PMOD
32	was	be	B-VP	VBD	O	23	SBAR
33	strongly	strongly	I-VP	RB	O	32	VMOD
34	decreased	decrease	I-VP	VBN	O	32	VC
35	.	.	O	.	O	10	P

1	Proliferation	Proliferation	B-NP	NN	O	12	SUB
2	,	,	O	,	O	1	P
3	as	as	B-SBAR	IN	O	1	NMOD
4	measured	measure	B-VP	VBN	O	3	SBAR
5	by	by	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	percentage	percentage	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	cells	cell	B-NP	NNS	O	8	PMOD
10	in	in	B-PP	IN	O	7	NMOD
11	cycle	cycle	B-NP	NN	O	10	PMOD
12	appeared	appear	B-VP	VBD	O	0	ROOT
13	normal	normal	B-ADJP	JJ	O	12	PRD
14	,	,	O	,	O	12	P
15	as	as	B-SBAR	IN	O	12	VMOD
16	did	do	O	VBD	O	15	DEP
17	rearrangement	rearrangement	B-NP	NN	O	19	NMOD
18	and	and	O	CC	O	19	NMOD
19	expression	expression	B-NP	NN	O	16	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	TCR	TCR	I-NP	NN	B-protein	23	NMOD
23	beta-chain	beta-chain	I-NP	NN	I-protein	20	PMOD
24	.	.	O	.	O	12	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	apoptosis	apoptosis	B-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	much	much	B-ADJP	RB	O	6	AMOD
6	higher	high	I-ADJP	JJR	O	4	PRD
7	in	in	B-PP	IN	O	4	VMOD
8	FTOC	FTOC	B-NP	NN	O	7	PMOD
9	infected	infect	B-VP	VBN	O	8	NMOD
10	with	with	B-PP	IN	O	9	VMOD
11	adenovirus	adenovirus	B-NP	NN	O	10	PMOD
12	containing	contain	B-VP	VBG	O	11	NMOD
13	mut-I	mut-I	B-NP	NN	B-protein	15	NMOD
14	kappa	kappa	I-NP	NN	I-protein	15	NMOD
15	B	B	I-NP	NN	I-protein	12	OBJ
16	than	than	B-PP	IN	O	12	VMOD
17	in	in	B-PP	IN	O	16	PMOD
18	FTOC	FTOC	B-NP	NN	O	17	PMOD
19	infected	infect	B-VP	VBN	O	18	NMOD
20	with	with	B-PP	IN	O	19	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	control	control	I-NP	NN	O	23	NMOD
23	virus	virus	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	4	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	results	result	I-NP	NNS	O	6	SUB
6	suggest	suggest	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	10	SUB
10	plays	play	B-VP	VBZ	O	7	SBAR
11	a	a	B-NP	DT	O	13	NMOD
12	crucial	crucial	I-NP	JJ	O	13	NMOD
13	role	role	I-NP	NN	O	10	OBJ
14	in	in	B-PP	IN	O	10	VMOD
15	ensuring	ensure	B-VP	VBG	O	14	PMOD
16	the	the	B-NP	DT	O	19	NMOD
17	differentiation	differentiation	I-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	survival	survival	I-NP	NN	O	15	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	thymocytes	thymocyte	B-NP	NNS	B-cell_type	20	PMOD
22	in	in	B-PP	IN	O	15	VMOD
23	the	the	B-NP	DT	O	25	NMOD
24	early	early	I-NP	JJ	O	25	NMOD
25	stages	stage	I-NP	NNS	O	22	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	their	their	B-NP	PRP$	O	28	NMOD
28	development	development	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	6	P

1	Differential	Differential	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	4E-BP1	4E-BP1	B-NP	NN	B-protein	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	4E-BP2	4E-BP2	I-NP	NN	B-protein	9	NMOD
7	,	,	O	,	O	9	P
8	two	two	B-NP	CD	O	9	NMOD
9	repressors	repressor	I-NP	NNS	O	3	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	translation	translation	B-NP	NN	O	12	NMOD
12	initiation	initiation	I-NP	NN	O	10	PMOD
13	,	,	O	,	O	2	P
14	during	during	B-PP	IN	O	2	NMOD
15	human	human	B-NP	JJ	B-cell_type	18	NMOD
16	myeloid	myeloid	I-NP	JJ	I-cell_type	18	NMOD
17	cell	cell	I-NP	NN	I-cell_type	18	NMOD
18	differentiation	differentiation	I-NP	NN	O	14	PMOD
19	.	.	O	.	O	2	P

1	Human	Human	B-NP	JJ	O	3	NMOD
2	myeloid	myeloid	I-NP	JJ	O	3	NMOD
3	differentiation	differentiation	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	accompanied	accompany	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	8	NMOD
8	decrease	decrease	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	cell	cell	B-NP	NN	O	11	NMOD
11	proliferation	proliferation	I-NP	NN	O	9	PMOD
12	.	.	O	.	O	4	P

1	Because	Because	B-SBAR	IN	O	14	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	translation	translation	I-NP	NN	O	4	NMOD
4	rate	rate	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	1	SBAR
6	an	an	B-NP	DT	O	8	NMOD
7	important	important	I-NP	JJ	O	8	NMOD
8	determinant	determinant	I-NP	NN	O	5	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	cell	cell	B-NP	NN	O	11	NMOD
11	proliferation	proliferation	I-NP	NN	O	9	PMOD
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	have	have	B-VP	VBP	O	0	ROOT
15	investigated	investigate	I-VP	VBN	O	14	VC
16	translation	translation	B-NP	NN	O	17	NMOD
17	initiation	initiation	I-NP	NN	O	15	OBJ
18	during	during	B-PP	IN	O	17	NMOD
19	human	human	B-NP	JJ	B-cell_type	22	NMOD
20	myeloid	myeloid	I-NP	JJ	I-cell_type	22	NMOD
21	cell	cell	I-NP	NN	I-cell_type	22	NMOD
22	differentiation	differentiation	I-NP	NN	O	18	PMOD
23	using	use	B-VP	VBG	O	22	NMOD
24	the	the	B-NP	DT	O	29	NMOD
25	HL-60	HL-60	I-NP	NN	B-cell_line	29	NMOD
26	promyelocytic	promyelocytic	I-NP	JJ	I-cell_line	29	NMOD
27	leukemia	leukemia	I-NP	NN	I-cell_line	29	NMOD
28	cell	cell	I-NP	NN	I-cell_line	29	NMOD
29	line	line	I-NP	NN	I-cell_line	35	NMOD
30	and	and	O	CC	O	35	NMOD
31	the	the	B-NP	DT	O	35	NMOD
32	U-937	U-937	I-NP	NN	B-cell_line	35	NMOD
33	monoblastic	monoblastic	I-NP	JJ	I-cell_line	35	NMOD
34	cell	cell	I-NP	NN	I-cell_line	35	NMOD
35	line	line	I-NP	NN	I-cell_line	23	OBJ
36	.	.	O	.	O	14	P

1	A	A	B-NP	DT	O	2	NMOD
2	decrease	decrease	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	translation	translation	I-NP	NN	O	6	NMOD
6	rate	rate	I-NP	NN	O	3	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	observed	observe	I-VP	VBN	O	7	VC
9	when	when	B-ADVP	WRB	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	cells	cell	I-NP	NNS	O	12	SUB
12	are	be	B-VP	VBP	O	9	SBAR
13	induced	induce	I-VP	VBN	O	12	VC
14	to	to	I-VP	TO	O	15	VMOD
15	differentiate	differentiate	I-VP	VB	O	13	VMOD
16	along	along	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	monocytic/macrophage	monocytic/macrophage	I-NP	NN	O	19	NMOD
19	pathway	pathway	I-NP	NN	O	16	PMOD
20	or	or	B-PP	CC	O	16	PMOD
21	along	along	B-PP	IN	O	16	PMOD
22	the	the	B-NP	DT	O	24	NMOD
23	granulocytic	granulocytic	I-NP	JJ	O	24	NMOD
24	pathway	pathway	I-NP	NN	O	21	PMOD
25	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	inhibition	inhibition	I-NP	NN	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	protein	protein	B-NP	NN	O	5	NMOD
5	synthesis	synthesis	I-NP	NN	O	3	PMOD
6	correlates	correlate	B-VP	VBZ	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	specific	specific	B-NP	JJ	O	9	NMOD
9	regulation	regulation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	two	two	B-NP	CD	O	12	NMOD
12	repressors	repressor	I-NP	NNS	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	translation	translation	B-NP	NN	O	15	NMOD
15	initiation	initiation	I-NP	NN	O	19	NMOD
16	,	,	O	,	O	19	P
17	4E-BP1	4E-BP1	B-NP	NN	B-protein	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	4E-BP2	4E-BP2	I-NP	NN	B-protein	13	PMOD
20	.	.	O	.	O	6	P

1	Induction	Induction	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	HL-60	HL-60	B-NP	NN	B-cell_line	7	NMOD
4	and	and	I-NP	CC	O	7	NMOD
5	U-937	U-937	I-NP	NN	B-cell_line	7	NMOD
6	cell	cell	I-NP	NN	I-cell_line	7	NMOD
7	differentiation	differentiation	I-NP	NN	O	2	PMOD
8	into	into	B-PP	IN	O	1	NMOD
9	monocytes/macrophages	monocytes/macrophage	B-NP	NNS	B-cell_type	8	PMOD
10	by	by	B-PP	IN	O	1	NMOD
11	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	13	NMOD
12	or	or	I-NP	CC	O	13	NMOD
13	PMA	PMA	I-NP	NN	O	10	PMOD
14	results	result	B-VP	VBZ	O	0	ROOT
15	in	in	B-PP	IN	O	14	VMOD
16	a	a	B-NP	DT	O	20	NMOD
17	dephosphorylation	dephosphorylation	I-NP	NN	O	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	consequent	consequent	B-NP	JJ	O	20	NMOD
20	activation	activation	I-NP	NN	O	15	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	4E-BP1	4E-BP1	B-NP	NN	B-protein	21	PMOD
23	.	.	O	.	O	14	P

1	Dephosphorylation	Dephosphorylation	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	4E-BP1	4E-BP1	B-NP	NN	B-protein	2	PMOD
4	was	be	B-VP	VBD	O	0	ROOT
5	also	also	I-VP	RB	O	4	VMOD
6	observed	observe	I-VP	VBN	O	4	VC
7	when	when	B-ADVP	WRB	O	6	VMOD
8	U-937	U-937	B-NP	NN	B-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	10	SUB
10	were	be	B-VP	VBD	O	7	SBAR
11	induced	induce	I-VP	VBN	O	10	VC
12	to	to	I-VP	TO	O	13	VMOD
13	differentiate	differentiate	I-VP	VB	O	11	VMOD
14	into	into	B-PP	IN	O	13	VMOD
15	monocytes/macrophages	monocytes/macrophage	B-NP	NNS	B-cell_type	14	PMOD
16	following	follow	B-PP	VBG	O	13	VMOD
17	treatment	treatment	B-NP	NN	O	16	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	retinoic	retinoic	B-NP	JJ	O	20	NMOD
20	acid	acid	I-NP	NN	O	22	NMOD
21	or	or	I-NP	CC	O	22	NMOD
22	DMSO	DMSO	I-NP	NN	O	18	PMOD
23	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	24	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	24	P
4	treatment	treatment	B-NP	NN	O	24	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	HL-60	HL-60	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
8	with	with	B-PP	IN	O	4	NMOD
9	retinoic	retinoic	B-NP	JJ	O	10	NMOD
10	acid	acid	I-NP	NN	O	12	NMOD
11	or	or	O	CC	O	12	NMOD
12	DMSO	DMSO	B-NP	NN	O	8	PMOD
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	results	result	B-VP	VBZ	O	14	SBAR
16	in	in	B-PP	IN	O	15	VMOD
17	a	a	B-NP	DT	O	19	NMOD
18	granulocytic	granulocytic	I-NP	JJ	O	19	NMOD
19	differentiation	differentiation	I-NP	NN	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	these	these	B-NP	DT	O	22	NMOD
22	cells	cell	I-NP	NNS	O	20	PMOD
23	,	,	O	,	O	4	P
24	decreases	decrease	B-VP	VBZ	O	0	ROOT
25	4E-BP1	4E-BP1	B-NP	NN	B-protein	26	NMOD
26	amount	amount	I-NP	NN	O	24	OBJ
27	without	without	B-PP	IN	O	24	VMOD
28	affecting	affect	B-VP	VBG	O	27	PMOD
29	its	its	B-NP	PRP$	O	30	NMOD
30	phosphorylation	phosphorylation	I-NP	NN	O	28	OBJ
31	and	and	O	CC	O	24	VMOD
32	strongly	strongly	B-VP	RB	O	24	VMOD
33	increases	increase	I-VP	VBZ	O	24	VMOD
34	4E-BP2	4E-BP2	B-NP	NN	B-protein	35	NMOD
35	amount	amount	I-NP	NN	O	33	OBJ
36	.	.	O	.	O	24	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	data	datum	I-NP	NNS	O	6	SUB
6	provide	provide	B-VP	VBP	O	0	ROOT
7	evidence	evidence	B-NP	NN	O	6	OBJ
8	for	for	B-PP	IN	O	7	NMOD
9	differential	differential	B-NP	JJ	O	10	NMOD
10	regulation	regulation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	translational	translational	I-NP	JJ	O	14	NMOD
14	machinery	machinery	I-NP	NN	O	11	PMOD
15	during	during	B-PP	IN	O	10	NMOD
16	human	human	B-NP	JJ	O	18	NMOD
17	myeloid	myeloid	I-NP	JJ	O	18	NMOD
18	differentiation	differentiation	I-NP	NN	O	15	PMOD
19	,	,	O	,	O	10	P
20	specific	specific	B-ADJP	JJ	O	10	NMOD
21	to	to	B-PP	TO	O	20	AMOD
22	the	the	B-NP	DT	O	24	NMOD
23	monocytic/macrophage	monocytic/macrophage	I-NP	NN	O	24	NMOD
24	pathway	pathway	I-NP	NN	O	21	PMOD
25	or	or	B-PP	CC	O	21	PMOD
26	to	to	B-PP	TO	O	21	PMOD
27	the	the	B-NP	DT	O	29	NMOD
28	granulocytic	granulocytic	I-NP	JJ	O	29	NMOD
29	pathway	pathway	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	6	P

1	Stimulation	Stimulation	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	CD40	CD40	B-NP	NN	B-protein	2	PMOD
4	on	on	B-PP	IN	O	1	NMOD
5	immunogenic	immunogenic	B-NP	JJ	O	8	NMOD
6	human	human	I-NP	JJ	O	8	NMOD
7	malignant	malignant	I-NP	JJ	O	8	NMOD
8	melanomas	melanoma	I-NP	NNS	O	4	PMOD
9	augments	augment	B-VP	VBZ	O	0	ROOT
10	their	their	B-NP	PRP$	O	14	NMOD
11	cytotoxic	cytotoxic	I-NP	JJ	O	14	NMOD
12	T	T	I-NP	NN	O	14	NMOD
13	lymphocyte-mediated	lymphocyte-mediated	I-NP	JJ	O	14	NMOD
14	lysis	lysis	I-NP	NN	O	9	OBJ
15	and	and	O	CC	O	9	VMOD
16	induces	induce	B-VP	VBZ	O	9	VMOD
17	apoptosis	apoptosis	B-NP	NN	O	16	OBJ
18	.	.	O	.	O	9	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	report	report	B-VP	VBP	O	0	ROOT
5	the	the	B-NP	DT	O	7	NMOD
6	functional	functional	I-NP	JJ	O	7	NMOD
7	expression	expression	I-NP	NN	O	4	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	CD40	CD40	B-NP	NN	B-protein	8	PMOD
10	on	on	B-PP	IN	O	7	NMOD
11	human	human	B-NP	JJ	O	13	NMOD
12	malignant	malignant	I-NP	JJ	O	13	NMOD
13	melanomas	melanoma	I-NP	NNS	O	10	PMOD
14	(	(	O	(	O	15	P
15	MMs	MM	B-NP	NNS	O	13	NMOD
16	)	)	O	)	O	15	P
17	.	.	O	.	O	4	P

1	Comparison	Comparison	B-NP	NN	O	15	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	tumor	tumor	B-NP	NN	O	4	NMOD
4	specimen	specimen	I-NP	NN	O	2	PMOD
5	from	from	B-PP	IN	O	1	NMOD
6	MM	MM	B-NP	NN	O	8	NMOD
7	precursor	precursor	I-NP	NN	O	8	NMOD
8	lesions	lesion	I-NP	NNS	O	14	NMOD
9	,	,	O	,	O	14	P
10	primary	primary	B-NP	JJ	O	11	NMOD
11	tumors	tumor	I-NP	NNS	O	14	NMOD
12	,	,	O	,	O	14	P
13	and	and	O	CC	O	14	NMOD
14	metastases	metastasis	B-NP	NNS	O	5	PMOD
15	revealed	reveal	B-VP	VBD	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	CD40	CD40	B-NP	NN	B-protein	19	NMOD
18	surface	surface	I-NP	NN	O	19	NMOD
19	expression	expression	I-NP	NN	O	20	SUB
20	is	be	B-VP	VBZ	O	16	SBAR
21	down-regulated	down-regulate	I-VP	VBN	O	20	VC
22	during	during	B-PP	IN	O	21	VMOD
23	tumor	tumor	B-NP	NN	O	24	NMOD
24	progression	progression	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	15	P

1	CD40	CD40	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	19	VMOD
4	confirmed	confirm	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	7	7	B-NP	CD	O	10	NMOD
7	human	human	I-NP	JJ	B-cell_line	10	NMOD
8	MM	MM	I-NP	NN	I-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	lines	line	I-NP	NNS	I-cell_line	5	PMOD
11	established	establish	B-VP	VBN	O	10	NMOD
12	from	from	B-PP	IN	O	11	VMOD
13	immunogenic	immunogenic	B-NP	JJ	O	15	NMOD
14	primary	primary	I-NP	JJ	O	15	NMOD
15	tumors	tumor	I-NP	NNS	O	17	NMOD
16	or	or	I-NP	CC	O	17	NMOD
17	metastases	metastasis	I-NP	NNS	O	12	PMOD
18	,	,	O	,	O	19	P
19	whereas	whereas	O	IN	O	0	ROOT
20	11	11	B-NP	CD	O	22	NMOD
21	cell	cell	I-NP	NN	B-cell_line	22	NMOD
22	lines	line	I-NP	NNS	I-cell_line	27	SUB
23	established	establish	B-VP	VBN	O	22	NMOD
24	from	from	B-PP	IN	O	23	VMOD
25	advanced	advance	B-NP	VBN	O	26	NMOD
26	stages	stage	I-NP	NNS	O	24	PMOD
27	were	be	B-VP	VBD	O	19	VMOD
28	CD40	CD40	B-ADJP	NN	B-protein	27	PRD
29	negative	negative	I-ADJP	JJ	O	28	AMOD
30	.	.	O	.	O	19	P

1	CD40	CD40	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	be	be	I-VP	VB	O	3	VC
5	enhanced	enhance	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	CD40-positive	CD40-positive	B-NP	JJ	O	8	NMOD
8	MM	MM	I-NP	NN	O	6	PMOD
9	by	by	B-PP	IN	O	5	VMOD
10	stimulation	stimulation	B-NP	NN	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	tumor	tumor	B-NP	NN	B-protein	16	NMOD
15	necrosis	necrosis	I-NP	NN	I-protein	16	NMOD
16	factor-alpha	factor-alpha	I-NP	NN	I-protein	11	PMOD
17	but	but	B-PP	CC	O	11	PMOD
18	not	not	B-PP	RB	O	19	PMOD
19	by	by	I-PP	IN	O	11	PMOD
20	interleukin	interleukin	B-NP	NN	B-protein	24	NMOD
21	(	(	O	(	I-protein	22	P
22	IL	IL	B-NP	NN	I-protein	20	NMOD
23	)	)	O	)	I-protein	22	P
24	-1beta	-1beta	B-NP	NN	I-protein	27	NMOD
25	or	or	O	CC	O	27	NMOD
26	CD40	CD40	B-NP	NN	B-protein	27	NMOD
27	triggering	triggering	I-NP	NN	O	19	PMOD
28	.	.	O	.	O	3	P

1	CD40	CD40	B-NP	NN	B-protein	2	NMOD
2	ligation	ligation	I-NP	NN	O	16	SUB
3	on	on	B-PP	IN	O	2	NMOD
4	MM	MM	B-NP	NN	O	3	PMOD
5	by	by	B-PP	IN	O	4	NMOD
6	CD40L-transfected	CD40L-transfected	B-NP	JJ	B-cell_line	8	NMOD
7	murine	murine	I-NP	JJ	I-cell_line	8	NMOD
8	L-cells	L-cell	I-NP	NNS	I-cell_line	5	PMOD
9	or	or	B-PP	CC	O	3	PMOD
10	by	by	B-PP	IN	O	3	PMOD
11	a	a	B-NP	DT	O	15	NMOD
12	soluble	soluble	I-NP	JJ	O	15	NMOD
13	CD40L	CD40L	I-NP	NN	B-protein	15	NMOD
14	fusion	fusion	I-NP	NN	I-protein	15	NMOD
15	protein	protein	I-NP	NN	I-protein	10	PMOD
16	up-regulated	up-regulate	B-VP	VBD	O	0	ROOT
17	their	their	B-NP	PRP$	O	18	NMOD
18	expression	expression	I-NP	NN	O	33	NMOD
19	of	of	B-PP	IN	O	18	NMOD
20	intercellular	intercellular	B-NP	JJ	B-protein	22	NMOD
21	adhesion	adhesion	I-NP	NN	I-protein	22	NMOD
22	molecule-1	molecule-1	I-NP	NN	I-protein	30	NMOD
23	and	and	I-NP	CC	O	30	NMOD
24	MHC	MHC	I-NP	NN	O	25	NMOD
25	class	class	I-NP	NN	O	30	NMOD
26	I	I	I-NP	CD	O	25	NMOD
27	and	and	O	CC	O	25	NMOD
28	class	class	B-NP	NN	B-protein	30	NMOD
29	II	II	B-NP	CD	I-protein	30	NMOD
30	molecules	molecule	I-NP	NNS	I-protein	19	PMOD
31	and	and	O	CC	O	33	NMOD
32	their	their	B-NP	PRP$	O	33	NMOD
33	secretion	secretion	I-NP	NN	O	16	OBJ
34	of	of	B-PP	IN	O	33	NMOD
35	IL-6	IL-6	B-NP	NN	B-protein	47	NMOD
36	,	,	O	,	O	47	P
37	IL-8	IL-8	B-NP	NN	B-protein	47	NMOD
38	,	,	O	,	O	47	P
39	tumor	tumor	B-NP	NN	B-protein	41	NMOD
40	necrosis	necrosis	I-NP	NN	I-protein	41	NMOD
41	factor-a	factor-a	I-NP	NN	I-protein	47	NMOD
42	,	,	O	,	O	47	P
43	and	and	O	CC	O	47	NMOD
44	granulocyte	granulocyte	B-NP	NN	B-protein	47	NMOD
45	macrophage	macrophage	B-NP	NN	I-protein	47	NMOD
46	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	47	NMOD
47	factor	factor	I-NP	NN	I-protein	34	PMOD
48	and	and	O	CC	O	16	VMOD
49	also	also	B-VP	RB	O	16	VMOD
50	induced	induce	I-VP	VBD	O	16	VMOD
51	a	a	B-NP	DT	O	53	NMOD
52	rapid	rapid	I-NP	JJ	O	53	NMOD
53	activation	activation	I-NP	NN	O	50	OBJ
54	of	of	B-PP	IN	O	53	NMOD
55	the	the	B-NP	DT	O	57	NMOD
56	transcription	transcription	I-NP	NN	B-protein	57	NMOD
57	factor	factor	I-NP	NN	I-protein	60	NMOD
58	nuclear	nuclear	B-NP	JJ	B-protein	60	NMOD
59	factor	factor	I-NP	NN	I-protein	60	NMOD
60	kappaB	kappaB	I-NP	NN	I-protein	54	PMOD
61	.	.	O	.	O	16	P

1	Furthermore	Furthermore	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	CD40	CD40	B-NP	NN	B-protein	4	NMOD
4	ligation	ligation	I-NP	NN	O	13	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	12	NMOD
7	HLA-A2+	HLA-A2+	I-NP	JJ	B-cell_line	9	AMOD
8	,	,	I-NP	,	I-cell_line	9	P
9	MelanA/MART1+	MelanA/MART1+	I-NP	JJ	I-cell_line	12	NMOD
10	MM	MM	I-NP	NN	I-cell_line	12	NMOD
11	cell	cell	I-NP	NN	I-cell_line	12	NMOD
12	line	line	I-NP	NN	I-cell_line	5	PMOD
13	enhanced	enhance	B-VP	VBD	O	0	ROOT
14	its	its	B-NP	PRP$	O	15	NMOD
15	susceptibility	susceptibility	I-NP	NN	O	13	OBJ
16	to	to	B-PP	TO	O	15	NMOD
17	specific	specific	B-NP	JJ	O	18	NMOD
18	lysis	lysis	I-NP	NN	O	16	PMOD
19	by	by	B-PP	IN	O	18	NMOD
20	a	a	B-NP	DT	O	25	NMOD
21	HLA-A2-restricted	HLA-A2-restricted	I-NP	JJ	B-cell_line	23	AMOD
22	,	,	I-NP	,	I-cell_line	23	P
23	MelanA/MART-1-specific	MelanA/MART-1-specific	I-NP	JJ	I-cell_line	25	NMOD
24	CTL	CTL	I-NP	NN	I-cell_line	25	NMOD
25	clone	clone	I-NP	NN	I-cell_line	19	PMOD
26	.	.	O	.	O	13	P

1	Finally	Finally	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	CD40	CD40	B-NP	NN	B-protein	4	NMOD
4	ligation	ligation	I-NP	NN	O	5	SUB
5	induced	induce	B-VP	VBD	O	0	ROOT
6	growth	growth	B-NP	NN	O	7	NMOD
7	inhibition	inhibition	I-NP	NN	O	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	apoptosis	apoptosis	I-NP	NN	O	5	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	MM	MM	B-NP	NN	O	10	PMOD
12	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	CD40-CD40L	CD40-CD40L	B-NP	NN	O	6	NMOD
6	interactions	interaction	I-NP	NNS	O	7	SUB
7	may	may	B-VP	MD	O	4	SBAR
8	play	play	I-VP	VB	O	7	VC
9	an	an	B-NP	DT	O	11	NMOD
10	important	important	I-NP	JJ	O	11	NMOD
11	role	role	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	8	VMOD
13	augmenting	augment	B-VP	VBG	O	12	PMOD
14	antitumor	antitumor	B-NP	JJ	O	15	NMOD
15	immunity	immunity	I-NP	NN	O	13	OBJ
16	and	and	O	CC	O	13	VMOD
17	inducing	induce	B-VP	VBG	O	13	VMOD
18	apoptosis	apoptosis	B-NP	NN	O	17	OBJ
19	in	in	B-PP	IN	O	17	VMOD
20	some	some	B-NP	DT	O	24	NMOD
21	CD40-positive	CD40-positive	I-NP	JJ	B-cell_line	24	NMOD
22	immunogenic	immunogenic	I-NP	JJ	I-cell_line	24	NMOD
23	human	human	I-NP	JJ	I-cell_line	24	NMOD
24	MMs	MM	I-NP	NNS	I-cell_line	19	PMOD
25	.	.	O	.	O	3	P

1	Essential	Essential	B-NP	JJ	O	2	NMOD
2	role	role	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	alveolar	alveolar	B-NP	JJ	B-cell_type	5	NMOD
5	macrophages	macrophage	I-NP	NNS	I-cell_type	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	intrapulmonary	intrapulmonary	B-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	9	PMOD
11	.	.	O	.	O	2	P

1	Acute	Acute	B-NP	JJ	O	3	NMOD
2	inflammatory	inflammatory	I-NP	JJ	O	3	NMOD
3	injury	injury	I-NP	NN	O	15	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	rat	rat	B-NP	NN	O	6	NMOD
6	lung	lung	I-NP	NN	O	4	PMOD
7	induced	induce	B-VP	VBN	O	3	NMOD
8	by	by	B-PP	IN	O	7	VMOD
9	deposition	deposition	B-NP	NN	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	immunoglobulin	immunoglobulin	B-NP	NN	B-protein	14	NMOD
12	G	G	I-NP	NN	I-protein	14	NMOD
13	immune	immune	I-NP	JJ	I-protein	14	NMOD
14	complexes	complex	I-NP	NNS	I-protein	10	PMOD
15	requires	require	B-VP	VBZ	O	0	ROOT
16	expression	expression	B-NP	NN	O	24	NMOD
17	of	of	B-PP	IN	O	16	NMOD
18	cytokines	cytokine	B-NP	NNS	B-protein	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	chemokines	chemokine	I-NP	NNS	B-protein	17	PMOD
21	as	as	B-CONJP	RB	O	24	NMOD
22	well	well	I-CONJP	RB	O	21	DEP
23	as	as	I-CONJP	IN	O	21	DEP
24	activation	activation	B-NP	NN	O	15	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	transcription	transcription	I-NP	NN	B-protein	28	NMOD
28	factor	factor	I-NP	NN	I-protein	34	NMOD
29	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD
30	factor	factor	I-NP	NN	I-protein	34	NMOD
31	(	(	O	(	I-protein	34	P
32	NF	NF	B-NP	NN	I-protein	34	NMOD
33	)	)	O	)	I-protein	34	P
34	-kappaB	-kappaB	B-NP	NN	I-protein	25	PMOD
35	.	.	O	.	O	15	P

1	There	There	B-NP	EX	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	little	little	B-NP	JJ	O	5	NMOD
4	direct	direct	I-NP	JJ	O	5	NMOD
5	evidence	evidence	I-NP	NN	O	2	PRD
6	regarding	regard	B-VP	VBG	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	role	role	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	alveolar	alveolar	B-NP	JJ	B-cell_type	11	NMOD
11	macrophages	macrophage	I-NP	NNS	I-cell_type	9	PMOD
12	in	in	B-PP	IN	O	8	NMOD
13	these	these	B-NP	DT	O	15	NMOD
14	activation	activation	I-NP	NN	O	15	NMOD
15	events	event	I-NP	NNS	O	12	PMOD
16	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	8	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	studies	study	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	8	P
6	rat	rat	B-NP	NN	O	7	NMOD
7	lungs	lung	I-NP	NNS	O	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	depleted	deplete	I-VP	VBN	O	8	VC
10	of	of	B-PP	IN	O	9	VMOD
11	alveolar	alveolar	B-NP	JJ	B-cell_type	12	NMOD
12	macrophages	macrophage	I-NP	NNS	I-cell_type	10	PMOD
13	by	by	B-PP	IN	O	9	VMOD
14	airway	airway	B-NP	NN	O	15	NMOD
15	instillation	instillation	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	liposome-encapsulated	liposome-encapsulated	B-NP	JJ	O	19	NMOD
18	dichloromethylene	dichloromethylene	I-NP	NN	O	19	NMOD
19	diphosphonate	diphosphonate	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	procedures	procedure	I-NP	NNS	O	14	SUB
3	,	,	O	,	O	2	P
4	which	which	B-NP	WDT	O	2	NMOD
5	greatly	greatly	B-VP	RB	O	6	VMOD
6	reduced	reduce	I-VP	VBD	O	4	SBAR
7	the	the	B-NP	DT	O	8	NMOD
8	number	number	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	retrievable	retrievable	B-NP	JJ	O	12	NMOD
11	alveolar	alveolar	I-NP	JJ	B-cell_type	12	NMOD
12	macrophages	macrophage	I-NP	NNS	I-cell_type	9	PMOD
13	,	,	O	,	O	2	P
14	suppressed	suppress	B-VP	VBD	O	0	ROOT
15	activation	activation	B-NP	NN	O	14	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	lung	lung	B-NP	NN	B-protein	18	NMOD
18	NF-kappaB	NF-kappaB	I-NP	NN	I-protein	16	PMOD
19	in	in	B-PP	IN	O	15	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	inflammatory	inflammatory	I-NP	JJ	O	22	NMOD
22	model	model	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	14	P

1	In	In	B-PP	IN	O	23	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	23	P
4	bronchoalveolar	bronchoalveolar	B-NP	JJ	O	6	NMOD
5	lavage	lavage	I-NP	NN	O	6	NMOD
6	levels	level	I-NP	NNS	O	17	NMOD
7	of	of	B-PP	IN	O	6	NMOD
8	tumor	tumor	B-NP	NN	B-protein	10	NMOD
9	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD
10	factor-alpha	factor-alpha	I-NP	NN	I-protein	7	PMOD
11	(	(	O	(	O	12	P
12	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	and	and	O	CC	O	17	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	CXC	CXC	I-NP	NN	B-protein	17	NMOD
17	chemokine	chemokine	I-NP	NN	I-protein	21	NMOD
18	,	,	O	,	O	21	P
19	macrophage	macrophage	B-NP	NN	B-protein	21	NMOD
20	inflammatory	inflammatory	I-NP	JJ	I-protein	21	NMOD
21	protein-2	protein-2	I-NP	NN	I-protein	23	SUB
22	,	,	O	,	O	21	P
23	were	be	B-VP	VBD	O	0	ROOT
24	substantially	substantially	I-VP	RB	O	23	VMOD
25	reduced	reduce	I-VP	VBN	O	23	VC
26	.	.	O	.	O	23	P

1	In	In	B-PP	IN	O	16	VMOD
2	parallel	parallel	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	16	P
4	upregulation	upregulation	B-NP	NN	O	14	NMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	lung	lung	I-NP	NN	B-protein	10	NMOD
8	vascular	vascular	I-NP	JJ	I-protein	10	NMOD
9	adhesion	adhesion	I-NP	NN	I-protein	10	NMOD
10	molecule	molecule	I-NP	NN	I-protein	5	PMOD
11	,	,	O	,	O	14	P
12	intercellular	intercellular	B-NP	JJ	B-protein	14	NMOD
13	adhesion	adhesion	I-NP	NN	I-protein	14	NMOD
14	molecule-1	molecule-1	I-NP	NN	I-protein	16	SUB
15	,	,	O	,	O	14	P
16	was	be	B-VP	VBD	O	0	ROOT
17	greatly	greatly	I-VP	RB	O	16	VMOD
18	reduced	reduce	I-VP	VBN	O	16	VC
19	by	by	B-PP	IN	O	18	VMOD
20	intrapulmonary	intrapulmonary	B-NP	JJ	O	21	NMOD
21	instillation	instillation	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	phosphonate-containing	phosphonate-containing	B-NP	JJ	O	24	NMOD
24	liposomes	liposome	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	16	P

1	Neutrophil	Neutrophil	B-NP	NN	O	4	NMOD
2	accumulation	accumulation	I-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	development	development	I-NP	NN	O	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	lung	lung	B-NP	NN	O	7	NMOD
7	injury	injury	I-NP	NN	O	5	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	also	also	I-VP	RB	O	8	VMOD
10	substantially	substantially	I-VP	RB	O	8	VMOD
11	diminished	diminish	I-VP	VBN	O	8	VC
12	.	.	O	.	O	8	P

1	Lung	Lung	B-NP	NN	O	2	NMOD
2	instillation	instillation	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	alveolar	alveolar	B-NP	JJ	O	8	NMOD
7	macrophage-depleted	macrophage-depleted	I-NP	JJ	O	8	NMOD
8	rats	rat	I-NP	NNS	O	5	PMOD
9	restored	restore	B-VP	VBD	O	0	ROOT
10	the	the	B-NP	DT	O	13	NMOD
11	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	13	NMOD
12	activation	activation	I-NP	NN	O	13	NMOD
13	response	response	I-NP	NN	O	9	OBJ
14	in	in	B-PP	IN	O	13	NMOD
15	whole	whole	B-NP	JJ	O	16	NMOD
16	lung	lung	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	,	,	O	,	O	15	P
6	in	in	B-PP	IN	O	15	VMOD
7	this	this	B-NP	DT	O	9	NMOD
8	inflammatory	inflammatory	I-NP	JJ	O	9	NMOD
9	model	model	I-NP	NN	O	6	PMOD
10	,	,	O	,	O	15	P
11	initial	initial	B-NP	JJ	O	12	NMOD
12	activation	activation	I-NP	NN	O	15	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	PMOD
15	occurs	occur	B-VP	VBZ	O	4	SBAR
16	in	in	B-PP	IN	O	15	VMOD
17	alveolar	alveolar	B-NP	JJ	B-cell_type	18	NMOD
18	macrophages	macrophage	I-NP	NNS	I-cell_type	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	ensuing	ensue	I-NP	VBG	O	22	NMOD
22	production	production	I-NP	NN	O	16	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	23	PMOD
25	may	may	B-VP	MD	O	15	VMOD
26	propagate	propagate	I-VP	VB	O	25	VC
27	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	28	NMOD
28	activation	activation	I-NP	NN	O	26	OBJ
29	to	to	B-PP	TO	O	28	NMOD
30	other	other	B-NP	JJ	O	32	NMOD
31	cell	cell	I-NP	NN	O	32	NMOD
32	types	type	I-NP	NNS	O	29	PMOD
33	in	in	B-PP	IN	O	32	NMOD
34	the	the	B-NP	DT	O	35	NMOD
35	lung	lung	I-NP	NN	O	33	PMOD
36	.	.	O	.	O	3	P

1	Role	Role	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	cellular	cellular	B-NP	JJ	B-protein	8	NMOD
4	tumor	tumor	I-NP	NN	I-protein	8	NMOD
5	necrosis	necrosis	I-NP	NN	I-protein	8	NMOD
6	factor	factor	I-NP	NN	I-protein	8	NMOD
7	receptor-associated	receptor-associated	I-NP	JJ	I-protein	8	NMOD
8	factors	factor	I-NP	NNS	I-protein	2	PMOD
9	in	in	B-PP	IN	O	1	NMOD
10	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	NMOD
11	activation	activation	B-NP	NN	O	14	NMOD
12	and	and	O	CC	O	14	NMOD
13	lymphocyte	lymphocyte	B-NP	NN	O	14	NMOD
14	transformation	transformation	I-NP	NN	O	9	PMOD
15	by	by	B-PP	IN	O	1	NMOD
16	herpesvirus	herpesvirus	B-NP	NN	O	18	NMOD
17	Saimiri	Saimiri	I-NP	NN	O	18	NMOD
18	STP	STP	I-NP	NN	B-protein	15	PMOD
19	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	3	NMOD
2	STP	STP	I-NP	NN	B-protein	3	NMOD
3	oncoproteins	oncoprotein	I-NP	NNS	I-protein	20	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	herpesvirus	herpesvirus	I-NP	NN	O	7	NMOD
7	saimiri	saimiri	I-NP	NN	O	13	NMOD
8	(	(	O	(	O	9	P
9	HVS	HVS	B-NP	NN	O	7	NMOD
10	)	)	O	)	O	9	P
11	subgroup	subgroup	B-NP	NN	O	13	NMOD
12	A	A	I-NP	NN	O	13	NMOD
13	strain	strain	I-NP	NN	O	18	NMOD
14	11	11	I-NP	CD	O	13	NMOD
15	and	and	O	CC	O	13	NMOD
16	subgroup	subgroup	B-NP	NN	O	18	NMOD
17	C	C	I-NP	NN	O	18	NMOD
18	strain	strain	I-NP	NN	O	4	PMOD
19	488	488	I-NP	CD	O	18	NMOD
20	are	be	B-VP	VBP	O	0	ROOT
21	now	now	I-VP	RB	O	20	VMOD
22	found	find	I-VP	VBN	O	20	VC
23	to	to	I-VP	TO	O	24	VMOD
24	be	be	I-VP	VB	O	22	VMOD
25	stably	stably	I-VP	RB	O	24	VMOD
26	associated	associate	I-VP	VBN	O	24	VC
27	with	with	B-PP	IN	O	26	VMOD
28	tumor	tumor	B-NP	NN	B-protein	32	NMOD
29	necrosis	necrosis	I-NP	NN	I-protein	32	NMOD
30	factor	factor	I-NP	NN	I-protein	32	NMOD
31	receptor-associated	receptor-associated	I-NP	JJ	I-protein	32	NMOD
32	factor	factor	I-NP	NN	I-protein	41	NMOD
33	(	(	O	(	O	34	P
34	TRAF	TRAF	B-NP	NN	B-protein	32	NMOD
35	)	)	O	)	O	34	P
36	1	1	B-NP	CD	O	32	NMOD
37	,	,	I-NP	,	O	32	P
38	2	2	I-NP	CD	O	32	NMOD
39	,	,	O	,	O	32	P
40	or	or	O	CC	O	41	NMOD
41	3	3	B-NP	CD	O	27	PMOD
42	.	.	O	.	O	20	P

1	Mutational	Mutational	B-NP	JJ	O	2	NMOD
2	analyses	analysis	I-NP	NNS	O	3	SUB
3	identified	identify	B-VP	VBD	O	0	ROOT
4	residues	residue	B-NP	NNS	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	PXQXT/S	PXQXT/S	B-NP	NN	B-protein	5	PMOD
7	in	in	B-PP	IN	O	4	NMOD
8	STP-A11	STP-A11	B-NP	NN	B-protein	7	PMOD
9	as	as	B-PP	IN	O	3	VMOD
10	critical	critical	B-ADJP	JJ	O	9	PMOD
11	for	for	B-PP	IN	O	10	AMOD
12	TRAF	TRAF	B-NP	NN	B-protein	13	NMOD
13	association	association	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	10	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	a	a	B-NP	DT	O	7	NMOD
5	somewhat	somewhat	I-NP	RB	O	6	AMOD
6	divergent	divergent	I-NP	JJ	O	7	NMOD
7	region	region	I-NP	NN	O	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	STP-C488	STP-C488	B-NP	NN	B-protein	8	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	critical	critical	B-ADJP	JJ	O	10	PRD
12	for	for	B-PP	IN	O	11	AMOD
13	TRAF	TRAF	B-NP	NN	B-protein	14	NMOD
14	association	association	I-NP	NN	O	12	PMOD
15	.	.	O	.	O	10	P

1	Mutational	Mutational	B-NP	JJ	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	4	SUB
3	also	also	B-ADVP	RB	O	4	VMOD
4	revealed	reveal	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	STP-C488	STP-C488	B-NP	NN	B-protein	7	SUB
7	induced	induce	B-VP	VBD	O	5	SBAR
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	9	NMOD
9	activation	activation	I-NP	NN	O	7	OBJ
10	that	that	B-NP	WDT	O	9	NMOD
11	was	be	B-VP	VBD	O	10	SBAR
12	correlated	correlate	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	its	its	B-NP	PRP$	O	15	NMOD
15	ability	ability	I-NP	NN	O	13	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	associate	associate	I-VP	VB	O	15	NMOD
18	with	with	B-PP	IN	O	17	VMOD
19	TRAFs	TRAF	B-NP	NNS	B-protein	18	PMOD
20	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	HVS	HVS	I-NP	NN	O	4	NMOD
3	STP-C488	STP-C488	I-NP	NN	O	4	NMOD
4	P10	P10	I-NP	NN	O	8	NMOD
5	--	--	O	:	O	4	P
6	>	>	O	SYM	O	8	NMOD
7	R	R	B-NP	NN	O	8	NMOD
8	mutant	mutant	I-NP	NN	O	9	SUB
9	was	be	B-VP	VBD	O	0	ROOT
10	deficient	deficient	B-ADJP	JJ	O	9	PRD
11	in	in	B-PP	IN	O	9	VMOD
12	human	human	B-NP	JJ	O	14	NMOD
13	T-lymphocyte	T-lymphocyte	I-NP	NN	O	14	NMOD
14	transformation	transformation	I-NP	NN	O	11	PMOD
15	to	to	B-PP	TO	O	14	NMOD
16	interleukin-2-independent	interleukin-2-independent	B-NP	JJ	O	17	NMOD
17	growth	growth	I-NP	NN	O	15	PMOD
18	but	but	O	CC	O	9	VMOD
19	showed	show	B-VP	VBD	O	9	VMOD
20	wild-type	wild-type	B-NP	JJ	O	21	NMOD
21	phenotype	phenotype	I-NP	NN	O	19	OBJ
22	for	for	B-PP	IN	O	21	NMOD
23	marmoset	marmoset	B-NP	NN	O	25	NMOD
24	T-lymphocyte	T-lymphocyte	I-NP	NN	O	25	NMOD
25	transformation	transformation	I-NP	NN	O	22	PMOD
26	in	in	B-ADVP	FW	O	19	VMOD
27	vitro	vitro	I-ADVP	FW	O	26	AMOD
28	and	and	O	CC	O	26	AMOD
29	in	in	B-ADVP	FW	O	26	AMOD
30	vivo	vivo	I-ADVP	FW	O	29	AMOD
31	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	7	NMOD
2	STP-C488	STP-C488	I-NP	NN	B-protein	7	NMOD
3	P10	P10	I-NP	NN	I-protein	7	NMOD
4	--	--	O	:	I-protein	7	P
5	>	>	O	SYM	I-protein	7	NMOD
6	R	R	B-NP	NN	I-protein	7	NMOD
7	mutant	mutant	I-NP	NN	I-protein	8	SUB
8	was	be	B-VP	VBD	O	20	VMOD
9	also	also	B-ADVP	RB	O	8	VMOD
10	defective	defective	B-ADJP	JJ	O	8	PRD
11	in	in	B-PP	IN	O	8	VMOD
12	Rat-1	Rat-1	B-NP	NN	O	14	NMOD
13	fibroblast	fibroblast	I-NP	NN	O	14	NMOD
14	transformation	transformation	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	20	P
16	and	and	O	CC	O	20	VMOD
17	fibroblast	fibroblast	B-NP	NN	O	19	NMOD
18	cell	cell	I-NP	NN	O	19	NMOD
19	transformation	transformation	I-NP	NN	O	20	SUB
20	was	be	B-VP	VBD	O	0	ROOT
21	blocked	block	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	a	a	B-NP	DT	O	26	NMOD
24	TRAF2	TRAF2	I-NP	NN	B-protein	26	NMOD
25	dominant-negative	dominant-negative	I-NP	JJ	O	26	NMOD
26	mutant	mutant	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	20	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	implicate	implicate	B-VP	VBP	O	0	ROOT
4	TRAFs	TRAF	B-NP	NNS	B-protein	3	OBJ
5	in	in	B-PP	IN	O	3	VMOD
6	STP-C488-mediated	STP-C488-mediated	B-NP	JJ	O	7	NMOD
7	transformation	transformation	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	human	human	B-NP	JJ	B-cell_type	10	NMOD
10	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	rodent	rodent	B-NP	JJ	B-cell_type	13	NMOD
13	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	8	PMOD
14	.	.	O	.	O	3	P

1	Other	Other	B-NP	JJ	O	2	NMOD
2	factors	factor	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	implicated	implicate	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	immortalization	immortalization	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	common	common	B-NP	JJ	B-cell_type	11	NMOD
9	marmoset	marmoset	I-NP	NN	I-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD
12	and	and	O	CC	O	3	VMOD
13	may	may	B-VP	MD	O	3	VMOD
14	also	also	I-VP	RB	O	13	VMOD
15	be	be	I-VP	VB	O	13	VC
16	critical	critical	B-ADJP	JJ	O	15	PRD
17	in	in	B-PP	IN	O	16	AMOD
18	the	the	B-NP	DT	O	19	NMOD
19	transformation	transformation	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	human	human	B-NP	JJ	B-cell_type	22	NMOD
22	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	25	NMOD
23	and	and	O	CC	O	25	NMOD
24	rodent	rodent	B-NP	JJ	B-cell_type	25	NMOD
25	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	20	PMOD
26	.	.	O	.	O	3	P

1	Regulation	Regulation	B-NP	NN	O	8	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	Fas	Fas	B-NP	NN	B-protein	4	NMOD
4	ligand	ligand	I-NP	NN	I-protein	5	NMOD
5	expression	expression	I-NP	NN	O	2	PMOD
6	and	and	O	CC	O	8	NMOD
7	cell	cell	B-NP	NN	O	8	NMOD
8	death	death	I-NP	NN	O	0	ROOT
9	by	by	B-PP	IN	O	8	NMOD
10	apoptosis-linked	apoptosis-linked	B-NP	JJ	B-DNA	11	NMOD
11	gene	gene	I-NP	NN	I-DNA	9	PMOD
12	4	4	I-NP	CD	I-DNA	11	NMOD
13	.	.	O	.	O	8	P

1	Programmed	Program	B-NP	VBN	O	3	NMOD
2	cell	cell	I-NP	NN	O	3	NMOD
3	death	death	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	6	NMOD
6	process	process	I-NP	NN	O	4	PRD
7	required	require	B-VP	VBN	O	6	NMOD
8	for	for	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	normal	normal	I-NP	JJ	O	11	NMOD
11	development	development	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	an	an	B-NP	DT	O	14	NMOD
14	organism	organism	I-NP	NN	O	12	PMOD
15	.	.	O	.	O	4	P

1	One	One	B-NP	CD	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	best	good	I-NP	JJS	O	7	NMOD
5	understood	understand	I-NP	VBN	O	7	NMOD
6	apoptotic	apoptotic	I-NP	JJ	O	7	NMOD
7	pathways	pathway	I-NP	NNS	O	2	PMOD
8	occurs	occur	B-VP	VBZ	O	0	ROOT
9	in	in	B-PP	IN	O	8	VMOD
10	T	T	B-NP	NN	B-cell_type	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
12	and	and	O	CC	O	8	VMOD
13	is	be	B-VP	VBZ	O	8	VMOD
14	mediated	mediate	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	Fas/Fas	Fas/Fas	B-NP	NN	B-protein	17	NMOD
17	ligand	ligand	I-NP	NN	I-protein	21	NMOD
18	(	(	O	(	O	19	P
19	FasL	FasL	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	interaction	interaction	B-NP	NN	O	15	PMOD
22	.	.	O	.	O	8	P

1	During	During	B-PP	IN	O	12	VMOD
2	studies	study	B-NP	NNS	O	1	PMOD
3	of	of	B-PP	IN	O	2	NMOD
4	apoptosis	apoptosis	B-NP	NN	O	3	PMOD
5	induced	induce	B-VP	VBN	O	4	NMOD
6	by	by	B-PP	IN	O	5	VMOD
7	T	T	B-NP	NN	B-protein	9	NMOD
8	cell-receptor	cell-receptor	I-NP	NN	I-protein	9	NMOD
9	engagement	engagement	I-NP	NN	O	6	PMOD
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	identified	identify	B-VP	VBD	O	0	ROOT
13	ALG-4F	ALG-4F	B-NP	NN	B-protein	17	NMOD
14	,	,	O	,	O	17	P
15	a	a	B-NP	DT	O	17	NMOD
16	truncated	truncate	I-NP	VBN	B-protein	17	NMOD
17	transcript	transcript	I-NP	NN	I-protein	12	OBJ
18	that	that	B-NP	WDT	O	17	NMOD
19	prevents	prevent	B-VP	VBZ	O	18	SBAR
20	T	T	B-NP	NN	O	23	NMOD
21	cell-receptor-induced	cell-receptor-induced	I-NP	JJ	O	20	AMOD
22	FasL	FasL	I-NP	NN	B-protein	23	NMOD
23	upregulation	upregulation	I-NP	NN	O	26	NMOD
24	and	and	O	CC	O	26	NMOD
25	cell	cell	B-NP	NN	O	26	NMOD
26	death	death	I-NP	NN	O	19	OBJ
27	.	.	O	.	O	12	P

1	Overexpression	Overexpression	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	full-length	full-length	B-NP	JJ	B-protein	4	NMOD
4	ALG-4	ALG-4	I-NP	NN	I-protein	2	PMOD
5	induced	induce	B-VP	VBD	O	0	ROOT
6	transcription	transcription	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	FasL	FasL	B-NP	NN	B-protein	7	PMOD
9	and	and	O	CC	O	5	VMOD
10	,	,	O	,	O	5	P
11	consequently	consequently	B-ADVP	RB	O	5	VMOD
12	,	,	O	,	O	5	P
13	apoptosis	apoptosis	B-NP	NN	O	5	VMOD
14	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	ALG-4	ALG-4	B-NP	NN	B-protein	6	SUB
6	is	be	B-VP	VBZ	O	4	SBAR
7	necessary	necessary	B-ADJP	JJ	O	9	AMOD
8	and	and	I-ADJP	CC	O	9	AMOD
9	sufficient	sufficient	I-ADJP	JJ	O	6	PRD
10	for	for	B-PP	IN	O	9	AMOD
11	FasL	FasL	B-NP	NN	B-protein	12	NMOD
12	expression	expression	I-NP	NN	O	10	PMOD
13	.	.	O	.	O	3	P

1	Fas/FasL	Fas/FasL	B-NP	NN	O	2	NMOD
2	interaction	interaction	I-NP	NN	O	3	SUB
3	initiates	initiate	B-VP	VBZ	O	14	VMOD
4	cell	cell	B-NP	NN	O	5	NMOD
5	death	death	I-NP	NN	O	3	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	many	many	B-NP	JJ	O	9	NMOD
8	other	other	I-NP	JJ	O	9	NMOD
9	systems	system	I-NP	NNS	O	6	PMOD
10	,	,	O	,	O	14	P
11	and	and	O	CC	O	14	VMOD
12	its	its	B-NP	PRP$	O	13	NMOD
13	dysregulation	dysregulation	I-NP	NN	O	14	SUB
14	is	be	B-VP	VBZ	O	0	ROOT
15	a	a	B-NP	DT	O	16	NMOD
16	mechanism	mechanism	I-NP	NN	O	14	PRD
17	by	by	B-PP	IN	O	16	NMOD
18	which	which	B-NP	WDT	O	17	PMOD
19	several	several	B-NP	JJ	O	21	NMOD
20	pathologic	pathologic	I-NP	JJ	O	21	NMOD
21	conditions	condition	I-NP	NNS	O	22	SUB
22	arise	arise	B-VP	VBP	O	17	SBAR
23	.	.	O	.	O	14	P

1	Understanding	Understand	B-VP	VBG	O	8	SUB
2	the	the	B-NP	DT	O	4	NMOD
3	molecular	molecular	I-NP	JJ	O	4	NMOD
4	mechanisms	mechanism	I-NP	NNS	O	1	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	FasL	FasL	B-NP	NN	B-protein	7	NMOD
7	regulation	regulation	I-NP	NN	O	5	PMOD
8	could	could	B-VP	MD	O	0	ROOT
9	be	be	I-VP	VB	O	8	VC
10	very	very	B-ADJP	RB	O	11	AMOD
11	useful	useful	I-ADJP	JJ	O	9	PRD
12	in	in	B-PP	IN	O	11	AMOD
13	elucidating	elucidate	B-VP	VBG	O	12	PMOD
14	how	how	B-ADVP	WRB	O	13	VMOD
15	these	these	B-NP	DT	O	16	NMOD
16	diseases	disease	I-NP	NNS	O	17	SUB
17	develop	develop	B-VP	VBP	O	14	SBAR
18	and	and	O	CC	O	17	VMOD
19	in	in	B-PP	IN	O	17	VMOD
20	identifying	identify	B-VP	VBG	O	19	PMOD
21	potential	potential	B-NP	JJ	O	22	AMOD
22	therapeutic	therapeutic	I-NP	JJ	O	23	NMOD
23	targets	target	I-NP	NNS	O	20	OBJ
24	.	.	O	.	O	8	P

1	High	High	B-NP	JJ	O	5	NMOD
2	molecular	molecular	I-NP	JJ	O	5	NMOD
3	weight	weight	I-NP	NN	O	5	NMOD
4	dextran	dextran	I-NP	NN	O	5	NMOD
5	sulfate	sulfate	I-NP	NN	O	6	SUB
6	increases	increase	B-VP	VBZ	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	activity	activity	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappaB-regulated	NF-kappaB-regulated	B-NP	JJ	B-DNA	11	NMOD
11	promoter	promoter	I-NP	NN	I-DNA	9	PMOD
12	in	in	B-PP	IN	O	8	NMOD
13	monocyte-derived	monocyte-derived	B-NP	JJ	B-cell_type	14	NMOD
14	macrophages	macrophage	I-NP	NNS	I-cell_type	12	PMOD
15	.	.	O	.	O	6	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	known	know	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	sulfated	sulfated	B-NP	JJ	O	6	NMOD
6	polysaccharides	polysaccharide	I-NP	NNS	O	7	SUB
7	can	can	B-VP	MD	O	4	SBAR
8	mimic	mimic	I-VP	VB	O	7	VC
9	the	the	B-NP	DT	O	10	NMOD
10	action	action	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	common	common	B-NP	JJ	B-protein	14	NMOD
13	T-cell	T-cell	I-NP	NN	I-protein	14	NMOD
14	mitogens	mitogen	I-NP	NNS	I-protein	11	PMOD
15	.	.	O	.	O	2	P

1	To	To	B-VP	TO	O	2	VMOD
2	investigate	investigate	I-VP	VB	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	basis	basis	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	mitogenic	mitogenic	I-NP	JJ	O	9	NMOD
9	effect	effect	I-NP	NN	O	22	VMOD
10	of	of	B-PP	IN	O	9	NMOD
11	high	high	B-NP	JJ	O	15	NMOD
12	molecular	molecular	I-NP	JJ	O	15	NMOD
13	weight	weight	I-NP	NN	O	15	NMOD
14	dextran	dextran	I-NP	NN	O	15	NMOD
15	sulfate	sulfate	I-NP	NN	O	10	PMOD
16	(	(	O	(	O	17	P
17	HMDS	HMDS	B-NP	NN	B-protein	15	NMOD
18	)	)	O	)	O	17	P
19	,	,	O	,	O	22	P
20	monocyte-derived	monocyte-derived	B-NP	JJ	B-cell_type	21	NMOD
21	macrophages	macrophage	I-NP	NNS	I-cell_type	22	SUB
22	were	be	B-VP	VBD	O	6	SBAR
23	transfected	transfecte	I-VP	VBN	O	22	VC
24	with	with	B-PP	IN	O	23	VMOD
25	recombinant	recombinant	B-NP	JJ	B-DNA	26	NMOD
26	plasmid	plasmid	I-NP	NN	I-DNA	24	PMOD
27	containing	contain	B-VP	VBG	O	26	NMOD
28	chloramphenicol	chloramphenicol	B-NP	NN	B-DNA	35	NMOD
29	acetyl	acetyl	I-NP	NN	I-DNA	35	NMOD
30	transferase	transferase	I-NP	NN	I-DNA	35	NMOD
31	(	(	O	(	I-DNA	32	P
32	CAT	CAT	B-NP	NN	I-DNA	30	NMOD
33	)	)	O	)	I-DNA	32	P
34	reporter	reporter	B-NP	NN	I-DNA	35	NMOD
35	gene	gene	I-NP	NN	I-DNA	27	OBJ
36	under	under	B-PP	IN	O	27	VMOD
37	the	the	B-NP	DT	O	38	NMOD
38	control	control	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	the	the	B-NP	DT	O	48	NMOD
41	HIV-1	HIV-1	I-NP	NN	B-DNA	48	NMOD
42	long	long	I-NP	JJ	I-DNA	48	NMOD
43	terminal	terminal	I-NP	JJ	I-DNA	48	NMOD
44	repeat	repeat	I-NP	NN	I-DNA	48	NMOD
45	(	(	O	(	I-DNA	48	P
46	LTR	LTR	B-NP	NN	I-DNA	48	NMOD
47	)	)	O	)	I-DNA	48	P
48	promoter	promoter	B-NP	NN	I-DNA	39	PMOD
49	,	,	O	,	O	48	P
50	which	which	B-NP	WDT	O	48	NMOD
51	is	be	B-VP	VBZ	O	50	SBAR
52	regulated	regulate	I-VP	VBN	O	51	VC
53	by	by	B-PP	IN	O	52	VMOD
54	transcription	transcription	B-NP	NN	B-protein	56	NMOD
55	factor	factor	I-NP	NN	I-protein	56	NMOD
56	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	53	PMOD
57	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	observed	observe	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	HMDS	HMDS	B-NP	NN	O	14	SUB
5	,	,	O	,	O	4	P
6	similar	similar	B-ADJP	JJ	O	4	NMOD
7	to	to	B-PP	TO	O	6	AMOD
8	bacterial	bacterial	B-NP	JJ	O	7	PMOD
9	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	8	NMOD
10	(	(	O	(	O	11	P
11	LPS	LPS	B-NP	NN	O	9	NMOD
12	)	)	O	)	O	11	P
13	,	,	O	,	O	4	P
14	increases	increase	B-VP	VBZ	O	3	SBAR
15	the	the	B-NP	DT	O	16	NMOD
16	expression	expression	I-NP	NN	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	CAT	CAT	B-NP	NN	B-DNA	20	NMOD
19	reporter	reporter	I-NP	NN	I-DNA	20	NMOD
20	gene	gene	I-NP	NN	I-DNA	17	PMOD
21	suggesting	suggest	B-VP	VBG	O	20	NMOD
22	increased	increase	B-NP	VBN	O	23	NMOD
23	activity	activity	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	24	PMOD
26	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	activation	activation	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	3	PMOD
5	correlated	correlate	B-VP	VBD	O	0	ROOT
6	with	with	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	increased	increase	I-NP	VBN	O	9	NMOD
9	expression	expression	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	B7.1	B7.1	B-NP	NN	B-protein	12	NMOD
12	molecules	molecule	I-NP	NNS	I-protein	10	PMOD
13	.	.	O	.	O	5	P

1	It	It	B-NP	PRP	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	postulated	postulate	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	this	this	B-NP	DT	O	7	NMOD
6	NF-kappaB-regulated	NF-kappaB-regulated	I-NP	JJ	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	8	SUB
8	might	might	B-VP	MD	O	4	SBAR
9	play	play	I-VP	VB	O	8	VC
10	a	a	B-NP	DT	O	11	NMOD
11	role	role	I-NP	NN	O	9	OBJ
12	in	in	B-PP	IN	O	9	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	activation	activation	I-NP	NN	O	23	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	accessory	accessory	I-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	as	as	B-CONJP	RB	O	23	NMOD
20	well	well	I-CONJP	RB	O	19	DEP
21	as	as	I-CONJP	IN	O	19	DEP
22	the	the	B-NP	DT	O	23	NMOD
23	rate	rate	I-NP	NN	O	12	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	replication	replication	B-NP	NN	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	HIV-1	HIV-1	B-NP	NN	O	26	PMOD
28	in	in	B-PP	IN	O	25	NMOD
29	monocyte-derived	monocyte-derived	B-NP	JJ	B-cell_type	30	NMOD
30	macrophages	macrophage	I-NP	NNS	I-cell_type	28	PMOD
31	.	.	O	.	O	2	P

1	Inhibition	Inhibition	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
4	B	B	I-NP	NN	I-protein	5	NMOD
5	activity	activity	I-NP	NN	O	2	PMOD
6	in	in	B-PP	IN	O	1	NMOD
7	human	human	B-NP	JJ	B-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	PMOD
10	induces	induce	B-VP	VBZ	O	0	ROOT
11	caspase-dependent	caspase-dependent	B-NP	JJ	O	12	NMOD
12	apoptosis	apoptosis	I-NP	NN	O	10	OBJ
13	without	without	B-PP	IN	O	12	NMOD
14	detectable	detectable	B-NP	JJ	O	15	NMOD
15	activation	activation	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	caspase-1	caspase-1	B-NP	NN	B-protein	19	NMOD
18	and	and	O	CC	I-protein	19	NMOD
19	-3	-3	B-NP	CD	I-protein	16	PMOD
20	.	.	O	.	O	10	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	2	NMOD
2	B	B	I-NP	NN	I-protein	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	involved	involve	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	8	NMOD
7	transcriptional	transcriptional	I-NP	JJ	O	8	NMOD
8	control	control	I-NP	NN	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	various	various	B-NP	JJ	B-DNA	11	NMOD
11	genes	gene	I-NP	NNS	I-DNA	9	PMOD
12	that	that	B-NP	WDT	O	11	NMOD
13	act	act	B-VP	VBP	O	12	SBAR
14	as	as	B-PP	IN	O	13	VMOD
15	extrinsic	extrinsic	B-NP	JJ	O	17	AMOD
16	and	and	I-NP	CC	O	17	AMOD
17	intrinsic	intrinsic	I-NP	JJ	O	19	NMOD
18	survival	survival	I-NP	NN	O	19	NMOD
19	factors	factor	I-NP	NNS	O	14	PMOD
20	for	for	B-PP	IN	O	19	NMOD
21	T	T	B-NP	NN	B-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
23	.	.	O	.	O	3	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	suppression	suppression	B-NP	NN	O	31	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
8	B	B	I-NP	NN	I-protein	9	NMOD
9	activity	activity	I-NP	NN	O	6	PMOD
10	with	with	B-PP	IN	O	5	NMOD
11	cell-permeable	cell-permeable	B-NP	JJ	O	13	NMOD
12	SN50	SN50	I-NP	NN	O	13	NMOD
13	peptide	peptide	I-NP	NN	O	10	PMOD
14	,	,	O	,	O	5	P
15	which	which	B-NP	WDT	O	5	NMOD
16	masks	mask	B-VP	VBZ	O	15	SBAR
17	the	the	B-NP	DT	O	20	NMOD
18	nuclear	nuclear	I-NP	JJ	B-protein	20	NMOD
19	localization	localization	I-NP	NN	I-protein	20	NMOD
20	sequence	sequence	I-NP	NN	I-protein	16	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	NF-kappa	NF-kappa	B-NP	NN	B-protein	24	NMOD
23	B1	B1	I-NP	NN	I-protein	24	NMOD
24	dimers	dimer	I-NP	NNS	I-protein	21	PMOD
25	and	and	O	CC	O	16	VMOD
26	prevents	prevent	B-VP	VBZ	O	16	VMOD
27	their	their	B-NP	PRP$	O	29	NMOD
28	nuclear	nuclear	I-NP	JJ	O	29	NMOD
29	localization	localization	I-NP	NN	O	26	OBJ
30	,	,	O	,	O	5	P
31	induces	induce	B-VP	VBZ	O	4	SBAR
32	apoptosis	apoptosis	B-NP	NN	O	31	OBJ
33	in	in	B-PP	IN	O	31	VMOD
34	resting	rest	B-NP	VBG	B-cell_type	37	NMOD
35	normal	normal	I-NP	JJ	I-cell_type	37	NMOD
36	human	human	I-NP	JJ	I-cell_type	37	NMOD
37	PBL	PBL	I-NP	NN	I-cell_type	33	PMOD
38	.	.	O	.	O	3	P

1	Inhibition	Inhibition	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	2	PMOD
5	resulted	result	B-VP	VBD	O	0	ROOT
6	in	in	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	externalization	externalization	I-NP	NN	O	19	NMOD
9	of	of	B-PP	IN	O	8	NMOD
10	phosphatidylserine	phosphatidylserine	B-NP	NN	O	9	PMOD
11	,	,	O	,	O	19	P
12	induction	induction	B-NP	NN	O	19	NMOD
13	of	of	B-PP	IN	O	12	NMOD
14	DNA	DNA	B-NP	NN	O	15	NMOD
15	breaks	break	I-NP	NNS	O	13	PMOD
16	,	,	O	,	O	19	P
17	and	and	O	CC	O	19	NMOD
18	morphological	morphological	B-NP	JJ	O	19	NMOD
19	changes	change	I-NP	NNS	O	6	PMOD
20	consistent	consistent	B-ADJP	JJ	O	19	NMOD
21	with	with	B-PP	IN	O	20	AMOD
22	apoptosis	apoptosis	B-NP	NN	O	21	PMOD
23	.	.	O	.	O	5	P

1	DNA	DNA	B-NP	NN	O	2	NMOD
2	fragmentation	fragmentation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	efficiently	efficiently	I-VP	RB	O	3	VMOD
5	blocked	block	I-VP	VBN	O	3	VC
6	by	by	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	caspase	caspase	I-NP	NN	O	10	NMOD
9	inhibitor	inhibitor	I-NP	NN	O	10	NMOD
10	Z-VAD-fmk	Z-VAD-fmk	I-NP	NN	B-protein	6	PMOD
11	and	and	O	CC	O	5	VMOD
12	partially	partially	B-VP	RB	O	13	VMOD
13	blocked	block	I-VP	VBN	O	5	VMOD
14	by	by	B-PP	IN	O	13	VMOD
15	Ac-DEVD-fmk	Ac-DEVD-fmk	B-NP	NN	B-protein	14	PMOD
16	,	,	O	,	O	5	P
17	suggesting	suggest	B-VP	VBG	O	5	VMOD
18	that	that	B-SBAR	IN	O	17	VMOD
19	SN50-mediated	SN50-mediated	B-NP	JJ	O	20	NMOD
20	apoptosis	apoptosis	I-NP	NN	O	21	SUB
21	is	be	B-VP	VBZ	O	18	SBAR
22	caspase-dependent	caspase-dependent	B-ADJP	JJ	O	21	PRD
23	.	.	O	.	O	3	P

1	Interestingly	Interestingly	B-ADVP	RB	O	39	VMOD
2	,	,	O	,	O	39	P
3	apoptosis	apoptosis	B-NP	NN	O	39	SUB
4	induced	induce	B-VP	VBN	O	3	NMOD
5	by	by	B-PP	IN	O	4	VMOD
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	8	NMOD
7	B	B	I-NP	NN	I-protein	8	NMOD
8	suppression	suppression	I-NP	NN	O	5	PMOD
9	,	,	O	,	O	3	P
10	in	in	B-PP	IN	O	3	NMOD
11	contrast	contrast	B-NP	NN	O	10	PMOD
12	to	to	B-PP	TO	O	3	NMOD
13	that	that	B-NP	DT	O	12	PMOD
14	induced	induce	B-VP	VBN	O	13	NMOD
15	by	by	B-PP	IN	O	14	VMOD
16	TPEN	TPEN	B-NP	NN	O	25	NMOD
17	(	(	O	(	O	25	P
18	N	N	B-NP	NN	O	25	NMOD
19	,	,	O	,	O	25	P
20	N	N	B-NP	NN	O	25	NMOD
21	,	,	O	,	O	25	P
22	N	N	B-NP	NN	O	25	NMOD
23	'	'	O	''	O	22	P
24	,	,	O	,	O	25	P
25	N'-tetrakis	N'-tetrakis	B-NP	NNP	O	34	NMOD
26	[	[	O	(	O	29	P
27	2-pyridylmethyl	2-pyridylmethyl	B-NP	NN	O	29	NMOD
28	]	]	I-NP	)	O	29	P
29	ethylenediamine	ethylenediamine	I-NP	NN	O	25	NMOD
30	)	)	O	)	O	29	P
31	or	or	O	CC	O	34	NMOD
32	soluble	soluble	B-NP	JJ	B-protein	34	NMOD
33	Fas	Fas	I-NP	NN	I-protein	34	NMOD
34	ligand	ligand	I-NP	NN	I-protein	15	PMOD
35	(	(	O	(	O	36	P
36	CD95	CD95	B-NP	NN	B-protein	34	NMOD
37	)	)	O	)	O	36	P
38	,	,	O	,	O	3	P
39	was	be	B-VP	VBD	O	0	ROOT
40	observed	observe	I-VP	VBN	O	39	VC
41	in	in	B-PP	IN	O	40	VMOD
42	the	the	B-NP	DT	O	41	PMOD
43	absence	absence	I-NP	NN	O	41	PMOD
44	of	of	B-PP	IN	O	41	PMOD
45	active	active	B-NP	JJ	O	48	NMOD
46	death	death	I-NP	NN	O	48	NMOD
47	effector	effector	I-NP	NN	O	48	NMOD
48	proteases	protease	I-NP	NNS	O	56	NMOD
49	caspase-1-like	caspase-1-like	B-ADJP	JJ	O	48	NMOD
50	(	(	O	(	O	53	P
51	IL-1	IL-1	B-NP	NN	B-protein	53	NMOD
52	converting	convert	B-VP	VBG	I-protein	53	NMOD
53	enzyme	enzyme	B-NP	NN	I-protein	48	NMOD
54	)	)	O	)	O	53	P
55	,	,	O	,	O	56	P
56	caspase-3-like	caspase-3-like	B-ADJP	JJ	O	41	PMOD
57	(	(	O	(	O	58	P
58	CPP32/Yama/apopain	CPP32/Yama/apopain	B-NP	NN	B-protein	56	NMOD
59	)	)	O	)	O	58	P
60	,	,	O	,	O	39	VMOD
61	and	and	O	CC	O	60	VMOD
62	caspase-6-like	caspase-6-like	B-ADJP	JJ	O	61	PRD
63	and	and	O	CC	O	62	AMOD
64	without	without	B-PP	IN	O	63	PMOD
65	cleavage	cleavage	B-NP	NN	O	64	PMOD
66	of	of	B-PP	IN	O	65	NMOD
67	caspase-3	caspase-3	B-NP	NN	B-protein	68	NMOD
68	substrates	substrate	I-NP	NNS	I-protein	77	NMOD
69	poly	poly	I-NP	NN	B-protein	73	NMOD
70	(	(	O	(	I-protein	71	P
71	ADP-ribose	ADP-ribose	B-NP	NN	I-protein	69	NMOD
72	)	)	O	)	I-protein	71	P
73	polymerase	polymerase	B-NP	NN	I-protein	77	NMOD
74	and	and	I-NP	CC	O	77	NMOD
75	DNA	DNA	I-NP	NN	B-protein	77	NMOD
76	fragmentation	fragmentation	I-NP	NN	I-protein	77	NMOD
77	factor-45	factor-45	I-NP	NN	I-protein	66	PMOD
78	.	.	O	.	O	39	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	either	either	B-NP	CC	O	9	VMOD
5	low	low	I-NP	JJ	O	6	NMOD
6	level	level	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	activation	activation	B-NP	NN	O	7	PMOD
9	is	be	B-VP	VBZ	O	3	VMOD
10	required	require	I-VP	VBN	O	9	VC
11	or	or	O	CC	O	12	DEP
12	that	that	B-SBAR	IN	O	9	VMOD
13	different	different	B-NP	JJ	O	14	NMOD
14	caspases	caspas	I-NP	NNS	B-protein	15	SUB
15	are	be	B-VP	VBP	O	12	SBAR
16	involved	involve	I-VP	VBN	O	15	VC
17	.	.	O	.	O	3	P

1	Preactivation	Preactivation	B-NP	NN	O	11	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	resulting	result	B-VP	VBG	O	1	NMOD
6	in	in	B-PP	IN	O	5	VMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	8	NMOD
8	B	B	I-NP	NN	I-protein	10	NMOD
9	nuclear	nuclear	I-NP	JJ	O	10	NMOD
10	translocation	translocation	I-NP	NN	O	6	PMOD
11	protected	protect	B-VP	VBD	O	0	ROOT
12	cells	cell	B-NP	NNS	O	11	OBJ
13	from	from	B-PP	IN	O	11	VMOD
14	SN50-induced	SN50-induced	B-NP	JJ	O	15	NMOD
15	apoptosis	apoptosis	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	11	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	an	an	B-NP	DT	O	6	NMOD
5	essential	essential	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	7	PMOD
10	in	in	B-PP	IN	O	6	NMOD
11	survival	survival	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	naive	naive	B-NP	JJ	B-cell_type	14	NMOD
14	PBL	PBL	I-NP	NN	I-cell_type	12	PMOD
15	.	.	O	.	O	3	P

1	Signaling	Signaling	B-NP	NN	O	2	NMOD
2	events	event	I-NP	NNS	O	0	ROOT
3	induced	induce	B-VP	VBN	O	2	NMOD
4	by	by	B-PP	IN	O	3	VMOD
5	lipopolysaccharide-activated	lipopolysaccharide-activated	B-NP	JJ	B-protein	7	NMOD
6	toll-like	toll-like	I-NP	JJ	I-protein	7	NMOD
7	receptor	receptor	I-NP	NN	I-protein	4	PMOD
8	2	2	I-NP	CD	I-protein	7	NMOD
9	.	.	O	.	O	2	P

1	Human	Human	B-NP	JJ	B-protein	3	NMOD
2	Toll-like	Toll-like	I-NP	JJ	I-protein	3	NMOD
3	receptor	receptor	I-NP	NN	I-protein	8	SUB
4	2	2	I-NP	CD	I-protein	3	NMOD
5	(	(	O	(	O	6	P
6	TLR2	TLR2	B-NP	NN	B-protein	3	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	signaling	signaling	I-NP	NN	B-protein	11	NMOD
11	receptor	receptor	I-NP	NN	I-protein	8	PRD
12	that	that	B-NP	WDT	O	11	NMOD
13	responds	respond	B-VP	VBZ	O	12	SBAR
14	to	to	B-PP	TO	O	13	VMOD
15	LPS	LPS	B-NP	NN	O	14	PMOD
16	and	and	O	CC	O	13	VMOD
17	activates	activate	B-VP	VBZ	O	13	VMOD
18	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	17	OBJ
19	.	.	O	.	O	8	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	investigate	investigate	B-VP	VBP	O	0	ROOT
5	further	further	B-ADVP	RBR	O	7	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	events	event	I-NP	NNS	O	4	OBJ
8	triggered	trigger	B-VP	VBN	O	7	NMOD
9	by	by	B-PP	IN	O	8	VMOD
10	TLR2	TLR2	B-NP	NN	B-protein	9	PMOD
11	in	in	B-PP	IN	O	8	VMOD
12	response	response	B-NP	NN	O	11	PMOD
13	to	to	B-PP	TO	O	12	NMOD
14	LPS	LPS	B-NP	NN	O	13	PMOD
15	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	23	DEP
4	TLR2	TLR2	B-NP	NN	B-protein	5	SUB
5	associates	associate	B-VP	VBZ	O	3	SBAR
6	with	with	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	13	NMOD
8	high-affinity	high-affinity	I-NP	JJ	B-protein	11	NMOD
9	LPS	LPS	I-NP	NN	I-protein	11	NMOD
10	binding	binding	I-NP	NN	I-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	13	NMOD
12	membrane	membrane	I-NP	NN	O	13	NMOD
13	CD14	CD14	I-NP	NN	B-protein	6	PMOD
14	to	to	B-VP	TO	O	15	VMOD
15	serve	serve	I-VP	VB	O	5	VMOD
16	as	as	B-PP	IN	O	15	VMOD
17	an	an	B-NP	DT	O	20	NMOD
18	LPS	LPS	I-NP	NN	B-protein	20	NMOD
19	receptor	receptor	I-NP	NN	I-protein	20	NMOD
20	complex	complex	I-NP	NN	I-protein	16	PMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	DEP
23	that	that	B-SBAR	IN	O	2	VMOD
24	LPS	LPS	B-NP	NN	O	25	NMOD
25	treatment	treatment	I-NP	NN	O	26	SUB
26	enhances	enhance	B-VP	VBZ	O	23	SBAR
27	the	the	B-NP	DT	O	28	NMOD
28	oligomerization	oligomerization	I-NP	NN	O	26	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	TLR2	TLR2	B-NP	NN	B-protein	29	PMOD
31	.	.	O	.	O	2	P

1	Concomitant	Concomitant	B-ADJP	JJ	O	12	SUB
2	with	with	B-PP	IN	O	1	AMOD
3	receptor	receptor	B-NP	NN	O	4	NMOD
4	oligomerization	oligomerization	I-NP	NN	O	2	PMOD
5	,	,	O	,	O	10	P
6	the	the	B-NP	DT	O	8	NMOD
7	IL-1R-associated	IL-1R-associated	I-NP	JJ	B-protein	8	NMOD
8	kinase	kinase	I-NP	NN	I-protein	10	NMOD
9	(	(	O	(	O	10	P
10	IRAK	IRAK	B-NP	NN	B-protein	1	NMOD
11	)	)	O	)	O	10	P
12	is	be	B-VP	VBZ	O	0	ROOT
13	recruited	recruit	I-VP	VBN	O	12	VC
14	to	to	B-PP	TO	O	13	VMOD
15	the	the	B-NP	DT	O	17	NMOD
16	TLR2	TLR2	I-NP	NN	B-protein	17	NMOD
17	complex	complex	I-NP	NN	I-protein	14	PMOD
18	.	.	O	.	O	12	P

1	Intracellular	Intracellular	B-NP	JJ	O	3	NMOD
2	deletion	deletion	I-NP	NN	O	3	NMOD
3	variants	variant	I-NP	NNS	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	TLR2	TLR2	B-NP	NN	B-protein	4	PMOD
6	lacking	lack	B-VP	VBG	O	5	NMOD
7	C-terminal	C-terminal	B-NP	JJ	O	11	NMOD
8	13	13	I-NP	CD	O	10	AMOD
9	or	or	I-NP	CC	O	10	AMOD
10	141	141	I-NP	CD	O	11	NMOD
11	aa	aa	I-NP	NN	O	6	OBJ
12	fail	fail	B-VP	VBP	O	0	ROOT
13	to	to	I-VP	TO	O	14	VMOD
14	recruit	recruit	I-VP	VB	O	12	VMOD
15	IRAK	IRAK	B-NP	NN	B-protein	14	OBJ
16	,	,	O	,	O	15	P
17	which	which	B-NP	WDT	O	15	NMOD
18	is	be	B-VP	VBZ	O	17	SBAR
19	consistent	consistent	B-ADJP	JJ	O	18	PRD
20	with	with	B-PP	IN	O	19	AMOD
21	the	the	B-NP	DT	O	22	NMOD
22	inability	inability	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	these	these	B-NP	DT	O	25	NMOD
25	mutants	mutant	I-NP	NNS	O	23	PMOD
26	to	to	B-VP	TO	O	27	VMOD
27	transmit	transmit	I-VP	VB	O	22	NMOD
28	LPS	LPS	B-NP	NN	O	30	NMOD
29	cellular	cellular	I-NP	JJ	O	30	NMOD
30	signaling	signaling	I-NP	NN	O	27	OBJ
31	.	.	O	.	O	12	P

1	Moreover	Moreover	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	both	both	B-NP	DT	O	5	NMOD
4	deletion	deletion	I-NP	NN	B-DNA	5	NMOD
5	mutants	mutant	I-NP	NNS	I-DNA	6	SUB
6	could	could	B-VP	MD	O	0	ROOT
7	still	still	I-VP	RB	O	6	VMOD
8	form	form	I-VP	VB	O	6	VC
9	complexes	complex	B-NP	NNS	O	8	OBJ
10	with	with	B-PP	IN	O	9	NMOD
11	wild-type	wild-type	B-NP	JJ	B-protein	12	NMOD
12	TLR2	TLR2	I-NP	NN	I-protein	10	PMOD
13	and	and	O	CC	O	8	VMOD
14	act	act	B-VP	VBP	O	8	VMOD
15	in	in	B-PP	IN	O	14	VMOD
16	a	a	O	DT	O	21	NMOD
17	dominant-negative	dominant-negative	O	JJ	O	21	NMOD
18	(	(	O	(	O	19	P
19	DN	DN	B-ADJP	JJ	O	17	AMOD
20	)	)	O	)	O	19	P
21	fashion	fashion	B-NP	NN	O	15	PMOD
22	to	to	B-VP	TO	O	23	VMOD
23	block	block	I-VP	VB	O	14	VMOD
24	TLR2-mediated	TLR2-mediated	B-NP	JJ	O	26	NMOD
25	signal	signal	I-NP	NN	O	26	NMOD
26	transduction	transduction	I-NP	NN	O	23	OBJ
27	.	.	O	.	O	6	P

1	DN	DN	B-NP	JJ	O	2	NMOD
2	constructs	construct	I-NP	NNS	O	17	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	myeloid	myeloid	B-NP	JJ	B-protein	6	NMOD
5	differentiation	differentiation	I-NP	NN	I-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	3	PMOD
7	,	,	O	,	O	17	P
8	IRAK	IRAK	B-NP	NN	B-protein	12	NMOD
9	,	,	O	,	O	12	P
10	TNF	TNF	B-NP	NN	B-protein	12	NMOD
11	receptor-associated	receptor-associated	I-NP	JJ	I-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	17	NMOD
13	6	6	I-NP	CD	I-protein	12	NMOD
14	,	,	O	,	O	17	P
15	and	and	O	CC	O	17	NMOD
16	NF-kappaB-inducing	NF-kappaB-inducing	B-NP	NN	B-protein	17	NMOD
17	kinase	kinase	I-NP	NN	I-protein	24	SUB
18	,	,	O	,	O	17	P
19	when	when	B-ADVP	WRB	O	17	NMOD
20	coexpressed	coexpresse	B-VP	VBN	O	19	SBAR
21	with	with	B-PP	IN	O	20	VMOD
22	TLR2	TLR2	B-NP	NN	B-protein	21	PMOD
23	,	,	O	,	O	17	P
24	abrogate	abrogate	B-VP	VBP	O	0	ROOT
25	TLR2-mediated	TLR2-mediated	B-NP	JJ	O	27	NMOD
26	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	27	NMOD
27	activation	activation	I-NP	NN	O	24	OBJ
28	.	.	O	.	O	24	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	reveal	reveal	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	7	NMOD
5	conserved	conserve	I-NP	VBN	O	7	NMOD
6	signaling	signaling	I-NP	NN	O	7	NMOD
7	pathway	pathway	I-NP	NN	O	3	OBJ
8	for	for	B-PP	IN	O	7	NMOD
9	TLR2	TLR2	B-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	IL-1Rs	IL-1R	I-NP	NNS	B-protein	8	PMOD
12	and	and	O	CC	O	3	VMOD
13	suggest	suggest	B-VP	VBP	O	3	VMOD
14	a	a	B-NP	DT	O	16	NMOD
15	molecular	molecular	I-NP	JJ	O	16	NMOD
16	mechanism	mechanism	I-NP	NN	O	13	OBJ
17	for	for	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	inhibition	inhibition	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	TLR2	TLR2	B-NP	NN	B-protein	20	PMOD
22	by	by	B-PP	IN	O	19	NMOD
23	DN	DN	B-NP	JJ	O	24	NMOD
24	variants	variant	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	3	P

1	Activation	Activation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	Janus	Janus	I-NP	NN	B-protein	7	NMOD
5	kinase	kinase	I-NP	NN	I-protein	7	NMOD
6	3-STAT5a	3-STAT5a	I-NP	NN	O	7	NMOD
7	pathway	pathway	I-NP	NN	O	2	PMOD
8	after	after	B-PP	IN	O	1	NMOD
9	CD40	CD40	B-NP	NN	B-protein	10	NMOD
10	triggering	triggering	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	human	human	B-NP	JJ	B-cell_type	13	NMOD
13	monocytes	monocyte	I-NP	NNS	I-cell_type	11	PMOD
14	but	but	B-PP	CC	O	11	PMOD
15	not	not	B-PP	RB	O	16	PMOD
16	of	of	I-PP	IN	O	11	PMOD
17	resting	rest	B-NP	VBG	B-cell_type	19	NMOD
18	B	B	I-NP	NN	I-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	.	.	O	.	O	1	P

1	CD40/CD40	CD40/CD40	B-NP	NN	B-protein	3	NMOD
2	ligand	ligand	I-NP	NN	O	3	NMOD
3	interactions	interaction	I-NP	NNS	O	4	SUB
4	play	play	B-VP	VBP	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	key	key	I-NP	JJ	O	7	NMOD
7	role	role	I-NP	NN	O	4	OBJ
8	in	in	B-PP	IN	O	4	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	immune	immune	I-NP	JJ	O	11	NMOD
11	responses	response	I-NP	NNS	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	B	B	B-NP	NN	B-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	20	NMOD
15	,	,	O	,	O	20	P
16	monocytes	monocyte	B-NP	NNS	B-cell_type	20	NMOD
17	,	,	O	,	O	20	P
18	and	and	O	CC	O	20	NMOD
19	dendritic	dendritic	B-NP	JJ	B-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
21	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	signal	signal	I-NP	NN	O	4	NMOD
3	transduction	transduction	I-NP	NN	O	4	NMOD
4	events	event	I-NP	NNS	O	12	SUB
5	triggered	trigger	B-VP	VBN	O	4	NMOD
6	by	by	B-PP	IN	O	5	VMOD
7	cross-linking	cross-linking	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	CD40	CD40	I-NP	NN	B-protein	11	NMOD
11	receptor	receptor	I-NP	NN	I-protein	8	PMOD
12	have	have	B-VP	VBP	O	23	VMOD
13	been	be	I-VP	VBN	O	12	VC
14	widely	widely	I-VP	RB	O	13	VMOD
15	studied	study	I-VP	VBN	O	13	VC
16	in	in	B-PP	IN	O	15	VMOD
17	B	B	B-NP	NN	B-cell_line	19	NMOD
18	cell	cell	I-NP	NN	I-cell_line	19	NMOD
19	lines	line	I-NP	NNS	I-cell_line	16	PMOD
20	,	,	O	,	O	23	P
21	but	but	O	CC	O	23	VMOD
22	little	little	B-NP	JJ	O	23	SUB
23	is	be	B-VP	VBZ	O	0	ROOT
24	known	know	I-VP	VBN	O	23	VC
25	about	about	B-PP	IN	O	24	VMOD
26	signaling	signaling	B-NP	NN	O	25	PMOD
27	following	follow	B-PP	VBG	O	26	NMOD
28	CD40	CD40	B-NP	NN	B-protein	29	NMOD
29	stimulation	stimulation	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	monocytes	monocyte	B-NP	NNS	B-cell_type	36	NMOD
32	and	and	O	CC	O	36	NMOD
33	resting	rest	B-NP	VBG	B-cell_type	36	NMOD
34	tonsillar	tonsillar	I-NP	JJ	I-cell_type	36	NMOD
35	B	B	I-NP	NN	I-cell_type	36	NMOD
36	cells	cell	I-NP	NNS	I-cell_type	30	PMOD
37	.	.	O	.	O	23	P

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	studied	study	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	7	NMOD
6	CD40	CD40	I-NP	NN	B-protein	7	NMOD
7	pathway	pathway	I-NP	NN	O	4	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	highly	highly	B-NP	RB	O	10	AMOD
10	purified	purify	I-NP	VBN	O	16	NMOD
11	human	human	I-NP	JJ	B-cell_type	12	NMOD
12	monocytes	monocyte	I-NP	NNS	I-cell_type	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	resting	rest	B-NP	VBG	B-cell_type	15	NMOD
15	B	B	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
17	.	.	O	.	O	4	P

1	After	After	B-PP	IN	O	21	VMOD
2	CD40	CD40	B-NP	NN	B-protein	3	NMOD
3	triggering	triggering	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	21	P
5	a	a	B-NP	DT	O	7	NMOD
6	similar	similar	I-NP	JJ	O	7	NMOD
7	activation	activation	I-NP	NN	O	21	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	20	NMOD
11	(	(	O	(	O	20	P
12	but	but	O	CC	O	20	NMOD
13	not	not	O	RB	O	12	DEP
14	of	of	B-PP	IN	O	12	PMOD
15	the	the	B-NP	DT	O	16	NMOD
16	AP-1	AP-1	I-NP	NN	B-protein	14	PMOD
17	)	)	O	)	O	20	P
18	transcription	transcription	B-NP	NN	B-protein	20	NMOD
19	factor	factor	I-NP	NN	I-protein	20	NMOD
20	complex	complex	I-NP	NN	I-protein	8	PMOD
21	occurred	occur	B-VP	VBD	O	0	ROOT
22	in	in	B-PP	IN	O	21	VMOD
23	both	both	B-NP	DT	O	25	NMOD
24	cell	cell	I-NP	NN	O	25	NMOD
25	preparations	preparation	I-NP	NNS	O	22	PMOD
26	.	.	O	.	O	21	P

1	However	However	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	the	the	B-NP	DT	O	4	NMOD
4	components	component	I-NP	NNS	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	8	NMOD
8	complexes	complex	I-NP	NNS	I-protein	5	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	different	different	B-ADJP	JJ	O	9	PRD
11	in	in	B-PP	IN	O	9	VMOD
12	monocytes	monocyte	B-NP	NNS	B-cell_type	15	NMOD
13	and	and	O	CC	O	15	NMOD
14	B	B	B-NP	NN	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
16	,	,	O	,	O	9	P
17	because	because	B-SBAR	IN	O	9	VMOD
18	p50	p50	B-NP	NN	B-protein	19	SUB
19	is	be	B-VP	VBZ	O	36	VMOD
20	part	part	B-NP	NN	O	19	PRD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	24	NMOD
24	complex	complex	I-NP	NN	I-protein	21	PMOD
25	induced	induce	B-VP	VBN	O	24	NMOD
26	by	by	B-PP	IN	O	25	VMOD
27	CD40	CD40	B-NP	NN	B-protein	28	NMOD
28	triggering	triggering	I-NP	NN	O	26	PMOD
29	in	in	B-PP	IN	O	25	VMOD
30	both	both	O	CC	O	34	NMOD
31	monocytes	monocyte	B-NP	NNS	B-cell_type	34	NMOD
32	and	and	O	CC	O	34	NMOD
33	B	B	B-NP	NN	B-cell_type	34	NMOD
34	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
35	,	,	O	,	O	36	P
36	whereas	whereas	O	IN	O	17	SBAR
37	p65	p65	B-NP	NN	B-protein	38	SUB
38	was	be	B-VP	VBD	O	36	SBAR
39	only	only	I-VP	RB	O	38	VMOD
40	induced	induce	I-VP	VBN	O	38	VC
41	in	in	B-PP	IN	O	40	VMOD
42	B	B	B-NP	NN	B-cell_type	43	NMOD
43	cells	cell	I-NP	NNS	I-cell_type	41	PMOD
44	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	29	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	29	P
4	although	although	B-SBAR	IN	O	29	VMOD
5	the	the	B-NP	DT	O	10	NMOD
6	Janus	Janus	I-NP	NN	B-protein	10	NMOD
7	kinase	kinase	I-NP	NN	I-protein	10	NMOD
8	3	3	I-NP	CD	I-protein	10	NMOD
9	tyrosine	tyrosine	I-NP	NN	I-protein	10	NMOD
10	kinase	kinase	I-NP	NN	I-protein	11	SUB
11	was	be	B-VP	VBD	O	4	SBAR
12	associated	associate	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	CD40	CD40	B-NP	NN	B-protein	15	NMOD
15	molecules	molecule	I-NP	NNS	O	13	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	both	both	O	CC	O	22	NMOD
18	monocytes	monocyte	B-NP	NNS	B-cell_type	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	resting	rest	B-NP	VBG	B-cell_type	21	NMOD
21	B	B	I-NP	NN	I-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
23	,	,	O	,	O	29	P
24	Janus	Janus	B-NP	NN	B-protein	25	NMOD
25	kinase	kinase	I-NP	NN	I-protein	28	NMOD
26	3	3	I-NP	CD	I-protein	25	NMOD
27	phosphorylation	phosphorylation	I-NP	NN	O	28	NMOD
28	induction	induction	I-NP	NN	O	29	SUB
29	was	be	B-VP	VBD	O	0	ROOT
30	observed	observe	I-VP	VBN	O	29	VC
31	only	only	B-ADVP	RB	O	32	PMOD
32	in	in	B-PP	IN	O	30	VMOD
33	CD40-activated	CD40-activated	B-NP	JJ	B-cell_line	34	NMOD
34	monocytes	monocyte	I-NP	NNS	I-cell_line	32	PMOD
35	,	,	O	,	O	30	P
36	with	with	B-PP	IN	O	30	VMOD
37	subsequent	subsequent	B-NP	JJ	O	38	NMOD
38	induction	induction	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	STAT5a	STAT5a	B-NP	NN	B-protein	43	NMOD
41	DNA	DNA	I-NP	NN	O	43	NMOD
42	binding	binding	I-NP	NN	O	43	NMOD
43	activity	activity	I-NP	NN	O	39	PMOD
44	in	in	B-PP	IN	O	38	NMOD
45	the	the	B-NP	DT	O	46	NMOD
46	nucleus	nucleus	I-NP	NN	O	44	PMOD
47	.	.	O	.	O	29	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	activation	activation	I-NP	NN	O	7	NMOD
7	signals	signal	I-NP	NNS	O	14	SUB
8	in	in	B-PP	IN	O	7	NMOD
9	human	human	B-NP	JJ	B-cell_type	11	NMOD
10	B	B	I-NP	NN	I-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	13	NMOD
12	and	and	O	CC	O	13	NMOD
13	monocytes	monocyte	B-NP	NNS	B-cell_type	8	PMOD
14	differ	differ	B-VP	VBP	O	4	SBAR
15	following	follow	I-VP	VBG	O	14	VMOD
16	CD40	CD40	B-NP	NN	B-protein	17	NMOD
17	stimulation	stimulation	I-NP	NN	O	15	OBJ
18	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	observation	observation	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	consistent	consistent	B-ADJP	JJ	O	3	PRD
5	with	with	B-PP	IN	O	4	AMOD
6	the	the	B-NP	DT	O	7	NMOD
7	detection	detection	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	normal	normal	B-NP	JJ	O	12	NMOD
10	CD40-induced	CD40-induced	I-NP	JJ	O	12	NMOD
11	monocyte	monocyte	I-NP	NN	O	12	NMOD
12	activation	activation	I-NP	NN	O	8	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	patients	patient	B-NP	NNS	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	CD40	CD40	B-NP	NN	B-protein	20	NMOD
17	ligand+	ligand+	I-NP	JJ	O	20	NMOD
18	hyper	hyper	I-NP	NN	O	20	NMOD
19	IgM	IgM	I-NP	NN	B-protein	20	NMOD
20	syndrome	syndrome	I-NP	NN	O	15	PMOD
21	in	in	B-PP	IN	O	7	NMOD
22	whom	whom	B-NP	WP	O	24	NMOD
23	a	a	B-NP	DT	O	24	NMOD
24	defect	defect	I-NP	NN	O	21	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	CD40-induced	CD40-induced	B-NP	JJ	O	29	NMOD
27	B	B	I-NP	NN	O	29	NMOD
28	cell	cell	I-NP	NN	O	29	NMOD
29	activation	activation	I-NP	NN	O	25	PMOD
30	has	have	B-VP	VBZ	O	3	VMOD
31	been	be	I-VP	VBN	O	30	VC
32	reported	report	I-VP	VBN	O	31	VC
33	.	.	O	.	O	3	P

1	Suppression	Suppression	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	4	NMOD
4	activation	activation	I-NP	NN	O	2	PMOD
5	in	in	B-PP	IN	O	1	NMOD
6	normal	normal	B-NP	JJ	B-cell_type	8	NMOD
7	T	T	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
9	by	by	B-PP	IN	O	1	NMOD
10	supernatant	supernatant	B-NP	JJ	O	11	NMOD
11	fluid	fluid	I-NP	NN	O	9	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	human	human	B-NP	JJ	O	16	NMOD
14	renal	renal	I-NP	JJ	O	16	NMOD
15	cell	cell	I-NP	NN	O	16	NMOD
16	carcinomas	carcinoma	I-NP	NNS	O	12	PMOD
17	.	.	O	.	O	1	P

1	T	T	B-NP	NN	B-cell_type	2	NMOD
2	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	with	with	B-PP	IN	O	4	NMOD
6	renal	renal	B-NP	JJ	O	8	NMOD
7	cell	cell	I-NP	NN	O	8	NMOD
8	carcinoma	carcinoma	I-NP	NN	O	5	PMOD
9	(	(	O	(	O	10	P
10	RCC	RCC	B-NP	NN	O	8	NMOD
11	)	)	O	)	O	10	P
12	show	show	B-VP	VBP	O	0	ROOT
13	reduced	reduce	I-VP	VBN	O	12	VC
14	immune	immune	B-NP	JJ	O	15	NMOD
15	function	function	I-NP	NN	O	18	NMOD
16	and	and	O	CC	O	18	NMOD
17	impaired	impaired	B-NP	JJ	O	18	NMOD
18	activation	activation	I-NP	NN	O	13	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	transcription	transcription	I-NP	NN	B-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	24	NMOD
23	,	,	O	,	O	24	P
24	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	19	PMOD
25	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	determined	determine	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	mechanism	mechanism	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	7	NMOD
7	suppression	suppression	I-NP	NN	O	5	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	RCC	RCC	B-NP	NN	O	13	NMOD
13	patient	patient	I-NP	NN	O	11	PMOD
14	and	and	O	CC	O	2	VMOD
15	determined	determine	B-VP	VBD	O	2	VMOD
16	whether	whether	B-SBAR	IN	O	15	VMOD
17	supernatant	supernatant	B-NP	JJ	O	18	NMOD
18	fluid	fluid	I-NP	NN	O	25	SUB
19	from	from	B-PP	IN	O	18	NMOD
20	RCC	RCC	B-NP	NN	O	21	NMOD
21	explants	explant	I-NP	NNS	O	19	PMOD
22	(	(	O	(	O	23	P
23	RCC-S	RCC-S	B-NP	NNS	O	21	NMOD
24	)	)	O	)	O	23	P
25	induced	induce	B-VP	VBD	O	16	SBAR
26	the	the	B-NP	DT	O	28	NMOD
27	same	same	I-NP	JJ	O	28	NMOD
28	phenotype	phenotype	I-NP	NN	O	25	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	31	NMOD
31	suppression	suppression	I-NP	NN	O	29	PMOD
32	in	in	B-PP	IN	O	28	NMOD
33	normal	normal	B-NP	JJ	B-cell_type	35	NMOD
34	T	T	I-NP	NN	I-cell_type	35	NMOD
35	cells	cell	I-NP	NNS	I-cell_type	32	PMOD
36	that	that	B-NP	WDT	O	28	NMOD
37	is	be	B-VP	VBZ	O	36	SBAR
38	observed	observe	I-VP	VBN	O	37	VC
39	in	in	B-PP	IN	O	38	VMOD
40	patient	patient	B-NP	NN	O	42	NMOD
41	T	T	I-NP	NN	O	42	NMOD
42	cells	cell	I-NP	NNS	O	39	PMOD
43	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	pattern	pattern	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	kappaB-binding	kappaB-binding	B-NP	JJ	O	5	NMOD
5	activity	activity	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	RCC	RCC	B-NP	NN	O	11	NMOD
11	patient	patient	I-NP	NN	O	9	PMOD
12	was	be	B-VP	VBD	O	0	ROOT
13	altered	alter	I-VP	VBN	O	12	VC
14	as	as	B-SBAR	IN	O	13	VMOD
15	compared	compare	B-VP	VBN	O	14	SBAR
16	to	to	B-PP	TO	O	15	VMOD
17	that	that	B-NP	DT	O	16	PMOD
18	seen	see	B-VP	VBN	O	17	NMOD
19	in	in	B-PP	IN	O	18	VMOD
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
22	obtained	obtain	B-VP	VBN	O	21	NMOD
23	from	from	B-PP	IN	O	22	VMOD
24	normal	normal	B-NP	JJ	O	25	NMOD
25	volunteers	volunteer	I-NP	NNS	O	23	PMOD
26	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	10	VMOD
2	some	some	B-NP	DT	O	3	NMOD
3	patients	patient	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	10	P
5	no	no	B-NP	DT	O	6	NMOD
6	activation	activation	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	RelA/NFkappaB1-binding	RelA/NFkappaB1-binding	B-NP	JJ	O	9	NMOD
9	activity	activity	I-NP	NN	O	7	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	detectable	detectable	B-ADJP	JJ	O	10	PRD
12	,	,	O	,	O	10	P
13	while	while	B-SBAR	IN	O	10	VMOD
14	in	in	B-PP	IN	O	18	VMOD
15	others	other	B-NP	NNS	O	14	PMOD
16	kappaB-binding	kappaB-binding	B-NP	JJ	O	17	NMOD
17	activity	activity	I-NP	NN	O	18	SUB
18	was	be	B-VP	VBD	O	24	VMOD
19	modestly	modestly	I-VP	RB	O	18	VMOD
20	induced	induce	I-VP	VBN	O	18	VC
21	but	but	O	CC	O	24	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	duration	duration	I-NP	NN	O	24	SUB
24	was	be	B-VP	VBD	O	13	SBAR
25	reduced	reduce	I-VP	VBN	O	24	VC
26	.	.	O	.	O	10	P

1	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	degraded	degrade	I-VP	VBN	O	2	VC
4	normally	normally	B-ADVP	RB	O	3	VMOD
5	following	follow	B-PP	VBG	O	3	VMOD
6	stimulation	stimulation	B-NP	NN	O	5	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	both	both	B-NP	CC	O	13	NMOD
9	normal	normal	I-NP	JJ	O	10	NMOD
10	controls	control	I-NP	NNS	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	T	T	B-NP	NN	B-cell_type	13	NMOD
13	cells	cell	B-NP	NNS	I-cell_type	7	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	RCC	RCC	B-NP	NN	O	16	NMOD
16	patients	patient	I-NP	NNS	O	14	PMOD
17	.	.	O	.	O	2	P

1	RCC-S	RCC-S	B-NP	NNS	O	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	alter	alter	I-VP	VB	O	2	VC
5	the	the	B-NP	DT	O	7	NMOD
6	cytoplasmic	cytoplasmic	I-NP	JJ	O	7	NMOD
7	levels	level	I-NP	NNS	O	4	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	RelA	RelA	B-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	NF-kappaB1	NF-kappaB1	I-NP	NN	B-protein	8	PMOD
12	but	but	O	CC	O	2	VMOD
13	did	do	B-VP	VBD	O	2	VMOD
14	suppress	suppress	I-VP	VB	O	13	VC
15	their	their	B-NP	PRP$	O	17	NMOD
16	nuclear	nuclear	I-NP	JJ	O	17	NMOD
17	localization	localization	I-NP	NN	O	14	OBJ
18	and	and	O	CC	O	2	VMOD
19	inhibited	inhibit	B-VP	VBD	O	2	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	activation	activation	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	RelA/NF-kappaB1	RelA/NF-kappaB1	B-NP	NN	B-protein	25	NMOD
24	binding	binding	I-NP	NN	I-protein	25	NMOD
25	complexes	complex	I-NP	NNS	I-protein	22	PMOD
26	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	RCC-S	RCC-S	B-NP	NNS	O	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	induce	induce	I-VP	VB	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	normal	normal	B-NP	JJ	B-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
12	the	the	B-NP	DT	O	14	NMOD
13	same	same	I-NP	JJ	O	14	NMOD
14	phenotype	phenotype	I-NP	NN	O	7	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	impaired	impaired	B-NP	JJ	O	18	NMOD
17	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	18	NMOD
18	activation	activation	I-NP	NN	O	15	PMOD
19	that	that	B-NP	WDT	O	18	NMOD
20	is	be	B-VP	VBZ	O	19	SBAR
21	detected	detect	I-VP	VBN	O	20	VC
22	in	in	B-PP	IN	O	21	VMOD
23	T	T	B-NP	NN	B-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	RCC	RCC	B-NP	NN	O	27	NMOD
27	patient	patient	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	3	P

1	It	It	B-NP	PRP	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	appears	appear	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	6	NMOD
6	suppression	suppression	I-NP	NN	O	9	SUB
7	by	by	B-PP	IN	O	6	NMOD
8	RCC-S	RCC-S	B-NP	NNS	O	7	PMOD
9	may	may	B-VP	MD	O	4	SBAR
10	contribute	contribute	I-VP	VB	O	9	VC
11	to	to	B-PP	TO	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	immunosuppression	immunosuppression	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	host	host	B-NP	NN	O	16	NMOD
16	immunity	immunity	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	3	P

1	Monoclonal	Monoclonal	B-NP	JJ	B-protein	4	NMOD
2	anti-endothelial	anti-endothelial	I-NP	JJ	I-protein	4	NMOD
3	cell	cell	I-NP	NN	I-protein	4	NMOD
4	antibodies	antibody	I-NP	NNS	I-protein	11	SUB
5	from	from	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	7	NMOD
7	patient	patient	I-NP	NN	O	5	PMOD
8	with	with	B-PP	IN	O	7	NMOD
9	Takayasu	Takayasu	B-NP	NN	O	10	NMOD
10	arteritis	arteritis	I-NP	NN	O	8	PMOD
11	activate	activate	B-VP	VBP	O	0	ROOT
12	endothelial	endothelial	B-NP	JJ	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	OBJ
14	from	from	B-PP	IN	O	11	VMOD
15	large	large	B-NP	JJ	O	16	NMOD
16	vessels	vessel	I-NP	NNS	O	14	PMOD
17	.	.	O	.	O	11	P

1	OBJECTIVE	OBJECTIVE	B-NP	NN	O	0	ROOT
2	:	:	O	:	O	1	P
3	To	To	B-VP	TO	O	4	VMOD
4	create	create	I-VP	VB	O	1	NMOD
5	monoclonal	monoclonal	B-NP	JJ	B-protein	8	NMOD
6	anti-endothelial	anti-endothelial	I-NP	JJ	I-protein	8	NMOD
7	cell	cell	I-NP	NN	I-protein	8	NMOD
8	antibodies	antibody	I-NP	NNS	I-protein	4	OBJ
9	(	(	O	(	O	10	P
10	mAECA	mAECA	B-NP	NNS	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	from	from	B-PP	IN	O	8	NMOD
13	a	a	B-NP	DT	O	14	NMOD
14	patient	patient	I-NP	NN	O	12	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	Takayasu	Takayasu	B-NP	NN	O	17	NMOD
17	arteritis	arteritis	I-NP	NN	O	15	PMOD
18	to	to	B-VP	TO	O	19	VMOD
19	evaluate	evaluate	I-VP	VB	O	17	NMOD
20	their	their	B-NP	PRP$	O	21	NMOD
21	ability	ability	I-NP	NN	O	19	OBJ
22	to	to	B-VP	TO	O	23	VMOD
23	activate	activate	I-VP	VB	O	21	NMOD
24	human	human	B-NP	JJ	B-cell_type	28	NMOD
25	umbilical	umbilical	I-NP	JJ	I-cell_type	28	NMOD
26	vein	vein	I-NP	NN	I-cell_type	28	NMOD
27	endothelial	endothelial	I-NP	JJ	I-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	23	OBJ
29	(	(	O	(	O	30	P
30	HUVEC	HUVEC	B-NP	NNS	B-cell_line	28	NMOD
31	)	)	O	)	O	30	P
32	,	,	O	,	O	4	P
33	and	and	O	CC	O	4	VMOD
34	to	to	B-VP	TO	O	35	VMOD
35	characterize	characterize	I-VP	VB	O	4	VMOD
36	the	the	B-NP	DT	O	37	NMOD
37	mechanism	mechanism	I-NP	NN	O	35	OBJ
38	of	of	B-PP	IN	O	37	NMOD
39	EC	EC	B-NP	NN	B-cell_type	40	NMOD
40	activation	activation	I-NP	NN	O	38	PMOD
41	.	.	O	.	O	4	P

1	METHODS	METHODS	B-NP	NNS	O	4	NMOD
2	:	:	O	:	O	1	P
3	A	A	B-NP	DT	O	4	NMOD
4	panel	panel	I-NP	NN	O	7	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	mAECA	mAECA	B-NP	NNS	B-protein	5	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	generated	generate	I-VP	VBN	O	7	VC
9	from	from	B-PP	IN	O	8	VMOD
10	peripheral	peripheral	B-NP	JJ	B-cell_type	12	NMOD
11	blood	blood	I-NP	NN	I-cell_type	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	15	NMOD
15	patient	patient	I-NP	NN	O	13	PMOD
16	with	with	B-PP	IN	O	15	NMOD
17	Takayasu	Takayasu	B-NP	NN	O	18	NMOD
18	arteritis	arteritis	I-NP	NN	O	16	PMOD
19	,	,	O	,	O	8	P
20	using	use	B-VP	VBG	O	8	VMOD
21	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	23	NMOD
22	virus	virus	I-NP	NN	O	23	NMOD
23	transformation	transformation	I-NP	NN	O	20	OBJ
24	.	.	O	.	O	7	P

1	Activity	Activity	B-NP	NN	O	21	SUB
2	against	against	B-PP	IN	O	1	NMOD
3	macrovascular	macrovascular	B-NP	JJ	B-cell_line	4	NMOD
4	EC	EC	I-NP	NN	I-cell_line	10	NMOD
5	(	(	O	(	O	6	P
6	HUVEC	HUVEC	B-NP	NN	B-cell_line	4	NMOD
7	)	)	O	)	O	6	P
8	and	and	O	CC	O	10	NMOD
9	microvascular	microvascular	B-NP	JJ	B-cell_line	10	NMOD
10	EC	EC	I-NP	NN	I-cell_line	15	NMOD
11	(	(	O	(	O	15	P
12	human	human	B-NP	JJ	B-cell_line	15	NMOD
13	bone	bone	I-NP	NN	I-cell_line	15	NMOD
14	marrow	marrow	I-NP	NN	I-cell_line	15	NMOD
15	EC	EC	I-NP	NN	I-cell_line	20	NMOD
16	immortalized	immortalize	B-VP	VBN	I-cell_line	15	NMOD
17	by	by	B-PP	IN	I-cell_line	16	VMOD
18	SV40	SV40	B-NP	NN	I-cell_line	17	PMOD
19	)	)	O	)	O	15	P
20	antigens	antigen	B-NP	NNS	O	2	PMOD
21	was	be	B-VP	VBD	O	0	ROOT
22	detected	detect	I-VP	VBN	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	enzyme-linked	enzyme-linked	B-NP	JJ	O	26	NMOD
25	immunosorbent	immunosorbent	I-NP	JJ	O	26	NMOD
26	assay	assay	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	21	P

1	Inhibition	Inhibition	B-NP	NN	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	used	use	I-VP	VBN	O	3	VC
5	to	to	B-VP	TO	O	6	VMOD
6	select	select	I-VP	VB	O	4	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	monoclonal	monoclonal	I-NP	JJ	B-protein	9	NMOD
9	antibodies	antibody	I-NP	NNS	I-protein	6	OBJ
10	(	(	O	(	O	11	P
11	mAECA	mAECA	B-NP	NNS	B-protein	9	NMOD
12	)	)	O	)	O	11	P
13	which	which	B-NP	WDT	O	9	NMOD
14	share	share	B-VP	VBP	O	13	SBAR
15	the	the	B-NP	DT	O	20	NMOD
16	same	same	I-NP	JJ	O	20	NMOD
17	EC	EC	I-NP	NN	O	20	NMOD
18	epitope	epitope	I-NP	NN	O	20	NMOD
19	binding	binding	I-NP	NN	O	20	NMOD
20	specificity	specificity	I-NP	NN	O	14	OBJ
21	as	as	B-PP	IN	O	14	VMOD
22	the	the	B-NP	DT	O	24	NMOD
23	total	total	I-NP	JJ	B-protein	24	NMOD
24	IgG-AECA	IgG-AECA	I-NP	NN	I-protein	21	PMOD
25	from	from	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	Takayasu	Takayasu	I-NP	NN	O	29	NMOD
28	arteritis	arteritis	I-NP	NN	O	29	NMOD
29	patient	patient	I-NP	NN	O	25	PMOD
30	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	binding	binding	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	mAECA	mAECA	I-NP	NNS	B-protein	3	PMOD
6	to	to	B-PP	TO	O	2	NMOD
7	human	human	B-NP	JJ	B-cell_type	9	NMOD
8	aortic	aortic	I-NP	JJ	I-cell_type	9	NMOD
9	EC	EC	I-NP	NN	I-cell_type	6	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	studied	study	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	immunohistochemistry	immunohistochemistry	B-NP	NN	O	12	PMOD
14	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	secretion	secretion	I-NP	NN	O	3	NMOD
3	levels	level	I-NP	NNS	O	16	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	interleukin-6	interleukin-6	B-NP	NN	B-protein	12	NMOD
6	(	(	O	(	O	7	P
7	IL-6	IL-6	B-NP	NN	B-protein	5	NMOD
8	)	)	O	)	O	7	P
9	and	and	O	CC	O	12	NMOD
10	von	von	B-NP	NN	B-protein	12	NMOD
11	Willebrand	Willebrand	I-NP	NN	I-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	4	PMOD
13	(	(	O	(	O	14	P
14	vWF	vWF	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	were	be	B-VP	VBD	O	0	ROOT
17	determined	determine	I-VP	VBN	O	16	VC
18	,	,	O	,	O	17	P
19	to	to	B-VP	TO	O	20	VMOD
20	serve	serve	I-VP	VB	O	17	VMOD
21	as	as	B-PP	IN	O	20	VMOD
22	markers	marker	B-NP	NNS	O	21	PMOD
23	for	for	B-PP	IN	O	22	NMOD
24	EC	EC	B-NP	NN	B-cell_type	25	NMOD
25	activation	activation	I-NP	NN	O	23	PMOD
26	.	.	O	.	O	16	P

1	The	The	B-NP	DT	O	3	NMOD
2	activated	activate	I-NP	VBN	B-cell_line	3	NMOD
3	EC	EC	I-NP	NN	I-cell_line	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	examined	examine	I-VP	VBN	O	4	VC
6	for	for	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	adherence	adherence	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	13	NMOD
11	monocytic	monocytic	I-NP	JJ	B-cell_line	13	NMOD
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD
13	line	line	I-NP	NN	I-cell_line	9	PMOD
14	(	(	O	(	O	15	P
15	U937	U937	B-NP	NN	B-cell_line	13	NMOD
16	)	)	O	)	O	15	P
17	,	,	O	,	O	6	P
18	as	as	B-CONJP	RB	O	6	PMOD
19	well	well	I-CONJP	RB	O	18	DEP
20	as	as	I-CONJP	IN	O	18	DEP
21	for	for	B-PP	IN	O	6	PMOD
22	expression	expression	B-NP	NN	O	21	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	vascular	vascular	B-NP	JJ	B-protein	27	NMOD
25	cell	cell	I-NP	NN	I-protein	27	NMOD
26	adhesion	adhesion	I-NP	NN	I-protein	27	NMOD
27	molecule	molecule	I-NP	NN	I-protein	36	NMOD
28	1	1	I-NP	CD	I-protein	27	NMOD
29	,	,	I-NP	,	O	32	P
30	intercellular	intercellular	I-NP	JJ	B-protein	32	NMOD
31	adhesion	adhesion	I-NP	NN	I-protein	32	NMOD
32	molecule	molecule	I-NP	NN	I-protein	27	NMOD
33	1	1	I-NP	CD	I-protein	32	NMOD
34	,	,	O	,	O	32	P
35	and	and	O	CC	O	36	NMOD
36	E-selectin	E-selectin	B-NP	NN	B-protein	23	PMOD
37	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	10	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	nuclear	nuclear	B-NP	JJ	O	5	NMOD
5	extracts	extract	I-NP	NNS	O	10	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	mAECA-treated	mAECA-treated	I-NP	JJ	B-cell_line	9	NMOD
9	EC	EC	I-NP	NN	I-cell_line	6	PMOD
10	were	be	B-VP	VBD	O	0	ROOT
11	analyzed	analyze	I-VP	VBN	O	10	VC
12	for	for	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	induction	induction	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	translocation	translocation	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	nuclear	nuclear	B-NP	JJ	B-protein	20	NMOD
19	factor	factor	I-NP	NN	I-protein	20	NMOD
20	kappaB	kappaB	I-NP	NN	I-protein	17	PMOD
21	(	(	O	(	O	22	P
22	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	20	NMOD
23	)	)	O	)	O	22	P
24	,	,	O	,	O	10	P
25	using	use	B-VP	VBG	O	10	VMOD
26	a	a	B-NP	DT	O	29	NMOD
27	specific	specific	I-NP	JJ	O	29	NMOD
28	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	29	NMOD
29	oligoprobe	oligoprobe	I-NP	NN	O	25	OBJ
30	in	in	B-PP	IN	O	29	NMOD
31	an	an	B-NP	DT	O	35	NMOD
32	electrophoretic	electrophoretic	I-NP	JJ	O	35	NMOD
33	mobility	mobility	I-NP	NN	O	35	NMOD
34	shift	shift	I-NP	NN	O	35	NMOD
35	assay	assay	I-NP	NN	O	30	PMOD
36	.	.	O	.	O	10	P

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT
2	:	:	O	:	O	1	P
3	Six	Six	B-NP	CD	O	4	NMOD
4	mAECA	mAECA	I-NP	NNS	B-protein	5	SUB
5	were	be	B-VP	VBD	O	1	NMOD
6	selected	select	I-VP	VBN	O	5	VC
7	,	,	O	,	O	5	P
8	the	the	B-NP	DT	O	9	NMOD
9	mixture	mixture	I-NP	NN	O	5	PRD
10	of	of	B-PP	IN	O	9	NMOD
11	which	which	B-NP	WDT	O	10	PMOD
12	produced	produce	B-VP	VBD	O	10	SBAR
13	100	100	B-NP	CD	O	14	AMOD
14	%	%	I-NP	NN	O	15	NMOD
15	inhibition	inhibition	I-NP	NN	O	12	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	binding	binding	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	original	original	I-NP	JJ	O	21	NMOD
21	IgG	IgG	I-NP	NN	B-protein	18	PMOD
22	(	(	O	(	O	21	P
23	from	from	B-PP	IN	O	21	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	patient	patient	I-NP	NN	O	23	PMOD
26	with	with	B-PP	IN	O	25	NMOD
27	Takayasu	Takayasu	B-NP	NN	O	28	NMOD
28	arteritis	arteritis	I-NP	NN	O	26	PMOD
29	)	)	O	)	O	21	P
30	to	to	B-PP	TO	O	17	NMOD
31	HUVEC	HUVEC	B-NP	NN	B-cell_line	30	PMOD
32	.	.	O	.	O	1	P

1	All	All	B-NP	DT	O	2	NMOD
2	mAECA	mAECA	I-NP	NNS	B-protein	3	SUB
3	possessed	possess	B-VP	VBD	O	12	VMOD
4	high	high	B-NP	JJ	O	5	NMOD
5	activity	activity	I-NP	NN	O	3	OBJ
6	against	against	B-PP	IN	O	3	VMOD
7	macrovascular	macrovascular	B-NP	JJ	B-cell_line	8	NMOD
8	EC	EC	I-NP	NN	I-cell_line	6	PMOD
9	,	,	O	,	O	12	P
10	but	but	O	CC	O	11	NMOD
11	none	none	B-NP	NN	O	12	SUB
12	had	have	B-VP	VBD	O	0	ROOT
13	significant	significant	B-NP	JJ	O	14	AMOD
14	antimicrovascular	antimicrovascular	I-NP	JJ	O	16	NMOD
15	EC	EC	I-NP	NN	O	16	NMOD
16	activity	activity	I-NP	NN	O	12	OBJ
17	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	2	NMOD
2	mAECA	mAECA	I-NP	NNS	B-protein	8	NMOD
3	,	,	O	,	O	8	P
4	but	but	O	CC	O	8	NMOD
5	not	not	O	RB	O	4	DEP
6	normal	normal	B-NP	JJ	B-protein	8	NMOD
7	human	human	I-NP	JJ	I-protein	8	NMOD
8	IgG	IgG	I-NP	NN	I-protein	10	SUB
9	,	,	O	,	O	8	P
10	had	have	B-VP	VBD	O	0	ROOT
11	anti-human	anti-human	B-NP	JJ	O	14	NMOD
12	aortic	aortic	I-NP	JJ	O	14	NMOD
13	EC	EC	I-NP	NN	O	14	NMOD
14	activity	activity	I-NP	NN	O	10	OBJ
15	.	.	O	.	O	10	P

1	Four	Four	B-NP	CD	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	6	6	I-NP	CD	O	5	NMOD
5	mAECA	mAECA	I-NP	NNS	B-protein	2	PMOD
6	activated	activate	B-VP	VBD	O	0	ROOT
7	EC	EC	B-NP	NN	B-cell_type	6	OBJ
8	,	,	O	,	O	7	P
9	manifested	manifest	B-VP	VBN	O	7	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	increased	increase	B-NP	VBN	O	15	NMOD
12	IL-6	IL-6	I-NP	NN	B-protein	15	NMOD
13	and	and	I-NP	CC	O	15	NMOD
14	vWF	vWF	I-NP	NN	B-protein	15	NMOD
15	secretion	secretion	I-NP	NN	O	10	PMOD
16	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	4	4	I-NP	CD	O	3	NMOD
3	mAECA	mAECA	I-NP	NNS	B-protein	4	SUB
4	induced	induce	B-VP	VBD	O	0	ROOT
5	EC	EC	B-NP	NN	B-cell_type	6	NMOD
6	expression	expression	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	adhesion	adhesion	B-NP	NN	B-protein	9	NMOD
9	molecules	molecule	I-NP	NNS	I-protein	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	increased	increase	B-NP	VBN	O	12	NMOD
12	adhesion	adhesion	I-NP	NN	O	7	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	U937	U937	B-NP	NN	B-cell_line	16	NMOD
15	monocytic	monocytic	I-NP	JJ	I-cell_line	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
17	to	to	B-PP	TO	O	12	NMOD
18	EC	EC	B-NP	NN	B-cell_type	17	PMOD
19	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	6	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	mAECA	mAECA	I-NP	NNS	B-protein	6	SUB
6	stimulated	stimulate	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	9	NMOD
8	nuclear	nuclear	I-NP	JJ	O	9	NMOD
9	translocation	translocation	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	14	NMOD
13	transcription	transcription	I-NP	NN	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	10	PMOD
15	.	.	O	.	O	6	P

1	CONCLUSION	CONCLUSION	B-NP	NN	O	5	SUB
2	:	:	O	:	O	1	P
3	Our	Our	B-NP	PRP$	O	4	NMOD
4	findings	finding	I-NP	NNS	O	1	NMOD
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	AECA	AECA	B-NP	NNS	B-protein	8	SUB
8	may	may	B-VP	MD	O	6	SBAR
9	directly	directly	I-VP	RB	O	8	VMOD
10	stimulate	stimulate	I-VP	VB	O	8	VC
11	EC	EC	B-NP	NN	B-cell_type	10	OBJ
12	in	in	B-PP	IN	O	10	VMOD
13	Takayasu	Takayasu	B-NP	NN	O	14	NMOD
14	arteritis	arteritis	I-NP	NN	O	12	PMOD
15	through	through	B-PP	IN	O	10	VMOD
16	elevation	elevation	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	adhesion	adhesion	B-NP	NN	B-protein	20	NMOD
19	molecule	molecule	I-NP	NN	I-protein	20	NMOD
20	expression	expression	I-NP	NN	O	17	PMOD
21	associated	associate	B-VP	VBN	O	20	NMOD
22	with	with	B-PP	IN	O	21	VMOD
23	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	24	NMOD
24	activation	activation	I-NP	NN	O	26	NMOD
25	and	and	O	CC	O	26	NMOD
26	adhesion	adhesion	B-NP	NN	O	22	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	monocytes	monocyte	B-NP	NNS	B-cell_type	27	PMOD
29	,	,	O	,	O	5	P
30	and	and	O	CC	O	5	VMOD
31	may	may	B-VP	MD	O	5	VMOD
32	therefore	therefore	I-VP	RB	O	31	VMOD
33	play	play	I-VP	VB	O	31	VC
34	a	a	B-NP	DT	O	36	NMOD
35	pathogenic	pathogenic	I-NP	JJ	O	36	NMOD
36	role	role	I-NP	NN	O	33	OBJ
37	in	in	B-PP	IN	O	33	VMOD
38	the	the	B-NP	DT	O	39	NMOD
39	development	development	I-NP	NN	O	37	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	42	NMOD
42	vasculopathy	vasculopathy	I-NP	NN	O	40	PMOD
43	in	in	B-PP	IN	O	39	NMOD
44	Takayasu	Takayasu	B-NP	NN	O	45	NMOD
45	arteritis	arteritis	I-NP	NN	O	43	PMOD
46	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	7	NMOD
2	Epstein-Barr	Epstein-Barr	I-NP	JJ	B-protein	7	NMOD
3	virus	virus	I-NP	NN	I-protein	7	NMOD
4	oncoprotein	oncoprotein	I-NP	NN	I-protein	7	NMOD
5	latent	latent	I-NP	JJ	I-protein	7	NMOD
6	membrane	membrane	I-NP	NN	I-protein	7	NMOD
7	protein	protein	I-NP	NN	I-protein	9	SUB
8	1	1	I-NP	CD	I-protein	7	NMOD
9	engages	engage	B-VP	VBZ	O	0	ROOT
10	the	the	B-NP	DT	O	15	NMOD
11	tumor	tumor	I-NP	NN	B-protein	15	NMOD
12	necrosis	necrosis	I-NP	NN	I-protein	15	NMOD
13	factor	factor	I-NP	NN	I-protein	15	NMOD
14	receptor-associated	receptor-associated	I-NP	JJ	I-protein	15	NMOD
15	proteins	protein	I-NP	NNS	I-protein	9	OBJ
16	TRADD	TRADD	I-NP	NN	B-protein	19	NMOD
17	and	and	O	CC	O	19	NMOD
18	receptor-interacting	receptor-interacting	B-NP	JJ	B-protein	19	NMOD
19	protein	protein	I-NP	NN	I-protein	15	NMOD
20	(	(	O	(	O	21	P
21	RIP	RIP	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	but	but	O	CC	O	9	VMOD
24	does	do	B-VP	VBZ	O	9	VMOD
25	not	not	I-VP	RB	O	24	VMOD
26	induce	induce	I-VP	VB	O	24	VC
27	apoptosis	apoptosis	B-NP	NN	O	26	OBJ
28	or	or	O	CC	O	26	VMOD
29	require	require	B-VP	VB	O	26	VMOD
30	RIP	RIP	B-NP	NN	B-protein	29	OBJ
31	for	for	B-PP	IN	O	29	VMOD
32	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	33	NMOD
33	activation	activation	I-NP	NN	O	31	PMOD
34	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	2	NMOD
2	site	site	I-NP	NN	O	39	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	12	NMOD
5	Epstein-Barr	Epstein-Barr	I-NP	JJ	B-protein	11	NMOD
6	virus	virus	I-NP	NN	I-protein	11	NMOD
7	(	(	O	(	I-protein	8	P
8	EBV	EBV	B-NP	NN	I-protein	6	NMOD
9	)	)	O	)	I-protein	8	P
10	transforming	transform	B-VP	VBG	I-protein	11	NMOD
11	protein	protein	B-NP	NN	I-protein	12	NMOD
12	LMP1	LMP1	I-NP	NN	B-protein	3	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	constitutively	constitutively	B-ADVP	RB	O	15	VMOD
15	associates	associate	B-VP	VBZ	O	13	SBAR
16	with	with	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	30	NMOD
18	tumor	tumor	I-NP	NN	B-protein	30	NMOD
19	necrosis	necrosis	I-NP	NN	I-protein	30	NMOD
20	factor	factor	I-NP	NN	I-protein	30	NMOD
21	receptor	receptor	I-NP	NN	I-protein	30	NMOD
22	1	1	I-NP	CD	I-protein	30	NMOD
23	(	(	I-NP	(	I-protein	30	P
24	TNFR1	TNFR1	I-NP	NN	I-protein	30	NMOD
25	)	)	I-NP	)	I-protein	30	P
26	-associated	-associated	I-NP	JJ	I-protein	30	NMOD
27	death	death	I-NP	NN	I-protein	30	NMOD
28	domain	domain	I-NP	NN	I-protein	30	NMOD
29	protein	protein	I-NP	NN	I-protein	30	NMOD
30	TRADD	TRADD	I-NP	NN	B-protein	16	PMOD
31	to	to	B-VP	TO	O	32	VMOD
32	mediate	mediate	I-VP	VB	O	15	VMOD
33	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	38	NMOD
34	and	and	I-NP	CC	O	38	NMOD
35	c-Jun	c-Jun	I-NP	NN	B-protein	38	NMOD
36	N-terminal	N-terminal	I-NP	JJ	I-protein	38	NMOD
37	kinase	kinase	I-NP	NN	I-protein	38	NMOD
38	activation	activation	I-NP	NN	O	32	OBJ
39	is	be	B-VP	VBZ	O	0	ROOT
40	critical	critical	B-ADJP	JJ	O	39	PRD
41	for	for	B-PP	IN	O	40	AMOD
42	long-term	long-term	B-NP	JJ	O	45	NMOD
43	lymphoblastoid	lymphoblastoid	I-NP	JJ	O	45	NMOD
44	cell	cell	I-NP	NN	O	45	NMOD
45	proliferation	proliferation	I-NP	NN	O	41	PMOD
46	.	.	O	.	O	39	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	find	find	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	LMP1	LMP1	B-NP	NN	B-protein	6	NMOD
6	signaling	signaling	I-NP	NN	O	9	SUB
7	through	through	B-PP	IN	O	6	NMOD
8	TRADD	TRADD	B-NP	NN	B-protein	7	PMOD
9	differs	differ	B-VP	VBZ	O	4	SBAR
10	from	from	B-PP	IN	O	9	VMOD
11	TNFR1	TNFR1	B-NP	NN	B-protein	12	NMOD
12	signaling	signaling	I-NP	NN	O	10	PMOD
13	through	through	B-PP	IN	O	12	NMOD
14	TRADD	TRADD	B-NP	NN	B-protein	13	PMOD
15	.	.	O	.	O	3	P

1	LMP1	LMP1	B-NP	NN	B-protein	2	SUB
2	needs	need	B-VP	VBZ	O	0	ROOT
3	only	only	B-NP	RB	O	6	NMOD
4	11	11	I-NP	CD	O	3	AMOD
5	amino	amino	I-NP	NN	O	6	NMOD
6	acids	acid	I-NP	NNS	O	2	OBJ
7	to	to	B-VP	TO	O	8	VMOD
8	activate	activate	I-VP	VB	O	2	VMOD
9	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	8	OBJ
10	or	or	O	CC	O	2	VMOD
11	synergize	synergize	B-VP	VB	O	2	VMOD
12	with	with	B-PP	IN	O	11	VMOD
13	TRADD	TRADD	B-NP	NN	B-protein	12	PMOD
14	in	in	B-PP	IN	O	11	VMOD
15	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	16	NMOD
16	activation	activation	I-NP	NN	O	14	PMOD
17	,	,	O	,	O	2	P
18	while	while	B-SBAR	IN	O	2	VMOD
19	TNFR1	TNFR1	B-NP	NN	B-protein	20	SUB
20	requires	require	B-VP	VBZ	O	18	SBAR
21	approximately	approximately	B-NP	RB	O	23	NMOD
22	70	70	I-NP	CD	O	21	AMOD
23	residues	residue	I-NP	NNS	O	20	OBJ
24	.	.	O	.	O	2	P

1	Further	Further	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	LMP1	LMP1	B-NP	NN	B-protein	4	SUB
4	does	do	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	require	require	I-VP	VB	O	4	VC
7	TRADD	TRADD	B-NP	NN	B-protein	8	NMOD
8	residues	residue	I-NP	NNS	O	6	OBJ
9	294	294	B-NP	CD	O	11	NMOD
10	to	to	B-PP	TO	O	11	NMOD
11	312	312	B-NP	CD	O	8	NMOD
12	for	for	B-PP	IN	O	8	NMOD
13	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	14	NMOD
14	activation	activation	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	4	P
16	while	while	B-SBAR	IN	O	4	VMOD
17	TNFR1	TNFR1	B-NP	NN	B-protein	18	SUB
18	requires	require	B-VP	VBZ	O	16	SBAR
19	TRADD	TRADD	B-NP	NN	B-protein	20	NMOD
20	residues	residue	I-NP	NNS	O	18	OBJ
21	296	296	B-NP	CD	O	23	AMOD
22	to	to	B-PP	TO	O	23	AMOD
23	302	302	B-NP	CD	O	20	NMOD
24	.	.	O	.	O	4	P

1	LMP1	LMP1	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	partially	partially	I-VP	RB	O	2	VMOD
4	blocked	block	I-VP	VBN	O	2	VC
5	for	for	B-PP	IN	O	4	VMOD
6	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	7	NMOD
7	activation	activation	I-NP	NN	O	5	PMOD
8	by	by	B-PP	IN	O	4	VMOD
9	a	a	B-NP	DT	O	11	NMOD
10	TRADD	TRADD	I-NP	NN	B-protein	11	NMOD
11	mutant	mutant	I-NP	NN	O	8	PMOD
12	consisting	consist	B-VP	VBG	O	11	NMOD
13	of	of	B-PP	IN	O	12	VMOD
14	residues	residue	B-NP	NNS	B-protein	13	PMOD
15	122	122	B-NP	CD	I-protein	17	NMOD
16	to	to	B-PP	TO	I-protein	17	NMOD
17	293	293	B-NP	CD	I-protein	14	NMOD
18	.	.	O	.	O	2	P

1	Unlike	Unlike	B-PP	IN	O	5	VMOD
2	TNFR1	TNFR1	B-NP	NN	B-protein	1	PMOD
3	,	,	O	,	O	5	P
4	LMP1	LMP1	B-NP	NN	B-protein	5	SUB
5	can	can	B-VP	MD	O	0	ROOT
6	interact	interact	I-VP	VB	O	5	VC
7	directly	directly	B-ADVP	RB	O	6	VMOD
8	with	with	B-PP	IN	O	6	VMOD
9	receptor-interacting	receptor-interacting	B-NP	JJ	B-protein	10	NMOD
10	protein	protein	I-NP	NN	I-protein	8	PMOD
11	(	(	O	(	O	12	P
12	RIP	RIP	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	and	and	O	CC	O	6	VMOD
15	stably	stably	B-VP	RB	O	16	VMOD
16	associates	associate	I-VP	VBZ	O	6	VMOD
17	with	with	B-PP	IN	O	16	VMOD
18	RIP	RIP	B-NP	NN	B-protein	17	PMOD
19	in	in	B-PP	IN	O	16	VMOD
20	EBV-transformed	EBV-transformed	B-NP	JJ	B-cell_line	23	NMOD
21	lymphoblastoid	lymphoblastoid	I-NP	JJ	I-cell_line	23	NMOD
22	cell	cell	I-NP	NN	I-cell_line	23	NMOD
23	lines	line	I-NP	NNS	I-cell_line	19	PMOD
24	.	.	O	.	O	5	P

1	Surprisingly	Surprisingly	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	LMP1	LMP1	B-NP	NN	B-protein	4	SUB
4	does	do	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	require	require	I-VP	VB	O	4	VC
7	RIP	RIP	B-NP	NN	B-protein	6	OBJ
8	for	for	B-PP	IN	O	6	VMOD
9	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	8	PMOD
11	.	.	O	.	O	4	P

1	Despite	Despite	B-PP	IN	O	10	VMOD
2	constitutive	constitutive	B-NP	JJ	O	3	NMOD
3	association	association	I-NP	NN	O	1	PMOD
4	with	with	B-PP	IN	O	3	NMOD
5	TRADD	TRADD	B-NP	NN	B-protein	7	NMOD
6	or	or	I-NP	CC	O	7	NMOD
7	RIP	RIP	I-NP	NN	B-protein	4	PMOD
8	,	,	O	,	O	10	P
9	LMP1	LMP1	B-NP	NN	B-protein	10	SUB
10	does	do	B-VP	VBZ	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	induce	induce	I-VP	VB	O	10	VC
13	apoptosis	apoptosis	B-NP	NN	O	12	OBJ
14	in	in	B-PP	IN	O	12	VMOD
15	EBV-negative	EBV-negative	B-NP	JJ	B-cell_line	23	NMOD
16	Burkitt	Burkitt	I-NP	NN	I-cell_line	23	NMOD
17	lymphoma	lymphoma	I-NP	NN	I-cell_line	23	NMOD
18	or	or	O	CC	I-cell_line	23	NMOD
19	human	human	B-NP	JJ	I-cell_line	23	NMOD
20	embryonic	embryonic	I-NP	JJ	I-cell_line	23	NMOD
21	kidney	kidney	I-NP	NN	I-cell_line	23	NMOD
22	293	293	B-NP	CD	I-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
24	.	.	O	.	O	10	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	add	add	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	different	different	I-NP	JJ	O	6	NMOD
6	perspective	perspective	I-NP	NN	O	3	OBJ
7	to	to	B-PP	TO	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	molecular	molecular	I-NP	JJ	O	10	NMOD
10	interactions	interaction	I-NP	NNS	O	7	PMOD
11	through	through	B-PP	IN	O	10	NMOD
12	which	which	B-NP	WDT	O	11	PMOD
13	LMP1	LMP1	B-NP	NN	B-protein	18	NMOD
14	,	,	O	,	O	18	P
15	TRADD	TRADD	B-NP	NN	B-protein	18	NMOD
16	,	,	O	,	O	18	P
17	and	and	O	CC	O	18	NMOD
18	RIP	RIP	B-NP	NN	B-protein	11	PMOD
19	participate	participate	B-VP	VBP	O	3	VMOD
20	in	in	B-PP	IN	O	19	VMOD
21	B-lymphocyte	B-lymphocyte	B-NP	NN	B-cell_type	22	NMOD
22	activation	activation	B-NP	NN	O	24	NMOD
23	and	and	O	CC	O	24	NMOD
24	growth	growth	B-NP	NN	O	20	PMOD
25	.	.	O	.	O	3	P

1	Regulatory	Regulatory	B-NP	JJ	O	2	NMOD
2	effects	effect	I-NP	NNS	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	interleukin-11	interleukin-11	B-NP	NN	B-protein	3	PMOD
5	during	during	B-PP	IN	O	2	NMOD
6	acute	acute	B-NP	JJ	O	9	NMOD
7	lung	lung	I-NP	NN	O	9	NMOD
8	inflammatory	inflammatory	I-NP	JJ	O	9	NMOD
9	injury	injury	I-NP	NN	O	5	PMOD
10	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	interleukin-11	interleukin-11	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	6	P
6	IL-11	IL-11	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	was	be	B-VP	VBD	O	0	ROOT
9	evaluated	evaluate	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	15	NMOD
12	IgG	IgG	I-NP	NN	B-protein	14	NMOD
13	immune	immune	I-NP	JJ	I-protein	14	NMOD
14	complex	complex	I-NP	NN	I-protein	15	NMOD
15	model	model	I-NP	NN	O	10	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	acute	acute	B-NP	JJ	O	19	NMOD
18	lung	lung	I-NP	NN	O	19	NMOD
19	injury	injury	I-NP	NN	O	16	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	rats	rat	B-NP	NNS	O	20	PMOD
22	.	.	O	.	O	8	P

1	IL-11	IL-11	B-NP	NN	B-RNA	4	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	protein	protein	I-NP	NN	O	5	SUB
5	were	be	B-VP	VBD	O	0	ROOT
6	both	both	O	DT	O	5	VMOD
7	up-regulated	up-regulate	B-VP	VBN	O	5	VC
8	during	during	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	course	course	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	this	this	B-NP	DT	O	14	NMOD
13	inflammatory	inflammatory	I-NP	JJ	O	14	NMOD
14	response	response	I-NP	NN	O	11	PMOD
15	.	.	O	.	O	5	P

1	Exogenously	Exogenously	B-NP	RB	O	2	AMOD
2	administered	administer	I-NP	VBN	O	3	NMOD
3	IL-11	IL-11	I-NP	NN	B-protein	5	SUB
4	substantially	substantially	B-VP	RB	O	5	VMOD
5	reduced	reduce	I-VP	VBD	O	0	ROOT
6	,	,	O	,	O	5	P
7	in	in	B-PP	IN	O	5	VMOD
8	a	a	B-NP	DT	O	10	NMOD
9	dose-dependent	dose-dependent	I-NP	JJ	O	10	NMOD
10	manner	manner	I-NP	NN	O	7	PMOD
11	,	,	O	,	O	5	P
12	the	the	B-NP	DT	O	14	NMOD
13	intrapulmonary	intrapulmonary	I-NP	JJ	O	14	NMOD
14	accumulation	accumulation	I-NP	NN	O	21	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	neutrophils	neutrophil	B-NP	NNS	B-cell_type	15	PMOD
17	and	and	O	CC	O	21	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	lung	lung	I-NP	NN	O	21	NMOD
20	vascular	vascular	I-NP	JJ	O	21	NMOD
21	leak	leak	I-NP	NN	O	5	VMOD
22	of	of	B-PP	IN	O	21	NMOD
23	albumin	albumin	B-NP	NN	B-protein	22	PMOD
24	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	5	NMOD
2	in	in	I-NP	FW	O	3	AMOD
3	vivo	vivo	I-NP	FW	O	5	NMOD
4	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	5	NMOD
5	effects	effect	I-NP	NNS	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	IL-11	IL-11	B-NP	NN	B-protein	6	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	associated	associate	I-VP	VBN	O	8	VC
10	with	with	B-PP	IN	O	9	VMOD
11	reduced	reduce	B-NP	VBN	O	13	NMOD
12	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	13	NMOD
13	activation	activation	I-NP	NN	O	10	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	lung	lung	B-NP	NN	O	14	PMOD
16	,	,	O	,	O	8	P
17	reduced	reduce	B-VP	VBD	O	8	VMOD
18	levels	level	B-NP	NNS	O	17	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	tumor	tumor	B-NP	NN	B-protein	23	NMOD
21	necrosis	necrosis	I-NP	NN	I-protein	23	NMOD
22	factor	factor	I-NP	NN	I-protein	23	NMOD
23	alpha	alpha	I-NP	NN	I-protein	19	PMOD
24	(	(	O	(	O	25	P
25	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	23	NMOD
26	)	)	O	)	O	25	P
27	in	in	B-PP	IN	O	17	VMOD
28	bronchoalveolar	bronchoalveolar	B-NP	JJ	O	29	NMOD
29	lavage	lavage	I-NP	NN	O	33	NMOD
30	(	(	O	(	O	31	P
31	BAL	BAL	B-NP	NN	O	29	NMOD
32	)	)	O	)	O	31	P
33	fluids	fluid	B-NP	NNS	O	27	PMOD
34	,	,	O	,	O	17	P
35	and	and	O	CC	O	17	VMOD
36	diminished	diminish	B-VP	VBN	O	17	VMOD
37	up-regulation	up-regulation	B-NP	NN	O	36	OBJ
38	of	of	B-PP	IN	O	37	NMOD
39	lung	lung	B-NP	NN	B-protein	41	NMOD
40	vascular	vascular	I-NP	JJ	I-protein	41	NMOD
41	ICAM-1	ICAM-1	I-NP	NN	I-protein	38	PMOD
42	.	.	O	.	O	8	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	35	VMOD
3	interesting	interesting	B-ADJP	JJ	O	2	PRD
4	that	that	B-SBAR	IN	O	3	AMOD
5	IL-11	IL-11	B-NP	NN	B-protein	6	SUB
6	did	do	B-VP	VBD	O	4	SBAR
7	not	not	I-VP	RB	O	6	VMOD
8	affect	affect	I-VP	VB	O	6	VC
9	BAL	BAL	B-NP	NN	O	11	NMOD
10	fluid	fluid	I-NP	NN	O	11	NMOD
11	content	content	I-NP	NN	O	19	NMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	CXC	CXC	I-NP	NN	B-protein	15	NMOD
15	chemokines	chemokine	I-NP	NNS	I-protein	12	PMOD
16	,	,	O	,	O	19	P
17	macrophage	macrophage	B-NP	NN	B-protein	19	NMOD
18	inflammatory	inflammatory	I-NP	JJ	I-protein	19	NMOD
19	protein-2	protein-2	I-NP	NN	I-protein	26	NMOD
20	(	(	O	(	O	21	P
21	MIP-2	MIP-2	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	and	and	O	CC	O	26	NMOD
24	cytokine-inducible	cytokine-inducible	B-NP	JJ	B-protein	26	NMOD
25	neutrophil	neutrophil	I-NP	NN	I-protein	26	NMOD
26	chemoattractant	chemoattractant	I-NP	NN	I-protein	8	OBJ
27	(	(	O	(	O	28	P
28	CINC	CINC	B-NP	NN	B-protein	26	NMOD
29	)	)	O	)	O	28	P
30	;	;	O	:	O	2	P
31	the	the	B-NP	DT	O	32	NMOD
32	presence	presence	I-NP	NN	O	35	SUB
33	of	of	B-PP	IN	O	32	NMOD
34	IL-11	IL-11	B-NP	NN	B-protein	33	PMOD
35	did	do	B-VP	VBD	O	0	ROOT
36	not	not	I-VP	RB	O	35	VMOD
37	affect	affect	I-VP	VB	O	35	VC
38	these	these	B-NP	DT	O	39	NMOD
39	chemokines	chemokine	I-NP	NNS	B-protein	37	OBJ
40	.	.	O	.	O	35	P

1	However	However	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	BAL	BAL	B-NP	NN	O	4	NMOD
4	content	content	I-NP	NN	O	7	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	C5a	C5a	B-NP	NN	B-protein	5	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	reduced	reduce	I-VP	VBN	O	7	VC
9	by	by	B-PP	IN	O	8	VMOD
10	IL-11	IL-11	B-NP	NN	B-protein	9	PMOD
11	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	14	DEP
5	IL-11	IL-11	B-NP	NN	B-protein	6	SUB
6	is	be	B-VP	VBZ	O	4	SBAR
7	a	a	B-NP	DT	O	9	NMOD
8	regulatory	regulatory	I-NP	JJ	B-protein	9	NMOD
9	cytokine	cytokine	I-NP	NN	I-protein	6	PRD
10	in	in	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	12	NMOD
12	lung	lung	I-NP	NN	O	10	PMOD
13	and	and	O	CC	O	14	DEP
14	that	that	B-SBAR	IN	O	3	VMOD
15	,	,	O	,	O	14	P
16	like	like	B-PP	IN	O	26	VMOD
17	other	other	B-NP	JJ	O	18	NMOD
18	members	member	I-NP	NNS	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	this	this	B-NP	DT	O	21	NMOD
21	family	family	I-NP	NN	O	19	PMOD
22	,	,	O	,	O	26	P
23	its	its	B-NP	PRP$	O	25	NMOD
24	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	25	NMOD
25	properties	property	I-NP	NNS	O	26	SUB
26	appear	appear	B-VP	VBP	O	14	SBAR
27	to	to	I-VP	TO	O	28	VMOD
28	be	be	I-VP	VB	O	26	VMOD
29	linked	link	I-VP	VBN	O	28	VC
30	to	to	B-PP	TO	O	29	VMOD
31	its	its	B-NP	PRP$	O	32	NMOD
32	suppression	suppression	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	35	NMOD
35	activation	activation	I-NP	NN	O	33	PMOD
36	,	,	O	,	O	14	P
37	diminished	diminish	B-VP	VBD	O	14	SBAR
38	production	production	B-NP	NN	O	37	OBJ
39	of	of	B-PP	IN	O	38	NMOD
40	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	39	PMOD
41	,	,	O	,	O	37	P
42	and	and	O	CC	O	44	NMOD
43	reduced	reduce	B-NP	VBN	O	44	NMOD
44	up-regulation	up-regulation	I-NP	NN	O	41	NMOD
45	of	of	B-PP	IN	O	44	NMOD
46	lung	lung	B-NP	NN	B-protein	48	NMOD
47	vascular	vascular	I-NP	JJ	I-protein	48	NMOD
48	ICAM-1	ICAM-1	I-NP	NN	I-protein	45	PMOD
49	.	.	O	.	O	44	P

1	ETS	ETS	B-NP	NN	B-protein	3	NMOD
2	transcription	transcription	I-NP	NN	I-protein	3	NMOD
3	factors	factor	I-NP	NNS	I-protein	4	SUB
4	regulate	regulate	B-VP	VBP	O	0	ROOT
5	an	an	B-NP	DT	O	7	NMOD
6	enhancer	enhancer	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	4	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	third	third	I-NP	JJ	B-DNA	11	NMOD
11	intron	intron	I-NP	NN	I-DNA	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	12	PMOD
14	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	describe	describe	B-VP	VBP	O	0	ROOT
3	an	an	B-NP	DT	O	5	NMOD
4	enhancer	enhancer	I-NP	NN	B-DNA	5	NMOD
5	site	site	I-NP	NN	I-DNA	2	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	third	third	I-NP	JJ	B-DNA	9	NMOD
9	intron	intron	I-NP	NN	I-DNA	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	tumor	tumor	B-NP	NN	B-protein	14	NMOD
12	necrosis	necrosis	I-NP	NN	I-protein	14	NMOD
13	factor	factor	I-NP	NN	I-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	10	PMOD
15	(	(	O	(	O	16	P
16	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	14	NMOD
17	)	)	O	)	O	16	P
18	.	.	O	.	O	2	P

1	A	A	B-NP	DT	O	3	NMOD
2	reporter	reporter	I-NP	NN	B-DNA	3	NMOD
3	construct	construct	I-NP	NN	I-DNA	13	SUB
4	containing	contain	B-VP	VBG	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	5'-flanking	5'-flanking	I-NP	JJ	B-DNA	7	NMOD
7	region	region	I-NP	NN	I-DNA	4	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	mouse	mouse	I-NP	NN	B-DNA	12	NMOD
11	TNF-alpha	TNF-alpha	I-NP	NN	I-DNA	12	NMOD
12	gene	gene	I-NP	NN	I-DNA	8	PMOD
13	displayed	display	B-VP	VBD	O	0	ROOT
14	weak	weak	B-NP	JJ	O	15	NMOD
15	activity	activity	I-NP	NN	O	13	OBJ
16	when	when	B-ADVP	WRB	O	13	VMOD
17	transfected	transfecte	B-VP	VBN	O	16	SBAR
18	into	into	B-PP	IN	O	17	VMOD
19	RAW264.7	RAW264.7	B-NP	NN	B-cell_line	21	NMOD
20	macrophage-like	macrophage-like	I-NP	JJ	I-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
22	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	2	NMOD
2	addition	addition	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	third	third	I-NP	JJ	B-DNA	6	NMOD
6	intron	intron	I-NP	NN	I-DNA	3	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	7	PMOD
9	to	to	B-PP	TO	O	2	NMOD
10	this	this	B-NP	DT	O	11	NMOD
11	construct	construct	I-NP	NN	O	9	PMOD
12	resulted	result	B-VP	VBD	O	0	ROOT
13	in	in	B-PP	IN	O	12	VMOD
14	an	an	B-NP	DT	O	15	NMOD
15	enhancement	enhancement	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	CAT	CAT	B-NP	NN	B-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	16	PMOD
19	.	.	O	.	O	12	P

1	This	This	B-NP	DT	O	2	NMOD
2	enhancement	enhancement	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	eliminated	eliminate	I-VP	VBN	O	3	VC
5	if	if	B-SBAR	IN	O	16	DEP
6	a	a	B-NP	DT	O	9	NMOD
7	conserved	conserve	I-NP	VBN	B-DNA	9	NMOD
8	20-bp	20-bp	I-NP	JJ	I-DNA	9	NMOD
9	sequence	sequence	I-NP	NN	I-DNA	10	SUB
10	was	be	B-VP	VBD	O	5	SBAR
11	removed	remove	I-VP	VBN	O	10	VC
12	from	from	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	intron	intron	I-NP	NN	B-DNA	12	PMOD
15	or	or	O	CC	O	16	DEP
16	if	if	B-SBAR	IN	O	4	VMOD
17	a	a	B-NP	DT	O	20	NMOD
18	dominant-negative	dominant-negative	I-NP	JJ	B-protein	20	NMOD
19	ets-binding	ets-binding	I-NP	JJ	I-protein	20	NMOD
20	factor	factor	I-NP	NN	I-protein	21	SUB
21	was	be	B-VP	VBD	O	16	SBAR
22	co-transfected	co-transfecte	I-VP	VBN	O	21	VC
23	with	with	B-PP	IN	O	22	VMOD
24	the	the	B-NP	DT	O	26	NMOD
25	reporter	reporter	I-NP	NN	B-DNA	26	NMOD
26	gene	gene	I-NP	NN	I-DNA	23	PMOD
27	.	.	O	.	O	3	P

1	Mutations	Mutation	B-NP	NNS	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	this	this	B-NP	DT	O	4	NMOD
4	site	site	I-NP	NN	O	2	PMOD
5	that	that	B-NP	WDT	O	1	NMOD
6	destroyed	destroy	B-VP	VBD	O	5	SBAR
7	potential	potential	B-NP	JJ	O	12	NMOD
8	ets	ets	I-NP	NN	B-DNA	12	NMOD
9	transcription	transcription	I-NP	NN	I-DNA	12	NMOD
10	factor	factor	I-NP	NN	I-DNA	12	NMOD
11	binding	binding	I-NP	NN	I-DNA	12	NMOD
12	sites	site	I-NP	NNS	I-DNA	6	OBJ
13	had	have	B-VP	VBD	O	0	ROOT
14	reduced	reduce	I-VP	VBN	O	13	VC
15	transcriptional	transcriptional	B-NP	JJ	O	16	NMOD
16	activity	activity	I-NP	NN	O	14	OBJ
17	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	4	NMOD
2	major	major	I-NP	JJ	O	4	NMOD
3	transcription	transcription	I-NP	NN	B-protein	4	NMOD
4	factor	factor	I-NP	NN	I-protein	10	SUB
5	that	that	B-NP	WDT	O	4	NMOD
6	bound	bind	B-VP	VBD	O	5	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	oligonucleotide	oligonucleotide	I-NP	NN	O	7	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	confirmed	confirm	I-VP	VBN	O	10	VC
12	to	to	I-VP	TO	O	13	VMOD
13	be	be	I-VP	VB	O	11	VMOD
14	GABP	GABP	B-NP	NN	B-protein	13	PRD
15	by	by	B-PP	IN	O	14	NMOD
16	supershift	supershift	B-NP	NN	O	19	NMOD
17	and	and	I-NP	CC	O	19	NMOD
18	competition	competition	I-NP	NN	O	19	NMOD
19	analysis	analysis	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	7	VMOD
2	RAW264.7	RAW264.7	B-NP	NN	B-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
4	,	,	O	,	O	7	P
5	the	the	B-NP	DT	O	6	NMOD
6	binding	binding	I-NP	NN	O	7	SUB
7	was	be	B-VP	VBD	O	18	VMOD
8	constitutive	constitutive	B-ADJP	JJ	O	18	VMOD
9	,	,	O	,	O	18	P
10	however	however	B-ADVP	RB	O	18	VMOD
11	,	,	O	,	O	18	P
12	in	in	B-PP	IN	O	18	VMOD
13	bone	bone	B-NP	NN	B-cell_type	15	NMOD
14	marrow-derived	marrow-derived	I-NP	JJ	I-cell_type	15	NMOD
15	macrophages	macrophage	I-NP	NNS	I-cell_type	12	PMOD
16	binding	binding	I-NP	NN	O	17	NMOD
17	activity	activity	I-NP	NN	O	18	SUB
18	was	be	B-VP	VBD	O	0	ROOT
19	shown	show	I-VP	VBN	O	18	VC
20	to	to	I-VP	TO	O	21	VMOD
21	be	be	I-VP	VB	O	19	VMOD
22	interferon-gamma	interferon-gamma	B-NP	NN	B-protein	21	PRD
23	inducible	inducible	B-ADJP	JJ	O	22	AMOD
24	.	.	O	.	O	18	P

1	This	This	B-NP	DT	O	2	SUB
2	may	may	B-VP	MD	O	0	ROOT
3	imply	imply	I-VP	VB	O	2	VC
4	a	a	B-NP	DT	O	5	NMOD
5	role	role	I-NP	NN	O	3	OBJ
6	for	for	B-PP	IN	O	5	NMOD
7	ets	ets	B-NP	NN	B-protein	9	NMOD
8	transcription	transcription	I-NP	NN	I-protein	9	NMOD
9	factors	factor	I-NP	NNS	I-protein	6	PMOD
10	in	in	B-PP	IN	O	5	NMOD
11	the	the	B-NP	DT	O	12	NMOD
12	production	production	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	13	PMOD
15	.	.	O	.	O	2	P

1	Abnormal	Abnormal	B-NP	JJ	O	4	NMOD
2	NF-kappa	NF-kappa	I-NP	NN	B-protein	4	NMOD
3	B	B	I-NP	NN	I-protein	4	NMOD
4	activity	activity	I-NP	NN	O	14	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	T	T	B-NP	NN	B-cell_type	7	NMOD
7	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	PMOD
8	from	from	B-PP	IN	O	7	NMOD
9	patients	patient	B-NP	NNS	O	8	PMOD
10	with	with	B-PP	IN	O	9	NMOD
11	systemic	systemic	B-NP	JJ	O	13	NMOD
12	lupus	lupus	I-NP	NN	O	13	NMOD
13	erythematosus	erythematosus	I-NP	NN	O	10	PMOD
14	is	be	B-VP	VBZ	O	0	ROOT
15	associated	associate	I-VP	VBN	O	14	VC
16	with	with	B-PP	IN	O	15	VMOD
17	decreased	decrease	B-NP	VBN	O	20	NMOD
18	p65-RelA	p65-RelA	I-NP	NN	B-protein	20	NMOD
19	protein	protein	I-NP	NN	O	20	NMOD
20	expression	expression	I-NP	NN	O	16	PMOD
21	.	.	O	.	O	14	P

1	Numerous	Numerous	B-NP	JJ	O	5	NMOD
2	cellular	cellular	I-NP	JJ	O	5	NMOD
3	and	and	I-NP	CC	O	5	NMOD
4	biochemical	biochemical	I-NP	JJ	O	5	NMOD
5	abnormalities	abnormality	I-NP	NNS	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	immune	immune	B-NP	JJ	O	8	NMOD
8	regulation	regulation	I-NP	NN	O	6	PMOD
9	have	have	B-VP	VBP	O	0	ROOT
10	been	be	I-VP	VBN	O	9	VC
11	described	describe	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	patients	patient	B-NP	NNS	O	12	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	systemic	systemic	B-NP	JJ	O	17	NMOD
16	lupus	lupus	I-NP	NN	O	17	NMOD
17	erythematosus	erythematosus	I-NP	NN	O	14	PMOD
18	(	(	O	(	O	19	P
19	SLE	SLE	B-NP	NN	O	17	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	13	P
22	including	include	B-PP	VBG	O	13	NMOD
23	surface	surface	B-NP	NN	O	27	NMOD
24	Ag	Ag	I-NP	NN	O	27	NMOD
25	receptor-initiated	receptor-initiated	I-NP	JJ	O	27	NMOD
26	signaling	signaling	I-NP	NN	O	27	NMOD
27	events	event	I-NP	NNS	O	30	NMOD
28	and	and	O	CC	O	30	NMOD
29	lymphokine	lymphokine	B-NP	NN	B-protein	30	NMOD
30	production	production	I-NP	NN	O	22	PMOD
31	.	.	O	.	O	9	P

1	Because	Because	B-SBAR	IN	O	26	VMOD
2	NF-kappa	NF-kappa	B-NP	NN	B-protein	3	NMOD
3	B	B	I-NP	NN	I-protein	4	SUB
4	contributes	contribute	B-VP	VBZ	O	1	SBAR
5	to	to	B-PP	TO	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	transcription	transcription	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	numerous	numerous	B-NP	JJ	O	11	NMOD
10	inflammatory	inflammatory	I-NP	JJ	B-DNA	11	NMOD
11	genes	gene	I-NP	NNS	I-DNA	8	PMOD
12	and	and	O	CC	O	4	VMOD
13	has	have	B-VP	VBZ	O	4	VMOD
14	been	be	I-VP	VBN	O	13	VC
15	shown	show	I-VP	VBN	O	14	VC
16	to	to	I-VP	TO	O	17	VMOD
17	be	be	I-VP	VB	O	15	VMOD
18	a	a	B-NP	DT	O	20	NMOD
19	molecular	molecular	I-NP	JJ	O	20	NMOD
20	target	target	I-NP	NN	O	17	PRD
21	of	of	B-PP	IN	O	20	NMOD
22	antiinflammatory	antiinflammatory	B-NP	JJ	O	23	NMOD
23	drugs	drug	I-NP	NNS	O	21	PMOD
24	,	,	O	,	O	26	P
25	we	we	B-NP	PRP	O	26	SUB
26	sought	seek	B-VP	VBD	O	0	ROOT
27	to	to	I-VP	TO	O	28	VMOD
28	characterize	characterize	I-VP	VB	O	26	VMOD
29	the	the	B-NP	DT	O	31	NMOD
30	functional	functional	I-NP	JJ	O	31	NMOD
31	role	role	I-NP	NN	O	28	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	37	NMOD
34	NF-kappa	NF-kappa	I-NP	NN	B-protein	37	NMOD
35	B	B	I-NP	NN	I-protein	37	NMOD
36	protein	protein	I-NP	NN	I-protein	37	NMOD
37	complex	complex	I-NP	NN	I-protein	32	PMOD
38	in	in	B-PP	IN	O	31	NMOD
39	lupus	lupus	B-NP	NN	B-cell_type	41	NMOD
40	T	T	I-NP	NN	I-cell_type	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_type	38	PMOD
42	.	.	O	.	O	26	P

1	Freshly	Freshly	B-NP	RB	O	2	AMOD
2	isolated	isolate	I-NP	VBN	O	18	NMOD
3	T	T	I-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	OBJ
5	from	from	B-PP	IN	O	2	VMOD
6	lupus	lupus	B-NP	NN	O	7	NMOD
7	patients	patient	I-NP	NNS	O	5	PMOD
8	,	,	O	,	O	18	P
9	rheumatoid	rheumatoid	B-NP	JJ	O	10	NMOD
10	arthritis	arthritis	I-NP	NN	O	14	NMOD
11	(	(	O	(	O	12	P
12	RA	RA	B-NP	NN	O	10	NMOD
13	)	)	O	)	O	12	P
14	patients	patient	B-NP	NNS	O	18	NMOD
15	,	,	O	,	O	18	P
16	and	and	O	CC	O	18	NMOD
17	normal	normal	B-NP	JJ	O	18	NMOD
18	individuals	individual	I-NP	NNS	O	19	SUB
19	were	be	B-VP	VBD	O	0	ROOT
20	activated	activate	I-VP	VBN	O	19	VC
21	physiologically	physiologically	B-ADVP	RB	O	20	VMOD
22	via	via	B-PP	IN	O	20	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	TCR	TCR	I-NP	NN	B-protein	22	PMOD
25	with	with	B-PP	IN	O	24	NMOD
26	anti-CD3	anti-CD3	B-NP	JJ	B-protein	28	AMOD
27	and	and	I-NP	CC	O	28	AMOD
28	anti-CD28	anti-CD28	I-NP	JJ	B-protein	29	NMOD
29	Abs	Ab	I-NP	NNS	I-protein	25	PMOD
30	to	to	B-VP	TO	O	31	VMOD
31	assess	assess	I-VP	VB	O	19	VMOD
32	proximal	proximal	B-NP	JJ	O	34	NMOD
33	membrane	membrane	I-NP	NN	O	34	NMOD
34	signaling	signaling	I-NP	NN	O	31	OBJ
35	,	,	O	,	O	31	P
36	and	and	O	CC	O	31	VMOD
37	with	with	B-PP	IN	O	31	VMOD
38	PMA	PMA	B-NP	NN	O	42	NMOD
39	and	and	O	CC	O	42	NMOD
40	a	a	B-NP	DT	O	42	NMOD
41	calcium	calcium	I-NP	NN	O	42	NMOD
42	ionophore	ionophore	I-NP	NN	O	37	PMOD
43	(	(	O	(	O	44	P
44	A23187	A23187	B-NP	NN	O	42	NMOD
45	)	)	O	)	O	44	P
46	to	to	B-VP	TO	O	47	VMOD
47	bypass	bypass	I-VP	VB	O	31	VMOD
48	membrane-mediated	membrane-mediated	B-NP	JJ	O	50	NMOD
49	signaling	signaling	I-NP	NN	O	50	NMOD
50	events	event	I-NP	NNS	O	47	OBJ
51	.	.	O	.	O	19	P

1	We	We	B-NP	PRP	O	2	SUB
2	measured	measure	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	7	NMOD
4	NF-kappa	NF-kappa	I-NP	NN	B-protein	7	NMOD
5	B	B	I-NP	NN	I-protein	7	NMOD
6	binding	binding	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	2	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	nuclear	nuclear	B-NP	JJ	O	10	NMOD
10	extracts	extract	I-NP	NNS	O	8	PMOD
11	by	by	B-PP	IN	O	2	VMOD
12	gel	gel	B-NP	NN	O	14	NMOD
13	shift	shift	I-NP	NN	O	14	NMOD
14	analysis	analysis	I-NP	NN	O	11	PMOD
15	.	.	O	.	O	2	P

1	When	When	B-ADVP	WRB	O	16	VMOD
2	compared	compare	B-PP	VBN	O	1	SBAR
3	with	with	B-PP	IN	O	2	VMOD
4	normal	normal	B-NP	JJ	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
6	,	,	O	,	O	16	P
7	the	the	B-NP	DT	O	8	NMOD
8	activation	activation	I-NP	NN	O	16	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
11	B	B	I-NP	NN	I-protein	12	NMOD
12	activity	activity	I-NP	NN	O	9	PMOD
13	in	in	B-PP	IN	O	8	NMOD
14	SLE	SLE	B-NP	NN	O	15	NMOD
15	patients	patient	I-NP	NNS	O	13	PMOD
16	was	be	B-VP	VBD	O	0	ROOT
17	significantly	significantly	I-VP	RB	O	16	VMOD
18	decreased	decrease	I-VP	VBN	O	16	VC
19	in	in	B-PP	IN	O	18	VMOD
20	SLE	SLE	B-NP	NN	O	19	PMOD
21	,	,	B-PP	,	O	19	P
22	but	but	I-PP	CC	O	19	PMOD
23	not	not	B-PP	RB	O	24	PMOD
24	in	in	I-PP	IN	O	19	PMOD
25	RA	RA	B-NP	NN	O	27	NMOD
26	,	,	O	,	O	27	P
27	patients	patient	B-NP	NNS	O	24	PMOD
28	.	.	O	.	O	16	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
2	B	B	I-NP	NN	I-protein	4	NMOD
3	binding	binding	I-NP	NN	O	4	NMOD
4	activity	activity	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	absent	absent	B-ADJP	JJ	O	5	PRD
7	in	in	B-PP	IN	O	6	AMOD
8	several	several	B-NP	JJ	O	10	NMOD
9	SLE	SLE	I-NP	NN	O	10	NMOD
10	patients	patient	I-NP	NNS	O	7	PMOD
11	who	who	B-NP	WP	O	10	NMOD
12	were	be	B-VP	VBD	O	11	SBAR
13	not	not	I-VP	RB	O	12	VMOD
14	receiving	receive	I-VP	VBG	O	12	VMOD
15	any	any	B-NP	DT	O	16	NMOD
16	medication	medication	I-NP	NN	O	14	OBJ
17	,	,	O	,	O	12	P
18	including	include	B-PP	VBG	O	12	VMOD
19	corticosteroids	corticosteroid	B-NP	NNS	O	18	PMOD
20	.	.	O	.	O	5	P

1	Also	Also	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
4	B	B	I-NP	NN	I-protein	5	NMOD
5	activity	activity	I-NP	NN	O	6	SUB
6	remained	remain	B-VP	VBD	O	0	ROOT
7	absent	absent	B-ADJP	JJ	O	6	PRD
8	in	in	B-PP	IN	O	6	VMOD
9	follow-up	follow-up	B-NP	JJ	O	10	NMOD
10	studies	study	I-NP	NNS	O	8	PMOD
11	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	9	VMOD
2	supershift	supershift	B-NP	NN	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	1	PMOD
4	using	use	B-VP	VBG	O	3	NMOD
5	specific	specific	B-NP	JJ	B-protein	6	NMOD
6	Abs	Ab	I-NP	NNS	I-protein	4	OBJ
7	,	,	O	,	O	9	P
8	we	we	B-NP	PRP	O	9	SUB
9	showed	show	B-VP	VBD	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	VMOD
11	,	,	O	,	O	27	P
12	in	in	B-PP	IN	O	27	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	group	group	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	SLE	SLE	B-NP	NN	O	17	NMOD
17	patients	patient	I-NP	NNS	O	15	PMOD
18	who	who	B-NP	WP	O	17	NMOD
19	displayed	display	B-VP	VBD	O	18	SBAR
20	undetectable	undetectable	B-NP	JJ	O	23	NMOD
21	NF-kappa	NF-kappa	I-NP	NN	B-protein	23	NMOD
22	B	B	I-NP	NN	I-protein	23	NMOD
23	activity	activity	I-NP	NN	O	19	OBJ
24	,	,	O	,	O	27	P
25	p65	p65	B-NP	NN	B-protein	26	NMOD
26	complexes	complex	I-NP	NNS	I-protein	27	SUB
27	were	be	B-VP	VBD	O	10	SBAR
28	not	not	I-VP	RB	O	27	VMOD
29	formed	form	I-VP	VBN	O	27	VC
30	.	.	O	.	O	9	P

1	Finally	Finally	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	immunoblot	immunoblot	B-NP	NN	O	4	NMOD
4	analysis	analysis	I-NP	NN	O	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	nuclear	nuclear	B-NP	JJ	O	7	NMOD
7	extracts	extract	I-NP	NNS	O	5	PMOD
8	showed	show	B-VP	VBD	O	0	ROOT
9	decreased	decrease	B-VP	VBN	O	8	VMOD
10	or	or	O	CC	O	14	NMOD
11	absent	absent	B-NP	JJ	O	14	NMOD
12	p65	p65	I-NP	NN	B-protein	14	NMOD
13	protein	protein	I-NP	NN	I-protein	14	NMOD
14	levels	level	I-NP	NNS	O	9	OBJ
15	.	.	O	.	O	8	P

1	As	As	B-SBAR	IN	O	17	VMOD
2	p65	p65	B-NP	NN	B-protein	3	NMOD
3	complexes	complex	I-NP	NNS	I-protein	4	SUB
4	are	be	B-VP	VBP	O	1	SBAR
5	transcriptionally	transcriptionally	B-ADJP	RB	O	6	AMOD
6	active	active	I-ADJP	JJ	O	4	PRD
7	in	in	B-PP	IN	O	4	VMOD
8	comparison	comparison	B-NP	NN	O	7	PMOD
9	to	to	B-PP	TO	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	p50	p50	I-NP	NN	B-protein	12	NMOD
12	homodimer	homodimer	I-NP	NN	I-protein	9	PMOD
13	,	,	O	,	O	17	P
14	this	this	B-NP	DT	O	16	NMOD
15	novel	novel	I-NP	JJ	O	16	NMOD
16	finding	finding	I-NP	NN	O	17	SUB
17	may	may	B-VP	MD	O	0	ROOT
18	provide	provide	I-VP	VB	O	17	VC
19	insight	insight	B-NP	NN	O	18	OBJ
20	on	on	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	22	NMOD
22	origin	origin	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	abnormal	abnormal	B-NP	JJ	B-protein	25	NMOD
25	cytokine	cytokine	I-NP	NN	I-protein	29	NMOD
26	or	or	O	CC	O	29	NMOD
27	other	other	B-NP	JJ	O	29	NMOD
28	gene	gene	I-NP	NN	O	29	NMOD
29	transcription	transcription	I-NP	NN	O	23	PMOD
30	in	in	B-PP	IN	O	22	NMOD
31	SLE	SLE	B-NP	NN	O	32	NMOD
32	patients	patient	I-NP	NNS	O	30	PMOD
33	.	.	O	.	O	17	P

1	Possible	Possible	B-NP	JJ	O	2	NMOD
2	differences	difference	I-NP	NNS	O	0	ROOT
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	mechanism	mechanism	I-NP	NN	O	7	NMOD
6	(	(	I-NP	(	O	7	P
7	s	s	I-NP	NNS	O	3	PMOD
8	)	)	O	)	O	7	P
9	of	of	B-PP	IN	O	7	NMOD
10	action	action	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	different	different	B-NP	JJ	O	15	NMOD
13	glucocorticoid	glucocorticoid	I-NP	NN	O	15	NMOD
14	hormone	hormone	I-NP	NN	O	15	NMOD
15	compounds	compound	I-NP	NNS	O	11	PMOD
16	.	.	O	.	O	2	P

1	Different	Different	B-NP	JJ	O	3	NMOD
2	glucocorticoid	glucocorticoid	I-NP	NN	O	3	NMOD
3	hormones	hormone	I-NP	NNS	O	7	SUB
4	(	(	O	(	O	5	P
5	GCH	GCH	B-NP	NN	O	3	NMOD
6	)	)	O	)	O	5	P
7	show	show	B-VP	VBP	O	0	ROOT
8	differences	difference	B-NP	NNS	O	7	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	intensity	intensity	I-NP	NN	O	9	PMOD
12	and	and	B-PP	CC	O	9	PMOD
13	in	in	B-PP	IN	O	9	PMOD
14	the	the	B-NP	DT	O	15	NMOD
15	kinetics	kinetic	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	their	their	B-NP	PRP$	O	19	NMOD
18	immunomodulating	immunomodulating	I-NP	JJ	O	19	NMOD
19	activity	activity	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	4	NMOD
2	mechanism	mechanism	I-NP	NN	O	4	NMOD
3	(	(	I-NP	(	O	4	P
4	s	s	I-NP	NNS	O	10	SUB
5	)	)	O	)	O	4	P
6	of	of	B-PP	IN	O	4	NMOD
7	action	action	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	GCH	GCH	B-NP	NN	O	8	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	under	under	B-PP	IN	O	10	PRD
12	investigation	investigation	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	10	P
14	but	but	O	CC	O	10	VMOD
15	is	be	B-NP	VBZ	O	10	VMOD
16	has	have	B-VP	VBZ	O	15	VMOD
17	been	be	I-VP	VBN	O	16	VC
18	noted	note	I-VP	VBN	O	17	VC
19	that	that	B-SBAR	IN	O	18	VMOD
20	they	they	B-NP	PRP	O	21	SUB
21	exert	exert	B-VP	VBP	O	19	SBAR
22	immune	immune	B-NP	JJ	O	23	NMOD
23	activity	activity	I-NP	NN	O	21	OBJ
24	via	via	B-PP	IN	O	21	VMOD
25	the	the	B-NP	DT	O	27	NMOD
26	genomic	genomic	I-NP	JJ	O	27	NMOD
27	pathway	pathway	I-NP	NN	O	24	PMOD
28	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	studied	study	I-VP	VBN	O	2	VC
4	the	the	B-NP	DT	O	5	NMOD
5	effects	effect	I-NP	NNS	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	prednisone	prednisone	B-NP	NN	O	18	NMOD
8	(	(	O	(	O	9	P
9	PDN	PDN	B-NP	NN	O	7	NMOD
10	)	)	O	)	O	9	P
11	,	,	O	,	O	18	P
12	deflazacort	deflazacort	B-NP	NN	O	18	NMOD
13	(	(	O	(	O	14	P
14	DFC	DFC	B-NP	NN	O	12	NMOD
15	)	)	O	)	O	14	P
16	,	,	O	,	O	18	P
17	and	and	O	CC	O	18	NMOD
18	dexamethasone	dexamethasone	B-NP	NN	O	6	PMOD
19	(	(	O	(	O	20	P
20	DXM	DXM	B-NP	NN	O	18	NMOD
21	)	)	O	)	O	20	P
22	on	on	B-PP	IN	O	5	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	production	production	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	cytokines	cytokine	B-NP	NNS	B-protein	43	NMOD
27	(	(	O	(	O	43	P
28	IL-2	IL-2	B-NP	NN	B-protein	43	NMOD
29	,	,	O	,	O	43	P
30	IL-6	IL-6	B-NP	NN	B-protein	43	NMOD
31	,	,	O	,	O	43	P
32	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	43	NMOD
33	,	,	O	,	O	34	P
34	IL-10	IL-10	B-NP	NN	B-protein	32	NMOD
35	)	)	O	)	O	34	P
36	by	by	B-PP	IN	O	32	NMOD
37	peripheral	peripheral	B-NP	JJ	B-cell_type	39	NMOD
38	T	T	I-NP	NN	I-cell_type	39	NMOD
39	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	36	PMOD
40	,	,	O	,	O	43	P
41	and	and	O	CC	O	43	NMOD
42	the	the	B-NP	DT	O	43	NMOD
43	effects	effect	I-NP	NNS	O	25	PMOD
44	on	on	B-PP	IN	O	43	NMOD
45	the	the	B-NP	DT	O	46	NMOD
46	inhibition	inhibition	I-NP	NN	O	44	PMOD
47	of	of	B-PP	IN	O	46	NMOD
48	NF-kB	NF-kB	B-NP	NN	B-protein	51	NMOD
49	DNA	DNA	I-NP	NN	O	51	NMOD
50	binding	binding	I-NP	NN	O	51	NMOD
51	activity	activity	I-NP	NN	O	47	PMOD
52	by	by	B-PP	IN	O	46	NMOD
53	activated	activate	B-NP	VBN	B-cell_line	56	NMOD
54	Jurkat	Jurkat	I-NP	NN	I-cell_line	56	NMOD
55	cell	cell	I-NP	NN	I-cell_line	56	NMOD
56	line	line	I-NP	NN	I-cell_line	52	PMOD
57	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	4	SUB
3	obtained	obtain	B-VP	VBN	O	2	NMOD
4	show	show	B-VP	VBP	O	43	VMOD
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	9	NMOD
7	three	three	I-NP	CD	O	9	NMOD
8	GCH	GCH	I-NP	NN	B-protein	9	NMOD
9	molecules	molecule	I-NP	NNS	I-protein	10	SUB
10	exert	exert	B-VP	VBP	O	5	SBAR
11	an	an	B-NP	DT	O	12	NMOD
12	immunosuppression	immunosuppression	I-NP	NN	O	10	OBJ
13	on	on	B-PP	IN	O	10	VMOD
14	cytokine	cytokine	B-NP	NN	B-protein	15	NMOD
15	production	production	I-NP	NN	O	22	NMOD
16	by	by	B-PP	IN	O	15	NMOD
17	T	T	B-NP	NN	B-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD
19	and	and	O	CC	O	22	NMOD
20	a	a	B-NP	DT	O	22	NMOD
21	strong	strong	I-NP	JJ	O	22	NMOD
22	decrease	decrease	I-NP	NN	O	13	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	nuclear	nuclear	I-NP	JJ	O	26	NMOD
26	translocation	translocation	I-NP	NN	O	23	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	NF-kB	NF-kB	B-NP	NN	B-protein	27	PMOD
29	in	in	B-PP	IN	O	22	NMOD
30	Jurkat	Jurkat	B-NP	NN	B-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	29	PMOD
32	;	;	O	:	O	43	P
33	moreover	moreover	B-ADVP	RB	O	43	VMOD
34	,	,	O	,	O	43	P
35	(	(	O	(	O	36	P
36	a	a	O	DT	O	43	VMOD
37	)	)	O	)	O	36	P
38	not	not	O	RB	O	43	VMOD
39	all	all	B-NP	PDT	O	38	AMOD
40	the	the	I-NP	DT	O	41	NMOD
41	cytokines	cytokine	I-NP	NNS	B-protein	43	SUB
42	investigated	investigate	B-VP	VBN	O	41	NMOD
43	were	be	B-VP	VBD	O	62	VMOD
44	affected	affect	I-VP	VBN	O	43	VC
45	,	,	O	,	O	44	P
46	and	and	O	CC	O	44	VMOD
47	not	not	B-PP	RB	O	48	PMOD
48	with	with	I-PP	IN	O	44	VMOD
49	the	the	B-NP	DT	O	51	NMOD
50	same	same	I-NP	JJ	O	51	NMOD
51	intensity	intensity	I-NP	NN	O	48	PMOD
52	,	,	O	,	O	44	P
53	by	by	B-PP	IN	O	44	VMOD
54	the	the	B-NP	DT	O	56	NMOD
55	three	three	I-NP	CD	O	56	NMOD
56	GCH	GCH	I-NP	NN	O	53	PMOD
57	and	and	O	CC	O	62	VMOD
58	(	(	B-LST	(	O	59	P
59	b	b	I-LST	LS	O	61	NMOD
60	)	)	O	)	O	59	P
61	DXM	DXM	B-NP	NN	O	62	SUB
62	inhibited	inhibit	B-VP	VBD	O	0	ROOT
63	the	the	B-NP	DT	O	65	NMOD
64	binding	binding	I-NP	NN	O	65	NMOD
65	activity	activity	I-NP	NN	O	62	OBJ
66	of	of	B-PP	IN	O	65	NMOD
67	NF-kB	NF-kB	B-NP	NN	B-protein	66	PMOD
68	less	less	B-ADJP	JJR	O	62	VMOD
69	than	than	B-PP	IN	O	68	AMOD
70	that	that	B-NP	DT	O	69	PMOD
71	of	of	B-PP	IN	O	70	NMOD
72	DFC	DFC	B-NP	NN	O	74	NMOD
73	and	and	I-NP	CC	O	74	NMOD
74	PDN	PDN	I-NP	NN	O	71	PMOD
75	.	.	O	.	O	62	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	in	in	B-PP	IN	O	3	PRD
5	agreement	agreement	B-NP	NN	O	4	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	concept	concept	I-NP	NN	O	6	PMOD
9	that	that	B-SBAR	IN	O	3	VMOD
10	different	different	B-NP	JJ	O	12	NMOD
11	GCH	GCH	I-NP	NN	O	12	NMOD
12	compounds	compound	I-NP	NNS	O	13	SUB
13	might	might	B-VP	MD	O	9	SBAR
14	differ	differ	I-VP	VB	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	their	their	B-NP	PRP$	O	20	NMOD
17	binding	binding	I-NP	NN	O	20	NMOD
18	and	and	I-NP	CC	O	20	NMOD
19	affinity	affinity	I-NP	NN	O	20	NMOD
20	properties	property	I-NP	NNS	O	15	PMOD
21	,	,	O	,	O	3	P
22	tissue-specific	tissue-specific	B-NP	JJ	O	23	NMOD
23	metabolism	metabolism	I-NP	NN	O	3	VMOD
24	,	,	O	,	O	25	P
25	and	and	O	CC	O	23	NMOD
26	interaction	interaction	B-NP	NN	O	25	PMOD
27	with	with	B-PP	IN	O	26	NMOD
28	transcription	transcription	B-NP	NN	B-protein	29	NMOD
29	factor	factor	I-NP	NN	I-protein	27	PMOD
30	.	.	O	.	O	25	P

1	The	The	B-NP	DT	O	3	NMOD
2	p53	p53	I-NP	NN	B-protein	3	NMOD
3	paradox	paradox	I-NP	NN	O	0	ROOT
4	in	in	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	pathogenesis	pathogenesis	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	tumor	tumor	B-NP	NN	O	9	NMOD
9	progression	progression	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	3	P

1	Recent	Recent	B-NP	JJ	O	2	NMOD
2	evidence	evidence	I-NP	NN	O	3	SUB
3	suggests	suggest	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	p53	p53	I-NP	NN	B-protein	7	NMOD
7	molecule	molecule	I-NP	NN	I-protein	8	SUB
8	appears	appear	B-VP	VBZ	O	4	SBAR
9	in	in	B-PP	IN	O	8	VMOD
10	two	two	B-NP	CD	O	12	NMOD
11	different	different	I-NP	JJ	O	12	NMOD
12	forms	form	I-NP	NNS	O	9	PMOD
13	:	:	O	:	O	3	P
14	the	the	B-NP	DT	O	16	NMOD
15	mutant	mutant	I-NP	JJ	B-protein	16	NMOD
16	p53	p53	I-NP	NN	I-protein	25	NMOD
17	that	that	B-NP	WDT	O	16	NMOD
18	stimulates	stimulate	B-VP	VBZ	O	17	SBAR
19	tumor	tumor	B-NP	NN	O	20	NMOD
20	progression	progression	I-NP	NN	O	18	OBJ
21	,	,	O	,	O	25	P
22	and	and	O	CC	O	25	NMOD
23	wild	wild	B-NP	JJ	B-protein	25	NMOD
24	type	type	I-NP	NN	I-protein	25	NMOD
25	p53	p53	I-NP	NN	I-protein	3	VMOD
26	that	that	B-NP	WDT	O	25	NMOD
27	inhibits	inhibit	B-VP	VBZ	O	26	SBAR
28	tumor	tumor	B-NP	NN	O	29	NMOD
29	progression	progression	I-NP	NN	O	27	OBJ
30	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	it	it	B-NP	PRP	O	5	SUB
5	has	have	B-VP	VBZ	O	0	ROOT
6	been	be	I-VP	VBN	O	5	VC
7	established	establish	I-VP	VBN	O	6	VC
8	that	that	B-SBAR	IN	O	7	VMOD
9	tumor	tumor	B-NP	NN	B-protein	11	NMOD
10	necrosis	necrosis	I-NP	NN	I-protein	11	NMOD
11	factor-alpha	factor-alpha	I-NP	NN	I-protein	15	SUB
12	(	(	O	(	O	13	P
13	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	can	can	B-VP	MD	O	8	SBAR
16	activate	activate	I-VP	VB	O	15	VC
17	the	the	B-NP	DT	O	18	NMOD
18	expression	expression	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	wild	wild	B-NP	JJ	B-protein	22	NMOD
21	type	type	I-NP	NN	I-protein	22	NMOD
22	p53	p53	I-NP	NN	I-protein	19	PMOD
23	in	in	B-PP	IN	O	16	VMOD
24	concert	concert	B-NP	NN	O	23	PMOD
25	with	with	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	nuclear	nuclear	I-NP	JJ	B-protein	29	NMOD
28	transcription	transcription	I-NP	NN	I-protein	29	NMOD
29	factor	factor	I-NP	NN	I-protein	32	NMOD
30	,	,	O	,	O	32	P
31	NF-kappa	NF-kappa	B-NP	NN	B-protein	32	NMOD
32	B	B	I-NP	NN	I-protein	25	PMOD
33	.	.	O	.	O	5	P

1	Both	Both	O	CC	O	5	NMOD
2	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	6	SUB
6	are	be	B-VP	VBP	O	0	ROOT
7	also	also	I-VP	RB	O	6	VMOD
8	involved	involve	I-VP	VBN	O	6	VC
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	stimulation	stimulation	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	pathway	pathway	I-NP	NN	O	12	PMOD
15	that	that	B-NP	WDT	O	11	NMOD
16	leads	lead	B-VP	VBZ	O	15	SBAR
17	to	to	B-PP	TO	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	expression	expression	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	major	major	B-NP	JJ	B-protein	29	NMOD
22	histocompatibility	histocompatibility	I-NP	NN	I-protein	29	NMOD
23	complex	complex	I-NP	NN	I-protein	29	NMOD
24	(	(	O	(	I-protein	29	P
25	MHC	MHC	B-NP	NN	I-protein	29	NMOD
26	)	)	O	)	I-protein	29	P
27	class	class	B-NP	NN	I-protein	29	NMOD
28	I	I	B-NP	CD	I-protein	29	NMOD
29	molecules	molecule	I-NP	NNS	I-protein	20	PMOD
30	and	and	O	CC	O	16	VMOD
31	,	,	O	,	O	16	P
32	hence	hence	B-ADVP	RB	O	16	VMOD
33	,	,	O	,	O	16	P
34	antigen	antigen	B-NP	NN	O	35	NMOD
35	presentation	presentation	I-NP	NN	O	33	NMOD
36	to	to	B-PP	TO	O	35	NMOD
37	the	the	B-NP	DT	O	39	NMOD
38	T	T	I-NP	NN	B-cell_type	39	NMOD
39	cells	cell	I-NP	NNS	I-cell_type	36	PMOD
40	.	.	O	.	O	35	P

1	In	In	B-PP	IN	O	5	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	paper	paper	I-NP	NN	O	1	PMOD
4	we	we	B-NP	PRP	O	5	SUB
5	shall	shall	B-VP	MD	O	0	ROOT
6	advance	advance	I-VP	VB	O	5	VC
7	the	the	B-NP	DT	O	8	NMOD
8	hypothesis	hypothesis	I-NP	NN	O	6	OBJ
9	that	that	B-NP	IN	O	8	NMOD
10	:	:	O	:	O	9	P
11	(	(	B-LST	(	O	12	P
12	i	i	I-LST	LS	O	16	VMOD
13	)	)	O	)	O	12	P
14	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	16	SUB
15	indirectly	indirectly	B-ADVP	RB	O	16	VMOD
16	controls	control	B-VP	VBZ	O	25	VMOD
17	immune	immune	B-NP	JJ	O	18	NMOD
18	surveillance	surveillance	I-NP	NN	O	16	OBJ
19	;	;	O	:	O	25	P
20	and	and	O	CC	O	25	VMOD
21	(	(	B-LST	(	O	22	P
22	ii	ii	I-LST	LS	O	25	VMOD
23	)	)	O	)	O	22	P
24	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	25	SUB
25	controls	control	B-VP	VBZ	O	9	SBAR
26	DNA	DNA	B-NP	NN	O	27	NMOD
27	repair	repair	I-NP	NN	O	30	NMOD
28	and	and	I-NP	CC	O	30	NMOD
29	tumor	tumor	I-NP	NN	O	30	NMOD
30	suppression	suppression	I-NP	NN	O	25	OBJ
31	through	through	B-PP	IN	O	25	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	regulation	regulation	I-NP	NN	O	31	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	wild	wild	B-NP	JJ	B-protein	37	NMOD
36	type	type	I-NP	NN	I-protein	37	NMOD
37	p53	p53	I-NP	NN	I-protein	34	PMOD
38	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	hypothesized	hypothesize	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	elevated	elevated	B-NP	JJ	O	8	NMOD
8	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	9	SUB
9	is	be	B-VP	VBZ	O	6	SBAR
10	primarily	primarily	B-ADJP	RB	O	11	AMOD
11	responsible	responsible	I-ADJP	JJ	O	9	PRD
12	for	for	B-PP	IN	O	11	AMOD
13	promoting	promote	B-VP	VBG	O	12	PMOD
14	tumor	tumor	B-NP	NN	O	15	NMOD
15	progression	progression	I-NP	NN	O	13	OBJ
16	.	.	O	.	O	4	P

1	Differential	Differential	B-NP	JJ	O	2	NMOD
2	effects	effect	I-NP	NNS	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	8	NMOD
5	and	and	O	CC	O	8	NMOD
6	tumor	tumor	B-NP	NN	B-protein	8	NMOD
7	necrosis	necrosis	I-NP	NN	I-protein	8	NMOD
8	factor	factor	I-NP	NN	I-protein	3	PMOD
9	on	on	B-PP	IN	O	2	NMOD
10	monocytic	monocytic	B-NP	JJ	B-protein	14	NMOD
11	IkappaB	IkappaB	I-NP	NN	I-protein	14	NMOD
12	kinase	kinase	I-NP	NN	I-protein	14	NMOD
13	signalsome	signalsome	I-NP	JJ	O	14	NMOD
14	activation	activation	I-NP	NN	O	17	NMOD
15	and	and	O	CC	O	17	NMOD
16	IkappaB	IkappaB	B-NP	NN	B-protein	17	NMOD
17	proteolysis	proteolysis	I-NP	NN	O	9	PMOD
18	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	inflammatory	inflammatory	I-NP	JJ	O	3	NMOD
3	mediators	mediator	I-NP	NNS	O	15	SUB
4	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	11	NMOD
5	(	(	O	(	O	6	P
6	LPS	LPS	B-NP	NN	O	4	NMOD
7	)	)	O	)	O	6	P
8	and	and	O	CC	O	11	NMOD
9	tumor	tumor	B-NP	NN	B-protein	11	NMOD
10	necrosis	necrosis	I-NP	NN	I-protein	11	NMOD
11	factor	factor	I-NP	NN	I-protein	3	NMOD
12	(	(	O	(	O	13	P
13	TNF	TNF	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	are	be	B-VP	VBP	O	0	ROOT
16	potent	potent	B-NP	JJ	O	17	NMOD
17	activators	activator	I-NP	NNS	O	15	PRD
18	of	of	B-PP	IN	O	17	NMOD
19	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	PMOD
20	.	.	O	.	O	15	P

1	This	This	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	compared	compare	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	effect	effect	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	stimuli	stimulus	I-NP	NNS	O	6	PMOD
9	on	on	B-PP	IN	O	5	NMOD
10	endogenous	endogenous	B-NP	JJ	O	12	NMOD
11	IkappaB	IkappaB	I-NP	NN	B-protein	12	NMOD
12	kinase	kinase	I-NP	NN	I-protein	20	NMOD
13	(	(	O	(	O	14	P
14	IKK	IKK	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	signalsome	signalsome	B-ADJP	JJ	O	20	NMOD
17	activation	activation	B-NP	NN	O	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	IkappaB	IkappaB	B-NP	NN	B-protein	20	NMOD
20	phosphorylation/proteolysis	phosphorylation/proteolysis	I-NP	NN	O	9	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	human	human	B-NP	JJ	B-cell_type	24	NMOD
23	monocytic	monocytic	I-NP	JJ	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
25	and	and	O	CC	O	3	VMOD
26	investigated	investigate	B-VP	VBD	O	3	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	role	role	I-NP	NN	O	26	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	32	NMOD
31	signalsome	signalsome	I-NP	JJ	B-protein	32	NMOD
32	proteins	protein	I-NP	NNS	I-protein	53	NMOD
33	IKK-alpha	IKK-alpha	I-NP	NN	B-protein	53	NMOD
34	,	,	O	,	O	53	P
35	IKK-beta	IKK-beta	B-NP	NN	B-protein	53	NMOD
36	,	,	O	,	O	53	P
37	NF-kappaB-inducing	NF-kappaB-inducing	B-NP	NN	B-protein	38	NMOD
38	kinase	kinase	I-NP	NN	I-protein	53	NMOD
39	(	(	O	(	O	40	P
40	NIK	NIK	B-NP	NN	B-protein	38	NMOD
41	)	)	O	)	O	40	P
42	,	,	O	,	O	47	P
43	IKK-gamma	IKK-gamma	B-NP	NN	B-protein	47	NMOD
44	(	(	O	(	O	47	P
45	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	47	NMOD
46	essential	essential	I-NP	JJ	O	47	NMOD
47	modulator	modulator	I-NP	NN	O	38	NMOD
48	)	)	O	)	O	47	P
49	,	,	O	,	O	53	P
50	and	and	O	CC	O	53	NMOD
51	IKK	IKK	B-NP	NN	B-protein	53	NMOD
52	complex-associated	complex-associated	I-NP	JJ	I-protein	53	NMOD
53	protein	protein	I-NP	NN	I-protein	29	PMOD
54	.	.	O	.	O	3	P

1	Kinase	Kinase	B-NP	NN	O	2	NMOD
2	assays	assay	I-NP	NNS	O	3	SUB
3	showed	show	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	TNF	TNF	B-NP	NN	B-protein	6	SUB
6	elicited	elicit	B-VP	VBD	O	4	SBAR
7	a	a	B-NP	DT	O	11	NMOD
8	rapid	rapid	I-NP	JJ	O	10	AMOD
9	but	but	I-NP	CC	O	10	AMOD
10	short-lived	short-lived	I-NP	JJ	O	11	NMOD
11	induction	induction	I-NP	NN	O	6	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	IKK	IKK	B-NP	NN	B-protein	14	NMOD
14	activity	activity	I-NP	NN	O	12	PMOD
15	with	with	B-PP	IN	O	6	VMOD
16	a	a	B-NP	DT	O	19	NMOD
17	3-fold	3-fold	I-NP	JJ	O	18	AMOD
18	greater	great	I-NP	JJR	O	19	NMOD
19	effect	effect	I-NP	NN	O	15	PMOD
20	on	on	B-PP	IN	O	19	NMOD
21	IKK-alpha	IKK-alpha	B-NP	NN	B-protein	20	PMOD
22	than	than	B-PP	IN	O	6	VMOD
23	on	on	B-PP	IN	O	22	PMOD
24	IKK-beta	IKK-beta	B-NP	NN	B-protein	23	PMOD
25	,	,	O	,	O	6	P
26	peaking	peak	B-VP	VBG	O	6	VMOD
27	at	at	B-PP	IN	O	26	VMOD
28	5	5	B-NP	CD	O	29	NMOD
29	min	min	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	LPS	LPS	B-NP	NN	O	6	SUB
5	predominantly	predominantly	B-ADVP	RB	O	6	VMOD
6	stimulated	stimulate	B-VP	VBD	O	0	ROOT
7	IKK-beta	IKK-beta	B-NP	NN	B-protein	8	NMOD
8	activity	activity	I-NP	NN	O	6	OBJ
9	,	,	O	,	O	8	P
10	which	which	B-NP	WDT	O	8	NMOD
11	slowly	slowly	B-ADVP	RB	O	12	VMOD
12	increased	increase	B-VP	VBD	O	10	SBAR
13	,	,	O	,	O	12	P
14	peaking	peak	B-VP	VBG	O	12	VMOD
15	at	at	B-PP	IN	O	14	VMOD
16	30	30	B-NP	CD	O	17	NMOD
17	min	min	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	6	P

1	A	A	B-NP	DT	O	3	NMOD
2	second	second	I-NP	JJ	O	3	NMOD
3	peak	peak	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	observed	observe	I-VP	VBN	O	4	VC
6	at	at	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	10	NMOD
8	later	later	I-NP	JJ	O	10	NMOD
9	time	time	I-NP	NN	O	10	NMOD
10	point	point	I-NP	NN	O	6	PMOD
11	following	follow	B-PP	VBG	O	10	NMOD
12	LPS	LPS	B-NP	NN	O	13	NMOD
13	stimulation	stimulation	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	4	P
15	which	which	B-NP	WDT	O	4	VMOD
16	consisted	consist	B-VP	VBD	O	15	SBAR
17	of	of	B-PP	IN	O	16	VMOD
18	both	both	O	CC	O	22	NMOD
19	IKK-alpha	IKK-alpha	B-NP	NN	B-protein	22	NMOD
20	and	and	O	CC	O	22	NMOD
21	-beta	-beta	B-NP	NN	O	22	NMOD
22	activity	activity	I-NP	NN	O	17	PMOD
23	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	endogenous	endogenous	I-NP	JJ	O	3	NMOD
3	levels	level	I-NP	NNS	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	signalsome	signalsome	I-NP	JJ	B-protein	7	NMOD
7	components	component	I-NP	NNS	I-protein	4	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	unaffected	unaffected	B-ADJP	JJ	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	stimulation	stimulation	B-NP	NN	O	10	PMOD
12	.	.	O	.	O	8	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	our	our	B-NP	PRP$	O	4	NMOD
4	studies	study	I-NP	NNS	O	5	SUB
5	showed	show	B-VP	VBD	O	0	ROOT
6	association	association	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	IKK-alpha/beta	IKK-alpha/beta	I-NP	NN	B-protein	10	NMOD
10	heterodimer	heterodimer	I-NP	NN	I-protein	7	PMOD
11	with	with	B-PP	IN	O	6	NMOD
12	NIK	NIK	B-NP	NN	B-protein	16	NMOD
13	,	,	I-NP	,	O	16	P
14	IkappaB-alpha	IkappaB-alpha	I-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	-epsilon	-epsilon	I-NP	NN	B-protein	11	PMOD
17	in	in	B-PP	IN	O	6	NMOD
18	unstimulated	unstimulated	B-NP	JJ	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
20	.	.	O	.	O	5	P

1	Exposure	Exposure	B-NP	NN	O	6	SUB
2	to	to	B-PP	TO	O	1	NMOD
3	LPS	LPS	B-NP	NN	O	5	NMOD
4	or	or	I-NP	CC	O	5	NMOD
5	TNF	TNF	I-NP	NN	B-protein	2	PMOD
6	led	lead	B-VP	VBD	O	22	VMOD
7	to	to	B-PP	TO	O	6	VMOD
8	differential	differential	B-NP	JJ	O	9	NMOD
9	patterns	pattern	I-NP	NNS	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	IkappaB-alpha	IkappaB-alpha	B-NP	NN	B-protein	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	IkappaB-epsilon	IkappaB-epsilon	I-NP	NN	B-protein	14	NMOD
14	disappearance	disappearance	I-NP	NN	O	10	PMOD
15	from	from	B-PP	IN	O	14	NMOD
16	and	and	O	CC	O	17	NMOD
17	reassembly	reassembly	B-NP	NN	O	15	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	signalsome	signalsome	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	22	P
22	whereas	whereas	O	IN	O	0	ROOT
23	IKK-alpha	IKK-alpha	B-NP	NN	B-protein	28	NMOD
24	,	,	O	,	O	28	P
25	IKK-beta	IKK-beta	B-NP	NN	B-protein	28	NMOD
26	,	,	O	,	O	28	P
27	and	and	O	CC	O	28	NMOD
28	NIK	NIK	B-NP	NN	B-protein	29	SUB
29	remained	remain	B-VP	VBD	O	22	VMOD
30	complex-associated	complex-associated	B-ADJP	JJ	O	29	PRD
31	.	.	O	.	O	22	P

1	NIK	NIK	B-NP	NN	B-protein	2	SUB
2	can	can	B-VP	MD	O	10	VMOD
3	not	not	I-VP	RB	O	2	VMOD
4	phosphorylate	phosphorylate	I-VP	VB	O	2	VC
5	IkappaB-alpha	IkappaB-alpha	B-NP	NN	B-protein	4	OBJ
6	directly	directly	B-ADVP	RB	O	4	VMOD
7	,	,	O	,	O	10	P
8	but	but	O	CC	O	10	VMOD
9	it	it	B-NP	PRP	O	10	SUB
10	appears	appear	B-VP	VBZ	O	0	ROOT
11	to	to	I-VP	TO	O	12	VMOD
12	be	be	I-VP	VB	O	10	VMOD
13	a	a	B-NP	DT	O	16	NMOD
14	functionally	functionally	I-NP	RB	O	15	AMOD
15	important	important	I-NP	JJ	O	16	NMOD
16	subunit	subunit	I-NP	NN	O	12	PRD
17	,	,	O	,	O	10	P
18	because	because	B-SBAR	IN	O	10	VMOD
19	mutated	mutate	B-NP	VBN	O	20	NMOD
20	NIK	NIK	I-NP	NN	B-protein	21	SUB
21	inhibited	inhibit	B-VP	VBD	O	18	SBAR
22	stimulus-induced	stimulus-induced	B-NP	JJ	O	24	NMOD
23	kappaB-dependent	kappaB-dependent	I-NP	JJ	O	24	NMOD
24	transcription	transcription	I-NP	NN	O	21	OBJ
25	more	more	B-ADVP	RBR	O	26	AMOD
26	effectively	effectively	I-ADVP	RB	O	21	VMOD
27	than	than	B-PP	IN	O	26	AMOD
28	mutated	mutate	B-NP	VBN	O	31	NMOD
29	IKK-alpha	IKK-alpha	I-NP	NN	B-protein	31	NMOD
30	or	or	I-NP	CC	O	31	NMOD
31	-beta	-beta	I-NP	NN	B-protein	27	PMOD
32	.	.	O	.	O	10	P

1	Overexpression	Overexpression	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	IKK	IKK	B-NP	NN	B-protein	5	NMOD
4	complex-associated	complex-associated	I-NP	JJ	I-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	2	PMOD
6	inhibited	inhibit	B-VP	VBD	O	0	ROOT
7	stimulus-mediated	stimulus-mediated	B-NP	JJ	O	8	NMOD
8	transcription	transcription	I-NP	NN	O	6	OBJ
9	,	,	O	,	O	6	P
10	whereas	whereas	O	IN	O	6	VMOD
11	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	NMOD
12	essential	essential	I-NP	JJ	O	13	NMOD
13	modulator	modulator	I-NP	NN	O	14	SUB
14	enhanced	enhance	B-VP	VBD	O	10	SBAR
15	it	it	B-NP	PRP	O	14	OBJ
16	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	understanding	understanding	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	LPS-	LPS-	B-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	TNF-induced	TNF-induced	B-NP	JJ	O	7	NMOD
7	signaling	signaling	I-NP	NN	O	3	PMOD
8	may	may	B-VP	MD	O	0	ROOT
9	allow	allow	I-VP	VB	O	8	VC
10	the	the	B-NP	DT	O	11	NMOD
11	development	development	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	specific	specific	B-NP	JJ	O	14	NMOD
14	strategies	strategy	I-NP	NNS	O	12	PMOD
15	to	to	B-VP	TO	O	16	VMOD
16	treat	treat	I-VP	VB	O	11	NMOD
17	sepsis-associated	sepsis-associated	B-NP	JJ	O	18	NMOD
18	disease	disease	I-NP	NN	O	16	OBJ
19	.	.	O	.	O	8	P

1	Activation	Activation	B-NP	NN	O	7	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	protein	protein	B-NP	NN	B-protein	5	NMOD
4	kinase	kinase	I-NP	NN	I-protein	5	NMOD
5	C	C	I-NP	NN	I-protein	2	PMOD
6	and	and	O	CC	O	7	NMOD
7	elevation	elevation	B-NP	NN	O	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	cAMP	cAMP	B-NP	NN	O	8	PMOD
10	interact	interact	B-VP	VBP	O	0	ROOT
11	synergistically	synergistically	B-ADVP	RB	O	10	VMOD
12	to	to	B-VP	TO	O	13	VMOD
13	raise	raise	I-VP	VB	O	10	VMOD
14	c-Fos	c-Fos	B-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	AP-1	AP-1	I-NP	NN	B-protein	17	NMOD
17	activity	activity	I-NP	NN	O	13	OBJ
18	in	in	B-PP	IN	O	17	NMOD
19	Jurkat	Jurkat	B-NP	NN	B-cell_line	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
21	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	earlier	earlier	I-VP	RBR	O	2	VMOD
4	found	find	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	in	in	B-PP	IN	O	17	VMOD
7	Jurkat	Jurkat	B-NP	NN	B-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
9	activation	activation	B-NP	NN	O	17	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	protein	protein	B-NP	NN	B-protein	13	NMOD
12	kinase	kinase	I-NP	NN	I-protein	13	NMOD
13	C	C	I-NP	NN	I-protein	10	PMOD
14	(	(	O	(	O	15	P
15	PKC	PKC	B-NP	NN	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	enhances	enhance	B-VP	VBZ	O	5	SBAR
18	the	the	B-NP	DT	O	21	NMOD
19	cyclic	cyclic	I-NP	JJ	O	21	NMOD
20	adenosine	adenosine	I-NP	NN	O	21	NMOD
21	monophosphate	monophosphate	I-NP	NN	O	25	NMOD
22	(	(	O	(	O	23	P
23	cAMP	cAMP	B-NP	NN	O	21	NMOD
24	)	)	O	)	O	23	P
25	accumulation	accumulation	B-NP	NN	O	17	OBJ
26	induced	induce	B-VP	VBN	O	25	NMOD
27	by	by	B-PP	IN	O	26	VMOD
28	adenosine	adenosine	B-NP	NN	B-protein	30	NMOD
29	receptor	receptor	I-NP	NN	I-protein	30	NMOD
30	stimulation	stimulation	I-NP	NN	O	32	NMOD
31	or	or	O	CC	O	32	NMOD
32	activation	activation	B-NP	NN	O	27	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	Gs	Gs	B-NP	NN	B-protein	33	PMOD
35	.	.	O	.	O	2	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	therefore	therefore	I-VP	RB	O	3	VMOD
5	examined	examine	I-VP	VBN	O	3	VC
6	the	the	B-NP	DT	O	7	NMOD
7	effect	effect	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	phorbol	phorbol	I-NP	NN	O	12	NMOD
11	ester	ester	I-NP	NN	O	12	NMOD
12	PMA	PMA	I-NP	NN	O	8	PMOD
13	(	(	O	(	O	16	P
14	phorbol	phorbol	B-NP	NN	O	16	NMOD
15	12-myristate	12-myristate	I-NP	NN	O	16	NMOD
16	13-acetate	13-acetate	I-NP	NN	O	12	NMOD
17	)	)	O	)	O	16	P
18	which	which	B-NP	WDT	O	12	NMOD
19	stimulates	stimulate	B-VP	VBZ	O	18	SBAR
20	PKC	PKC	B-NP	NN	B-protein	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	a	a	B-NP	DT	O	23	NMOD
23	combination	combination	I-NP	NN	O	19	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	adenosine	adenosine	I-NP	NN	B-protein	29	NMOD
27	receptor	receptor	I-NP	NN	I-protein	29	NMOD
28	agonist	agonist	I-NP	NN	O	29	NMOD
29	NECA	NECA	I-NP	NN	O	39	NMOD
30	(	(	O	(	O	36	P
31	5'-	5'-	B-NP	CD	O	36	NMOD
32	(	(	O	(	O	36	P
33	N-ethyl	N-ethyl	B-NP	NN	O	36	NMOD
34	)	)	O	)	O	36	P
35	-carboxamido	-carboxamido	B-NP	JJ	O	36	NMOD
36	adenosine	adenosine	I-NP	NN	O	29	NMOD
37	)	)	O	)	O	36	P
38	and	and	O	CC	O	39	NMOD
39	forskolin	forskolin	B-NP	NN	O	24	PMOD
40	to	to	B-VP	TO	O	41	VMOD
41	raise	raise	I-VP	VB	O	39	NMOD
42	cAMP	cAMP	B-NP	NN	O	41	OBJ
43	,	,	O	,	O	7	P
44	on	on	B-PP	IN	O	7	NMOD
45	the	the	B-NP	DT	O	46	NMOD
46	levels	level	I-NP	NNS	O	44	PMOD
47	of	of	B-PP	IN	O	46	NMOD
48	c-Fos	c-Fos	B-NP	NN	B-protein	50	NMOD
49	and	and	I-NP	CC	O	50	NMOD
50	Jun	Jun	I-NP	NN	B-protein	47	PMOD
51	and	and	B-PP	CC	O	44	PMOD
52	on	on	B-PP	IN	O	44	PMOD
53	the	the	B-NP	DT	O	57	NMOD
54	binding	binding	I-NP	NN	O	57	NMOD
55	and	and	O	CC	O	57	NMOD
56	transcriptional	transcriptional	B-NP	JJ	O	57	NMOD
57	activity	activity	I-NP	NN	O	52	PMOD
58	of	of	B-PP	IN	O	57	NMOD
59	the	the	B-NP	DT	O	61	NMOD
60	transcription	transcription	I-NP	NN	B-protein	61	NMOD
61	factor	factor	I-NP	NN	I-protein	64	NMOD
62	,	,	O	,	O	64	P
63	activator	activator	B-NP	NN	B-protein	64	NMOD
64	protein-1	protein-1	I-NP	NN	I-protein	58	PMOD
65	(	(	O	(	O	66	P
66	AP-1	AP-1	B-NP	NN	B-protein	64	NMOD
67	)	)	O	)	O	66	P
68	.	.	O	.	O	3	P

1	PMA	PMA	B-NP	NN	O	2	NMOD
2	treatment	treatment	I-NP	NN	O	3	SUB
3	caused	cause	B-VP	VBD	O	0	ROOT
4	a	a	B-NP	DT	O	8	NMOD
5	concentration-	concentration-	I-NP	NN	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	time-dependent	time-dependent	B-NP	JJ	O	8	NMOD
8	increase	increase	I-NP	NN	O	3	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	both	both	O	CC	O	13	NMOD
11	c-Fos	c-Fos	B-NP	NN	B-protein	13	NMOD
12	and	and	O	CC	O	13	NMOD
13	Jun	Jun	B-NP	NN	B-protein	14	NMOD
14	immunoreactivity	immunoreactivity	I-NP	NN	O	9	PMOD
15	in	in	B-PP	IN	O	3	VMOD
16	contrast	contrast	B-NP	NN	O	15	PMOD
17	to	to	B-PP	TO	O	15	PMOD
18	cAMP	cAMP	B-NP	NN	O	19	NMOD
19	elevation	elevation	I-NP	NN	O	15	PMOD
20	that	that	B-NP	WDT	O	19	NMOD
21	had	have	B-VP	VBD	O	20	SBAR
22	only	only	B-NP	RB	O	25	NMOD
23	a	a	I-NP	DT	O	25	NMOD
24	slight	slight	I-NP	JJ	O	25	NMOD
25	effect	effect	I-NP	NN	O	21	OBJ
26	.	.	O	.	O	3	P

1	Both	Both	O	CC	O	5	NMOD
2	PMA	PMA	B-NP	NN	O	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	combination	combination	I-NP	NN	O	10	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	NECA	NECA	B-NP	NN	B-protein	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	forskolin	forskolin	I-NP	NN	O	6	PMOD
10	acted	act	B-VP	VBD	O	0	ROOT
11	together	together	B-ADVP	RB	O	10	VMOD
12	either	either	O	CC	O	14	VMOD
13	to	to	B-VP	TO	O	14	VMOD
14	increase	increase	I-VP	VB	O	10	VMOD
15	(	(	O	(	O	16	P
16	c-Fos	c-Fos	B-NP	NN	B-protein	14	OBJ
17	)	)	O	)	O	16	P
18	or	or	O	CC	O	14	VMOD
19	decrease	decrease	B-NP	NN	O	24	NMOD
20	(	(	O	(	O	21	P
21	Jun	Jun	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	protein	protein	B-NP	NN	O	24	NMOD
24	levels	level	I-NP	NNS	O	14	VMOD
25	as	as	B-CONJP	RB	O	24	NMOD
26	well	well	I-CONJP	RB	O	25	DEP
27	as	as	I-CONJP	IN	O	25	DEP
28	increasing	increase	B-VP	VBG	O	25	DEP
29	AP-1	AP-1	B-NP	NN	B-protein	30	NMOD
30	binding	binding	I-NP	NN	O	28	OBJ
31	,	,	O	,	O	10	P
32	as	as	B-SBAR	IN	O	10	VMOD
33	judged	judge	B-VP	VBN	O	32	SBAR
34	by	by	B-PP	IN	O	33	VMOD
35	gel-shift	gel-shift	B-NP	JJ	O	36	NMOD
36	assay	assay	I-NP	NN	O	34	PMOD
37	,	,	O	,	O	41	P
38	and	and	O	CC	O	41	NMOD
39	AP-1	AP-1	B-NP	NN	B-protein	41	NMOD
40	transcriptional	transcriptional	I-NP	JJ	O	41	NMOD
41	activity	activity	I-NP	NN	O	10	VMOD
42	.	.	O	.	O	10	P

1	Furthermore	Furthermore	B-ADVP	RB	O	3	VMOD
2	there	there	B-NP	EX	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	clear-cut	clear-cut	I-NP	JJ	O	6	NMOD
6	synergy	synergy	I-NP	NN	O	3	PRD
7	between	between	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	PKC	PKC	I-NP	NN	B-protein	10	NMOD
10	stimulator	stimulator	I-NP	NN	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	cAMP	cAMP	I-NP	NN	O	15	NMOD
14	elevating	elevate	B-VP	VBG	O	15	NMOD
15	agents	agent	B-NP	NNS	O	7	PMOD
16	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	simultaneous	simultaneous	I-NP	JJ	O	7	NMOD
7	activation	activation	I-NP	NN	O	14	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	PKC	PKC	B-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	elevation	elevation	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	cAMP	cAMP	B-NP	NN	O	12	PMOD
14	leads	lead	B-VP	VBZ	O	4	SBAR
15	to	to	B-PP	TO	O	14	VMOD
16	an	an	B-NP	DT	O	20	NMOD
17	enhanced	enhance	I-NP	VBN	O	20	NMOD
18	AP-1	AP-1	I-NP	NN	B-protein	20	NMOD
19	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD
20	activity	activity	I-NP	NN	O	15	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	a	a	B-NP	DT	O	25	NMOD
23	T-leukemia	T-leukemia	I-NP	NN	B-cell_line	25	NMOD
24	cell	cell	I-NP	NN	I-cell_line	25	NMOD
25	line	line	I-NP	NN	I-cell_line	21	PMOD
26	,	,	O	,	O	3	P
27	suggesting	suggest	B-VP	VBG	O	3	VMOD
28	that	that	B-SBAR	IN	O	27	VMOD
29	the	the	B-NP	DT	O	32	NMOD
30	previously	previously	I-NP	RB	O	31	AMOD
31	observed	observe	I-NP	VBN	O	32	NMOD
32	interaction	interaction	I-NP	NN	O	39	SUB
33	between	between	B-PP	IN	O	32	NMOD
34	the	the	B-NP	DT	O	38	NMOD
35	parallel	parallel	I-NP	JJ	O	38	NMOD
36	signal	signal	I-NP	NN	O	38	NMOD
37	transduction	transduction	I-NP	NN	O	38	NMOD
38	pathways	pathway	I-NP	NNS	O	33	PMOD
39	may	may	B-VP	MD	O	28	SBAR
40	have	have	I-VP	VB	O	39	VC
41	functional	functional	B-NP	JJ	O	42	NMOD
42	consequences	consequence	I-NP	NNS	O	40	OBJ
43	at	at	B-PP	IN	O	40	VMOD
44	the	the	B-NP	DT	O	45	NMOD
45	level	level	I-NP	NN	O	43	PMOD
46	of	of	B-PP	IN	O	45	NMOD
47	gene	gene	B-NP	NN	O	48	NMOD
48	transcription	transcription	I-NP	NN	O	46	PMOD
49	.	.	O	.	O	3	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	interaction	interaction	I-NP	NN	O	0	ROOT
3	between	between	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	8	NMOD
5	two	two	I-NP	CD	O	8	NMOD
6	zinc	zinc	I-NP	NN	B-protein	8	NMOD
7	finger	finger	I-NP	NN	I-protein	8	NMOD
8	domains	domain	I-NP	NNS	I-protein	3	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	v-erb	v-erb	I-NP	NN	B-protein	13	NMOD
12	A	A	I-NP	NN	I-protein	13	NMOD
13	oncoprotein	oncoprotein	I-NP	NN	I-protein	9	PMOD
14	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	4	NMOD
2	v-erb	v-erb	I-NP	NN	B-DNA	4	NMOD
3	A	A	I-NP	NN	I-DNA	4	NMOD
4	oncogene	oncogene	I-NP	NN	I-DNA	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	avian	avian	B-NP	JJ	O	8	NMOD
7	erythroblastosis	erythroblastosis	I-NP	NN	O	8	NMOD
8	virus	virus	I-NP	NN	O	5	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	a	a	B-NP	DT	O	15	NMOD
11	mutated	mutate	I-NP	VBN	O	14	AMOD
12	and	and	I-NP	CC	O	14	AMOD
13	virally	virally	I-NP	RB	O	14	AMOD
14	transduced	transduce	I-NP	VBN	O	15	NMOD
15	copy	copy	I-NP	NN	O	9	PRD
16	of	of	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	20	NMOD
18	host	host	I-NP	NN	B-DNA	20	NMOD
19	cell	cell	I-NP	NN	I-DNA	20	NMOD
20	gene	gene	I-NP	NN	I-DNA	16	PMOD
21	encoding	encode	B-VP	VBG	O	20	NMOD
22	a	a	B-NP	DT	O	25	NMOD
23	thyroid	thyroid	I-NP	NN	B-protein	25	NMOD
24	hormone	hormone	I-NP	NN	I-protein	25	NMOD
25	receptor	receptor	I-NP	NN	I-protein	21	OBJ
26	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	2	NMOD
2	protein	protein	I-NP	NN	O	9	SUB
3	expressed	express	B-VP	VBN	O	2	NMOD
4	by	by	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	v-erb	v-erb	I-NP	NN	B-DNA	8	NMOD
7	A	A	I-NP	NN	I-DNA	8	NMOD
8	oncogene	oncogene	I-NP	NN	I-DNA	4	PMOD
9	binds	bind	B-VP	VBZ	O	0	ROOT
10	to	to	B-PP	TO	O	9	VMOD
11	DNA	DNA	B-NP	NN	O	10	PMOD
12	and	and	O	CC	O	9	VMOD
13	acts	act	B-VP	VBZ	O	9	VMOD
14	as	as	B-PP	IN	O	13	VMOD
15	a	a	B-NP	DT	O	18	NMOD
16	dominant	dominant	I-NP	JJ	O	18	NMOD
17	negative	negative	I-NP	JJ	O	18	NMOD
18	inhibitor	inhibitor	I-NP	NN	O	14	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	both	both	O	CC	O	31	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	thyroid	thyroid	I-NP	NN	B-protein	24	NMOD
23	hormone	hormone	I-NP	NN	I-protein	24	NMOD
24	receptor	receptor	I-NP	NN	I-protein	31	NMOD
25	and	and	O	CC	O	31	NMOD
26	the	the	B-NP	DT	O	31	NMOD
27	closely	closely	I-NP	RB	O	28	AMOD
28	related	related	I-NP	JJ	O	31	NMOD
29	retinoic	retinoic	I-NP	JJ	B-protein	31	NMOD
30	acid	acid	I-NP	NN	I-protein	31	NMOD
31	receptor	receptor	I-NP	NN	I-protein	19	PMOD
32	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	4	NMOD
2	v-erb	v-erb	I-NP	NN	B-protein	4	NMOD
3	A	A	I-NP	NN	I-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	5	SUB
5	has	have	B-VP	VBZ	O	0	ROOT
6	sustained	sustain	I-VP	VBN	O	5	VC
7	two	two	B-NP	CD	O	10	NMOD
8	amino	amino	I-NP	JJ	O	10	NMOD
9	acid	acid	I-NP	NN	O	10	NMOD
10	alterations	alteration	I-NP	NNS	O	6	OBJ
11	within	within	B-PP	IN	O	6	VMOD
12	its	its	B-NP	PRP$	O	14	NMOD
13	DNA-binding	DNA-binding	I-NP	JJ	B-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	11	PMOD
15	relative	relative	B-ADVP	JJ	O	16	PMOD
16	to	to	B-PP	TO	O	6	VMOD
17	that	that	B-NP	DT	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	c-erb	c-erb	B-NP	NN	B-protein	20	NMOD
20	A	A	I-NP	NN	I-protein	18	PMOD
21	,	,	O	,	O	6	P
22	one	one	B-NP	CD	O	23	NMOD
23	of	of	B-PP	IN	O	6	VMOD
24	which	which	B-NP	WDT	O	23	PMOD
25	,	,	O	,	O	23	P
26	at	at	B-PP	IN	O	23	NMOD
27	serine	serine	B-NP	NN	O	26	PMOD
28	61	61	I-NP	CD	O	27	NMOD
29	,	,	O	,	O	23	P
30	is	be	B-VP	VBZ	O	23	SBAR
31	known	know	I-VP	VBN	O	30	VC
32	to	to	I-VP	TO	O	33	VMOD
33	be	be	I-VP	VB	O	31	VMOD
34	important	important	B-ADJP	JJ	O	33	PRD
35	for	for	B-PP	IN	O	34	AMOD
36	v-erb	v-erb	B-NP	NN	B-protein	38	NMOD
37	A	A	I-NP	NN	I-protein	38	NMOD
38	function	function	I-NP	NN	O	35	PMOD
39	in	in	B-PP	IN	O	38	NMOD
40	the	the	B-NP	DT	O	42	NMOD
41	neoplastic	neoplastic	I-NP	JJ	B-cell_type	42	NMOD
42	cell	cell	I-NP	NN	I-cell_type	39	PMOD
43	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	second	second	I-NP	JJ	O	7	NMOD
7	alteration	alteration	I-NP	NN	O	14	SUB
8	,	,	O	,	O	7	P
9	at	at	B-PP	IN	O	7	NMOD
10	threonine	threonine	B-NP	NN	O	9	PMOD
11	78	78	I-NP	CD	O	10	NMOD
12	,	,	O	,	O	7	P
13	also	also	B-ADVP	RB	O	14	VMOD
14	plays	play	B-VP	VBZ	O	4	SBAR
15	an	an	B-NP	DT	O	16	NMOD
16	important	important	I-NP	JJ	O	14	OBJ
17	,	,	O	,	O	14	P
18	although	although	B-SBAR	IN	O	14	VMOD
19	more	more	B-ADJP	RBR	O	20	AMOD
20	indirect	indirect	I-ADJP	JJ	O	22	NMOD
21	,	,	O	,	O	20	P
22	role	role	B-NP	NN	O	24	NMOD
23	:	:	O	:	O	22	P
24	alteration	alteration	B-NP	NN	O	39	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	27	NMOD
27	sequence	sequence	I-NP	NN	O	25	PMOD
28	at	at	B-PP	IN	O	24	NMOD
29	threonine	threonine	B-NP	NN	O	28	PMOD
30	78	78	I-NP	CD	O	29	NMOD
31	such	such	B-ADVP	JJ	O	32	DEP
32	that	that	B-SBAR	IN	O	24	NMOD
33	it	it	B-NP	PRP	O	34	SUB
34	resembles	resemble	B-VP	VBZ	O	32	SBAR
35	that	that	B-NP	DT	O	34	OBJ
36	of	of	B-PP	IN	O	35	NMOD
37	c-erb	c-erb	B-NP	NN	B-protein	38	NMOD
38	A	A	I-NP	NN	I-protein	36	PMOD
39	can	can	B-VP	MD	O	18	SBAR
40	act	act	I-VP	VB	O	39	VC
41	as	as	B-PP	IN	O	40	VMOD
42	an	an	B-NP	DT	O	44	NMOD
43	intragenic	intragenic	I-NP	JJ	O	44	NMOD
44	suppressor	suppressor	I-NP	NN	O	41	PMOD
45	and	and	O	CC	O	14	VMOD
46	can	can	B-VP	MD	O	14	VMOD
47	partially	partially	I-VP	RB	O	46	VMOD
48	restore	restore	I-VP	VB	O	46	VC
49	function	function	B-NP	NN	O	48	OBJ
50	to	to	B-PP	TO	O	48	VMOD
51	a	a	B-NP	DT	O	54	NMOD
52	v-erb	v-erb	I-NP	NN	B-protein	54	NMOD
53	A	A	I-NP	NN	I-protein	54	NMOD
54	protein	protein	I-NP	NN	I-protein	50	PMOD
55	rendered	render	B-VP	VBD	O	54	NMOD
56	defective	defective	B-NP	JJ	O	55	VMOD
57	due	due	I-NP	JJ	O	58	PMOD
58	to	to	B-PP	TO	O	55	VMOD
59	a	a	B-NP	DT	O	60	NMOD
60	mutation	mutation	I-NP	NN	O	58	PMOD
61	at	at	B-PP	IN	O	60	NMOD
62	position	position	B-NP	NN	B-protein	61	PMOD
63	61	61	I-NP	CD	I-protein	62	NMOD
64	.	.	O	.	O	2	P

1	Threonine	Threonine	B-NP	NN	O	3	SUB
2	78	78	I-NP	CD	O	1	NMOD
3	lies	lie	B-VP	VBZ	O	0	ROOT
4	within	within	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	D-box	D-box	I-NP	NN	B-DNA	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	v-erb	v-erb	I-NP	NN	B-protein	11	NMOD
10	A	A	I-NP	NN	I-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	14	NMOD
12	,	,	O	,	O	14	P
13	a	a	B-NP	DT	O	14	NMOD
14	region	region	I-NP	NN	O	7	PMOD
15	thought	think	B-VP	VBN	O	14	NMOD
16	to	to	I-VP	TO	O	17	VMOD
17	mediate	mediate	I-VP	VB	O	15	VMOD
18	receptor-receptor	receptor-receptor	B-NP	JJ	O	19	NMOD
19	dimerizations	dimerization	I-NP	NNS	O	17	OBJ
20	,	,	O	,	O	3	P
21	and	and	O	CC	O	3	VMOD
22	is	be	B-VP	VBZ	O	3	VMOD
23	not	not	O	RB	O	22	VMOD
24	in	in	B-PP	IN	O	22	PRD
25	physical	physical	B-NP	JJ	O	26	NMOD
26	proximity	proximity	I-NP	NN	O	24	PMOD
27	to	to	B-PP	TO	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	serine	serine	I-NP	NN	O	27	PMOD
30	at	at	B-PP	IN	O	29	NMOD
31	position	position	B-NP	NN	B-protein	30	PMOD
32	61	61	I-NP	CD	I-protein	31	NMOD
33	.	.	O	.	O	3	P

1	It	It	B-NP	PRP	O	3	SUB
2	therefore	therefore	B-ADVP	RB	O	3	VMOD
3	appears	appear	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	14	DEP
5	an	an	B-NP	DT	O	7	NMOD
6	indirect	indirect	I-NP	JJ	O	7	NMOD
7	interaction	interaction	I-NP	NN	O	8	SUB
8	occurs	occur	B-VP	VBZ	O	4	SBAR
9	between	between	B-PP	IN	O	8	VMOD
10	these	these	B-NP	DT	O	12	NMOD
11	two	two	I-NP	CD	O	12	NMOD
12	sites	site	I-NP	NNS	O	9	PMOD
13	and	and	O	CC	O	14	DEP
14	that	that	B-SBAR	IN	O	3	VMOD
15	this	this	B-NP	DT	O	16	NMOD
16	interaction	interaction	I-NP	NN	O	17	SUB
17	is	be	B-VP	VBZ	O	14	SBAR
18	crucial	crucial	B-ADJP	JJ	O	17	PRD
19	for	for	B-PP	IN	O	18	AMOD
20	v-erb	v-erb	B-NP	NN	B-protein	22	NMOD
21	A	A	I-NP	NN	I-protein	22	NMOD
22	function	function	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	3	P

1	Inhibition	Inhibition	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	transcription	transcription	B-NP	NN	B-protein	4	NMOD
4	factors	factor	I-NP	NNS	I-protein	2	PMOD
5	belonging	belong	B-VP	VBG	O	4	NMOD
6	to	to	B-PP	TO	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	rel/NF-kappa	rel/NF-kappa	I-NP	NN	B-protein	10	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	family	family	I-NP	NN	I-protein	6	PMOD
11	by	by	B-PP	IN	O	1	NMOD
12	a	a	B-NP	DT	O	15	NMOD
13	transdominant	transdominant	I-NP	JJ	B-protein	15	NMOD
14	negative	negative	I-NP	JJ	I-protein	15	NMOD
15	mutant	mutant	I-NP	NN	I-protein	11	PMOD
16	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	3	NMOD
2	KBF1	KBF1	I-NP	NN	B-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	24	SUB
4	,	,	O	,	O	3	P
5	which	which	B-NP	WDT	O	3	NMOD
6	binds	bind	B-VP	VBZ	O	5	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	enhancer	enhancer	I-NP	NN	B-DNA	10	NMOD
10	A	A	I-NP	NN	I-DNA	7	PMOD
11	located	located	B-ADJP	JJ	O	10	NMOD
12	in	in	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	14	NMOD
14	promoter	promoter	I-NP	NN	B-DNA	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	22	NMOD
17	mouse	mouse	I-NP	NN	B-DNA	22	NMOD
18	MHC	MHC	I-NP	NN	I-DNA	22	NMOD
19	class	class	I-NP	NN	I-DNA	22	NMOD
20	I	I	I-NP	CD	I-DNA	22	NMOD
21	gene	gene	I-NP	NN	I-DNA	22	NMOD
22	H-2Kb	H-2Kb	I-NP	NN	O	15	PMOD
23	,	,	O	,	O	3	P
24	is	be	B-VP	VBZ	O	0	ROOT
25	indistinguishable	indistinguishable	B-ADJP	JJ	O	24	PRD
26	from	from	B-PP	IN	O	25	AMOD
27	the	the	B-NP	DT	O	31	NMOD
28	p50	p50	I-NP	NN	B-protein	31	NMOD
29	DNA	DNA	I-NP	NN	I-protein	31	NMOD
30	binding	binding	I-NP	NN	I-protein	31	NMOD
31	subunit	subunit	I-NP	NN	I-protein	26	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	37	NMOD
34	transcription	transcription	I-NP	NN	B-protein	37	NMOD
35	factor	factor	I-NP	NN	I-protein	37	NMOD
36	NF-kappa	NF-kappa	I-NP	NN	B-protein	37	NMOD
37	B	B	I-NP	NN	I-protein	32	PMOD
38	,	,	O	,	O	31	P
39	which	which	B-NP	WDT	O	31	NMOD
40	regulates	regulate	B-VP	VBZ	O	39	SBAR
41	a	a	B-NP	DT	O	42	NMOD
42	series	series	I-NP	NN	O	40	OBJ
43	of	of	B-PP	IN	O	42	NMOD
44	genes	gene	B-NP	NNS	B-DNA	43	PMOD
45	involved	involve	B-VP	VBN	O	44	NMOD
46	in	in	B-PP	IN	O	45	VMOD
47	immune	immune	B-NP	JJ	O	49	AMOD
48	and	and	I-NP	CC	O	49	AMOD
49	inflammatory	inflammatory	I-NP	JJ	O	50	NMOD
50	responses	response	I-NP	NNS	O	46	PMOD
51	.	.	O	.	O	24	P

1	The	The	B-NP	DT	O	3	NMOD
2	KBF1/p50	KBF1/p50	I-NP	NN	B-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	4	SUB
4	binds	bind	B-VP	VBZ	O	0	ROOT
5	as	as	B-PP	IN	O	4	VMOD
6	a	a	B-NP	DT	O	7	NMOD
7	homodimer	homodimer	I-NP	NN	B-protein	5	PMOD
8	but	but	O	CC	O	4	VMOD
9	can	can	B-VP	MD	O	4	VMOD
10	also	also	I-VP	RB	O	9	VMOD
11	form	form	I-VP	VB	O	9	VC
12	heterodimers	heterodimer	B-NP	NNS	B-protein	11	OBJ
13	with	with	B-PP	IN	O	11	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	products	product	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	other	other	B-NP	JJ	O	18	NMOD
18	members	member	I-NP	NNS	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	same	same	I-NP	JJ	O	22	NMOD
22	family	family	I-NP	NN	O	19	PMOD
23	,	,	O	,	O	4	P
24	like	like	B-PP	IN	O	4	VMOD
25	the	the	B-NP	DT	O	32	NMOD
26	c-rel	c-rel	I-NP	NN	B-DNA	28	NMOD
27	and	and	O	CC	I-DNA	28	NMOD
28	v-rel	v-rel	B-NP	NN	I-DNA	32	NMOD
29	(	(	B-NP	(	I-DNA	30	P
30	proto	proto	I-NP	NN	I-DNA	28	NMOD
31	)	)	I-NP	)	I-DNA	30	P
32	oncogenes	oncogene	I-NP	NNS	I-DNA	24	PMOD
33	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	dimerization	dimerization	I-NP	NN	B-protein	3	NMOD
3	domain	domain	I-NP	NN	I-protein	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	KBF1/p50	KBF1/p50	B-NP	NN	B-protein	4	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	contained	contain	I-VP	VBN	O	6	VC
8	between	between	B-PP	IN	O	7	VMOD
9	amino	amino	B-NP	NN	B-protein	10	NMOD
10	acids	acid	I-NP	NNS	I-protein	8	PMOD
11	201	201	B-NP	CD	I-protein	13	NMOD
12	and	and	O	CC	I-protein	13	NMOD
13	367	367	B-NP	CD	I-protein	10	NMOD
14	.	.	O	.	O	6	P

1	A	A	B-NP	DT	O	2	NMOD
2	mutant	mutant	I-NP	NN	O	23	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	KBF1/p50	KBF1/p50	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	7	P
6	delta	delta	B-NP	SYM	B-protein	7	NMOD
7	SP	SP	I-NP	NN	I-protein	4	NMOD
8	)	)	O	)	O	7	P
9	,	,	O	,	O	2	P
10	unable	unable	B-ADJP	JJ	O	16	AMOD
11	to	to	B-VP	TO	O	12	VMOD
12	bind	bind	I-VP	VB	O	10	AMOD
13	to	to	B-PP	TO	O	12	VMOD
14	DNA	DNA	B-NP	NN	O	13	PMOD
15	but	but	O	CC	O	16	AMOD
16	able	able	B-ADJP	JJ	O	2	NMOD
17	to	to	B-VP	TO	O	18	VMOD
18	form	form	I-VP	VB	O	16	AMOD
19	homo-	homo-	B-NP	JJ	O	18	OBJ
20	or	or	O	CC	O	21	NMOD
21	heterodimers	heterodimer	B-NP	NNS	B-protein	19	NMOD
22	,	,	O	,	O	2	P
23	has	have	B-VP	VBZ	O	0	ROOT
24	been	be	I-VP	VBN	O	23	VC
25	constructed	construct	I-VP	VBN	O	24	VC
26	.	.	O	.	O	23	P

1	This	This	B-NP	DT	O	2	NMOD
2	protein	protein	I-NP	NN	O	3	SUB
3	reduces	reduce	B-VP	VBZ	O	0	ROOT
4	or	or	I-VP	CC	O	3	VMOD
5	abolishes	abolish	I-VP	VBZ	O	3	VMOD
6	in	in	B-ADVP	FW	O	3	VMOD
7	vitro	vitro	I-ADVP	FW	O	6	AMOD
8	the	the	B-NP	DT	O	11	NMOD
9	DNA	DNA	I-NP	NN	O	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	activity	activity	I-NP	NN	O	3	VMOD
12	of	of	B-PP	IN	O	11	NMOD
13	wild-type	wild-type	B-NP	JJ	B-protein	14	NMOD
14	proteins	protein	I-NP	NNS	I-protein	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	same	same	I-NP	JJ	O	18	NMOD
18	family	family	I-NP	NN	O	15	PMOD
19	(	(	O	(	O	24	P
20	KBF1/p50	KBF1/p50	B-NP	NN	B-protein	24	NMOD
21	,	,	O	,	O	24	P
22	c-	c-	B-NP	NN	O	24	NMOD
23	and	and	O	CC	O	24	NMOD
24	v-rel	v-rel	B-NP	NN	B-protein	18	NMOD
25	)	)	O	)	O	24	P
26	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	mutant	mutant	I-NP	NN	O	4	SUB
3	also	also	B-ADVP	RB	O	4	VMOD
4	functions	function	B-VP	VBZ	O	39	VMOD
5	in	in	B-ADVP	FW	O	4	VMOD
6	vivo	vivo	I-ADVP	FW	O	5	AMOD
7	as	as	B-PP	IN	O	4	VMOD
8	a	a	B-NP	DT	O	12	NMOD
9	trans-acting	trans-acting	I-NP	JJ	B-protein	12	NMOD
10	dominant	dominant	I-NP	JJ	I-protein	12	NMOD
11	negative	negative	I-NP	JJ	I-protein	12	NMOD
12	regulator	regulator	I-NP	NN	I-protein	7	PMOD
13	:	:	O	:	O	4	P
14	the	the	B-NP	DT	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	inducibility	inducibility	I-NP	NN	O	39	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	22	NMOD
19	HIV	HIV	I-NP	NN	B-DNA	22	NMOD
20	long	long	I-NP	JJ	I-DNA	22	NMOD
21	terminal	terminal	I-NP	JJ	I-DNA	22	NMOD
22	repeat	repeat	I-NP	NN	I-DNA	17	PMOD
23	(	(	O	(	O	22	P
24	which	which	B-NP	WDT	O	22	NMOD
25	contains	contain	B-VP	VBZ	O	24	SBAR
26	two	two	B-NP	CD	O	25	OBJ
27	potential	potential	I-NP	JJ	O	26	NMOD
28	NF-kappa	NF-kappa	I-NP	NN	B-DNA	31	NMOD
29	B	B	I-NP	NN	I-DNA	31	NMOD
30	binding	binding	I-NP	NN	I-DNA	31	NMOD
31	sites	site	I-NP	NNS	I-DNA	26	NMOD
32	)	)	O	)	O	22	P
33	by	by	B-PP	IN	O	16	NMOD
34	phorbol	phorbol	B-NP	NN	O	35	NMOD
35	ester	ester	I-NP	NN	O	33	PMOD
36	(	(	O	(	O	37	P
37	PMA	PMA	B-NP	NN	O	35	NMOD
38	)	)	O	)	O	37	P
39	is	be	B-VP	VBZ	O	0	ROOT
40	inhibited	inhibit	I-VP	VBN	O	39	VC
41	when	when	B-ADVP	WRB	O	40	VMOD
42	it	it	B-NP	PRP	O	43	SUB
43	is	be	B-VP	VBZ	O	41	SBAR
44	co-transfected	co-transfecte	I-VP	VBN	O	43	VC
45	into	into	B-PP	IN	O	44	VMOD
46	CD4+	CD4+	B-NP	JJ	B-cell_type	48	NMOD
47	T	T	I-NP	NN	I-cell_type	48	NMOD
48	cells	cell	I-NP	NNS	I-cell_type	45	PMOD
49	with	with	B-PP	IN	O	48	NMOD
50	the	the	B-NP	DT	O	53	NMOD
51	delta	delta	I-NP	NN	B-protein	53	NMOD
52	SP	SP	I-NP	NN	I-protein	53	NMOD
53	mutant	mutant	I-NP	NN	I-protein	49	PMOD
54	.	.	O	.	O	39	P

1	Similarly	Similarly	B-ADVP	RB	O	18	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	basal	basal	I-NP	JJ	O	10	NMOD
4	as	as	B-CONJP	RB	O	10	NMOD
5	well	well	I-CONJP	RB	O	4	DEP
6	as	as	I-CONJP	IN	O	4	DEP
7	TNF	TNF	B-NP	NN	B-protein	10	NMOD
8	or	or	O	CC	O	10	NMOD
9	IL1-induced	IL1-induced	B-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	18	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	17	NMOD
13	MHC	MHC	I-NP	NN	B-DNA	17	NMOD
14	class	class	I-NP	NN	I-DNA	17	NMOD
15	I	I	I-NP	CD	I-DNA	17	NMOD
16	H-2Kb	H-2Kb	I-NP	NN	I-DNA	17	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	11	PMOD
18	can	can	B-VP	MD	O	0	ROOT
19	be	be	I-VP	VB	O	18	VC
20	inhibited	inhibit	I-VP	VBN	O	19	VC
21	by	by	B-PP	IN	O	20	VMOD
22	this	this	B-NP	DT	O	23	NMOD
23	mutant	mutant	I-NP	NN	O	21	PMOD
24	in	in	B-PP	IN	O	20	VMOD
25	two	two	B-NP	CD	O	28	NMOD
26	different	different	I-NP	JJ	O	28	NMOD
27	cell	cell	I-NP	NN	B-cell_line	28	NMOD
28	lines	line	I-NP	NNS	I-cell_line	24	PMOD
29	.	.	O	.	O	18	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	constitute	constitute	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	7	NMOD
5	first	first	I-NP	JJ	O	7	NMOD
6	formal	formal	I-NP	JJ	O	7	NMOD
7	demonstration	demonstration	I-NP	NN	O	3	OBJ
8	that	that	B-SBAR	IN	O	7	NMOD
9	these	these	B-NP	DT	O	10	NMOD
10	genes	gene	I-NP	NNS	O	11	SUB
11	are	be	B-VP	VBP	O	8	SBAR
12	regulated	regulate	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	members	member	B-NP	NNS	O	13	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	rel/NF-kappa	rel/NF-kappa	I-NP	NN	B-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	family	family	I-NP	NN	I-protein	15	PMOD
20	.	.	O	.	O	3	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	3	NMOD
2	B	B	I-NP	NN	I-protein	3	NMOD
3	activity	activity	I-NP	NN	O	0	ROOT
4	in	in	B-PP	IN	O	3	NMOD
5	T	T	B-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
7	stably	stably	B-VP	RB	O	8	VMOD
8	expressing	express	I-VP	VBG	O	6	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	Tax	Tax	I-NP	NN	B-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	human	human	B-NP	JJ	O	18	NMOD
14	T	T	I-NP	NN	O	18	NMOD
15	cell	cell	I-NP	NN	O	18	NMOD
16	lymphotropic	lymphotropic	I-NP	JJ	O	18	NMOD
17	virus	virus	I-NP	NN	O	18	NMOD
18	type	type	I-NP	NN	O	12	PMOD
19	I	I	I-NP	CD	O	18	NMOD
20	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	23	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	constitutive	constitutive	B-NP	JJ	O	6	NMOD
5	Tax	Tax	I-NP	NN	B-protein	6	NMOD
6	expression	expression	I-NP	NN	O	3	PMOD
7	on	on	B-PP	IN	O	2	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	interaction	interaction	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
12	B	B	I-NP	NN	I-protein	10	PMOD
13	with	with	B-PP	IN	O	9	NMOD
14	its	its	B-NP	PRP$	O	16	NMOD
15	recognition	recognition	I-NP	NN	B-DNA	16	NMOD
16	sequence	sequence	I-NP	NN	I-DNA	13	PMOD
17	and	and	B-PP	CC	O	7	PMOD
18	on	on	B-PP	IN	O	7	PMOD
19	NF-kappa	NF-kappa	B-NP	NN	B-DNA	22	NMOD
20	B-dependent	B-dependent	I-NP	JJ	I-DNA	19	AMOD
21	gene	gene	I-NP	NN	I-DNA	22	NMOD
22	expression	expression	I-NP	NN	O	18	PMOD
23	was	be	B-VP	VBD	O	0	ROOT
24	examined	examine	I-VP	VBN	O	23	VC
25	in	in	B-PP	IN	O	24	VMOD
26	T	T	B-NP	NN	B-cell_line	30	NMOD
27	lymphoid	lymphoid	I-NP	JJ	I-cell_line	30	NMOD
28	Jurkat	Jurkat	I-NP	NN	I-cell_line	30	NMOD
29	cell	cell	I-NP	NN	I-cell_line	30	NMOD
30	lines	line	I-NP	NNS	I-cell_line	25	PMOD
31	(	(	O	(	O	34	P
32	19D	19D	B-NP	NN	B-cell_line	34	NMOD
33	and	and	O	CC	O	34	NMOD
34	9J	9J	B-NP	NN	B-cell_line	30	NMOD
35	)	)	O	)	O	34	P
36	stably	stably	B-VP	RB	O	37	VMOD
37	transformed	transform	I-VP	VBN	O	30	NMOD
38	with	with	B-PP	IN	O	37	VMOD
39	a	a	B-NP	DT	O	42	NMOD
40	Tax	Tax	I-NP	NN	B-DNA	42	NMOD
41	expression	expression	I-NP	NN	I-DNA	42	NMOD
42	vector	vector	I-NP	NN	I-DNA	38	PMOD
43	.	.	O	.	O	23	P

1	Tax	Tax	B-NP	NN	B-protein	5	NMOD
2	expressing	express	B-VP	VBG	O	5	NMOD
3	T	T	B-NP	NN	B-cell_line	5	NMOD
4	cell	cell	I-NP	NN	I-cell_line	5	NMOD
5	lines	line	I-NP	NNS	I-cell_line	6	SUB
6	contained	contain	B-VP	VBD	O	0	ROOT
7	a	a	B-NP	DT	O	9	NMOD
8	constitutive	constitutive	I-NP	JJ	O	9	NMOD
9	level	level	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	14	NMOD
12	B	B	I-NP	NN	I-protein	14	NMOD
13	binding	binding	I-NP	NN	O	14	NMOD
14	activity	activity	I-NP	NN	O	10	PMOD
15	,	,	O	,	O	6	P
16	detectable	detectable	B-ADJP	JJ	O	6	VMOD
17	by	by	B-PP	IN	O	16	AMOD
18	mobility	mobility	B-NP	NN	O	20	NMOD
19	shift	shift	I-NP	NN	O	20	NMOD
20	assay	assay	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	uv	uv	B-NP	NN	O	23	NMOD
23	cross-linking	cross-linking	I-NP	NN	O	17	PMOD
24	using	use	B-VP	VBG	O	23	NMOD
25	a	a	B-NP	DT	O	29	NMOD
26	palindromic	palindromic	I-NP	JJ	B-DNA	29	NMOD
27	NF-kappa	NF-kappa	I-NP	NN	I-DNA	29	NMOD
28	B	B	I-NP	NN	I-DNA	29	NMOD
29	probe	probe	I-NP	NN	I-DNA	24	OBJ
30	homologous	homologous	B-ADJP	JJ	O	29	NMOD
31	to	to	B-PP	TO	O	30	AMOD
32	the	the	B-NP	DT	O	36	NMOD
33	interferon	interferon	I-NP	NN	B-DNA	36	NMOD
34	beta	beta	I-NP	NN	I-DNA	36	NMOD
35	PRDII	PRDII	I-NP	NN	I-DNA	36	NMOD
36	site	site	I-NP	NN	I-DNA	31	PMOD
37	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	9	VMOD
2	Jurkat	Jurkat	B-NP	NN	B-cell_line	4	NMOD
3	and	and	O	CC	O	4	NMOD
4	NC2.10	NC2.10	B-NP	NN	O	1	PMOD
5	induction	induction	B-NP	NN	O	9	SUB
6	with	with	B-PP	IN	O	5	NMOD
7	phorbol	phorbol	B-NP	NN	O	8	NMOD
8	esters	ester	I-NP	NNS	O	6	PMOD
9	resulted	result	B-VP	VBD	O	27	VMOD
10	in	in	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	appearance	appearance	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	new	new	B-NP	JJ	O	17	NMOD
15	DNA	DNA	I-NP	NN	B-protein	17	NMOD
16	binding	binding	I-NP	NN	I-protein	17	NMOD
17	proteins	protein	I-NP	NNS	I-protein	13	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	85	85	B-NP	CD	O	25	NMOD
20	,	,	I-NP	,	O	25	P
21	75	75	I-NP	CD	O	25	NMOD
22	,	,	O	,	O	25	P
23	and	and	O	CC	O	25	NMOD
24	54	54	B-NP	CD	B-protein	25	NMOD
25	kDa	kDa	I-NP	NN	I-protein	18	PMOD
26	,	,	O	,	O	27	P
27	whereas	whereas	O	IN	O	0	ROOT
28	in	in	B-PP	IN	O	41	VMOD
29	Tax	Tax	B-NP	NN	B-cell_line	31	NMOD
30	expressing	expressing	I-NP	NN	I-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	28	PMOD
32	the	the	B-NP	DT	O	34	NMOD
33	85-kDa	85-kDa	I-NP	JJ	B-protein	34	NMOD
34	protein	protein	I-NP	NN	I-protein	40	NMOD
35	and	and	O	CC	O	40	NMOD
36	a	a	B-NP	DT	O	40	NMOD
37	92-kDa	92-kDa	I-NP	JJ	B-protein	40	NMOD
38	DNA	DNA	I-NP	NN	I-protein	40	NMOD
39	binding	binding	I-NP	NN	I-protein	40	NMOD
40	protein	protein	I-NP	NN	I-protein	41	SUB
41	were	be	B-VP	VBD	O	27	VMOD
42	constitutively	constitutively	I-VP	RB	O	41	VMOD
43	induced	induce	I-VP	VBN	O	41	VC
44	.	.	O	.	O	27	P

1	Expression	Expression	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Tax	Tax	B-NP	NN	B-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	2	PMOD
5	in	in	B-PP	IN	O	1	NMOD
6	19D	19D	B-NP	NN	B-cell_line	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	9J	9J	B-NP	NN	B-cell_line	5	PMOD
9	resulted	result	B-VP	VBD	O	0	ROOT
10	in	in	B-PP	IN	O	9	VMOD
11	transcription	transcription	B-NP	NN	O	26	NMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	21	NMOD
14	endogenous	endogenous	I-NP	JJ	B-DNA	21	NMOD
15	NF-kappa	NF-kappa	I-NP	NN	I-DNA	21	NMOD
16	B-dependent	B-dependent	I-NP	JJ	I-DNA	15	AMOD
17	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	I-DNA	21	NMOD
18	colony	colony	I-NP	NN	I-DNA	21	NMOD
19	stimulating	stimulating	I-NP	NN	I-DNA	21	NMOD
20	factor	factor	I-NP	NN	I-DNA	21	NMOD
21	gene	gene	I-NP	NN	I-DNA	12	PMOD
22	and	and	O	CC	O	26	NMOD
23	increased	increase	B-NP	VBD	O	26	NMOD
24	basal	basal	I-NP	JJ	O	26	NMOD
25	level	level	I-NP	NN	O	26	NMOD
26	expression	expression	I-NP	NN	O	10	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	transfected	transfecte	B-NP	VBN	O	31	NMOD
29	NF-kappa	NF-kappa	I-NP	NN	B-DNA	31	NMOD
30	B-regulated	B-regulated	I-NP	JJ	I-DNA	29	AMOD
31	promoters	promoter	I-NP	NNS	I-DNA	27	PMOD
32	.	.	O	.	O	9	P

1	Nonetheless	Nonetheless	B-ADVP	RB	O	11	VMOD
2	transcription	transcription	B-NP	NN	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	both	both	O	CC	O	10	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	endogenous	endogenous	I-NP	JJ	O	10	NMOD
7	and	and	O	CC	O	10	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	transfected	transfecte	I-NP	VBN	O	10	NMOD
10	gene	gene	I-NP	NN	O	3	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	inducible	inducible	B-ADJP	JJ	O	11	PRD
13	by	by	B-PP	IN	O	12	AMOD
14	PMA	PMA	B-NP	NN	O	15	NMOD
15	treatment	treatment	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	11	P

1	Tax	Tax	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	Jurkat	Jurkat	B-NP	NN	B-cell_line	6	NMOD
5	T	T	I-NP	NN	I-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	3	PMOD
7	may	may	B-VP	MD	O	0	ROOT
8	alter	alter	I-VP	VB	O	7	VC
9	the	the	B-NP	DT	O	10	NMOD
10	stoichiometry	stoichiometry	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	16	NMOD
13	B	B	I-NP	NN	I-protein	16	NMOD
14	DNA	DNA	I-NP	NN	B-protein	16	NMOD
15	binding	binding	I-NP	NN	I-protein	16	NMOD
16	proteins	protein	I-NP	NNS	I-protein	11	PMOD
17	and	and	O	CC	O	8	VMOD
18	thus	thus	O	RB	O	8	VMOD
19	change	change	B-VP	VB	O	8	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	expression	expression	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	NF-kappa	NF-kappa	B-NP	NN	B-DNA	25	NMOD
24	B-regulated	B-regulated	I-NP	JJ	I-DNA	23	AMOD
25	promoters	promoter	I-NP	NNS	I-DNA	22	PMOD
26	.	.	O	.	O	7	P

1	Anti-CD2	Anti-CD2	B-NP	NN	B-protein	3	NMOD
2	receptor	receptor	I-NP	NN	I-protein	3	NMOD
3	antibodies	antibody	I-NP	NNS	I-protein	4	SUB
4	activate	activate	B-VP	VBP	O	0	ROOT
5	the	the	B-NP	DT	O	9	NMOD
6	HIV	HIV	I-NP	NN	B-DNA	9	NMOD
7	long	long	I-NP	JJ	I-DNA	9	NMOD
8	terminal	terminal	I-NP	JJ	I-DNA	9	NMOD
9	repeat	repeat	I-NP	NN	I-DNA	4	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	T	T	B-NP	NN	B-cell_type	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD
13	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	7	NMOD
2	CD2	CD2	I-NP	NN	B-protein	7	NMOD
3	T	T	I-NP	NN	I-protein	7	NMOD
4	lymphocyte	lymphocyte	I-NP	NN	I-protein	7	NMOD
5	glycoprotein	glycoprotein	I-NP	NN	I-protein	7	NMOD
6	surface	surface	I-NP	NN	I-protein	7	NMOD
7	molecule	molecule	I-NP	NN	I-protein	8	SUB
8	mediates	mediate	B-VP	VBZ	O	0	ROOT
9	both	both	B-NP	DT	O	10	NMOD
10	cell	cell	I-NP	NN	O	17	NMOD
11	to	to	B-PP	TO	O	10	NMOD
12	cell	cell	B-NP	NN	O	13	NMOD
13	adhesion	adhesion	I-NP	NN	O	11	PMOD
14	and	and	O	CC	O	17	NMOD
15	T	T	B-NP	NN	O	17	NMOD
16	cell	cell	I-NP	NN	O	17	NMOD
17	activation	activation	I-NP	NN	O	20	NMOD
18	,	,	O	,	O	20	P
19	two	two	B-NP	CD	O	20	NMOD
20	processes	process	I-NP	NNS	O	8	OBJ
21	that	that	B-NP	WDT	O	20	NMOD
22	are	be	B-VP	VBP	O	21	SBAR
23	involved	involve	I-VP	VBN	O	22	VC
24	in	in	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	spread	spread	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	HIV	HIV	B-NP	NN	O	29	NMOD
29	infection	infection	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	8	P

1	Treatment	Treatment	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	chronically	chronically	B-NP	RB	O	4	AMOD
4	HIV-infected	HIV-infected	I-NP	JJ	O	5	NMOD
5	PBMC	PBMC	I-NP	NN	B-cell_type	2	PMOD
6	with	with	B-PP	IN	O	1	NMOD
7	anti-CD2	anti-CD2	B-NP	JJ	B-protein	8	NMOD
8	mAb	mAb	I-NP	NN	I-protein	6	PMOD
9	has	have	B-VP	VBZ	O	0	ROOT
10	been	be	I-VP	VBN	O	9	VC
11	shown	show	I-VP	VBN	O	10	VC
12	to	to	I-VP	TO	O	13	VMOD
13	induce	induce	I-VP	VB	O	11	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	expression	expression	I-NP	NN	O	13	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	infectious	infectious	B-NP	JJ	O	18	NMOD
18	virus	virus	I-NP	NN	O	16	PMOD
19	from	from	B-PP	IN	O	15	NMOD
20	these	these	B-NP	DT	O	21	NMOD
21	cultures	culture	I-NP	NNS	O	19	PMOD
22	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	5	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	we	we	B-NP	PRP	O	5	SUB
5	investigated	investigate	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	7	NMOD
7	mechanisms	mechanism	I-NP	NNS	O	5	OBJ
8	whereby	whereby	B-ADVP	WRB	O	7	NMOD
9	anti-CD2	anti-CD2	B-NP	JJ	B-protein	10	NMOD
10	antibodies	antibody	I-NP	NNS	I-protein	11	SUB
11	stimulate	stimulate	B-VP	VBP	O	8	SBAR
12	viral	viral	B-NP	JJ	O	13	NMOD
13	production	production	I-NP	NN	O	11	OBJ
14	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	treatment	treatment	B-NP	NN	O	13	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	transiently	transiently	B-NP	RB	O	7	AMOD
7	transfected	transfecte	I-NP	VBN	O	9	NMOD
8	T	T	I-NP	NN	B-cell_type	9	NMOD
9	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	PMOD
10	with	with	B-PP	IN	O	4	NMOD
11	anti-CD2	anti-CD2	B-NP	JJ	B-protein	12	NMOD
12	antibodies	antibody	I-NP	NNS	I-protein	10	PMOD
13	results	result	B-VP	VBZ	O	3	SBAR
14	in	in	B-PP	IN	O	13	VMOD
15	activation	activation	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	HIV	HIV	I-NP	NN	B-DNA	21	NMOD
19	long	long	I-NP	JJ	I-DNA	21	NMOD
20	terminal	terminal	I-NP	JJ	I-DNA	21	NMOD
21	repeat	repeat	I-NP	NN	I-DNA	16	PMOD
22	.	.	O	.	O	2	P

1	Furthermore	Furthermore	B-ADVP	RB	O	16	VMOD
2	,	,	O	,	O	16	P
3	CAT	CAT	B-NP	NN	B-protein	4	NMOD
4	assays	assay	I-NP	NNS	O	16	SUB
5	using	use	B-VP	VBG	O	4	NMOD
6	mutated	mutate	B-NP	VBN	O	11	NMOD
7	HIV	HIV	I-NP	NN	B-DNA	11	NMOD
8	long	long	I-NP	JJ	I-DNA	11	NMOD
9	terminal	terminal	I-NP	JJ	I-DNA	11	NMOD
10	repeat-CAT	repeat-CAT	I-NP	NN	I-DNA	11	NMOD
11	constructs	construct	I-NP	NNS	I-DNA	15	NMOD
12	and	and	O	CC	O	15	NMOD
13	gel	gel	B-NP	NN	O	15	NMOD
14	shift	shift	I-NP	NN	O	15	NMOD
15	assays	assay	I-NP	NNS	O	5	OBJ
16	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
17	that	that	B-SBAR	IN	O	16	VMOD
18	this	this	B-NP	DT	O	19	NMOD
19	activation	activation	I-NP	NN	O	20	SUB
20	is	be	B-VP	VBZ	O	17	SBAR
21	dependent	dependent	B-ADJP	JJ	O	20	PRD
22	on	on	B-PP	IN	O	21	AMOD
23	the	the	B-NP	DT	O	26	NMOD
24	NF-kappa	NF-kappa	I-NP	NN	B-DNA	26	NMOD
25	B	B	I-NP	NN	I-DNA	26	NMOD
26	enhancer	enhancer	I-NP	NN	I-DNA	22	PMOD
27	.	.	O	.	O	16	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	interaction	interaction	B-NP	NN	O	15	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	CD2	CD2	B-NP	NN	B-protein	6	PMOD
8	with	with	B-PP	IN	O	5	NMOD
9	its	its	B-NP	PRP$	O	11	NMOD
10	natural	natural	I-NP	JJ	O	11	NMOD
11	ligand	ligand	I-NP	NN	O	13	NMOD
12	,	,	O	,	O	13	P
13	LFA-3	LFA-3	B-NP	NN	B-protein	8	PMOD
14	,	,	O	,	O	5	P
15	may	may	B-VP	MD	O	4	SBAR
16	play	play	I-VP	VB	O	15	VC
17	a	a	B-NP	DT	O	18	NMOD
18	role	role	I-NP	NN	O	16	OBJ
19	in	in	B-PP	IN	O	16	VMOD
20	regulation	regulation	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	HIV	HIV	B-NP	NN	O	23	NMOD
23	expression	expression	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	3	P

1	v-erbA	v-erbA	B-NP	NN	B-protein	2	NMOD
2	overexpression	overexpression	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	required	require	I-VP	VBN	O	3	VC
5	to	to	I-VP	TO	O	6	VMOD
6	extinguish	extinguish	I-VP	VB	O	4	VMOD
7	c-erbA	c-erbA	B-NP	NN	B-protein	8	NMOD
8	function	function	I-NP	NN	O	14	NMOD
9	in	in	B-PP	IN	O	8	NMOD
10	erythroid	erythroid	B-NP	JJ	B-cell_type	12	NMOD
11	cell	cell	I-NP	NN	I-cell_type	12	NMOD
12	differentiation	differentiation	I-NP	NN	O	9	PMOD
13	and	and	O	CC	O	14	NMOD
14	regulation	regulation	B-NP	NN	O	6	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	20	NMOD
17	erbA	erbA	I-NP	NN	B-DNA	20	NMOD
18	target	target	I-NP	NN	I-DNA	20	NMOD
19	gene	gene	I-NP	NN	I-DNA	20	NMOD
20	CAII	CAII	I-NP	NN	B-DNA	15	PMOD
21	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	v-erbA	v-erbA	I-NP	NN	B-protein	3	NMOD
3	oncoprotein	oncoprotein	I-NP	NN	I-protein	4	SUB
4	represents	represent	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	8	NMOD
6	retrovirus-transduced	retrovirus-transduced	I-NP	JJ	O	8	NMOD
7	oncogenic	oncogenic	I-NP	JJ	O	8	NMOD
8	version	version	I-NP	NN	O	4	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	9	PMOD
11	thyroid	thyroid	I-NP	NN	B-protein	12	NMOD
12	hormone	hormone	I-NP	NN	I-protein	10	NMOD
13	(	(	O	(	I-protein	14	P
14	T3/T4	T3/T4	B-NP	NN	I-protein	12	NMOD
15	)	)	O	)	I-protein	14	P
16	receptor	receptor	B-NP	NN	I-protein	12	NMOD
17	c-erbA	c-erbA	I-NP	NN	B-protein	16	NMOD
18	(	(	I-NP	(	I-protein	20	P
19	type	type	I-NP	NN	I-protein	20	NMOD
20	alpha	alpha	I-NP	NN	I-protein	17	NMOD
21	)	)	O	)	I-protein	20	P
22	.	.	O	.	O	4	P

1	It	It	B-NP	PRP	O	2	SUB
2	contributes	contribute	B-VP	VBZ	O	0	ROOT
3	to	to	B-PP	TO	O	2	VMOD
4	virus-induced	virus-induced	B-NP	JJ	O	5	NMOD
5	erythroleukemia	erythroleukemia	I-NP	NN	O	3	PMOD
6	by	by	B-PP	IN	O	2	VMOD
7	efficiently	efficiently	B-ADVP	RB	O	8	VMOD
8	arresting	arrest	B-VP	VBG	O	6	PMOD
9	differentiation	differentiation	B-NP	NN	O	8	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	red	red	B-NP	JJ	B-cell_type	13	NMOD
12	cell	cell	I-NP	NN	I-cell_type	13	NMOD
13	progenitors	progenitor	I-NP	NNS	I-cell_type	10	PMOD
14	and	and	B-PP	CC	O	6	PMOD
15	by	by	B-PP	IN	O	6	PMOD
16	suppressing	suppress	B-VP	VBG	O	15	PMOD
17	transcription	transcription	B-NP	NN	O	16	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	erythrocyte-specific	erythrocyte-specific	B-NP	JJ	B-DNA	20	NMOD
20	genes	gene	I-NP	NNS	I-DNA	18	PMOD
21	.	.	O	.	O	2	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	v-erbA	v-erbA	B-NP	NN	B-protein	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	c-erbA	c-erbA	B-NP	NN	B-protein	9	SUB
9	bind	bind	B-VP	VBP	O	5	SBAR
10	directly	directly	B-ADVP	RB	O	9	VMOD
11	to	to	B-PP	TO	O	9	VMOD
12	sequences	sequence	B-NP	NNS	O	11	PMOD
13	within	within	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	promoter	promoter	I-NP	NN	B-DNA	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	erythrocyte-specific	erythrocyte-specific	I-NP	JJ	B-protein	20	NMOD
19	carbonic	carbonic	I-NP	JJ	I-protein	20	NMOD
20	anhydrase	anhydrase	I-NP	NN	I-protein	27	NMOD
21	II	II	I-NP	CD	I-protein	20	NMOD
22	(	(	O	(	O	23	P
23	CAII	CAII	B-NP	NN	B-DNA	20	NMOD
24	)	)	O	)	O	23	P
25	,	,	O	,	O	27	P
26	a	a	B-NP	DT	O	27	NMOD
27	gene	gene	I-NP	NN	O	16	PMOD
28	whose	whose	B-NP	WP$	O	27	NMOD
29	transcription	transcription	I-NP	NN	O	28	NMOD
30	is	be	B-VP	VBZ	O	28	SBAR
31	efficiently	efficiently	I-VP	RB	O	30	VMOD
32	suppressed	suppress	I-VP	VBN	O	30	VC
33	by	by	B-PP	IN	O	32	VMOD
34	v-erbA	v-erbA	B-NP	NN	B-protein	33	PMOD
35	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	3	NMOD
2	erbA-binding	erbA-binding	I-NP	JJ	B-DNA	3	NMOD
3	site	site	I-NP	NN	I-DNA	4	SUB
4	confers	confer	B-VP	VBZ	O	0	ROOT
5	thyroid	thyroid	B-NP	NN	O	7	NMOD
6	hormone	hormone	I-NP	NN	O	7	NMOD
7	responsiveness	responsiveness	I-NP	NN	O	4	OBJ
8	to	to	B-PP	TO	O	7	NMOD
9	a	a	B-NP	DT	O	11	NMOD
10	heterologous	heterologous	I-NP	JJ	B-DNA	11	NMOD
11	promoter	promoter	I-NP	NN	I-DNA	8	PMOD
12	in	in	B-PP	IN	O	4	VMOD
13	transient	transient	B-NP	JJ	O	15	NMOD
14	expression	expression	I-NP	NN	O	15	NMOD
15	experiments	experiment	I-NP	NNS	O	12	PMOD
16	and	and	O	CC	O	4	VMOD
17	is	be	B-VP	VBZ	O	4	VMOD
18	a	a	B-NP	DT	O	19	NMOD
19	target	target	I-NP	NN	O	17	PRD
20	for	for	B-PP	IN	O	19	NMOD
21	efficient	efficient	B-NP	JJ	O	22	NMOD
22	down-regulation	down-regulation	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	CAII	CAII	B-NP	NN	B-DNA	25	NMOD
25	transcription	transcription	I-NP	NN	O	23	PMOD
26	by	by	B-PP	IN	O	22	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	v-erbA	v-erbA	I-NP	NN	B-protein	29	NMOD
29	oncoprotein	oncoprotein	I-NP	NN	I-protein	26	PMOD
30	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	21	VMOD
2	stably	stably	B-NP	RB	B-cell_line	3	AMOD
3	transformed	transform	I-NP	VBN	I-cell_line	4	NMOD
4	erythroblasts	erythroblast	I-NP	NNS	I-cell_line	1	PMOD
5	coexpressing	coexpresse	B-VP	VBG	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	v-erbA	v-erbA	I-NP	NN	B-protein	8	NMOD
8	oncoprotein	oncoprotein	I-NP	NN	I-protein	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	c-erbA/T3	c-erbA/T3	I-NP	NN	B-protein	12	NMOD
12	receptor	receptor	I-NP	NN	I-protein	5	OBJ
13	at	at	B-PP	IN	O	5	VMOD
14	an	an	B-NP	DT	O	17	NMOD
15	approximately	approximately	I-NP	RB	O	16	AMOD
16	equimolar	equimolar	I-NP	JJ	O	17	NMOD
17	ratio	ratio	I-NP	NN	O	13	PMOD
18	,	,	O	,	O	21	P
19	c-erbA	c-erbA	B-NP	NN	B-protein	20	NMOD
20	activity	activity	I-NP	NN	O	21	SUB
21	is	be	B-VP	VBZ	O	0	ROOT
22	dominant	dominant	B-ADJP	JJ	O	21	PRD
23	over	over	B-PP	IN	O	22	AMOD
24	v-erbA	v-erbA	B-NP	NN	B-protein	23	PMOD
25	.	.	O	.	O	21	P

1	T3	T3	B-NP	NN	O	3	SUB
2	efficiently	efficiently	B-ADVP	RB	O	3	VMOD
3	induced	induce	B-VP	VBD	O	0	ROOT
4	erythroid	erythroid	B-NP	JJ	O	5	NMOD
5	differentiation	differentiation	I-NP	NN	O	3	OBJ
6	in	in	B-PP	IN	O	3	VMOD
7	these	these	B-NP	DT	O	8	NMOD
8	cells	cell	I-NP	NNS	O	6	PMOD
9	,	,	O	,	O	3	P
10	thus	thus	B-ADVP	RB	O	3	VMOD
11	overcoming	overcome	B-VP	VBG	O	3	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	v-erbA-mediated	v-erbA-mediated	I-NP	JJ	O	15	NMOD
14	differentiation	differentiation	I-NP	NN	O	15	NMOD
15	arrest	arrest	I-NP	NN	O	11	OBJ
16	.	.	O	.	O	3	P

1	Likewise	Likewise	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	T3	T3	B-NP	NN	O	4	SUB
4	activated	activate	B-VP	VBD	O	0	ROOT
5	CAII	CAII	B-NP	NN	B-DNA	6	NMOD
6	transcription	transcription	I-NP	NN	O	11	NMOD
7	as	as	B-CONJP	RB	O	11	NMOD
8	well	well	I-CONJP	RB	O	7	DEP
9	as	as	I-CONJP	IN	O	7	DEP
10	transient	transient	B-NP	JJ	O	11	NMOD
11	expression	expression	I-NP	NN	O	4	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	16	NMOD
14	T3-responsive	T3-responsive	I-NP	JJ	B-DNA	16	NMOD
15	reporter	reporter	I-NP	NN	I-DNA	16	NMOD
16	gene	gene	I-NP	NN	I-DNA	12	PMOD
17	containing	contain	B-VP	VBG	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	CAII-specific	CAII-specific	I-NP	JJ	B-DNA	21	NMOD
20	erbA-binding	erbA-binding	I-NP	JJ	I-DNA	21	NMOD
21	site	site	I-NP	NN	I-DNA	17	OBJ
22	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	c-erbA-dependent	c-erbA-dependent	I-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	9	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	this	this	B-NP	DT	O	8	NMOD
6	CAII	CAII	I-NP	NN	B-DNA	8	NMOD
7	reporter	reporter	I-NP	NN	I-DNA	8	NMOD
8	construct	construct	I-NP	NN	I-DNA	4	PMOD
9	could	could	B-VP	MD	O	0	ROOT
10	only	only	I-VP	RB	O	9	VMOD
11	be	be	I-VP	VB	O	9	VC
12	suppressed	suppress	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	very	very	B-NP	RB	O	15	AMOD
15	high	high	I-NP	JJ	O	16	NMOD
16	amounts	amount	I-NP	NNS	O	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	v-erbA	v-erbA	B-NP	NN	B-protein	17	PMOD
19	.	.	O	.	O	9	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	overexpression	overexpression	B-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	v-erbA	v-erbA	B-NP	NN	B-protein	6	PMOD
8	is	be	B-VP	VBZ	O	4	SBAR
9	required	require	I-VP	VBN	O	8	VC
10	for	for	B-PP	IN	O	9	VMOD
11	its	its	B-NP	PRP$	O	12	NMOD
12	function	function	I-NP	NN	O	10	PMOD
13	as	as	B-PP	IN	O	12	NMOD
14	an	an	B-NP	DT	O	15	NMOD
15	oncoprotein	oncoprotein	I-NP	NN	B-protein	13	PMOD
16	.	.	O	.	O	3	P

1	NF-X2	NF-X2	B-NP	NN	B-protein	8	SUB
2	that	that	B-NP	WDT	O	1	NMOD
3	binds	bind	B-VP	VBZ	O	2	SBAR
4	to	to	B-PP	TO	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	DRA	DRA	I-NP	NN	B-DNA	7	NMOD
7	X2-box	X2-box	I-NP	NN	I-DNA	4	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	activator	activator	B-NP	NN	B-protein	10	NMOD
10	protein	protein	I-NP	NN	I-protein	8	PRD
11	1	1	I-NP	CD	I-protein	10	NMOD
12	.	.	O	.	O	8	P

1	Expression	Expression	B-NP	NN	O	2	NMOD
2	cloning	cloning	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	c-Jun	c-Jun	B-NP	NN	B-protein	3	PMOD
5	.	.	O	.	O	2	P

1	Human	Human	B-NP	JJ	B-protein	5	NMOD
2	class	class	I-NP	NN	I-protein	5	NMOD
3	II	II	I-NP	CD	I-protein	5	NMOD
4	MHC	MHC	I-NP	NN	I-protein	5	NMOD
5	Ag	Ag	I-NP	NN	I-protein	6	SUB
6	are	be	B-VP	VBP	O	0	ROOT
7	a	a	B-NP	DT	O	8	NMOD
8	family	family	I-NP	NN	O	6	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	cell	cell	B-NP	NN	B-protein	12	NMOD
11	surface	surface	I-NP	NN	I-protein	12	NMOD
12	glycoproteins	glycoprotein	I-NP	NNS	I-protein	9	PMOD
13	.	.	O	.	O	6	P

1	Their	Their	B-NP	PRP$	O	3	NMOD
2	constitutive	constitutive	I-NP	JJ	O	3	NMOD
3	expression	expression	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	limited	limit	I-VP	VBN	O	4	VC
6	to	to	B-PP	TO	O	5	VMOD
7	B	B	B-NP	NN	B-cell_type	8	NMOD
8	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	thymic	thymic	B-NP	JJ	B-cell_type	12	NMOD
11	epithelial	epithelial	I-NP	JJ	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
13	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	7	VMOD
2	many	many	B-NP	JJ	O	4	NMOD
3	other	other	I-NP	JJ	O	4	NMOD
4	cells	cell	I-NP	NNS	O	1	PMOD
5	their	their	B-NP	PRP$	O	6	NMOD
6	expression	expression	I-NP	NN	O	7	SUB
7	can	can	B-VP	MD	O	0	ROOT
8	be	be	I-VP	VB	O	7	VC
9	induced	induce	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	7	P

1	Conserved	Conserve	B-NP	VBN	O	4	NMOD
2	upstream	upstream	I-NP	JJ	B-DNA	4	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	NMOD
4	sequences	sequence	I-NP	NNS	I-DNA	5	SUB
5	regulate	regulate	B-VP	VBP	O	0	ROOT
6	this	this	B-NP	DT	O	8	NMOD
7	tissue-specific	tissue-specific	I-NP	JJ	O	8	NMOD
8	expression	expression	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	class	class	B-NP	NN	B-DNA	12	NMOD
11	II	II	B-NP	CD	I-DNA	12	NMOD
12	genes	gene	I-NP	NNS	I-DNA	9	PMOD
13	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	12	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	DRA	DRA	I-NP	NN	B-DNA	4	NMOD
4	promoter	promoter	I-NP	NN	I-DNA	1	PMOD
5	,	,	O	,	O	12	P
6	one	one	B-NP	CD	O	12	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	11	NMOD
9	cis-acting	cis-acting	I-NP	JJ	B-DNA	11	NMOD
10	regulatory	regulatory	I-NP	JJ	I-DNA	11	NMOD
11	motifs	motif	I-NP	NNS	I-DNA	7	PMOD
12	is	be	B-VP	VBZ	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	X2-box	X2-box	I-NP	NN	B-DNA	12	PRD
15	to	to	B-PP	TO	O	14	NMOD
16	which	which	B-NP	WDT	O	15	PMOD
17	nuclear	nuclear	B-NP	JJ	B-protein	19	NMOD
18	factor	factor	I-NP	NN	I-protein	19	NMOD
19	X2	X2	I-NP	NN	I-protein	23	SUB
20	(	(	O	(	O	21	P
21	NF-X2	NF-X2	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	binds	bind	B-VP	VBZ	O	15	SBAR
24	.	.	O	.	O	12	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	present	present	B-VP	VBP	O	0	ROOT
5	the	the	B-NP	DT	O	8	NMOD
6	isolation	isolation	I-NP	NN	O	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	characterization	characterization	I-NP	NN	O	4	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	full-length	full-length	I-NP	JJ	B-DNA	13	NMOD
12	cDNA	cDNA	I-NP	NN	I-DNA	13	NMOD
13	clone	clone	I-NP	NN	I-DNA	9	PMOD
14	encoding	encode	B-VP	VBG	O	13	NMOD
15	NF-X2	NF-X2	B-NP	NN	B-protein	14	OBJ
16	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	3	NMOD
2	cDNA	cDNA	I-NP	NN	B-DNA	3	NMOD
3	clone	clone	I-NP	NN	I-DNA	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	isolated	isolate	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	expression	expression	B-NP	NN	O	9	NMOD
8	cDNA	cDNA	I-NP	NN	O	9	NMOD
9	cloning	cloning	I-NP	NN	O	6	PMOD
10	,	,	O	,	O	4	P
11	and	and	O	CC	O	4	VMOD
12	encodes	encode	B-VP	VBZ	O	4	VMOD
13	the	the	B-NP	DT	O	16	NMOD
14	human	human	I-NP	JJ	B-protein	16	NMOD
15	c-Jun	c-Jun	I-NP	NN	I-protein	16	NMOD
16	protein	protein	I-NP	NN	I-protein	12	OBJ
17	,	,	O	,	O	16	P
18	which	which	B-NP	WDT	O	16	NMOD
19	together	together	B-ADVP	RB	O	20	PMOD
20	with	with	B-PP	IN	O	22	VMOD
21	c-Fos	c-Fos	B-NP	NN	B-protein	20	PMOD
22	forms	form	B-VP	VBZ	O	18	SBAR
23	the	the	B-NP	DT	O	28	NMOD
24	heterodimeric	heterodimeric	I-NP	JJ	B-protein	28	NMOD
25	activator	activator	I-NP	NN	I-protein	28	NMOD
26	protein-1	protein-1	I-NP	NN	I-protein	28	NMOD
27	transcription	transcription	I-NP	NN	I-protein	28	NMOD
28	complex	complex	I-NP	NN	I-protein	22	OBJ
29	.	.	O	.	O	4	P

1	Whereas	Whereas	B-SBAR	IN	O	12	VMOD
2	c-Fos/c-Jun	c-Fos/c-Jun	B-NP	NN	B-protein	3	NMOD
3	heterodimers	heterodimer	I-NP	NNS	I-protein	4	SUB
4	do	do	B-VP	VBP	O	1	SBAR
5	not	not	I-VP	RB	O	4	VMOD
6	exist	exist	I-VP	VB	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	B	B	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	,	,	O	,	O	12	P
11	they	they	B-NP	PRP	O	12	SUB
12	form	form	B-VP	VBP	O	0	ROOT
13	and	and	O	CC	O	12	VMOD
14	bind	bind	B-VP	VBP	O	12	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	X2-box	X2-box	I-NP	NN	B-DNA	15	PMOD
18	in	in	B-PP	IN	O	14	VMOD
19	class	class	B-NP	NN	B-cell_line	22	NMOD
20	II	II	I-NP	CD	I-cell_line	22	NMOD
21	nonexpressing	nonexpressing	I-NP	JJ	I-cell_line	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
23	.	.	O	.	O	12	P

1	Thus	Thus	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	c-Fos/c-Jun	c-Fos/c-Jun	B-NP	NN	B-protein	4	NMOD
4	heterodimers	heterodimer	I-NP	NNS	I-protein	5	SUB
5	might	might	B-VP	MD	O	0	ROOT
6	contribute	contribute	I-VP	VB	O	5	VC
7	to	to	B-PP	TO	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	repression	repression	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	DRA	DRA	B-NP	NN	B-DNA	13	NMOD
12	gene	gene	I-NP	NN	I-DNA	13	NMOD
13	expression	expression	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	5	P

1	Regulation	Regulation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	jun	jun	B-NP	NN	B-DNA	6	NMOD
4	and	and	I-NP	CC	I-DNA	6	NMOD
5	fos	fos	I-NP	NN	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	7	NMOD
7	expression	expression	I-NP	NN	O	2	PMOD
8	in	in	B-PP	IN	O	1	NMOD
9	human	human	B-NP	JJ	B-cell_type	10	NMOD
10	monocytes	monocyte	I-NP	NNS	I-cell_type	8	PMOD
11	by	by	B-PP	IN	O	1	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	macrophage	macrophage	I-NP	NN	B-protein	15	NMOD
14	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	15	NMOD
15	factor	factor	I-NP	NN	I-protein	11	PMOD
16	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	4	NMOD
2	macrophage	macrophage	I-NP	NN	B-protein	4	NMOD
3	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	4	NMOD
4	factor	factor	I-NP	NN	I-protein	8	SUB
5	(	(	O	(	O	6	P
6	M-CSF	M-CSF	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	required	require	I-VP	VBN	O	8	VC
10	for	for	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	growth	growth	B-NP	NN	O	14	NMOD
13	and	and	O	CC	O	14	NMOD
14	differentiation	differentiation	B-NP	NN	O	10	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	mononuclear	mononuclear	B-NP	JJ	B-cell_type	17	NMOD
17	phagocytes	phagocyte	I-NP	NNS	I-cell_type	15	PMOD
18	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	the	the	B-NP	DT	O	5	NMOD
4	signaling	signaling	I-NP	NN	O	5	NMOD
5	events	event	I-NP	NNS	O	10	SUB
6	responsible	responsible	B-ADJP	JJ	O	5	NMOD
7	for	for	B-PP	IN	O	6	AMOD
8	these	these	B-NP	DT	O	9	NMOD
9	effects	effect	I-NP	NNS	O	7	PMOD
10	remain	remain	B-VP	VBP	O	0	ROOT
11	unclear	unclear	B-ADJP	JJ	O	10	PRD
12	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	examined	examine	I-VP	VBN	O	4	VC
6	the	the	B-NP	DT	O	7	NMOD
7	effects	effect	I-NP	NNS	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	M-CSF	M-CSF	B-NP	NN	B-protein	8	PMOD
10	on	on	B-PP	IN	O	7	NMOD
11	potential	potential	B-NP	JJ	O	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathways	pathway	I-NP	NNS	O	10	PMOD
14	involving	involve	B-VP	VBG	O	13	NMOD
15	expression	expression	B-NP	NN	O	14	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	O	DT	O	23	NMOD
18	jun	jun	B-NP	NN	B-DNA	20	NMOD
19	and	and	O	CC	I-DNA	20	NMOD
20	fos	fos	B-NP	NN	I-DNA	23	NMOD
21	early	early	B-NP	JJ	I-DNA	23	NMOD
22	response	response	I-NP	NN	I-DNA	23	NMOD
23	genes	gene	I-NP	NNS	I-DNA	16	PMOD
24	.	.	O	.	O	4	P

1	Low	Low	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	c-jun	c-jun	B-NP	NN	B-RNA	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-RNA	3	PMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	detectable	detectable	B-ADJP	JJ	O	6	PRD
8	in	in	B-PP	IN	O	6	VMOD
9	resting	rest	B-NP	VBG	B-cell_type	13	NMOD
10	human	human	I-NP	JJ	I-cell_type	13	NMOD
11	peripheral	peripheral	I-NP	JJ	I-cell_type	13	NMOD
12	blood	blood	I-NP	NN	I-cell_type	13	NMOD
13	monocytes	monocyte	I-NP	NNS	I-cell_type	8	PMOD
14	.	.	O	.	O	6	P

1	Treatment	Treatment	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	these	these	B-NP	DT	O	4	NMOD
4	cells	cell	I-NP	NNS	O	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	10	10	B-NP	CD	O	13	NMOD
7	(	(	O	(	O	13	P
8	3	3	B-NP	CD	O	13	NMOD
9	)	)	O	)	O	13	P
10	units/ml	units/ml	B-NP	NN	O	13	NMOD
11	human	human	I-NP	JJ	B-protein	13	NMOD
12	recombinant	recombinant	I-NP	JJ	I-protein	13	NMOD
13	M-CSF	M-CSF	I-NP	NN	I-protein	5	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	associated	associate	I-VP	VBN	O	14	VC
16	with	with	B-PP	IN	O	15	VMOD
17	rapid	rapid	B-NP	JJ	O	19	AMOD
18	and	and	I-NP	CC	O	19	AMOD
19	transient	transient	I-NP	JJ	O	20	NMOD
20	increases	increase	I-NP	NNS	O	16	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	c-jun	c-jun	B-NP	NN	B-RNA	24	NMOD
23	mRNA	mRNA	I-NP	NN	I-RNA	24	NMOD
24	levels	level	I-NP	NNS	O	21	PMOD
25	.	.	O	.	O	14	P

1	Nuclear	Nuclear	B-NP	JJ	O	3	NMOD
2	run-on	run-on	I-NP	JJ	O	3	NMOD
3	assays	assay	I-NP	NNS	O	7	NMOD
4	and	and	O	CC	O	7	NMOD
5	mRNA	mRNA	B-NP	NN	O	7	NMOD
6	stability	stability	I-NP	NN	O	7	NMOD
7	studies	study	I-NP	NNS	O	8	SUB
8	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	M-CSF	M-CSF	B-NP	NN	B-protein	11	SUB
11	regulates	regulate	B-VP	VBZ	O	9	SBAR
12	c-jun	c-jun	B-NP	NN	B-DNA	13	NMOD
13	expression	expression	I-NP	NN	O	11	OBJ
14	by	by	B-PP	IN	O	11	VMOD
15	both	both	O	CC	O	23	NMOD
16	an	an	B-NP	DT	O	17	NMOD
17	increase	increase	I-NP	NN	O	23	NMOD
18	in	in	B-PP	IN	O	17	NMOD
19	transcription	transcription	B-NP	NN	O	20	NMOD
20	rate	rate	I-NP	NN	O	18	PMOD
21	and	and	O	CC	O	23	NMOD
22	a	a	B-NP	DT	O	23	NMOD
23	prolongation	prolongation	I-NP	NN	O	14	PMOD
24	in	in	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	half-life	half-life	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	c-jun	c-jun	B-NP	NN	B-RNA	29	NMOD
29	transcripts	transcript	I-NP	NNS	I-RNA	27	PMOD
30	.	.	O	.	O	8	P

1	M-CSF	M-CSF	B-NP	NN	B-protein	2	NMOD
2	treatment	treatment	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	also	also	I-VP	RB	O	3	VMOD
5	associated	associate	I-VP	VBN	O	3	VC
6	with	with	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	9	NMOD
8	rapid	rapid	I-NP	JJ	O	9	NMOD
9	induction	induction	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	jun-B	jun-B	I-NP	NN	B-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	10	PMOD
14	,	,	O	,	O	5	P
15	although	although	B-SBAR	IN	O	5	VMOD
16	expression	expression	B-NP	NN	O	20	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	this	this	B-NP	DT	O	19	NMOD
19	gene	gene	I-NP	NN	O	17	PMOD
20	was	be	B-VP	VBD	O	15	SBAR
21	prolonged	prolong	I-VP	VBN	O	20	VC
22	compared	compare	B-VP	VBN	O	21	VMOD
23	to	to	B-PP	TO	O	22	VMOD
24	that	that	B-NP	DT	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	c-jun	c-jun	B-NP	NN	B-DNA	25	PMOD
27	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	3	SUB
2	further	further	B-ADVP	RB	O	3	VMOD
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	M-CSF	M-CSF	B-NP	NN	B-protein	6	SUB
6	increases	increase	B-VP	VBZ	O	4	SBAR
7	c-fos	c-fos	B-NP	NN	B-RNA	9	NMOD
8	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD
9	levels	level	I-NP	NNS	O	6	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	B-cell_type	12	NMOD
12	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD
13	through	through	B-PP	IN	O	6	VMOD
14	control	control	B-NP	NN	O	13	PMOD
15	at	at	B-PP	IN	O	6	VMOD
16	both	both	B-NP	CC	O	21	NMOD
17	the	the	I-NP	DT	O	21	NMOD
18	transcriptional	transcriptional	I-NP	JJ	O	21	NMOD
19	and	and	I-NP	CC	O	21	NMOD
20	posttranscriptional	posttranscriptional	I-NP	JJ	O	21	NMOD
21	levels	level	I-NP	NNS	O	15	PMOD
22	.	.	O	.	O	3	P

1	Maximal	Maximal	B-NP	JJ	O	2	NMOD
2	induction	induction	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	c-fos	c-fos	I-NP	NN	B-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	followed	follow	I-VP	VBN	O	7	VC
9	by	by	B-PP	IN	O	8	VMOD
10	that	that	B-NP	DT	O	9	PMOD
11	for	for	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	fos-B	fos-B	I-NP	NN	B-DNA	14	NMOD
14	gene	gene	I-NP	NN	I-DNA	11	PMOD
15	.	.	O	.	O	7	P

1	Moreover	Moreover	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	M-CSF-induced	M-CSF-induced	B-NP	JJ	O	4	NMOD
4	expression	expression	I-NP	NN	O	12	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	fos-related	fos-related	I-NP	JJ	B-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	10	NMOD
9	,	,	O	,	O	10	P
10	fra-1	fra-1	B-NP	NN	B-DNA	5	PMOD
11	,	,	O	,	O	4	P
12	was	be	B-VP	VBD	O	0	ROOT
13	delayed	delay	I-VP	VBN	O	12	VC
14	compared	compare	B-VP	VBN	O	13	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	that	that	B-NP	DT	O	15	PMOD
17	for	for	B-PP	IN	O	16	NMOD
18	both	both	O	CC	O	21	NMOD
19	c-fos	c-fos	B-NP	NN	B-DNA	21	NMOD
20	and	and	O	CC	O	21	NMOD
21	fos-B	fos-B	B-NP	NN	B-DNA	17	PMOD
22	.	.	O	.	O	12	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	the	the	B-NP	DT	O	5	NMOD
5	results	result	I-NP	NNS	O	6	SUB
6	indicate	indicate	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	23	DEP
8	M-CSF	M-CSF	B-NP	NN	B-protein	9	NMOD
9	treatment	treatment	I-NP	NN	O	10	SUB
10	is	be	B-VP	VBZ	O	7	SBAR
11	associated	associate	I-VP	VBN	O	10	VC
12	with	with	B-PP	IN	O	11	VMOD
13	differential	differential	B-NP	JJ	O	14	NMOD
14	activation	activation	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	multiple	multiple	B-NP	JJ	O	17	NMOD
17	members	member	I-NP	NNS	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	jun/fos	jun/fos	I-NP	NN	B-protein	21	NMOD
21	family	family	I-NP	NN	I-protein	18	PMOD
22	and	and	O	CC	O	23	DEP
23	that	that	B-SBAR	IN	O	6	VMOD
24	expression	expression	B-NP	NN	O	28	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	these	these	B-NP	DT	O	27	NMOD
27	genes	gene	I-NP	NNS	O	25	PMOD
28	could	could	B-VP	MD	O	23	SBAR
29	contribute	contribute	I-VP	VB	O	28	VC
30	to	to	B-PP	TO	O	29	VMOD
31	nuclear	nuclear	B-NP	JJ	O	33	NMOD
32	signaling	signaling	I-NP	NN	O	33	NMOD
33	mechanisms	mechanism	I-NP	NNS	O	30	PMOD
34	that	that	B-NP	WDT	O	33	NMOD
35	regulate	regulate	B-VP	VBP	O	34	SBAR
36	a	a	B-NP	DT	O	38	NMOD
37	specific	specific	I-NP	JJ	O	38	NMOD
38	program	program	I-NP	NN	O	35	OBJ
39	of	of	B-PP	IN	O	38	NMOD
40	monocyte	monocyte	B-NP	NN	O	41	NMOD
41	differentiation	differentiation	I-NP	NN	O	39	PMOD
42	.	.	O	.	O	6	P

1	cAMP-dependent	cAMP-dependent	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	13	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	proenkephalin	proenkephalin	B-NP	NN	O	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	JunD	JunD	B-NP	NN	B-protein	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	JunB	JunB	B-NP	NN	B-protein	5	PMOD
9	:	:	O	:	O	2	P
10	positive	positive	B-NP	JJ	O	13	NMOD
11	and	and	I-NP	CC	O	13	NMOD
12	negative	negative	I-NP	JJ	O	13	NMOD
13	effects	effect	I-NP	NNS	O	0	ROOT
14	of	of	B-PP	IN	O	13	NMOD
15	AP-1	AP-1	B-NP	NN	B-protein	16	NMOD
16	proteins	protein	I-NP	NNS	I-protein	14	PMOD
17	.	.	O	.	O	13	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	JunD	JunD	B-NP	NN	B-protein	7	NMOD
5	,	,	O	,	O	7	P
6	a	a	B-NP	DT	O	7	NMOD
7	component	component	I-NP	NN	O	15	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	AP-1	AP-1	I-NP	NN	B-protein	13	NMOD
11	transcription	transcription	I-NP	NN	I-protein	13	NMOD
12	factor	factor	I-NP	NN	I-protein	13	NMOD
13	complex	complex	I-NP	NN	I-protein	8	PMOD
14	,	,	O	,	O	7	P
15	activates	activate	B-VP	VBZ	O	3	SBAR
16	transcription	transcription	B-NP	NN	O	15	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	human	human	I-NP	JJ	B-DNA	21	NMOD
20	proenkephalin	proenkephalin	I-NP	NN	I-DNA	21	NMOD
21	gene	gene	I-NP	NN	I-DNA	17	PMOD
22	in	in	B-PP	IN	O	15	VMOD
23	a	a	B-NP	DT	O	24	NMOD
24	fashion	fashion	I-NP	NN	O	22	PMOD
25	that	that	B-NP	WDT	O	24	NMOD
26	is	be	B-VP	VBZ	O	25	SBAR
27	completely	completely	B-ADJP	RB	O	28	AMOD
28	dependent	dependent	I-ADJP	JJ	O	26	PRD
29	upon	upon	B-PP	IN	O	28	AMOD
30	the	the	B-NP	DT	O	33	NMOD
31	cAMP-dependent	cAMP-dependent	I-NP	JJ	B-protein	33	NMOD
32	protein	protein	I-NP	NN	I-protein	33	NMOD
33	kinase	kinase	I-NP	NN	I-protein	37	NMOD
34	,	,	O	,	O	37	P
35	protein	protein	B-NP	NN	B-protein	37	NMOD
36	kinase	kinase	I-NP	NN	I-protein	37	NMOD
37	A	A	I-NP	NN	I-protein	29	PMOD
38	.	.	O	.	O	2	P

1	Activation	Activation	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	proenkephalin	proenkephalin	B-NP	NN	O	4	NMOD
4	transcription	transcription	I-NP	NN	O	2	PMOD
5	by	by	B-PP	IN	O	1	NMOD
6	JunD	JunD	B-NP	NN	B-protein	5	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	dependent	dependent	B-ADJP	JJ	O	7	PRD
9	upon	upon	B-PP	IN	O	8	AMOD
10	a	a	B-NP	DT	O	13	NMOD
11	previously	previously	I-NP	RB	O	12	AMOD
12	characterized	characterize	I-NP	VBN	O	13	NMOD
13	cAMP-	cAMP-	B-NP	NN	O	28	SUB
14	,	,	O	,	O	28	P
15	phorbol	phorbol	B-NP	NN	O	16	NMOD
16	ester-	ester-	I-NP	NN	O	28	SUB
17	,	,	O	,	O	28	P
18	and	and	O	CC	O	19	NMOD
19	Ca	Ca	B-NP	NN	B-DNA	24	NMOD
20	(	(	O	(	I-DNA	21	P
21	2+	2+	B-ADJP	JJ	I-DNA	19	NMOD
22	)	)	O	)	I-DNA	21	P
23	-inducible	-inducible	B-NP	JJ	I-DNA	24	NMOD
24	enhancer	enhancer	I-NP	NN	I-DNA	28	SUB
25	,	,	O	,	O	28	P
26	and	and	O	CC	O	28	VMOD
27	JunD	JunD	B-NP	NN	B-protein	28	SUB
28	is	be	B-VP	VBZ	O	9	SBAR
29	shown	show	I-VP	VBN	O	28	VC
30	to	to	I-VP	TO	O	31	VMOD
31	bind	bind	I-VP	VB	O	29	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	enhancer	enhancer	I-NP	NN	B-DNA	31	OBJ
34	as	as	B-PP	IN	O	31	VMOD
35	a	a	B-NP	DT	O	36	NMOD
36	homodimer	homodimer	I-NP	NN	B-protein	34	PMOD
37	.	.	O	.	O	7	P

1	Another	Another	B-NP	DT	O	2	NMOD
2	component	component	I-NP	NN	O	9	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	AP-1	AP-1	I-NP	NN	B-protein	7	NMOD
6	transcription	transcription	I-NP	NN	I-protein	7	NMOD
7	complex	complex	I-NP	NN	I-protein	3	PMOD
8	,	,	O	,	O	9	P
9	JunB	JunB	B-NP	NN	B-protein	11	SUB
10	,	,	O	,	O	9	P
11	is	be	B-VP	VBZ	O	0	ROOT
12	shown	show	I-VP	VBN	O	11	VC
13	to	to	I-VP	TO	O	14	VMOD
14	inhibit	inhibit	I-VP	VB	O	12	VMOD
15	activation	activation	B-NP	NN	O	14	OBJ
16	mediated	mediate	B-VP	VBN	O	15	NMOD
17	by	by	B-PP	IN	O	16	VMOD
18	JunD	JunD	B-NP	NN	B-protein	17	PMOD
19	.	.	O	.	O	11	P

1	As	As	B-PP	IN	O	21	VMOD
2	a	a	B-NP	DT	O	4	NMOD
3	homodimer	homodimer	I-NP	NN	O	4	NMOD
4	JunB	JunB	B-NP	NN	B-protein	5	SUB
5	is	be	B-VP	VBZ	O	1	SBAR
6	unable	unable	B-ADJP	JJ	O	5	PRD
7	to	to	B-VP	TO	O	8	VMOD
8	bind	bind	I-VP	VB	O	6	AMOD
9	the	the	B-NP	DT	O	10	NMOD
10	enhancer	enhancer	I-NP	NN	B-DNA	8	OBJ
11	;	;	O	:	O	1	P
12	however	however	O	RB	O	21	VMOD
13	in	in	B-PP	IN	O	21	VMOD
14	the	the	I-PP	DT	O	13	PMOD
15	presence	presence	I-PP	NN	O	13	PMOD
16	of	of	I-PP	IN	O	13	PMOD
17	c-Fos	c-Fos	B-NP	NN	B-protein	13	PMOD
18	,	,	O	,	O	21	P
19	high-affinity	high-affinity	B-NP	JJ	O	20	NMOD
20	binding	binding	I-NP	NN	O	21	SUB
21	is	be	B-VP	VBZ	O	0	ROOT
22	observed	observe	I-VP	VBN	O	21	VC
23	.	.	O	.	O	21	P

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	JunD	JunD	B-NP	NN	B-protein	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	shown	show	I-VP	VBN	O	4	VC
6	to	to	I-VP	TO	O	7	VMOD
7	activate	activate	I-VP	VB	O	5	VMOD
8	transcription	transcription	B-NP	NN	O	7	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	genes	gene	B-NP	NNS	B-DNA	9	PMOD
11	linked	link	B-VP	VBN	O	10	NMOD
12	to	to	B-PP	TO	O	11	VMOD
13	both	both	O	CC	O	19	NMOD
14	cAMP	cAMP	B-NP	NN	O	19	NMOD
15	and	and	O	CC	O	19	NMOD
16	phorbol	phorbol	B-NP	NN	O	19	NMOD
17	ester	ester	I-NP	NN	O	19	NMOD
18	response	response	I-NP	NN	O	19	NMOD
19	elements	element	I-NP	NNS	O	12	PMOD
20	in	in	B-PP	IN	O	11	VMOD
21	a	a	B-NP	DT	O	25	NMOD
22	protein	protein	I-NP	NN	O	23	AMOD
23	kinase	kinase	I-NP	NN	O	25	NMOD
24	A-dependent	A-dependent	I-NP	JJ	O	23	AMOD
25	fashion	fashion	I-NP	NN	O	20	PMOD
26	,	,	O	,	O	10	P
27	further	further	B-ADVP	RB	O	28	VMOD
28	blurring	blur	B-VP	VBG	O	10	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	distinction	distinction	I-NP	NN	O	28	OBJ
31	between	between	B-PP	IN	O	30	NMOD
32	these	these	B-NP	DT	O	34	NMOD
33	response	response	I-NP	NN	O	34	NMOD
34	elements	element	I-NP	NNS	O	31	PMOD
35	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	transcriptional	transcriptional	I-NP	JJ	O	7	NMOD
7	activity	activity	I-NP	NN	O	12	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	an	an	B-NP	DT	O	11	NMOD
10	AP-1-related	AP-1-related	I-NP	JJ	B-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	8	PMOD
12	is	be	B-VP	VBZ	O	4	SBAR
13	regulated	regulate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	cAMP-dependent	cAMP-dependent	I-NP	JJ	O	18	NMOD
17	second-messenger	second-messenger	I-NP	NN	O	18	NMOD
18	pathway	pathway	I-NP	NN	O	14	PMOD
19	and	and	O	CC	O	3	VMOD
20	suggest	suggest	B-VP	VBP	O	3	VMOD
21	that	that	B-SBAR	IN	O	20	VMOD
22	JunD	JunD	B-NP	NN	B-protein	26	NMOD
23	and	and	O	CC	O	26	NMOD
24	other	other	B-NP	JJ	O	26	NMOD
25	AP-1-related	AP-1-related	I-NP	JJ	B-protein	26	NMOD
26	proteins	protein	I-NP	NNS	I-protein	27	SUB
27	may	may	B-VP	MD	O	21	SBAR
28	play	play	I-VP	VB	O	27	VC
29	an	an	B-NP	DT	O	31	NMOD
30	important	important	I-NP	JJ	O	31	NMOD
31	role	role	I-NP	NN	O	28	OBJ
32	in	in	B-PP	IN	O	28	VMOD
33	the	the	B-NP	DT	O	34	NMOD
34	regulation	regulation	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	gene	gene	B-NP	NN	O	37	NMOD
37	expression	expression	I-NP	NN	O	35	PMOD
38	by	by	B-PP	IN	O	34	NMOD
39	cAMP-dependent	cAMP-dependent	B-NP	JJ	O	42	NMOD
40	intracellular	intracellular	I-NP	JJ	O	42	NMOD
41	signaling	signaling	I-NP	NN	O	42	NMOD
42	pathways	pathway	I-NP	NNS	O	38	PMOD
43	.	.	O	.	O	3	P

1	Induction	Induction	B-NP	NN	O	8	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	monocytic	monocytic	B-NP	JJ	O	4	NMOD
4	differentiation	differentiation	I-NP	NN	O	2	PMOD
5	and	and	O	CC	O	8	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	O	8	NMOD
7	B-like	B-like	I-NP	JJ	O	8	NMOD
8	activities	activity	I-NP	NNS	O	0	ROOT
9	by	by	B-PP	IN	O	8	NMOD
10	human	human	B-NP	JJ	O	14	NMOD
11	immunodeficiency	immunodeficiency	I-NP	NN	O	14	NMOD
12	virus	virus	I-NP	NN	O	14	NMOD
13	1	1	I-NP	CD	O	14	NMOD
14	infection	infection	I-NP	NN	O	9	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	myelomonoblastic	myelomonoblastic	B-NP	JJ	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	effects	effect	I-NP	NNS	O	21	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	human	human	B-NP	JJ	O	6	NMOD
5	immunodeficiency	immunodeficiency	I-NP	NN	O	6	NMOD
6	virus	virus	I-NP	NN	O	11	NMOD
7	1	1	I-NP	CD	O	6	NMOD
8	(	(	O	(	O	9	P
9	HIV-1	HIV-1	B-NP	NN	O	6	NMOD
10	)	)	O	)	O	9	P
11	infection	infection	B-NP	NN	O	3	PMOD
12	on	on	B-PP	IN	O	2	NMOD
13	cellular	cellular	B-NP	JJ	O	14	NMOD
14	differentiation	differentiation	I-NP	NN	O	20	NMOD
15	and	and	O	CC	O	20	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	20	NMOD
17	B	B	I-NP	NN	I-protein	20	NMOD
18	DNA	DNA	I-NP	NN	O	20	NMOD
19	binding	binding	I-NP	NN	O	20	NMOD
20	activity	activity	I-NP	NN	O	12	PMOD
21	have	have	B-VP	VBP	O	0	ROOT
22	been	be	I-VP	VBN	O	21	VC
23	investigated	investigate	I-VP	VBN	O	22	VC
24	in	in	B-PP	IN	O	23	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	new	new	I-NP	JJ	O	27	NMOD
27	model	model	I-NP	NN	O	24	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	myeloid	myeloid	B-NP	JJ	O	30	NMOD
30	differentiation	differentiation	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	21	P

1	PLB-985	PLB-985	B-NP	NN	B-cell_line	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_line	3	SUB
3	represent	represent	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	8	NMOD
5	bipotential	bipotential	I-NP	JJ	B-cell_line	8	NMOD
6	myelomonoblastic	myelomonoblastic	I-NP	JJ	I-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	population	population	I-NP	NN	I-cell_line	3	OBJ
9	capable	capable	B-ADJP	JJ	O	8	NMOD
10	of	of	B-PP	IN	O	9	AMOD
11	either	either	B-NP	CC	O	14	AMOD
12	granulocytic	granulocytic	I-NP	JJ	O	14	AMOD
13	or	or	I-NP	CC	O	14	AMOD
14	monocytic	monocytic	I-NP	JJ	O	15	NMOD
15	differentiation	differentiation	I-NP	NN	O	10	PMOD
16	after	after	B-PP	IN	O	15	NMOD
17	induction	induction	B-NP	NN	O	16	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	appropriate	appropriate	B-NP	JJ	O	20	NMOD
20	inducers	inducer	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	3	P

1	By	By	B-PP	IN	O	15	VMOD
2	virtue	virtue	B-NP	NN	O	1	PMOD
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	presence	presence	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	CD4	CD4	B-NP	NN	B-protein	6	PMOD
8	on	on	B-PP	IN	O	2	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	cell	cell	I-NP	NN	O	11	NMOD
11	surface	surface	I-NP	NN	O	8	PMOD
12	,	,	O	,	O	15	P
13	PLB-985	PLB-985	B-NP	NN	B-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	15	SUB
15	were	be	B-VP	VBD	O	0	ROOT
16	chronically	chronically	I-VP	RB	O	15	VMOD
17	infected	infect	I-VP	VBN	O	15	VC
18	with	with	B-PP	IN	O	17	VMOD
19	HIV-1	HIV-1	B-NP	NN	O	21	NMOD
20	strain	strain	I-NP	NN	O	21	NMOD
21	IIIB	IIIB	I-NP	NN	O	18	PMOD
22	.	.	O	.	O	15	P

1	PLB-IIIB	PLB-IIIB	B-NP	NN	B-cell_line	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_line	4	SUB
3	clearly	clearly	B-ADVP	RB	O	4	VMOD
4	possessed	possess	B-VP	VBD	O	0	ROOT
5	a	a	B-NP	DT	O	8	NMOD
6	more	more	I-NP	RBR	O	7	AMOD
7	monocytic	monocytic	I-NP	JJ	O	8	NMOD
8	phenotype	phenotype	I-NP	NN	O	4	OBJ
9	than	than	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	parental	parental	I-NP	JJ	B-cell_type	12	NMOD
12	myeloblasts	myeloblast	I-NP	NNS	I-cell_type	9	PMOD
13	,	,	O	,	O	4	P
14	as	as	B-SBAR	IN	O	4	VMOD
15	determined	determine	B-VP	VBN	O	14	SBAR
16	by	by	B-PP	IN	O	15	VMOD
17	differential	differential	B-NP	JJ	O	18	NMOD
18	staining	staining	I-NP	NN	O	16	PMOD
19	,	,	O	,	O	4	P
20	increased	increase	B-NP	VBN	O	21	NMOD
21	expression	expression	I-NP	NN	O	29	NMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	myeloid-specific	myeloid-specific	I-NP	JJ	B-protein	26	NMOD
25	surface	surface	I-NP	NN	I-protein	26	NMOD
26	markers	marker	I-NP	NNS	I-protein	22	PMOD
27	,	,	O	,	O	29	P
28	and	and	O	CC	O	29	NMOD
29	transcription	transcription	B-NP	NN	O	4	OBJ
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	c-fms	c-fms	I-NP	NN	B-DNA	33	NMOD
33	proto-oncogene	proto-oncogene	I-NP	NN	I-DNA	30	PMOD
34	.	.	O	.	O	4	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
2	B	B	I-NP	NN	I-protein	4	NMOD
3	binding	binding	I-NP	NN	O	4	NMOD
4	activity	activity	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	inducible	inducible	B-ADJP	JJ	O	5	PRD
7	by	by	B-PP	IN	O	6	AMOD
8	tumor	tumor	B-NP	NN	B-protein	10	NMOD
9	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	phorbol	phorbol	B-NP	NN	O	14	NMOD
13	myristate	myristate	I-NP	NN	O	14	NMOD
14	acetate	acetate	I-NP	NN	O	7	PMOD
15	in	in	B-PP	IN	O	14	NMOD
16	PLB-985	PLB-985	B-NP	NN	B-cell_line	15	PMOD
17	.	.	O	.	O	5	P

1	However	However	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	in	in	B-PP	IN	O	15	VMOD
4	PLB-IIIB	PLB-IIIB	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	3	PMOD
6	,	,	O	,	O	15	P
7	constitutive	constitutive	B-NP	JJ	O	8	NMOD
8	expression	expression	I-NP	NN	O	15	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	14	NMOD
11	novel	novel	I-NP	JJ	O	14	NMOD
12	NF-kappa	NF-kappa	I-NP	NN	B-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	complex	complex	I-NP	NN	I-protein	9	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	detected	detect	I-VP	VBN	O	15	VC
17	,	,	O	,	O	16	P
18	composed	compose	B-VP	VBN	O	16	VMOD
19	of	of	B-PP	IN	O	18	VMOD
20	proteins	protein	B-NP	NNS	O	19	PMOD
21	ranging	range	B-VP	VBG	O	20	NMOD
22	between	between	B-PP	IN	O	21	VMOD
23	70	70	B-NP	CD	O	25	AMOD
24	and	and	O	CC	O	25	AMOD
25	110	110	B-NP	CD	O	26	NMOD
26	kD	kD	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	15	P

1	These	These	B-NP	DT	O	2	NMOD
2	proteins	protein	I-NP	NNS	O	3	SUB
3	interacted	interact	B-VP	VBD	O	0	ROOT
4	specifically	specifically	B-ADVP	RB	O	3	VMOD
5	with	with	B-PP	IN	O	3	VMOD
6	the	the	B-NP	DT	O	10	NMOD
7	symmetric	symmetric	I-NP	JJ	B-DNA	10	NMOD
8	NF-kappa	NF-kappa	I-NP	NN	I-DNA	10	NMOD
9	B	B	I-NP	NN	I-DNA	10	NMOD
10	site	site	I-NP	NN	I-DNA	5	PMOD
11	from	from	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	18	NMOD
13	interferon	interferon	I-NP	NN	B-DNA	14	NMOD
14	beta	beta	I-NP	NN	I-DNA	18	NMOD
15	(	(	O	(	I-DNA	16	P
16	IFN-beta	IFN-beta	B-NP	NN	I-DNA	14	NMOD
17	)	)	O	)	I-DNA	16	P
18	promoter	promoter	B-NP	NN	I-DNA	11	PMOD
19	.	.	O	.	O	3	P

1	Mutations	Mutation	B-NP	NNS	O	13	SUB
2	affecting	affect	B-VP	VBG	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	5	5	I-NP	CD	B-DNA	7	NMOD
5	'	'	I-NP	SYM	I-DNA	7	NMOD
6	guanine	guanine	I-NP	NN	I-DNA	7	NMOD
7	residues	residue	I-NP	NNS	I-DNA	2	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	kappa	kappa	I-NP	NN	B-DNA	12	NMOD
11	B	B	I-NP	NN	I-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	8	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	unable	unable	B-ADJP	JJ	O	13	PRD
15	to	to	B-VP	TO	O	16	VMOD
16	compete	compete	I-VP	VB	O	14	AMOD
17	for	for	B-PP	IN	O	16	VMOD
18	these	these	B-NP	DT	O	21	NMOD
19	NF-kappa	NF-kappa	I-NP	NN	B-protein	21	NMOD
20	B-related	B-related	I-NP	JJ	I-protein	19	AMOD
21	proteins	protein	I-NP	NNS	I-protein	17	PMOD
22	.	.	O	.	O	13	P

1	Inducibility	Inducibility	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	endogenous	endogenous	B-NP	JJ	O	7	NMOD
4	IFN-beta	IFN-beta	I-NP	NN	B-protein	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	IFN-alpha	IFN-alpha	I-NP	NN	B-protein	7	NMOD
7	RNA	RNA	I-NP	NN	O	2	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	also	also	I-VP	RB	O	8	VMOD
10	increased	increase	I-VP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	PLB-IIIB	PLB-IIIB	B-NP	NN	B-cell_line	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_line	11	PMOD
14	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	19	DEP
5	HIV-1	HIV-1	B-NP	NN	O	6	NMOD
6	infection	infection	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	myelomonoblastic	myelomonoblastic	B-NP	JJ	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	may	may	B-VP	MD	O	4	SBAR
11	select	select	I-VP	VB	O	10	VC
12	for	for	B-PP	IN	O	11	VMOD
13	a	a	B-NP	DT	O	17	NMOD
14	more	more	I-NP	RBR	O	15	AMOD
15	mature	mature	I-NP	JJ	O	17	NMOD
16	monocytic	monocytic	I-NP	JJ	O	17	NMOD
17	phenotype	phenotype	I-NP	NN	O	12	PMOD
18	and	and	O	CC	O	19	DEP
19	that	that	B-SBAR	IN	O	3	VMOD
20	unique	unique	B-NP	JJ	O	22	NMOD
21	subunit	subunit	I-NP	NN	O	22	NMOD
22	associations	association	I-NP	NNS	O	29	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	NF-kappa	NF-kappa	B-NP	NN	B-protein	28	NMOD
25	B	B	I-NP	NN	I-protein	28	NMOD
26	DNA	DNA	I-NP	NN	B-protein	28	NMOD
27	binding	binding	I-NP	NN	I-protein	28	NMOD
28	proteins	protein	I-NP	NNS	I-protein	23	PMOD
29	may	may	B-VP	MD	O	19	SBAR
30	contribute	contribute	I-VP	VB	O	29	VC
31	to	to	B-PP	TO	O	30	VMOD
32	differential	differential	B-NP	JJ	O	36	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	O	36	NMOD
34	B-mediated	B-mediated	I-NP	JJ	O	33	AMOD
35	gene	gene	I-NP	NN	O	36	NMOD
36	expression	expression	I-NP	NN	O	31	PMOD
37	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	AP-1	AP-1	I-NP	NN	B-DNA	3	NMOD
3	site	site	I-NP	NN	I-DNA	13	NMOD
4	at	at	B-PP	IN	O	3	NMOD
5	-150	-150	B-NP	CD	B-DNA	6	NMOD
6	bp	bp	I-NP	NN	I-DNA	4	PMOD
7	,	,	B-NP	,	O	13	P
8	but	but	I-NP	CC	O	13	NMOD
9	not	not	I-NP	RB	O	8	DEP
10	the	the	B-NP	DT	O	13	NMOD
11	NF-kappa	NF-kappa	I-NP	NN	B-DNA	13	NMOD
12	B	B	I-NP	NN	I-DNA	13	NMOD
13	site	site	I-NP	NN	I-DNA	15	SUB
14	,	,	O	,	O	13	P
15	is	be	B-VP	VBZ	O	0	ROOT
16	likely	likely	B-ADJP	JJ	O	15	PRD
17	to	to	B-VP	TO	O	18	VMOD
18	represent	represent	I-VP	VB	O	16	AMOD
19	the	the	B-NP	DT	O	21	NMOD
20	major	major	I-NP	JJ	O	21	NMOD
21	target	target	I-NP	NN	O	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	protein	protein	B-NP	NN	B-protein	25	NMOD
24	kinase	kinase	I-NP	NN	I-protein	25	NMOD
25	C	C	I-NP	NN	I-protein	22	PMOD
26	in	in	B-PP	IN	O	21	NMOD
27	the	the	B-NP	DT	O	30	NMOD
28	interleukin	interleukin	I-NP	NN	B-DNA	30	NMOD
29	2	2	I-NP	CD	I-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	26	PMOD
31	.	.	O	.	O	15	P

1	Stimulation	Stimulation	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	antigen	antigen	B-NP	NN	O	5	PMOD
7	results	result	B-VP	VBZ	O	0	ROOT
8	in	in	B-PP	IN	O	7	VMOD
9	activation	activation	B-NP	NN	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	several	several	B-NP	JJ	O	12	NMOD
12	kinases	kinase	I-NP	NNS	B-protein	10	PMOD
13	,	,	O	,	O	12	P
14	including	include	B-PP	VBG	O	12	NMOD
15	protein	protein	B-NP	NN	B-protein	17	NMOD
16	kinase	kinase	I-NP	NN	I-protein	17	NMOD
17	C	C	I-NP	NN	I-protein	14	PMOD
18	(	(	O	(	O	19	P
19	PKC	PKC	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	17	P
22	that	that	B-NP	WDT	O	17	NMOD
23	may	may	B-VP	MD	O	22	SBAR
24	mediate	mediate	I-VP	VB	O	23	VC
25	the	the	B-NP	DT	O	27	NMOD
26	later	later	I-NP	JJ	O	27	NMOD
27	induction	induction	I-NP	NN	O	24	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	activation-related	activation-related	B-NP	JJ	B-DNA	30	NMOD
30	genes	gene	I-NP	NNS	I-DNA	28	PMOD
31	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	examined	examine	I-VP	VBN	O	2	VC
4	the	the	B-NP	DT	O	6	NMOD
5	potential	potential	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	PKC	PKC	B-NP	NN	B-protein	7	PMOD
9	in	in	B-PP	IN	O	6	NMOD
10	induction	induction	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	18	NMOD
13	interleukin	interleukin	I-NP	NN	B-DNA	18	NMOD
14	2	2	I-NP	CD	I-DNA	13	NMOD
15	(	(	O	(	I-DNA	16	P
16	IL-2	IL-2	B-NP	NN	I-DNA	13	NMOD
17	)	)	O	)	I-DNA	16	P
18	gene	gene	B-NP	NN	I-DNA	11	PMOD
19	in	in	B-PP	IN	O	10	NMOD
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
22	stimulated	stimulate	B-VP	VBN	O	21	NMOD
23	through	through	B-PP	IN	O	22	VMOD
24	the	the	B-NP	DT	O	28	NMOD
25	T	T	I-NP	NN	B-protein	28	NMOD
26	cell	cell	I-NP	NN	I-protein	28	NMOD
27	receptor/CD3	receptor/CD3	I-NP	NN	I-protein	28	NMOD
28	complex	complex	I-NP	NN	I-protein	23	PMOD
29	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	previously	previously	I-VP	RB	O	2	VMOD
4	shown	show	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	prolonged	prolonged	B-NP	JJ	O	7	NMOD
7	treatment	treatment	I-NP	NN	O	18	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	14	NMOD
10	untransformed	untransformed	I-NP	JJ	B-protein	14	NMOD
11	T	T	I-NP	NN	I-protein	14	NMOD
12	cell	cell	I-NP	NN	I-protein	14	NMOD
13	clone	clone	I-NP	NN	I-protein	14	NMOD
14	Ar-5	Ar-5	I-NP	NN	I-protein	8	PMOD
15	with	with	B-PP	IN	O	7	NMOD
16	phorbol	phorbol	B-NP	NN	O	17	NMOD
17	esters	ester	I-NP	NNS	O	15	PMOD
18	results	result	B-VP	VBZ	O	5	SBAR
19	in	in	B-PP	IN	O	18	VMOD
20	downmodulation	downmodulation	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	26	NMOD
23	alpha	alpha	I-NP	NN	B-protein	25	NMOD
24	and	and	I-NP	CC	I-protein	25	NMOD
25	beta	beta	I-NP	NN	I-protein	26	NMOD
26	isozymes	isozyme	I-NP	NNS	I-protein	21	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	PKC	PKC	B-NP	NN	B-protein	27	PMOD
29	,	,	O	,	O	18	P
30	and	and	O	CC	O	18	VMOD
31	abrogates	abrogate	B-VP	VBZ	O	18	VMOD
32	induction	induction	B-NP	NN	O	31	OBJ
33	of	of	B-PP	IN	O	32	NMOD
34	IL-2	IL-2	B-NP	NN	B-RNA	37	NMOD
35	mRNA	mRNA	I-NP	NN	I-RNA	37	NMOD
36	and	and	I-NP	CC	O	37	NMOD
37	protein	protein	I-NP	NN	O	33	PMOD
38	.	.	O	.	O	2	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	phorbol	phorbol	B-NP	NN	O	7	NMOD
6	ester	ester	I-NP	NN	O	7	NMOD
7	treatment	treatment	I-NP	NN	O	9	SUB
8	also	also	B-ADVP	RB	O	9	VMOD
9	abolishes	abolish	B-VP	VBZ	O	4	SBAR
10	induction	induction	B-NP	NN	O	9	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	14	NMOD
13	acetyltransferase	acetyltransferase	I-NP	NN	I-protein	14	NMOD
14	activity	activity	I-NP	NN	O	11	PMOD
15	in	in	B-PP	IN	O	10	NMOD
16	Ar-5	Ar-5	B-NP	NN	B-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
18	transfected	transfecte	B-VP	VBN	O	17	NMOD
19	with	with	B-PP	IN	O	18	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	plasmid	plasmid	I-NP	NN	B-DNA	19	PMOD
22	containing	contain	B-VP	VBG	O	21	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	IL-2	IL-2	I-NP	NN	B-DNA	25	NMOD
25	promoter	promoter	I-NP	NN	I-DNA	22	OBJ
26	linked	link	B-VP	VBN	O	25	NMOD
27	to	to	B-PP	TO	O	26	VMOD
28	this	this	B-NP	DT	O	30	NMOD
29	reporter	reporter	I-NP	NN	B-DNA	30	NMOD
30	gene	gene	I-NP	NN	I-DNA	27	PMOD
31	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	IL-2	IL-2	I-NP	NN	B-DNA	3	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	SUB
4	contains	contain	B-VP	VBZ	O	0	ROOT
5	binding	bind	I-VP	VBG	B-DNA	6	NMOD
6	sites	site	B-NP	NNS	I-DNA	4	OBJ
7	for	for	B-PP	IN	O	6	NMOD
8	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD
9	factors	factor	I-NP	NNS	I-protein	7	PMOD
10	including	include	B-PP	VBG	O	9	NMOD
11	NFAT-1	NFAT-1	B-NP	NN	B-protein	19	NMOD
12	,	,	O	,	O	19	P
13	Oct	Oct	B-NP	NN	B-protein	19	NMOD
14	,	,	O	,	O	19	P
15	NF-kappa	NF-kappa	B-NP	NN	B-protein	16	NMOD
16	B	B	I-NP	NN	I-protein	19	NMOD
17	,	,	O	,	O	19	P
18	and	and	O	CC	O	19	NMOD
19	AP-1	AP-1	B-NP	NN	B-protein	10	PMOD
20	,	,	O	,	O	19	P
21	which	which	B-NP	WDT	O	19	NMOD
22	are	be	B-VP	VBP	O	21	SBAR
23	all	all	B-ADVP	RB	O	22	VMOD
24	potentially	potentially	B-ADJP	RB	O	25	AMOD
25	sensitive	sensitive	I-ADJP	JJ	O	22	PRD
26	to	to	B-PP	TO	O	25	AMOD
27	activation	activation	B-NP	NN	O	26	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	PKC	PKC	B-NP	NN	B-protein	28	PMOD
30	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	23	DEP
4	induction	induction	B-NP	NN	O	14	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	7	NMOD
7	trimer	trimer	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	NFAT	NFAT	I-NP	NN	B-DNA	12	NMOD
11	and	and	I-NP	CC	I-DNA	12	NMOD
12	Oct	Oct	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	8	PMOD
14	is	be	B-VP	VBZ	O	3	SBAR
15	not	not	O	RB	O	14	VMOD
16	sensitive	sensitive	B-ADJP	JJ	O	14	PRD
17	to	to	B-PP	TO	O	16	AMOD
18	phorbol	phorbol	B-NP	NN	O	20	NMOD
19	ester	ester	I-NP	NN	O	20	NMOD
20	treatment	treatment	I-NP	NN	O	17	PMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	DEP
23	that	that	B-SBAR	IN	O	2	VMOD
24	mutations	mutation	B-NP	NNS	O	30	SUB
25	in	in	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	NF-kappa	NF-kappa	I-NP	NN	B-DNA	29	NMOD
28	B	B	I-NP	NN	I-DNA	29	NMOD
29	site	site	I-NP	NN	I-DNA	25	PMOD
30	have	have	B-VP	VBP	O	23	SBAR
31	no	no	B-NP	DT	O	32	NMOD
32	effect	effect	I-NP	NN	O	30	OBJ
33	on	on	B-PP	IN	O	30	VMOD
34	inducibility	inducibility	B-NP	NN	O	33	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	IL-2	IL-2	I-NP	NN	B-DNA	38	NMOD
38	promoter	promoter	I-NP	NN	I-DNA	35	PMOD
39	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	15	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	15	P
4	mutations	mutation	B-NP	NNS	O	15	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	AP-1	AP-1	I-NP	NN	B-DNA	8	NMOD
8	site	site	I-NP	NN	I-DNA	5	PMOD
9	located	located	B-ADJP	JJ	O	8	NMOD
10	at	at	B-PP	IN	O	9	AMOD
11	-150	-150	B-NP	CD	B-DNA	12	NMOD
12	bp	bp	I-NP	NN	I-DNA	10	PMOD
13	almost	almost	B-ADVP	RB	O	15	VMOD
14	completely	completely	I-ADVP	RB	O	13	AMOD
15	abrogate	abrogate	I-VP	VBP	O	33	VMOD
16	induction	induction	B-NP	NN	O	15	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	IL-2	IL-2	I-NP	NN	B-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	17	PMOD
21	,	,	O	,	O	33	P
22	and	and	O	CC	O	23	NMOD
23	appearance	appearance	B-NP	NN	O	33	SUB
24	of	of	B-PP	IN	O	23	NMOD
25	an	an	B-NP	DT	O	28	NMOD
26	inducible	inducible	I-NP	JJ	B-protein	28	NMOD
27	nuclear	nuclear	I-NP	JJ	I-protein	28	NMOD
28	factor	factor	I-NP	NN	I-protein	24	PMOD
29	binding	bind	B-VP	VBG	O	28	NMOD
30	to	to	B-PP	TO	O	29	VMOD
31	this	this	B-NP	DT	O	32	NMOD
32	site	site	I-NP	NN	O	30	PMOD
33	is	be	B-VP	VBZ	O	0	ROOT
34	sensitive	sensitive	B-ADJP	JJ	O	33	PRD
35	to	to	B-PP	TO	O	34	AMOD
36	PKC	PKC	B-NP	NN	B-protein	37	NMOD
37	depletion	depletion	I-NP	NN	O	35	PMOD
38	.	.	O	.	O	33	P

1	Moreover	Moreover	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	cotransfections	cotransfection	B-NP	NNS	O	11	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	c-fos	c-fos	B-NP	NN	B-DNA	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	c-jun	c-jun	B-NP	NN	B-DNA	9	NMOD
8	expression	expression	I-NP	NN	O	9	NMOD
9	plasmids	plasmid	I-NP	NNS	O	4	PMOD
10	markedly	markedly	B-ADVP	RB	O	11	VMOD
11	enhance	enhance	B-VP	VBP	O	0	ROOT
12	induction	induction	B-NP	NN	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	IL-2	IL-2	I-NP	NN	B-DNA	16	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
17	in	in	B-PP	IN	O	12	NMOD
18	minimally	minimally	B-NP	RB	B-cell_line	19	AMOD
19	stimulated	stimulate	I-NP	VBN	I-cell_line	21	NMOD
20	T	T	I-NP	NN	I-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
22	.	.	O	.	O	11	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	AP-1	AP-1	I-NP	NN	B-DNA	7	NMOD
7	site	site	I-NP	NN	I-DNA	11	SUB
8	at	at	B-PP	IN	O	7	NMOD
9	-150	-150	B-NP	CD	B-DNA	10	NMOD
10	bp	bp	I-NP	NN	I-DNA	8	PMOD
11	represents	represent	B-VP	VBZ	O	4	SBAR
12	a	a	B-NP	DT	O	13	NMOD
13	major	major	I-NP	JJ	O	20	NMOD
14	,	,	O	,	O	20	P
15	if	if	B-CONJP	IN	O	20	NMOD
16	not	not	I-CONJP	RB	O	15	DEP
17	the	the	B-NP	DT	O	20	NMOD
18	only	only	I-NP	JJ	O	20	NMOD
19	,	,	I-NP	,	O	20	P
20	site	site	I-NP	NN	O	11	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	PKC	PKC	B-NP	NN	B-protein	23	NMOD
23	responsiveness	responsiveness	I-NP	NN	O	21	PMOD
24	in	in	B-PP	IN	O	20	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	IL-2	IL-2	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
28	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	jun	jun	B-NP	NN	B-DNA	9	NMOD
5	and	and	I-NP	CC	I-DNA	9	NMOD
6	fos	fos	I-NP	NN	I-DNA	9	NMOD
7	gene	gene	I-NP	NN	I-DNA	9	NMOD
8	family	family	I-NP	NN	I-DNA	9	NMOD
9	members	member	I-NP	NNS	I-DNA	3	PMOD
10	in	in	B-PP	IN	O	2	NMOD
11	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	NN	O	14	NMOD
12	induced	induce	I-NP	VBD	O	14	NMOD
13	hemopoietic	hemopoietic	I-NP	JJ	O	14	NMOD
14	differentiation	differentiation	I-NP	NN	O	10	PMOD
15	.	.	O	.	O	2	P

1	Terminal	Terminal	B-NP	JJ	O	2	NMOD
2	differentiation	differentiation	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	leukemic	leukemic	I-NP	JJ	B-cell_line	7	NMOD
6	cell	cell	I-NP	NN	I-cell_line	7	NMOD
7	lines	line	I-NP	NNS	I-cell_line	3	PMOD
8	U-937	U-937	B-NP	NN	B-cell_line	10	NMOD
9	and	and	O	CC	O	10	NMOD
10	HL-60	HL-60	B-NP	NN	B-cell_line	7	NMOD
11	by	by	B-PP	IN	O	2	NMOD
12	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	NN	O	11	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	accompanied	accompany	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	marked	marked	B-NP	JJ	O	17	NMOD
17	changes	change	I-NP	NNS	O	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	gene	gene	B-NP	NN	O	20	NMOD
20	expression	expression	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	expression	expression	I-NP	NN	O	17	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	jun	jun	B-NP	NN	B-DNA	16	NMOD
12	and	and	I-NP	CC	I-DNA	16	NMOD
13	fos	fos	I-NP	NN	I-DNA	16	NMOD
14	gene	gene	I-NP	NN	I-DNA	16	NMOD
15	family	family	I-NP	NN	I-DNA	16	NMOD
16	members	member	I-NP	NNS	I-DNA	10	PMOD
17	is	be	B-VP	VBZ	O	7	SBAR
18	induced	induce	I-VP	VBN	O	17	VC
19	with	with	B-PP	IN	O	18	VMOD
20	variable	variable	B-NP	JJ	O	21	NMOD
21	kinetics	kinetic	I-NP	NNS	O	19	PMOD
22	during	during	B-PP	IN	O	18	VMOD
23	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	NN	O	25	NMOD
24	induced	induce	I-NP	VBD	O	25	NMOD
25	differentiation	differentiation	I-NP	NN	O	22	PMOD
26	,	,	O	,	O	18	P
27	with	with	B-PP	IN	O	18	VMOD
28	c-jun	c-jun	B-NP	NN	B-DNA	29	NMOD
29	expression	expression	I-NP	NN	O	32	NMOD
30	best	well	B-NP	RBS	O	32	NMOD
31	paralleling	paralleling	I-NP	JJ	O	32	NMOD
32	differentiation	differentiation	I-NP	NN	O	27	PMOD
33	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	generation	generation	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	AP-1	AP-1	B-NP	NN	B-protein	5	NMOD
5	complexes	complex	I-NP	NNS	I-protein	3	PMOD
6	,	,	O	,	O	2	P
7	as	as	B-SBAR	IN	O	2	NMOD
8	measured	measure	B-VP	VBN	O	7	SBAR
9	by	by	B-PP	IN	O	8	VMOD
10	DNA	DNA	B-NP	NN	O	12	NMOD
11	binding	binding	I-NP	NN	O	12	NMOD
12	activity	activity	I-NP	NN	O	9	PMOD
13	,	,	O	,	O	2	P
14	closely	closely	B-ADVP	RB	O	15	VMOD
15	parallels	parallel	B-VP	VBZ	O	0	ROOT
16	morphological	morphological	B-NP	JJ	O	17	NMOD
17	differentiation	differentiation	I-NP	NN	O	15	OBJ
18	.	.	O	.	O	15	P

1	Furthermore	Furthermore	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	the	the	B-NP	DT	O	4	NMOD
4	ability	ability	I-NP	NN	O	12	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	these	these	B-NP	DT	O	7	NMOD
7	complexes	complex	I-NP	NNS	O	5	PMOD
8	to	to	B-VP	TO	O	9	VMOD
9	regulate	regulate	I-VP	VB	O	4	NMOD
10	gene	gene	B-NP	NN	O	11	NMOD
11	expression	expression	I-NP	NN	O	9	OBJ
12	is	be	B-VP	VBZ	O	0	ROOT
13	demonstrated	demonstrate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	increased	increase	B-NP	VBN	O	16	NMOD
16	transcription	transcription	I-NP	NN	O	25	NMOD
17	from	from	B-PP	IN	O	16	NMOD
18	an	an	B-NP	DT	O	22	NMOD
19	AP-1	AP-1	I-NP	NN	B-DNA	22	NMOD
20	driven	driven	I-NP	JJ	I-DNA	22	NMOD
21	reporter	reporter	I-NP	NN	I-DNA	22	NMOD
22	construct	construct	I-NP	NN	I-DNA	17	PMOD
23	and	and	O	CC	O	25	NMOD
24	marked	marked	B-NP	JJ	O	25	NMOD
25	increases	increase	I-NP	NNS	O	14	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	28	NMOD
28	expression	expression	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	endogenous	endogenous	B-NP	JJ	B-DNA	33	NMOD
31	AP-1	AP-1	I-NP	NN	I-DNA	33	NMOD
32	regulated	regulated	I-NP	JJ	I-DNA	33	NMOD
33	genes	gene	I-NP	NNS	I-DNA	29	PMOD
34	.	.	O	.	O	12	P

1	Differentiation	Differentiation	B-NP	NN	O	2	NMOD
2	assays	assay	I-NP	NNS	O	8	SUB
3	using	use	B-VP	VBG	O	2	NMOD
4	water	water	B-NP	NN	O	7	NMOD
5	soluble	soluble	I-NP	JJ	O	7	NMOD
6	phorbol	phorbol	I-NP	NN	O	7	NMOD
7	esters	ester	I-NP	NNS	O	3	OBJ
8	reveal	reveal	B-VP	VBP	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	differentiation	differentiation	B-NP	NN	O	11	SUB
11	becomes	become	B-VP	VBZ	O	9	SBAR
12	irreversible	irreversible	B-ADJP	JJ	O	11	PRD
13	soon	soon	B-ADVP	RB	O	14	PMOD
14	after	after	B-SBAR	IN	O	12	AMOD
15	AP-1	AP-1	B-NP	NN	B-protein	16	SUB
16	appears	appear	B-VP	VBZ	O	14	SBAR
17	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	3	NMOD
2	tight	tight	I-NP	JJ	O	3	NMOD
3	correlation	correlation	I-NP	NN	O	16	SUB
4	between	between	B-PP	IN	O	3	NMOD
5	c-jun	c-jun	B-NP	NN	B-DNA	6	NMOD
6	expression	expression	I-NP	NN	O	4	PMOD
7	,	,	O	,	O	16	P
8	the	the	B-NP	DT	O	9	NMOD
9	generation	generation	I-NP	NN	O	16	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	AP-1	AP-1	B-NP	NN	B-protein	12	NMOD
12	activity	activity	I-NP	NN	O	10	PMOD
13	,	,	O	,	O	16	P
14	and	and	O	CC	O	16	VMOD
15	differentiation	differentiation	B-NP	NN	O	16	SUB
16	suggests	suggest	B-VP	VBZ	O	0	ROOT
17	a	a	B-NP	DT	O	19	NMOD
18	critical	critical	I-NP	JJ	O	19	NMOD
19	role	role	I-NP	NN	O	16	OBJ
20	for	for	B-PP	IN	O	19	NMOD
21	this	this	B-NP	DT	O	25	NMOD
22	gene	gene	I-NP	NN	O	25	NMOD
23	and	and	O	CC	O	25	NMOD
24	transcriptional	transcriptional	B-NP	JJ	B-protein	25	NMOD
25	complex	complex	I-NP	NN	I-protein	20	PMOD
26	during	during	B-PP	IN	O	19	NMOD
27	this	this	B-NP	DT	O	28	NMOD
28	process	process	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	16	P

1	Characterization	Characterization	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	4	NMOD
4	cofactor	cofactor	I-NP	NN	B-protein	2	PMOD
5	that	that	B-NP	WDT	O	4	NMOD
6	regulates	regulate	B-VP	VBZ	O	5	SBAR
7	dimerization	dimerization	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	a	a	B-NP	DT	O	12	NMOD
10	mammalian	mammalian	I-NP	JJ	B-protein	12	NMOD
11	homeodomain	homeodomain	I-NP	NN	I-protein	12	NMOD
12	protein	protein	I-NP	NN	I-protein	8	PMOD
13	.	.	O	.	O	1	P

1	Dimerization	Dimerization	B-NP	NN	O	5	SUB
2	among	among	B-PP	IN	O	1	NMOD
3	transcription	transcription	B-NP	NN	B-protein	4	NMOD
4	factors	factor	I-NP	NNS	I-protein	2	PMOD
5	has	have	B-VP	VBZ	O	0	ROOT
6	become	become	I-VP	VBN	O	5	VC
7	a	a	B-NP	DT	O	9	NMOD
8	recurrent	recurrent	I-NP	JJ	O	9	NMOD
9	theme	theme	I-NP	NN	O	6	OBJ
10	in	in	B-PP	IN	O	6	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	regulation	regulation	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	eukaryotic	eukaryotic	B-NP	JJ	B-DNA	16	NMOD
15	gene	gene	I-NP	NN	I-DNA	16	NMOD
16	expression	expression	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	5	P

1	Hepatocyte	Hepatocyte	B-NP	NN	B-protein	4	NMOD
2	nuclear	nuclear	I-NP	JJ	I-protein	4	NMOD
3	factor-1	factor-1	I-NP	NN	I-protein	4	NMOD
4	alpha	alpha	I-NP	NN	I-protein	9	SUB
5	(	(	O	(	O	7	P
6	HNF-1	HNF-1	B-NP	NN	B-protein	7	NMOD
7	alpha	alpha	I-NP	NN	I-protein	4	NMOD
8	)	)	O	)	O	7	P
9	is	be	B-VP	VBZ	O	0	ROOT
10	a	a	B-NP	DT	O	12	NMOD
11	homeodomain-containing	homeodomain-containing	I-NP	JJ	B-protein	12	NMOD
12	protein	protein	I-NP	NN	I-protein	9	PRD
13	that	that	B-NP	WDT	O	12	NMOD
14	functions	function	B-VP	VBZ	O	13	SBAR
15	as	as	B-PP	IN	O	14	VMOD
16	a	a	B-NP	DT	O	17	NMOD
17	dimer	dimer	I-NP	NN	B-protein	15	PMOD
18	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	3	NMOD
2	dimerization	dimerization	I-NP	NN	B-protein	3	NMOD
3	cofactor	cofactor	I-NP	NN	I-protein	10	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	HNF-1	HNF-1	B-NP	NN	B-protein	6	NMOD
6	alpha	alpha	I-NP	NN	I-protein	4	PMOD
7	(	(	O	(	O	8	P
8	DCoH	DCoH	B-NP	NN	B-protein	6	NMOD
9	)	)	O	)	O	8	P
10	was	be	B-VP	VBD	O	0	ROOT
11	identified	identify	I-VP	VBN	O	10	VC
12	that	that	B-NP	WDT	O	10	VMOD
13	displayed	display	B-VP	VBD	O	30	VMOD
14	a	a	B-NP	DT	O	17	NMOD
15	restricted	restricted	I-NP	JJ	O	17	NMOD
16	tissue	tissue	I-NP	NN	O	17	NMOD
17	distribution	distribution	I-NP	NN	O	13	OBJ
18	and	and	O	CC	O	13	VMOD
19	did	do	B-VP	VBD	O	13	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	bind	bind	I-VP	VB	O	19	VC
22	to	to	B-PP	TO	O	21	VMOD
23	DNA	DNA	B-NP	NN	O	22	PMOD
24	,	,	O	,	O	30	P
25	but	but	O	CC	O	30	VMOD
26	,	,	O	,	O	30	P
27	rather	rather	B-ADVP	RB	O	30	VMOD
28	,	,	O	,	O	30	P
29	selectively	selectively	B-VP	RB	O	30	VMOD
30	stabilized	stabilize	I-VP	VBD	O	12	SBAR
31	HNF-1	HNF-1	B-NP	NN	B-protein	33	NMOD
32	alpha	alpha	I-NP	NN	I-protein	33	NMOD
33	dimers	dimer	I-NP	NNS	I-protein	30	OBJ
34	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	formation	formation	I-NP	NN	O	20	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	9	NMOD
5	stable	stable	I-NP	JJ	O	9	NMOD
6	tetrameric	tetrameric	I-NP	JJ	B-protein	9	NMOD
7	DCoH-HNF-1	DCoH-HNF-1	I-NP	NN	I-protein	9	NMOD
8	alpha	alpha	I-NP	NN	I-protein	9	NMOD
9	complex	complex	I-NP	NN	I-protein	3	PMOD
10	,	,	O	,	O	2	P
11	which	which	B-NP	WDT	O	2	NMOD
12	required	require	B-VP	VBD	O	11	SBAR
13	the	the	B-NP	DT	O	15	NMOD
14	dimerization	dimerization	I-NP	NN	B-protein	15	NMOD
15	domain	domain	I-NP	NN	I-protein	12	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	HNF-1	HNF-1	B-NP	NN	B-protein	18	NMOD
18	alpha	alpha	I-NP	NN	I-protein	16	PMOD
19	,	,	O	,	O	2	P
20	did	do	B-VP	VBD	O	0	ROOT
21	not	not	I-VP	RB	O	20	VMOD
22	change	change	I-VP	VB	O	20	VC
23	the	the	B-NP	DT	O	26	NMOD
24	DNA	DNA	I-NP	NN	O	26	NMOD
25	binding	binding	I-NP	NN	O	26	NMOD
26	characteristics	characteristic	I-NP	NNS	O	22	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	HNF-1	HNF-1	B-NP	NN	B-protein	29	NMOD
29	alpha	alpha	I-NP	NN	I-protein	27	PMOD
30	,	,	O	,	O	20	P
31	but	but	O	CC	O	20	VMOD
32	enhanced	enhance	B-VP	VBD	O	20	VMOD
33	its	its	B-NP	PRP$	O	35	NMOD
34	transcriptional	transcriptional	I-NP	JJ	O	35	NMOD
35	activity	activity	I-NP	NN	O	32	OBJ
36	.	.	O	.	O	20	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	DCoH	DCoH	B-NP	NN	B-protein	4	SUB
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	confer	confer	I-VP	VB	O	4	VC
7	transcriptional	transcriptional	B-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	OBJ
9	to	to	B-PP	TO	O	6	VMOD
10	the	the	B-NP	DT	O	14	NMOD
11	GAL4	GAL4	I-NP	NN	B-protein	14	NMOD
12	DNA	DNA	I-NP	NN	I-protein	14	NMOD
13	binding	binding	I-NP	NN	I-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	9	PMOD
15	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	DCoH	DCoH	B-NP	NN	B-protein	6	SUB
6	regulates	regulate	B-VP	VBZ	O	4	SBAR
7	formation	formation	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	transcriptionally	transcriptionally	B-NP	RB	O	10	AMOD
10	active	active	I-NP	JJ	O	12	NMOD
11	tetrameric	tetrameric	I-NP	JJ	B-protein	12	NMOD
12	complexes	complex	I-NP	NNS	I-protein	8	PMOD
13	and	and	O	CC	O	6	VMOD
14	may	may	B-VP	MD	O	6	VMOD
15	contribute	contribute	I-VP	VB	O	14	VC
16	to	to	B-PP	TO	O	15	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	developmental	developmental	I-NP	JJ	O	19	NMOD
19	specificity	specificity	I-NP	NN	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	22	NMOD
22	complex	complex	I-NP	NN	O	20	PMOD
23	.	.	O	.	O	3	P

1	Nuclear	Nuclear	B-NP	JJ	B-protein	4	NMOD
2	factor	factor	I-NP	NN	I-protein	4	NMOD
3	kappa	kappa	I-NP	NN	I-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	5	SUB
5	activates	activate	B-VP	VBZ	O	0	ROOT
6	proenkephalin	proenkephalin	B-NP	NN	O	7	NMOD
7	transcription	transcription	I-NP	NN	O	5	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	8	PMOD
11	.	.	O	.	O	5	P

1	Upon	Upon	B-PP	IN	O	6	VMOD
2	activation	activation	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	T	T	B-NP	NN	B-cell_type	5	NMOD
5	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	SUB
6	accumulate	accumulate	B-VP	VBP	O	0	ROOT
7	high	high	B-NP	JJ	O	8	NMOD
8	levels	level	I-NP	NNS	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	neuropeptide	neuropeptide	I-NP	NN	O	12	NMOD
12	enkephalin	enkephalin	I-NP	NN	O	9	PMOD
13	which	which	B-NP	WDT	O	8	NMOD
14	correlate	correlate	B-VP	VBP	O	13	SBAR
15	with	with	B-PP	IN	O	14	VMOD
16	high	high	B-NP	JJ	O	17	NMOD
17	levels	level	I-NP	NNS	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	proenkephalin	proenkephalin	B-NP	NN	B-RNA	20	NMOD
20	mRNA	mRNA	I-NP	NN	I-RNA	18	PMOD
21	in	in	B-PP	IN	O	17	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	cells	cell	I-NP	NNS	O	21	PMOD
24	.	.	O	.	O	6	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	investigated	investigate	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	transcriptional	transcriptional	I-NP	JJ	O	6	NMOD
6	basis	basis	I-NP	NN	O	3	OBJ
7	for	for	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	9	NMOD
9	changes	change	I-NP	NNS	O	7	PMOD
10	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	proenkephalin	proenkephalin	I-NP	NN	B-DNA	3	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	SUB
4	contains	contain	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	sequence	sequence	I-NP	NN	O	7	NMOD
7	GGGGACGTCCCC	GGGGACGTCCCC	I-NP	NN	O	4	OBJ
8	,	,	O	,	O	7	P
9	named	name	B-VP	VBN	O	7	NMOD
10	B2	B2	B-NP	NN	B-protein	9	VMOD
11	,	,	O	,	O	7	P
12	which	which	B-NP	WDT	O	7	NMOD
13	is	be	B-VP	VBZ	O	12	SBAR
14	similar	similar	B-ADJP	JJ	O	13	PRD
15	to	to	B-PP	TO	O	14	AMOD
16	the	the	B-NP	DT	O	20	NMOD
17	kappa	kappa	I-NP	NN	B-DNA	20	NMOD
18	B	B	I-NP	NN	I-DNA	20	NMOD
19	sequence	sequence	I-NP	NN	I-DNA	20	NMOD
20	GGGGACTTTCC	GGGGACTTTCC	I-NP	NN	O	24	NMOD
21	,	,	O	,	O	24	P
22	the	the	B-NP	DT	O	24	NMOD
23	binding	bind	I-NP	VBG	B-DNA	24	NMOD
24	site	site	I-NP	NN	I-DNA	15	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	transcription	transcription	I-NP	NN	B-protein	28	NMOD
28	factor	factor	I-NP	NN	I-protein	35	NMOD
29	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD
30	factor	factor	I-NP	NN	I-protein	35	NMOD
31	(	(	O	(	I-protein	35	P
32	NF	NF	B-NP	NN	I-protein	35	NMOD
33	)	)	O	)	I-protein	35	P
34	-kappa	-kappa	B-NP	NN	I-protein	35	NMOD
35	B	B	I-NP	NN	I-protein	25	PMOD
36	.	.	O	.	O	4	P

1	Activation	Activation	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD
5	induces	induce	B-VP	VBZ	O	0	ROOT
6	an	an	B-NP	DT	O	10	NMOD
7	NF-kappa	NF-kappa	I-NP	NN	O	10	NMOD
8	B-like	B-like	I-NP	JJ	O	7	AMOD
9	binding	binding	I-NP	NN	O	10	NMOD
10	activity	activity	I-NP	NN	O	5	OBJ
11	to	to	B-PP	TO	O	5	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	B2	B2	I-NP	NN	B-DNA	14	NMOD
14	site	site	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	5	P
16	concomitant	concomitant	B-ADJP	JJ	O	5	VMOD
17	with	with	B-PP	IN	O	16	AMOD
18	activation	activation	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	proenkephalin	proenkephalin	I-NP	NN	B-DNA	22	NMOD
22	promoter	promoter	I-NP	NN	I-DNA	19	PMOD
23	.	.	O	.	O	5	P

1	Mutations	Mutation	B-NP	NNS	O	6	SUB
2	at	at	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	B2	B2	I-NP	NN	B-DNA	5	NMOD
5	site	site	I-NP	NN	O	2	PMOD
6	abolish	abolish	B-VP	VBP	O	0	ROOT
7	this	this	B-NP	DT	O	9	NMOD
8	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	6	OBJ
10	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	purified	purify	I-NP	VBN	O	3	NMOD
3	homodimer	homodimer	I-NP	NN	B-protein	15	SUB
4	(	(	O	(	O	6	P
5	two	two	B-NP	CD	O	6	NMOD
6	p50s	p50	I-NP	NNS	B-protein	3	NMOD
7	)	)	O	)	O	6	P
8	of	of	B-PP	IN	O	3	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	DNA-binding	DNA-binding	I-NP	JJ	B-protein	11	NMOD
11	subunit	subunit	I-NP	NN	I-protein	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	NF-kappa	NF-kappa	B-NP	NN	B-protein	14	NMOD
14	B	B	I-NP	NN	I-protein	12	PMOD
15	binds	bind	B-VP	VBZ	O	0	ROOT
16	the	the	B-NP	DT	O	18	NMOD
17	B2	B2	I-NP	NN	B-DNA	18	NMOD
18	site	site	I-NP	NN	O	15	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	proenkephalin	proenkephalin	B-NP	NN	O	19	PMOD
21	relatively	relatively	B-ADVP	RB	O	15	VMOD
22	better	well	I-ADVP	RBR	O	21	AMOD
23	than	than	B-SBAR	IN	O	21	AMOD
24	does	do	O	VBZ	O	23	DEP
25	the	the	O	DT	O	34	NMOD
26	heterotetramer	heterotetramer	B-NP	NN	B-protein	34	NMOD
27	(	(	O	(	O	32	P
28	two	two	B-NP	CD	O	29	NMOD
29	p65s	p65	I-NP	NNS	B-protein	32	NMOD
30	plus	plus	O	CC	O	32	NMOD
31	two	two	B-NP	CD	O	32	NMOD
32	p50s	p50	I-NP	NNS	B-protein	26	NMOD
33	)	)	O	)	O	32	P
34	form	form	B-NP	NN	O	24	SUB
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	37	NMOD
37	factor	factor	I-NP	NN	O	35	PMOD
38	.	.	O	.	O	15	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	appears	appear	B-VP	VBZ	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	8	NMOD
7	T-cell-specific	T-cell-specific	I-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	13	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	proenkephalin	proenkephalin	I-NP	NN	B-DNA	12	NMOD
12	promoter	promoter	I-NP	NN	I-DNA	9	PMOD
13	is	be	B-VP	VBZ	O	5	SBAR
14	mediated	mediate	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	15	PMOD
18	.	.	O	.	O	4	P

1	However	However	B-ADVP	RB	O	30	VMOD
2	,	,	O	,	O	30	P
3	as	as	B-SBAR	IN	O	30	VMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	6	SUB
6	is	be	B-VP	VBZ	O	16	VMOD
7	ubiquitous	ubiquitous	B-ADJP	JJ	O	6	PRD
8	and	and	O	CC	O	16	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	transcriptional	transcriptional	I-NP	JJ	O	11	NMOD
11	activation	activation	I-NP	NN	O	16	SUB
12	through	through	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	B2	B2	I-NP	NN	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	12	PMOD
16	is	be	B-VP	VBZ	O	3	SBAR
17	T	T	B-NP	NN	O	18	NMOD
18	cell	cell	I-NP	NN	O	19	AMOD
19	specific	specific	B-ADJP	JJ	O	16	PRD
20	,	,	O	,	O	30	P
21	yet	yet	B-NP	RB	O	24	NMOD
22	another	another	I-NP	DT	O	24	NMOD
23	T-cell-specific	T-cell-specific	I-NP	JJ	B-protein	24	NMOD
24	factor	factor	I-NP	NN	I-protein	30	SUB
25	which	which	B-NP	WDT	O	24	NMOD
26	synergizes	synergize	B-VP	VBZ	O	25	SBAR
27	with	with	B-PP	IN	O	26	VMOD
28	NF-kappa	NF-kappa	B-NP	NN	B-protein	29	NMOD
29	B	B	I-NP	NN	I-protein	27	PMOD
30	should	should	B-VP	MD	O	0	ROOT
31	be	be	I-VP	VB	O	30	VC
32	considered	consider	I-VP	VBN	O	31	VC
33	.	.	O	.	O	30	P

1	ETS1	ETS1	B-NP	NN	B-protein	2	SUB
2	transactivates	transactivate	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	6	NMOD
4	human	human	I-NP	JJ	B-DNA	6	NMOD
5	GM-CSF	GM-CSF	I-NP	NN	I-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	2	OBJ
7	in	in	B-PP	IN	O	6	NMOD
8	Jurkat	Jurkat	B-NP	NN	B-cell_line	10	NMOD
9	T	T	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	7	PMOD
11	stimulated	stimulate	B-VP	VBN	O	10	NMOD
12	with	with	B-PP	IN	O	11	VMOD
13	PMA	PMA	B-NP	NN	O	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	ionomycin	ionomycin	I-NP	NN	O	12	PMOD
16	.	.	O	.	O	2	P

1	Activation	Activation	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	5	NMOD
4	helper	helper	I-NP	NN	I-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
6	results	result	B-VP	VBZ	O	0	ROOT
7	in	in	B-PP	IN	O	6	VMOD
8	coordinate	coordinate	B-NP	JJ	O	9	NMOD
9	expression	expression	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	12	NMOD
12	number	number	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	cytokines	cytokine	B-NP	NNS	B-protein	13	PMOD
15	involved	involve	B-VP	VBN	O	14	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	differentiation	differentiation	B-NP	NN	O	21	NMOD
18	,	,	O	,	O	21	P
19	proliferation	proliferation	B-NP	NN	O	21	NMOD
20	and	and	O	CC	O	21	NMOD
21	activation	activation	B-NP	NN	O	16	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	haematopoietic	haematopoietic	I-NP	JJ	O	25	NMOD
25	system	system	I-NP	NN	O	22	PMOD
26	.	.	O	.	O	6	P

1	Granulocyte-macrophage	Granulocyte-macrophage	B-NP	JJ	B-protein	3	NMOD
2	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	7	SUB
4	(	(	O	(	O	5	P
5	GM-CSF	GM-CSF	B-NP	NN	B-protein	3	NMOD
6	)	)	O	)	O	5	P
7	is	be	B-VP	VBZ	O	0	ROOT
8	one	one	B-NP	CD	O	10	NMOD
9	such	such	I-NP	JJ	O	10	NMOD
10	cytokine	cytokine	I-NP	NN	B-protein	7	PRD
11	whose	whose	B-NP	WP$	O	10	NMOD
12	increased	increase	I-NP	VBN	O	11	NMOD
13	expression	expression	I-NP	NN	O	11	NMOD
14	results	result	B-VP	VBZ	O	11	SBAR
15	partly	partly	B-ADVP	RB	O	14	VMOD
16	from	from	B-PP	IN	O	14	VMOD
17	increases	increase	B-NP	NNS	O	16	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	transcription	transcription	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	7	P

1	Cis-acting	Cis-acting	B-NP	JJ	B-DNA	2	NMOD
2	elements	element	I-NP	NNS	I-DNA	12	SUB
3	with	with	B-PP	IN	O	2	NMOD
4	NF	NF	B-NP	NN	B-protein	6	NMOD
5	kappa	kappa	I-NP	NN	I-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	11	NMOD
7	,	,	O	,	O	11	P
8	AP-1	AP-1	B-NP	NN	B-protein	11	NMOD
9	and	and	O	CC	O	11	NMOD
10	ETS-like	ETS-like	B-NP	JJ	B-DNA	11	NMOD
11	motifs	motif	I-NP	NNS	I-DNA	3	PMOD
12	have	have	B-VP	VBP	O	0	ROOT
13	been	be	I-VP	VBN	O	12	VC
14	identified	identify	I-VP	VBN	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	promoter	promoter	I-NP	NN	B-DNA	18	NMOD
18	region	region	I-NP	NN	I-DNA	15	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	GM-CSF	GM-CSF	I-NP	NN	B-DNA	22	NMOD
22	gene	gene	I-NP	NN	I-DNA	19	PMOD
23	,	,	O	,	O	18	P
24	which	which	B-NP	WDT	O	18	NMOD
25	are	be	B-VP	VBP	O	24	SBAR
26	important	important	B-ADJP	JJ	O	25	PRD
27	for	for	B-PP	IN	O	26	AMOD
28	transcriptional	transcriptional	B-NP	JJ	O	29	NMOD
29	activity	activity	I-NP	NN	O	27	PMOD
30	following	follow	B-PP	VBG	O	29	NMOD
31	PMA	PMA	B-NP	NN	O	34	NMOD
32	and	and	O	CC	O	34	NMOD
33	ionomycin	ionomycin	B-NP	NN	O	34	NMOD
34	stimulation	stimulation	I-NP	NN	O	30	PMOD
35	.	.	O	.	O	12	P

1	A	A	B-NP	DT	O	2	NMOD
2	number	number	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	ETS	ETS	I-NP	NN	B-protein	6	NMOD
6	family	family	I-NP	NN	I-protein	3	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	transcription	transcription	B-NP	NN	B-protein	9	NMOD
9	factors	factor	I-NP	NNS	I-protein	7	PMOD
10	are	be	B-VP	VBP	O	0	ROOT
11	expressed	express	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	,	,	O	,	O	14	P
16	including	include	B-PP	VBG	O	14	NMOD
17	ETS1	ETS1	B-NP	NN	B-protein	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	ELF1	ELF1	I-NP	NN	B-protein	16	PMOD
20	.	.	O	.	O	10	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	describe	describe	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	ability	ability	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	factors	factor	I-NP	NNS	O	6	PMOD
9	to	to	B-VP	TO	O	10	VMOD
10	interact	interact	I-VP	VB	O	5	NMOD
11	with	with	B-PP	IN	O	10	VMOD
12	a	a	B-NP	DT	O	13	NMOD
13	site	site	I-NP	NN	O	11	PMOD
14	(	(	O	(	O	15	P
15	GM5	GM5	B-NP	NN	B-DNA	13	NMOD
16	)	)	O	)	O	15	P
17	,	,	O	,	O	5	P
18	located	located	B-ADJP	JJ	O	5	NMOD
19	within	within	B-PP	IN	O	18	AMOD
20	the	the	B-NP	DT	O	22	NMOD
21	CLE0	CLE0	I-NP	NN	B-DNA	22	NMOD
22	element	element	I-NP	NN	I-DNA	26	NMOD
23	,	,	O	,	O	26	P
24	-47	-47	B-NP	CD	B-DNA	26	NMOD
25	to	to	B-PP	TO	I-DNA	26	NMOD
26	-40	-40	B-NP	CD	I-DNA	19	PMOD
27	upstream	upstream	B-ADVP	RB	I-DNA	26	NMOD
28	of	of	B-PP	IN	O	26	NMOD
29	the	the	B-NP	DT	O	33	NMOD
30	GM-CSF	GM-CSF	I-NP	NN	B-DNA	33	NMOD
31	transcription	transcription	I-NP	NN	I-DNA	33	NMOD
32	initiation	initiation	I-NP	NN	I-DNA	33	NMOD
33	site	site	I-NP	NN	I-DNA	28	PMOD
34	.	.	O	.	O	3	P

1	Exogenous	Exogenous	B-NP	JJ	O	2	NMOD
2	ETS1	ETS1	I-NP	NN	B-protein	6	NMOD
3	,	,	O	,	O	6	P
4	but	but	O	CC	O	6	NMOD
5	not	not	O	RB	O	4	DEP
6	ELF1	ELF1	B-NP	NN	B-protein	8	SUB
7	,	,	O	,	O	6	P
8	can	can	B-VP	MD	O	0	ROOT
9	transactivate	transactivate	I-VP	VB	O	8	VC
10	GM-CSF	GM-CSF	B-NP	NN	B-protein	9	OBJ
11	,	,	O	,	O	9	P
12	through	through	B-PP	IN	O	9	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	GM5	GM5	I-NP	NN	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	12	PMOD
16	,	,	O	,	O	9	P
17	in	in	B-PP	IN	O	9	VMOD
18	a	a	B-NP	DT	O	21	NMOD
19	PMA/ionomycin	PMA/ionomycin	I-NP	NN	O	20	AMOD
20	dependent	dependent	I-NP	JJ	O	21	NMOD
21	manner	manner	I-NP	NN	O	17	PMOD
22	.	.	O	.	O	8	P

1	Other	Other	B-NP	JJ	O	4	NMOD
2	unidentified	unidentified	I-NP	JJ	O	4	NMOD
3	ETS-like	ETS-like	I-NP	JJ	B-protein	4	NMOD
4	factors	factor	I-NP	NNS	I-protein	9	SUB
5	present	present	B-ADJP	JJ	O	4	NMOD
6	in	in	B-PP	IN	O	5	AMOD
7	Jurkat	Jurkat	B-NP	NN	B-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
9	are	be	B-VP	VBP	O	0	ROOT
10	also	also	B-ADVP	RB	O	9	VMOD
11	capable	capable	B-ADJP	JJ	O	9	PRD
12	of	of	B-PP	IN	O	11	AMOD
13	binding	bind	B-VP	VBG	O	12	PMOD
14	GM5	GM5	B-NP	NN	B-DNA	13	OBJ
15	.	.	O	.	O	9	P

1	Mutation	Mutation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	core	core	I-NP	NN	O	7	NMOD
5	ETS	ETS	I-NP	NN	B-DNA	7	NMOD
6	binding	binding	I-NP	NN	I-DNA	7	NMOD
7	site	site	I-NP	NN	I-DNA	2	PMOD
8	from	from	B-PP	IN	O	1	NMOD
9	-GGAA-	-GGAA-	B-NP	NN	B-DNA	8	PMOD
10	to	to	B-PP	TO	I-DNA	11	NMOD
11	-GGAT-	-GGAT-	B-NP	NN	I-DNA	8	PMOD
12	prevents	prevent	B-VP	VBZ	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	binding	binding	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	ETS-like	ETS-like	B-NP	JJ	B-protein	17	NMOD
17	factors	factor	I-NP	NNS	I-protein	15	PMOD
18	with	with	B-PP	IN	O	14	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	exception	exception	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	ETS1	ETS1	B-NP	NN	B-protein	21	PMOD
23	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	GM-CSF	GM-CSF	I-NP	NN	B-DNA	3	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	14	SUB
4	,	,	O	,	O	3	P
5	modified	modify	B-VP	VBN	O	3	NMOD
6	in	in	B-PP	IN	O	5	VMOD
7	this	this	B-NP	DT	O	8	NMOD
8	way	way	I-NP	NN	O	6	PMOD
9	to	to	B-VP	TO	O	10	VMOD
10	be	be	I-VP	VB	O	8	NMOD
11	ETS1	ETS1	B-NP	NN	B-protein	12	AMOD
12	specific	specific	B-ADJP	JJ	O	10	PRD
13	,	,	O	,	O	3	P
14	is	be	B-VP	VBZ	O	0	ROOT
15	fully	fully	B-ADJP	RB	O	16	AMOD
16	responsive	responsive	I-ADJP	JJ	O	14	PRD
17	to	to	B-PP	TO	O	16	AMOD
18	PMA/ionomycin	PMA/ionomycin	B-NP	NN	O	19	NMOD
19	induction	induction	I-NP	NN	O	17	PMOD
20	,	,	O	,	O	14	P
21	in	in	B-PP	IN	O	14	VMOD
22	addition	addition	B-NP	NN	O	21	PMOD
23	to	to	B-PP	TO	O	22	NMOD
24	ETS1	ETS1	B-NP	NN	B-protein	25	NMOD
25	transactivation	transactivation	I-NP	NN	O	23	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	the	the	I-PP	DT	O	28	NMOD
28	presence	presence	I-PP	NN	O	26	PMOD
29	of	of	I-PP	IN	O	28	NMOD
30	PMA	PMA	B-NP	NN	O	32	NMOD
31	and	and	I-NP	CC	O	32	NMOD
32	ionomycin	ionomycin	I-NP	NN	O	29	PMOD
33	.	.	O	.	O	14	P

1	Together	Together	B-ADVP	RB	O	4	VMOD
2	these	these	B-NP	DT	O	3	NMOD
3	data	datum	I-NP	NNS	O	4	SUB
4	suggest	suggest	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	ETS1	ETS1	B-NP	NN	B-protein	7	SUB
7	may	may	B-VP	MD	O	5	SBAR
8	be	be	I-VP	VB	O	7	VC
9	involved	involve	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	mediating	mediate	B-VP	VBG	O	10	PMOD
12	the	the	B-NP	DT	O	15	NMOD
13	increased	increase	I-NP	VBN	O	15	NMOD
14	GM-CSF	GM-CSF	I-NP	NN	B-protein	15	NMOD
15	production	production	I-NP	NN	O	11	OBJ
16	associated	associate	B-VP	VBN	O	15	NMOD
17	with	with	B-PP	IN	O	16	VMOD
18	T	T	B-NP	NN	O	20	NMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	activation	activation	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	4	P

1	Tissue-specific	Tissue-specific	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	rabbit	rabbit	I-NP	NN	B-DNA	7	NMOD
6	15-lipoxygenase	15-lipoxygenase	I-NP	NN	I-DNA	7	NMOD
7	gene	gene	I-NP	NN	I-DNA	3	PMOD
8	in	in	B-PP	IN	O	2	NMOD
9	erythroid	erythroid	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	by	by	B-PP	IN	O	2	NMOD
12	a	a	B-NP	DT	O	14	NMOD
13	transcriptional	transcriptional	I-NP	JJ	B-DNA	14	NMOD
14	silencer	silencer	I-NP	NN	I-DNA	11	PMOD
15	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	6	NMOD
2	15-lipoxygenase	15-lipoxygenase	I-NP	NN	B-DNA	6	NMOD
3	(	(	O	(	I-DNA	4	P
4	lox	lox	B-NP	NN	I-DNA	2	NMOD
5	)	)	O	)	I-DNA	4	P
6	gene	gene	B-NP	NN	I-DNA	7	SUB
7	is	be	B-VP	VBZ	O	0	ROOT
8	expressed	express	I-VP	VBN	O	7	VC
9	in	in	B-PP	IN	O	8	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	tissue-specific	tissue-specific	I-NP	JJ	O	12	NMOD
12	manner	manner	I-NP	NN	O	9	PMOD
13	,	,	O	,	O	8	P
14	predominantly	predominantly	B-ADVP	RB	O	15	PMOD
15	in	in	B-PP	IN	O	8	VMOD
16	erythroid	erythroid	B-NP	JJ	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	but	but	B-CONJP	CC	O	15	PMOD
19	also	also	I-CONJP	RB	O	15	PMOD
20	in	in	B-PP	IN	O	15	PMOD
21	airway	airway	B-NP	NN	B-cell_type	23	NMOD
22	epithelial	epithelial	I-NP	JJ	I-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	25	NMOD
24	and	and	O	CC	O	25	NMOD
25	eosinophils	eosinophil	B-NP	NNS	B-cell_type	20	PMOD
26	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	in	in	B-PP	IN	O	2	VMOD
4	this	this	B-NP	DT	O	5	NMOD
5	report	report	I-NP	NN	O	3	PMOD
6	that	that	B-SBAR	IN	O	2	VMOD
7	the	the	B-NP	DT	O	11	NMOD
8	5	5	I-NP	CD	B-DNA	10	AMOD
9	'	'	I-NP	SYM	I-DNA	10	AMOD
10	flanking	flank	I-NP	VBG	I-DNA	11	NMOD
11	DNA	DNA	I-NP	NN	I-DNA	16	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	15-lox	15-lox	I-NP	JJ	B-DNA	15	NMOD
15	gene	gene	I-NP	NN	I-DNA	12	PMOD
16	contains	contain	B-VP	VBZ	O	6	SBAR
17	sequences	sequence	B-NP	NNS	O	16	OBJ
18	which	which	B-NP	WDT	O	17	NMOD
19	down-regulate	down-regulate	B-VP	VBP	O	18	SBAR
20	its	its	B-NP	PRP$	O	21	NMOD
21	activity	activity	I-NP	NN	O	19	OBJ
22	in	in	B-PP	IN	O	19	VMOD
23	a	a	B-NP	DT	O	24	NMOD
24	variety	variety	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	non-erythroid	non-erythroid	B-NP	JJ	B-cell_line	28	NMOD
27	cell	cell	I-NP	NN	I-cell_line	28	NMOD
28	lines	line	I-NP	NNS	I-cell_line	25	PMOD
29	but	but	B-PP	CC	O	25	PMOD
30	not	not	B-PP	RB	O	31	PMOD
31	in	in	I-PP	IN	O	25	PMOD
32	two	two	B-NP	CD	O	35	NMOD
33	erythroid	erythroid	I-NP	JJ	B-cell_line	35	NMOD
34	cell	cell	I-NP	NN	I-cell_line	35	NMOD
35	lines	line	I-NP	NNS	I-cell_line	31	PMOD
36	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	element	element	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	characteristics	characteristic	B-NP	NNS	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	8	NMOD
7	transcriptional	transcriptional	I-NP	JJ	B-DNA	8	NMOD
8	'silencer	'silencer	I-NP	NN	I-DNA	5	PMOD
9	'	'	O	''	I-DNA	4	P
10	since	since	B-SBAR	IN	O	3	VMOD
11	it	it	B-NP	PRP	O	12	SUB
12	functions	function	B-VP	VBZ	O	10	SBAR
13	in	in	B-PP	IN	O	12	VMOD
14	both	both	B-NP	DT	O	15	NMOD
15	orientations	orientation	I-NP	NNS	O	13	PMOD
16	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	main	main	I-NP	JJ	O	3	NMOD
3	activity	activity	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	silencer	silencer	I-NP	NN	B-DNA	4	PMOD
7	has	have	B-VP	VBZ	O	0	ROOT
8	been	be	I-VP	VBN	O	7	VC
9	mapped	map	I-VP	VBN	O	8	VC
10	to	to	B-PP	TO	O	9	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	first	first	I-NP	JJ	O	14	NMOD
13	900	900	I-NP	CD	O	14	NMOD
14	bp	bp	I-NP	NN	O	10	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	5	5	B-NP	CD	B-DNA	19	NMOD
17	'	'	I-NP	SYM	I-DNA	19	NMOD
18	flanking	flanking	I-NP	NN	I-DNA	19	NMOD
19	DNA	DNA	I-NP	NN	I-DNA	15	PMOD
20	,	,	O	,	O	7	P
21	which	which	B-NP	WDT	O	7	VMOD
22	contains	contain	B-VP	VBZ	O	21	SBAR
23	nine	nine	B-NP	CD	O	25	NMOD
24	binding	bind	I-NP	VBG	O	25	NMOD
25	sites	site	I-NP	NNS	O	22	OBJ
26	for	for	B-PP	IN	O	25	NMOD
27	a	a	B-NP	DT	O	29	NMOD
28	nuclear	nuclear	I-NP	JJ	B-protein	29	NMOD
29	factor	factor	I-NP	NN	I-protein	26	PMOD
30	present	present	B-ADJP	JJ	O	29	NMOD
31	in	in	B-PP	IN	O	30	AMOD
32	non-erythroid	non-erythroid	B-NP	JJ	B-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD
34	but	but	B-PP	CC	O	31	PMOD
35	not	not	B-PP	RB	O	36	PMOD
36	in	in	I-PP	IN	O	31	PMOD
37	erythroid	erythroid	B-NP	JJ	B-cell_type	38	NMOD
38	cells	cell	I-NP	NNS	I-cell_type	36	PMOD
39	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	3	NMOD
2	binding	bind	I-NP	VBG	B-DNA	3	NMOD
3	sites	site	I-NP	NNS	I-DNA	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	similar	similar	B-NP	JJ	O	6	NMOD
6	sequences	sequence	I-NP	NNS	O	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	multiple	multiple	B-NP	JJ	O	9	NMOD
9	copies	copy	I-NP	NNS	O	14	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	binding	bind	I-NP	VBG	B-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	10	PMOD
14	confer	confer	B-VP	VBP	O	4	VMOD
15	tissue-specific	tissue-specific	B-NP	JJ	O	16	NMOD
16	down-regulation	down-regulation	I-NP	NN	O	14	OBJ
17	when	when	B-ADVP	WRB	O	14	VMOD
18	attached	attach	B-VP	VBN	O	17	SBAR
19	to	to	B-PP	TO	O	18	VMOD
20	a	a	B-NP	DT	O	24	NMOD
21	minimal	minimal	I-NP	JJ	B-DNA	24	NMOD
22	lox	lox	I-NP	NN	I-DNA	24	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	24	NMOD
24	fragment	fragment	I-NP	NN	I-DNA	19	PMOD
25	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	5	NMOD
2	5	5	I-NP	CD	B-DNA	4	AMOD
3	'	'	I-NP	SYM	I-DNA	4	AMOD
4	flanking	flank	I-NP	VBG	I-DNA	5	NMOD
5	DNA	DNA	I-NP	NN	I-DNA	7	SUB
6	also	also	B-ADVP	RB	O	7	VMOD
7	contains	contain	B-VP	VBZ	O	0	ROOT
8	a	a	B-NP	DT	O	9	NMOD
9	cluster	cluster	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	three	three	B-NP	CD	O	13	NMOD
12	binding	bind	I-NP	VBG	B-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	10	PMOD
14	for	for	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	GATA	GATA	I-NP	NN	B-protein	17	NMOD
17	family	family	I-NP	NN	I-protein	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	transcription	transcription	B-NP	NN	B-protein	20	NMOD
20	factors	factor	I-NP	NNS	I-protein	18	PMOD
21	.	.	O	.	O	7	P

1	Coexpression	Coexpression	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
4	B/Rel	B/Rel	I-NP	NN	I-protein	6	NMOD
5	and	and	O	CC	O	6	NMOD
6	Sp1	Sp1	B-NP	NN	B-protein	8	NMOD
7	transcription	transcription	B-NP	NN	B-protein	8	NMOD
8	factors	factor	I-NP	NNS	I-protein	2	PMOD
9	in	in	B-PP	IN	O	1	NMOD
10	human	human	B-NP	JJ	O	17	NMOD
11	immunodeficiency	immunodeficiency	I-NP	NN	O	17	NMOD
12	virus	virus	I-NP	NN	O	17	NMOD
13	1-induced	1-induced	B-NP	JJ	O	15	AMOD
14	,	,	I-NP	,	O	15	P
15	dendritic	dendritic	I-NP	JJ	O	17	NMOD
16	cell-T-cell	cell-T-cell	I-NP	NN	O	17	NMOD
17	syncytia	syncytia	I-NP	NN	O	9	PMOD
18	.	.	O	.	O	1	P

1	Productive	Productive	B-NP	JJ	O	2	NMOD
2	infection	infection	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	T	T	B-NP	NN	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
6	with	with	B-PP	IN	O	2	NMOD
7	human	human	B-NP	JJ	O	9	NMOD
8	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD
9	virus	virus	I-NP	NN	O	6	PMOD
10	1	1	I-NP	CD	O	9	NMOD
11	(	(	O	(	O	12	P
12	HIV-1	HIV-1	B-NP	NN	O	9	NMOD
13	)	)	O	)	O	12	P
14	typically	typically	B-ADVP	RB	O	15	VMOD
15	requires	require	B-VP	VBZ	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	T	T	I-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	20	SUB
20	be	be	B-VP	VB	O	16	SBAR
21	stimulated	stimulate	I-VP	VBN	O	20	VC
22	with	with	B-PP	IN	O	21	VMOD
23	antigens	antigen	B-NP	NNS	O	25	NMOD
24	or	or	I-NP	CC	O	25	NMOD
25	mitogens	mitogen	I-NP	NNS	B-protein	22	PMOD
26	.	.	O	.	O	15	P

1	This	This	B-NP	DT	O	2	NMOD
2	requirement	requirement	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	been	be	I-VP	VBN	O	3	VC
5	attributed	attribute	I-VP	VBN	O	4	VC
6	to	to	B-PP	TO	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	14	NMOD
11	transcription	transcription	I-NP	NN	B-protein	14	NMOD
12	factor	factor	I-NP	NN	I-protein	14	NMOD
13	NF-kappa	NF-kappa	I-NP	NN	B-protein	14	NMOD
14	B	B	I-NP	NN	I-protein	9	PMOD
15	,	,	O	,	O	14	P
16	which	which	B-NP	WDT	O	14	NMOD
17	synergizes	synergize	B-VP	VBZ	O	16	SBAR
18	with	with	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	23	NMOD
20	constitutive	constitutive	I-NP	JJ	B-protein	22	NMOD
21	transcription	transcription	I-NP	NN	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	23	NMOD
23	Sp1	Sp1	I-NP	NN	B-protein	18	PMOD
24	to	to	B-VP	TO	O	25	VMOD
25	drive	drive	I-VP	VB	O	17	VMOD
26	the	the	B-NP	DT	O	28	NMOD
27	HIV-1	HIV-1	I-NP	NN	B-DNA	28	NMOD
28	promoter	promoter	I-NP	NN	I-DNA	25	OBJ
29	.	.	O	.	O	3	P

1	Recently	Recently	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	found	find	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	vigorous	vigorous	B-NP	JJ	O	8	NMOD
8	replication	replication	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	HIV-1	HIV-1	B-NP	NN	O	9	PMOD
11	takes	take	B-VP	VBZ	O	6	SBAR
12	place	place	B-NP	NN	O	11	OBJ
13	in	in	B-PP	IN	O	11	VMOD
14	nonactivated	nonactivated	B-NP	JJ	B-cell_type	17	NMOD
15	memory	memory	I-NP	NN	I-cell_type	17	NMOD
16	T	T	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
18	after	after	B-PP	IN	O	11	VMOD
19	syncytium	syncytium	B-NP	NN	O	20	NMOD
20	formation	formation	I-NP	NN	O	18	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	dendritic	dendritic	B-NP	JJ	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
24	(	(	O	(	O	25	P
25	DCs	DC	B-NP	NNS	B-cell_type	23	NMOD
26	)	)	O	)	O	25	P
27	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	3	NMOD
2	syncytia	syncytia	I-NP	NN	O	3	NMOD
3	lack	lack	I-NP	NN	O	5	NMOD
4	activated	activate	B-VP	VBN	O	5	NMOD
5	cells	cell	B-NP	NNS	O	0	ROOT
6	as	as	B-SBAR	IN	O	5	NMOD
7	determined	determine	B-VP	VBN	O	6	SBAR
8	by	by	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	staining	staining	B-NP	NN	O	11	PMOD
13	for	for	B-PP	IN	O	10	NMOD
14	Ki-67	Ki-67	B-NP	NN	B-protein	17	NMOD
15	cell	cell	I-NP	NN	I-protein	17	NMOD
16	cycle	cycle	I-NP	NN	I-protein	17	NMOD
17	antigen	antigen	I-NP	NN	I-protein	13	PMOD
18	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	4	NMOD
2	expression	expression	I-NP	NN	O	4	NMOD
3	and	and	O	CC	O	4	NMOD
4	activity	activity	B-NP	NN	O	10	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	Sp1	Sp1	B-NP	NN	B-protein	5	PMOD
10	were	be	B-VP	VBD	O	0	ROOT
11	,	,	O	,	O	10	P
12	therefore	therefore	B-ADVP	RB	O	10	VMOD
13	,	,	O	,	O	10	P
14	analyzed	analyze	B-VP	VBN	O	10	VC
15	in	in	B-PP	IN	O	14	VMOD
16	isolated	isolate	B-NP	VBN	O	20	NMOD
17	T	T	I-NP	NN	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	20	NMOD
19	and	and	O	CC	O	20	NMOD
20	DCs	DC	B-NP	NNS	B-cell_type	15	PMOD
21	from	from	B-PP	IN	O	20	NMOD
22	humans	human	B-NP	NNS	O	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	mice	mouse	I-NP	NNS	O	21	PMOD
25	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	used	use	I-VP	VBN	O	2	VC
4	immunolabeling	immunolabeling	B-NP	NN	O	16	NMOD
5	,	,	O	,	O	16	P
6	Western	Western	B-NP	NN	O	8	NMOD
7	blot	blot	I-NP	NN	O	8	NMOD
8	analysis	analysis	I-NP	NN	O	16	NMOD
9	,	,	O	,	O	16	P
10	and	and	O	CC	O	16	NMOD
11	electrophoretic	electrophoretic	B-NP	JJ	O	13	NMOD
12	mobility	mobility	I-NP	NN	O	13	NMOD
13	shift	shift	I-NP	NN	O	16	NMOD
14	and	and	I-NP	CC	O	16	NMOD
15	supershift	supershift	I-NP	NN	O	16	NMOD
16	assays	assay	I-NP	NNS	O	3	OBJ
17	.	.	O	.	O	2	P

1	T	T	B-NP	NN	B-cell_type	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_type	3	SUB
3	lack	lack	B-VP	VBP	O	0	ROOT
4	active	active	B-NP	JJ	O	6	NMOD
5	NF-kappa	NF-kappa	I-NP	NN	B-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	3	OBJ
7	but	but	O	CC	O	3	VMOD
8	express	express	B-VP	VBP	O	3	VMOD
9	Sp1	Sp1	B-NP	NN	B-protein	8	OBJ
10	as	as	B-SBAR	IN	O	8	VMOD
11	expected	expect	B-VP	VBN	O	10	SBAR
12	.	.	O	.	O	3	P

1	DCs	DC	B-NP	NNS	B-cell_type	2	SUB
2	express	express	B-VP	VBP	O	0	ROOT
3	high	high	B-NP	JJ	O	4	NMOD
4	levels	level	I-NP	NNS	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	all	all	B-NP	DT	O	12	NMOD
7	known	know	I-NP	VBN	O	12	NMOD
8	NF-kappa	NF-kappa	I-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	12	NMOD
10	and	and	I-NP	CC	O	12	NMOD
11	Rel	Rel	I-NP	NN	B-protein	12	NMOD
12	proteins	protein	I-NP	NNS	I-protein	5	PMOD
13	,	,	O	,	O	2	P
14	with	with	B-PP	IN	O	2	VMOD
15	activity	activity	B-NP	NN	O	16	SUB
16	residing	reside	B-VP	VBG	O	14	PMOD
17	primarily	primarily	B-ADVP	RB	O	16	VMOD
18	within	within	B-PP	IN	O	16	VMOD
19	RelB	RelB	B-NP	NN	B-protein	24	NMOD
20	,	,	O	,	O	24	P
21	p50	p50	B-NP	NN	B-protein	24	NMOD
22	,	,	O	,	O	24	P
23	and	and	O	CC	O	24	NMOD
24	p65	p65	B-NP	NN	B-protein	18	PMOD
25	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	DCs	DC	B-NP	NNS	B-cell_type	4	SUB
4	lack	lack	B-VP	VBP	O	0	ROOT
5	Sp1	Sp1	B-NP	NN	B-protein	4	OBJ
6	,	,	O	,	O	5	P
7	which	which	B-NP	WDT	O	5	NMOD
8	may	may	B-VP	MD	O	7	SBAR
9	explain	explain	I-VP	VB	O	8	VC
10	the	the	B-NP	DT	O	11	NMOD
11	failure	failure	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	HIV-1	HIV-1	B-NP	NN	O	12	PMOD
14	to	to	B-VP	TO	O	15	VMOD
15	replicate	replicate	I-VP	VB	O	11	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	purified	purify	B-NP	VBN	O	18	NMOD
18	DCs	DC	I-NP	NNS	B-cell_type	16	PMOD
19	.	.	O	.	O	4	P

1	Coexpression	Coexpression	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	6	NMOD
5	and	and	O	CC	O	6	NMOD
6	Sp1	Sp1	B-NP	NN	B-protein	2	PMOD
7	occurs	occur	B-VP	VBZ	O	0	ROOT
8	in	in	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	12	NMOD
10	heterologous	heterologous	I-NP	JJ	B-cell_type	12	NMOD
11	DC-T-cell	DC-T-cell	I-NP	NN	I-cell_type	12	NMOD
12	syncytia	syncytia	I-NP	NN	I-cell_type	8	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	are	be	B-VP	VBP	O	13	SBAR
15	induced	induce	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	HIV-1	HIV-1	B-NP	NN	O	16	PMOD
18	.	.	O	.	O	7	P

1	Therefore	Therefore	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	HIV-1-induced	HIV-1-induced	B-NP	JJ	O	5	NMOD
4	cell	cell	I-NP	NN	O	5	NMOD
5	fusion	fusion	I-NP	NN	O	6	SUB
6	brings	bring	B-VP	VBZ	O	0	ROOT
7	together	together	B-ADVP	RB	O	6	VMOD
8	factors	factor	B-NP	NNS	O	6	OBJ
9	that	that	B-NP	WDT	O	8	NMOD
10	upregulate	upregulate	B-VP	VBP	O	9	SBAR
11	virus	virus	B-NP	NN	O	12	NMOD
12	transcription	transcription	I-NP	NN	O	10	OBJ
13	.	.	O	.	O	6	P

1	Since	Since	B-SBAR	IN	O	17	VMOD
2	DCs	DC	B-NP	NNS	B-cell_type	6	NMOD
3	and	and	O	CC	O	6	NMOD
4	memory	memory	B-NP	NN	B-cell_type	6	NMOD
5	T	T	I-NP	NN	I-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	8	SUB
7	frequently	frequently	B-ADVP	RB	O	8	VMOD
8	traffic	traffic	B-VP	VBP	O	1	SBAR
9	together	together	B-ADVP	RB	O	8	VMOD
10	in	in	B-ADVP	FW	O	8	VMOD
11	situ	situ	I-ADVP	FW	O	10	AMOD
12	,	,	O	,	O	17	P
13	these	these	B-NP	DT	O	14	NMOD
14	unusual	unusual	I-NP	JJ	O	17	SUB
15	heterologous	heterologous	I-NP	JJ	B-cell_type	16	NMOD
16	syncytia	syncytia	I-NP	NN	I-cell_type	14	NMOD
17	could	could	B-VP	MD	O	0	ROOT
18	develop	develop	I-VP	VB	O	17	VC
19	in	in	B-PP	IN	O	18	VMOD
20	infected	infected	B-NP	JJ	O	21	NMOD
21	individuals	individual	I-NP	NNS	O	19	PMOD
22	and	and	O	CC	O	18	VMOD
23	lead	lead	B-VP	VBP	O	18	VMOD
24	to	to	B-PP	TO	O	23	VMOD
25	chronic	chronic	B-NP	JJ	O	27	NMOD
26	HIV-1	HIV-1	I-NP	NN	O	27	NMOD
27	replication	replication	I-NP	NN	O	24	PMOD
28	without	without	B-PP	IN	O	27	NMOD
29	ostensible	ostensible	B-NP	JJ	O	31	NMOD
30	immune	immune	I-NP	JJ	O	31	NMOD
31	stimulation	stimulation	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	17	P

1	Costimulation	Costimulation	B-NP	NN	O	2	NMOD
2	requirement	requirement	I-NP	NN	O	0	ROOT
3	for	for	B-PP	IN	O	2	NMOD
4	AP-1	AP-1	B-NP	NN	B-protein	10	NMOD
5	and	and	O	CC	O	10	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
7	B	B	I-NP	NN	I-protein	10	NMOD
8	transcription	transcription	I-NP	NN	O	10	NMOD
9	factor	factor	I-NP	NN	O	10	NMOD
10	activation	activation	I-NP	NN	O	3	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	T	T	B-NP	NN	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	transcriptional	transcriptional	I-NP	JJ	O	3	NMOD
3	activity	activity	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	IL-2	IL-2	I-NP	NN	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	4	PMOD
8	requires	require	B-VP	VBZ	O	0	ROOT
9	T-cell	T-cell	B-NP	NN	B-cell_type	10	NMOD
10	costimulation	costimulation	I-NP	NN	O	8	OBJ
11	delivered	deliver	B-VP	VBN	O	10	NMOD
12	by	by	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	TCR	TCR	I-NP	NN	B-protein	19	NMOD
15	and	and	O	CC	O	19	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	auxiliary	auxiliary	I-NP	JJ	B-protein	19	NMOD
18	receptor	receptor	I-NP	NN	I-protein	19	NMOD
19	CD28	CD28	I-NP	NN	I-protein	12	PMOD
20	.	.	O	.	O	8	P

1	Several	Several	B-NP	JJ	O	3	NMOD
2	transcription	transcription	I-NP	NN	B-protein	3	NMOD
3	factors	factor	I-NP	NNS	I-protein	4	SUB
4	participate	participate	B-VP	VBP	O	0	ROOT
5	in	in	B-PP	IN	O	4	VMOD
6	IL-2	IL-2	B-NP	NN	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	8	NMOD
8	activation	activation	I-NP	NN	O	5	PMOD
9	,	,	O	,	O	8	P
10	among	among	B-PP	IN	O	8	NMOD
11	which	which	B-NP	WDT	O	10	PMOD
12	are	be	B-VP	VBP	O	10	SBAR
13	AP-1-like	AP-1-like	B-NP	JJ	B-protein	14	NMOD
14	factors	factor	I-NP	NNS	I-protein	12	PRD
15	and	and	O	CC	O	17	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	14	NMOD
18	.	.	O	.	O	4	P

1	Protein	Protein	B-NP	NN	O	2	NMOD
2	phosphorylation	phosphorylation	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	19	VMOD
4	an	an	B-NP	DT	O	6	NMOD
5	important	important	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	in	in	B-PP	IN	O	3	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	regulation	regulation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	these	these	B-NP	DT	O	13	NMOD
12	two	two	I-NP	CD	O	13	NMOD
13	factors	factor	I-NP	NNS	O	10	PMOD
14	:	:	O	:	O	3	P
15	(	(	B-LST	(	O	16	P
16	1	1	I-LST	LS	O	19	VMOD
17	)	)	O	)	O	16	P
18	it	it	B-NP	PRP	O	19	SUB
19	induces	induce	B-VP	VBZ	O	34	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	transactivating	transactivate	I-NP	VBG	O	22	NMOD
22	capacity	capacity	I-NP	NN	O	19	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	27	NMOD
25	AP-1	AP-1	I-NP	NN	B-protein	27	NMOD
26	protein	protein	I-NP	NN	I-protein	27	NMOD
27	c-Jun	c-Jun	I-NP	NN	B-protein	23	PMOD
28	;	;	O	:	O	34	P
29	and	and	O	CC	O	34	VMOD
30	(	(	B-LST	(	O	31	P
31	2	2	I-LST	LS	O	34	VMOD
32	)	)	O	)	O	31	P
33	it	it	B-NP	PRP	O	34	SUB
34	is	be	B-VP	VBZ	O	0	ROOT
35	involved	involve	I-VP	VBN	O	34	VC
36	in	in	B-PP	IN	O	35	VMOD
37	the	the	B-NP	DT	O	38	NMOD
38	release	release	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	the	the	B-NP	DT	O	42	NMOD
41	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	42	NMOD
42	inhibitor	inhibitor	I-NP	NN	I-protein	46	NMOD
43	,	,	O	,	O	46	P
44	I	I	B-NP	NN	B-protein	46	NMOD
45	kappa	kappa	I-NP	NN	I-protein	46	NMOD
46	B	B	I-NP	NN	I-protein	39	PMOD
47	,	,	O	,	O	46	P
48	from	from	B-PP	IN	O	38	NMOD
49	NF-kappa	NF-kappa	B-NP	NN	B-protein	50	NMOD
50	B	B	I-NP	NN	I-protein	48	PMOD
51	,	,	O	,	O	35	P
52	allowing	allow	B-VP	VBG	O	35	VMOD
53	translocation	translocation	B-NP	NN	O	52	OBJ
54	of	of	B-PP	IN	O	53	NMOD
55	the	the	B-NP	DT	O	56	NMOD
56	latter	latter	I-NP	JJ	O	54	PMOD
57	into	into	B-PP	IN	O	53	NMOD
58	the	the	B-NP	DT	O	59	NMOD
59	nucleus	nucleus	I-NP	NN	O	57	PMOD
60	.	.	O	.	O	34	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	recently	recently	I-VP	RB	O	2	VMOD
4	shown	show	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	both	both	O	CC	O	9	VMOD
7	phosphorylation	phosphorylation	B-NP	NN	O	8	NMOD
8	processes	process	I-NP	NNS	O	9	SUB
9	require	require	B-VP	VBP	O	5	SBAR
10	T-cell	T-cell	B-NP	NN	O	11	NMOD
11	costimulation	costimulation	I-NP	NN	O	9	OBJ
12	.	.	O	.	O	2	P

1	Furthermore	Furthermore	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	in	in	B-PP	IN	O	15	VMOD
4	activated	activate	B-NP	VBN	B-cell_type	6	NMOD
5	T	T	I-NP	NN	I-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
7	,	,	O	,	O	15	P
8	the	the	B-NP	DT	O	9	NMOD
9	kinetics	kinetic	I-NP	NNS	O	15	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	two	two	I-NP	CD	O	14	NMOD
13	phosphorylation	phosphorylation	I-NP	NN	O	14	NMOD
14	events	event	I-NP	NNS	O	10	PMOD
15	are	be	B-VP	VBP	O	0	ROOT
16	essentially	essentially	B-ADJP	RB	O	17	AMOD
17	similar	similar	I-ADJP	JJ	O	15	PRD
18	.	.	O	.	O	15	P

1	According	Accord	B-PP	VBG	O	15	VMOD
2	to	to	B-PP	TO	O	1	PMOD
3	our	our	B-NP	PRP$	O	4	NMOD
4	results	result	I-NP	NNS	O	2	PMOD
5	,	,	O	,	O	15	P
6	however	however	B-ADVP	RB	O	15	VMOD
7	,	,	O	,	O	15	P
8	the	the	B-NP	DT	O	9	NMOD
9	kinases	kinase	I-NP	NNS	B-protein	15	SUB
10	responsible	responsible	B-ADJP	JJ	O	9	NMOD
11	for	for	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	14	NMOD
13	two	two	I-NP	CD	O	14	NMOD
14	processes	process	I-NP	NNS	O	11	PMOD
15	are	be	B-VP	VBP	O	0	ROOT
16	distinct	distinct	B-NP	JJ	O	17	NMOD
17	entities	entity	I-NP	NNS	O	15	PRD
18	.	.	O	.	O	15	P

1	Whereas	Whereas	B-SBAR	IN	O	20	VMOD
2	TPCK	TPCK	B-NP	NN	B-protein	3	SUB
3	inhibits	inhibit	B-VP	VBZ	O	1	SBAR
4	phosphorylation	phosphorylation	B-NP	NN	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	I	I	B-NP	NN	B-protein	8	NMOD
7	kappa	kappa	I-NP	NN	I-protein	8	NMOD
8	B	B	I-NP	NN	I-protein	5	PMOD
9	and	and	O	CC	O	3	VMOD
10	,	,	O	,	O	3	P
11	consequently	consequently	B-ADVP	RB	O	3	VMOD
12	,	,	O	,	O	20	P
13	activation	activation	B-NP	NN	O	20	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	NF-kappa	NF-kappa	B-NP	NN	B-protein	16	NMOD
16	B	B	I-NP	NN	I-protein	14	PMOD
17	,	,	O	,	O	20	P
18	it	it	B-NP	PRP	O	20	SUB
19	markedly	markedly	B-ADVP	RB	O	20	VMOD
20	enhances	enhance	B-VP	VBZ	O	0	ROOT
21	the	the	B-NP	DT	O	22	NMOD
22	activity	activity	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	JNK	JNK	B-NP	NN	B-protein	23	PMOD
25	,	,	O	,	O	20	P
26	the	the	B-NP	DT	O	29	NMOD
27	MAP	MAP	I-NP	NN	B-protein	29	NMOD
28	kinase-related	kinase-related	I-NP	JJ	I-protein	29	NMOD
29	kinase	kinase	I-NP	NN	I-protein	20	VMOD
30	that	that	B-NP	WDT	O	29	NMOD
31	phosphorylates	phosphorylate	B-VP	VBZ	O	30	SBAR
32	the	the	B-NP	DT	O	34	NMOD
33	transactivation	transactivation	I-NP	NN	B-protein	34	NMOD
34	domain	domain	I-NP	NN	I-protein	31	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	c-Jun	c-Jun	B-NP	NN	B-protein	35	PMOD
37	.	.	O	.	O	20	P

1	We	We	B-NP	PRP	O	5	SUB
2	,	,	O	,	O	5	P
3	therefore	therefore	B-ADVP	RB	O	5	VMOD
4	,	,	O	,	O	5	P
5	propose	propose	B-VP	VBP	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	activation	activation	I-NP	NN	O	8	NMOD
8	scheme	scheme	I-NP	NN	O	5	OBJ
9	presented	present	B-VP	VBN	O	8	NMOD
10	in	in	B-PP	IN	O	9	VMOD
11	FIGURE	FIGURE	B-NP	NN	O	10	PMOD
12	3	3	I-NP	CD	O	11	NMOD
13	for	for	B-PP	IN	O	11	NMOD
14	T-cell	T-cell	B-NP	NN	O	15	NMOD
15	costimulation	costimulation	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	5	P

1	Costimulation	Costimulation	B-NP	NN	O	2	SUB
2	results	result	B-VP	VBZ	O	0	ROOT
3	in	in	B-PP	IN	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	activation	activation	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	a	a	B-NP	DT	O	9	NMOD
8	signaling	signaling	I-NP	NN	O	9	NMOD
9	pathway	pathway	I-NP	NN	O	6	PMOD
10	that	that	B-NP	WDT	O	9	NMOD
11	leads	lead	B-VP	VBZ	O	10	SBAR
12	to	to	B-PP	TO	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	simultaneous	simultaneous	I-NP	JJ	O	15	NMOD
15	induction	induction	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	two	two	I-NP	CD	O	20	NMOD
19	transcription	transcription	I-NP	NN	B-protein	20	NMOD
20	factors	factor	I-NP	NNS	I-protein	25	NMOD
21	,	,	O	,	O	25	P
22	AP-1	AP-1	B-NP	NN	B-protein	25	NMOD
23	and	and	O	CC	O	25	NMOD
24	NF-kappa	NF-kappa	B-NP	NN	B-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	16	PMOD
26	.	.	O	.	O	2	P

1	Integration	Integration	B-NP	NN	O	11	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	signals	signal	I-NP	NNS	O	2	PMOD
5	generated	generate	B-VP	VBN	O	4	NMOD
6	by	by	B-PP	IN	O	5	VMOD
7	TCR	TCR	B-NP	NN	B-protein	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	CD28	CD28	I-NP	NN	B-protein	10	NMOD
10	engagement	engagement	I-NP	NN	O	6	PMOD
11	occurs	occur	B-VP	VBZ	O	0	ROOT
12	along	along	B-PP	IN	O	11	VMOD
13	this	this	B-NP	DT	O	14	NMOD
14	pathway	pathway	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	14	P
16	which	which	B-NP	WDT	O	14	NMOD
17	then	then	B-ADVP	RB	O	18	VMOD
18	bifurcates	bifurcate	B-VP	VBZ	O	16	SBAR
19	to	to	I-VP	TO	O	20	VMOD
20	induce	induce	I-VP	VB	O	18	VMOD
21	I	I	B-NP	NN	B-protein	24	NMOD
22	kappa	kappa	I-NP	NN	I-protein	24	NMOD
23	B	B	I-NP	NN	I-protein	24	NMOD
24	phosphorylation	phosphorylation	I-NP	NN	O	28	NMOD
25	and	and	O	CC	O	28	NMOD
26	NF-kappa	NF-kappa	B-NP	NN	B-protein	28	NMOD
27	B	B	I-NP	NN	I-protein	28	NMOD
28	activation	activation	I-NP	NN	O	20	OBJ
29	on	on	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	32	NMOD
31	one	one	I-NP	CD	O	32	NMOD
32	hand	hand	I-NP	NN	O	29	PMOD
33	,	,	O	,	O	12	P
34	and	and	O	CC	O	12	DEP
35	JNK	JNK	B-NP	NN	B-protein	36	NMOD
36	activation	activation	B-NP	NN	O	39	NMOD
37	and	and	O	CC	O	39	NMOD
38	c-Jun	c-Jun	B-NP	NN	B-protein	39	NMOD
39	phosphorylation	phosphorylation	I-NP	NN	O	12	PMOD
40	on	on	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	42	NMOD
42	other	other	I-NP	JJ	O	40	PMOD
43	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	2	SUB
2	are	be	B-VP	VBP	O	0	ROOT
3	currently	currently	I-VP	RB	O	2	VMOD
4	engaged	engage	I-VP	VBN	O	2	VC
5	in	in	B-PP	IN	O	4	VMOD
6	defining	define	B-VP	VBG	O	5	PMOD
7	where	where	B-ADVP	WRB	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	two	two	I-NP	CD	O	10	NMOD
10	signals	signal	I-NP	NNS	O	11	SUB
11	integrate	integrate	B-VP	VBP	O	7	SBAR
12	along	along	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	16	NMOD
14	AP-1/NF-kappa	AP-1/NF-kappa	I-NP	NN	O	16	NMOD
15	B	B	I-NP	NN	O	16	NMOD
16	pathway	pathway	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	2	P

1	Cupric	Cupric	B-NP	JJ	O	2	NMOD
2	ion	ion	I-NP	NN	O	3	SUB
3	blocks	block	B-VP	VBZ	O	0	ROOT
4	NF	NF	B-NP	NN	B-protein	6	NMOD
5	kappa	kappa	I-NP	NN	I-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	7	NMOD
7	activation	activation	I-NP	NN	O	3	OBJ
8	through	through	B-PP	IN	O	3	VMOD
9	inhibiting	inhibit	B-VP	VBG	O	8	PMOD
10	the	the	B-NP	DT	O	12	NMOD
11	signal-induced	signal-induced	I-NP	JJ	O	12	NMOD
12	phosphorylation	phosphorylation	I-NP	NN	O	9	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	I	I	B-NP	NN	B-protein	17	NMOD
15	kappa	kappa	I-NP	NN	I-protein	17	NMOD
16	B	B	I-NP	NN	I-protein	17	NMOD
17	alpha	alpha	I-NP	NN	I-protein	13	PMOD
18	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	6	NMOD
2	transcription	transcription	I-NP	NN	B-protein	6	NMOD
3	factor	factor	I-NP	NN	I-protein	6	NMOD
4	NF	NF	I-NP	NN	B-protein	6	NMOD
5	kappa	kappa	I-NP	NN	I-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	25	SUB
7	,	,	O	,	O	6	P
8	which	which	B-NP	WDT	O	6	NMOD
9	regulates	regulate	B-VP	VBZ	O	8	SBAR
10	expression	expression	B-NP	NN	O	9	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	various	various	B-NP	JJ	O	14	NMOD
13	cellular	cellular	I-NP	JJ	B-DNA	14	NMOD
14	genes	gene	I-NP	NNS	I-DNA	11	PMOD
15	involved	involve	B-VP	VBN	O	14	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	immune	immune	B-NP	JJ	O	18	NMOD
18	responses	response	I-NP	NNS	O	21	NMOD
19	and	and	O	CC	O	21	NMOD
20	viral	viral	B-NP	JJ	B-DNA	21	NMOD
21	genes	gene	I-NP	NNS	I-DNA	16	PMOD
22	including	include	B-PP	VBG	O	21	NMOD
23	HIV	HIV	B-NP	NN	O	22	PMOD
24	,	,	O	,	O	6	P
25	is	be	B-VP	VBZ	O	0	ROOT
26	sequestered	sequester	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	cytoplasm	cytoplasm	I-NP	NN	O	27	PMOD
30	as	as	B-PP	IN	O	26	VMOD
31	a	a	B-NP	DT	O	32	NMOD
32	complex	complex	I-NP	NN	O	30	PMOD
33	with	with	B-PP	IN	O	32	NMOD
34	an	an	B-NP	DT	O	39	NMOD
35	inhibitory	inhibitory	I-NP	JJ	O	39	NMOD
36	protein	protein	I-NP	NN	O	39	NMOD
37	I	I	I-NP	NN	B-protein	39	NMOD
38	kappa	kappa	I-NP	NN	I-protein	39	NMOD
39	B	B	I-NP	NN	I-protein	33	PMOD
40	.	.	O	.	O	25	P

1	Various	Various	B-NP	JJ	O	3	NMOD
2	extracellular	extracellular	I-NP	JJ	O	3	NMOD
3	signals	signal	I-NP	NNS	O	4	SUB
4	induce	induce	B-VP	VBP	O	0	ROOT
5	phosphorylation	phosphorylation	B-NP	NN	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	rapid	rapid	B-NP	JJ	O	8	NMOD
8	degradation	degradation	I-NP	NN	O	4	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	I	I	B-NP	NN	B-protein	13	NMOD
11	kappa	kappa	I-NP	NN	I-protein	13	NMOD
12	B	B	I-NP	NN	I-protein	13	NMOD
13	alpha	alpha	I-NP	NN	I-protein	9	PMOD
14	to	to	B-VP	TO	O	15	VMOD
15	release	release	I-VP	VB	O	4	VMOD
16	NF	NF	B-NP	NN	B-protein	18	NMOD
17	kappa	kappa	I-NP	NN	I-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	15	OBJ
19	.	.	O	.	O	4	P

1	Cu2+	Cu2+	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	found	find	I-VP	VBN	O	2	VC
4	to	to	I-VP	TO	O	5	VMOD
5	inhibit	inhibit	I-VP	VB	O	3	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	activation	activation	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	NF	NF	B-NP	NN	B-protein	11	NMOD
10	kappa	kappa	I-NP	NN	I-protein	11	NMOD
11	B	B	I-NP	NN	I-protein	8	PMOD
12	induced	induce	B-VP	VBN	O	11	NMOD
13	by	by	B-PP	IN	O	12	VMOD
14	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	19	NMOD
15	,	,	O	,	O	19	P
16	TPA	TPA	B-NP	NN	O	19	NMOD
17	,	,	O	,	O	19	P
18	or	or	O	CC	O	19	NMOD
19	H2O2	H2O2	B-NP	NN	O	13	PMOD
20	.	.	O	.	O	2	P

1	Deoxycholate	Deoxycholate	B-NP	NN	O	2	NMOD
2	treatment	treatment	I-NP	NN	O	18	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	cytoplasmic	cytoplasmic	I-NP	JJ	O	6	NMOD
6	extract	extract	I-NP	NN	O	3	PMOD
7	prepared	prepare	B-VP	VBN	O	6	NMOD
8	from	from	B-PP	IN	O	7	VMOD
9	cells	cell	B-NP	NNS	O	8	PMOD
10	stimulated	stimulate	B-VP	VBN	O	9	NMOD
11	by	by	B-PP	IN	O	10	VMOD
12	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	11	PMOD
13	in	in	B-PP	IN	O	10	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	presence	presence	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	Cu2+	Cu2+	B-NP	NN	O	16	PMOD
18	resulted	result	B-VP	VBD	O	0	ROOT
19	in	in	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	release	release	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	NF	NF	B-NP	NN	B-protein	25	NMOD
24	kappa	kappa	I-NP	NN	I-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	22	PMOD
26	from	from	B-PP	IN	O	21	NMOD
27	I	I	B-NP	NN	B-protein	30	NMOD
28	kappa	kappa	I-NP	NN	I-protein	30	NMOD
29	B	B	I-NP	NN	I-protein	30	NMOD
30	alpha	alpha	I-NP	NN	I-protein	26	PMOD
31	,	,	O	,	O	18	P
32	indicating	indicate	B-VP	VBG	O	18	VMOD
33	that	that	B-SBAR	IN	O	32	VMOD
34	Cu2+	Cu2+	B-NP	NN	O	35	SUB
35	interferes	interfere	B-VP	VBZ	O	33	SBAR
36	with	with	B-PP	IN	O	35	VMOD
37	the	the	B-NP	DT	O	38	NMOD
38	dissociation	dissociation	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	the	the	B-NP	DT	O	46	NMOD
41	NF	NF	I-NP	NN	B-protein	46	NMOD
42	kappa	kappa	I-NP	NN	I-protein	46	NMOD
43	B-I	B-I	I-NP	NN	I-protein	46	NMOD
44	kappa	kappa	I-NP	NN	I-protein	46	NMOD
45	B	B	I-NP	NN	I-protein	46	NMOD
46	complex	complex	I-NP	NN	I-protein	39	PMOD
47	.	.	O	.	O	18	P

1	Neither	Neither	O	CC	O	4	NMOD
2	phosphorylation	phosphorylation	B-NP	NN	O	4	NMOD
3	nor	nor	I-NP	CC	O	4	NMOD
4	degradation	degradation	I-NP	NN	O	10	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	I	I	B-NP	NN	B-protein	9	NMOD
7	kappa	kappa	I-NP	NN	I-protein	9	NMOD
8	B	B	I-NP	NN	I-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	5	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	observed	observe	I-VP	VBN	O	10	VC
12	upon	upon	B-PP	IN	O	11	VMOD
13	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	14	NMOD
14	stimulation	stimulation	I-NP	NN	O	12	PMOD
15	in	in	B-PP	IN	O	14	NMOD
16	the	the	I-PP	DT	O	17	NMOD
17	presence	presence	I-PP	NN	O	15	PMOD
18	of	of	I-PP	IN	O	17	NMOD
19	Cu2+	Cu2+	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	10	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Cu2+	Cu2+	B-NP	NN	O	6	SUB
6	inhibits	inhibit	B-VP	VBZ	O	4	SBAR
7	the	the	B-NP	DT	O	8	NMOD
8	release	release	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	NF	NF	B-NP	NN	B-protein	12	NMOD
11	kappa	kappa	I-NP	NN	I-protein	12	NMOD
12	B	B	I-NP	NN	I-protein	9	PMOD
13	by	by	B-PP	IN	O	6	VMOD
14	blockade	blockade	B-NP	NN	O	13	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	a	a	B-NP	DT	O	17	NMOD
17	signal	signal	I-NP	NN	O	15	PMOD
18	leading	lead	B-VP	VBG	O	17	NMOD
19	to	to	B-PP	TO	O	18	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	phosphorylation	phosphorylation	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	I	I	B-NP	NN	B-protein	26	NMOD
24	kappa	kappa	I-NP	NN	I-protein	26	NMOD
25	B	B	I-NP	NN	I-protein	26	NMOD
26	alpha	alpha	I-NP	NN	I-protein	22	PMOD
27	.	.	O	.	O	3	P

1	Salicylates	Salicylate	B-NP	NNS	O	2	SUB
2	inhibit	inhibit	B-VP	VBP	O	0	ROOT
3	lipopolysaccharide-induced	lipopolysaccharide-induced	B-NP	JJ	O	5	NMOD
4	transcriptional	transcriptional	I-NP	JJ	O	5	NMOD
5	activation	activation	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	tissue	tissue	I-NP	NN	B-DNA	10	NMOD
9	factor	factor	I-NP	NN	I-DNA	10	NMOD
10	gene	gene	I-NP	NN	I-DNA	6	PMOD
11	in	in	B-PP	IN	O	5	NMOD
12	human	human	B-NP	JJ	B-cell_type	14	NMOD
13	monocytic	monocytic	I-NP	JJ	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
15	.	.	O	.	O	2	P

1	Binding	Binding	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	plasma	plasma	B-NP	NN	B-protein	5	NMOD
4	Factor	Factor	I-NP	NN	I-protein	5	NMOD
5	VII/VIIa	VII/VIIa	I-NP	NN	I-protein	2	PMOD
6	to	to	B-PP	TO	O	1	NMOD
7	the	the	B-NP	DT	O	13	NMOD
8	tissue	tissue	I-NP	NN	B-protein	13	NMOD
9	factor	factor	I-NP	NN	I-protein	13	NMOD
10	(	(	O	(	I-protein	13	P
11	TF	TF	B-NP	NN	I-protein	13	NMOD
12	)	)	O	)	I-protein	13	P
13	receptor	receptor	B-NP	NN	I-protein	6	PMOD
14	initiates	initiate	B-VP	VBZ	O	0	ROOT
15	the	the	B-NP	DT	O	18	NMOD
16	coagulation	coagulation	I-NP	NN	B-protein	18	NMOD
17	protease	protease	I-NP	NN	I-protein	18	NMOD
18	cascades	cascade	I-NP	NNS	O	14	OBJ
19	.	.	O	.	O	14	P

1	TF	TF	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	6	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	circulating	circulate	B-VP	VBG	B-cell_type	5	NMOD
5	monocytes	monocyte	B-NP	NNS	I-cell_type	3	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	associated	associate	I-VP	VBN	O	6	VC
8	with	with	B-PP	IN	O	7	VMOD
9	thrombotic	thrombotic	B-NP	JJ	O	11	AMOD
10	and	and	I-NP	CC	O	11	AMOD
11	inflammatory	inflammatory	I-NP	JJ	O	12	NMOD
12	complications	complication	I-NP	NNS	O	8	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	15	NMOD
15	variety	variety	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	diseases	disease	B-NP	NNS	O	16	PMOD
18	.	.	O	.	O	6	P

1	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	18	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	human	human	I-NP	JJ	B-DNA	7	NMOD
6	TF	TF	I-NP	NN	I-DNA	7	NMOD
7	gene	gene	I-NP	NN	I-DNA	3	PMOD
8	in	in	B-PP	IN	O	2	NMOD
9	monocytic	monocytic	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	exposed	expose	B-VP	VBN	O	10	NMOD
12	to	to	B-PP	TO	O	11	VMOD
13	bacterial	bacterial	B-NP	JJ	O	12	PMOD
14	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	13	NMOD
15	(	(	O	(	O	16	P
16	LPS	LPS	B-NP	NN	O	14	NMOD
17	)	)	O	)	O	16	P
18	is	be	B-VP	VBZ	O	0	ROOT
19	mediated	mediate	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	binding	binding	B-NP	NN	O	20	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	c-Rel/p65	c-Rel/p65	B-NP	NN	B-protein	24	NMOD
24	heterodimers	heterodimer	I-NP	NNS	I-protein	22	PMOD
25	to	to	B-PP	TO	O	21	NMOD
26	a	a	B-NP	DT	O	29	NMOD
27	kappa	kappa	I-NP	NN	B-DNA	29	NMOD
28	B	B	I-NP	NN	I-DNA	29	NMOD
29	site	site	I-NP	NN	I-DNA	25	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	TF	TF	I-NP	NN	B-DNA	33	NMOD
33	promoter	promoter	I-NP	NN	I-DNA	30	PMOD
34	.	.	O	.	O	18	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	report	report	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	a	a	B-NP	DT	O	7	NMOD
7	family	family	I-NP	NN	O	17	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	anti-inflammatory	anti-inflammatory	B-NP	JJ	O	10	NMOD
10	agents	agent	I-NP	NNS	O	8	PMOD
11	,	,	O	,	O	7	P
12	known	know	B-VP	VBN	O	7	NMOD
13	as	as	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	salicylates	salicylate	I-NP	NNS	O	13	PMOD
16	,	,	O	,	O	7	P
17	inhibited	inhibit	B-VP	VBD	O	5	SBAR
18	LPS	LPS	B-NP	NN	O	19	NMOD
19	induction	induction	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	TF	TF	B-NP	NN	B-protein	22	NMOD
22	activity	activity	I-NP	NN	O	26	NMOD
23	and	and	I-NP	CC	O	26	NMOD
24	TF	TF	I-NP	NN	B-DNA	26	NMOD
25	gene	gene	I-NP	NN	I-DNA	26	NMOD
26	transcription	transcription	I-NP	NN	O	20	PMOD
27	in	in	B-PP	IN	O	19	NMOD
28	human	human	B-NP	JJ	B-cell_type	29	NMOD
29	monocytes	monocyte	I-NP	NNS	I-cell_type	33	NMOD
30	and	and	O	CC	O	33	NMOD
31	monocytic	monocytic	B-NP	JJ	B-cell_line	33	NMOD
32	THP-1	THP-1	I-NP	NN	I-cell_line	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_line	27	PMOD
34	at	at	B-PP	IN	O	17	VMOD
35	clinically	clinically	B-NP	RB	O	36	AMOD
36	relevant	relevant	I-NP	JJ	O	37	NMOD
37	doses	dose	I-NP	NNS	O	34	PMOD
38	.	.	O	.	O	4	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	sodium	sodium	B-NP	NN	O	4	NMOD
4	salicylate	salicylate	I-NP	NN	O	5	SUB
5	blocked	block	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	9	NMOD
7	LPS-induced	LPS-induced	I-NP	JJ	O	9	NMOD
8	proteolytic	proteolytic	I-NP	JJ	O	9	NMOD
9	degradation	degradation	I-NP	NN	O	5	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	I	I	B-NP	NN	B-protein	14	NMOD
12	kappa	kappa	I-NP	NN	I-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	10	PMOD
15	,	,	O	,	O	14	P
16	which	which	B-NP	WDT	O	14	NMOD
17	prevented	prevent	B-VP	VBD	O	16	SBAR
18	the	the	B-NP	DT	O	20	NMOD
19	nuclear	nuclear	I-NP	JJ	O	20	NMOD
20	translocation	translocation	I-NP	NN	O	17	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	c-Rel/p65	c-Rel/p65	B-NP	NN	B-protein	23	NMOD
23	heterodimers	heterodimer	I-NP	NNS	I-protein	21	PMOD
24	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	14	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	14	P
4	two	two	B-NP	CD	O	8	NMOD
5	other	other	I-NP	JJ	O	8	NMOD
6	nonsteroidal	nonsteroidal	I-NP	JJ	O	7	AMOD
7	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	8	NMOD
8	drugs	drug	I-NP	NNS	O	12	NMOD
9	,	,	O	,	O	12	P
10	ibuprofen	ibuprofen	B-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	indomethacin	indomethacin	I-NP	NN	O	14	SUB
13	,	,	O	,	O	12	P
14	did	do	B-VP	VBD	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	inhibit	inhibit	I-VP	VB	O	14	VC
17	LPS	LPS	B-NP	NN	O	18	NMOD
18	induction	induction	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	TF	TF	I-NP	NN	B-DNA	22	NMOD
22	gene	gene	I-NP	NN	I-DNA	19	PMOD
23	.	.	O	.	O	14	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicated	indicate	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	salicylates	salicylate	B-NP	NNS	O	6	SUB
6	inhibited	inhibit	B-VP	VBD	O	4	SBAR
7	LPS	LPS	B-NP	NN	O	8	NMOD
8	induction	induction	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	TF	TF	B-NP	NN	B-DNA	12	NMOD
11	gene	gene	I-NP	NN	I-DNA	12	NMOD
12	transcription	transcription	I-NP	NN	O	9	PMOD
13	in	in	B-PP	IN	O	8	NMOD
14	monocytic	monocytic	B-NP	JJ	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	by	by	B-PP	IN	O	6	VMOD
17	preventing	prevent	B-VP	VBG	O	16	PMOD
18	nuclear	nuclear	B-NP	JJ	O	19	NMOD
19	translocation	translocation	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	c-Rel/p65	c-Rel/p65	B-NP	NN	B-protein	22	NMOD
22	heterodimers	heterodimer	I-NP	NNS	I-protein	20	PMOD
23	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	clinical	clinical	I-NP	JJ	O	3	NMOD
3	benefits	benefit	I-NP	NNS	O	19	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	salicylates	salicylate	B-NP	NNS	O	4	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	treatment	treatment	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	several	several	B-NP	JJ	O	11	NMOD
11	diseases	disease	I-NP	NNS	O	9	PMOD
12	,	,	O	,	O	11	P
13	including	include	B-PP	VBG	O	11	NMOD
14	atherosclerosis	atherosclerosis	B-NP	NN	O	17	NMOD
15	and	and	O	CC	O	17	NMOD
16	rheumatoid	rheumatoid	B-NP	JJ	O	17	NMOD
17	arthritis	arthritis	I-NP	NN	O	13	PMOD
18	,	,	O	,	O	3	P
19	may	may	B-VP	MD	O	0	ROOT
20	be	be	I-VP	VB	O	19	VC
21	related	relate	I-VP	VBN	O	20	PRD
22	to	to	B-PP	TO	O	21	AMOD
23	their	their	B-NP	PRP$	O	24	NMOD
24	ability	ability	I-NP	NN	O	22	PMOD
25	to	to	B-VP	TO	O	26	VMOD
26	reduce	reduce	I-VP	VB	O	24	NMOD
27	monocyte	monocyte	B-NP	NN	O	29	NMOD
28	gene	gene	I-NP	NN	O	29	NMOD
29	expression	expression	I-NP	NN	O	26	OBJ
30	.	.	O	.	O	19	P

1	CIITA	CIITA	B-NP	NN	B-protein	2	SUB
2	activates	activate	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	expression	expression	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	MHC	MHC	B-NP	NN	B-DNA	9	NMOD
7	class	class	I-NP	NN	I-DNA	9	NMOD
8	II	II	B-NP	CD	I-DNA	9	NMOD
9	genes	gene	I-NP	NNS	I-DNA	5	PMOD
10	in	in	B-PP	IN	O	4	NMOD
11	mouse	mouse	B-NP	NN	B-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
14	.	.	O	.	O	2	P

1	It	It	B-NP	PRP	O	2	SUB
2	has	have	B-VP	VBZ	O	29	VMOD
3	long	long	I-VP	RB	O	2	VMOD
4	been	be	I-VP	VBN	O	2	VC
5	a	a	B-NP	DT	O	6	NMOD
6	puzzle	puzzle	I-NP	NN	O	4	PRD
7	that	that	B-NP	IN	O	6	NMOD
8	MHC	MHC	B-NP	NN	B-protein	11	NMOD
9	class	class	I-NP	NN	I-protein	11	NMOD
10	II	II	B-NP	CD	I-protein	11	NMOD
11	molecules	molecule	I-NP	NNS	I-protein	12	SUB
12	are	be	B-VP	VBP	O	7	SBAR
13	expressed	express	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	human	human	B-NP	JJ	B-cell_type	17	NMOD
16	T	T	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
18	after	after	B-PP	IN	O	13	VMOD
19	activation	activation	B-NP	NN	O	18	PMOD
20	but	but	B-PP	CC	O	18	PMOD
21	not	not	B-PP	RB	O	22	PMOD
22	in	in	I-PP	IN	O	18	PMOD
23	mouse	mouse	B-NP	NN	B-cell_type	25	NMOD
24	T	T	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
26	;	;	O	:	O	29	P
27	this	this	B-NP	DT	O	28	NMOD
28	expression	expression	I-NP	NN	O	29	SUB
29	is	be	B-VP	VBZ	O	0	ROOT
30	believed	believe	I-VP	VBN	O	29	VC
31	to	to	I-VP	TO	O	32	VMOD
32	play	play	I-VP	VB	O	30	VMOD
33	a	a	B-NP	DT	O	34	NMOD
34	role	role	I-NP	NN	O	32	OBJ
35	in	in	B-PP	IN	O	32	VMOD
36	the	the	B-NP	DT	O	40	NMOD
37	cell	cell	I-NP	NN	O	40	NMOD
38	mediated	mediated	I-NP	JJ	O	40	NMOD
39	immune	immune	I-NP	JJ	O	40	NMOD
40	response	response	I-NP	NN	O	35	PMOD
41	.	.	O	.	O	29	P

1	Recently	Recently	B-ADVP	RB	O	10	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	MHC	MHC	I-NP	NN	B-protein	6	NMOD
4	class	class	I-NP	NN	I-protein	6	NMOD
5	II	II	I-NP	CD	I-protein	6	NMOD
6	transactivator	transactivator	I-NP	NN	I-protein	10	SUB
7	(	(	O	(	O	8	P
8	CIITA	CIITA	B-NP	NN	B-protein	6	NMOD
9	)	)	O	)	O	8	P
10	has	have	B-VP	VBZ	O	0	ROOT
11	been	be	I-VP	VBN	O	10	VC
12	reported	report	I-VP	VBN	O	11	VC
13	to	to	I-VP	TO	O	14	VMOD
14	be	be	I-VP	VB	O	12	VMOD
15	a	a	B-NP	DT	O	18	NMOD
16	major	major	I-NP	JJ	B-protein	18	NMOD
17	regulatory	regulatory	I-NP	JJ	I-protein	18	NMOD
18	factor	factor	I-NP	NN	I-protein	14	PRD
19	for	for	B-PP	IN	O	18	NMOD
20	both	both	O	CC	O	26	NMOD
21	the	the	B-NP	DT	O	26	NMOD
22	constitutive	constitutive	I-NP	JJ	O	26	NMOD
23	and	and	I-NP	CC	O	26	NMOD
24	IFN	IFN	I-NP	NN	B-protein	26	NMOD
25	inducible	inducible	I-NP	JJ	O	26	NMOD
26	expression	expression	I-NP	NN	O	19	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	MHC	MHC	B-NP	NN	B-DNA	31	NMOD
29	class	class	I-NP	NN	I-DNA	31	NMOD
30	II	II	B-NP	CD	I-DNA	31	NMOD
31	genes	gene	I-NP	NNS	I-DNA	27	PMOD
32	.	.	O	.	O	10	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	human	human	B-NP	JJ	B-cell_type	7	NMOD
6	T	T	I-NP	NN	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	12	SUB
8	expressing	express	B-VP	VBG	O	7	NMOD
9	MHC	MHC	B-NP	NN	B-protein	10	NMOD
10	class	class	I-NP	NN	I-protein	8	OBJ
11	II	II	I-NP	CD	I-protein	10	NMOD
12	have	have	B-VP	VBP	O	4	SBAR
13	CIITA	CIITA	B-NP	NN	B-protein	14	NMOD
14	transcripts	transcript	I-NP	NNS	O	12	OBJ
15	while	while	B-SBAR	IN	O	12	VMOD
16	MHC	MHC	B-NP	NN	B-cell_type	21	NMOD
17	class	class	I-NP	NN	I-cell_type	21	NMOD
18	II-negative	II-negative	I-NP	JJ	I-cell_type	21	NMOD
19	human	human	I-NP	JJ	I-cell_type	21	NMOD
20	T	T	I-NP	NN	I-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	25	NMOD
22	and	and	O	CC	O	25	NMOD
23	mouse	mouse	B-NP	NN	B-cell_type	25	NMOD
24	T	T	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	26	SUB
26	do	do	B-VP	VBP	O	15	SBAR
27	not	not	O	RB	O	26	VMOD
28	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	expression	expression	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	MHC	MHC	B-NP	NN	B-DNA	7	NMOD
5	class	class	I-NP	NN	I-DNA	7	NMOD
6	II	II	B-NP	CD	I-DNA	7	NMOD
7	genes	gene	I-NP	NNS	I-DNA	3	PMOD
8	in	in	B-PP	IN	O	2	NMOD
9	mouse	mouse	B-NP	NN	B-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
12	can	can	B-VP	MD	O	0	ROOT
13	be	be	I-VP	VB	O	12	VC
14	reconstituted	reconstitute	I-VP	VBN	O	13	VC
15	upon	upon	B-PP	IN	O	14	VMOD
16	transfection	transfection	B-NP	NN	O	15	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	human	human	I-NP	JJ	B-DNA	21	NMOD
20	CIITA	CIITA	I-NP	NN	I-DNA	21	NMOD
21	cDNA	cDNA	I-NP	NN	I-DNA	17	PMOD
22	.	.	O	.	O	12	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	expression	expression	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	CIITA	CIITA	B-NP	NN	B-protein	7	PMOD
9	explains	explain	B-VP	VBZ	O	4	SBAR
10	the	the	B-NP	DT	O	13	NMOD
11	expression	expression	I-NP	NN	O	13	NMOD
12	or	or	I-NP	CC	O	13	NMOD
13	lack	lack	I-NP	NN	O	9	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	expression	expression	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	MHC	MHC	B-NP	NN	B-protein	18	NMOD
18	class	class	I-NP	NN	I-protein	16	PMOD
19	II	II	I-NP	CD	I-protein	18	NMOD
20	in	in	B-PP	IN	O	18	NMOD
21	human	human	B-NP	JJ	B-cell_type	25	NMOD
22	and	and	I-NP	CC	I-cell_type	25	NMOD
23	mouse	mouse	I-NP	NN	I-cell_type	25	NMOD
24	T	T	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
26	respectively	respectively	B-ADVP	RB	O	9	VMOD
27	.	.	O	.	O	3	P

1	Identification	Identification	B-NP	NN	O	17	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	an	an	B-NP	DT	O	9	NMOD
4	I	I	I-NP	NN	B-protein	9	NMOD
5	kappa	kappa	I-NP	NN	I-protein	9	NMOD
6	B	B	I-NP	NN	I-protein	9	NMOD
7	alpha-associated	alpha-associated	I-NP	JJ	I-protein	9	NMOD
8	protein	protein	I-NP	NN	I-protein	9	NMOD
9	kinase	kinase	I-NP	NN	I-protein	2	PMOD
10	in	in	B-PP	IN	O	1	NMOD
11	a	a	B-NP	DT	O	15	NMOD
12	human	human	I-NP	JJ	B-cell_line	15	NMOD
13	monocytic	monocytic	I-NP	JJ	I-cell_line	15	NMOD
14	cell	cell	I-NP	NN	I-cell_line	15	NMOD
15	line	line	I-NP	NN	I-cell_line	10	PMOD
16	and	and	O	CC	O	17	NMOD
17	determination	determination	B-NP	NN	O	0	ROOT
18	of	of	B-PP	IN	O	17	NMOD
19	its	its	B-NP	PRP$	O	21	NMOD
20	phosphorylation	phosphorylation	I-NP	NN	B-protein	21	NMOD
21	sites	site	I-NP	NNS	I-protein	18	PMOD
22	on	on	B-PP	IN	O	17	NMOD
23	I	I	B-NP	NN	B-protein	26	NMOD
24	kappa	kappa	I-NP	NN	I-protein	26	NMOD
25	B	B	I-NP	NN	I-protein	26	NMOD
26	alpha	alpha	I-NP	NN	I-protein	22	PMOD
27	.	.	O	.	O	17	P

1	Nuclear	Nuclear	B-NP	JJ	B-protein	4	NMOD
2	factor	factor	I-NP	NN	I-protein	4	NMOD
3	kappa	kappa	I-NP	NN	I-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	9	SUB
5	(	(	O	(	O	7	P
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	4	NMOD
8	)	)	O	)	O	7	P
9	is	be	B-VP	VBZ	O	0	ROOT
10	stored	store	I-VP	VBN	O	9	VC
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	cytoplasm	cytoplasm	I-NP	NN	O	11	PMOD
14	as	as	B-PP	IN	O	10	VMOD
15	an	an	B-NP	DT	O	17	NMOD
16	inactive	inactive	I-NP	JJ	O	17	NMOD
17	form	form	I-NP	NN	O	14	PMOD
18	through	through	B-PP	IN	O	10	VMOD
19	interaction	interaction	B-NP	NN	O	18	PMOD
20	with	with	B-PP	IN	O	19	NMOD
21	I	I	B-NP	NN	B-protein	23	NMOD
22	kappa	kappa	I-NP	NN	I-protein	23	NMOD
23	B	B	I-NP	NN	I-protein	20	PMOD
24	.	.	O	.	O	9	P

1	Stimulation	Stimulation	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	cells	cell	B-NP	NNS	O	2	PMOD
4	leads	lead	B-VP	VBZ	O	0	ROOT
5	to	to	B-PP	TO	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	rapid	rapid	I-NP	JJ	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	I	I	B-NP	NN	B-protein	13	NMOD
11	kappa	kappa	I-NP	NN	I-protein	13	NMOD
12	B	B	I-NP	NN	I-protein	13	NMOD
13	alpha	alpha	I-NP	NN	I-protein	9	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	is	be	B-VP	VBZ	O	15	SBAR
17	presumed	presume	I-VP	VBN	O	16	VC
18	to	to	I-VP	TO	O	19	VMOD
19	be	be	I-VP	VB	O	17	VMOD
20	important	important	B-ADJP	JJ	O	19	PRD
21	for	for	B-PP	IN	O	20	AMOD
22	the	the	B-NP	DT	O	24	NMOD
23	subsequent	subsequent	I-NP	JJ	O	24	NMOD
24	degradation	degradation	I-NP	NN	O	21	PMOD
25	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	recently	recently	I-VP	RB	O	2	VMOD
4	reported	report	I-VP	VBN	O	2	VC
5	the	the	B-NP	DT	O	6	NMOD
6	establishment	establishment	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	9	NMOD
9	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	16	NMOD
10	(	(	O	(	O	11	P
11	LPS	LPS	B-NP	NN	O	9	NMOD
12	)	)	O	)	O	11	P
13	-dependent	-dependent	B-NP	JJ	O	16	NMOD
14	cell-free	cell-free	I-NP	JJ	O	16	NMOD
15	activation	activation	I-NP	NN	O	16	NMOD
16	system	system	I-NP	NN	O	7	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	NF-kappa	NF-kappa	B-NP	NN	B-protein	19	NMOD
19	B	B	I-NP	NN	I-protein	17	PMOD
20	in	in	B-PP	IN	O	6	NMOD
21	association	association	B-NP	NN	O	20	PMOD
22	with	with	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	induction	induction	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	I	I	B-NP	NN	B-protein	30	NMOD
27	kappa	kappa	I-NP	NN	I-protein	30	NMOD
28	B	B	I-NP	NN	I-protein	30	NMOD
29	alpha	alpha	I-NP	NN	I-protein	30	NMOD
30	phosphorylation	phosphorylation	I-NP	NN	O	25	PMOD
31	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	have	have	B-VP	VBP	O	0	ROOT
7	identified	identify	I-VP	VBN	O	6	VC
8	a	a	B-NP	DT	O	9	NMOD
9	kinase	kinase	I-NP	NN	B-protein	7	OBJ
10	in	in	B-PP	IN	O	7	VMOD
11	cell	cell	B-NP	NN	O	12	NMOD
12	extracts	extract	I-NP	NNS	O	10	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	19	NMOD
15	LPS-stimulated	LPS-stimulated	I-NP	JJ	B-cell_line	19	NMOD
16	human	human	I-NP	JJ	I-cell_line	19	NMOD
17	monocytic	monocytic	I-NP	JJ	I-cell_line	19	NMOD
18	cell	cell	I-NP	NN	I-cell_line	19	NMOD
19	line	line	I-NP	NN	I-cell_line	21	NMOD
20	,	,	O	,	O	21	P
21	THP-1	THP-1	B-NP	NN	B-cell_line	13	PMOD
22	,	,	O	,	O	21	P
23	that	that	B-NP	WDT	O	21	NMOD
24	specifically	specifically	B-ADVP	RB	O	25	VMOD
25	binds	bind	B-VP	VBZ	O	23	SBAR
26	and	and	I-VP	CC	O	25	VMOD
27	phosphorylates	phosphorylate	I-VP	VBZ	O	25	VMOD
28	I	I	B-NP	NN	B-protein	31	NMOD
29	kappa	kappa	I-NP	NN	I-protein	31	NMOD
30	B	B	I-NP	NN	I-protein	31	NMOD
31	alpha	alpha	I-NP	NN	I-protein	25	OBJ
32	.	.	O	.	O	6	P

1	LPS	LPS	B-NP	NN	O	2	NMOD
2	stimulation	stimulation	I-NP	NN	O	4	SUB
3	transiently	transiently	B-ADVP	RB	O	4	VMOD
4	enhanced	enhance	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	11	NMOD
6	I	I	I-NP	NN	B-protein	11	NMOD
7	kappa	kappa	I-NP	NN	I-protein	11	NMOD
8	B	B	I-NP	NN	I-protein	11	NMOD
9	alpha-bound	alpha-bound	I-NP	JJ	I-protein	11	NMOD
10	kinase	kinase	I-NP	NN	I-protein	11	NMOD
11	activity	activity	I-NP	NN	O	4	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	THP-1	THP-1	B-NP	NN	B-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	12	PMOD
15	.	.	O	.	O	4	P

1	Mutational	Mutational	B-NP	JJ	O	2	NMOD
2	analyses	analysis	I-NP	NNS	O	10	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	I	I	B-NP	NN	B-protein	7	NMOD
5	kappa	kappa	I-NP	NN	I-protein	7	NMOD
6	B	B	I-NP	NN	I-protein	7	NMOD
7	alpha	alpha	I-NP	NN	I-protein	3	PMOD
8	and	and	O	CC	O	10	NMOD
9	competition	competition	B-NP	NN	O	10	NMOD
10	experiments	experiment	I-NP	NNS	O	15	SUB
11	with	with	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	synthetic	synthetic	I-NP	JJ	O	14	NMOD
14	peptides	peptide	I-NP	NNS	O	11	PMOD
15	identified	identify	B-VP	VBD	O	0	ROOT
16	major	major	B-NP	JJ	O	18	NMOD
17	phosphorylation	phosphorylation	I-NP	NN	B-protein	18	NMOD
18	sites	site	I-NP	NNS	I-protein	15	OBJ
19	by	by	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	bound	bind	I-NP	VBN	B-protein	22	NMOD
22	kinase	kinase	I-NP	NN	I-protein	19	PMOD
23	as	as	B-PP	IN	O	22	NMOD
24	Ser	Ser	B-NP	NN	B-protein	27	NMOD
25	and	and	I-NP	CC	O	27	NMOD
26	Thr	Thr	I-NP	NN	O	27	NMOD
27	residues	residue	I-NP	NNS	O	23	PMOD
28	in	in	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	32	NMOD
30	C-terminal	C-terminal	I-NP	JJ	B-protein	32	NMOD
31	acidic	acidic	I-NP	JJ	I-protein	32	NMOD
32	domain	domain	I-NP	NN	I-protein	28	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	I	I	B-NP	NN	B-protein	37	NMOD
35	kappa	kappa	I-NP	NN	I-protein	37	NMOD
36	B	B	I-NP	NN	I-protein	37	NMOD
37	alpha	alpha	I-NP	NN	I-protein	33	PMOD
38	.	.	O	.	O	15	P

1	Moreover	Moreover	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	peptide	peptide	I-NP	NN	O	21	SUB
8	,	,	O	,	O	7	P
9	corresponding	correspond	B-VP	VBG	O	7	NMOD
10	to	to	B-PP	TO	O	9	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	C-terminal	C-terminal	I-NP	JJ	B-protein	14	NMOD
13	acidic	acidic	I-NP	JJ	I-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	10	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	I	I	B-NP	NN	B-protein	19	NMOD
17	kappa	kappa	I-NP	NN	I-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	alpha	alpha	I-NP	NN	I-protein	15	PMOD
20	,	,	O	,	O	7	P
21	blocked	block	B-VP	VBD	O	5	SBAR
22	the	the	B-NP	DT	O	26	NMOD
23	LPS-induced	LPS-induced	I-NP	JJ	O	26	NMOD
24	NF-kappa	NF-kappa	I-NP	NN	B-protein	26	NMOD
25	B	B	I-NP	NN	I-protein	26	NMOD
26	activation	activation	I-NP	NN	O	31	NMOD
27	as	as	B-CONJP	RB	O	31	NMOD
28	well	well	I-CONJP	RB	O	27	DEP
29	as	as	I-CONJP	IN	O	27	DEP
30	inducible	inducible	B-NP	JJ	O	31	NMOD
31	phosphorylation	phosphorylation	I-NP	NN	O	21	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	endogenous	endogenous	B-NP	JJ	O	37	NMOD
34	I	I	I-NP	NN	B-protein	37	NMOD
35	kappa	kappa	I-NP	NN	I-protein	37	NMOD
36	B	B	I-NP	NN	I-protein	37	NMOD
37	alpha	alpha	I-NP	NN	I-protein	32	PMOD
38	in	in	B-PP	IN	O	21	VMOD
39	a	a	B-NP	DT	O	41	NMOD
40	cell-free	cell-free	I-NP	JJ	O	41	NMOD
41	system	system	I-NP	NN	O	38	PMOD
42	using	use	B-VP	VBG	O	21	VMOD
43	THP-1	THP-1	B-NP	NN	B-cell_line	44	NMOD
44	cells	cell	I-NP	NNS	I-cell_line	42	OBJ
45	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggested	suggest	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	bound	bind	I-NP	VBN	B-protein	7	NMOD
7	kinase	kinase	I-NP	NN	I-protein	8	SUB
8	is	be	B-VP	VBZ	O	4	SBAR
9	involved	involve	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathway	pathway	I-NP	NN	O	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	LPS	LPS	B-NP	NN	O	14	PMOD
16	by	by	B-PP	IN	O	9	VMOD
17	inducing	induce	B-VP	VBG	O	16	PMOD
18	the	the	B-NP	DT	O	19	NMOD
19	phosphorylation	phosphorylation	I-NP	NN	O	31	NMOD
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	C-terminal	C-terminal	I-NP	JJ	B-protein	23	NMOD
23	region	region	I-NP	NN	I-protein	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	I	I	B-NP	NN	B-protein	28	NMOD
26	kappa	kappa	I-NP	NN	I-protein	28	NMOD
27	B	B	I-NP	NN	I-protein	28	NMOD
28	alpha	alpha	I-NP	NN	I-protein	24	PMOD
29	and	and	O	CC	O	31	NMOD
30	subsequent	subsequent	B-NP	JJ	O	31	NMOD
31	dissociation	dissociation	I-NP	NN	O	17	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	39	NMOD
34	NF-kappa	NF-kappa	I-NP	NN	B-protein	39	NMOD
35	B.I	B.I	I-NP	NN	I-protein	39	NMOD
36	kappa	kappa	I-NP	NN	I-protein	39	NMOD
37	B	B	I-NP	NN	I-protein	39	NMOD
38	alpha	alpha	I-NP	NN	I-protein	39	NMOD
39	complex	complex	I-NP	NN	I-protein	32	PMOD
40	.	.	O	.	O	3	P

1	Triggering	Triggering	B-NP	NN	O	16	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	human	human	I-NP	JJ	B-DNA	6	NMOD
5	interleukin-6	interleukin-6	I-NP	NN	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	interferon-gamma	interferon-gamma	B-NP	NN	B-protein	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	tumor	tumor	B-NP	NN	B-protein	12	NMOD
11	necrosis	necrosis	I-NP	NN	I-protein	12	NMOD
12	factor-alpha	factor-alpha	I-NP	NN	I-protein	7	PMOD
13	in	in	B-PP	IN	O	1	NMOD
14	monocytic	monocytic	B-NP	JJ	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	involves	involve	B-VP	VBZ	O	0	ROOT
17	cooperation	cooperation	B-NP	NN	O	16	OBJ
18	between	between	B-PP	IN	O	17	NMOD
19	interferon	interferon	B-NP	NN	B-protein	21	NMOD
20	regulatory	regulatory	I-NP	JJ	I-protein	21	NMOD
21	factor-1	factor-1	I-NP	NN	I-protein	30	NMOD
22	,	,	O	,	O	30	P
23	NF	NF	B-NP	NN	B-protein	25	NMOD
24	kappa	kappa	I-NP	NN	I-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	30	NMOD
26	,	,	O	,	O	30	P
27	and	and	O	CC	O	30	NMOD
28	Sp1	Sp1	B-NP	NN	B-protein	30	NMOD
29	transcription	transcription	I-NP	NN	B-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	18	PMOD
31	.	.	O	.	O	16	P

1	We	We	B-NP	PRP	O	2	SUB
2	investigated	investigate	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	basis	basis	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	synergistic	synergistic	I-NP	JJ	O	9	NMOD
9	induction	induction	I-NP	NN	O	6	PMOD
10	by	by	B-PP	IN	O	9	NMOD
11	interferon-gamma	interferon-gamma	B-NP	NN	B-protein	17	NMOD
12	(	(	O	(	O	13	P
13	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	/tumor	/tumor	B-NP	NN	B-protein	17	NMOD
16	necrosis	necrosis	I-NP	NN	I-protein	17	NMOD
17	factor-alpha	factor-alpha	I-NP	NN	I-protein	10	PMOD
18	(	(	O	(	O	19	P
19	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	of	of	B-PP	IN	O	17	NMOD
22	human	human	B-NP	JJ	B-DNA	27	NMOD
23	interleukin-6	interleukin-6	I-NP	NN	I-DNA	27	NMOD
24	(	(	O	(	I-DNA	25	P
25	IL-6	IL-6	B-NP	NN	I-DNA	23	NMOD
26	)	)	O	)	I-DNA	25	P
27	gene	gene	B-NP	NN	I-DNA	21	PMOD
28	in	in	B-PP	IN	O	27	NMOD
29	THP-1	THP-1	B-NP	NN	B-cell_line	31	NMOD
30	monocytic	monocytic	I-NP	JJ	I-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	28	PMOD
32	,	,	O	,	O	2	P
33	and	and	O	CC	O	2	VMOD
34	compared	compare	B-VP	VBD	O	2	VMOD
35	it	it	B-NP	PRP	O	34	OBJ
36	with	with	B-PP	IN	O	34	VMOD
37	the	the	B-NP	DT	O	38	NMOD
38	basis	basis	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	this	this	B-NP	DT	O	41	NMOD
41	induction	induction	I-NP	NN	O	39	PMOD
42	by	by	B-PP	IN	O	41	NMOD
43	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	42	PMOD
44	(	(	O	(	O	45	P
45	LPS	LPS	B-NP	NN	O	43	NMOD
46	)	)	O	)	O	45	P
47	.	.	O	.	O	2	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	6	SUB
3	with	with	B-PP	IN	O	2	NMOD
4	IL-6	IL-6	B-NP	NN	B-DNA	5	NMOD
5	promoter	promoter	I-NP	NN	I-DNA	3	PMOD
6	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	three	three	B-NP	CD	O	9	NMOD
9	regions	region	I-NP	NNS	O	10	SUB
10	are	be	B-VP	VBP	O	7	SBAR
11	the	the	B-NP	DT	O	12	NMOD
12	targets	target	I-NP	NNS	O	10	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	IFN-gamma	IFN-gamma	I-NP	NN	B-protein	17	NMOD
16	and/or	and/or	I-NP	CC	O	17	NMOD
17	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	18	NMOD
18	action	action	I-NP	NN	O	13	PMOD
19	,	,	O	,	O	10	P
20	whereas	whereas	O	IN	O	10	VMOD
21	only	only	B-NP	RB	O	22	NMOD
22	one	one	I-NP	CD	O	26	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	these	these	B-NP	DT	O	25	NMOD
25	regions	region	I-NP	NNS	O	23	PMOD
26	seemed	seem	B-VP	VBD	O	20	SBAR
27	to	to	I-VP	TO	O	28	VMOD
28	be	be	I-VP	VB	O	26	VMOD
29	implicated	implicate	I-VP	VBN	O	28	VC
30	in	in	B-PP	IN	O	29	VMOD
31	LPS	LPS	B-NP	NN	O	32	NMOD
32	activation	activation	I-NP	NN	O	30	PMOD
33	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	three	three	I-NP	CD	O	3	NMOD
3	regions	region	I-NP	NNS	O	5	SUB
4	concerned	concern	B-ADJP	VBN	O	3	NMOD
5	are	be	B-VP	VBP	O	0	ROOT
6	:	:	O	:	O	5	P
7	1	1	B-LST	LS	O	5	VMOD
8	)	)	O	)	O	7	P
9	a	a	B-NP	DT	O	10	NMOD
10	region	region	I-NP	NN	O	14	NMOD
11	between	between	B-NP	IN	O	14	NMOD
12	-73	-73	I-NP	CD	B-DNA	14	NMOD
13	and	and	I-NP	CC	I-DNA	14	NMOD
14	-36	-36	I-NP	CD	I-DNA	7	NMOD
15	,	,	O	,	O	14	P
16	which	which	B-NP	WDT	O	14	NMOD
17	is	be	B-VP	VBZ	O	16	SBAR
18	the	the	B-NP	DT	O	20	NMOD
19	minimal	minimal	I-NP	JJ	B-DNA	20	NMOD
20	element	element	I-NP	NN	I-DNA	17	PRD
21	inducible	inducible	B-ADJP	JJ	O	20	NMOD
22	by	by	B-PP	IN	O	21	AMOD
23	LPS	LPS	B-NP	NN	O	25	NMOD
24	or	or	I-NP	CC	O	25	NMOD
25	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	22	PMOD
26	;	;	O	:	O	7	DEP
27	2	2	B-LST	LS	O	26	VMOD
28	)	)	O	)	O	27	P
29	an	an	B-NP	DT	O	30	NMOD
30	element	element	I-NP	NN	O	27	DEP
31	located	located	B-ADJP	JJ	O	30	NMOD
32	between	between	B-PP	IN	O	31	AMOD
33	-181	-181	B-NP	CD	B-DNA	35	NMOD
34	and	and	I-NP	CC	I-DNA	35	NMOD
35	-73	-73	I-NP	CD	I-DNA	32	PMOD
36	,	,	O	,	O	35	P
37	which	which	B-NP	WDT	O	35	NMOD
38	appeared	appear	B-VP	VBD	O	37	SBAR
39	to	to	I-VP	TO	O	40	VMOD
40	regulate	regulate	I-VP	VB	O	38	VMOD
41	the	the	B-NP	DT	O	42	NMOD
42	response	response	I-NP	NN	O	40	OBJ
43	to	to	B-PP	TO	O	42	NMOD
44	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	46	NMOD
45	and	and	I-NP	CC	O	46	NMOD
46	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	43	PMOD
47	negatively	negatively	B-ADVP	RB	O	40	VMOD
48	;	;	O	:	O	38	VMOD
49	and	and	O	CC	O	48	VMOD
50	3	3	B-LST	LS	O	49	DEP
51	)	)	O	)	O	50	P
52	a	a	B-NP	DT	O	54	NMOD
53	distal	distal	I-NP	JJ	B-DNA	54	NMOD
54	element	element	I-NP	NN	I-DNA	50	DEP
55	upstream	upstream	B-ADJP	JJ	O	54	NMOD
56	of	of	B-PP	IN	O	55	AMOD
57	-224	-224	B-NP	CD	O	56	PMOD
58	,	,	O	,	O	54	P
59	which	which	B-NP	WDT	O	54	NMOD
60	was	be	B-VP	VBD	O	59	SBAR
61	inducible	inducible	B-ADJP	JJ	O	60	PRD
62	by	by	B-PP	IN	O	61	AMOD
63	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	62	PMOD
64	alone	alone	B-ADVP	RB	O	63	NMOD
65	.	.	O	.	O	5	P

1	LPS	LPS	B-NP	NN	O	2	NMOD
2	signaling	signaling	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	found	find	I-VP	VBN	O	3	VC
5	to	to	I-VP	TO	O	6	VMOD
6	involve	involve	I-VP	VB	O	4	VMOD
7	NF	NF	B-NP	NN	B-protein	9	NMOD
8	kappa	kappa	I-NP	NN	I-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	activation	activation	I-NP	NN	O	6	OBJ
11	by	by	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	p50/p65	p50/p65	I-NP	NN	B-protein	14	NMOD
14	heterodimers	heterodimer	I-NP	NNS	I-protein	11	PMOD
15	.	.	O	.	O	3	P

1	Synergistic	Synergistic	B-NP	JJ	O	2	NMOD
2	induction	induction	I-NP	NN	O	17	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	IL-6	IL-6	I-NP	NN	B-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	3	PMOD
7	by	by	B-PP	IN	O	2	NMOD
8	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	7	PMOD
11	,	,	O	,	O	2	P
12	in	in	B-PP	IN	O	2	NMOD
13	monocytic	monocytic	B-NP	JJ	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	,	,	O	,	O	17	P
16	involved	involve	B-NP	VBN	O	17	NMOD
17	cooperation	cooperation	I-NP	NN	O	0	ROOT
18	between	between	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	26	NMOD
20	IRF-1	IRF-1	I-NP	NN	B-protein	26	NMOD
21	and	and	I-NP	CC	O	26	NMOD
22	NF	NF	I-NP	NN	B-protein	26	NMOD
23	kappa	kappa	I-NP	NN	I-protein	26	NMOD
24	B	B	I-NP	NN	I-protein	26	NMOD
25	p65	p65	I-NP	NN	I-protein	26	NMOD
26	homodimers	homodimer	I-NP	NNS	I-protein	18	PMOD
27	with	with	B-PP	IN	O	17	NMOD
28	concomitant	concomitant	B-NP	JJ	O	29	NMOD
29	removal	removal	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	negative	negative	I-NP	JJ	O	33	NMOD
33	effect	effect	I-NP	NN	O	30	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	the	the	B-NP	DT	O	38	NMOD
36	retinoblastoma	retinoblastoma	I-NP	NN	B-DNA	38	NMOD
37	control	control	I-NP	NN	I-DNA	38	NMOD
38	element	element	I-NP	NN	I-DNA	34	PMOD
39	present	present	B-ADJP	JJ	O	38	NMOD
40	in	in	B-PP	IN	O	39	AMOD
41	the	the	B-NP	DT	O	43	NMOD
42	IL-6	IL-6	I-NP	NN	B-DNA	43	NMOD
43	promoter	promoter	I-NP	NN	I-DNA	40	PMOD
44	.	.	O	.	O	17	P

1	This	This	B-NP	DT	O	2	NMOD
2	removal	removal	I-NP	NN	O	3	SUB
3	occurred	occur	B-VP	VBD	O	0	ROOT
4	by	by	B-PP	IN	O	3	VMOD
5	activation	activation	B-NP	NN	O	4	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	constitutive	constitutive	I-NP	JJ	B-protein	10	NMOD
9	Sp1	Sp1	I-NP	NN	I-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	6	PMOD
11	,	,	O	,	O	3	P
12	whose	whose	B-NP	WP$	O	3	VMOD
13	increased	increase	B-VP	VBD	O	18	VMOD
14	binding	binding	B-NP	NN	O	15	NMOD
15	activity	activity	I-NP	NN	O	13	OBJ
16	and	and	O	CC	O	18	VMOD
17	phosphorylation	phosphorylation	B-NP	NN	O	18	SUB
18	were	be	B-VP	VBD	O	12	SBAR
19	mediated	mediate	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	lymphotoxin	lymphotoxin	I-NP	NN	B-DNA	3	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	stimulated	stimulate	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	HTLV-I	HTLV-I	B-NP	NN	B-protein	9	NMOD
8	tax	tax	I-NP	NN	I-protein	9	NMOD
9	activation	activation	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
12	B	B	I-NP	NN	I-protein	10	PMOD
13	in	in	B-PP	IN	O	9	NMOD
14	human	human	B-NP	JJ	B-cell_line	16	NMOD
15	T-cell	T-cell	I-NP	NN	I-cell_line	16	NMOD
16	lines	line	I-NP	NNS	I-cell_line	13	PMOD
17	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	5	NMOD
2	HTLV-I	HTLV-I	I-NP	NN	B-protein	5	NMOD
3	transcriptional	transcriptional	I-NP	JJ	I-protein	5	NMOD
4	activator	activator	I-NP	NN	I-protein	5	NMOD
5	tax	tax	I-NP	NN	I-protein	6	SUB
6	was	be	B-VP	VBD	O	0	ROOT
7	used	use	I-VP	VBN	O	6	VC
8	to	to	B-VP	TO	O	9	VMOD
9	gain	gain	I-VP	VB	O	7	VMOD
10	insight	insight	B-NP	NN	O	9	OBJ
11	into	into	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	mechanism	mechanism	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	lymphotoxin	lymphotoxin	B-NP	NN	B-DNA	22	NMOD
16	(	(	O	(	I-DNA	22	P
17	LT	LT	B-NP	NN	I-DNA	22	NMOD
18	;	;	O	:	I-DNA	22	P
19	TNF-beta	TNF-beta	B-NP	NN	I-DNA	22	NMOD
20	)	)	O	)	I-DNA	22	P
21	gene	gene	B-NP	NN	I-DNA	22	NMOD
22	induction	induction	I-NP	NN	O	14	PMOD
23	.	.	O	.	O	6	P

1	Tax-expressing	Tax-expressing	B-NP	JJ	B-cell_line	3	NMOD
2	cell	cell	I-NP	NN	I-cell_line	3	NMOD
3	lines	line	I-NP	NNS	I-cell_line	4	SUB
4	produce	produce	B-VP	VBP	O	0	ROOT
5	LT	LT	B-NP	NN	B-protein	7	NMOD
6	biologic	biologic	I-NP	JJ	O	7	NMOD
7	activity	activity	I-NP	NN	O	4	OBJ
8	.	.	O	.	O	4	P

1	An	An	B-NP	DT	O	8	NMOD
2	LT	LT	I-NP	NN	B-DNA	3	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	8	NMOD
4	(	(	O	(	I-DNA	8	P
5	LT-293	LT-293	B-NP	NN	I-DNA	8	NMOD
6	)	)	O	)	I-DNA	8	P
7	CAT	CAT	B-NP	NN	I-DNA	8	NMOD
8	construct	construct	I-NP	NN	I-DNA	15	SUB
9	that	that	B-NP	WDT	O	8	NMOD
10	contained	contain	B-VP	VBD	O	9	SBAR
11	an	an	B-NP	DT	O	14	NMOD
12	NF-kappa	NF-kappa	I-NP	NN	B-DNA	14	NMOD
13	B	B	I-NP	NN	I-DNA	14	NMOD
14	site	site	I-NP	NN	I-DNA	10	OBJ
15	was	be	B-VP	VBD	O	0	ROOT
16	active	active	B-ADJP	JJ	O	15	PRD
17	in	in	B-PP	IN	O	15	VMOD
18	the	the	B-NP	DT	O	22	NMOD
19	LT-producing	LT-producing	I-NP	JJ	B-cell_line	22	NMOD
20	C81-66-45	C81-66-45	I-NP	NN	I-cell_line	22	NMOD
21	cell	cell	I-NP	NN	I-cell_line	22	NMOD
22	line	line	I-NP	NN	I-cell_line	17	PMOD
23	,	,	O	,	O	22	P
24	which	which	B-NP	WDT	O	22	NMOD
25	contains	contain	B-VP	VBZ	O	24	SBAR
26	defective	defective	B-NP	JJ	O	27	NMOD
27	HTLV-I	HTLV-I	I-NP	NN	O	25	OBJ
28	but	but	O	CC	O	25	VMOD
29	expresses	express	B-VP	VBZ	O	25	VMOD
30	tax	tax	B-NP	NN	B-protein	29	OBJ
31	.	.	O	.	O	15	P

1	The	The	B-NP	DT	O	2	NMOD
2	observation	observation	I-NP	NN	O	17	SUB
3	that	that	B-SBAR	IN	O	2	NMOD
4	a	a	B-NP	DT	O	8	NMOD
5	mutated	mutate	I-NP	VBN	B-DNA	8	NMOD
6	LT-kappa	LT-kappa	I-NP	NN	I-DNA	8	NMOD
7	B	B	I-NP	NN	I-DNA	8	NMOD
8	construct	construct	I-NP	NN	I-DNA	12	SUB
9	(	(	O	(	O	10	P
10	M1-CAT	M1-CAT	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	was	be	B-VP	VBD	O	3	SBAR
13	inactive	inactive	B-ADJP	JJ	O	12	PRD
14	in	in	B-PP	IN	O	13	AMOD
15	C81-66-45	C81-66-45	B-NP	NN	B-cell_line	14	PMOD
16	,	,	O	,	O	2	P
17	confirmed	confirm	B-VP	VBD	O	0	ROOT
18	the	the	B-NP	DT	O	19	NMOD
19	importance	importance	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	NF-kappa	NF-kappa	B-NP	NN	B-protein	22	NMOD
22	B	B	I-NP	NN	I-protein	20	PMOD
23	in	in	B-PP	IN	O	19	NMOD
24	LT	LT	B-NP	NN	B-DNA	26	NMOD
25	gene	gene	I-NP	NN	I-DNA	26	NMOD
26	expression	expression	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	17	P

1	Tax	Tax	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	transfected	transfecte	I-VP	VBN	O	2	VC
4	into	into	B-PP	IN	O	3	VMOD
5	HTLV-I-negative	HTLV-I-negative	B-NP	JJ	B-cell_line	8	NMOD
6	human	human	I-NP	JJ	I-cell_line	8	NMOD
7	T-cell	T-cell	I-NP	NN	I-cell_line	8	NMOD
8	lines	line	I-NP	NNS	I-cell_line	4	PMOD
9	.	.	O	.	O	2	P

1	Jurkat	Jurkat	B-NP	NN	B-cell_line	3	NMOD
2	T	T	I-NP	NN	I-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	7	SUB
4	stably	stably	B-VP	RB	O	5	VMOD
5	expressing	express	I-VP	VBG	O	3	NMOD
6	tax	tax	B-NP	NN	B-protein	5	OBJ
7	contained	contain	B-VP	VBD	O	0	ROOT
8	elevated	elevated	B-NP	JJ	O	9	NMOD
9	levels	level	I-NP	NNS	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
12	B	B	I-NP	NN	I-protein	10	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	directly	directly	B-ADVP	RB	O	15	VMOD
15	bound	bind	B-VP	VBD	O	13	SBAR
16	to	to	B-PP	TO	O	15	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	LT-kappa	LT-kappa	I-NP	NN	B-DNA	20	NMOD
19	B	B	I-NP	NN	I-DNA	20	NMOD
20	site	site	I-NP	NN	I-DNA	16	PMOD
21	.	.	O	.	O	7	P

1	Tax	Tax	B-NP	NN	B-protein	10	SUB
2	co-transfected	co-transfecte	B-VP	VBN	O	1	NMOD
3	with	with	B-PP	IN	O	2	VMOD
4	reporter	reporter	B-NP	NN	B-DNA	5	NMOD
5	constructs	construct	I-NP	NNS	I-DNA	3	PMOD
6	into	into	B-PP	IN	O	5	NMOD
7	Jurkat	Jurkat	B-NP	NN	B-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
9	maximally	maximally	B-ADVP	RB	O	10	VMOD
10	activated	activate	B-VP	VBD	O	0	ROOT
11	HTLV-I-LTR-CAT	HTLV-I-LTR-CAT	B-NP	NN	B-protein	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	kappa	kappa	I-NP	NN	B-protein	14	NMOD
14	B-fos-CAT	B-fos-CAT	I-NP	NN	I-protein	10	OBJ
15	and	and	O	CC	O	10	VMOD
16	also	also	B-ADVP	RB	O	10	VMOD
17	activated	activate	B-VP	VBD	O	10	VMOD
18	LT-293	LT-293	B-NP	NN	B-DNA	17	OBJ
19	to	to	B-PP	TO	O	17	VMOD
20	a	a	B-NP	DT	O	22	NMOD
21	lesser	less	I-NP	JJR	O	22	NMOD
22	extent	extent	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	7	VMOD
2	JM	JM	B-NP	NN	B-cell_line	4	NMOD
3	T	T	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	,	,	O	,	O	7	P
6	tax	tax	B-NP	NN	B-protein	7	SUB
7	induced	induce	B-VP	VBD	O	0	ROOT
8	LT-293	LT-293	B-NP	NN	B-DNA	9	NMOD
9	activity	activity	I-NP	NN	O	7	OBJ
10	by	by	B-PP	IN	O	7	VMOD
11	two-	two-	B-NP	CD	O	13	NMOD
12	to	to	B-PP	TO	O	11	NMOD
13	four-fold	four-fold	B-NP	RB	O	10	PMOD
14	,	,	O	,	O	7	P
15	though	though	B-SBAR	IN	O	7	VMOD
16	there	there	B-NP	EX	O	17	SUB
17	was	be	B-VP	VBD	O	15	SBAR
18	no	no	B-NP	DT	O	19	NMOD
19	induction	induction	I-NP	NN	O	17	PRD
20	of	of	B-PP	IN	O	19	NMOD
21	M1-CAT	M1-CAT	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	increase	increase	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	LT-293	LT-293	B-NP	NN	B-DNA	6	NMOD
5	CAT	CAT	I-NP	NN	B-protein	6	NMOD
6	activity	activity	I-NP	NN	O	3	PMOD
7	mirrored	mirror	B-VP	VBD	O	0	ROOT
8	the	the	B-NP	DT	O	9	NMOD
9	increase	increase	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	LT	LT	B-NP	NN	B-protein	13	NMOD
12	biologic	biologic	I-NP	JJ	O	13	NMOD
13	activity	activity	I-NP	NN	O	10	PMOD
14	seen	see	B-VP	VBN	O	13	NMOD
15	under	under	B-PP	IN	O	14	VMOD
16	these	these	B-NP	DT	O	17	NMOD
17	conditions	condition	I-NP	NNS	O	15	PMOD
18	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	5	NMOD
3	,	,	O	,	O	5	P
4	the	the	B-NP	DT	O	5	NMOD
5	first	first	I-NP	JJ	O	17	SUB
6	to	to	B-VP	TO	O	7	VMOD
7	demonstrate	demonstrate	I-VP	VB	O	5	NMOD
8	induction	induction	B-NP	NN	O	7	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	LT	LT	B-NP	NN	B-DNA	11	NMOD
11	promoter	promoter	I-NP	NN	I-DNA	12	NMOD
12	activity	activity	I-NP	NN	O	9	PMOD
13	over	over	B-PP	IN	O	8	NMOD
14	basal	basal	B-NP	JJ	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	PMOD
16	,	,	O	,	O	5	P
17	indicate	indicate	B-VP	VBP	O	0	ROOT
18	that	that	B-SBAR	IN	O	17	VMOD
19	HTLV-I	HTLV-I	B-NP	NN	B-protein	20	NMOD
20	tax	tax	I-NP	NN	I-protein	21	SUB
21	causes	cause	B-VP	VBZ	O	18	SBAR
22	low-level	low-level	B-NP	JJ	O	23	NMOD
23	activation	activation	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	both	both	O	CC	O	31	NMOD
26	endogenous	endogenous	B-NP	JJ	O	27	NMOD
27	LT	LT	I-NP	NN	B-protein	31	NMOD
28	and	and	O	CC	O	31	NMOD
29	the	the	B-NP	DT	O	31	NMOD
30	LT	LT	I-NP	NN	B-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
32	,	,	O	,	O	21	P
33	at	at	B-ADVP	IN	O	35	PMOD
34	least	least	I-ADVP	JJS	O	33	AMOD
35	in	in	B-PP	IN	O	37	PMOD
36	part	part	B-NP	NN	O	35	PMOD
37	through	through	B-PP	IN	O	21	VMOD
38	activation	activation	B-NP	NN	O	37	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	NF-kappa	NF-kappa	B-NP	NN	B-protein	41	NMOD
41	B	B	I-NP	NN	I-protein	39	PMOD
42	.	.	O	.	O	17	P

1	Induction	Induction	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	tyrosine	tyrosine	B-NP	NN	O	4	NMOD
4	phosphorylation	phosphorylation	I-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	T-cell	T-cell	B-NP	NN	B-cell_type	7	NMOD
7	activation	activation	I-NP	NN	O	2	PMOD
8	by	by	B-PP	IN	O	1	NMOD
9	vanadate	vanadate	B-NP	NN	O	10	NMOD
10	peroxide	peroxide	I-NP	NN	O	13	NMOD
11	,	,	O	,	O	13	P
12	an	an	B-NP	DT	O	13	NMOD
13	inhibitor	inhibitor	I-NP	NN	O	8	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	protein	protein	B-NP	NN	B-protein	17	NMOD
16	tyrosine	tyrosine	I-NP	NN	I-protein	17	NMOD
17	phosphatases	phosphatas	I-NP	NNS	I-protein	14	PMOD
18	.	.	O	.	O	1	P

1	Rapid	Rapid	B-NP	JJ	O	3	NMOD
2	tyrosine	tyrosine	I-NP	NN	O	3	NMOD
3	phosphorylation	phosphorylation	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	key	key	B-NP	JJ	B-protein	7	NMOD
6	cellular	cellular	I-NP	JJ	I-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	4	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	crucial	crucial	I-NP	JJ	O	11	NMOD
11	event	event	I-NP	NN	O	8	PRD
12	in	in	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	transduction	transduction	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	activation	activation	B-NP	NN	O	17	NMOD
17	signals	signal	I-NP	NNS	O	15	PMOD
18	to	to	B-PP	TO	O	14	NMOD
19	T-lymphocytes	T-lymphocyte	B-NP	NNS	B-cell_type	18	PMOD
20	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	regulatory	regulatory	I-NP	JJ	O	3	NMOD
3	role	role	I-NP	NN	O	14	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	protein	protein	B-NP	NN	B-protein	7	NMOD
6	tyrosine	tyrosine	I-NP	NN	I-protein	7	NMOD
7	phosphatases	phosphatas	I-NP	NNS	I-protein	4	PMOD
8	(	(	O	(	O	9	P
9	PTPases	PTPas	B-NP	NNS	B-protein	7	NMOD
10	)	)	O	)	O	9	P
11	in	in	B-PP	IN	O	3	NMOD
12	this	this	B-NP	DT	O	13	NMOD
13	process	process	I-NP	NN	O	11	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	explored	explore	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	studying	study	B-VP	VBG	O	16	PMOD
18	the	the	B-NP	DT	O	19	NMOD
19	effects	effect	I-NP	NNS	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	a	a	B-NP	DT	O	24	NMOD
22	powerful	powerful	I-NP	JJ	O	24	NMOD
23	PTPase	PTPase	I-NP	NN	B-protein	24	NMOD
24	inhibitor	inhibitor	I-NP	NN	O	27	NMOD
25	,	,	O	,	O	27	P
26	vanadate	vanadate	B-NP	NN	O	27	NMOD
27	peroxide	peroxide	I-NP	NN	O	20	PMOD
28	(	(	O	(	O	29	P
29	pervanadate	pervanadate	B-NP	NN	O	27	NMOD
30	)	)	O	)	O	29	P
31	,	,	O	,	O	15	P
32	on	on	B-PP	IN	O	15	VMOD
33	the	the	B-NP	DT	O	35	NMOD
34	activation	activation	I-NP	NN	O	35	NMOD
35	cascade	cascade	I-NP	NN	O	32	PMOD
36	of	of	B-PP	IN	O	35	NMOD
37	Jurkat	Jurkat	B-NP	NN	B-cell_line	40	NMOD
38	human	human	I-NP	JJ	I-cell_line	40	NMOD
39	leukaemic	leukaemic	I-NP	JJ	I-cell_line	40	NMOD
40	T-cells	T-cell	I-NP	NNS	I-cell_line	36	PMOD
41	.	.	O	.	O	14	P

1	Pervanadate	Pervanadate	B-NP	NN	O	2	SUB
2	induced	induce	B-VP	VBD	O	0	ROOT
3	activation	activation	B-NP	NN	O	20	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	tyrosine	tyrosine	I-NP	NN	B-protein	7	NMOD
7	kinases	kinase	I-NP	NNS	I-protein	4	PMOD
8	lck	lck	I-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	fyn	fyn	I-NP	NN	B-protein	7	NMOD
11	(	(	O	(	O	14	P
12	4-	4-	B-NP	CD	O	14	AMOD
13	and	and	O	CC	O	14	AMOD
14	3-fold	3-fold	B-ADJP	RB	O	7	NMOD
15	respectively	respectively	I-ADJP	RB	O	14	NMOD
16	)	)	O	)	O	14	P
17	and	and	O	CC	O	20	NMOD
18	a	a	B-NP	DT	O	20	NMOD
19	dramatic	dramatic	I-NP	JJ	O	20	NMOD
20	increase	increase	I-NP	NN	O	2	OBJ
21	in	in	B-PP	IN	O	20	NMOD
22	tyrosine	tyrosine	B-NP	NN	O	23	NMOD
23	phosphorylation	phosphorylation	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	cellular	cellular	B-NP	JJ	B-protein	26	NMOD
26	proteins	protein	I-NP	NNS	I-protein	24	PMOD
27	,	,	O	,	O	31	P
28	notably	notably	B-NP	RB	O	31	NMOD
29	phospholipase	phospholipase	I-NP	NN	B-protein	31	NMOD
30	C	C	I-NP	NN	I-protein	31	NMOD
31	gamma	gamma	I-NP	NN	I-protein	26	NMOD
32	1	1	I-NP	CD	I-protein	31	NMOD
33	.	.	O	.	O	2	P

1	After	After	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	event	event	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	observed	observe	B-VP	VBD	O	0	ROOT
7	a	a	B-NP	DT	O	8	NMOD
8	rise	rise	I-NP	NN	O	6	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	intracellular	intracellular	B-NP	JJ	O	12	NMOD
11	Ca2+	Ca2+	I-NP	NN	O	12	NMOD
12	concentration	concentration	I-NP	NN	O	9	PMOD
13	,	,	O	,	O	8	P
14	corresponding	correspond	B-VP	VBG	O	8	NMOD
15	to	to	B-PP	TO	O	14	VMOD
16	an	an	B-NP	DT	O	17	NMOD
17	influx	influx	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	required	require	B-VP	VBD	O	0	ROOT
4	surface	surface	B-NP	NN	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	CD45	CD45	I-NP	NN	B-protein	9	NMOD
9	PTPase	PTPase	I-NP	NN	I-protein	6	PMOD
10	and	and	O	CC	O	3	VMOD
11	was	be	B-VP	VBD	O	3	VMOD
12	not	not	I-VP	RB	O	11	VMOD
13	observed	observe	I-VP	VBN	O	11	VC
14	in	in	B-PP	IN	O	13	VMOD
15	CD45-deficient	CD45-deficient	B-NP	JJ	B-cell_line	16	NMOD
16	variants	variant	I-NP	NNS	I-cell_line	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	Jurkat	Jurkat	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	13	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	CD45-negative	CD45-negative	I-NP	JJ	B-cell_line	4	NMOD
4	variant	variant	I-NP	NN	I-cell_line	1	PMOD
5	,	,	O	,	O	13	P
6	the	the	B-NP	DT	O	7	NMOD
7	effect	effect	I-NP	NN	O	13	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	pervanadate	pervanadate	B-NP	NN	O	8	PMOD
10	on	on	B-PP	IN	O	7	NMOD
11	tyrosine	tyrosine	B-NP	NN	O	12	NMOD
12	phosphorylation	phosphorylation	I-NP	NN	O	10	PMOD
13	was	be	B-VP	VBD	O	20	VMOD
14	globally	globally	I-VP	RB	O	13	VMOD
15	decreased	decrease	I-VP	VBN	O	13	VC
16	and	and	O	CC	O	20	VMOD
17	some	some	B-NP	DT	O	19	NMOD
18	phosphorylated	phosphorylate	I-NP	VBN	O	19	NMOD
19	substrates	substrate	I-NP	NNS	O	20	SUB
20	were	be	B-VP	VBD	O	0	ROOT
21	specifically	specifically	B-ADJP	RB	O	22	AMOD
22	missing	missing	I-ADJP	JJ	O	20	PRD
23	.	.	O	.	O	20	P

1	Pervanadate	Pervanadate	B-NP	NN	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	stimulated	stimulate	B-VP	VBD	O	0	ROOT
4	transcription	transcription	B-NP	NN	O	10	NMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	c-fos	c-fos	I-NP	NN	B-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	5	PMOD
9	and	and	O	CC	O	10	NMOD
10	accumulation	accumulation	B-NP	NN	O	19	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	its	its	B-NP	PRP$	O	13	NMOD
13	mRNA	mRNA	I-NP	NN	B-RNA	11	PMOD
14	as	as	B-CONJP	RB	O	19	NMOD
15	well	well	I-CONJP	RB	O	14	DEP
16	as	as	I-CONJP	IN	O	14	DEP
17	several	several	B-NP	JJ	O	19	NMOD
18	other	other	I-NP	JJ	O	19	NMOD
19	hallmarks	hallmark	I-NP	NNS	O	3	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	T-lymphocyte	T-lymphocyte	B-NP	NN	B-cell_type	22	NMOD
22	activation	activation	I-NP	NN	O	20	PMOD
23	such	such	B-PP	JJ	O	24	PMOD
24	as	as	I-PP	IN	O	22	NMOD
25	surface	surface	B-NP	NN	O	26	NMOD
26	expression	expression	I-NP	NN	O	36	NMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	30	NMOD
29	CD69	CD69	I-NP	NN	B-protein	30	NMOD
30	antigen	antigen	I-NP	NN	I-protein	27	PMOD
31	and	and	O	CC	O	36	NMOD
32	the	the	B-NP	DT	O	36	NMOD
33	interleukin	interleukin	I-NP	NN	B-protein	36	NMOD
34	2	2	I-NP	CD	I-protein	36	NMOD
35	receptor	receptor	I-NP	NN	I-protein	36	NMOD
36	alpha-chain	alpha-chain	I-NP	NN	I-protein	24	PMOD
37	(	(	O	(	O	38	P
38	CD25	CD25	B-NP	NN	B-protein	36	NMOD
39	)	)	O	)	O	38	P
40	.	.	O	.	O	3	P

1	Pervanadate	Pervanadate	B-NP	NN	O	2	SUB
2	synergized	synergize	B-VP	VBD	O	0	ROOT
3	with	with	B-PP	IN	O	2	VMOD
4	signals	signal	B-NP	NNS	O	3	PMOD
5	delivered	deliver	B-VP	VBN	O	4	NMOD
6	by	by	B-PP	IN	O	5	VMOD
7	T-cell	T-cell	B-NP	NN	B-protein	9	NMOD
8	antigen	antigen	I-NP	NN	I-protein	9	NMOD
9	receptor	receptor	I-NP	NN	I-protein	10	NMOD
10	engagement	engagement	I-NP	NN	O	6	PMOD
11	or	or	B-PP	CC	O	6	PMOD
12	by	by	B-PP	IN	O	6	PMOD
13	a	a	B-NP	DT	O	15	NMOD
14	phorbol	phorbol	I-NP	NN	O	15	NMOD
15	ester	ester	I-NP	NN	O	12	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	induce	induce	I-VP	VB	O	2	VMOD
18	interleukin	interleukin	B-NP	NN	B-protein	20	NMOD
19	2	2	I-NP	CD	I-protein	20	NMOD
20	production	production	I-NP	NN	O	17	OBJ
21	.	.	O	.	O	2	P

1	Pervanadate	Pervanadate	B-NP	NN	O	2	SUB
2	activated	activate	B-VP	VBD	O	0	ROOT
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	2	OBJ
5	,	,	O	,	O	2	P
6	as	as	B-SBAR	IN	O	2	VMOD
7	shown	show	B-VP	VBN	O	6	SBAR
8	by	by	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	10	NMOD
10	increase	increase	I-NP	NN	O	8	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	DNA-binding	DNA-binding	B-NP	JJ	O	13	NMOD
13	activity	activity	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	this	this	B-NP	DT	O	17	NMOD
16	transcription	transcription	I-NP	NN	B-protein	17	NMOD
17	factor	factor	I-NP	NN	I-protein	14	PMOD
18	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	3	SUB
2	thus	thus	B-ADVP	RB	O	3	VMOD
3	conclude	conclude	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	PTPases	PTPas	B-NP	NNS	B-protein	6	SUB
6	play	play	B-VP	VBP	O	4	SBAR
7	a	a	B-NP	DT	O	9	NMOD
8	crucial	crucial	I-NP	JJ	O	9	NMOD
9	role	role	I-NP	NN	O	6	OBJ
10	in	in	B-PP	IN	O	6	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	negative	negative	I-NP	JJ	O	13	NMOD
13	regulation	regulation	I-NP	NN	O	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	signal	signal	B-NP	NN	O	16	NMOD
16	transduction	transduction	I-NP	NN	O	14	PMOD
17	culminating	culminate	B-VP	VBG	O	16	NMOD
18	in	in	B-PP	IN	O	17	VMOD
19	T-lymphocyte	T-lymphocyte	B-NP	NN	B-cell_type	20	NMOD
20	activation	activation	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	3	P

1	Moreover	Moreover	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	induction	induction	B-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	tyrosine	tyrosine	B-NP	NN	O	6	NMOD
6	phosphorylation	phosphorylation	I-NP	NN	O	4	PMOD
7	appears	appear	B-VP	VBZ	O	0	ROOT
8	sufficient	sufficient	B-NP	JJ	O	7	PRD
9	per	per	I-NP	FW	O	10	NMOD
10	se	se	I-NP	FW	O	8	NMOD
11	to	to	B-VP	TO	O	12	VMOD
12	initiate	initiate	I-VP	VB	O	8	AMOD
13	a	a	B-NP	DT	O	16	NMOD
14	complete	complete	I-NP	JJ	O	16	NMOD
15	activation	activation	I-NP	NN	O	16	NMOD
16	programme	programme	I-NP	NN	O	12	OBJ
17	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	7	NMOD
2	interleukin-8	interleukin-8	I-NP	NN	B-DNA	3	NMOD
3	AP-1	AP-1	I-NP	NN	I-DNA	7	NMOD
4	and	and	O	CC	I-DNA	7	NMOD
5	kappa	kappa	B-NP	NN	I-DNA	7	NMOD
6	B-like	B-like	I-NP	JJ	I-DNA	7	NMOD
7	sites	site	I-NP	NNS	I-DNA	8	SUB
8	are	be	B-VP	VBP	O	0	ROOT
9	genetic	genetic	B-NP	JJ	O	11	NMOD
10	end	end	I-NP	NN	O	11	NMOD
11	targets	target	I-NP	NNS	O	8	PRD
12	of	of	B-PP	IN	O	11	NMOD
13	FK506-sensitive	FK506-sensitive	B-NP	JJ	O	14	NMOD
14	pathway	pathway	I-NP	NN	O	12	PMOD
15	accompanied	accompany	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	calcium	calcium	B-NP	NN	O	18	NMOD
18	mobilization	mobilization	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	8	P

1	FK506	FK506	B-NP	NN	O	4	NMOD
2	,	,	O	,	O	4	P
3	an	an	B-NP	DT	O	4	NMOD
4	immunosuppressant	immunosuppressant	I-NP	NN	O	6	SUB
5	,	,	O	,	O	4	P
6	inhibits	inhibit	B-VP	VBZ	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	production	production	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	several	several	B-NP	JJ	O	9	PMOD
11	cytokines	cytokine	I-NP	NNS	B-protein	10	NMOD
12	in	in	B-PP	IN	O	8	NMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	PMOD
15	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	observed	observe	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	FK506	FK506	B-NP	NN	O	5	SUB
5	suppressed	suppress	B-VP	VBD	O	3	SBAR
6	the	the	B-NP	DT	O	7	NMOD
7	transcription	transcription	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	a	a	B-NP	DT	O	11	NMOD
10	chemotactic	chemotactic	I-NP	JJ	B-protein	11	NMOD
11	cytokine	cytokine	I-NP	NN	I-protein	8	PMOD
12	,	,	O	,	O	15	P
13	interleukin-8	interleukin-8	B-NP	NN	B-protein	15	NMOD
14	(	(	O	(	O	15	P
15	IL-8	IL-8	B-NP	NN	B-protein	11	NMOD
16	)	)	O	)	O	15	P
17	in	in	B-PP	IN	O	5	VMOD
18	a	a	B-NP	DT	O	22	NMOD
19	human	human	I-NP	JJ	B-cell_line	22	NMOD
20	T	T	I-NP	NN	I-cell_line	22	NMOD
21	cell	cell	I-NP	NN	I-cell_line	22	NMOD
22	line	line	I-NP	NN	I-cell_line	25	NMOD
23	,	,	O	,	O	25	P
24	Jurkat	Jurkat	B-NP	NN	B-cell_line	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
26	,	,	O	,	O	5	P
27	activated	activate	B-VP	VBN	O	5	VMOD
28	by	by	B-PP	IN	O	27	VMOD
29	phorbol	phorbol	B-NP	NN	O	31	NMOD
30	12-myristate	12-myristate	I-NP	NN	O	31	NMOD
31	13-acetate	13-acetate	I-NP	NN	O	36	NMOD
32	(	(	O	(	O	33	P
33	PMA	PMA	B-NP	NN	O	31	NMOD
34	)	)	O	)	O	33	P
35	and	and	O	CC	O	36	NMOD
36	calcium	calcium	B-NP	NN	O	40	NMOD
37	(	(	O	(	O	38	P
38	Ca2+	Ca2+	B-NP	NN	O	36	NMOD
39	)	)	O	)	O	38	P
40	ionophore	ionophore	B-NP	NN	O	28	PMOD
41	(	(	O	(	O	42	P
42	ionomycin	ionomycin	B-NP	NN	O	40	NMOD
43	)	)	O	)	O	42	P
44	.	.	O	.	O	2	P

1	By	By	B-PP	IN	O	17	VMOD
2	deleted	delete	B-VP	VBN	O	1	SBAR
3	and	and	O	CC	O	2	VMOD
4	mutated	mutate	B-VP	VBN	O	2	VMOD
5	analysis	analysis	B-NP	NN	O	4	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	IL-8	IL-8	I-NP	NN	B-DNA	9	NMOD
9	promoters	promoter	I-NP	NNS	I-DNA	6	PMOD
10	,	,	O	,	O	17	P
11	the	the	B-NP	DT	O	16	NMOD
12	AP-1	AP-1	I-NP	NN	B-DNA	16	NMOD
13	and	and	I-NP	CC	I-DNA	16	NMOD
14	kappa	kappa	I-NP	NN	I-DNA	16	NMOD
15	B-like	B-like	I-NP	JJ	I-DNA	16	NMOD
16	sites	site	I-NP	NNS	I-DNA	17	SUB
17	were	be	B-VP	VBD	O	0	ROOT
18	identified	identify	I-VP	VBN	O	17	VC
19	as	as	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	responsive	responsive	I-NP	JJ	B-DNA	22	NMOD
22	elements	element	I-NP	NNS	I-DNA	19	PMOD
23	for	for	B-PP	IN	O	22	NMOD
24	PMA	PMA	B-NP	NN	O	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	ionomycin	ionomycin	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	17	P

1	FK506	FK506	B-NP	NN	O	2	SUB
2	suppressed	suppress	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	transcriptions	transcription	I-NP	NNS	O	25	NMOD
5	through	through	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	11	NMOD
7	AP-1	AP-1	I-NP	NN	B-protein	11	NMOD
8	or	or	I-NP	CC	O	11	NMOD
9	kappa	kappa	I-NP	NN	B-DNA	11	NMOD
10	B-like	B-like	I-NP	JJ	I-DNA	11	NMOD
11	sites	site	I-NP	NNS	I-DNA	5	PMOD
12	induced	induce	B-VP	VBN	O	11	NMOD
13	by	by	B-PP	IN	O	12	VMOD
14	PMA	PMA	B-NP	NN	O	16	NMOD
15	plus	plus	O	CC	O	16	NMOD
16	Ca	Ca	B-NP	NN	O	21	NMOD
17	(	(	O	(	O	18	P
18	2+	2+	B-ADJP	JJ	O	16	NMOD
19	)	)	O	)	O	18	P
20	-mobilizing	-mobilizing	B-NP	JJ	O	21	NMOD
21	agents	agent	I-NP	NNS	O	13	PMOD
22	,	,	O	,	O	25	P
23	but	but	B-CONJP	CC	O	25	NMOD
24	not	not	I-CONJP	RB	O	23	DEP
25	those	those	B-NP	DT	O	2	OBJ
26	induced	induce	B-VP	VBN	O	25	NMOD
27	by	by	B-PP	IN	O	26	VMOD
28	Ca	Ca	B-NP	NN	O	33	NMOD
29	(	(	O	(	O	30	P
30	2+	2+	B-ADJP	JJ	O	28	NMOD
31	)	)	O	)	O	30	P
32	-independent	-independent	B-NP	JJ	O	33	NMOD
33	stimuli	stimulus	I-NP	NNS	O	27	PMOD
34	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	7	VMOD
2	gel	gel	B-NP	NN	O	4	NMOD
3	retardation	retardation	I-NP	NN	O	4	NMOD
4	analysis	analysis	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	FK506	FK506	B-NP	NN	O	7	SUB
7	had	have	B-VP	VBD	O	0	ROOT
8	little	little	B-NP	JJ	O	9	NMOD
9	effect	effect	I-NP	NN	O	7	OBJ
10	on	on	B-PP	IN	O	7	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	binding	binding	I-NP	NN	O	10	PMOD
13	to	to	B-PP	TO	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	AP-1	AP-1	I-NP	NN	B-DNA	16	NMOD
16	site	site	I-NP	NN	I-DNA	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	PMA/ionomycin-induced	PMA/ionomycin-induced	B-NP	JJ	B-protein	20	NMOD
19	nuclear	nuclear	I-NP	JJ	I-protein	20	NMOD
20	factors	factor	I-NP	NNS	I-protein	17	PMOD
21	,	,	O	,	O	20	P
22	which	which	B-NP	WDT	O	20	NMOD
23	were	be	B-VP	VBD	O	22	SBAR
24	recognized	recognize	I-VP	VBN	O	23	VC
25	with	with	B-PP	IN	O	24	VMOD
26	anti-JunD	anti-JunD	B-NP	JJ	B-protein	29	NMOD
27	or	or	I-NP	CC	O	29	NMOD
28	c-Fos	c-Fos	I-NP	NN	B-protein	29	NMOD
29	antibody	antibody	I-NP	NN	I-protein	25	PMOD
30	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	FK506	FK506	B-NP	NN	O	6	NMOD
5	or	or	O	CC	O	6	NMOD
6	EGTA	EGTA	B-NP	NN	O	12	SUB
7	(	(	O	(	O	9	P
8	Ca2+	Ca2+	B-NP	NN	O	9	NMOD
9	chelator	chelator	I-NP	NN	O	6	NMOD
10	)	)	O	)	O	9	P
11	similarly	similarly	B-VP	RB	O	12	VMOD
12	affected	affect	I-VP	VBD	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	formation	formation	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	kappa	kappa	B-NP	NN	B-protein	20	NMOD
17	B-like	B-like	I-NP	JJ	I-protein	20	NMOD
18	site	site	I-NP	NN	I-protein	20	NMOD
19	binding	binding	I-NP	NN	I-protein	20	NMOD
20	complexes	complex	I-NP	NNS	I-protein	15	PMOD
21	,	,	O	,	O	14	P
22	which	which	B-NP	WDT	O	14	NMOD
23	were	be	B-VP	VBD	O	22	SBAR
24	not	not	I-VP	RB	O	23	VMOD
25	recognized	recognize	I-VP	VBN	O	23	VC
26	by	by	B-PP	IN	O	25	VMOD
27	any	any	B-NP	DT	O	28	NMOD
28	antibodies	antibody	I-NP	NNS	B-protein	26	PMOD
29	against	against	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	34	NMOD
31	human	human	I-NP	JJ	B-protein	34	NMOD
32	Rel	Rel	I-NP	NN	I-protein	34	NMOD
33	family	family	I-NP	NN	I-protein	34	NMOD
34	proteins	protein	I-NP	NNS	I-protein	29	PMOD
35	(	(	O	(	O	43	P
36	c-Rel	c-Rel	B-NP	NN	B-protein	43	NMOD
37	,	,	O	,	O	43	P
38	p65	p65	B-NP	NN	B-protein	43	NMOD
39	,	,	O	,	O	43	P
40	p50	p50	B-NP	NN	B-protein	43	NMOD
41	,	,	O	,	O	43	P
42	and	and	O	CC	O	43	NMOD
43	p49	p49	B-NP	NN	B-protein	34	NMOD
44	)	)	O	)	O	43	P
45	.	.	O	.	O	12	P

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	confirmed	confirm	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	7	NMOD
6	previous	previous	I-NP	JJ	O	7	NMOD
7	report	report	I-NP	NN	O	4	OBJ
8	that	that	B-SBAR	IN	O	7	NMOD
9	FK506	FK506	B-NP	NN	O	10	SUB
10	suppressed	suppress	B-VP	VBD	O	8	SBAR
11	the	the	B-NP	DT	O	13	NMOD
12	PMA/ionomycin-induced	PMA/ionomycin-induced	I-NP	JJ	O	13	NMOD
13	activation	activation	I-NP	NN	O	10	OBJ
14	through	through	B-PP	IN	O	10	VMOD
15	authentic	authentic	B-NP	JJ	O	14	PMOD
16	kappa	kappa	I-NP	NN	B-DNA	18	NMOD
17	B	B	I-NP	NN	I-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	15	NMOD
19	of	of	B-PP	IN	O	15	NMOD
20	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	24	NMOD
21	(	(	O	(	I-DNA	24	P
22	Ig	Ig	B-NP	NN	I-DNA	24	NMOD
23	)	)	O	)	I-DNA	24	P
24	gene	gene	B-NP	NN	I-DNA	19	PMOD
25	,	,	O	,	O	24	P
26	to	to	B-PP	TO	O	15	NMOD
27	which	which	B-NP	WDT	O	26	PMOD
28	NF-kappa	NF-kappa	B-NP	NN	B-protein	30	NMOD
29	B	B	I-NP	NN	I-protein	30	NMOD
30	binding	binding	I-NP	NN	O	26	PMOD
31	was	be	B-VP	VBD	O	4	VMOD
32	also	also	I-VP	RB	O	31	VMOD
33	decreased	decrease	I-VP	VBN	O	31	VC
34	by	by	B-PP	IN	O	33	VMOD
35	FK506	FK506	B-NP	NN	O	34	PMOD
36	,	,	O	,	O	4	P
37	indicating	indicate	B-VP	VBG	O	4	VMOD
38	that	that	B-SBAR	IN	O	37	VMOD
39	both	both	O	CC	O	48	NMOD
40	IL-8	IL-8	B-NP	NN	B-DNA	43	NMOD
41	kappa	kappa	I-NP	NN	I-DNA	43	NMOD
42	B-like	B-like	I-NP	JJ	I-DNA	43	NMOD
43	site	site	I-NP	NN	I-DNA	48	NMOD
44	and	and	I-NP	CC	O	48	NMOD
45	Ig	Ig	I-NP	NN	O	48	NMOD
46	kappa	kappa	I-NP	NN	B-DNA	48	NMOD
47	B	B	I-NP	NN	I-DNA	48	NMOD
48	site	site	I-NP	NN	I-DNA	49	SUB
49	are	be	B-VP	VBP	O	38	SBAR
50	FK506-sensitive	FK506-sensitive	B-ADJP	JJ	O	49	PRD
51	in	in	B-PP	IN	O	50	AMOD
52	spite	spite	B-NP	NN	O	51	PMOD
53	of	of	B-PP	IN	O	52	NMOD
54	the	the	B-NP	DT	O	55	NMOD
55	difference	difference	I-NP	NN	O	53	PMOD
56	of	of	B-PP	IN	O	55	NMOD
57	binding	bind	B-NP	VBG	B-protein	58	NMOD
58	factors	factor	I-NP	NNS	I-protein	56	PMOD
59	.	.	O	.	O	4	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	not	not	B-CONJP	RB	O	29	VMOD
6	only	only	I-CONJP	RB	O	5	DEP
7	the	the	B-NP	DT	O	13	NMOD
8	reported	report	I-NP	VBN	O	13	NMOD
9	IL-2	IL-2	I-NP	NN	B-DNA	10	NMOD
10	NF-AT	NF-AT	I-NP	NN	I-DNA	13	NMOD
11	and	and	I-NP	CC	I-DNA	13	NMOD
12	NFIL-2A	NFIL-2A	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	18	NMOD
14	and	and	O	CC	O	18	NMOD
15	Ig	Ig	B-NP	NN	O	18	NMOD
16	kappa	kappa	I-NP	NN	B-DNA	18	NMOD
17	B	B	I-NP	NN	I-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	28	NMOD
19	,	,	O	,	O	28	P
20	but	but	B-CONJP	CC	O	28	NMOD
21	also	also	I-CONJP	RB	O	20	DEP
22	the	the	B-NP	DT	O	24	NMOD
23	IL-8	IL-8	I-NP	NN	B-protein	24	NMOD
24	AP-1	AP-1	I-NP	NN	O	28	NMOD
25	and	and	O	CC	O	28	NMOD
26	kappa	kappa	B-NP	NN	B-DNA	28	NMOD
27	B-like	B-like	I-NP	JJ	I-DNA	28	NMOD
28	sites	site	I-NP	NNS	I-DNA	29	SUB
29	are	be	B-VP	VBP	O	4	SBAR
30	terminals	terminal	B-NP	NNS	O	29	PRD
31	of	of	B-PP	IN	O	30	NMOD
32	FK506-sensitive	FK506-sensitive	B-NP	JJ	O	33	NMOD
33	pathway	pathway	I-NP	NN	O	31	PMOD
34	involving	involve	B-VP	VBG	O	33	NMOD
35	Ca2+	Ca2+	B-NP	NN	O	36	NMOD
36	mobilization	mobilization	I-NP	NN	O	34	OBJ
37	.	.	O	.	O	3	P

1	Monocyte	Monocyte	B-NP	NN	O	2	NMOD
2	tethering	tethering	I-NP	NN	O	5	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	P-selectin	P-selectin	B-NP	NN	B-protein	3	PMOD
5	regulates	regulate	B-VP	VBZ	O	0	ROOT
6	monocyte	monocyte	B-NP	NN	B-protein	8	NMOD
7	chemotactic	chemotactic	I-NP	JJ	I-protein	8	NMOD
8	protein-1	protein-1	I-NP	NN	I-protein	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	tumor	tumor	B-NP	NN	B-protein	12	NMOD
11	necrosis	necrosis	I-NP	NN	I-protein	12	NMOD
12	factor-alpha	factor-alpha	I-NP	NN	I-protein	13	NMOD
13	secretion	secretion	I-NP	NN	O	5	OBJ
14	.	.	O	.	O	5	P

1	Signal	Signal	B-NP	NN	O	2	NMOD
2	integration	integration	I-NP	NN	O	6	NMOD
3	and	and	O	CC	O	6	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	6	NMOD
5	B	B	I-NP	NN	I-protein	6	NMOD
6	translocation	translocation	I-NP	NN	O	0	ROOT
7	[	[	O	(	O	8	P
8	see	see	B-VP	VB	O	6	NMOD
9	comments	comment	B-NP	NNS	O	8	OBJ
10	]	]	O	)	O	6	P

1	Adhesion	Adhesion	B-NP	NN	B-protein	2	NMOD
2	molecules	molecule	I-NP	NNS	I-protein	10	SUB
3	that	that	B-NP	WDT	O	2	NMOD
4	tether	tether	B-VP	VBP	O	3	SBAR
5	circulating	circulate	I-VP	VBG	B-cell_type	6	NMOD
6	leukocytes	leukocyte	B-NP	NNS	I-cell_type	4	OBJ
7	to	to	B-PP	TO	O	4	VMOD
8	endothelial	endothelial	B-NP	JJ	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	may	may	B-VP	MD	O	0	ROOT
11	also	also	I-VP	RB	O	10	VMOD
12	transduce	transduce	I-VP	VB	O	10	VC
13	or	or	I-VP	CC	O	12	VMOD
14	modulate	modulate	I-VP	VB	O	12	VMOD
15	outside-in	outside-in	B-NP	JJ	O	16	NMOD
16	signals	signal	I-NP	NNS	O	12	VMOD
17	for	for	B-PP	IN	O	16	NMOD
18	cellular	cellular	B-NP	JJ	O	19	NMOD
19	activation	activation	I-NP	NN	O	17	PMOD
20	,	,	O	,	O	10	P
21	providing	provide	B-VP	VBG	O	10	VMOD
22	an	an	B-NP	DT	O	25	NMOD
23	initial	initial	I-NP	JJ	O	25	NMOD
24	regulatory	regulatory	I-NP	JJ	O	25	NMOD
25	point	point	I-NP	NN	O	21	OBJ
26	in	in	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	inflammatory	inflammatory	I-NP	JJ	O	29	NMOD
29	response	response	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	10	P

1	Adhesion	Adhesion	B-NP	NN	O	14	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-cell_type	4	NMOD
4	monocytes	monocyte	I-NP	NNS	I-cell_type	2	PMOD
5	to	to	B-PP	TO	O	1	NMOD
6	P-selectin	P-selectin	B-NP	NN	B-protein	5	PMOD
7	,	,	O	,	O	14	P
8	the	the	B-NP	DT	O	14	NMOD
9	most	most	I-NP	RBS	O	10	AMOD
10	rapidly	rapidly	I-NP	RB	O	11	AMOD
11	expressed	express	I-NP	VBN	O	14	NMOD
12	endothelial	endothelial	I-NP	JJ	B-protein	14	NMOD
13	tethering	tethering	I-NP	NN	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	16	SUB
15	,	,	O	,	O	14	P
16	increased	increase	B-VP	VBD	O	0	ROOT
17	the	the	B-NP	DT	O	18	NMOD
18	secretion	secretion	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	monocyte	monocyte	B-NP	NN	B-protein	22	NMOD
21	chemotactic	chemotactic	I-NP	JJ	I-protein	22	NMOD
22	protein-1	protein-1	I-NP	NN	I-protein	29	NMOD
23	(	(	O	(	O	24	P
24	MCP-1	MCP-1	B-NP	NN	B-protein	22	NMOD
25	)	)	O	)	O	24	P
26	and	and	O	CC	O	29	NMOD
27	tumor	tumor	B-NP	NN	B-protein	29	NMOD
28	necrosis	necrosis	I-NP	NN	I-protein	29	NMOD
29	factor-alpha	factor-alpha	I-NP	NN	I-protein	19	PMOD
30	(	(	O	(	O	31	P
31	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	29	NMOD
32	)	)	O	)	O	31	P
33	by	by	B-PP	IN	O	16	VMOD
34	the	the	B-NP	DT	O	35	NMOD
35	leukocytes	leukocyte	I-NP	NNS	B-cell_type	33	PMOD
36	when	when	B-ADVP	WRB	O	16	VMOD
37	they	they	B-NP	PRP	O	38	SUB
38	were	be	B-VP	VBD	O	36	SBAR
39	stimulated	stimulate	I-VP	VBN	O	38	VC
40	with	with	B-PP	IN	O	39	VMOD
41	platelet-activating	platelet-activating	B-NP	JJ	B-protein	42	NMOD
42	factor	factor	I-NP	NN	I-protein	40	PMOD
43	.	.	O	.	O	16	P

1	Increased	Increase	B-NP	VBN	O	3	NMOD
2	cytokine	cytokine	I-NP	NN	B-protein	3	NMOD
3	secretion	secretion	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	specifically	specifically	I-VP	RB	O	4	VMOD
6	inhibited	inhibit	I-VP	VBN	O	4	VC
7	by	by	B-PP	IN	O	6	VMOD
8	G1	G1	B-NP	NN	O	12	NMOD
9	,	,	O	,	O	12	P
10	an	an	B-NP	DT	O	12	NMOD
11	anti-P-selectin	anti-P-selectin	I-NP	JJ	B-protein	12	NMOD
12	mAb	mAb	I-NP	NN	I-protein	7	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	prevents	prevent	B-VP	VBZ	O	13	SBAR
15	P-selectin	P-selectin	B-NP	NN	B-protein	14	OBJ
16	from	from	B-PP	IN	O	14	VMOD
17	binding	bind	B-VP	VBG	O	16	PMOD
18	to	to	B-PP	TO	O	17	VMOD
19	its	its	B-NP	PRP$	O	20	NMOD
20	ligand	ligand	I-NP	NN	O	18	PMOD
21	(	(	O	(	O	24	P
22	P-selectin	P-selectin	B-NP	NN	B-protein	24	NMOD
23	glycoprotein	glycoprotein	I-NP	NN	I-protein	24	NMOD
24	ligand-1	ligand-1	I-NP	NN	I-protein	20	NMOD
25	)	)	O	)	O	24	P
26	on	on	B-PP	IN	O	20	NMOD
27	myeloid	myeloid	B-NP	JJ	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	.	.	O	.	O	4	P

1	Moreover	Moreover	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	tethering	tethering	B-NP	NN	O	7	SUB
4	by	by	B-PP	IN	O	3	NMOD
5	P-selectin	P-selectin	B-NP	NN	B-protein	4	PMOD
6	specifically	specifically	B-ADVP	RB	O	7	VMOD
7	enhanced	enhance	B-VP	VBD	O	0	ROOT
8	nuclear	nuclear	B-NP	JJ	O	9	NMOD
9	translocation	translocation	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	nuclear	nuclear	B-NP	JJ	B-protein	13	NMOD
12	factor-kappa	factor-kappa	I-NP	NN	I-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	21	NMOD
14	(	(	O	(	O	16	P
15	NF-kappa	NF-kappa	B-NP	NN	B-protein	16	NMOD
16	B	B	I-NP	NN	I-protein	13	NMOD
17	)	)	O	)	O	16	P
18	,	,	O	,	O	21	P
19	a	a	B-NP	DT	O	21	NMOD
20	transcription	transcription	I-NP	NN	B-protein	21	NMOD
21	factor	factor	I-NP	NN	I-protein	10	PMOD
22	required	require	B-VP	VBN	O	21	NMOD
23	for	for	B-PP	IN	O	22	VMOD
24	expression	expression	B-NP	NN	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	MCP-1	MCP-1	B-NP	NN	B-protein	33	NMOD
27	,	,	O	,	O	33	P
28	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	33	NMOD
29	,	,	O	,	O	33	P
30	and	and	O	CC	O	33	NMOD
31	other	other	B-NP	JJ	O	33	NMOD
32	immediate-early	immediate-early	I-NP	JJ	B-DNA	33	NMOD
33	genes	gene	I-NP	NNS	I-DNA	25	PMOD
34	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	P-selectin	P-selectin	B-NP	NN	B-protein	13	SUB
6	,	,	O	,	O	5	P
7	through	through	B-PP	IN	O	5	NMOD
8	its	its	B-NP	PRP$	O	9	NMOD
9	ligands	ligand	I-NP	NNS	O	7	PMOD
10	on	on	B-PP	IN	O	9	NMOD
11	monocytes	monocyte	B-NP	NNS	B-cell_type	10	PMOD
12	,	,	O	,	O	5	P
13	may	may	B-VP	MD	O	4	SBAR
14	locally	locally	I-VP	RB	O	13	VMOD
15	regulate	regulate	I-VP	VB	O	13	VC
16	cytokine	cytokine	B-NP	NN	B-protein	17	NMOD
17	secretion	secretion	I-NP	NN	O	15	OBJ
18	in	in	B-PP	IN	O	15	VMOD
19	inflamed	inflamed	B-NP	JJ	O	20	NMOD
20	tissues	tissue	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	3	P

1	HMG-I	HMG-I	B-NP	NN	B-protein	2	SUB
2	binds	bind	B-VP	VBZ	O	0	ROOT
3	to	to	B-PP	TO	O	2	VMOD
4	GATA	GATA	B-NP	NN	B-DNA	5	NMOD
5	motifs	motif	I-NP	NNS	I-DNA	3	PMOD
6	:	:	O	:	O	2	P
7	implications	implication	B-NP	NNS	O	2	VMOD
8	for	for	B-PP	IN	O	7	NMOD
9	an	an	B-NP	DT	O	11	NMOD
10	HPFH	HPFH	I-NP	NN	O	11	NMOD
11	syndrome	syndrome	I-NP	NN	O	8	PMOD
12	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	examined	examine	I-VP	VBN	O	2	VC
4	binding	binding	B-NP	NN	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	nuclear	nuclear	I-NP	JJ	B-protein	8	NMOD
8	protein	protein	I-NP	NN	I-protein	9	NMOD
9	HMG-I	HMG-I	I-NP	NN	B-protein	5	PMOD
10	to	to	B-PP	TO	O	4	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	human	human	I-NP	JJ	B-DNA	14	NMOD
13	gamma-globin	gamma-globin	I-NP	NN	I-DNA	14	NMOD
14	promoter	promoter	I-NP	NN	I-DNA	10	PMOD
15	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	find	find	B-VP	VBP	O	26	VMOD
3	that	that	B-SBAR	IN	O	2	VMOD
4	HMG-I	HMG-I	B-NP	NN	B-protein	5	SUB
5	binds	bind	B-VP	VBZ	O	3	SBAR
6	preferentially	preferentially	B-ADVP	RB	O	5	VMOD
7	to	to	B-PP	TO	O	5	VMOD
8	the	the	B-NP	DT	O	7	PMOD
9	more	more	I-NP	JJR	O	8	NMOD
10	3	3	I-NP	CD	O	9	NMOD
11	'	'	B-NP	SYM	O	10	NMOD
12	of	of	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	14	NMOD
14	pair	pair	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	GATA	GATA	B-NP	NN	B-DNA	17	NMOD
17	motifs	motif	I-NP	NNS	I-DNA	15	PMOD
18	in	in	B-PP	IN	O	5	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	gamma-globin	gamma-globin	I-NP	NN	B-DNA	21	NMOD
21	promoter	promoter	I-NP	NN	I-DNA	18	PMOD
22	;	;	O	:	O	26	P
23	this	this	B-NP	DT	O	25	NMOD
24	paired	paired	I-NP	JJ	B-DNA	25	NMOD
25	motif	motif	I-NP	NN	I-DNA	26	SUB
26	is	be	B-VP	VBZ	O	0	ROOT
27	bound	bind	I-VP	VBN	O	26	VC
28	by	by	B-PP	IN	O	27	VMOD
29	the	the	B-NP	DT	O	32	NMOD
30	erythroid	erythroid	I-NP	JJ	B-protein	32	NMOD
31	factor	factor	I-NP	NN	I-protein	32	NMOD
32	GATA-1	GATA-1	I-NP	NN	I-protein	28	PMOD
33	.	.	O	.	O	26	P

1	A	A	B-NP	DT	O	4	NMOD
2	naturally	naturally	I-NP	RB	O	3	AMOD
3	occurring	occur	I-NP	VBG	O	4	NMOD
4	mutation	mutation	I-NP	NN	O	15	SUB
5	(	(	O	(	O	7	P
6	-175	-175	B-NP	CD	O	7	NMOD
7	T-C	T-C	I-NP	NN	O	4	NMOD
8	)	)	O	)	O	7	P
9	in	in	B-PP	IN	O	4	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	area	area	I-NP	NN	O	9	PMOD
12	bound	bind	B-VP	VBN	O	4	NMOD
13	by	by	B-PP	IN	O	12	VMOD
14	HMG-I	HMG-I	B-NP	NN	B-protein	13	PMOD
15	results	result	B-VP	VBZ	O	41	VMOD
16	in	in	B-PP	IN	O	15	VMOD
17	overexpression	overexpression	B-NP	NN	O	29	NMOD
18	of	of	B-PP	IN	O	17	NMOD
19	gamma-globin	gamma-globin	B-NP	NN	B-protein	18	PMOD
20	in	in	B-PP	IN	O	17	NMOD
21	adult	adult	B-NP	JJ	B-cell_type	24	NMOD
22	red	red	I-NP	JJ	I-cell_type	24	NMOD
23	blood	blood	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
25	(	(	O	(	O	26	P
26	HPFH	HPFH	B-NP	NN	B-cell_type	24	NMOD
27	)	)	O	)	O	26	P
28	and	and	O	CC	O	29	NMOD
29	up-regulation	up-regulation	B-NP	NN	O	16	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	gamma-globin	gamma-globin	I-NP	NN	B-DNA	33	NMOD
33	promoter	promoter	I-NP	NN	I-DNA	30	PMOD
34	in	in	B-PP	IN	O	29	NMOD
35	in	in	B-NP	FW	O	36	AMOD
36	vitro	vitro	I-NP	FW	O	38	NMOD
37	expression	expression	I-NP	NN	O	38	NMOD
38	assays	assay	I-NP	NNS	O	34	PMOD
39	;	;	O	:	O	41	P
40	HMG-I	HMG-I	B-NP	NN	B-protein	41	SUB
41	does	do	B-VP	VBZ	O	0	ROOT
42	not	not	I-VP	RB	O	41	VMOD
43	bind	bind	I-VP	VB	O	41	VC
44	to	to	B-PP	TO	O	43	VMOD
45	this	this	B-NP	DT	O	47	NMOD
46	mutant	mutant	I-NP	JJ	B-DNA	47	NMOD
47	sequence	sequence	I-NP	NN	I-DNA	44	PMOD
48	.	.	O	.	O	41	P

1	A	A	B-NP	DT	O	2	NMOD
2	survey	survey	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	GATA	GATA	B-NP	NN	B-DNA	5	NMOD
5	motifs	motif	I-NP	NNS	I-DNA	3	PMOD
6	from	from	B-PP	IN	O	5	NMOD
7	other	other	B-NP	JJ	O	9	NMOD
8	globin	globin	I-NP	NN	B-DNA	9	NMOD
9	cis-elements	cis-element	I-NP	NNS	I-DNA	6	PMOD
10	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
11	HMG-I	HMG-I	B-NP	NN	B-protein	10	OBJ
12	binding	bind	B-VP	VBG	O	11	NMOD
13	to	to	B-PP	TO	O	12	VMOD
14	most	most	B-NP	JJS	O	13	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	them	them	B-NP	PRP	O	15	PMOD
17	.	.	O	.	O	10	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	implicate	implicate	B-VP	VBP	O	11	VMOD
4	HMG-I	HMG-I	B-NP	NN	B-protein	3	OBJ
5	in	in	B-PP	IN	O	3	VMOD
6	the	the	B-NP	DT	O	8	NMOD
7	HPFH	HPFH	I-NP	NN	B-cell_type	8	NMOD
8	phenotype	phenotype	I-NP	NN	O	5	PMOD
9	;	;	O	:	O	11	P
10	we	we	B-NP	PRP	O	11	SUB
11	speculate	speculate	B-VP	VBP	O	0	ROOT
12	that	that	B-SBAR	IN	O	11	VMOD
13	it	it	B-NP	PRP	O	14	SUB
14	may	may	B-VP	MD	O	12	SBAR
15	participate	participate	I-VP	VB	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	formation	formation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	multiprotein	multiprotein	B-NP	NN	B-protein	21	NMOD
21	complexes	complex	I-NP	NNS	I-protein	19	PMOD
22	that	that	B-NP	WDT	O	21	NMOD
23	regulate	regulate	B-VP	VBP	O	22	SBAR
24	globin	globin	B-NP	NN	B-DNA	26	NMOD
25	gene	gene	I-NP	NN	I-DNA	26	NMOD
26	expression	expression	I-NP	NN	O	23	OBJ
27	.	.	O	.	O	11	P

1	Positive	Positive	B-NP	JJ	O	4	NMOD
2	and	and	I-NP	CC	O	4	NMOD
3	negative	negative	I-NP	JJ	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-DNA	10	NMOD
7	colony-stimulating	colony-stimulating	I-NP	JJ	I-DNA	10	NMOD
8	factor	factor	I-NP	NN	I-DNA	10	NMOD
9	promoter	promoter	I-NP	NN	I-DNA	10	NMOD
10	activity	activity	I-NP	NN	O	5	PMOD
11	by	by	B-PP	IN	O	4	NMOD
12	AML1-related	AML1-related	B-NP	JJ	B-protein	14	NMOD
13	transcription	transcription	I-NP	NN	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	16	NMOD
15	,	,	O	,	O	16	P
16	PEBP2	PEBP2	B-NP	NN	B-protein	11	PMOD
17	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	9	NMOD
2	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	B-DNA	9	NMOD
3	colony-stimulating	colony-stimulating	I-NP	JJ	I-DNA	9	NMOD
4	factor	factor	I-NP	NN	I-DNA	9	NMOD
5	(	(	O	(	I-DNA	9	P
6	GM-CSF	GM-CSF	B-NP	NN	I-DNA	9	NMOD
7	)	)	O	)	I-DNA	9	P
8	gene	gene	B-NP	NN	I-DNA	9	NMOD
9	promoter	promoter	I-NP	NN	I-DNA	10	SUB
10	contains	contain	B-VP	VBZ	O	0	ROOT
11	a	a	B-NP	DT	O	13	NMOD
12	consensus	consensus	I-NP	NN	B-DNA	13	NMOD
13	sequence	sequence	I-NP	NN	I-DNA	10	OBJ
14	for	for	B-PP	IN	O	10	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	polyomavirus	polyomavirus	I-NP	NN	B-protein	18	NMOD
17	enhancer	enhancer	I-NP	NN	I-protein	18	NMOD
18	binding-protein	binding-protein	I-NP	NN	I-protein	24	NMOD
19	2	2	I-NP	CD	I-protein	18	NMOD
20	(	(	O	(	I-protein	24	P
21	PEBP2	PEBP2	B-NP	NN	I-protein	24	NMOD
22	)	)	O	)	I-protein	24	P
23	transcription	transcription	B-NP	NN	I-protein	24	NMOD
24	factor	factor	I-NP	NN	I-protein	14	PMOD
25	,	,	O	,	O	24	P
26	which	which	B-NP	WDT	O	24	NMOD
27	consists	consist	B-VP	VBZ	O	26	SBAR
28	of	of	B-PP	IN	O	27	VMOD
29	alpha	alpha	B-NP	NN	B-protein	31	NMOD
30	and	and	O	CC	I-protein	31	NMOD
31	beta	beta	B-NP	NN	I-protein	32	NMOD
32	subunits	subunit	I-NP	NNS	I-protein	28	PMOD
33	.	.	O	.	O	10	P

1	There	There	B-NP	EX	O	2	SUB
2	are	be	B-VP	VBP	O	0	ROOT
3	at	at	B-NP	IN	O	6	NMOD
4	least	least	I-NP	JJS	O	3	AMOD
5	two	two	I-NP	CD	O	3	AMOD
6	genes	gene	I-NP	NNS	O	12	NMOD
7	,	,	O	,	O	12	P
8	alpha	alpha	B-NP	NN	B-DNA	9	NMOD
9	A	A	I-NP	NN	I-DNA	12	NMOD
10	and	and	I-NP	CC	O	12	NMOD
11	alpha	alpha	I-NP	NN	B-DNA	12	NMOD
12	B	B	I-NP	NN	I-DNA	2	PRD
13	,	,	O	,	O	12	P
14	encoding	encode	B-VP	VBG	O	12	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	alpha	alpha	I-NP	NN	B-protein	17	NMOD
17	subunit	subunit	I-NP	NN	I-protein	14	OBJ
18	.	.	O	.	O	2	P

1	alpha	alpha	B-NP	NN	B-DNA	2	NMOD
2	B	B	I-NP	NN	I-DNA	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	mouse	mouse	I-NP	NN	B-DNA	6	NMOD
6	homologue	homologue	I-NP	NN	I-DNA	3	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	human	human	B-NP	JJ	B-DNA	10	NMOD
9	AML1	AML1	I-NP	NN	I-DNA	10	NMOD
10	gene	gene	I-NP	NN	I-DNA	7	PMOD
11	detected	detect	B-VP	VBN	O	6	NMOD
12	at	at	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	breakpoints	breakpoint	I-NP	NNS	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	t	t	B-NP	NN	B-DNA	23	NMOD
17	(	(	O	(	I-DNA	20	P
18	8	8	B-NP	CD	I-DNA	20	NMOD
19	;	;	O	:	I-DNA	20	P
20	21	21	B-NP	CD	I-DNA	16	NMOD
21	)	)	O	)	I-DNA	20	P
22	and	and	O	CC	O	23	NMOD
23	t	t	B-NP	NN	O	30	NMOD
24	(	(	O	(	O	30	P
25	3	3	B-NP	CD	O	30	NMOD
26	;	;	O	:	O	30	P
27	21	21	B-NP	CD	O	30	NMOD
28	)	)	O	)	O	27	P
29	myeloid	myeloid	B-NP	JJ	O	30	NMOD
30	leukemias	leukemia	I-NP	NNS	O	15	PMOD
31	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	examined	examine	B-VP	VBD	O	0	ROOT
3	alpha	alpha	B-NP	NN	B-protein	4	NMOD
4	A1	A1	I-NP	NN	I-protein	16	NMOD
5	(	(	O	(	O	9	P
6	an	an	B-NP	DT	O	9	NMOD
7	alpha	alpha	I-NP	NN	B-protein	9	NMOD
8	A-gene	A-gene	I-NP	JJ	I-protein	9	NMOD
9	product	product	I-NP	NN	I-protein	4	NMOD
10	)	)	O	)	O	9	P
11	and	and	O	CC	O	16	NMOD
12	alpha	alpha	B-NP	NN	B-protein	13	NMOD
13	B1	B1	I-NP	NN	I-protein	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	alpha	alpha	B-NP	NN	B-protein	16	NMOD
16	B2	B2	I-NP	NN	I-protein	2	OBJ
17	(	(	O	(	O	21	P
18	two	two	B-NP	CD	O	21	NMOD
19	alpha	alpha	I-NP	NN	B-protein	21	NMOD
20	B-encoded	B-encoded	I-NP	JJ	I-protein	21	NMOD
21	isomers	isomer	I-NP	NNS	I-protein	16	NMOD
22	)	)	O	)	O	21	P
23	for	for	B-PP	IN	O	16	NMOD
24	their	their	B-NP	PRP$	O	25	NMOD
25	effects	effect	I-NP	NNS	O	23	PMOD
26	on	on	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	GM-CSF	GM-CSF	I-NP	NN	B-DNA	29	NMOD
29	promoter	promoter	I-NP	NN	I-DNA	26	PMOD
30	.	.	O	.	O	2	P

1	PEBP2	PEBP2	B-NP	NN	B-protein	3	NMOD
2	alpha	alpha	I-NP	NN	I-protein	3	NMOD
3	A1	A1	I-NP	NN	I-protein	11	NMOD
4	,	,	O	,	O	11	P
5	alpha	alpha	B-NP	NN	B-protein	6	NMOD
6	B1	B1	I-NP	NN	I-protein	11	NMOD
7	,	,	O	,	O	11	P
8	and	and	O	CC	O	10	NMOD
9	alpha	alpha	B-NP	NN	B-protein	10	NMOD
10	B2	B2	I-NP	NN	I-protein	11	NMOD
11	proteins	protein	I-NP	NNS	I-protein	12	SUB
12	bound	bind	B-VP	VBD	O	0	ROOT
13	the	the	B-NP	DT	O	15	NMOD
14	PEBP2	PEBP2	I-NP	NN	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	12	OBJ
16	within	within	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	mouse	mouse	I-NP	NN	B-DNA	20	NMOD
19	GM-CSF	GM-CSF	I-NP	NN	I-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	16	PMOD
21	.	.	O	.	O	12	P

1	PEBP2	PEBP2	B-NP	NN	B-protein	3	NMOD
2	alpha	alpha	I-NP	NN	I-protein	3	NMOD
3	A1	A1	I-NP	NN	I-protein	6	NMOD
4	and	and	O	CC	O	6	NMOD
5	alpha	alpha	B-NP	NN	B-protein	6	NMOD
6	B1	B1	I-NP	NN	I-protein	7	SUB
7	enhanced	enhance	B-VP	VBD	O	0	ROOT
8	the	the	B-NP	DT	O	9	NMOD
9	expression	expression	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	15	NMOD
12	GM-CSF	GM-CSF	I-NP	NN	B-DNA	15	NMOD
13	promoter-driven	promoter-driven	I-NP	JJ	I-DNA	15	NMOD
14	reporter	reporter	I-NP	NN	I-DNA	15	NMOD
15	plasmid	plasmid	I-NP	NN	I-DNA	10	PMOD
16	in	in	B-PP	IN	O	9	NMOD
17	unstimulated	unstimulated	B-NP	JJ	B-cell_line	19	AMOD
18	and	and	I-NP	CC	I-cell_line	19	AMOD
19	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	I-NP	NN	I-cell_line	24	NMOD
20	13-acetate/phytohemagglutinin-stimulated	13-acetate/phytohemagglutinin-stimulated	I-NP	JJ	I-cell_line	19	AMOD
21	human	human	I-NP	JJ	I-cell_line	24	NMOD
22	Jurkat	Jurkat	I-NP	NN	I-cell_line	24	NMOD
23	T	T	I-NP	NN	I-cell_line	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_line	16	PMOD
25	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	7	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	the	the	B-NP	DT	O	6	NMOD
5	promoter	promoter	I-NP	NN	O	6	NMOD
6	activity	activity	I-NP	NN	O	7	SUB
7	was	be	B-VP	VBD	O	0	ROOT
8	suppressed	suppress	I-VP	VBN	O	7	VC
9	by	by	B-PP	IN	O	8	VMOD
10	alpha	alpha	B-NP	NN	B-protein	11	NMOD
11	B2	B2	I-NP	NN	I-protein	9	PMOD
12	.	.	O	.	O	7	P

1	Coexpression	Coexpression	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	alpha	alpha	B-NP	NN	B-protein	4	NMOD
4	B1	B1	I-NP	NN	I-protein	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	alpha	alpha	B-NP	NN	B-protein	7	NMOD
7	B2	B2	I-NP	NN	I-protein	2	PMOD
8	showed	show	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	promoter	promoter	I-NP	NN	O	12	NMOD
12	activity	activity	I-NP	NN	O	13	SUB
13	could	could	B-VP	MD	O	9	SBAR
14	be	be	I-VP	VB	O	13	VC
15	determined	determine	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	21	NMOD
18	alpha	alpha	I-NP	NN	B-protein	21	NMOD
19	B1/alpha	B1/alpha	I-NP	NN	I-protein	21	NMOD
20	B2	B2	I-NP	NN	I-protein	21	NMOD
21	ratio	ratio	I-NP	NN	O	16	PMOD
22	.	.	O	.	O	8	P

1	Jurkat	Jurkat	B-NP	NN	O	3	NMOD
2	cell	cell	I-NP	NN	O	3	NMOD
3	extract	extract	I-NP	NN	O	4	SUB
4	contained	contain	B-VP	VBD	O	0	ROOT
5	PEBP2	PEBP2	B-NP	NN	B-protein	9	NMOD
6	site-binding	site-binding	I-NP	JJ	I-protein	9	NMOD
7	protein	protein	I-NP	NN	I-protein	9	NMOD
8	(	(	I-NP	(	O	9	P
9	s	s	I-NP	NNS	O	4	OBJ
10	)	)	O	)	O	9	P
11	that	that	B-NP	WDT	O	9	NMOD
12	cross-reacted	cross-reacte	B-VP	VBD	O	11	SBAR
13	with	with	B-PP	IN	O	12	VMOD
14	antimouse	antimouse	B-NP	JJ	B-protein	17	NMOD
15	alpha	alpha	I-NP	NN	I-protein	17	NMOD
16	A1	A1	I-NP	NN	I-protein	17	NMOD
17	antibodies	antibody	I-NP	NNS	I-protein	13	PMOD
18	.	.	O	.	O	4	P

1	Northern	Northern	B-NP	NN	O	3	NMOD
2	blot	blot	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	indicated	indicate	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	expression	expression	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	human	human	B-NP	JJ	B-protein	11	NMOD
9	PEBP2	PEBP2	I-NP	NN	I-protein	11	NMOD
10	alpha	alpha	I-NP	NN	I-protein	11	NMOD
11	A	A	I-NP	NN	I-protein	14	NMOD
12	,	,	O	,	O	14	P
13	alpha	alpha	B-NP	NN	B-DNA	14	NMOD
14	B	B	I-NP	NN	I-DNA	7	PMOD
15	(	(	O	(	O	16	P
16	AML1	AML1	B-NP	NN	B-protein	14	NMOD
17	)	)	O	)	O	16	P
18	,	,	O	,	O	21	P
19	and	and	O	CC	O	21	NMOD
20	beta	beta	B-NP	NN	B-DNA	21	NMOD
21	genes	gene	I-NP	NNS	I-DNA	4	VMOD
22	in	in	B-PP	IN	O	21	NMOD
23	Jurkat	Jurkat	B-NP	NN	B-cell_line	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_line	22	PMOD
25	.	.	O	.	O	4	P

1	Although	Although	B-SBAR	IN	O	22	VMOD
2	further	further	B-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	are	be	B-VP	VBP	O	1	SBAR
5	required	require	I-VP	VBN	O	4	VC
6	to	to	B-VP	TO	O	7	VMOD
7	determine	determine	I-VP	VB	O	1	SBAR
8	the	the	B-NP	DT	O	10	NMOD
9	precise	precise	I-NP	JJ	O	10	NMOD
10	role	role	I-NP	NN	O	7	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	PEBP2	PEBP2	B-NP	NN	B-protein	11	PMOD
13	in	in	B-PP	IN	O	10	NMOD
14	the	the	B-NP	DT	O	17	NMOD
15	GM-CSF	GM-CSF	I-NP	NN	B-DNA	16	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	17	NMOD
17	activity	activity	I-NP	NN	O	13	PMOD
18	,	,	O	,	O	22	P
19	the	the	B-NP	DT	O	21	NMOD
20	present	present	I-NP	JJ	O	21	NMOD
21	findings	finding	I-NP	NNS	O	22	SUB
22	suggested	suggest	B-VP	VBD	O	0	ROOT
23	the	the	B-NP	DT	O	24	NMOD
24	importance	importance	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	relative	relative	I-NP	JJ	O	28	NMOD
28	ratio	ratio	I-NP	NN	O	25	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	different	different	B-NP	JJ	O	29	PMOD
31	PEBP2	PEBP2	I-NP	NN	B-protein	32	NMOD
32	isoforms	isoform	I-NP	NNS	I-protein	30	NMOD
33	in	in	B-PP	IN	O	24	NMOD
34	regulating	regulate	B-VP	VBG	O	33	PMOD
35	the	the	B-NP	DT	O	36	NMOD
36	levels	level	I-NP	NNS	O	34	OBJ
37	of	of	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	40	NMOD
39	promoter	promoter	I-NP	NN	O	40	NMOD
40	activity	activity	I-NP	NN	O	37	PMOD
41	.	.	O	.	O	22	P

1	Differential	Differential	B-NP	JJ	O	2	NMOD
2	induction	induction	I-NP	NN	O	11	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	NF-AT	NF-AT	I-NP	NN	B-protein	6	NMOD
6	complex	complex	I-NP	NN	I-protein	3	PMOD
7	during	during	B-PP	IN	O	2	NMOD
8	restimulation	restimulation	B-NP	NN	O	7	PMOD
9	and	and	O	CC	O	11	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	induction	induction	I-NP	NN	O	0	ROOT
12	of	of	B-PP	IN	O	11	NMOD
13	T-cell	T-cell	B-NP	NN	O	14	NMOD
14	anergy	anergy	I-NP	NN	O	12	PMOD
15	.	.	O	.	O	11	P

1	Stimulation	Stimulation	B-NP	NN	O	20	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-cell_line	6	NMOD
4	CD4+	CD4+	I-NP	JJ	I-cell_line	6	NMOD
5	T-cell	T-cell	I-NP	NN	I-cell_line	6	NMOD
6	clones	clone	I-NP	NNS	I-cell_line	2	PMOD
7	through	through	B-PP	IN	O	1	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	T-cell	T-cell	I-NP	NN	B-protein	10	NMOD
10	receptor	receptor	I-NP	NN	I-protein	7	PMOD
11	(	(	O	(	O	12	P
12	TcR	TcR	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	by	by	B-PP	IN	O	1	NMOD
15	high	high	B-NP	JJ	O	16	NMOD
16	doses	dose	I-NP	NNS	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	specific	specific	B-NP	JJ	O	19	NMOD
19	peptide	peptide	I-NP	NN	O	17	PMOD
20	results	result	B-VP	VBZ	O	0	ROOT
21	in	in	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	induction	induction	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	a	a	B-NP	DT	O	27	NMOD
26	long-lived	long-lived	I-NP	JJ	O	27	NMOD
27	state	state	I-NP	NN	O	24	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	nonresponsiveness	nonresponsiveness	B-NP	NN	O	28	PMOD
30	that	that	B-NP	WDT	O	29	NMOD
31	has	have	B-VP	VBZ	O	30	SBAR
32	been	be	I-VP	VBN	O	31	VC
33	called	call	I-VP	VBN	O	32	VC
34	anergy	anergy	B-NP	NN	O	33	VMOD
35	.	.	O	.	O	20	P

1	During	During	B-PP	IN	O	9	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	induction	induction	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	anergy	anergy	B-NP	NN	O	4	PMOD
6	,	,	O	,	O	9	P
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	9	SUB
9	are	be	B-VP	VBP	O	0	ROOT
10	phenotypically	phenotypically	B-ADJP	RB	O	11	AMOD
11	similar	similar	I-ADJP	JJ	O	9	PRD
12	to	to	B-PP	TO	O	11	AMOD
13	cells	cell	B-NP	NNS	O	12	PMOD
14	responding	respond	B-VP	VBG	O	13	NMOD
15	to	to	B-PP	TO	O	14	VMOD
16	an	an	B-NP	DT	O	18	NMOD
17	immunogenic	immunogenic	I-NP	JJ	O	18	NMOD
18	stimulus	stimulus	I-NP	NN	O	15	PMOD
19	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	2	NMOD
2	amount	amount	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	TcR	TcR	B-NP	NN	B-protein	3	PMOD
5	at	at	B-PP	IN	O	2	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	cell	cell	I-NP	NN	O	8	NMOD
8	surface	surface	I-NP	NN	O	5	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	downmodulated	downmodulate	I-VP	VBN	O	9	VC
11	,	,	O	,	O	9	P
12	whereas	whereas	O	IN	O	9	VMOD
13	the	the	B-NP	DT	O	17	NMOD
14	CD2	CD2	I-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	I-protein	16	NMOD
16	CD25	CD25	I-NP	NN	I-protein	17	NMOD
17	receptors	receptor	I-NP	NNS	I-protein	18	SUB
18	are	be	B-VP	VBP	O	12	SBAR
19	increased	increase	I-VP	VBN	O	18	VC
20	.	.	O	.	O	9	P

1	When	When	B-ADVP	WRB	O	9	VMOD
2	restimulated	restimulate	B-VP	VBN	O	1	SBAR
3	,	,	O	,	O	9	P
4	however	however	B-ADVP	RB	O	9	VMOD
5	,	,	O	,	O	9	P
6	anergic	anergic	B-NP	JJ	B-cell_type	8	NMOD
7	T	T	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	9	SUB
9	fail	fail	B-VP	VBP	O	0	ROOT
10	to	to	I-VP	TO	O	11	VMOD
11	up-regulate	up-regulate	I-VP	VB	O	9	VMOD
12	transcription	transcription	B-NP	NN	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	IL-2	IL-2	I-NP	NN	B-DNA	16	NMOD
16	gene	gene	I-NP	NN	I-DNA	13	PMOD
17	and	and	B-PP	CC	O	11	VMOD
18	in	in	B-PP	IN	O	11	VMOD
19	consequence	consequence	B-NP	NN	O	18	PMOD
20	do	do	B-VP	VBP	O	9	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	produce	produce	I-VP	VB	O	20	VC
23	IL-2	IL-2	B-NP	NN	B-protein	22	OBJ
24	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	have	have	B-VP	VBP	O	0	ROOT
7	compared	compare	I-VP	VBN	O	6	VC
8	the	the	B-NP	DT	O	9	NMOD
9	ability	ability	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	various	various	B-NP	JJ	O	10	PMOD
12	transcription	transcription	I-NP	NN	B-protein	13	NMOD
13	factors	factor	I-NP	NNS	I-protein	11	NMOD
14	to	to	B-VP	TO	O	15	VMOD
15	bind	bind	I-VP	VB	O	9	NMOD
16	to	to	B-PP	TO	O	15	VMOD
17	their	their	B-NP	PRP$	O	19	NMOD
18	appropriate	appropriate	I-NP	JJ	O	19	NMOD
19	site	site	I-NP	NN	O	16	PMOD
20	on	on	B-PP	IN	O	19	NMOD
21	DNA	DNA	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	6	P

1	Factors	Factor	B-NP	NNS	O	2	SUB
2	were	be	B-VP	VBD	O	0	ROOT
3	isolated	isolate	I-VP	VBN	O	2	VC
4	from	from	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	nuclei	nucleus	I-NP	NNS	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	T	T	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	that	that	B-NP	WDT	O	6	NMOD
11	were	be	B-VP	VBD	O	10	SBAR
12	in	in	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	induction	induction	I-NP	NN	O	15	NMOD
15	phase	phase	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	anergy	anergy	B-NP	NN	O	16	PMOD
18	or	or	O	CC	O	11	VMOD
19	were	be	B-VP	VBD	O	11	VMOD
20	undergoing	undergo	I-VP	VBG	O	19	VC
21	activation	activation	B-NP	NN	O	20	OBJ
22	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	pattern	pattern	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	binding	binding	B-NP	NN	O	5	NMOD
5	activity	activity	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	restimulated	restimulate	B-NP	VBN	O	9	NMOD
8	T	T	I-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	consistent	consistent	B-ADJP	JJ	O	10	PRD
12	with	with	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	14	NMOD
14	pattern	pattern	I-NP	NN	O	12	PMOD
15	that	that	B-NP	WDT	O	14	NMOD
16	has	have	B-VP	VBZ	O	15	SBAR
17	previously	previously	I-VP	RB	O	16	VMOD
18	been	be	I-VP	VBN	O	16	VC
19	shown	show	I-VP	VBN	O	18	VC
20	to	to	I-VP	TO	O	21	VMOD
21	regulate	regulate	I-VP	VB	O	19	VMOD
22	T-cell-specific	T-cell-specific	B-NP	JJ	O	23	NMOD
23	expression	expression	I-NP	NN	O	30	NMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	IL-2	IL-2	I-NP	NN	B-protein	24	PMOD
27	and	and	O	CC	O	30	NMOD
28	the	the	B-NP	DT	O	30	NMOD
29	beta	beta	I-NP	NN	B-protein	30	NMOD
30	chain	chain	I-NP	NN	I-protein	21	OBJ
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	TcR	TcR	I-NP	NN	B-DNA	34	NMOD
34	genes	gene	I-NP	NNS	I-DNA	31	PMOD
35	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	measured	measure	I-NP	VBN	O	3	NMOD
3	binding	binding	I-NP	NN	O	8	SUB
4	to	to	B-PP	TO	O	3	NMOD
5	a	a	B-NP	DT	O	7	NMOD
6	TCF-1	TCF-1	I-NP	NN	B-DNA	7	NMOD
7	site	site	I-NP	NN	I-DNA	4	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	the	the	B-NP	DT	O	10	NMOD
10	same	same	I-NP	JJ	O	8	PRD
11	in	in	B-PP	IN	O	8	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	nuclei	nucleus	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	resting	rest	B-NP	VBG	O	21	NMOD
16	,	,	O	,	O	21	P
17	activated	activate	B-VP	VBN	O	21	NMOD
18	,	,	O	,	O	21	P
19	and	and	O	CC	O	21	NMOD
20	anergized	anergize	B-NP	VBN	B-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
22	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	inducible	inducible	I-NP	JJ	B-protein	3	NMOD
3	factors	factor	I-NP	NNS	I-protein	13	NMOD
4	NK-kappa	NK-kappa	I-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	13	NMOD
6	,	,	O	,	O	13	P
7	beta	beta	B-NP	NN	B-protein	8	NMOD
8	E2	E2	I-NP	NN	I-protein	13	NMOD
9	,	,	O	,	O	13	P
10	CD28RC	CD28RC	B-NP	NN	B-protein	13	NMOD
11	,	,	O	,	O	13	P
12	and	and	O	CC	O	13	NMOD
13	AP-1	AP-1	B-NP	NN	B-protein	14	SUB
14	are	be	B-VP	VBP	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	expressed	express	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	resting	rest	B-NP	VBG	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
20	and	and	O	CC	O	14	VMOD
21	are	be	B-VP	VBP	O	14	VMOD
22	twofold	twofold	B-ADJP	RB	O	23	AMOD
23	lower	low	I-ADJP	JJR	O	21	PRD
24	in	in	B-PP	IN	O	23	AMOD
25	anergized	anergize	B-VP	VBN	O	24	PMOD
26	as	as	B-SBAR	IN	O	21	VMOD
27	compared	compare	B-PP	VBN	O	26	SBAR
28	with	with	B-PP	IN	O	27	VMOD
29	activated	activate	B-NP	VBN	B-cell_type	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_type	28	PMOD
31	.	.	O	.	O	14	P

1	In	In	B-PP	IN	O	7	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	anergic	anergic	B-NP	JJ	B-cell_type	6	NMOD
5	T	T	I-NP	NN	I-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	7	SUB
7	express	express	B-VP	VBP	O	0	ROOT
8	approximately	approximately	B-NP	RB	O	9	NMOD
9	eightfold	eightfold	I-NP	RB	O	10	AMOD
10	lower	low	I-NP	JJR	O	11	NMOD
11	amounts	amount	I-NP	NNS	O	7	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	NF-AT	NF-AT	B-NP	NN	B-protein	16	NMOD
14	,	,	O	,	O	16	P
15	a	a	B-NP	DT	O	16	NMOD
16	member	member	I-NP	NN	O	12	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	class	class	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	inducible	inducible	B-NP	JJ	B-protein	22	NMOD
22	factors	factor	I-NP	NNS	I-protein	20	PMOD
23	that	that	B-NP	WDT	O	19	NMOD
24	regulates	regulate	B-VP	VBZ	O	23	SBAR
25	IL-2	IL-2	B-NP	NN	B-DNA	27	NMOD
26	gene	gene	I-NP	NN	I-DNA	27	NMOD
27	transcription	transcription	I-NP	NN	O	24	OBJ
28	.	.	O	.	O	7	P

1	(	(	O	(	O	2	P
2	ABSTRACT	ABSTRACT	B-NP	NN	O	0	ROOT
3	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD
4	AT	AT	B-PP	IN	O	3	VMOD
5	250	250	B-NP	CD	O	6	NMOD
6	WORDS	WORDS	I-NP	NNS	O	4	PMOD
7	)	)	O	)	O	2	P

1	The	The	B-NP	DT	O	4	NMOD
2	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	4	NMOD
3	gene	gene	I-NP	NN	I-protein	4	NMOD
4	product	product	I-NP	NN	I-protein	6	SUB
5	negatively	negatively	B-ADVP	RB	O	6	VMOD
6	regulates	regulate	B-VP	VBZ	O	0	ROOT
7	transcriptional	transcriptional	B-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	OBJ
9	mediated	mediate	B-VP	VBN	O	8	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	15	NMOD
12	human	human	I-NP	JJ	B-protein	15	NMOD
13	cytomegalovirus	cytomegalovirus	I-NP	NN	I-protein	15	NMOD
14	IE2	IE2	I-NP	NN	I-protein	15	NMOD
15	protein	protein	I-NP	NN	I-protein	10	PMOD
16	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	IE2	IE2	I-NP	NN	B-protein	4	NMOD
3	gene	gene	I-NP	NN	I-protein	4	NMOD
4	product	product	I-NP	NN	I-protein	11	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	human	human	B-NP	JJ	O	7	NMOD
7	cytomegalovirus	cytomegalovirus	I-NP	NN	O	5	PMOD
8	(	(	O	(	O	9	P
9	HCMV	HCMV	B-NP	NN	O	7	NMOD
10	)	)	O	)	O	9	P
11	is	be	B-VP	VBZ	O	0	ROOT
12	one	one	B-NP	CD	O	11	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	18	NMOD
15	few	few	I-NP	JJ	O	18	NMOD
16	viral	viral	I-NP	JJ	B-protein	18	NMOD
17	regulatory	regulatory	I-NP	JJ	I-protein	18	NMOD
18	proteins	protein	I-NP	NNS	I-protein	13	PMOD
19	expressed	express	B-VP	VBN	O	18	NMOD
20	immediately	immediately	B-ADVP	RB	O	19	VMOD
21	upon	upon	B-PP	IN	O	19	VMOD
22	infection	infection	B-NP	NN	O	21	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	host	host	I-NP	NN	B-cell_type	26	NMOD
26	cell	cell	I-NP	NN	I-cell_type	23	PMOD
27	.	.	O	.	O	11	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	6	NMOD
4	potent	potent	I-NP	JJ	O	6	NMOD
5	transcriptional	transcriptional	I-NP	JJ	B-protein	6	NMOD
6	activator	activator	I-NP	NN	I-protein	2	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	many	many	B-NP	JJ	O	7	PMOD
9	viral	viral	I-NP	JJ	B-DNA	8	NMOD
10	and	and	I-NP	CC	I-DNA	8	NMOD
11	cellular	cellular	I-NP	JJ	I-DNA	8	NMOD
12	promoters	promoter	I-NP	NNS	I-DNA	8	NMOD
13	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	found	find	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	8	NMOD
6	susceptibility	susceptibility	I-NP	NN	I-protein	8	NMOD
7	gene	gene	I-NP	NN	I-protein	8	NMOD
8	product	product	I-NP	NN	I-protein	13	SUB
9	(	(	O	(	O	10	P
10	Rb	Rb	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	dramatically	dramatically	B-ADVP	RB	O	13	VMOD
13	suppressed	suppress	B-VP	VBD	O	3	SBAR
14	this	this	B-NP	DT	O	16	NMOD
15	IE2	IE2	I-NP	NN	B-protein	16	NMOD
16	transactivation	transactivation	I-NP	NN	O	13	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	various	various	B-NP	JJ	O	19	NMOD
19	promoters	promoter	I-NP	NNS	B-DNA	17	PMOD
20	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	unlike	unlike	B-PP	IN	O	12	VMOD
4	another	another	B-NP	DT	O	7	NMOD
5	tumor	tumor	I-NP	NN	B-protein	7	NMOD
6	suppressor	suppressor	I-NP	NN	I-protein	7	NMOD
7	protein	protein	I-NP	NN	I-protein	3	PMOD
8	,	,	O	,	O	12	P
9	p53	p53	B-NP	NN	B-protein	11	NMOD
10	,	,	O	,	O	11	P
11	Rb	Rb	B-NP	NN	B-protein	12	SUB
12	did	do	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	have	have	I-VP	VB	O	12	VC
15	any	any	B-NP	DT	O	17	NMOD
16	significant	significant	I-NP	JJ	O	17	NMOD
17	effect	effect	I-NP	NN	O	14	OBJ
18	on	on	B-PP	IN	O	14	VMOD
19	basal	basal	B-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	transcription	transcription	B-NP	NN	O	21	PMOD
23	,	,	O	,	O	12	P
24	suggesting	suggest	B-VP	VBG	O	12	VMOD
25	that	that	B-SBAR	IN	O	24	VMOD
26	Rb	Rb	B-NP	NN	B-protein	28	SUB
27	specifically	specifically	B-ADVP	RB	O	28	VMOD
28	interacts	interact	B-VP	VBZ	O	25	SBAR
29	with	with	B-PP	IN	O	28	VMOD
30	IE2	IE2	B-NP	NN	B-protein	33	NMOD
31	rather	rather	B-PP	RB	O	33	VMOD
32	than	than	I-PP	IN	O	31	DEP
33	other	other	B-NP	JJ	O	29	PMOD
34	cellular	cellular	I-NP	JJ	B-protein	35	NMOD
35	factors	factor	I-NP	NNS	I-protein	33	NMOD
36	involved	involve	B-VP	VBN	O	33	NMOD
37	in	in	B-PP	IN	O	36	VMOD
38	the	the	B-NP	DT	O	41	NMOD
39	general	general	I-NP	JJ	O	41	NMOD
40	transcription	transcription	I-NP	NN	O	41	NMOD
41	machinery	machinery	I-NP	NN	O	37	PMOD
42	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	found	find	B-VP	VBD	O	0	ROOT
3	by	by	B-PP	IN	O	2	VMOD
4	protein-affinity	protein-affinity	B-NP	JJ	O	5	NMOD
5	chromatography	chromatography	I-NP	NN	O	3	PMOD
6	that	that	B-SBAR	IN	O	2	VMOD
7	Rb	Rb	B-NP	NN	B-protein	18	SUB
8	in	in	B-PP	IN	O	7	NMOD
9	nuclear	nuclear	B-NP	JJ	O	10	NMOD
10	extracts	extract	I-NP	NNS	O	8	PMOD
11	or	or	O	CC	O	12	VMOD
12	produced	produce	B-VP	VBN	O	7	NMOD
13	by	by	B-PP	IN	O	12	VMOD
14	in	in	B-NP	FW	O	15	AMOD
15	vitro	vitro	I-NP	FW	O	16	NMOD
16	translation	translation	I-NP	NN	O	13	PMOD
17	directly	directly	B-ADVP	RB	O	18	VMOD
18	bound	bind	B-VP	VBD	O	6	SBAR
19	to	to	B-PP	TO	O	18	VMOD
20	IE2	IE2	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	2	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Rb	Rb	B-NP	NN	B-protein	6	SUB
6	may	may	B-VP	MD	O	4	SBAR
7	regulate	regulate	I-VP	VB	O	6	VC
8	the	the	B-NP	DT	O	10	NMOD
9	life	life	I-NP	NN	O	10	NMOD
10	cycle	cycle	I-NP	NN	O	7	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	HCMV	HCMV	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	endemic	endemic	B-ADJP	JJ	O	15	PRD
17	in	in	B-PP	IN	O	16	AMOD
18	the	the	B-NP	DT	O	20	NMOD
19	human	human	I-NP	JJ	B-cell_type	20	NMOD
20	population	population	I-NP	NN	I-cell_type	17	PMOD
21	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	data	datum	I-NP	NNS	O	5	SUB
5	may	may	B-VP	MD	O	0	ROOT
6	provide	provide	I-VP	VB	O	5	VC
7	new	new	B-NP	JJ	O	8	NMOD
8	insights	insight	I-NP	NNS	O	6	OBJ
9	into	into	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	slow	slow	I-NP	JJ	O	12	NMOD
12	rate	rate	I-NP	NN	O	22	NMOD
13	of	of	B-PP	IN	O	12	NMOD
14	HCMV	HCMV	B-NP	NN	O	16	NMOD
15	DNA	DNA	I-NP	NN	O	16	NMOD
16	replication	replication	I-NP	NN	O	13	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	cells	cell	B-NP	NNS	O	17	PMOD
19	and	and	O	CC	O	22	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	possible	possible	I-NP	JJ	O	22	NMOD
22	involvement	involvement	I-NP	NN	O	9	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	HCMV	HCMV	B-NP	NN	O	23	PMOD
25	in	in	B-PP	IN	O	22	NMOD
26	tumorigenesis	tumorigenesis	B-NP	NN	O	25	PMOD
27	.	.	O	.	O	5	P

1	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	5	NMOD
2	virus	virus	I-NP	NN	O	5	NMOD
3	replicative	replicative	I-NP	JJ	O	5	NMOD
4	gene	gene	I-NP	NN	O	5	NMOD
5	transcription	transcription	I-NP	NN	O	16	NMOD
6	during	during	B-PP	IN	O	5	NMOD
7	de	de	B-NP	FW	O	8	AMOD
8	novo	novo	I-NP	FW	O	9	NMOD
9	infection	infection	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	B-cell_type	12	NMOD
12	thymocytes	thymocyte	I-NP	NNS	I-cell_type	10	PMOD
13	:	:	O	:	O	5	P
14	simultaneous	simultaneous	B-NP	JJ	O	16	NMOD
15	early	early	I-NP	JJ	O	16	NMOD
16	expression	expression	I-NP	NN	O	22	NMOD
17	of	of	B-PP	IN	O	16	NMOD
18	BZLF-1	BZLF-1	B-NP	NN	B-protein	17	PMOD
19	and	and	O	CC	O	22	NMOD
20	its	its	B-NP	PRP$	O	22	NMOD
21	repressor	repressor	I-NP	NN	O	22	NMOD
22	RAZ	RAZ	I-NP	NN	B-protein	0	ROOT
23	.	.	O	.	O	22	P

1	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	2	NMOD
2	virus	virus	I-NP	NN	O	6	SUB
3	(	(	O	(	O	4	P
4	EBV	EBV	B-NP	NN	O	2	NMOD
5	)	)	O	)	O	4	P
6	is	be	B-VP	VBZ	O	0	ROOT
7	known	know	I-VP	VBN	O	6	VC
8	to	to	I-VP	TO	O	9	VMOD
9	infect	infect	I-VP	VB	O	7	VMOD
10	B	B	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	14	NMOD
12	and	and	O	CC	O	14	NMOD
13	epithelial	epithelial	B-NP	JJ	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	9	OBJ
15	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	3	NMOD
2	and	and	O	CC	O	3	NMOD
3	others	other	B-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	shown	show	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	EBV	EBV	B-NP	NN	O	8	SUB
8	can	can	B-VP	MD	O	6	SBAR
9	also	also	I-VP	RB	O	8	VMOD
10	infect	infect	I-VP	VB	O	8	VC
11	a	a	B-NP	DT	O	12	NMOD
12	subset	subset	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	thymocytes	thymocyte	B-NP	NNS	B-cell_type	13	PMOD
15	.	.	O	.	O	4	P

1	Infection	Infection	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	thymocytes	thymocyte	B-NP	NNS	B-cell_type	2	PMOD
4	was	be	B-VP	VBD	O	0	ROOT
5	accompanied	accompany	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	appearance	appearance	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	linear	linear	B-NP	JJ	B-DNA	12	NMOD
11	EBV	EBV	I-NP	NN	I-DNA	12	NMOD
12	genome	genome	I-NP	NN	I-DNA	9	PMOD
13	within	within	B-PP	IN	O	8	NMOD
14	8	8	B-NP	CD	O	15	NMOD
15	hr	hr	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	infection	infection	B-NP	NN	O	16	PMOD
18	.	.	O	.	O	4	P

1	Circularization	Circularization	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	EBV	EBV	I-NP	NN	B-DNA	5	NMOD
5	genome	genome	I-NP	NN	I-DNA	2	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	detected	detect	I-VP	VBN	O	6	VC
9	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	in	in	B-PP	IN	O	2	PRD
4	contrast	contrast	B-NP	NN	O	3	PMOD
5	to	to	B-PP	TO	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	infection	infection	I-NP	NN	O	5	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	B	B	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	where	where	B-ADVP	WRB	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	genome	genome	I-NP	NN	O	14	SUB
14	can	can	B-VP	MD	O	11	SBAR
15	circularize	circularize	I-VP	VB	O	14	VC
16	within	within	B-PP	IN	O	15	VMOD
17	24	24	B-NP	CD	O	18	NMOD
18	hr	hr	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	infection	infection	B-NP	NN	O	19	PMOD
21	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	appearance	appearance	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	8	NMOD
5	BamHI	BamHI	I-NP	NN	B-protein	8	NMOD
6	ZLF-1	ZLF-1	I-NP	NN	I-protein	8	NMOD
7	gene	gene	I-NP	NN	I-protein	8	NMOD
8	product	product	I-NP	NN	I-protein	10	NMOD
9	,	,	O	,	O	10	P
10	ZEBRA	ZEBRA	B-NP	NN	B-protein	3	PMOD
11	,	,	O	,	O	2	P
12	by	by	B-PP	IN	O	2	NMOD
13	RT-PCR	RT-PCR	B-NP	NN	O	12	PMOD
14	,	,	O	,	O	2	P
15	was	be	B-VP	VBD	O	0	ROOT
16	observed	observe	I-VP	VBN	O	15	VC
17	within	within	B-PP	IN	O	16	VMOD
18	8	8	B-NP	CD	O	19	NMOD
19	hr	hr	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	infection	infection	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	15	P

1	The	The	B-NP	DT	O	2	NMOD
2	appearance	appearance	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	7	NMOD
5	novel	novel	I-NP	JJ	O	7	NMOD
6	fusion	fusion	I-NP	NN	B-protein	7	NMOD
7	transcript	transcript	I-NP	NN	I-protein	3	PMOD
8	(	(	O	(	O	9	P
9	RAZ	RAZ	B-NP	NN	B-protein	7	NMOD
10	)	)	O	)	O	9	P
11	,	,	O	,	O	2	P
12	which	which	B-NP	WDT	O	2	NMOD
13	comprised	comprise	B-VP	VBD	O	25	VMOD
14	regions	region	B-NP	NNS	O	13	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	BZLF-1	BZLF-1	I-NP	NN	B-DNA	18	NMOD
18	locus	locus	I-NP	NN	I-DNA	15	PMOD
19	and	and	O	CC	O	25	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	adjacent	adjacent	I-NP	JJ	O	23	NMOD
22	BRLF-1	BRLF-1	I-NP	NN	B-DNA	23	NMOD
23	locus	locus	I-NP	NN	I-DNA	25	SUB
24	,	,	O	,	O	23	P
25	was	be	B-VP	VBD	O	12	SBAR
26	detected	detect	I-VP	VBN	O	25	VC
27	by	by	B-PP	IN	O	26	VMOD
28	RT-PCR	RT-PCR	B-NP	NN	O	27	PMOD
29	.	.	O	.	O	2	P

1	ZEBRA	ZEBRA	B-NP	NN	B-protein	2	NMOD
2	protein	protein	I-NP	NN	I-protein	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	also	also	I-VP	RB	O	3	VMOD
5	identified	identify	I-VP	VBN	O	3	VC
6	in	in	B-PP	IN	O	5	VMOD
7	infected	infected	B-NP	JJ	O	6	PMOD
8	thymocytes	thymocyte	I-NP	NNS	B-cell_type	7	NMOD
9	by	by	B-PP	IN	O	5	VMOD
10	immunoprecipitation	immunoprecipitation	B-NP	NN	O	9	PMOD
11	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	we	we	B-NP	PRP	O	5	SUB
5	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	EBNA-1	EBNA-1	I-NP	NN	B-DNA	9	NMOD
9	gene	gene	I-NP	NN	I-DNA	13	SUB
10	in	in	B-PP	IN	O	9	NMOD
11	infected	infected	B-NP	JJ	O	10	PMOD
12	thymocytes	thymocyte	I-NP	NNS	B-cell_type	11	NMOD
13	was	be	B-VP	VBD	O	6	SBAR
14	transcribed	transcribe	I-VP	VBN	O	13	VC
15	from	from	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	Fp	Fp	I-NP	NN	B-DNA	18	NMOD
18	promoter	promoter	I-NP	NN	I-DNA	15	PMOD
19	,	,	O	,	O	15	P
20	rather	rather	B-PP	RB	O	15	PMOD
21	than	than	I-PP	IN	O	20	DEP
22	from	from	B-PP	IN	O	15	PMOD
23	the	the	B-NP	DT	O	25	NMOD
24	Cp/Wp	Cp/Wp	I-NP	NN	B-DNA	25	NMOD
25	promoter	promoter	I-NP	NN	I-DNA	22	PMOD
26	which	which	B-NP	WDT	O	25	NMOD
27	is	be	B-VP	VBZ	O	26	SBAR
28	used	use	I-VP	VBN	O	27	VC
29	in	in	B-PP	IN	O	28	VMOD
30	latently	latently	B-NP	RB	B-cell_type	33	NMOD
31	infected	infected	I-NP	JJ	I-cell_type	33	NMOD
32	B	B	I-NP	NN	I-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
34	.	.	O	.	O	5	P

1	Transcripts	Transcript	B-NP	NNS	O	12	SUB
2	encoding	encode	B-VP	VBG	O	1	NMOD
3	gp350/220	gp350/220	B-NP	NN	B-protein	8	NMOD
4	,	,	O	,	O	8	P
5	the	the	B-NP	DT	O	8	NMOD
6	major	major	I-NP	JJ	B-protein	8	NMOD
7	coat	coat	I-NP	NN	I-protein	8	NMOD
8	protein	protein	I-NP	NN	I-protein	2	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	EBV	EBV	B-NP	NN	O	9	PMOD
11	,	,	O	,	O	1	P
12	were	be	B-VP	VBD	O	17	VMOD
13	identified	identify	I-VP	VBN	O	12	VC
14	,	,	O	,	O	17	P
15	but	but	O	CC	O	17	VMOD
16	we	we	B-NP	PRP	O	17	SUB
17	did	do	B-VP	VBD	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	find	find	I-VP	VB	O	17	VC
20	any	any	B-NP	DT	O	21	NMOD
21	evidence	evidence	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	transcription	transcription	B-NP	NN	O	22	PMOD
24	from	from	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	LMP-2A	LMP-2A	I-NP	NN	B-DNA	29	NMOD
27	or	or	I-NP	CC	O	29	NMOD
28	EBER-1	EBER-1	I-NP	NN	B-DNA	29	NMOD
29	loci	locus	I-NP	NNS	I-DNA	24	PMOD
30	in	in	B-PP	IN	O	23	NMOD
31	infected	infected	B-NP	JJ	O	32	NMOD
32	thymocytes	thymocyte	I-NP	NNS	B-cell_type	30	PMOD
33	.	.	O	.	O	17	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	de	de	B-NP	FW	O	6	AMOD
6	novo	novo	I-NP	FW	O	8	NMOD
7	EBV	EBV	I-NP	NN	O	8	NMOD
8	infection	infection	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	thymocytes	thymocyte	B-NP	NNS	B-cell_type	9	PMOD
11	differs	differ	B-VP	VBZ	O	4	SBAR
12	from	from	B-PP	IN	O	11	VMOD
13	infection	infection	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	B	B	B-NP	NN	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
17	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	main	main	I-NP	JJ	O	3	NMOD
3	difference	difference	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	PRD
6	with	with	B-PP	IN	O	11	VMOD
7	thymocytes	thymocyte	B-NP	NNS	B-cell_type	6	PMOD
8	,	,	O	,	O	11	P
9	no	no	B-NP	DT	O	10	NMOD
10	evidence	evidence	I-NP	NN	O	11	SUB
11	could	could	B-VP	MD	O	5	SBAR
12	be	be	I-VP	VB	O	11	VC
13	found	find	I-VP	VBN	O	12	VC
14	that	that	B-SBAR	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	virus	virus	I-NP	NN	O	18	SUB
17	ever	ever	B-ADVP	RB	O	18	VMOD
18	circularizes	circularize	B-VP	VBZ	O	14	SBAR
19	.	.	O	.	O	4	P

1	Rather	Rather	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	EBV	EBV	B-NP	NN	O	4	SUB
4	remains	remain	B-VP	VBZ	O	0	ROOT
5	in	in	B-PP	IN	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	linear	linear	I-NP	JJ	O	8	NMOD
8	configuration	configuration	I-NP	NN	O	5	PMOD
9	from	from	B-PP	IN	O	8	NMOD
10	which	which	B-NP	WDT	O	9	PMOD
11	replicative	replicative	B-NP	JJ	B-DNA	12	NMOD
12	genes	gene	I-NP	NNS	I-DNA	13	SUB
13	are	be	B-VP	VBP	O	9	SBAR
14	transcribed	transcribe	I-VP	VBN	O	13	VC
15	.	.	O	.	O	4	P

1	Induction	Induction	B-NP	NN	O	11	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	Sp1	Sp1	B-NP	NN	B-protein	4	NMOD
4	phosphorylation	phosphorylation	I-NP	NN	O	2	PMOD
5	and	and	O	CC	O	11	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	O	11	NMOD
7	B-independent	B-independent	I-NP	JJ	O	11	NMOD
8	HIV	HIV	I-NP	NN	O	11	NMOD
9	promoter	promoter	I-NP	NN	O	11	NMOD
10	domain	domain	I-NP	NN	O	11	NMOD
11	activity	activity	I-NP	NN	O	0	ROOT
12	in	in	B-PP	IN	O	11	NMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	PMOD
15	stimulated	stimulate	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	okadaic	okadaic	B-NP	JJ	O	18	NMOD
18	acid	acid	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	26	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	the	the	B-NP	DT	O	7	NMOD
5	purely	purely	I-NP	RB	O	6	AMOD
6	enhancer-dependent	enhancer-dependent	I-NP	JJ	O	7	NMOD
7	effect	effect	I-NP	NN	O	1	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	cytokines	cytokine	B-NP	NNS	B-protein	8	PMOD
10	such	such	B-PP	JJ	O	11	PMOD
11	as	as	I-PP	IN	O	9	NMOD
12	TNF	TNF	B-NP	NN	B-protein	11	PMOD
13	on	on	B-PP	IN	O	7	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	activity	activity	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	HIV	HIV	I-NP	NN	B-DNA	20	NMOD
19	regulatory	regulatory	I-NP	JJ	I-DNA	20	NMOD
20	region	region	I-NP	NN	I-DNA	16	PMOD
21	(	(	O	(	O	22	P
22	LTR	LTR	B-NP	NN	B-DNA	20	NMOD
23	)	)	O	)	O	22	P
24	,	,	O	,	O	26	P
25	we	we	B-NP	PRP	O	26	SUB
26	observed	observe	B-VP	VBD	O	0	ROOT
27	that	that	B-SBAR	IN	O	26	VMOD
28	okadaic	okadaic	B-NP	JJ	O	29	NMOD
29	acid	acid	I-NP	NN	O	33	SUB
30	(	(	O	(	O	31	P
31	OKA	OKA	B-NP	NN	O	29	NMOD
32	)	)	O	)	O	31	P
33	activates	activate	B-VP	VBZ	O	27	SBAR
34	HIV	HIV	B-NP	NN	O	35	NMOD
35	transcription	transcription	I-NP	NN	O	33	OBJ
36	through	through	B-PP	IN	O	33	VMOD
37	both	both	O	CC	O	39	NMOD
38	the	the	B-NP	DT	O	39	NMOD
39	enhancer	enhancer	I-NP	NN	B-DNA	36	PMOD
40	,	,	O	,	O	33	P
41	responding	respond	B-VP	VBG	O	33	VMOD
42	to	to	B-PP	TO	O	41	VMOD
43	the	the	B-NP	DT	O	46	NMOD
44	factor	factor	I-NP	NN	O	46	NMOD
45	NF-kappa	NF-kappa	I-NP	NN	B-protein	46	NMOD
46	B	B	I-NP	NN	I-protein	51	NMOD
47	,	,	O	,	O	51	P
48	and	and	O	CC	O	51	NMOD
49	the	the	B-NP	DT	O	51	NMOD
50	promoter	promoter	I-NP	NN	B-DNA	51	NMOD
51	domain	domain	I-NP	NN	I-DNA	42	PMOD
52	of	of	B-PP	IN	O	51	NMOD
53	the	the	B-NP	DT	O	54	NMOD
54	LTR	LTR	I-NP	NN	B-DNA	52	PMOD
55	.	.	O	.	O	26	P

1	The	The	B-NP	DT	O	2	NMOD
2	inducibility	inducibility	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HIV	HIV	B-NP	NN	B-DNA	8	NMOD
5	LTR-driven	LTR-driven	I-NP	JJ	I-DNA	8	NMOD
6	luciferase	luciferase	I-NP	NN	I-DNA	8	NMOD
7	expression	expression	I-NP	NN	I-DNA	8	NMOD
8	constructs	construct	I-NP	NNS	I-DNA	3	PMOD
9	in	in	B-PP	IN	O	2	NMOD
10	lymphoblastoid	lymphoblastoid	B-NP	JJ	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	stimulated	stimulate	B-VP	VBN	O	11	NMOD
13	by	by	B-PP	IN	O	12	VMOD
14	OKA	OKA	B-NP	NN	O	13	PMOD
15	depended	depend	B-VP	VBD	O	0	ROOT
16	on	on	B-PP	IN	O	15	VMOD
17	both	both	B-NP	CC	O	24	NMOD
18	functional	functional	I-NP	JJ	O	21	NMOD
19	Sp1	Sp1	I-NP	NN	B-DNA	21	NMOD
20	binding	binding	I-NP	NN	I-DNA	21	NMOD
21	elements	element	I-NP	NNS	I-DNA	24	NMOD
22	and	and	O	CC	O	24	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	ability	ability	I-NP	NN	O	16	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	TATA	TATA	I-NP	NN	B-DNA	28	NMOD
28	box	box	I-NP	NN	I-DNA	25	PMOD
29	to	to	B-VP	TO	O	30	VMOD
30	bind	bind	I-VP	VB	O	24	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	protein	protein	I-NP	NN	O	33	NMOD
33	TBP	TBP	I-NP	NN	B-protein	30	OBJ
34	.	.	O	.	O	15	P

1	In	In	B-PP	IN	O	10	VMOD
2	both	both	O	CC	O	6	NMOD
3	transformed	transform	B-VP	VBN	O	6	NMOD
4	and	and	O	CC	O	6	NMOD
5	normal	normal	B-NP	JJ	B-cell_type	6	NMOD
6	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	1	PMOD
7	,	,	O	,	O	10	P
8	OKA	OKA	B-NP	NN	O	9	NMOD
9	stimulation	stimulation	I-NP	NN	O	10	SUB
10	induced	induce	B-VP	VBD	O	0	ROOT
11	intense	intense	B-NP	JJ	O	12	NMOD
12	phosphorylation	phosphorylation	I-NP	NN	O	24	NMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	constitutively	constitutively	I-NP	RB	O	16	AMOD
16	expressed	express	I-NP	VBN	O	18	NMOD
17	Sp1	Sp1	I-NP	NN	B-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	13	PMOD
19	in	in	B-PP	IN	O	12	NMOD
20	the	the	B-NP	DT	O	21	NMOD
21	nucleus	nucleus	I-NP	NN	O	19	PMOD
22	,	,	O	,	O	24	P
23	a	a	B-NP	DT	O	24	NMOD
24	property	property	I-NP	NN	O	10	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	OKA	OKA	B-NP	NN	O	25	PMOD
27	not	not	B-VP	RB	O	28	VMOD
28	shared	share	I-VP	VBN	O	26	NMOD
29	by	by	B-PP	IN	O	28	VMOD
30	TNF	TNF	B-NP	NN	B-protein	38	NMOD
31	,	,	O	,	O	38	P
32	phorbol	phorbol	B-NP	NN	O	33	NMOD
33	ester	ester	I-NP	NN	O	38	NMOD
34	,	,	O	,	O	38	P
35	or	or	O	CC	O	38	NMOD
36	PHA	PHA	B-NP	NN	B-protein	38	NMOD
37	and	and	O	CC	O	38	NMOD
38	interleukin	interleukin	B-NP	NN	B-protein	29	PMOD
39	2	2	I-NP	CD	I-protein	38	NMOD
40	.	.	O	.	O	10	P

1	Responsiveness	Responsiveness	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	LTR	LTR	B-NP	NN	B-DNA	4	NMOD
4	constructs	construct	I-NP	NNS	I-DNA	2	PMOD
5	deleted	delete	B-VP	VBN	O	4	NMOD
6	of	of	B-PP	IN	O	5	VMOD
7	kappa	kappa	B-NP	NN	B-DNA	9	NMOD
8	B	B	I-NP	NN	I-DNA	9	NMOD
9	elements	element	I-NP	NNS	I-DNA	6	PMOD
10	to	to	B-PP	TO	O	1	NMOD
11	HIV	HIV	B-NP	NN	B-protein	13	NMOD
12	Tat	Tat	I-NP	NN	I-protein	13	NMOD
13	expression	expression	I-NP	NN	O	10	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	increased	increase	I-VP	VBN	O	14	VC
16	upon	upon	B-PP	IN	O	15	VMOD
17	OKA	OKA	B-NP	NN	O	21	NMOD
18	but	but	B-NP	CC	O	21	NMOD
19	not	not	I-NP	RB	O	18	DEP
20	TNF	TNF	B-NP	NN	B-protein	21	NMOD
21	stimulation	stimulation	I-NP	NN	O	16	PMOD
22	.	.	O	.	O	14	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	SP1	SP1	B-NP	NN	B-protein	6	NMOD
6	phosphorylation	phosphorylation	I-NP	NN	O	20	SUB
7	induced	induce	B-VP	VBN	O	6	NMOD
8	by	by	B-PP	IN	O	7	VMOD
9	OKA	OKA	B-NP	NN	B-protein	13	NMOD
10	,	,	O	,	O	13	P
11	a	a	B-NP	DT	O	13	NMOD
12	selective	selective	I-NP	JJ	O	13	NMOD
13	inhibitor	inhibitor	I-NP	NN	O	8	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	serine-threonine	serine-threonine	I-NP	JJ	B-protein	18	NMOD
17	phosphatase	phosphatase	I-NP	NN	I-protein	18	NMOD
18	PP2A	PP2A	I-NP	NN	B-protein	14	PMOD
19	,	,	O	,	O	6	P
20	facilitates	facilitate	B-VP	VBZ	O	4	SBAR
21	the	the	B-NP	DT	O	22	NMOD
22	formation	formation	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	a	a	B-NP	DT	O	26	NMOD
25	transcription	transcription	I-NP	NN	B-protein	26	NMOD
26	complex	complex	I-NP	NN	I-protein	23	PMOD
27	involving	involve	B-VP	VBG	O	26	NMOD
28	general	general	B-NP	JJ	O	30	NMOD
29	transcription	transcription	I-NP	NN	B-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	37	NMOD
31	,	,	O	,	O	37	P
32	HIV	HIV	B-NP	NN	B-protein	33	NMOD
33	Tat	Tat	I-NP	NN	I-protein	37	NMOD
34	,	,	O	,	O	37	P
35	and	and	O	CC	O	37	NMOD
36	Sp1	Sp1	B-NP	NN	B-protein	37	NMOD
37	proteins	protein	I-NP	NNS	I-protein	27	OBJ
38	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	formation	formation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	complex	complex	I-NP	NN	O	3	PMOD
6	would	would	B-VP	MD	O	0	ROOT
7	increase	increase	I-VP	VB	O	6	VC
8	,	,	O	,	O	7	P
9	independently	independently	B-ADVP	RB	O	7	VMOD
10	of	of	B-PP	IN	O	9	AMOD
11	an	an	B-NP	DT	O	10	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	synergy	synergy	B-NP	NN	O	12	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	NF-kappa	NF-kappa	B-NP	NN	B-protein	16	NMOD
16	B	B	I-NP	NN	I-protein	21	NMOD
17	,	,	O	,	O	21	P
18	the	the	B-NP	DT	O	21	NMOD
19	low	low	I-NP	JJ	O	21	NMOD
20	basal	basal	I-NP	JJ	O	21	NMOD
21	activity	activity	I-NP	NN	O	14	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	HIV	HIV	I-NP	NN	B-DNA	25	NMOD
25	LTR	LTR	I-NP	NN	I-DNA	22	PMOD
26	observed	observe	B-VP	VBN	O	25	NMOD
27	in	in	B-PP	IN	O	26	VMOD
28	normal	normal	B-NP	JJ	B-cell_type	30	NMOD
29	T	T	I-NP	NN	I-cell_type	30	NMOD
30	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	27	PMOD
31	.	.	O	.	O	6	P

1	Human	Human	B-NP	JJ	O	6	NMOD
2	MHC	MHC	I-NP	NN	B-DNA	6	NMOD
3	class	class	I-NP	NN	I-DNA	6	NMOD
4	II	II	I-NP	CD	I-DNA	6	NMOD
5	gene	gene	I-NP	NN	I-DNA	6	NMOD
6	transcription	transcription	I-NP	NN	O	0	ROOT
7	directed	direct	B-VP	VBN	O	6	NMOD
8	by	by	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	carboxyl	carboxyl	I-NP	NN	B-protein	11	NMOD
11	terminus	terminus	I-NP	NN	I-protein	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	CIITA	CIITA	B-NP	NN	B-protein	15	NMOD
14	,	,	O	,	O	15	P
15	one	one	B-NP	CD	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	defective	defective	I-NP	JJ	B-DNA	19	NMOD
19	genes	gene	I-NP	NNS	I-DNA	16	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	type	type	B-NP	NN	O	26	NMOD
22	II	II	I-NP	CD	O	26	NMOD
23	MHC	MHC	I-NP	NN	B-protein	26	NMOD
24	combined	combined	I-NP	JJ	O	26	NMOD
25	immune	immune	I-NP	JJ	O	26	NMOD
26	deficiency	deficiency	I-NP	NN	O	20	PMOD
27	.	.	O	.	O	6	P

1	Type	Type	B-NP	NN	B-protein	5	NMOD
2	II	II	I-NP	CD	I-protein	5	NMOD
3	major	major	I-NP	JJ	I-protein	5	NMOD
4	histocompatibility	histocompatibility	I-NP	NN	I-protein	5	NMOD
5	complex	complex	I-NP	NN	I-protein	8	NMOD
6	combined	combined	I-NP	JJ	O	8	NMOD
7	immune	immune	I-NP	JJ	O	8	NMOD
8	deficiency	deficiency	I-NP	NN	O	19	SUB
9	(	(	O	(	O	17	P
10	type	type	B-NP	NN	O	13	NMOD
11	II	II	I-NP	CD	O	13	NMOD
12	MHC	MHC	I-NP	NN	B-protein	13	NMOD
13	CID	CID	I-NP	NN	O	17	NMOD
14	or	or	O	CC	O	17	NMOD
15	bare	bare	B-NP	JJ	O	17	NMOD
16	lymphocyte	lymphocyte	I-NP	NN	O	17	NMOD
17	syndrome	syndrome	I-NP	NN	O	8	NMOD
18	)	)	O	)	O	17	P
19	is	be	B-VP	VBZ	O	0	ROOT
20	a	a	B-NP	DT	O	23	NMOD
21	congenital	congenital	I-NP	JJ	O	23	NMOD
22	immunodeficiency	immunodeficiency	I-NP	NN	O	23	NMOD
23	disease	disease	I-NP	NN	O	19	PRD
24	characterized	characterize	B-VP	VBN	O	23	NMOD
25	by	by	B-PP	IN	O	24	VMOD
26	absent	absent	B-NP	JJ	O	30	NMOD
27	MHC	MHC	I-NP	NN	B-protein	30	NMOD
28	class	class	I-NP	NN	I-protein	30	NMOD
29	II	II	I-NP	CD	I-protein	30	NMOD
30	expression	expression	I-NP	NN	O	25	PMOD
31	.	.	O	.	O	19	P

1	Four	Four	B-NP	CD	O	4	NMOD
2	distinct	distinct	I-NP	JJ	O	4	NMOD
3	complementation	complementation	I-NP	NN	O	4	NMOD
4	groups	group	I-NP	NNS	O	5	SUB
5	have	have	B-VP	VBP	O	0	ROOT
6	been	be	I-VP	VBN	O	5	VC
7	identified	identify	I-VP	VBN	O	6	VC
8	.	.	O	.	O	5	P

1	Recently	Recently	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	the	the	B-NP	DT	O	5	NMOD
4	defective	defective	I-NP	JJ	B-DNA	5	NMOD
5	gene	gene	I-NP	NN	I-DNA	13	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	group	group	B-NP	NN	O	12	NMOD
8	II	II	I-NP	CD	O	12	NMOD
9	type	type	I-NP	NN	O	12	NMOD
10	II	II	I-NP	CD	O	12	NMOD
11	MHC	MHC	I-NP	NN	B-protein	12	NMOD
12	CID	CID	I-NP	NN	O	6	PMOD
13	has	have	B-VP	VBZ	O	0	ROOT
14	been	be	I-VP	VBN	O	13	VC
15	isolated	isolate	I-VP	VBN	O	14	VC
16	and	and	O	CC	O	15	VMOD
17	termed	term	B-VP	VBN	O	15	VMOD
18	CIITA	CIITA	B-NP	NN	B-protein	17	VMOD
19	.	.	O	.	O	13	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	CIITA	CIITA	B-NP	NN	B-protein	7	SUB
7	is	be	B-VP	VBZ	O	5	SBAR
8	an	an	B-NP	DT	O	14	NMOD
9	MHC	MHC	I-NP	NN	B-protein	10	NMOD
10	class	class	I-NP	NN	I-protein	14	NMOD
11	II	II	I-NP	CD	I-protein	10	AMOD
12	gene-specific	gene-specific	I-NP	JJ	O	10	AMOD
13	transcription	transcription	I-NP	NN	O	14	NMOD
14	activator	activator	I-NP	NN	O	7	PRD
15	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	transcription	transcription	I-NP	NN	O	4	NMOD
3	activation	activation	I-NP	NN	O	4	NMOD
4	function	function	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	provided	provide	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	11	NMOD
9	N-terminal	N-terminal	I-NP	JJ	B-protein	11	NMOD
10	acidic	acidic	I-NP	JJ	I-protein	11	NMOD
11	domain	domain	I-NP	NN	I-protein	7	PMOD
12	(	(	O	(	O	14	P
13	amino	amino	B-NP	NN	B-protein	14	NMOD
14	acids	acid	I-NP	NNS	I-protein	11	NMOD
15	26-137	26-137	B-NP	CD	I-protein	14	NMOD
16	)	)	O	)	O	14	P
17	,	,	O	,	O	11	P
18	which	which	B-NP	WDT	O	11	NMOD
19	is	be	B-VP	VBZ	O	18	SBAR
20	experimentally	experimentally	B-ADJP	RB	O	21	AMOD
21	exchangeable	exchangeable	I-ADJP	JJ	O	19	PRD
22	with	with	B-PP	IN	O	21	AMOD
23	a	a	B-NP	DT	O	27	NMOD
24	heterologous	heterologous	I-NP	JJ	B-protein	27	NMOD
25	viral	viral	I-NP	JJ	I-protein	27	NMOD
26	transcription-activating	transcription-activating	I-NP	JJ	I-protein	27	NMOD
27	domain	domain	I-NP	NN	I-protein	22	PMOD
28	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	specificity	specificity	I-NP	NN	O	19	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	CIITA	CIITA	B-NP	NN	B-protein	3	PMOD
5	for	for	B-PP	IN	O	2	NMOD
6	three	three	B-NP	CD	O	17	NMOD
7	major	major	I-NP	JJ	O	11	NMOD
8	MHC	MHC	I-NP	NN	B-DNA	11	NMOD
9	class	class	I-NP	NN	I-DNA	11	NMOD
10	II	II	B-NP	CD	I-DNA	11	NMOD
11	genes	gene	I-NP	NNS	I-DNA	6	NMOD
12	,	,	O	,	O	17	P
13	DR	DR	B-NP	NN	B-DNA	17	NMOD
14	,	,	O	,	O	17	P
15	DQ	DQ	B-NP	NN	B-DNA	17	NMOD
16	and	and	I-NP	CC	O	17	NMOD
17	DP	DP	I-NP	NN	B-DNA	5	PMOD
18	,	,	O	,	O	2	P
19	is	be	B-VP	VBZ	O	0	ROOT
20	mediated	mediate	I-VP	VBN	O	19	VC
21	by	by	B-PP	IN	O	20	VMOD
22	its	its	B-NP	PRP$	O	25	NMOD
23	remaining	remain	I-NP	VBG	O	25	NMOD
24	C-terminal	C-terminal	I-NP	JJ	B-protein	25	NMOD
25	residues	residue	I-NP	NNS	I-protein	21	PMOD
26	(	(	O	(	O	28	P
27	amino	amino	B-NP	NN	B-protein	28	NMOD
28	acids	acid	I-NP	NNS	I-protein	25	NMOD
29	317-1130	317-1130	B-NP	CD	I-protein	28	NMOD
30	)	)	O	)	O	28	P
31	.	.	O	.	O	19	P

1	The	The	B-NP	DT	O	2	NMOD
2	transactivation	transactivation	I-NP	NN	O	11	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	multiple	multiple	B-NP	JJ	B-DNA	6	NMOD
5	cis	cis	I-NP	NN	I-DNA	6	NMOD
6	elements	element	I-NP	NNS	I-DNA	3	PMOD
7	,	,	O	,	O	11	P
8	especially	especially	B-NP	RB	O	11	NMOD
9	S	S	I-NP	NN	O	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	X2	X2	I-NP	NN	B-DNA	24	SUB
12	,	,	O	,	O	11	P
13	of	of	B-PP	IN	O	11	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	DR	DR	I-NP	NN	B-DNA	18	NMOD
16	alpha	alpha	I-NP	NN	I-DNA	18	NMOD
17	proximal	proximal	I-NP	JJ	I-DNA	18	NMOD
18	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
19	in	in	B-PP	IN	O	11	NMOD
20	group	group	B-NP	NN	B-cell_line	23	NMOD
21	II	II	I-NP	CD	I-cell_line	23	NMOD
22	CID	CID	I-NP	NN	I-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	19	PMOD
24	is	be	B-VP	VBZ	O	0	ROOT
25	CIITA	CIITA	B-NP	NN	B-protein	26	AMOD
26	dependent	dependent	B-ADJP	JJ	O	24	PRD
27	.	.	O	.	O	24	P

1	Since	Since	B-SBAR	IN	O	15	VMOD
2	CIITA	CIITA	B-NP	NN	B-protein	3	NMOD
3	overexpression	overexpression	I-NP	NN	O	7	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	normal	normal	B-NP	JJ	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
7	did	do	B-VP	VBD	O	1	SBAR
8	not	not	I-VP	RB	O	7	VMOD
9	increase	increase	I-VP	VB	O	7	VC
10	class	class	B-NP	NN	O	12	NMOD
11	II	II	I-NP	CD	O	12	NMOD
12	expression	expression	I-NP	NN	O	9	OBJ
13	,	,	O	,	O	15	P
14	we	we	B-NP	PRP	O	15	SUB
15	propose	propose	B-VP	VBP	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	initiation	initiation	B-NP	NN	O	21	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	CIITA	CIITA	B-NP	NN	B-protein	20	NMOD
20	expression	expression	I-NP	NN	O	18	PMOD
21	serves	serve	B-VP	VBZ	O	16	SBAR
22	as	as	B-PP	IN	O	21	VMOD
23	the	the	B-NP	DT	O	25	NMOD
24	on-off	on-off	I-NP	JJ	O	25	NMOD
25	switch	switch	I-NP	NN	O	22	PMOD
26	,	,	O	,	O	21	P
27	while	while	B-SBAR	IN	O	21	VMOD
28	availability	availability	B-NP	NN	O	35	SUB
29	of	of	B-PP	IN	O	28	NMOD
30	downstream	downstream	B-NP	JJ	O	33	NMOD
31	interactor	interactor	I-NP	NN	O	33	NMOD
32	(	(	I-NP	(	O	33	P
33	s	s	I-NP	NNS	O	29	PMOD
34	)	)	O	)	O	33	P
35	limits	limit	B-VP	VBZ	O	27	SBAR
36	transcription	transcription	B-NP	NN	O	35	OBJ
37	.	.	O	.	O	15	P

1	Abnormal	Abnormal	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	IL-2	IL-2	I-NP	NN	B-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	3	PMOD
7	in	in	B-PP	IN	O	2	NMOD
8	lpr	lpr	B-NP	NN	O	11	NMOD
9	CD4-CD8-	CD4-CD8-	I-NP	JJ	B-cell_line	11	NMOD
10	T	T	I-NP	NN	I-cell_line	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	7	PMOD
12	results	result	B-VP	VBZ	O	0	ROOT
13	in	in	B-PP	IN	O	12	VMOD
14	constitutive	constitutive	B-NP	JJ	O	15	NMOD
15	expression	expression	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	20	NMOD
18	novel	novel	I-NP	JJ	O	20	NMOD
19	nuclear	nuclear	I-NP	JJ	B-protein	20	NMOD
20	factor	factor	I-NP	NN	I-protein	25	NMOD
21	of	of	B-PP	IN	I-protein	25	NMOD
22	activated	activate	B-NP	VBN	I-protein	25	NMOD
23	T	T	I-NP	NN	I-protein	25	NMOD
24	cells-binding	cells-binding	I-NP	JJ	I-protein	25	NMOD
25	factor	factor	I-NP	NN	I-protein	16	PMOD
26	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	inert	inert	I-NP	JJ	O	3	NMOD
3	quality	quality	I-NP	NN	O	16	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	MRL-Ipr/Ipr	MRL-Ipr/Ipr	B-NP	NN	B-cell_line	15	NMOD
6	(	(	O	(	I-cell_line	7	P
7	Ipr	Ipr	B-NP	NN	I-cell_line	5	NMOD
8	)	)	O	)	I-cell_line	7	P
9	peripheral	peripheral	O	JJ	I-cell_line	15	NMOD
10	CD4-CD8-	CD4-CD8-	O	CD4-CD8-	I-cell_line	15	NMOD
11	(	(	O	(	I-cell_line	15	P
12	CD4-8-	CD4-8-	O	JJ	I-cell_line	15	NMOD
13	)	)	O	)	I-cell_line	15	P
14	T	T	B-NP	NN	I-cell_line	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
16	manifests	manifest	B-VP	VBZ	O	0	ROOT
17	primarily	primarily	B-ADVP	RB	O	16	VMOD
18	as	as	B-PP	IN	O	16	VMOD
19	an	an	B-NP	DT	O	20	NMOD
20	inability	inability	I-NP	NN	O	18	PMOD
21	to	to	B-VP	TO	O	22	VMOD
22	proliferate	proliferate	I-VP	VB	O	20	NMOD
23	or	or	I-VP	CC	O	22	VMOD
24	produce	produce	I-VP	VB	O	22	VMOD
25	IL-2	IL-2	B-NP	NN	B-protein	24	OBJ
26	in	in	B-PP	IN	O	24	VMOD
27	response	response	B-NP	NN	O	26	PMOD
28	to	to	B-PP	TO	O	27	NMOD
29	TCR	TCR	B-NP	NN	B-protein	32	NMOD
30	or	or	O	CC	O	32	NMOD
31	mitogenic	mitogenic	B-NP	JJ	O	32	NMOD
32	stimulation	stimulation	I-NP	NN	O	28	PMOD
33	.	.	O	.	O	16	P

1	Yet	Yet	B-NP	RB	O	3	AMOD
2	these	these	I-NP	DT	O	3	AMOD
3	same	same	I-NP	JJ	O	4	NMOD
4	cells	cell	I-NP	NNS	O	5	SUB
5	do	do	B-VP	VBP	O	0	ROOT
6	initiate	initiate	I-VP	VB	O	5	VC
7	early	early	B-NP	JJ	O	10	NMOD
8	TCR-mediated	TCR-mediated	I-NP	JJ	O	10	NMOD
9	signaling	signaling	I-NP	NN	O	10	NMOD
10	events	event	I-NP	NNS	O	6	OBJ
11	,	,	O	,	O	10	P
12	such	such	B-PP	JJ	O	13	PMOD
13	as	as	I-PP	IN	O	10	NMOD
14	generation	generation	B-NP	NN	O	21	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	inositol	inositol	B-NP	NN	O	17	NMOD
17	phosphates	phosphate	I-NP	NNS	O	15	PMOD
18	and	and	O	CC	O	21	NMOD
19	increased	increase	B-NP	VBN	O	21	NMOD
20	intracellular	intracellular	I-NP	JJ	O	21	NMOD
21	calcium	calcium	I-NP	NN	O	13	PMOD
22	.	.	O	.	O	5	P

1	They	They	B-NP	PRP	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	display	display	B-VP	VBP	O	0	ROOT
4	constitutively	constitutively	B-NP	RB	O	5	AMOD
5	high	high	I-NP	JJ	O	6	NMOD
6	levels	level	I-NP	NNS	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	p59fyn	p59fyn	B-NP	NN	B-protein	13	NMOD
9	and	and	I-NP	CC	O	13	NMOD
10	CD3	CD3	I-NP	NN	B-protein	13	NMOD
11	zeta	zeta	I-NP	NN	I-protein	13	NMOD
12	tyrosine	tyrosine	I-NP	NN	O	13	NMOD
13	phosphorylation	phosphorylation	I-NP	NN	O	7	PMOD
14	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	generation	generation	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	second	second	B-NP	JJ	O	5	NMOD
5	messengers	messenger	I-NP	NNS	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
9	normally	normally	B-ADVP	RB	O	10	VMOD
10	leads	lead	B-VP	VBZ	O	0	ROOT
11	to	to	B-PP	TO	O	10	VMOD
12	downstream	downstream	B-NP	JJ	O	13	NMOD
13	signaling	signaling	I-NP	NN	O	11	PMOD
14	that	that	B-NP	WDT	O	13	NMOD
15	results	result	B-VP	VBZ	O	14	SBAR
16	in	in	B-PP	IN	O	15	VMOD
17	transcriptional	transcriptional	B-NP	JJ	O	18	NMOD
18	activation	activation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	IL-2	IL-2	I-NP	NN	B-DNA	22	NMOD
22	gene	gene	I-NP	NN	I-DNA	19	PMOD
23	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	5	SUB
2	,	,	O	,	O	5	P
3	therefore	therefore	B-ADVP	RB	O	5	VMOD
4	,	,	O	,	O	5	P
5	compared	compare	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	activation	activation	I-NP	NN	O	8	NMOD
8	state	state	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	14	NMOD
11	IL-2	IL-2	I-NP	NN	B-DNA	14	NMOD
12	gene	gene	I-NP	NN	I-DNA	14	NMOD
13	promoter	promoter	I-NP	NN	I-DNA	14	NMOD
14	region	region	I-NP	NN	I-DNA	9	PMOD
15	in	in	B-PP	IN	O	8	NMOD
16	freshly	freshly	B-NP	RB	O	17	AMOD
17	isolated	isolate	I-NP	VBN	O	19	AMOD
18	and	and	I-NP	CC	O	19	AMOD
19	stimulated	stimulate	I-NP	VBN	O	23	NMOD
20	Ipr	Ipr	I-NP	NN	B-cell_line	23	NMOD
21	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	23	NMOD
22	T	T	I-NP	NN	I-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
24	with	with	B-PP	IN	O	5	VMOD
25	that	that	B-NP	DT	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	normal	normal	B-NP	JJ	B-cell_type	29	NMOD
28	T	T	I-NP	NN	I-cell_type	29	NMOD
29	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	26	PMOD
30	.	.	O	.	O	5	P

1	Levels	Level	B-NP	NNS	O	16	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	octamer	octamer	I-NP	NN	B-DNA	7	NMOD
5	,	,	O	,	O	7	P
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	2	PMOD
8	(	(	O	(	O	10	P
9	p50-p65	p50-p65	B-NP	NN	B-protein	10	NMOD
10	heterodimer	heterodimer	I-NP	NN	I-protein	7	NMOD
11	)	)	O	)	O	10	P
12	,	,	O	,	O	16	P
13	and	and	O	CC	O	16	NMOD
14	AP-1	AP-1	B-NP	NN	B-protein	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	I-protein	16	NMOD
16	factors	factor	I-NP	NNS	I-protein	17	SUB
17	are	be	B-VP	VBP	O	0	ROOT
18	constitutively	constitutively	I-VP	RB	O	17	VMOD
19	elevated	elevate	I-VP	VBN	O	17	VC
20	in	in	B-PP	IN	O	19	VMOD
21	freshly	freshly	B-NP	RB	O	22	AMOD
22	isolated	isolate	I-NP	VBN	O	26	NMOD
23	Ipr	Ipr	I-NP	NN	B-cell_line	26	NMOD
24	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	26	NMOD
25	T	T	I-NP	NN	I-cell_line	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_line	20	PMOD
27	,	,	O	,	O	17	P
28	consistent	consistent	B-ADJP	JJ	O	17	PRD
29	with	with	B-PP	IN	O	28	AMOD
30	the	the	B-NP	DT	O	32	NMOD
31	activated	activate	I-NP	VBN	O	32	NMOD
32	phenotype	phenotype	I-NP	NN	O	29	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	these	these	B-NP	DT	O	35	NMOD
35	cells	cell	I-NP	NNS	O	33	PMOD
36	.	.	O	.	O	17	P

1	Upon	Upon	B-PP	IN	O	22	VMOD
2	stimulation	stimulation	B-NP	NN	O	1	PMOD
3	with	with	B-PP	IN	O	2	NMOD
4	mitogens	mitogen	B-NP	NNS	B-protein	3	PMOD
5	,	,	O	,	O	22	P
6	formation	formation	B-NP	NN	O	22	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	transactivating	transactivate	I-NP	VBG	B-protein	10	NMOD
10	complex	complex	I-NP	NN	I-protein	7	PMOD
11	,	,	O	,	O	22	P
12	nuclear	nuclear	B-NP	JJ	B-protein	13	NMOD
13	factor	factor	I-NP	NN	I-protein	22	SUB
14	of	of	B-PP	IN	I-protein	13	NMOD
15	activated	activate	B-NP	VBN	I-protein	17	NMOD
16	T	T	I-NP	NN	I-protein	17	NMOD
17	cells	cell	I-NP	NNS	I-protein	14	PMOD
18	(	(	O	(	O	19	P
19	NF-AT	NF-AT	B-NP	NN	B-protein	13	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	13	P
22	occurs	occur	B-VP	VBZ	O	0	ROOT
23	with	with	B-PP	IN	O	22	VMOD
24	normal	normal	B-NP	JJ	O	25	NMOD
25	kinetics	kinetic	I-NP	NNS	O	23	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	Ipr	Ipr	B-NP	NN	B-cell_line	30	NMOD
28	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	30	NMOD
29	T	T	I-NP	NN	I-cell_line	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
31	.	.	O	.	O	22	P

1	Yet	Yet	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	the	the	B-NP	DT	O	4	NMOD
4	levels	level	I-NP	NNS	O	11	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	activating	activate	I-NP	VBG	O	9	NMOD
8	NF-AT	NF-AT	I-NP	NN	B-protein	9	NMOD
9	complex	complex	I-NP	NN	I-protein	5	PMOD
10	never	never	B-ADVP	RB	O	11	VMOD
11	reach	reach	B-VP	VBP	O	0	ROOT
12	those	those	B-NP	DT	O	11	OBJ
13	observed	observe	B-VP	VBN	O	12	NMOD
14	in	in	B-PP	IN	O	13	VMOD
15	similarly	similarly	B-NP	RB	O	16	AMOD
16	stimulated	stimulate	I-NP	VBN	O	19	NMOD
17	normal	normal	I-NP	JJ	O	19	NMOD
18	T	T	I-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
20	.	.	O	.	O	11	P

1	Furthermore	Furthermore	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	nuclear	nuclear	B-NP	JJ	O	4	NMOD
4	extracts	extract	I-NP	NNS	O	10	SUB
5	from	from	B-PP	IN	O	4	NMOD
6	Ipr	Ipr	B-NP	NN	B-cell_line	9	NMOD
7	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	9	NMOD
8	T	T	I-NP	NN	I-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
10	display	display	B-VP	VBP	O	0	ROOT
11	high	high	B-NP	JJ	O	12	NMOD
12	levels	level	I-NP	NNS	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	18	NMOD
15	novel	novel	I-NP	JJ	O	16	AMOD
16	specific	specific	I-NP	JJ	O	18	NMOD
17	binding	binding	I-NP	NN	O	18	NMOD
18	activity	activity	I-NP	NN	O	13	PMOD
19	at	at	B-PP	IN	O	10	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	NF-AT	NF-AT	I-NP	NN	B-DNA	22	NMOD
22	site	site	I-NP	NN	I-DNA	19	PMOD
23	,	,	O	,	O	10	P
24	which	which	B-NP	WDT	O	10	VMOD
25	is	be	B-VP	VBZ	O	24	SBAR
26	present	present	B-ADJP	JJ	O	25	PRD
27	at	at	B-PP	IN	O	26	AMOD
28	much	much	B-NP	RB	O	29	AMOD
29	lower	low	I-NP	JJR	O	30	NMOD
30	levels	level	I-NP	NNS	O	27	PMOD
31	in	in	B-PP	IN	O	30	NMOD
32	freshly	freshly	B-NP	RB	B-cell_type	33	AMOD
33	isolated	isolate	I-NP	VBN	I-cell_type	36	NMOD
34	normal	normal	I-NP	JJ	I-cell_type	36	NMOD
35	T	T	I-NP	NN	I-cell_type	36	NMOD
36	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	31	PMOD
37	.	.	O	.	O	10	P

1	Upon	Upon	B-PP	IN	O	13	VMOD
2	mitogenic	mitogenic	B-NP	JJ	O	3	NMOD
3	stimulation	stimulation	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	13	P
5	the	the	B-NP	DT	O	7	NMOD
6	binding	binding	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	13	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	novel	novel	I-NP	JJ	O	12	NMOD
11	NF-AT-binding	NF-AT-binding	I-NP	JJ	B-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	8	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	rapidly	rapidly	I-VP	RB	O	13	VMOD
15	down-regulated	down-regulate	I-VP	VBN	O	13	VC
16	in	in	B-PP	IN	O	15	VMOD
17	normal	normal	B-NP	JJ	O	19	NMOD
18	T	T	I-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	,	,	O	,	O	13	P
21	but	but	O	CC	O	13	VMOD
22	persists	persist	B-VP	VBZ	O	13	VMOD
23	at	at	B-PP	IN	O	22	VMOD
24	high	high	B-NP	JJ	O	25	NMOD
25	levels	level	I-NP	NNS	O	23	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	Ipr	Ipr	B-NP	NN	B-cell_line	30	NMOD
28	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	30	NMOD
29	T	T	I-NP	NN	I-cell_line	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
31	.	.	O	.	O	13	P

1	These	These	B-NP	DT	O	3	NMOD
2	two	two	I-NP	CD	O	3	NMOD
3	abnormalities	abnormality	I-NP	NNS	O	8	SUB
4	at	at	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	NF-AT	NF-AT	I-NP	NN	B-DNA	7	NMOD
7	site	site	I-NP	NN	I-DNA	4	PMOD
8	provide	provide	B-VP	VBP	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	potential	potential	I-NP	JJ	O	11	NMOD
11	mechanism	mechanism	I-NP	NN	O	8	OBJ
12	to	to	B-VP	TO	O	13	VMOD
13	account	account	I-VP	VB	O	11	NMOD
14	for	for	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	defect	defect	I-NP	NN	O	14	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	IL-2	IL-2	B-NP	NN	B-protein	19	NMOD
19	production	production	I-NP	NN	O	17	PMOD
20	from	from	B-PP	IN	O	19	NMOD
21	Ipr	Ipr	B-NP	NN	B-cell_line	24	NMOD
22	CD4-8-	CD4-8-	I-NP	NN	I-cell_line	24	NMOD
23	T	T	I-NP	NN	I-cell_line	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_line	20	PMOD
25	.	.	O	.	O	8	P

1	GM-CSF	GM-CSF	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	IL-2	IL-2	I-NP	NN	B-protein	4	SUB
4	share	share	B-VP	VBP	O	0	ROOT
5	common	common	B-NP	JJ	O	7	NMOD
6	control	control	I-NP	NN	O	7	NMOD
7	mechanisms	mechanism	I-NP	NNS	O	4	OBJ
8	in	in	B-PP	IN	O	4	VMOD
9	response	response	B-NP	NN	O	8	PMOD
10	to	to	B-PP	TO	O	9	NMOD
11	costimulatory	costimulatory	B-NP	JJ	O	12	NMOD
12	signals	signal	I-NP	NNS	O	10	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	T	T	B-NP	NN	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	.	.	O	.	O	4	P

1	Antigen	Antigen	B-NP	NN	O	19	SUB
2	complexed	complexe	B-VP	VBN	O	1	NMOD
3	with	with	B-PP	IN	O	2	VMOD
4	major	major	B-NP	JJ	B-protein	11	NMOD
5	histocompatibility	histocompatibility	I-NP	NN	I-protein	11	NMOD
6	complex	complex	I-NP	NN	I-protein	11	NMOD
7	class	class	I-NP	NN	I-protein	11	NMOD
8	I	I	B-NP	CD	I-protein	11	NMOD
9	or	or	I-NP	CC	I-protein	11	NMOD
10	II	II	I-NP	CD	I-protein	11	NMOD
11	molecules	molecule	I-NP	NNS	I-protein	3	PMOD
12	on	on	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	surface	surface	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	antigen	antigen	B-NP	NN	B-cell_type	18	NMOD
17	presenting	presenting	I-NP	NN	I-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	interacts	interact	B-VP	VBZ	O	0	ROOT
20	with	with	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	24	NMOD
22	T	T	I-NP	NN	B-protein	24	NMOD
23	cell	cell	I-NP	NN	I-protein	24	NMOD
24	receptor	receptor	I-NP	NN	I-protein	20	PMOD
25	(	(	O	(	O	26	P
26	TCR	TCR	B-NP	NN	B-protein	24	NMOD
27	)	)	O	)	O	26	P
28	on	on	B-PP	IN	O	24	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	surface	surface	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	T	T	B-NP	NN	B-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD
34	and	and	O	CC	O	19	VMOD
35	initiates	initiate	B-VP	VBZ	O	19	VMOD
36	an	an	B-NP	DT	O	38	NMOD
37	activation	activation	I-NP	NN	O	38	NMOD
38	cascade	cascade	I-NP	NN	O	35	OBJ
39	.	.	O	.	O	19	P

1	So	So	O	RB	O	21	VMOD
2	called	call	B-VP	VBN	O	4	NMOD
3	costimulatory	costimulatory	B-NP	JJ	O	4	NMOD
4	signals	signal	I-NP	NNS	O	21	SUB
5	,	,	O	,	O	4	P
6	mediated	mediate	B-VP	VBN	O	4	NMOD
7	by	by	B-PP	IN	O	6	VMOD
8	other	other	B-NP	JJ	O	11	NMOD
9	cell	cell	I-NP	NN	O	11	NMOD
10	surface	surface	I-NP	NN	O	11	NMOD
11	interactions	interaction	I-NP	NNS	O	14	NMOD
12	or	or	O	CC	O	14	NMOD
13	soluble	soluble	B-NP	JJ	B-protein	14	NMOD
14	cytokines	cytokine	I-NP	NNS	I-protein	7	PMOD
15	produced	produce	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	antigen	antigen	B-NP	NN	B-cell_type	19	NMOD
18	presenting	presenting	I-NP	NN	I-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	,	,	O	,	O	4	P
21	are	be	B-VP	VBP	O	0	ROOT
22	also	also	I-VP	RB	O	21	VMOD
23	required	require	I-VP	VBN	O	21	VC
24	for	for	B-PP	IN	O	23	VMOD
25	complete	complete	B-NP	JJ	O	28	NMOD
26	T	T	I-NP	NN	O	28	NMOD
27	cell	cell	I-NP	NN	O	28	NMOD
28	activation	activation	I-NP	NN	O	24	PMOD
29	.	.	O	.	O	21	P

1	High	High	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	cytokine	cytokine	B-NP	NN	B-DNA	6	NMOD
5	gene	gene	I-NP	NN	I-DNA	6	NMOD
6	expression	expression	I-NP	NN	O	3	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	T	T	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	also	also	B-ADVP	RB	O	11	VMOD
11	required	require	B-VP	VBD	O	0	ROOT
12	both	both	O	CC	O	16	NMOD
13	TCR	TCR	B-NP	NN	B-protein	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	costimulatory	costimulatory	B-NP	JJ	O	16	NMOD
16	signals	signal	I-NP	NNS	O	11	OBJ
17	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	4	NMOD
2	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	B-protein	4	NMOD
3	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	4	NMOD
4	factor	factor	I-NP	NN	I-protein	5	SUB
5	requires	require	B-VP	VBZ	O	0	ROOT
6	sequences	sequence	B-NP	NNS	O	18	NMOD
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	promoter	promoter	I-NP	NN	B-DNA	7	PMOD
10	as	as	B-CONJP	RB	O	6	NMOD
11	well	well	I-CONJP	RB	O	10	DEP
12	as	as	I-CONJP	IN	O	10	DEP
13	a	a	B-NP	DT	O	18	NMOD
14	powerful	powerful	I-NP	JJ	O	18	NMOD
15	enhancer	enhancer	I-NP	NN	B-DNA	18	NMOD
16	located	located	I-NP	JJ	O	18	AMOD
17	3kb	3kb	I-NP	JJ	B-DNA	18	AMOD
18	upstream	upstream	I-NP	JJ	I-DNA	5	OBJ
19	to	to	B-VP	TO	O	20	VMOD
20	respond	respond	I-VP	VB	O	18	NMOD
21	to	to	B-PP	TO	O	20	VMOD
22	TCR-like	TCR-like	B-NP	JJ	O	23	NMOD
23	signals	signal	I-NP	NNS	O	21	PMOD
24	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	5	NMOD
2	promoter	promoter	I-NP	NN	B-DNA	5	NMOD
3	and	and	I-NP	CC	O	5	NMOD
4	enhancer	enhancer	I-NP	NN	B-DNA	5	NMOD
5	regions	region	I-NP	NNS	I-DNA	6	SUB
6	are	be	B-VP	VBP	O	0	ROOT
7	mainly	mainly	I-VP	RB	O	6	VMOD
8	activated	activate	I-VP	VBN	O	6	VC
9	by	by	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	transcription	transcription	I-NP	NN	B-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	14	NMOD
13	nuclear	nuclear	B-NP	JJ	B-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	9	PMOD
15	of	of	B-PP	IN	I-protein	14	NMOD
16	activated	activate	B-NP	VBN	I-protein	18	NMOD
17	T	T	I-NP	NN	I-protein	18	NMOD
18	cells	cell	I-NP	NNS	I-protein	15	PMOD
19	(	(	O	(	O	20	P
20	NFAT	NFAT	B-NP	NN	B-protein	14	NMOD
21	)	)	O	)	O	20	P
22	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	activation	activation	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NFAT	NFAT	B-NP	NN	B-protein	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	TCR	TCR	B-NP	NN	B-protein	7	NMOD
7	signals	signal	I-NP	NNS	O	5	PMOD
8	has	have	B-VP	VBZ	O	0	ROOT
9	been	be	I-VP	VBN	O	8	VC
10	well	well	I-VP	RB	O	9	VMOD
11	described	describe	I-VP	VBN	O	9	VC
12	for	for	B-PP	IN	O	11	VMOD
13	interleukin-2	interleukin-2	B-NP	NN	B-protein	19	NMOD
14	(	(	O	(	O	15	P
15	IL-2	IL-2	B-NP	NN	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	and	and	O	CC	O	19	NMOD
18	IL-4	IL-4	B-NP	NN	B-DNA	19	NMOD
19	gene	gene	I-NP	NN	I-DNA	20	NMOD
20	transcription	transcription	I-NP	NN	O	12	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	T	T	B-NP	NN	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
24	.	.	O	.	O	8	P

1	Costimulatory	Costimulatory	B-NP	JJ	O	2	NMOD
2	signals	signal	I-NP	NNS	O	17	SUB
3	,	,	O	,	O	2	P
4	such	such	B-PP	JJ	O	5	PMOD
5	as	as	I-PP	IN	O	2	NMOD
6	activation	activation	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	12	NMOD
9	CD28	CD28	I-NP	NN	B-protein	12	NMOD
10	cell	cell	I-NP	NN	I-protein	12	NMOD
11	surface	surface	I-NP	NN	I-protein	12	NMOD
12	molecule	molecule	I-NP	NN	I-protein	7	PMOD
13	on	on	B-PP	IN	O	6	NMOD
14	T	T	B-NP	NN	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	,	,	O	,	O	2	P
17	lead	lead	B-VP	VBP	O	0	ROOT
18	to	to	B-PP	TO	O	17	VMOD
19	activation	activation	B-NP	NN	O	18	PMOD
20	through	through	B-PP	IN	O	17	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	distinct	distinct	I-NP	JJ	O	23	NMOD
23	region	region	I-NP	NN	O	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	32	NMOD
26	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	B-DNA	32	NMOD
27	colony-stimulating	colony-stimulating	I-NP	JJ	I-DNA	32	NMOD
28	factor	factor	I-NP	NN	I-DNA	32	NMOD
29	(	(	O	(	I-DNA	32	P
30	GM-CSF	GM-CSF	B-NP	NN	I-DNA	32	NMOD
31	)	)	O	)	I-DNA	32	P
32	promoter	promoter	B-NP	NN	I-DNA	24	PMOD
33	.	.	O	.	O	17	P

1	This	This	B-NP	DT	O	2	NMOD
2	region	region	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	termed	term	I-VP	VBN	O	3	VC
5	the	the	B-NP	DT	O	8	NMOD
6	CK-1	CK-1	I-NP	NN	B-DNA	8	NMOD
7	or	or	I-NP	CC	O	8	NMOD
8	CD28RE	CD28RE	I-NP	NN	B-DNA	4	VMOD
9	and	and	O	CC	O	3	VMOD
10	appears	appear	B-VP	VBZ	O	3	VMOD
11	to	to	I-VP	TO	O	12	VMOD
12	bind	bind	I-VP	VB	O	10	VMOD
13	specific	specific	B-NP	JJ	O	14	NMOD
14	members	member	I-NP	NNS	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	NF-kappa	NF-kappa	I-NP	NN	B-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	family	family	I-NP	NN	I-protein	15	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	transcription	transcription	B-NP	NN	B-protein	22	NMOD
22	factors	factor	I-NP	NNS	I-protein	20	PMOD
23	.	.	O	.	O	3	P

1	Human	Human	B-NP	JJ	O	5	NMOD
2	T	T	I-NP	NN	O	5	NMOD
3	leukemia	leukemia	I-NP	NN	O	5	NMOD
4	virus	virus	I-NP	NN	O	5	NMOD
5	type	type	I-NP	NN	O	10	SUB
6	1	1	I-NP	CD	O	5	NMOD
7	(	(	O	(	O	8	P
8	HTLV-1	HTLV-1	B-NP	NN	O	5	NMOD
9	)	)	O	)	O	8	P
10	infects	infect	B-VP	VBZ	O	0	ROOT
11	T	T	B-NP	NN	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	OBJ
13	and	and	O	CC	O	10	VMOD
14	can	can	B-VP	MD	O	10	VMOD
15	lead	lead	I-VP	VB	O	14	VC
16	to	to	I-VP	TO	O	17	VMOD
17	increase	increase	I-VP	VB	O	15	VMOD
18	GM-CSF	GM-CSF	B-NP	NN	B-protein	19	NMOD
19	expression	expression	I-NP	NN	O	17	OBJ
20	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	found	find	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	HTLV-1	HTLV-1	I-NP	NN	B-protein	8	NMOD
7	transactivator	transactivator	I-NP	NN	I-protein	8	NMOD
8	protein	protein	I-NP	NN	I-protein	10	NMOD
9	,	,	O	,	O	10	P
10	tax	tax	B-NP	NN	B-protein	12	SUB
11	,	,	O	,	O	10	P
12	acts	act	B-VP	VBZ	O	4	SBAR
13	as	as	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	16	NMOD
15	costimulatory	costimulatory	I-NP	JJ	O	16	NMOD
16	signal	signal	I-NP	NN	O	13	PMOD
17	for	for	B-PP	IN	O	12	VMOD
18	GM-CSF	GM-CSF	B-NP	NN	B-protein	22	NMOD
19	and	and	I-NP	CC	O	22	NMOD
20	IL-2	IL-2	I-NP	NN	B-DNA	22	NMOD
21	gene	gene	I-NP	NN	I-DNA	22	NMOD
22	transcription	transcription	I-NP	NN	O	17	PMOD
23	,	,	O	,	O	12	P
24	in	in	B-SBAR	IN	O	25	DEP
25	that	that	I-SBAR	IN	O	12	VMOD
26	it	it	B-NP	PRP	O	27	SUB
27	can	can	B-VP	MD	O	25	SBAR
28	cooperate	cooperate	I-VP	VB	O	27	VC
29	with	with	B-PP	IN	O	28	VMOD
30	TCR	TCR	B-NP	NN	B-protein	31	NMOD
31	signals	signal	I-NP	NNS	O	29	PMOD
32	to	to	B-VP	TO	O	33	VMOD
33	mediate	mediate	I-VP	VB	O	28	VMOD
34	high	high	B-NP	JJ	O	37	NMOD
35	level	level	I-NP	NN	O	37	NMOD
36	gene	gene	I-NP	NN	O	37	NMOD
37	expression	expression	I-NP	NN	O	33	OBJ
38	.	.	O	.	O	2	P

1	Tax	Tax	B-NP	NN	B-protein	2	SUB
2	activates	activate	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	GM-CSF	GM-CSF	I-NP	NN	B-DNA	5	NMOD
5	promoter	promoter	I-NP	NN	I-DNA	2	OBJ
6	through	through	B-PP	IN	O	2	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	CK-1/CD28RE	CK-1/CD28RE	I-NP	NN	B-DNA	9	NMOD
9	region	region	I-NP	NN	I-DNA	6	PMOD
10	and	and	O	CC	O	2	VMOD
11	also	also	B-VP	RB	O	2	VMOD
12	activates	activate	I-VP	VBZ	O	2	VMOD
13	nuclear	nuclear	B-NP	JJ	B-protein	15	NMOD
14	factor-kappa	factor-kappa	I-NP	NN	I-protein	15	NMOD
15	B	B	I-NP	NN	I-protein	12	OBJ
16	binding	bind	B-VP	VBG	O	15	NMOD
17	to	to	B-PP	TO	O	16	VMOD
18	this	this	B-NP	DT	O	19	NMOD
19	region	region	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	other	other	B-NP	JJ	O	5	NMOD
4	transcription	transcription	I-NP	NN	B-protein	5	NMOD
5	factors	factor	I-NP	NNS	I-protein	7	NMOD
6	or	or	O	CC	O	7	NMOD
7	coactivators	coactivator	B-NP	NNS	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
10	B	B	I-NP	NN	I-protein	8	PMOD
11	are	be	B-VP	VBP	O	18	VMOD
12	required	require	I-VP	VBN	O	11	VC
13	for	for	B-PP	IN	O	12	VMOD
14	tax	tax	B-NP	NN	B-protein	15	NMOD
15	activation	activation	I-NP	NN	O	13	PMOD
16	but	but	O	CC	O	18	VMOD
17	these	these	B-NP	DT	O	18	SUB
18	remain	remain	B-VP	VBP	O	0	ROOT
19	to	to	I-VP	TO	O	20	VMOD
20	be	be	I-VP	VB	O	18	VMOD
21	identified	identify	I-VP	VBN	O	20	VC
22	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	2	NMOD
2	CK-1/CD28RE	CK-1/CD28RE	I-NP	NN	B-DNA	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	GM-CSF	GM-CSF	B-NP	NN	B-protein	3	PMOD
5	shows	show	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	high	high	I-NP	JJ	O	8	NMOD
8	degree	degree	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	similarity	similarity	B-NP	NN	O	9	PMOD
11	to	to	B-PP	TO	O	8	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	IL-2	IL-2	I-NP	NN	B-protein	14	NMOD
14	CD28RE	CD28RE	I-NP	NN	B-DNA	18	NMOD
15	and	and	O	CC	O	18	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	IL-3	IL-3	I-NP	NN	B-DNA	18	NMOD
18	gene	gene	I-NP	NN	I-DNA	11	PMOD
19	also	also	B-ADVP	RB	O	5	VMOD
20	contains	contain	B-VP	VBZ	O	5	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	related	related	I-NP	JJ	O	23	NMOD
23	region	region	I-NP	NN	O	20	OBJ
24	.	.	O	.	O	5	P

1	This	This	B-NP	DT	O	2	NMOD
2	observation	observation	I-NP	NN	O	20	SUB
3	,	,	O	,	O	2	P
4	together	together	B-ADVP	RB	O	2	NMOD
5	with	with	B-PP	IN	O	2	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	fact	fact	I-NP	NN	O	5	PMOD
8	that	that	B-SBAR	IN	O	2	NMOD
9	both	both	O	CC	O	12	NMOD
10	GM-CSF	GM-CSF	B-NP	NN	B-protein	12	NMOD
11	and	and	O	CC	O	12	NMOD
12	IL-2	IL-2	B-NP	NN	B-protein	13	SUB
13	respond	respond	B-VP	VBP	O	8	SBAR
14	to	to	B-PP	TO	O	13	VMOD
15	TCR	TCR	B-NP	NN	B-protein	16	NMOD
16	signals	signal	I-NP	NNS	O	14	PMOD
17	via	via	B-PP	IN	O	13	VMOD
18	NFAT	NFAT	B-NP	NN	B-protein	17	PMOD
19	,	,	O	,	O	2	P
20	implies	imply	B-VP	VBZ	O	0	ROOT
21	a	a	B-NP	DT	O	23	NMOD
22	high	high	I-NP	JJ	O	23	NMOD
23	degree	degree	I-NP	NN	O	20	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	conservation	conservation	B-NP	NN	O	24	PMOD
26	in	in	B-PP	IN	O	20	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	regulation	regulation	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	cytokine	cytokine	B-NP	NN	B-DNA	32	NMOD
31	gene	gene	I-NP	NN	I-DNA	32	NMOD
32	expression	expression	I-NP	NN	O	29	PMOD
33	in	in	B-PP	IN	O	32	NMOD
34	T	T	B-NP	NN	B-cell_type	35	NMOD
35	cells	cell	I-NP	NNS	I-cell_type	33	PMOD
36	.	.	O	.	O	20	P

1	MIP1	MIP1	B-NP	NN	B-protein	4	NMOD
2	alpha	alpha	I-NP	NN	I-protein	4	NMOD
3	nuclear	nuclear	I-NP	JJ	I-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	12	NMOD
5	(	(	O	(	O	6	P
6	MNP	MNP	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	,	,	O	,	O	12	P
9	a	a	B-NP	DT	O	12	NMOD
10	novel	novel	I-NP	JJ	O	12	NMOD
11	transcription	transcription	I-NP	NN	B-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	0	ROOT
13	expressed	express	B-VP	VBN	O	12	NMOD
14	in	in	B-PP	IN	O	13	VMOD
15	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
17	that	that	B-NP	WDT	O	12	NMOD
18	is	be	B-VP	VBZ	O	17	SBAR
19	crucial	crucial	B-ADJP	JJ	O	18	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	transcription	transcription	B-NP	NN	O	20	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	27	NMOD
24	human	human	I-NP	JJ	B-DNA	27	NMOD
25	MIP-1	MIP-1	I-NP	NN	I-DNA	27	NMOD
26	alpha	alpha	I-NP	NN	I-DNA	27	NMOD
27	gene	gene	I-NP	NN	I-DNA	22	PMOD
28	.	.	O	.	O	12	P

1	Murine	Murine	B-NP	JJ	B-protein	6	NMOD
2	macrophage	macrophage	I-NP	NN	I-protein	6	NMOD
3	inflammatory	inflammatory	I-NP	JJ	I-protein	6	NMOD
4	protein	protein	I-NP	NN	I-protein	6	NMOD
5	1	1	I-NP	CD	I-protein	6	NMOD
6	alpha	alpha	I-NP	NN	I-protein	14	NMOD
7	(	(	O	(	O	9	P
8	MIP-1	MIP-1	B-NP	NN	B-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	6	NMOD
10	)	)	O	)	O	9	P
11	and	and	O	CC	O	14	NMOD
12	its	its	B-NP	PRP$	O	14	NMOD
13	human	human	I-NP	JJ	B-protein	14	NMOD
14	equivalent	equivalent	I-NP	NN	I-protein	23	SUB
15	(	(	O	(	O	21	P
16	GOS19	GOS19	B-NP	NN	B-protein	21	NMOD
17	,	,	O	,	O	21	P
18	LD78	LD78	B-NP	NN	B-protein	21	NMOD
19	,	,	O	,	O	21	P
20	or	or	O	CC	O	21	NMOD
21	AT464	AT464	B-NP	NN	B-protein	14	NMOD
22	)	)	O	)	O	21	P
23	are	be	B-VP	VBP	O	0	ROOT
24	members	member	B-NP	NNS	O	23	PRD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	-C-C	-C-C	I-NP	NN	B-protein	28	NMOD
28	family	family	I-NP	NN	I-protein	25	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	low-molecular-weight	low-molecular-weight	B-NP	JJ	B-protein	31	NMOD
31	chemokines	chemokine	I-NP	NNS	I-protein	29	PMOD
32	.	.	O	.	O	23	P

1	Secreted	Secrete	B-VP	VBN	O	13	VMOD
2	from	from	B-PP	IN	O	1	VMOD
3	activated	activate	B-NP	VBN	B-cell_type	5	NMOD
4	T	T	I-NP	NN	I-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	macrophages	macrophage	B-NP	NNS	B-cell_type	2	PMOD
8	,	,	O	,	O	13	P
9	bone	bone	B-NP	NN	O	12	NMOD
10	marrow-derived	marrow-derived	I-NP	JJ	B-protein	12	NMOD
11	MIP-1	MIP-1	I-NP	NN	I-protein	12	NMOD
12	alpha/GOS19	alpha/GOS19	I-NP	NN	I-protein	13	SUB
13	inhibits	inhibit	B-VP	VBZ	O	0	ROOT
14	primitive	primitive	B-NP	JJ	B-cell_type	17	NMOD
15	hematopoietic	hematopoietic	I-NP	JJ	I-cell_type	17	NMOD
16	stem	stem	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	13	OBJ
18	and	and	O	CC	O	13	VMOD
19	appears	appear	B-VP	VBZ	O	13	VMOD
20	to	to	I-VP	TO	O	21	VMOD
21	be	be	I-VP	VB	O	19	VMOD
22	involved	involve	I-VP	VBN	O	21	VC
23	in	in	B-PP	IN	O	22	VMOD
24	the	the	B-NP	DT	O	26	NMOD
25	homeostatic	homeostatic	I-NP	JJ	O	26	NMOD
26	control	control	I-NP	NN	O	23	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	stem	stem	B-NP	NN	O	30	NMOD
29	cell	cell	I-NP	NN	O	30	NMOD
30	proliferation	proliferation	I-NP	NN	O	27	PMOD
31	.	.	O	.	O	13	P

1	It	It	B-NP	PRP	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	induces	induce	B-VP	VBZ	O	0	ROOT
4	chemotaxis	chemotaxis	B-NP	NN	O	7	NMOD
5	and	and	I-NP	CC	O	7	NMOD
6	inflammatory	inflammatory	I-NP	JJ	O	7	NMOD
7	responses	response	I-NP	NNS	O	3	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	mature	mature	B-NP	JJ	B-cell_type	11	NMOD
10	cell	cell	I-NP	NN	I-cell_type	11	NMOD
11	types	type	I-NP	NNS	I-cell_type	8	PMOD
12	.	.	O	.	O	3	P

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	important	important	B-ADJP	JJ	O	4	PRD
6	to	to	B-VP	TO	O	7	VMOD
7	understand	understand	I-VP	VB	O	5	AMOD
8	the	the	B-NP	DT	O	9	NMOD
9	mechanisms	mechanism	I-NP	NNS	O	7	OBJ
10	which	which	B-NP	WDT	O	9	NMOD
11	control	control	B-VP	VBP	O	10	SBAR
12	the	the	B-NP	DT	O	13	NMOD
13	expression	expression	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	MIP-1	MIP-1	B-NP	NN	B-protein	16	NMOD
16	alpha/GOS19	alpha/GOS19	I-NP	NN	I-protein	14	PMOD
17	.	.	O	.	O	4	P

1	Previous	Previous	B-NP	JJ	O	2	NMOD
2	work	work	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	shown	show	I-VP	VBN	O	3	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	in	in	B-PP	IN	O	23	VMOD
7	Jurkat	Jurkat	B-NP	NN	B-cell_line	9	NMOD
8	T	T	I-NP	NN	I-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
10	,	,	O	,	O	23	P
11	a	a	B-NP	DT	O	12	NMOD
12	set	set	I-NP	NN	O	23	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	widely	widely	B-NP	RB	O	15	AMOD
15	expressed	express	I-NP	VBN	O	17	NMOD
16	transcription	transcription	I-NP	NN	B-protein	17	NMOD
17	factors	factor	I-NP	NNS	I-protein	13	PMOD
18	(	(	O	(	O	21	P
19	the	the	B-NP	DT	O	21	NMOD
20	ICK-1	ICK-1	I-NP	NN	B-protein	21	NMOD
21	family	family	I-NP	NN	I-protein	17	NMOD
22	)	)	O	)	O	21	P
23	affect	affect	B-VP	VBP	O	5	SBAR
24	the	the	B-NP	DT	O	26	NMOD
25	GOS19	GOS19	I-NP	NN	B-DNA	26	NMOD
26	promoter	promoter	I-NP	NN	I-DNA	23	OBJ
27	.	.	O	.	O	3	P

1	One	One	B-NP	CD	O	2	NMOD
2	member	member	I-NP	NN	O	4	NMOD
3	,	,	O	,	O	4	P
4	ICK-1A	ICK-1A	B-NP	NN	B-protein	6	SUB
5	,	,	O	,	O	4	P
6	behaves	behave	B-VP	VBZ	O	0	ROOT
7	as	as	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	11	NMOD
9	strong	strong	I-NP	JJ	B-protein	11	NMOD
10	negative	negative	I-NP	JJ	I-protein	11	NMOD
11	regulator	regulator	I-NP	NN	I-protein	7	PMOD
12	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	communication	communication	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	provide	provide	B-VP	VBP	O	0	ROOT
7	evidence	evidence	B-NP	NN	O	6	OBJ
8	that	that	B-SBAR	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	pathway	pathway	I-NP	NN	O	19	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	induction	induction	B-NP	NN	O	11	PMOD
13	in	in	B-PP	IN	O	10	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	macrophage	macrophage	I-NP	NN	B-cell_line	18	NMOD
16	cell	cell	I-NP	NN	I-cell_line	18	NMOD
17	line	line	I-NP	NN	I-cell_line	18	NMOD
18	U937	U937	I-NP	NN	I-cell_line	13	PMOD
19	is	be	B-VP	VBZ	O	8	SBAR
20	different	different	B-ADJP	JJ	O	19	PRD
21	from	from	B-PP	IN	O	20	AMOD
22	that	that	B-NP	DT	O	21	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	Jurkat	Jurkat	B-NP	NN	B-cell_line	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_line	23	PMOD
26	.	.	O	.	O	6	P

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	9	NMOD
7	ICK-1	ICK-1	I-NP	NN	B-DNA	9	NMOD
8	binding	binding	I-NP	NN	I-DNA	9	NMOD
9	site	site	I-NP	NN	I-DNA	10	SUB
10	does	do	B-VP	VBZ	O	5	SBAR
11	not	not	I-VP	RB	O	10	VMOD
12	confer	confer	I-VP	VB	O	10	VC
13	negative	negative	B-NP	JJ	O	14	NMOD
14	regulation	regulation	I-NP	NN	O	12	OBJ
15	in	in	B-PP	IN	O	12	VMOD
16	U937	U937	B-NP	NN	B-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
18	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	provide	provide	B-VP	VBP	O	0	ROOT
3	evidence	evidence	B-NP	NN	O	18	NMOD
4	for	for	B-PP	IN	O	3	NMOD
5	an	an	B-NP	DT	O	8	NMOD
6	additional	additional	I-NP	JJ	O	8	NMOD
7	binding	bind	I-NP	VBG	B-DNA	8	NMOD
8	site	site	I-NP	NN	I-DNA	4	PMOD
9	,	,	O	,	O	18	P
10	the	the	B-NP	DT	O	18	NMOD
11	MIP-1	MIP-1	I-NP	NN	B-DNA	14	NMOD
12	alpha	alpha	I-NP	NN	I-DNA	14	NMOD
13	nuclear	nuclear	I-NP	JJ	I-DNA	14	NMOD
14	protein	protein	I-NP	NN	I-DNA	18	NMOD
15	(	(	O	(	I-DNA	16	P
16	MNP	MNP	B-NP	NN	I-DNA	14	NMOD
17	)	)	O	)	I-DNA	16	P
18	site	site	B-NP	NN	I-DNA	2	OBJ
19	,	,	O	,	O	18	P
20	which	which	B-NP	WDT	O	18	NMOD
21	overlaps	overlap	B-VP	VBZ	O	20	SBAR
22	the	the	B-NP	DT	O	24	NMOD
23	ICK-1	ICK-1	I-NP	NN	B-DNA	24	NMOD
24	site	site	I-NP	NN	I-DNA	21	OBJ
25	.	.	O	.	O	2	P

1	Interaction	Interaction	B-NP	NN	O	10	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	nuclear	nuclear	B-NP	JJ	O	4	NMOD
4	extracts	extract	I-NP	NNS	O	2	PMOD
5	from	from	B-PP	IN	O	4	NMOD
6	various	various	B-NP	JJ	O	8	NMOD
7	cell	cell	I-NP	NN	O	8	NMOD
8	lines	line	I-NP	NNS	O	5	PMOD
9	and	and	O	CC	O	10	NMOD
10	tissue	tissue	B-NP	NN	O	15	SUB
11	with	with	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	MNP	MNP	I-NP	NN	B-DNA	14	NMOD
14	site	site	I-NP	NN	I-DNA	11	PMOD
15	leads	lead	B-VP	VBZ	O	0	ROOT
16	to	to	B-PP	TO	O	15	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	formation	formation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	fast-migrating	fast-migrating	B-NP	JJ	B-protein	22	NMOD
21	protein-DNA	protein-DNA	I-NP	JJ	I-protein	22	NMOD
22	complexes	complex	I-NP	NNS	I-protein	19	PMOD
23	with	with	B-PP	IN	O	18	NMOD
24	similar	similar	B-NP	JJ	O	26	AMOD
25	but	but	I-NP	CC	O	26	AMOD
26	distinct	distinct	I-NP	JJ	O	28	NMOD
27	electrophoretic	electrophoretic	I-NP	JJ	O	28	NMOD
28	mobilities	mobility	I-NP	NNS	O	23	PMOD
29	.	.	O	.	O	15	P

1	A	A	B-NP	DT	O	2	NMOD
2	mutation	mutation	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	MNP	MNP	I-NP	NN	B-DNA	6	NMOD
6	site	site	I-NP	NN	I-DNA	3	PMOD
7	which	which	B-NP	WDT	O	6	NMOD
8	does	do	B-VP	VBZ	O	7	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	abrogate	abrogate	I-VP	VB	O	8	VC
11	ICK-1	ICK-1	B-NP	NN	B-protein	12	NMOD
12	binding	binding	I-NP	NN	O	10	OBJ
13	inactivates	inactivate	B-VP	VBZ	O	0	ROOT
14	the	the	B-NP	DT	O	16	NMOD
15	GOS19.1	GOS19.1	I-NP	NN	B-DNA	16	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	13	OBJ
17	in	in	B-PP	IN	O	16	NMOD
18	U937	U937	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	and	and	O	CC	O	13	VMOD
21	reduces	reduce	B-VP	VBZ	O	13	VMOD
22	its	its	B-NP	PRP$	O	23	NMOD
23	activity	activity	I-NP	NN	O	21	OBJ
24	by	by	B-PP	IN	O	21	VMOD
25	fourfold	fourfold	B-ADVP	RB	O	24	PMOD
26	in	in	B-PP	IN	O	21	VMOD
27	Jurkat	Jurkat	B-NP	NN	B-cell_line	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
29	.	.	O	.	O	13	P

1	We	We	B-NP	PRP	O	2	SUB
2	propose	propose	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	MNP	MNP	I-NP	NN	B-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	8	NMOD
7	(	(	I-NP	(	O	8	P
8	s	s	I-NP	NNS	O	10	NMOD
9	)	)	O	)	O	8	P
10	binding	binding	B-NP	NN	O	15	SUB
11	at	at	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	MNP	MNP	I-NP	NN	B-DNA	14	NMOD
14	site	site	I-NP	NN	I-DNA	11	PMOD
15	constitutes	constitute	B-VP	VBZ	O	3	SBAR
16	a	a	B-NP	DT	O	21	NMOD
17	novel	novel	I-NP	JJ	O	19	NMOD
18	transcription	transcription	I-NP	NN	B-protein	19	NMOD
19	factor	factor	I-NP	NN	I-protein	21	NMOD
20	(	(	B-NP	(	O	21	P
21	s	s	I-NP	NNS	O	15	OBJ
22	)	)	O	)	O	15	P
23	expressed	express	B-VP	VBN	O	15	VMOD
24	in	in	B-PP	IN	O	23	VMOD
25	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	24	PMOD
27	.	.	O	.	O	2	P

1	Ligand-dependent	Ligand-dependent	B-NP	JJ	O	2	NMOD
2	repression	repression	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	8	NMOD
5	erythroid	erythroid	I-NP	JJ	B-protein	7	NMOD
6	transcription	transcription	I-NP	NN	I-protein	7	NMOD
7	factor	factor	I-NP	NN	I-protein	8	NMOD
8	GATA-1	GATA-1	I-NP	NN	B-protein	3	PMOD
9	by	by	B-PP	IN	O	2	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	estrogen	estrogen	I-NP	NN	B-protein	12	NMOD
12	receptor	receptor	I-NP	NN	I-protein	9	PMOD
13	.	.	O	.	O	2	P

1	High-dose	High-dose	B-NP	JJ	O	3	NMOD
2	estrogen	estrogen	I-NP	NN	O	3	NMOD
3	administration	administration	I-NP	NN	O	4	SUB
4	induces	induce	B-VP	VBZ	O	0	ROOT
5	anemia	anemia	B-NP	NN	O	4	OBJ
6	in	in	B-PP	IN	O	4	VMOD
7	mammals	mammal	B-NP	NNS	O	6	PMOD
8	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	5	VMOD
2	chickens	chicken	B-NP	NNS	O	1	PMOD
3	,	,	O	,	O	5	P
4	estrogens	estrogen	B-NP	NNS	O	5	SUB
5	stimulate	stimulate	B-VP	VBP	O	0	ROOT
6	outgrowth	outgrowth	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	bone	bone	B-NP	NN	B-cell_type	12	NMOD
9	marrow-derived	marrow-derived	I-NP	JJ	I-cell_type	12	NMOD
10	erythroid	erythroid	I-NP	JJ	I-cell_type	12	NMOD
11	progenitor	progenitor	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
13	and	and	O	CC	O	5	VMOD
14	delay	delay	B-VP	VBP	O	5	VMOD
15	their	their	B-NP	PRP$	O	16	NMOD
16	maturation	maturation	I-NP	NN	O	14	OBJ
17	.	.	O	.	O	5	P

1	This	This	B-NP	DT	O	2	NMOD
2	delay	delay	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	associated	associate	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	down-regulation	down-regulation	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	many	many	B-NP	JJ	O	10	AMOD
9	erythroid	erythroid	I-NP	JJ	B-DNA	10	AMOD
10	cell-specific	cell-specific	I-NP	JJ	I-DNA	11	NMOD
11	genes	gene	I-NP	NNS	I-DNA	7	PMOD
12	,	,	O	,	O	11	P
13	including	include	B-PP	VBG	O	11	NMOD
14	alpha-	alpha-	B-NP	NN	O	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	beta-globin	beta-globin	I-NP	NN	B-protein	29	NMOD
17	,	,	O	,	O	29	P
18	band	band	B-NP	NN	B-protein	29	NMOD
19	3	3	I-NP	CD	I-protein	18	NMOD
20	,	,	O	,	O	29	P
21	band	band	B-NP	NN	O	29	NMOD
22	4.1	4.1	I-NP	CD	O	21	NMOD
23	,	,	O	,	O	29	P
24	and	and	O	CC	O	29	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	erythroid	erythroid	I-NP	JJ	B-protein	29	NMOD
27	cell-specific	cell-specific	I-NP	JJ	I-protein	29	NMOD
28	histone	histone	I-NP	NN	I-protein	29	NMOD
29	H5	H5	I-NP	NN	I-protein	13	PMOD
30	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	estrogens	estrogen	B-NP	NNS	O	7	SUB
6	also	also	B-ADVP	RB	O	7	VMOD
7	reduce	reduce	B-VP	VBP	O	4	SBAR
8	the	the	B-NP	DT	O	9	NMOD
9	number	number	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	erythroid	erythroid	B-NP	JJ	B-cell_type	13	NMOD
12	progenitor	progenitor	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	primary	primary	B-NP	JJ	B-cell_line	19	NMOD
16	human	human	I-NP	JJ	I-cell_line	19	NMOD
17	bone	bone	I-NP	NN	I-cell_line	19	NMOD
18	marrow	marrow	I-NP	NN	I-cell_line	19	NMOD
19	cultures	culture	I-NP	NNS	I-cell_line	14	PMOD
20	.	.	O	.	O	2	P

1	To	To	B-VP	TO	O	2	VMOD
2	address	address	I-VP	VB	O	12	VMOD
3	potential	potential	B-NP	JJ	O	4	NMOD
4	mechanisms	mechanism	I-NP	NNS	O	2	OBJ
5	by	by	B-PP	IN	O	4	NMOD
6	which	which	B-NP	WDT	O	5	PMOD
7	estrogens	estrogen	B-NP	NNS	O	8	SUB
8	suppress	suppress	B-VP	VBP	O	5	SBAR
9	erythropoiesis	erythropoiesis	B-NP	NN	O	8	OBJ
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	have	have	B-VP	VBP	O	0	ROOT
13	examined	examine	I-VP	VBN	O	12	VC
14	their	their	B-NP	PRP$	O	15	NMOD
15	effects	effect	I-NP	NNS	O	13	OBJ
16	on	on	B-PP	IN	O	15	NMOD
17	GATA-1	GATA-1	B-NP	NN	B-protein	22	NMOD
18	,	,	O	,	O	22	P
19	an	an	B-NP	DT	O	22	NMOD
20	erythroid	erythroid	I-NP	JJ	B-protein	22	NMOD
21	transcription	transcription	I-NP	NN	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	16	PMOD
23	that	that	B-NP	WDT	O	22	NMOD
24	participates	participate	B-VP	VBZ	O	23	SBAR
25	in	in	B-PP	IN	O	24	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	regulation	regulation	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	majority	majority	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	erythroid	erythroid	B-NP	JJ	B-DNA	34	NMOD
33	cell-specific	cell-specific	I-NP	JJ	I-DNA	34	NMOD
34	genes	gene	I-NP	NNS	I-DNA	31	PMOD
35	and	and	O	CC	O	24	VMOD
36	is	be	B-VP	VBZ	O	24	VMOD
37	necessary	necessary	B-ADJP	JJ	O	36	PRD
38	for	for	B-PP	IN	O	37	AMOD
39	full	full	B-NP	JJ	O	40	NMOD
40	maturation	maturation	I-NP	NN	O	38	PMOD
41	of	of	B-PP	IN	O	40	NMOD
42	erythrocytes	erythrocyte	B-NP	NNS	B-cell_type	41	PMOD
43	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	24	DEP
4	the	the	B-NP	DT	O	6	NMOD
5	transcriptional	transcriptional	I-NP	JJ	O	6	NMOD
6	activity	activity	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	GATA-1	GATA-1	B-NP	NN	B-protein	7	PMOD
9	is	be	B-VP	VBZ	O	3	SBAR
10	strongly	strongly	I-VP	RB	O	9	VMOD
11	repressed	repress	I-VP	VBN	O	9	VC
12	by	by	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	estrogen	estrogen	I-NP	NN	B-protein	15	NMOD
15	receptor	receptor	I-NP	NN	I-protein	12	PMOD
16	(	(	O	(	O	17	P
17	ER	ER	B-NP	NN	B-protein	15	NMOD
18	)	)	O	)	O	17	P
19	in	in	B-PP	IN	O	11	VMOD
20	a	a	B-NP	DT	O	22	NMOD
21	ligand-dependent	ligand-dependent	I-NP	JJ	O	22	NMOD
22	manner	manner	I-NP	NN	O	19	PMOD
23	and	and	O	CC	O	24	DEP
24	that	that	B-SBAR	IN	O	2	VMOD
25	this	this	B-NP	DT	O	26	NMOD
26	repression	repression	I-NP	NN	O	27	SUB
27	is	be	B-VP	VBZ	O	24	SBAR
28	reversible	reversible	B-ADJP	JJ	O	27	PRD
29	in	in	B-PP	IN	O	28	AMOD
30	the	the	I-PP	DT	O	29	PMOD
31	presence	presence	I-PP	NN	O	29	PMOD
32	of	of	I-PP	IN	O	28	AMOD
33	4-hydroxytamoxifen	4-hydroxytamoxifen	B-NP	NN	O	32	PMOD
34	.	.	O	.	O	2	P

1	ER-mediated	ER-mediated	B-NP	JJ	O	2	NMOD
2	repression	repression	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	GATA-1	GATA-1	B-NP	NN	B-protein	5	NMOD
5	activity	activity	I-NP	NN	O	3	PMOD
6	occurs	occur	B-VP	VBZ	O	0	ROOT
7	on	on	B-PP	IN	O	6	VMOD
8	an	an	B-NP	DT	O	10	NMOD
9	artificial	artificial	I-NP	JJ	B-DNA	10	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	7	PMOD
11	containing	contain	B-VP	VBG	O	10	NMOD
12	a	a	B-NP	DT	O	13	NMOD
13	single	single	I-NP	JJ	O	11	OBJ
14	GATA-binding	GATA-binding	I-NP	JJ	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	13	NMOD
16	,	,	O	,	O	13	P
17	as	as	B-CONJP	RB	O	13	NMOD
18	well	well	I-CONJP	RB	O	17	DEP
19	as	as	I-CONJP	IN	O	17	DEP
20	in	in	B-PP	IN	O	13	NMOD
21	the	the	B-NP	DT	O	22	NMOD
22	context	context	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	an	an	B-NP	DT	O	26	NMOD
25	intact	intact	I-NP	JJ	B-DNA	26	NMOD
26	promoter	promoter	I-NP	NN	I-DNA	23	PMOD
27	which	which	B-NP	WDT	O	26	NMOD
28	is	be	B-VP	VBZ	O	27	SBAR
29	normally	normally	I-VP	RB	O	28	VMOD
30	regulated	regulate	I-VP	VBN	O	28	VC
31	by	by	B-PP	IN	O	30	VMOD
32	GATA-1	GATA-1	B-NP	NN	B-protein	31	PMOD
33	.	.	O	.	O	6	P

1	GATA-1	GATA-1	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	ER	ER	I-NP	NN	B-protein	4	SUB
4	bind	bind	B-VP	VBP	O	0	ROOT
5	to	to	B-PP	TO	O	4	VMOD
6	each	each	B-NP	DT	O	7	NMOD
7	other	other	I-NP	JJ	O	5	PMOD
8	in	in	B-ADVP	FW	O	4	VMOD
9	vitro	vitro	I-ADVP	FW	O	8	AMOD
10	in	in	B-PP	IN	O	4	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	absence	absence	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	DNA	DNA	B-NP	NN	O	13	PMOD
15	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	12	VMOD
2	coimmunoprecipitation	coimmunoprecipitation	B-NP	NN	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	12	SUB
4	using	use	B-VP	VBG	O	3	NMOD
5	transfected	transfecte	B-NP	VBN	O	7	NMOD
6	COS	COS	I-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	11	NMOD
8	,	,	O	,	O	11	P
9	GATA-1	GATA-1	B-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	ER	ER	I-NP	NN	B-protein	4	OBJ
12	associate	associate	B-VP	VBP	O	0	ROOT
13	in	in	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	16	NMOD
15	ligand-dependent	ligand-dependent	I-NP	JJ	O	16	NMOD
16	manner	manner	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	12	P

1	Mapping	Map	B-NP	VBG	O	2	NMOD
2	experiments	experiment	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	GATA-1	GATA-1	B-NP	NN	B-protein	9	NMOD
6	and	and	O	CC	O	9	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	ER	ER	I-NP	NN	B-protein	9	NMOD
9	form	form	I-NP	NN	O	13	NMOD
10	at	at	B-NP	IN	O	13	NMOD
11	least	least	I-NP	JJS	O	10	AMOD
12	two	two	I-NP	CD	O	10	AMOD
13	contacts	contact	I-NP	NNS	O	4	SBAR
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	involve	involve	B-VP	VBP	O	15	SBAR
17	the	the	B-NP	DT	O	19	NMOD
18	finger	finger	I-NP	NN	O	19	NMOD
19	region	region	I-NP	NN	O	24	NMOD
20	and	and	O	CC	O	24	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	N-terminal	N-terminal	I-NP	JJ	B-protein	24	NMOD
23	activation	activation	I-NP	NN	I-protein	24	NMOD
24	domain	domain	I-NP	NN	I-protein	16	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	GATA-1	GATA-1	B-NP	NN	B-protein	25	PMOD
27	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	speculate	speculate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	estrogens	estrogen	B-NP	NNS	O	5	SUB
5	exert	exert	B-VP	VBP	O	3	SBAR
6	effects	effect	B-NP	NNS	O	5	OBJ
7	on	on	B-PP	IN	O	5	VMOD
8	erythropoiesis	erythropoiesis	B-NP	NN	O	7	PMOD
9	by	by	B-PP	IN	O	5	VMOD
10	modulating	modulate	B-VP	VBG	O	9	PMOD
11	GATA-1	GATA-1	B-NP	NN	B-protein	12	NMOD
12	activity	activity	I-NP	NN	O	10	OBJ
13	through	through	B-PP	IN	O	10	VMOD
14	protein-protein	protein-protein	B-NP	JJ	O	15	NMOD
15	interaction	interaction	I-NP	NN	O	13	PMOD
16	with	with	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	ER	ER	I-NP	NN	B-protein	16	PMOD
19	.	.	O	.	O	2	P

1	(	(	O	(	O	2	P
2	ABSTRACT	ABSTRACT	B-NP	NN	O	0	ROOT
3	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD
4	AT	AT	B-PP	IN	O	3	VMOD
5	250	250	B-NP	CD	O	6	NMOD
6	WORDS	WORDS	I-NP	NNS	O	4	PMOD
7	)	)	O	)	O	2	P

1	Activation	Activation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	pp90rsk	pp90rsk	B-NP	NN	B-protein	9	NMOD
4	and	and	O	CC	O	9	NMOD
5	early	early	B-NP	JJ	B-DNA	9	NMOD
6	growth	growth	I-NP	NN	I-DNA	9	NMOD
7	response-1	response-1	I-NP	NN	I-DNA	9	NMOD
8	gene	gene	I-NP	NN	I-DNA	9	NMOD
9	expression	expression	I-NP	NN	O	2	PMOD
10	by	by	B-PP	IN	O	1	NMOD
11	pokeweed	pokeweed	B-NP	NN	B-protein	12	NMOD
12	mitogen	mitogen	I-NP	NN	I-protein	10	PMOD
13	in	in	B-PP	IN	O	1	NMOD
14	human	human	B-NP	JJ	B-cell_type	16	NMOD
15	B	B	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
17	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	examined	examine	I-VP	VBN	O	4	VC
6	the	the	B-NP	DT	O	7	NMOD
7	effects	effect	I-NP	NNS	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	pokeweed	pokeweed	B-NP	NN	B-protein	10	NMOD
10	mitogen	mitogen	I-NP	NN	I-protein	8	PMOD
11	(	(	O	(	O	12	P
12	PWM	PWM	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	on	on	B-PP	IN	O	7	NMOD
15	the	the	B-NP	DT	O	16	NMOD
16	induction	induction	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	early	early	B-NP	JJ	B-DNA	21	NMOD
19	growth	growth	I-NP	NN	I-DNA	21	NMOD
20	response-1	response-1	I-NP	NN	I-DNA	21	NMOD
21	gene	gene	I-NP	NN	I-DNA	17	PMOD
22	(	(	O	(	O	23	P
23	EGR-1	EGR-1	B-NP	NN	B-DNA	21	NMOD
24	)	)	O	)	O	23	P
25	in	in	B-PP	IN	O	16	NMOD
26	normal	normal	B-NP	JJ	B-cell_type	29	NMOD
27	human	human	I-NP	JJ	I-cell_type	29	NMOD
28	B	B	I-NP	NN	I-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	25	PMOD
30	.	.	O	.	O	4	P

1	PWM	PWM	B-NP	NN	B-protein	2	SUB
2	regulates	regulate	B-VP	VBZ	O	0	ROOT
3	EGR-1	EGR-1	B-NP	NN	B-DNA	5	NMOD
4	gene	gene	I-NP	NN	I-DNA	5	NMOD
5	expression	expression	I-NP	NN	O	2	OBJ
6	by	by	B-PP	IN	O	2	VMOD
7	both	both	B-NP	CC	O	11	NMOD
8	transcriptional	transcriptional	I-NP	JJ	O	11	NMOD
9	and	and	I-NP	CC	O	11	NMOD
10	post-transcriptional	post-transcriptional	I-NP	JJ	O	11	NMOD
11	mechanisms	mechanism	I-NP	NNS	O	6	PMOD
12	.	.	O	.	O	2	P

1	Transient	Transient	B-NP	JJ	O	3	NMOD
2	transfection	transfection	I-NP	NN	O	3	NMOD
3	assays	assay	I-NP	NNS	O	17	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	EGR-1	EGR-1	B-NP	NN	B-DNA	7	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	7	NMOD
7	fragments	fragment	I-NP	NNS	I-DNA	4	PMOD
8	linked	link	B-VP	VBN	O	7	NMOD
9	to	to	B-PP	TO	O	8	VMOD
10	the	the	B-NP	DT	O	16	NMOD
11	chloramphenicol	chloramphenicol	I-NP	NN	B-DNA	12	NMOD
12	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	16	NMOD
13	(	(	O	(	I-DNA	14	P
14	CAT	CAT	B-NP	NN	I-DNA	12	NMOD
15	)	)	O	)	I-DNA	14	P
16	gene	gene	B-NP	NN	I-DNA	9	PMOD
17	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
18	that	that	B-SBAR	IN	O	17	VMOD
19	PWM	PWM	B-NP	NN	B-protein	22	NMOD
20	induced	induce	B-VP	VBD	O	22	NMOD
21	EGR-1	EGR-1	B-NP	NN	B-DNA	22	NMOD
22	transcription	transcription	I-NP	NN	O	23	SUB
23	is	be	B-VP	VBZ	O	18	SBAR
24	conferred	confer	I-VP	VBN	O	23	VC
25	by	by	B-PP	IN	O	24	VMOD
26	the	the	B-NP	DT	O	28	NMOD
27	CArG	CArG	I-NP	NN	B-DNA	28	NMOD
28	motif	motif	I-NP	NN	I-DNA	25	PMOD
29	(	(	O	(	O	35	P
30	C	C	B-NP	NN	B-DNA	31	NMOD
31	C	C	I-NP	NN	I-DNA	35	NMOD
32	[	[	O	(	I-DNA	35	P
33	AT	AT	B-NP	NN	I-DNA	35	NMOD
34	]	]	O	)	I-DNA	35	P
35	6GG	6GG	B-NP	NN	I-DNA	28	NMOD
36	)	)	O	)	O	35	P
37	in	in	B-PP	IN	O	28	NMOD
38	the	the	B-NP	DT	O	40	NMOD
39	EGR-1	EGR-1	I-NP	NN	B-DNA	40	NMOD
40	promoter	promoter	I-NP	NN	I-DNA	37	PMOD
41	.	.	O	.	O	17	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	4	SUB
3	further	further	B-ADVP	RB	O	4	VMOD
4	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	activation	activation	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	S6	S6	B-NP	NN	B-protein	9	NMOD
9	kinase	kinase	I-NP	NN	I-protein	7	PMOD
10	(	(	O	(	O	11	P
11	pp90rsk	pp90rsk	B-NP	NN	B-protein	9	NMOD
12	)	)	O	)	O	11	P
13	,	,	O	,	O	6	P
14	evidenced	evidence	B-VP	VBN	O	6	NMOD
15	by	by	B-PP	IN	O	14	VMOD
16	phosphorylation	phosphorylation	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	S6	S6	B-NP	NN	B-protein	22	NMOD
19	and	and	I-NP	CC	O	22	NMOD
20	serum	serum	I-NP	NN	B-protein	22	NMOD
21	response	response	I-NP	NN	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	26	NMOD
23	(	(	O	(	O	24	P
24	SRF	SRF	B-NP	NN	B-protein	22	NMOD
25	)	)	O	)	O	24	P
26	peptides	peptide	B-NP	NNS	O	17	PMOD
27	,	,	O	,	O	4	P
28	in	in	B-PP	IN	O	4	VMOD
29	PWM	PWM	B-NP	NN	B-cell_line	32	NMOD
30	treated	treated	I-NP	JJ	I-cell_line	32	NMOD
31	B	B	I-NP	NN	I-cell_line	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_line	28	PMOD
33	.	.	O	.	O	4	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	findings	finding	I-NP	NNS	O	6	SUB
6	suggest	suggest	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	PWM	PWM	B-NP	NN	B-protein	9	SUB
9	is	be	B-VP	VBZ	O	7	SBAR
10	able	able	B-ADJP	JJ	O	9	PRD
11	to	to	B-VP	TO	O	12	VMOD
12	initiate	initiate	I-VP	VB	O	10	AMOD
13	an	an	B-NP	DT	O	16	NMOD
14	intracytoplasmic	intracytoplasmic	I-NP	JJ	O	16	NMOD
15	signalling	signalling	I-NP	NN	O	16	NMOD
16	cascade	cascade	I-NP	NN	O	19	NMOD
17	and	and	O	CC	O	19	NMOD
18	EGR-1	EGR-1	B-NP	NN	B-protein	19	NMOD
19	induction	induction	I-NP	NN	O	12	OBJ
20	in	in	B-PP	IN	O	19	NMOD
21	normal	normal	B-NP	JJ	B-cell_type	24	NMOD
22	human	human	I-NP	JJ	I-cell_type	24	NMOD
23	B	B	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
25	.	.	O	.	O	6	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	2	NMOD
2	B	B	I-NP	NN	I-protein	3	SUB
3	controls	control	B-VP	VBZ	O	0	ROOT
4	expression	expression	B-NP	NN	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	inhibitor	inhibitor	B-NP	NN	O	10	NMOD
7	I	I	I-NP	NN	B-protein	10	NMOD
8	kappa	kappa	I-NP	NN	I-protein	10	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	alpha	alpha	I-NP	NN	I-protein	5	PMOD
11	:	:	O	:	O	3	P
12	evidence	evidence	B-NP	NN	O	3	VMOD
13	for	for	B-PP	IN	O	12	NMOD
14	an	an	B-NP	DT	O	17	NMOD
15	inducible	inducible	I-NP	JJ	O	17	NMOD
16	autoregulatory	autoregulatory	I-NP	JJ	O	17	NMOD
17	pathway	pathway	I-NP	NN	O	13	PMOD
18	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	eukaryotic	eukaryotic	I-NP	JJ	B-protein	4	NMOD
3	transcription	transcription	I-NP	NN	I-protein	4	NMOD
4	factor	factor	I-NP	NN	I-protein	7	NMOD
5	nuclear	nuclear	I-NP	JJ	B-protein	7	NMOD
6	factor-kappa	factor-kappa	I-NP	NN	I-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	12	SUB
8	(	(	O	(	O	10	P
9	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
10	B	B	I-NP	NN	I-protein	7	NMOD
11	)	)	O	)	O	10	P
12	participates	participate	B-VP	VBZ	O	0	ROOT
13	in	in	B-PP	IN	O	12	VMOD
14	many	many	B-NP	JJ	O	15	NMOD
15	parts	part	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	genetic	genetic	I-NP	JJ	O	19	NMOD
19	program	program	I-NP	NN	O	16	PMOD
20	mediating	mediate	B-VP	VBG	O	19	NMOD
21	T	T	B-NP	NN	B-cell_type	22	NMOD
22	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	20	OBJ
23	activation	activation	I-NP	NN	O	25	NMOD
24	and	and	O	CC	O	25	NMOD
25	growth	growth	B-NP	NN	O	22	NMOD
26	.	.	O	.	O	12	P

1	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD
2	expression	expression	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	3	PMOD
6	occurs	occur	B-VP	VBZ	O	0	ROOT
7	after	after	B-PP	IN	O	6	VMOD
8	its	its	B-NP	PRP$	O	10	NMOD
9	induced	induce	I-NP	VBN	O	10	NMOD
10	dissociation	dissociation	I-NP	NN	O	7	PMOD
11	from	from	B-PP	IN	O	10	NMOD
12	its	its	B-NP	PRP$	O	18	NMOD
13	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	18	NMOD
14	inhibitor	inhibitor	I-NP	NN	I-protein	18	NMOD
15	I	I	I-NP	NN	B-protein	18	NMOD
16	kappa	kappa	I-NP	NN	I-protein	18	NMOD
17	B	B	I-NP	NN	I-protein	18	NMOD
18	alpha	alpha	I-NP	NN	I-protein	11	PMOD
19	.	.	O	.	O	6	P

1	Phorbol	Phorbol	B-NP	NN	O	2	NMOD
2	ester	ester	I-NP	NN	O	6	NMOD
3	and	and	O	CC	O	6	NMOD
4	tumor	tumor	B-NP	NN	B-protein	6	NMOD
5	necrosis	necrosis	I-NP	NN	I-protein	6	NMOD
6	factor-alpha	factor-alpha	I-NP	NN	I-protein	7	NMOD
7	induction	induction	I-NP	NN	O	12	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	nuclear	nuclear	B-NP	JJ	B-protein	11	NMOD
10	NF-kappa	NF-kappa	I-NP	NN	I-protein	11	NMOD
11	B	B	I-NP	NN	I-protein	8	PMOD
12	is	be	B-VP	VBZ	O	0	ROOT
13	associated	associate	I-VP	VBN	O	12	VC
14	with	with	B-PP	IN	O	13	VMOD
15	both	both	O	CC	O	17	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	degradation	degradation	I-NP	NN	O	26	NMOD
18	of	of	B-PP	IN	O	17	NMOD
19	performed	perform	B-NP	VBN	O	23	NMOD
20	I	I	I-NP	NN	B-protein	23	NMOD
21	kappa	kappa	I-NP	NN	I-protein	23	NMOD
22	B	B	I-NP	NN	I-protein	23	NMOD
23	alpha	alpha	I-NP	NN	I-protein	18	PMOD
24	and	and	O	CC	O	26	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	activation	activation	I-NP	NN	O	14	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	I	I	B-NP	NN	B-protein	33	NMOD
29	kappa	kappa	I-NP	NN	I-protein	33	NMOD
30	B	B	I-NP	NN	I-protein	33	NMOD
31	alpha	alpha	I-NP	NN	I-protein	33	NMOD
32	gene	gene	I-NP	NN	O	33	NMOD
33	expression	expression	I-NP	NN	O	27	PMOD
34	.	.	O	.	O	12	P

1	Transfection	Transfection	B-NP	NN	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	10	NMOD
6	I	I	I-NP	NN	B-DNA	10	NMOD
7	kappa	kappa	I-NP	NN	I-DNA	10	NMOD
8	B	B	I-NP	NN	I-DNA	10	NMOD
9	alpha	alpha	I-NP	NN	I-DNA	10	NMOD
10	gene	gene	I-NP	NN	I-DNA	11	SUB
11	is	be	B-VP	VBZ	O	4	SBAR
12	specifically	specifically	I-VP	RB	O	11	VMOD
13	induced	induce	I-VP	VBN	O	11	VC
14	by	by	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	65-kilodalton	65-kilodalton	I-NP	JJ	B-protein	18	NMOD
17	transactivating	transactivating	I-NP	NN	I-protein	18	NMOD
18	subunit	subunit	I-NP	NN	I-protein	14	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	NF-kappa	NF-kappa	B-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	19	PMOD
22	.	.	O	.	O	3	P

1	Association	Association	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	9	NMOD
4	newly	newly	I-NP	RB	O	5	AMOD
5	synthesized	synthesize	I-NP	VBN	O	9	NMOD
6	I	I	I-NP	NN	B-protein	9	NMOD
7	kappa	kappa	I-NP	NN	I-protein	9	NMOD
8	B	B	I-NP	NN	I-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	2	PMOD
10	with	with	B-PP	IN	O	1	NMOD
11	p65	p65	B-NP	NN	B-protein	10	PMOD
12	restores	restore	B-VP	VBZ	O	0	ROOT
13	intracellular	intracellular	B-NP	JJ	O	14	NMOD
14	inhibition	inhibition	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	20	NMOD
17	B	B	I-NP	NN	I-protein	20	NMOD
18	DNA	DNA	I-NP	NN	O	20	NMOD
19	binding	binding	I-NP	NN	O	20	NMOD
20	activity	activity	I-NP	NN	O	15	PMOD
21	and	and	O	CC	O	12	VMOD
22	prolongs	prolong	B-VP	VBZ	O	12	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	survival	survival	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	this	this	B-NP	DT	O	28	NMOD
27	labile	labile	I-NP	JJ	O	28	NMOD
28	inhibitor	inhibitor	I-NP	NN	O	25	PMOD
29	.	.	O	.	O	12	P

1	Together	Together	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	results	result	I-NP	NNS	O	5	SUB
5	show	show	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	8	NMOD
8	B	B	I-NP	NN	I-protein	9	SUB
9	controls	control	B-VP	VBZ	O	6	SBAR
10	the	the	B-NP	DT	O	11	NMOD
11	expression	expression	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	I	I	B-NP	NN	B-protein	16	NMOD
14	kappa	kappa	I-NP	NN	I-protein	16	NMOD
15	B	B	I-NP	NN	I-protein	16	NMOD
16	alpha	alpha	I-NP	NN	I-protein	12	PMOD
17	by	by	B-PP	IN	O	9	VMOD
18	means	mean	B-NP	NNS	O	17	PMOD
19	of	of	B-PP	IN	O	17	PMOD
20	an	an	B-NP	DT	O	23	NMOD
21	inducible	inducible	I-NP	JJ	O	23	NMOD
22	autoregulatory	autoregulatory	I-NP	JJ	O	23	NMOD
23	pathway	pathway	I-NP	NN	O	17	PMOD
24	.	.	O	.	O	5	P

1	Activation	Activation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	primary	primary	B-NP	JJ	B-cell_type	5	NMOD
4	human	human	I-NP	JJ	I-cell_type	5	NMOD
5	T-lymphocytes	T-lymphocyte	I-NP	NNS	I-cell_type	2	PMOD
6	through	through	B-PP	IN	O	1	NMOD
7	CD2	CD2	B-NP	NN	B-protein	9	NMOD
8	plus	plus	O	CC	I-protein	9	NMOD
9	CD28	CD28	B-NP	NN	I-protein	11	NMOD
10	adhesion	adhesion	I-NP	NN	I-protein	11	NMOD
11	molecules	molecule	I-NP	NNS	I-protein	6	PMOD
12	induces	induce	B-VP	VBZ	O	0	ROOT
13	long-term	long-term	B-NP	JJ	O	15	NMOD
14	nuclear	nuclear	I-NP	JJ	O	15	NMOD
15	expression	expression	I-NP	NN	O	12	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	NF-kappa	NF-kappa	B-NP	NN	B-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	16	PMOD
19	.	.	O	.	O	12	P

1	Stimulation	Stimulation	B-NP	NN	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	highly	highly	B-NP	RB	B-cell_type	4	AMOD
4	purified	purify	I-NP	VBN	I-cell_type	6	NMOD
5	human	human	I-NP	JJ	I-cell_type	6	NMOD
6	T-cells	T-cell	I-NP	NNS	I-cell_type	2	PMOD
7	via	via	B-PP	IN	O	1	NMOD
8	CD2	CD2	B-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	CD28	CD28	I-NP	NN	B-protein	12	NMOD
11	adhesion	adhesion	I-NP	NN	B-protein	12	NMOD
12	molecules	molecule	I-NP	NNS	I-protein	7	PMOD
13	induces	induce	B-VP	VBZ	O	0	ROOT
14	and	and	I-VP	CC	O	13	VMOD
15	maintains	maintain	I-VP	VBZ	O	13	VMOD
16	proliferation	proliferation	B-NP	NN	O	13	VMOD
17	for	for	B-PP	IN	O	13	VMOD
18	more	more	B-NP	JJR	O	19	AMOD
19	than	than	I-NP	IN	O	21	NMOD
20	3	3	I-NP	CD	O	19	AMOD
21	weeks	week	I-NP	NNS	O	17	PMOD
22	.	.	O	.	O	13	P

1	This	This	B-NP	DT	O	9	NMOD
2	potent	potent	I-NP	JJ	O	9	NMOD
3	interleukin	interleukin	I-NP	NN	B-protein	9	NMOD
4	2	2	I-NP	CD	I-protein	3	NMOD
5	(	(	O	(	O	6	P
6	IL-2	IL-2	B-NP	NN	B-protein	3	NMOD
7	)	)	O	)	O	6	P
8	-dependent	-dependent	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	10	SUB
10	does	do	B-VP	VBZ	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	require	require	I-VP	VB	O	10	VC
13	monocytes	monocyte	B-NP	NNS	B-cell_type	16	NMOD
14	or	or	O	CC	O	16	NMOD
15	accessory	accessory	B-NP	JJ	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	12	OBJ
17	.	.	O	.	O	10	P

1	Long-lasting	Long-lasting	B-NP	JJ	O	3	NMOD
2	IL-2	IL-2	I-NP	NN	B-protein	3	NMOD
3	receptivity	receptivity	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	associated	associate	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	high-level	high-level	B-NP	JJ	O	8	NMOD
8	expression	expression	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	20	NMOD
11	inducible	inducible	I-NP	JJ	O	20	NMOD
12	IL-2	IL-2	I-NP	NN	B-DNA	15	NMOD
13	receptor	receptor	I-NP	NN	I-DNA	15	NMOD
14	alpha	alpha	I-NP	NN	I-DNA	15	NMOD
15	chain	chain	I-NP	NN	I-DNA	20	NMOD
16	(	(	O	(	I-DNA	18	P
17	IL-2R	IL-2R	B-NP	NN	I-DNA	18	NMOD
18	alpha	alpha	I-NP	NN	I-DNA	15	NMOD
19	)	)	O	)	I-DNA	18	P
20	gene	gene	B-NP	NN	I-DNA	9	PMOD
21	that	that	B-NP	WDT	O	20	NMOD
22	is	be	B-VP	VBZ	O	21	SBAR
23	regulated	regulate	I-VP	VBN	O	22	VC
24	at	at	B-PP	IN	O	23	VMOD
25	both	both	B-NP	CC	O	29	NMOD
26	transcriptional	transcriptional	I-NP	JJ	O	29	NMOD
27	and	and	I-NP	CC	O	29	NMOD
28	posttranscriptional	posttranscriptional	I-NP	JJ	O	29	NMOD
29	levels	level	I-NP	NNS	O	24	PMOD
30	.	.	O	.	O	4	P

1	Increase	Increase	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	IL-2R	IL-2R	B-NP	NN	B-DNA	6	NMOD
4	alpha	alpha	I-NP	NN	I-DNA	6	NMOD
5	gene	gene	I-NP	NN	I-DNA	6	NMOD
6	transcription	transcription	I-NP	NN	O	2	PMOD
7	involves	involve	B-VP	VBZ	O	0	ROOT
8	the	the	B-NP	DT	O	10	NMOD
9	enhanced	enhance	I-NP	VBN	O	10	NMOD
10	binding	binding	I-NP	NN	O	7	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	16	NMOD
13	transcription	transcription	I-NP	NN	B-protein	16	NMOD
14	factor	factor	I-NP	NN	I-protein	16	NMOD
15	NF-kappa	NF-kappa	I-NP	NN	B-protein	16	NMOD
16	B	B	I-NP	NN	I-protein	11	PMOD
17	to	to	B-PP	TO	O	10	NMOD
18	its	its	B-NP	PRP$	O	20	NMOD
19	consensus	consensus	I-NP	NN	B-DNA	20	NMOD
20	sequence	sequence	I-NP	NN	I-DNA	17	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	5'-regulatory	5'-regulatory	I-NP	JJ	B-DNA	24	NMOD
24	region	region	I-NP	NN	I-DNA	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	IL-2R	IL-2R	I-NP	NN	B-DNA	29	NMOD
28	alpha	alpha	I-NP	NN	I-DNA	29	NMOD
29	gene	gene	I-NP	NN	I-DNA	25	PMOD
30	.	.	O	.	O	7	P

1	To	To	B-VP	TO	O	2	VMOD
2	dissect	dissect	I-VP	VB	O	18	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	basis	basis	I-NP	NN	O	2	OBJ
6	for	for	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	unusually	unusually	I-NP	RB	O	9	AMOD
9	persistent	persistent	I-NP	JJ	O	10	NMOD
10	transcription	transcription	I-NP	NN	O	6	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	IL-2R	IL-2R	I-NP	NN	B-DNA	15	NMOD
14	alpha	alpha	I-NP	NN	I-DNA	15	NMOD
15	gene	gene	I-NP	NN	I-DNA	11	PMOD
16	,	,	O	,	O	18	P
17	we	we	B-NP	PRP	O	18	SUB
18	analyzed	analyze	B-VP	VBD	O	0	ROOT
19	nuclear	nuclear	B-NP	JJ	O	21	NMOD
20	NF-kappa	NF-kappa	I-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	22	NMOD
22	binding	bind	B-VP	VBG	O	18	VMOD
23	to	to	B-PP	TO	O	22	NMOD
24	a	a	B-NP	DT	O	31	NMOD
25	radiolabeled	radiolabele	I-NP	VBN	O	31	NMOD
26	IL-2R	IL-2R	I-NP	NN	B-protein	31	NMOD
27	alpha	alpha	I-NP	NN	I-protein	31	NMOD
28	kappa	kappa	I-NP	NN	O	31	NMOD
29	B-specific	B-specific	I-NP	JJ	O	31	NMOD
30	oligonucleotide	oligonucleotide	I-NP	NN	O	31	NMOD
31	probe	probe	I-NP	NN	O	23	PMOD
32	during	during	B-PP	IN	O	22	VMOD
33	the	the	B-NP	DT	O	35	NMOD
34	time	time	I-NP	NN	O	35	NMOD
35	course	course	I-NP	NN	O	32	PMOD
36	of	of	B-PP	IN	O	35	NMOD
37	CD2	CD2	B-NP	NN	B-protein	39	NMOD
38	+	+	I-NP	CC	O	39	NMOD
39	CD28	CD28	I-NP	NN	B-protein	40	NMOD
40	activation	activation	I-NP	NN	O	36	PMOD
41	.	.	O	.	O	18	P

1	Resting	Rest	B-NP	VBG	O	4	NMOD
2	T-cell	T-cell	I-NP	NN	O	4	NMOD
3	nuclear	nuclear	I-NP	JJ	O	4	NMOD
4	extracts	extract	I-NP	NNS	O	5	SUB
5	contained	contain	B-VP	VBD	O	0	ROOT
6	KBF1/p50	KBF1/p50	B-NP	NN	B-protein	7	NMOD
7	homodimer	homodimer	I-NP	NN	I-protein	5	OBJ
8	.	.	O	.	O	5	P

1	After	After	B-PP	IN	O	9	VMOD
2	stimulation	stimulation	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	9	P
4	two	two	B-NP	CD	O	8	NMOD
5	new	new	I-NP	JJ	O	8	NMOD
6	kappa	kappa	I-NP	NN	B-protein	8	NMOD
7	B-specific	B-specific	I-NP	JJ	I-protein	8	NMOD
8	complexes	complex	I-NP	NNS	I-protein	9	SUB
9	were	be	B-VP	VBD	O	0	ROOT
10	identified	identify	I-VP	VBN	O	9	VC
11	as	as	B-PP	IN	O	10	VMOD
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	15	NMOD
13	B	B	I-NP	NN	I-protein	15	NMOD
14	p50-p65	p50-p65	I-NP	NN	B-protein	15	NMOD
15	heterodimer	heterodimer	I-NP	NN	I-protein	19	NMOD
16	and	and	O	CC	O	19	NMOD
17	putative	putative	B-NP	JJ	O	19	NMOD
18	c-Rel	c-Rel	I-NP	NN	B-protein	19	NMOD
19	homodimer	homodimer	I-NP	NN	I-protein	22	NMOD
20	or	or	O	CC	O	22	NMOD
21	c-Rel-p65	c-Rel-p65	B-NP	NN	B-protein	22	NMOD
22	heterodimer	heterodimer	I-NP	NN	I-protein	11	PMOD
23	.	.	O	.	O	9	P

1	Both	Both	B-NP	DT	O	3	NMOD
2	inducible	inducible	I-NP	JJ	O	3	NMOD
3	complexes	complex	I-NP	NNS	O	4	SUB
4	persisted	persist	B-VP	VBD	O	0	ROOT
5	for	for	B-PP	IN	O	4	VMOD
6	at	at	B-NP	IN	O	9	NMOD
7	least	least	I-NP	JJS	O	6	AMOD
8	3	3	I-NP	CD	O	6	AMOD
9	weeks	week	I-NP	NNS	O	5	PMOD
10	.	.	O	.	O	4	P

1	Their	Their	B-NP	PRP$	O	3	NMOD
2	relative	relative	I-NP	JJ	O	3	NMOD
3	levels	level	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	very	very	B-ADJP	RB	O	6	AMOD
6	similar	similar	I-ADJP	JJ	O	4	PRD
7	for	for	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	9	NMOD
9	duration	duration	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	proliferation	proliferation	B-NP	NN	O	10	PMOD
12	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	8	VMOD
2	parallel	parallel	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	CD2	CD2	B-NP	NN	B-protein	6	NMOD
5	+	+	O	CC	O	6	NMOD
6	CD28	CD28	B-NP	NN	B-protein	7	NMOD
7	activation	activation	I-NP	NN	O	8	SUB
8	triggered	trigger	B-VP	VBD	O	0	ROOT
9	a	a	B-NP	DT	O	13	NMOD
10	significant	significant	I-NP	JJ	O	13	NMOD
11	intracellular	intracellular	I-NP	JJ	O	13	NMOD
12	thiol	thiol	I-NP	NN	O	13	NMOD
13	decrease	decrease	I-NP	NN	O	8	OBJ
14	,	,	O	,	O	8	P
15	suggesting	suggest	B-VP	VBG	O	8	VMOD
16	that	that	B-SBAR	IN	O	15	VMOD
17	oxygen	oxygen	B-NP	NN	O	18	NMOD
18	radicals	radical	I-NP	NNS	O	19	SUB
19	are	be	B-VP	VBP	O	16	SBAR
20	involved	involve	I-VP	VBN	O	19	VC
21	in	in	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	24	NMOD
23	signaling	signaling	I-NP	NN	O	24	NMOD
24	pathway	pathway	I-NP	NN	O	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	adhesion	adhesion	B-NP	NN	B-protein	27	NMOD
27	molecules	molecule	I-NP	NNS	I-protein	25	PMOD
28	.	.	O	.	O	8	P

1	Finally	Finally	B-ADVP	RB	O	26	VMOD
2	,	,	O	,	O	26	P
3	micromolar	micromolar	B-NP	JJ	O	4	NMOD
4	amounts	amount	I-NP	NNS	O	26	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	pyrrolidine	pyrrolidine	B-NP	NN	O	7	NMOD
7	dithiocarbamate	dithiocarbamate	I-NP	NN	O	12	NMOD
8	,	,	O	,	O	12	P
9	an	an	B-NP	DT	O	12	NMOD
10	oxygen	oxygen	I-NP	NN	O	12	NMOD
11	radical	radical	I-NP	NN	O	12	NMOD
12	scavenger	scavenger	I-NP	NN	O	5	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	efficiently	efficiently	B-ADVP	RB	O	15	VMOD
15	blocked	block	B-VP	VBD	O	13	SBAR
16	the	the	B-NP	DT	O	18	NMOD
17	nuclear	nuclear	I-NP	JJ	O	18	NMOD
18	appearance	appearance	I-NP	NN	O	15	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	NF-kappa	NF-kappa	B-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	19	PMOD
22	in	in	B-PP	IN	O	18	NMOD
23	T-lymphocytes	T-lymphocyte	B-NP	NNS	B-cell_type	22	PMOD
24	,	,	O	,	O	26	P
25	also	also	B-ADVP	RB	O	26	VMOD
26	inhibited	inhibit	B-VP	VBD	O	0	ROOT
27	IL-2	IL-2	B-NP	NN	B-protein	28	NMOD
28	secretion	secretion	I-NP	NN	O	38	NMOD
29	,	,	O	,	O	38	P
30	IL-2R	IL-2R	B-NP	NN	B-protein	34	NMOD
31	alpha	alpha	I-NP	NN	I-protein	34	NMOD
32	cell	cell	I-NP	NN	O	34	NMOD
33	surface	surface	I-NP	NN	O	34	NMOD
34	expression	expression	I-NP	NN	O	38	NMOD
35	,	,	O	,	O	38	P
36	and	and	O	CC	O	38	NMOD
37	T-cell	T-cell	B-NP	NN	B-cell_type	38	NMOD
38	proliferation	proliferation	I-NP	NN	O	26	OBJ
39	.	.	O	.	O	26	P

1	Together	Together	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	results	result	I-NP	NNS	O	5	SUB
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	8	NMOD
8	B	B	I-NP	NN	I-protein	9	SUB
9	plays	play	B-VP	VBZ	O	6	SBAR
10	an	an	B-NP	DT	O	12	NMOD
11	important	important	I-NP	JJ	O	12	NMOD
12	role	role	I-NP	NN	O	9	OBJ
13	in	in	B-PP	IN	O	9	VMOD
14	long-term	long-term	B-NP	JJ	O	15	NMOD
15	activation	activation	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	human	human	B-NP	JJ	B-cell_type	19	NMOD
18	primary	primary	I-NP	JJ	I-cell_type	19	NMOD
19	T-lymphocytes	T-lymphocyte	I-NP	NNS	I-cell_type	16	PMOD
20	via	via	B-PP	IN	O	15	NMOD
21	CD2	CD2	B-NP	NN	B-protein	23	NMOD
22	+	+	I-NP	CC	O	23	NMOD
23	CD28	CD28	I-NP	NN	B-protein	20	PMOD
24	.	.	O	.	O	5	P

1	Synergism	Synergism	B-NP	NN	O	0	ROOT
2	between	between	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	9	NMOD
4	CD3	CD3	I-NP	NN	B-protein	5	NMOD
5	antigen-	antigen-	I-NP	NN	I-protein	9	NMOD
6	and	and	O	CC	O	9	NMOD
7	CD2	CD2	B-NP	NN	B-protein	9	NMOD
8	antigen-derived	antigen-derived	I-NP	JJ	O	9	NMOD
9	signals	signal	I-NP	NNS	O	2	PMOD
10	.	.	O	.	O	1	P

1	Exploration	Exploration	B-NP	NN	O	11	NMOD
2	at	at	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	level	level	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	induction	induction	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	DNA-binding	DNA-binding	B-NP	JJ	B-protein	9	NMOD
9	proteins	protein	I-NP	NNS	I-protein	7	PMOD
10	and	and	O	CC	O	11	NMOD
11	characterization	characterization	B-NP	NN	O	0	ROOT
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	inhibitory	inhibitory	I-NP	JJ	O	15	NMOD
15	activity	activity	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	cyclosporine	cyclosporine	B-NP	NN	O	16	PMOD
18	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	demonstrated	demonstrate	I-VP	VBN	O	2	VC
4	earlier	earlier	B-ADVP	RBR	O	3	VMOD
5	that	that	B-SBAR	IN	O	3	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	crosslinkage	crosslinkage	I-NP	NN	O	16	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	CD3/TCR	CD3/TCR	I-NP	NN	B-protein	11	NMOD
11	complex	complex	I-NP	NN	I-protein	8	PMOD
12	with	with	B-PP	IN	O	7	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	CD2	CD2	I-NP	NN	B-protein	15	NMOD
15	antigen	antigen	I-NP	NN	I-protein	12	PMOD
16	results	result	B-VP	VBZ	O	5	SBAR
17	in	in	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	proliferation	proliferation	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	normal	normal	B-NP	JJ	B-cell_type	24	NMOD
22	human	human	I-NP	JJ	I-cell_type	24	NMOD
23	T	T	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
25	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	synergism	synergism	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	perceptible	perceptible	B-ADJP	JJ	O	6	PRD
8	at	at	B-PP	IN	O	6	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	level	level	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	induction	induction	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	IL-2	IL-2	I-NP	NN	B-DNA	16	NMOD
16	gene	gene	I-NP	NN	I-DNA	19	NMOD
17	,	,	O	,	O	19	P
18	a	a	B-NP	DT	O	19	NMOD
19	process	process	I-NP	NN	O	13	PMOD
20	critical	critical	B-ADJP	JJ	O	19	NMOD
21	for	for	B-PP	IN	O	20	AMOD
22	T	T	B-NP	NN	O	24	NMOD
23	cell	cell	I-NP	NN	O	24	NMOD
24	growth	growth	I-NP	NN	O	21	PMOD
25	.	.	O	.	O	6	P

1	To	To	B-VP	TO	O	3	VMOD
2	further	further	I-VP	RB	O	3	VMOD
3	understand	understand	I-VP	VB	O	14	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	molecular	molecular	I-NP	JJ	O	7	AMOD
6	and	and	I-NP	CC	O	7	AMOD
7	nuclear	nuclear	I-NP	JJ	O	8	NMOD
8	basis	basis	I-NP	NN	O	3	OBJ
9	for	for	B-PP	IN	O	8	NMOD
10	this	this	B-NP	DT	O	11	NMOD
11	synergism	synergism	I-NP	NN	O	9	PMOD
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	have	have	B-VP	VBP	O	0	ROOT
15	explored	explore	I-VP	VBN	O	14	VC
16	the	the	B-NP	DT	O	17	NMOD
17	induction	induction	I-NP	NN	O	15	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	DNA-binding	DNA-binding	B-NP	JJ	B-protein	20	NMOD
20	proteins	protein	I-NP	NNS	I-protein	18	PMOD
21	in	in	B-PP	IN	O	17	NMOD
22	highly	highly	B-NP	RB	B-cell_type	23	AMOD
23	purified	purify	I-NP	VBN	I-cell_type	27	NMOD
24	normal	normal	I-NP	JJ	I-cell_type	27	NMOD
25	human	human	I-NP	JJ	I-cell_type	27	NMOD
26	T	T	I-NP	NN	I-cell_type	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
28	signaled	signal	B-VP	VBN	O	27	NMOD
29	via	via	B-PP	IN	O	28	VMOD
30	the	the	B-NP	DT	O	34	NMOD
31	CD3	CD3	I-NP	NN	B-protein	33	NMOD
32	and/or	and/or	I-NP	CC	O	33	NMOD
33	CD2	CD2	I-NP	NN	B-protein	34	NMOD
34	proteins	protein	I-NP	NNS	I-protein	29	PMOD
35	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	17	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	transmembrane	transmembrane	B-NP	NN	O	5	NMOD
5	signaling	signaling	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
9	with	with	B-PP	IN	O	5	NMOD
10	ionomycin	ionomycin	B-NP	NN	O	9	PMOD
11	,	,	O	,	O	17	P
12	and/or	and/or	O	CC	O	17	NMOD
13	sn-1	sn-1	B-NP	NN	O	17	NMOD
14	,	,	O	,	O	17	P
15	2	2	B-NP	CD	O	17	NMOD
16	dioctanoyl	dioctanoyl	I-NP	NN	O	17	NMOD
17	glycerol	glycerol	I-NP	NN	O	19	SUB
18	,	,	O	,	O	17	P
19	was	be	B-VP	VBD	O	0	ROOT
20	also	also	I-VP	RB	O	19	VMOD
21	determined	determine	I-VP	VBN	O	19	VC
22	.	.	O	.	O	19	P

1	The	The	B-NP	DT	O	2	NMOD
2	emergence	emergence	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD
5	binding	binding	I-NP	NN	I-protein	6	NMOD
6	proteins	protein	I-NP	NNS	I-protein	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	investigated	investigate	I-VP	VBN	O	7	VC
9	using	use	B-VP	VBG	O	8	VMOD
10	interleukin-2	interleukin-2	B-NP	NN	B-DNA	11	AMOD
11	sequence	sequence	I-NP	NN	I-DNA	14	NMOD
12	specific	specific	I-NP	JJ	O	11	AMOD
13	oligonucleotide	oligonucleotide	I-NP	NN	O	14	NMOD
14	probes	probe	I-NP	NNS	O	9	OBJ
15	in	in	B-PP	IN	O	9	VMOD
16	the	the	B-NP	DT	O	20	NMOD
17	electrophoretic	electrophoretic	I-NP	JJ	O	20	NMOD
18	mobility	mobility	I-NP	NN	O	20	NMOD
19	shift	shift	I-NP	NN	O	20	NMOD
20	assay	assay	I-NP	NN	O	15	PMOD
21	.	.	O	.	O	7	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	for	for	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	first	first	I-NP	JJ	O	7	NMOD
7	time	time	I-NP	NN	O	4	PMOD
8	that	that	B-ADVP	IN	O	3	VMOD
9	CD3	CD3	B-VP	NN	B-protein	11	NMOD
10	antigen-derived	antigen-derived	B-NP	JJ	O	11	NMOD
11	signals	signal	I-NP	NNS	O	15	NMOD
12	and	and	O	CC	O	15	NMOD
13	CD2	CD2	B-NP	NN	B-protein	15	NMOD
14	antigen-derived	antigen-derived	I-NP	JJ	O	15	NMOD
15	signals	signal	I-NP	NNS	O	16	SUB
16	are	be	B-VP	VBP	O	8	SBAR
17	synergistic	synergistic	B-ADJP	JJ	O	16	PRD
18	in	in	B-PP	IN	O	16	VMOD
19	inducing	induce	B-VP	VBG	O	18	PMOD
20	the	the	B-NP	DT	O	21	NMOD
21	emergence	emergence	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	transcription	transcription	B-NP	NN	B-protein	24	NMOD
24	factors	factor	I-NP	NNS	I-protein	22	PMOD
25	that	that	B-NP	WDT	O	24	NMOD
26	bind	bind	B-VP	VBP	O	25	SBAR
27	to	to	B-PP	TO	O	26	VMOD
28	the	the	B-NP	DT	O	35	NMOD
29	NF-AT1	NF-AT1	I-NP	NN	B-protein	35	NMOD
30	,	,	O	,	O	35	P
31	AP-1	AP-1	B-NP	NN	B-protein	35	NMOD
32	,	,	O	,	O	35	P
33	and	and	O	CC	O	35	NMOD
34	NF-kB	NF-kB	B-NP	NN	B-DNA	35	NMOD
35	sites	site	I-NP	NNS	I-DNA	27	PMOD
36	located	located	B-ADJP	JJ	O	35	NMOD
37	in	in	B-PP	IN	O	36	AMOD
38	the	the	B-NP	DT	O	40	NMOD
39	promoter/enhancer	promoter/enhancer	I-NP	NN	B-DNA	40	NMOD
40	region	region	I-NP	NN	I-DNA	37	PMOD
41	of	of	B-PP	IN	O	40	NMOD
42	the	the	B-NP	DT	O	44	NMOD
43	IL-2	IL-2	I-NP	NN	B-DNA	44	NMOD
44	gene	gene	I-NP	NN	I-DNA	41	PMOD
45	.	.	O	.	O	3	P

1	Moreover	Moreover	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	cyclosporine	cyclosporine	B-NP	NN	O	13	SUB
4	,	,	O	,	O	3	P
5	at	at	B-PP	IN	O	3	NMOD
6	concentrations	concentration	B-NP	NNS	O	5	PMOD
7	readily	readily	B-VP	RB	O	8	VMOD
8	accomplished	accomplish	I-VP	VBN	O	6	NMOD
9	in	in	B-PP	IN	O	8	VMOD
10	clinical	clinical	B-NP	JJ	O	11	NMOD
11	practice	practice	I-NP	NN	O	9	PMOD
12	,	,	O	,	O	3	P
13	was	be	B-VP	VBD	O	0	ROOT
14	found	find	I-VP	VBN	O	13	VC
15	to	to	I-VP	TO	O	16	VMOD
16	inhibit	inhibit	I-VP	VB	O	14	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	emergence	emergence	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	these	these	B-NP	DT	O	22	NMOD
21	DNA-binding	DNA-binding	I-NP	JJ	B-protein	22	NMOD
22	proteins	protein	I-NP	NNS	I-protein	19	PMOD
23	in	in	B-PP	IN	O	18	NMOD
24	normal	normal	B-NP	JJ	B-cell_type	27	NMOD
25	human	human	I-NP	JJ	I-cell_type	27	NMOD
26	T	T	I-NP	NN	I-cell_type	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
28	signaled	signal	B-VP	VBN	O	27	NMOD
29	via	via	B-PP	IN	O	28	VMOD
30	cell	cell	B-NP	NN	B-protein	32	NMOD
31	surface	surface	I-NP	NN	I-protein	32	NMOD
32	proteins	protein	I-NP	NNS	I-protein	29	PMOD
33	implicated	implicate	B-VP	VBN	O	32	NMOD
34	in	in	B-PP	IN	O	33	VMOD
35	antigen-dependent	antigen-dependent	B-NP	JJ	O	38	NMOD
36	T	T	I-NP	NN	O	38	NMOD
37	cell	cell	I-NP	NN	O	38	NMOD
38	activation	activation	I-NP	NN	O	34	PMOD
39	and	and	B-PP	CC	O	34	PMOD
40	in	in	B-PP	IN	O	34	PMOD
41	T	T	B-NP	NN	B-cell_type	42	NMOD
42	cells	cell	I-NP	NNS	I-cell_type	40	PMOD
43	stimulated	stimulate	B-VP	VBN	O	42	NMOD
44	by	by	B-PP	IN	O	43	VMOD
45	mobilization	mobilization	B-NP	NN	O	50	NMOD
46	of	of	B-PP	IN	O	45	NMOD
47	cellular	cellular	B-NP	JJ	O	48	NMOD
48	calcium	calcium	I-NP	NN	O	46	PMOD
49	and	and	O	CC	O	50	NMOD
50	activation	activation	B-NP	NN	O	44	PMOD
51	of	of	B-PP	IN	O	50	NMOD
52	protein	protein	B-NP	NN	B-protein	54	NMOD
53	kinase	kinase	I-NP	NN	I-protein	54	NMOD
54	C	C	I-NP	NN	I-protein	51	PMOD
55	.	.	O	.	O	13	P

1	Antisense	Antisense	B-NP	JJ	O	2	NMOD
2	oligonucleotides	oligonucleotide	I-NP	NNS	O	10	SUB
3	to	to	B-PP	TO	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	p65	p65	I-NP	NN	B-protein	6	NMOD
6	subunit	subunit	I-NP	NN	I-protein	3	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	7	PMOD
10	block	block	B-VP	VBP	O	0	ROOT
11	CD11b	CD11b	B-NP	NN	B-protein	12	NMOD
12	expression	expression	I-NP	NN	O	10	OBJ
13	and	and	O	CC	O	10	VMOD
14	alter	alter	B-VP	VB	O	10	VMOD
15	adhesion	adhesion	B-NP	NN	O	16	NMOD
16	properties	property	I-NP	NNS	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	differentiated	differentiate	B-NP	VBN	O	20	NMOD
19	HL-60	HL-60	I-NP	NN	B-cell_line	20	NMOD
20	granulocytes	granulocyte	I-NP	NNS	I-cell_line	17	PMOD
21	.	.	O	.	O	10	P

1	NF-kappa	NF-kappa	B-NP	NN	B-protein	2	NMOD
2	B	B	I-NP	NN	I-protein	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	pleiotropic	pleiotropic	I-NP	JJ	B-protein	6	NMOD
6	regulator	regulator	I-NP	NN	I-protein	3	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	9	NMOD
9	variety	variety	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	genes	gene	B-NP	NNS	O	10	PMOD
12	implicated	implicate	B-VP	VBN	O	11	NMOD
13	in	in	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	cellular	cellular	I-NP	JJ	O	16	NMOD
16	response	response	I-NP	NN	O	13	PMOD
17	to	to	B-PP	TO	O	16	NMOD
18	injury	injury	B-NP	NN	O	17	PMOD
19	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	function	function	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	been	be	I-VP	VBN	O	3	VC
5	attributed	attribute	I-VP	VBN	O	4	VC
6	to	to	B-PP	TO	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	coordinated	coordinate	I-NP	VBN	O	9	NMOD
9	binding	binding	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	subunits	subunit	B-NP	NNS	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	NF-kappa	NF-kappa	B-NP	NN	B-protein	14	NMOD
14	B	B	I-NP	NN	I-protein	12	PMOD
15	to	to	B-PP	TO	O	9	NMOD
16	distinct	distinct	B-NP	JJ	O	17	NMOD
17	regions	region	I-NP	NNS	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	promoter	promoter	I-NP	NN	B-DNA	21	NMOD
21	elements	element	I-NP	NNS	I-DNA	18	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	numerous	numerous	B-NP	JJ	O	24	NMOD
24	genes	gene	I-NP	NNS	O	22	PMOD
25	,	,	O	,	O	24	P
26	including	include	B-PP	VBG	O	24	NMOD
27	cytokines	cytokine	B-NP	NNS	B-protein	35	NMOD
28	,	,	O	,	O	35	P
29	growth	growth	B-NP	NN	B-protein	31	NMOD
30	factor	factor	I-NP	NN	I-protein	31	NMOD
31	receptors	receptor	I-NP	NNS	I-protein	35	NMOD
32	,	,	O	,	O	35	P
33	and	and	O	CC	O	35	NMOD
34	adhesion	adhesion	B-NP	NN	B-protein	35	NMOD
35	molecules	molecule	I-NP	NNS	I-protein	26	PMOD
36	.	.	O	.	O	3	P

1	Antisense	Antisense	B-NP	JJ	O	3	NMOD
2	phosphorothioate	phosphorothioate	I-NP	NN	O	3	NMOD
3	oligonucleotides	oligonucleotide	I-NP	NNS	O	15	SUB
4	to	to	B-PP	TO	O	3	NMOD
5	the	the	B-NP	DT	O	9	NMOD
6	p50	p50	I-NP	NN	B-protein	9	NMOD
7	and	and	I-NP	CC	O	9	NMOD
8	p65	p65	I-NP	NN	B-protein	9	NMOD
9	subunits	subunit	I-NP	NNS	I-protein	4	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	NF-kappa	NF-kappa	I-NP	NN	B-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	complex	complex	I-NP	NN	I-protein	10	PMOD
15	were	be	B-VP	VBD	O	0	ROOT
16	used	use	I-VP	VBN	O	15	VC
17	to	to	B-VP	TO	O	18	VMOD
18	define	define	I-VP	VB	O	16	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	physiologic	physiologic	I-NP	JJ	O	21	NMOD
21	role	role	I-NP	NN	O	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	this	this	B-NP	DT	O	25	NMOD
24	transcription	transcription	I-NP	NN	B-protein	25	NMOD
25	factor	factor	I-NP	NN	I-protein	22	PMOD
26	in	in	B-PP	IN	O	21	NMOD
27	resting	rest	B-NP	VBG	B-cell_type	29	AMOD
28	and	and	I-NP	CC	I-cell_type	29	AMOD
29	stimulated	stimulate	I-NP	VBN	I-cell_type	30	NMOD
30	granulocytes	granulocyte	I-NP	NNS	I-cell_type	26	PMOD
31	.	.	O	.	O	15	P

1	A	A	B-NP	DT	O	2	NMOD
2	reduction	reduction	I-NP	NN	O	8	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	p65	p65	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	produced	produce	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	treatment	treatment	B-NP	NN	O	10	PMOD
12	with	with	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	16	NMOD
14	phosphorothioate	phosphorothioate	I-NP	NN	O	16	NMOD
15	antisense	antisense	I-NP	JJ	O	16	NMOD
16	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	2	NMOD
2	reduction	reduction	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	accompanied	accompany	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	rapid	rapid	B-NP	JJ	O	7	NMOD
7	changes	change	I-NP	NNS	O	5	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	cellular	cellular	I-NP	JJ	O	11	NMOD
11	adhesion	adhesion	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	dimethyl	dimethyl	B-NP	NN	B-cell_line	17	NMOD
14	sulfoxide-differentiated	sulfoxide-differentiated	I-NP	JJ	I-cell_line	17	NMOD
15	HL-60	HL-60	I-NP	NN	I-cell_line	17	NMOD
16	leukemia	leukemia	I-NP	NN	I-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	12	PMOD
18	stimulated	stimulate	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	B-NP	NN	O	21	NMOD
21	13-acetate	13-acetate	I-NP	NN	O	19	PMOD
22	(	(	O	(	O	23	P
23	TPA	TPA	B-NP	NN	O	21	NMOD
24	)	)	O	)	O	23	P
25	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	effects	effect	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	characterized	characterize	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	marked	marked	I-NP	JJ	O	8	NMOD
8	reduction	reduction	I-NP	NN	O	5	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	CD11b	CD11b	B-NP	NN	B-protein	12	NMOD
11	integrin	integrin	I-NP	NN	I-protein	12	NMOD
12	expression	expression	I-NP	NN	O	9	PMOD
13	on	on	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	surface	surface	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	treated	treat	B-NP	VBN	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
19	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	6	NMOD
4	p65	p65	I-NP	NN	B-protein	6	NMOD
5	antisense	antisense	I-NP	JJ	O	6	NMOD
6	oligomer	oligomer	I-NP	NN	O	8	SUB
7	effectively	effectively	B-VP	RB	O	8	VMOD
8	abolished	abolish	I-VP	VBD	O	0	ROOT
9	an	an	B-NP	DT	O	10	NMOD
10	upregulation	upregulation	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	CD11b	CD11b	B-NP	NN	B-protein	11	PMOD
13	that	that	B-NP	WDT	O	10	NMOD
14	was	be	B-VP	VBD	O	13	SBAR
15	produced	produce	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	formyl-met-leu-phe	formyl-met-leu-phe	B-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	TPA	TPA	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	7	NMOD
4	p65	p65	I-NP	NN	B-protein	7	NMOD
5	antisense	antisense	I-NP	JJ	O	7	NMOD
6	phosphorothioate	phosphorothioate	I-NP	NN	O	7	NMOD
7	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	NN	O	8	SUB
8	had	have	B-VP	VBD	O	0	ROOT
9	no	no	B-NP	DT	O	11	NMOD
10	significant	significant	I-NP	JJ	O	11	NMOD
11	effect	effect	I-NP	NN	O	8	OBJ
12	on	on	B-PP	IN	O	8	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	production	production	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	reactive	reactive	B-NP	JJ	O	18	NMOD
17	oxygen	oxygen	I-NP	NN	O	18	NMOD
18	intermediates	intermediate	I-NP	NNS	O	15	PMOD
19	or	or	B-PP	CC	O	12	PMOD
20	on	on	B-PP	IN	O	12	PMOD
21	phagocytosis	phagocytosis	B-NP	NN	O	20	PMOD
22	by	by	B-PP	IN	O	21	NMOD
23	these	these	B-NP	DT	O	24	NMOD
24	cells	cell	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	antisense	antisense	B-NP	JJ	O	6	NMOD
6	oligomers	oligomer	I-NP	NNS	O	9	SUB
7	to	to	B-PP	TO	O	6	NMOD
8	p65	p65	B-NP	NN	B-protein	7	PMOD
9	can	can	B-VP	MD	O	4	SBAR
10	be	be	I-VP	VB	O	9	VC
11	used	use	I-VP	VBN	O	10	VC
12	to	to	B-VP	TO	O	13	VMOD
13	define	define	I-VP	VB	O	11	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	role	role	I-NP	NN	O	13	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	NF-kappa	NF-kappa	B-NP	NN	B-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	16	PMOD
19	in	in	B-PP	IN	O	15	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	activation	activation	I-NP	NN	O	22	NMOD
22	pathways	pathway	I-NP	NNS	O	19	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	neutrophils	neutrophil	B-NP	NNS	B-cell_type	23	PMOD
25	.	.	O	.	O	3	P

1	Human	Human	B-NP	JJ	B-DNA	6	NMOD
2	interferon	interferon	I-NP	NN	I-DNA	6	NMOD
3	regulatory	regulatory	I-NP	JJ	I-DNA	6	NMOD
4	factor	factor	I-NP	NN	I-DNA	6	NMOD
5	2	2	I-NP	CD	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	0	ROOT
7	.	.	O	.	O	6	P

1	Intron-exon	Intron-exon	B-NP	JJ	O	2	NMOD
2	organization	organization	I-NP	NN	O	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	functional	functional	B-NP	JJ	O	5	NMOD
5	analysis	analysis	I-NP	NN	O	0	ROOT
6	of	of	B-PP	IN	O	5	NMOD
7	5'-flanking	5'-flanking	B-NP	JJ	B-DNA	8	NMOD
8	region	region	I-NP	NN	I-DNA	6	PMOD
9	.	.	O	.	O	5	P

1	Interferon	Interferon	B-NP	NN	B-protein	3	NMOD
2	regulatory	regulatory	I-NP	JJ	I-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	8	SUB
4	2	2	I-NP	CD	I-protein	3	NMOD
5	(	(	O	(	O	6	P
6	IRF-2	IRF-2	B-NP	NN	B-protein	3	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	12	NMOD
10	transcriptional	transcriptional	I-NP	JJ	B-protein	12	NMOD
11	regulatory	regulatory	I-NP	JJ	I-protein	12	NMOD
12	protein	protein	I-NP	NN	I-protein	8	PRD
13	that	that	B-NP	WDT	O	12	NMOD
14	terminates	terminate	B-VP	VBZ	O	13	SBAR
15	interferon	interferon	B-NP	NN	B-protein	17	NMOD
16	beta	beta	I-NP	NN	I-protein	17	NMOD
17	expression	expression	I-NP	NN	O	14	OBJ
18	initiated	initiate	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	interferon	interferon	B-NP	NN	B-protein	22	NMOD
21	regulatory	regulatory	I-NP	JJ	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	19	PMOD
23	1	1	I-NP	CD	I-protein	22	NMOD
24	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	isolated	isolate	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	9	NMOD
8	genomic	genomic	I-NP	JJ	B-DNA	9	NMOD
9	DNA	DNA	I-NP	NN	I-DNA	6	OBJ
10	for	for	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	B-DNA	13	NMOD
12	IRF-2	IRF-2	I-NP	NN	I-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	10	PMOD
14	,	,	O	,	O	6	P
15	determined	determine	B-VP	VBD	O	6	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	intron-exon	intron-exon	I-NP	JJ	O	18	NMOD
18	structure	structure	I-NP	NN	O	15	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	human	human	I-NP	JJ	B-DNA	23	NMOD
22	IRF-2	IRF-2	I-NP	NN	I-DNA	23	NMOD
23	gene	gene	I-NP	NN	I-DNA	19	PMOD
24	,	,	O	,	O	6	P
25	mapped	map	B-VP	VBD	O	6	VMOD
26	the	the	B-NP	DT	O	30	NMOD
27	major	major	I-NP	JJ	B-DNA	30	NMOD
28	transcription	transcription	I-NP	NN	I-DNA	30	NMOD
29	initiation	initiation	I-NP	NN	I-DNA	30	NMOD
30	site	site	I-NP	NN	I-DNA	25	OBJ
31	,	,	O	,	O	6	P
32	identified	identify	B-VP	VBD	O	6	VMOD
33	a	a	B-NP	DT	O	34	NMOD
34	number	number	I-NP	NN	O	32	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	potential	potential	B-NP	JJ	O	38	NMOD
37	regulatory	regulatory	I-NP	JJ	B-DNA	38	NMOD
38	elements	element	I-NP	NNS	I-DNA	35	PMOD
39	in	in	B-PP	IN	O	38	NMOD
40	the	the	B-NP	DT	O	42	NMOD
41	5'-flanking	5'-flanking	I-NP	JJ	B-DNA	42	NMOD
42	region	region	I-NP	NN	I-DNA	39	PMOD
43	,	,	O	,	O	6	P
44	and	and	O	CC	O	6	VMOD
45	localized	localize	B-VP	VBD	O	6	VMOD
46	the	the	B-NP	DT	O	48	NMOD
47	IRF-2	IRF-2	I-NP	NN	B-DNA	48	NMOD
48	gene	gene	I-NP	NN	I-DNA	45	OBJ
49	on	on	B-PP	IN	O	48	NMOD
50	human	human	B-NP	JJ	B-DNA	51	NMOD
51	chromosome	chromosome	I-NP	NN	I-DNA	49	PMOD
52	4	4	I-NP	CD	I-DNA	51	NMOD
53	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	IRF-2	IRF-2	I-NP	NN	B-DNA	4	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	NMOD
4	region	region	I-NP	NN	I-DNA	5	SUB
5	contains	contain	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	CpG	CpG	I-NP	NN	B-DNA	8	NMOD
8	island	island	I-NP	NN	I-DNA	5	OBJ
9	,	,	O	,	O	5	P
10	with	with	B-PP	IN	O	5	VMOD
11	several	several	B-NP	JJ	O	13	NMOD
12	GC	GC	I-NP	NN	B-DNA	13	NMOD
13	boxes	box	I-NP	NNS	I-DNA	29	NMOD
14	,	,	O	,	O	29	P
15	a	a	B-NP	DT	O	19	NMOD
16	putative	putative	I-NP	JJ	O	19	NMOD
17	NF-kappa	NF-kappa	I-NP	NN	B-DNA	19	NMOD
18	B-binding	B-binding	I-NP	JJ	I-DNA	19	NMOD
19	site	site	I-NP	NN	I-DNA	29	NMOD
20	,	,	O	,	O	29	P
21	and	and	O	CC	O	24	NMOD
22	a	a	B-NP	DT	O	24	NMOD
23	CAAT	CAAT	I-NP	NN	B-DNA	24	NMOD
24	box	box	I-NP	NN	I-DNA	29	NMOD
25	,	,	O	,	O	29	P
26	but	but	O	CC	O	29	NMOD
27	no	no	B-NP	DT	O	29	NMOD
28	TATA	TATA	I-NP	NN	B-DNA	29	NMOD
29	box	box	I-NP	NN	I-DNA	10	PMOD
30	.	.	O	.	O	5	P

1	When	When	B-ADVP	WRB	O	14	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	promoter	promoter	I-NP	NN	B-DNA	4	NMOD
4	region	region	I-NP	NN	I-DNA	5	SUB
5	was	be	B-VP	VBD	O	1	SBAR
6	linked	link	I-VP	VBN	O	5	VC
7	with	with	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	11	NMOD
9	heterologous	heterologous	I-NP	JJ	B-DNA	11	NMOD
10	reporter	reporter	I-NP	NN	I-DNA	11	NMOD
11	gene	gene	I-NP	NN	I-DNA	7	PMOD
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	found	find	B-VP	VBD	O	0	ROOT
15	that	that	B-SBAR	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	promoter	promoter	I-NP	NN	B-DNA	18	NMOD
18	region	region	I-NP	NN	I-DNA	19	SUB
19	is	be	B-VP	VBZ	O	15	SBAR
20	inducible	inducible	B-ADJP	JJ	O	19	PRD
21	by	by	B-PP	IN	O	20	AMOD
22	both	both	B-NP	DT	O	23	NMOD
23	interferons	interferon	I-NP	NNS	B-protein	32	NMOD
24	(	(	O	(	O	27	P
25	interferon-alpha	interferon-alpha	B-NP	NN	B-protein	27	NMOD
26	and	and	O	CC	I-protein	27	NMOD
27	-gamma	-gamma	B-NP	NN	I-protein	23	NMOD
28	)	)	O	)	O	27	P
29	and	and	O	CC	O	32	NMOD
30	interferon	interferon	B-NP	NN	B-protein	32	NMOD
31	regulatory	regulatory	I-NP	JJ	I-protein	32	NMOD
32	factor	factor	I-NP	NN	I-protein	21	PMOD
33	1	1	I-NP	CD	I-protein	32	NMOD
34	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	region	region	I-NP	NN	O	7	SUB
3	which	which	B-NP	WDT	O	2	NMOD
4	induced	induce	B-VP	VBD	O	3	SBAR
5	these	these	B-NP	DT	O	6	NMOD
6	inductions	induction	I-NP	NNS	O	4	OBJ
7	was	be	B-VP	VBD	O	0	ROOT
8	identified	identify	I-VP	VBN	O	7	VC
9	as	as	B-PP	IN	O	8	VMOD
10	being	be	B-VP	VBG	O	9	PMOD
11	confined	confine	I-VP	VBN	O	10	VC
12	to	to	B-PP	TO	O	11	VMOD
13	40	40	B-NP	CD	B-DNA	14	NMOD
14	nucleotides	nucleotide	I-NP	NNS	I-DNA	12	PMOD
15	5	5	B-NP	CD	I-DNA	14	NMOD
16	'	'	B-NP	SYM	I-DNA	14	NMOD
17	to	to	B-PP	TO	O	14	NMOD
18	the	the	B-NP	DT	O	22	NMOD
19	major	major	I-NP	JJ	B-DNA	22	NMOD
20	transcriptional	transcriptional	I-NP	JJ	I-DNA	22	NMOD
21	initiation	initiation	I-NP	NN	I-DNA	22	NMOD
22	site	site	I-NP	NN	I-DNA	17	PMOD
23	by	by	B-PP	IN	O	22	NMOD
24	testing	test	B-VP	VBG	O	23	PMOD
25	a	a	B-NP	DT	O	26	NMOD
26	series	series	I-NP	NN	O	24	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	clones	clone	B-NP	NNS	O	27	PMOD
29	with	with	B-PP	IN	O	26	NMOD
30	truncated	truncate	B-NP	VBN	B-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	IRF-2	IRF-2	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	7	P

1	This	This	B-NP	DT	O	2	NMOD
2	region	region	I-NP	NN	O	3	SUB
3	contains	contain	B-VP	VBZ	O	0	ROOT
4	elements	element	B-NP	NNS	O	3	OBJ
5	which	which	B-NP	WDT	O	4	NMOD
6	are	be	B-VP	VBP	O	5	SBAR
7	shared	share	I-VP	VBN	O	6	VC
8	with	with	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	transcriptional	transcriptional	I-NP	JJ	B-DNA	11	NMOD
11	enhancers	enhancer	I-NP	NNS	I-DNA	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	other	other	B-NP	JJ	O	14	NMOD
14	genes	gene	I-NP	NNS	O	12	PMOD
15	including	include	B-PP	VBG	O	14	NMOD
16	interferon	interferon	B-NP	NN	B-protein	18	NMOD
17	regulatory	regulatory	I-NP	JJ	I-protein	18	NMOD
18	factor	factor	I-NP	NN	I-protein	26	NMOD
19	1	1	I-NP	CD	I-protein	18	NMOD
20	,	,	O	,	O	26	P
21	interferon	interferon	B-NP	NN	B-protein	22	NMOD
22	beta	beta	I-NP	NN	I-protein	26	NMOD
23	,	,	O	,	O	26	P
24	and	and	O	CC	O	26	NMOD
25	interferon-inducible	interferon-inducible	B-NP	JJ	B-DNA	26	NMOD
26	genes	gene	I-NP	NNS	I-DNA	15	PMOD
27	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	interferon	interferon	B-NP	NN	B-protein	7	NMOD
6	regulatory	regulatory	I-NP	JJ	I-protein	7	NMOD
7	factor	factor	I-NP	NN	I-protein	11	SUB
8	1	1	I-NP	CD	I-protein	7	NMOD
9	not	not	B-CONJP	RB	O	11	VMOD
10	only	only	I-CONJP	RB	O	9	DEP
11	triggers	trigger	B-VP	VBZ	O	23	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	19	NMOD
16	interferon	interferon	I-NP	NN	B-protein	19	NMOD
17	signal	signal	I-NP	NN	O	19	NMOD
18	transduction	transduction	I-NP	NN	O	19	NMOD
19	pathway	pathway	I-NP	NN	O	14	PMOD
20	,	,	O	,	O	23	P
21	but	but	O	CC	O	23	VMOD
22	also	also	B-ADVP	RB	O	23	VMOD
23	may	may	B-VP	MD	O	4	SBAR
24	play	play	I-VP	VB	O	23	VC
25	a	a	B-NP	DT	O	26	NMOD
26	role	role	I-NP	NN	O	24	OBJ
27	in	in	B-PP	IN	O	24	VMOD
28	limiting	limit	B-VP	VBG	O	27	PMOD
29	the	the	B-NP	DT	O	30	NMOD
30	duration	duration	I-NP	NN	O	28	OBJ
31	of	of	B-PP	IN	O	30	NMOD
32	this	this	B-NP	DT	O	33	NMOD
33	response	response	I-NP	NN	O	31	PMOD
34	by	by	B-PP	IN	O	28	VMOD
35	activating	activate	B-VP	VBG	O	34	PMOD
36	the	the	B-NP	DT	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	35	OBJ
38	of	of	B-PP	IN	O	37	NMOD
39	IRF-2	IRF-2	B-NP	NN	B-protein	38	PMOD
40	.	.	O	.	O	3	P

1	Overproduction	Overproduction	B-NP	NN	O	11	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	NFKB2	NFKB2	B-NP	NN	B-protein	8	NMOD
4	(	(	O	(	O	5	P
5	lyt-10	lyt-10	B-NP	NN	B-protein	3	NMOD
6	)	)	O	)	O	5	P
7	and	and	O	CC	O	8	NMOD
8	c-Rel	c-Rel	B-NP	NN	B-protein	2	PMOD
9	:	:	O	:	O	1	P
10	a	a	B-NP	DT	O	11	NMOD
11	mechanism	mechanism	I-NP	NN	O	0	ROOT
12	for	for	B-PP	IN	O	11	NMOD
13	HTLV-I	HTLV-I	B-NP	NN	O	15	NMOD
14	Tax-mediated	Tax-mediated	I-NP	JJ	O	15	NMOD
15	trans-activation	trans-activation	I-NP	NN	O	12	PMOD
16	via	via	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	NF-kappa	NF-kappa	I-NP	NN	B-protein	21	NMOD
19	B	B	I-NP	NN	I-protein	21	NMOD
20	signalling	signalling	I-NP	NN	O	21	NMOD
21	pathway	pathway	I-NP	NN	O	16	PMOD
22	.	.	O	.	O	11	P

1	Molecular	Molecular	B-NP	JJ	O	6	NMOD
2	,	,	I-NP	,	O	6	P
3	biochemical	biochemical	I-NP	JJ	O	6	NMOD
4	and	and	I-NP	CC	O	6	NMOD
5	epidemiological	epidemiological	I-NP	JJ	O	6	NMOD
6	evidence	evidence	I-NP	NN	O	7	SUB
7	implicate	implicate	B-VP	VBP	O	0	ROOT
8	HTLV-I	HTLV-I	B-NP	NN	O	7	OBJ
9	as	as	B-PP	IN	O	7	VMOD
10	an	an	B-NP	DT	O	12	NMOD
11	etiologic	etiologic	I-NP	JJ	O	12	NMOD
12	agent	agent	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	adult	adult	B-NP	JJ	O	17	NMOD
15	T	T	I-NP	NN	O	17	NMOD
16	cell	cell	I-NP	NN	O	17	NMOD
17	leukemia	leukemia	I-NP	NN	O	13	PMOD
18	(	(	O	(	O	19	P
19	ATL	ATL	B-NP	NN	O	17	NMOD
20	)	)	O	)	O	19	P
21	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	3	NMOD
2	Tax	Tax	I-NP	NN	B-protein	3	NMOD
3	protein	protein	I-NP	NN	I-protein	10	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	HTLV-I	HTLV-I	B-NP	NN	O	4	PMOD
6	,	,	O	,	O	10	P
7	a	a	B-NP	DT	O	10	NMOD
8	positive	positive	I-NP	JJ	B-protein	10	NMOD
9	transcriptional	transcriptional	I-NP	JJ	I-protein	10	NMOD
10	activator	activator	I-NP	NN	I-protein	16	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	HTLV-I	HTLV-I	B-NP	NN	O	14	NMOD
13	gene	gene	I-NP	NN	O	14	NMOD
14	expression	expression	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	10	P
16	is	be	B-VP	VBZ	O	0	ROOT
17	a	a	B-NP	DT	O	19	NMOD
18	viral	viral	I-NP	JJ	B-DNA	19	NMOD
19	oncogene	oncogene	I-NP	NN	I-DNA	16	PRD
20	that	that	B-NP	WDT	O	19	NMOD
21	also	also	B-ADVP	RB	O	22	VMOD
22	increases	increase	B-VP	VBZ	O	20	SBAR
23	transcription	transcription	B-NP	NN	O	22	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	cellular	cellular	B-NP	JJ	B-DNA	26	NMOD
26	genes	gene	I-NP	NNS	I-DNA	24	PMOD
27	including	include	B-PP	VBG	O	26	NMOD
28	GM-CSF	GM-CSF	B-NP	NN	B-protein	33	NMOD
29	,	,	O	,	O	33	P
30	IL-2R	IL-2R	B-NP	NN	B-protein	31	NMOD
31	alpha	alpha	I-NP	NN	I-protein	33	NMOD
32	and	and	O	CC	O	33	NMOD
33	IL-2	IL-2	B-NP	NN	B-protein	27	PMOD
34	.	.	O	.	O	16	P

1	One	One	B-NP	CD	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	cellular	cellular	I-NP	JJ	O	5	NMOD
5	targets	target	I-NP	NNS	O	2	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	trans-activating	trans-activating	I-NP	JJ	O	9	NMOD
9	effects	effect	I-NP	NNS	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	Tax	Tax	B-NP	NN	B-protein	10	PMOD
12	is	be	B-VP	VBZ	O	0	ROOT
13	the	the	B-NP	DT	O	16	NMOD
14	NF-kappa	NF-kappa	I-NP	NN	B-protein	16	NMOD
15	B/Rel	B/Rel	I-NP	NN	I-protein	16	NMOD
16	family	family	I-NP	NN	I-protein	12	PRD
17	of	of	B-PP	IN	O	16	NMOD
18	transcription	transcription	B-NP	NN	B-protein	19	NMOD
19	factors	factor	I-NP	NNS	I-protein	22	NMOD
20	,	,	O	,	O	22	P
21	pleiotropic	pleiotropic	B-NP	JJ	B-protein	22	NMOD
22	regulators	regulator	I-NP	NNS	I-protein	17	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	immunoregulatory	immunoregulatory	B-NP	JJ	B-protein	30	NMOD
25	,	,	I-NP	,	O	30	P
26	cytokine	cytokine	I-NP	NN	B-protein	30	NMOD
27	and	and	I-NP	CC	O	30	NMOD
28	viral	viral	I-NP	JJ	O	30	NMOD
29	gene	gene	I-NP	NN	O	30	NMOD
30	expression	expression	I-NP	NN	O	23	PMOD
31	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	report	report	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	NFKB2	NFKB2	B-NP	NN	B-protein	13	NMOD
9	(	(	O	(	O	10	P
10	lyt-10	lyt-10	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	and	and	O	CC	O	13	NMOD
13	c-Rel	c-Rel	B-NP	NN	B-protein	14	SUB
14	are	be	B-VP	VBP	O	7	SBAR
15	overexpressed	overexpresse	I-VP	VBN	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	HTLV-I	HTLV-I	B-NP	NN	O	21	NMOD
18	infected	infected	I-NP	JJ	O	21	NMOD
19	and	and	I-NP	CC	O	21	NMOD
20	Tax-expressing	Tax-expressing	I-NP	JJ	B-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	16	PMOD
22	and	and	O	CC	O	14	VMOD
23	,	,	O	,	O	14	P
24	together	together	B-ADVP	RB	O	14	VMOD
25	,	,	O	,	O	14	P
26	account	account	B-VP	VBP	O	14	VMOD
27	for	for	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	majority	majority	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	36	NMOD
32	constitutive	constitutive	I-NP	JJ	O	36	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	B-protein	36	NMOD
34	B	B	I-NP	NN	I-protein	36	NMOD
35	binding	binding	I-NP	NN	O	36	NMOD
36	activity	activity	I-NP	NN	O	30	PMOD
37	in	in	B-PP	IN	O	36	NMOD
38	these	these	B-NP	DT	O	39	NMOD
39	cells	cell	I-NP	NNS	O	37	PMOD
40	before	before	B-PP	IN	O	26	VMOD
41	and	and	I-PP	CC	O	40	PMOD
42	after	after	I-PP	IN	O	40	PMOD
43	PMA	PMA	B-NP	NN	O	44	NMOD
44	stimulation	stimulation	I-NP	NN	O	40	PMOD
45	.	.	O	.	O	6	P

1	Most	Most	B-ADVP	RBS	O	2	AMOD
2	importantly	importantly	I-ADVP	RB	O	5	VMOD
3	,	,	O	,	O	5	P
4	we	we	B-NP	PRP	O	5	SUB
5	show	show	B-VP	VBP	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	Tax-dependent	Tax-dependent	I-NP	JJ	O	8	NMOD
8	correlation	correlation	I-NP	NN	O	5	OBJ
9	between	between	B-PP	IN	O	8	NMOD
10	expression	expression	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	NFKB2	NFKB2	B-NP	NN	B-protein	17	NMOD
13	(	(	O	(	O	14	P
14	p100	p100	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	and	and	O	CC	O	17	NMOD
17	processing	processing	B-NP	NN	O	11	PMOD
18	to	to	B-PP	TO	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	DNA	DNA	I-NP	NN	O	22	NMOD
21	binding	binding	I-NP	NN	O	22	NMOD
22	NFKB2	NFKB2	I-NP	NN	O	33	NMOD
23	(	(	O	(	O	24	P
24	p52	p52	B-NP	NN	B-protein	22	NMOD
25	)	)	O	)	O	24	P
26	form	form	B-NP	NN	O	22	NMOD
27	,	,	O	,	O	33	P
28	induction	induction	B-NP	NN	O	33	NMOD
29	of	of	B-PP	IN	O	28	NMOD
30	c-Rel	c-Rel	B-NP	NN	B-protein	29	PMOD
31	,	,	O	,	O	33	P
32	and	and	O	CC	O	33	NMOD
33	trans-activation	trans-activation	B-NP	NN	O	18	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	NF-kappa	NF-kappa	B-NP	NN	B-DNA	38	NMOD
36	B-mediated	B-mediated	I-NP	JJ	I-DNA	35	AMOD
37	gene	gene	I-NP	NN	I-DNA	38	NMOD
38	expression	expression	I-NP	NN	O	34	PMOD
39	.	.	O	.	O	5	P

1	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	NFKB2	NFKB2	I-NP	NN	B-protein	5	NMOD
5	precursor	precursor	I-NP	NN	O	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	physically	physically	I-VP	RB	O	6	VMOD
8	associated	associate	I-VP	VBN	O	6	VC
9	with	with	B-PP	IN	O	8	VMOD
10	c-Rel	c-Rel	B-NP	NN	B-protein	9	PMOD
11	and	and	B-PP	CC	O	9	PMOD
12	with	with	B-PP	IN	O	9	PMOD
13	Tax	Tax	B-NP	NN	B-protein	12	PMOD
14	in	in	B-PP	IN	O	8	VMOD
15	HTLV-I	HTLV-I	B-NP	NN	B-cell_line	17	NMOD
16	infected	infected	I-NP	JJ	I-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
18	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	propose	propose	B-VP	VBP	O	27	VMOD
3	that	that	B-SBAR	IN	O	2	VMOD
4	NFKB2	NFKB2	B-NP	NN	B-protein	5	NMOD
5	synthesis	synthesis	I-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	processing	processing	I-NP	NN	O	8	SUB
8	allows	allow	B-VP	VBZ	O	3	SBAR
9	continuous	continuous	B-NP	JJ	O	11	NMOD
10	nuclear	nuclear	I-NP	JJ	O	11	NMOD
11	expression	expression	I-NP	NN	O	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	an	an	B-NP	DT	O	16	NMOD
14	otherwise	otherwise	I-NP	RB	O	16	NMOD
15	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	16	NMOD
16	protein	protein	I-NP	NN	I-protein	12	PMOD
17	and	and	O	CC	O	8	VMOD
18	,	,	O	,	O	8	P
19	in	in	B-PP	IN	O	8	VMOD
20	conjunction	conjunction	B-NP	NN	O	19	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	overexpression	overexpression	B-NP	NN	O	21	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	c-Rel	c-Rel	B-NP	NN	B-protein	23	PMOD
25	,	,	O	,	O	27	P
26	NFKB2	NFKB2	B-NP	NN	B-protein	27	SUB
27	alters	alter	B-VP	VBZ	O	0	ROOT
28	the	the	B-NP	DT	O	32	NMOD
29	NF-kappa	NF-kappa	I-NP	NN	B-protein	32	NMOD
30	B	B	I-NP	NN	I-protein	32	NMOD
31	signalling	signalling	I-NP	NN	O	32	NMOD
32	pathway	pathway	I-NP	NN	O	27	OBJ
33	and	and	O	CC	O	27	VMOD
34	contributes	contribute	B-VP	VBZ	O	27	VMOD
35	to	to	B-PP	TO	O	34	VMOD
36	leukemic	leukemic	B-NP	JJ	O	37	NMOD
37	transformation	transformation	I-NP	NN	O	35	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	T	T	B-NP	NN	B-cell_type	40	NMOD
40	cells	cell	I-NP	NNS	I-cell_type	38	PMOD
41	by	by	B-PP	IN	O	37	NMOD
42	HTLV-I	HTLV-I	B-NP	NN	O	41	PMOD
43	.	.	O	.	O	27	P

1	Autoregulation	Autoregulation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	NF-kappa	NF-kappa	I-NP	NN	B-protein	7	NMOD
5	B	B	I-NP	NN	I-protein	7	NMOD
6	transactivator	transactivator	I-NP	NN	I-protein	7	NMOD
7	RelA	RelA	I-NP	NN	B-protein	2	PMOD
8	(	(	O	(	O	9	P
9	p65	p65	B-NP	NN	B-protein	7	NMOD
10	)	)	O	)	O	9	P
11	by	by	B-PP	IN	O	1	NMOD
12	multiple	multiple	B-NP	JJ	O	14	NMOD
13	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	14	NMOD
14	inhibitors	inhibitor	I-NP	NNS	I-protein	11	PMOD
15	containing	contain	B-VP	VBG	O	14	NMOD
16	ankyrin	ankyrin	B-NP	NN	B-protein	17	NMOD
17	motifs	motif	I-NP	NNS	I-protein	15	OBJ
18	.	.	O	.	O	1	P

1	RelA	RelA	B-NP	NN	B-protein	5	SUB
2	(	(	O	(	O	3	P
3	p65	p65	B-NP	NN	B-protein	1	NMOD
4	)	)	O	)	O	3	P
5	functions	function	B-VP	VBZ	O	0	ROOT
6	as	as	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	critical	critical	I-NP	JJ	O	10	NMOD
9	transactivating	transactivate	I-NP	VBG	O	10	NMOD
10	component	component	I-NP	NN	O	6	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	17	NMOD
13	heterodimeric	heterodimeric	I-NP	JJ	B-protein	17	NMOD
14	p50-p65	p50-p65	I-NP	NN	I-protein	17	NMOD
15	NF-kappa	NF-kappa	I-NP	NN	I-protein	17	NMOD
16	B	B	I-NP	NN	I-protein	17	NMOD
17	complex	complex	I-NP	NN	I-protein	11	PMOD
18	and	and	O	CC	O	5	VMOD
19	contains	contain	B-VP	VBZ	O	5	VMOD
20	a	a	B-NP	DT	O	23	NMOD
21	high-affinity	high-affinity	I-NP	JJ	B-DNA	23	NMOD
22	binding	bind	I-NP	VBG	I-DNA	23	NMOD
23	site	site	I-NP	NN	I-DNA	19	OBJ
24	for	for	B-PP	IN	O	23	NMOD
25	its	its	B-NP	PRP$	O	27	NMOD
26	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	27	NMOD
27	inhibitor	inhibitor	I-NP	NN	I-protein	32	NMOD
28	,	,	O	,	O	32	P
29	I	I	B-NP	NN	B-protein	32	NMOD
30	kappa	kappa	I-NP	NN	I-protein	32	NMOD
31	B	B	I-NP	NN	I-protein	32	NMOD
32	alpha	alpha	I-NP	NN	I-protein	24	PMOD
33	.	.	O	.	O	5	P

1	After	After	B-PP	IN	O	9	VMOD
2	cellular	cellular	B-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	9	P
5	I	I	B-NP	NN	B-protein	8	NMOD
6	kappa	kappa	I-NP	NN	I-protein	8	NMOD
7	B	B	I-NP	NN	I-protein	8	NMOD
8	alpha	alpha	I-NP	NN	I-protein	9	SUB
9	is	be	B-VP	VBZ	O	0	ROOT
10	rapidly	rapidly	I-VP	RB	O	11	VMOD
11	degraded	degrade	I-VP	VBN	O	9	VC
12	in	in	B-PP	IN	O	11	VMOD
13	concert	concert	B-NP	NN	O	12	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	induced	induce	I-NP	VBN	O	18	NMOD
17	nuclear	nuclear	I-NP	JJ	O	18	NMOD
18	translocation	translocation	I-NP	NN	O	14	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	NF-kappa	NF-kappa	B-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	19	PMOD
22	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	study	study	I-NP	NN	O	4	SUB
4	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	tumor	tumor	B-NP	NN	B-protein	8	NMOD
7	necrosis	necrosis	I-NP	NN	I-protein	8	NMOD
8	factor	factor	I-NP	NN	I-protein	10	NMOD
9	alpha-induced	alpha-induced	I-NP	JJ	O	10	NMOD
10	degradation	degradation	I-NP	NN	O	20	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	I	I	B-NP	NN	B-protein	15	NMOD
13	kappa	kappa	I-NP	NN	I-protein	15	NMOD
14	B	B	I-NP	NN	I-protein	15	NMOD
15	alpha	alpha	I-NP	NN	I-protein	11	PMOD
16	in	in	B-PP	IN	O	10	NMOD
17	human	human	B-NP	JJ	B-cell_type	19	NMOD
18	T	T	I-NP	NN	I-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	is	be	B-VP	VBZ	O	5	SBAR
21	preceded	precede	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	its	its	B-NP	PRP$	O	25	NMOD
24	rapid	rapid	I-NP	JJ	O	25	NMOD
25	phosphorylation	phosphorylation	I-NP	NN	O	22	PMOD
26	in	in	B-ADVP	FW	O	25	NMOD
27	vivo	vivo	I-ADVP	FW	O	26	AMOD
28	.	.	O	.	O	4	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	these	these	B-NP	DT	O	4	NMOD
4	effects	effect	I-NP	NNS	O	10	SUB
5	on	on	B-PP	IN	O	4	NMOD
6	I	I	B-NP	NN	B-protein	9	NMOD
7	kappa	kappa	I-NP	NN	I-protein	9	NMOD
8	B	B	I-NP	NN	I-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	5	PMOD
10	result	result	B-VP	VBP	O	0	ROOT
11	in	in	B-PP	IN	O	10	VMOD
12	nuclear	nuclear	B-NP	JJ	O	13	NMOD
13	mobilization	mobilization	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	only	only	B-NP	RB	O	17	NMOD
16	a	a	I-NP	DT	O	17	NMOD
17	fraction	fraction	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	entire	entire	I-NP	JJ	O	22	NMOD
21	cytoplasmic	cytoplasmic	I-NP	JJ	O	22	NMOD
22	pool	pool	I-NP	NN	O	18	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	RelA	RelA	B-NP	NN	B-protein	23	PMOD
25	.	.	O	.	O	10	P

1	Subsequent	Subsequent	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	revealed	reveal	I-VP	VBN	O	3	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	(	(	B-LST	(	O	7	P
7	i	i	I-LST	LS	O	11	VMOD
8	)	)	O	)	O	7	P
9	cytoplasmic	cytoplasmic	B-NP	JJ	B-protein	10	NMOD
10	RelA	RelA	I-NP	NN	I-protein	11	SUB
11	is	be	B-VP	VBZ	O	94	VMOD
12	stably	stably	I-VP	RB	O	11	VMOD
13	associated	associate	I-VP	VBN	O	11	VC
14	not	not	B-CONJP	RB	O	13	VMOD
15	only	only	I-CONJP	RB	O	14	DEP
16	with	with	B-PP	IN	O	14	PMOD
17	I	I	B-NP	NN	B-protein	20	NMOD
18	kappa	kappa	I-NP	NN	I-protein	20	NMOD
19	B	B	I-NP	NN	I-protein	20	NMOD
20	alpha	alpha	I-NP	NN	I-protein	16	PMOD
21	but	but	B-CONJP	CC	O	14	PMOD
22	also	also	I-CONJP	RB	O	21	DEP
23	with	with	B-PP	IN	O	14	PMOD
24	other	other	B-NP	JJ	O	27	NMOD
25	ankyrin	ankyrin	I-NP	NN	B-protein	27	NMOD
26	motif-rich	motif-rich	I-NP	JJ	I-protein	27	NMOD
27	proteins	protein	I-NP	NNS	I-protein	23	PMOD
28	including	include	B-PP	VBG	O	27	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	products	product	I-NP	NNS	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	B-protein	34	NMOD
34	B2	B2	I-NP	NN	I-protein	40	NMOD
35	(	(	O	(	O	36	P
36	p100	p100	B-NP	NN	B-protein	34	NMOD
37	)	)	O	)	O	36	P
38	and	and	O	CC	O	40	NMOD
39	NF-kappa	NF-kappa	B-NP	NN	B-protein	40	NMOD
40	B1	B1	I-NP	NN	I-protein	44	NMOD
41	(	(	O	(	O	42	P
42	p105	p105	B-NP	NN	O	40	NMOD
43	)	)	O	)	O	42	P
44	genes	gene	B-NP	NNS	O	31	PMOD
45	;	;	O	:	O	94	P
46	(	(	B-LST	(	O	47	P
47	ii	ii	I-LST	LS	O	60	VMOD
48	)	)	O	)	O	47	P
49	in	in	B-PP	IN	O	60	VMOD
50	contrast	contrast	B-NP	NN	O	49	PMOD
51	to	to	B-PP	TO	O	49	PMOD
52	RelA-I	RelA-I	B-NP	NN	B-protein	55	NMOD
53	kappa	kappa	I-NP	NN	I-protein	55	NMOD
54	B	B	I-NP	NN	I-protein	55	NMOD
55	alpha	alpha	I-NP	NN	I-protein	49	PMOD
56	,	,	O	,	O	60	P
57	RelA-p100	RelA-p100	B-NP	NN	B-protein	59	NMOD
58	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	59	NMOD
59	complexes	complex	I-NP	NNS	I-protein	60	SUB
60	are	be	B-VP	VBP	O	94	VMOD
61	not	not	I-VP	RB	O	60	VMOD
62	dissociated	dissociate	I-VP	VBN	O	60	VC
63	following	follow	B-PP	VBG	O	62	VMOD
64	tumor	tumor	B-NP	NN	B-protein	68	NMOD
65	necrosis	necrosis	I-NP	NN	I-protein	68	NMOD
66	factor	factor	I-NP	NN	I-protein	68	NMOD
67	alpha	alpha	I-NP	NN	I-protein	68	NMOD
68	activation	activation	I-NP	NN	O	63	PMOD
69	;	;	O	:	O	94	P
70	(	(	B-LST	(	O	71	P
71	iii	iii	I-LST	LS	O	74	VMOD
72	)	)	O	)	O	71	P
73	p100	p100	B-NP	NN	B-protein	74	SUB
74	functions	function	B-VP	VBZ	O	94	VMOD
75	as	as	B-PP	IN	O	74	VMOD
76	a	a	B-NP	DT	O	78	NMOD
77	potent	potent	I-NP	JJ	O	78	NMOD
78	inhibitor	inhibitor	I-NP	NN	O	75	PMOD
79	of	of	B-PP	IN	O	78	NMOD
80	RelA-mediated	RelA-mediated	B-NP	JJ	O	81	NMOD
81	transcription	transcription	I-NP	NN	O	79	PMOD
82	in	in	B-ADVP	FW	O	81	NMOD
83	vivo	vivo	I-ADVP	FW	O	82	AMOD
84	;	;	O	:	O	94	P
85	(	(	B-LST	(	O	86	P
86	iv	iv	I-LST	LS	O	94	VMOD
87	)	)	O	)	O	86	P
88	the	the	B-NP	DT	O	89	NMOD
89	interaction	interaction	I-NP	NN	O	94	SUB
90	of	of	B-PP	IN	O	89	NMOD
91	RelA	RelA	B-NP	NN	B-protein	93	NMOD
92	and	and	I-NP	CC	O	93	NMOD
93	p100	p100	I-NP	NN	B-protein	90	PMOD
94	involves	involve	B-VP	VBZ	O	130	VMOD
95	the	the	B-NP	DT	O	99	NMOD
96	conserved	conserve	I-NP	VBN	B-protein	99	NMOD
97	Rel	Rel	I-NP	NN	I-protein	99	NMOD
98	homology	homology	I-NP	NN	I-protein	99	NMOD
99	domain	domain	I-NP	NN	I-protein	108	NMOD
100	of	of	B-PP	IN	O	99	NMOD
101	both	both	B-NP	DT	O	102	NMOD
102	proteins	protein	B-NP	NNS	O	100	PMOD
103	but	but	B-NP	CC	O	108	NMOD
104	not	not	I-NP	RB	O	103	DEP
105	the	the	B-NP	DT	O	108	NMOD
106	nuclear	nuclear	I-NP	JJ	B-protein	108	NMOD
107	localization	localization	I-NP	NN	I-protein	108	NMOD
108	signal	signal	I-NP	NN	I-protein	94	OBJ
109	of	of	B-PP	IN	O	108	NMOD
110	RelA	RelA	B-NP	NN	B-protein	109	PMOD
111	,	,	O	,	O	108	P
112	which	which	B-NP	WDT	O	108	NMOD
113	is	be	B-VP	VBZ	O	112	SBAR
114	required	require	I-VP	VBN	O	113	VC
115	for	for	B-PP	IN	O	114	VMOD
116	I	I	B-NP	NN	B-protein	120	NMOD
117	kappa	kappa	I-NP	NN	I-protein	120	NMOD
118	B	B	I-NP	NN	I-protein	120	NMOD
119	alpha	alpha	I-NP	NN	I-protein	120	NMOD
120	binding	binding	I-NP	NN	O	115	PMOD
121	;	;	O	:	O	130	P
122	(	(	B-LST	(	O	123	P
123	v	v	I-LST	LS	O	130	VMOD
124	)	)	O	)	O	123	P
125	p100	p100	B-NP	NN	B-protein	126	NMOD
126	inhibition	inhibition	I-NP	NN	O	130	SUB
127	of	of	B-PP	IN	O	126	NMOD
128	RelA	RelA	B-NP	NN	B-protein	129	NMOD
129	function	function	I-NP	NN	O	127	PMOD
130	requires	require	B-VP	VBZ	O	158	VMOD
131	the	the	B-NP	DT	O	135	NMOD
132	C-terminal	C-terminal	I-NP	JJ	B-protein	135	NMOD
133	ankyrin	ankyrin	I-NP	NN	I-protein	135	NMOD
134	motif	motif	I-NP	NN	I-protein	135	NMOD
135	domain	domain	I-NP	NN	I-protein	130	OBJ
136	,	,	O	,	O	135	P
137	which	which	B-NP	WDT	O	135	NMOD
138	mediates	mediate	B-VP	VBZ	O	137	SBAR
139	cytoplasmic	cytoplasmic	B-NP	JJ	O	140	NMOD
140	retention	retention	I-NP	NN	O	138	OBJ
141	of	of	B-PP	IN	O	140	NMOD
142	RelA	RelA	B-NP	NN	B-protein	141	PMOD
143	;	;	O	:	O	158	P
144	and	and	O	CC	O	158	VMOD
145	(	(	B-LST	(	O	146	P
146	vi	vi	I-LST	LS	O	158	VMOD
147	)	)	O	)	O	146	P
148	as	as	B-SBAR	IN	O	158	SUB
149	observed	observe	B-VP	VBN	O	148	SBAR
150	with	with	B-PP	IN	O	149	VMOD
151	I	I	B-NP	NN	B-protein	154	NMOD
152	kappa	kappa	I-NP	NN	I-protein	154	NMOD
153	B	B	I-NP	NN	I-protein	154	NMOD
154	alpha	alpha	I-NP	NN	I-protein	157	NMOD
155	,	,	O	,	O	157	P
156	nuclear	nuclear	B-NP	JJ	O	157	NMOD
157	RelA	RelA	I-NP	NN	B-protein	150	PMOD
158	stimulates	stimulate	B-VP	VBZ	O	5	SBAR
159	p100	p100	B-NP	NN	B-RNA	160	NMOD
160	mRNA	mRNA	I-NP	NN	I-RNA	163	NMOD
161	and	and	O	CC	O	163	NMOD
162	protein	protein	B-NP	NN	O	163	NMOD
163	expression	expression	I-NP	NN	O	158	OBJ
164	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	4	SUB
3	thus	thus	B-ADVP	RB	O	4	VMOD
4	reveal	reveal	B-VP	VBP	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	presence	presence	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	13	NMOD
9	second	second	I-NP	JJ	O	13	NMOD
10	inducible	inducible	I-NP	JJ	O	13	NMOD
11	autoregulated	autoregulated	I-NP	JJ	O	13	NMOD
12	inhibitory	inhibitory	I-NP	JJ	O	13	NMOD
13	pathway	pathway	I-NP	NN	O	7	PMOD
14	that	that	B-NP	WDT	O	13	NMOD
15	helps	help	B-VP	VBZ	O	14	SBAR
16	ensure	ensure	I-VP	VB	O	15	VMOD
17	the	the	B-NP	DT	O	21	NMOD
18	rapid	rapid	I-NP	JJ	O	20	AMOD
19	but	but	I-NP	CC	O	20	AMOD
20	transient	transient	I-NP	JJ	O	21	NMOD
21	action	action	I-NP	NN	O	16	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD
24	NF-kappa	NF-kappa	I-NP	NN	I-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	22	PMOD
26	.	.	O	.	O	4	P

1	Calcineurin	Calcineurin	B-NP	NN	B-protein	2	SUB
2	acts	act	B-VP	VBZ	O	0	ROOT
3	in	in	B-PP	IN	O	2	VMOD
4	synergy	synergy	B-NP	NN	O	3	PMOD
5	with	with	B-PP	IN	O	3	PMOD
6	PMA	PMA	B-NP	NN	O	3	PMOD
7	to	to	B-VP	TO	O	8	VMOD
8	inactivate	inactivate	I-VP	VB	O	2	VMOD
9	I	I	B-NP	NN	B-protein	11	NMOD
10	kappa	kappa	I-NP	NN	I-protein	11	NMOD
11	B/MAD3	B/MAD3	I-NP	NN	I-protein	14	NMOD
12	,	,	O	,	O	14	P
13	an	an	B-NP	DT	O	14	NMOD
14	inhibitor	inhibitor	I-NP	NN	O	8	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	15	PMOD
18	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	6	NMOD
2	interleukin-2	interleukin-2	I-NP	NN	B-DNA	6	NMOD
3	(	(	O	(	I-DNA	4	P
4	IL-2	IL-2	B-NP	NN	I-DNA	2	NMOD
5	)	)	O	)	I-DNA	4	P
6	promoter	promoter	B-NP	NN	I-DNA	7	SUB
7	consists	consist	B-VP	VBZ	O	0	ROOT
8	of	of	B-PP	IN	O	7	VMOD
9	several	several	B-NP	JJ	O	18	NMOD
10	independent	independent	I-NP	JJ	O	18	NMOD
11	T	T	I-NP	NN	O	13	NMOD
12	cell	cell	I-NP	NN	O	13	NMOD
13	receptor	receptor	I-NP	NN	O	18	NMOD
14	(	(	I-NP	(	O	15	P
15	TcR	TcR	I-NP	NN	B-protein	13	NMOD
16	)	)	I-NP	)	O	15	P
17	responsive	responsive	I-NP	JJ	O	18	NMOD
18	elements	element	I-NP	NNS	O	8	PMOD
19	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	induction	induction	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	promoters	promoter	B-NP	NNS	B-DNA	3	PMOD
5	dependent	dependent	B-ADJP	JJ	O	4	NMOD
6	on	on	B-PP	IN	O	5	AMOD
7	these	these	B-NP	DT	O	8	NMOD
8	elements	element	I-NP	NNS	O	6	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	inhibitable	inhibitable	B-ADJP	JJ	O	9	PRD
11	by	by	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	13	NMOD
13	immunosuppressants	immunosuppressant	I-NP	NNS	O	11	PMOD
14	cyclosporin	cyclosporin	I-NP	NN	O	15	NMOD
15	A	A	I-NP	NN	O	20	NMOD
16	(	(	O	(	O	17	P
17	CsA	CsA	B-NP	NN	O	15	NMOD
18	)	)	O	)	O	17	P
19	and	and	O	CC	O	20	NMOD
20	tacrolimus	tacrolimus	B-NP	NN	O	13	NMOD
21	(	(	O	(	O	22	P
22	FK-506	FK-506	B-NP	NN	O	20	NMOD
23	)	)	O	)	O	22	P
24	.	.	O	.	O	9	P

1	Calcineurin	Calcineurin	B-NP	NN	B-protein	6	NMOD
2	,	,	O	,	O	6	P
3	a	a	B-NP	DT	O	6	NMOD
4	Ca2+/calmodulin-dependent	Ca2+/calmodulin-dependent	I-NP	JJ	B-protein	6	NMOD
5	protein	protein	I-NP	NN	I-protein	6	NMOD
6	phosphatase	phosphatase	I-NP	NN	I-protein	8	SUB
7	,	,	O	,	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	the	the	B-NP	DT	O	13	NMOD
10	FK-506-	FK-506-	I-NP	NN	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	CsA-sensitive	CsA-sensitive	B-NP	JJ	B-protein	13	NMOD
13	enzyme	enzyme	I-NP	NN	I-protein	8	PRD
14	required	require	B-VP	VBN	O	13	NMOD
15	for	for	B-PP	IN	O	14	VMOD
16	TcR	TcR	B-NP	NN	B-protein	18	NMOD
17	mediated	mediated	I-NP	JJ	O	16	AMOD
18	activation	activation	I-NP	NN	O	15	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	IL-2	IL-2	I-NP	NN	B-DNA	22	NMOD
22	promoter	promoter	I-NP	NN	I-DNA	19	PMOD
23	.	.	O	.	O	8	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	a	a	B-NP	DT	O	7	NMOD
5	constitutively	constitutively	I-NP	RB	O	6	AMOD
6	active	active	I-NP	JJ	O	7	NMOD
7	form	form	I-NP	NN	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	calcineurin	calcineurin	B-NP	NN	B-protein	8	PMOD
10	partially	partially	B-ADVP	RB	O	11	VMOD
11	substitutes	substitute	B-VP	VBZ	O	3	SBAR
12	for	for	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	Ca2+	Ca2+	I-NP	NN	O	15	NMOD
15	co-stimulus	co-stimulus	I-NP	NN	O	12	PMOD
16	required	require	B-VP	VBN	O	15	NMOD
17	to	to	I-VP	TO	O	18	VMOD
18	activate	activate	I-VP	VB	O	16	VMOD
19	the	the	B-NP	DT	O	22	NMOD
20	IL-2	IL-2	I-NP	NN	B-DNA	22	NMOD
21	promoter	promoter	I-NP	NN	I-DNA	22	NMOD
22	elements	element	I-NP	NNS	I-DNA	18	OBJ
23	IL-2A	IL-2A	I-NP	NN	B-DNA	34	NMOD
24	(	(	O	(	O	23	P
25	which	which	B-NP	WDT	O	23	NMOD
26	binds	bind	B-VP	VBZ	O	25	SBAR
27	the	the	B-NP	DT	O	28	NMOD
28	factors	factor	I-NP	NNS	O	26	OBJ
29	OAP	OAP	B-NP	NN	B-protein	31	NMOD
30	and	and	O	CC	O	31	NMOD
31	Oct-1	Oct-1	B-NP	NN	B-protein	28	NMOD
32	)	)	O	)	O	23	P
33	and	and	O	CC	O	34	NMOD
34	IL-2E	IL-2E	B-NP	NN	B-DNA	22	NMOD
35	(	(	O	(	O	34	P
36	which	which	B-NP	WDT	O	34	NMOD
37	binds	bind	B-VP	VBZ	O	36	SBAR
38	NF-AT	NF-AT	B-NP	NN	B-protein	37	OBJ
39	)	)	O	)	O	34	P
40	,	,	O	,	O	11	P
41	and	and	O	CC	O	11	VMOD
42	completely	completely	B-VP	RB	O	43	VMOD
43	substitutes	substitute	I-VP	VBZ	O	11	VMOD
44	for	for	B-PP	IN	O	43	VMOD
45	the	the	B-NP	DT	O	47	NMOD
46	Ca2+	Ca2+	I-NP	NN	O	47	NMOD
47	co-stimulus	co-stimulus	I-NP	NN	O	44	PMOD
48	required	require	B-VP	VBN	O	47	NMOD
49	to	to	B-VP	TO	O	50	VMOD
50	stimulate	stimulate	I-VP	VB	O	48	VMOD
51	an	an	B-NP	DT	O	54	NMOD
52	NF-kappa	NF-kappa	I-NP	NN	B-DNA	54	NMOD
53	B-dependent	B-dependent	I-NP	JJ	I-DNA	54	NMOD
54	element	element	I-NP	NN	I-DNA	50	OBJ
55	.	.	O	.	O	2	P

1	Calcineurin	Calcineurin	B-NP	NN	B-protein	2	SUB
2	stimulates	stimulate	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	6	NMOD
4	NF-kappa	NF-kappa	I-NP	NN	B-DNA	6	NMOD
5	B	B	I-NP	NN	I-DNA	6	NMOD
6	element	element	I-NP	NN	I-DNA	2	OBJ
7	by	by	B-PP	IN	O	2	VMOD
8	enhancing	enhance	B-VP	VBG	O	7	PMOD
9	inactivation	inactivation	B-NP	NN	O	8	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	I	I	B-NP	NN	B-protein	13	NMOD
12	kappa	kappa	I-NP	NN	I-protein	13	NMOD
13	B/MAD3	B/MAD3	I-NP	NN	I-protein	16	NMOD
14	,	,	O	,	O	16	P
15	an	an	B-NP	DT	O	16	NMOD
16	inhibitor	inhibitor	I-NP	NN	O	10	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	NF-kappa	NF-kappa	B-NP	NN	B-protein	19	NMOD
19	B	B	I-NP	NN	I-protein	17	PMOD
20	,	,	O	,	O	16	P
21	thereby	thereby	B-ADVP	RB	O	22	VMOD
22	increasing	increase	B-VP	VBG	O	16	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	amount	amount	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	nuclear	nuclear	B-NP	JJ	B-protein	31	NMOD
27	NF-kappa	NF-kappa	I-NP	NN	I-protein	31	NMOD
28	B	B	I-NP	NN	I-protein	31	NMOD
29	DNA	DNA	I-NP	NN	O	31	NMOD
30	binding	binding	I-NP	NN	O	31	NMOD
31	activity	activity	I-NP	NN	O	25	PMOD
32	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	provide	provide	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	first	first	I-NP	JJ	O	6	NMOD
6	demonstration	demonstration	I-NP	NN	O	3	OBJ
7	in	in	B-ADVP	FW	O	6	NMOD
8	vivo	vivo	I-ADVP	FW	O	7	AMOD
9	that	that	B-SBAR	IN	O	6	NMOD
10	activation	activation	B-NP	NN	O	15	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	a	a	B-NP	DT	O	14	NMOD
13	protein	protein	I-NP	NN	B-protein	14	NMOD
14	phosphatase	phosphatase	I-NP	NN	I-protein	11	PMOD
15	can	can	B-VP	MD	O	9	SBAR
16	inactivate	inactivate	I-VP	VB	O	15	VC
17	I	I	B-NP	NN	B-protein	19	NMOD
18	kappa	kappa	I-NP	NN	I-protein	19	NMOD
19	B	B	I-NP	NN	I-protein	16	OBJ
20	,	,	O	,	O	3	P
21	and	and	O	CC	O	3	VMOD
22	suggest	suggest	B-VP	VBP	O	3	VMOD
23	one	one	B-NP	CD	O	25	NMOD
24	possible	possible	I-NP	JJ	O	25	NMOD
25	explanation	explanation	I-NP	NN	O	22	OBJ
26	for	for	B-PP	IN	O	25	NMOD
27	mechanism-based	mechanism-based	B-NP	JJ	O	28	NMOD
28	toxicities	toxicity	I-NP	NNS	O	26	PMOD
29	associated	associate	B-VP	VBN	O	28	NMOD
30	with	with	B-PP	IN	O	29	VMOD
31	FK-506	FK-506	B-NP	NN	O	33	NMOD
32	and	and	I-NP	CC	O	33	NMOD
33	CsA	CsA	I-NP	NN	O	30	PMOD
34	by	by	B-PP	IN	O	33	NMOD
35	demonstrating	demonstrate	B-VP	VBG	O	34	PMOD
36	that	that	B-SBAR	IN	O	35	VMOD
37	these	these	B-NP	DT	O	38	NMOD
38	drugs	drug	I-NP	NNS	O	39	SUB
39	can	can	B-VP	MD	O	36	SBAR
40	inhibit	inhibit	I-VP	VB	O	39	VC
41	the	the	B-NP	DT	O	43	NMOD
42	calcineurin-dependent	calcineurin-dependent	I-NP	JJ	O	43	NMOD
43	activation	activation	I-NP	NN	O	40	OBJ
44	of	of	B-PP	IN	O	43	NMOD
45	a	a	B-NP	DT	O	49	NMOD
46	virtually	virtually	I-NP	RB	O	49	NMOD
47	ubiquitous	ubiquitous	I-NP	JJ	B-protein	49	NMOD
48	transcription	transcription	I-NP	NN	I-protein	49	NMOD
49	factor	factor	I-NP	NN	I-protein	44	PMOD
50	.	.	O	.	O	3	P

1	Activation	Activation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	interleukin	interleukin	I-NP	NN	B-DNA	6	NMOD
5	6	6	I-NP	CD	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	Mycobacterium	Mycobacterium	B-NP	NN	O	9	NMOD
9	tuberculosis	tuberculosis	I-NP	NN	O	11	NMOD
10	or	or	I-NP	CC	O	11	NMOD
11	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	7	PMOD
12	is	be	B-VP	VBZ	O	0	ROOT
13	mediated	mediate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	nuclear	nuclear	B-NP	JJ	B-protein	16	NMOD
16	factors	factor	I-NP	NNS	I-protein	20	NMOD
17	NF-IL6	NF-IL6	B-NP	NN	B-protein	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	NF-kappa	NF-kappa	B-NP	NN	B-protein	20	NMOD
20	B	B	I-NP	NN	I-protein	24	SUB
21	[	[	O	(	O	24	P
22	published	publish	B-NP	VBN	O	23	NMOD
23	erratum	erratum	I-NP	NN	O	24	SUB
24	appears	appear	B-VP	VBZ	O	14	SBAR
25	in	in	B-PP	IN	O	24	VMOD
26	Proc	Proc	B-NP	NNP	O	32	NMOD
27	Natl	Natl	I-NP	NNP	O	32	NMOD
28	Acad	Acad	I-NP	NNP	O	32	NMOD
29	Sci	Sci	I-NP	NNP	O	32	NMOD
30	U	U	I-NP	NNP	O	32	NMOD
31	S	S	I-NP	NNP	O	32	NMOD
32	A	A	I-NP	NNP	O	42	NMOD
33	1995	1995	I-NP	CD	O	32	NMOD
34	Apr	Apr	B-PP	IN	O	42	NMOD
35	11	11	B-NP	CD	O	42	NMOD
36	;	;	O	:	O	42	P
37	92	92	B-NP	CD	O	39	NMOD
38	(	(	O	(	O	39	P
39	8	8	B-NP	CD	O	42	NMOD
40	)	)	O	)	O	39	P
41	:	:	O	:	O	42	P
42	3632	3632	B-NP	CD	O	25	PMOD
43	]	]	O	)	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	host	host	I-NP	NN	O	3	NMOD
3	response	response	I-NP	NN	O	7	SUB
4	to	to	B-PP	TO	O	3	NMOD
5	Mycobacterium	Mycobacterium	B-NP	NN	O	6	NMOD
6	tuberculosis	tuberculosis	I-NP	NN	O	4	PMOD
7	includes	include	B-VP	VBZ	O	0	ROOT
8	granuloma	granuloma	B-NP	NN	O	9	NMOD
9	formation	formation	I-NP	NN	O	7	OBJ
10	at	at	B-PP	IN	O	9	NMOD
11	sites	site	B-NP	NNS	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	infection	infection	B-NP	NN	O	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	systemic	systemic	B-NP	JJ	O	16	NMOD
16	symptoms	symptom	I-NP	NNS	O	12	PMOD
17	.	.	O	.	O	7	P

1	Cytokines	Cytokine	B-NP	NNS	B-protein	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	been	be	I-VP	VBN	O	2	VC
4	identified	identify	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	immunohistochemistry	immunohistochemistry	B-NP	NN	O	5	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	granulomas	granuloma	B-NP	NNS	O	7	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	animal	animal	B-NP	NN	O	11	NMOD
11	models	model	I-NP	NNS	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	bacillus	bacillus	B-NP	NN	O	14	NMOD
14	Calmette-Guerin	Calmette-Guerin	I-NP	NN	O	18	NMOD
15	(	(	O	(	O	16	P
16	BCG	BCG	B-NP	NN	O	14	NMOD
17	)	)	O	)	O	16	P
18	infection	infection	B-NP	NN	O	12	PMOD
19	and	and	O	CC	O	2	VMOD
20	are	be	B-VP	VBP	O	2	VMOD
21	released	release	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	mononuclear	mononuclear	B-NP	JJ	B-cell_type	24	NMOD
24	phagocytes	phagocyte	I-NP	NNS	I-cell_type	22	PMOD
25	upon	upon	B-PP	IN	O	21	VMOD
26	stimulation	stimulation	B-NP	NN	O	25	PMOD
27	by	by	B-PP	IN	O	26	NMOD
28	mycobacterial	mycobacterial	B-NP	JJ	B-protein	29	NMOD
29	proteins	protein	I-NP	NNS	I-protein	27	PMOD
30	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	12	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	regard	regard	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	12	P
5	the	the	B-NP	DT	O	7	NMOD
6	cytokine	cytokine	I-NP	NN	B-protein	7	NMOD
7	interleukin	interleukin	I-NP	NN	B-protein	12	SUB
8	6	6	I-NP	CD	I-protein	7	NMOD
9	(	(	O	(	O	10	P
10	IL-6	IL-6	B-NP	NN	B-protein	7	NMOD
11	)	)	O	)	O	10	P
12	may	may	B-VP	MD	O	0	ROOT
13	play	play	I-VP	VB	O	12	VC
14	a	a	B-NP	DT	O	15	NMOD
15	role	role	I-NP	NN	O	13	OBJ
16	in	in	B-PP	IN	O	13	VMOD
17	the	the	B-NP	DT	O	22	NMOD
18	clinical	clinical	I-NP	JJ	O	19	NMOD
19	manifestations	manifestation	I-NP	NNS	O	22	NMOD
20	and	and	O	CC	O	22	NMOD
21	pathological	pathological	B-NP	JJ	O	22	NMOD
22	events	event	I-NP	NNS	O	16	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	tuberculosis	tuberculosis	B-NP	NN	O	25	NMOD
25	infection	infection	I-NP	NN	O	23	PMOD
26	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	demonstrated	demonstrate	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	lipoarabinomannan	lipoarabinomannan	B-NP	NN	B-protein	25	SUB
6	(	(	O	(	O	7	P
7	LAM	LAM	B-NP	NN	B-protein	5	NMOD
8	)	)	O	)	O	7	P
9	from	from	B-PP	IN	O	5	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	mycobacterial	mycobacterial	I-NP	JJ	O	13	NMOD
12	cell	cell	I-NP	NN	O	13	NMOD
13	wall	wall	I-NP	NN	O	9	PMOD
14	,	,	O	,	O	5	P
15	which	which	B-NP	WDT	O	5	NMOD
16	was	be	B-VP	VBD	O	15	SBAR
17	virtually	virtually	B-ADJP	RB	O	18	AMOD
18	devoid	devoid	I-ADJP	JJ	O	16	PRD
19	of	of	B-PP	IN	O	18	AMOD
20	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	19	PMOD
21	(	(	O	(	O	22	P
22	LPS	LPS	B-NP	NN	O	20	NMOD
23	)	)	O	)	O	22	P
24	,	,	O	,	O	5	P
25	stimulated	stimulate	B-VP	VBD	O	4	SBAR
26	mononuclear	mononuclear	B-NP	JJ	B-cell_type	27	NMOD
27	phagocytes	phagocyte	I-NP	NNS	I-cell_type	29	SUB
28	to	to	B-VP	TO	O	29	VMOD
29	release	release	I-VP	VB	O	25	VMOD
30	IL-6	IL-6	B-NP	NN	B-protein	29	OBJ
31	in	in	B-PP	IN	O	29	VMOD
32	a	a	B-NP	DT	O	34	NMOD
33	dose-response	dose-response	I-NP	JJ	O	34	NMOD
34	manner	manner	I-NP	NN	O	31	PMOD
35	.	.	O	.	O	2	P

1	LAM	LAM	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	LPS	LPS	I-NP	NN	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	potent	potent	B-NP	JJ	O	6	NMOD
6	inducers	inducer	I-NP	NNS	O	4	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	IL-6	IL-6	B-NP	NN	B-DNA	10	NMOD
9	gene	gene	I-NP	NN	I-DNA	10	NMOD
10	expression	expression	I-NP	NN	O	7	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD
13	blood	blood	I-NP	NN	I-cell_type	14	NMOD
14	monocytes	monocyte	I-NP	NNS	I-cell_type	11	PMOD
15	.	.	O	.	O	4	P

1	Both	Both	O	CC	O	7	NMOD
2	LAM-	LAM-	B-NP	NN	O	7	NMOD
3	and	and	O	CC	O	7	NMOD
4	LPS-inducible	LPS-inducible	B-NP	JJ	B-DNA	7	NMOD
5	IL-6	IL-6	I-NP	NN	I-DNA	7	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	7	NMOD
7	activity	activity	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	localized	localized	B-ADJP	JJ	O	8	PRD
10	to	to	B-PP	TO	O	9	AMOD
11	a	a	B-NP	DT	O	13	NMOD
12	DNA	DNA	I-NP	NN	B-DNA	13	NMOD
13	fragment	fragment	I-NP	NN	I-DNA	18	NMOD
14	,	,	O	,	O	18	P
15	positions	position	B-NP	NNS	O	18	NMOD
16	-158	-158	B-NP	CD	B-DNA	18	NMOD
17	to	to	B-PP	TO	I-DNA	18	NMOD
18	-49	-49	B-NP	CD	I-DNA	10	PMOD
19	,	,	O	,	O	8	P
20	by	by	B-PP	IN	O	8	VMOD
21	deletion	deletion	B-NP	NN	O	22	NMOD
22	analysis	analysis	I-NP	NN	O	26	NMOD
23	and	and	O	CC	O	26	NMOD
24	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	26	NMOD
25	acetyltransferase	acetyltransferase	I-NP	NN	I-protein	26	NMOD
26	assay	assay	I-NP	NN	O	20	PMOD
27	.	.	O	.	O	8	P

1	Two	Two	B-NP	CD	O	4	NMOD
2	nuclear	nuclear	I-NP	JJ	B-protein	4	NMOD
3	factor	factor	I-NP	NN	I-protein	4	NMOD
4	NF-IL6	NF-IL6	I-NP	NN	I-protein	27	NMOD
5	(	(	O	(	O	13	P
6	positions	position	B-NP	NNS	O	9	NMOD
7	-153	-153	B-NP	CD	B-DNA	9	AMOD
8	to	to	B-PP	TO	I-DNA	9	AMOD
9	-145	-145	B-NP	CD	I-DNA	13	NMOD
10	and	and	O	CC	O	13	NMOD
11	-83	-83	B-NP	CD	B-DNA	13	NMOD
12	to	to	B-PP	TO	I-DNA	13	NMOD
13	-75	-75	B-NP	CD	I-DNA	4	NMOD
14	)	)	O	)	O	13	P
15	and	and	O	CC	O	27	NMOD
16	one	one	B-NP	CD	O	27	NMOD
17	nuclear	nuclear	I-NP	JJ	B-DNA	27	NMOD
18	factor	factor	I-NP	NN	I-DNA	20	NMOD
19	NF-kappa	NF-kappa	I-NP	NN	I-DNA	20	NMOD
20	B	B	I-NP	NN	I-DNA	27	NMOD
21	(	(	O	(	I-DNA	22	P
22	positions	position	B-NP	NNS	I-DNA	27	NMOD
23	-72	-72	B-NP	CD	I-DNA	25	NMOD
24	to	to	B-PP	TO	I-DNA	25	NMOD
25	-63	-63	B-NP	CD	I-DNA	22	NMOD
26	)	)	O	)	I-DNA	22	P
27	motifs	motif	B-NP	NNS	I-DNA	28	SUB
28	are	be	B-VP	VBP	O	0	ROOT
29	present	present	B-ADJP	JJ	O	28	PRD
30	within	within	B-PP	IN	O	29	AMOD
31	this	this	B-NP	DT	O	32	NMOD
32	fragment	fragment	I-NP	NN	O	30	PMOD
33	.	.	O	.	O	28	P

1	Site-directed	Site-directed	B-NP	JJ	O	2	NMOD
2	mutagenesis	mutagenesis	I-NP	NN	O	14	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	one	one	B-NP	CD	O	3	PMOD
5	or	or	I-NP	CC	O	4	AMOD
6	more	more	I-NP	JJR	O	4	AMOD
7	of	of	B-PP	IN	O	4	NMOD
8	these	these	B-NP	DT	O	9	NMOD
9	motifs	motif	I-NP	NNS	O	7	PMOD
10	within	within	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	IL-6	IL-6	I-NP	NN	B-DNA	13	NMOD
13	promoter	promoter	I-NP	NN	I-DNA	10	PMOD
14	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
15	that	that	B-SBAR	IN	O	22	DEP
16	each	each	B-NP	DT	O	17	SUB
17	has	have	B-VP	VBZ	O	15	SBAR
18	positive	positive	B-NP	JJ	O	20	NMOD
19	regulatory	regulatory	I-NP	JJ	O	20	NMOD
20	activity	activity	I-NP	NN	O	17	OBJ
21	and	and	O	CC	O	22	DEP
22	that	that	B-SBAR	IN	O	14	VMOD
23	they	they	B-NP	PRP	O	24	SUB
24	could	could	B-VP	MD	O	22	SBAR
25	act	act	I-VP	VB	O	24	VC
26	in	in	B-PP	IN	O	25	VMOD
27	a	a	B-NP	DT	O	31	NMOD
28	function-	function-	I-NP	NN	O	30	AMOD
29	and	and	I-NP	CC	O	30	AMOD
30	orientation-independent	orientation-independent	I-NP	JJ	O	31	NMOD
31	manner	manner	I-NP	NN	O	26	PMOD
32	.	.	O	.	O	14	P

1	Deletion	Deletion	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	all	all	B-NP	DT	O	5	NMOD
4	three	three	I-NP	CD	O	5	NMOD
5	elements	element	I-NP	NNS	O	2	PMOD
6	abolished	abolish	B-VP	VBD	O	0	ROOT
7	inducibility	inducibility	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	IL-6	IL-6	B-NP	NN	B-DNA	11	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	11	NMOD
11	activity	activity	I-NP	NN	O	8	PMOD
12	by	by	B-PP	IN	O	6	VMOD
13	both	both	O	CC	O	16	NMOD
14	LAM	LAM	B-NP	NN	B-protein	16	NMOD
15	and	and	O	CC	O	16	NMOD
16	LPS	LPS	B-NP	NN	O	12	PMOD
17	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	conclude	conclude	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	9	NMOD
5	NF-IL6	NF-IL6	I-NP	NN	B-DNA	9	NMOD
6	and	and	I-NP	CC	I-DNA	9	NMOD
7	NF-kappa	NF-kappa	I-NP	NN	I-DNA	9	NMOD
8	B	B	I-NP	NN	I-DNA	9	NMOD
9	sites	site	I-NP	NNS	I-DNA	10	SUB
10	mediate	mediate	B-VP	VBP	O	3	SBAR
11	IL-6	IL-6	B-NP	NN	B-protein	12	NMOD
12	induction	induction	I-NP	NN	O	10	OBJ
13	in	in	B-PP	IN	O	10	VMOD
14	response	response	I-PP	NN	O	13	PMOD
15	to	to	I-PP	TO	O	14	NMOD
16	both	both	O	CC	O	19	NMOD
17	LPS	LPS	B-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	LAM	LAM	I-NP	NN	B-protein	15	PMOD
20	,	,	O	,	O	10	P
21	acting	act	B-VP	VBG	O	10	VMOD
22	as	as	B-PP	IN	O	21	VMOD
23	bacterial	bacterial	B-NP	JJ	B-DNA	27	NMOD
24	or	or	I-NP	CC	I-DNA	27	NMOD
25	mycobacterial	mycobacterial	I-NP	JJ	I-DNA	27	NMOD
26	response	response	I-NP	NN	I-DNA	27	NMOD
27	elements	element	I-NP	NNS	I-DNA	22	PMOD
28	.	.	O	.	O	2	P

1	Calcineurin	Calcineurin	B-NP	NN	B-protein	2	SUB
2	activates	activate	B-VP	VBZ	O	0	ROOT
3	transcription	transcription	B-NP	NN	O	2	OBJ
4	from	from	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	GM-CSF	GM-CSF	I-NP	NN	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	4	PMOD
8	in	in	B-PP	IN	O	3	NMOD
9	synergy	synergy	B-NP	NN	O	8	PMOD
10	with	with	B-PP	IN	O	9	NMOD
11	either	either	O	CC	O	17	NMOD
12	protein	protein	B-NP	NN	B-protein	14	NMOD
13	kinase	kinase	I-NP	NN	I-protein	14	NMOD
14	C	C	I-NP	NN	I-protein	17	NMOD
15	or	or	O	CC	O	17	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	O	17	NMOD
17	B/AP-1	B/AP-1	I-NP	NN	O	10	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	T	T	B-NP	NN	B-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	18	PMOD
21	.	.	O	.	O	2	P

1	Two	Two	B-NP	CD	O	3	NMOD
2	cis-acting	cis-acting	I-NP	JJ	B-DNA	3	NMOD
3	elements	element	I-NP	NNS	I-DNA	7	NMOD
4	GM-kappa	GM-kappa	I-NP	NN	B-DNA	5	NMOD
5	B/GC-box	B/GC-box	I-NP	NN	I-DNA	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	CLE0	CLE0	I-NP	NN	B-DNA	18	SUB
8	,	,	O	,	O	7	P
9	of	of	B-PP	IN	O	7	NMOD
10	the	the	B-NP	DT	O	17	NMOD
11	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	B-DNA	17	NMOD
12	colony-stimulating	colony-stimulating	I-NP	JJ	I-DNA	17	NMOD
13	factor	factor	I-NP	NN	I-DNA	17	NMOD
14	(	(	O	(	I-DNA	15	P
15	GM-CSF	GM-CSF	B-NP	NN	I-DNA	13	NMOD
16	)	)	O	)	I-DNA	15	P
17	gene	gene	B-NP	NN	I-DNA	9	PMOD
18	are	be	B-VP	VBP	O	0	ROOT
19	required	require	I-VP	VBN	O	18	VC
20	for	for	B-PP	IN	O	19	VMOD
21	maximal	maximal	B-NP	JJ	O	22	NMOD
22	induction	induction	I-NP	NN	O	20	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	Jurkat	Jurkat	B-NP	NN	B-cell_line	26	NMOD
25	T	T	I-NP	NN	I-cell_line	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_line	23	PMOD
27	by	by	B-PP	IN	O	22	NMOD
28	costimulation	costimulation	B-NP	NN	O	27	PMOD
29	with	with	B-PP	IN	O	22	NMOD
30	phorbol-12-myristate	phorbol-12-myristate	B-NP	NN	O	31	NMOD
31	acetate	acetate	I-NP	NN	O	37	NMOD
32	(	(	O	(	O	33	P
33	PMA	PMA	B-NP	NN	O	31	NMOD
34	)	)	O	)	O	33	P
35	and	and	O	CC	O	37	NMOD
36	Ca2+	Ca2+	B-NP	NN	O	37	NMOD
37	ionophore	ionophore	I-NP	NN	O	29	PMOD
38	(	(	O	(	O	39	P
39	A23187	A23187	B-NP	NN	O	37	NMOD
40	)	)	O	)	O	39	P
41	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	4	NMOD
2	GM-kappa	GM-kappa	I-NP	NN	B-DNA	4	NMOD
3	B	B	I-NP	NN	I-DNA	4	NMOD
4	sequence	sequence	I-NP	NN	I-DNA	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	recognized	recognize	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	7	PMOD
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	is	be	B-VP	VBZ	O	11	SBAR
13	mainly	mainly	I-VP	RB	O	12	VMOD
14	induced	induce	I-VP	VBN	O	12	VC
15	by	by	B-PP	IN	O	14	VMOD
16	PMA	PMA	B-NP	NN	O	15	PMOD
17	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	CLE0	CLE0	I-NP	NN	B-DNA	3	NMOD
3	sequence	sequence	I-NP	NN	I-DNA	4	SUB
4	interacts	interact	B-VP	VBZ	O	0	ROOT
5	with	with	B-PP	IN	O	4	VMOD
6	factors	factor	B-NP	NNS	O	5	PMOD
7	,	,	O	,	O	4	P
8	related	related	B-ADJP	JJ	O	4	VMOD
9	to	to	B-PP	TO	O	8	AMOD
10	a	a	B-NP	DT	O	12	NMOD
11	PMA-induced	PMA-induced	I-NP	JJ	O	12	NMOD
12	AP-1	AP-1	I-NP	NN	B-protein	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	a	a	B-NP	DT	O	16	NMOD
15	PMA/A23187-induced	PMA/A23187-induced	I-NP	JJ	O	16	NMOD
16	NF-AT	NF-AT	I-NP	NN	B-protein	9	PMOD
17	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	examined	examine	B-VP	VBD	O	0	ROOT
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	signal	signal	B-NP	NN	B-protein	6	NMOD
5	transducing	transducing	I-NP	NN	I-protein	6	NMOD
6	components	component	I-NP	NNS	I-protein	10	SUB
7	in	in	B-PP	IN	O	6	NMOD
8	T	T	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	can	can	B-VP	MD	O	3	SBAR
11	activate	activate	I-VP	VB	O	10	VC
12	transcription	transcription	B-NP	NN	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	GM-CSF	GM-CSF	I-NP	NN	B-DNA	16	NMOD
16	gene	gene	I-NP	NN	I-DNA	13	PMOD
17	.	.	O	.	O	2	P

1	Cotransfection	Cotransfection	B-NP	NN	O	16	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	NF-kappa	NF-kappa	B-NP	NN	B-protein	4	NMOD
4	B	B	I-NP	NN	I-protein	10	NMOD
5	(	(	O	(	O	6	P
6	p50/p65	p50/p65	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	-	-	B-NP	HYPH	O	4	P
9	or	or	O	CC	O	10	NMOD
10	AP-1	AP-1	B-NP	NN	B-protein	2	PMOD
11	(	(	O	(	O	12	P
12	c-Jun/c-Fos	c-Jun/c-Fos	B-NP	NN	O	10	NMOD
13	)	)	O	)	O	12	P
14	-	-	B-NP	HYPH	O	1	P
15	expression	expression	I-NP	NN	O	16	NMOD
16	vectors	vector	I-NP	NNS	O	28	SUB
17	into	into	B-PP	IN	O	16	NMOD
18	Jurkat	Jurkat	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	with	with	B-PP	IN	O	16	NMOD
21	a	a	B-NP	DT	O	23	NMOD
22	luciferase	luciferase	I-NP	NN	B-DNA	23	NMOD
23	reporter	reporter	I-NP	NN	I-DNA	20	PMOD
24	containing	contain	B-VP	VBG	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	GM-CSF	GM-CSF	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	OBJ
28	did	do	B-VP	VBD	O	0	ROOT
29	not	not	I-VP	RB	O	28	VMOD
30	stimulate	stimulate	I-VP	VB	O	28	VC
31	transcription	transcription	B-NP	NN	O	30	OBJ
32	from	from	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	35	NMOD
34	GM-CSF	GM-CSF	I-NP	NN	B-DNA	35	NMOD
35	promoter	promoter	I-NP	NN	I-DNA	32	PMOD
36	.	.	O	.	O	28	P

1	In	In	B-PP	IN	O	14	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	14	P
4	cotransfection	cotransfection	B-NP	NN	O	14	SUB
5	with	with	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	7	NMOD
7	combination	combination	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
10	B	B	I-NP	NN	I-protein	12	NMOD
11	and	and	O	CC	O	12	NMOD
12	AP-1	AP-1	B-NP	NN	B-protein	8	PMOD
13	significantly	significantly	B-ADVP	RB	O	14	VMOD
14	augmented	augment	B-VP	VBD	O	0	ROOT
15	transcription	transcription	B-NP	NN	O	14	OBJ
16	from	from	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	GM-CSF	GM-CSF	I-NP	NN	B-DNA	19	NMOD
19	promoter	promoter	I-NP	NN	I-DNA	16	PMOD
20	containing	contain	B-VP	VBG	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	GM-kappa	GM-kappa	I-NP	NN	B-DNA	23	NMOD
23	B/GC-box	B/GC-box	I-NP	NN	I-DNA	26	NMOD
24	and	and	O	CC	O	26	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	CLE0	CLE0	I-NP	NN	B-DNA	20	OBJ
27	(	(	O	(	O	28	P
28	AP-1/NF-AT	AP-1/NF-AT	B-NP	NN	B-protein	26	NMOD
29	)	)	O	)	O	28	P
30	.	.	O	.	O	14	P

1	Expression	Expression	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	14	NMOD
4	constitutively	constitutively	I-NP	RB	O	5	AMOD
5	active	active	I-NP	JJ	O	14	NMOD
6	calcineurin	calcineurin	I-NP	NN	B-protein	14	NMOD
7	(	(	O	(	O	8	P
8	CN	CN	B-NP	NN	B-protein	6	NMOD
9	)	)	O	)	O	8	P
10	,	,	O	,	O	14	P
11	a	a	B-NP	DT	O	14	NMOD
12	Ca2+/calmodulin-dependent	Ca2+/calmodulin-dependent	I-NP	JJ	B-protein	14	NMOD
13	protein	protein	I-NP	NN	I-protein	14	NMOD
14	phosphatase	phosphatase	I-NP	NN	I-protein	2	PMOD
15	,	,	O	,	O	14	P
16	potentiated	potentiate	B-VP	VBN	O	14	NMOD
17	by	by	B-PP	IN	O	16	VMOD
18	two	two	B-NP	CD	O	22	NMOD
19	fold	fold	I-NP	RB	O	22	NMOD
20	the	the	I-NP	DT	O	22	NMOD
21	transcriptional	transcriptional	I-NP	JJ	O	22	NMOD
22	activation	activation	I-NP	NN	O	17	PMOD
23	by	by	B-PP	IN	O	22	NMOD
24	NF-kappa	NF-kappa	B-NP	NN	B-protein	25	NMOD
25	B/AP-1	B/AP-1	I-NP	NN	I-protein	23	PMOD
26	.	.	O	.	O	1	P

1	Both	Both	O	CC	O	15	VMOD
2	constitutively	constitutively	B-NP	RB	O	3	AMOD
3	active	active	I-NP	JJ	O	4	NMOD
4	forms	form	I-NP	NNS	O	15	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	CN	CN	B-NP	NN	B-protein	10	NMOD
7	and	and	O	CC	O	10	NMOD
8	protein	protein	B-NP	NN	B-protein	10	NMOD
9	kinase	kinase	I-NP	NN	I-protein	10	NMOD
10	C	C	I-NP	NN	I-protein	5	PMOD
11	(	(	O	(	O	12	P
12	PKC	PKC	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	synergistically	synergistically	B-ADVP	RB	O	15	VMOD
15	activated	activate	B-VP	VBD	O	0	ROOT
16	transcription	transcription	B-NP	NN	O	15	OBJ
17	from	from	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	GM-CSF	GM-CSF	I-NP	NN	B-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	17	PMOD
21	.	.	O	.	O	15	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	cooperation	cooperation	B-NP	NN	O	14	SUB
6	among	among	B-PP	IN	O	5	NMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	8	NMOD
8	B-	B-	I-NP	NN	I-protein	13	NMOD
9	,	,	O	,	O	13	P
10	AP-1-	AP-1-	B-NP	NN	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	NF-AT-binding	NF-AT-binding	B-NP	JJ	B-DNA	13	NMOD
13	sequences	sequence	I-NP	NNS	I-DNA	6	PMOD
14	is	be	B-VP	VBZ	O	4	SBAR
15	required	require	I-VP	VBN	O	14	VC
16	for	for	B-PP	IN	O	15	VMOD
17	induction	induction	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	GM-CSF	GM-CSF	I-NP	NN	B-DNA	21	NMOD
21	gene	gene	I-NP	NN	I-DNA	18	PMOD
22	through	through	B-PP	IN	O	17	NMOD
23	PKC-	PKC-	B-NP	NN	B-protein	27	NMOD
24	and	and	I-NP	CC	O	27	NMOD
25	Ca2+-	Ca2+-	I-NP	NN	O	27	NMOD
26	signaling	signaling	I-NP	NN	O	27	NMOD
27	pathways	pathway	I-NP	NNS	O	22	PMOD
28	downstream	downstream	B-ADJP	JJ	O	27	NMOD
29	of	of	B-PP	IN	O	28	AMOD
30	T	T	B-NP	NN	O	32	NMOD
31	cell	cell	I-NP	NN	O	32	NMOD
32	activation	activation	I-NP	NN	O	29	PMOD
33	.	.	O	.	O	3	P

1	Cell-specific	Cell-specific	B-NP	JJ	O	3	NMOD
2	bifunctional	bifunctional	I-NP	JJ	O	3	NMOD
3	role	role	I-NP	NN	O	0	ROOT
4	of	of	B-PP	IN	O	3	NMOD
5	Jun	Jun	B-NP	NN	B-protein	8	NMOD
6	oncogene	oncogene	I-NP	NN	I-protein	8	NMOD
7	family	family	I-NP	NN	I-protein	8	NMOD
8	members	member	I-NP	NNS	I-protein	4	PMOD
9	on	on	B-PP	IN	O	3	NMOD
10	glucocorticoid	glucocorticoid	B-NP	NN	O	12	NMOD
11	receptor-dependent	receptor-dependent	I-NP	JJ	O	10	AMOD
12	transcription	transcription	I-NP	NN	O	9	PMOD
13	.	.	O	.	O	3	P

1	Interaction	Interaction	B-NP	NN	O	18	SUB
2	between	between	B-PP	IN	O	1	NMOD
3	protein	protein	B-NP	NN	B-protein	5	NMOD
4	kinase	kinase	I-NP	NN	I-protein	5	NMOD
5	C	C	I-NP	NN	I-protein	12	NMOD
6	(	(	O	(	O	7	P
7	PKC	PKC	B-NP	NN	B-protein	5	NMOD
8	)	)	O	)	O	7	P
9	-	-	O	HYPH	O	5	P
10	and	and	O	CC	O	12	NMOD
11	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	12	NMOD
12	receptor	receptor	I-NP	NN	I-protein	17	NMOD
13	(	(	O	(	O	14	P
14	GR	GR	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	-mediated	-mediated	B-NP	JJ	O	17	NMOD
17	signaling	signaling	I-NP	NN	O	2	PMOD
18	is	be	B-VP	VBZ	O	0	ROOT
19	suggested	suggest	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	ability	ability	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	PKC	PKC	I-NP	NN	B-protein	23	PMOD
26	activating	activate	B-VP	VBG	O	25	NMOD
27	phorbol	phorbol	B-NP	NN	O	29	NMOD
28	ester	ester	I-NP	NN	O	29	NMOD
29	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	I-NP	NN	O	26	OBJ
30	(	(	O	(	O	31	P
31	TPA	TPA	B-NP	NN	O	29	NMOD
32	)	)	O	)	O	31	P
33	to	to	B-VP	TO	O	34	VMOD
34	inhibit	inhibit	I-VP	VB	O	22	NMOD
35	GR-dependent	GR-dependent	B-NP	JJ	O	36	NMOD
36	transcription	transcription	I-NP	NN	O	34	OBJ
37	of	of	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	48	NMOD
39	mouse	mouse	I-NP	NN	B-DNA	42	NMOD
40	mammary	mammary	I-NP	JJ	I-DNA	42	NMOD
41	tumor	tumor	I-NP	NN	I-DNA	42	NMOD
42	virus	virus	I-NP	NN	I-DNA	48	NMOD
43	(	(	O	(	I-DNA	44	P
44	MMTV	MMTV	B-NP	NN	I-DNA	42	NMOD
45	)	)	O	)	I-DNA	44	P
46	long	long	B-NP	JJ	I-DNA	48	NMOD
47	terminal	terminal	I-NP	JJ	I-DNA	48	NMOD
48	repeat	repeat	I-NP	NN	I-DNA	37	PMOD
49	(	(	O	(	O	50	P
50	LTR	LTR	B-NP	NN	B-DNA	48	NMOD
51	)	)	O	)	O	50	P
52	.	.	O	.	O	18	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	this	this	B-NP	DT	O	6	NMOD
6	interference	interference	I-NP	NN	O	7	SUB
7	is	be	B-VP	VBZ	O	4	SBAR
8	cell	cell	B-NP	NN	O	7	PRD
9	specific	specific	I-NP	JJ	O	8	AMOD
10	,	,	O	,	O	7	P
11	as	as	B-SBAR	IN	O	7	VMOD
12	TPA	TPA	B-NP	NN	O	13	SUB
13	augmented	augment	B-VP	VBD	O	11	SBAR
14	dexamethasone-induced	dexamethasone-induced	B-NP	JJ	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	activation	activation	I-NP	NN	O	13	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	MMTV	MMTV	I-NP	NN	B-DNA	20	NMOD
20	LTR	LTR	I-NP	NN	I-DNA	17	PMOD
21	in	in	B-PP	IN	O	16	NMOD
22	several	several	B-NP	JJ	O	25	NMOD
23	T	T	I-NP	NN	B-cell_line	25	NMOD
24	cell	cell	I-NP	NN	I-cell_line	25	NMOD
25	lines	line	I-NP	NNS	I-cell_line	21	PMOD
26	but	but	O	CC	O	13	VMOD
27	was	be	B-VP	VBD	O	13	VMOD
28	inhibitory	inhibitory	B-ADJP	JJ	O	27	PRD
29	in	in	B-PP	IN	O	28	AMOD
30	NIH-3T3	NIH-3T3	B-NP	NN	B-cell_line	31	NMOD
31	fibroblasts	fibroblast	I-NP	NNS	I-cell_line	29	PMOD
32	.	.	O	.	O	3	P

1	TPA-GR	TPA-GR	B-NP	NN	O	2	NMOD
2	synergism	synergism	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	determined	determine	I-VP	VBN	O	3	VC
5	to	to	I-VP	TO	O	6	VMOD
6	have	have	I-VP	VB	O	4	VMOD
7	occurred	occur	I-VP	VBN	O	6	VC
8	at	at	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	15	NMOD
10	GR-responsive	GR-responsive	I-NP	JJ	B-DNA	15	NMOD
11	element	element	I-NP	NN	I-DNA	15	NMOD
12	(	(	I-NP	(	O	13	P
13	GRE	GRE	I-NP	NN	B-DNA	11	NMOD
14	)	)	I-NP	)	O	13	P
15	level	level	I-NP	NN	O	8	PMOD
16	by	by	B-PP	IN	O	7	VMOD
17	functional	functional	B-NP	JJ	O	18	NMOD
18	analysis	analysis	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	deletion	deletion	B-NP	NN	B-DNA	21	NMOD
21	mutants	mutant	I-NP	NNS	I-DNA	25	NMOD
22	or	or	O	CC	O	25	NMOD
23	synthetic	synthetic	B-NP	JJ	B-DNA	25	NMOD
24	GRE	GRE	I-NP	NN	I-DNA	25	NMOD
25	oligonucleotides	oligonucleotide	I-NP	NNS	I-DNA	19	PMOD
26	driving	drive	B-VP	VBG	O	25	NMOD
27	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	29	NMOD
28	acetyl-transferase	acetyl-transferase	I-NP	NN	I-protein	29	NMOD
29	expression	expression	I-NP	NN	O	26	OBJ
30	.	.	O	.	O	3	P

1	Synergism	Synergism	B-NP	NN	O	2	SUB
2	required	require	B-VP	VBD	O	9	VMOD
3	an	an	B-NP	DT	O	7	NMOD
4	intact	intact	I-NP	JJ	O	7	NMOD
5	GR	GR	I-NP	NN	B-protein	7	NMOD
6	DNA-binding	DNA-binding	I-NP	JJ	I-protein	7	NMOD
7	domain	domain	I-NP	NN	I-protein	2	OBJ
8	,	,	O	,	O	9	P
9	whereas	whereas	O	IN	O	0	ROOT
10	amino-	amino-	B-NP	NN	B-protein	12	AMOD
11	or	or	O	CC	I-protein	12	AMOD
12	carboxyl-terminal	carboxyl-terminal	B-NP	JJ	I-protein	13	NMOD
13	domains	domain	I-NP	NNS	I-protein	14	SUB
14	were	be	B-VP	VBD	O	9	VMOD
15	dispensable	dispensable	B-ADJP	JJ	O	14	PRD
16	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	abrogated	abrogate	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	9	NMOD
7	PKC	PKC	I-NP	NN	B-protein	9	NMOD
8	inhibitor	inhibitor	I-NP	NN	O	9	NMOD
9	staurosporine	staurosporine	I-NP	NN	O	5	PMOD
10	,	,	O	,	O	3	P
11	suggesting	suggest	B-VP	VBG	O	3	VMOD
12	a	a	B-NP	DT	O	13	NMOD
13	role	role	I-NP	NN	O	11	OBJ
14	for	for	B-PP	IN	O	13	NMOD
15	PKC	PKC	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	3	P

1	Increased	Increase	B-VP	VBN	O	8	NMOD
2	c-jun	c-jun	B-NP	NN	B-DNA	8	NMOD
3	,	,	O	,	O	8	P
4	jun-B	jun-B	B-NP	NN	B-protein	8	NMOD
5	,	,	O	,	O	8	P
6	and	and	O	CC	O	8	NMOD
7	jun-D	jun-D	B-NP	NN	B-protein	8	NMOD
8	expression	expression	I-NP	NN	O	15	NMOD
9	above	above	B-PP	IN	O	8	NMOD
10	basal	basal	B-NP	JJ	O	11	NMOD
11	levels	level	I-NP	NNS	O	9	PMOD
12	and	and	O	CC	O	15	NMOD
13	increased	increase	B-NP	VBN	O	15	NMOD
14	transcriptional	transcriptional	I-NP	JJ	O	15	NMOD
15	activity	activity	I-NP	NN	O	25	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	AP-1/TPA	AP-1/TPA	B-NP	NN	B-DNA	19	NMOD
18	responsive	responsive	I-NP	JJ	I-DNA	19	NMOD
19	elements	element	I-NP	NNS	I-DNA	16	PMOD
20	fused	fuse	B-VP	VBN	O	19	NMOD
21	to	to	B-PP	TO	O	20	VMOD
22	chloramphenicol	chloramphenicol	B-NP	NN	B-DNA	24	NMOD
23	acetyl-transferase	acetyl-transferase	I-NP	NN	I-DNA	24	NMOD
24	vectors	vector	I-NP	NNS	I-DNA	21	PMOD
25	were	be	B-VP	VBD	O	0	ROOT
26	observed	observe	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	T	T	B-NP	NN	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	27	PMOD
30	treated	treat	B-VP	VBN	O	29	NMOD
31	with	with	B-PP	IN	O	30	VMOD
32	TPA	TPA	B-NP	NN	O	31	PMOD
33	alone	alone	B-ADVP	RB	O	32	NMOD
34	or	or	O	CC	O	31	PMOD
35	in	in	B-PP	IN	O	31	PMOD
36	combination	combination	B-NP	NN	O	35	PMOD
37	with	with	B-PP	IN	O	36	NMOD
38	dexamethasone	dexamethasone	B-NP	NN	O	37	PMOD
39	.	.	O	.	O	25	P

1	The	The	B-NP	DT	O	2	NMOD
2	ability	ability	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	Jun	Jun	B-NP	NN	B-protein	5	NMOD
5	proteins	protein	I-NP	NNS	I-protein	3	PMOD
6	to	to	B-VP	TO	O	7	VMOD
7	cooperate	cooperate	I-VP	VB	O	2	NMOD
8	with	with	B-PP	IN	O	7	VMOD
9	GR	GR	B-NP	NN	B-protein	8	PMOD
10	in	in	B-PP	IN	O	7	VMOD
11	T	T	B-NP	NN	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
13	has	have	B-VP	VBZ	O	0	ROOT
14	been	be	I-VP	VBN	O	13	VC
15	investigated	investigate	I-VP	VBN	O	14	VC
16	after	after	B-PP	IN	O	15	VMOD
17	transfection	transfection	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	c-jun	c-jun	B-NP	NN	B-DNA	26	NMOD
20	,	,	O	,	O	26	P
21	jun-B	jun-B	B-NP	NN	B-protein	26	NMOD
22	,	,	O	,	O	26	P
23	or	or	O	CC	O	26	NMOD
24	jun-D	jun-D	B-NP	NN	B-DNA	26	NMOD
25	expression	expression	I-NP	NN	I-DNA	26	NMOD
26	vectors	vector	I-NP	NNS	I-DNA	18	PMOD
27	,	,	O	,	O	17	P
28	which	which	B-NP	WDT	O	17	NMOD
29	augmented	augment	B-VP	VBD	O	28	SBAR
30	GR-dependent	GR-dependent	B-NP	JJ	O	31	NMOD
31	transcription	transcription	I-NP	NN	O	29	OBJ
32	from	from	B-PP	IN	O	31	NMOD
33	either	either	O	CC	O	37	NMOD
34	MMTV	MMTV	B-NP	NN	B-DNA	35	NMOD
35	LTR	LTR	I-NP	NN	I-DNA	37	NMOD
36	or	or	I-NP	CC	O	37	NMOD
37	GRE	GRE	I-NP	NN	B-DNA	32	PMOD
38	.	.	O	.	O	13	P

1	Conversely	Conversely	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	c-jun	c-jun	B-NP	NN	B-DNA	5	NMOD
4	and	and	O	CC	O	5	NMOD
5	jun-B	jun-B	B-NP	NN	B-protein	6	NMOD
6	transfection	transfection	I-NP	NN	O	7	SUB
7	blunted	blunt	B-VP	VBD	O	0	ROOT
8	GR-dependent	GR-dependent	B-NP	JJ	O	9	NMOD
9	transcription	transcription	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	HeLa	HeLa	B-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
13	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	presence	presence	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	c-fos	c-fos	B-NP	NN	B-DNA	3	PMOD
5	had	have	B-VP	VBD	O	42	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	negative	negative	I-NP	JJ	O	8	NMOD
8	influence	influence	I-NP	NN	O	5	OBJ
9	on	on	B-PP	IN	O	5	VMOD
10	GR	GR	B-NP	NN	B-protein	11	NMOD
11	function	function	I-NP	NN	O	9	PMOD
12	and	and	O	CC	O	5	VMOD
13	correlated	correlate	B-VP	VBD	O	5	VMOD
14	with	with	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	20	NMOD
16	cell-specific	cell-specific	I-NP	JJ	O	20	NMOD
17	synergistic	synergistic	I-NP	JJ	O	20	NMOD
18	or	or	I-NP	CC	O	20	NMOD
19	antagonistic	antagonistic	I-NP	JJ	O	20	NMOD
20	activity	activity	I-NP	NN	O	14	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	Jun	Jun	B-NP	NN	B-protein	21	PMOD
23	with	with	B-PP	IN	O	13	VMOD
24	respect	respect	B-NP	NN	O	23	PMOD
25	to	to	B-PP	TO	O	24	NMOD
26	GR	GR	B-NP	NN	B-protein	25	PMOD
27	;	;	O	:	O	42	P
28	high	high	B-NP	JJ	O	30	NMOD
29	basal	basal	I-NP	JJ	O	30	NMOD
30	expression	expression	I-NP	NN	O	41	NMOD
31	of	of	B-PP	IN	O	30	NMOD
32	c-fos	c-fos	B-NP	NN	B-DNA	31	PMOD
33	as	as	B-CONJP	RB	O	41	NMOD
34	well	well	I-CONJP	RB	O	33	DEP
35	as	as	I-CONJP	IN	O	33	DEP
36	AP-1	AP-1	B-NP	NN	B-protein	38	NMOD
37	DNA	DNA	I-NP	NN	O	38	NMOD
38	binding	binding	I-NP	NN	O	41	NMOD
39	and	and	O	CC	O	41	NMOD
40	transcriptional	transcriptional	B-NP	JJ	O	41	NMOD
41	activity	activity	I-NP	NN	O	42	SUB
42	were	be	B-VP	VBD	O	0	ROOT
43	observed	observe	I-VP	VBN	O	42	VC
44	in	in	B-PP	IN	O	43	VMOD
45	HeLa	HeLa	B-NP	NN	B-cell_line	46	NMOD
46	cells	cell	I-NP	NNS	I-cell_line	44	PMOD
47	,	,	B-PP	,	O	44	P
48	but	but	I-PP	CC	O	44	PMOD
49	not	not	B-PP	RB	O	50	PMOD
50	in	in	I-PP	IN	O	44	PMOD
51	T	T	B-NP	NN	B-cell_type	52	NMOD
52	cells	cell	I-NP	NNS	I-cell_type	50	PMOD
53	.	.	O	.	O	42	P

1	Furthermore	Furthermore	B-NP	RB	O	6	VMOD
2	overexpression	overexpression	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	exogenous	exogenous	B-NP	JJ	B-protein	5	NMOD
5	c-fos	c-fos	I-NP	NN	I-protein	3	PMOD
6	has	have	B-VP	VBZ	O	0	ROOT
7	an	an	B-NP	DT	O	9	NMOD
8	inhibitory	inhibitory	I-NP	JJ	O	9	NMOD
9	effect	effect	I-NP	NN	O	6	OBJ
10	on	on	B-PP	IN	O	6	VMOD
11	GR-dependent	GR-dependent	B-NP	JJ	O	12	NMOD
12	transcription	transcription	I-NP	NN	O	10	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	GRE	GRE	B-NP	NN	B-DNA	13	PMOD
15	in	in	B-PP	IN	O	12	NMOD
16	T	T	B-NP	NN	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	propose	propose	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	Jun	Jun	B-NP	NN	B-protein	5	SUB
5	plays	play	B-VP	VBZ	O	3	SBAR
6	a	a	B-NP	DT	O	8	NMOD
7	bifunctional	bifunctional	I-NP	JJ	O	8	NMOD
8	role	role	I-NP	NN	O	5	OBJ
9	on	on	B-PP	IN	O	5	VMOD
10	GR-dependent	GR-dependent	B-NP	JJ	O	12	NMOD
11	transcriptional	transcriptional	I-NP	JJ	O	12	NMOD
12	activation	activation	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	GRE	GRE	B-NP	NN	B-DNA	13	PMOD
15	,	,	O	,	O	5	P
16	selecting	select	B-VP	VBG	O	5	VMOD
17	either	either	O	CC	O	20	AMOD
18	synergistic	synergistic	B-NP	JJ	O	20	AMOD
19	or	or	I-NP	CC	O	20	AMOD
20	antagonistic	antagonistic	I-NP	JJ	O	21	NMOD
21	activity	activity	I-NP	NN	O	16	OBJ
22	depending	depend	B-PP	VBG	O	16	VMOD
23	on	on	B-PP	IN	O	22	PMOD
24	the	the	B-NP	DT	O	26	NMOD
25	cell-specific	cell-specific	I-NP	JJ	O	26	NMOD
26	microenvironment	microenvironment	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	9	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	regard	regard	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	9	P
5	intracellular	intracellular	B-NP	JJ	O	6	NMOD
6	levels	level	I-NP	NNS	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	c-fos	c-fos	B-NP	NN	B-protein	7	PMOD
9	appear	appear	B-VP	VBP	O	0	ROOT
10	to	to	I-VP	TO	O	11	VMOD
11	be	be	I-VP	VB	O	9	VMOD
12	influential	influential	B-ADJP	JJ	O	11	PRD
13	.	.	O	.	O	9	P

1	Defective	Defective	B-NP	JJ	O	2	NMOD
2	translocation	translocation	I-NP	NN	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	protein	protein	B-NP	NN	B-protein	6	NMOD
5	kinase	kinase	I-NP	NN	I-protein	6	NMOD
6	C	C	I-NP	NN	I-protein	3	PMOD
7	in	in	B-PP	IN	O	2	NMOD
8	multidrug-resistant	multidrug-resistant	B-NP	JJ	B-cell_line	10	NMOD
9	HL-60	HL-60	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	7	PMOD
11	confers	confer	B-VP	VBZ	O	0	ROOT
12	a	a	B-NP	DT	O	14	NMOD
13	reversible	reversible	I-NP	JJ	O	14	NMOD
14	loss	loss	I-NP	NN	O	11	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	phorbol	phorbol	B-NP	NN	O	19	NMOD
17	ester-induced	ester-induced	I-NP	JJ	O	16	AMOD
18	monocytic	monocytic	I-NP	JJ	O	19	NMOD
19	differentiation	differentiation	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	11	P

1	Previous	Previous	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	demonstrated	demonstrate	I-VP	VBN	O	3	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	human	human	B-NP	JJ	B-cell_line	10	NMOD
7	HL-60	HL-60	I-NP	NN	I-cell_line	10	NMOD
8	myeloid	myeloid	I-NP	JJ	I-cell_line	10	NMOD
9	leukemia	leukemia	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	11	SUB
11	differentiate	differentiate	B-VP	VBP	O	5	SBAR
12	in	in	B-PP	IN	O	11	VMOD
13	response	response	B-NP	NN	O	12	PMOD
14	to	to	B-PP	TO	O	13	NMOD
15	phorbol	phorbol	B-NP	NN	O	16	NMOD
16	esters	ester	I-NP	NNS	O	14	PMOD
17	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	event	event	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	associated	associate	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	induction	induction	B-NP	NN	O	14	NMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	12	NMOD
9	c-jun	c-jun	I-NP	NN	B-DNA	12	NMOD
10	early	early	I-NP	JJ	I-DNA	12	NMOD
11	response	response	I-NP	NN	I-DNA	12	NMOD
12	gene	gene	I-NP	NN	I-DNA	7	PMOD
13	and	and	I-NP	CC	O	14	NMOD
14	appearance	appearance	I-NP	NN	O	5	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	a	a	B-NP	DT	O	18	NMOD
17	monocytic	monocytic	I-NP	JJ	B-cell_type	18	NMOD
18	phenotype	phenotype	I-NP	NN	I-cell_type	15	PMOD
19	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	examined	examine	I-VP	VBN	O	4	VC
6	the	the	B-NP	DT	O	7	NMOD
7	effects	effect	I-NP	NNS	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	vincristine-selected	vincristine-selected	B-NP	JJ	O	11	AMOD
10	,	,	I-NP	,	O	11	P
11	multidrug	multidrug	I-NP	JJ	O	12	NMOD
12	resistance	resistance	I-NP	NN	O	8	PMOD
13	on	on	B-PP	IN	O	7	NMOD
14	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	NN	O	21	NMOD
15	(	(	I-NP	(	O	21	P
16	TPA	TPA	I-NP	NN	O	21	NMOD
17	)	)	I-NP	)	O	21	P
18	-induced	-induced	I-NP	JJ	O	21	NMOD
19	HL-60	HL-60	I-NP	NN	O	21	NMOD
20	cell	cell	I-NP	NN	O	21	NMOD
21	differentiation	differentiation	I-NP	NN	O	13	PMOD
22	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	multidrug-resistant	multidrug-resistant	B-NP	JJ	B-cell_line	7	NMOD
6	HL-60	HL-60	I-NP	NN	I-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	12	SUB
8	,	,	O	,	O	7	P
9	designated	designate	B-VP	VBN	O	7	NMOD
10	HL-60/vinc	HL-60/vinc	B-NP	NN	B-cell_line	9	VMOD
11	,	,	O	,	O	7	P
12	fail	fail	B-VP	VBP	O	4	SBAR
13	to	to	I-VP	TO	O	14	VMOD
14	respond	respond	I-VP	VB	O	12	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	TPA	TPA	B-NP	NN	O	15	PMOD
17	with	with	B-PP	IN	O	14	VMOD
18	an	an	B-NP	DT	O	19	NMOD
19	increase	increase	I-NP	NN	O	17	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	c-jun	c-jun	B-NP	NN	B-RNA	22	NMOD
22	transcripts	transcript	I-NP	NNS	I-RNA	26	NMOD
23	or	or	O	CC	O	26	NMOD
24	other	other	B-NP	JJ	O	26	NMOD
25	phenotypic	phenotypic	I-NP	JJ	O	26	NMOD
26	characteristics	characteristic	I-NP	NNS	O	20	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	monocytic	monocytic	B-NP	JJ	O	29	NMOD
29	differentiation	differentiation	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	3	P

1	By	By	B-PP	IN	O	19	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	19	P
4	treatment	treatment	B-NP	NN	O	19	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	HL-60/vinc	HL-60/vinc	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
8	with	with	B-PP	IN	O	4	NMOD
9	okadaic	okadaic	B-NP	JJ	O	10	NMOD
10	acid	acid	I-NP	NN	O	13	NMOD
11	,	,	O	,	O	13	P
12	an	an	B-NP	DT	O	13	NMOD
13	inhibitor	inhibitor	I-NP	NN	O	8	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	serine/threonine	serine/threonine	B-NP	NN	B-protein	17	NMOD
16	protein	protein	I-NP	NN	I-protein	17	NMOD
17	phosphatases	phosphatas	I-NP	NNS	I-protein	14	PMOD
18	,	,	O	,	O	13	P
19	induces	induce	B-VP	VBZ	O	0	ROOT
20	c-jun	c-jun	B-NP	NN	B-DNA	21	NMOD
21	transcription	transcription	I-NP	NN	O	27	NMOD
22	,	,	O	,	O	27	P
23	growth	growth	B-NP	NN	O	24	NMOD
24	arrest	arrest	I-NP	NN	O	27	NMOD
25	,	,	O	,	O	27	P
26	and	and	O	CC	O	27	NMOD
27	expression	expression	B-NP	NN	O	19	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	31	NMOD
30	c-fms	c-fms	I-NP	NN	B-DNA	31	NMOD
31	gene	gene	I-NP	NN	I-DNA	28	PMOD
32	.	.	O	.	O	19	P

1	Studies	Study	B-NP	NNS	O	2	SUB
2	were	be	B-VP	VBD	O	0	ROOT
3	also	also	I-VP	RB	O	2	VMOD
4	performed	perform	I-VP	VBN	O	2	VC
5	with	with	B-PP	IN	O	4	VMOD
6	an	an	B-NP	DT	O	8	NMOD
7	HL-60/vinc	HL-60/vinc	I-NP	NN	B-cell_line	8	NMOD
8	revertant	revertant	I-NP	NN	I-cell_line	12	NMOD
9	(	(	O	(	O	10	P
10	HL-60/vinc/R	HL-60/vinc/R	B-NP	NN	B-cell_line	8	NMOD
11	)	)	O	)	O	10	P
12	line	line	B-NP	NN	O	5	PMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	has	have	B-VP	VBZ	O	13	SBAR
15	regained	regain	I-VP	VBN	O	14	VC
16	partial	partial	B-NP	JJ	O	17	NMOD
17	sensitivity	sensitivity	I-NP	NN	O	15	OBJ
18	to	to	B-PP	TO	O	17	NMOD
19	vincristine	vincristine	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	finding	finding	I-NP	NN	O	19	NMOD
3	that	that	B-SBAR	IN	O	2	NMOD
4	HL-60/vinc/R	HL-60/vinc/R	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	6	SUB
6	respond	respond	B-VP	VBP	O	3	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	TPA	TPA	B-NP	NN	O	7	PMOD
9	with	with	B-PP	IN	O	6	VMOD
10	induction	induction	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	a	a	B-NP	DT	O	14	NMOD
13	monocytic	monocytic	I-NP	JJ	O	14	NMOD
14	phenotype	phenotype	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	19	P
16	but	but	O	CC	O	19	NMOD
17	not	not	O	RB	O	16	DEP
18	c-jun	c-jun	B-NP	NN	B-DNA	19	NMOD
19	expression	expression	I-NP	NN	O	21	SUB
20	,	,	O	,	O	19	P
21	suggests	suggest	B-VP	VBZ	O	0	ROOT
22	that	that	B-SBAR	IN	O	21	VMOD
23	c-jun	c-jun	B-NP	NN	B-DNA	24	NMOD
24	induction	induction	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	22	SBAR
26	not	not	O	RB	O	25	VMOD
27	obligatory	obligatory	B-ADJP	JJ	O	25	PRD
28	for	for	B-PP	IN	O	27	AMOD
29	monocytic	monocytic	B-NP	JJ	O	30	NMOD
30	differentiation	differentiation	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	21	P

1	Other	Other	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	4	SUB
3	further	further	B-ADVP	RB	O	4	VMOD
4	demonstrate	demonstrate	B-VP	VBP	O	22	VMOD
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	10	NMOD
7	jun-B	jun-B	I-NP	NN	B-DNA	10	NMOD
8	and	and	I-NP	CC	I-DNA	10	NMOD
9	fra-1	fra-1	I-NP	NN	I-DNA	10	NMOD
10	genes	gene	I-NP	NNS	I-DNA	11	SUB
11	are	be	B-VP	VBP	O	5	SBAR
12	induced	induce	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	TPA	TPA	B-NP	NN	O	13	PMOD
15	in	in	B-PP	IN	O	12	VMOD
16	both	both	O	CC	O	20	NMOD
17	HL-60/vinc	HL-60/vinc	B-NP	NN	B-cell_line	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	HL-60/vinc/R	HL-60/vinc/R	B-NP	NN	B-cell_line	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
21	,	,	O	,	O	22	P
22	whereas	whereas	O	IN	O	0	ROOT
23	c-fos	c-fos	B-NP	NN	B-DNA	24	NMOD
24	expression	expression	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	22	VMOD
26	attenuated	attenuate	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	30	NMOD
29	HL-60/vinc	HL-60/vinc	I-NP	NN	B-cell_line	30	NMOD
30	line	line	I-NP	NN	I-cell_line	27	PMOD
31	.	.	O	.	O	22	P

1	Since	Since	B-SBAR	IN	O	12	VMOD
2	TPA	TPA	B-NP	NN	O	3	SUB
3	activates	activate	B-VP	VBZ	O	1	SBAR
4	protein	protein	B-NP	NN	B-protein	6	NMOD
5	kinase	kinase	I-NP	NN	I-protein	6	NMOD
6	C	C	I-NP	NN	I-protein	3	OBJ
7	(	(	O	(	O	8	P
8	PKC	PKC	B-NP	NN	B-protein	6	NMOD
9	)	)	O	)	O	8	P
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	examined	examine	B-VP	VBD	O	0	ROOT
13	translocation	translocation	B-NP	NN	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	PKC	PKC	B-NP	NN	B-protein	14	PMOD
16	from	from	B-PP	IN	O	13	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	cytosol	cytosol	I-NP	NN	O	16	PMOD
19	to	to	B-PP	TO	O	13	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	membrane	membrane	I-NP	NN	O	22	NMOD
22	fraction	fraction	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	12	P

1	Although	Although	B-SBAR	IN	O	15	VMOD
2	HL-60	HL-60	B-NP	NN	B-cell_line	5	NMOD
3	and	and	I-NP	CC	O	5	NMOD
4	HL-60/vinc/R	HL-60/vinc/R	I-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	6	SUB
6	demonstrated	demonstrate	B-VP	VBD	O	1	SBAR
7	translocation	translocation	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	PKC	PKC	B-NP	NN	B-protein	10	NMOD
10	activity	activity	I-NP	NN	O	8	PMOD
11	,	,	O	,	O	15	P
12	this	this	B-NP	DT	O	14	NMOD
13	subcellular	subcellular	I-NP	JJ	O	14	NMOD
14	redistribution	redistribution	I-NP	NN	O	15	SUB
15	was	be	B-VP	VBD	O	0	ROOT
16	undetectable	undetectable	B-ADJP	JJ	O	15	PRD
17	in	in	B-PP	IN	O	15	VMOD
18	HL-60/vinc	HL-60/vinc	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	.	.	O	.	O	15	P

1	Activity	Activity	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	mitogen-activated	mitogen-activated	I-NP	JJ	B-protein	7	NMOD
5	protein	protein	I-NP	NN	I-protein	7	NMOD
6	kinase	kinase	I-NP	NN	I-protein	7	NMOD
7	family	family	I-NP	NN	I-protein	2	PMOD
8	with	with	B-PP	IN	O	1	NMOD
9	associated	associate	B-NP	VBN	O	10	NMOD
10	phosphorylation	phosphorylation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	c-Jun	c-Jun	B-NP	NN	B-protein	13	NMOD
13	Y-peptide	Y-peptide	I-NP	NN	I-protein	11	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	markedly	markedly	I-VP	RB	O	14	VMOD
16	diminished	diminish	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	TPA-treated	TPA-treated	B-NP	JJ	B-cell_line	20	NMOD
19	HL-60/vinc	HL-60/vinc	I-NP	NN	I-cell_line	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
21	,	,	B-PP	,	O	17	P
22	but	but	I-PP	CC	O	17	PMOD
23	not	not	B-PP	RB	O	24	PMOD
24	in	in	I-PP	IN	O	17	PMOD
25	response	response	B-NP	NN	O	24	PMOD
26	to	to	B-PP	TO	O	25	NMOD
27	okadaic	okadaic	B-NP	JJ	O	28	NMOD
28	acid	acid	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	14	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	findings	finding	I-NP	NNS	O	6	SUB
6	suggest	suggest	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	vincristine	vincristine	B-NP	NN	O	9	NMOD
9	resistance	resistance	I-NP	NN	O	10	SUB
10	confers	confer	B-VP	VBZ	O	7	SBAR
11	insensitivity	insensitivity	B-NP	NN	O	10	OBJ
12	to	to	B-PP	TO	O	11	NMOD
13	TPA-induced	TPA-induced	B-NP	JJ	O	14	NMOD
14	differentiation	differentiation	I-NP	NN	O	12	PMOD
15	and	and	O	CC	O	10	VMOD
16	can	can	B-VP	MD	O	10	VMOD
17	include	include	I-VP	VB	O	16	VC
18	defects	defect	B-NP	NNS	O	24	NMOD
19	in	in	B-PP	IN	O	18	NMOD
20	PKC-mediated	PKC-mediated	B-NP	JJ	O	22	NMOD
21	signaling	signaling	I-NP	NN	O	22	NMOD
22	events	event	I-NP	NNS	O	19	PMOD
23	and	and	O	CC	O	24	NMOD
24	induction	induction	B-NP	NN	O	17	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	jun/fos	jun/fos	B-NP	NN	B-DNA	30	NMOD
27	early	early	I-NP	JJ	I-DNA	30	NMOD
28	response	response	I-NP	NN	I-DNA	30	NMOD
29	gene	gene	I-NP	NN	I-DNA	30	NMOD
30	expression	expression	I-NP	NN	O	25	PMOD
31	.	.	O	.	O	6	P

1	Initiation	Initiation	B-NP	NN	B-protein	3	NMOD
2	binding	binding	I-NP	NN	I-protein	3	NMOD
3	repressor	repressor	I-NP	NN	I-protein	6	NMOD
4	,	,	O	,	O	6	P
5	a	a	B-NP	DT	O	6	NMOD
6	factor	factor	I-NP	NN	O	20	SUB
7	that	that	B-NP	WDT	O	6	NMOD
8	binds	bind	B-VP	VBZ	O	7	SBAR
9	to	to	B-PP	TO	O	8	VMOD
10	the	the	B-NP	DT	O	13	NMOD
11	transcription	transcription	I-NP	NN	B-DNA	13	NMOD
12	initiation	initiation	I-NP	NN	I-DNA	13	NMOD
13	site	site	I-NP	NN	I-DNA	9	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	histone	histone	I-NP	NN	B-DNA	18	NMOD
17	h5	h5	I-NP	NN	I-DNA	18	NMOD
18	gene	gene	I-NP	NN	I-DNA	14	PMOD
19	,	,	O	,	O	6	P
20	is	be	B-VP	VBZ	O	0	ROOT
21	a	a	B-NP	DT	O	23	NMOD
22	glycosylated	glycosylate	I-NP	VBN	B-protein	23	NMOD
23	member	member	I-NP	NN	I-protein	20	PRD
24	of	of	B-PP	IN	O	23	NMOD
25	a	a	B-NP	DT	O	26	NMOD
26	family	family	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	cell	cell	B-NP	NN	B-protein	30	NMOD
29	growth	growth	I-NP	NN	I-protein	30	NMOD
30	regulators	regulator	I-NP	NNS	I-protein	27	PMOD
31	[	[	O	(	O	32	P
32	corrected	correct	B-VP	VBN	O	30	NMOD
33	]	]	O	)	O	32	P
34	[	[	O	(	O	37	P
35	published	publish	B-NP	VBN	O	36	NMOD
36	erratum	erratum	I-NP	NN	O	37	SUB
37	appears	appear	B-VP	VBZ	O	30	NMOD
38	in	in	B-PP	IN	O	37	VMOD
39	Mol	Mol	B-NP	NNP	O	43	NMOD
40	Cell	Cell	I-NP	NNP	O	43	NMOD
41	Biol	Biol	I-NP	NNP	O	43	NMOD
42	1996	1996	I-NP	CD	O	43	NMOD
43	Feb	Feb	I-NP	NNP	O	50	NMOD
44	;	;	O	:	O	50	P
45	16	16	B-NP	CD	O	47	NMOD
46	(	(	O	(	O	47	P
47	2	2	B-NP	CD	O	50	NMOD
48	)	)	O	)	O	47	P
49	:	:	O	:	O	50	P
50	735	735	B-NP	CD	O	38	PMOD
51	]	]	O	)	O	20	P

1	Initiation	Initiation	B-NP	NN	B-protein	3	NMOD
2	binding	binding	I-NP	NN	I-protein	3	NMOD
3	repressor	repressor	I-NP	NN	I-protein	10	SUB
4	[	[	O	(	O	5	P
5	corrected	correct	B-VP	VBN	O	3	NMOD
6	]	]	O	)	O	5	P
7	(	(	O	(	O	8	P
8	IBR	IBR	B-NP	NN	B-protein	3	NMOD
9	)	)	O	)	O	8	P
10	is	be	B-VP	VBZ	O	0	ROOT
11	a	a	B-NP	DT	O	14	NMOD
12	chicken	chicken	I-NP	NN	B-protein	14	NMOD
13	erythrocyte	erythrocyte	I-NP	NN	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	10	PRD
15	(	(	O	(	O	23	P
16	apparent	apparent	B-NP	JJ	O	18	NMOD
17	molecular	molecular	I-NP	JJ	O	18	NMOD
18	mass	mass	I-NP	NN	O	23	NMOD
19	,	,	O	,	O	23	P
20	70	70	B-NP	CD	O	22	AMOD
21	to	to	I-NP	TO	O	22	AMOD
22	73	73	I-NP	CD	O	23	NMOD
23	kDa	kDa	I-NP	NN	O	14	NMOD
24	)	)	O	)	O	23	P
25	that	that	B-NP	WDT	O	14	NMOD
26	binds	bind	B-VP	VBZ	O	25	SBAR
27	to	to	B-PP	TO	O	26	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	sequences	sequence	I-NP	NNS	O	27	PMOD
30	spanning	span	B-VP	VBG	O	29	NMOD
31	the	the	B-NP	DT	O	34	NMOD
32	transcription	transcription	I-NP	NN	B-DNA	34	NMOD
33	initiation	initiation	I-NP	NN	I-DNA	34	NMOD
34	site	site	I-NP	NN	I-DNA	30	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	39	NMOD
37	histone	histone	I-NP	NN	B-DNA	39	NMOD
38	h5	h5	I-NP	NN	I-DNA	39	NMOD
39	gene	gene	I-NP	NN	I-DNA	35	PMOD
40	,	,	O	,	O	10	P
41	repressing	repress	B-VP	VBG	O	10	VMOD
42	its	its	B-NP	PRP$	O	43	NMOD
43	transcription	transcription	I-NP	NN	O	41	OBJ
44	.	.	O	.	O	10	P

1	A	A	B-NP	DT	O	2	NMOD
2	variety	variety	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	other	other	B-NP	JJ	O	5	NMOD
5	cells	cell	I-NP	NNS	O	3	PMOD
6	,	,	O	,	O	5	P
7	including	include	B-PP	VBG	O	5	NMOD
8	transformed	transform	B-VP	VBN	B-cell_type	10	NMOD
9	erythroid	erythroid	B-NP	JJ	I-cell_type	10	NMOD
10	precursors	precursor	I-NP	NNS	I-cell_type	7	PMOD
11	,	,	O	,	O	2	P
12	do	do	B-VP	VBP	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	have	have	I-VP	VB	O	12	VC
15	IBR	IBR	B-NP	NN	B-protein	18	NMOD
16	but	but	O	CC	O	18	NMOD
17	a	a	B-NP	DT	O	18	NMOD
18	factor	factor	I-NP	NN	O	14	OBJ
19	referred	refer	B-VP	VBN	O	18	NMOD
20	to	to	B-PP	TO	O	19	VMOD
21	as	as	B-PP	IN	O	19	VMOD
22	IBF	IBF	B-NP	NN	B-protein	21	PMOD
23	(	(	O	(	O	27	P
24	68	68	B-NP	CD	O	26	AMOD
25	to	to	O	TO	O	26	AMOD
26	70	70	B-NP	CD	O	27	NMOD
27	kDa	kDa	I-NP	NN	O	22	NMOD
28	)	)	O	)	O	27	P
29	that	that	B-NP	WDT	O	22	NMOD
30	recognizes	recognize	B-VP	VBZ	O	29	SBAR
31	the	the	B-NP	DT	O	34	NMOD
32	same	same	I-NP	JJ	O	34	NMOD
33	IBR	IBR	I-NP	NN	B-DNA	34	NMOD
34	sites	site	I-NP	NNS	I-DNA	30	OBJ
35	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	cloned	clone	I-VP	VBN	O	2	VC
4	the	the	B-NP	DT	O	6	NMOD
5	IBR	IBR	I-NP	NN	B-DNA	6	NMOD
6	cDNA	cDNA	I-NP	NN	I-DNA	3	OBJ
7	and	and	O	CC	O	3	VMOD
8	studied	study	B-VP	VBD	O	3	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	relationship	relationship	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	IBR	IBR	B-NP	NN	B-protein	14	NMOD
13	and	and	I-NP	CC	O	14	NMOD
14	IBF	IBF	I-NP	NN	B-protein	11	PMOD
15	.	.	O	.	O	2	P

1	IBR	IBR	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	6	NMOD
4	503-amino-acid-long	503-amino-acid-long	I-NP	JJ	B-protein	6	NMOD
5	acidic	acidic	I-NP	JJ	I-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	2	PRD
7	which	which	B-NP	WDT	O	6	NMOD
8	is	be	B-VP	VBZ	O	7	SBAR
9	99.0	99.0	B-NP	CD	O	10	NMOD
10	%	%	I-NP	NN	O	11	AMOD
11	identical	identical	B-ADJP	JJ	O	21	AMOD
12	to	to	B-PP	TO	O	11	AMOD
13	the	the	B-NP	DT	O	18	NMOD
14	recently	recently	I-NP	RB	O	15	AMOD
15	reported	report	I-NP	VBN	O	18	NMOD
16	human	human	I-NP	JJ	B-protein	18	NMOD
17	NRF-1/alpha-Pal	NRF-1/alpha-Pal	I-NP	JJ	I-protein	18	NMOD
18	factor	factor	I-NP	NN	I-protein	12	PMOD
19	and	and	O	CC	O	21	AMOD
20	highly	highly	B-ADJP	RB	O	21	AMOD
21	related	related	I-ADJP	JJ	O	8	PRD
22	to	to	B-PP	TO	O	21	AMOD
23	the	the	B-NP	DT	O	26	NMOD
24	invertebrate	invertebrate	I-NP	NN	O	26	NMOD
25	transcription	transcription	I-NP	NN	B-protein	26	NMOD
26	factors	factor	I-NP	NNS	I-protein	22	PMOD
27	P3A2	P3A2	B-NP	NN	B-protein	32	NMOD
28	and	and	O	CC	O	32	NMOD
29	erected	erect	B-NP	VBN	B-protein	32	NMOD
30	wing	wing	I-NP	NN	I-protein	32	NMOD
31	gene	gene	I-NP	NN	I-protein	32	NMOD
32	product	product	I-NP	NN	I-protein	26	NMOD
33	(	(	O	(	O	34	P
34	EWG	EWG	B-NP	NN	B-protein	32	NMOD
35	)	)	O	)	O	34	P
36	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	present	present	B-VP	VBP	O	0	ROOT
3	evidence	evidence	B-NP	NN	O	2	OBJ
4	that	that	B-SBAR	IN	O	3	NMOD
5	IBR	IBR	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	IBF	IBF	I-NP	NN	B-protein	8	SUB
8	are	be	B-VP	VBP	O	4	SBAR
9	most	most	B-NP	RBS	O	11	AMOD
10	likely	likely	I-NP	JJ	O	11	AMOD
11	identical	identical	I-NP	JJ	O	12	NMOD
12	proteins	protein	I-NP	NNS	O	8	PRD
13	,	,	O	,	O	8	P
14	differing	differ	B-VP	VBG	O	8	VMOD
15	in	in	B-PP	IN	O	14	VMOD
16	their	their	B-NP	PRP$	O	17	NMOD
17	degree	degree	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	glycosylation	glycosylation	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	analyzed	analyze	I-VP	VBN	O	2	VC
4	several	several	B-NP	JJ	O	6	NMOD
5	molecular	molecular	I-NP	JJ	O	6	NMOD
6	aspects	aspect	I-NP	NNS	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	IBR/F	IBR/F	B-NP	NN	B-protein	7	PMOD
9	and	and	O	CC	O	3	VMOD
10	shown	show	B-VP	VBN	O	3	VMOD
11	that	that	B-SBAR	IN	O	19	DEP
12	the	the	B-NP	DT	O	13	NMOD
13	factor	factor	I-NP	NN	O	14	SUB
14	associates	associate	B-VP	VBZ	O	11	SBAR
15	as	as	B-PP	IN	O	14	VMOD
16	stable	stable	B-NP	JJ	O	17	NMOD
17	homodimers	homodimer	I-NP	NNS	B-protein	15	PMOD
18	and	and	O	CC	O	19	DEP
19	that	that	B-SBAR	IN	O	10	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	dimer	dimer	I-NP	NN	B-protein	22	SUB
22	is	be	B-VP	VBZ	O	19	SBAR
23	the	the	B-NP	DT	O	26	NMOD
24	relevant	relevant	I-NP	JJ	B-protein	26	NMOD
25	DNA-binding	DNA-binding	I-NP	JJ	I-protein	26	NMOD
26	species	specie	I-NP	NNS	I-protein	22	PRD
27	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	5	NMOD
2	evolutionarily	evolutionarily	I-NP	RB	O	3	AMOD
3	conserved	conserve	I-NP	VBN	O	5	NMOD
4	N-terminal	N-terminal	I-NP	JJ	B-protein	5	NMOD
5	half	half	I-NP	NN	I-protein	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	IBR/F	IBR/F	B-NP	NN	B-protein	6	PMOD
8	harbors	harbor	B-VP	VBZ	O	0	ROOT
9	the	the	B-NP	DT	O	11	NMOD
10	DNA-binding/dimerization	DNA-binding/dimerization	I-NP	NN	B-protein	11	NMOD
11	domain	domain	I-NP	NN	I-protein	39	NMOD
12	(	(	O	(	O	18	P
13	outer	outer	B-NP	JJ	O	14	NMOD
14	limits	limit	I-NP	NNS	O	18	NMOD
15	,	,	O	,	O	18	P
16	127	127	B-NP	CD	B-DNA	18	AMOD
17	to	to	B-PP	TO	I-DNA	18	AMOD
18	283	283	B-NP	CD	I-DNA	11	NMOD
19	)	)	O	)	O	18	P
20	,	,	O	,	O	39	P
21	one	one	B-NP	CD	O	27	NMOD
22	or	or	O	CC	O	27	NMOD
23	several	several	B-NP	JJ	O	27	NMOD
24	casein	casein	I-NP	NN	B-protein	27	NMOD
25	kinase	kinase	I-NP	NN	I-protein	27	NMOD
26	II	II	B-NP	CD	I-protein	27	NMOD
27	sites	site	I-NP	NNS	I-protein	39	NMOD
28	(	(	O	(	O	31	P
29	37	37	B-NP	CD	B-DNA	31	NMOD
30	to	to	O	TO	I-DNA	31	NMOD
31	67	67	B-NP	CD	I-DNA	27	NMOD
32	)	)	O	)	O	31	P
33	,	,	O	,	O	39	P
34	and	and	O	CC	O	39	NMOD
35	a	a	B-NP	DT	O	39	NMOD
36	bipartite	bipartite	I-NP	JJ	B-protein	39	NMOD
37	nuclear	nuclear	I-NP	JJ	I-protein	39	NMOD
38	localization	localization	I-NP	NN	I-protein	39	NMOD
39	signal	signal	I-NP	NN	I-protein	8	OBJ
40	(	(	O	(	O	43	P
41	89	89	B-NP	CD	O	43	NMOD
42	to	to	O	TO	O	43	NMOD
43	106	106	O	CD	O	39	NMOD
44	)	)	O	)	O	43	P
45	which	which	B-NP	WDT	O	39	NMOD
46	appears	appear	B-VP	VBZ	O	45	SBAR
47	to	to	I-VP	TO	O	48	VMOD
48	be	be	I-VP	VB	O	46	VMOD
49	necessary	necessary	B-ADJP	JJ	O	48	PRD
50	for	for	B-PP	IN	O	49	AMOD
51	nuclear	nuclear	B-NP	JJ	O	52	NMOD
52	targeting	targeting	I-NP	NN	O	50	PMOD
53	.	.	O	.	O	8	P

1	Binding	Binding	B-NP	NN	O	3	NMOD
2	site	site	I-NP	NN	O	3	NMOD
3	selection	selection	I-NP	NN	O	4	SUB
4	revealed	reveal	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	16	DEP
6	the	the	B-NP	DT	O	9	NMOD
7	alternating	alternate	I-NP	VBG	B-protein	9	NMOD
8	RCGCRYGCGY	RCGCRYGCGY	I-NP	NN	I-protein	9	NMOD
9	consensus	consensus	I-NP	NN	I-protein	10	SUB
10	constitutes	constitute	B-VP	VBZ	O	5	SBAR
11	high-affinity	high-affinity	B-NP	JJ	O	14	NMOD
12	IBR/F	IBR/F	I-NP	NN	B-DNA	14	NMOD
13	binding	binding	I-NP	NN	I-DNA	14	NMOD
14	sites	site	I-NP	NNS	I-DNA	10	OBJ
15	and	and	O	CC	O	16	DEP
16	that	that	B-SBAR	IN	O	4	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	direct-repeat	direct-repeat	I-NP	JJ	B-DNA	20	NMOD
19	palindrome	palindrome	I-NP	NN	I-DNA	20	NMOD
20	TGCGCATGCGCA	TGCGCATGCGCA	I-NP	NN	O	21	SUB
21	is	be	B-VP	VBZ	O	16	SBAR
22	the	the	B-NP	DT	O	24	NMOD
23	optimal	optimal	I-NP	JJ	B-DNA	24	NMOD
24	site	site	I-NP	NN	I-DNA	21	PRD
25	.	.	O	.	O	4	P

1	A	A	B-NP	DT	O	2	NMOD
2	survey	survey	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	genes	gene	B-NP	NNS	B-DNA	3	PMOD
5	potentially	potentially	B-VP	RB	O	6	VMOD
6	regulated	regulate	I-VP	VBN	O	4	NMOD
7	by	by	B-PP	IN	O	6	VMOD
8	this	this	B-NP	DT	O	9	NMOD
9	family	family	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	factors	factor	B-NP	NNS	O	10	PMOD
12	primarily	primarily	B-ADVP	RB	O	13	VMOD
13	revealed	reveal	B-VP	VBD	O	0	ROOT
14	genes	gene	B-NP	NNS	O	13	OBJ
15	involved	involve	B-VP	VBN	O	14	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	growth-related	growth-related	B-NP	JJ	O	18	NMOD
18	metabolism	metabolism	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	13	P

1	Inhibition	Inhibition	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	NF-AT	NF-AT	B-NP	NN	B-protein	6	NMOD
4	signal	signal	I-NP	NN	O	6	NMOD
5	transduction	transduction	I-NP	NN	O	6	NMOD
6	events	event	I-NP	NNS	O	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	a	a	B-NP	DT	O	10	NMOD
9	dominant-negative	dominant-negative	I-NP	JJ	B-protein	10	NMOD
10	form	form	I-NP	NN	I-protein	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	calcineurin	calcineurin	B-NP	NN	B-protein	11	PMOD
13	.	.	O	.	O	1	P

1	An	An	B-NP	DT	O	2	NMOD
2	inhibitory	inhibitory	I-NP	JJ	O	5	NMOD
3	,	,	O	,	O	5	P
4	"	"	O	``	O	5	P
5	dominant-negative	dominant-negative	B-ADJP	JJ	O	17	VMOD
6	,	,	O	,	O	17	P
7	"	"	O	''	O	17	P
8	form	form	B-NP	NN	O	17	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	16	NMOD
11	calcineurin	calcineurin	I-NP	NN	B-protein	16	NMOD
12	catalytic	catalytic	I-NP	JJ	I-protein	16	NMOD
13	(	(	O	(	I-protein	16	P
14	A	A	B-NP	NN	I-protein	16	NMOD
15	)	)	O	)	I-protein	16	P
16	subunit	subunit	B-NP	NN	I-protein	9	PMOD
17	was	be	B-VP	VBD	O	35	VMOD
18	prepared	prepare	I-VP	VBN	O	17	VC
19	,	,	O	,	O	18	P
20	which	which	B-NP	WDT	O	18	VMOD
21	lacks	lack	B-VP	VBZ	O	20	SBAR
22	the	the	B-NP	DT	O	24	NMOD
23	calmodulin-binding	calmodulin-binding	I-NP	JJ	B-protein	24	NMOD
24	domain	domain	I-NP	NN	I-protein	21	OBJ
25	,	,	O	,	O	29	P
26	autoinhibitory	autoinhibitory	B-NP	JJ	B-protein	27	NMOD
27	domain	domain	I-NP	NN	I-protein	29	NMOD
28	and	and	O	CC	O	29	NMOD
29	most	most	B-NP	JJS	O	35	SUB
30	of	of	B-PP	IN	O	29	NMOD
31	its	its	B-NP	PRP$	O	33	NMOD
32	catalytic	catalytic	I-NP	JJ	O	33	NMOD
33	core	core	I-NP	NN	O	30	PMOD
34	but	but	O	CC	O	29	VMOD
35	possesses	possess	B-VP	VBZ	O	0	ROOT
36	the	the	B-NP	DT	O	43	NMOD
37	regulatory	regulatory	I-NP	JJ	B-protein	43	NMOD
38	(	(	O	(	I-protein	39	P
39	B	B	B-NP	NN	I-protein	37	AMOD
40	)	)	O	)	I-protein	39	P
41	subunit	subunit	B-NP	NN	I-protein	43	NMOD
42	binding	binding	I-NP	NN	I-protein	43	NMOD
43	domain	domain	I-NP	NN	I-protein	35	OBJ
44	.	.	O	.	O	35	P

1	When	When	B-ADVP	WRB	O	25	VMOD
2	tested	test	B-VP	VBN	O	1	SBAR
3	for	for	B-PP	IN	O	2	VMOD
4	its	its	B-NP	PRP$	O	5	NMOD
5	ability	ability	I-NP	NN	O	3	PMOD
6	to	to	B-VP	TO	O	7	VMOD
7	block	block	I-VP	VB	O	5	NMOD
8	calcineurin-dependent	calcineurin-dependent	B-NP	JJ	O	9	NMOD
9	signaling	signaling	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	Jurkat	Jurkat	B-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
13	,	,	O	,	O	25	P
14	expression	expression	B-NP	NN	O	25	SUB
15	of	of	B-PP	IN	O	14	NMOD
16	this	this	B-NP	DT	O	24	NMOD
17	"	"	I-NP	``	B-DNA	24	P
18	B-subunit	B-subunit	I-NP	JJ	I-DNA	24	NMOD
19	knock-out	knock-out	I-NP	JJ	I-DNA	24	NMOD
20	"	"	O	''	I-DNA	19	P
21	(	(	O	(	I-DNA	22	P
22	BKO	BKO	B-NP	NN	I-DNA	24	NMOD
23	)	)	O	)	I-DNA	22	P
24	construct	construct	B-NP	NN	I-DNA	15	PMOD
25	suppressed	suppress	B-VP	VBD	O	0	ROOT
26	reporter	reporter	B-NP	NN	B-DNA	28	NMOD
27	gene	gene	I-NP	NN	I-DNA	28	NMOD
28	activity	activity	I-NP	NN	O	36	NMOD
29	driven	drive	B-VP	VBN	O	28	NMOD
30	by	by	B-PP	IN	O	29	VMOD
31	NF-AT	NF-AT	B-NP	NN	B-protein	30	PMOD
32	,	,	O	,	O	36	P
33	the	the	B-NP	DT	O	36	NMOD
34	pivotal	pivotal	I-NP	JJ	O	36	NMOD
35	promoter	promoter	I-NP	NN	B-DNA	36	NMOD
36	element	element	I-NP	NN	I-DNA	25	OBJ
37	for	for	B-PP	IN	O	36	NMOD
38	interleukin	interleukin	B-NP	NN	B-DNA	43	NMOD
39	(	(	O	(	I-DNA	40	P
40	IL	IL	B-NP	NN	I-DNA	38	NMOD
41	)	)	O	)	I-DNA	40	P
42	-2	-2	B-NP	CD	I-DNA	43	NMOD
43	gene	gene	I-NP	NN	I-DNA	44	NMOD
44	induction	induction	I-NP	NN	O	37	PMOD
45	.	.	O	.	O	25	P

1	Immunoprecipitation	Immunoprecipitation	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	epitope-labeled	epitope-labeled	B-NP	JJ	B-protein	4	NMOD
4	BKO	BKO	I-NP	NN	I-protein	2	PMOD
5	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
6	for	for	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	formation	formation	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	12	NMOD
11	tight	tight	I-NP	JJ	O	12	NMOD
12	complex	complex	I-NP	NN	O	9	PMOD
13	with	with	B-PP	IN	O	12	NMOD
14	endogenous	endogenous	B-NP	JJ	B-protein	16	NMOD
15	B	B	I-NP	NN	I-protein	16	NMOD
16	subunit	subunit	I-NP	NN	I-protein	13	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	Jurkat	Jurkat	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	,	,	O	,	O	5	P
21	consistent	consistent	B-ADJP	JJ	O	5	VMOD
22	with	with	B-PP	IN	O	21	AMOD
23	an	an	B-NP	DT	O	25	NMOD
24	inhibitory	inhibitory	I-NP	JJ	O	25	NMOD
25	mechanism	mechanism	I-NP	NN	O	22	PMOD
26	that	that	B-NP	WDT	O	25	NMOD
27	involves	involve	B-VP	VBZ	O	26	SBAR
28	the	the	B-NP	DT	O	29	NMOD
29	sequestration	sequestration	I-NP	NN	O	27	OBJ
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	B	B	I-NP	NN	B-protein	33	NMOD
33	subunit	subunit	I-NP	NN	I-protein	30	PMOD
34	.	.	O	.	O	5	P

1	Furthermore	Furthermore	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	the	the	B-NP	DT	O	7	NMOD
4	sharply	sharply	I-NP	RB	O	5	AMOD
5	reduced	reduce	I-NP	VBN	O	7	NMOD
6	NF-AT	NF-AT	I-NP	NN	B-protein	7	NMOD
7	activity	activity	I-NP	NN	O	12	SUB
8	produced	produce	B-VP	VBN	O	7	NMOD
9	by	by	B-PP	IN	O	8	VMOD
10	co-transfecting	co-transfecte	B-VP	VBG	B-DNA	11	NMOD
11	BKO	BKO	B-NP	NN	I-DNA	9	PMOD
12	could	could	B-VP	MD	O	0	ROOT
13	be	be	I-VP	VB	O	12	VC
14	"	"	O	``	O	15	P
15	rescued	rescue	B-ADJP	VBN	O	13	VC
16	"	"	O	''	O	15	P
17	by	by	B-PP	IN	O	15	VMOD
18	overexpression	overexpression	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	transfected	transfecte	B-NP	VBN	O	22	NMOD
21	B	B	I-NP	NN	B-protein	22	NMOD
22	subunit	subunit	I-NP	NN	I-protein	19	PMOD
23	,	,	O	,	O	15	P
24	suggesting	suggest	B-VP	VBG	O	15	VMOD
25	that	that	B-SBAR	IN	O	24	VMOD
26	depletion	depletion	B-NP	NN	O	30	SUB
27	of	of	B-PP	IN	O	26	NMOD
28	this	this	B-NP	DT	O	29	NMOD
29	subunit	subunit	I-NP	NN	O	27	PMOD
30	was	be	B-VP	VBD	O	25	SBAR
31	responsible	responsible	B-ADJP	JJ	O	30	PRD
32	for	for	B-PP	IN	O	31	AMOD
33	the	the	B-NP	DT	O	34	NMOD
34	inhibition	inhibition	I-NP	NN	O	32	PMOD
35	.	.	O	.	O	12	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	potential	potential	I-NP	JJ	O	6	NMOD
6	utility	utility	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	agents	agent	B-NP	NNS	O	7	PMOD
9	that	that	B-NP	WDT	O	8	NMOD
10	disrupt	disrupt	B-VP	VBP	O	9	SBAR
11	calcineurin-mediated	calcineurin-mediated	B-NP	JJ	O	14	NMOD
12	signal	signal	I-NP	NN	O	14	NMOD
13	transduction	transduction	I-NP	NN	O	14	NMOD
14	pathways	pathway	I-NP	NNS	O	10	OBJ
15	by	by	B-PP	IN	O	10	VMOD
16	blocking	block	B-VP	VBG	O	15	PMOD
17	formation	formation	B-NP	NN	O	16	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	catalytically	catalytically	I-NP	RB	B-protein	21	AMOD
21	active	active	I-NP	JJ	I-protein	22	NMOD
22	dimer	dimer	I-NP	NN	I-protein	18	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	calcineurin	calcineurin	B-NP	NN	B-protein	25	NMOD
25	A	A	I-NP	NN	O	27	NMOD
26	and	and	I-NP	CC	O	27	NMOD
27	B	B	I-NP	NN	B-protein	28	NMOD
28	subunits	subunit	I-NP	NNS	I-protein	23	PMOD
29	.	.	O	.	O	3	P

1	Modulation	Modulation	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	endogenous	endogenous	B-NP	JJ	O	5	NMOD
4	IL-1	IL-1	I-NP	NN	B-protein	5	NMOD
5	beta	beta	I-NP	NN	I-protein	9	NMOD
6	and	and	I-NP	CC	O	9	NMOD
7	IL-1	IL-1	I-NP	NN	B-protein	9	NMOD
8	receptor	receptor	I-NP	NN	O	9	NMOD
9	antagonist	antagonist	I-NP	NN	O	2	PMOD
10	results	result	B-VP	VBZ	O	0	ROOT
11	in	in	B-PP	IN	O	10	VMOD
12	opposing	oppose	B-VP	VBG	O	13	NMOD
13	effects	effect	B-NP	NNS	O	11	PMOD
14	on	on	B-PP	IN	O	13	NMOD
15	HIV	HIV	B-NP	NN	O	16	NMOD
16	expression	expression	I-NP	NN	O	14	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	chronically	chronically	B-NP	RB	B-cell_type	19	AMOD
19	infected	infected	I-NP	JJ	I-cell_type	21	NMOD
20	monocytic	monocytic	I-NP	JJ	I-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
22	.	.	O	.	O	10	P

1	A	A	B-NP	DT	O	2	NMOD
2	proportion	proportion	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HIV-infected	HIV-infected	B-NP	JJ	O	5	NMOD
5	individuals	individual	I-NP	NNS	O	3	PMOD
6	experience	experience	B-VP	VBP	O	0	ROOT
7	episodes	episode	B-NP	NNS	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	localized	localized	B-NP	JJ	O	13	NMOD
10	or	or	I-NP	CC	O	13	NMOD
11	systemic	systemic	I-NP	JJ	O	13	NMOD
12	bacterial	bacterial	I-NP	JJ	O	13	NMOD
13	infections	infection	I-NP	NNS	O	8	PMOD
14	caused	cause	B-VP	VBN	O	13	NMOD
15	by	by	B-PP	IN	O	14	VMOD
16	Gram-negative	Gram-negative	B-NP	JJ	O	17	NMOD
17	bacteria	bacteria	I-NP	NNS	O	15	PMOD
18	.	.	O	.	O	6	P

1	Many	Many	B-NP	JJ	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	clinical	clinical	I-NP	JJ	O	6	NMOD
5	side	side	I-NP	NN	O	6	NMOD
6	effects	effect	I-NP	NNS	O	2	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	9	NMOD
9	infections	infection	I-NP	NNS	O	7	PMOD
10	are	be	B-VP	VBP	O	0	ROOT
11	associated	associate	I-VP	VBN	O	10	VC
12	with	with	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	production	production	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	proinflammatory	proinflammatory	B-NP	JJ	B-protein	17	NMOD
17	cytokines	cytokine	I-NP	NNS	I-protein	27	NMOD
18	,	,	O	,	O	17	P
19	which	which	B-NP	WDT	O	17	NMOD
20	are	be	B-VP	VBP	O	19	SBAR
21	induced	induce	I-VP	VBN	O	20	VC
22	primarily	primarily	B-ADVP	RB	O	21	VMOD
23	by	by	B-PP	IN	O	21	VMOD
24	LPS	LPS	B-NP	NN	O	23	PMOD
25	,	,	O	,	O	27	P
26	a	a	B-NP	DT	O	27	NMOD
27	constituent	constituent	I-NP	NN	O	15	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	32	NMOD
30	bacterial	bacterial	I-NP	JJ	O	32	NMOD
31	cell	cell	I-NP	NN	O	32	NMOD
32	wall	wall	I-NP	NN	O	28	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	Gram-negative	Gram-negative	B-NP	JJ	O	35	NMOD
35	bacteria	bacteria	I-NP	NNS	O	33	PMOD
36	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	study	study	I-NP	NN	O	4	SUB
4	examines	examine	B-VP	VBZ	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	mechanisms	mechanism	I-NP	NNS	O	4	OBJ
7	involved	involve	B-VP	VBN	O	6	NMOD
8	in	in	B-PP	IN	O	7	VMOD
9	LPS-mediated	LPS-mediated	B-NP	JJ	O	10	NMOD
10	induction	induction	I-NP	NN	O	21	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	HIV	HIV	B-NP	NN	O	13	NMOD
13	expression	expression	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	10	NMOD
15	U1	U1	B-NP	NN	B-cell_line	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
17	,	,	O	,	O	21	P
18	a	a	B-NP	DT	O	21	NMOD
19	promonocytic	promonocytic	I-NP	JJ	B-cell_line	21	NMOD
20	cell	cell	I-NP	NN	I-cell_line	21	NMOD
21	line	line	I-NP	NN	I-cell_line	8	PMOD
22	chronically	chronically	B-ADJP	RB	O	23	VMOD
23	infected	infect	I-ADJP	VBN	O	21	NMOD
24	with	with	B-PP	IN	O	23	VMOD
25	HIV	HIV	B-NP	NN	O	24	PMOD
26	.	.	O	.	O	4	P

1	Stimulation	Stimulation	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	U1	U1	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
5	by	by	B-PP	IN	O	1	NMOD
6	LPS	LPS	B-NP	NN	O	5	PMOD
7	alone	alone	B-ADVP	RB	O	1	NMOD
8	induced	induce	B-VP	VBD	O	0	ROOT
9	minimal	minimal	B-NP	JJ	O	10	NMOD
10	levels	level	I-NP	NNS	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	HIV	HIV	B-NP	NN	O	13	NMOD
13	expression	expression	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	8	P
15	which	which	B-NP	WDT	O	8	VMOD
16	was	be	B-VP	VBD	O	15	SBAR
17	significantly	significantly	I-VP	RB	O	16	VMOD
18	enhanced	enhance	I-VP	VBN	O	16	VC
19	by	by	B-PP	IN	O	18	VMOD
20	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-protein	22	NMOD
21	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	19	PMOD
23	(	(	O	(	O	24	P
24	GM-CSF	GM-CSF	B-NP	NN	B-protein	22	NMOD
25	)	)	O	)	O	24	P
26	.	.	O	.	O	8	P

1	Costimulation	Costimulation	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	U1	U1	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	LPS	LPS	B-NP	NN	O	8	NMOD
7	plus	plus	O	CC	O	8	NMOD
8	GM-CSF	GM-CSF	B-NP	NN	B-protein	5	PMOD
9	resulted	result	B-VP	VBD	O	49	VMOD
10	in	in	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	accumulation	accumulation	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	steady-state	steady-state	B-NP	JJ	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	HIV	HIV	B-NP	NN	B-RNA	18	NMOD
18	RNA	RNA	I-NP	NN	I-RNA	16	PMOD
19	;	;	O	:	O	49	P
20	however	however	B-ADVP	RB	O	49	VMOD
21	,	,	O	,	O	49	P
22	only	only	B-NP	RB	O	25	NMOD
23	a	a	I-NP	DT	O	25	NMOD
24	weak	weak	I-NP	JJ	O	25	NMOD
25	induction	induction	I-NP	NN	O	49	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	HIV	HIV	B-NP	NN	O	31	NMOD
28	long	long	I-NP	JJ	O	31	NMOD
29	terminal	terminal	I-NP	JJ	O	31	NMOD
30	repeat-driven	repeat-driven	I-NP	JJ	O	31	NMOD
31	transcription	transcription	I-NP	NN	O	26	PMOD
32	,	,	O	,	O	25	P
33	which	which	B-NP	WDT	O	25	NMOD
34	was	be	B-VP	VBD	O	33	SBAR
35	not	not	I-VP	RB	O	34	VMOD
36	associated	associate	I-VP	VBN	O	34	VC
37	with	with	B-PP	IN	O	36	VMOD
38	the	the	B-NP	DT	O	39	NMOD
39	activation	activation	I-NP	NN	O	37	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	47	NMOD
42	cellular	cellular	I-NP	JJ	B-protein	44	NMOD
43	transcription	transcription	I-NP	NN	I-protein	44	NMOD
44	factor	factor	I-NP	NN	I-protein	47	NMOD
45	nuclear	nuclear	I-NP	JJ	B-protein	47	NMOD
46	factor-kappa	factor-kappa	I-NP	NN	I-protein	47	NMOD
47	B	B	I-NP	NN	I-protein	40	PMOD
48	,	,	O	,	O	25	P
49	was	be	B-VP	VBD	O	0	ROOT
50	noted	note	I-VP	VBN	O	49	VC
51	.	.	O	.	O	49	P

1	Costimulation	Costimulation	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	cells	cell	B-NP	NNS	O	2	PMOD
4	with	with	B-PP	IN	O	1	NMOD
5	LPS	LPS	B-NP	NN	O	7	NMOD
6	plus	plus	O	CC	O	7	NMOD
7	GM-CSF	GM-CSF	B-NP	NN	B-protein	4	PMOD
8	induced	induce	B-VP	VBD	O	0	ROOT
9	the	the	B-NP	DT	O	10	NMOD
10	production	production	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	proinflammatory	proinflammatory	B-NP	JJ	B-protein	13	NMOD
13	cytokines	cytokine	I-NP	NNS	I-protein	20	NMOD
14	,	,	O	,	O	20	P
15	IL-8	IL-8	B-NP	NN	B-protein	20	NMOD
16	,	,	O	,	O	20	P
17	IL-1	IL-1	B-NP	NN	B-protein	18	NMOD
18	beta	beta	I-NP	NN	I-protein	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	IL-6	IL-6	I-NP	NN	B-protein	24	NMOD
21	,	,	B-NP	,	O	24	P
22	but	but	I-NP	CC	O	24	NMOD
23	not	not	I-NP	RB	O	22	DEP
24	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	11	PMOD
25	.	.	O	.	O	8	P

1	IL-1	IL-1	B-NP	NN	B-protein	3	NMOD
2	receptor	receptor	I-NP	NN	I-protein	3	NMOD
3	antagonist	antagonist	I-NP	NN	O	7	SUB
4	(	(	O	(	O	5	P
5	ra	ra	B-NP	NN	O	3	NMOD
6	)	)	O	)	O	5	P
7	inhibited	inhibit	B-VP	VBD	O	0	ROOT
8	LPS	LPS	B-NP	NN	O	9	NMOD
9	enhancement	enhancement	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	HIV	HIV	B-NP	NN	O	12	NMOD
12	expression	expression	I-NP	NN	O	10	PMOD
13	in	in	B-PP	IN	O	9	NMOD
14	GM-CSF-stimulated	GM-CSF-stimulated	B-NP	JJ	B-cell_line	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
16	,	,	O	,	O	7	P
17	suggesting	suggest	B-VP	VBG	O	7	VMOD
18	that	that	B-SBAR	IN	O	17	VMOD
19	endogenous	endogenous	B-NP	JJ	O	20	NMOD
20	IL-1	IL-1	I-NP	NN	B-protein	21	SUB
21	was	be	B-VP	VBD	O	18	SBAR
22	involved	involve	I-VP	VBN	O	21	VC
23	in	in	B-PP	IN	O	22	VMOD
24	LPS-mediated	LPS-mediated	B-NP	JJ	O	26	NMOD
25	viral	viral	I-NP	JJ	O	26	NMOD
26	production	production	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	7	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	regard	regard	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	7	P
5	anti-inflammatory	anti-inflammatory	B-NP	JJ	B-protein	6	NMOD
6	cytokines	cytokine	I-NP	NNS	I-protein	7	SUB
7	inhibited	inhibit	B-VP	VBD	O	18	VMOD
8	LPS	LPS	B-NP	NN	O	12	NMOD
9	plus	plus	O	CC	O	12	NMOD
10	GM-CSF-stimulated	GM-CSF-stimulated	B-NP	JJ	O	12	NMOD
11	HIV	HIV	I-NP	NN	O	12	NMOD
12	expression	expression	I-NP	NN	O	7	OBJ
13	,	,	O	,	O	18	P
14	and	and	O	CC	O	16	NMOD
15	this	this	B-NP	DT	O	16	NMOD
16	effect	effect	I-NP	NN	O	18	SUB
17	closely	closely	B-ADVP	RB	O	18	VMOD
18	correlated	correlate	B-VP	VBD	O	0	ROOT
19	with	with	B-PP	IN	O	18	VMOD
20	inhibition	inhibition	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	IL-1	IL-1	B-NP	NN	B-protein	24	NMOD
23	beta	beta	I-NP	NN	I-protein	24	NMOD
24	release	release	I-NP	NN	O	21	PMOD
25	and	and	O	CC	O	18	VMOD
26	,	,	O	,	O	18	P
27	in	in	B-PP	IN	O	18	VMOD
28	particular	particular	B-ADJP	JJ	O	27	PMOD
29	,	,	O	,	O	18	P
30	with	with	B-PP	IN	O	18	VMOD
31	up-regulation	up-regulation	B-NP	NN	O	30	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	endogenous	endogenous	B-NP	JJ	O	35	NMOD
34	IL-1ra	IL-1ra	I-NP	NN	B-protein	35	NMOD
35	production	production	I-NP	NN	O	32	PMOD
36	.	.	O	.	O	18	P

1	Thus	Thus	B-ADVP	RB	O	21	VMOD
2	,	,	O	,	O	21	P
3	the	the	B-NP	DT	O	4	NMOD
4	balance	balance	I-NP	NN	O	21	SUB
5	between	between	B-PP	IN	O	4	NMOD
6	an	an	B-NP	DT	O	10	NMOD
7	endogenously	endogenously	I-NP	RB	O	8	AMOD
8	produced	produce	I-NP	VBN	O	10	NMOD
9	viral	viral	I-NP	JJ	O	10	NMOD
10	inducer	inducer	I-NP	NN	O	17	NMOD
11	(	(	O	(	O	13	P
12	IL-1	IL-1	B-NP	NN	B-protein	13	NMOD
13	beta	beta	I-NP	NN	I-protein	10	NMOD
14	)	)	O	)	O	13	P
15	and	and	O	CC	O	17	NMOD
16	an	an	B-NP	DT	O	17	NMOD
17	inhibitor	inhibitor	I-NP	NN	O	5	PMOD
18	(	(	O	(	O	19	P
19	IL-1ra	IL-1ra	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	may	may	B-VP	MD	O	0	ROOT
22	represent	represent	I-VP	VB	O	21	VC
23	an	an	B-NP	DT	O	25	NMOD
24	important	important	I-NP	JJ	O	25	NMOD
25	pathway	pathway	I-NP	NN	O	22	OBJ
26	leading	lead	B-VP	VBG	O	25	NMOD
27	to	to	B-PP	TO	O	26	VMOD
28	modulation	modulation	B-NP	NN	O	27	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	HIV	HIV	B-NP	NN	O	31	NMOD
31	expression	expression	I-NP	NN	O	29	PMOD
32	from	from	B-PP	IN	O	31	NMOD
33	monocytic	monocytic	B-NP	JJ	B-cell_type	34	NMOD
34	cells	cell	I-NP	NNS	I-cell_type	32	PMOD
35	.	.	O	.	O	21	P

1	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	interleukin-2	interleukin-2	I-NP	NN	B-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	3	PMOD
7	in	in	B-PP	IN	O	2	NMOD
8	normal	normal	B-NP	JJ	B-cell_type	13	NMOD
9	human	human	I-NP	JJ	I-cell_type	13	NMOD
10	peripheral	peripheral	I-NP	JJ	I-cell_type	13	NMOD
11	blood	blood	I-NP	NN	I-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
14	.	.	O	.	O	2	P

1	Convergence	Convergence	B-NP	NN	O	6	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	costimulatory	costimulatory	B-NP	JJ	O	4	NMOD
4	signals	signal	I-NP	NNS	O	2	PMOD
5	and	and	I-NP	CC	O	6	NMOD
6	differences	difference	I-NP	NNS	O	0	ROOT
7	from	from	B-PP	IN	O	6	NMOD
8	transformed	transform	B-NP	VBN	B-cell_type	10	NMOD
9	T	T	I-NP	NN	I-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
11	.	.	O	.	O	6	P

1	To	To	B-VP	TO	O	2	VMOD
2	study	study	I-VP	VB	O	12	VMOD
3	transcriptional	transcriptional	B-NP	JJ	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	2	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	normal	normal	B-NP	JJ	B-cell_type	9	NMOD
7	human	human	I-NP	JJ	I-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	have	have	B-VP	VBP	O	0	ROOT
13	optimized	optimize	I-VP	VBN	O	12	VC
14	conditions	condition	B-NP	NNS	O	13	OBJ
15	for	for	B-PP	IN	O	14	NMOD
16	transient	transient	B-NP	JJ	O	17	NMOD
17	transfection	transfection	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	12	P

1	Interleukin-2	Interleukin-2	B-NP	NN	B-protein	7	NMOD
2	(	(	I-NP	(	O	3	P
3	IL-2	IL-2	I-NP	NN	B-protein	1	NMOD
4	)	)	I-NP	)	O	3	P
5	promoter-reporter	promoter-reporter	I-NP	JJ	O	7	NMOD
6	gene	gene	I-NP	NN	O	7	NMOD
7	behavior	behavior	I-NP	NN	O	9	SUB
8	closely	closely	B-ADVP	RB	O	9	VMOD
9	parallels	parallel	B-VP	VBZ	O	0	ROOT
10	the	the	B-NP	DT	O	12	NMOD
11	endogenous	endogenous	I-NP	JJ	B-DNA	12	NMOD
12	gene	gene	I-NP	NN	I-DNA	9	OBJ
13	in	in	B-PP	IN	O	9	VMOD
14	response	response	I-PP	NN	O	13	PMOD
15	to	to	I-PP	TO	O	14	NMOD
16	T	T	B-NP	NN	B-protein	18	NMOD
17	cell	cell	I-NP	NN	I-protein	18	NMOD
18	receptor	receptor	I-NP	NN	I-protein	21	NMOD
19	and	and	O	CC	O	21	NMOD
20	costimulatory	costimulatory	B-NP	JJ	O	21	NMOD
21	signals	signal	I-NP	NNS	O	15	PMOD
22	.	.	O	.	O	9	P

1	As	As	B-SBAR	IN	O	17	VMOD
2	assessed	assess	B-VP	VBN	O	1	SBAR
3	with	with	B-PP	IN	O	2	VMOD
4	mutagenized	mutagenize	B-NP	VBN	B-DNA	5	NMOD
5	promoters	promoter	I-NP	NNS	I-DNA	3	PMOD
6	,	,	O	,	O	17	P
7	the	the	B-NP	DT	O	12	NMOD
8	most	most	I-NP	RBS	O	9	AMOD
9	important	important	I-NP	JJ	O	12	NMOD
10	IL-2	IL-2	I-NP	NN	B-DNA	12	NMOD
11	cis-regulatory	cis-regulatory	I-NP	JJ	I-DNA	12	NMOD
12	elements	element	I-NP	NNS	I-DNA	17	SUB
13	in	in	B-PP	IN	O	12	NMOD
14	normal	normal	B-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
17	are	be	B-VP	VBP	O	0	ROOT
18	the	the	B-NP	DT	O	21	NMOD
19	proximal	proximal	I-NP	JJ	B-DNA	21	NMOD
20	AP-1	AP-1	I-NP	NN	I-DNA	21	NMOD
21	site	site	I-NP	NN	I-DNA	26	NMOD
22	and	and	O	CC	O	26	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	NF-	NF-	I-NP	NF-	B-DNA	26	NMOD
25	kappaB	kappaB	I-NP	NN	I-DNA	26	NMOD
26	site	site	I-NP	NN	I-DNA	17	PRD
27	.	.	O	.	O	17	P

1	Both	Both	O	CC	O	3	NMOD
2	primary	primary	B-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	13	NMOD
4	,	,	O	,	O	3	P
5	with	with	B-PP	IN	O	3	NMOD
6	phytohemagglutinin	phytohemagglutinin	B-NP	NN	B-protein	8	NMOD
7	or	or	I-NP	CC	O	8	NMOD
8	antibodies	antibody	I-NP	NNS	O	5	PMOD
9	to	to	B-PP	TO	O	8	NMOD
10	CD3	CD3	B-NP	NN	B-protein	9	PMOD
11	,	,	O	,	O	13	P
12	and	and	O	CC	O	13	NMOD
13	costimulation	costimulation	B-NP	NN	O	35	SUB
14	,	,	O	,	O	13	P
15	provided	provide	B-PP	VBN	O	13	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	pairs	pair	B-NP	NNS	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	CD2	CD2	B-NP	NN	B-protein	20	NMOD
20	antibodies	antibody	I-NP	NNS	I-protein	33	NMOD
21	or	or	O	CC	O	33	NMOD
22	B7-positive	B7-positive	B-NP	JJ	O	28	AMOD
23	(	(	O	(	O	25	P
24	B	B	B-NP	NN	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	22	NMOD
26	)	)	O	)	O	25	P
27	or	or	O	CC	O	28	AMOD
28	B7-negative	B7-negative	O	JJ	B-cell_line	33	NMOD
29	(	(	O	(	I-cell_line	30	P
30	endothelial	endothelial	B-ADJP	JJ	I-cell_line	28	AMOD
31	)	)	O	)	I-cell_line	30	P
32	accessory	accessory	B-NP	JJ	I-cell_line	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
34	,	,	O	,	O	13	P
35	are	be	B-VP	VBP	O	0	ROOT
36	mediated	mediate	I-VP	VBN	O	35	VC
37	through	through	B-PP	IN	O	36	VMOD
38	the	the	B-NP	DT	O	40	NMOD
39	same	same	I-NP	JJ	O	40	NMOD
40	cis-elements	cis-element	I-NP	NNS	B-DNA	37	PMOD
41	.	.	O	.	O	35	P

1	Interestingly	Interestingly	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	the	the	B-NP	DT	O	5	NMOD
4	nuclear	nuclear	I-NP	JJ	B-DNA	5	NMOD
5	factor	factor	I-NP	NN	I-DNA	11	SUB
6	of	of	B-PP	IN	I-DNA	5	NMOD
7	activated	activate	B-NP	VBN	I-DNA	10	NMOD
8	T	T	I-NP	NN	I-DNA	10	NMOD
9	cell	cell	I-NP	NN	I-DNA	10	NMOD
10	sites	site	I-NP	NNS	I-DNA	6	PMOD
11	are	be	B-VP	VBP	O	0	ROOT
12	much	much	B-ADJP	RB	O	11	PRD
13	less	less	I-ADJP	RBR	O	12	AMOD
14	important	important	I-ADJP	JJ	O	12	AMOD
15	in	in	B-PP	IN	O	11	VMOD
16	normal	normal	B-NP	JJ	B-cell_type	18	NMOD
17	T	T	I-NP	NN	I-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	than	than	B-PP	IN	O	11	VMOD
20	in	in	B-PP	IN	O	19	PMOD
21	Jurkat	Jurkat	B-NP	NN	B-cell_line	23	NMOD
22	T	T	I-NP	NN	I-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	20	PMOD
24	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	2	SUB
2	conclude	conclude	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	18	DEP
4	IL-2	IL-2	B-NP	NN	B-protein	6	NMOD
5	transcriptional	transcriptional	I-NP	JJ	O	6	NMOD
6	regulation	regulation	I-NP	NN	O	7	SUB
7	differs	differ	B-VP	VBZ	O	3	SBAR
8	in	in	B-PP	IN	O	7	VMOD
9	tumor	tumor	B-NP	NN	B-cell_line	11	NMOD
10	cell	cell	I-NP	NN	I-cell_line	11	NMOD
11	lines	line	I-NP	NNS	I-cell_line	8	PMOD
12	compared	compare	B-PP	VBN	O	7	VMOD
13	with	with	B-PP	IN	O	12	VMOD
14	normal	normal	B-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
17	and	and	O	CC	O	18	DEP
18	that	that	B-SBAR	IN	O	2	VMOD
19	different	different	B-NP	JJ	O	21	NMOD
20	costimulatory	costimulatory	I-NP	JJ	O	21	NMOD
21	signals	signal	I-NP	NNS	O	22	SUB
22	converge	converge	B-VP	VBP	O	18	SBAR
23	on	on	B-PP	IN	O	22	VMOD
24	the	the	B-NP	DT	O	26	NMOD
25	same	same	I-NP	JJ	O	26	NMOD
26	cis-elements	cis-element	I-NP	NNS	B-DNA	23	PMOD
27	in	in	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	30	NMOD
29	IL-2	IL-2	I-NP	NN	B-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	27	PMOD
31	.	.	O	.	O	2	P

1	A	A	B-NP	DT	O	3	NMOD
2	hydrophobic	hydrophobic	I-NP	JJ	B-protein	3	NMOD
3	domain	domain	I-NP	NN	I-protein	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	Ca2+-modulating	Ca2+-modulating	B-NP	JJ	B-protein	7	NMOD
6	cyclophilin	cyclophilin	I-NP	NN	I-protein	7	NMOD
7	ligand	ligand	I-NP	NN	I-protein	4	PMOD
8	modulates	modulate	B-VP	VBZ	O	0	ROOT
9	calcium	calcium	B-NP	NN	O	11	NMOD
10	influx	influx	I-NP	NN	O	11	NMOD
11	signaling	signaling	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	PMOD
15	.	.	O	.	O	8	P

1	Ca2+-modulating	Ca2+-modulating	B-NP	JJ	B-protein	3	NMOD
2	cyclophilin	cyclophilin	I-NP	NN	I-protein	3	NMOD
3	ligand	ligand	I-NP	NN	I-protein	7	SUB
4	(	(	O	(	O	5	P
5	CAML	CAML	B-NP	NN	B-protein	3	NMOD
6	)	)	O	)	O	5	P
7	was	be	B-VP	VBD	O	20	VMOD
8	originally	originally	I-VP	RB	O	7	VMOD
9	described	describe	I-VP	VBN	O	7	VC
10	as	as	B-PP	IN	O	9	VMOD
11	a	a	B-NP	DT	O	14	NMOD
12	cyclophilin	cyclophilin	I-NP	NN	B-protein	14	NMOD
13	B-binding	B-binding	I-NP	JJ	I-protein	14	NMOD
14	protein	protein	I-NP	NN	I-protein	10	PMOD
15	whose	whose	B-NP	WP$	O	14	NMOD
16	overexpression	overexpression	I-NP	NN	O	15	NMOD
17	in	in	B-PP	IN	O	16	NMOD
18	T	T	B-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
20	causes	cause	B-VP	VBZ	O	0	ROOT
21	a	a	B-NP	DT	O	22	NMOD
22	rise	rise	I-NP	NN	O	20	OBJ
23	in	in	B-PP	IN	O	20	VMOD
24	intracellular	intracellular	B-NP	JJ	O	25	NMOD
25	calcium	calcium	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	20	P
27	thus	thus	B-ADVP	RB	O	28	VMOD
28	activating	activate	B-VP	VBG	O	20	VMOD
29	transcription	transcription	B-NP	NN	B-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	28	OBJ
31	responsible	responsible	B-ADJP	JJ	O	30	NMOD
32	for	for	B-PP	IN	O	31	AMOD
33	the	the	B-NP	DT	O	36	NMOD
34	early	early	I-NP	JJ	O	36	NMOD
35	immune	immune	I-NP	JJ	O	36	NMOD
36	response	response	I-NP	NN	O	32	PMOD
37	.	.	O	.	O	20	P

1	As	As	B-SBAR	IN	O	15	VMOD
2	reported	report	B-VP	VBN	O	1	SBAR
3	here	here	B-ADVP	RB	O	2	VMOD
4	,	,	O	,	O	15	P
5	structure-function	structure-function	B-NP	JJ	O	6	NMOD
6	analysis	analysis	I-NP	NN	O	15	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	CAML	CAML	I-NP	NN	B-DNA	10	NMOD
10	gene	gene	I-NP	NN	I-DNA	7	PMOD
11	in	in	B-PP	IN	O	6	NMOD
12	Jurkat	Jurkat	B-NP	NN	B-cell_line	14	NMOD
13	T	T	I-NP	NN	I-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	11	PMOD
15	indicates	indicate	B-VP	VBZ	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	two	two	B-NP	CD	O	24	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	CAML	CAML	B-NP	NN	B-protein	20	NMOD
20	's	's	B-NP	POS	O	18	PMOD
21	putative	putative	I-NP	JJ	B-protein	23	NMOD
22	membrane-spanning	membrane-spanning	I-NP	JJ	I-protein	23	NMOD
23	domains	domain	I-NP	NNS	I-protein	20	NMOD
24	are	be	B-VP	VBP	O	16	SBAR
25	necessary	necessary	B-ADJP	JJ	O	27	AMOD
26	and	and	I-ADJP	CC	O	27	AMOD
27	sufficient	sufficient	I-ADJP	JJ	O	24	PRD
28	for	for	B-PP	IN	O	27	AMOD
29	the	the	B-NP	DT	O	30	NMOD
30	modulation	modulation	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	intracellular	intracellular	B-NP	JJ	O	33	NMOD
33	calcium	calcium	I-NP	NN	O	31	PMOD
34	.	.	O	.	O	15	P

1	We	We	B-NP	PRP	O	2	SUB
2	propose	propose	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	7	NMOD
5	hydrophobic	hydrophobic	I-NP	JJ	B-protein	7	NMOD
6	C-terminal	C-terminal	I-NP	JJ	I-protein	7	NMOD
7	tail	tail	I-NP	NN	I-protein	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	CAML	CAML	B-NP	NN	B-protein	8	PMOD
10	forms	form	B-VP	VBZ	O	3	SBAR
11	its	its	B-NP	PRP$	O	13	NMOD
12	effector	effector	I-NP	NN	B-protein	13	NMOD
13	domain	domain	I-NP	NN	I-protein	10	OBJ
14	,	,	O	,	O	2	P
15	thus	thus	B-ADVP	RB	O	16	VMOD
16	implicating	implicate	B-VP	VBG	O	2	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	N-terminal	N-terminal	I-NP	JJ	B-protein	20	NMOD
19	hydrophilic	hydrophilic	I-NP	JJ	I-protein	20	NMOD
20	domain	domain	I-NP	NN	I-protein	16	OBJ
21	in	in	B-PP	IN	O	16	VMOD
22	a	a	B-NP	DT	O	24	NMOD
23	regulatory	regulatory	I-NP	JJ	O	24	NMOD
24	role	role	I-NP	NN	O	21	PMOD
25	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	define	define	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	7	NMOD
5	novel	novel	I-NP	JJ	B-protein	7	NMOD
6	protein	protein	I-NP	NN	I-protein	7	NMOD
7	motif	motif	I-NP	NN	I-protein	3	OBJ
8	that	that	B-NP	WDT	O	7	NMOD
9	functions	function	B-VP	VBZ	O	8	SBAR
10	in	in	B-PP	IN	O	9	VMOD
11	intracellular	intracellular	B-NP	JJ	O	13	NMOD
12	calcium	calcium	I-NP	NN	O	13	NMOD
13	signaling	signaling	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	3	P

1	Interactions	Interaction	B-NP	NNS	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	5	NMOD
4	transcriptional	transcriptional	I-NP	JJ	B-protein	5	NMOD
5	activator	activator	I-NP	NN	I-protein	2	PMOD
6	in	in	B-PP	IN	O	1	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	env	env	I-NP	NN	B-DNA	9	NMOD
9	gene	gene	I-NP	NN	I-DNA	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	15	NMOD
12	mouse	mouse	I-NP	NN	O	15	NMOD
13	mammary	mammary	I-NP	JJ	O	15	NMOD
14	tumor	tumor	I-NP	NN	O	15	NMOD
15	virus	virus	I-NP	NN	O	10	PMOD
16	with	with	B-PP	IN	O	15	NMOD
17	activation-dependent	activation-dependent	B-NP	JJ	O	22	NMOD
18	,	,	I-NP	,	O	22	P
19	T	T	I-NP	NN	B-protein	22	NMOD
20	cell-specific	cell-specific	I-NP	JJ	I-protein	22	NMOD
21	transacting	transact	I-NP	VBG	I-protein	22	NMOD
22	factors	factor	I-NP	NNS	I-protein	16	PMOD
23	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	7	NMOD
2	mouse	mouse	I-NP	NN	B-DNA	7	NMOD
3	mammary	mammary	I-NP	JJ	I-DNA	7	NMOD
4	tumor	tumor	I-NP	NN	I-DNA	7	NMOD
5	virus	virus	I-NP	NN	I-DNA	7	NMOD
6	env	env	I-NP	NN	I-DNA	7	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	SUB
8	contains	contain	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	transcriptional	transcriptional	I-NP	JJ	B-protein	11	NMOD
11	activator	activator	I-NP	NN	I-protein	8	OBJ
12	(	(	O	(	O	13	P
13	META	META	B-NP	NN	B-DNA	11	NMOD
14	)	)	O	)	O	13	P
15	that	that	B-NP	WDT	O	11	NMOD
16	can	can	B-VP	MD	O	15	SBAR
17	control	control	I-VP	VB	O	16	VC
18	transcription	transcription	B-NP	NN	O	17	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	25	NMOD
21	adjacent	adjacent	I-NP	JJ	B-DNA	25	NMOD
22	long	long	I-NP	JJ	I-DNA	25	NMOD
23	terminal	terminal	I-NP	JJ	I-DNA	25	NMOD
24	repeat	repeat	I-NP	NN	I-DNA	25	NMOD
25	region	region	I-NP	NN	I-DNA	19	PMOD
26	.	.	O	.	O	8	P

1	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD
2	control	control	I-NP	NN	O	5	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	META	META	B-NP	NN	B-protein	3	PMOD
5	parallels	parallel	B-VP	VBZ	O	0	ROOT
6	that	that	B-NP	DT	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	several	several	B-NP	JJ	O	10	NMOD
9	lymphokine	lymphokine	I-NP	NN	B-DNA	10	NMOD
10	genes	gene	I-NP	NNS	I-DNA	7	PMOD
11	,	,	O	,	O	5	P
12	being	be	B-VP	VBG	O	5	VMOD
13	specific	specific	B-ADJP	JJ	O	12	VMOD
14	to	to	B-PP	TO	O	13	AMOD
15	T	T	B-NP	NN	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
17	,	,	O	,	O	13	P
18	dependent	dependent	B-ADJP	JJ	O	13	NMOD
19	on	on	B-PP	IN	O	18	AMOD
20	their	their	B-NP	PRP$	O	21	NMOD
21	activation	activation	I-NP	NN	O	19	PMOD
22	,	,	O	,	O	13	P
23	and	and	O	CC	O	13	DEP
24	inhibited	inhibit	B-VP	VBN	O	13	DEP
25	by	by	B-PP	IN	O	24	VMOD
26	the	the	B-NP	DT	O	29	NMOD
27	immunosuppressive	immunosuppressive	I-NP	JJ	O	29	NMOD
28	drug	drug	I-NP	NN	O	29	NMOD
29	cyclosporine	cyclosporine	I-NP	NN	O	25	PMOD
30	(	(	O	(	O	31	P
31	CsA	CsA	B-NP	NN	O	29	NMOD
32	)	)	O	)	O	31	P
33	.	.	O	.	O	5	P

1	DNase	DNase	B-NP	NN	B-protein	3	NMOD
2	I	I	I-NP	CD	I-protein	3	NMOD
3	footprinting	footprinting	I-NP	NN	O	4	SUB
4	indicated	indicate	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD
7	factors	factor	I-NP	NNS	I-protein	12	SUB
8	from	from	B-PP	IN	O	7	NMOD
9	activated	activate	B-NP	VBN	B-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	8	PMOD
12	bound	bind	B-VP	VBD	O	5	SBAR
13	a	a	B-NP	DT	O	15	NMOD
14	promoter-proximal	promoter-proximal	I-NP	JJ	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	12	OBJ
16	,	,	O	,	O	25	P
17	META	META	B-NP	NN	B-DNA	25	NMOD
18	(	(	O	(	I-DNA	19	P
19	P	P	B-NP	NN	I-DNA	17	NMOD
20	)	)	O	)	I-DNA	19	P
21	,	,	O	,	O	25	P
22	and	and	O	CC	O	25	NMOD
23	a	a	B-NP	DT	O	25	NMOD
24	promoter-distal	promoter-distal	I-NP	JJ	B-DNA	25	NMOD
25	site	site	I-NP	NN	I-DNA	15	NMOD
26	,	,	O	,	O	27	P
27	META	META	B-NP	NN	B-DNA	25	NMOD
28	(	(	O	(	I-DNA	29	P
29	D+	D+	B-NP	NN	I-DNA	27	NMOD
30	)	)	O	)	I-DNA	29	P
31	,	,	O	,	O	27	P
32	within	within	B-PP	IN	O	27	NMOD
33	the	the	B-NP	DT	O	37	NMOD
34	400-base	400-base	I-NP	JJ	B-DNA	37	NMOD
35	pair	pair	I-NP	NN	I-DNA	37	NMOD
36	META	META	I-NP	NN	I-DNA	37	NMOD
37	region	region	I-NP	NN	I-DNA	32	PMOD
38	.	.	O	.	O	4	P

1	Nuclear	Nuclear	B-NP	JJ	B-protein	2	NMOD
2	factors	factor	I-NP	NNS	I-protein	12	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	unstimulated	unstimulated	B-NP	JJ	O	3	PMOD
5	,	,	B-PP	,	O	3	P
6	but	but	I-PP	CC	O	3	PMOD
7	not	not	I-PP	RB	O	8	PMOD
8	from	from	B-PP	IN	O	3	PMOD
9	activated	activate	B-NP	VBN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	,	,	O	,	O	2	P
12	bound	bind	B-VP	VBD	O	0	ROOT
13	a	a	B-NP	DT	O	14	NMOD
14	site	site	I-NP	NN	O	12	OBJ
15	,	,	O	,	O	16	P
16	META	META	B-NP	NN	B-DNA	14	NMOD
17	(	(	O	(	I-DNA	18	P
18	D-	D-	B-NP	NN	I-DNA	16	NMOD
19	)	)	O	)	I-DNA	18	P
20	,	,	O	,	O	16	P
21	adjacent	adjacent	B-ADJP	JJ	O	16	NMOD
22	to	to	B-PP	TO	O	21	AMOD
23	META	META	B-NP	NN	B-DNA	22	PMOD
24	(	(	O	(	I-DNA	25	P
25	D+	D+	B-NP	NN	I-DNA	23	NMOD
26	)	)	O	)	I-DNA	25	P
27	.	.	O	.	O	12	P

1	META	META	B-NP	NN	B-DNA	5	SUB
2	(	(	O	(	I-DNA	3	P
3	D+	D+	B-NP	NN	I-DNA	1	NMOD
4	)	)	O	)	I-DNA	3	P
5	directed	direct	B-VP	VBD	O	17	VMOD
6	transcription	transcription	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	11	NMOD
9	linked	link	I-NP	VBN	O	11	NMOD
10	luciferase	luciferase	I-NP	NN	B-DNA	11	NMOD
11	gene	gene	I-NP	NN	I-DNA	7	PMOD
12	,	,	O	,	O	17	P
13	and	and	O	CC	O	17	VMOD
14	gel	gel	B-NP	NN	O	16	NMOD
15	shift	shift	I-NP	NN	O	16	NMOD
16	analysis	analysis	I-NP	NN	O	17	SUB
17	revealed	reveal	B-VP	VBD	O	0	ROOT
18	binding	binding	B-NP	NN	O	17	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	inducible	inducible	B-NP	JJ	O	22	AMOD
21	,	,	I-NP	,	O	22	P
22	CsA-sensitive	CsA-sensitive	I-NP	JJ	B-protein	25	NMOD
23	T	T	I-NP	NN	I-protein	25	NMOD
24	cell	cell	I-NP	NN	I-protein	25	NMOD
25	factors	factor	I-NP	NNS	I-protein	19	PMOD
26	,	,	O	,	O	25	P
27	in	in	B-PP	IN	O	18	NMOD
28	parallel	parallel	B-NP	NN	O	27	PMOD
29	with	with	B-PP	IN	O	28	NMOD
30	transfection	transfection	B-NP	NN	O	31	NMOD
31	results	result	I-NP	NNS	O	29	PMOD
32	.	.	O	.	O	17	P

1	Authentic	Authentic	B-NP	JJ	O	5	NMOD
2	NFAT	NFAT	I-NP	NN	B-protein	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	1	NMOD
5	targets	target	I-NP	NNS	O	6	SUB
6	did	do	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	compete	compete	I-VP	VB	O	6	VC
9	for	for	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	18	NMOD
11	META	META	I-NP	NN	B-protein	16	NMOD
12	(	(	O	(	I-protein	13	P
13	D+	D+	B-NP	NN	I-protein	11	NMOD
14	)	)	O	)	I-protein	13	P
15	binding	binding	B-NP	NN	I-protein	16	NMOD
16	factor	factor	I-NP	NN	I-protein	18	NMOD
17	(	(	I-NP	(	O	18	P
18	s	s	I-NP	NNS	O	9	PMOD
19	)	)	O	)	O	18	P
20	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	SV40	SV40	I-NP	NN	B-DNA	4	NMOD
3	core	core	I-NP	NN	I-DNA	4	NMOD
4	sequence	sequence	I-NP	NN	I-DNA	5	SUB
5	competed	compete	B-VP	VBD	O	19	VMOD
6	for	for	B-PP	IN	O	5	VMOD
7	META	META	B-NP	NN	B-protein	12	NMOD
8	(	(	O	(	I-protein	12	P
9	D+	D+	B-NP	NN	I-protein	12	NMOD
10	)	)	O	)	I-protein	12	P
11	binding	binding	B-NP	NN	I-protein	12	NMOD
12	factors	factor	I-NP	NNS	I-protein	6	PMOD
13	,	,	O	,	O	19	P
14	but	but	O	CC	O	19	VMOD
15	META	META	B-NP	NN	B-DNA	19	SUB
16	(	(	O	(	I-DNA	17	P
17	D+	D+	B-NP	NN	I-DNA	15	NMOD
18	)	)	O	)	I-DNA	17	P
19	failed	fail	B-VP	VBD	O	0	ROOT
20	to	to	I-VP	TO	O	21	VMOD
21	compete	compete	I-VP	VB	O	19	VMOD
22	for	for	B-PP	IN	O	21	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	complexes	complex	I-NP	NNS	O	22	PMOD
25	obtained	obtain	B-VP	VBN	O	24	NMOD
26	with	with	B-PP	IN	O	25	VMOD
27	the	the	B-NP	DT	O	29	NMOD
28	SV40	SV40	I-NP	NN	O	29	NMOD
29	probe	probe	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	19	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	7	SUB
3	,	,	O	,	O	2	P
4	taken	take	B-VP	VBN	O	2	NMOD
5	together	together	B-ADVP	RB	O	4	VMOD
6	,	,	O	,	O	2	P
7	indicate	indicate	B-VP	VBP	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	META	META	B-NP	NN	B-DNA	13	SUB
10	(	(	O	(	I-DNA	11	P
11	D+	D+	B-NP	NN	I-DNA	9	NMOD
12	)	)	O	)	I-DNA	11	P
13	is	be	B-VP	VBZ	O	8	SBAR
14	a	a	B-NP	DT	O	15	NMOD
15	novel	novel	I-NP	JJ	O	32	NMOD
16	transcriptional	transcriptional	I-NP	JJ	B-DNA	18	NMOD
17	enhancer	enhancer	I-NP	NN	I-DNA	18	NMOD
18	element	element	I-NP	NN	I-DNA	15	NMOD
19	that	that	B-NP	WDT	O	15	NMOD
20	is	be	B-VP	VBZ	O	19	SBAR
21	similar	similar	B-ADJP	JJ	O	20	PRD
22	in	in	B-PP	IN	O	21	AMOD
23	its	its	B-NP	PRP$	O	25	NMOD
24	cell-type	cell-type	I-NP	JJ	O	25	NMOD
25	specificity	specificity	I-NP	NN	O	22	PMOD
26	,	,	O	,	O	32	P
27	activation	activation	B-NP	NN	O	28	NMOD
28	dependence	dependence	I-NP	NN	O	32	NMOD
29	,	,	O	,	O	32	P
30	and	and	O	CC	O	32	NMOD
31	CsA	CsA	B-NP	NN	O	32	NMOD
32	sensitivity	sensitivity	I-NP	NN	O	13	PRD
33	to	to	B-PP	TO	O	32	NMOD
34	the	the	B-NP	DT	O	36	NMOD
35	NFAT	NFAT	I-NP	NN	B-DNA	36	NMOD
36	element	element	I-NP	NN	I-DNA	33	PMOD
37	.	.	O	.	O	7	P

1	It	It	B-NP	PRP	O	2	SUB
2	may	may	B-VP	MD	O	0	ROOT
3	be	be	I-VP	VB	O	2	VC
4	relevant	relevant	B-ADJP	JJ	O	3	PRD
5	to	to	B-PP	TO	O	4	AMOD
6	the	the	B-NP	DT	O	7	NMOD
7	role	role	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	MMTV	MMTV	B-NP	NN	B-protein	8	PMOD
10	in	in	B-PP	IN	O	7	NMOD
11	expression	expression	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	Mls	Ml	B-NP	NNS	B-protein	14	NMOD
14	antigens	antigen	I-NP	NNS	I-protein	17	NMOD
15	or	or	O	CC	O	17	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	induction	induction	I-NP	NN	O	12	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	T	T	B-NP	NN	B-cell_type	21	NMOD
20	cell	cell	I-NP	NN	I-cell_type	21	NMOD
21	lymphomas	lymphoma	I-NP	NNS	I-cell_type	18	PMOD
22	.	.	O	.	O	2	P

1	Monocytic	Monocytic	B-NP	JJ	O	5	NMOD
2	cell	cell	I-NP	NN	O	5	NMOD
3	type-specific	type-specific	I-NP	JJ	O	2	AMOD
4	transcriptional	transcriptional	I-NP	JJ	O	5	NMOD
5	induction	induction	I-NP	NN	O	0	ROOT
6	of	of	B-PP	IN	O	5	NMOD
7	collagenase	collagenase	B-NP	NN	B-protein	6	PMOD
8	.	.	O	.	O	5	P

1	Interstitial	Interstitial	B-NP	JJ	O	2	NMOD
2	collagenase	collagenase	I-NP	NN	B-protein	8	NMOD
3	(	(	O	(	O	4	P
4	MMP-1	MMP-1	B-NP	NN	B-protein	2	NMOD
5	)	)	O	)	O	4	P
6	,	,	O	,	O	8	P
7	a	a	B-NP	DT	O	8	NMOD
8	metalloproteinase	metalloproteinase	I-NP	NN	B-protein	20	SUB
9	produced	produce	B-VP	VBN	O	8	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	resident	resident	B-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	inflammatory	inflammatory	I-NP	JJ	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
15	during	during	B-PP	IN	O	9	VMOD
16	connective	connective	B-NP	JJ	O	18	NMOD
17	tissue	tissue	I-NP	NN	O	18	NMOD
18	turnover	turnover	I-NP	NN	O	15	PMOD
19	,	,	O	,	O	8	P
20	cleaves	cleave	B-VP	VBZ	O	0	ROOT
21	type	type	B-NP	NN	B-protein	24	NMOD
22	I	I	I-NP	CD	I-protein	24	NMOD
23	collagen	collagen	I-NP	NN	I-protein	24	NMOD
24	fibrils	fibril	I-NP	NNS	I-protein	20	OBJ
25	.	.	O	.	O	20	P

1	This	This	B-NP	DT	O	3	NMOD
2	catalytic	catalytic	I-NP	JJ	O	3	NMOD
3	event	event	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	rate	rate	B-NP	NN	O	4	PRD
6	limiting	limit	B-VP	VBG	O	5	NMOD
7	in	in	B-PP	IN	O	6	VMOD
8	remodeling	remodeling	B-NP	NN	O	7	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	tissues	tissue	B-NP	NNS	O	9	PMOD
11	rich	rich	B-ADJP	JJ	O	10	NMOD
12	in	in	B-PP	IN	O	11	AMOD
13	fibrillar	fibrillar	B-NP	JJ	B-protein	14	NMOD
14	collagen	collagen	I-NP	NN	I-protein	12	PMOD
15	such	such	B-PP	JJ	O	16	PMOD
16	as	as	I-PP	IN	O	14	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	skin	skin	I-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	lungs	lung	I-NP	NNS	O	16	PMOD
21	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	collagenase	collagenase	B-NP	NN	B-protein	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	is	be	B-VP	VBZ	O	21	VMOD
7	cell-type	cell-type	B-ADJP	JJ	O	8	AMOD
8	specific	specific	B-ADJP	JJ	O	6	PRD
9	;	;	O	:	O	21	P
10	bacterial	bacterial	B-NP	JJ	O	11	NMOD
11	LPS	LPS	I-NP	NN	O	13	NMOD
12	and	and	I-NP	CC	O	13	NMOD
13	zymosan	zymosan	I-NP	NN	O	19	NMOD
14	,	,	O	,	O	19	P
15	a	a	B-NP	DT	O	19	NMOD
16	yeast	yeast	I-NP	NN	O	19	NMOD
17	cell	cell	I-NP	NN	O	19	NMOD
18	wall	wall	I-NP	NN	O	19	NMOD
19	derivative	derivative	I-NP	NN	O	21	SUB
20	,	,	O	,	O	19	P
21	are	be	B-VP	VBP	O	0	ROOT
22	potent	potent	B-NP	JJ	O	23	NMOD
23	inducers	inducer	I-NP	NNS	O	21	PRD
24	of	of	B-PP	IN	O	23	NMOD
25	collagenase	collagenase	B-NP	NN	B-protein	26	NMOD
26	expression	expression	I-NP	NN	O	24	PMOD
27	in	in	B-PP	IN	O	26	NMOD
28	macrophages	macrophage	B-NP	NNS	B-cell_type	27	PMOD
29	,	,	O	,	O	21	P
30	but	but	O	CC	O	21	VMOD
31	do	do	B-VP	VBP	O	21	VMOD
32	not	not	I-VP	RB	O	31	VMOD
33	alter	alter	I-VP	VB	O	31	VC
34	fibroblast	fibroblast	B-NP	NN	O	36	NMOD
35	collagenase	collagenase	I-NP	NN	B-protein	36	NMOD
36	expression	expression	I-NP	NN	O	33	OBJ
37	.	.	O	.	O	21	P

1	Since	Since	B-SBAR	IN	O	17	VMOD
2	promoter	promoter	B-NP	NN	B-DNA	3	NMOD
3	elements	element	I-NP	NNS	I-DNA	10	SUB
4	controlling	control	B-VP	VBG	O	3	NMOD
5	collagenase	collagenase	B-NP	NN	B-protein	6	NMOD
6	transcription	transcription	I-NP	NN	O	4	OBJ
7	in	in	B-PP	IN	O	4	VMOD
8	monocytic	monocytic	B-NP	JJ	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	have	have	B-VP	VBP	O	1	SBAR
11	not	not	I-VP	RB	O	10	VMOD
12	been	be	I-VP	VBN	O	10	VC
13	previously	previously	I-VP	RB	O	12	VMOD
14	defined	define	I-VP	VBN	O	12	VC
15	,	,	O	,	O	17	P
16	we	we	B-NP	PRP	O	17	SUB
17	sought	seek	B-VP	VBD	O	0	ROOT
18	to	to	I-VP	TO	O	19	VMOD
19	delineate	delineate	I-VP	VB	O	17	VMOD
20	responsive	responsive	B-NP	JJ	O	22	NMOD
21	cis-acting	cis-acting	I-NP	JJ	B-DNA	22	NMOD
22	elements	element	I-NP	NNS	I-DNA	19	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	collagenase	collagenase	I-NP	NN	B-DNA	26	NMOD
26	promoter	promoter	I-NP	NN	I-DNA	23	PMOD
27	in	in	B-PP	IN	O	19	VMOD
28	transiently	transiently	B-NP	RB	O	29	AMOD
29	transfected	transfecte	I-NP	VBN	O	30	NMOD
30	human	human	I-NP	JJ	B-cell_line	41	NMOD
31	(	(	O	(	I-cell_line	32	P
32	U937	U937	B-NP	NN	I-cell_line	30	NMOD
33	)	)	O	)	I-cell_line	32	P
34	and	and	O	CC	I-cell_line	35	AMOD
35	murine	murine	B-NP	JJ	I-cell_line	41	NMOD
36	(	(	O	(	I-cell_line	37	P
37	J774	J774	B-NP	NN	I-cell_line	35	AMOD
38	)	)	I-NP	)	I-cell_line	37	P
39	monocytic	monocytic	I-NP	JJ	I-cell_line	41	NMOD
40	cell	cell	I-NP	NN	I-cell_line	41	NMOD
41	lines	line	I-NP	NNS	I-cell_line	27	PMOD
42	.	.	O	.	O	17	P

1	Deletion	Deletion	B-NP	NN	O	2	NMOD
2	constructs	construct	I-NP	NNS	O	18	SUB
3	containing	contain	B-VP	VBG	O	2	NMOD
4	as	as	B-NP	RB	O	6	AMOD
5	little	little	I-NP	JJ	O	6	AMOD
6	as	as	I-NP	IN	O	8	NMOD
7	72	72	I-NP	CD	O	6	AMOD
8	bp	bp	I-NP	NN	O	3	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	5	5	B-NP	CD	B-DNA	13	NMOD
11	'	'	I-NP	SYM	I-DNA	12	AMOD
12	-flanking	-flanking	I-NP	JJ	I-DNA	13	NMOD
13	sequence	sequence	I-NP	NN	I-DNA	9	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	collagenase	collagenase	I-NP	NN	B-DNA	17	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	14	PMOD
18	were	be	B-VP	VBD	O	27	VMOD
19	sufficient	sufficient	B-ADJP	JJ	O	18	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	LPS-	LPS-	B-NP	NN	O	25	NMOD
22	or	or	O	CC	O	25	NMOD
23	zymosan-mediated	zymosan-mediated	B-NP	JJ	O	25	NMOD
24	transcriptional	transcriptional	I-NP	JJ	O	25	NMOD
25	induction	induction	I-NP	NN	O	20	PMOD
26	,	,	O	,	O	27	P
27	whereas	whereas	O	IN	O	0	ROOT
28	phorbol	phorbol	B-NP	NN	O	29	NMOD
29	inducibility	inducibility	I-NP	NN	O	30	SUB
30	exhibited	exhibit	B-VP	VBD	O	27	VMOD
31	an	an	B-NP	DT	O	33	NMOD
32	absolute	absolute	I-NP	JJ	O	33	NMOD
33	requirement	requirement	I-NP	NN	O	30	OBJ
34	for	for	B-PP	IN	O	33	NMOD
35	upstream	upstream	B-NP	JJ	B-DNA	36	NMOD
36	elements	element	I-NP	NNS	I-DNA	34	PMOD
37	including	include	B-PP	VBG	O	36	NMOD
38	the	the	B-NP	DT	O	43	NMOD
39	polyoma	polyoma	I-NP	NN	B-DNA	43	NMOD
40	enhancer	enhancer	I-NP	NN	I-DNA	43	NMOD
41	A-binding	A-binding	I-NP	JJ	I-DNA	43	NMOD
42	protein-3	protein-3	I-NP	NN	I-DNA	43	NMOD
43	site	site	I-NP	NN	I-DNA	51	NMOD
44	(	(	O	(	O	47	P
45	-83	-83	B-NP	CD	B-DNA	47	NMOD
46	to	to	O	TO	I-DNA	47	NMOD
47	-91	-91	B-NP	CD	I-DNA	43	NMOD
48	)	)	O	)	O	47	P
49	and	and	O	CC	O	51	NMOD
50	TTCA	TTCA	B-NP	NN	B-DNA	51	NMOD
51	sequence	sequence	I-NP	NN	I-DNA	37	PMOD
52	(	(	O	(	O	55	P
53	-102	-102	B-NP	CD	B-DNA	55	NMOD
54	to	to	O	TO	I-DNA	55	NMOD
55	-105	-105	B-NP	CD	I-DNA	51	NMOD
56	)	)	O	)	O	55	P
57	in	in	B-PP	IN	O	51	NMOD
58	both	both	B-NP	CC	O	62	NMOD
59	monocytic	monocytic	I-NP	JJ	B-cell_type	60	NMOD
60	cells	cell	I-NP	NNS	I-cell_type	62	NMOD
61	and	and	I-NP	CC	O	62	NMOD
62	fibroblasts	fibroblast	I-NP	NNS	B-cell_type	57	PMOD
63	.	.	O	.	O	27	P

1	Mutagenesis	Mutagenesis	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	9	NMOD
4	activator	activator	I-NP	NN	B-DNA	9	NMOD
5	protein-1	protein-1	I-NP	NN	I-DNA	9	NMOD
6	[	[	O	(	I-DNA	9	P
7	AP-1	AP-1	B-NP	NN	I-DNA	9	NMOD
8	]	]	O	)	I-DNA	9	P
9	site	site	B-NP	NN	I-DNA	2	PMOD
10	at	at	B-PP	IN	O	1	NMOD
11	-72	-72	B-NP	CD	O	10	PMOD
12	abolished	abolish	B-VP	VBD	O	0	ROOT
13	basal	basal	B-NP	JJ	B-DNA	15	NMOD
14	promoter	promoter	I-NP	NN	I-DNA	15	NMOD
15	activity	activity	I-NP	NN	O	18	NMOD
16	and	and	O	CC	O	18	NMOD
17	LPS/zymosan	LPS/zymosan	B-NP	NN	O	18	NMOD
18	inducibility	inducibility	I-NP	NN	O	12	OBJ
19	,	,	O	,	O	12	P
20	while	while	B-SBAR	IN	O	12	VMOD
21	mutagenesis	mutagenesis	B-NP	NN	O	30	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	an	an	B-NP	DT	O	25	NMOD
24	NF-kappaB-like	NF-kappaB-like	I-NP	JJ	B-DNA	25	NMOD
25	site	site	I-NP	NN	I-DNA	22	PMOD
26	at	at	B-PP	IN	O	21	NMOD
27	-20	-20	B-NP	CD	B-DNA	29	NMOD
28	to	to	B-PP	TO	I-DNA	29	NMOD
29	-10	-10	B-NP	CD	I-DNA	26	PMOD
30	had	have	B-VP	VBD	O	20	SBAR
31	no	no	B-NP	DT	O	32	NMOD
32	effect	effect	I-NP	NN	O	30	OBJ
33	.	.	O	.	O	12	P

1	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD
2	extracts	extract	I-NP	NNS	O	8	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	LPS-	LPS-	B-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	zymosan-treated	zymosan-treated	B-NP	JJ	B-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
8	showed	show	B-VP	VBD	O	19	VMOD
9	strong	strong	B-NP	JJ	O	11	NMOD
10	AP-1	AP-1	I-NP	NN	B-protein	11	NMOD
11	activity	activity	I-NP	NN	O	8	OBJ
12	by	by	B-PP	IN	O	11	NMOD
13	gel-shift	gel-shift	B-NP	JJ	O	14	NMOD
14	analysis	analysis	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	19	P
16	and	and	O	CC	O	19	VMOD
17	supershift	supershift	B-NP	NN	O	18	NMOD
18	analysis	analysis	I-NP	NN	O	19	SUB
19	showed	show	B-VP	VBD	O	0	ROOT
20	the	the	B-NP	DT	O	22	NMOD
21	AP-1	AP-1	I-NP	NN	B-protein	22	NMOD
22	complexes	complex	I-NP	NNS	I-protein	23	SUB
23	contained	contain	B-VP	VBD	O	19	VMOD
24	specific	specific	B-NP	JJ	O	25	NMOD
25	members	member	I-NP	NNS	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	both	both	O	CC	O	33	NMOD
28	the	the	O	DT	O	33	NMOD
29	jun	jun	B-NP	NN	B-DNA	33	NMOD
30	and	and	I-NP	CC	I-DNA	33	NMOD
31	fos	fos	I-NP	NN	I-DNA	33	NMOD
32	gene	gene	I-NP	NN	I-DNA	33	NMOD
33	families	family	I-NP	NNS	I-DNA	26	PMOD
34	.	.	O	.	O	19	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	,	,	O	,	O	4	P
6	in	in	B-PP	IN	O	20	VMOD
7	contrast	contrast	B-NP	NN	O	6	PMOD
8	to	to	B-PP	TO	O	6	PMOD
9	most	most	B-NP	JJS	O	11	NMOD
10	LPS	LPS	I-NP	NN	O	11	NMOD
11	effects	effect	I-NP	NNS	O	6	PMOD
12	,	,	O	,	O	20	P
13	AP-1	AP-1	B-NP	NN	B-protein	18	NMOD
14	,	,	O	,	O	18	P
15	but	but	O	CC	O	18	NMOD
16	not	not	O	RB	O	15	DEP
17	nuclear	nuclear	B-NP	JJ	B-protein	18	NMOD
18	factor-kappaB	factor-kappaB	I-NP	NN	I-protein	20	SUB
19	,	,	O	,	O	18	P
20	mediates	mediate	B-VP	VBZ	O	4	SBAR
21	LPS	LPS	B-NP	NN	O	22	NMOD
22	induction	induction	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	collagenase	collagenase	B-NP	NN	B-protein	25	NMOD
25	transcription	transcription	I-NP	NN	O	23	PMOD
26	in	in	B-PP	IN	O	22	NMOD
27	macrophagelike	macrophagelike	B-NP	JJ	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	24	VMOD
2	,	,	O	,	O	24	P
3	as	as	B-SBAR	IN	O	24	VMOD
4	compared	compare	B-VP	VBN	O	3	SBAR
5	to	to	B-PP	TO	O	4	VMOD
6	regulation	regulation	B-NP	NN	O	5	PMOD
7	by	by	B-PP	IN	O	6	NMOD
8	phorbol	phorbol	B-NP	NN	O	9	NMOD
9	ester	ester	I-NP	NN	O	7	PMOD
10	,	,	O	,	O	24	P
11	collagenase	collagenase	B-NP	NN	B-protein	12	NMOD
12	induction	induction	I-NP	NN	O	24	SUB
13	in	in	B-PP	IN	O	12	NMOD
14	monocytic	monocytic	B-NP	JJ	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	by	by	B-PP	IN	O	12	NMOD
17	cell	cell	B-NP	NN	O	19	NMOD
18	wall	wall	I-NP	NN	O	19	NMOD
19	derivatives	derivative	I-NP	NNS	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	bacteria	bacteria	B-NP	NNS	O	23	NMOD
22	or	or	I-NP	CC	O	23	NMOD
23	yeast	yeast	I-NP	NN	O	20	PMOD
24	is	be	B-VP	VBZ	O	0	ROOT
25	largely	largely	B-ADJP	RB	O	26	AMOD
26	independent	independent	I-ADJP	JJ	O	24	PRD
27	of	of	B-PP	IN	O	26	AMOD
28	upstream	upstream	B-NP	JJ	B-DNA	30	NMOD
29	promoter	promoter	I-NP	NN	I-DNA	30	NMOD
30	sequences	sequence	I-NP	NNS	I-DNA	27	PMOD
31	.	.	O	.	O	24	P

1	Inhibitory	Inhibitory	B-NP	JJ	O	2	NMOD
2	effect	effect	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	E3330	E3330	B-NP	NN	O	9	NMOD
5	,	,	O	,	O	9	P
6	a	a	B-NP	DT	O	9	NMOD
7	novel	novel	I-NP	JJ	O	9	NMOD
8	quinone	quinone	I-NP	NN	O	9	NMOD
9	derivative	derivative	I-NP	NN	O	3	PMOD
10	able	able	B-ADJP	JJ	O	9	NMOD
11	to	to	B-VP	TO	O	12	VMOD
12	suppress	suppress	I-VP	VB	O	10	AMOD
13	tumor	tumor	B-NP	NN	B-protein	15	NMOD
14	necrosis	necrosis	I-NP	NN	I-protein	15	NMOD
15	factor-alpha	factor-alpha	I-NP	NN	I-protein	16	NMOD
16	generation	generation	I-NP	NN	O	12	OBJ
17	,	,	O	,	O	2	P
18	on	on	B-PP	IN	O	2	NMOD
19	activation	activation	B-NP	NN	O	18	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	nuclear	nuclear	B-NP	JJ	B-protein	23	NMOD
22	factor-kappa	factor-kappa	I-NP	NN	I-protein	23	NMOD
23	B	B	I-NP	NN	I-protein	20	PMOD
24	.	.	O	.	O	2	P

1	(	(	O	(	O	2	P
2	2E	2E	B-NP	NN	O	22	SUB
3	)	)	O	)	O	2	P
4	-3-	-3-	B-NP	CD	O	2	NMOD
5	[	[	O	(	O	22	P
6	5-	5-	B-NP	CD	O	17	NMOD
7	(	(	O	(	O	17	P
8	2	2	B-NP	CD	O	17	NMOD
9	,	,	O	,	O	17	P
10	3-Dimethoxy-6-methyl-1	3-Dimethoxy-6-methyl-1	B-NP	NN	O	17	NMOD
11	,	,	O	,	O	12	P
12	4-benzoquinoyl	4-benzoquinoyl	B-NP	NN	O	10	NMOD
13	)	)	O	)	O	12	P
14	]	]	O	)	O	17	P
15	-2-nonyl-2-	-2-nonyl-2-	B-NP	CD	O	17	NMOD
16	propenoic	propenoic	I-NP	JJ	O	17	NMOD
17	acid	acid	I-NP	NN	O	22	SUB
18	(	(	O	(	O	19	P
19	E3330	E3330	B-NP	NN	O	17	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	17	P
22	is	be	B-VP	VBZ	O	0	ROOT
23	a	a	B-NP	DT	O	25	NMOD
24	novel	novel	I-NP	JJ	O	25	NMOD
25	agent	agent	I-NP	NN	O	22	PRD
26	with	with	B-PP	IN	O	25	NMOD
27	hepatoprotective	hepatoprotective	B-NP	JJ	O	28	NMOD
28	activity	activity	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	22	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	effect	effect	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	E3330	E3330	B-NP	NN	O	5	PMOD
7	on	on	B-PP	IN	O	4	NMOD
8	transcriptional	transcriptional	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	tumor	tumor	B-NP	NN	B-DNA	18	NMOD
12	necrosis	necrosis	I-NP	NN	I-DNA	18	NMOD
13	factor	factor	I-NP	NN	I-DNA	18	NMOD
14	(	(	O	(	I-DNA	18	P
15	TNF	TNF	B-NP	NN	I-DNA	18	NMOD
16	)	)	O	)	I-DNA	18	P
17	-alpha	-alpha	B-NP	NN	I-DNA	18	NMOD
18	gene	gene	I-NP	NN	I-DNA	10	PMOD
19	and	and	B-PP	CC	O	7	PMOD
20	on	on	B-PP	IN	O	7	PMOD
21	nuclear	nuclear	B-NP	JJ	B-protein	27	NMOD
22	factor	factor	I-NP	NN	I-protein	27	NMOD
23	(	(	O	(	I-protein	27	P
24	NF	NF	B-NP	NN	I-protein	27	NMOD
25	)	)	O	)	I-protein	27	P
26	-kappa	-kappa	B-NP	NN	I-protein	27	NMOD
27	B	B	I-NP	NN	I-protein	28	NMOD
28	activation	activation	I-NP	NN	O	20	PMOD
29	.	.	O	.	O	2	P

1	Nuclear	Nuclear	B-NP	JJ	O	3	NMOD
2	run-on	run-on	I-NP	JJ	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	E3330	E3330	B-NP	NN	O	7	SUB
7	decreases	decrease	B-VP	VBZ	O	5	SBAR
8	transcriptional	transcriptional	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	TNF-alpha	TNF-alpha	B-NP	NN	B-DNA	12	NMOD
12	gene	gene	I-NP	NN	I-DNA	10	PMOD
13	induced	induce	B-VP	VBN	O	9	NMOD
14	by	by	B-PP	IN	O	13	VMOD
15	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	19	NMOD
16	(	(	O	(	O	17	P
17	LPS	LPS	B-NP	NN	O	15	NMOD
18	)	)	O	)	O	17	P
19	stimulation	stimulation	B-NP	NN	O	14	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	human	human	B-NP	JJ	B-cell_type	23	NMOD
22	peripheral	peripheral	I-NP	JJ	I-cell_type	23	NMOD
23	monocytes	monocyte	I-NP	NNS	I-cell_type	20	PMOD
24	.	.	O	.	O	4	P

1	To	To	B-VP	TO	O	2	VMOD
2	investigate	investigate	I-VP	VB	O	8	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	inhibitory	inhibitory	I-NP	JJ	O	5	NMOD
5	mechanisms	mechanism	I-NP	NNS	O	2	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	constructed	construct	B-VP	VBD	O	0	ROOT
9	a	a	B-NP	DT	O	18	NMOD
10	secreted-type	secreted-type	I-NP	JJ	B-DNA	18	NMOD
11	placental	placental	I-NP	JJ	I-DNA	18	NMOD
12	alkaline	alkaline	I-NP	NN	I-DNA	18	NMOD
13	phosphatase	phosphatase	I-NP	NN	I-DNA	18	NMOD
14	(	(	O	(	I-DNA	18	P
15	PLAP	PLAP	B-NP	NN	I-DNA	18	NMOD
16	)	)	O	)	I-DNA	18	P
17	reporter	reporter	B-NP	NN	I-DNA	18	NMOD
18	gene	gene	I-NP	NN	I-DNA	8	OBJ
19	whose	whose	B-NP	WP$	O	18	NMOD
20	transcription	transcription	I-NP	NN	O	19	NMOD
21	is	be	B-VP	VBZ	O	19	SBAR
22	controlled	control	I-VP	VBN	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	a	a	B-NP	DT	O	28	NMOD
25	1.4-kb	1.4-kb	I-NP	JJ	B-DNA	28	NMOD
26	human	human	I-NP	JJ	I-DNA	28	NMOD
27	TNF-alpha	TNF-alpha	I-NP	NN	I-DNA	28	NMOD
28	promoter	promoter	I-NP	NN	I-DNA	23	PMOD
29	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	3	NMOD
2	stable	stable	I-NP	JJ	O	3	NMOD
3	transformant	transformant	I-NP	NN	O	15	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	8	NMOD
6	PLAP	PLAP	I-NP	NN	B-DNA	8	NMOD
7	reporter	reporter	I-NP	NN	I-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	4	PMOD
9	derived	derive	B-VP	VBN	O	8	NMOD
10	from	from	B-PP	IN	O	9	VMOD
11	human	human	B-NP	JJ	B-cell_line	14	NMOD
12	monocytic	monocytic	I-NP	JJ	I-cell_line	14	NMOD
13	cell	cell	I-NP	NN	I-cell_line	14	NMOD
14	line	line	I-NP	NN	I-cell_line	10	PMOD
15	showed	show	B-VP	VBD	O	25	VMOD
16	very	very	B-NP	RB	O	17	AMOD
17	little	little	I-NP	JJ	O	18	NMOD
18	activity	activity	I-NP	NN	O	15	OBJ
19	on	on	B-PP	IN	O	15	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	promoter	promoter	I-NP	NN	B-DNA	19	PMOD
22	before	before	B-PP	IN	O	15	VMOD
23	stimulation	stimulation	B-NP	NN	O	22	PMOD
24	,	,	O	,	O	25	P
25	whereas	whereas	O	IN	O	0	ROOT
26	LPS	LPS	B-NP	NN	O	27	NMOD
27	stimulation	stimulation	I-NP	NN	O	28	SUB
28	led	lead	B-VP	VBD	O	25	VMOD
29	to	to	B-PP	TO	O	28	VMOD
30	a	a	B-NP	DT	O	32	NMOD
31	dramatic	dramatic	I-NP	JJ	O	32	NMOD
32	increase	increase	I-NP	NN	O	29	PMOD
33	in	in	B-PP	IN	O	32	NMOD
34	PLAP	PLAP	B-NP	NN	B-protein	35	NMOD
35	activity	activity	I-NP	NN	O	33	PMOD
36	.	.	O	.	O	25	P

1	E3330	E3330	B-NP	NN	O	2	SUB
2	inhibited	inhibit	B-VP	VBD	O	0	ROOT
3	this	this	B-NP	DT	O	6	NMOD
4	induced	induce	I-NP	VBN	O	6	NMOD
5	promoter	promoter	I-NP	NN	O	6	NMOD
6	activity	activity	I-NP	NN	O	2	OBJ
7	in	in	B-PP	IN	O	2	VMOD
8	a	a	B-NP	DT	O	10	NMOD
9	dose-dependent	dose-dependent	I-NP	JJ	O	10	NMOD
10	manner	manner	I-NP	NN	O	7	PMOD
11	.	.	O	.	O	2	P

1	There	There	B-NP	EX	O	2	SUB
2	are	be	B-VP	VBP	O	0	ROOT
3	four	four	B-NP	CD	O	2	PRD
4	putative	putative	I-NP	JJ	O	3	NMOD
5	NF-kappa	NF-kappa	I-NP	NN	B-DNA	8	NMOD
6	B	B	I-NP	NN	I-DNA	8	NMOD
7	binding	binding	I-NP	NN	I-DNA	8	NMOD
8	sites	site	I-NP	NNS	I-DNA	3	NMOD
9	(	(	O	(	O	20	P
10	kappa	kappa	B-NP	NN	B-DNA	11	NMOD
11	B-1	B-1	I-NP	NN	I-DNA	20	NMOD
12	,	,	O	,	O	20	P
13	kappa	kappa	B-NP	NN	B-DNA	14	NMOD
14	B-2	B-2	I-NP	NN	I-DNA	20	NMOD
15	,	,	O	,	O	20	P
16	kappa	kappa	B-NP	NN	B-DNA	17	NMOD
17	B-3	B-3	I-NP	NN	I-DNA	20	NMOD
18	,	,	O	,	O	20	P
19	kappa	kappa	B-NP	NN	B-DNA	20	NMOD
20	B-4	B-4	I-NP	NN	I-DNA	3	NMOD
21	)	)	O	)	O	20	P
22	in	in	B-PP	IN	O	3	NMOD
23	human	human	B-NP	JJ	B-DNA	25	NMOD
24	TNF-alpha	TNF-alpha	I-NP	NN	I-DNA	25	NMOD
25	promoter	promoter	I-NP	NN	I-DNA	22	PMOD
26	.	.	O	.	O	2	P

1	By	By	B-PP	IN	O	8	VMOD
2	using	use	B-VP	VBG	O	1	PMOD
3	mutated	mutate	B-NP	VBN	B-DNA	5	NMOD
4	promoter-PLAP	promoter-PLAP	I-NP	NN	I-DNA	5	NMOD
5	plasmids	plasmid	I-NP	NNS	I-DNA	2	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	established	establish	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	these	these	B-NP	DT	O	13	NMOD
11	NF-kappa	NF-kappa	I-NP	NN	B-DNA	13	NMOD
12	B	B	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	14	SUB
14	were	be	B-VP	VBD	O	9	SBAR
15	necessary	necessary	B-ADJP	JJ	O	14	PRD
16	for	for	B-PP	IN	O	15	AMOD
17	induction	induction	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	20	NMOD
20	transcription	transcription	I-NP	NN	O	18	PMOD
21	on	on	B-PP	IN	O	17	NMOD
22	stimulation	stimulation	B-NP	NN	O	21	PMOD
23	with	with	B-PP	IN	O	22	NMOD
24	LPS	LPS	B-NP	NN	O	23	PMOD
25	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	4	NMOD
2	gel	gel	I-NP	NN	O	4	NMOD
3	retardation	retardation	I-NP	NN	O	4	NMOD
4	experiment	experiment	I-NP	NN	O	9	SUB
5	with	with	B-PP	IN	O	4	NMOD
6	synthetic	synthetic	B-NP	JJ	O	8	NMOD
7	double-stranded	double-stranded	I-NP	JJ	O	8	NMOD
8	oligonucleotides	oligonucleotide	I-NP	NNS	O	5	PMOD
9	showed	show	B-VP	VBD	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	VMOD
11	activated	activate	B-NP	VBN	O	13	NMOD
12	NF-kappa	NF-kappa	I-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	18	SUB
14	consisting	consist	B-VP	VBG	O	13	NMOD
15	of	of	B-PP	IN	O	14	VMOD
16	p50/p65	p50/p65	B-NP	NN	B-protein	17	NMOD
17	heterodimer	heterodimer	I-NP	NN	I-protein	15	PMOD
18	bound	bind	B-VP	VBD	O	10	SBAR
19	to	to	B-PP	TO	O	18	VMOD
20	all	all	B-NP	DT	O	21	NMOD
21	four	four	I-NP	CD	O	19	PMOD
22	putative	putative	I-NP	JJ	O	21	NMOD
23	NF-kappa	NF-kappa	I-NP	NN	B-DNA	26	NMOD
24	B	B	I-NP	NN	I-DNA	26	NMOD
25	DNA	DNA	I-NP	NN	I-DNA	26	NMOD
26	probes	probe	I-NP	NNS	I-DNA	21	NMOD
27	,	,	O	,	O	18	P
28	suggesting	suggest	B-VP	VBG	O	18	VMOD
29	that	that	B-SBAR	IN	O	28	VMOD
30	all	all	B-NP	DT	O	31	NMOD
31	four	four	I-NP	CD	O	37	SUB
32	putative	putative	I-NP	JJ	O	31	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	B-DNA	36	NMOD
34	B	B	I-NP	NN	I-DNA	36	NMOD
35	recognition	recognition	I-NP	NN	I-DNA	36	NMOD
36	sites	site	I-NP	NNS	I-DNA	31	NMOD
37	play	play	B-VP	VBP	O	29	SBAR
38	an	an	B-NP	DT	O	40	NMOD
39	important	important	I-NP	JJ	O	40	NMOD
40	role	role	I-NP	NN	O	37	OBJ
41	in	in	B-PP	IN	O	37	VMOD
42	inducible	inducible	B-NP	JJ	O	44	NMOD
43	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	44	NMOD
44	expression	expression	I-NP	NN	O	41	PMOD
45	.	.	O	.	O	9	P

1	E3330	E3330	B-NP	NN	O	2	SUB
2	decreased	decrease	B-VP	VBD	O	0	ROOT
3	activated	activate	I-VP	VBN	O	5	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	2	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	nuclei	nucleus	B-NP	NNS	O	6	PMOD
8	,	,	O	,	O	2	P
9	suggesting	suggest	B-VP	VBG	O	2	VMOD
10	that	that	B-SBAR	IN	O	9	VMOD
11	E3330	E3330	B-NP	NN	O	12	SUB
12	inhibits	inhibit	B-VP	VBZ	O	10	SBAR
13	NF-kappa	NF-kappa	B-NP	NN	B-protein	15	NMOD
14	B	B	I-NP	NN	I-protein	15	NMOD
15	activation	activation	I-NP	NN	O	17	NMOD
16	and/or	and/or	O	CC	O	17	NMOD
17	translocation	translocation	B-NP	NN	O	12	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	nuclei	nucleus	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	2	P

1	Western	Western	B-NP	NN	O	3	NMOD
2	blotting	blotting	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	9	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	anti-I	anti-I	B-NP	JJ	B-protein	8	NMOD
6	kappa	kappa	I-NP	NN	I-protein	8	NMOD
7	B-alpha	B-alpha	I-NP	NN	I-protein	8	NMOD
8	antibody	antibody	I-NP	NN	I-protein	4	PMOD
9	indicated	indicate	B-VP	VBD	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	VMOD
11	E3330	E3330	B-NP	NN	O	12	SUB
12	inhibited	inhibit	B-VP	VBD	O	10	SBAR
13	degradation	degradation	B-NP	NN	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	I	I	B-NP	NN	B-protein	17	NMOD
16	kappa	kappa	I-NP	NN	I-protein	17	NMOD
17	B-alpha	B-alpha	I-NP	NN	I-protein	14	PMOD
18	,	,	O	,	O	17	P
19	which	which	B-NP	WDT	O	17	NMOD
20	is	be	B-VP	VBZ	O	19	SBAR
21	an	an	B-NP	DT	O	23	NMOD
22	inhibitory	inhibitory	I-NP	JJ	B-protein	23	NMOD
23	protein	protein	I-NP	NN	I-protein	20	PRD
24	of	of	B-PP	IN	O	23	NMOD
25	NF-kappa	NF-kappa	B-NP	NN	B-protein	26	NMOD
26	B	B	I-NP	NN	I-protein	24	PMOD
27	,	,	O	,	O	12	P
28	in	in	B-PP	IN	O	12	VMOD
29	LPS-stimulated	LPS-stimulated	B-NP	JJ	B-cell_line	30	NMOD
30	monocytes	monocyte	I-NP	NNS	I-cell_line	28	PMOD
31	.	.	O	.	O	9	P

1	E3330	E3330	B-NP	NN	O	2	SUB
2	may	may	B-VP	MD	O	0	ROOT
3	suppress	suppress	I-VP	VB	O	2	VC
4	the	the	B-NP	DT	O	5	NMOD
5	production	production	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	active	active	B-NP	JJ	O	9	NMOD
8	oxygen	oxygen	I-NP	NN	O	9	NMOD
9	species	specie	I-NP	NNS	O	6	PMOD
10	serving	serve	B-VP	VBG	O	9	NMOD
11	as	as	B-PP	IN	O	10	VMOD
12	common	common	B-NP	JJ	O	13	NMOD
13	messengers	messenger	I-NP	NNS	O	11	PMOD
14	to	to	B-VP	TO	O	15	VMOD
15	activate	activate	I-VP	VB	O	10	VMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	15	OBJ
18	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	p16	p16	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	E2F-dependent	E2F-dependent	I-NP	JJ	B-protein	10	NMOD
8	thymidine	thymidine	I-NP	NN	I-protein	10	NMOD
9	kinase	kinase	I-NP	NN	I-protein	10	NMOD
10	regulation	regulation	I-NP	NN	O	5	PMOD
11	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	20	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	alterations	alteration	B-NP	NNS	O	3	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	MTS1	MTS1	I-NP	NN	B-DNA	10	NMOD
8	tumor	tumor	I-NP	NN	I-DNA	10	NMOD
9	suppressor	suppressor	I-NP	NN	I-DNA	10	NMOD
10	gene	gene	I-NP	NN	I-DNA	5	PMOD
11	on	on	B-PP	IN	O	2	NMOD
12	chromosome	chromosome	B-NP	NN	B-DNA	13	NMOD
13	9p21	9p21	I-NP	NN	I-DNA	11	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	encodes	encode	B-VP	VBZ	O	15	SBAR
17	p16	p16	B-NP	NN	B-protein	16	OBJ
18	,	,	O	,	O	20	P
19	the	the	B-NP	DT	O	20	NMOD
20	inhibitor	inhibitor	I-NP	NN	O	0	ROOT
21	of	of	B-PP	IN	O	20	NMOD
22	cyclin-dependent-kinase-4	cyclin-dependent-kinase-4	B-NP	NN	B-protein	24	NMOD
23	and	and	O	CC	I-protein	24	NMOD
24	6	6	B-NP	CD	I-protein	21	PMOD
25	,	,	O	,	O	20	P
26	in	in	B-PP	IN	O	20	NMOD
27	tumorigenesis	tumorigenesis	B-NP	NN	O	26	PMOD
28	is	be	B-VP	VBZ	O	26	SBAR
29	not	not	O	RB	O	28	VMOD
30	yet	yet	B-ADJP	RB	O	28	VMOD
31	clear	clear	I-ADJP	JJ	O	28	PRD
32	.	.	O	.	O	20	P

1	Phosphorylation	Phosphorylation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	2	PMOD
6	by	by	B-PP	IN	O	1	NMOD
7	cyclin-dependent	cyclin-dependent	B-NP	JJ	B-protein	8	NMOD
8	kinases	kinase	I-NP	NNS	I-protein	6	PMOD
9	4	4	B-NP	CD	I-protein	11	NMOD
10	and	and	I-NP	CC	I-protein	11	NMOD
11	6	6	I-NP	CD	I-protein	8	NMOD
12	prevents	prevent	B-VP	VBZ	O	0	ROOT
13	its	its	B-NP	PRP$	O	14	NMOD
14	interaction	interaction	I-NP	NN	O	12	OBJ
15	with	with	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	transcription	transcription	I-NP	NN	B-protein	19	NMOD
18	factor	factor	I-NP	NN	I-protein	19	NMOD
19	E2F	E2F	I-NP	NN	B-protein	15	PMOD
20	,	,	O	,	O	19	P
21	which	which	B-NP	WDT	O	19	NMOD
22	subsequently	subsequently	B-ADVP	RB	O	23	VMOD
23	promotes	promote	B-VP	VBZ	O	21	SBAR
24	the	the	B-NP	DT	O	25	NMOD
25	expression	expression	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	S	S	B-NP	NN	B-DNA	30	NMOD
28	phase	phase	I-NP	NN	I-DNA	30	NMOD
29	regulated	regulated	I-NP	JJ	I-DNA	30	NMOD
30	genes	gene	I-NP	NNS	I-DNA	26	PMOD
31	,	,	O	,	O	30	P
32	such	such	B-PP	JJ	O	33	PMOD
33	as	as	I-PP	IN	O	30	NMOD
34	thymidine	thymidine	B-NP	NN	B-protein	35	NMOD
35	kinase	kinase	I-NP	NN	I-protein	33	PMOD
36	.	.	O	.	O	12	P

1	Although	Although	B-SBAR	IN	O	14	VMOD
2	a	a	B-NP	DT	O	3	NMOD
3	role	role	I-NP	NN	O	9	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	p16	p16	B-NP	NN	B-protein	4	PMOD
6	in	in	B-PP	IN	O	3	NMOD
7	this	this	B-NP	DT	O	8	NMOD
8	regulation	regulation	I-NP	NN	O	6	PMOD
9	has	have	B-VP	VBZ	O	1	SBAR
10	been	be	I-VP	VBN	O	9	VC
11	presumed	presume	I-VP	VBN	O	10	VC
12	,	,	O	,	O	14	P
13	there	there	B-NP	EX	O	14	SUB
14	is	be	B-VP	VBZ	O	0	ROOT
15	no	no	B-NP	DT	O	16	NMOD
16	proof	proof	I-NP	NN	O	14	PRD
17	so	so	B-ADVP	RB	O	14	VMOD
18	far	far	I-ADVP	RB	O	17	AMOD
19	that	that	B-SBAR	IN	O	14	VMOD
20	loss	loss	B-NP	NN	O	27	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	this	this	B-NP	DT	O	25	NMOD
23	tumor	tumor	I-NP	NN	B-DNA	25	NMOD
24	suppressor	suppressor	I-NP	NN	I-DNA	25	NMOD
25	gene	gene	I-NP	NN	I-DNA	21	PMOD
26	really	really	B-ADVP	RB	O	27	VMOD
27	affects	affect	B-VP	VBZ	O	19	SBAR
28	E2F-mediated	E2F-mediated	B-NP	JJ	O	29	NMOD
29	regulations	regulation	I-NP	NNS	O	27	OBJ
30	.	.	O	.	O	14	P

1	We	We	B-NP	PRP	O	2	SUB
2	investigated	investigate	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	thymidine	thymidine	B-NP	NN	B-protein	7	NMOD
7	kinase	kinase	I-NP	NN	I-protein	5	PMOD
8	in	in	B-PP	IN	O	4	NMOD
9	phytohemagglutinin-stimulated	phytohemagglutinin-stimulated	B-NP	JJ	B-cell_line	12	NMOD
10	normal	normal	I-NP	JJ	I-cell_line	12	NMOD
11	human	human	I-NP	JJ	I-cell_line	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	8	PMOD
13	and	and	B-PP	CC	O	8	PMOD
14	in	in	B-PP	IN	O	8	PMOD
15	the	the	B-NP	DT	O	22	NMOD
16	p16-negative	p16-negative	I-NP	JJ	B-cell_line	22	NMOD
17	human	human	I-NP	JJ	I-cell_line	22	NMOD
18	acute	acute	I-NP	JJ	I-cell_line	22	NMOD
19	lymphoblastic	lymphoblastic	I-NP	JJ	I-cell_line	22	NMOD
20	leukemia	leukemia	I-NP	NN	I-cell_line	22	NMOD
21	cell	cell	I-NP	NN	I-cell_line	22	NMOD
22	lines	line	I-NP	NNS	I-cell_line	26	NMOD
23	,	,	O	,	O	26	P
24	MOLT-4	MOLT-4	B-NP	NN	B-cell_line	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	CEM	CEM	I-NP	NN	B-cell_line	14	PMOD
27	.	.	O	.	O	2	P

1	Compared	Compare	B-PP	VBN	O	10	SUB
2	to	to	B-PP	TO	O	1	VMOD
3	normal	normal	B-NP	JJ	B-cell_type	4	NMOD
4	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	NMOD
5	,	,	O	,	O	9	P
6	MOLT-4	MOLT-4	B-NP	NN	B-cell_line	9	NMOD
7	and	and	I-NP	CC	I-cell_line	9	NMOD
8	CEM	CEM	I-NP	NN	I-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
10	exhibited	exhibit	B-VP	VBD	O	0	ROOT
11	an	an	B-NP	DT	O	15	NMOD
12	altered	altered	I-NP	JJ	O	15	NMOD
13	cell	cell	I-NP	NN	O	15	NMOD
14	cycle	cycle	I-NP	NN	O	15	NMOD
15	regulation	regulation	I-NP	NN	O	10	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	thymidine	thymidine	B-NP	NN	B-protein	18	NMOD
18	kinase	kinase	I-NP	NN	I-protein	24	NMOD
19	,	,	O	,	O	24	P
20	a	a	B-NP	DT	O	24	NMOD
21	much	much	I-NP	RB	O	22	AMOD
22	higher	high	I-NP	JJR	O	24	NMOD
23	intracellular	intracellular	I-NP	JJ	O	24	NMOD
24	activity	activity	I-NP	NN	O	16	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	this	this	B-NP	DT	O	27	NMOD
27	enzyme	enzyme	I-NP	NN	B-protein	25	PMOD
28	,	,	O	,	O	34	P
29	and	and	O	CC	O	34	NMOD
30	higher	high	B-NP	JJR	O	34	NMOD
31	thymidine	thymidine	I-NP	NN	B-RNA	34	NMOD
32	kinase	kinase	I-NP	NN	I-RNA	34	NMOD
33	mRNA	mRNA	I-NP	NN	I-RNA	34	NMOD
34	expression	expression	I-NP	NN	O	10	VMOD
35	.	.	O	.	O	10	P

1	Transient	Transient	B-NP	JJ	O	2	NMOD
2	expression	expression	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	p16	p16	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	normal	normal	B-NP	JJ	B-cell_type	8	NMOD
7	human	human	I-NP	JJ	I-cell_type	8	NMOD
8	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	PMOD
9	caused	cause	B-VP	VBD	O	0	ROOT
10	arrest	arrest	B-NP	NN	O	9	OBJ
11	in	in	B-PP	IN	O	9	VMOD
12	G1	G1	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	9	P
14	but	but	O	CC	O	9	VMOD
15	was	be	B-VP	VBD	O	9	VMOD
16	without	without	B-PP	IN	O	15	PRD
17	effect	effect	B-NP	NN	O	16	PMOD
18	on	on	B-PP	IN	O	15	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	cell	cell	I-NP	NN	O	21	NMOD
21	growth	growth	I-NP	NN	O	18	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	MOLT-4	MOLT-4	B-NP	NN	B-cell_line	26	NMOD
24	and	and	I-NP	CC	I-cell_line	26	NMOD
25	CEM	CEM	I-NP	NN	I-cell_line	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_line	22	PMOD
27	,	,	O	,	O	9	P
28	although	although	B-SBAR	IN	O	9	VMOD
29	all	all	B-NP	DT	O	32	SUB
30	of	of	B-PP	IN	O	29	NMOD
31	them	them	B-NP	PRP	O	30	PMOD
32	express	express	B-VP	VBP	O	28	SBAR
33	functional	functional	B-NP	JJ	O	35	NMOD
34	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	35	NMOD
35	protein	protein	I-NP	NN	I-protein	32	OBJ
36	.	.	O	.	O	9	P

1	Nevertheless	Nevertheless	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	in	in	B-PP	IN	O	13	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	two	two	I-NP	CD	O	8	NMOD
6	leukemia	leukemia	I-NP	NN	B-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	lines	line	I-NP	NNS	I-cell_line	3	PMOD
9	transient	transient	B-NP	JJ	O	10	NMOD
10	overexpression	overexpression	I-NP	NN	O	13	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	p16	p16	B-NP	NN	B-protein	11	PMOD
13	reestablished	reestablish	B-VP	VBD	O	0	ROOT
14	the	the	B-NP	DT	O	16	NMOD
15	normal	normal	I-NP	JJ	O	16	NMOD
16	regulation	regulation	I-NP	NN	O	13	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	thymidine	thymidine	B-NP	NN	B-protein	19	NMOD
19	kinase	kinase	I-NP	NN	I-protein	17	PMOD
20	,	,	O	,	O	13	P
21	paralleled	parallel	B-VP	VBN	O	13	VMOD
22	by	by	B-PP	IN	O	21	VMOD
23	an	an	B-NP	DT	O	24	NMOD
24	increase	increase	I-NP	NN	O	33	NMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	underphosphorylated	underphosphorylated	I-NP	JJ	O	28	NMOD
28	form	form	I-NP	NN	O	25	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	retinoblastoma	retinoblastoma	B-NP	NN	B-protein	31	NMOD
31	protein	protein	I-NP	NN	I-protein	29	PMOD
32	and	and	O	CC	O	33	NMOD
33	decrease	decrease	B-NP	NN	O	22	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	free	free	B-NP	JJ	O	36	NMOD
36	E2F	E2F	I-NP	NN	B-protein	34	PMOD
37	bound	bind	B-VP	VBD	O	21	VMOD
38	to	to	B-PP	TO	O	37	VMOD
39	its	its	B-NP	PRP$	O	40	NMOD
40	motif	motif	I-NP	NN	O	38	PMOD
41	in	in	B-PP	IN	O	40	NMOD
42	the	the	B-NP	DT	O	45	NMOD
43	thymidine	thymidine	I-NP	NN	B-DNA	45	NMOD
44	kinase	kinase	I-NP	NN	I-DNA	45	NMOD
45	promoter	promoter	I-NP	NN	I-DNA	41	PMOD
46	.	.	O	.	O	13	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	loss	loss	B-NP	NN	O	7	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	p16	p16	B-NP	NN	B-protein	5	PMOD
7	causes	cause	B-VP	VBZ	O	3	SBAR
8	upregulation	upregulation	B-NP	NN	O	7	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	this	this	B-NP	DT	O	14	NMOD
11	DNA	DNA	I-NP	NN	B-protein	14	NMOD
12	precursor	precursor	I-NP	NN	I-protein	14	NMOD
13	pathway	pathway	I-NP	NN	I-protein	14	NMOD
14	enzyme	enzyme	I-NP	NN	I-protein	9	PMOD
15	via	via	B-PP	IN	O	7	VMOD
16	activation	activation	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	E2F	E2F	B-NP	NN	B-protein	17	PMOD
19	by	by	B-PP	IN	O	16	NMOD
20	a	a	B-NP	DT	O	21	NMOD
21	mechanism	mechanism	I-NP	NN	O	19	PMOD
22	involving	involve	B-VP	VBG	O	21	NMOD
23	retinoblastoma	retinoblastoma	B-NP	NN	B-protein	24	NMOD
24	protein	protein	I-NP	NN	I-protein	22	OBJ
25	.	.	O	.	O	2	P

1	Rel-deficient	Rel-deficient	B-NP	JJ	B-cell_type	3	NMOD
2	T	T	I-NP	NN	I-cell_type	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_type	4	SUB
4	exhibit	exhibit	B-VP	VBP	O	0	ROOT
5	defects	defect	B-NP	NNS	O	4	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	production	production	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	interleukin	interleukin	B-NP	NN	B-protein	14	NMOD
10	3	3	I-NP	CD	I-protein	9	NMOD
11	and	and	O	CC	O	14	NMOD
12	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-protein	14	NMOD
13	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	8	PMOD
15	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	c-rel	c-rel	I-NP	NN	B-DNA	3	NMOD
3	protooncogene	protooncogene	I-NP	NN	I-DNA	4	SUB
4	encodes	encode	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	6	NMOD
6	subunit	subunit	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	NF-kappa	NF-kappa	I-NP	NN	B-protein	11	NMOD
10	B-like	B-like	I-NP	JJ	I-protein	11	NMOD
11	family	family	I-NP	NN	I-protein	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	transcription	transcription	B-NP	NN	B-protein	14	NMOD
14	factors	factor	I-NP	NNS	I-protein	12	PMOD
15	.	.	O	.	O	4	P

1	Mice	Mouse	B-NP	NNS	O	4	SUB
2	lacking	lack	B-VP	VBG	O	1	NMOD
3	Rel	Rel	B-NP	NN	B-protein	2	OBJ
4	are	be	B-VP	VBP	O	0	ROOT
5	defective	defective	B-ADJP	JJ	O	4	PRD
6	in	in	B-PP	IN	O	5	AMOD
7	mitogenic	mitogenic	B-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	B	B	B-NP	NN	B-cell_type	12	NMOD
11	and	and	O	CC	I-cell_type	12	NMOD
12	T	T	B-NP	NN	I-cell_type	13	NMOD
13	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	9	PMOD
14	and	and	O	CC	O	4	VMOD
15	display	display	B-VP	VBP	O	4	VMOD
16	impaired	impaired	B-NP	JJ	O	18	NMOD
17	humoral	humoral	I-NP	JJ	O	18	NMOD
18	immunity	immunity	I-NP	NN	O	15	OBJ
19	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	24	VMOD
2	an	an	B-NP	DT	O	3	NMOD
3	attempt	attempt	I-NP	NN	O	1	PMOD
4	to	to	B-VP	TO	O	5	VMOD
5	identify	identify	I-VP	VB	O	3	NMOD
6	changes	change	B-NP	NNS	O	5	OBJ
7	in	in	B-PP	IN	O	6	NMOD
8	gene	gene	B-NP	NN	O	9	NMOD
9	expression	expression	I-NP	NN	O	7	PMOD
10	that	that	B-NP	WDT	O	6	NMOD
11	accompany	accompany	B-VP	VBP	O	10	SBAR
12	the	the	B-NP	DT	O	15	NMOD
13	T-cell	T-cell	I-NP	NN	O	15	NMOD
14	stimulation	stimulation	I-NP	NN	O	15	NMOD
15	defects	defect	I-NP	NNS	O	11	OBJ
16	associated	associate	B-VP	VBN	O	15	NMOD
17	with	with	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	loss	loss	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	Rel	Rel	B-NP	NN	B-protein	20	PMOD
22	,	,	O	,	O	24	P
23	we	we	B-NP	PRP	O	24	SUB
24	have	have	B-VP	VBP	O	0	ROOT
25	examined	examine	I-VP	VBN	O	24	VC
26	the	the	B-NP	DT	O	27	NMOD
27	expression	expression	I-NP	NN	O	35	NMOD
28	of	of	B-PP	IN	O	27	NMOD
29	cell	cell	B-NP	NN	B-protein	32	NMOD
30	surface	surface	I-NP	NN	I-protein	32	NMOD
31	activation	activation	I-NP	NN	I-protein	32	NMOD
32	markers	marker	I-NP	NNS	I-protein	28	PMOD
33	and	and	O	CC	O	35	NMOD
34	cytokine	cytokine	B-NP	NN	B-protein	35	NMOD
35	production	production	I-NP	NN	O	25	OBJ
36	in	in	B-PP	IN	O	35	NMOD
37	mitogen-stimulated	mitogen-stimulated	B-NP	JJ	B-cell_line	40	NMOD
38	Rel-/-	Rel-/-	I-NP	JJ	I-cell_line	40	NMOD
39	T	T	I-NP	NN	I-cell_line	40	NMOD
40	cells	cell	I-NP	NNS	I-cell_line	36	PMOD
41	.	.	O	.	O	24	P

1	The	The	B-NP	DT	O	2	NMOD
2	expression	expression	I-NP	NN	O	28	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	cell	cell	B-NP	NN	B-protein	6	NMOD
5	surface	surface	I-NP	NN	I-protein	6	NMOD
6	markers	marker	I-NP	NNS	I-protein	3	PMOD
7	including	include	B-PP	VBG	O	6	NMOD
8	the	the	B-NP	DT	O	17	NMOD
9	interleukin	interleukin	I-NP	NN	B-protein	17	NMOD
10	2	2	I-NP	CD	I-protein	17	NMOD
11	receptor	receptor	I-NP	NN	I-protein	17	NMOD
12	alpha	alpha	I-NP	NN	I-protein	17	NMOD
13	(	(	O	(	I-protein	17	P
14	IL-2R	IL-2R	B-NP	NN	I-protein	17	NMOD
15	alpha	alpha	I-NP	NN	I-protein	17	NMOD
16	)	)	O	)	I-protein	17	P
17	chain	chain	B-NP	NN	I-protein	24	NMOD
18	(	(	O	(	O	19	P
19	CD25	CD25	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	24	P
22	CD69	CD69	B-NP	NN	B-protein	24	NMOD
23	and	and	O	CC	O	24	NMOD
24	L-selectin	L-selectin	B-NP	NN	B-protein	7	PMOD
25	(	(	O	(	O	26	P
26	CD62	CD62	B-NP	NN	B-protein	24	NMOD
27	)	)	O	)	O	26	P
28	is	be	B-VP	VBZ	O	39	VMOD
29	normal	normal	B-ADJP	JJ	O	28	PRD
30	in	in	B-PP	IN	O	29	AMOD
31	mitogen-activated	mitogen-activated	B-NP	JJ	B-cell_line	34	NMOD
32	Rel-/-	Rel-/-	I-NP	JJ	I-cell_line	34	NMOD
33	T	T	I-NP	NN	I-cell_line	34	NMOD
34	cells	cell	I-NP	NNS	I-cell_line	30	PMOD
35	,	,	O	,	O	39	P
36	but	but	O	CC	O	39	VMOD
37	cytokine	cytokine	B-NP	NN	B-protein	38	NMOD
38	production	production	I-NP	NN	O	39	SUB
39	is	be	B-VP	VBZ	O	0	ROOT
40	impaired	impaired	B-ADJP	JJ	O	39	PRD
41	.	.	O	.	O	39	P

1	In	In	B-PP	IN	O	44	VMOD
2	Rel-/-	Rel-/-	B-NP	JJ	B-cell_line	6	NMOD
3	splenic	splenic	I-NP	JJ	I-cell_line	6	NMOD
4	T	T	I-NP	NN	I-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	cultures	culture	I-NP	NNS	I-cell_line	1	PMOD
7	stimulated	stimulate	B-VP	VBN	O	6	NMOD
8	with	with	B-PP	IN	O	7	VMOD
9	phorbol	phorbol	B-NP	NN	O	11	NMOD
10	12-myristate	12-myristate	I-NP	NN	O	11	NMOD
11	13-acetate	13-acetate	I-NP	NN	O	13	NMOD
12	and	and	I-NP	CC	O	13	NMOD
13	ionomycin	ionomycin	I-NP	NN	O	8	PMOD
14	,	,	O	,	O	44	P
15	the	the	B-NP	DT	O	16	NMOD
16	levels	level	I-NP	NNS	O	44	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	IL-3	IL-3	B-NP	NN	B-protein	33	NMOD
19	,	,	O	,	O	33	P
20	IL-5	IL-5	B-NP	NN	B-protein	33	NMOD
21	,	,	O	,	O	33	P
22	granulocyte-	granulocyte-	B-NP	NN	B-protein	25	NMOD
23	macrophage	macrophage	B-NP	NN	I-protein	25	NMOD
24	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	25	NMOD
25	factor	factor	I-NP	NN	I-protein	33	NMOD
26	(	(	O	(	O	27	P
27	GM-CSF	GM-CSF	B-NP	NN	B-protein	25	NMOD
28	)	)	O	)	O	27	P
29	,	,	O	,	O	33	P
30	tumor	tumor	B-NP	NN	B-protein	33	NMOD
31	necrosis	necrosis	I-NP	NN	I-protein	33	NMOD
32	factor	factor	I-NP	NN	I-protein	33	NMOD
33	alpha	alpha	I-NP	NN	I-protein	17	PMOD
34	(	(	O	(	O	35	P
35	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	33	NMOD
36	)	)	O	)	O	35	P
37	,	,	O	,	O	44	P
38	and	and	O	CC	O	44	VMOD
39	gamma	gamma	B-NP	NN	B-protein	40	NMOD
40	interferon	interferon	I-NP	NN	I-protein	44	SUB
41	(	(	O	(	O	42	P
42	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	40	NMOD
43	)	)	O	)	O	42	P
44	were	be	B-VP	VBD	O	0	ROOT
45	only	only	B-ADVP	RB	O	48	NMOD
46	2-	2-	B-NP	CD	O	48	NMOD
47	to	to	B-PP	TO	O	46	NMOD
48	3-fold	3-fold	B-NP	RB	O	49	AMOD
49	lower	low	I-NP	JJR	O	44	PRD
50	compared	compare	B-PP	VBN	O	49	AMOD
51	with	with	B-PP	IN	O	50	PMOD
52	normal	normal	B-NP	JJ	B-cell_type	54	NMOD
53	T	T	I-NP	NN	I-cell_type	54	NMOD
54	cells	cell	I-NP	NNS	I-cell_type	51	PMOD
55	.	.	O	.	O	44	P

1	In	In	B-PP	IN	O	17	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	17	P
4	anti-CD3	anti-CD3	B-NP	JJ	B-protein	6	AMOD
5	and	and	I-NP	CC	O	6	AMOD
6	anti-CD28	anti-CD28	I-NP	JJ	B-protein	10	NMOD
7	stimulated	stimulate	I-NP	VBN	O	10	NMOD
8	Rel-/-	Rel-/-	I-NP	JJ	B-cell_line	10	NMOD
9	T	T	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	17	SUB
11	,	,	O	,	O	10	P
12	which	which	B-NP	WDT	O	10	NMOD
13	fail	fail	B-VP	VBP	O	12	SBAR
14	to	to	I-VP	TO	O	15	VMOD
15	proliferate	proliferate	I-VP	VB	O	13	VMOD
16	,	,	O	,	O	10	P
17	make	make	B-VP	VB	O	0	ROOT
18	little	little	B-NP	JJ	O	21	NMOD
19	or	or	I-NP	CC	O	21	NMOD
20	no	no	I-NP	DT	O	21	NMOD
21	detectable	detectable	I-NP	JJ	O	22	NMOD
22	cytokines	cytokine	I-NP	NNS	B-protein	17	OBJ
23	.	.	O	.	O	17	P

1	Exogenous	Exogenous	B-NP	JJ	O	2	NMOD
2	IL-2	IL-2	I-NP	NN	B-protein	18	SUB
3	,	,	O	,	O	2	P
4	which	which	B-NP	WDT	O	2	NMOD
5	restitutes	restitute	B-VP	VBZ	O	4	SBAR
6	the	the	B-NP	DT	O	8	NMOD
7	proliferative	proliferative	I-NP	JJ	O	8	NMOD
8	response	response	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	16	NMOD
11	anti-CD3-	anti-CD3-	I-NP	JJ	B-protein	16	NMOD
12	and	and	I-NP	CC	O	16	NMOD
13	anti-CD28-treated	anti-CD28-treated	I-NP	JJ	O	16	NMOD
14	Rel-/-	Rel-/-	I-NP	JJ	O	16	NMOD
15	T	T	I-NP	NN	O	16	NMOD
16	cells	cell	I-NP	NNS	O	9	PMOD
17	,	,	O	,	O	2	P
18	restores	restore	B-VP	VBZ	O	0	ROOT
19	production	production	B-NP	NN	O	18	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	IL-5	IL-5	B-NP	NN	B-protein	26	NMOD
22	,	,	O	,	O	26	P
23	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	26	NMOD
24	,	,	O	,	O	26	P
25	and	and	O	CC	O	26	NMOD
26	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	33	NMOD
27	,	,	O	,	O	33	P
28	but	but	O	CC	O	33	NMOD
29	not	not	O	RB	O	28	DEP
30	IL-3	IL-3	B-NP	NN	B-protein	33	NMOD
31	and	and	O	CC	O	33	NMOD
32	GM-CSF	GM-CSF	B-NP	NN	B-protein	33	NMOD
33	expression	expression	I-NP	NN	O	20	PMOD
34	to	to	B-PP	TO	O	18	VMOD
35	approximately	approximately	B-NP	RB	O	36	AMOD
36	normal	normal	I-NP	JJ	O	37	NMOD
37	levels	level	I-NP	NNS	O	34	PMOD
38	.	.	O	.	O	18	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	mitogen-activated	mitogen-activated	B-NP	JJ	B-cell_line	7	NMOD
5	Rel-/-	Rel-/-	I-NP	JJ	I-cell_line	7	NMOD
6	T	T	I-NP	NN	I-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
8	,	,	O	,	O	12	P
9	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	B-NP	JJ	B-cell_line	11	NMOD
10	Rel-/-	Rel-/-	I-NP	JJ	I-cell_line	11	NMOD
11	macrophages	macrophage	I-NP	NNS	I-cell_line	12	SUB
12	produce	produce	B-VP	VBP	O	0	ROOT
13	higher	high	B-ADJP	JJR	O	12	VMOD
14	than	than	B-PP	IN	O	13	AMOD
15	normal	normal	B-NP	JJ	O	16	NMOD
16	levels	level	I-NP	NNS	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	GM-CSF	GM-CSF	B-NP	NN	B-protein	17	PMOD
19	.	.	O	.	O	12	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	establish	establish	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Rel	Rel	B-NP	NN	B-protein	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	function	function	I-VP	VB	O	6	VC
8	as	as	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	12	NMOD
10	activator	activator	I-NP	NN	O	12	NMOD
11	or	or	I-NP	CC	O	12	NMOD
12	repressor	repressor	I-NP	NN	O	8	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	gene	gene	B-NP	NN	O	15	NMOD
15	expression	expression	I-NP	NN	O	13	PMOD
16	and	and	O	CC	O	6	VMOD
17	is	be	B-VP	VBZ	O	6	VMOD
18	required	require	I-VP	VBN	O	17	VC
19	by	by	B-PP	IN	O	18	VMOD
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	19	PMOD
22	for	for	B-PP	IN	O	21	NMOD
23	production	production	B-NP	NN	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	IL-3	IL-3	B-NP	NN	B-protein	27	NMOD
26	and	and	I-NP	CC	O	27	NMOD
27	GM-CSF	GM-CSF	I-NP	NN	B-protein	24	PMOD
28	.	.	O	.	O	3	P

1	Human	Human	B-NP	JJ	O	5	NMOD
2	T	T	I-NP	NN	O	5	NMOD
3	lymphotropic	lymphotropic	I-NP	JJ	O	5	NMOD
4	virus-I	virus-I	I-NP	NN	O	5	NMOD
5	infection	infection	I-NP	NN	O	10	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	human	human	B-NP	JJ	B-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	PMOD
10	induces	induce	B-VP	VBZ	O	0	ROOT
11	expression	expression	B-NP	NN	O	10	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	beta-galactoside-binding	beta-galactoside-binding	I-NP	JJ	B-protein	15	NMOD
15	lectin	lectin	I-NP	NN	I-protein	17	NMOD
16	,	,	O	,	O	17	P
17	galectin-3	galectin-3	B-NP	NN	B-protein	12	PMOD
18	.	.	O	.	O	10	P

1	Animal	Animal	B-NP	NN	O	2	NMOD
2	lectins	lectin	I-NP	NNS	B-protein	3	SUB
3	play	play	B-VP	VBP	O	0	ROOT
4	important	important	B-NP	JJ	O	5	NMOD
5	roles	role	I-NP	NNS	O	3	OBJ
6	in	in	B-PP	IN	O	3	VMOD
7	a	a	B-NP	DT	O	8	NMOD
8	variety	variety	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	biological	biological	B-NP	JJ	O	11	NMOD
11	processes	process	I-NP	NNS	O	9	PMOD
12	via	via	B-PP	IN	O	3	VMOD
13	their	their	B-NP	PRP$	O	14	NMOD
14	recognition	recognition	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	glycoconjugates	glycoconjugate	B-NP	NNS	O	15	PMOD
17	.	.	O	.	O	3	P

1	Galectin-3	Galectin-3	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	28	VMOD
3	a	a	B-NP	DT	O	5	NMOD
4	beta-galactoside-binding	beta-galactoside-binding	I-NP	JJ	B-protein	5	NMOD
5	lectin	lectin	I-NP	NN	I-protein	2	PRD
6	previously	previously	B-VP	RB	O	7	VMOD
7	designated	designate	I-VP	VBN	O	5	NMOD
8	as	as	B-PP	IN	O	7	VMOD
9	epsilon	epsilon	B-NP	NN	B-protein	10	NMOD
10	BP	BP	I-NP	NN	I-protein	23	NMOD
11	(	(	O	(	O	13	P
12	IgE-binding	IgE-binding	B-NP	JJ	B-protein	13	NMOD
13	protein	protein	I-NP	NN	I-protein	10	NMOD
14	)	)	O	)	O	13	P
15	,	,	O	,	O	23	P
16	CBP35	CBP35	B-NP	NN	B-protein	23	NMOD
17	,	,	O	,	O	23	P
18	Mac-2	Mac-2	B-NP	NN	B-protein	23	NMOD
19	,	,	O	,	O	23	P
20	L-29	L-29	B-NP	NN	B-protein	23	NMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	NMOD
23	L-34	L-34	B-NP	NN	B-protein	8	PMOD
24	,	,	O	,	O	28	P
25	and	and	O	CC	O	28	VMOD
26	its	its	B-NP	PRP$	O	27	NMOD
27	expression	expression	I-NP	NN	O	28	SUB
28	has	have	B-VP	VBZ	O	0	ROOT
29	been	be	I-VP	VBN	O	28	VC
30	associated	associate	I-VP	VBN	O	29	VC
31	with	with	B-PP	IN	O	30	VMOD
32	various	various	B-NP	JJ	O	36	NMOD
33	physiological	physiological	I-NP	JJ	O	32	NMOD
34	and	and	I-NP	CC	O	32	NMOD
35	pathological	pathological	I-NP	JJ	O	36	NMOD
36	processes	process	I-NP	NNS	O	31	PMOD
37	,	,	O	,	O	36	P
38	including	include	B-PP	VBG	O	36	NMOD
39	cell	cell	B-NP	NN	O	40	NMOD
40	growth	growth	I-NP	NN	O	46	NMOD
41	,	,	O	,	O	46	P
42	tumor	tumor	B-NP	NN	O	43	NMOD
43	transformation	transformation	I-NP	NN	O	46	NMOD
44	,	,	O	,	O	46	P
45	and	and	O	CC	O	46	NMOD
46	metastasis	metastasis	B-NP	NN	O	38	PMOD
47	.	.	O	.	O	28	P

1	Galectin-3	Galectin-3	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	widely	widely	I-VP	RB	O	2	VMOD
4	distributed	distribute	I-VP	VBN	O	2	VC
5	in	in	B-PP	IN	O	4	VMOD
6	various	various	B-NP	JJ	O	7	NMOD
7	tissues	tissue	I-NP	NNS	O	10	NMOD
8	and	and	O	CC	O	10	NMOD
9	cell	cell	B-NP	NN	O	10	NMOD
10	types	type	I-NP	NNS	O	5	PMOD
11	and	and	O	CC	O	2	VMOD
12	is	be	B-VP	VBZ	O	2	VMOD
13	expressed	express	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	many	many	B-NP	JJ	O	14	PMOD
16	leukocytes	leukocyte	I-NP	NNS	B-cell_type	15	NMOD
17	,	,	O	,	O	13	P
18	with	with	B-PP	IN	O	13	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	notable	notable	I-NP	JJ	O	21	NMOD
21	exception	exception	I-NP	NN	O	18	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	B	B	B-NP	NN	B-cell_type	25	NMOD
24	and	and	O	CC	I-cell_type	25	NMOD
25	T	T	B-NP	NN	I-cell_type	26	NMOD
26	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	22	PMOD
27	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	galectin-3	galectin-3	B-NP	NN	B-protein	6	SUB
6	is	be	B-VP	VBZ	O	4	SBAR
7	abundantly	abundantly	I-VP	RB	O	6	VMOD
8	expressed	express	I-VP	VBN	O	6	VC
9	in	in	B-PP	IN	O	8	VMOD
10	a	a	B-NP	DT	O	11	NMOD
11	number	number	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	human	human	B-NP	JJ	B-cell_line	16	NMOD
14	T	T	I-NP	NN	I-cell_line	16	NMOD
15	lymphotropic	lymphotropic	I-NP	JJ	I-cell_line	16	NMOD
16	virus	virus	I-NP	NN	I-cell_line	24	NMOD
17	(	(	O	(	I-cell_line	18	P
18	HTLV	HTLV	B-NP	NN	I-cell_line	16	NMOD
19	)	)	O	)	I-cell_line	18	P
20	-I-infected	-I-infected	B-NP	JJ	I-cell_line	24	NMOD
21	human	human	I-NP	JJ	I-cell_line	24	NMOD
22	T	T	I-NP	NN	I-cell_line	24	NMOD
23	cell	cell	I-NP	NN	I-cell_line	24	NMOD
24	lines	line	I-NP	NNS	I-cell_line	12	PMOD
25	,	,	O	,	O	24	P
26	including	include	B-PP	VBG	O	24	NMOD
27	F6T	F6T	B-NP	NN	B-protein	37	NMOD
28	,	,	O	,	O	37	P
29	HUT	HUT	B-NP	NN	B-cell_line	37	NMOD
30	102	102	I-NP	CD	I-cell_line	29	NMOD
31	,	,	O	,	O	37	P
32	K3T	K3T	B-NP	NN	B-cell_line	37	NMOD
33	,	,	O	,	O	37	P
34	MT-2	MT-2	B-NP	NN	B-cell_line	37	NMOD
35	,	,	O	,	O	37	P
36	and	and	O	CC	O	37	NMOD
37	SLB-I	SLB-I	B-NP	NN	B-protein	26	PMOD
38	,	,	O	,	O	6	P
39	but	but	O	CC	O	6	VMOD
40	is	be	B-VP	VBZ	O	6	VMOD
41	not	not	I-VP	RB	O	40	VMOD
42	expressed	express	I-VP	VBN	O	40	VC
43	in	in	B-PP	IN	O	42	VMOD
44	non-HTLV-I-infected	non-HTLV-I-infected	B-NP	JJ	B-cell_line	47	NMOD
45	T	T	I-NP	NN	I-cell_line	47	NMOD
46	cell	cell	I-NP	NN	I-cell_line	47	NMOD
47	lines	line	I-NP	NNS	I-cell_line	43	PMOD
48	such	such	B-PP	JJ	O	49	PMOD
49	as	as	I-PP	IN	O	47	NMOD
50	Jurkat	Jurkat	B-NP	NN	B-cell_line	55	NMOD
51	,	,	O	,	O	55	P
52	CEM	CEM	B-NP	NN	B-cell_line	55	NMOD
53	,	,	O	,	O	55	P
54	and	and	O	CC	O	55	NMOD
55	MOLT-4	MOLT-4	B-NP	NN	B-cell_line	49	PMOD
56	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	7	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	the	the	B-NP	DT	O	6	NMOD
5	galectin-3	galectin-3	I-NP	NN	B-protein	6	NMOD
6	level	level	I-NP	NN	O	7	SUB
7	was	be	B-VP	VBD	O	0	ROOT
8	markedly	markedly	I-VP	RB	O	7	VMOD
9	increased	increase	I-VP	VBN	O	7	VC
10	in	in	B-PP	IN	O	9	VMOD
11	human	human	B-NP	JJ	B-cell_type	12	NMOD
12	thymocytes	thymocyte	I-NP	NNS	I-cell_type	10	PMOD
13	after	after	B-PP	IN	O	9	VMOD
14	infection	infection	B-NP	NN	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	HTLV-I	HTLV-I	B-NP	NN	O	15	PMOD
17	as	as	B-PP	IN	O	14	NMOD
18	compared	compare	B-PP	VBN	O	17	SBAR
19	with	with	B-PP	IN	O	18	VMOD
20	uninfected	uninfected	B-NP	JJ	B-cell_type	21	NMOD
21	thymocytes	thymocyte	I-NP	NNS	I-cell_type	19	PMOD
22	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	up-regulation	up-regulation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	galectin-3	galectin-3	B-NP	NN	B-protein	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	appeared	appear	B-VP	VBD	O	0	ROOT
7	to	to	I-VP	TO	O	8	VMOD
8	correlate	correlate	I-VP	VB	O	6	VMOD
9	well	well	B-ADVP	RB	O	8	VMOD
10	with	with	B-PP	IN	O	8	VMOD
11	HTLV-I	HTLV-I	B-NP	NN	O	13	NMOD
12	gene	gene	I-NP	NN	O	13	NMOD
13	expression	expression	I-NP	NN	O	10	PMOD
14	,	,	O	,	O	6	P
15	as	as	B-SBAR	IN	O	6	VMOD
16	undetectable	undetectable	B-NP	JJ	O	20	NMOD
17	or	or	I-NP	CC	O	20	NMOD
18	very	very	I-NP	RB	O	19	AMOD
19	low	low	I-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	23	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	galectin-3	galectin-3	B-NP	NN	B-protein	21	PMOD
23	were	be	B-VP	VBD	O	15	SBAR
24	found	find	I-VP	VBN	O	23	VC
25	in	in	B-PP	IN	O	24	VMOD
26	the	the	B-NP	DT	O	31	NMOD
27	S1T	S1T	I-NP	NN	B-cell_line	31	NMOD
28	and	and	I-NP	CC	I-cell_line	31	NMOD
29	ATL-1K	ATL-1K	I-NP	NN	I-cell_line	31	NMOD
30	cell	cell	I-NP	NN	I-cell_line	31	NMOD
31	lines	line	I-NP	NNS	I-cell_line	25	PMOD
32	,	,	O	,	O	31	P
33	which	which	B-NP	WDT	O	31	NMOD
34	are	be	B-VP	VBP	O	33	SBAR
35	nonproductively	nonproductively	I-VP	RB	O	34	VMOD
36	infected	infect	I-VP	VBN	O	34	VC
37	with	with	B-PP	IN	O	36	VMOD
38	HTLV-I	HTLV-I	B-NP	NN	O	37	PMOD
39	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	8	VMOD
2	co-transfection	co-transfection	B-NP	NN	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	8	P
5	the	the	B-NP	DT	O	7	NMOD
6	galectin-3	galectin-3	I-NP	NN	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	significantly	significantly	I-VP	RB	O	8	VMOD
10	up-regulated	up-regulate	I-VP	VBN	O	8	VC
11	by	by	B-PP	IN	O	10	VMOD
12	expression	expression	B-NP	NN	O	13	NMOD
13	vectors	vector	I-NP	NNS	O	11	PMOD
14	encoding	encode	B-VP	VBG	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	40-kd	40-kd	I-NP	JJ	B-protein	18	NMOD
17	Tax	Tax	I-NP	NN	I-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	22	NMOD
19	,	,	O	,	O	22	P
20	a	a	B-NP	DT	O	22	NMOD
21	potent	potent	I-NP	JJ	O	22	NMOD
22	transactivator	transactivator	I-NP	NN	B-protein	14	OBJ
23	in	in	B-PP	IN	O	22	NMOD
24	HTLV-I	HTLV-I	B-NP	NN	O	23	PMOD
25	.	.	O	.	O	8	P

1	Analysis	Analysis	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	various	various	B-NP	JJ	O	5	NMOD
4	Tax	Tax	I-NP	NN	B-protein	5	NMOD
5	mutants	mutant	I-NP	NNS	I-protein	2	PMOD
6	suggested	suggest	B-VP	VBD	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	galectin-3	galectin-3	B-NP	NN	B-DNA	9	NMOD
9	promoter	promoter	I-NP	NN	I-DNA	10	NMOD
10	induction	induction	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	7	SBAR
12	dependent	dependent	B-ADJP	JJ	O	11	PRD
13	on	on	B-PP	IN	O	12	AMOD
14	activation	activation	B-NP	NN	O	37	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	23	NMOD
17	cyclic-AMP-responsive	cyclic-AMP-responsive	I-NP	JJ	B-protein	23	NMOD
18	element	element	I-NP	NN	I-protein	23	NMOD
19	binding	binding	I-NP	NN	I-protein	23	NMOD
20	protein/activation	protein/activation	I-NP	NN	I-protein	23	NMOD
21	transcription	transcription	I-NP	NN	I-protein	23	NMOD
22	factor	factor	I-NP	NN	I-protein	23	NMOD
23	family	family	I-NP	NN	I-protein	15	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	transcription	transcription	B-NP	NN	B-protein	26	NMOD
26	factors	factor	I-NP	NNS	I-protein	24	PMOD
27	and	and	O	CC	O	37	NMOD
28	,	,	O	,	O	37	P
29	to	to	B-PP	TO	O	37	NMOD
30	a	a	B-NP	DT	O	32	NMOD
31	lesser	less	I-NP	JJR	O	32	NMOD
32	extent	extent	I-NP	NN	O	29	PMOD
33	,	,	O	,	O	37	P
34	nuclear	nuclear	B-NP	JJ	B-protein	37	NMOD
35	factor-kappa	factor-kappa	I-NP	NN	I-protein	37	NMOD
36	B/Rel	B/Rel	I-NP	NN	I-protein	37	NMOD
37	induction	induction	I-NP	NN	O	13	PMOD
38	.	.	O	.	O	6	P

1	Transfection	Transfection	B-NP	NN	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-cell_line	6	NMOD
4	promonocytic	promonocytic	I-NP	JJ	I-cell_line	6	NMOD
5	U-937	U-937	I-NP	NN	I-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
7	with	with	B-PP	IN	O	1	NMOD
8	an	an	B-NP	DT	O	12	NMOD
9	HTLV-I	HTLV-I	I-NP	NN	B-DNA	12	NMOD
10	Tax	Tax	I-NP	NN	I-DNA	12	NMOD
11	expression	expression	I-NP	NN	I-DNA	12	NMOD
12	vector	vector	I-NP	NN	I-DNA	7	PMOD
13	induced	induce	B-VP	VBD	O	0	ROOT
14	galectin-3	galectin-3	B-NP	NN	B-protein	15	NMOD
15	expression	expression	I-NP	NN	O	13	OBJ
16	in	in	B-PP	IN	O	13	VMOD
17	this	this	B-NP	DT	O	19	NMOD
18	cell	cell	I-NP	NN	B-cell_line	19	NMOD
19	line	line	I-NP	NN	I-cell_line	16	PMOD
20	.	.	O	.	O	13	P

1	Functionally	Functionally	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	galectin-3	galectin-3	B-NP	NN	B-protein	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	shown	show	I-VP	VBN	O	4	VC
6	to	to	I-VP	TO	O	7	VMOD
7	activate	activate	I-VP	VB	O	5	VMOD
8	interleukin-2	interleukin-2	B-NP	NN	B-protein	9	NMOD
9	production	production	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	7	VMOD
11	Jurkat	Jurkat	B-NP	NN	B-cell_line	13	NMOD
12	T	T	I-NP	NN	I-cell_line	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
14	.	.	O	.	O	4	P

1	Together	Together	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	findings	finding	I-NP	NNS	O	5	SUB
5	raise	raise	B-VP	VBP	O	0	ROOT
6	the	the	B-NP	DT	O	7	NMOD
7	possibility	possibility	I-NP	NN	O	5	OBJ
8	that	that	B-SBAR	IN	O	7	NMOD
9	HTLV-I	HTLV-I	B-NP	NN	B-protein	11	NMOD
10	Tax	Tax	I-NP	NN	I-protein	11	NMOD
11	production	production	I-NP	NN	O	12	SUB
12	induces	induce	B-VP	VBZ	O	8	SBAR
13	the	the	B-NP	DT	O	14	NMOD
14	transcription	transcription	I-NP	NN	O	19	NMOD
15	and	and	I-NP	CC	O	19	NMOD
16	subsequent	subsequent	I-NP	JJ	O	17	NMOD
17	synthesis	synthesis	I-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	secretion	secretion	I-NP	NN	O	12	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	galectin-3	galectin-3	B-NP	NN	B-protein	20	PMOD
22	,	,	O	,	O	21	P
23	which	which	B-NP	WDT	O	21	NMOD
24	in	in	B-PP	IN	O	26	VMOD
25	turn	turn	B-NP	NN	O	24	PMOD
26	may	may	B-VP	MD	O	23	SBAR
27	further	further	I-VP	RB	O	28	VMOD
28	activate	activate	I-VP	VB	O	26	VC
29	these	these	B-NP	DT	O	31	NMOD
30	T	T	I-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	28	OBJ
32	and	and	O	CC	O	28	VMOD
33	contribute	contribute	B-VP	VBP	O	28	VMOD
34	to	to	B-PP	TO	O	33	VMOD
35	the	the	B-NP	DT	O	37	NMOD
36	altered	alter	I-NP	VBN	O	37	NMOD
37	properties	property	I-NP	NNS	O	34	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	cell	cell	B-NP	NN	O	40	NMOD
40	growth	growth	I-NP	NN	O	38	PMOD
41	found	find	B-VP	VBN	O	40	NMOD
42	in	in	B-PP	IN	O	41	VMOD
43	adult	adult	B-NP	JJ	O	46	NMOD
44	T	T	I-NP	NN	O	46	NMOD
45	cell	cell	I-NP	NN	O	46	NMOD
46	leukemia	leukemia	I-NP	NN	O	42	PMOD
47	induced	induce	B-VP	VBN	O	46	NMOD
48	by	by	B-PP	IN	O	47	VMOD
49	HTLV-I	HTLV-I	B-NP	NN	O	48	PMOD
50	.	.	O	.	O	5	P

1	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD
2	appearance	appearance	I-NP	NN	O	16	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	5	NMOD
5	factor	factor	I-NP	NN	O	3	PMOD
6	that	that	B-NP	WDT	O	5	NMOD
7	binds	bind	B-VP	VBZ	O	6	SBAR
8	the	the	B-NP	DT	O	11	NMOD
9	CD28	CD28	I-NP	NN	B-DNA	11	NMOD
10	response	response	I-NP	NN	I-DNA	11	NMOD
11	element	element	I-NP	NN	I-DNA	7	OBJ
12	within	within	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	interleukin-2	interleukin-2	I-NP	NN	B-DNA	15	NMOD
15	enhancer	enhancer	I-NP	NN	I-DNA	12	PMOD
16	correlates	correlate	B-VP	VBZ	O	0	ROOT
17	with	with	B-PP	IN	O	16	VMOD
18	interleukin-2	interleukin-2	B-NP	NN	B-protein	19	NMOD
19	production	production	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	16	P

1	Activation	Activation	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD
5	requires	require	B-VP	VBZ	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	combined	combined	I-NP	JJ	O	8	NMOD
8	signaling	signaling	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	T	T	I-NP	NN	B-protein	13	NMOD
12	cell	cell	I-NP	NN	I-protein	13	NMOD
13	receptor	receptor	I-NP	NN	I-protein	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	costimulatory	costimulatory	B-NP	JJ	B-protein	16	NMOD
16	molecules	molecule	I-NP	NNS	I-protein	9	PMOD
17	such	such	B-PP	JJ	O	18	PMOD
18	as	as	I-PP	IN	O	16	NMOD
19	CD28	CD28	B-NP	NN	B-protein	18	PMOD
20	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	ability	ability	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	T	T	B-NP	NN	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
6	to	to	B-VP	TO	O	7	VMOD
7	produce	produce	I-VP	VB	O	2	NMOD
8	interleukin-2	interleukin-2	B-NP	NN	B-protein	7	OBJ
9	(	(	O	(	O	10	P
10	IL-2	IL-2	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	is	be	B-VP	VBZ	O	0	ROOT
13	a	a	B-NP	DT	O	16	NMOD
14	critical	critical	I-NP	JJ	O	16	NMOD
15	control	control	I-NP	NN	O	16	NMOD
16	point	point	I-NP	NN	O	12	PRD
17	in	in	B-PP	IN	O	16	NMOD
18	T	T	B-NP	NN	B-cell_type	20	NMOD
19	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	20	NMOD
20	activation	activation	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	IL-2	IL-2	I-NP	NN	B-DNA	3	NMOD
3	enhancer	enhancer	I-NP	NN	I-DNA	4	SUB
4	contains	contain	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	functional	functional	I-NP	JJ	O	7	NMOD
7	motif	motif	I-NP	NN	O	4	OBJ
8	named	name	B-VP	VBN	O	7	NMOD
9	CD28	CD28	B-NP	NN	B-DNA	11	NMOD
10	response	response	I-NP	NN	I-DNA	11	NMOD
11	element	element	I-NP	NN	I-DNA	8	VMOD
12	(	(	O	(	O	13	P
13	CD28RE	CD28RE	B-NP	NN	B-DNA	11	NMOD
14	)	)	O	)	O	13	P
15	that	that	B-NP	WDT	O	7	NMOD
16	serves	serve	B-VP	VBZ	O	15	SBAR
17	a	a	B-NP	DT	O	18	NMOD
18	role	role	I-NP	NN	O	16	OBJ
19	as	as	B-PP	IN	O	16	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	target	target	I-NP	NN	O	19	PMOD
22	for	for	B-PP	IN	O	21	NMOD
23	mitogenic	mitogenic	B-NP	JJ	O	27	NMOD
24	T	T	I-NP	NN	O	27	NMOD
25	cell	cell	I-NP	NN	O	27	NMOD
26	activation	activation	I-NP	NN	O	27	NMOD
27	signals	signal	I-NP	NNS	O	22	PMOD
28	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	CD28RE	CD28RE	I-NP	NN	B-DNA	3	NMOD
3	sequence	sequence	I-NP	NN	I-DNA	4	SUB
4	reveals	reveal	B-VP	VBZ	O	0	ROOT
5	similarity	similarity	B-NP	NN	O	4	OBJ
6	to	to	B-PP	TO	O	5	NMOD
7	the	the	B-NP	DT	O	11	NMOD
8	consensus	consensus	I-NP	NN	B-DNA	11	NMOD
9	kappaB	kappaB	I-NP	NN	I-DNA	11	NMOD
10	binding	binding	I-NP	NN	I-DNA	11	NMOD
11	motif	motif	I-NP	NN	I-DNA	6	PMOD
12	.	.	O	.	O	4	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	CD28RE	CD28RE	B-NP	NN	B-DNA	6	SUB
6	binds	bind	B-VP	VBZ	O	4	SBAR
7	an	an	B-NP	DT	O	9	NMOD
8	inducible	inducible	I-NP	JJ	O	9	NMOD
9	protein	protein	I-NP	NN	O	6	OBJ
10	with	with	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	13	NMOD
12	molecular	molecular	I-NP	JJ	O	13	NMOD
13	mass	mass	I-NP	NN	O	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	approximately	approximately	B-NP	RB	O	17	NMOD
16	35	35	I-NP	CD	O	15	AMOD
17	kDa	kDa	I-NP	NN	O	14	PMOD
18	called	call	B-VP	VBN	O	9	NMOD
19	nuclear	nuclear	B-NP	JJ	B-protein	20	NMOD
20	factor	factor	I-NP	NN	I-protein	18	VMOD
21	of	of	B-PP	IN	I-protein	20	NMOD
22	mitogenic-activated	mitogenic-activated	B-NP	JJ	I-protein	24	NMOD
23	T	T	I-NP	NN	I-protein	24	NMOD
24	cells	cell	I-NP	NNS	I-protein	21	PMOD
25	(	(	O	(	O	26	P
26	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	20	NMOD
27	)	)	O	)	O	26	P
28	that	that	B-NP	WDT	O	9	NMOD
29	is	be	B-VP	VBZ	O	28	SBAR
30	clearly	clearly	B-ADJP	RB	O	31	AMOD
31	different	different	I-ADJP	JJ	O	29	PRD
32	from	from	B-PP	IN	O	31	AMOD
33	the	the	B-NP	DT	O	38	NMOD
34	known	know	I-NP	VBN	O	38	NMOD
35	NF-	NF-	I-NP	NF-	B-protein	38	NMOD
36	kappaB/Rel	kappaB/Rel	I-NP	NN	I-protein	38	NMOD
37	family	family	I-NP	NN	I-protein	38	NMOD
38	members	member	I-NP	NNS	I-protein	32	PMOD
39	.	.	O	.	O	3	P

1	Induction	Induction	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	2	PMOD
4	was	be	B-VP	VBD	O	0	ROOT
5	shown	show	I-VP	VBN	O	4	VC
6	to	to	I-VP	TO	O	7	VMOD
7	depend	depend	I-VP	VB	O	5	VMOD
8	on	on	B-PP	IN	O	7	VMOD
9	de	de	B-NP	FW	O	10	AMOD
10	novo	novo	I-NP	FW	O	12	NMOD
11	protein	protein	I-NP	NN	O	12	NMOD
12	synthesis	synthesis	I-NP	NN	O	8	PMOD
13	and	and	O	CC	O	4	VMOD
14	was	be	B-VP	VBD	O	4	VMOD
15	restricted	restricted	B-ADJP	JJ	O	14	PRD
16	to	to	B-PP	TO	O	15	AMOD
17	T	T	B-NP	NN	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
19	that	that	B-NP	WDT	O	18	NMOD
20	received	receive	B-VP	VBD	O	19	SBAR
21	a	a	B-NP	DT	O	23	NMOD
22	mitogenic	mitogenic	I-NP	JJ	O	23	NMOD
23	combination	combination	I-NP	NN	O	20	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	T	T	B-NP	NN	O	27	NMOD
26	cell	cell	I-NP	NN	O	27	NMOD
27	stimuli	stimulus	I-NP	NNS	O	24	PMOD
28	,	,	O	,	O	27	P
29	not	not	B-VP	RB	O	31	VMOD
30	necessarily	necessarily	I-VP	RB	O	29	AMOD
31	including	include	I-VP	VBG	O	27	NMOD
32	CD28	CD28	B-NP	NN	B-protein	33	NMOD
33	signaling	signaling	I-NP	NN	O	31	OBJ
34	.	.	O	.	O	4	P

1	Nonmitogenic	Nonmitogenic	B-NP	JJ	O	4	NMOD
2	T	T	I-NP	NN	O	4	NMOD
3	cell	cell	I-NP	NN	O	4	NMOD
4	stimulation	stimulation	I-NP	NN	O	5	SUB
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	result	result	I-VP	VB	O	5	VC
8	in	in	B-PP	IN	O	7	VMOD
9	appearance	appearance	B-NP	NN	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	mitogenic	mitogenic	B-NP	JJ	O	6	NMOD
6	combinations	combination	I-NP	NNS	O	12	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	T	T	B-NP	NN	O	11	NMOD
9	cell	cell	I-NP	NN	O	11	NMOD
10	activation	activation	I-NP	NN	O	11	NMOD
11	signals	signal	I-NP	NNS	O	7	PMOD
12	are	be	B-VP	VBP	O	4	SBAR
13	integrated	integrate	I-VP	VBN	O	12	VC
14	at	at	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	level	level	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	19	NMOD
19	induction	induction	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	3	P

1	Similar	Similar	B-ADJP	JJ	O	11	VMOD
2	to	to	B-PP	TO	O	1	AMOD
3	its	its	B-NP	PRP$	O	4	NMOD
4	effect	effect	I-NP	NN	O	2	PMOD
5	on	on	B-PP	IN	O	4	NMOD
6	IL-2	IL-2	B-NP	NN	B-protein	7	NMOD
7	production	production	I-NP	NN	O	5	PMOD
8	,	,	O	,	O	11	P
9	cyclosporin	cyclosporin	B-NP	NN	O	10	NMOD
10	A	A	I-NP	NN	O	11	SUB
11	inhibited	inhibit	B-VP	VBD	O	0	ROOT
12	the	the	B-NP	DT	O	13	NMOD
13	induction	induction	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	11	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	data	datum	I-NP	NNS	O	6	SUB
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	nuclear	nuclear	I-NP	JJ	O	10	NMOD
10	appearance	appearance	I-NP	NN	O	13	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	NF-MATp35	NF-MATp35	B-NP	NN	B-protein	11	PMOD
13	shows	show	B-VP	VBZ	O	7	SBAR
14	excellent	excellent	B-NP	JJ	O	15	NMOD
15	correlation	correlation	I-NP	NN	O	13	OBJ
16	with	with	B-PP	IN	O	15	NMOD
17	IL-2	IL-2	B-NP	NN	B-protein	18	NMOD
18	production	production	I-NP	NN	O	16	PMOD
19	,	,	O	,	O	18	P
20	which	which	B-NP	WDT	O	18	NMOD
21	is	be	B-VP	VBZ	O	20	SBAR
22	a	a	B-NP	DT	O	24	NMOD
23	unique	unique	I-NP	JJ	O	24	NMOD
24	characteristic	characteristic	I-NP	NN	O	21	PRD
25	among	among	B-PP	IN	O	24	NMOD
26	nuclear	nuclear	B-NP	JJ	B-protein	27	NMOD
27	factors	factor	I-NP	NNS	I-protein	25	PMOD
28	implicated	implicate	B-VP	VBN	O	27	NMOD
29	in	in	B-PP	IN	O	28	VMOD
30	the	the	B-NP	DT	O	31	NMOD
31	control	control	I-NP	NN	O	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	IL-2	IL-2	B-NP	NN	B-DNA	35	NMOD
34	gene	gene	I-NP	NN	I-DNA	35	NMOD
35	expression	expression	I-NP	NN	O	32	PMOD
36	.	.	O	.	O	6	P

1	Preassociation	Preassociation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	STAT1	STAT1	B-NP	NN	B-protein	2	PMOD
4	with	with	B-PP	IN	O	1	NMOD
5	STAT2	STAT2	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	STAT3	STAT3	I-NP	NN	B-protein	4	PMOD
8	in	in	B-PP	IN	O	1	NMOD
9	separate	separate	B-NP	JJ	O	11	NMOD
10	signalling	signalling	I-NP	NN	B-protein	11	NMOD
11	complexes	complex	I-NP	NNS	I-protein	8	PMOD
12	prior	prior	B-ADVP	RB	O	13	PMOD
13	to	to	B-PP	TO	O	1	NMOD
14	cytokine	cytokine	B-NP	NN	B-protein	15	NMOD
15	stimulation	stimulation	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	1	P

1	A	A	B-NP	DT	O	2	NMOD
2	variety	variety	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	cytokines	cytokine	B-NP	NNS	B-protein	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	growth	growth	B-NP	NN	B-protein	7	NMOD
7	factors	factor	I-NP	NNS	I-protein	3	PMOD
8	act	act	B-VP	VBP	O	0	ROOT
9	through	through	B-PP	IN	O	8	VMOD
10	an	an	B-NP	DT	O	11	NMOD
11	induction	induction	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	gene	gene	B-NP	NN	O	14	NMOD
14	expression	expression	I-NP	NN	O	12	PMOD
15	mediated	mediate	B-VP	VBN	O	11	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	a	a	B-NP	DT	O	18	NMOD
18	family	family	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	latent	latent	B-NP	JJ	B-protein	22	NMOD
21	transcription	transcription	I-NP	NN	I-protein	22	NMOD
22	factors	factor	I-NP	NNS	I-protein	33	NMOD
23	called	call	B-VP	VBN	O	33	NMOD
24	STAT	STAT	B-NP	NN	B-protein	33	NMOD
25	(	(	O	(	O	31	P
26	signal	signal	B-NP	NN	B-protein	31	NMOD
27	transducers	transducer	I-NP	NNS	I-protein	31	NMOD
28	and	and	O	CC	I-protein	31	NMOD
29	activators	activator	B-NP	NNS	I-protein	31	NMOD
30	of	of	B-PP	IN	I-protein	31	NMOD
31	transcription	transcription	B-NP	NN	I-protein	24	NMOD
32	)	)	O	)	O	31	P
33	proteins	protein	B-NP	NNS	O	19	PMOD
34	.	.	O	.	O	8	P

1	Ligand-induced	Ligand-induced	B-NP	JJ	O	3	NMOD
2	tyrosine	tyrosine	I-NP	NN	O	3	NMOD
3	phosphorylation	phosphorylation	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	STATs	STAT	I-NP	NNS	B-protein	4	PMOD
7	promotes	promote	B-VP	VBZ	O	0	ROOT
8	their	their	B-NP	PRP$	O	12	NMOD
9	homodimer	homodimer	I-NP	NN	B-protein	12	NMOD
10	and	and	I-NP	CC	O	12	NMOD
11	heterodimer	heterodimer	I-NP	NN	O	12	NMOD
12	formation	formation	I-NP	NN	O	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	subsequent	subsequent	B-NP	JJ	O	16	NMOD
15	nuclear	nuclear	I-NP	JJ	O	16	NMOD
16	translocation	translocation	I-NP	NN	O	7	OBJ
17	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	STAT	STAT	B-NP	NN	B-protein	7	NMOD
6	protein	protein	I-NP	NN	I-protein	7	NMOD
7	heterocomplexes	heterocomplex	I-NP	NNS	I-protein	8	SUB
8	exist	exist	B-VP	VBP	O	4	SBAR
9	prior	prior	B-ADVP	RB	O	8	VMOD
10	to	to	B-PP	TO	O	8	VMOD
11	cytokine	cytokine	B-NP	NN	B-protein	12	NMOD
12	treatment	treatment	I-NP	NN	O	10	PMOD
13	.	.	O	.	O	2	P

1	When	When	B-ADVP	WRB	O	25	VMOD
2	unstimulated	unstimulated	B-NP	JJ	B-cell_line	4	NMOD
3	HeLa	HeLa	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	5	SUB
5	are	be	B-VP	VBP	O	1	SBAR
6	ruptured	rupture	I-VP	VBN	O	5	VC
7	in	in	B-PP	IN	O	6	VMOD
8	hypotonic	hypotonic	B-NP	JJ	O	9	NMOD
9	buffer	buffer	I-NP	NN	O	7	PMOD
10	without	without	B-PP	IN	O	9	NMOD
11	salt	salt	B-NP	NN	O	13	NMOD
12	or	or	I-NP	CC	O	13	NMOD
13	detergent	detergent	I-NP	NN	O	10	PMOD
14	,	,	O	,	O	25	P
15	immunoadsorption	immunoadsorption	B-NP	NN	O	25	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	either	either	O	CC	O	20	NMOD
18	STAT1	STAT1	B-NP	NN	B-protein	20	NMOD
19	or	or	I-NP	CC	O	20	NMOD
20	STAT2	STAT2	I-NP	NN	B-protein	16	PMOD
21	from	from	B-PP	IN	O	15	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	resulting	result	I-NP	VBG	O	24	NMOD
24	cytosol	cytosol	I-NP	NN	O	21	PMOD
25	yields	yield	B-VP	VBZ	O	0	ROOT
26	coimmunoadsorption	coimmunoadsorption	B-NP	NN	O	25	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	other	other	I-NP	JJ	O	27	PMOD
30	STAT	STAT	I-NP	NN	B-protein	31	NMOD
31	protein	protein	I-NP	NN	I-protein	29	NMOD
32	.	.	O	.	O	25	P

1	Similarly	Similarly	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	STAT1-STAT3	STAT1-STAT3	B-NP	NN	B-protein	4	NMOD
4	heterocomplexes	heterocomplex	I-NP	NNS	I-protein	5	SUB
5	are	be	B-VP	VBP	O	0	ROOT
6	coimmunoadsorbed	coimmunoadsorbe	I-VP	VBN	O	5	VC
7	from	from	B-PP	IN	O	6	VMOD
8	hypotonic	hypotonic	B-NP	JJ	O	9	NMOD
9	cytosol	cytosol	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	5	P

1	STAT1	STAT1	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	STAT2	STAT2	I-NP	NN	B-protein	5	NMOD
4	or	or	I-NP	CC	O	5	NMOD
5	STAT1	STAT1	I-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	STAT3	STAT3	I-NP	NN	B-protein	13	SUB
8	translated	translate	B-VP	VBN	O	7	NMOD
9	in	in	B-PP	IN	O	8	VMOD
10	reticulocyte	reticulocyte	B-NP	NN	O	11	NMOD
11	lysate	lysate	I-NP	NN	O	9	PMOD
12	spontaneously	spontaneously	B-VP	RB	O	13	VMOD
13	form	form	I-VP	VBP	O	0	ROOT
14	heterocomplexes	heterocomplex	B-NP	NNS	B-protein	13	OBJ
15	when	when	B-ADVP	WRB	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	translation	translation	I-NP	NN	O	18	NMOD
18	lysates	lysate	I-NP	NNS	O	19	SUB
19	are	be	B-VP	VBP	O	15	SBAR
20	mixed	mix	I-VP	VBN	O	19	VC
21	at	at	B-PP	IN	O	20	VMOD
22	0	0	B-NP	CD	O	23	NMOD
23	degrees	degree	I-NP	NNS	O	21	PMOD
24	C	C	B-ADJP	JJ	O	23	NMOD
25	.	.	O	.	O	13	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	interferon-alpha	interferon-alpha	B-NP	NN	B-protein	8	NMOD
6	/beta-induced	/beta-induced	I-NP	JJ	O	8	NMOD
7	tyrosine	tyrosine	I-NP	NN	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	9	SUB
9	increases	increase	B-VP	VBZ	O	4	SBAR
10	the	the	B-NP	DT	O	11	NMOD
11	stability	stability	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	20	NMOD
14	preexisting	preexisting	I-NP	JJ	O	20	NMOD
15	,	,	I-NP	,	O	20	P
16	latent	latent	I-NP	JJ	O	20	NMOD
17	,	,	I-NP	,	O	20	P
18	STAT1-STAT2	STAT1-STAT2	I-NP	NN	B-protein	20	NMOD
19	signaling	signaling	I-NP	NN	I-protein	20	NMOD
20	complex	complex	I-NP	NN	I-protein	12	PMOD
21	.	.	O	.	O	3	P

1	Newly	Newly	B-NP	RB	O	2	AMOD
2	translated	translate	I-NP	VBN	O	3	NMOD
3	STAT1	STAT1	I-NP	NN	B-protein	4	SUB
4	binds	bind	B-VP	VBZ	O	15	VMOD
5	in	in	B-PP	IN	O	4	VMOD
6	equilibrium	equilibrium	B-NP	NN	O	7	NMOD
7	fashion	fashion	I-NP	NN	O	5	PMOD
8	to	to	B-PP	TO	O	7	NMOD
9	STAT2	STAT2	B-NP	NN	B-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	STAT3	STAT3	I-NP	NN	B-protein	8	PMOD
12	,	,	O	,	O	15	P
13	but	but	O	CC	O	15	VMOD
14	we	we	B-NP	PRP	O	15	SUB
15	show	show	B-VP	VBP	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	STAT2	STAT2	B-NP	NN	B-protein	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	STAT3	STAT3	I-NP	NN	B-protein	20	SUB
20	exist	exist	B-VP	VBP	O	16	SBAR
21	in	in	B-PP	IN	O	20	VMOD
22	separate	separate	B-NP	JJ	O	23	NMOD
23	heterocomplexes	heterocomplex	I-NP	NNS	B-protein	21	PMOD
24	with	with	B-PP	IN	O	20	VMOD
25	STAT1	STAT1	B-NP	NN	B-protein	24	PMOD
26	,	,	O	,	O	15	P
27	consistent	consistent	B-ADJP	JJ	O	15	VMOD
28	with	with	B-PP	IN	O	27	AMOD
29	a	a	B-NP	DT	O	30	NMOD
30	model	model	I-NP	NN	O	28	PMOD
31	in	in	B-PP	IN	O	30	NMOD
32	which	which	B-NP	WDT	O	31	PMOD
33	STAT1	STAT1	B-NP	NN	B-protein	34	SUB
34	contains	contain	B-VP	VBZ	O	31	SBAR
35	a	a	B-NP	DT	O	38	NMOD
36	common	common	I-NP	JJ	O	38	NMOD
37	binding	bind	I-NP	VBG	O	38	NMOD
38	site	site	I-NP	NN	O	34	OBJ
39	for	for	B-PP	IN	O	38	NMOD
40	other	other	B-NP	JJ	O	42	NMOD
41	STAT	STAT	I-NP	NN	B-protein	42	NMOD
42	proteins	protein	I-NP	NNS	I-protein	39	PMOD
43	.	.	O	.	O	15	P

1	Inhibition	Inhibition	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	p105	p105	B-NP	NN	B-protein	4	NMOD
4	processing	processing	I-NP	NN	O	2	PMOD
5	by	by	B-PP	IN	O	1	NMOD
6	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	5	PMOD
8	in	in	B-PP	IN	O	1	NMOD
9	transiently	transiently	B-NP	RB	B-cell_line	10	AMOD
10	transfected	transfecte	I-NP	VBN	I-cell_line	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_line	8	PMOD
12	.	.	O	.	O	1	P

1	Regulation	Regulation	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	transcription	transcription	I-NP	NN	B-protein	6	NMOD
5	factor	factor	I-NP	NN	I-protein	6	NMOD
6	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	2	PMOD
7	involves	involve	B-VP	VBZ	O	0	ROOT
8	proteasome-mediated	proteasome-mediated	B-NP	JJ	O	9	NMOD
9	processing	processing	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	15	NMOD
12	NF-kappaB1	NF-kappaB1	I-NP	NN	B-protein	15	NMOD
13	p105	p105	I-NP	NN	I-protein	15	NMOD
14	precursor	precursor	I-NP	NN	I-protein	15	NMOD
15	protein	protein	I-NP	NN	I-protein	10	PMOD
16	,	,	O	,	O	15	P
17	which	which	B-NP	WDT	O	15	NMOD
18	generates	generate	B-VP	VBZ	O	17	SBAR
19	the	the	B-NP	DT	O	21	NMOD
20	p50	p50	I-NP	NN	B-protein	21	NMOD
21	subunit	subunit	I-NP	NN	I-protein	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	22	PMOD
24	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	processing	processing	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	p105	p105	B-NP	NN	B-protein	3	PMOD
5	occurs	occur	B-VP	VBZ	O	0	ROOT
6	constitutively	constitutively	B-ADVP	RB	O	5	VMOD
7	in	in	B-ADVP	FW	O	5	VMOD
8	vivo	vivo	I-ADVP	FW	O	7	AMOD
9	but	but	O	CC	O	5	VMOD
10	can	can	B-VP	MD	O	5	VMOD
11	be	be	I-VP	VB	O	10	VC
12	markedly	markedly	I-VP	RB	O	11	VMOD
13	enhanced	enhance	I-VP	VBN	O	11	VC
14	by	by	B-PP	IN	O	13	VMOD
15	various	various	B-NP	JJ	O	18	NMOD
16	cellular	cellular	I-NP	JJ	O	18	NMOD
17	activation	activation	I-NP	NN	O	18	NMOD
18	agents	agent	I-NP	NNS	O	14	PMOD
19	,	,	O	,	O	5	P
20	although	although	B-SBAR	IN	O	5	VMOD
21	the	the	B-NP	DT	O	24	NMOD
22	underlying	underlying	I-NP	JJ	O	24	NMOD
23	regulatory	regulatory	I-NP	JJ	O	24	NMOD
24	mechanism	mechanism	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	20	SBAR
26	not	not	O	RB	O	25	VMOD
27	yet	yet	B-ADJP	RB	O	26	AMOD
28	clear	clear	I-ADJP	JJ	O	25	PRD
29	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	7	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	signal-mediated	signal-mediated	B-NP	JJ	O	10	NMOD
10	induction	induction	I-NP	NN	O	18	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	p105	p105	B-NP	NN	B-protein	13	NMOD
13	processing	processing	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	10	NMOD
15	human	human	B-NP	JJ	B-cell_type	17	NMOD
16	T	T	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
18	is	be	B-VP	VBZ	O	8	SBAR
19	associated	associate	I-VP	VBN	O	18	VC
20	with	with	B-PP	IN	O	19	VMOD
21	de	de	B-NP	FW	O	22	AMOD
22	novo	novo	I-NP	FW	O	23	NMOD
23	synthesis	synthesis	I-NP	NN	O	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	this	this	B-NP	DT	O	27	NMOD
26	precursor	precursor	I-NP	NN	B-protein	27	NMOD
27	protein	protein	I-NP	NN	I-protein	24	PMOD
28	.	.	O	.	O	7	P

1	Transient	Transient	B-NP	JJ	O	3	NMOD
2	transfection	transfection	I-NP	NN	O	3	NMOD
3	studies	study	I-NP	NNS	O	8	SUB
4	performed	perform	B-VP	VBN	O	3	NMOD
5	in	in	B-PP	IN	O	4	VMOD
6	COS7	COS7	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
8	revealed	reveal	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	the	the	B-NP	DT	O	14	NMOD
11	newly	newly	I-NP	RB	O	12	AMOD
12	synthesized	synthesize	I-NP	VBN	O	14	NMOD
13	p105	p105	I-NP	NN	B-protein	14	NMOD
14	protein	protein	I-NP	NN	O	15	SUB
15	appears	appear	B-VP	VBZ	O	9	SBAR
16	to	to	I-VP	TO	O	17	VMOD
17	be	be	I-VP	VB	O	15	VMOD
18	more	more	B-ADVP	RBR	O	19	AMOD
19	rapidly	rapidly	I-ADVP	RB	O	17	VMOD
20	processed	process	B-VP	VBD	O	17	VMOD
21	compared	compare	I-VP	VBN	O	20	VC
22	to	to	B-PP	TO	O	21	VMOD
23	its	its	B-NP	PRP$	O	25	NMOD
24	accumulated	accumulated	I-NP	JJ	O	25	NMOD
25	form	form	I-NP	NN	O	22	PMOD
26	that	that	B-NP	WDT	O	25	NMOD
27	is	be	B-VP	VBZ	O	26	SBAR
28	already	already	I-VP	RB	O	27	VMOD
29	associated	associate	I-VP	VBN	O	27	VC
30	with	with	B-PP	IN	O	29	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	processed	process	I-NP	VBN	O	33	NMOD
33	product	product	I-NP	NN	O	34	NMOD
34	p50	p50	I-NP	NN	B-protein	30	PMOD
35	.	.	O	.	O	8	P

1	Interestingly	Interestingly	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	5	NMOD
4	processing	processing	I-NP	NN	O	5	NMOD
5	rate	rate	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	p105	p105	B-NP	NN	B-protein	6	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	markedly	markedly	I-VP	RB	O	8	VMOD
10	inhibited	inhibit	I-VP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	cells	cell	B-NP	NNS	O	11	PMOD
13	co-transfected	co-transfecte	B-VP	VBN	O	12	NMOD
14	with	with	B-PP	IN	O	13	VMOD
15	p50	p50	B-NP	NN	B-protein	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	other	other	B-NP	JJ	O	19	NMOD
18	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	19	NMOD
19	subunits	subunit	I-NP	NNS	I-protein	14	PMOD
20	,	,	O	,	O	19	P
21	including	include	B-PP	VBG	O	19	NMOD
22	RelA	RelA	B-NP	NN	B-protein	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	c-Rel	c-Rel	I-NP	NN	B-protein	21	PMOD
25	,	,	O	,	O	24	P
26	that	that	B-NP	WDT	O	24	NMOD
27	physically	physically	B-ADVP	RB	O	28	VMOD
28	interact	interact	B-VP	VBP	O	26	SBAR
29	with	with	B-PP	IN	O	28	VMOD
30	p105	p105	B-NP	NN	B-protein	29	PMOD
31	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	processing	processing	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	p105	p105	B-NP	NN	B-protein	7	PMOD
9	is	be	B-VP	VBZ	O	4	SBAR
10	subject	subject	B-ADJP	JJ	O	9	PRD
11	to	to	B-PP	TO	O	10	AMOD
12	negative	negative	B-NP	JJ	O	13	NMOD
13	regulation	regulation	I-NP	NN	O	11	PMOD
14	by	by	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	various	various	I-NP	JJ	O	18	NMOD
17	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	18	NMOD
18	subunits	subunit	I-NP	NNS	I-protein	14	PMOD
19	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	3	SUB
2	further	further	B-ADVP	RB	O	3	VMOD
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	p105	p105	B-NP	NN	B-protein	6	SUB
6	undergoes	undergo	B-VP	VBZ	O	4	SBAR
7	degradation	degradation	B-NP	NN	O	6	OBJ
8	in	in	B-PP	IN	O	6	VMOD
9	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	B-NP	JJ	B-cell_line	12	NMOD
10	human	human	I-NP	JJ	I-cell_line	12	NMOD
11	monocytic	monocytic	I-NP	JJ	I-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	8	PMOD
13	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	5	NMOD
4	inducible	inducible	I-NP	JJ	O	5	NMOD
5	degradation	degradation	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	p105	p105	B-NP	NN	B-protein	6	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	coupled	couple	I-VP	VBN	O	8	VC
11	with	with	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	generation	generation	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	p50	p50	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	8	P

1	Together	Together	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	studies	study	I-NP	NNS	O	5	SUB
5	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	11	NMOD
8	processing	processing	I-NP	NN	O	11	NMOD
9	and	and	I-NP	CC	O	11	NMOD
10	inducible	inducible	I-NP	JJ	O	11	NMOD
11	degradation	degradation	I-NP	NN	O	14	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	p105	p105	B-NP	NN	B-protein	12	PMOD
14	are	be	B-VP	VBP	O	6	SBAR
15	differentially	differentially	I-VP	RB	O	14	VMOD
16	regulated	regulate	I-VP	VBN	O	14	VC
17	.	.	O	.	O	5	P

1	Globin	Globin	B-NP	NN	B-DNA	3	NMOD
2	gene	gene	I-NP	NN	I-DNA	3	NMOD
3	switching	switching	I-NP	NN	O	0	ROOT
4	.	.	O	.	O	3	P

1	In	In	B-NP	FW	O	2	AMOD
2	vivo	vivo	I-NP	FW	O	4	NMOD
3	protein-DNA	protein-DNA	I-NP	JJ	O	4	NMOD
4	interactions	interaction	I-NP	NNS	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	human	human	I-NP	JJ	B-DNA	9	NMOD
8	beta-globin	beta-globin	I-NP	NN	I-DNA	9	NMOD
9	locus	locus	I-NP	NN	I-DNA	5	PMOD
10	in	in	B-PP	IN	O	4	NMOD
11	erythroid	erythroid	B-NP	JJ	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
13	expressing	express	B-VP	VBG	O	4	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	fetal	fetal	I-NP	JJ	O	21	NMOD
16	or	or	O	CC	O	21	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	adult	adult	I-NP	JJ	O	21	NMOD
19	globin	globin	I-NP	NN	O	21	NMOD
20	gene	gene	I-NP	NN	O	21	NMOD
21	program	program	I-NP	NN	O	13	OBJ
22	.	.	O	.	O	4	P

1	To	To	B-VP	TO	O	2	VMOD
2	characterize	characterize	I-VP	VB	O	18	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	protein-DNA	protein-DNA	I-NP	JJ	O	5	NMOD
5	interactions	interaction	I-NP	NNS	O	2	OBJ
6	important	important	B-ADJP	JJ	O	5	NMOD
7	for	for	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	10	NMOD
9	developmental	developmental	I-NP	JJ	O	10	NMOD
10	control	control	I-NP	NN	O	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	human	human	I-NP	JJ	B-DNA	15	NMOD
14	beta-globin	beta-globin	I-NP	NN	I-DNA	15	NMOD
15	locus	locus	I-NP	NN	I-DNA	11	PMOD
16	,	,	O	,	O	18	P
17	we	we	B-NP	PRP	O	18	SUB
18	analyzed	analyze	B-VP	VBD	O	0	ROOT
19	by	by	B-PP	IN	O	18	VMOD
20	in	in	B-NP	FW	O	21	AMOD
21	vivo	vivo	I-NP	FW	O	24	NMOD
22	dimethyl	dimethyl	I-NP	NN	O	24	NMOD
23	sulfate	sulfate	I-NP	NN	O	24	NMOD
24	footprinting	footprinting	I-NP	NN	O	26	NMOD
25	erythroid	erythroid	I-NP	JJ	B-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
27	expressing	express	B-VP	VBG	O	26	NMOD
28	either	either	O	CC	O	36	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	fetal	fetal	I-NP	JJ	O	36	NMOD
31	or	or	O	CC	O	36	NMOD
32	the	the	B-NP	DT	O	36	NMOD
33	adult	adult	I-NP	JJ	O	36	NMOD
34	globin	globin	I-NP	NN	O	36	NMOD
35	developmental	developmental	I-NP	JJ	O	36	NMOD
36	program	program	I-NP	NN	O	27	OBJ
37	.	.	O	.	O	18	P

1	In	In	B-PP	IN	O	26	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	locus	locus	I-NP	NN	B-DNA	5	NMOD
4	control	control	I-NP	NN	I-DNA	5	NMOD
5	region	region	I-NP	NN	I-DNA	1	PMOD
6	(	(	O	(	O	7	P
7	LCR	LCR	B-NP	NN	B-DNA	5	NMOD
8	)	)	O	)	O	7	P
9	of	of	B-PP	IN	O	5	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	beta-globin	beta-globin	I-NP	NN	B-DNA	12	NMOD
12	locus	locus	I-NP	NN	I-DNA	9	PMOD
13	,	,	O	,	O	26	P
14	in	in	B-NP	FW	O	15	AMOD
15	vivo	vivo	I-NP	FW	O	16	NMOD
16	footprints	footprint	I-NP	NNS	O	26	SUB
17	on	on	B-PP	IN	O	16	NMOD
18	NF-E2	NF-E2	B-NP	NN	B-protein	25	NMOD
19	(	(	O	(	O	21	P
20	or	or	O	CC	O	21	DEP
21	AP-1	AP-1	B-NP	NN	B-protein	18	NMOD
22	)	)	O	)	O	21	P
23	and	and	O	CC	O	25	NMOD
24	GATA-1	GATA-1	B-NP	NN	B-DNA	25	NMOD
25	motifs	motif	I-NP	NNS	I-DNA	17	PMOD
26	remained	remain	B-VP	VBD	O	0	ROOT
27	the	the	B-NP	DT	O	28	NMOD
28	same	same	I-NP	JJ	O	26	PRD
29	regardless	regardless	B-ADVP	RB	O	26	VMOD
30	of	of	B-PP	IN	O	29	AMOD
31	whether	whether	B-SBAR	IN	O	30	PMOD
32	the	the	B-NP	DT	O	33	NMOD
33	fetal	fetal	I-NP	JJ	O	38	NMOD
34	or	or	O	CC	O	38	NMOD
35	the	the	B-NP	DT	O	38	NMOD
36	adult	adult	I-NP	JJ	B-DNA	38	NMOD
37	globin	globin	I-NP	NN	I-DNA	38	NMOD
38	genes	gene	I-NP	NNS	I-DNA	39	SUB
39	are	be	B-VP	VBP	O	31	SBAR
40	expressed	express	I-VP	VBN	O	39	VC
41	.	.	O	.	O	26	P

1	In	In	B-PP	IN	O	13	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	13	P
4	in	in	B-NP	FW	O	5	AMOD
5	vivo	vivo	I-NP	FW	O	6	NMOD
6	footprints	footprint	I-NP	NNS	O	13	SUB
7	on	on	B-PP	IN	O	6	NMOD
8	GT	GT	B-NP	NN	B-DNA	12	NMOD
9	(	(	O	(	I-DNA	10	P
10	CACCC	CACCC	B-NP	NN	I-DNA	8	NMOD
11	)	)	O	)	I-DNA	10	P
12	motifs	motif	B-NP	NNS	I-DNA	7	PMOD
13	differed	differ	B-VP	VBD	O	0	ROOT
14	between	between	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	cells	cell	I-NP	NNS	O	14	PMOD
17	expressing	express	B-VP	VBG	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	fetal	fetal	I-NP	JJ	O	24	NMOD
20	or	or	O	CC	O	24	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	adult	adult	I-NP	JJ	O	24	NMOD
23	globin	globin	I-NP	NN	O	24	NMOD
24	program	program	I-NP	NN	O	17	OBJ
25	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	9	VMOD
2	promoter	promoter	B-NP	NN	B-DNA	3	NMOD
3	regions	region	I-NP	NNS	I-DNA	1	PMOD
4	,	,	O	,	O	9	P
5	the	the	B-NP	DT	O	8	NMOD
6	actively	actively	I-NP	RB	B-DNA	8	NMOD
7	transcribed	transcribe	I-NP	VBN	I-DNA	8	NMOD
8	genes	gene	I-NP	NNS	I-DNA	9	SUB
9	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
10	extensive	extensive	B-NP	JJ	O	13	NMOD
11	and	and	I-NP	CC	O	13	NMOD
12	consistent	consistent	I-NP	JJ	O	13	NMOD
13	footprints	footprint	I-NP	NNS	O	9	OBJ
14	over	over	B-PP	IN	O	9	VMOD
15	the	the	B-NP	DT	O	17	NMOD
16	canonical	canonical	I-NP	JJ	B-DNA	17	NMOD
17	elements	element	I-NP	NNS	I-DNA	14	PMOD
18	,	,	O	,	O	17	P
19	such	such	B-PP	JJ	O	20	PMOD
20	as	as	I-PP	IN	O	17	NMOD
21	CACCC	CACCC	B-NP	NN	B-DNA	24	NMOD
22	and	and	I-NP	CC	I-DNA	24	NMOD
23	CCAAT	CCAAT	I-NP	NN	I-DNA	24	NMOD
24	motifs	motif	I-NP	NNS	I-DNA	20	PMOD
25	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	5	NMOD
2	adult	adult	I-NP	JJ	B-cell_type	5	NMOD
3	globin	globin	I-NP	NN	I-cell_type	5	NMOD
4	expressing	expressing	I-NP	NN	I-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	6	SUB
6	displayed	display	B-VP	VBD	O	0	ROOT
7	more	more	B-NP	RBR	O	8	AMOD
8	extensive	extensive	I-NP	JJ	O	9	NMOD
9	footprints	footprint	I-NP	NNS	O	6	OBJ
10	than	than	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	15	NMOD
12	fetal	fetal	I-NP	JJ	B-cell_type	15	NMOD
13	globin	globin	I-NP	NN	I-cell_type	15	NMOD
14	expressing	expressing	I-NP	NN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
16	in	in	B-PP	IN	O	9	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	3	3	I-NP	CD	B-DNA	21	NMOD
19	'	'	I-NP	SYM	I-DNA	20	AMOD
20	regulatory	regulatory	I-NP	JJ	I-DNA	21	NMOD
21	sequences	sequence	I-NP	NNS	I-DNA	16	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	both	both	O	CC	O	29	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	Agamma-	Agamma-	I-NP	NN	O	29	NMOD
26	and	and	O	CC	O	29	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	beta-globin	beta-globin	I-NP	NN	B-DNA	29	NMOD
29	genes	gene	I-NP	NNS	I-DNA	22	PMOD
30	,	,	O	,	O	6	P
31	suggesting	suggest	B-VP	VBG	O	6	VMOD
32	a	a	B-NP	DT	O	33	NMOD
33	role	role	I-NP	NN	O	31	OBJ
34	of	of	B-PP	IN	O	33	NMOD
35	these	these	B-NP	DT	O	38	NMOD
36	3	3	I-NP	CD	B-DNA	38	NMOD
37	'	'	I-NP	SYM	I-DNA	38	NMOD
38	elements	element	I-NP	NNS	I-DNA	34	PMOD
39	in	in	B-PP	IN	O	33	NMOD
40	beta-globin	beta-globin	B-NP	NN	B-DNA	42	NMOD
41	gene	gene	I-NP	NN	I-DNA	42	NMOD
42	expression	expression	I-NP	NN	O	39	PMOD
43	.	.	O	.	O	6	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	29	DEP
5	the	the	B-NP	DT	O	6	NMOD
6	bulk	bulk	I-NP	NN	O	18	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	protein-DNA	protein-DNA	B-NP	JJ	O	9	NMOD
9	interactions	interaction	I-NP	NNS	O	7	PMOD
10	that	that	B-NP	WDT	O	6	NMOD
11	underlies	underlie	B-VP	VBZ	O	10	SBAR
12	the	the	B-NP	DT	O	14	NMOD
13	developmental	developmental	I-NP	JJ	O	14	NMOD
14	control	control	I-NP	NN	O	11	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	globin	globin	B-NP	NN	B-DNA	17	NMOD
17	genes	gene	I-NP	NNS	I-DNA	15	PMOD
18	takes	take	B-VP	VBZ	O	4	SBAR
19	place	place	B-NP	NN	O	18	OBJ
20	in	in	B-PP	IN	O	18	VMOD
21	the	the	B-NP	DT	O	26	NMOD
22	gamma-	gamma-	I-NP	NN	B-DNA	26	NMOD
23	and	and	I-NP	CC	I-DNA	26	NMOD
24	beta-globin	beta-globin	I-NP	NN	I-DNA	26	NMOD
25	gene	gene	I-NP	NN	I-DNA	26	NMOD
26	promoters	promoter	I-NP	NNS	I-DNA	20	PMOD
27	,	,	O	,	O	29	P
28	and	and	O	CC	O	29	DEP
29	that	that	B-SBAR	IN	O	3	VMOD
30	GT	GT	B-NP	NN	B-DNA	31	NMOD
31	motifs	motif	I-NP	NNS	I-DNA	37	SUB
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	36	NMOD
34	beta-globin	beta-globin	I-NP	NN	B-DNA	36	NMOD
35	locus	locus	I-NP	NN	I-DNA	36	NMOD
36	LCR	LCR	I-NP	NN	B-DNA	32	PMOD
37	may	may	B-VP	MD	O	29	SBAR
38	play	play	I-VP	VB	O	37	VC
39	a	a	B-NP	DT	O	40	NMOD
40	role	role	I-NP	NN	O	38	OBJ
41	in	in	B-PP	IN	O	38	VMOD
42	the	the	B-NP	DT	O	44	NMOD
43	developmental	developmental	I-NP	JJ	O	44	NMOD
44	regulation	regulation	I-NP	NN	O	41	PMOD
45	of	of	B-PP	IN	O	44	NMOD
46	human	human	B-NP	JJ	B-DNA	48	NMOD
47	beta-globin	beta-globin	I-NP	NN	I-DNA	48	NMOD
48	gene	gene	I-NP	NN	I-DNA	49	NMOD
49	expression	expression	I-NP	NN	O	45	PMOD
50	,	,	O	,	O	38	P
51	perhaps	perhaps	B-ADVP	RB	O	52	PMOD
52	by	by	B-PP	IN	O	38	VMOD
53	increasing	increase	B-VP	VBG	O	52	PMOD
54	the	the	B-NP	DT	O	55	NMOD
55	probability	probability	I-NP	NN	O	53	OBJ
56	of	of	B-PP	IN	O	55	NMOD
57	interaction	interaction	B-NP	NN	O	56	PMOD
58	of	of	B-PP	IN	O	57	NMOD
59	the	the	B-NP	DT	O	61	NMOD
60	LCR	LCR	I-NP	NN	B-protein	61	NMOD
61	holocomplex	holocomplex	I-NP	NN	I-protein	58	PMOD
62	with	with	B-PP	IN	O	57	NMOD
63	the	the	B-NP	DT	O	64	NMOD
64	fetal	fetal	I-NP	JJ	O	69	NMOD
65	or	or	O	CC	O	69	NMOD
66	the	the	B-NP	DT	O	67	NMOD
67	adult	adult	I-NP	JJ	B-DNA	69	NMOD
68	globin	globin	I-NP	NN	I-DNA	69	NMOD
69	gene	gene	I-NP	NN	I-DNA	62	PMOD
70	.	.	O	.	O	3	P

1	Interleukin	Interleukin	B-NP	NN	B-protein	3	SUB
2	10	10	I-NP	CD	I-protein	1	NMOD
3	induced	induce	B-VP	VBD	O	0	ROOT
4	c-fos	c-fos	B-NP	NN	B-DNA	5	NMOD
5	expression	expression	I-NP	NN	O	3	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	human	human	B-NP	JJ	B-cell_type	9	NMOD
8	B	B	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
10	by	by	B-PP	IN	O	3	VMOD
11	activation	activation	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	divergent	divergent	B-NP	JJ	B-protein	15	NMOD
14	protein	protein	I-NP	NN	I-protein	15	NMOD
15	kinases	kinase	I-NP	NNS	I-protein	12	PMOD
16	.	.	O	.	O	3	P

1	IL-10	IL-10	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	potent	potent	I-NP	JJ	O	5	NMOD
5	mediator	mediator	I-NP	NN	O	2	PRD
6	of	of	B-PP	IN	O	5	NMOD
7	human	human	B-NP	JJ	O	10	NMOD
8	B	B	I-NP	NN	O	10	NMOD
9	cell	cell	I-NP	NN	O	10	NMOD
10	growth	growth	I-NP	NN	O	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	plasma	plasma	B-NP	NN	O	14	NMOD
13	cell	cell	I-NP	NN	O	14	NMOD
14	formation	formation	I-NP	NN	O	6	PMOD
15	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	signal	signal	B-NP	NN	O	4	NMOD
4	transduction	transduction	I-NP	NN	O	10	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	IL-10	IL-10	B-NP	NN	B-protein	5	PMOD
7	in	in	B-PP	IN	O	4	NMOD
8	B	B	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	poorly	poorly	B-ADJP	RB	O	10	VMOD
12	understood	understand	I-ADJP	VBN	O	10	VC
13	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	15	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	the	the	B-NP	DT	O	5	NMOD
5	effect	effect	I-NP	NN	O	15	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	IL-10	IL-10	B-NP	NN	B-protein	6	PMOD
8	on	on	B-PP	IN	O	5	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	expression	expression	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	protooncogene	protooncogene	I-NP	NN	B-DNA	14	NMOD
14	c-fos	c-fos	I-NP	NN	I-DNA	11	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	investigated	investigate	I-VP	VBN	O	15	VC
17	,	,	O	,	O	16	P
18	because	because	B-SBAR	IN	O	16	VMOD
19	Fos	Fos	B-NP	NN	B-protein	20	SUB
20	plays	play	B-VP	VBZ	O	18	SBAR
21	a	a	B-NP	DT	O	23	NMOD
22	potential	potential	I-NP	JJ	O	23	NMOD
23	role	role	I-NP	NN	O	20	OBJ
24	in	in	B-PP	IN	O	20	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	regulation	regulation	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	B	B	B-NP	NN	B-cell_type	29	NMOD
29	cell	cell	I-NP	NN	I-cell_type	27	PMOD
30	proliferation	proliferation	I-NP	NN	O	29	NMOD
31	and	and	O	CC	O	29	NMOD
32	differentiation	differentiation	B-NP	NN	O	29	NMOD
33	.	.	O	.	O	15	P

1	B	B	B-NP	NN	B-cell_type	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_type	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	purified	purify	I-VP	VBN	O	3	VC
5	from	from	B-PP	IN	O	4	VMOD
6	buffy	buffy	B-NP	JJ	O	8	NMOD
7	coat	coat	I-NP	NN	O	8	NMOD
8	preparations	preparation	I-NP	NNS	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	healthy	healthy	B-NP	JJ	O	12	NMOD
11	blood	blood	I-NP	NN	O	12	NMOD
12	donors	donor	I-NP	NNS	O	9	PMOD
13	by	by	B-PP	IN	O	4	VMOD
14	positive	positive	B-NP	JJ	O	15	NMOD
15	selection	selection	I-NP	NN	O	13	PMOD
16	using	use	B-VP	VBG	O	15	NMOD
17	an	an	B-NP	DT	O	21	NMOD
18	anti	anti	I-NP	JJ	B-protein	21	NMOD
19	CD20	CD20	I-NP	NN	I-protein	21	NMOD
20	monoclonal	monoclonal	I-NP	JJ	I-protein	21	NMOD
21	antibody	antibody	I-NP	NN	I-protein	26	NMOD
22	and	and	O	CC	O	26	NMOD
23	a	a	B-NP	DT	O	26	NMOD
24	MiniMACS	MiniMACS	I-NP	NNP	O	26	NMOD
25	separation	separation	I-NP	NN	O	26	NMOD
26	unit	unit	I-NP	NN	O	16	OBJ
27	.	.	O	.	O	3	P

1	B	B	B-NP	NN	B-cell_type	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_type	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	prestimulated	prestimulate	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	SAC	SAC	B-NP	NN	O	5	PMOD
7	for	for	B-PP	IN	O	6	NMOD
8	48	48	B-NP	CD	O	9	NMOD
9	hrs	hr	I-NP	NNS	O	7	PMOD
10	.	.	O	.	O	3	P

1	Then	Then	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	cells	cell	B-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	incubated	incubate	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	medium	medium	B-NP	NN	O	9	NMOD
8	or	or	I-NP	CC	O	9	NMOD
9	IL-10	IL-10	I-NP	NN	B-protein	6	PMOD
10	(	(	O	(	O	12	P
11	100	100	B-NP	CD	O	12	NMOD
12	ng/ml	ng/ml	I-NP	NN	O	9	NMOD
13	)	)	O	)	O	12	P
14	for	for	B-PP	IN	O	5	VMOD
15	10	10	B-NP	CD	O	17	AMOD
16	to	to	I-NP	TO	O	17	AMOD
17	120	120	I-NP	CD	O	18	NMOD
18	min	min	I-NP	NN	O	14	PMOD
19	.	.	O	.	O	4	P

1	RNA	RNA	B-NP	NN	B-RNA	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	extracted	extract	I-VP	VBN	O	2	VC
4	by	by	B-PP	IN	O	3	VMOD
5	phenol/chloroform	phenol/chloroform	B-NP	NN	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	c-fos	c-fos	B-NP	NN	B-DNA	8	NMOD
8	expression	expression	I-NP	NN	O	4	PMOD
9	was	be	B-VP	VBD	O	2	VMOD
10	analyzed	analyze	I-VP	VBN	O	9	VC
11	by	by	B-PP	IN	O	10	VMOD
12	PCR	PCR	B-NP	NN	O	15	NMOD
13	assisted	assist	B-VP	VBD	O	15	NMOD
14	mRNA	mRNA	B-NP	NN	O	15	NMOD
15	assay	assay	I-NP	NN	O	11	PMOD
16	.	.	O	.	O	2	P

1	A	A	B-NP	DT	O	5	NMOD
2	significant	significant	I-NP	JJ	O	5	NMOD
3	2-4	2-4	I-NP	CD	O	5	NMOD
4	fold	fold	I-NP	JJ	O	5	NMOD
5	increase	increase	I-NP	NN	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	c-fos	c-fos	B-NP	NN	B-DNA	8	NMOD
8	expression	expression	I-NP	NN	O	6	PMOD
9	was	be	B-VP	VBD	O	0	ROOT
10	observed	observe	I-VP	VBN	O	9	VC
11	within	within	B-PP	IN	O	10	VMOD
12	30	30	B-NP	CD	O	13	NMOD
13	min	min	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	stimulation	stimulation	B-NP	NN	O	14	PMOD
16	with	with	B-PP	IN	O	15	NMOD
17	IL-10	IL-10	B-NP	NN	B-protein	16	PMOD
18	(	(	O	(	O	21	P
19	p	p	B-NP	NN	O	21	SUB
20	<	<	O	SYM	O	21	VMOD
21	0.01	0.01	B-NP	CD	O	9	VMOD
22	)	)	O	)	O	21	P
23	.	.	O	.	O	9	P

1	After	After	B-PP	IN	O	6	VMOD
2	2	2	B-NP	CD	O	3	NMOD
3	hrs	hr	I-NP	NNS	O	1	PMOD
4	c-fos	c-fos	I-NP	NN	B-DNA	5	NMOD
5	expression	expression	I-NP	NN	O	6	SUB
6	declined	decline	B-VP	VBD	O	0	ROOT
7	to	to	B-PP	TO	O	6	VMOD
8	basal	basal	B-NP	JJ	O	9	NMOD
9	levels	level	I-NP	NNS	O	7	PMOD
10	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	IL-10	IL-10	B-NP	NN	B-protein	3	PMOD
5	was	be	B-VP	VBD	O	0	ROOT
6	dose-dependent	dose-dependent	B-ADJP	JJ	O	5	PRD
7	with	with	B-PP	IN	O	6	AMOD
8	a	a	B-NP	DT	O	10	NMOD
9	maximum	maximum	I-NP	NN	O	10	NMOD
10	stimulation	stimulation	I-NP	NN	O	7	PMOD
11	using	use	B-VP	VBG	O	10	NMOD
12	100	100	B-NP	CD	O	13	NMOD
13	ng/ml	ng/ml	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	IL-10	IL-10	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	IL-10	IL-10	I-NP	NN	B-protein	3	NMOD
3	effect	effect	I-NP	NN	O	7	SUB
4	on	on	B-PP	IN	O	3	NMOD
5	c-fos	c-fos	B-NP	NN	B-DNA	6	NMOD
6	expression	expression	I-NP	NN	O	4	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	blocked	block	I-VP	VBN	O	7	VC
10	by	by	B-PP	IN	O	9	VMOD
11	polymyxin	polymyxin	B-NP	NN	O	12	NMOD
12	B	B	I-NP	NN	O	10	PMOD
13	.	.	O	.	O	7	P

1	Using	Use	B-VP	VBG	O	19	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	tyrosine	tyrosine	I-NP	NN	B-protein	6	NMOD
4	kinase	kinase	I-NP	NN	I-protein	6	NMOD
5	inhibitor	inhibitor	I-NP	NN	O	6	NMOD
6	genistein	genistein	I-NP	NN	O	1	OBJ
7	(	(	O	(	O	9	P
8	10	10	B-NP	CD	O	9	NMOD
9	microM	microM	I-NP	NN	O	6	NMOD
10	)	)	O	)	O	9	P
11	a	a	B-NP	DT	O	13	NMOD
12	complete	complete	I-NP	JJ	O	13	NMOD
13	inhibition	inhibition	I-NP	NN	O	19	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	IL-10	IL-10	B-NP	NN	B-protein	18	NMOD
16	induced	induced	I-NP	JJ	O	18	NMOD
17	c-fos	c-fos	I-NP	NN	B-DNA	18	NMOD
18	expression	expression	I-NP	NN	O	14	PMOD
19	was	be	B-VP	VBD	O	0	ROOT
20	observed	observe	I-VP	VBN	O	19	VC
21	.	.	O	.	O	19	P

1	In	In	B-PP	IN	O	18	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	18	P
4	H-7	H-7	B-NP	NN	O	12	NMOD
5	(	(	O	(	O	7	P
6	10	10	B-NP	CD	O	7	NMOD
7	microM	microM	I-NP	NN	O	4	NMOD
8	)	)	O	)	O	7	P
9	,	,	O	,	O	12	P
10	a	a	B-NP	DT	O	12	NMOD
11	specific	specific	I-NP	JJ	O	12	NMOD
12	inhibitor	inhibitor	I-NP	NN	O	18	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	serine/threonine	serine/threonine	B-NP	NN	B-protein	15	NMOD
15	kinases	kinase	I-NP	NNS	I-protein	13	PMOD
16	,	,	O	,	O	12	P
17	significantly	significantly	B-VP	RB	O	18	VMOD
18	blocked	block	I-VP	VBD	O	0	ROOT
19	IL-10	IL-10	B-NP	NN	B-protein	22	NMOD
20	mediated	mediated	I-NP	JJ	O	22	NMOD
21	c-fos	c-fos	I-NP	NN	B-DNA	22	NMOD
22	expression	expression	I-NP	NN	O	18	OBJ
23	(	(	O	(	O	18	VMOD
24	p	p	B-NP	NN	O	23	NMOD
25	<	<	O	SYM	O	24	NMOD
26	0.05	0.05	B-NP	CD	O	25	AMOD
27	)	)	O	)	O	24	P
28	.	.	O	.	O	18	P

1	In	In	B-PP	IN	O	6	VMOD
2	conclusion	conclusion	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	data	datum	I-NP	NNS	O	6	SUB
6	show	show	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	IL-10	IL-10	B-NP	NN	B-protein	9	SUB
9	induces	induce	B-VP	VBZ	O	7	SBAR
10	c-fos	c-fos	B-NP	NN	B-DNA	11	NMOD
11	expression	expression	I-NP	NN	O	9	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	human	human	B-NP	JJ	B-cell_type	14	NMOD
14	B-cells	B-cell	I-NP	NNS	I-cell_type	12	PMOD
15	by	by	B-PP	IN	O	9	VMOD
16	activation	activation	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	tyrosine	tyrosine	B-NP	NN	O	21	NMOD
19	and	and	I-NP	CC	O	21	NMOD
20	serine/threonine	serine/threonine	I-NP	NN	B-protein	21	NMOD
21	kinases	kinase	I-NP	NNS	I-protein	17	PMOD
22	.	.	O	.	O	6	P

1	Since	Since	B-SBAR	IN	O	15	VMOD
2	this	this	B-NP	DT	O	3	SUB
3	is	be	B-VP	VBZ	O	1	SBAR
4	the	the	B-NP	DT	O	6	NMOD
5	first	first	I-NP	JJ	O	6	NMOD
6	report	report	I-NP	NN	O	9	SUB
7	on	on	B-PP	IN	O	6	NMOD
8	IL-10	IL-10	B-NP	NN	B-protein	7	PMOD
9	induced	induce	B-VP	VBD	O	3	VMOD
10	signal	signal	B-NP	NN	O	11	NMOD
11	transduction	transduction	I-NP	NN	O	9	OBJ
12	,	,	O	,	O	15	P
13	these	these	B-NP	DT	O	14	NMOD
14	data	datum	I-NP	NNS	O	15	SUB
15	may	may	B-VP	MD	O	0	ROOT
16	help	help	I-VP	VB	O	15	VC
17	to	to	I-VP	TO	O	18	VMOD
18	identify	identify	I-VP	VB	O	16	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	intracellular	intracellular	I-NP	JJ	O	21	NMOD
21	mechanisms	mechanism	I-NP	NNS	O	18	OBJ
22	by	by	B-PP	IN	O	21	NMOD
23	which	which	B-NP	WDT	O	22	PMOD
24	IL-10	IL-10	B-NP	NN	B-protein	25	SUB
25	stimulates	stimulate	B-VP	VBZ	O	22	SBAR
26	human	human	B-NP	JJ	B-cell_type	27	NMOD
27	B-cells	B-cell	I-NP	NNS	I-cell_type	25	OBJ
28	.	.	O	.	O	15	P

1	IL-10	IL-10	B-NP	NN	B-protein	2	SUB
2	inhibits	inhibit	B-VP	VBZ	O	0	ROOT
3	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD
4	factor-kappa	factor-kappa	I-NP	NN	I-protein	7	NMOD
5	B/Rel	B/Rel	I-NP	NN	I-protein	7	NMOD
6	nuclear	nuclear	I-NP	JJ	O	7	NMOD
7	activity	activity	I-NP	NN	O	2	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	CD3-stimulated	CD3-stimulated	B-NP	JJ	B-cell_line	13	NMOD
10	human	human	I-NP	JJ	I-cell_line	13	NMOD
11	peripheral	peripheral	I-NP	JJ	I-cell_line	13	NMOD
12	T	T	I-NP	NN	I-cell_line	13	NMOD
13	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	8	PMOD
14	.	.	O	.	O	2	P

1	IL-10	IL-10	B-NP	NN	B-protein	3	SUB
2	markedly	markedly	B-ADVP	RB	O	3	VMOD
3	reduces	reduce	B-VP	VBZ	O	0	ROOT
4	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD
5	factor	factor	I-NP	NN	I-protein	10	NMOD
6	(	(	O	(	I-protein	10	P
7	NF	NF	B-NP	NN	I-protein	10	NMOD
8	)	)	O	)	I-protein	10	P
9	-kappa	-kappa	B-NP	NN	I-protein	10	NMOD
10	B/Rel	B/Rel	I-NP	NN	I-protein	12	NMOD
11	nuclear	nuclear	I-NP	JJ	O	12	NMOD
12	activity	activity	I-NP	NN	O	3	OBJ
13	induced	induce	B-VP	VBN	O	12	NMOD
14	in	in	B-PP	IN	O	13	VMOD
15	PBMC	PBMC	B-NP	NN	B-cell_type	14	PMOD
16	by	by	B-PP	IN	O	13	VMOD
17	stimulation	stimulation	B-NP	NN	O	16	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	anti-CD3	anti-CD3	I-NP	JJ	B-protein	21	NMOD
21	mAb	mAb	I-NP	NN	I-protein	22	NMOD
22	OKT3	OKT3	I-NP	NN	B-protein	18	PMOD
23	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	inhibition	inhibition	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	exerted	exert	I-VP	VBN	O	3	VC
5	specifically	specifically	B-ADVP	RB	O	4	VMOD
6	on	on	B-PP	IN	O	4	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	NF-kappa	NF-kappa	I-NP	NN	B-protein	10	NMOD
9	B/Rel	B/Rel	I-NP	NN	I-protein	10	NMOD
10	activation	activation	I-NP	NN	O	6	PMOD
11	induced	induce	B-VP	VBN	O	10	NMOD
12	by	by	B-PP	IN	O	11	VMOD
13	mAb	mAb	B-NP	NN	B-protein	14	NMOD
14	OKT3	OKT3	I-NP	NN	I-protein	17	NMOD
15	,	,	B-NP	,	O	17	P
16	and	and	I-NP	CC	O	17	NMOD
17	not	not	I-NP	RB	O	12	PMOD
18	that	that	B-NP	DT	O	17	NMOD
19	produced	produce	B-VP	VBN	O	17	NMOD
20	by	by	B-PP	IN	O	19	VMOD
21	PMA	PMA	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	3	P

1	As	As	B-SBAR	IN	O	31	VMOD
2	judged	judge	B-VP	VBN	O	1	SBAR
3	by	by	B-PP	IN	O	2	VMOD
4	supershifting	supershifte	B-VP	VBG	O	3	PMOD
5	the	the	B-NP	DT	O	7	NMOD
6	DNA-protein	DNA-protein	I-NP	JJ	B-protein	7	NMOD
7	complexes	complex	I-NP	NNS	I-protein	4	OBJ
8	with	with	B-PP	IN	O	7	NMOD
9	Abs	Ab	B-NP	NNS	B-protein	8	PMOD
10	recognizing	recognize	B-VP	VBG	O	9	NMOD
11	specific	specific	B-NP	JJ	O	12	NMOD
12	components	component	I-NP	NNS	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	NF-kappa	NF-kappa	I-NP	NN	B-protein	18	NMOD
16	B/Rel	B/Rel	I-NP	NN	I-protein	18	NMOD
17	protein	protein	I-NP	NN	I-protein	18	NMOD
18	family	family	I-NP	NN	I-protein	13	PMOD
19	,	,	O	,	O	31	P
20	the	the	B-NP	DT	O	21	NMOD
21	p50/p65	p50/p65	I-NP	NN	B-protein	27	NMOD
22	(	(	O	(	O	24	P
23	Rel	Rel	B-NP	NN	B-protein	24	NMOD
24	A	A	I-NP	NN	I-protein	21	NMOD
25	)	)	I-NP	)	O	24	P
26	heterodimeric	heterodimeric	I-NP	JJ	O	27	NMOD
27	form	form	I-NP	NN	O	31	SUB
28	of	of	B-PP	IN	O	27	NMOD
29	NF-kappa	NF-kappa	B-NP	NN	B-protein	30	NMOD
30	B	B	I-NP	NN	I-protein	28	PMOD
31	is	be	B-VP	VBZ	O	0	ROOT
32	primarily	primarily	I-VP	RB	O	31	VMOD
33	affected	affect	I-VP	VBN	O	31	VC
34	.	.	O	.	O	31	P

1	The	The	B-NP	DT	O	3	NMOD
2	maximal	maximal	I-NP	JJ	O	3	NMOD
3	effect	effect	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	observed	observe	I-VP	VBN	O	4	VC
6	at	at	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	IL-10	IL-10	I-NP	NN	B-protein	9	NMOD
9	concentration	concentration	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	20	20	B-NP	CD	O	12	NMOD
12	U/ml	U/ml	I-NP	NN	O	10	PMOD
13	.	.	O	.	O	4	P

1	IL-10	IL-10	B-NP	NN	B-protein	3	NMOD
2	inhibitory	inhibitory	I-NP	JJ	O	3	NMOD
3	activity	activity	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	exerted	exert	I-VP	VBN	O	4	VC
6	on	on	B-PP	IN	O	5	VMOD
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	PMOD
9	and	and	O	CC	O	4	VMOD
10	is	be	B-VP	VBZ	O	4	VMOD
11	mediated	mediate	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	monocytes	monocyte	B-NP	NNS	B-cell_type	12	PMOD
14	.	.	O	.	O	4	P

1	Indeed	Indeed	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	monocytes	monocyte	B-NP	NNS	B-cell_type	7	SUB
4	pretreated	pretreate	B-VP	VBN	O	3	NMOD
5	with	with	B-PP	IN	O	4	VMOD
6	IL-10	IL-10	B-NP	NN	B-protein	5	PMOD
7	are	be	B-VP	VBP	O	0	ROOT
8	able	able	B-ADJP	JJ	O	7	PRD
9	so	so	B-VP	RB	O	10	VMOD
10	inhibit	inhibit	I-VP	VB	O	8	AMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
12	B	B	I-NP	NN	I-protein	14	NMOD
13	nuclear	nuclear	I-NP	JJ	O	14	NMOD
14	activity	activity	I-NP	NN	O	10	OBJ
15	in	in	B-PP	IN	O	10	VMOD
16	purified	purify	B-NP	VBN	B-cell_type	18	NMOD
17	T	T	I-NP	NN	I-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	15	PMOD
19	stimulated	stimulate	B-VP	VBN	O	18	NMOD
20	with	with	B-PP	IN	O	19	VMOD
21	OKT3	OKT3	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	7	P

1	Soluble	Soluble	B-NP	JJ	B-protein	2	NMOD
2	factors	factor	I-NP	NNS	I-protein	3	SUB
3	do	do	B-VP	VBP	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	appear	appear	I-VP	VB	O	3	VC
6	to	to	I-VP	TO	O	7	VMOD
7	be	be	I-VP	VB	O	5	VMOD
8	involved	involve	I-VP	VBN	O	7	VC
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	mechanism	mechanism	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	inhibition	inhibition	B-NP	NN	O	12	PMOD
14	.	.	O	.	O	3	P

1	On	On	B-PP	IN	O	22	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	other	other	I-NP	JJ	O	4	NMOD
4	hand	hand	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	22	P
6	the	the	B-NP	DT	O	7	NMOD
7	up-regulation	up-regulation	I-NP	NN	O	22	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	CD80	CD80	B-NP	NN	B-protein	10	NMOD
10	Ag	Ag	I-NP	NN	I-protein	8	PMOD
11	,	,	O	,	O	7	P
12	found	find	B-VP	VBN	O	7	NMOD
13	on	on	B-PP	IN	O	12	VMOD
14	monocytes	monocyte	B-NP	NNS	B-cell_type	13	PMOD
15	obtained	obtain	B-VP	VBN	O	14	NMOD
16	from	from	B-PP	IN	O	15	VMOD
17	PBMC	PBMC	B-NP	NN	B-cell_type	16	PMOD
18	incubated	incubate	B-VP	VBN	O	17	NMOD
19	with	with	B-PP	IN	O	18	VMOD
20	OKT3	OKT3	B-NP	NN	B-protein	19	PMOD
21	,	,	O	,	O	7	P
22	is	be	B-VP	VBZ	O	35	VMOD
23	not	not	I-VP	RB	O	22	VMOD
24	detected	detect	I-VP	VBN	O	22	VC
25	after	after	B-PP	IN	O	24	VMOD
26	addition	addition	B-NP	NN	O	25	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	IL-10	IL-10	B-NP	NN	B-protein	27	PMOD
29	,	,	O	,	O	35	P
30	and	and	O	CC	O	35	VMOD
31	the	the	B-NP	DT	O	34	NMOD
32	anti-CD28	anti-CD28	I-NP	JJ	B-protein	34	NMOD
33	mAb	mAb	I-NP	NN	I-protein	34	NMOD
34	CLB-CD28/1	CLB-CD28/1	I-NP	NN	B-protein	35	SUB
35	restores	restore	B-VP	VBZ	O	0	ROOT
36	the	the	B-NP	DT	O	40	NMOD
37	NF-kappa	NF-kappa	I-NP	NN	B-protein	38	NMOD
38	B/Rel	B/Rel	I-NP	NN	I-protein	40	NMOD
39	nuclear	nuclear	I-NP	JJ	O	40	NMOD
40	activity	activity	I-NP	NN	O	35	OBJ
41	in	in	B-PP	IN	O	40	NMOD
42	IL-10-inhibited	IL-10-inhibited	B-NP	JJ	B-cell_line	43	NMOD
43	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	41	PMOD
44	.	.	O	.	O	35	P

1	Therefore	Therefore	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	the	the	B-NP	DT	O	6	NMOD
4	NF-kappa	NF-kappa	I-NP	NN	B-protein	6	NMOD
5	B/Rel	B/Rel	I-NP	NN	I-protein	6	NMOD
6	inhibition	inhibition	I-NP	NN	O	7	SUB
7	might	might	B-VP	MD	O	0	ROOT
8	be	be	I-VP	VB	O	7	VC
9	ascribed	ascribe	I-VP	VBN	O	8	VC
10	to	to	B-PP	TO	O	9	VMOD
11	a	a	B-NP	DT	O	12	NMOD
12	lack	lack	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	cooperation	cooperation	B-NP	NN	O	13	PMOD
15	between	between	B-PP	IN	O	12	NMOD
16	accessory	accessory	B-NP	JJ	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	T	T	B-NP	NN	B-cell_type	20	NMOD
20	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	15	PMOD
21	,	,	O	,	O	9	P
22	resulting	result	B-VP	VBG	O	9	VMOD
23	from	from	B-PP	IN	O	22	VMOD
24	down-regulation	down-regulation	B-NP	NN	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	a	a	B-NP	DT	O	28	NMOD
27	costimulatory	costimulatory	I-NP	JJ	B-protein	28	NMOD
28	molecule	molecule	I-NP	NN	I-protein	25	PMOD
29	,	,	O	,	O	28	P
30	such	such	B-PP	JJ	O	31	PMOD
31	as	as	I-PP	IN	O	28	NMOD
32	CD80	CD80	B-NP	NN	B-protein	31	PMOD
33	,	,	O	,	O	32	P
34	produced	produce	B-VP	VBN	O	32	NMOD
35	by	by	B-PP	IN	O	34	VMOD
36	IL-10	IL-10	B-NP	NN	B-protein	35	PMOD
37	on	on	B-PP	IN	O	34	VMOD
38	activated	activate	B-NP	VBN	B-cell_type	39	NMOD
39	monocytes	monocyte	I-NP	NNS	I-cell_type	37	PMOD
40	.	.	O	.	O	7	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	IL-10	IL-10	B-NP	NN	B-protein	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	inhibit	inhibit	I-VP	VB	O	6	VC
8	the	the	B-NP	DT	O	9	NMOD
9	induction	induction	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappa	NF-kappa	B-NP	NN	B-protein	14	NMOD
12	B/Rel	B/Rel	I-NP	NN	I-protein	14	NMOD
13	nuclear	nuclear	I-NP	JJ	O	14	NMOD
14	activity	activity	I-NP	NN	O	10	PMOD
15	in	in	B-PP	IN	O	7	VMOD
16	CD3-stimulated	CD3-stimulated	B-NP	JJ	B-cell_line	18	NMOD
17	T	T	I-NP	NN	I-cell_line	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	15	PMOD
19	.	.	O	.	O	3	P

1	Since	Since	B-SBAR	IN	O	25	VMOD
2	inappropriate	inappropriate	B-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	kappa	kappa	B-NP	NN	B-DNA	7	NMOD
6	B-driven	B-driven	I-NP	JJ	I-DNA	7	NMOD
7	genes	gene	I-NP	NNS	I-DNA	4	PMOD
8	has	have	B-VP	VBZ	O	1	SBAR
9	a	a	B-NP	DT	O	11	NMOD
10	physiopathologic	physiopathologic	I-NP	JJ	O	11	NMOD
11	role	role	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	8	VMOD
13	a	a	B-NP	DT	O	14	NMOD
14	number	number	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	diseases	disease	B-NP	NNS	O	15	PMOD
17	,	,	O	,	O	16	P
18	such	such	B-PP	JJ	O	19	PMOD
19	as	as	I-PP	IN	O	16	NMOD
20	HIV	HIV	B-NP	NN	O	21	NMOD
21	infection	infection	I-NP	NN	O	19	PMOD
22	,	,	O	,	O	25	P
23	our	our	B-NP	PRP$	O	24	NMOD
24	findings	finding	I-NP	NNS	O	25	SUB
25	support	support	B-VP	VBP	O	0	ROOT
26	the	the	B-NP	DT	O	27	NMOD
27	possibility	possibility	I-NP	NN	O	25	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	using	use	B-VP	VBG	O	28	PMOD
30	this	this	B-NP	DT	O	31	NMOD
31	cytokine	cytokine	I-NP	NN	B-protein	29	OBJ
32	to	to	B-VP	TO	O	33	VMOD
33	suppress	suppress	I-VP	VB	O	27	NMOD
34	an	an	B-NP	DT	O	36	NMOD
35	undesirable	undesirable	I-NP	JJ	O	36	NMOD
36	activation	activation	I-NP	NN	O	33	OBJ
37	of	of	B-PP	IN	O	36	NMOD
38	these	these	B-NP	DT	O	40	NMOD
39	transcription	transcription	I-NP	NN	B-protein	40	NMOD
40	factors	factor	I-NP	NNS	I-protein	37	PMOD
41	.	.	O	.	O	25	P

1	Vitamin	Vitamin	B-NP	NN	O	2	NMOD
2	D3-	D3-	I-NP	NN	O	5	AMOD
3	and	and	O	CC	O	5	AMOD
4	retinoic	retinoic	B-NP	JJ	O	5	AMOD
5	acid-induced	acid-induced	I-NP	JJ	O	7	NMOD
6	monocytic	monocytic	I-NP	JJ	O	7	NMOD
7	differentiation	differentiation	I-NP	NN	O	9	NMOD
8	:	:	O	:	O	7	P
9	interactions	interaction	B-NP	NNS	O	0	ROOT
10	between	between	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	15	NMOD
12	endogenous	endogenous	I-NP	JJ	B-protein	15	NMOD
13	vitamin	vitamin	I-NP	NN	I-protein	15	NMOD
14	D3	D3	I-NP	NN	I-protein	15	NMOD
15	receptor	receptor	I-NP	NN	I-protein	24	NMOD
16	,	,	O	,	O	24	P
17	retinoic	retinoic	B-NP	JJ	B-protein	19	NMOD
18	acid	acid	I-NP	NN	I-protein	19	NMOD
19	receptors	receptor	I-NP	NNS	I-protein	24	NMOD
20	,	,	O	,	O	24	P
21	and	and	O	CC	O	24	NMOD
22	retinoid	retinoid	B-NP	NN	B-protein	24	NMOD
23	X	X	I-NP	NN	I-protein	24	NMOD
24	receptors	receptor	I-NP	NNS	I-protein	10	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	U-937	U-937	B-NP	NN	B-cell_line	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_line	25	PMOD
28	.	.	O	.	O	9	P

1	Retinoic	Retinoic	B-NP	JJ	O	2	NMOD
2	acid	acid	I-NP	NN	O	14	SUB
3	(	(	O	(	O	4	P
4	RA	RA	B-NP	NN	O	2	NMOD
5	)	)	O	)	O	4	P
6	and	and	O	CC	O	14	VMOD
7	1	1	B-NP	CD	O	14	VMOD
8	,	,	O	,	O	14	P
9	25	25	B-NP	CD	O	10	NMOD
10	alpha-dihydroxycholecalciferol	alpha-dihydroxycholecalciferol	I-NP	NN	O	14	SUB
11	(	(	O	(	O	12	P
12	VitD3	VitD3	B-NP	NN	O	10	NMOD
13	)	)	O	)	O	12	P
14	are	be	B-VP	VBP	O	0	ROOT
15	potent	potent	B-NP	JJ	O	16	NMOD
16	regulators	regulator	I-NP	NNS	O	14	PRD
17	of	of	B-PP	IN	O	16	NMOD
18	hematopoletic	hematopoletic	B-NP	JJ	O	19	NMOD
19	differentiation	differentiation	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	14	P

1	Yet	Yet	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	little	little	B-NP	JJ	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	known	know	I-VP	VBN	O	4	VC
6	as	as	B-PP	IN	O	5	VMOD
7	to	to	B-PP	TO	O	6	PMOD
8	how	how	B-ADVP	WRB	O	21	DEP
9	the	the	B-NP	DT	O	14	NMOD
10	RA	RA	I-NP	NN	B-protein	14	NMOD
11	and	and	I-NP	CC	I-protein	14	NMOD
12	VitD3	VitD3	I-NP	NN	I-protein	14	NMOD
13	receptor	receptor	I-NP	NN	I-protein	14	NMOD
14	network	network	I-NP	NN	I-protein	15	SUB
15	operates	operate	B-VP	VBZ	O	8	SBAR
16	in	in	B-PP	IN	O	15	VMOD
17	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
19	,	,	O	,	O	21	P
20	and	and	O	CC	O	21	DEP
21	whether	whether	B-SBAR	IN	O	6	PMOD
22	receptor	receptor	B-NP	NN	O	23	NMOD
23	interactions	interaction	I-NP	NNS	O	24	SUB
24	can	can	B-VP	MD	O	21	SBAR
25	explain	explain	I-VP	VB	O	24	VC
26	the	the	B-NP	DT	O	27	NMOD
27	interplay	interplay	I-NP	NN	O	25	OBJ
28	between	between	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	33	NMOD
30	RA-	RA-	I-NP	NN	O	33	NMOD
31	and	and	O	CC	O	33	NMOD
32	VitD3-signaling	VitD3-signaling	B-NP	JJ	O	33	NMOD
33	pathways	pathway	I-NP	NNS	O	28	PMOD
34	during	during	B-PP	IN	O	25	VMOD
35	differentiation	differentiation	B-NP	NN	O	34	PMOD
36	.	.	O	.	O	4	P

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	analyzed	analyze	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	expression	expression	I-NP	NN	O	13	NMOD
7	,	,	O	,	O	13	P
8	DNA	DNA	B-NP	NN	O	9	NMOD
9	binding	binding	I-NP	NN	O	13	NMOD
10	,	,	O	,	O	13	P
11	and	and	O	CC	O	13	NMOD
12	transcriptional	transcriptional	B-NP	JJ	O	13	NMOD
13	activity	activity	I-NP	NN	O	4	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	20	NMOD
16	endogenous	endogenous	I-NP	JJ	B-protein	20	NMOD
17	RA	RA	I-NP	NN	I-protein	19	NMOD
18	and	and	I-NP	CC	I-protein	19	NMOD
19	VitD3	VitD3	I-NP	NN	I-protein	20	NMOD
20	receptors	receptor	I-NP	NNS	I-protein	14	PMOD
21	[	[	O	(	O	20	NMOD
22	retinoic	retinoic	B-NP	JJ	B-protein	24	NMOD
23	acid	acid	I-NP	NN	I-protein	24	NMOD
24	receptors	receptor	I-NP	NNS	I-protein	31	NMOD
25	(	(	O	(	O	26	P
26	RARs	RAR	B-NP	NNS	B-protein	24	NMOD
27	)	)	O	)	O	26	P
28	,	,	O	,	O	31	P
29	retinoid	retinoid	B-NP	JJ	B-protein	31	NMOD
30	X	X	I-NP	NN	I-protein	31	NMOD
31	receptors	receptor	I-NP	NNS	I-protein	21	NMOD
32	(	(	O	(	O	33	P
33	RXRs	RXR	B-NP	NNS	B-protein	31	NMOD
34	)	)	O	)	O	33	P
35	,	,	O	,	O	31	P
36	and	and	O	CC	O	35	VMOD
37	VitD3	VitD3	B-NP	NN	B-protein	38	NMOD
38	receptor	receptor	I-NP	NN	I-protein	36	OBJ
39	(	(	O	(	O	40	P
40	VDR	VDR	B-NP	NN	B-protein	38	NMOD
41	)	)	O	)	O	40	P
42	]	]	O	)	O	38	P
43	in	in	B-PP	IN	O	38	NMOD
44	the	the	B-NP	DT	O	47	NMOD
45	U-937	U-937	I-NP	NN	B-cell_line	47	NMOD
46	cell	cell	I-NP	NN	I-cell_line	47	NMOD
47	line	line	I-NP	NN	I-cell_line	43	PMOD
48	,	,	O	,	O	47	P
49	in	in	B-PP	IN	O	47	NMOD
50	which	which	B-NP	WDT	O	49	PMOD
51	RA	RA	B-NP	NN	O	53	NMOD
52	and	and	I-NP	CC	O	53	NMOD
53	VitD3	VitD3	I-NP	NN	O	54	SUB
54	induce	induce	B-VP	VBP	O	49	SBAR
55	distinct	distinct	B-NP	JJ	O	58	NMOD
56	monocytic	monocytic	I-NP	JJ	O	58	NMOD
57	differentiation	differentiation	I-NP	NN	O	58	NMOD
58	pathways	pathway	I-NP	NNS	O	54	OBJ
59	.	.	O	.	O	36	P

1	VitD3	VitD3	B-NP	NN	O	2	NMOD
2	induction	induction	I-NP	NN	O	3	SUB
3	resulted	result	B-VP	VBD	O	0	ROOT
4	in	in	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	formation	formation	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	VDR/RXR	VDR/RXR	B-NP	NN	B-protein	10	NMOD
9	DNA-binding	DNA-binding	I-NP	JJ	I-protein	10	NMOD
10	complexes	complex	I-NP	NNS	I-protein	7	PMOD
11	on	on	B-PP	IN	O	6	NMOD
12	both	both	O	CC	O	19	NMOD
13	VitD3	VitD3	B-NP	NN	B-DNA	15	NMOD
14	response	response	I-NP	NN	I-DNA	15	NMOD
15	elements	element	I-NP	NNS	I-DNA	19	NMOD
16	and	and	O	CC	O	19	NMOD
17	RA	RA	B-NP	NN	B-DNA	19	NMOD
18	response	response	I-NP	NN	I-DNA	19	NMOD
19	elements	element	I-NP	NNS	I-DNA	11	PMOD
20	(	(	O	(	O	21	P
21	RAREs	RARE	B-NP	NNS	B-DNA	19	NMOD
22	)	)	O	)	O	21	P
23	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	transcriptional	transcriptional	B-NP	JJ	O	4	NMOD
4	activation	activation	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	only	only	I-VP	RB	O	5	VMOD
7	observed	observe	I-VP	VBN	O	5	VC
8	from	from	B-PP	IN	O	7	VMOD
9	a	a	B-NP	DT	O	14	NMOD
10	VitD3	VitD3	I-NP	NN	B-DNA	14	NMOD
11	response	response	I-NP	NN	I-DNA	14	NMOD
12	element-driven	element-driven	I-NP	JJ	I-DNA	14	NMOD
13	reporter	reporter	I-NP	NN	I-DNA	14	NMOD
14	construct	construct	I-NP	NN	I-DNA	8	PMOD
15	.	.	O	.	O	5	P

1	Several	Several	B-NP	JJ	O	3	NMOD
2	DNA-binding	DNA-binding	I-NP	JJ	B-protein	3	NMOD
3	complexes	complex	I-NP	NNS	I-protein	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	detected	detect	I-VP	VBN	O	4	VC
6	on	on	B-PP	IN	O	5	VMOD
7	RAREs	RARE	B-NP	NNS	B-DNA	6	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	undifferentiated	undifferentiated	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	.	.	O	.	O	4	P

1	Stimulation	Stimulation	B-NP	NN	O	4	SUB
2	by	by	B-PP	IN	O	1	NMOD
3	RA	RA	B-NP	NN	O	2	PMOD
4	resulted	result	B-VP	VBD	O	0	ROOT
5	in	in	B-PP	IN	O	4	VMOD
6	increased	increase	B-NP	VBN	O	10	NMOD
7	RAR	RAR	I-NP	NN	B-protein	10	NMOD
8	beta/RXR	beta/RXR	I-NP	NN	O	10	NMOD
9	DNA	DNA	I-NP	NN	O	10	NMOD
10	binding	binding	I-NP	NN	O	18	NMOD
11	,	,	O	,	O	18	P
12	activated	activate	B-VP	VBN	O	14	NMOD
13	RARE-dependent	RARE-dependent	B-NP	JJ	O	14	NMOD
14	transcription	transcription	I-NP	NN	O	18	NMOD
15	,	,	O	,	O	18	P
16	and	and	O	CC	O	18	NMOD
17	increased	increase	B-NP	VBN	O	18	NMOD
18	expression	expression	I-NP	NN	O	5	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	RAR-beta	RAR-beta	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	4	P

1	Concomitant	Concomitant	B-NP	JJ	O	2	NMOD
2	stimulation	stimulation	I-NP	NN	O	5	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	VitD3	VitD3	B-NP	NN	O	3	PMOD
5	inhibited	inhibit	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	RA-stimulated	RA-stimulated	I-NP	JJ	O	8	NMOD
8	formation	formation	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	RAR	RAR	B-NP	NN	B-protein	12	NMOD
11	beta/RXR	beta/RXR	I-NP	NN	I-protein	12	NMOD
12	heterodimers	heterodimer	I-NP	NNS	I-protein	9	PMOD
13	,	,	O	,	O	5	P
14	favoring	favor	B-VP	VBG	O	5	VMOD
15	VDR/RXR	VDR/RXR	B-NP	NN	O	16	NMOD
16	binding	binding	I-NP	NN	O	14	OBJ
17	to	to	B-PP	TO	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	RARE	RARE	I-NP	NN	B-DNA	17	PMOD
20	.	.	O	.	O	5	P

1	Also	Also	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	VitD3	VitD3	B-NP	NN	O	4	SUB
4	inhibited	inhibit	B-VP	VBD	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	expression	expression	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	CD23	CD23	B-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	CD49f	CD49f	I-NP	NN	B-protein	13	NMOD
11	,	,	O	,	O	13	P
12	characteristic	characteristic	B-NP	JJ	O	13	NMOD
13	markers	marker	I-NP	NNS	O	7	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	retinoid-induced	retinoid-induced	B-NP	JJ	O	18	NMOD
16	U-937	U-937	I-NP	NN	B-cell_line	18	NMOD
17	cell	cell	I-NP	NN	I-cell_line	18	NMOD
18	differentiation	differentiation	I-NP	NN	O	14	PMOD
19	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	15	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	15	P
4	neither	neither	O	CC	O	9	NMOD
5	the	the	B-NP	DT	O	9	NMOD
6	RA-stimulated	RA-stimulated	I-NP	JJ	O	8	AMOD
7	,	,	I-NP	,	O	8	P
8	RARE-mediated	RARE-mediated	I-NP	JJ	O	9	NMOD
9	transcription	transcription	I-NP	NN	O	14	NMOD
10	nor	nor	O	CC	O	14	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	induced	induce	I-NP	VBN	O	14	NMOD
13	RAR-beta	RAR-beta	I-NP	NN	B-protein	14	NMOD
14	expression	expression	I-NP	NN	O	15	SUB
15	was	be	B-VP	VBD	O	0	ROOT
16	suppressed	suppress	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	VitD3	VitD3	B-NP	NN	O	17	PMOD
19	,	,	O	,	O	16	P
20	suggesting	suggest	B-VP	VBG	O	16	VMOD
21	that	that	B-SBAR	IN	O	20	VMOD
22	VitD3	VitD3	B-NP	NN	O	24	SUB
23	selectively	selectively	B-ADVP	RB	O	24	VMOD
24	inhibited	inhibit	B-VP	VBD	O	21	SBAR
25	the	the	B-NP	DT	O	28	NMOD
26	retinoid-induced	retinoid-induced	I-NP	JJ	O	28	NMOD
27	differentiation	differentiation	I-NP	NN	O	28	NMOD
28	program	program	I-NP	NN	O	33	NMOD
29	but	but	B-NP	CC	O	33	NMOD
30	not	not	I-NP	RB	O	29	DEP
31	the	the	B-NP	DT	O	33	NMOD
32	RARE-mediated	RARE-mediated	I-NP	JJ	O	33	NMOD
33	signal	signal	I-NP	NN	O	24	OBJ
34	.	.	O	.	O	15	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	complex	complex	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	for	for	B-PP	IN	O	6	NMOD
8	VitD3	VitD3	B-NP	NN	O	7	PMOD
9	in	in	B-PP	IN	O	6	NMOD
10	modifying	modify	B-VP	VBG	O	9	PMOD
11	the	the	B-NP	DT	O	14	NMOD
12	retinoid	retinoid	I-NP	NN	O	14	NMOD
13	differentiation	differentiation	I-NP	NN	O	14	NMOD
14	pathway	pathway	I-NP	NN	O	10	OBJ
15	and	and	O	CC	O	3	VMOD
16	may	may	B-VP	MD	O	3	VMOD
17	have	have	I-VP	VB	O	16	VC
18	implications	implication	B-NP	NNS	O	17	OBJ
19	for	for	B-PP	IN	O	18	NMOD
20	differentiation-inducing	differentiation-inducing	B-NP	JJ	O	21	NMOD
21	therapy	therapy	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	hematopoietic	hematopoietic	B-NP	JJ	O	24	NMOD
24	tumors	tumor	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	3	P

1	Calcium-dependent	Calcium-dependent	B-NP	JJ	O	4	NMOD
2	immediate-early	immediate-early	I-NP	JJ	B-DNA	4	NMOD
3	gene	gene	I-NP	NN	I-DNA	4	NMOD
4	induction	induction	I-NP	NN	O	7	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	5	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	negatively	negatively	I-VP	RB	O	7	VMOD
9	regulated	regulate	I-VP	VBN	O	7	VC
10	by	by	B-PP	IN	O	9	VMOD
11	p21Ha-ras	p21Ha-ras	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	induction	induction	I-NP	NN	O	20	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	immediate-early	immediate-early	O	JJ	B-DNA	9	NMOD
5	(	(	O	(	I-DNA	6	P
6	IE	IE	B-ADJP	JJ	I-DNA	4	AMOD
7	)	)	O	)	I-DNA	6	P
8	response	response	B-NP	NN	I-DNA	9	NMOD
9	genes	gene	I-NP	NNS	I-DNA	3	PMOD
10	,	,	O	,	O	9	P
11	such	such	B-PP	JJ	O	12	PMOD
12	as	as	I-PP	IN	O	9	NMOD
13	egr-1	egr-1	B-NP	NN	B-DNA	18	NMOD
14	,	,	O	,	O	18	P
15	c-fos	c-fos	B-NP	NN	B-DNA	18	NMOD
16	,	,	O	,	O	18	P
17	and	and	O	CC	O	18	NMOD
18	c-jun	c-jun	B-NP	NN	B-DNA	12	PMOD
19	,	,	O	,	O	2	P
20	occurs	occur	B-VP	VBZ	O	0	ROOT
21	rapidly	rapidly	B-ADVP	RB	O	20	VMOD
22	after	after	B-PP	IN	O	20	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	activation	activation	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	T	T	B-NP	NN	B-cell_type	27	NMOD
27	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	25	PMOD
28	.	.	O	.	O	20	P

1	The	The	B-NP	DT	O	2	NMOD
2	process	process	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	activation	activation	B-NP	NN	O	3	PMOD
5	involves	involve	B-VP	VBZ	O	0	ROOT
6	calcium	calcium	B-NP	NN	O	7	NMOD
7	mobilization	mobilization	I-NP	NN	O	19	NMOD
8	,	,	O	,	O	19	P
9	activation	activation	B-NP	NN	O	19	NMOD
10	of	of	B-PP	IN	O	9	NMOD
11	protein	protein	B-NP	NN	B-protein	13	NMOD
12	kinase	kinase	I-NP	NN	I-protein	13	NMOD
13	C	C	I-NP	NN	I-protein	10	PMOD
14	(	(	O	(	O	15	P
15	PKC	PKC	B-NP	NN	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	,	,	O	,	O	19	P
18	and	and	O	CC	O	19	NMOD
19	phosphorylation	phosphorylation	B-NP	NN	O	5	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	tyrosine	tyrosine	B-NP	NN	B-protein	22	NMOD
22	kinases	kinase	I-NP	NNS	I-protein	20	PMOD
23	.	.	O	.	O	5	P

1	p21	p21	B-NP	NN	B-protein	10	NMOD
2	(	(	O	(	I-protein	3	P
3	ras	ras	B-NP	NN	I-protein	1	NMOD
4	)	)	O	)	I-protein	3	P
5	,	,	O	,	O	10	P
6	a	a	B-NP	DT	O	10	NMOD
7	guanine	guanine	I-NP	NN	B-protein	10	NMOD
8	nucleotide	nucleotide	I-NP	NN	I-protein	10	NMOD
9	binding	binding	I-NP	NN	I-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	12	SUB
11	,	,	O	,	O	10	P
12	mediates	mediate	B-VP	VBZ	O	0	ROOT
13	T-cell	T-cell	B-NP	NN	O	15	NMOD
14	signal	signal	I-NP	NN	O	15	NMOD
15	transduction	transduction	I-NP	NN	O	12	OBJ
16	through	through	B-PP	IN	O	15	NMOD
17	PKC-dependent	PKC-dependent	B-NP	JJ	O	19	AMOD
18	and	and	I-NP	CC	O	19	AMOD
19	PKC-independent	PKC-independent	I-NP	JJ	O	20	NMOD
20	pathways	pathway	I-NP	NNS	O	16	PMOD
21	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	2	NMOD
2	involvement	involvement	I-NP	NN	O	14	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	p21	p21	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	I-protein	6	P
6	ras	ras	B-NP	NN	I-protein	4	NMOD
7	)	)	O	)	I-protein	6	P
8	in	in	B-PP	IN	O	2	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	regulation	regulation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	calcium-dependent	calcium-dependent	B-NP	JJ	O	13	NMOD
13	signals	signal	I-NP	NNS	O	11	PMOD
14	has	have	B-VP	VBZ	O	0	ROOT
15	been	be	I-VP	VBN	O	14	VC
16	suggested	suggest	I-VP	VBN	O	15	VC
17	through	through	B-PP	IN	O	16	VMOD
18	analysis	analysis	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	its	its	B-NP	PRP$	O	21	NMOD
21	role	role	I-NP	NN	O	19	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	activation	activation	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	NF-AT	NF-AT	B-NP	NN	B-protein	25	PMOD
27	.	.	O	.	O	14	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	investigated	investigate	I-VP	VBN	O	2	VC
4	the	the	B-NP	DT	O	5	NMOD
5	inductions	induction	I-NP	NNS	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	IE	IE	I-NP	JJ	B-DNA	9	NMOD
9	genes	gene	I-NP	NNS	I-DNA	6	PMOD
10	in	in	B-PP	IN	O	5	NMOD
11	response	response	B-NP	NN	O	10	PMOD
12	to	to	B-PP	TO	O	10	PMOD
13	calcium	calcium	B-NP	NN	O	14	NMOD
14	signals	signal	I-NP	NNS	O	10	PMOD
15	in	in	B-PP	IN	O	5	NMOD
16	Jurkat	Jurkat	B-NP	NN	B-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
18	(	(	O	(	O	5	P
19	in	in	B-PP	IN	O	5	NMOD
20	the	the	I-PP	DT	O	19	PMOD
21	presence	presence	I-PP	NN	O	19	PMOD
22	of	of	I-PP	IN	O	19	PMOD
23	activated	activate	B-NP	VBN	O	24	NMOD
24	p21	p21	I-NP	NN	B-protein	32	NMOD
25	(	(	O	(	I-protein	26	P
26	ras	ras	B-NP	NN	I-protein	24	NMOD
27	)	)	O	)	I-protein	26	P
28	)	)	O	)	O	24	P
29	and	and	O	CC	O	32	NMOD
30	their	their	B-NP	PRP$	O	32	NMOD
31	correlated	correlate	I-NP	VBN	O	32	NMOD
32	consequences	consequence	I-NP	NNS	O	19	PMOD
33	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	expression	expression	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	activated	activate	B-NP	VBN	O	3	PMOD
5	p21	p21	I-NP	NN	B-protein	4	NMOD
6	(	(	O	(	I-protein	7	P
7	ras	ras	B-NP	NN	I-protein	5	NMOD
8	)	)	O	)	I-protein	7	P
9	negatively	negatively	B-ADVP	RB	O	10	VMOD
10	regulated	regulate	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	12	NMOD
12	induction	induction	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	IE	IE	B-NP	JJ	B-DNA	15	NMOD
15	genes	gene	I-NP	NNS	I-DNA	13	PMOD
16	by	by	B-PP	IN	O	10	VMOD
17	calcium	calcium	B-NP	NN	O	18	NMOD
18	ionophore	ionophore	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	10	P

1	This	This	B-NP	DT	O	2	NMOD
2	inhibition	inhibition	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	calcium-activated	calcium-activated	B-NP	JJ	O	7	NMOD
5	IE	IE	I-NP	NN	B-DNA	7	NMOD
6	gene	gene	I-NP	NN	I-DNA	7	NMOD
7	induction	induction	I-NP	NN	O	3	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	reversed	reverse	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	treatment	treatment	B-NP	NN	O	10	PMOD
12	with	with	B-PP	IN	O	11	NMOD
13	cyclosporin	cyclosporin	B-NP	NN	O	14	NMOD
14	A	A	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	8	P
16	suggesting	suggest	B-VP	VBG	O	8	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	involvement	involvement	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	calcineurin	calcineurin	B-NP	NN	B-protein	19	PMOD
21	in	in	B-PP	IN	O	18	NMOD
22	this	this	B-NP	DT	O	23	NMOD
23	regulation	regulation	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	3	NMOD
2	later	later	I-NP	JJ	O	3	NMOD
3	result	result	I-NP	NN	O	15	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	inhibition	inhibition	B-NP	NN	O	4	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	this	this	B-NP	DT	O	9	NMOD
8	activation	activation	I-NP	NN	O	9	NMOD
9	pathway	pathway	I-NP	NN	O	6	PMOD
10	by	by	B-PP	IN	O	5	NMOD
11	p21	p21	B-NP	NN	B-protein	10	PMOD
12	(	(	O	(	I-protein	13	P
13	ras	ras	B-NP	NN	I-protein	11	NMOD
14	)	)	O	)	I-protein	13	P
15	was	be	B-VP	VBD	O	0	ROOT
16	down-regulation	down-regulation	B-NP	NN	O	28	NMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	activity	activity	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	transcription	transcription	I-NP	NN	B-protein	24	NMOD
23	factor	factor	I-NP	NN	I-protein	24	NMOD
24	AP-1	AP-1	I-NP	NN	B-protein	20	PMOD
25	and	and	O	CC	O	28	NMOD
26	subsequent	subsequent	B-NP	JJ	O	28	NMOD
27	coordinate	coordinate	I-NP	JJ	O	28	NMOD
28	reductions	reduction	I-NP	NNS	O	15	PRD
29	in	in	B-PP	IN	O	28	NMOD
30	IL-2	IL-2	B-NP	NN	B-protein	32	NMOD
31	gene	gene	I-NP	NN	O	32	NMOD
32	expression	expression	I-NP	NN	O	35	NMOD
33	and	and	O	CC	O	35	NMOD
34	protein	protein	B-NP	NN	O	35	NMOD
35	production	production	I-NP	NN	O	29	PMOD
36	.	.	O	.	O	15	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	p2l	p2l	B-NP	NN	B-protein	9	SUB
6	(	(	O	(	I-protein	7	P
7	ras	ras	B-NP	NN	I-protein	5	NMOD
8	)	)	O	)	I-protein	7	P
9	is	be	B-VP	VBZ	O	4	SBAR
10	an	an	B-NP	DT	O	12	NMOD
11	essential	essential	I-NP	JJ	O	12	NMOD
12	mediator	mediator	I-NP	NN	O	9	PRD
13	in	in	B-PP	IN	O	12	NMOD
14	generating	generate	B-VP	VBG	O	13	PMOD
15	not	not	B-CONJP	RB	O	22	NMOD
16	only	only	I-CONJP	RB	O	15	DEP
17	positive	positive	B-ADJP	JJ	O	22	NMOD
18	but	but	B-CONJP	CC	O	22	NMOD
19	also	also	I-CONJP	RB	O	18	DEP
20	negative	negative	B-NP	JJ	O	22	NMOD
21	modulatory	modulatory	I-NP	JJ	O	22	NMOD
22	mechanisms	mechanism	I-NP	NNS	O	14	OBJ
23	controlling	control	B-VP	VBG	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	competence	competence	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	T	T	B-NP	NN	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	in	in	B-PP	IN	O	23	VMOD
30	response	response	B-NP	NN	O	29	PMOD
31	to	to	B-PP	TO	O	29	PMOD
32	inductive	inductive	B-NP	JJ	O	33	NMOD
33	stimulations	stimulation	I-NP	NNS	O	29	PMOD
34	.	.	O	.	O	3	P

1	Apoptosis	Apoptosis	B-NP	NN	O	3	NMOD
2	signaling	signaling	I-NP	NN	O	3	NMOD
3	pathways	pathway	I-NP	NNS	O	10	NMOD
4	in	in	B-PP	IN	O	3	NMOD
5	normal	normal	B-NP	JJ	B-cell_type	7	NMOD
6	T	T	I-NP	NN	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
8	:	:	O	:	O	3	P
9	differential	differential	B-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	0	ROOT
11	of	of	B-PP	IN	O	10	NMOD
12	Bcl-2	Bcl-2	B-NP	NN	B-protein	18	NMOD
13	and	and	I-NP	CC	O	18	NMOD
14	IL-1beta-converting	IL-1beta-converting	I-NP	NN	B-protein	18	NMOD
15	enzyme	enzyme	I-NP	NN	I-protein	18	NMOD
16	family	family	I-NP	NN	I-protein	18	NMOD
17	protease	protease	I-NP	NN	O	18	NMOD
18	inhibitors	inhibitor	I-NP	NNS	O	11	PMOD
19	on	on	B-PP	IN	O	10	NMOD
20	glucocorticoid-	glucocorticoid-	B-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	Fas-mediated	Fas-mediated	B-NP	JJ	O	23	NMOD
23	cytotoxicity	cytotoxicity	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	10	P

1	Fas-mediated	Fas-mediated	B-NP	JJ	O	2	NMOD
2	apoptosis	apoptosis	I-NP	NN	O	3	SUB
3	plays	play	B-VP	VBZ	O	0	ROOT
4	an	an	B-NP	DT	O	6	NMOD
5	important	important	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	in	in	B-PP	IN	O	3	VMOD
8	regulating	regulate	B-VP	VBG	O	7	PMOD
9	the	the	B-NP	DT	O	11	NMOD
10	immune	immune	I-NP	JJ	O	11	NMOD
11	response	response	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	peripheral	peripheral	B-NP	JJ	B-cell_type	15	NMOD
14	T	T	I-NP	NN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	.	.	O	.	O	3	P

1	Restimulation	Restimulation	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	5	NMOD
4	cell	cell	I-NP	NN	I-cell_type	5	NMOD
5	blasts	blast	I-NP	NNS	I-cell_type	2	PMOD
6	up-regulates	up-regulate	B-VP	VBZ	O	0	ROOT
7	Fas	Fas	B-NP	NN	B-protein	11	NMOD
8	and	and	I-NP	CC	O	11	NMOD
9	Fas	Fas	I-NP	NN	B-protein	11	NMOD
10	ligand	ligand	I-NP	NN	I-protein	11	NMOD
11	expression	expression	I-NP	NN	O	6	OBJ
12	,	,	O	,	O	6	P
13	with	with	B-PP	IN	O	6	VMOD
14	subsequent	subsequent	B-NP	JJ	O	15	NMOD
15	interaction	interaction	I-NP	NN	O	13	PMOD
16	leading	lead	B-VP	VBG	O	15	NMOD
17	to	to	B-PP	TO	O	16	VMOD
18	cell	cell	B-NP	NN	O	19	NMOD
19	death	death	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	6	P

1	Overexpression	Overexpression	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Bcl-2	Bcl-2	B-NP	NN	B-protein	2	PMOD
4	in	in	B-PP	IN	O	1	NMOD
5	tumor	tumor	B-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
7	blocks	block	B-VP	VBZ	O	19	VMOD
8	apoptosis	apoptosis	B-NP	NN	O	7	OBJ
9	induced	induce	B-VP	VBN	O	8	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	many	many	B-NP	JJ	O	12	NMOD
12	stimuli	stimulus	I-NP	NNS	O	10	PMOD
13	,	,	O	,	O	19	P
14	but	but	O	CC	O	19	VMOD
15	inhibition	inhibition	B-NP	NN	O	19	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	Fas-mediated	Fas-mediated	B-NP	JJ	O	18	NMOD
18	killing	killing	I-NP	NN	O	16	PMOD
19	has	have	B-VP	VBZ	O	0	ROOT
20	not	not	I-VP	RB	O	19	VMOD
21	been	be	I-VP	VBN	O	19	VC
22	consistently	consistently	I-VP	RB	O	21	VMOD
23	observed	observe	I-VP	VBN	O	21	VC
24	.	.	O	.	O	19	P

1	To	To	B-VP	TO	O	2	VMOD
2	examine	examine	I-VP	VB	O	14	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	behavior	behavior	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	Bcl-2	Bcl-2	B-NP	NN	B-protein	5	PMOD
7	in	in	B-PP	IN	O	4	NMOD
8	normal	normal	B-NP	JJ	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	,	,	O	,	O	14	P
11	T	T	B-NP	NN	B-cell_type	13	NMOD
12	cell	cell	I-NP	NN	I-cell_type	13	NMOD
13	blasts	blast	I-NP	NNS	I-cell_type	14	SUB
14	were	be	B-VP	VBD	O	0	ROOT
15	transiently	transiently	I-VP	RB	O	14	VMOD
16	transfected	transfecte	I-VP	VBN	O	14	VC
17	with	with	B-PP	IN	O	16	VMOD
18	Bcl-2	Bcl-2	B-NP	NN	B-protein	22	NMOD
19	and	and	I-NP	CC	O	22	NMOD
20	related	related	I-NP	JJ	O	22	NMOD
21	gene	gene	I-NP	NN	B-protein	22	NMOD
22	products	product	I-NP	NNS	I-protein	17	PMOD
23	to	to	B-VP	TO	O	24	VMOD
24	determine	determine	I-VP	VB	O	14	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	effect	effect	I-NP	NN	O	24	OBJ
27	on	on	B-PP	IN	O	26	NMOD
28	apoptotic	apoptotic	B-NP	JJ	O	29	NMOD
29	signaling	signaling	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	14	P

1	Transient	Transient	B-NP	JJ	O	2	NMOD
2	overexpression	overexpression	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	Bcl-2	Bcl-2	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	mouse	mouse	B-NP	NN	O	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	human	human	B-NP	JJ	B-cell_type	11	NMOD
9	T	T	B-NP	NN	I-cell_type	11	NMOD
10	cell	cell	I-NP	NN	I-cell_type	11	NMOD
11	blasts	blast	I-NP	NNS	I-cell_type	5	PMOD
12	did	do	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	block	block	I-VP	VB	O	12	VC
15	Fas-mediated	Fas-mediated	B-NP	JJ	O	16	NMOD
16	apoptosis	apoptosis	I-NP	NN	O	14	OBJ
17	,	,	O	,	O	12	P
18	whereas	whereas	O	IN	O	12	VMOD
19	etoposide-	etoposide-	B-NP	NN	O	22	NMOD
20	and	and	O	CC	O	22	NMOD
21	glucocorticoid-induced	glucocorticoid-induced	B-NP	JJ	O	22	NMOD
22	cytotoxicity	cytotoxicity	I-NP	NN	O	23	SUB
23	was	be	B-VP	VBD	O	18	SBAR
24	potently	potently	I-VP	RB	O	23	VMOD
25	inhibited	inhibit	I-VP	VBN	O	23	VC
26	.	.	O	.	O	12	P

1	Expression	Expression	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Bcl-xL	Bcl-xL	B-NP	NN	B-protein	7	NMOD
4	and	and	I-NP	CC	O	7	NMOD
5	adenovirus	adenovirus	I-NP	NN	B-protein	7	NMOD
6	E1B	E1B	I-NP	NN	I-protein	7	NMOD
7	19K	19K	I-NP	NN	I-protein	2	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	interfere	interfere	I-VP	VB	O	8	VC
11	with	with	B-PP	IN	O	10	VMOD
12	anti-Fas	anti-Fas	B-NP	JJ	O	13	NMOD
13	killing	killing	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	interleukin-1beta-converting	interleukin-1beta-converting	B-NP	JJ	O	8	NMOD
5	enzyme	enzyme	I-NP	NN	O	8	NMOD
6	family	family	I-NP	NN	O	8	NMOD
7	protease	protease	I-NP	NN	O	8	NMOD
8	inhibitors	inhibitor	I-NP	NNS	O	11	NMOD
9	Ac-DEVD-CHO	Ac-DEVD-CHO	I-NP	NN	O	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	CrmA	CrmA	I-NP	NN	B-protein	12	SUB
12	blocked	block	B-VP	VBD	O	0	ROOT
13	Fas-mediated	Fas-mediated	B-NP	JJ	O	14	NMOD
14	apoptosis	apoptosis	I-NP	NN	O	12	OBJ
15	.	.	O	.	O	12	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	peripheral	peripheral	B-NP	JJ	B-cell_type	7	NMOD
6	T	T	I-NP	NN	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	8	SUB
8	use	use	B-VP	VBP	O	4	SBAR
9	distinct	distinct	B-NP	JJ	O	12	NMOD
10	apoptosis	apoptosis	I-NP	NN	O	12	NMOD
11	signaling	signaling	I-NP	NN	O	12	NMOD
12	pathways	pathway	I-NP	NNS	O	8	OBJ
13	with	with	B-PP	IN	O	12	NMOD
14	differential	differential	B-NP	JJ	O	15	NMOD
15	sensitivity	sensitivity	I-NP	NN	O	23	NMOD
16	to	to	B-PP	TO	O	15	NMOD
17	Bcl-2	Bcl-2	B-NP	NN	B-protein	16	PMOD
18	and	and	O	CC	O	23	NMOD
19	interleukin-1beta-converting	interleukin-1beta-converting	B-NP	JJ	O	23	NMOD
20	enzyme	enzyme	I-NP	NN	O	23	NMOD
21	family	family	I-NP	NN	O	23	NMOD
22	protease	protease	I-NP	NN	O	23	NMOD
23	inhibitors	inhibitor	I-NP	NNS	O	13	PMOD
24	.	.	O	.	O	3	P

1	Since	Since	B-SBAR	IN	O	18	VMOD
2	T	T	B-NP	NN	B-cell_type	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_type	5	SUB
4	normally	normally	B-ADVP	RB	O	5	VMOD
5	express	express	B-VP	VBP	O	1	SBAR
6	Bcl-2	Bcl-2	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	Bcl-xL	Bcl-xL	I-NP	NN	B-protein	5	OBJ
9	following	follow	B-PP	VBG	O	5	VMOD
10	activation	activation	B-NP	NN	O	9	PMOD
11	,	,	O	,	O	18	P
12	their	their	B-NP	PRP$	O	13	NMOD
13	inability	inability	I-NP	NN	O	18	SUB
14	to	to	B-VP	TO	O	15	VMOD
15	block	block	I-VP	VB	O	13	NMOD
16	Fas-mediated	Fas-mediated	B-NP	JJ	O	17	NMOD
17	apoptosis	apoptosis	I-NP	NN	O	15	OBJ
18	may	may	B-VP	MD	O	0	ROOT
19	allow	allow	I-VP	VB	O	18	VC
20	for	for	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	elimination	elimination	I-NP	NN	O	29	NMOD
23	of	of	B-PP	IN	O	22	NMOD
24	self-reactive	self-reactive	B-NP	JJ	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
26	and	and	O	CC	O	29	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	appropriate	appropriate	I-NP	JJ	O	29	NMOD
29	regulation	regulation	I-NP	NN	O	20	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	immune	immune	B-NP	JJ	O	32	NMOD
32	responses	response	I-NP	NNS	O	30	PMOD
33	.	.	O	.	O	18	P

1	Interferons	Interferon	B-NP	NNS	B-protein	2	SUB
2	induce	induce	B-VP	VBP	O	0	ROOT
3	normal	normal	B-NP	JJ	O	9	NMOD
4	and	and	I-NP	CC	O	9	NMOD
5	aberrant	aberrant	I-NP	JJ	O	9	NMOD
6	retinoic-acid	retinoic-acid	I-NP	JJ	B-protein	9	NMOD
7	receptors	receptor	I-NP	NNS	I-protein	9	NMOD
8	type	type	I-NP	NN	I-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	2	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	acute	acute	B-NP	JJ	B-cell_type	14	NMOD
12	promyelocytic	promyelocytic	I-NP	JJ	I-cell_type	14	NMOD
13	leukemia	leukemia	I-NP	NN	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
15	:	:	O	:	O	2	P
16	potentiation	potentiation	B-NP	NN	O	2	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	induction	induction	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	retinoid-dependent	retinoid-dependent	B-NP	JJ	B-protein	23	NMOD
22	differentiation	differentiation	I-NP	NN	I-protein	23	NMOD
23	markers	marker	I-NP	NNS	I-protein	20	PMOD
24	.	.	O	.	O	2	P

1	Treatment	Treatment	B-NP	NN	O	32	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	11	NMOD
4	acute	acute	I-NP	JJ	B-cell_line	5	AMOD
5	promyelocytic	promyelocytic	I-NP	JJ	I-cell_line	10	NMOD
6	(	(	O	(	I-cell_line	7	P
7	APL	APL	B-NP	NN	I-cell_line	5	AMOD
8	)	)	O	)	I-cell_line	7	P
9	cell	cell	B-NP	NN	I-cell_line	10	NMOD
10	line	line	I-NP	NN	I-cell_line	11	NMOD
11	NB4	NB4	I-NP	NN	B-cell_line	2	PMOD
12	with	with	B-PP	IN	O	1	NMOD
13	interferon	interferon	B-NP	NN	B-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	30	NMOD
15	(	(	O	(	O	30	P
16	IFN	IFN	B-NP	NN	B-protein	30	NMOD
17	(	(	O	(	I-protein	18	P
18	alpha	alpha	B-NP	NN	I-protein	16	NMOD
19	)	)	O	)	I-protein	18	P
20	)	)	O	)	O	30	P
21	,	,	O	,	O	30	P
22	as	as	B-CONJP	RB	O	30	NMOD
23	well	well	I-CONJP	RB	O	22	DEP
24	as	as	I-CONJP	IN	O	22	DEP
25	IFN	IFN	B-NP	NN	B-protein	30	NMOD
26	(	(	O	(	I-protein	27	P
27	beta	beta	B-NP	NN	I-protein	25	NMOD
28	)	)	O	)	I-protein	27	P
29	and	and	O	CC	I-protein	30	NMOD
30	gamma	gamma	B-NP	NN	I-protein	12	PMOD
31	,	,	O	,	O	1	P
32	results	result	B-VP	VBZ	O	0	ROOT
33	in	in	B-PP	IN	O	32	VMOD
34	an	an	B-NP	DT	O	36	NMOD
35	increased	increase	I-NP	VBN	O	36	NMOD
36	expression	expression	I-NP	NN	O	33	PMOD
37	of	of	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	39	NMOD
39	transcripts	transcript	I-NP	NNS	O	37	PMOD
40	coding	cod	B-VP	VBG	O	39	NMOD
41	for	for	B-PP	IN	O	40	VMOD
42	retinoic-acid	retinoic-acid	B-NP	NN	B-protein	45	NMOD
43	receptor	receptor	I-NP	NN	I-protein	45	NMOD
44	type	type	I-NP	NN	I-protein	45	NMOD
45	alpha	alpha	I-NP	NN	I-protein	58	NMOD
46	(	(	O	(	O	58	P
47	RAR	RAR	B-NP	NN	B-protein	58	NMOD
48	(	(	O	(	I-protein	49	P
49	alpha	alpha	B-NP	NN	I-protein	47	NMOD
50	)	)	O	)	I-protein	49	P
51	)	)	O	)	O	58	P
52	and	and	O	CC	O	58	NMOD
53	the	the	B-NP	DT	O	58	NMOD
54	leukemia-specific	leukemia-specific	I-NP	JJ	B-protein	58	NMOD
55	retinoic	retinoic	I-NP	JJ	I-protein	58	NMOD
56	acid	acid	I-NP	NN	I-protein	58	NMOD
57	receptor	receptor	I-NP	NN	I-protein	58	NMOD
58	PML-RAR	PML-RAR	I-NP	NN	B-protein	41	PMOD
59	.	.	O	.	O	32	P

1	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD
2	induction	induction	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	11	NMOD
5	RAR	RAR	I-NP	NN	B-RNA	11	NMOD
6	(	(	O	(	I-RNA	7	P
7	alpha	alpha	B-NP	NN	I-RNA	5	NMOD
8	)	)	O	)	I-RNA	7	P
9	and	and	O	CC	I-RNA	11	NMOD
10	PML-RAR	PML-RAR	B-NP	NN	I-RNA	11	NMOD
11	mRNAs	mRNA	I-NP	NNS	I-RNA	3	PMOD
12	is	be	B-VP	VBZ	O	16	VMOD
13	rapid	rapid	B-ADJP	JJ	O	12	PRD
14	and	and	O	CC	O	16	VMOD
15	it	it	B-NP	PRP	O	16	SUB
16	is	be	B-VP	VBZ	O	0	ROOT
17	parallelled	parallel	I-VP	VBN	O	16	VC
18	by	by	B-PP	IN	O	17	VMOD
19	an	an	B-NP	DT	O	20	NMOD
20	increase	increase	I-NP	NN	O	18	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	corresponding	corresponding	I-NP	JJ	B-protein	24	NMOD
24	proteins	protein	I-NP	NNS	I-protein	21	PMOD
25	.	.	O	.	O	16	P

1	Up-regulation	Up-regulation	B-NP	NN	O	16	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	RAR	RAR	B-NP	NN	B-protein	10	NMOD
4	(	(	O	(	I-protein	5	P
5	alpha	alpha	B-NP	NN	I-protein	3	NMOD
6	)	)	O	)	I-protein	5	P
7	and	and	O	CC	O	10	NMOD
8	PML-RAR	PML-RAR	B-NP	NN	B-protein	10	NMOD
9	gene	gene	I-NP	NN	O	10	NMOD
10	expression	expression	I-NP	NN	O	2	PMOD
11	by	by	B-PP	IN	O	1	NMOD
12	IFN	IFN	B-NP	NN	B-protein	11	PMOD
13	(	(	O	(	I-protein	14	P
14	alpha	alpha	B-NP	NN	I-protein	12	NMOD
15	)	)	O	)	I-protein	14	P
16	is	be	B-VP	VBZ	O	0	ROOT
17	accompanied	accompany	I-VP	VBN	O	16	VC
18	by	by	B-PP	IN	O	17	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	strong	strong	I-NP	JJ	O	21	NMOD
21	potentiation	potentiation	I-NP	NN	O	18	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	induction	induction	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	2	2	B-NP	CD	O	29	NMOD
27	retinoid-dependent	retinoid-dependent	I-NP	JJ	B-protein	29	NMOD
28	granulocytic	granulocytic	I-NP	JJ	I-protein	29	NMOD
29	markers	marker	I-NP	NNS	I-protein	40	NMOD
30	,	,	O	,	O	40	P
31	i.e.	i.e.	B-NP	FW	O	40	NMOD
32	,	,	O	,	O	40	P
33	granulocyte-colony-stimulating	granulocyte-colony-stimulating	B-NP	JJ	B-RNA	36	NMOD
34	factor	factor	I-NP	NN	I-RNA	36	NMOD
35	receptor	receptor	I-NP	NN	I-RNA	36	NMOD
36	mRNA	mRNA	I-NP	NN	I-RNA	40	NMOD
37	and	and	O	CC	O	40	NMOD
38	leukocyte	leukocyte	B-NP	NN	B-protein	40	NMOD
39	alkaline	alkaline	I-NP	NN	I-protein	40	NMOD
40	phosphatase	phosphatase	I-NP	NN	I-protein	25	PMOD
41	.	.	O	.	O	16	P

1	However	However	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	IFN	IFN	B-NP	NN	B-protein	7	SUB
4	(	(	O	(	I-protein	5	P
5	alpha	alpha	B-NP	NN	I-protein	3	NMOD
6	)	)	O	)	I-protein	5	P
7	does	do	B-VP	VBZ	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	have	have	I-VP	VB	O	7	VC
10	any	any	B-NP	DT	O	11	NMOD
11	effects	effect	I-NP	NNS	O	9	OBJ
12	on	on	B-PP	IN	O	9	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	retinoid-dependent	retinoid-dependent	I-NP	JJ	O	15	NMOD
15	regulation	regulation	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	myeloid	myeloid	I-NP	JJ	B-protein	20	NMOD
19	surface	surface	I-NP	NN	I-protein	20	NMOD
20	markers	marker	I-NP	NNS	I-protein	16	PMOD
21	CD11b	CD11b	I-NP	NN	B-protein	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	CD33	CD33	I-NP	NN	B-protein	20	NMOD
24	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	3	NMOD
2	IFN-dependent	IFN-dependent	I-NP	JJ	O	3	NMOD
3	increase	increase	I-NP	NN	O	13	NMOD
4	in	in	B-PP	IN	O	3	NMOD
5	RAR	RAR	B-NP	NN	B-protein	9	NMOD
6	(	(	O	(	I-protein	7	P
7	alpha	alpha	B-NP	NN	I-protein	5	NMOD
8	)	)	O	)	I-protein	7	P
9	levels	level	B-NP	NNS	O	4	PMOD
10	and	and	O	CC	O	13	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	enhancing	enhancing	I-NP	NN	O	13	NMOD
13	effect	effect	I-NP	NN	O	22	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	16	NMOD
16	cytokine	cytokine	I-NP	NN	B-protein	14	PMOD
17	on	on	B-PP	IN	O	13	NMOD
18	retinoid-dependent	retinoid-dependent	B-NP	JJ	B-protein	20	NMOD
19	granulocytic	granulocytic	I-NP	JJ	I-protein	20	NMOD
20	markers	marker	I-NP	NNS	I-protein	21	NMOD
21	expression	expression	I-NP	NN	O	17	PMOD
22	may	may	B-VP	MD	O	0	ROOT
23	be	be	I-VP	VB	O	22	VC
24	a	a	B-NP	DT	O	25	NMOD
25	characteristic	characteristic	I-NP	NN	O	23	PRD
26	of	of	B-PP	IN	O	25	NMOD
27	PML-RAR	PML-RAR	B-NP	NN	B-cell_line	29	NMOD
28	positive	positive	I-NP	JJ	I-cell_line	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
30	,	,	O	,	O	22	P
31	since	since	B-SBAR	IN	O	22	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	phenomena	phenomenon	I-NP	NNS	O	34	SUB
34	are	be	B-VP	VBP	O	31	SBAR
35	not	not	I-VP	RB	O	34	VMOD
36	observed	observe	I-VP	VBN	O	34	VC
37	in	in	B-PP	IN	O	36	VMOD
38	HL-60	HL-60	B-NP	NN	B-cell_line	39	NMOD
39	promyelocytes	promyelocyte	I-NP	NNS	I-cell_line	37	PMOD
40	.	.	O	.	O	22	P

1	Interferons	Interferon	B-NP	NNS	B-protein	5	NMOD
2	as	as	B-CONJP	RB	O	5	NMOD
3	well	well	I-CONJP	RB	O	2	DEP
4	as	as	I-CONJP	IN	O	2	DEP
5	retinoids	retinoid	B-NP	NNS	O	6	SUB
6	inhibit	inhibit	B-VP	VBP	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	growth	growth	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	NB4	NB4	B-NP	NN	B-cell_line	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_line	9	PMOD
12	,	,	O	,	O	6	P
13	although	although	B-SBAR	IN	O	6	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	2	2	I-NP	CD	O	16	NMOD
16	classes	class	I-NP	NNS	O	19	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	compounds	compound	B-NP	NNS	O	17	PMOD
19	do	do	B-VP	VBP	O	13	SBAR
20	not	not	I-VP	RB	O	19	VMOD
21	significantly	significantly	I-VP	RB	O	19	VMOD
22	interact	interact	I-VP	VB	O	19	VC
23	in	in	B-PP	IN	O	22	VMOD
24	terms	term	B-NP	NNS	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	anti-proliferative	anti-proliferative	B-NP	JJ	O	27	NMOD
27	activity	activity	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	6	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	possible	possible	I-NP	JJ	O	6	NMOD
6	use	use	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	combinations	combination	B-NP	NNS	O	7	PMOD
9	between	between	B-PP	IN	O	8	NMOD
10	IFNs	IFN	B-NP	NNS	B-protein	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	retinoic	retinoic	B-NP	JJ	O	13	NMOD
13	acid	acid	I-NP	NN	O	9	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	cyto-differentiating	cyto-differentiating	I-NP	JJ	O	17	NMOD
17	treatment	treatment	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	APL	APL	B-NP	NN	O	20	NMOD
20	patients	patient	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	3	P

1	An	An	B-NP	DT	O	4	NMOD
2	IL-2	IL-2	I-NP	NN	B-DNA	4	NMOD
3	response	response	I-NP	NN	I-DNA	4	NMOD
4	element	element	I-NP	NN	I-DNA	13	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	12	NMOD
7	human	human	I-NP	JJ	B-DNA	12	NMOD
8	IL-2	IL-2	I-NP	NN	I-DNA	12	NMOD
9	receptor	receptor	I-NP	NN	I-DNA	12	NMOD
10	alpha	alpha	I-NP	NN	I-DNA	12	NMOD
11	chain	chain	I-NP	NN	I-DNA	12	NMOD
12	promoter	promoter	I-NP	NN	I-DNA	5	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	a	a	B-NP	DT	O	16	NMOD
15	composite	composite	I-NP	JJ	B-DNA	16	NMOD
16	element	element	I-NP	NN	I-DNA	13	PRD
17	that	that	B-NP	WDT	O	16	NMOD
18	binds	bind	B-VP	VBZ	O	17	SBAR
19	Stat5	Stat5	B-NP	NN	B-protein	31	NMOD
20	,	,	O	,	O	25	P
21	Elf-1	Elf-1	B-NP	NN	B-protein	25	NMOD
22	,	,	O	,	O	25	P
23	HMG-I	HMG-I	B-NP	NN	B-protein	25	NMOD
24	(	(	O	(	I-protein	25	P
25	Y	Y	B-NP	NN	I-protein	19	NMOD
26	)	)	O	)	I-protein	25	P
27	and	and	O	CC	O	31	NMOD
28	a	a	B-NP	DT	O	31	NMOD
29	GATA	GATA	I-NP	NN	B-protein	31	NMOD
30	family	family	I-NP	NN	I-protein	31	NMOD
31	protein	protein	I-NP	NN	I-protein	18	OBJ
32	.	.	O	.	O	13	P

1	Expression	Expression	B-NP	NN	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	12	NMOD
4	human	human	I-NP	JJ	B-DNA	12	NMOD
5	interleukin-2	interleukin-2	I-NP	NN	I-DNA	12	NMOD
6	(	(	O	(	I-DNA	7	P
7	IL-2	IL-2	B-NP	NN	I-DNA	5	NMOD
8	)	)	O	)	I-DNA	7	P
9	receptor	receptor	B-NP	NN	I-DNA	12	NMOD
10	alpha	alpha	I-NP	NN	I-DNA	12	NMOD
11	chain	chain	I-NP	NN	I-DNA	12	NMOD
12	gene	gene	I-NP	NN	I-DNA	2	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	potently	potently	I-VP	RB	O	13	VMOD
15	upregulated	upregulate	I-VP	VBN	O	13	VC
16	by	by	B-PP	IN	O	15	VMOD
17	its	its	B-NP	PRP$	O	19	NMOD
18	own	own	I-NP	JJ	O	19	NMOD
19	ligand	ligand	I-NP	NN	O	21	NMOD
20	,	,	O	,	O	21	P
21	IL-2	IL-2	B-NP	NN	B-protein	16	PMOD
22	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	characterize	characterize	B-VP	VBP	O	0	ROOT
7	an	an	B-NP	DT	O	12	NMOD
8	essential	essential	I-NP	JJ	O	12	NMOD
9	upstream	upstream	I-NP	JJ	O	12	NMOD
10	IL-2	IL-2	I-NP	NN	B-DNA	12	NMOD
11	response	response	I-NP	NN	I-DNA	12	NMOD
12	element	element	I-NP	NN	I-DNA	43	NMOD
13	that	that	B-NP	WDT	O	12	NMOD
14	contains	contain	B-VP	VBZ	O	13	SBAR
15	both	both	O	CC	O	20	NMOD
16	consensus	consensus	B-NP	NN	B-DNA	20	NMOD
17	and	and	O	CC	I-DNA	20	NMOD
18	non-consensus	non-consensus	B-NP	JJ	I-DNA	20	NMOD
19	GAS	GAS	I-NP	NN	I-DNA	20	NMOD
20	motifs	motif	I-NP	NNS	I-DNA	14	OBJ
21	,	,	O	,	O	31	P
22	two	two	B-NP	CD	O	31	NMOD
23	putative	putative	I-NP	JJ	O	22	NMOD
24	Ets	Ets	I-NP	NN	B-DNA	26	NMOD
25	binding	binding	I-NP	NN	I-DNA	26	NMOD
26	sites	site	I-NP	NNS	I-DNA	22	NMOD
27	(	(	O	(	O	28	P
28	EBS	EBS	B-NP	NN	B-DNA	22	NMOD
29	)	)	O	)	O	28	P
30	,	,	O	,	O	31	P
31	one	one	B-NP	CD	O	32	NMOD
32	of	of	B-PP	IN	O	12	NMOD
33	which	which	B-NP	WDT	O	32	PMOD
34	overlaps	overlap	B-VP	VBZ	O	32	SBAR
35	the	the	B-NP	DT	O	38	NMOD
36	consensus	consensus	I-NP	NN	B-DNA	38	NMOD
37	GAS	GAS	I-NP	NN	I-DNA	38	NMOD
38	motif	motif	I-NP	NN	I-DNA	34	OBJ
39	,	,	O	,	O	43	P
40	and	and	O	CC	O	43	NMOD
41	a	a	B-NP	DT	O	43	NMOD
42	GATA	GATA	I-NP	NN	B-DNA	43	NMOD
43	motif	motif	I-NP	NN	I-DNA	6	OBJ
44	,	,	O	,	O	43	P
45	which	which	B-NP	WDT	O	43	NMOD
46	overlaps	overlap	B-VP	VBZ	O	45	SBAR
47	the	the	B-NP	DT	O	50	NMOD
48	non-consensus	non-consensus	I-NP	JJ	B-DNA	50	NMOD
49	GAS	GAS	I-NP	NN	I-DNA	50	NMOD
50	motif	motif	I-NP	NN	I-DNA	46	OBJ
51	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	although	although	B-SBAR	IN	O	19	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	individual	individual	I-NP	JJ	O	7	NMOD
7	components	component	I-NP	NNS	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	this	this	B-NP	DT	O	10	NMOD
10	element	element	I-NP	NN	O	8	PMOD
11	do	do	B-VP	VBP	O	4	SBAR
12	not	not	I-VP	RB	O	11	VMOD
13	respond	respond	I-VP	VB	O	11	VC
14	to	to	B-PP	TO	O	13	VMOD
15	IL-2	IL-2	B-NP	NN	B-protein	14	PMOD
16	,	,	O	,	O	19	P
17	together	together	B-ADVP	RB	O	19	VMOD
18	they	they	B-NP	PRP	O	19	SUB
19	form	form	B-VP	VBP	O	3	SBAR
20	a	a	B-NP	DT	O	22	NMOD
21	composite	composite	I-NP	JJ	B-DNA	22	NMOD
22	element	element	I-NP	NN	I-DNA	19	OBJ
23	capable	capable	B-ADJP	JJ	O	22	NMOD
24	of	of	B-PP	IN	O	23	AMOD
25	conferring	confer	B-VP	VBG	O	24	PMOD
26	IL-2	IL-2	B-NP	NN	B-protein	27	NMOD
27	responsiveness	responsiveness	I-NP	NN	O	25	OBJ
28	to	to	B-PP	TO	O	27	NMOD
29	a	a	B-NP	DT	O	31	NMOD
30	heterologous	heterologous	I-NP	JJ	B-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	28	PMOD
32	.	.	O	.	O	2	P

1	Multiple	Multiple	B-NP	JJ	O	2	NMOD
2	factors	factor	I-NP	NNS	O	16	SUB
3	including	include	B-PP	VBG	O	2	NMOD
4	Stat5	Stat5	B-NP	NN	B-protein	15	NMOD
5	,	,	O	,	O	15	P
6	Elf-1	Elf-1	B-NP	NN	B-protein	15	NMOD
7	,	,	O	,	O	15	P
8	HMG-I	HMG-I	B-NP	NN	B-protein	15	NMOD
9	(	(	O	(	I-protein	10	P
10	Y	Y	B-NP	NN	I-protein	8	NMOD
11	)	)	O	)	I-protein	10	P
12	and	and	O	CC	O	15	NMOD
13	GATA	GATA	B-NP	NN	B-protein	15	NMOD
14	family	family	I-NP	NN	I-protein	15	NMOD
15	proteins	protein	I-NP	NNS	I-protein	3	PMOD
16	bind	bind	B-VP	VBP	O	0	ROOT
17	to	to	B-PP	TO	O	16	VMOD
18	the	the	B-NP	DT	O	21	NMOD
19	IL-2	IL-2	I-NP	NN	B-DNA	21	NMOD
20	response	response	I-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	mutation	mutation	I-NP	NN	O	17	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	any	any	B-NP	DT	O	26	NMOD
26	one	one	I-NP	CD	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	these	these	B-NP	DT	O	30	NMOD
29	binding	bind	I-NP	VBG	B-DNA	30	NMOD
30	sites	site	I-NP	NNS	I-DNA	27	PMOD
31	diminishes	diminish	B-VP	VBZ	O	16	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	activity	activity	I-NP	NN	O	31	OBJ
34	of	of	B-PP	IN	O	33	NMOD
35	this	this	B-NP	DT	O	36	NMOD
36	element	element	I-NP	NN	O	34	PMOD
37	.	.	O	.	O	16	P

1	An	An	B-NP	DT	O	5	NMOD
2	unidentified	unidentified	I-NP	JJ	O	5	NMOD
3	Ets	Ets	I-NP	NN	B-protein	5	NMOD
4	family	family	I-NP	NN	I-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	6	SUB
6	binds	bind	B-VP	VBZ	O	0	ROOT
7	to	to	B-PP	TO	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	EBS	EBS	I-NP	NN	B-DNA	7	PMOD
10	overlapping	overlap	B-VP	VBG	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	consensus	consensus	I-NP	NN	B-DNA	14	NMOD
13	GAS	GAS	I-NP	NN	I-DNA	14	NMOD
14	motif	motif	I-NP	NN	I-DNA	10	OBJ
15	and	and	O	CC	O	6	VMOD
16	appears	appear	B-VP	VBZ	O	6	VMOD
17	to	to	I-VP	TO	O	19	VMOD
18	negatively	negatively	I-VP	RB	O	19	VMOD
19	regulate	regulate	I-VP	VB	O	16	VMOD
20	the	the	B-NP	DT	O	24	NMOD
21	human	human	I-NP	JJ	B-DNA	24	NMOD
22	IL-2R	IL-2R	I-NP	NN	I-DNA	24	NMOD
23	alpha	alpha	I-NP	NN	I-DNA	24	NMOD
24	promoter	promoter	I-NP	NN	I-DNA	19	OBJ
25	.	.	O	.	O	6	P

1	Thus	Thus	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	IL-2-induced	IL-2-induced	B-NP	JJ	O	7	NMOD
4	IL-2R	IL-2R	I-NP	NN	O	7	NMOD
5	alpha	alpha	I-NP	NN	O	7	NMOD
6	promoter	promoter	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	8	SUB
8	requires	require	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	12	NMOD
10	complex	complex	I-NP	JJ	B-DNA	12	NMOD
11	upstream	upstream	I-NP	JJ	I-DNA	12	NMOD
12	element	element	I-NP	NN	I-DNA	8	OBJ
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	appears	appear	B-VP	VBZ	O	14	SBAR
16	to	to	I-VP	TO	O	17	VMOD
17	contain	contain	I-VP	VB	O	15	VMOD
18	binding	bind	B-NP	VBG	B-DNA	19	NMOD
19	sites	site	I-NP	NNS	I-DNA	17	OBJ
20	for	for	B-PP	IN	O	19	NMOD
21	both	both	B-NP	CC	O	24	AMOD
22	positive	positive	I-NP	JJ	B-protein	24	AMOD
23	and	and	I-NP	CC	I-protein	24	AMOD
24	negative	negative	I-NP	JJ	I-protein	26	NMOD
25	regulatory	regulatory	I-NP	JJ	I-protein	26	NMOD
26	factors	factor	I-NP	NNS	I-protein	20	PMOD
27	.	.	O	.	O	8	P

1	Active	Active	B-NP	JJ	O	2	NMOD
2	suppression	suppression	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	9	NMOD
5	class	class	I-NP	NN	B-DNA	9	NMOD
6	II	II	I-NP	CD	I-DNA	9	NMOD
7	transactivator-encoding	transactivator-encoding	I-NP	JJ	I-DNA	9	NMOD
8	AIR-1	AIR-1	I-NP	NN	I-DNA	9	NMOD
9	locus	locus	I-NP	NN	I-DNA	3	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	responsible	responsible	B-ADJP	JJ	O	10	PRD
12	for	for	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	14	NMOD
14	lack	lack	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	major	major	B-NP	JJ	B-DNA	22	NMOD
17	histocompatibility	histocompatibility	I-NP	NN	I-DNA	22	NMOD
18	complex	complex	I-NP	NN	I-DNA	22	NMOD
19	class	class	I-NP	NN	I-DNA	22	NMOD
20	II	II	I-NP	CD	I-DNA	22	NMOD
21	gene	gene	I-NP	NN	I-DNA	22	NMOD
22	expression	expression	I-NP	NN	O	15	PMOD
23	observed	observe	B-VP	VBN	O	22	NMOD
24	during	during	B-PP	IN	O	23	VMOD
25	differentiation	differentiation	B-NP	NN	O	24	PMOD
26	from	from	B-PP	IN	O	25	NMOD
27	B	B	B-NP	NN	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	to	to	B-PP	TO	O	25	NMOD
30	plasma	plasma	B-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
32	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	27	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	the	the	B-NP	DT	O	6	NMOD
5	genetic	genetic	I-NP	JJ	O	6	NMOD
6	control	control	I-NP	NN	O	27	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	major	major	B-NP	JJ	B-DNA	17	NMOD
9	histocompatibility	histocompatibility	I-NP	NN	I-DNA	17	NMOD
10	complex	complex	I-NP	NN	I-DNA	17	NMOD
11	(	(	O	(	I-DNA	17	P
12	MHC	MHC	B-NP	NN	I-DNA	17	NMOD
13	)	)	O	)	I-DNA	17	P
14	class	class	B-NP	NN	I-DNA	17	NMOD
15	II	II	I-NP	CD	I-DNA	17	NMOD
16	gene	gene	I-NP	NN	I-DNA	17	NMOD
17	expression	expression	I-NP	NN	O	7	PMOD
18	during	during	B-PP	IN	O	6	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	transition	transition	I-NP	NN	O	18	PMOD
21	from	from	B-PP	IN	O	20	NMOD
22	B	B	B-NP	NN	B-cell_type	23	NMOD
23	cell	cell	I-NP	NN	I-cell_type	21	PMOD
24	to	to	B-PP	TO	O	20	NMOD
25	plasma	plasma	B-NP	NN	B-cell_type	26	NMOD
26	cell	cell	I-NP	NN	I-cell_type	24	PMOD
27	has	have	B-VP	VBZ	O	0	ROOT
28	been	be	I-VP	VBN	O	27	VC
29	analyzed	analyze	I-VP	VBN	O	28	VC
30	.	.	O	.	O	27	P

1	Class	Class	B-NP	NN	B-protein	3	NMOD
2	II	II	B-NP	CD	I-protein	3	NMOD
3	molecules	molecule	I-NP	NNS	I-protein	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	expressed	express	I-VP	VBN	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	plasma	plasma	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	because	because	B-PP	IN	O	6	VMOD
11	of	of	I-PP	IN	O	10	PMOD
12	an	an	B-NP	DT	O	14	NMOD
13	active	active	I-NP	JJ	O	14	NMOD
14	suppression	suppression	I-NP	NN	O	10	PMOD
15	resulting	result	B-VP	VBG	O	14	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	abrogation	abrogation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	class	class	B-NP	NN	B-DNA	23	NMOD
21	II	II	I-NP	CD	I-DNA	23	NMOD
22	gene	gene	I-NP	NN	I-DNA	23	NMOD
23	transcription	transcription	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	the	the	B-NP	DT	O	9	NMOD
6	plasma	plasma	I-NP	NN	B-protein	9	NMOD
7	cell-specific	cell-specific	I-NP	JJ	I-protein	9	NMOD
8	repressor	repressor	I-NP	NN	I-protein	9	NMOD
9	function	function	I-NP	NN	O	21	SUB
10	,	,	O	,	O	9	P
11	designated	designate	B-VP	VBN	O	9	NMOD
12	SIR	SIR	B-NP	NN	B-DNA	14	NMOD
13	(	(	O	(	O	14	P
14	suppressor	suppressor	B-NP	NN	O	11	VMOD
15	of	of	B-PP	IN	O	14	NMOD
16	immune	immune	B-NP	JJ	B-DNA	18	NMOD
17	response	response	I-NP	NN	I-DNA	18	NMOD
18	genes	gene	I-NP	NNS	I-DNA	15	PMOD
19	)	)	O	)	O	9	P
20	,	,	O	,	O	9	P
21	does	do	B-VP	VBZ	O	4	SBAR
22	not	not	I-VP	RB	O	21	VMOD
23	act	act	I-VP	VB	O	21	VC
24	directly	directly	B-ADVP	RB	O	25	PMOD
25	on	on	B-PP	IN	O	23	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	transcription	transcription	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	class	class	B-NP	NN	B-DNA	31	NMOD
30	II	II	I-NP	CD	I-DNA	31	NMOD
31	genes	gene	I-NP	NNS	I-DNA	28	PMOD
32	,	,	O	,	O	25	P
33	but	but	O	CC	O	25	PMOD
34	instead	instead	B-ADVP	RB	O	25	PMOD
35	on	on	B-PP	IN	O	25	PMOD
36	the	the	B-NP	DT	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	35	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	the	the	B-NP	DT	O	41	NMOD
40	AIR-1	AIR-1	I-NP	NN	B-DNA	41	NMOD
41	gene	gene	I-NP	NN	I-DNA	38	PMOD
42	,	,	O	,	O	41	P
43	whose	whose	B-NP	WP$	O	41	NMOD
44	product	product	I-NP	NN	O	43	NMOD
45	,	,	O	,	O	54	P
46	the	the	B-NP	DT	O	49	NMOD
47	class	class	I-NP	NN	B-protein	49	NMOD
48	II	II	I-NP	CD	I-protein	49	NMOD
49	transactivator	transactivator	I-NP	NN	I-protein	54	SUB
50	(	(	O	(	O	51	P
51	CIITA	CIITA	B-NP	NN	B-protein	49	NMOD
52	)	)	O	)	O	51	P
53	,	,	O	,	O	49	P
54	is	be	B-VP	VBZ	O	43	SBAR
55	fundamental	fundamental	B-ADJP	JJ	O	54	PRD
56	for	for	B-PP	IN	O	55	AMOD
57	the	the	B-NP	DT	O	58	NMOD
58	regulation	regulation	I-NP	NN	O	56	PMOD
59	of	of	B-PP	IN	O	58	NMOD
60	the	the	B-NP	DT	O	64	NMOD
61	constitutive	constitutive	I-NP	JJ	O	63	AMOD
62	and	and	I-NP	CC	O	63	AMOD
63	inducible	inducible	I-NP	JJ	O	64	NMOD
64	expression	expression	I-NP	NN	O	59	PMOD
65	of	of	B-PP	IN	O	64	NMOD
66	MHC	MHC	B-NP	NN	B-DNA	69	NMOD
67	class	class	I-NP	NN	I-DNA	69	NMOD
68	II	II	B-NP	CD	I-DNA	69	NMOD
69	genes	gene	I-NP	NNS	I-DNA	65	PMOD
70	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	unambiguously	unambiguously	I-VP	RB	O	2	VMOD
4	demonstrated	demonstrate	I-VP	VBN	O	2	VC
5	by	by	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	fact	fact	I-NP	NN	O	5	PMOD
8	that	that	B-SBAR	IN	O	7	NMOD
9	plasmacytoma	plasmacytoma	B-NP	NN	B-cell_line	13	NMOD
10	x	x	I-NP	NN	I-cell_line	13	NMOD
11	B	B	I-NP	NN	I-cell_line	13	NMOD
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD
13	hybrids	hybrid	I-NP	NNS	I-cell_line	22	SUB
14	carrying	carry	B-VP	VBG	O	13	NMOD
15	an	an	B-NP	DT	O	17	NMOD
16	AIR-1	AIR-1	I-NP	NN	B-DNA	17	NMOD
17	locus	locus	I-NP	NN	I-DNA	14	OBJ
18	derived	derive	B-VP	VBN	O	17	NMOD
19	from	from	B-PP	IN	O	18	VMOD
20	CIITA-expressing	CIITA-expressing	B-NP	JJ	B-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	19	PMOD
22	do	do	B-VP	VBP	O	8	SBAR
23	not	not	I-VP	RB	O	22	VMOD
24	express	express	I-VP	VB	O	22	VC
25	CIITA-specific	CIITA-specific	B-NP	JJ	B-RNA	26	NMOD
26	transcripts	transcript	I-NP	NNS	I-RNA	24	OBJ
27	.	.	O	.	O	2	P

1	Transfection	Transfection	B-NP	NN	O	18	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	4	NMOD
4	cDNA	cDNA	I-NP	NN	B-DNA	2	PMOD
5	containing	contain	B-VP	VBG	O	4	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	human	human	I-NP	JJ	B-DNA	10	NMOD
8	CIITA	CIITA	I-NP	NN	I-DNA	10	NMOD
9	coding	coding	I-NP	NN	I-DNA	10	NMOD
10	sequence	sequence	I-NP	NN	I-DNA	5	OBJ
11	under	under	B-PP	IN	O	5	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	control	control	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	an	an	B-NP	DT	O	17	NMOD
16	heterologous	heterologous	I-NP	JJ	B-DNA	17	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	14	PMOD
18	restores	restore	B-VP	VBZ	O	0	ROOT
19	expression	expression	B-NP	NN	O	18	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	human	human	B-NP	JJ	B-DNA	25	NMOD
22	MHC	MHC	I-NP	NN	I-DNA	25	NMOD
23	class	class	I-NP	NN	I-DNA	25	NMOD
24	II	II	B-NP	CD	I-DNA	25	NMOD
25	genes	gene	I-NP	NNS	I-DNA	20	PMOD
26	in	in	B-PP	IN	O	19	NMOD
27	the	the	B-NP	DT	O	28	NMOD
28	hybrids	hybrid	I-NP	NNS	O	26	PMOD
29	and	and	O	CC	O	18	VMOD
30	is	be	B-VP	VBZ	O	18	VMOD
31	responsible	responsible	B-ADJP	JJ	O	30	PRD
32	for	for	B-PP	IN	O	31	AMOD
33	de	de	B-NP	FW	O	34	AMOD
34	novo	novo	I-NP	FW	O	35	NMOD
35	expression	expression	I-NP	NN	O	32	PMOD
36	of	of	B-PP	IN	O	35	NMOD
37	mouse	mouse	B-NP	NN	B-DNA	41	NMOD
38	MHC	MHC	I-NP	NN	I-DNA	41	NMOD
39	class	class	I-NP	NN	I-DNA	41	NMOD
40	II	II	B-NP	CD	I-DNA	41	NMOD
41	genes	gene	I-NP	NNS	I-DNA	36	PMOD
42	in	in	B-PP	IN	O	35	NMOD
43	both	both	O	CC	O	51	NMOD
44	the	the	B-NP	DT	O	48	NMOD
45	mouse	mouse	I-NP	NN	B-cell_line	48	NMOD
46	plasmacytoma	plasmacytoma	I-NP	NN	I-cell_line	48	NMOD
47	cell	cell	I-NP	NN	I-cell_line	48	NMOD
48	line	line	I-NP	NN	I-cell_line	51	NMOD
49	and	and	O	CC	O	51	NMOD
50	the	the	B-NP	DT	O	51	NMOD
51	hybrids	hybrid	I-NP	NNS	B-cell_line	42	PMOD
52	.	.	O	.	O	18	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	confirm	confirm	B-VP	VBP	O	0	ROOT
4	and	and	I-VP	CC	O	3	VMOD
5	extend	extend	I-VP	VBP	O	3	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	notion	notion	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	functional	functional	I-NP	JJ	O	11	NMOD
11	conservation	conservation	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	16	NMOD
14	AIR-1	AIR-1	I-NP	NN	B-protein	16	NMOD
15	gene	gene	I-NP	NN	I-protein	16	NMOD
16	product	product	I-NP	NN	I-protein	12	PMOD
17	across	across	B-PP	IN	O	11	NMOD
18	species	specie	B-NP	NNS	O	19	NMOD
19	barriers	barrier	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	3	P

1	Interestingly	Interestingly	B-ADVP	RB	O	16	VMOD
2	,	,	O	,	O	16	P
3	in	in	B-PP	IN	O	16	VMOD
4	CIITA-transfected	CIITA-transfected	B-NP	JJ	B-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	hybrids	hybrid	I-NP	NNS	I-cell_line	3	PMOD
7	,	,	O	,	O	16	P
8	cell	cell	B-NP	NN	O	10	NMOD
9	surface	surface	I-NP	NN	O	10	NMOD
10	expression	expression	I-NP	NN	O	16	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	human	human	I-NP	JJ	B-protein	15	NMOD
14	HLA-DQ	HLA-DQ	I-NP	NN	I-protein	15	NMOD
15	heterodimer	heterodimer	I-NP	NN	I-protein	11	PMOD
16	was	be	B-VP	VBD	O	0	ROOT
17	not	not	I-VP	RB	O	16	VMOD
18	observed	observe	I-VP	VBN	O	16	VC
19	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	2	NMOD
2	result	result	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	not	not	O	RB	O	3	VMOD
5	attributable	attributable	B-ADJP	JJ	O	3	PRD
6	to	to	B-PP	TO	O	5	AMOD
7	lack	lack	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	HLA-DQ	HLA-DQ	B-NP	NN	B-protein	10	NMOD
10	alpha	alpha	I-NP	NN	I-protein	14	NMOD
11	or	or	O	CC	O	14	NMOD
12	-DQ	-DQ	B-NP	NN	O	14	NMOD
13	beta	beta	I-NP	NN	O	14	NMOD
14	transcription	transcription	I-NP	NN	O	8	PMOD
15	,	,	O	,	O	3	P
16	because	because	B-SBAR	IN	O	3	VMOD
17	both	both	B-NP	DT	O	18	NMOD
18	transcripts	transcript	I-NP	NNS	O	19	SUB
19	were	be	B-VP	VBD	O	16	SBAR
20	present	present	B-ADJP	JJ	O	19	PRD
21	in	in	B-PP	IN	O	20	AMOD
22	the	the	B-NP	DT	O	24	NMOD
23	CIITA-transfected	CIITA-transfected	I-NP	JJ	B-cell_line	24	NMOD
24	hybrids	hybrid	I-NP	NNS	I-cell_line	21	PMOD
25	,	,	O	,	O	19	P
26	although	although	B-SBAR	IN	O	19	VMOD
27	at	at	B-PP	IN	O	26	DEP
28	reduced	reduce	B-NP	VBN	O	29	NMOD
29	levels	level	I-NP	NNS	O	27	PMOD
30	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	4	SUB
3	further	further	B-ADVP	RB	O	4	VMOD
4	support	support	B-VP	VBP	O	0	ROOT
5	our	our	B-NP	PRP$	O	7	NMOD
6	previous	previous	I-NP	JJ	O	7	NMOD
7	observations	observation	I-NP	NNS	O	4	OBJ
8	on	on	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	distinct	distinct	I-NP	JJ	O	11	NMOD
11	regulation	regulation	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	expression	expression	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	20	NMOD
16	human	human	I-NP	JJ	B-DNA	20	NMOD
17	HLA-DQ	HLA-DQ	I-NP	NN	I-DNA	20	NMOD
18	class	class	I-NP	NN	I-DNA	20	NMOD
19	II	II	I-NP	CD	I-DNA	20	NMOD
20	subset	subset	I-NP	NN	I-DNA	14	PMOD
21	,	,	O	,	O	20	P
22	which	which	B-NP	WDT	O	20	NMOD
23	may	may	B-VP	MD	O	22	SBAR
24	be	be	I-VP	VB	O	23	VC
25	thus	thus	I-VP	RB	O	24	VMOD
26	controlled	control	I-VP	VBN	O	24	VC
27	at	at	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	30	NMOD
29	posttranscriptional	posttranscriptional	I-NP	JJ	O	30	NMOD
30	level	level	I-NP	NN	O	27	PMOD
31	by	by	B-PP	IN	O	26	VMOD
32	a	a	B-NP	DT	O	34	NMOD
33	CIITA-independent	CIITA-independent	I-NP	JJ	O	34	NMOD
34	mechanism	mechanism	I-NP	NN	O	31	PMOD
35	.	.	O	.	O	4	P

1	Silencing	Silencing	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-protein	6	NMOD
4	fetal	fetal	I-NP	JJ	I-protein	6	NMOD
5	globin	globin	I-NP	NN	I-protein	6	NMOD
6	expression	expression	I-NP	NN	O	2	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	impaired	impaired	B-ADJP	JJ	O	7	PRD
9	in	in	B-PP	IN	O	8	AMOD
10	the	the	B-NP	DT	O	11	NMOD
11	absence	absence	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	19	NMOD
14	adult	adult	I-NP	JJ	B-protein	19	NMOD
15	beta-globin	beta-globin	I-NP	NN	I-protein	19	NMOD
16	gene	gene	I-NP	NN	I-protein	19	NMOD
17	activator	activator	I-NP	NN	I-protein	19	NMOD
18	protein	protein	I-NP	NN	I-protein	19	NMOD
19	EKLF	EKLF	I-NP	NN	B-protein	12	PMOD
20	.	.	O	.	O	7	P

1	Globin	Globin	B-NP	NN	B-DNA	2	NMOD
2	genes	gene	I-NP	NNS	I-DNA	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	subject	subject	B-ADJP	JJ	O	3	PRD
5	to	to	B-PP	TO	O	4	AMOD
6	tissue-specific	tissue-specific	B-NP	JJ	O	9	AMOD
7	and	and	I-NP	CC	O	9	AMOD
8	developmental	developmental	I-NP	JJ	O	9	AMOD
9	stage-specific	stage-specific	I-NP	JJ	O	10	NMOD
10	regulation	regulation	I-NP	NN	O	5	PMOD
11	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	2	NMOD
2	switch	switch	I-NP	NN	O	16	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	human	human	B-NP	JJ	B-protein	3	PMOD
5	fetal	fetal	I-NP	JJ	I-protein	4	NMOD
6	(	(	O	(	I-protein	7	P
7	gamma	gamma	B-NP	NN	I-protein	5	NMOD
8	)	)	O	)	I-protein	7	P
9	-to	-to	B-PP	TO	O	15	NMOD
10	adult	adult	B-ADJP	JJ	B-protein	15	NMOD
11	(	(	O	(	I-protein	14	P
12	beta	beta	B-NP	NN	I-protein	14	NMOD
13	)	)	O	)	I-protein	14	P
14	-globin	-globin	B-NP	NN	I-protein	15	NMOD
15	expression	expression	I-NP	NN	O	3	PMOD
16	occurs	occur	B-VP	VBZ	O	0	ROOT
17	within	within	B-PP	IN	O	16	VMOD
18	erythroid	erythroid	B-NP	JJ	B-cell_type	20	NMOD
19	precursor	precursor	I-NP	NN	I-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	adult	adult	I-NP	JJ	B-cell_type	24	NMOD
24	lineage	lineage	I-NP	NN	I-cell_type	21	PMOD
25	.	.	O	.	O	16	P

1	Previously	Previously	B-ADVP	RB	O	5	VMOD
2	we	we	B-NP	PRP	O	4	NMOD
3	and	and	O	CC	O	4	NMOD
4	others	other	B-NP	NNS	O	5	SUB
5	showed	show	B-VP	VBD	O	0	ROOT
6	by	by	B-PP	IN	O	5	VMOD
7	targeted	target	B-NP	VBN	O	9	NMOD
8	gene	gene	I-NP	NN	O	9	NMOD
9	disruption	disruption	I-NP	NN	O	6	PMOD
10	that	that	B-SBAR	IN	O	5	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	zinc	zinc	I-NP	NN	B-DNA	14	NMOD
13	finger	finger	I-NP	NN	I-DNA	14	NMOD
14	gene	gene	I-NP	NN	I-DNA	18	NMOD
15	,	,	O	,	O	18	P
16	erythroid	erythroid	B-NP	JJ	B-protein	18	NMOD
17	Kruppel-like	Kruppel-like	I-NP	JJ	I-protein	18	NMOD
18	factor	factor	I-NP	NN	I-protein	23	SUB
19	(	(	O	(	O	20	P
20	EKLF	EKLF	B-NP	NN	B-protein	18	NMOD
21	)	)	O	)	O	20	P
22	,	,	O	,	O	18	P
23	is	be	B-VP	VBZ	O	10	SBAR
24	required	require	I-VP	VBN	O	23	VC
25	for	for	B-PP	IN	O	24	VMOD
26	expression	expression	B-NP	NN	O	25	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	30	NMOD
29	beta-globin	beta-globin	I-NP	NN	B-DNA	30	NMOD
30	gene	gene	I-NP	NN	I-DNA	27	PMOD
31	in	in	B-PP	IN	O	26	NMOD
32	mice	mouse	B-NP	NNS	O	31	PMOD
33	,	,	O	,	O	24	P
34	presumably	presumably	B-ADVP	RB	O	35	PMOD
35	through	through	B-PP	IN	O	24	VMOD
36	interaction	interaction	B-NP	NN	O	35	PMOD
37	with	with	B-PP	IN	O	36	NMOD
38	a	a	B-NP	DT	O	41	NMOD
39	high-affinity	high-affinity	I-NP	JJ	B-DNA	41	NMOD
40	binding	bind	I-NP	VBG	I-DNA	41	NMOD
41	site	site	I-NP	NN	I-DNA	37	PMOD
42	in	in	B-PP	IN	O	41	NMOD
43	the	the	B-NP	DT	O	45	NMOD
44	proximal	proximal	I-NP	JJ	B-DNA	45	NMOD
45	promoter	promoter	I-NP	NN	I-DNA	42	PMOD
46	.	.	O	.	O	5	P

1	To	To	B-VP	TO	O	2	VMOD
2	examine	examine	I-VP	VB	O	17	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	role	role	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	EKLF	EKLF	B-NP	NN	B-protein	5	PMOD
7	in	in	B-PP	IN	O	4	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	developmental	developmental	I-NP	JJ	O	10	NMOD
10	regulation	regulation	I-NP	NN	O	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	human	human	I-NP	JJ	B-DNA	15	NMOD
14	gamma-globin	gamma-globin	I-NP	NN	I-DNA	15	NMOD
15	gene	gene	I-NP	NN	I-DNA	11	PMOD
16	we	we	B-NP	PRP	O	17	SUB
17	interbred	interbreed	B-VP	VBD	O	0	ROOT
18	EKLF	EKLF	B-NP	NN	B-protein	19	NMOD
19	heterozygotes	heterozygote	I-NP	NNS	I-protein	17	OBJ
20	(	(	O	(	O	21	P
21	+/-	+/-	B-NP	SYM	O	19	NMOD
22	)	)	O	)	O	21	P
23	with	with	B-PP	IN	O	19	NMOD
24	mice	mouse	B-NP	NNS	O	23	PMOD
25	harboring	harbor	B-VP	VBG	O	24	NMOD
26	a	a	B-NP	DT	O	32	NMOD
27	human	human	I-NP	JJ	B-DNA	32	NMOD
28	beta-globin	beta-globin	I-NP	NN	I-DNA	32	NMOD
29	yeast	yeast	I-NP	NN	I-DNA	32	NMOD
30	artificial	artificial	I-NP	JJ	I-DNA	32	NMOD
31	chromosome	chromosome	I-NP	NN	I-DNA	32	NMOD
32	transgene	transgene	I-NP	NN	I-DNA	25	OBJ
33	.	.	O	.	O	17	P

1	We	We	B-NP	PRP	O	2	SUB
2	find	find	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	in	in	B-PP	IN	O	20	VMOD
5	the	the	B-NP	DT	O	4	PMOD
6	absence	absence	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	EKLF	EKLF	B-NP	NN	B-protein	7	PMOD
9	,	,	O	,	O	20	P
10	while	while	B-SBAR	IN	O	20	VMOD
11	human	human	B-NP	JJ	B-protein	13	NMOD
12	beta-globin	beta-globin	I-NP	NN	I-protein	13	NMOD
13	expression	expression	I-NP	NN	O	14	SUB
14	is	be	B-VP	VBZ	O	10	SBAR
15	dramatically	dramatically	I-VP	RB	O	14	VMOD
16	reduced	reduce	I-VP	VBN	O	14	VC
17	,	,	O	,	O	20	P
18	gamma-globin	gamma-globin	B-NP	NN	B-RNA	19	NMOD
19	transcripts	transcript	I-NP	NNS	I-RNA	20	SUB
20	are	be	B-VP	VBP	O	3	SBAR
21	elevated	elevate	I-VP	VBN	O	20	VC
22	approximately	approximately	B-ADVP	RB	O	21	VMOD
23	5-fold	5-fold	I-ADVP	RB	O	22	AMOD
24	.	.	O	.	O	2	P

1	Impaired	Impaired	B-NP	JJ	O	2	NMOD
2	silencing	silencing	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	gamma-globin	gamma-globin	B-NP	NN	B-protein	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	identifies	identify	B-VP	VBZ	O	0	ROOT
7	EKLF	EKLF	B-NP	NN	B-protein	6	OBJ
8	as	as	B-PP	IN	O	6	VMOD
9	the	the	B-NP	DT	O	12	NMOD
10	first	first	I-NP	JJ	O	12	NMOD
11	transcription	transcription	I-NP	NN	B-protein	12	NMOD
12	factor	factor	I-NP	NN	I-protein	8	PMOD
13	participating	participate	B-VP	VBG	O	12	NMOD
14	quantitatively	quantitatively	B-ADVP	RB	O	13	VMOD
15	in	in	B-PP	IN	O	13	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	gamma-globin	gamma-globin	I-NP	NN	B-protein	15	PMOD
18	to	to	B-PP	TO	O	13	VMOD
19	beta-globin	beta-globin	B-NP	NN	B-protein	20	NMOD
20	switch	switch	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	6	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	compatible	compatible	B-ADJP	JJ	O	3	PRD
5	with	with	B-PP	IN	O	4	AMOD
6	a	a	B-NP	DT	O	8	NMOD
7	competitive	competitive	I-NP	JJ	O	8	NMOD
8	model	model	I-NP	NN	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	switching	switching	B-NP	NN	O	9	PMOD
11	in	in	B-PP	IN	O	8	NMOD
12	which	which	B-NP	WDT	O	11	PMOD
13	EKLF	EKLF	B-NP	NN	B-protein	14	SUB
14	mediates	mediate	B-VP	VBZ	O	11	SBAR
15	an	an	B-NP	DT	O	18	NMOD
16	adult	adult	I-NP	JJ	O	17	AMOD
17	stage-specific	stage-specific	I-NP	JJ	O	18	NMOD
18	interaction	interaction	I-NP	NN	O	14	OBJ
19	between	between	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	beta-globin	beta-globin	I-NP	NN	B-DNA	23	NMOD
22	gene	gene	I-NP	NN	I-DNA	23	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	28	NMOD
24	and	and	O	CC	O	28	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	locus	locus	I-NP	NN	B-DNA	28	NMOD
27	control	control	I-NP	NN	I-DNA	28	NMOD
28	region	region	I-NP	NN	I-DNA	19	PMOD
29	that	that	B-NP	WDT	O	28	NMOD
30	excludes	exclude	B-VP	VBZ	O	29	SBAR
31	the	the	B-NP	DT	O	33	NMOD
32	gamma-globin	gamma-globin	I-NP	NN	B-DNA	33	NMOD
33	gene	gene	I-NP	NN	I-DNA	30	OBJ
34	.	.	O	.	O	3	P

1	Nasal	Nasal	B-NP	JJ	B-cell_type	5	NMOD
2	NK-	NK-	I-NP	NN	I-cell_type	5	NMOD
3	and	and	I-NP	CC	I-cell_type	5	NMOD
4	T-cell	T-cell	I-NP	NN	I-cell_type	5	NMOD
5	lymphomas	lymphoma	I-NP	NNS	I-cell_type	6	SUB
6	share	share	B-VP	VBP	O	0	ROOT
7	the	the	B-NP	DT	O	9	NMOD
8	same	same	I-NP	JJ	O	9	NMOD
9	type	type	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	13	NMOD
12	virus	virus	I-NP	NN	O	13	NMOD
13	latency	latency	I-NP	NN	O	10	PMOD
14	as	as	B-PP	IN	O	6	VMOD
15	nasopharyngeal	nasopharyngeal	B-NP	JJ	O	16	NMOD
16	carcinoma	carcinoma	I-NP	NN	O	20	NMOD
17	and	and	O	CC	O	20	NMOD
18	Hodgkin	Hodgkin	B-NP	NN	O	19	NMOD
19	's	's	B-NP	POS	O	20	NMOD
20	disease	disease	I-NP	NN	O	14	PMOD
21	.	.	O	.	O	6	P

1	Nasal	Nasal	B-NP	JJ	B-cell_type	3	NMOD
2	T/NK-cell	T/NK-cell	I-NP	NN	I-cell_type	3	NMOD
3	lymphomas	lymphoma	I-NP	NNS	I-cell_type	4	SUB
4	can	can	B-VP	MD	O	0	ROOT
5	be	be	I-VP	VB	O	4	VC
6	further	further	B-ADJP	RBR	O	5	VMOD
7	separated	separate	I-ADJP	VBN	O	5	VC
8	into	into	B-PP	IN	O	7	VMOD
9	those	those	B-NP	DT	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	natural	natural	B-NP	JJ	B-cell_type	17	NMOD
12	killer	killer	I-NP	NN	I-cell_type	17	NMOD
13	(	(	O	(	I-cell_type	14	P
14	NK	NK	B-NP	NN	I-cell_type	12	NMOD
15	)	)	O	)	I-cell_type	14	P
16	cell	cell	B-NP	NN	I-cell_type	17	NMOD
17	lineage	lineage	I-NP	NN	I-cell_type	10	PMOD
18	or	or	B-PP	CC	O	10	PMOD
19	of	of	B-PP	IN	O	10	PMOD
20	T-cell	T-cell	B-NP	NN	B-cell_type	21	NMOD
21	lineage	lineage	I-NP	NN	I-cell_type	19	PMOD
22	,	,	O	,	O	8	P
23	with	with	B-PP	IN	O	8	PMOD
24	differences	difference	B-NP	NNS	O	23	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	cellular	cellular	B-NP	JJ	O	27	NMOD
27	phenotype	phenotype	I-NP	NN	O	39	NMOD
28	,	,	O	,	O	39	P
29	T-cell	T-cell	B-NP	NN	B-protein	30	NMOD
30	receptor	receptor	I-NP	NN	I-protein	35	NMOD
31	(	(	O	(	O	32	P
32	TcR	TcR	B-NP	NN	O	30	NMOD
33	)	)	O	)	O	32	P
34	gene	gene	B-NP	NN	O	35	NMOD
35	rearrangement	rearrangement	I-NP	NN	O	39	NMOD
36	and	and	O	CC	O	39	NMOD
37	TcR	TcR	B-NP	NN	B-protein	39	NMOD
38	transcript	transcript	I-NP	NN	O	39	NMOD
39	expression	expression	I-NP	NN	O	25	PMOD
40	.	.	O	.	O	4	P

1	Both	Both	O	CC	O	5	NMOD
2	NK-	NK-	B-NP	NN	B-cell_type	4	NMOD
3	and	and	I-NP	CC	I-cell_type	4	NMOD
4	T-cell	T-cell	I-NP	NN	I-cell_type	5	NMOD
5	subtypes	subtype	I-NP	NNS	I-cell_type	6	SUB
6	are	be	B-VP	VBP	O	0	ROOT
7	closely	closely	I-VP	RB	O	8	VMOD
8	associated	associate	I-VP	VBN	O	6	VC
9	with	with	B-PP	IN	O	8	VMOD
10	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	11	NMOD
11	virus	virus	I-NP	NN	O	9	PMOD
12	(	(	O	(	O	13	P
13	EBV	EBV	B-NP	NN	O	11	NMOD
14	)	)	O	)	O	13	P
15	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	8	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	8	P
5	EBV	EBV	B-NP	NN	B-DNA	7	NMOD
6	gene	gene	I-NP	NN	I-DNA	7	NMOD
7	expression	expression	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	determined	determine	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	23	23	B-NP	CD	O	12	NMOD
12	cases	case	I-NP	NNS	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	nasal	nasal	B-NP	JJ	O	15	NMOD
15	lymphoma	lymphoma	I-NP	NN	O	13	PMOD
16	(	(	O	(	O	17	P
17	NL	NL	B-NP	NN	B-protein	15	NMOD
18	)	)	O	)	O	17	P
19	by	by	B-PP	IN	O	9	VMOD
20	in	in	B-NP	FW	O	21	AMOD
21	situ	situ	I-NP	FW	O	22	NMOD
22	hybridisation	hybridisation	I-NP	NN	O	30	NMOD
23	(	(	O	(	O	24	P
24	ISH	ISH	B-NP	NN	O	22	NMOD
25	)	)	O	)	O	24	P
26	,	,	O	,	O	30	P
27	reverse	reverse	B-NP	JJ	O	30	NMOD
28	transcriptase-polymerase	transcriptase-polymerase	I-NP	NN	O	30	NMOD
29	chain	chain	I-NP	NN	O	30	NMOD
30	reaction	reaction	I-NP	NN	O	35	NMOD
31	(	(	O	(	O	32	P
32	RT-PCR	RT-PCR	B-NP	NN	O	30	NMOD
33	)	)	O	)	O	32	P
34	and	and	O	CC	O	35	NMOD
35	immunohistochemistry	immunohistochemistry	B-NP	NN	O	19	PMOD
36	(	(	O	(	O	37	P
37	IH	IH	B-NP	NN	O	35	NMOD
38	)	)	O	)	O	37	P
39	.	.	O	.	O	8	P

1	Of	Of	B-PP	IN	O	7	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	23	23	I-NP	CD	O	4	NMOD
4	cases	case	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	7	P
6	19	19	B-NP	CD	O	7	SUB
7	were	be	B-VP	VBD	O	0	ROOT
8	classified	classify	I-VP	VBN	O	7	VC
9	as	as	B-PP	IN	O	8	VMOD
10	NK-cell	NK-cell	B-NP	NN	O	9	PMOD
11	and	and	O	CC	O	7	VMOD
12	4	4	B-NP	CD	O	15	NMOD
13	as	as	B-SBAR	IN	O	15	NMOD
14	T-cell	T-cell	B-NP	NN	O	15	NMOD
15	tumours	tumour	I-NP	NNS	O	7	PRD
16	.	.	O	.	O	7	P

1	ISH	ISH	B-NP	NN	O	7	SUB
2	for	for	B-PP	IN	O	1	NMOD
3	EBV-encoded	EBV-encoded	B-NP	JJ	B-RNA	6	NMOD
4	small	small	I-NP	JJ	I-RNA	6	NMOD
5	non-polyadenylated	non-polyadenylated	I-NP	JJ	I-RNA	6	NMOD
6	RNAs	RNA	I-NP	NNS	I-RNA	2	PMOD
7	showed	show	B-VP	VBD	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	all	all	B-NP	DT	O	10	NMOD
10	cases	case	I-NP	NNS	O	8	SBAR
11	,	,	O	,	O	10	P
12	whether	whether	B-SBAR	IN	O	10	VMOD
13	NK	NK	B-NP	NN	O	15	NMOD
14	or	or	I-NP	CC	O	15	NMOD
15	T	T	I-NP	NN	O	17	SUB
16	,	,	O	,	O	15	P
17	harboured	harbour	B-VP	VBD	O	12	SBAR
18	EBV	EBV	B-NP	NN	O	17	OBJ
19	in	in	B-PP	IN	O	17	VMOD
20	virtually	virtually	B-NP	RB	O	21	AMOD
21	all	all	I-NP	DT	O	23	NMOD
22	tumour	tumour	I-NP	NN	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
24	.	.	O	.	O	7	P

1	RT-PCR	RT-PCR	B-NP	NN	O	2	SUB
2	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	NL	NL	B-NP	NNP	B-cell_type	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	both	both	B-NP	DT	O	7	NMOD
7	subtypes	subtype	I-NP	NNS	O	5	PMOD
8	expressed	express	B-VP	VBD	O	3	SBAR
9	EBNAI	EBNAI	B-NP	NN	B-protein	8	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	QUK	QUK	I-NP	NN	O	14	NMOD
13	splice	splice	I-NP	NN	O	14	NMOD
14	pattern	pattern	I-NP	NN	O	29	NMOD
15	,	,	O	,	O	29	P
16	the	the	B-NP	DT	O	19	NMOD
17	latent	latent	I-NP	JJ	B-protein	19	NMOD
18	membrane	membrane	I-NP	NN	I-protein	19	NMOD
19	proteins	protein	I-NP	NNS	I-protein	29	NMOD
20	,	,	O	,	O	29	P
21	LMP1	LMP1	B-NP	NN	B-protein	23	NMOD
22	and	and	O	CC	I-protein	23	NMOD
23	2	2	B-NP	CD	I-protein	29	NMOD
24	and	and	O	CC	O	29	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	BamHI	BamHI	I-NP	NN	B-RNA	29	NMOD
27	A	A	I-NP	NN	I-RNA	29	NMOD
28	rightward	rightward	I-NP	JJ	I-RNA	29	NMOD
29	transcripts	transcript	I-NP	NNS	I-RNA	10	PMOD
30	in	in	B-PP	IN	O	8	VMOD
31	the	the	B-NP	DT	O	32	NMOD
32	absence	absence	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	EBNA2	EBNA2	B-NP	NN	B-RNA	35	NMOD
35	mRNAs	mRNA	I-NP	NNS	I-RNA	33	PMOD
36	,	,	O	,	O	8	P
37	compatible	compatible	B-ADJP	JJ	O	8	VMOD
38	with	with	B-PP	IN	O	37	AMOD
39	the	the	B-NP	DT	O	43	NMOD
40	latency	latency	I-NP	NN	O	43	NMOD
41	type	type	I-NP	NN	O	43	NMOD
42	II	II	I-NP	CD	O	43	NMOD
43	pattern	pattern	I-NP	NN	O	38	PMOD
44	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	11	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	analysis	analysis	B-NP	NN	O	11	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	EBV	EBV	B-NP	NN	B-protein	8	NMOD
7	protein	protein	I-NP	NN	I-protein	8	NMOD
8	expression	expression	I-NP	NN	O	5	PMOD
9	by	by	B-PP	IN	O	8	NMOD
10	IH	IH	B-NP	NN	O	9	PMOD
11	revealed	reveal	B-VP	VBD	O	0	ROOT
12	a	a	B-NP	DT	O	14	NMOD
13	heterogeneous	heterogeneous	I-NP	JJ	O	14	NMOD
14	pattern	pattern	I-NP	NN	O	11	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	EBV	EBV	B-NP	NN	B-DNA	18	NMOD
17	gene	gene	I-NP	NN	I-DNA	18	NMOD
18	expression	expression	I-NP	NN	O	15	PMOD
19	at	at	B-PP	IN	O	14	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	single-cell	single-cell	I-NP	JJ	O	22	NMOD
22	level	level	I-NP	NN	O	19	PMOD
23	consisting	consist	B-VP	VBG	O	22	NMOD
24	of	of	B-PP	IN	O	23	VMOD
25	both	both	O	CC	O	30	NMOD
26	LMP1+	LMP1+	B-NP	NN	B-cell_type	30	NMOD
27	and	and	I-NP	CC	I-cell_type	30	NMOD
28	LMP1-	LMP1-	I-NP	NN	I-cell_type	30	NMOD
29	tumour	tumour	I-NP	NN	I-cell_type	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_type	24	PMOD
31	,	,	O	,	O	11	P
32	suggesting	suggest	B-VP	VBG	O	11	VMOD
33	a	a	B-NP	DT	O	34	NMOD
34	mixture	mixture	I-NP	NN	O	32	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	latency	latency	B-NP	NN	O	35	PMOD
37	I	I	I-NP	CD	O	39	NMOD
38	and	and	I-NP	CC	O	39	NMOD
39	II	II	I-NP	CD	O	36	NMOD
40	.	.	O	.	O	11	P

1	Although	Although	B-SBAR	IN	O	30	VMOD
2	2	2	B-NP	CD	B-RNA	5	NMOD
3	early	early	I-NP	JJ	I-RNA	5	NMOD
4	lytic	lytic	I-NP	JJ	I-RNA	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-RNA	9	NMOD
6	,	,	O	,	O	9	P
7	BZLF1	BZLF1	B-NP	NN	B-protein	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	BHRF1	BHRF1	B-NP	NN	B-protein	11	SUB
10	,	,	O	,	O	9	P
11	were	be	B-VP	VBD	O	1	SBAR
12	also	also	I-VP	RB	O	11	VMOD
13	detected	detect	I-VP	VBN	O	11	VC
14	in	in	B-PP	IN	O	13	VMOD
15	13	13	B-NP	CD	O	17	AMOD
16	and	and	I-NP	CC	O	17	AMOD
17	10	10	I-NP	CD	O	18	NMOD
18	cases	case	I-NP	NNS	O	14	PMOD
19	,	,	O	,	O	30	P
20	respectively	respectively	B-ADVP	RB	O	30	VMOD
21	,	,	O	,	O	30	P
22	the	the	B-NP	DT	O	23	NMOD
23	lack	lack	I-NP	NN	O	30	SUB
24	of	of	B-PP	IN	O	23	NMOD
25	ZEBRA	ZEBRA	B-NP	NN	B-protein	26	NMOD
26	staining	staining	I-NP	NN	O	24	PMOD
27	in	in	B-PP	IN	O	23	NMOD
28	any	any	B-NP	DT	O	29	NMOD
29	case	case	I-NP	NN	O	27	PMOD
30	indicates	indicate	B-VP	VBZ	O	0	ROOT
31	that	that	B-SBAR	IN	O	30	VMOD
32	these	these	B-NP	DT	O	34	NMOD
33	lytic	lytic	I-NP	JJ	B-RNA	34	NMOD
34	transcripts	transcript	I-NP	NNS	I-RNA	35	SUB
35	are	be	B-VP	VBP	O	31	SBAR
36	most	most	I-VP	RBS	O	37	AMOD
37	likely	likely	I-VP	RB	O	38	VMOD
38	expressed	express	I-VP	VBN	O	35	VC
39	by	by	B-PP	IN	O	38	VMOD
40	rare	rare	B-NP	JJ	B-cell_type	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_type	39	PMOD
42	in	in	B-PP	IN	O	38	VMOD
43	the	the	B-NP	DT	O	44	NMOD
44	biopsies	biopsy	I-NP	NNS	O	42	PMOD
45	entering	enter	B-VP	VBG	O	44	NMOD
46	lytic	lytic	B-NP	JJ	O	47	NMOD
47	cycle	cycle	I-NP	NN	O	45	OBJ
48	.	.	O	.	O	30	P

1	The	The	B-NP	DT	O	4	NMOD
2	viral	viral	I-NP	JJ	O	4	NMOD
3	transcriptional	transcriptional	I-NP	JJ	O	4	NMOD
4	pattern	pattern	I-NP	NN	O	15	SUB
5	similar	similar	B-ADJP	JJ	O	4	NMOD
6	to	to	B-PP	TO	O	5	AMOD
7	that	that	B-NP	DT	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	nasopharyngeal	nasopharyngeal	B-NP	JJ	O	10	NMOD
10	carcinoma	carcinoma	I-NP	NN	O	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	Hodgkin	Hodgkin	B-NP	NN	O	13	NMOD
13	's	's	B-NP	POS	O	14	NMOD
14	disease	disease	I-NP	NN	O	8	PMOD
15	suggests	suggest	B-VP	VBZ	O	0	ROOT
16	that	that	B-SBAR	IN	O	15	VMOD
17	EBV	EBV	B-NP	NN	O	18	SUB
18	can	can	B-VP	MD	O	16	SBAR
19	exploit	exploit	I-VP	VB	O	18	VC
20	common	common	B-NP	JJ	O	22	NMOD
21	regulatory	regulatory	I-NP	JJ	O	22	NMOD
22	mechanisms	mechanism	I-NP	NNS	O	19	OBJ
23	for	for	B-PP	IN	O	22	NMOD
24	gene	gene	B-NP	NN	O	25	NMOD
25	transcription	transcription	I-NP	NN	O	23	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	diverse	diverse	B-NP	JJ	B-cell_type	30	NMOD
28	host	host	I-NP	NN	I-cell_type	30	NMOD
29	cell	cell	I-NP	NN	I-cell_type	30	NMOD
30	types	type	I-NP	NNS	I-cell_type	26	PMOD
31	.	.	O	.	O	15	P

1	Down-regulation	Down-regulation	B-NP	NN	O	11	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	immunogenic	immunogenic	B-NP	JJ	B-protein	4	NMOD
4	proteins	protein	I-NP	NNS	I-protein	2	PMOD
5	(	(	O	(	O	6	P
6	EBNA2-EBNA6	EBNA2-EBNA6	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	in	in	B-PP	IN	O	1	NMOD
9	nasal	nasal	B-NP	JJ	O	10	NMOD
10	lymphoma	lymphoma	I-NP	NN	O	8	PMOD
11	may	may	B-VP	MD	O	0	ROOT
12	enable	enable	I-VP	VB	O	11	VC
13	tumour	tumour	B-NP	NN	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	16	SUB
15	to	to	B-VP	TO	O	16	VMOD
16	evade	evade	I-VP	VB	O	12	VMOD
17	host	host	B-NP	NN	O	20	NMOD
18	cytotoxic	cytotoxic	I-NP	JJ	O	20	NMOD
19	T-cell	T-cell	I-NP	NN	O	20	NMOD
20	surveillance	surveillance	I-NP	NN	O	16	OBJ
21	.	.	O	.	O	11	P

1	Identification	Identification	B-NP	NN	O	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	characterization	characterization	I-NP	NN	O	0	ROOT
4	of	of	B-PP	IN	O	3	NMOD
5	a	a	B-NP	DT	O	7	NMOD
6	leukocyte-specific	leukocyte-specific	I-NP	JJ	O	7	NMOD
7	component	component	I-NP	NN	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	nuclear	nuclear	I-NP	JJ	O	11	NMOD
11	body	body	I-NP	NN	O	8	PMOD
12	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	nuclear	nuclear	I-NP	JJ	O	3	NMOD
3	body	body	I-NP	NN	O	7	SUB
4	(	(	O	(	O	5	P
5	NB	NB	B-NP	NN	O	3	NMOD
6	)	)	O	)	O	5	P
7	is	be	B-VP	VBZ	O	0	ROOT
8	a	a	B-NP	DT	O	10	NMOD
9	cellular	cellular	I-NP	JJ	O	10	NMOD
10	organelle	organelle	I-NP	NN	O	7	PRD
11	that	that	B-NP	WDT	O	10	NMOD
12	is	be	B-VP	VBZ	O	11	SBAR
13	involved	involve	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	pathogenesis	pathogenesis	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	acute	acute	B-NP	JJ	O	20	NMOD
19	promyelocytic	promyelocytic	I-NP	JJ	O	20	NMOD
20	leukemia	leukemia	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	viral	viral	B-NP	JJ	O	23	NMOD
23	infection	infection	I-NP	NN	O	17	PMOD
24	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	NB	NB	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	also	also	B-ADVP	RB	O	3	VMOD
5	a	a	B-NP	DT	O	6	NMOD
6	target	target	I-NP	NN	O	3	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	antibodies	antibody	B-NP	NNS	B-protein	7	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	serum	serum	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	patients	patient	B-NP	NNS	O	12	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	20	NMOD
16	autoimmune	autoimmune	I-NP	JJ	O	20	NMOD
17	disease	disease	I-NP	NN	O	20	NMOD
18	primary	primary	B-NP	JJ	O	20	NMOD
19	biliary	biliary	I-NP	JJ	O	20	NMOD
20	cirrhosis	cirrhosis	I-NP	NN	O	14	PMOD
21	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	13	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	13	P
5	serum	serum	B-NP	NN	O	13	SUB
6	from	from	B-PP	IN	O	5	NMOD
7	a	a	B-NP	DT	O	8	NMOD
8	patient	patient	I-NP	NN	O	6	PMOD
9	with	with	B-PP	IN	O	8	NMOD
10	primary	primary	B-NP	JJ	O	12	NMOD
11	biliary	biliary	I-NP	JJ	O	12	NMOD
12	cirrhosis	cirrhosis	I-NP	NN	O	9	PMOD
13	was	be	B-VP	VBD	O	0	ROOT
14	used	use	I-VP	VBN	O	13	VC
15	to	to	B-VP	TO	O	16	VMOD
16	identify	identify	I-VP	VB	O	14	VMOD
17	a	a	B-NP	DT	O	18	NMOD
18	cDNA	cDNA	I-NP	NN	B-DNA	16	OBJ
19	encoding	encode	B-VP	VBG	O	18	NMOD
20	a	a	B-NP	DT	O	22	NMOD
21	novel	novel	I-NP	JJ	O	22	NMOD
22	component	component	I-NP	NN	O	29	NMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	NB	NB	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	29	P
27	a	a	B-NP	DT	O	29	NMOD
28	140-kDa	140-kDa	I-NP	JJ	B-protein	29	NMOD
29	protein	protein	I-NP	NN	I-protein	19	OBJ
30	designated	designate	B-VP	VBN	O	29	NMOD
31	Sp140	Sp140	B-NP	NN	B-protein	30	VMOD
32	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	5	NMOD
2	predicted	predict	I-NP	VBN	O	5	NMOD
3	amino	amino	I-NP	NN	O	5	NMOD
4	acid	acid	I-NP	NN	O	5	NMOD
5	sequence	sequence	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	amino-terminal	amino-terminal	I-NP	JJ	B-protein	9	NMOD
9	portion	portion	I-NP	NN	I-protein	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	Sp140	Sp140	B-NP	NN	B-protein	10	PMOD
12	was	be	B-VP	VBD	O	0	ROOT
13	similar	similar	B-ADJP	JJ	O	12	PRD
14	to	to	B-PP	TO	O	13	AMOD
15	Sp100	Sp100	B-NP	NN	B-protein	21	NMOD
16	,	,	O	,	O	21	P
17	a	a	B-NP	DT	O	21	NMOD
18	previously	previously	I-NP	RB	O	19	AMOD
19	identified	identify	I-NP	VBN	O	21	NMOD
20	NB	NB	I-NP	NN	B-protein	21	NMOD
21	protein	protein	I-NP	NN	I-protein	14	PMOD
22	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	carboxyl	carboxyl	I-NP	NN	B-protein	3	NMOD
3	portion	portion	I-NP	NN	I-protein	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	Sp140	Sp140	B-NP	NN	B-protein	4	PMOD
6	contained	contain	B-VP	VBD	O	0	ROOT
7	a	a	B-NP	DT	O	9	NMOD
8	zinc-finger	zinc-finger	I-NP	NN	B-protein	9	NMOD
9	domain	domain	I-NP	NN	I-protein	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	a	a	B-NP	DT	O	12	NMOD
12	bromodomain	bromodomain	I-NP	NN	B-protein	14	NMOD
13	,	,	O	,	O	14	P
14	motifs	motif	B-NP	NNS	O	6	OBJ
15	that	that	B-NP	WDT	O	14	NMOD
16	are	be	B-VP	VBP	O	15	SBAR
17	present	present	B-ADJP	JJ	O	16	PRD
18	in	in	B-PP	IN	O	17	AMOD
19	proteins	protein	B-NP	NNS	O	18	PMOD
20	regulating	regulate	B-VP	VBG	O	19	NMOD
21	gene	gene	B-NP	NN	O	22	NMOD
22	transcription	transcription	I-NP	NN	O	20	OBJ
23	.	.	O	.	O	6	P

1	High	High	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	Sp140	Sp140	B-NP	NN	B-RNA	5	NMOD
5	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	detected	detect	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	human	human	B-NP	JJ	O	10	NMOD
10	spleen	spleen	I-NP	NN	O	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD
13	blood	blood	I-NP	NN	I-cell_type	14	NMOD
14	leukocytes	leukocyte	I-NP	NNS	I-cell_type	8	PMOD
15	,	,	O	,	O	20	P
16	but	but	O	CC	O	20	NMOD
17	not	not	O	RB	O	16	DEP
18	other	other	B-NP	JJ	O	20	NMOD
19	human	human	I-NP	JJ	O	20	NMOD
20	tissues	tissue	I-NP	NNS	O	6	PRD
21	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	level	level	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	SP140	SP140	B-NP	NN	B-RNA	5	NMOD
5	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	myeloid	myeloid	B-NP	JJ	B-cell_line	10	NMOD
8	precursor	precursor	I-NP	NN	I-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	lines	line	I-NP	NNS	I-cell_line	6	PMOD
11	HL60	HL60	B-NP	NN	B-cell_line	13	NMOD
12	and	and	I-NP	CC	O	13	NMOD
13	NB4	NB4	I-NP	NN	B-cell_line	10	NMOD
14	markedly	markedly	B-ADVP	RB	O	15	VMOD
15	increased	increase	B-VP	VBD	O	0	ROOT
16	in	in	B-PP	IN	O	15	VMOD
17	response	response	B-NP	NN	O	16	PMOD
18	to	to	B-PP	TO	O	16	PMOD
19	chemically	chemically	B-NP	RB	O	20	AMOD
20	induced	induce	I-NP	VBN	O	22	NMOD
21	cellular	cellular	I-NP	JJ	O	22	NMOD
22	differentiation	differentiation	I-NP	NN	O	16	PMOD
23	.	.	O	.	O	15	P

1	Immunohistochemical	Immunohistochemical	B-NP	JJ	O	2	NMOD
2	techniques	technique	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	used	use	I-VP	VBN	O	3	VC
5	to	to	B-VP	TO	O	6	VMOD
6	demonstrate	demonstrate	I-VP	VB	O	4	VMOD
7	that	that	B-SBAR	IN	O	6	VMOD
8	SP140	SP140	B-NP	NN	B-protein	9	SUB
9	localized	localize	B-VP	VBD	O	7	SBAR
10	to	to	B-PP	TO	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	NB	NB	I-NP	NN	O	10	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	differentiated	differentiate	B-NP	VBN	O	18	NMOD
15	HL60	HL60	I-NP	NN	B-cell_line	18	NMOD
16	and	and	I-NP	CC	O	18	NMOD
17	NB4	NB4	I-NP	NN	B-cell_line	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
19	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	location	location	I-NP	NN	O	10	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	Sp140	Sp140	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	NB	NB	I-NP	NN	O	5	PMOD
8	,	,	O	,	O	10	P
9	and	and	O	CC	O	10	NMOD
10	expression	expression	B-NP	NN	O	21	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	this	this	B-NP	DT	O	13	NMOD
13	gene	gene	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	10	NMOD
15	cells	cell	B-NP	NNS	O	14	PMOD
16	involved	involve	B-VP	VBN	O	15	NMOD
17	in	in	B-PP	IN	O	16	VMOD
18	host	host	B-NP	NN	O	19	NMOD
19	defense	defense	I-NP	NN	O	17	PMOD
20	,	,	O	,	O	10	P
21	suggest	suggest	B-VP	VBP	O	0	ROOT
22	that	that	B-SBAR	IN	O	21	VMOD
23	Sp140	Sp140	B-NP	NN	B-protein	24	SUB
24	may	may	B-VP	MD	O	22	SBAR
25	be	be	I-VP	VB	O	24	VC
26	involved	involve	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	pathogenesis	pathogenesis	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	acute	acute	B-NP	JJ	O	33	NMOD
32	promyelocytic	promyelocytic	I-NP	JJ	O	33	NMOD
33	leukemia	leukemia	I-NP	NN	O	36	NMOD
34	and	and	O	CC	O	36	NMOD
35	viral	viral	B-NP	JJ	O	36	NMOD
36	infection	infection	I-NP	NN	O	30	PMOD
37	.	.	O	.	O	21	P

1	Potent	Potent	B-NP	JJ	O	6	NMOD
2	gene	gene	I-NP	NN	O	6	NMOD
3	regulatory	regulatory	I-NP	JJ	O	6	NMOD
4	and	and	I-NP	CC	O	6	NMOD
5	antiproliferative	antiproliferative	I-NP	JJ	O	6	NMOD
6	activities	activity	I-NP	NNS	O	0	ROOT
7	of	of	B-PP	IN	O	6	NMOD
8	20-methyl	20-methyl	B-NP	NN	O	9	NMOD
9	analogues	analogue	I-NP	NNS	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	1	1	B-NP	CD	O	15	NMOD
12	,	,	I-NP	,	O	15	P
13	25	25	I-NP	CD	O	15	NMOD
14	dihydroxyvitamin	dihydroxyvitamin	I-NP	NN	O	15	NMOD
15	D3	D3	I-NP	NN	O	10	PMOD
16	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	biological	biological	I-NP	JJ	O	4	NMOD
3	active	active	I-NP	JJ	O	4	NMOD
4	form	form	I-NP	NN	O	12	NMOD
5	of	of	B-PP	IN	O	4	NMOD
6	vitamin	vitamin	B-NP	NN	O	7	NMOD
7	D3	D3	I-NP	NN	O	5	PMOD
8	,	,	O	,	O	12	P
9	1	1	B-NP	CD	O	12	NMOD
10	,	,	O	,	O	12	P
11	25-dihydroxyvitamin	25-dihydroxyvitamin	B-NP	NN	O	12	NMOD
12	D3	D3	I-NP	NN	O	17	SUB
13	(	(	O	(	O	14	P
14	VD	VD	B-NP	NN	O	12	NMOD
15	)	)	O	)	O	14	P
16	,	,	O	,	O	12	P
17	regulates	regulate	B-VP	VBZ	O	0	ROOT
18	cellular	cellular	B-NP	JJ	O	21	NMOD
19	growth	growth	B-NP	NN	O	21	NMOD
20	and	and	O	CC	O	21	NMOD
21	differentiation	differentiation	B-NP	NN	O	17	OBJ
22	.	.	O	.	O	17	P

1	This	This	B-NP	DT	O	2	SUB
2	provides	provide	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	hormone	hormone	I-NP	NN	O	2	OBJ
5	with	with	B-PP	IN	O	4	NMOD
6	an	an	B-NP	DT	O	9	NMOD
7	interesting	interesting	I-NP	JJ	O	9	NMOD
8	therapeutic	therapeutic	I-NP	JJ	O	9	NMOD
9	potential	potential	I-NP	NN	O	5	PMOD
10	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	hypercalcemia	hypercalcemia	B-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	side	side	I-NP	NN	O	7	NMOD
7	effect	effect	I-NP	NN	O	4	PRD
8	,	,	O	,	O	7	P
9	which	which	B-NP	WDT	O	7	NMOD
10	is	be	B-VP	VBZ	O	9	SBAR
11	caused	cause	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	VD	VD	B-NP	NN	O	14	NMOD
14	's	's	B-NP	POS	O	16	NMOD
15	classical	classical	I-NP	JJ	O	16	NMOD
16	action	action	I-NP	NN	O	19	NMOD
17	,	,	O	,	O	19	P
18	the	the	B-NP	DT	O	19	NMOD
19	regulation	regulation	I-NP	NN	O	12	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	calcium	calcium	B-NP	NN	O	22	NMOD
22	homeostasis	homeostasis	I-NP	NN	O	20	PMOD
23	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	2	SUB
2	made	make	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	need	need	I-NP	NN	O	2	OBJ
5	for	for	B-PP	IN	O	4	NMOD
6	VD	VD	B-NP	NN	O	7	NMOD
7	analogues	analogue	I-NP	NNS	O	5	PMOD
8	with	with	B-PP	IN	O	7	NMOD
9	selectively	selectively	B-NP	RB	O	10	AMOD
10	increased	increase	I-NP	VBN	O	13	NMOD
11	cell	cell	I-NP	NN	O	13	NMOD
12	regulatory	regulatory	I-NP	JJ	O	13	NMOD
13	properties	property	I-NP	NNS	O	8	PMOD
14	.	.	O	.	O	2	P

1	Studies	Study	B-NP	NNS	O	5	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	20-epi	20-epi	B-NP	JJ	O	4	NMOD
4	analogues	analogue	I-NP	NNS	O	2	PMOD
5	pointed	point	B-VP	VBD	O	0	ROOT
6	out	out	B-PRT	RP	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	importance	importance	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	carbon-20	carbon-20	I-NP	NN	O	12	NMOD
12	position	position	I-NP	NN	O	9	PMOD
13	and	and	O	CC	O	5	VMOD
14	led	lead	B-VP	VBD	O	5	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	development	development	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	20-methyl	20-methyl	B-NP	NN	O	20	NMOD
20	derivatives	derivative	I-NP	NNS	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	VD	VD	B-NP	NN	O	21	PMOD
23	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	22	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	report	report	I-NP	NN	O	1	PMOD
4	the	the	B-NP	DT	O	6	NMOD
5	biological	biological	I-NP	JJ	O	6	NMOD
6	properties	property	I-NP	NNS	O	1	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	compounds	compound	I-NP	NNS	O	7	PMOD
10	ZK161422	ZK161422	I-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	ZK157202	ZK157202	I-NP	NN	O	9	NMOD
13	,	,	O	,	O	6	P
14	which	which	B-NP	WDT	O	6	NMOD
15	are	be	B-VP	VBP	O	14	SBAR
16	20-methyl-	20-methyl-	B-ADJP	JJ	O	18	NMOD
17	and	and	O	CC	O	18	NMOD
18	20-methyl-23-eneanalogues	20-methyl-23-eneanalogue	B-NP	NNS	O	15	PRD
19	,	,	O	,	O	22	P
20	respectively	respectively	B-ADVP	RB	O	22	VMOD
21	,	,	O	,	O	22	P
22	have	have	B-VP	VBP	O	0	ROOT
23	been	be	I-VP	VBN	O	22	VC
24	analyzed	analyze	I-VP	VBN	O	23	VC
25	in	in	B-PP	IN	O	24	VMOD
26	comparison	comparison	B-NP	NN	O	25	PMOD
27	with	with	B-PP	IN	O	26	NMOD
28	VD	VD	B-NP	NN	O	27	PMOD
29	.	.	O	.	O	22	P

1	Both	Both	B-NP	DT	O	2	NMOD
2	compounds	compound	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	about	about	B-PP	IN	O	3	VMOD
5	2-fold	2-fold	B-NP	RB	O	6	AMOD
6	lower	low	I-NP	JJR	O	7	NMOD
7	affinity	affinity	I-NP	NN	O	4	PMOD
8	to	to	B-PP	TO	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	VD	VD	I-NP	NN	B-protein	11	NMOD
11	receptor	receptor	I-NP	NN	I-protein	8	PMOD
12	(	(	O	(	O	13	P
13	VDR	VDR	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	than	than	B-PP	IN	O	3	VMOD
16	VD	VD	B-NP	NN	O	15	PMOD
17	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	compared	compare	B-PP	VBN	O	10	VMOD
4	to	to	B-PP	TO	O	3	VMOD
5	VD	VD	B-NP	NN	O	4	PMOD
6	,	,	O	,	O	10	P
7	their	their	B-NP	PRP$	O	9	NMOD
8	antiproliferative	antiproliferative	I-NP	JJ	O	9	NMOD
9	effect	effect	I-NP	NN	O	10	SUB
10	is	be	B-VP	VBZ	O	0	ROOT
11	up	up	B-PP	IN	O	10	PRD
12	to	to	B-PP	TO	O	11	PMOD
13	30-fold	30-fold	B-NP	RB	O	14	AMOD
14	higher	high	I-NP	JJR	O	12	PMOD
15	on	on	B-PP	IN	O	14	NMOD
16	human	human	B-NP	JJ	B-cell_type	20	NMOD
17	peripheral	peripheral	I-NP	JJ	I-cell_type	20	NMOD
18	blood	blood	I-NP	NN	I-cell_type	20	NMOD
19	mononuclear	mononuclear	I-NP	JJ	I-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
21	and	and	O	CC	O	10	VMOD
22	even	even	B-ADVP	RB	O	10	VMOD
23	up	up	I-ADVP	RB	O	22	AMOD
24	to	to	B-PP	TO	O	22	AMOD
25	300-fold	300-fold	B-NP	RB	O	26	AMOD
26	higher	high	I-NP	JJR	O	24	PMOD
27	on	on	B-PP	IN	O	26	NMOD
28	human	human	B-NP	JJ	B-cell_line	32	NMOD
29	breast	breast	I-NP	NN	I-cell_line	32	NMOD
30	cancer	cancer	I-NP	NN	I-cell_line	32	NMOD
31	MCF-7	MCF-7	I-NP	NN	I-cell_line	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_line	27	PMOD
33	.	.	O	.	O	10	P

1	Whereas	Whereas	B-PP	IN	O	13	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	hypercalcemic	hypercalcemic	I-NP	JJ	O	4	NMOD
4	effect	effect	I-NP	NN	O	7	SUB
5	for	for	B-PP	IN	O	4	NMOD
6	ZK157202	ZK157202	B-NP	NN	O	5	PMOD
7	is	be	B-VP	VBZ	O	1	SBAR
8	also	also	I-VP	RB	O	7	VMOD
9	increased	increase	I-VP	VBN	O	7	VC
10	10-fold	10-fold	B-ADVP	RB	O	9	VMOD
11	,	,	O	,	O	13	P
12	ZK161422	ZK161422	B-NP	NN	O	13	SUB
13	has	have	B-VP	VBZ	O	0	ROOT
14	the	the	B-NP	DT	O	17	NMOD
15	same	same	I-NP	JJ	O	17	NMOD
16	calcium-mobilizing	calcium-mobilizing	I-NP	JJ	O	17	NMOD
17	potency	potency	I-NP	NN	O	13	OBJ
18	as	as	B-PP	IN	O	13	VMOD
19	VD	VD	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	13	P

1	Moreover	Moreover	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	ZK161422	ZK161422	B-NP	NN	O	7	NMOD
4	,	,	O	,	O	7	P
5	but	but	O	CC	O	7	NMOD
6	not	not	O	RB	O	5	DEP
7	ZK157202	ZK157202	B-NP	NN	O	9	SUB
8	,	,	O	,	O	7	P
9	showed	show	B-VP	VBD	O	0	ROOT
10	preference	preference	B-NP	NN	O	9	OBJ
11	for	for	B-PP	IN	O	10	NMOD
12	gene	gene	B-NP	NN	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	a	a	B-NP	DT	O	16	NMOD
16	promoter	promoter	I-NP	NN	B-DNA	14	PMOD
17	carrying	carry	B-VP	VBG	O	16	NMOD
18	a	a	B-NP	DT	O	21	NMOD
19	VD	VD	I-NP	NN	B-DNA	21	NMOD
20	response	response	I-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	17	OBJ
22	with	with	B-PP	IN	O	21	NMOD
23	a	a	B-NP	DT	O	25	NMOD
24	palindromic	palindromic	I-NP	JJ	O	25	NMOD
25	arrangement	arrangement	I-NP	NN	O	22	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	two	two	B-NP	CD	O	31	NMOD
28	hexameric	hexameric	I-NP	JJ	B-DNA	31	NMOD
29	receptor	receptor	I-NP	NN	I-DNA	31	NMOD
30	binding	binding	I-NP	NN	I-DNA	31	NMOD
31	sites	site	I-NP	NNS	I-DNA	26	PMOD
32	spaced	space	B-VP	VBN	O	31	NMOD
33	by	by	B-PP	IN	O	32	VMOD
34	9	9	B-NP	CD	O	35	NMOD
35	nucleotides	nucleotide	B-NP	NNS	O	33	PMOD
36	(	(	O	(	O	37	P
37	IP9	IP9	B-NP	NN	B-protein	35	NMOD
38	)	)	O	)	O	37	P
39	rather	rather	B-PP	RB	O	35	NMOD
40	than	than	I-PP	IN	O	39	DEP
41	for	for	B-PP	IN	O	35	NMOD
42	activation	activation	B-NP	NN	O	41	PMOD
43	from	from	B-PP	IN	O	42	NMOD
44	a	a	B-NP	DT	O	46	NMOD
45	response	response	I-NP	NN	O	46	NMOD
46	element	element	I-NP	NN	O	43	PMOD
47	formed	form	B-VP	VBN	O	46	NMOD
48	by	by	B-PP	IN	O	47	VMOD
49	a	a	B-NP	DT	O	51	NMOD
50	direct	direct	I-NP	JJ	O	51	NMOD
51	repeat	repeat	I-NP	NN	O	48	PMOD
52	spaced	space	B-VP	VBN	O	51	NMOD
53	by	by	B-PP	IN	O	52	VMOD
54	3	3	B-NP	CD	O	55	NMOD
55	nucleotides	nucleotide	B-NP	NNS	O	53	PMOD
56	(	(	O	(	O	57	P
57	DR3	DR3	B-NP	NN	B-protein	55	NMOD
58	)	)	O	)	O	57	P
59	.	.	O	.	O	9	P

1	This	This	B-NP	DT	O	2	NMOD
2	observation	observation	I-NP	NN	O	3	SUB
3	supports	support	B-VP	VBZ	O	0	ROOT
4	a	a	B-NP	DT	O	5	NMOD
5	model	model	I-NP	NN	O	3	OBJ
6	,	,	O	,	O	5	P
7	in	in	B-PP	IN	O	5	NMOD
8	which	which	B-NP	WDT	O	7	PMOD
9	promoter	promoter	B-NP	NN	O	10	NMOD
10	selectivity	selectivity	I-NP	NN	O	7	PMOD
11	reflects	reflect	B-VP	VBZ	O	3	VMOD
12	the	the	B-NP	DT	O	16	NMOD
13	selectively	selectively	I-NP	RB	O	14	AMOD
14	increased	increase	I-NP	VBN	O	16	NMOD
15	antiproliferative	antiproliferative	I-NP	JJ	O	16	NMOD
16	effect	effect	I-NP	NN	O	11	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	VD	VD	B-NP	NN	O	19	NMOD
19	analogues	analogue	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	3	P

1	Second	Second	B-NP	JJ	O	3	NMOD
2	messenger	messenger	I-NP	NN	O	3	NMOD
3	up-regulation	up-regulation	I-NP	NN	O	9	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	androgen	androgen	B-NP	NN	B-DNA	8	NMOD
6	receptor	receptor	I-NP	NN	I-DNA	8	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	NMOD
8	transcription	transcription	I-NP	NN	O	4	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	absent	absent	B-ADJP	JJ	O	9	PRD
11	in	in	B-PP	IN	O	10	AMOD
12	androgen	androgen	B-NP	NN	B-cell_line	18	NMOD
13	insensitive	insensitive	I-NP	JJ	I-cell_line	18	NMOD
14	human	human	I-NP	JJ	I-cell_line	18	NMOD
15	prostatic	prostatic	I-NP	JJ	I-cell_line	18	NMOD
16	carcinoma	carcinoma	I-NP	NN	I-cell_line	18	NMOD
17	cell	cell	I-NP	NN	I-cell_line	18	NMOD
18	lines	line	I-NP	NNS	I-cell_line	22	NMOD
19	,	,	O	,	O	22	P
20	PC-3	PC-3	B-NP	NN	B-cell_line	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	DU-145	DU-145	I-NP	NN	B-cell_line	11	PMOD
23	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	3	NMOD
2	theoretical	theoretical	I-NP	JJ	O	3	NMOD
3	pathway	pathway	I-NP	NN	O	15	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	transcriptional	transcriptional	B-NP	JJ	O	6	NMOD
6	regulation	regulation	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	14	NMOD
9	androgen	androgen	I-NP	NN	B-DNA	10	NMOD
10	receptor	receptor	I-NP	NN	I-DNA	14	NMOD
11	(	(	O	(	I-DNA	12	P
12	AR	AR	B-NP	NN	I-DNA	10	NMOD
13	)	)	O	)	I-DNA	12	P
14	gene	gene	B-NP	NN	I-DNA	7	PMOD
15	is	be	B-VP	VBZ	O	0	ROOT
16	via	via	B-PP	IN	O	15	PRD
17	a	a	B-NP	DT	O	20	NMOD
18	cAMP	cAMP	I-NP	NN	B-DNA	20	NMOD
19	response	response	I-NP	NN	I-DNA	20	NMOD
20	element	element	I-NP	NN	I-DNA	16	PMOD
21	(	(	O	(	O	22	P
22	CRE	CRE	B-NP	NN	B-DNA	20	NMOD
23	)	)	O	)	O	22	P
24	present	present	B-ADJP	JJ	O	20	NMOD
25	in	in	B-PP	IN	O	24	AMOD
26	its	its	B-NP	PRP$	O	28	NMOD
27	promoter	promoter	I-NP	NN	B-DNA	28	NMOD
28	region	region	I-NP	NN	I-DNA	25	PMOD
29	(	(	O	(	O	32	P
30	-508	-508	B-NP	CD	B-DNA	32	NMOD
31	to	to	O	TO	I-DNA	32	NMOD
32	-501	-501	B-NP	CD	I-DNA	28	NMOD
33	)	)	O	)	O	32	P
34	.	.	O	.	O	15	P

1	After	After	B-PP	IN	O	11	VMOD
2	20	20	B-NP	CD	O	3	NMOD
3	h	h	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	stimulation	stimulation	B-NP	NN	O	4	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	8-bromo-cAMP	8-bromo-cAMP	B-NP	NN	O	6	PMOD
8	,	,	O	,	O	11	P
9	AR	AR	B-NP	NN	B-RNA	10	NMOD
10	mRNA	mRNA	I-NP	NN	I-RNA	11	SUB
11	was	be	B-VP	VBD	O	0	ROOT
12	upregulated	upregulate	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	LNCaP	LNCaP	B-NP	NN	B-cell_line	13	PMOD
15	but	but	B-PP	CC	O	13	PMOD
16	not	not	B-PP	RB	O	17	PMOD
17	in	in	I-PP	IN	O	13	PMOD
18	either	either	O	CC	O	23	NMOD
19	PC-3	PC-3	B-NP	NN	B-protein	23	NMOD
20	or	or	O	CC	O	23	NMOD
21	DU-145	DU-145	B-NP	NN	B-cell_line	23	NMOD
22	cell	cell	I-NP	NN	I-cell_line	23	NMOD
23	lines	line	I-NP	NNS	I-cell_line	17	PMOD
24	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	demonstrated	demonstrate	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	22	DEP
5	the	the	B-NP	DT	O	6	NMOD
6	level	level	I-NP	NN	O	14	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	CRE	CRE	B-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	I-protein	10	NMOD
10	protein	protein	I-NP	NN	I-protein	7	PMOD
11	(	(	O	(	O	12	P
12	CREB	CREB	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	was	be	B-VP	VBD	O	4	SBAR
15	the	the	B-NP	DT	O	16	NMOD
16	same	same	I-NP	JJ	O	14	PRD
17	in	in	B-PP	IN	O	14	VMOD
18	all	all	B-NP	DT	O	20	NMOD
19	cell	cell	I-NP	NN	B-cell_line	20	NMOD
20	lines	line	I-NP	NNS	I-cell_line	17	PMOD
21	and	and	O	CC	O	22	DEP
22	that	that	B-SBAR	IN	O	3	VMOD
23	the	the	B-NP	DT	O	26	NMOD
24	putative	putative	I-NP	JJ	O	26	NMOD
25	AR-CRE	AR-CRE	I-NP	NN	O	26	NMOD
26	forms	form	I-NP	NNS	O	31	NMOD
27	specific	specific	B-NP	JJ	O	29	AMOD
28	and	and	I-NP	CC	O	29	AMOD
29	compatible	compatible	I-NP	JJ	O	31	NMOD
30	protein	protein	I-NP	NN	O	31	NMOD
31	interactions	interaction	I-NP	NNS	O	22	SBAR
32	with	with	B-PP	IN	O	31	NMOD
33	CREB	CREB	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	ability	ability	I-NP	NN	O	13	SUB
3	to	to	B-VP	TO	O	4	VMOD
4	regulate	regulate	I-VP	VB	O	2	NMOD
5	AR	AR	B-NP	NN	B-DNA	7	NMOD
6	gene	gene	I-NP	NN	I-DNA	7	NMOD
7	transcription	transcription	I-NP	NN	O	4	OBJ
8	via	via	B-PP	IN	O	4	VMOD
9	the	the	B-NP	DT	O	12	NMOD
10	second	second	I-NP	JJ	O	12	NMOD
11	messenger	messenger	I-NP	NN	O	12	NMOD
12	pathway	pathway	I-NP	NN	O	8	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	lost	lose	I-VP	VBN	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	21	NMOD
17	PC-3	PC-3	I-NP	NN	B-cell_line	21	NMOD
18	and	and	I-NP	CC	I-cell_line	21	NMOD
19	DU-145	DU-145	I-NP	NN	I-cell_line	21	NMOD
20	cell	cell	I-NP	NN	I-cell_line	21	NMOD
21	lines	line	I-NP	NNS	I-cell_line	15	PMOD
22	.	.	O	.	O	13	P

1	This	This	B-NP	DT	O	2	SUB
2	may	may	B-VP	MD	O	0	ROOT
3	be	be	I-VP	VB	O	2	VC
4	an	an	B-NP	DT	O	7	NMOD
5	important	important	I-NP	JJ	O	6	AMOD
6	primary	primary	I-NP	JJ	O	7	NMOD
7	mechanism	mechanism	I-NP	NN	O	3	PRD
8	of	of	B-PP	IN	O	7	NMOD
9	androgen	androgen	B-NP	NN	O	10	NMOD
10	insensitivity	insensitivity	I-NP	NN	O	8	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	prostate	prostate	B-NP	NN	O	13	NMOD
13	cancer	cancer	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	2	P

1	Activation	Activation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	6	NMOD
5	transcription	transcription	I-NP	NN	B-protein	6	NMOD
6	factor	factor	I-NP	NN	I-protein	2	PMOD
7	in	in	B-PP	IN	O	1	NMOD
8	a	a	B-NP	DT	O	11	NMOD
9	T-lymphocytic	T-lymphocytic	I-NP	JJ	B-cell_line	11	NMOD
10	cell	cell	I-NP	NN	I-cell_line	11	NMOD
11	line	line	I-NP	NN	I-cell_line	7	PMOD
12	by	by	B-PP	IN	O	1	NMOD
13	hypochlorous	hypochlorous	B-NP	JJ	O	14	NMOD
14	acid	acid	I-NP	NN	O	12	PMOD
15	.	.	O	.	O	1	P

1	Reactive	Reactive	B-NP	JJ	O	3	NMOD
2	oxygen	oxygen	I-NP	NN	O	3	NMOD
3	species	specie	I-NP	NNS	O	11	SUB
4	(	(	O	(	O	5	P
5	ROS	ROS	B-NP	NNS	O	3	NMOD
6	)	)	O	)	O	5	P
7	such	such	B-PP	JJ	O	8	PMOD
8	as	as	I-PP	IN	O	3	NMOD
9	hydrogen	hydrogen	B-NP	NN	O	10	NMOD
10	peroxide	peroxide	I-NP	NN	O	8	PMOD
11	serve	serve	B-VP	VBP	O	0	ROOT
12	as	as	B-PP	IN	O	11	VMOD
13	second	second	B-NP	JJ	O	14	NMOD
14	messengers	messenger	I-NP	NNS	O	12	PMOD
15	in	in	B-PP	IN	O	11	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	induction	induction	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	transcription	transcription	I-NP	NN	B-protein	22	NMOD
21	factor	factor	I-NP	NN	I-protein	22	NMOD
22	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	18	PMOD
23	,	,	O	,	O	11	P
24	and	and	O	CC	O	11	VMOD
25	hence	hence	B-ADVP	RB	O	11	VMOD
26	in	in	B-PP	IN	O	11	VMOD
27	the	the	B-NP	DT	O	30	NMOD
28	activation	activation	I-NP	NN	O	30	NMOD
29	and	and	O	CC	O	30	NMOD
30	replication	replication	B-NP	NN	O	26	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	human	human	B-NP	JJ	O	35	NMOD
33	immunodeficiency	immunodeficiency	I-NP	NN	O	35	NMOD
34	virus	virus	I-NP	NN	O	35	NMOD
35	type	type	I-NP	NN	O	31	PMOD
36	1	1	I-NP	CD	O	35	NMOD
37	(	(	O	(	O	38	P
38	HIV-1	HIV-1	B-NP	NN	O	35	NMOD
39	)	)	O	)	O	38	P
40	in	in	B-PP	IN	O	30	NMOD
41	human	human	B-NP	JJ	B-cell_type	42	NMOD
42	cells	cell	I-NP	NNS	I-cell_type	40	PMOD
43	.	.	O	.	O	11	P

1	During	During	B-PP	IN	O	8	VMOD
2	inflammatory	inflammatory	B-NP	JJ	O	3	NMOD
3	reactions	reaction	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	8	P
5	many	many	B-NP	JJ	O	7	NMOD
6	oxidative	oxidative	I-NP	JJ	O	7	NMOD
7	species	specie	I-NP	NNS	O	8	SUB
8	are	be	B-VP	VBP	O	0	ROOT
9	produced	produce	I-VP	VBN	O	8	VC
10	,	,	O	,	O	9	P
11	one	one	B-NP	CD	O	12	NMOD
12	of	of	B-PP	IN	O	9	VMOD
13	which	which	B-NP	WDT	O	12	PMOD
14	is	be	B-VP	VBZ	O	12	SBAR
15	hypochlorous	hypochlorous	B-NP	JJ	O	16	NMOD
16	acid	acid	I-NP	NN	O	14	PRD
17	(	(	O	(	O	18	P
18	HOCl	HOCl	B-NP	NN	O	16	NMOD
19	)	)	O	)	O	18	P
20	,	,	O	,	O	16	P
21	which	which	B-NP	WDT	O	16	NMOD
22	is	be	B-VP	VBZ	O	21	SBAR
23	responsible	responsible	B-ADJP	JJ	O	22	PRD
24	for	for	B-PP	IN	O	23	AMOD
25	the	the	B-NP	DT	O	27	NMOD
26	microbicidal	microbicidal	I-NP	JJ	O	27	NMOD
27	effects	effect	I-NP	NNS	O	24	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	activated	activate	B-NP	VBN	O	32	NMOD
30	human	human	I-NP	JJ	B-cell_type	32	NMOD
31	polymorphonuclear	polymorphonuclear	I-NP	JJ	I-cell_type	32	NMOD
32	leukocytes	leukocyte	I-NP	NNS	I-cell_type	28	PMOD
33	.	.	O	.	O	8	P

1	Treatment	Treatment	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	6	NMOD
4	T-lymphocytic	T-lymphocytic	I-NP	JJ	B-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	line	line	I-NP	NN	I-cell_line	2	PMOD
7	with	with	B-PP	IN	O	1	NMOD
8	micromolar	micromolar	B-NP	JJ	O	9	NMOD
9	concentrations	concentration	I-NP	NNS	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	HOCl	HOCl	B-NP	NN	O	10	PMOD
12	promoted	promote	B-VP	VBD	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	appearance	appearance	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	transcription	transcription	B-NP	NN	B-protein	18	NMOD
17	factor	factor	I-NP	NN	I-protein	18	NMOD
18	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	15	PMOD
19	(	(	O	(	O	22	P
20	the	the	B-NP	DT	O	22	NMOD
21	heterodimer	heterodimer	I-NP	NN	B-protein	22	NMOD
22	p50/p65	p50/p65	I-NP	NN	I-protein	18	NMOD
23	)	)	O	)	O	22	P
24	in	in	B-PP	IN	O	12	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	nucleus	nucleus	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	cells	cell	I-NP	NNS	O	27	PMOD
30	,	,	O	,	O	12	P
31	even	even	B-ADVP	RB	O	32	PMOD
32	in	in	B-PP	IN	O	12	VMOD
33	the	the	B-NP	DT	O	34	NMOD
34	absence	absence	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	de	de	B-NP	FW	O	37	AMOD
37	novo	novo	I-NP	FW	O	39	NMOD
38	protein	protein	I-NP	NN	O	39	NMOD
39	synthesis	synthesis	I-NP	NN	O	35	PMOD
40	.	.	O	.	O	12	P

1	Western	Western	B-NP	NN	O	3	NMOD
2	blot	blot	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	8	NMOD
6	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	8	NMOD
7	inhibitory	inhibitory	I-NP	JJ	I-protein	8	NMOD
8	subunits	subunit	I-NP	NNS	I-protein	4	PMOD
9	(	(	O	(	O	10	P
10	IkappaB	IkappaB	B-NP	NN	B-protein	8	NMOD
11	)	)	O	)	O	10	P
12	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
13	that	that	B-SBAR	IN	O	12	VMOD
14	both	both	O	CC	O	19	NMOD
15	IkappaB-alpha	IkappaB-alpha	B-NP	NN	B-protein	16	NMOD
16	proteolysis	proteolysis	I-NP	NN	O	19	NMOD
17	and	and	O	CC	O	19	NMOD
18	p105	p105	B-NP	NN	B-protein	19	NMOD
19	processing	processing	I-NP	NN	O	20	SUB
20	were	be	B-VP	VBD	O	13	SBAR
21	induced	induce	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	treatment	treatment	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	12	P

1	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	2	NMOD
2	activation	activation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	very	very	B-ADJP	RB	O	5	AMOD
5	effective	effective	I-ADJP	JJ	O	3	PRD
6	when	when	B-ADVP	WRB	O	5	AMOD
7	cells	cell	B-NP	NNS	O	8	SUB
8	were	be	B-VP	VBD	O	6	SBAR
9	subjected	subject	I-VP	VBN	O	8	VC
10	to	to	B-PP	TO	O	9	VMOD
11	hyperthermia	hyperthermia	B-NP	NN	O	10	PMOD
12	before	before	B-PP	IN	O	9	VMOD
13	being	be	B-VP	VBG	O	12	PMOD
14	treated	treat	I-VP	VBN	O	13	VC
15	with	with	B-PP	IN	O	14	VMOD
16	HOCl	HOCl	B-NP	NN	O	15	PMOD
17	.	.	O	.	O	3	P

1	Various	Various	B-NP	JJ	O	2	NMOD
2	antioxidants	antioxidant	I-NP	NNS	O	13	SUB
3	,	,	O	,	O	2	P
4	such	such	B-PP	JJ	O	5	PMOD
5	as	as	I-PP	IN	O	2	NMOD
6	pyrrolidine	pyrrolidine	B-NP	NN	O	7	NMOD
7	dithiocarbamate	dithiocarbamate	I-NP	NN	O	12	NMOD
8	,	,	O	,	O	12	P
9	p-bromophenacyl-bromide	p-bromophenacyl-bromide	B-NP	NN	O	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	nordihydroguaiaretic	nordihydroguaiaretic	B-NP	JJ	O	12	NMOD
12	acid	acid	I-NP	NN	O	5	PMOD
13	could	could	B-VP	MD	O	0	ROOT
14	strongly	strongly	I-VP	RB	O	13	VMOD
15	reduce	reduce	I-VP	VB	O	13	VC
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	17	NMOD
17	translocation	translocation	I-NP	NN	O	15	OBJ
18	,	,	O	,	O	15	P
19	demonstrating	demonstrate	B-VP	VBG	O	15	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	importance	importance	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	oxidative	oxidative	B-NP	JJ	O	24	NMOD
24	species	specie	I-NP	NNS	O	22	PMOD
25	in	in	B-PP	IN	O	19	VMOD
26	the	the	B-NP	DT	O	28	NMOD
27	transduction	transduction	I-NP	NN	O	28	NMOD
28	mechanism	mechanism	I-NP	NN	O	25	PMOD
29	.	.	O	.	O	13	P

1	Moreover	Moreover	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	ACH-2	ACH-2	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	10	SUB
5	treated	treat	B-VP	VBN	O	4	NMOD
6	with	with	B-PP	IN	O	5	VMOD
7	HOCl	HOCl	B-NP	NN	O	9	NMOD
8	or	or	I-NP	CC	O	9	NMOD
9	H2O2	H2O2	I-NP	NN	O	6	PMOD
10	released	release	B-VP	VBD	O	0	ROOT
11	tumour	tumour	B-NP	NN	B-protein	13	NMOD
12	necrosis	necrosis	I-NP	NN	I-protein	13	NMOD
13	factor-alpha	factor-alpha	I-NP	NN	I-protein	10	OBJ
14	(	(	O	(	O	15	P
15	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	in	in	B-PP	IN	O	10	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	supernatants	supernatant	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	importance	importance	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	5	NMOD
5	release	release	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	8	NMOD
8	induction	induction	I-NP	NN	O	6	PMOD
9	by	by	B-PP	IN	O	8	NMOD
10	HOCl	HOCl	B-NP	NN	O	12	NMOD
11	or	or	I-NP	CC	O	12	NMOD
12	H2O2	H2O2	I-NP	NN	O	9	PMOD
13	was	be	B-VP	VBD	O	43	VMOD
14	demonstrated	demonstrate	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	fact	fact	I-NP	NN	O	15	PMOD
18	that	that	B-SBAR	IN	O	17	NMOD
19	:	:	O	:	O	28	P
20	(	(	B-LST	(	O	21	P
21	1	1	I-LST	LS	O	25	NMOD
22	)	)	O	)	O	21	P
23	the	the	B-NP	DT	O	25	NMOD
24	nuclear	nuclear	I-NP	JJ	O	25	NMOD
25	appearance	appearance	I-NP	NN	O	28	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	26	PMOD
28	was	be	B-VP	VBD	O	18	SBAR
29	promoted	promote	I-VP	VBN	O	28	VC
30	in	in	B-PP	IN	O	29	VMOD
31	untreated	untreated	B-NP	JJ	B-cell_type	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_type	30	PMOD
33	;	;	O	:	O	43	P
34	and	and	O	CC	O	38	NMOD
35	(	(	B-LST	(	O	36	P
36	2	2	I-LST	LS	O	38	NMOD
37	)	)	O	)	O	36	P
38	synergism	synergism	B-NP	NN	O	43	SUB
39	between	between	B-PP	IN	O	38	NMOD
40	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	42	NMOD
41	and	and	I-NP	CC	O	42	NMOD
42	HOCl	HOCl	I-NP	NN	O	39	PMOD
43	was	be	B-VP	VBD	O	0	ROOT
44	detected	detect	I-VP	VBN	O	43	VC
45	.	.	O	.	O	43	P

1	Collectively	Collectively	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	results	result	I-NP	NNS	O	5	SUB
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	HOCl	HOCl	B-NP	NN	O	8	SUB
8	should	should	B-VP	MD	O	6	SBAR
9	be	be	I-VP	VB	O	8	VC
10	considered	consider	I-VP	VBN	O	9	VC
11	as	as	B-PP	IN	O	10	VMOD
12	an	an	B-NP	DT	O	14	NMOD
13	oxidative	oxidative	I-NP	JJ	O	14	NMOD
14	species	specie	I-NP	NNS	O	11	PMOD
15	capable	capable	B-ADJP	JJ	O	14	NMOD
16	of	of	B-PP	IN	O	15	AMOD
17	inducing	induce	B-VP	VBG	O	16	PMOD
18	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	17	OBJ
19	in	in	B-PP	IN	O	17	VMOD
20	a	a	B-NP	DT	O	23	NMOD
21	T-lymphocytic	T-lymphocytic	I-NP	JJ	B-cell_line	23	NMOD
22	cell	cell	I-NP	NN	I-cell_line	23	NMOD
23	line	line	I-NP	NN	I-cell_line	19	PMOD
24	through	through	B-PP	IN	O	17	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	transduction	transduction	I-NP	NN	O	27	NMOD
27	mechanism	mechanism	I-NP	NN	O	24	PMOD
28	involving	involve	B-VP	VBG	O	27	NMOD
29	ROS	ROS	B-NP	NNS	O	28	OBJ
30	,	,	O	,	O	29	P
31	and	and	O	CC	O	29	NMOD
32	having	have	B-VP	VBG	O	29	NMOD
33	a	a	B-NP	DT	O	35	NMOD
34	long-distance	long-distance	I-NP	JJ	O	35	NMOD
35	effect	effect	I-NP	NN	O	32	OBJ
36	through	through	B-PP	IN	O	32	VMOD
37	subsequent	subsequent	B-NP	JJ	O	39	NMOD
38	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	39	NMOD
39	release	release	I-NP	NN	O	36	PMOD
40	.	.	O	.	O	5	P

1	Thymocytes	Thymocyte	B-NP	NNS	B-cell_type	2	SUB
2	control	control	B-VP	VBP	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	CD4	CD4	I-NP	NN	B-DNA	5	NMOD
5	gene	gene	I-NP	NN	I-DNA	2	OBJ
6	differently	differently	B-ADVP	RB	O	7	PMOD
7	from	from	B-PP	IN	O	5	NMOD
8	mature	mature	B-NP	JJ	B-cell_type	10	NMOD
9	T	T	I-NP	NN	I-cell_type	10	NMOD
10	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD
11	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	analyzed	analyze	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	activity	activity	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	enhancer	enhancer	I-NP	NN	B-DNA	13	NMOD
8	,	,	O	,	O	13	P
9	the	the	B-NP	DT	O	10	NMOD
10	promoter	promoter	I-NP	NN	B-DNA	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	silencer	silencer	I-NP	NN	B-DNA	5	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	human	human	I-NP	JJ	B-DNA	18	NMOD
17	CD4	CD4	I-NP	NN	I-DNA	18	NMOD
18	gene	gene	I-NP	NN	I-DNA	14	PMOD
19	during	during	B-PP	IN	O	4	NMOD
20	T	T	B-NP	NN	O	22	NMOD
21	cell	cell	I-NP	NN	O	22	NMOD
22	development	development	I-NP	NN	O	19	PMOD
23	using	use	B-VP	VBG	O	22	NMOD
24	transgenic	transgenic	B-NP	JJ	O	25	NMOD
25	mice	mouse	I-NP	NNS	O	23	OBJ
26	.	.	O	.	O	2	P

1	Immunofluorescence	Immunofluorescence	B-NP	NN	O	2	NMOD
2	studies	study	I-NP	NNS	O	18	SUB
3	on	on	B-PP	IN	O	2	NMOD
4	thymic	thymic	B-NP	JJ	B-cell_type	5	NMOD
5	populations	population	I-NP	NNS	I-cell_type	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	mice	mouse	B-NP	NNS	O	6	PMOD
8	carrying	carry	B-VP	VBG	O	7	NMOD
9	transgenes	transgene	B-NP	NNS	O	8	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	various	various	B-NP	JJ	O	12	NMOD
12	combinations	combination	I-NP	NNS	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	these	these	B-NP	DT	O	17	NMOD
15	regulatory	regulatory	I-NP	JJ	B-DNA	17	NMOD
16	DNA	DNA	I-NP	NN	I-DNA	17	NMOD
17	elements	element	I-NP	NNS	I-DNA	13	PMOD
18	revealed	reveal	B-VP	VBD	O	0	ROOT
19	that	that	B-SBAR	IN	O	18	VMOD
20	thymocytes	thymocyte	B-NP	NNS	B-cell_type	21	SUB
21	control	control	B-VP	VBP	O	19	SBAR
22	the	the	B-NP	DT	O	24	NMOD
23	CD4	CD4	I-NP	NN	B-DNA	24	NMOD
24	gene	gene	I-NP	NN	I-DNA	21	OBJ
25	in	in	B-PP	IN	O	21	VMOD
26	a	a	B-NP	DT	O	28	NMOD
27	different	different	I-NP	JJ	O	28	NMOD
28	manner	manner	I-NP	NN	O	25	PMOD
29	than	than	B-PP	IN	O	21	VMOD
30	mature	mature	B-NP	JJ	B-cell_type	33	NMOD
31	peripheral	peripheral	I-NP	JJ	I-cell_type	33	NMOD
32	T	T	I-NP	NN	I-cell_type	33	NMOD
33	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	29	PMOD
34	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	4	NMOD
2	5'-positive	5'-positive	I-NP	JJ	B-DNA	4	NMOD
3	regulatory	regulatory	I-NP	JJ	I-DNA	4	NMOD
4	unit	unit	I-NP	NN	I-DNA	14	NMOD
5	,	,	O	,	O	4	P
6	consisting	consist	B-VP	VBG	O	4	NMOD
7	of	of	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	promoter	promoter	I-NP	NN	B-DNA	7	PMOD
10	and	and	O	CC	O	14	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	5	5	I-NP	CD	B-DNA	14	NMOD
13	'	'	I-NP	SYM	I-DNA	14	NMOD
14	enhancer	enhancer	I-NP	NN	I-DNA	16	SUB
15	,	,	O	,	O	14	P
16	is	be	B-VP	VBZ	O	0	ROOT
17	already	already	B-ADVP	RB	O	16	VMOD
18	active	active	B-ADJP	JJ	O	16	PRD
19	at	at	B-PP	IN	O	18	AMOD
20	the	the	B-NP	DT	O	25	NMOD
21	CD4-CD8-double-negative	CD4-CD8-double-negative	I-NP	JJ	O	25	NMOD
22	(	(	O	(	O	23	P
23	DN	DN	B-ADJP	JJ	O	21	AMOD
24	)	)	O	)	O	23	P
25	stage	stage	B-NP	NN	O	19	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	development	development	B-NP	NN	O	26	PMOD
28	.	.	O	.	O	16	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	its	its	B-NP	PRP$	O	4	NMOD
4	activity	activity	I-NP	NN	O	5	SUB
5	becomes	become	B-VP	VBZ	O	0	ROOT
6	lower	low	B-ADJP	JJR	O	12	NMOD
7	in	in	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	9	NMOD
9	double-positive	double-positive	I-NP	JJ	O	7	PMOD
10	and	and	O	CC	O	12	NMOD
11	a	a	B-NP	DT	O	12	NMOD
12	fraction	fraction	I-NP	NN	O	5	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	CD4+	CD4+	I-NP	JJ	B-cell_type	18	NMOD
16	CD8int/-	CD8int/-	I-NP	JJ	I-cell_type	18	NMOD
17	cell	cell	I-NP	NN	I-cell_type	18	NMOD
18	population	population	I-NP	NN	I-cell_type	13	PMOD
19	,	,	O	,	O	5	P
20	indicating	indicate	B-VP	VBG	O	5	VMOD
21	that	that	B-SBAR	IN	O	20	VMOD
22	an	an	B-NP	DT	O	24	NMOD
23	additional	additional	I-NP	JJ	O	24	NMOD
24	enhancer	enhancer	I-NP	NN	B-DNA	40	SUB
25	,	,	O	,	O	24	P
26	located	located	B-ADJP	JJ	O	24	NMOD
27	in	in	B-PP	IN	O	26	AMOD
28	either	either	O	CC	O	34	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	first	first	I-NP	JJ	O	34	NMOD
31	or	or	O	CC	O	34	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	third	third	I-NP	JJ	B-DNA	34	NMOD
34	intron	intron	I-NP	NN	I-DNA	27	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	CD4	CD4	I-NP	NN	B-DNA	38	NMOD
38	gene	gene	I-NP	NN	I-DNA	35	PMOD
39	,	,	O	,	O	24	P
40	is	be	B-VP	VBZ	O	21	SBAR
41	required	require	I-VP	VBN	O	40	VC
42	for	for	B-PP	IN	O	41	VMOD
43	CD4	CD4	B-NP	NN	B-DNA	45	NMOD
44	gene	gene	I-NP	NN	I-DNA	45	NMOD
45	expression	expression	I-NP	NN	O	42	PMOD
46	in	in	B-PP	IN	O	45	NMOD
47	this	this	B-NP	DT	O	48	NMOD
48	population	population	I-NP	NN	O	46	PMOD
49	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	5	NMOD
2	other	other	I-NP	JJ	O	5	NMOD
3	studied	study	I-NP	VBN	O	5	NMOD
4	regulatory	regulatory	I-NP	JJ	B-DNA	5	NMOD
5	element	element	I-NP	NN	I-DNA	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	the	the	B-NP	DT	O	10	NMOD
8	minimal	minimal	I-NP	JJ	B-DNA	10	NMOD
9	CD4	CD4	I-NP	NN	I-DNA	10	NMOD
10	silencer	silencer	I-NP	NN	I-DNA	6	PRD
11	which	which	B-NP	WDT	O	10	NMOD
12	inhibits	inhibit	B-VP	VBZ	O	11	SBAR
13	CD4	CD4	B-NP	NN	B-DNA	15	NMOD
14	gene	gene	I-NP	NN	I-DNA	15	NMOD
15	expression	expression	I-NP	NN	O	12	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	peripheral	peripheral	B-NP	JJ	B-cell_type	20	NMOD
18	CD8	CD8	I-NP	NN	I-cell_type	20	NMOD
19	T	T	I-NP	NN	I-cell_type	20	NMOD
20	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD
21	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	2	NMOD
2	silencer	silencer	I-NP	NN	B-DNA	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	inactive	inactive	B-ADJP	JJ	O	3	PRD
5	in	in	B-PP	IN	O	4	AMOD
6	the	the	B-NP	DT	O	10	NMOD
7	most	most	I-NP	RBS	O	10	NMOD
8	immature	immature	I-NP	JJ	B-cell_type	10	NMOD
9	DN	DN	I-NP	JJ	I-cell_type	10	NMOD
10	thymocytes	thymocyte	I-NP	NNS	I-cell_type	5	PMOD
11	,	,	O	,	O	10	P
12	which	which	B-NP	WDT	O	10	NMOD
13	probably	probably	B-ADVP	RB	O	14	VMOD
14	use	use	B-VP	VBP	O	12	SBAR
15	a	a	B-NP	DT	O	18	NMOD
16	distinct	distinct	I-NP	JJ	O	18	NMOD
17	silencer	silencer	I-NP	NN	O	18	NMOD
18	mechanism	mechanism	I-NP	NN	O	14	OBJ
19	to	to	B-VP	TO	O	20	VMOD
20	down-regulate	down-regulate	I-VP	VB	O	14	VMOD
21	CD4	CD4	B-NP	NN	B-DNA	23	NMOD
22	gene	gene	I-NP	NN	I-DNA	23	NMOD
23	expression	expression	I-NP	NN	O	20	OBJ
24	.	.	O	.	O	3	P

1	Unexpectedly	Unexpectedly	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	CD4	CD4	I-NP	NN	B-DNA	5	NMOD
5	silencer	silencer	I-NP	NN	I-DNA	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	also	also	B-ADVP	RB	O	6	VMOD
8	active	active	B-ADJP	JJ	O	6	PRD
9	in	in	B-PP	IN	O	6	VMOD
10	CD4+	CD4+	B-NP	JJ	B-cell_type	12	NMOD
11	CD8int/-	CD8int/-	I-NP	JJ	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	thymus	thymus	I-NP	NN	O	13	PMOD
16	,	,	O	,	O	6	P
17	implying	imply	B-VP	VBG	O	6	VMOD
18	that	that	B-SBAR	IN	O	17	VMOD
19	an	an	B-NP	DT	O	20	NMOD
20	anti-silencer	anti-silencer	I-NP	NN	O	21	SUB
21	may	may	B-VP	MD	O	18	SBAR
22	be	be	I-VP	VB	O	21	VC
23	required	require	I-VP	VBN	O	22	VC
24	to	to	I-VP	TO	O	25	VMOD
25	resume	resume	I-VP	VB	O	23	VMOD
26	CD4	CD4	B-NP	NN	B-protein	27	NMOD
27	expression	expression	I-NP	NN	O	25	OBJ
28	in	in	B-PP	IN	O	25	VMOD
29	this	this	B-NP	DT	O	31	NMOD
30	cell	cell	I-NP	NN	O	31	NMOD
31	population	population	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	6	P

1	Altogether	Altogether	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	CD4	CD4	I-NP	NN	B-DNA	5	NMOD
5	gene	gene	I-NP	NN	I-DNA	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	regulated	regulate	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	several	several	B-NP	JJ	O	14	NMOD
10	positive	positive	I-NP	JJ	O	14	NMOD
11	and	and	I-NP	CC	O	14	NMOD
12	negative	negative	I-NP	JJ	O	14	NMOD
13	regulatory	regulatory	I-NP	JJ	O	14	NMOD
14	mechanisms	mechanism	I-NP	NNS	O	8	PMOD
15	which	which	B-NP	WDT	O	14	NMOD
16	come	come	B-VP	VBP	O	15	SBAR
17	into	into	B-PP	IN	O	16	VMOD
18	play	play	B-NP	NN	O	17	PMOD
19	in	in	B-PP	IN	O	16	VMOD
20	a	a	B-NP	DT	O	23	NMOD
21	developmentally	developmentally	I-NP	RB	O	22	AMOD
22	coordinated	coordinate	I-NP	VBN	O	23	NMOD
23	manner	manner	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	6	P

1	Triggering	Triggering	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	HLA-DR	HLA-DR	B-NP	NN	B-protein	4	NMOD
4	antigens	antigen	I-NP	NNS	I-protein	2	PMOD
5	differentially	differentially	B-ADVP	RB	O	6	VMOD
6	modulates	modulate	B-VP	VBZ	O	0	ROOT
7	tumor	tumor	B-NP	NN	B-protein	11	NMOD
8	necrosis	necrosis	I-NP	NN	I-protein	11	NMOD
9	factor	factor	I-NP	NN	I-protein	11	NMOD
10	alpha	alpha	I-NP	NN	I-protein	11	NMOD
11	release	release	I-NP	NN	O	6	OBJ
12	by	by	B-PP	IN	O	11	NMOD
13	B	B	B-NP	NN	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	at	at	B-PP	IN	O	11	NMOD
16	distinct	distinct	B-NP	JJ	O	17	NMOD
17	stage	stage	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	maturation	maturation	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	6	P

1	Triggering	Triggering	B-NP	NN	O	72	VMOD
2	of	of	B-PP	IN	O	1	NMOD
3	HLA	HLA	B-NP	NN	B-protein	6	NMOD
4	class	class	I-NP	NN	I-protein	6	NMOD
5	II	II	B-NP	CD	I-protein	6	NMOD
6	antigens	antigen	I-NP	NNS	I-protein	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	anti-HLA-DR	anti-HLA-DR	I-NP	JJ	B-protein	11	NMOD
10	monoclonal	monoclonal	I-NP	JJ	I-protein	11	NMOD
11	antibody	antibody	I-NP	NN	I-protein	15	NMOD
12	(	(	O	(	O	13	P
13	mAb	mAb	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	L243	L243	B-NP	NN	O	24	SUB
16	significantly	significantly	B-ADVP	RB	O	24	VMOD
17	(	(	O	(	O	24	P
18	P	P	B-NP	NN	O	24	SUB
19	<	<	O	SYM	O	18	NMOD
20	0.05	0.05	B-NP	CD	O	19	AMOD
21	)	)	O	)	O	24	P
22	and	and	O	CC	O	24	VMOD
23	differentially	differentially	B-VP	RB	O	24	VMOD
24	enhanced	enhance	I-VP	VBD	O	7	SBAR
25	the	the	B-NP	DT	O	26	NMOD
26	release	release	I-NP	NN	O	24	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	tumor	tumor	B-NP	NN	B-protein	31	NMOD
29	necrosis	necrosis	I-NP	NN	I-protein	31	NMOD
30	factor	factor	I-NP	NN	I-protein	31	NMOD
31	alpha	alpha	I-NP	NN	I-protein	27	PMOD
32	(	(	O	(	O	33	P
33	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	31	NMOD
34	)	)	O	)	O	33	P
35	by	by	B-PP	IN	O	24	VMOD
36	the	the	B-NP	DT	O	40	NMOD
37	non-Hodgkin	non-Hodgkin	I-NP	NN	B-cell_type	38	NMOD
38	's	's	B-NP	POS	I-cell_type	40	NMOD
39	lymphoma	lymphoma	I-NP	NN	I-cell_type	40	NMOD
40	cells	cell	I-NP	NNS	I-cell_type	46	NMOD
41	Ri-I	Ri-I	I-NP	NN	B-cell_line	46	NMOD
42	,	,	O	,	O	46	P
43	Ci-I	Ci-I	B-NP	NN	B-cell_line	46	NMOD
44	,	,	O	,	O	46	P
45	and	and	O	CC	O	46	NMOD
46	Sc-I	Sc-I	B-NP	NN	B-cell_line	35	PMOD
47	,	,	O	,	O	46	P
48	which	which	B-NP	WDT	O	46	NMOD
49	are	be	B-VP	VBP	O	48	SBAR
50	at	at	B-PP	IN	O	49	PRD
51	a	a	B-NP	DT	O	53	NMOD
52	distinct	distinct	I-NP	JJ	O	53	NMOD
53	stage	stage	I-NP	NN	O	50	PMOD
54	of	of	B-PP	IN	O	53	NMOD
55	B-cell	B-cell	B-NP	NN	B-cell_type	56	NMOD
56	differentiation	differentiation	I-NP	NN	O	54	PMOD
57	,	,	O	,	O	1	P
58	and	and	O	CC	O	1	NMOD
59	by	by	B-PP	IN	O	58	PMOD
60	the	the	B-NP	DT	O	66	NMOD
61	more	more	I-NP	RBR	O	62	AMOD
62	mature	mature	I-NP	JJ	O	66	NMOD
63	Burkitt	Burkitt	I-NP	NN	B-cell_line	66	NMOD
64	lymphoma	lymphoma	I-NP	NN	I-cell_line	66	NMOD
65	cell	cell	I-NP	NN	I-cell_line	66	NMOD
66	Raji	Raji	I-NP	NN	I-cell_line	59	PMOD
67	;	;	O	:	O	1	P
68	in	in	B-PP	IN	O	1	NMOD
69	contrast	contrast	B-NP	NN	O	68	PMOD
70	,	,	O	,	O	72	P
71	it	it	B-NP	PRP	O	72	SUB
72	did	do	B-VP	VBD	O	0	ROOT
73	not	not	I-VP	RB	O	72	VMOD
74	induce	induce	I-VP	VB	O	72	VC
75	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	76	NMOD
76	release	release	I-NP	NN	O	74	OBJ
77	by	by	B-PP	IN	O	74	VMOD
78	the	the	B-NP	DT	O	81	NMOD
79	pre-B	pre-B	I-NP	JJ	B-cell_type	81	NMOD
80	leukemia	leukemia	I-NP	NN	I-cell_type	81	NMOD
81	cells	cell	I-NP	NNS	I-cell_type	84	NMOD
82	Nalm-6	Nalm-6	I-NP	NN	B-protein	84	NMOD
83	and	and	I-NP	CC	O	84	NMOD
84	BV173	BV173	I-NP	NN	B-cell_line	77	PMOD
85	.	.	O	.	O	72	P

1	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	2	NMOD
2	release	release	I-NP	NN	O	3	SUB
3	peaked	peak	B-VP	VBD	O	13	VMOD
4	at	at	B-PP	IN	O	3	VMOD
5	24	24	B-NP	CD	O	6	NMOD
6	h	h	I-NP	NN	O	4	PMOD
7	and	and	O	CC	O	3	VMOD
8	decreased	decrease	B-VP	VBD	O	3	VMOD
9	thereafter	thereafter	B-ADVP	RB	O	8	VMOD
10	,	,	O	,	O	13	P
11	and	and	O	CC	O	13	VMOD
12	it	it	B-NP	PRP	O	13	SUB
13	was	be	B-VP	VBD	O	0	ROOT
14	dose	dose	B-ADJP	NN	O	13	PRD
15	dependent	dependent	I-ADJP	JJ	O	14	AMOD
16	and	and	O	CC	O	13	VMOD
17	preceded	precede	B-VP	VBN	O	13	VC
18	by	by	B-PP	IN	O	17	VMOD
19	an	an	B-NP	DT	O	20	NMOD
20	increase	increase	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	TNF-alpha	TNF-alpha	B-NP	NN	B-RNA	23	NMOD
23	mRNA	mRNA	I-NP	NN	I-RNA	21	PMOD
24	detectable	detectable	B-ADJP	JJ	O	20	NMOD
25	after	after	B-PP	IN	O	24	AMOD
26	3	3	B-NP	CD	O	27	NMOD
27	h	h	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	stimulation	stimulation	B-NP	NN	O	28	PMOD
30	with	with	B-PP	IN	O	29	NMOD
31	mAb	mAb	B-NP	NN	B-protein	32	NMOD
32	L243	L243	I-NP	NN	I-protein	30	PMOD
33	.	.	O	.	O	13	P

1	Secreted	Secrete	B-NP	VBN	O	2	NMOD
2	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	3	SUB
3	mediated	mediate	B-VP	VBD	O	39	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	enhancement	enhancement	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD
8	factor	factor	I-NP	NN	I-protein	10	NMOD
9	kappa	kappa	I-NP	NN	I-protein	10	NMOD
10	B	B	I-NP	NN	I-protein	17	NMOD
11	(	(	O	(	O	13	P
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	10	NMOD
14	)	)	O	)	O	13	P
15	and	and	O	CC	O	17	NMOD
16	activator	activator	B-NP	NN	B-protein	17	NMOD
17	protein-1	protein-1	I-NP	NN	I-protein	22	NMOD
18	(	(	O	(	O	19	P
19	AP-1	AP-1	B-NP	NN	B-protein	17	NMOD
20	)	)	O	)	O	19	P
21	binding	binding	B-NP	NN	O	22	NMOD
22	activity	activity	I-NP	NN	O	6	PMOD
23	;	;	O	:	O	39	P
24	in	in	B-PP	IN	O	39	VMOD
25	fact	fact	B-NP	NN	O	24	PMOD
26	,	,	O	,	O	39	P
27	the	the	B-NP	DT	O	28	NMOD
28	triggering	triggering	I-NP	NN	O	39	SUB
29	of	of	B-PP	IN	O	28	NMOD
30	HLA-DR	HLA-DR	B-NP	NN	B-protein	31	NMOD
31	antigens	antigen	I-NP	NNS	I-protein	29	PMOD
32	in	in	B-PP	IN	O	28	NMOD
33	the	the	B-NP	DT	O	34	NMOD
34	presence	presence	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	antihuman	antihuman	B-NP	JJ	B-protein	38	NMOD
37	TNF-alpha-neutralizing	TNF-alpha-neutralizing	I-NP	JJ	I-protein	38	NMOD
38	antibodies	antibody	I-NP	NNS	I-protein	35	PMOD
39	did	do	B-VP	VBD	O	0	ROOT
40	not	not	I-VP	RB	O	39	VMOD
41	upregulate	upregulate	I-VP	VB	O	39	VC
42	NF-kappa	NF-kappa	B-NP	NN	B-protein	43	NMOD
43	B	B	I-NP	NN	I-protein	45	NMOD
44	and	and	O	CC	O	45	NMOD
45	AP-1	AP-1	B-NP	NN	B-protein	41	OBJ
46	.	.	O	.	O	39	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	released	release	B-NP	VBN	O	5	NMOD
5	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	6	SUB
6	was	be	B-VP	VBD	O	30	VMOD
7	not	not	O	RB	O	6	VMOD
8	responsible	responsible	B-ADJP	JJ	O	6	PRD
9	for	for	B-PP	IN	O	8	AMOD
10	the	the	B-NP	DT	O	12	NMOD
11	homotypic	homotypic	I-NP	JJ	O	12	NMOD
12	aggregation	aggregation	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	Ri-I	Ri-I	B-NP	NN	B-cell_line	22	NMOD
15	,	,	O	,	O	22	P
16	Ci-I	Ci-I	B-NP	NN	B-cell_line	22	NMOD
17	,	,	O	,	O	22	P
18	Sc-I	Sc-I	B-NP	NN	B-cell_line	22	NMOD
19	,	,	O	,	O	22	P
20	and	and	O	CC	O	22	NMOD
21	Raji	Raji	B-NP	NN	B-cell_line	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
23	induced	induce	B-VP	VBN	O	22	NMOD
24	by	by	B-PP	IN	O	23	VMOD
25	mAb	mAb	B-NP	NN	B-protein	26	NMOD
26	L243	L243	I-NP	NN	I-protein	24	PMOD
27	,	,	O	,	O	30	P
28	and	and	O	CC	O	30	VMOD
29	it	it	B-NP	PRP	O	30	SUB
30	did	do	B-VP	VBD	O	0	ROOT
31	not	not	I-VP	RB	O	30	VMOD
32	affect	affect	I-VP	VB	O	30	VC
33	the	the	B-NP	DT	O	34	NMOD
34	proliferation	proliferation	I-NP	NN	O	32	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	B	B	B-NP	NN	B-cell_type	37	NMOD
37	cells	cell	I-NP	NNS	I-cell_type	35	PMOD
38	investigated	investigate	B-VP	VBN	O	37	NMOD
39	.	.	O	.	O	30	P

1	Altogether	Altogether	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	our	our	B-NP	PRP$	O	4	NMOD
4	data	datum	I-NP	NNS	O	5	SUB
5	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	:	:	O	:	O	6	P
8	(	(	B-LST	(	O	9	P
9	a	a	I-LST	LS	O	24	VMOD
10	)	)	O	)	O	9	P
11	the	the	B-NP	DT	O	12	NMOD
12	ability	ability	I-NP	NN	O	24	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	B	B	B-NP	NN	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	release	release	I-VP	VB	O	12	NMOD
18	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	17	OBJ
19	after	after	B-PP	IN	O	17	VMOD
20	triggering	triggering	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	HLA-DR	HLA-DR	B-NP	NN	B-protein	23	NMOD
23	antigens	antigen	I-NP	NNS	I-protein	21	PMOD
24	depends	depend	B-VP	VBZ	O	38	VMOD
25	on	on	B-PP	IN	O	24	VMOD
26	their	their	B-NP	PRP$	O	27	NMOD
27	stage	stage	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	differentiation	differentiation	B-NP	NN	O	28	PMOD
30	;	;	O	:	O	38	P
31	(	(	B-LST	(	O	32	P
32	b	b	I-LST	LS	O	34	NMOD
33	)	)	O	)	O	32	P
34	levels	level	B-NP	NNS	O	38	SUB
35	of	of	B-PP	IN	O	34	NMOD
36	released	release	B-NP	VBN	O	37	NMOD
37	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	35	PMOD
38	seem	seem	B-VP	VBP	O	65	VMOD
39	to	to	I-VP	TO	O	40	VMOD
40	correlate	correlate	I-VP	VB	O	38	VMOD
41	with	with	B-PP	IN	O	40	VMOD
42	the	the	B-NP	DT	O	43	NMOD
43	stage	stage	I-NP	NN	O	41	PMOD
44	of	of	B-PP	IN	O	43	NMOD
45	B-cell	B-cell	B-NP	NN	O	46	NMOD
46	maturation	maturation	I-NP	NN	O	44	PMOD
47	but	but	O	CC	O	38	VMOD
48	do	do	B-VP	VBP	O	38	VMOD
49	not	not	I-VP	RB	O	48	VMOD
50	correlate	correlate	I-VP	VB	O	48	VC
51	with	with	B-PP	IN	O	50	VMOD
52	the	the	B-NP	DT	O	53	NMOD
53	amounts	amount	I-NP	NNS	O	51	PMOD
54	of	of	B-PP	IN	O	53	NMOD
55	cell	cell	B-NP	NN	B-protein	58	NMOD
56	surface	surface	I-NP	NN	I-protein	58	NMOD
57	HLA-DR	HLA-DR	I-NP	NN	I-protein	58	NMOD
58	antigens	antigen	I-NP	NNS	I-protein	54	PMOD
59	;	;	O	:	O	65	P
60	(	(	B-LST	(	O	61	P
61	c	c	I-LST	LS	O	65	VMOD
62	)	)	O	)	O	61	P
63	secreted	secrete	B-NP	VBN	O	64	NMOD
64	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	65	SUB
65	regulates	regulate	B-VP	VBZ	O	92	VMOD
66	the	the	B-NP	DT	O	67	NMOD
67	levels	level	I-NP	NNS	O	65	OBJ
68	of	of	B-PP	IN	O	67	NMOD
69	expression	expression	B-NP	NN	O	68	PMOD
70	of	of	B-PP	IN	O	69	NMOD
71	NF-kappa	NF-kappa	B-NP	NN	B-protein	72	NMOD
72	B	B	I-NP	NN	I-protein	74	NMOD
73	and	and	O	CC	O	74	NMOD
74	AP-1	AP-1	B-NP	NN	B-protein	70	PMOD
75	by	by	B-PP	IN	O	65	VMOD
76	an	an	B-NP	DT	O	78	NMOD
77	autocrine	autocrine	I-NP	JJ	O	78	NMOD
78	loop	loop	I-NP	NN	O	75	PMOD
79	;	;	O	:	O	92	P
80	and	and	O	CC	O	85	NMOD
81	(	(	B-LST	(	O	82	P
82	d	d	I-LST	LS	O	85	NMOD
83	)	)	O	)	O	82	P
84	intracellular	intracellular	B-NP	JJ	O	85	NMOD
85	signals	signal	I-NP	NNS	O	92	SUB
86	mediating	mediate	B-VP	VBG	O	85	NMOD
87	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	88	NMOD
88	release	release	I-NP	NN	O	86	OBJ
89	by	by	B-PP	IN	O	88	NMOD
90	B	B	B-NP	NN	B-cell_type	91	NMOD
91	cells	cell	I-NP	NNS	I-cell_type	89	PMOD
92	are	be	B-VP	VBP	O	6	SBAR
93	distinct	distinct	B-ADJP	JJ	O	92	PRD
94	from	from	B-PP	IN	O	93	AMOD
95	those	those	B-NP	DT	O	100	NMOD
96	regulating	regulate	I-NP	VBG	O	100	NMOD
97	homotypic	homotypic	I-NP	JJ	O	100	NMOD
98	aggregation	aggregation	I-NP	NN	O	100	NMOD
99	and	and	I-NP	CC	O	100	NMOD
100	proliferation	proliferation	I-NP	NN	O	94	PMOD
101	.	.	O	.	O	5	P

1	Cytomegalovirus	Cytomegalovirus	B-NP	NN	B-DNA	4	NMOD
2	immediate	immediate	I-NP	JJ	I-DNA	4	NMOD
3	early	early	I-NP	JJ	I-DNA	4	NMOD
4	genes	gene	I-NP	NNS	I-DNA	5	SUB
5	upregulate	upregulate	B-VP	VBP	O	0	ROOT
6	interleukin-6	interleukin-6	B-NP	NN	B-protein	8	NMOD
7	gene	gene	I-NP	NN	O	8	NMOD
8	expression	expression	I-NP	NN	O	5	OBJ
9	.	.	O	.	O	5	P

1	BACKGROUND	BACKGROUND	B-NP	NN	O	6	NMOD
2	:	:	O	:	O	1	P
3	The	The	B-NP	DT	O	6	NMOD
4	immediate	immediate	I-NP	JJ	B-DNA	6	NMOD
5	early	early	I-NP	JJ	I-DNA	6	NMOD
6	genes	gene	I-NP	NNS	I-DNA	16	SUB
7	(	(	O	(	O	8	P
8	IE	IE	B-NP	NN	B-DNA	6	NMOD
9	)	)	O	)	O	8	P
10	of	of	B-PP	IN	O	6	NMOD
11	human	human	B-NP	JJ	O	12	NMOD
12	cytomegalovirus	cytomegalovirus	I-NP	NN	O	10	PMOD
13	(	(	O	(	O	14	P
14	CMV	CMV	B-NP	NN	O	12	NMOD
15	)	)	O	)	O	14	P
16	can	can	B-VP	MD	O	0	ROOT
17	be	be	I-VP	VB	O	16	VC
18	expressed	express	I-VP	VBN	O	17	VC
19	in	in	B-PP	IN	O	18	VMOD
20	monocytic	monocytic	B-NP	JJ	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
22	and	and	O	CC	O	16	VMOD
23	are	be	B-VP	VBP	O	16	VMOD
24	known	know	I-VP	VBN	O	23	VC
25	to	to	I-VP	TO	O	26	VMOD
26	regulate	regulate	I-VP	VB	O	24	VMOD
27	viral	viral	B-NP	JJ	B-DNA	30	NMOD
28	and	and	I-NP	CC	I-DNA	30	NMOD
29	cellular	cellular	I-NP	JJ	I-DNA	30	NMOD
30	genes	gene	I-NP	NNS	I-DNA	26	OBJ
31	.	.	O	.	O	16	P

1	Interleukin-6	Interleukin-6	B-NP	NN	B-protein	5	SUB
2	(	(	O	(	O	3	P
3	IL-6	IL-6	B-NP	NN	B-protein	1	NMOD
4	)	)	O	)	O	3	P
5	plays	play	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	central	central	I-NP	JJ	O	8	NMOD
8	role	role	I-NP	NN	O	5	OBJ
9	in	in	B-PP	IN	O	5	VMOD
10	numerous	numerous	B-NP	JJ	O	14	NMOD
11	inflammatory	inflammatory	I-NP	JJ	O	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	immune	immune	I-NP	JJ	O	14	NMOD
14	processes	process	I-NP	NNS	O	9	PMOD
15	.	.	O	.	O	5	P

1	Interleukin-6	Interleukin-6	B-NP	NN	B-protein	2	NMOD
2	levels	level	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	increased	increase	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	lung	lung	B-NP	NN	O	8	NMOD
7	transplant	transplant	I-NP	NN	O	8	NMOD
8	patients	patient	I-NP	NNS	O	5	PMOD
9	clinically	clinically	B-VP	RB	O	10	VMOD
10	diagnosed	diagnose	I-VP	VBN	O	8	NMOD
11	with	with	B-PP	IN	O	10	VMOD
12	CMV	CMV	B-NP	NN	O	13	NMOD
13	pneumonitis	pneumonitis	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	IL-6	IL-6	B-NP	NN	B-protein	3	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	dependent	dependent	B-ADJP	JJ	O	5	PRD
7	on	on	B-PP	IN	O	6	AMOD
8	various	various	B-NP	JJ	O	9	NMOD
9	stimuli	stimulus	I-NP	NNS	O	7	PMOD
10	that	that	B-NP	WDT	O	9	NMOD
11	include	include	B-VP	VBP	O	10	SBAR
12	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	21	NMOD
13	(	(	O	(	O	14	P
14	LPS	LPS	B-NP	NN	O	12	NMOD
15	)	)	O	)	O	14	P
16	,	,	O	,	O	21	P
17	viruses	virus	B-NP	NNS	O	21	NMOD
18	,	,	O	,	O	21	P
19	and	and	O	CC	O	21	NMOD
20	other	other	B-NP	JJ	O	21	NMOD
21	cytokines	cytokine	I-NP	NNS	B-protein	11	OBJ
22	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	examined	examine	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	ability	ability	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	CMV	CMV	B-NP	NN	B-protein	10	NMOD
8	IE	IE	I-NP	NN	I-protein	10	NMOD
9	gene	gene	I-NP	NN	I-protein	10	NMOD
10	products	product	I-NP	NNS	I-protein	6	PMOD
11	to	to	B-VP	TO	O	12	VMOD
12	modulate	modulate	I-VP	VB	O	5	NMOD
13	IL-6	IL-6	B-NP	NN	B-protein	14	NMOD
14	production	production	I-NP	NN	O	12	OBJ
15	.	.	O	.	O	3	P

1	METHODS	METHODS	B-NP	NNS	O	4	NMOD
2	:	:	O	:	O	1	P
3	THP-1	THP-1	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	9	NMOD
5	,	,	O	,	O	9	P
6	a	a	B-NP	DT	O	9	NMOD
7	monocytic	monocytic	I-NP	JJ	B-cell_line	9	NMOD
8	cell	cell	I-NP	NN	I-cell_line	9	NMOD
9	line	line	I-NP	NN	I-cell_line	11	SUB
10	,	,	O	,	O	9	P
11	were	be	B-VP	VBD	O	0	ROOT
12	transfected	transfecte	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	17	NMOD
15	CMV	CMV	I-NP	NN	B-DNA	17	NMOD
16	IE	IE	I-NP	NN	I-DNA	17	NMOD
17	genes	gene	I-NP	NNS	I-DNA	13	PMOD
18	.	.	O	.	O	11	P

1	Interleukin-6	Interleukin-6	B-NP	NN	B-protein	2	NMOD
2	protein	protein	I-NP	NN	I-protein	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	IL-6	IL-6	B-NP	NN	B-RNA	5	NMOD
5	mRNA	mRNA	I-NP	NN	I-RNA	6	SUB
6	were	be	B-VP	VBD	O	0	ROOT
7	measured	measure	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	control	control	B-NP	NN	O	15	NMOD
10	and	and	O	CC	O	15	NMOD
11	CMV	CMV	B-NP	NN	B-cell_type	15	NMOD
12	immediate	immediate	I-NP	JJ	I-cell_type	15	NMOD
13	early	early	I-NP	JJ	I-cell_type	15	NMOD
14	transfected	transfecte	I-NP	VBN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
16	.	.	O	.	O	6	P

1	Cotransfection	Cotransfection	B-NP	NN	O	10	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	CMV	CMV	B-NP	NN	B-DNA	5	NMOD
4	IE	IE	I-NP	NN	I-DNA	5	NMOD
5	genes	gene	I-NP	NNS	I-DNA	2	PMOD
6	and	and	O	CC	O	10	NMOD
7	IL-6	IL-6	B-NP	NN	B-protein	10	NMOD
8	chloramphenicol	chloramphenicol	I-NP	NN	O	10	NMOD
9	acetyl	acetyl	I-NP	NN	O	10	NMOD
10	transferase	transferase	I-NP	NN	O	15	NMOD
11	(	(	O	(	O	12	P
12	CAT	CAT	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	or	or	O	CC	O	15	NMOD
15	IL-6	IL-6	B-NP	NN	B-protein	17	NMOD
16	luciferase	luciferase	I-NP	NN	O	17	NMOD
17	constructs	construct	I-NP	NNS	O	18	SUB
18	were	be	B-VP	VBD	O	0	ROOT
19	used	use	I-VP	VBN	O	18	VC
20	to	to	B-VP	TO	O	21	VMOD
21	study	study	I-VP	VB	O	19	VMOD
22	IL-6	IL-6	B-NP	NN	B-DNA	24	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	24	NMOD
24	activity	activity	I-NP	NN	O	21	OBJ
25	.	.	O	.	O	18	P

1	RESULTS	RESULTS	B-NP	NNS	O	7	NMOD
2	:	:	O	:	O	7	P
3	Interleukin-6	Interleukin-6	B-NP	NN	B-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	mRNA	mRNA	B-NP	NN	B-RNA	7	NMOD
7	production	production	I-NP	NN	O	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	significantly	significantly	I-VP	RB	O	8	VMOD
10	increased	increase	I-VP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	cells	cell	B-NP	NNS	O	11	PMOD
13	transfected	transfecte	B-VP	VBN	O	12	NMOD
14	with	with	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	CMV	CMV	I-NP	NN	B-DNA	18	NMOD
17	IE	IE	I-NP	NN	I-DNA	18	NMOD
18	genes	gene	I-NP	NNS	I-DNA	14	PMOD
19	and	and	O	CC	O	13	VMOD
20	stimulated	stimulate	B-VP	VBN	O	13	VMOD
21	with	with	B-PP	IN	O	20	VMOD
22	LPS	LPS	B-NP	NN	O	21	PMOD
23	compared	compare	B-VP	VBN	O	20	VMOD
24	to	to	B-PP	TO	O	23	PMOD
25	LPS-stimulated	LPS-stimulated	B-NP	JJ	B-cell_line	27	NMOD
26	control	control	I-NP	NN	I-cell_line	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_line	24	PMOD
28	.	.	O	.	O	8	P

1	Cytomegalovirus	Cytomegalovirus	B-NP	NN	B-protein	4	NMOD
2	IE	IE	I-NP	NN	I-protein	4	NMOD
3	gene	gene	I-NP	NN	I-protein	4	NMOD
4	products	product	I-NP	NNS	I-protein	6	SUB
5	significantly	significantly	B-ADVP	RB	O	6	VMOD
6	enhanced	enhance	B-VP	VBD	O	0	ROOT
7	LPS	LPS	B-NP	NN	O	8	NMOD
8	stimulation	stimulation	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	IL-6	IL-6	B-NP	NN	B-DNA	12	NMOD
11	promoter	promoter	I-NP	NN	I-DNA	12	NMOD
12	activity	activity	I-NP	NN	O	9	PMOD
13	in	in	B-PP	IN	O	8	NMOD
14	both	both	O	CC	O	15	NMOD
15	IL-6	IL-6	B-NP	NN	B-protein	16	NMOD
16	CAT	CAT	I-NP	NN	O	20	NMOD
17	and	and	O	CC	O	20	NMOD
18	IL-6	IL-6	B-NP	NN	B-protein	20	NMOD
19	luciferase	luciferase	I-NP	NN	O	20	NMOD
20	assays	assay	I-NP	NNS	O	13	PMOD
21	.	.	O	.	O	6	P

1	A	A	B-NP	DT	O	3	NMOD
2	deletion	deletion	I-NP	NN	B-DNA	3	NMOD
3	construct	construct	I-NP	NN	I-DNA	17	SUB
4	that	that	B-NP	WDT	O	3	NMOD
5	contains	contain	B-VP	VBZ	O	4	SBAR
6	a	a	B-NP	DT	O	9	NMOD
7	NF-kappa	NF-kappa	I-NP	NN	B-DNA	9	NMOD
8	B	B	I-NP	NN	I-DNA	9	NMOD
9	site	site	I-NP	NN	I-DNA	5	OBJ
10	but	but	O	CC	O	5	VMOD
11	is	be	B-VP	VBZ	O	5	VMOD
12	missing	miss	I-VP	VBG	O	11	VC
13	the	the	B-NP	DT	O	16	NMOD
14	multiple	multiple	I-NP	JJ	O	16	NMOD
15	response	response	I-NP	NN	O	16	NMOD
16	region	region	I-NP	NN	O	12	OBJ
17	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
18	a	a	B-NP	DT	O	20	NMOD
19	continued	continued	I-NP	JJ	O	20	NMOD
20	increase	increase	I-NP	NN	O	17	OBJ
21	in	in	B-PP	IN	O	20	NMOD
22	IL-6	IL-6	B-NP	NN	B-protein	24	NMOD
23	luciferase	luciferase	I-NP	NN	B-protein	24	NMOD
24	activity	activity	I-NP	NN	O	21	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	LPS-stimulated	LPS-stimulated	B-NP	JJ	B-cell_line	29	NMOD
27	CMV	CMV	I-NP	NN	I-cell_line	29	NMOD
28	transfected	transfected	I-NP	JJ	I-cell_line	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_line	25	PMOD
30	.	.	O	.	O	17	P

1	CONCLUSION	CONCLUSION	B-NP	NN	O	7	NMOD
2	:	:	O	:	O	1	P
3	Cytomegalovirus	Cytomegalovirus	B-NP	NN	B-protein	7	NMOD
4	immediate	immediate	I-NP	JJ	I-protein	7	NMOD
5	early	early	I-NP	JJ	I-protein	7	NMOD
6	gene	gene	I-NP	NN	I-protein	7	NMOD
7	products	product	I-NP	NNS	I-protein	9	SUB
8	significantly	significantly	B-ADVP	RB	O	9	VMOD
9	enhanced	enhance	B-VP	VBD	O	0	ROOT
10	expression	expression	B-NP	NN	O	9	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	IL-6	IL-6	B-NP	NN	B-protein	11	PMOD
13	in	in	B-PP	IN	O	10	NMOD
14	LPS-stimulated	LPS-stimulated	B-NP	JJ	B-cell_line	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
16	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	2	NMOD
2	increase	increase	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	IL-6	IL-6	B-NP	NN	B-protein	6	NMOD
5	luciferase	luciferase	I-NP	NN	B-protein	6	NMOD
6	activity	activity	I-NP	NN	O	3	PMOD
7	occurs	occur	B-VP	VBZ	O	0	ROOT
8	in	in	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	multiple	multiple	I-NP	JJ	B-DNA	15	NMOD
14	response	response	I-NP	NN	I-DNA	15	NMOD
15	region	region	I-NP	NN	I-DNA	11	PMOD
16	,	,	O	,	O	7	P
17	the	the	B-NP	DT	O	18	NMOD
18	area	area	I-NP	NN	O	7	VMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	IL-6	IL-6	I-NP	NN	B-DNA	22	NMOD
22	promoter	promoter	I-NP	NN	I-DNA	19	PMOD
23	responsive	responsive	B-ADJP	JJ	O	22	NMOD
24	to	to	B-PP	TO	O	23	AMOD
25	IL-1	IL-1	B-NP	NN	B-protein	36	NMOD
26	,	,	O	,	O	36	P
27	TNF	TNF	B-NP	NN	B-protein	28	NMOD
28	alpha	alpha	I-NP	NN	I-protein	36	NMOD
29	,	,	O	,	O	36	P
30	cyclic	cyclic	B-NP	JJ	O	31	NMOD
31	amp	amp	I-NP	NN	O	36	NMOD
32	,	,	O	,	O	36	P
33	and	and	O	CC	O	36	NMOD
34	phorbol	phorbol	B-NP	NN	O	36	NMOD
35	12-myristate	12-myristate	I-NP	NN	O	36	NMOD
36	13-acetate	13-acetate	I-NP	NN	O	24	PMOD
37	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	ability	ability	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	CMV	CMV	B-NP	NN	B-protein	7	NMOD
5	IE	IE	I-NP	NN	I-protein	7	NMOD
6	gene	gene	I-NP	NN	I-protein	7	NMOD
7	products	product	I-NP	NNS	I-protein	3	PMOD
8	to	to	B-VP	TO	O	9	VMOD
9	enhance	enhance	I-VP	VB	O	2	NMOD
10	IL-6	IL-6	B-NP	NN	B-protein	11	NMOD
11	production	production	I-NP	NN	O	9	OBJ
12	may	may	B-VP	MD	O	0	ROOT
13	play	play	I-VP	VB	O	12	VC
14	an	an	B-NP	DT	O	16	NMOD
15	important	important	I-NP	JJ	O	16	NMOD
16	role	role	I-NP	NN	O	13	OBJ
17	in	in	B-PP	IN	O	13	VMOD
18	immune	immune	B-NP	JJ	O	20	NMOD
19	inflammatory	inflammatory	I-NP	JJ	O	20	NMOD
20	states	state	I-NP	NNS	O	17	PMOD
21	associated	associate	B-VP	VBN	O	20	NMOD
22	with	with	B-PP	IN	O	21	VMOD
23	CMV	CMV	B-NP	NN	O	24	NMOD
24	infection	infection	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	12	P

1	Homodimerization	Homodimerization	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	9	NMOD
4	human	human	I-NP	JJ	B-protein	9	NMOD
5	interleukin	interleukin	I-NP	NN	I-protein	9	NMOD
6	4	4	I-NP	CD	I-protein	9	NMOD
7	receptor	receptor	I-NP	NN	I-protein	9	NMOD
8	alpha	alpha	I-NP	NN	I-protein	9	NMOD
9	chain	chain	I-NP	NN	I-protein	2	PMOD
10	induces	induce	B-VP	VBZ	O	0	ROOT
11	Cepsilon	Cepsilon	B-NP	NN	B-RNA	13	NMOD
12	germline	germline	I-NP	NN	I-RNA	13	NMOD
13	transcripts	transcript	I-NP	NNS	I-RNA	10	OBJ
14	in	in	B-PP	IN	O	10	VMOD
15	B	B	B-NP	NN	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	absence	absence	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	26	NMOD
22	interleukin	interleukin	I-NP	NN	B-protein	26	NMOD
23	2	2	I-NP	CD	I-protein	26	NMOD
24	receptor	receptor	I-NP	NN	I-protein	26	NMOD
25	gamma	gamma	I-NP	NN	I-protein	26	NMOD
26	chain	chain	I-NP	NN	I-protein	20	PMOD
27	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	cytokines	cytokine	I-NP	NNS	B-protein	9	NMOD
3	interleukin	interleukin	I-NP	NN	B-protein	5	NMOD
4	(	(	O	(	I-protein	5	P
5	IL	IL	B-NP	NN	I-protein	2	NMOD
6	)	)	O	)	I-protein	5	P
7	-4	-4	B-NP	CD	I-protein	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	IL-13	IL-13	B-NP	NN	B-protein	10	SUB
10	play	play	B-VP	VBP	O	0	ROOT
11	a	a	B-NP	DT	O	13	NMOD
12	critical	critical	I-NP	JJ	O	13	NMOD
13	role	role	I-NP	NN	O	10	OBJ
14	in	in	B-PP	IN	O	10	VMOD
15	inducing	induce	B-VP	VBG	O	14	PMOD
16	Cepsilon	Cepsilon	B-NP	NN	B-RNA	18	NMOD
17	germline	germline	I-NP	NN	I-RNA	18	NMOD
18	transcripts	transcript	I-NP	NNS	I-RNA	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	IgE	IgE	B-NP	NN	B-protein	22	NMOD
21	isotype	isotype	I-NP	NN	I-protein	22	NMOD
22	switching	switching	I-NP	NN	O	15	OBJ
23	in	in	B-PP	IN	O	22	NMOD
24	human	human	B-NP	JJ	B-cell_type	26	NMOD
25	B	B	I-NP	NN	I-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
27	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	IL-4	IL-4	I-NP	NN	B-protein	3	NMOD
3	receptor	receptor	I-NP	NN	I-protein	10	SUB
4	(	(	O	(	O	5	P
5	IL-4R	IL-4R	B-NP	NN	B-protein	3	NMOD
6	)	)	O	)	O	5	P
7	in	in	B-PP	IN	O	3	NMOD
8	B	B	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	composed	compose	I-VP	VBN	O	10	VC
12	of	of	B-PP	IN	O	11	VMOD
13	two	two	B-NP	CD	O	14	NMOD
14	chains	chain	I-NP	NNS	O	12	PMOD
15	,	,	O	,	O	10	P
16	the	the	B-NP	DT	O	19	NMOD
17	IL-4-binding	IL-4-binding	I-NP	JJ	B-protein	19	NMOD
18	IL-4Ralpha	IL-4Ralpha	I-NP	NN	I-protein	19	NMOD
19	chain	chain	I-NP	NN	I-protein	34	NMOD
20	,	,	O	,	O	19	P
21	which	which	B-NP	WDT	O	19	NMOD
22	is	be	B-VP	VBZ	O	21	SBAR
23	shared	share	I-VP	VBN	O	22	VC
24	with	with	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	IL-13R	IL-13R	I-NP	NN	B-protein	24	PMOD
27	,	,	O	,	O	34	P
28	and	and	O	CC	O	34	NMOD
29	the	the	B-NP	DT	O	34	NMOD
30	IL-2Rgamma	IL-2Rgamma	I-NP	NN	B-protein	34	NMOD
31	(	(	O	(	I-protein	34	P
32	gammac	gammac	B-NP	NN	I-protein	34	NMOD
33	)	)	O	)	I-protein	34	P
34	chain	chain	B-NP	NN	I-protein	10	PRD
35	,	,	O	,	O	34	P
36	which	which	B-NP	WDT	O	34	NMOD
37	is	be	B-VP	VBZ	O	36	SBAR
38	shared	share	I-VP	VBN	O	37	VC
39	with	with	B-PP	IN	O	38	VMOD
40	IL-7R	IL-7R	B-NP	NN	B-protein	45	NMOD
41	,	,	O	,	O	45	P
42	IL-9R	IL-9R	B-NP	NN	B-protein	45	NMOD
43	,	,	O	,	O	45	P
44	and	and	O	CC	O	45	NMOD
45	IL-15R	IL-15R	B-NP	NN	B-protein	39	PMOD
46	.	.	O	.	O	10	P

1	IL-4	IL-4	B-NP	NN	B-protein	2	SUB
2	induces	induce	B-VP	VBZ	O	0	ROOT
3	Cepsilon	Cepsilon	B-NP	NN	B-RNA	5	NMOD
4	germline	germline	I-NP	NN	I-RNA	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-RNA	9	NMOD
6	and	and	O	CC	O	9	NMOD
7	IgE	IgE	B-NP	NN	B-protein	9	NMOD
8	isotype	isotype	I-NP	NN	I-protein	9	NMOD
9	switching	switching	I-NP	NN	O	2	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	B	B	B-NP	NN	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	patients	patient	B-NP	NNS	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	gammac	gammac	B-NP	NN	B-protein	18	NMOD
17	chain	chain	I-NP	NN	I-protein	18	NMOD
18	deficiency	deficiency	I-NP	NN	O	15	PMOD
19	.	.	O	.	O	2	P

1	Induction	Induction	B-NP	NN	O	16	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Cepsilon	Cepsilon	B-NP	NN	B-RNA	5	NMOD
4	germline	germline	I-NP	NN	I-RNA	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-RNA	2	PMOD
6	by	by	B-PP	IN	O	1	NMOD
7	IL-4	IL-4	B-NP	NN	B-protein	6	PMOD
8	in	in	B-PP	IN	O	1	NMOD
9	B	B	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	that	that	B-NP	WDT	O	1	NMOD
12	lack	lack	B-VP	VBP	O	11	SBAR
13	the	the	B-NP	DT	O	15	NMOD
14	gammac	gammac	I-NP	NN	B-protein	15	NMOD
15	chain	chain	I-NP	NN	I-protein	12	OBJ
16	may	may	B-VP	MD	O	0	ROOT
17	involve	involve	I-VP	VB	O	16	VC
18	signaling	signaling	B-NP	NN	O	17	OBJ
19	via	via	B-PP	IN	O	17	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	IL-13R	IL-13R	I-NP	NN	B-protein	19	PMOD
22	.	.	O	.	O	16	P

1	Alternatively	Alternatively	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	IL-4Ralpha	IL-4Ralpha	I-NP	NN	B-protein	5	NMOD
5	chain	chain	I-NP	NN	I-protein	6	SUB
6	may	may	B-VP	MD	O	0	ROOT
7	transduce	transduce	I-VP	VB	O	6	VC
8	intracellular	intracellular	B-NP	JJ	O	9	NMOD
9	signals	signal	I-NP	NNS	O	7	OBJ
10	that	that	B-NP	WDT	O	9	NMOD
11	lead	lead	B-VP	VBP	O	10	SBAR
12	to	to	B-PP	TO	O	11	VMOD
13	Cepsilon	Cepsilon	B-NP	NN	B-DNA	15	NMOD
14	gene	gene	I-NP	NN	I-DNA	15	NMOD
15	transcription	transcription	I-NP	NN	O	12	PMOD
16	independently	independently	B-ADVP	RB	O	17	PMOD
17	of	of	B-PP	IN	O	15	NMOD
18	its	its	B-NP	PRP$	O	19	NMOD
19	association	association	I-NP	NN	O	17	PMOD
20	with	with	B-PP	IN	O	19	NMOD
21	other	other	B-NP	JJ	O	22	NMOD
22	chains	chain	I-NP	NNS	O	20	PMOD
23	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	ligand-induced	ligand-induced	B-NP	JJ	O	5	NMOD
5	homodimerization	homodimerization	I-NP	NN	O	28	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	chimeric	chimeric	B-NP	JJ	B-protein	9	NMOD
8	surface	surface	I-NP	NN	I-protein	9	NMOD
9	receptors	receptor	I-NP	NNS	I-protein	6	PMOD
10	consisting	consist	B-VP	VBG	O	9	NMOD
11	of	of	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	16	NMOD
13	extracellular	extracellular	I-NP	JJ	B-protein	15	AMOD
14	and	and	I-NP	CC	I-protein	15	AMOD
15	transmembrane	transmembrane	I-NP	JJ	I-protein	16	NMOD
16	domains	domain	I-NP	NNS	I-protein	11	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	erythropoietin	erythropoietin	I-NP	NN	B-protein	20	NMOD
20	receptor	receptor	I-NP	NN	I-protein	17	PMOD
21	and	and	B-PP	CC	O	17	PMOD
22	of	of	B-PP	IN	O	17	PMOD
23	the	the	B-NP	DT	O	25	NMOD
24	intracellular	intracellular	I-NP	JJ	B-protein	25	NMOD
25	domain	domain	I-NP	NN	I-protein	22	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	IL-4Ralpha	IL-4Ralpha	B-NP	NN	B-protein	26	PMOD
28	induces	induce	B-VP	VBZ	O	3	SBAR
29	Janus	Janus	B-NP	NN	B-protein	30	NMOD
30	kinase	kinase	I-NP	NN	I-protein	35	NMOD
31	1	1	I-NP	CD	I-protein	30	NMOD
32	(	(	O	(	O	33	P
33	Jak1	Jak1	B-NP	NN	B-protein	30	NMOD
34	)	)	O	)	O	33	P
35	activation	activation	B-NP	NN	O	43	NMOD
36	,	,	O	,	O	43	P
37	STAT6	STAT6	B-NP	NN	B-protein	38	NMOD
38	activation	activation	I-NP	NN	O	43	NMOD
39	,	,	O	,	O	43	P
40	and	and	O	CC	O	43	NMOD
41	Cepsilon	Cepsilon	B-NP	NN	B-RNA	43	NMOD
42	germline	germline	I-NP	NN	I-RNA	43	NMOD
43	transcripts	transcript	I-NP	NNS	I-RNA	28	OBJ
44	in	in	B-PP	IN	O	28	VMOD
45	human	human	B-NP	JJ	B-cell_line	49	NMOD
46	B	B	I-NP	NN	I-cell_line	49	NMOD
47	cell	cell	I-NP	NN	I-cell_line	49	NMOD
48	line	line	I-NP	NN	I-cell_line	49	NMOD
49	BJAB	BJAB	I-NP	NN	I-cell_line	44	PMOD
50	.	.	O	.	O	2	P

1	Disruption	Disruption	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	Jak1-binding	Jak1-binding	I-NP	JJ	B-protein	7	NMOD
5	proline-rich	proline-rich	I-NP	JJ	I-protein	7	NMOD
6	Box1	Box1	I-NP	NN	I-protein	7	NMOD
7	region	region	I-NP	NN	I-protein	2	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	IL-4Ralpha	IL-4Ralpha	B-NP	NN	B-protein	8	PMOD
10	abolished	abolish	B-VP	VBD	O	0	ROOT
11	signaling	signaling	B-NP	NN	O	10	OBJ
12	by	by	B-PP	IN	O	10	VMOD
13	this	this	B-NP	DT	O	15	NMOD
14	chimeric	chimeric	I-NP	JJ	B-protein	15	NMOD
15	receptor	receptor	I-NP	NN	I-protein	12	PMOD
16	.	.	O	.	O	10	P

1	Furthermore	Furthermore	B-ADVP	RB	O	24	VMOD
2	,	,	O	,	O	24	P
3	B	B	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	24	SUB
5	transfected	transfecte	B-VP	VBN	O	4	NMOD
6	with	with	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	10	NMOD
8	chimeric	chimeric	I-NP	JJ	B-protein	10	NMOD
9	CD8alpha/IL-4Ralpha	CD8alpha/IL-4Ralpha	I-NP	NN	I-protein	10	NMOD
10	receptor	receptor	I-NP	NN	I-protein	6	PMOD
11	,	,	O	,	O	4	P
12	which	which	B-NP	WDT	O	4	NMOD
13	is	be	B-VP	VBZ	O	12	SBAR
14	expressed	express	I-VP	VBN	O	13	VC
15	on	on	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	cell	cell	I-NP	NN	O	18	NMOD
18	surface	surface	I-NP	NN	O	15	PMOD
19	as	as	B-PP	IN	O	14	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	homodimer	homodimer	I-NP	NN	B-protein	19	PMOD
22	,	,	O	,	O	4	P
23	constitutively	constitutively	B-ADVP	RB	O	24	VMOD
24	expressed	express	B-VP	VBD	O	0	ROOT
25	Cepsilon	Cepsilon	B-NP	NN	B-RNA	27	NMOD
26	germline	germline	I-NP	NN	I-RNA	27	NMOD
27	transcripts	transcript	I-NP	NNS	I-RNA	24	OBJ
28	.	.	O	.	O	24	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	homodimerization	homodimerization	B-NP	NN	O	10	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	IL-4Ralpha	IL-4Ralpha	I-NP	NN	B-protein	9	NMOD
9	chain	chain	I-NP	NN	I-protein	6	PMOD
10	is	be	B-VP	VBZ	O	4	SBAR
11	sufficient	sufficient	B-ADJP	JJ	O	10	PRD
12	to	to	B-VP	TO	O	13	VMOD
13	transduce	transduce	I-VP	VB	O	11	AMOD
14	Jak1-dependent	Jak1-dependent	B-NP	JJ	O	16	NMOD
15	intracellular	intracellular	I-NP	JJ	O	16	NMOD
16	signals	signal	I-NP	NNS	O	13	OBJ
17	that	that	B-NP	WDT	O	16	NMOD
18	lead	lead	B-VP	VBP	O	17	SBAR
19	to	to	B-PP	TO	O	18	VMOD
20	IgE	IgE	B-NP	NN	B-protein	22	NMOD
21	isotype	isotype	I-NP	NN	I-protein	22	NMOD
22	switching	switching	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	3	P

1	Characterization	Characterization	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	peripheral	peripheral	B-NP	JJ	B-cell_type	5	NMOD
4	blood	blood	I-NP	NN	I-cell_type	5	NMOD
5	T-lymphocytes	T-lymphocyte	I-NP	NNS	I-cell_type	2	PMOD
6	transduced	transduce	B-VP	VBN	O	5	NMOD
7	with	with	B-PP	IN	O	6	VMOD
8	HTLV-I	HTLV-I	B-NP	NN	B-protein	10	NMOD
9	Tax	Tax	I-NP	NN	I-protein	10	NMOD
10	mutants	mutant	I-NP	NNS	I-protein	7	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	different	different	B-NP	JJ	O	14	NMOD
13	trans-activating	trans-activating	I-NP	JJ	O	14	NMOD
14	phenotypes	phenotype	I-NP	NNS	O	11	PMOD
15	.	.	O	.	O	1	P

1	Tax1	Tax1	B-NP	NN	B-protein	5	NMOD
2	,	,	O	,	O	5	P
3	a	a	B-NP	DT	O	5	NMOD
4	transcriptional	transcriptional	I-NP	JJ	B-protein	5	NMOD
5	trans-activator	trans-activator	I-NP	NN	I-protein	18	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	12	NMOD
8	Human	Human	I-NP	JJ	O	12	NMOD
9	T-cell	T-cell	I-NP	NN	O	12	NMOD
10	leukemia	leukemia	I-NP	NN	O	12	NMOD
11	virus	virus	I-NP	NN	O	12	NMOD
12	type	type	I-NP	NN	O	6	PMOD
13	I	I	I-NP	CD	O	12	NMOD
14	(	(	O	(	O	15	P
15	HTLV-I	HTLV-I	B-NP	NN	O	12	NMOD
16	)	)	O	)	O	15	P
17	,	,	O	,	O	5	P
18	induces	induce	B-VP	VBZ	O	0	ROOT
19	the	the	B-NP	DT	O	20	NMOD
20	expression	expression	I-NP	NN	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	many	many	B-NP	JJ	O	21	PMOD
23	cellular	cellular	I-NP	JJ	B-DNA	24	NMOD
24	genes	gene	I-NP	NNS	I-DNA	22	NMOD
25	through	through	B-PP	IN	O	18	VMOD
26	interaction	interaction	B-NP	NN	O	25	PMOD
27	with	with	B-PP	IN	O	26	NMOD
28	at	at	B-NP	IN	O	34	NMOD
29	least	least	I-NP	JJS	O	28	AMOD
30	three	three	I-NP	CD	O	28	AMOD
31	distinct	distinct	I-NP	JJ	O	28	AMOD
32	cellular	cellular	I-NP	JJ	B-protein	34	NMOD
33	transcription	transcription	I-NP	NN	I-protein	34	NMOD
34	factors	factor	I-NP	NNS	I-protein	27	PMOD
35	;	;	O	:	O	18	P
36	CREB/ATF	CREB/ATF	B-NP	NN	B-protein	41	NMOD
37	,	,	O	,	O	41	P
38	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	41	NMOD
39	,	,	O	,	O	41	P
40	and	and	O	CC	O	41	NMOD
41	SRF	SRF	B-NP	NN	B-protein	18	VMOD
42	.	.	O	.	O	18	P

1	This	This	B-NP	DT	O	3	NMOD
2	Tax1-induced	Tax1-induced	I-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	cellular	cellular	B-NP	JJ	B-DNA	6	NMOD
6	genes	gene	I-NP	NNS	I-DNA	4	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	considered	consider	I-VP	VBN	O	7	VC
9	to	to	I-VP	TO	O	10	VMOD
10	be	be	I-VP	VB	O	8	VMOD
11	a	a	B-NP	DT	O	13	NMOD
12	critical	critical	I-NP	JJ	O	13	NMOD
13	event	event	I-NP	NN	O	10	PRD
14	in	in	B-PP	IN	O	13	NMOD
15	T-cell	T-cell	B-NP	NN	O	16	NMOD
16	transformation	transformation	I-NP	NN	O	14	PMOD
17	by	by	B-PP	IN	O	13	NMOD
18	HTLV-I	HTLV-I	B-NP	NN	O	17	PMOD
19	.	.	O	.	O	7	P

1	To	To	B-VP	TO	O	2	VMOD
2	elucidate	elucidate	I-VP	VB	O	15	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	role	role	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	each	each	B-NP	DT	O	9	NMOD
7	Tax1-inducible	Tax1-inducible	I-NP	JJ	O	9	NMOD
8	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD
9	pathway	pathway	I-NP	NN	O	5	PMOD
10	in	in	B-PP	IN	O	4	NMOD
11	T-cell	T-cell	B-NP	NN	O	12	NMOD
12	transformation	transformation	I-NP	NN	O	10	PMOD
13	,	,	O	,	O	15	P
14	we	we	B-NP	PRP	O	15	SUB
15	introduced	introduce	B-VP	VBD	O	0	ROOT
16	Tax1	Tax1	B-NP	NN	B-protein	17	NMOD
17	mutants	mutant	I-NP	NNS	I-protein	15	OBJ
18	with	with	B-PP	IN	O	15	VMOD
19	different	different	B-NP	JJ	O	21	NMOD
20	trans-activating	trans-activating	I-NP	JJ	O	21	NMOD
21	phenotypes	phenotype	I-NP	NNS	O	18	PMOD
22	into	into	B-PP	IN	O	21	NMOD
23	peripheral	peripheral	B-NP	JJ	B-cell_type	25	NMOD
24	blood	blood	I-NP	NN	I-cell_type	25	NMOD
25	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	22	PMOD
26	(	(	O	(	O	27	P
27	PBL	PBL	B-NP	NN	B-cell_type	25	NMOD
28	)	)	O	)	O	27	P
29	by	by	B-PP	IN	O	15	VMOD
30	retroviral	retroviral	B-NP	JJ	O	31	NMOD
31	vectors	vector	I-NP	NNS	O	29	PMOD
32	.	.	O	.	O	15	P

1	Analysis	Analysis	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	these	these	B-NP	DT	O	4	NMOD
4	PBLs	PBL	I-NP	NNS	B-cell_type	2	PMOD
5	revealed	reveal	B-VP	VBD	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	activation	activation	B-NP	NN	O	12	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	11	NMOD
11	pathway	pathway	I-NP	NN	O	8	PMOD
12	is	be	B-VP	VBZ	O	6	SBAR
13	sufficient	sufficient	B-ADJP	JJ	O	12	PRD
14	to	to	B-VP	TO	O	15	VMOD
15	promote	promote	I-VP	VB	O	13	AMOD
16	the	the	B-NP	DT	O	18	NMOD
17	growth	growth	I-NP	NN	O	18	NMOD
18	response	response	I-NP	NN	O	15	OBJ
19	to	to	B-PP	TO	O	18	NMOD
20	IL-2	IL-2	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	5	P

1	However	However	B-ADVP	RB	O	27	VMOD
2	,	,	O	,	O	27	P
3	for	for	B-PP	IN	O	27	VMOD
4	the	the	B-NP	DT	O	6	NMOD
5	clonal	clonal	I-NP	JJ	O	6	NMOD
6	expansion	expansion	I-NP	NN	O	3	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	CD4+	CD4+	B-NP	JJ	B-cell_type	9	NMOD
9	T-cells	T-cell	I-NP	NNS	I-cell_type	7	PMOD
10	,	,	O	,	O	3	P
11	which	which	B-NP	WDT	O	3	PMOD
12	is	be	B-VP	VBZ	O	11	SBAR
13	a	a	B-NP	DT	O	15	NMOD
14	characteristic	characteristic	I-NP	JJ	O	15	NMOD
15	result	result	I-NP	NN	O	12	PRD
16	of	of	B-PP	IN	O	15	NMOD
17	HTLV-I	HTLV-I	B-NP	NN	O	18	NMOD
18	infection	infection	I-NP	NN	O	16	PMOD
19	,	,	O	,	O	27	P
20	activation	activation	B-NP	NN	O	27	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	26	NMOD
23	CREB/ATF	CREB/ATF	I-NP	NN	B-protein	25	NMOD
24	and	and	I-NP	CC	O	25	NMOD
25	SRF	SRF	I-NP	NN	B-protein	26	NMOD
26	pathways	pathway	I-NP	NNS	O	21	PMOD
27	is	be	B-VP	VBZ	O	0	ROOT
28	also	also	I-VP	RB	O	27	VMOD
29	required	require	I-VP	VBN	O	27	VC
30	.	.	O	.	O	27	P

1	Involvement	Involvement	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	N-terminal	N-terminal	I-NP	JJ	B-protein	5	NMOD
5	region	region	I-NP	NN	I-protein	2	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	12	NMOD
8	human	human	I-NP	JJ	B-protein	12	NMOD
9	mineralocorticoid	mineralocorticoid	I-NP	NN	I-protein	12	NMOD
10	receptor	receptor	I-NP	NN	I-protein	12	NMOD
11	hormone-binding	hormone-binding	I-NP	JJ	I-protein	12	NMOD
12	domain	domain	I-NP	NN	I-protein	6	PMOD
13	in	in	B-PP	IN	O	1	NMOD
14	agonist	agonist	B-NP	NN	O	17	NMOD
15	and	and	I-NP	CC	O	17	NMOD
16	antagonist	antagonist	I-NP	NN	O	17	NMOD
17	binding	binding	I-NP	NN	O	13	PMOD
18	as	as	B-SBAR	IN	O	1	NMOD
19	revealed	reveal	B-VP	VBN	O	18	SBAR
20	by	by	B-PP	IN	O	19	VMOD
21	a	a	B-NP	DT	O	24	NMOD
22	new	new	I-NP	JJ	B-protein	24	NMOD
23	monoclonal	monoclonal	I-NP	JJ	I-protein	24	NMOD
24	antibody	antibody	I-NP	NN	I-protein	20	PMOD
25	.	.	O	.	O	1	P

1	To	To	B-VP	TO	O	2	VMOD
2	gain	gain	I-VP	VB	O	21	VMOD
3	a	a	B-NP	DT	O	5	NMOD
4	better	good	I-NP	JJR	O	5	NMOD
5	understanding	understanding	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	mechanism	mechanism	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	binding	bind	B-VP	VBG	O	9	PMOD
11	to	to	B-PP	TO	O	10	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	human	human	I-NP	JJ	B-protein	15	NMOD
14	mineralocorticoid	mineralocorticoid	I-NP	NN	I-protein	15	NMOD
15	receptor	receptor	I-NP	NN	I-protein	11	PMOD
16	(	(	O	(	O	17	P
17	hMR	hMR	B-NP	NN	B-protein	15	NMOD
18	)	)	O	)	O	17	P
19	,	,	O	,	O	21	P
20	we	we	B-NP	PRP	O	21	SUB
21	developed	develop	B-VP	VBD	O	0	ROOT
22	a	a	B-NP	DT	O	23	NMOD
23	new	new	I-NP	JJ	O	21	OBJ
24	monoclonal	monoclonal	I-NP	JJ	B-protein	25	NMOD
25	antibody	antibody	I-NP	NN	I-protein	23	NMOD
26	(	(	O	(	O	27	P
27	mAb	mAb	B-NP	NN	B-protein	25	NMOD
28	)	)	O	)	O	27	P
29	raised	raise	B-VP	VBN	O	23	NMOD
30	against	against	B-PP	IN	O	29	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	hormone-binding	hormone-binding	I-NP	JJ	B-protein	33	NMOD
33	domain	domain	I-NP	NN	I-protein	30	PMOD
34	(	(	O	(	O	35	P
35	HBD	HBD	B-NP	NN	B-protein	33	NMOD
36	)	)	O	)	O	35	P
37	.	.	O	.	O	21	P

1	For	For	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	purpose	purpose	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	mice	mouse	B-NP	NNS	O	6	SUB
6	were	be	B-VP	VBD	O	0	ROOT
7	immunized	immunize	I-VP	VBN	O	6	VC
8	with	with	B-PP	IN	O	7	VMOD
9	a	a	B-NP	DT	O	11	NMOD
10	fusion	fusion	I-NP	NN	B-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	8	PMOD
12	including	include	B-PP	VBG	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	sequence	sequence	I-NP	NN	O	15	NMOD
15	Thr729-Lys984	Thr729-Lys984	I-NP	NN	B-protein	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	hMR	hMR	B-NP	NN	B-protein	16	PMOD
18	.	.	O	.	O	6	P

1	After	After	B-PP	IN	O	7	VMOD
2	ELISA	ELISA	B-NP	NN	O	3	NMOD
3	screening	screening	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	7	P
5	mAb	mAb	B-NP	NN	B-protein	6	NMOD
6	18C7	18C7	I-NP	NN	I-protein	7	SUB
7	was	be	B-VP	VBD	O	0	ROOT
8	selected	select	I-VP	VBN	O	7	VC
9	for	for	B-PP	IN	O	8	VMOD
10	its	its	B-NP	PRP$	O	11	NMOD
11	specificity	specificity	I-NP	NN	O	9	PMOD
12	towards	towards	B-PP	IN	O	8	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	HBD	HBD	I-NP	NN	B-protein	12	PMOD
15	.	.	O	.	O	7	P

1	This	This	B-NP	DT	O	2	NMOD
2	antibody	antibody	I-NP	NN	O	3	SUB
3	recognized	recognize	B-VP	VBD	O	0	ROOT
4	both	both	O	CC	O	10	NMOD
5	the	the	B-NP	DT	O	10	NMOD
6	denatured	denature	I-NP	VBN	O	10	NMOD
7	and	and	I-NP	CC	O	10	NMOD
8	native	native	I-NP	JJ	B-protein	10	NMOD
9	MR	MR	I-NP	NN	I-protein	10	NMOD
10	forms	form	I-NP	NNS	I-protein	23	NMOD
11	,	,	O	,	O	10	P
12	as	as	B-CONJP	RB	O	23	NMOD
13	well	well	I-CONJP	RB	O	12	DEP
14	as	as	I-CONJP	IN	O	12	DEP
15	the	the	B-NP	DT	O	18	NMOD
16	hetero-oligomeric	hetero-oligomeric	I-NP	JJ	B-protein	18	NMOD
17	MR	MR	I-NP	NN	I-protein	18	NMOD
18	form	form	I-NP	NN	I-protein	23	NMOD
19	and	and	O	CC	O	23	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	transformed	transform	I-NP	VBN	B-protein	23	NMOD
22	MR	MR	I-NP	NN	I-protein	23	NMOD
23	state	state	I-NP	NN	I-protein	3	OBJ
24	.	.	O	.	O	3	P

1	By	By	B-PP	IN	O	11	VMOD
2	using	use	B-VP	VBG	O	1	PMOD
3	several	several	B-NP	JJ	O	5	NMOD
4	HBD	HBD	I-NP	NN	B-protein	5	NMOD
5	subfragments	subfragment	I-NP	NNS	I-protein	2	OBJ
6	,	,	O	,	O	11	P
7	the	the	B-NP	DT	O	10	NMOD
8	mAb	mAb	I-NP	NN	B-protein	10	NMOD
9	18C7	18C7	I-NP	NN	I-protein	10	NMOD
10	epitope	epitope	I-NP	NN	I-protein	11	SUB
11	was	be	B-VP	VBD	O	0	ROOT
12	located	locate	I-VP	VBN	O	11	PRD
13	in	in	B-PP	IN	O	12	AMOD
14	the	the	B-NP	DT	O	16	NMOD
15	N-terminal	N-terminal	I-NP	JJ	B-protein	16	NMOD
16	region	region	I-NP	NN	I-protein	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	HBD	HBD	I-NP	NN	B-protein	17	PMOD
20	from	from	B-PP	IN	O	16	NMOD
21	Thr729	Thr729	B-NP	NN	B-protein	20	PMOD
22	to	to	B-PP	TO	O	20	PMOD
23	Leu765	Leu765	B-NP	NN	B-protein	20	PMOD
24	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	3	SUB
2	then	then	B-ADVP	RB	O	3	VMOD
3	studied	study	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	effect	effect	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	antibody	antibody	I-NP	NN	O	6	PMOD
9	on	on	B-PP	IN	O	5	NMOD
10	aldosterone	aldosterone	B-NP	NN	O	12	NMOD
11	and	and	O	CC	O	12	NMOD
12	progesterone	progesterone	B-NP	NN	O	13	NMOD
13	binding	binding	B-NP	NN	O	9	PMOD
14	to	to	B-PP	TO	O	13	NMOD
15	the	the	B-NP	DT	O	16	NMOD
16	hMR	hMR	I-NP	NN	B-protein	14	PMOD
17	.	.	O	.	O	3	P

1	When	When	B-ADVP	WRB	O	10	VMOD
2	18C7	18C7	B-NP	NN	B-protein	3	SUB
3	was	be	B-VP	VBD	O	1	SBAR
4	incubated	incubate	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	liganded	liganded	B-NP	JJ	B-protein	7	NMOD
7	MR	MR	I-NP	NN	I-protein	5	PMOD
8	,	,	O	,	O	10	P
9	it	it	B-NP	PRP	O	10	SUB
10	was	be	B-VP	VBD	O	0	ROOT
11	able	able	B-ADJP	JJ	O	10	PRD
12	to	to	B-VP	TO	O	14	VMOD
13	partly	partly	I-VP	RB	O	14	VMOD
14	displace	displace	I-VP	VB	O	11	AMOD
15	(	(	O	(	O	17	P
16	20	20	B-NP	CD	O	17	NMOD
17	%	%	I-NP	NN	O	14	OBJ
18	)	)	O	)	O	17	P
19	the	the	B-NP	DT	O	20	NMOD
20	hormone	hormone	I-NP	NN	O	14	OBJ
21	from	from	B-PP	IN	O	20	NMOD
22	its	its	B-NP	PRP$	O	24	NMOD
23	binding	bind	I-NP	VBG	O	24	NMOD
24	site	site	I-NP	NN	O	21	PMOD
25	.	.	O	.	O	10	P

1	When	When	B-ADVP	WRB	O	14	VMOD
2	18C7	18C7	B-NP	NN	B-protein	3	SUB
3	was	be	B-VP	VBD	O	1	SBAR
4	incubated	incubate	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	MR	MR	B-NP	NN	B-protein	5	PMOD
7	before	before	B-PP	IN	O	4	VMOD
8	aldosterone	aldosterone	B-NP	NN	O	10	NMOD
9	or	or	I-NP	CC	O	10	NMOD
10	progesterone	progesterone	I-NP	NN	O	7	PMOD
11	,	,	O	,	O	14	P
12	the	the	B-NP	DT	O	13	NMOD
13	antibody	antibody	I-NP	NN	O	14	SUB
14	inhibited	inhibit	B-VP	VBD	O	0	ROOT
15	75-80	75-80	B-NP	CD	O	16	NMOD
16	%	%	I-NP	NN	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	binding	binding	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	18C7	18C7	B-NP	NN	B-protein	3	PMOD
5	on	on	B-PP	IN	O	2	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	binding	binding	I-NP	NN	O	5	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	similar	similar	B-ADJP	JJ	O	8	PRD
10	with	with	B-PP	IN	O	9	AMOD
11	both	both	B-NP	DT	O	12	NMOD
12	hormones	hormone	I-NP	NNS	O	10	PMOD
13	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	4	NMOD
2	sucrose	sucrose	I-NP	NN	O	4	NMOD
3	gradient	gradient	I-NP	NN	O	4	NMOD
4	analysis	analysis	I-NP	NN	O	5	SUB
5	indicated	indicate	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	simultaneous	simultaneous	I-NP	JJ	O	8	NMOD
8	presence	presence	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	two	two	B-NP	CD	O	11	NMOD
11	kinds	kind	I-NP	NNS	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	receptor	receptor	B-NP	NN	B-protein	14	NMOD
14	complexes	complex	I-NP	NNS	I-protein	12	PMOD
15	:	:	O	:	O	5	P
16	the	the	B-NP	DT	O	18	NMOD
17	steroid-MR	steroid-MR	I-NP	NN	B-protein	18	NMOD
18	complex	complex	I-NP	NN	I-protein	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	antibody-MR	antibody-MR	I-NP	JJ	B-protein	22	NMOD
22	complex	complex	I-NP	NN	I-protein	5	OBJ
23	.	.	O	.	O	5	P

1	After	After	B-PP	IN	O	12	VMOD
2	its	its	B-NP	PRP$	O	4	NMOD
3	associated	associate	I-NP	VBN	O	4	NMOD
4	proteins	protein	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	12	P
6	especially	especially	B-ADVP	RB	O	10	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	heat-shock	heat-shock	I-NP	NN	B-protein	10	NMOD
9	protein	protein	I-NP	NN	I-protein	10	NMOD
10	hsp90	hsp90	I-NP	NN	I-protein	12	SUB
11	,	,	O	,	O	10	P
12	had	have	B-VP	VBD	O	22	VMOD
13	been	be	I-VP	VBN	O	12	VC
14	cross-linked	cross-linked	B-ADJP	JJ	O	13	PRD
15	with	with	B-PP	IN	O	14	AMOD
16	the	the	B-NP	DT	O	17	NMOD
17	hMR	hMR	I-NP	NN	B-protein	15	PMOD
18	by	by	B-PP	IN	O	14	AMOD
19	dimethylpimelimidate	dimethylpimelimidate	B-NP	NN	O	18	PMOD
20	,	,	O	,	O	22	P
21	18C7	18C7	B-NP	NN	B-protein	22	SUB
22	was	be	B-VP	VBD	O	0	ROOT
23	still	still	B-ADVP	RB	O	22	VMOD
24	able	able	B-ADJP	JJ	O	22	PRD
25	to	to	B-VP	TO	O	26	VMOD
26	react	react	I-VP	VB	O	24	AMOD
27	with	with	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	receptor	receptor	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	22	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicated	indicate	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	epitope	epitope	I-NP	NN	B-protein	10	SUB
7	recognized	recognize	B-VP	VBN	O	6	NMOD
8	by	by	B-PP	IN	O	7	VMOD
9	18C7	18C7	B-NP	NN	B-protein	8	PMOD
10	was	be	B-VP	VBD	O	4	SBAR
11	directly	directly	I-VP	RB	O	10	VMOD
12	implicated	implicate	I-VP	VBN	O	10	VC
13	in	in	B-PP	IN	O	12	VMOD
14	hormone	hormone	B-NP	NN	O	15	NMOD
15	binding	binding	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	lack	lack	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	steroid	steroid	B-NP	NN	O	5	NMOD
5	binding	binding	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	HBD	HBD	B-NP	NN	B-protein	8	NMOD
8	mutants	mutant	I-NP	NNS	I-protein	6	PMOD
9	with	with	B-PP	IN	O	5	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	Thr729-Leu765	Thr729-Leu765	I-NP	JJ	B-protein	12	NMOD
12	sequence	sequence	I-NP	NN	I-protein	9	PMOD
13	deleted	delete	B-VP	VBN	O	12	NMOD
14	[	[	O	(	O	12	NMOD
15	Jalaguier	Jalaguier	B-NP	NNP	O	21	NMOD
16	,	,	O	,	O	21	P
17	Mesnier	Mesnier	B-NP	NNP	O	21	NMOD
18	,	,	O	,	O	21	P
19	Leger	Leger	B-NP	NNP	O	21	NMOD
20	and	and	O	CC	O	21	NMOD
21	Auzou	Auzou	B-NP	NNP	O	26	NMOD
22	(	(	O	(	O	23	P
23	1996	1996	B-NP	CD	O	26	NMOD
24	)	)	O	)	O	23	P
25	J.Steroid	J.Steroid	B-NP	NN	O	26	NMOD
26	Biochem.Mol.Biol.57	Biochem.Mol.Biol.57	I-NP	NN	O	30	SUB
27	,	,	O	,	O	28	P
28	43-50	43-50	B-NP	CD	O	26	NMOD
29	]	]	O	)	O	28	P
30	supports	support	B-VP	VBZ	O	14	SBAR
31	this	this	B-NP	DT	O	32	NMOD
32	hypothesis	hypothesis	I-NP	NN	O	30	OBJ
33	.	.	O	.	O	2	P

1	Because	Because	B-PP	IN	O	12	VMOD
2	of	of	I-PP	IN	O	1	PMOD
3	the	the	B-NP	DT	O	5	NMOD
4	similar	similar	I-NP	JJ	O	5	NMOD
5	behaviours	behaviour	I-NP	NNS	O	1	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	aldosterone	aldosterone	B-NP	NN	O	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	progesterone	progesterone	I-NP	NN	O	6	PMOD
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	conclude	conclude	B-VP	VBP	O	0	ROOT
13	that	that	B-SBAR	IN	O	12	VMOD
14	the	the	B-NP	DT	O	17	NMOD
15	N-terminal	N-terminal	I-NP	JJ	B-protein	17	NMOD
16	Thr729-Leu765	Thr729-Leu765	I-NP	NN	I-protein	17	NMOD
17	region	region	I-NP	NN	I-protein	21	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	HBD	HBD	I-NP	NN	B-protein	18	PMOD
21	is	be	B-VP	VBZ	O	13	SBAR
22	similarly	similarly	I-VP	RB	O	21	VMOD
23	involved	involve	I-VP	VBN	O	21	VC
24	in	in	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	binding	binding	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	both	both	B-NP	DT	O	29	NMOD
29	hormones	hormone	I-NP	NNS	O	27	PMOD
30	.	.	O	.	O	12	P

1	Abnormal	Abnormal	B-NP	JJ	O	4	NMOD
2	T	T	I-NP	NN	O	4	NMOD
3	lymphocyte	lymphocyte	I-NP	NN	O	4	NMOD
4	development	development	I-NP	NN	O	0	ROOT
5	induced	induce	B-VP	VBN	O	4	NMOD
6	by	by	B-PP	IN	O	5	VMOD
7	targeted	target	B-NP	VBN	O	8	NMOD
8	overexpression	overexpression	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	IkappaB	IkappaB	B-NP	NN	B-protein	11	NMOD
11	alpha	alpha	I-NP	NN	I-protein	9	PMOD
12	.	.	O	.	O	4	P

1	A	A	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	12	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	thymic	thymic	B-NP	JJ	O	5	NMOD
5	maturation	maturation	I-NP	NN	O	3	PMOD
6	for	for	B-PP	IN	O	5	NMOD
7	factors	factor	B-NP	NNS	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	11	NMOD
11	family	family	I-NP	NN	I-protein	8	PMOD
12	has	have	B-VP	VBZ	O	0	ROOT
13	long	long	I-VP	RB	O	12	VMOD
14	been	be	I-VP	VBN	O	12	VC
15	suspected	suspect	I-VP	VBN	O	14	VC
16	,	,	O	,	O	12	P
17	but	but	O	CC	O	12	VMOD
18	not	not	B-VP	RB	O	12	VMOD
19	yet	yet	I-VP	RB	O	12	VMOD
20	proven	prove	I-VP	VBN	O	12	VC
21	.	.	O	.	O	12	P

1	Transgenic	Transgenic	B-NP	JJ	O	2	NMOD
2	mice	mouse	I-NP	NNS	O	10	SUB
3	with	with	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	6	NMOD
5	lymphocyte-specific	lymphocyte-specific	I-NP	JJ	O	6	NMOD
6	defect	defect	I-NP	NN	O	3	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	9	NMOD
9	activation	activation	I-NP	NN	O	7	PMOD
10	were	be	B-VP	VBD	O	0	ROOT
11	produced	produce	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	targeted	target	B-NP	VBN	O	14	NMOD
14	expression	expression	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	human	human	B-NP	JJ	B-protein	18	NMOD
17	IkappaB	IkappaB	I-NP	NN	I-protein	18	NMOD
18	alpha	alpha	I-NP	NN	I-protein	15	PMOD
19	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	thymic	thymic	I-NP	JJ	O	3	NMOD
3	cellularity	cellularity	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	these	these	B-NP	DT	O	6	NMOD
6	mice	mouse	I-NP	NNS	O	4	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	significantly	significantly	I-VP	RB	O	7	VMOD
9	decreased	decrease	I-VP	VBN	O	7	VC
10	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	proportion	proportion	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	mature	mature	B-NP	JJ	O	6	AMOD
5	,	,	I-NP	,	O	6	P
6	TCRhigh	TCRhigh	I-NP	JJ	B-cell_type	7	NMOD
7	thymocytes	thymocyte	I-NP	NNS	I-cell_type	3	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	alphabeta	alphabeta	I-NP	NN	B-cell_type	11	NMOD
11	lineage	lineage	I-NP	NN	I-cell_type	8	PMOD
12	was	be	B-VP	VBD	O	20	VMOD
13	reduced	reduce	I-VP	VBN	O	12	VC
14	,	,	O	,	O	20	P
15	and	and	O	CC	O	19	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	remaining	remain	I-NP	VBG	O	19	NMOD
18	TCRhigh	TCRhigh	I-NP	JJ	B-cell_type	19	NMOD
19	population	population	I-NP	NN	I-cell_type	20	SUB
20	contained	contain	B-VP	VBD	O	0	ROOT
21	an	an	B-NP	DT	O	24	NMOD
22	unusually	unusually	I-NP	RB	O	23	AMOD
23	high	high	I-NP	JJ	O	24	NMOD
24	proportion	proportion	I-NP	NN	O	20	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	double-positive	double-positive	B-NP	JJ	B-cell_line	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_line	25	PMOD
28	.	.	O	.	O	20	P

1	This	This	B-NP	DT	O	2	NMOD
2	defect	defect	I-NP	NN	O	5	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	maturation	maturation	B-NP	NN	O	3	PMOD
5	resulted	result	B-VP	VBD	O	0	ROOT
6	in	in	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	10	NMOD
8	transgene	transgene	I-NP	NN	O	10	NMOD
9	dose-dependent	dose-dependent	I-NP	JJ	O	10	NMOD
10	reduction	reduction	I-NP	NN	O	6	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD
13	T	T	I-NP	NN	I-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	PMOD
15	,	,	O	,	O	5	P
16	with	with	B-PP	IN	O	5	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	CD8	CD8	I-NP	NN	B-cell_type	19	NMOD
19	lineage	lineage	I-NP	NN	I-cell_type	20	SUB
20	being	be	B-VP	VBG	O	16	PMOD
21	more	more	I-VP	RBR	O	22	AMOD
22	severely	severely	I-VP	RB	O	23	VMOD
23	affected	affect	I-VP	VBN	O	20	VC
24	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	provide	provide	B-VP	VBP	O	0	ROOT
4	direct	direct	B-NP	JJ	O	5	NMOD
5	evidence	evidence	I-NP	NN	O	3	OBJ
6	for	for	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	involvement	involvement	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	NN	B-protein	12	NMOD
11	family	family	I-NP	NN	I-protein	12	NMOD
12	proteins	protein	I-NP	NNS	I-protein	9	PMOD
13	in	in	B-PP	IN	O	8	NMOD
14	late	late	B-NP	JJ	O	15	NMOD
15	stages	stage	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	T	T	B-NP	NN	B-cell_type	19	NMOD
18	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	19	NMOD
19	development	development	I-NP	NN	O	16	PMOD
20	,	,	O	,	O	8	P
21	coincident	coincident	B-ADJP	JJ	O	8	NMOD
22	with	with	B-PP	IN	O	21	AMOD
23	positive	positive	B-NP	JJ	O	26	NMOD
24	and	and	I-NP	CC	O	26	NMOD
25	negative	negative	I-NP	JJ	O	26	NMOD
26	selection	selection	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	3	P

1	Sequential	Sequential	B-NP	JJ	O	2	NMOD
2	development	development	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	structural	structural	B-NP	JJ	O	7	NMOD
5	and	and	I-NP	CC	O	7	NMOD
6	functional	functional	I-NP	JJ	O	7	NMOD
7	alterations	alteration	I-NP	NNS	O	3	PMOD
8	in	in	B-PP	IN	O	2	NMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	from	from	B-PP	IN	O	10	NMOD
12	tumor-bearing	tumor-bearing	B-NP	JJ	O	13	NMOD
13	mice	mouse	I-NP	NNS	O	11	PMOD
14	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	8	NMOD
2	TCR	TCR	I-NP	NN	O	4	NMOD
3	alpha	alpha	I-NP	NN	O	4	NMOD
4	beta	beta	I-NP	NN	O	8	NMOD
5	or	or	O	CC	O	8	NMOD
6	-gamma	-gamma	B-NP	NN	B-protein	8	NMOD
7	delta	delta	I-NP	NN	I-protein	8	NMOD
8	chains	chain	I-NP	NNS	I-protein	9	SUB
9	bind	bind	B-VP	VBP	O	0	ROOT
10	the	the	B-NP	DT	O	12	NMOD
11	peptide	peptide	I-NP	NN	O	12	NMOD
12	ligand	ligand	I-NP	NN	O	9	OBJ
13	,	,	O	,	O	9	P
14	whereas	whereas	O	IN	O	9	VMOD
15	the	the	B-NP	DT	O	24	NMOD
16	associated	associate	I-NP	VBN	O	20	NMOD
17	CD3	CD3	I-NP	NN	B-protein	20	NMOD
18	delta	delta	I-NP	NN	I-protein	20	NMOD
19	epsilon	epsilon	I-NP	NN	I-protein	20	NMOD
20	gamma	gamma	I-NP	NN	I-protein	24	NMOD
21	and	and	O	CC	O	24	NMOD
22	TCR	TCR	B-NP	NN	B-protein	24	NMOD
23	zeta	zeta	I-NP	NN	I-protein	24	NMOD
24	subunits	subunit	I-NP	NNS	I-protein	25	SUB
25	couple	couple	B-VP	VBP	O	14	SBAR
26	the	the	B-NP	DT	O	27	NMOD
27	TCR	TCR	I-NP	NN	B-protein	25	OBJ
28	to	to	B-PP	TO	O	25	VMOD
29	intracellular	intracellular	B-NP	JJ	O	32	NMOD
30	signal	signal	I-NP	NN	O	32	NMOD
31	transduction	transduction	I-NP	NN	O	32	NMOD
32	components	component	I-NP	NNS	O	28	PMOD
33	.	.	O	.	O	9	P

1	Recently	Recently	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	several	several	B-NP	JJ	O	4	NMOD
4	groups	group	I-NP	NNS	O	5	SUB
5	have	have	B-VP	VBP	O	0	ROOT
6	described	describe	I-VP	VBN	O	5	VC
7	marked	marked	B-NP	JJ	O	8	NMOD
8	alterations	alteration	I-NP	NNS	O	6	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	signal	signal	B-NP	NN	B-DNA	12	NMOD
11	transduction	transduction	I-NP	NN	I-DNA	12	NMOD
12	elements	element	I-NP	NNS	I-DNA	9	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	T	T	B-NP	NN	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	from	from	B-PP	IN	O	15	NMOD
17	cancer	cancer	B-NP	NN	O	18	NMOD
18	patients	patient	I-NP	NNS	O	16	PMOD
19	or	or	B-PP	CC	O	13	PMOD
20	in	in	B-PP	IN	O	13	PMOD
21	mice	mouse	B-NP	NNS	O	20	PMOD
22	bearing	bear	B-VP	VBG	O	21	NMOD
23	tumor	tumor	B-NP	NN	O	22	OBJ
24	for	for	B-PP	IN	O	23	NMOD
25	a	a	B-NP	DT	O	27	NMOD
26	few	few	I-NP	JJ	O	27	NMOD
27	weeks	week	I-NP	NNS	O	24	PMOD
28	(	(	O	(	O	31	P
29	>	>	B-NP	SYM	O	31	NMOD
30	26	26	B-NP	CD	O	31	NMOD
31	days	day	I-NP	NNS	O	27	NMOD
32	)	)	O	)	O	31	P
33	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	sequence	sequence	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	these	these	B-NP	DT	O	6	NMOD
6	alterations	alteration	I-NP	NNS	O	3	PMOD
7	develop	develop	B-VP	VBP	O	0	ROOT
8	is	be	B-VP	VBZ	O	7	VMOD
9	unknown	unknown	B-ADJP	JJ	O	8	PRD
10	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	aim	aim	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	study	study	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	to	to	B-VP	TO	O	8	VMOD
8	explore	explore	I-VP	VB	O	6	PRD
9	the	the	B-NP	DT	O	10	NMOD
10	kinetics	kinetic	I-NP	NNS	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	development	development	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	alterations	alteration	B-NP	NNS	O	14	PMOD
16	in	in	B-PP	IN	O	13	NMOD
17	signal	signal	B-NP	NN	B-protein	19	NMOD
18	transduction	transduction	I-NP	NN	I-protein	19	NMOD
19	molecules	molecule	I-NP	NNS	I-protein	16	PMOD
20	(	(	O	(	O	28	P
21	TCR	TCR	B-NP	NN	B-protein	23	NMOD
22	zeta	zeta	I-NP	NN	I-protein	23	NMOD
23	chain	chain	I-NP	NN	I-protein	28	NMOD
24	,	,	O	,	O	28	P
25	NF	NF	B-NP	NN	B-protein	28	NMOD
26	kappaB	kappaB	I-NP	NN	I-protein	28	NMOD
27	family	family	I-NP	NN	I-protein	28	NMOD
28	proteins	protein	I-NP	NNS	I-protein	19	NMOD
29	,	,	O	,	O	28	NMOD
30	and	and	O	CC	O	29	VMOD
31	tyrosine	tyrosine	B-NP	NN	B-protein	32	NMOD
32	kinase	kinase	I-NP	NN	I-protein	30	OBJ
33	p56	p56	I-NP	NN	B-protein	32	NMOD
34	(	(	O	(	I-protein	35	P
35	lck	lck	B-NP	NN	I-protein	33	NMOD
36	)	)	O	)	I-protein	35	P
37	)	)	O	)	O	32	P
38	in	in	B-PP	IN	O	32	NMOD
39	mice	mouse	B-NP	NNS	O	38	PMOD
40	bearing	bear	B-VP	VBG	O	39	NMOD
41	MC38	MC38	B-NP	NN	O	43	NMOD
42	colon	colon	I-NP	NN	O	43	NMOD
43	adenocarcinoma	adenocarcinoma	I-NP	NN	O	40	OBJ
44	.	.	O	.	O	30	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	alterations	alteration	B-NP	NNS	O	22	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	NF	NF	B-NP	NN	B-protein	10	NMOD
8	kappaB	kappaB	I-NP	NN	I-protein	10	NMOD
9	family	family	I-NP	NN	I-protein	10	NMOD
10	proteins	protein	I-NP	NNS	I-protein	6	PMOD
11	,	,	O	,	O	12	P
12	specifically	specifically	B-ADVP	RB	O	22	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	failure	failure	I-NP	NN	O	12	AMOD
15	of	of	B-PP	IN	O	14	NMOD
16	p65	p65	B-NP	NN	B-protein	17	NMOD
17	translocation	translocation	I-NP	NN	O	15	PMOD
18	to	to	B-PP	TO	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	nucleus	nucleus	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	14	P
22	occur	occur	B-VP	VBP	O	4	SBAR
23	earlier	earlier	B-ADVP	RBR	O	22	VMOD
24	and	and	B-ADVP	CC	O	22	VMOD
25	more	more	B-ADVP	RBR	O	26	AMOD
26	frequently	frequently	I-ADVP	RB	O	22	VMOD
27	than	than	B-PP	IN	O	26	AMOD
28	the	the	B-NP	DT	O	29	NMOD
29	decrease	decrease	I-NP	NN	O	27	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	zeta-chain	zeta-chain	B-NP	NN	B-protein	30	PMOD
32	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	defects	defect	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	paralleled	parallel	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	an	an	B-NP	DT	O	8	NMOD
7	impaired	impaired	I-NP	JJ	O	8	NMOD
8	ability	ability	I-NP	NN	O	5	PMOD
9	to	to	B-VP	TO	O	10	VMOD
10	produce	produce	I-VP	VB	O	8	NMOD
11	Th1	Th1	B-NP	NN	B-protein	12	NMOD
12	cytokines	cytokine	I-NP	NNS	I-protein	10	OBJ
13	(	(	O	(	O	16	P
14	IL-2	IL-2	B-NP	NN	B-protein	16	NMOD
15	and	and	O	CC	O	16	NMOD
16	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	8	NMOD
17	)	)	O	)	O	16	P
18	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	3	NMOD
2	initial	initial	I-NP	JJ	O	3	NMOD
3	changes	change	I-NP	NNS	O	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	followed	follow	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	eventual	eventual	I-NP	JJ	O	9	NMOD
9	loss	loss	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	TCR	TCR	B-NP	NN	B-protein	13	NMOD
12	zeta	zeta	I-NP	NN	I-protein	13	NMOD
13	chain	chain	I-NP	NN	I-protein	22	NMOD
14	and	and	O	CC	O	22	NMOD
15	p56	p56	B-NP	NN	B-protein	22	NMOD
16	(	(	O	(	I-protein	17	P
17	lck	lck	B-NP	NN	I-protein	15	NMOD
18	)	)	O	)	I-protein	17	P
19	and	and	O	CC	O	22	NMOD
20	a	a	B-NP	DT	O	22	NMOD
21	marked	marked	I-NP	JJ	O	22	NMOD
22	decrease	decrease	I-NP	NN	O	10	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	cytotoxic	cytotoxic	B-NP	JJ	O	25	NMOD
25	function	function	I-NP	NN	O	23	PMOD
26	.	.	O	.	O	4	P

1	An	An	B-NP	DT	O	3	NMOD
2	increased	increase	I-NP	VBN	O	3	NMOD
3	rate	rate	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	lysosomal	lysosomal	B-NP	JJ	O	6	NMOD
6	degradation	degradation	I-NP	NN	O	4	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	one	one	B-NP	CD	O	7	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	mechanisms	mechanism	I-NP	NNS	O	9	PMOD
12	responsible	responsible	B-ADJP	JJ	O	11	NMOD
13	for	for	B-PP	IN	O	12	AMOD
14	the	the	B-NP	DT	O	15	NMOD
15	loss	loss	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	zeta-chain	zeta-chain	B-NP	NN	B-protein	16	PMOD
18	.	.	O	.	O	7	P

1	An	An	B-NP	DT	O	3	NMOD
2	isotype-specific	isotype-specific	I-NP	JJ	O	3	NMOD
3	activator	activator	I-NP	NN	O	0	ROOT
4	of	of	B-PP	IN	O	3	NMOD
5	major	major	B-NP	JJ	B-DNA	13	NMOD
6	histocompatibility	histocompatibility	I-NP	NN	I-DNA	13	NMOD
7	complex	complex	I-NP	NN	I-DNA	13	NMOD
8	(	(	O	(	I-DNA	13	P
9	MHC	MHC	B-NP	NN	I-DNA	13	NMOD
10	)	)	O	)	I-DNA	13	P
11	class	class	B-NP	NN	I-DNA	13	NMOD
12	II	II	I-NP	CD	I-DNA	13	NMOD
13	genes	gene	I-NP	NNS	I-DNA	4	PMOD
14	that	that	B-NP	WDT	O	3	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	independent	independent	B-ADJP	JJ	O	15	PRD
17	of	of	B-PP	IN	O	16	AMOD
18	class	class	B-NP	NN	B-protein	20	NMOD
19	II	II	I-NP	CD	I-protein	20	NMOD
20	transactivator	transactivator	I-NP	NN	I-protein	17	PMOD
21	.	.	O	.	O	3	P

1	Patients	Patient	B-NP	NNS	O	13	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	one	one	B-NP	CD	O	4	NMOD
4	type	type	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	major	major	B-NP	JJ	B-protein	12	NMOD
7	histocompatibility	histocompatibility	I-NP	NN	I-protein	12	NMOD
8	complex	complex	I-NP	NN	I-protein	12	NMOD
9	class	class	I-NP	NN	I-protein	12	NMOD
10	II	II	I-NP	CD	I-protein	12	NMOD
11	combined	combined	I-NP	JJ	O	12	NMOD
12	immunodeficiency	immunodeficiency	I-NP	NN	O	5	PMOD
13	have	have	B-VP	VBP	O	0	ROOT
14	mutations	mutation	B-NP	NNS	O	13	OBJ
15	in	in	B-PP	IN	O	13	VMOD
16	a	a	B-NP	DT	O	17	NMOD
17	gene	gene	I-NP	NN	O	15	PMOD
18	termed	term	B-VP	VBN	O	17	NMOD
19	class	class	B-NP	NN	B-protein	21	NMOD
20	II	II	I-NP	CD	I-protein	21	NMOD
21	transactivator	transactivator	I-NP	NN	I-protein	18	VMOD
22	(	(	O	(	O	23	P
23	CIITA	CIITA	B-NP	NN	B-protein	21	NMOD
24	)	)	O	)	O	23	P
25	,	,	O	,	O	17	P
26	which	which	B-NP	WDT	O	17	NMOD
27	coordinately	coordinately	B-ADVP	RB	O	28	VMOD
28	controls	control	B-VP	VBZ	O	26	SBAR
29	the	the	B-NP	DT	O	30	NMOD
30	transcription	transcription	I-NP	NN	O	28	OBJ
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	38	NMOD
33	three	three	I-NP	CD	O	38	NMOD
34	major	major	I-NP	JJ	O	38	NMOD
35	human	human	I-NP	JJ	B-DNA	38	NMOD
36	class	class	I-NP	NN	I-DNA	38	NMOD
37	II	II	B-NP	CD	I-DNA	38	NMOD
38	genes	gene	I-NP	NNS	I-DNA	45	NMOD
39	,	,	O	,	O	45	P
40	HLA-DR	HLA-DR	B-NP	NN	B-DNA	45	NMOD
41	,	,	O	,	O	45	P
42	-DQ	-DQ	B-NP	NN	B-protein	45	NMOD
43	,	,	O	,	O	45	P
44	and	and	O	CC	O	45	NMOD
45	-DP	-DP	B-NP	NN	B-protein	31	PMOD
46	.	.	O	.	O	13	P

1	However	However	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	the	the	B-NP	DT	O	8	NMOD
4	experimentally	experimentally	I-NP	RB	O	5	AMOD
5	derived	derive	I-NP	VBN	O	8	NMOD
6	B-lymphoblastoid	B-lymphoblastoid	I-NP	JJ	B-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	line	line	I-NP	NN	I-cell_line	10	NMOD
9	,	,	O	,	O	10	P
10	clone	clone	B-NP	NN	B-cell_line	13	SUB
11	13	13	I-NP	CD	I-cell_line	10	NMOD
12	,	,	O	,	O	10	P
13	expresses	express	B-VP	VBZ	O	0	ROOT
14	high	high	B-NP	JJ	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	HLADQ	HLADQ	B-NP	NN	B-protein	16	PMOD
18	in	in	B-PP	IN	O	13	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	absence	absence	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	HLA-DR	HLA-DR	B-NP	NN	B-protein	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	HLA-DP	HLA-DP	I-NP	NN	B-DNA	21	PMOD
25	,	,	O	,	O	13	P
26	despite	despite	B-PP	IN	O	13	VMOD
27	its	its	B-NP	PRP$	O	28	NMOD
28	mapping	mapping	I-NP	NN	O	26	PMOD
29	by	by	B-PP	IN	O	28	NMOD
30	complementation	complementation	B-NP	NN	O	31	NMOD
31	analysis	analysis	I-NP	NN	O	29	PMOD
32	to	to	B-PP	TO	O	31	NMOD
33	this	this	B-NP	DT	O	34	NMOD
34	group	group	I-NP	NN	O	32	PMOD
35	.	.	O	.	O	13	P

1	It	It	B-NP	PRP	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	possible	possible	B-ADJP	JJ	O	2	PRD
4	that	that	B-SBAR	IN	O	2	VMOD
5	one	one	B-NP	CD	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	11	NMOD
8	clone	clone	I-NP	NN	B-DNA	11	NMOD
9	13	13	I-NP	CD	I-DNA	11	NMOD
10	CIITA	CIITA	I-NP	NN	I-DNA	11	NMOD
11	alleles	allele	I-NP	NNS	I-DNA	6	PMOD
12	bore	bear	B-VP	VBD	O	4	SBAR
13	a	a	B-NP	DT	O	14	NMOD
14	mutation	mutation	I-NP	NN	O	12	OBJ
15	that	that	B-NP	WDT	O	14	NMOD
16	allowed	allow	B-VP	VBD	O	15	SBAR
17	HLA-DQ	HLA-DQ	B-NP	NN	B-DNA	24	NMOD
18	,	,	O	,	O	24	P
19	but	but	O	CC	O	24	NMOD
20	not	not	O	RB	O	19	DEP
21	HLA-DR	HLA-DR	B-NP	NN	B-protein	24	NMOD
22	or	or	O	CC	O	24	NMOD
23	-DP	-DP	B-NP	NN	O	24	NMOD
24	transcription	transcription	I-NP	NN	O	16	OBJ
25	.	.	O	.	O	2	P

1	Alternatively	Alternatively	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	another	another	B-NP	DT	O	4	NMOD
4	factor	factor	I-NP	NN	O	10	SUB
5	,	,	O	,	O	4	P
6	distinct	distinct	B-ADJP	JJ	O	4	NMOD
7	from	from	B-PP	IN	O	6	AMOD
8	CIITA	CIITA	B-NP	NN	B-protein	7	PMOD
9	,	,	O	,	O	4	P
10	might	might	B-VP	MD	O	0	ROOT
11	control	control	I-VP	VB	O	10	VC
12	HLA-DQ	HLA-DQ	B-NP	NN	B-DNA	13	NMOD
13	expression	expression	I-NP	NN	O	11	OBJ
14	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	ectopic	ectopic	B-NP	JJ	O	6	NMOD
6	expression	expression	I-NP	NN	O	20	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	CIITA	CIITA	B-NP	NN	B-DNA	9	NMOD
9	cDNAs	cDNA	I-NP	NNS	I-DNA	7	PMOD
10	derived	derive	B-VP	VBN	O	9	NMOD
11	by	by	B-PP	IN	O	10	VMOD
12	reverse	reverse	B-NP	JJ	B-protein	16	NMOD
13	transcriptase	transcriptase	I-NP	NN	I-protein	16	NMOD
14	polymerase	polymerase	I-NP	NN	O	16	NMOD
15	chain	chain	I-NP	NN	O	16	NMOD
16	reaction	reaction	I-NP	NN	O	11	PMOD
17	from	from	B-PP	IN	O	16	NMOD
18	clone	clone	B-NP	NN	B-cell_line	17	PMOD
19	13	13	I-NP	CD	I-cell_line	18	NMOD
20	do	do	B-VP	VBP	O	4	SBAR
21	not	not	I-VP	RB	O	20	VMOD
22	restore	restore	I-VP	VB	O	20	VC
23	expression	expression	B-NP	NN	O	22	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	HLA-DQ	HLA-DQ	B-NP	NN	B-DNA	24	PMOD
26	in	in	B-PP	IN	O	23	NMOD
27	another	another	B-NP	DT	O	30	NMOD
28	CIITA-deficient	CIITA-deficient	I-NP	JJ	B-cell_line	30	NMOD
29	cell	cell	I-NP	NN	I-cell_line	30	NMOD
30	line	line	I-NP	NN	I-cell_line	32	NMOD
31	,	,	O	,	O	32	P
32	RJ2.2.5	RJ2.2.5	B-NP	NN	B-cell_line	26	PMOD
33	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	7	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	no	no	B-NP	DT	O	6	NMOD
5	CIITA	CIITA	I-NP	NN	B-protein	6	NMOD
6	protein	protein	I-NP	NN	O	7	SUB
7	is	be	B-VP	VBZ	O	0	ROOT
8	detectable	detectable	B-ADJP	JJ	O	7	PRD
9	in	in	B-PP	IN	O	8	AMOD
10	clone	clone	B-NP	NN	B-cell_line	13	NMOD
11	13	13	I-NP	CD	I-cell_line	13	NMOD
12	nuclear	nuclear	I-NP	JJ	O	13	NMOD
13	extracts	extract	I-NP	NNS	O	9	PMOD
14	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	somatic	somatic	B-NP	JJ	O	6	NMOD
5	cell	cell	I-NP	NN	O	6	NMOD
6	fusion	fusion	I-NP	NN	O	12	SUB
7	between	between	B-PP	IN	O	6	NMOD
8	clone	clone	B-NP	NN	B-cell_line	11	NMOD
9	13	13	I-NP	CD	I-cell_line	8	NMOD
10	and	and	O	CC	O	11	NMOD
11	RJ2.2.5	RJ2.2.5	B-NP	NN	B-cell_line	7	PMOD
12	restored	restore	B-VP	VBD	O	0	ROOT
13	expression	expression	B-NP	NN	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	HLA-DQ	HLA-DQ	I-NP	NN	B-DNA	17	NMOD
17	haplotype	haplotype	I-NP	NN	O	14	PMOD
18	encoded	encode	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	23	NMOD
21	RJ2.2.5	RJ2.2.5	I-NP	NN	B-DNA	23	NMOD
22	DQB	DQB	I-NP	NN	I-DNA	23	NMOD
23	gene	gene	I-NP	NN	I-DNA	19	PMOD
24	.	.	O	.	O	12	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	data	datum	I-NP	NNS	O	6	SUB
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	existence	existence	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	an	an	B-NP	DT	O	14	NMOD
11	HLA-DQ	HLA-DQ	I-NP	NN	B-protein	14	NMOD
12	isotype-specific	isotype-specific	I-NP	JJ	I-protein	14	NMOD
13	trans-acting	trans-acting	I-NP	JJ	I-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	9	PMOD
15	,	,	O	,	O	14	P
16	which	which	B-NP	WDT	O	14	NMOD
17	functions	function	B-VP	VBZ	O	16	SBAR
18	independently	independently	B-ADVP	RB	O	17	VMOD
19	of	of	B-PP	IN	O	18	AMOD
20	CIITA	CIITA	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	6	P

1	Induction	Induction	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	cytokine	cytokine	B-NP	NN	B-protein	4	NMOD
4	expression	expression	I-NP	NN	O	2	PMOD
5	in	in	B-PP	IN	O	1	NMOD
6	leukocytes	leukocyte	B-NP	NNS	B-cell_type	5	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	binding	binding	B-NP	NN	O	7	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	thrombin-stimulated	thrombin-stimulated	B-NP	JJ	B-cell_type	11	NMOD
11	platelets	platelet	I-NP	NNS	I-cell_type	9	PMOD
12	.	.	O	.	O	1	P

1	BACKGROUND	BACKGROUND	B-NP	NN	O	4	NMOD
2	:	:	O	:	O	1	P
3	Activated	Activate	B-NP	VBN	B-cell_type	4	NMOD
4	platelets	platelet	I-NP	NNS	I-cell_type	5	SUB
5	tether	tether	B-VP	VBP	O	0	ROOT
6	and	and	I-VP	CC	O	5	VMOD
7	activate	activate	I-VP	VBP	O	5	VMOD
8	myeloid	myeloid	B-NP	JJ	B-cell_type	9	NMOD
9	leukocytes	leukocyte	I-NP	NNS	I-cell_type	7	OBJ
10	.	.	O	.	O	5	P

1	To	To	B-VP	TO	O	2	VMOD
2	investigate	investigate	I-VP	VB	O	18	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	potential	potential	I-NP	JJ	O	5	NMOD
5	relevance	relevance	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	this	this	B-NP	DT	O	8	NMOD
8	mechanism	mechanism	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	5	NMOD
10	acute	acute	B-NP	JJ	O	12	NMOD
11	myocardial	myocardial	I-NP	JJ	O	12	NMOD
12	infarction	infarction	I-NP	NN	O	9	PMOD
13	(	(	O	(	O	14	P
14	AMI	AMI	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	,	,	O	,	O	18	P
17	we	we	B-NP	PRP	O	18	SUB
18	examined	examine	B-VP	VBD	O	0	ROOT
19	cytokine	cytokine	B-NP	NN	B-protein	20	NMOD
20	induction	induction	I-NP	NN	O	26	NMOD
21	by	by	B-PP	IN	O	20	NMOD
22	leukocyte-platelet	leukocyte-platelet	B-NP	JJ	O	23	NMOD
23	adhesion	adhesion	I-NP	NN	O	21	PMOD
24	and	and	O	CC	O	26	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	occurrence	occurrence	I-NP	NN	O	18	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	leukocyte-platelet	leukocyte-platelet	B-NP	JJ	O	29	NMOD
29	conjugates	conjugate	I-NP	NNS	O	27	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	patients	patient	B-NP	NNS	O	30	PMOD
32	with	with	B-PP	IN	O	31	NMOD
33	AMI	AMI	B-NP	NN	O	32	PMOD
34	.	.	O	.	O	18	P

1	METHODS	METHODS	B-NP	NNS	O	3	NMOD
2	AND	AND	I-NP	CC	O	3	NMOD
3	RESULTS	RESULTS	I-NP	NNS	O	0	ROOT
4	:	:	O	:	O	5	P
5	We	We	B-NP	PRP	O	6	SUB
6	obtained	obtain	B-VP	VBD	O	3	NMOD
7	peripheral	peripheral	B-NP	JJ	O	10	NMOD
8	venous	venous	I-NP	JJ	O	10	NMOD
9	blood	blood	I-NP	NN	O	10	NMOD
10	samples	sample	I-NP	NNS	O	6	OBJ
11	in	in	B-PP	IN	O	10	NMOD
12	20	20	B-NP	CD	O	13	NMOD
13	patients	patient	I-NP	NNS	O	11	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	AMI	AMI	B-NP	NN	O	14	PMOD
16	before	before	B-PP	IN	O	10	NMOD
17	and	and	O	CC	O	16	PMOD
18	daily	daily	B-ADVP	RB	O	19	AMOD
19	for	for	B-PP	IN	O	16	PMOD
20	5	5	B-NP	CD	O	21	NMOD
21	days	day	I-NP	NNS	O	19	PMOD
22	after	after	B-PP	IN	O	21	NMOD
23	direct	direct	B-NP	JJ	O	27	NMOD
24	percutaneous	percutaneous	I-NP	JJ	O	27	NMOD
25	transluminal	transluminal	I-NP	JJ	O	27	NMOD
26	coronary	coronary	I-NP	JJ	O	27	NMOD
27	angioplasty	angioplasty	I-NP	NN	O	22	PMOD
28	(	(	O	(	O	29	P
29	PTCA	PTCA	B-NP	NN	B-protein	27	NMOD
30	)	)	O	)	O	29	P
31	and	and	O	CC	O	16	PMOD
32	in	in	B-PP	IN	O	16	PMOD
33	20	20	B-NP	CD	O	34	NMOD
34	patients	patient	I-NP	NNS	O	32	PMOD
35	undergoing	undergo	B-VP	VBG	O	34	NMOD
36	elective	elective	B-NP	JJ	O	37	NMOD
37	PTCA	PTCA	I-NP	NN	O	35	OBJ
38	.	.	O	.	O	3	P

1	Throughout	Throughout	B-PP	IN	O	14	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	study	study	I-NP	NN	O	4	NMOD
4	period	period	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	14	P
6	CD41	CD41	B-NP	NN	B-protein	7	NMOD
7	immunofluorescence	immunofluorescence	I-NP	NN	O	14	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	leukocytes	leukocyte	B-NP	NNS	B-cell_type	8	PMOD
10	(	(	O	(	O	12	P
11	flow	flow	B-NP	NN	O	12	NMOD
12	cytometry	cytometry	I-NP	NN	O	9	NMOD
13	)	)	O	)	O	12	P
14	revealed	reveal	B-VP	VBD	O	0	ROOT
15	increased	increase	B-NP	VBN	O	17	NMOD
16	leukocyte-platelet	leukocyte-platelet	I-NP	JJ	O	17	NMOD
17	adhesion	adhesion	I-NP	NN	O	14	OBJ
18	in	in	B-PP	IN	O	17	NMOD
19	patients	patient	B-NP	NNS	O	18	PMOD
20	with	with	B-PP	IN	O	19	NMOD
21	AMI	AMI	B-NP	NN	O	20	PMOD
22	compared	compare	B-PP	VBN	O	14	VMOD
23	with	with	B-PP	IN	O	22	VMOD
24	control	control	B-NP	NN	O	25	NMOD
25	patients	patient	I-NP	NNS	O	29	NMOD
26	(	(	O	(	O	29	P
27	mean	mean	B-NP	NN	O	29	NMOD
28	+/-	+/-	O	CC	O	29	NMOD
29	SE	SE	B-NP	NN	O	23	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	fluorescence	fluorescence	B-NP	NN	O	30	PMOD
32	[	[	O	(	O	33	P
33	channels	channel	B-NP	NNS	O	31	NMOD
34	]	]	O	)	O	33	P
35	before	before	B-PP	IN	O	29	NMOD
36	PTCA	PTCA	B-NP	NN	O	35	PMOD
37	:	:	O	:	O	22	P
38	77	77	B-NP	CD	O	44	NMOD
39	+/-	+/-	I-NP	CC	O	44	NMOD
40	16	16	I-NP	CD	O	44	NMOD
41	versus	versus	I-NP	CC	O	44	NMOD
42	35	35	I-NP	CD	O	44	NMOD
43	+/-	+/-	I-NP	CC	O	44	NMOD
44	9	9	I-NP	CD	O	22	PMOD
45	;	;	O	:	O	48	P
46	P	P	B-NP	NN	O	48	SUB
47	=	=	B-VP	SYM	O	48	VMOD
48	.003	.003	B-NP	CD	O	44	NMOD
49	)	)	O	)	O	48	P
50	.	.	O	.	O	14	P

1	In	In	B-ADVP	FW	O	7	VMOD
2	vitro	vitro	I-ADVP	FW	O	1	AMOD
3	,	,	O	,	O	7	P
4	thrombin-stimulated	thrombin-stimulated	B-NP	JJ	B-cell_type	6	NMOD
5	fixed	fixed	I-NP	JJ	I-cell_type	6	NMOD
6	platelets	platelet	I-NP	NNS	I-cell_type	7	SUB
7	bound	bind	B-VP	VBD	O	0	ROOT
8	to	to	B-PP	TO	O	7	VMOD
9	neutrophils	neutrophil	B-NP	NNS	B-cell_type	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	monocytes	monocyte	I-NP	NNS	B-cell_type	8	PMOD
12	.	.	O	.	O	7	P

1	Within	Within	B-PP	IN	O	6	VMOD
2	2	2	B-NP	CD	O	3	NMOD
3	hours	hour	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	6	P
5	this	this	B-NP	DT	O	6	SUB
6	resulted	result	B-VP	VBD	O	0	ROOT
7	in	in	B-PP	IN	O	6	VMOD
8	increased	increase	B-NP	VBN	O	9	NMOD
9	mRNA	mRNA	I-NP	NN	B-RNA	7	PMOD
10	for	for	B-PP	IN	O	9	NMOD
11	interleukin	interleukin	B-NP	NN	B-protein	28	NMOD
12	(	(	O	(	I-protein	13	P
13	IL	IL	B-NP	NN	I-protein	11	NMOD
14	)	)	O	)	I-protein	13	P
15	,	,	O	,	I-protein	28	P
16	1	1	B-NP	CD	I-protein	17	NMOD
17	beta	beta	B-NP	SYM	I-protein	28	NMOD
18	,	,	O	,	O	28	P
19	IL-8	IL-8	B-NP	NN	B-protein	28	NMOD
20	,	,	O	,	O	28	P
21	and	and	O	CC	O	28	NMOD
22	monocyte	monocyte	B-NP	NN	B-protein	28	NMOD
23	chemoattractant	chemoattractant	I-NP	NN	I-protein	28	NMOD
24	protein	protein	I-NP	NN	I-protein	28	NMOD
25	(	(	O	(	I-protein	26	P
26	MCP	MCP	B-NP	NN	I-protein	24	NMOD
27	)	)	O	)	I-protein	26	P
28	-1	-1	B-NP	CD	I-protein	10	PMOD
29	in	in	B-PP	IN	O	28	NMOD
30	unfractionated	unfractionated	B-NP	JJ	B-cell_type	31	NMOD
31	leukocytes	leukocyte	I-NP	NNS	I-cell_type	29	PMOD
32	.	.	O	.	O	6	P

1	After	After	B-PP	IN	O	14	VMOD
2	4	4	B-NP	CD	O	3	NMOD
3	hours	hour	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	14	P
5	IL-1	IL-1	B-NP	NN	B-protein	6	NMOD
6	beta	beta	I-NP	NN	I-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	IL-8	IL-8	I-NP	NN	B-protein	9	NMOD
9	concentration	concentration	I-NP	NN	O	14	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	cell-free	cell-free	I-NP	JJ	O	13	NMOD
13	supernatant	supernatant	I-NP	NN	O	10	PMOD
14	had	have	B-VP	VBD	O	33	VMOD
15	increased	increase	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	268	268	B-NP	CD	O	19	AMOD
18	+/-	+/-	I-NP	CC	O	19	AMOD
19	36	36	I-NP	CD	O	25	NMOD
20	%	%	I-NP	NN	O	25	NMOD
21	and	and	I-NP	CC	O	25	NMOD
22	210	210	I-NP	CD	O	24	AMOD
23	+/-	+/-	I-NP	SYM	O	24	AMOD
24	7	7	I-NP	CD	O	25	NMOD
25	%	%	I-NP	NN	O	16	PMOD
26	,	,	O	,	O	15	P
27	respectively	respectively	B-ADVP	RB	O	15	VMOD
28	,	,	O	,	O	33	P
29	and	and	O	CC	O	32	NMOD
30	cellular	cellular	B-NP	JJ	O	32	NMOD
31	MCP-1	MCP-1	I-NP	NN	B-protein	32	NMOD
32	content	content	I-NP	NN	O	33	SUB
33	had	have	B-VP	VBD	O	0	ROOT
34	increased	increase	I-VP	VBN	O	33	VC
35	by	by	B-PP	IN	O	34	VMOD
36	170	170	B-NP	CD	O	38	AMOD
37	+/-	+/-	I-NP	SYM	O	38	AMOD
38	8	8	I-NP	CD	O	39	NMOD
39	%	%	I-NP	NN	O	35	PMOD
40	.	.	O	.	O	33	P

1	Addition	Addition	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	activated	activate	B-NP	VBN	B-cell_type	4	NMOD
4	platelets	platelet	I-NP	NNS	I-cell_type	2	PMOD
5	to	to	B-PP	TO	O	1	NMOD
6	adherent	adherent	B-NP	JJ	B-cell_type	7	NMOD
7	monocytes	monocyte	I-NP	NNS	I-cell_type	5	PMOD
8	had	have	B-VP	VBD	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	similar	similar	I-NP	JJ	O	11	NMOD
11	effect	effect	I-NP	NN	O	8	OBJ
12	and	and	O	CC	O	8	VMOD
13	was	be	B-VP	VBD	O	8	VMOD
14	associated	associate	I-VP	VBN	O	13	VC
15	with	with	B-PP	IN	O	14	VMOD
16	nuclear	nuclear	B-NP	JJ	B-protein	19	NMOD
17	factor-kappa	factor-kappa	I-NP	NN	I-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	activation	activation	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	8	P

1	Inhibition	Inhibition	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	binding	binding	B-NP	NN	O	2	PMOD
4	by	by	B-PP	IN	O	1	NMOD
5	anti-P	anti-P	B-NP	JJ	B-protein	7	NMOD
6	selectin	selectin	I-NP	NN	I-protein	7	NMOD
7	antibodies	antibody	I-NP	NNS	I-protein	4	PMOD
8	reduced	reduce	B-VP	VBD	O	0	ROOT
9	the	the	B-NP	DT	O	10	NMOD
10	effect	effect	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	activated	activate	B-NP	VBN	B-cell_type	13	NMOD
13	platelets	platelet	I-NP	NNS	I-cell_type	11	PMOD
14	on	on	B-PP	IN	O	8	VMOD
15	cytokine	cytokine	B-NP	NN	B-protein	16	NMOD
16	production	production	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	8	P

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT
2	:	:	O	:	O	1	P
3	In	In	B-PP	IN	O	10	VMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	with	with	B-PP	IN	O	4	NMOD
6	AMI	AMI	B-NP	NN	O	5	PMOD
7	,	,	O	,	O	10	P
8	leukocyte-platelet	leukocyte-platelet	B-NP	JJ	O	9	NMOD
9	adhesion	adhesion	I-NP	NN	O	10	SUB
10	is	be	B-VP	VBZ	O	1	NMOD
11	increased	increase	I-VP	VBN	O	10	VC
12	.	.	O	.	O	10	P

1	Binding	Binding	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	activated	activate	B-NP	VBN	B-cell_type	4	NMOD
4	platelets	platelet	I-NP	NNS	I-cell_type	2	PMOD
5	induces	induce	B-VP	VBZ	O	0	ROOT
6	IL-1	IL-1	B-NP	NN	B-protein	7	NMOD
7	beta	beta	I-NP	NN	I-protein	12	NMOD
8	,	,	O	,	O	12	P
9	IL-8	IL-8	B-NP	NN	B-protein	12	NMOD
10	,	,	O	,	O	12	P
11	and	and	O	CC	O	12	NMOD
12	MCP-1	MCP-1	B-NP	NN	B-protein	5	OBJ
13	in	in	B-PP	IN	O	5	VMOD
14	leukocytes	leukocyte	B-NP	NNS	B-cell_type	13	PMOD
15	.	.	O	.	O	5	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	leukocyte-platelet	leukocyte-platelet	B-NP	JJ	O	6	NMOD
6	adhesion	adhesion	I-NP	NN	O	7	SUB
7	contributes	contribute	B-VP	VBZ	O	4	SBAR
8	to	to	B-PP	TO	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	regulation	regulation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	inflammatory	inflammatory	B-NP	JJ	O	13	NMOD
13	responses	response	I-NP	NNS	O	11	PMOD
14	in	in	B-PP	IN	O	10	NMOD
15	AMI	AMI	B-NP	NN	O	14	PMOD
16	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	5	NMOD
2	class	class	I-NP	NN	B-protein	4	NMOD
3	II	II	I-NP	CD	I-protein	4	NMOD
4	trans-activator	trans-activator	I-NP	NN	I-protein	5	NMOD
5	CIITA	CIITA	I-NP	NN	B-protein	6	SUB
6	interacts	interact	B-VP	VBZ	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	11	NMOD
9	TBP-associated	TBP-associated	I-NP	JJ	B-protein	11	NMOD
10	factor	factor	I-NP	NN	I-protein	11	NMOD
11	TAFII32	TAFII32	I-NP	NN	I-protein	7	PMOD
12	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	5	NMOD
2	class	class	I-NP	NN	B-protein	5	NMOD
3	II	II	I-NP	CD	I-protein	5	NMOD
4	trans-	trans-	I-NP	JJ	I-protein	5	NMOD
5	activator	activator	I-NP	NN	I-protein	9	SUB
6	(	(	O	(	O	7	P
7	CIITA	CIITA	B-NP	NN	B-protein	5	NMOD
8	)	)	O	)	O	7	P
9	is	be	B-VP	VBZ	O	0	ROOT
10	the	the	B-NP	DT	O	13	NMOD
11	main	main	I-NP	JJ	O	13	NMOD
12	transcriptional	transcriptional	I-NP	JJ	O	13	NMOD
13	co-activator	co-activator	I-NP	NN	O	9	PRD
14	for	for	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	16	NMOD
16	expression	expression	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	MHC	MHC	B-NP	NN	B-protein	21	NMOD
19	class	class	I-NP	NN	I-protein	21	NMOD
20	II	II	B-NP	CD	I-protein	21	NMOD
21	proteins	protein	I-NP	NNS	I-protein	17	PMOD
22	.	.	O	.	O	9	P

1	Its	Its	B-NP	PRP$	O	5	NMOD
2	N-terminal	N-terminal	I-NP	JJ	B-protein	5	NMOD
3	125	125	I-NP	CD	I-protein	5	NMOD
4	amino	amino	I-NP	NN	I-protein	5	NMOD
5	acids	acid	I-NP	NNS	I-protein	6	SUB
6	function	function	B-VP	VBP	O	0	ROOT
7	as	as	B-PP	IN	O	6	VMOD
8	an	an	B-NP	DT	O	12	NMOD
9	independent	independent	I-NP	JJ	B-protein	12	NMOD
10	transcriptional	transcriptional	I-NP	JJ	I-protein	12	NMOD
11	activation	activation	I-NP	NN	I-protein	12	NMOD
12	domain	domain	I-NP	NN	I-protein	7	PMOD
13	.	.	O	.	O	6	P

1	Analyses	Analysis	B-NP	NNS	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	primary	primary	I-NP	JJ	B-DNA	7	NMOD
5	amino	amino	I-NP	NN	I-DNA	7	NMOD
6	acid	acid	I-NP	NN	I-DNA	7	NMOD
7	sequence	sequence	I-NP	NN	I-DNA	2	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	activation	activation	I-NP	NN	O	11	NMOD
11	domain	domain	I-NP	NN	O	8	PMOD
12	predict	predict	B-VP	VBP	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	presence	presence	I-NP	NN	O	19	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	three	three	B-NP	CD	O	17	NMOD
17	alpha-helices	alpha-helice	I-NP	NNS	B-protein	15	PMOD
18	,	,	O	,	O	19	P
19	each	each	B-NP	DT	O	12	OBJ
20	with	with	B-PP	IN	O	12	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	high	high	I-NP	JJ	O	23	NMOD
23	proportion	proportion	I-NP	NN	O	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	acidic	acidic	B-NP	JJ	O	26	NMOD
26	residues	residue	I-NP	NNS	O	24	PMOD
27	.	.	O	.	O	12	P

1	Using	Use	B-VP	VBG	O	6	VMOD
2	site-directed	site-directed	B-NP	JJ	O	3	NMOD
3	mutagenesis	mutagenesis	I-NP	NN	O	1	OBJ
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	found	find	B-VP	VBD	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	two	two	B-NP	CD	O	13	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	these	these	B-NP	DT	O	12	NMOD
11	predicted	predict	I-NP	VBN	O	12	NMOD
12	alpha-helices	alpha-helice	I-NP	NNS	B-protein	9	PMOD
13	are	be	B-VP	VBP	O	7	SBAR
14	required	require	I-VP	VBN	O	13	VC
15	for	for	B-PP	IN	O	14	VMOD
16	full	full	B-NP	JJ	O	18	NMOD
17	transcriptional	transcriptional	I-NP	JJ	O	18	NMOD
18	activation	activation	I-NP	NN	O	15	PMOD
19	by	by	B-PP	IN	O	18	NMOD
20	CIITA	CIITA	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	6	P

1	Moreover	Moreover	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	a	a	B-NP	DT	O	5	NMOD
4	CIITA	CIITA	I-NP	NN	B-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	11	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	which	which	B-NP	WDT	O	6	PMOD
8	both	both	O	CC	O	10	NMOD
9	functional	functional	B-NP	JJ	O	10	NMOD
10	alpha-helices	alpha-helice	I-NP	NNS	B-protein	6	PMOD
11	have	have	B-VP	VBP	O	0	ROOT
12	been	be	I-VP	VBN	O	11	VC
13	deleted	delete	I-VP	VBN	O	12	VC
14	displays	display	B-VP	VBZ	O	11	VMOD
15	a	a	B-NP	DT	O	18	NMOD
16	dominant	dominant	I-NP	JJ	O	18	NMOD
17	negative	negative	I-NP	JJ	O	18	NMOD
18	phenotype	phenotype	I-NP	NN	O	14	OBJ
19	.	.	O	.	O	11	P

1	This	This	B-NP	DT	O	3	NMOD
2	activation	activation	I-NP	NN	O	3	NMOD
3	domain	domain	I-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	CIITA	CIITA	B-NP	NN	B-protein	4	PMOD
6	interacts	interact	B-VP	VBZ	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	11	NMOD
9	32	32	I-NP	CD	B-protein	10	AMOD
10	kDa	kDa	I-NP	NN	I-protein	11	NMOD
11	subunit	subunit	I-NP	NN	I-protein	19	NMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	17	NMOD
14	general	general	I-NP	JJ	B-protein	16	NMOD
15	transcription	transcription	I-NP	NN	I-protein	16	NMOD
16	complex	complex	I-NP	NN	I-protein	17	NMOD
17	TFIID	TFIID	I-NP	NN	B-protein	12	PMOD
18	,	,	O	,	O	19	P
19	TAFII32	TAFII32	B-NP	NN	B-protein	7	PMOD
20	.	.	O	.	O	6	P

1	Decreased	Decrease	B-NP	VBN	O	3	NMOD
2	transcriptional	transcriptional	I-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	9	SUB
4	by	by	B-PP	IN	O	3	NMOD
5	N-terminal	N-terminal	B-NP	JJ	B-protein	6	NMOD
6	deletions	deletion	I-NP	NNS	I-protein	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	CIITA	CIITA	B-NP	NN	B-protein	7	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	correlated	correlate	I-VP	VBN	O	9	VC
11	directly	directly	B-ADVP	RB	O	10	VMOD
12	with	with	B-PP	IN	O	10	VMOD
13	their	their	B-NP	PRP$	O	15	NMOD
14	reduced	reduce	I-NP	VBN	O	15	NMOD
15	binding	binding	I-NP	NN	O	12	PMOD
16	to	to	B-PP	TO	O	15	NMOD
17	TAFII32	TAFII32	B-NP	NN	B-protein	16	PMOD
18	.	.	O	.	O	9	P

1	We	We	B-NP	PRP	O	2	SUB
2	conclude	conclude	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	interactions	interaction	B-NP	NNS	O	9	SUB
5	between	between	B-PP	IN	O	4	NMOD
6	TAFII32	TAFII32	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	CIITA	CIITA	I-NP	NN	B-protein	5	PMOD
9	are	be	B-VP	VBP	O	3	SBAR
10	responsible	responsible	B-ADJP	JJ	O	9	PRD
11	for	for	B-PP	IN	O	10	AMOD
12	activation	activation	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	class	class	B-NP	NN	B-DNA	16	NMOD
15	II	II	B-NP	CD	I-DNA	16	NMOD
16	genes	gene	I-NP	NNS	I-DNA	13	PMOD
17	.	.	O	.	O	2	P

1	Lipopolysaccharide	Lipopolysaccharide	B-NP	NN	O	2	NMOD
2	induction	induction	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	8	NMOD
5	tumor	tumor	I-NP	NN	B-DNA	8	NMOD
6	necrosis	necrosis	I-NP	NN	I-DNA	8	NMOD
7	factor-alpha	factor-alpha	I-NP	NN	I-DNA	8	NMOD
8	promoter	promoter	I-NP	NN	I-DNA	3	PMOD
9	in	in	B-PP	IN	O	2	NMOD
10	human	human	B-NP	JJ	B-cell_type	12	NMOD
11	monocytic	monocytic	I-NP	JJ	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
13	.	.	O	.	O	2	P

1	Regulation	Regulation	B-NP	NN	O	0	ROOT
2	by	by	B-PP	IN	O	1	NMOD
3	Egr-1	Egr-1	B-NP	NN	B-protein	10	NMOD
4	,	,	O	,	O	10	P
5	c-Jun	c-Jun	B-NP	NN	B-protein	10	NMOD
6	,	,	O	,	O	10	P
7	and	and	O	CC	O	10	NMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	NMOD
9	transcription	transcription	I-NP	NN	B-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	2	PMOD
11	.	.	O	.	O	1	P

1	Biosynthesis	Biosynthesis	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	tumor	tumor	B-NP	NN	B-protein	5	NMOD
4	necrosis	necrosis	I-NP	NN	I-protein	5	NMOD
5	factor-alpha	factor-alpha	I-NP	NN	I-protein	2	PMOD
6	(	(	O	(	O	7	P
7	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	5	NMOD
8	)	)	O	)	O	7	P
9	is	be	B-VP	VBZ	O	0	ROOT
10	predominantly	predominantly	B-ADVP	RB	O	9	VMOD
11	by	by	B-PP	IN	O	9	VMOD
12	cells	cell	B-NP	NNS	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	monocytic	monocytic	I-NP	JJ	B-cell_type	16	NMOD
16	lineage	lineage	I-NP	NN	I-cell_type	13	PMOD
17	.	.	O	.	O	9	P

1	This	This	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	examined	examine	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	role	role	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	various	various	B-NP	JJ	O	6	PMOD
8	cis-acting	cis-acting	I-NP	JJ	B-DNA	10	NMOD
9	regulatory	regulatory	I-NP	JJ	I-DNA	10	NMOD
10	elements	element	I-NP	NNS	I-DNA	7	NMOD
11	in	in	B-PP	IN	O	5	NMOD
12	the	the	B-NP	DT	O	17	NMOD
13	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	17	NMOD
14	(	(	O	(	O	15	P
15	LPS	LPS	B-NP	NN	O	13	NMOD
16	)	)	O	)	O	15	P
17	induction	induction	B-NP	NN	O	11	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	human	human	I-NP	JJ	B-DNA	22	NMOD
21	TNF-alpha	TNF-alpha	I-NP	NN	I-DNA	22	NMOD
22	promoter	promoter	I-NP	NN	I-DNA	18	PMOD
23	in	in	B-PP	IN	O	17	NMOD
24	cells	cell	B-NP	NNS	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	monocytic	monocytic	B-NP	JJ	B-cell_type	27	NMOD
27	lineage	lineage	I-NP	NN	I-cell_type	25	PMOD
28	.	.	O	.	O	3	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	16	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	monocytic	monocytic	B-NP	JJ	B-cell_line	6	NMOD
5	THP-1	THP-1	I-NP	NN	I-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	3	PMOD
7	transfected	transfecte	B-VP	VBN	O	6	NMOD
8	with	with	B-PP	IN	O	7	VMOD
9	plasmids	plasmid	B-NP	NNS	B-DNA	8	PMOD
10	containing	contain	B-VP	VBG	O	9	NMOD
11	various	various	B-NP	JJ	O	12	NMOD
12	lengths	length	I-NP	NNS	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	TNF-alpha	TNF-alpha	B-NP	NN	B-DNA	15	NMOD
15	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
16	localized	localize	B-VP	VBD	O	0	ROOT
17	enhancer	enhancer	B-NP	NN	B-DNA	18	NMOD
18	elements	element	I-NP	NNS	I-DNA	16	OBJ
19	in	in	B-PP	IN	O	16	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	region	region	I-NP	NN	O	27	NMOD
22	(	(	O	(	O	27	P
23	-182	-182	B-NP	CD	B-DNA	27	NMOD
24	to	to	I-NP	TO	I-DNA	27	NMOD
25	-37	-37	I-NP	CD	I-DNA	27	NMOD
26	base	base	I-NP	NN	I-DNA	27	NMOD
27	pairs	pair	I-NP	NNS	I-DNA	19	PMOD
28	(	(	O	(	O	29	P
29	bp	bp	B-NP	NN	O	27	NMOD
30	)	)	O	)	O	29	P
31	)	)	O	)	O	27	P
32	that	that	B-NP	WDT	O	27	NMOD
33	were	be	B-VP	VBD	O	32	SBAR
34	required	require	I-VP	VBN	O	33	VC
35	for	for	B-PP	IN	O	34	VMOD
36	optimal	optimal	B-NP	JJ	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	35	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	the	the	B-NP	DT	O	41	NMOD
40	TNF-alpha	TNF-alpha	I-NP	NN	B-DNA	41	NMOD
41	gene	gene	I-NP	NN	I-DNA	38	PMOD
42	in	in	B-PP	IN	O	37	NMOD
43	response	response	I-PP	NN	O	42	PMOD
44	to	to	I-PP	TO	O	43	NMOD
45	LPS	LPS	B-NP	NN	O	44	PMOD
46	.	.	O	.	O	16	P

1	Two	Two	B-NP	CD	O	2	NMOD
2	regions	region	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	28	VMOD
4	identified	identify	I-VP	VBN	O	3	VC
5	:	:	O	:	O	3	P
6	region	region	B-NP	NN	B-DNA	14	SUB
7	I	I	I-NP	CD	I-DNA	6	NMOD
8	(	(	O	(	O	12	P
9	-182	-182	B-NP	CD	B-DNA	11	AMOD
10	to	to	O	TO	I-DNA	11	AMOD
11	-162	-162	B-NP	CD	I-DNA	12	NMOD
12	bp	bp	I-NP	NN	I-DNA	6	NMOD
13	)	)	O	)	O	12	P
14	contained	contain	B-VP	VBD	O	3	VMOD
15	an	an	B-NP	DT	O	18	NMOD
16	overlapping	overlap	I-NP	VBG	O	18	NMOD
17	Sp1/Egr-1	Sp1/Egr-1	I-NP	NN	B-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	14	OBJ
19	,	,	O	,	O	28	P
20	and	and	O	CC	O	21	NMOD
21	region	region	B-NP	NN	B-DNA	28	SUB
22	II	II	I-NP	CD	I-DNA	21	NMOD
23	(	(	O	(	O	26	P
24	-119	-119	B-NP	CD	B-DNA	26	NMOD
25	to	to	O	TO	I-DNA	26	NMOD
26	-88	-88	B-NP	CD	I-DNA	21	NMOD
27	)	)	O	)	O	26	P
28	contained	contain	B-VP	VBD	O	0	ROOT
29	CRE	CRE	B-NP	NN	B-DNA	31	NMOD
30	and	and	I-NP	CC	O	31	NMOD
31	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	36	NMOD
32	(	(	O	(	O	34	P
33	designated	designate	B-NP	VBN	O	34	NMOD
34	kappaB3	kappaB3	I-NP	NN	B-DNA	31	NMOD
35	)	)	I-NP	)	O	34	P
36	sites	site	I-NP	NNS	O	28	OBJ
37	.	.	O	.	O	28	P

1	In	In	B-PP	IN	O	16	VMOD
2	unstimulated	unstimulated	B-NP	JJ	O	3	NMOD
3	THP-1	THP-1	I-NP	NN	B-cell_line	1	PMOD
4	,	,	O	,	O	16	P
5	CRE-binding	CRE-binding	B-NP	JJ	B-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	16	SUB
7	and	and	O	CC	O	16	VMOD
8	,	,	O	,	O	16	P
9	to	to	B-PP	TO	O	16	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	lesser	less	I-NP	JJR	O	12	NMOD
12	extent	extent	I-NP	NN	O	9	PMOD
13	,	,	O	,	O	16	P
14	c-Jun	c-Jun	B-NP	NN	B-protein	15	NMOD
15	complexes	complex	I-NP	NNS	I-protein	16	SUB
16	were	be	B-VP	VBD	O	0	ROOT
17	found	find	I-VP	VBN	O	16	VC
18	to	to	I-VP	TO	O	19	VMOD
19	bind	bind	I-VP	VB	O	17	VMOD
20	to	to	B-PP	TO	O	19	VMOD
21	the	the	B-NP	DT	O	23	NMOD
22	CRE	CRE	I-NP	NN	B-DNA	23	NMOD
23	site	site	I-NP	NN	I-DNA	20	PMOD
24	.	.	O	.	O	16	P

1	LPS	LPS	B-NP	NN	O	2	NMOD
2	stimulation	stimulation	I-NP	NN	O	3	SUB
3	increased	increase	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	binding	binding	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	c-Jun-containing	c-Jun-containing	B-NP	JJ	B-protein	8	NMOD
8	complexes	complex	I-NP	NNS	I-protein	6	PMOD
9	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	6	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	LPS	LPS	B-NP	NN	O	5	NMOD
5	stimulation	stimulation	I-NP	NN	O	6	SUB
6	induced	induce	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	binding	binding	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	cognate	cognate	B-NP	JJ	B-protein	12	NMOD
11	nuclear	nuclear	I-NP	JJ	I-protein	12	NMOD
12	factors	factor	I-NP	NNS	I-protein	9	PMOD
13	to	to	B-PP	TO	O	8	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	Egr-1	Egr-1	I-NP	NN	B-DNA	17	NMOD
16	and	and	I-NP	CC	I-DNA	17	NMOD
17	kappaB3	kappaB3	I-NP	NN	I-DNA	18	NMOD
18	sites	site	I-NP	NNS	I-DNA	13	PMOD
19	,	,	O	,	O	18	P
20	which	which	B-NP	WDT	O	18	NMOD
21	were	be	B-VP	VBD	O	20	SBAR
22	identified	identify	I-VP	VBN	O	21	VC
23	as	as	B-PP	IN	O	22	VMOD
24	Egr-1	Egr-1	B-NP	NN	B-protein	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	p50/p65	p50/p65	I-NP	NN	B-protein	23	PMOD
27	,	,	O	,	O	26	P
28	respectively	respectively	B-ADVP	RB	O	26	NMOD
29	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	5	NMOD
2	CRE	CRE	I-NP	NN	B-DNA	5	NMOD
3	and	and	I-NP	CC	I-DNA	5	NMOD
4	kappaB3	kappaB3	I-NP	NN	I-DNA	5	NMOD
5	sites	site	I-NP	NNS	I-DNA	10	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	region	region	B-NP	NN	B-DNA	6	PMOD
8	II	II	I-NP	CD	I-DNA	7	NMOD
9	together	together	B-ADVP	RB	O	10	VMOD
10	conferred	confer	B-VP	VBD	O	0	ROOT
11	strong	strong	B-NP	JJ	O	13	NMOD
12	LPS	LPS	I-NP	NN	O	13	NMOD
13	responsiveness	responsiveness	I-NP	NN	O	10	OBJ
14	to	to	B-PP	TO	O	13	NMOD
15	a	a	B-NP	DT	O	17	NMOD
16	heterologous	heterologous	I-NP	JJ	B-DNA	17	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	14	PMOD
18	,	,	O	,	O	10	P
19	whereas	whereas	O	IN	O	10	VMOD
20	individually	individually	B-ADVP	RB	O	22	VMOD
21	they	they	B-NP	PRP	O	22	SUB
22	failed	fail	B-VP	VBD	O	19	SBAR
23	to	to	I-VP	TO	O	24	VMOD
24	provide	provide	I-VP	VB	O	22	VMOD
25	transcriptional	transcriptional	B-NP	JJ	O	26	NMOD
26	activation	activation	I-NP	NN	O	24	OBJ
27	.	.	O	.	O	10	P

1	Furthermore	Furthermore	B-ADVP	RB	O	14	VMOD
2	,	,	O	,	O	14	P
3	increasing	increase	B-VP	VBG	O	5	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	spacing	spacing	I-NP	NN	O	14	SUB
6	between	between	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	CRE	CRE	I-NP	NN	B-DNA	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	kappaB3	kappaB3	I-NP	NN	B-DNA	12	NMOD
12	sites	site	I-NP	NNS	I-DNA	6	PMOD
13	completely	completely	B-ADVP	RB	O	14	VMOD
14	abolished	abolish	B-VP	VBD	O	0	ROOT
15	LPS	LPS	B-NP	NN	O	16	NMOD
16	induction	induction	I-NP	NN	O	14	OBJ
17	,	,	O	,	O	14	P
18	suggesting	suggest	B-VP	VBG	O	14	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	cooperative	cooperative	I-NP	JJ	O	21	NMOD
21	interaction	interaction	I-NP	NN	O	18	OBJ
22	between	between	B-PP	IN	O	21	NMOD
23	c-Jun	c-Jun	B-NP	NN	B-protein	24	NMOD
24	complexes	complex	I-NP	NNS	I-protein	26	NMOD
25	and	and	O	CC	O	26	NMOD
26	p50/p65	p50/p65	B-NP	NN	B-protein	22	PMOD
27	.	.	O	.	O	14	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	maximal	maximal	B-NP	JJ	O	7	NMOD
6	LPS	LPS	I-NP	NN	O	7	NMOD
7	induction	induction	I-NP	NN	O	12	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	TNF-alpha	TNF-alpha	I-NP	NN	B-DNA	11	NMOD
11	promoter	promoter	I-NP	NN	I-DNA	8	PMOD
12	is	be	B-VP	VBZ	O	4	SBAR
13	mediated	mediate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	concerted	concerted	B-NP	JJ	O	16	NMOD
16	participation	participation	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	at	at	B-NP	IN	O	24	NMOD
19	least	least	I-NP	JJS	O	18	AMOD
20	two	two	I-NP	CD	O	18	AMOD
21	separate	separate	I-NP	JJ	O	24	NMOD
22	cis-acting	cis-acting	I-NP	JJ	B-DNA	24	NMOD
23	regulatory	regulatory	I-NP	JJ	I-DNA	24	NMOD
24	elements	element	I-NP	NNS	I-DNA	17	PMOD
25	.	.	O	.	O	3	P

1	Involvement	Involvement	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	Rel	Rel	B-NP	NN	B-protein	9	NMOD
4	,	,	O	,	O	9	P
5	Fos	Fos	B-NP	NN	B-protein	9	NMOD
6	,	,	O	,	O	9	P
7	and	and	O	CC	O	9	NMOD
8	Jun	Jun	B-NP	NN	B-protein	9	NMOD
9	proteins	protein	I-NP	NNS	I-protein	2	PMOD
10	in	in	B-PP	IN	O	1	NMOD
11	binding	binding	B-NP	NN	O	12	NMOD
12	activity	activity	I-NP	NN	O	10	PMOD
13	to	to	B-PP	TO	O	12	NMOD
14	the	the	B-NP	DT	O	20	NMOD
15	IL-2	IL-2	I-NP	NN	B-DNA	20	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	20	NMOD
17	CD28	CD28	I-NP	NN	I-DNA	20	NMOD
18	response	response	I-NP	NN	I-DNA	20	NMOD
19	element/AP-1	element/AP-1	I-NP	NN	I-DNA	20	NMOD
20	sequence	sequence	I-NP	NN	I-DNA	13	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	human	human	B-NP	JJ	B-cell_type	24	NMOD
23	T	T	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
25	.	.	O	.	O	1	P

1	CD28	CD28	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	an	an	B-NP	DT	O	6	NMOD
4	important	important	I-NP	JJ	O	6	NMOD
5	costimulatory	costimulatory	I-NP	JJ	B-protein	6	NMOD
6	molecule	molecule	I-NP	NN	I-protein	2	PRD
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	activation	activation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	B-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
14	.	.	O	.	O	2	P

1	Costimulation	Costimulation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	through	through	B-PP	IN	O	1	NMOD
6	both	both	O	CC	O	11	NMOD
7	the	the	B-NP	DT	O	11	NMOD
8	Ag	Ag	I-NP	NN	B-protein	9	NMOD
9	receptor	receptor	I-NP	NN	I-protein	11	NMOD
10	and	and	I-NP	CC	O	11	NMOD
11	CD28	CD28	I-NP	NN	B-protein	5	PMOD
12	leads	lead	B-VP	VBZ	O	0	ROOT
13	to	to	B-PP	TO	O	12	VMOD
14	high	high	B-NP	JJ	O	17	NMOD
15	level	level	I-NP	NN	O	17	NMOD
16	IL-2	IL-2	I-NP	NN	B-protein	17	NMOD
17	production	production	I-NP	NN	O	13	PMOD
18	,	,	O	,	O	17	P
19	which	which	B-NP	WDT	O	17	NMOD
20	is	be	B-VP	VBZ	O	19	SBAR
21	vital	vital	B-ADJP	JJ	O	20	PRD
22	to	to	B-PP	TO	O	21	AMOD
23	the	the	B-NP	DT	O	24	NMOD
24	development	development	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	an	an	B-NP	DT	O	28	NMOD
27	immune	immune	I-NP	JJ	O	28	NMOD
28	response	response	I-NP	NN	O	25	PMOD
29	in	in	B-ADVP	FW	O	28	NMOD
30	vivo	vivo	I-ADVP	FW	O	29	AMOD
31	.	.	O	.	O	12	P

1	Previous	Previous	B-NP	JJ	O	2	NMOD
2	reports	report	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	suggested	suggest	I-VP	VBN	O	3	VC
5	the	the	B-NP	DT	O	7	NMOD
6	CD28	CD28	I-NP	NN	B-protein	7	NMOD
7	stimulation	stimulation	I-NP	NN	O	8	SUB
8	contributes	contribute	B-VP	VBZ	O	4	VMOD
9	to	to	B-PP	TO	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	activation	activation	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	IL-2	IL-2	I-NP	NN	B-DNA	15	NMOD
15	promoter	promoter	I-NP	NN	I-DNA	12	PMOD
16	by	by	B-PP	IN	O	11	NMOD
17	up-regulating	up-regulate	B-VP	VBG	O	16	PMOD
18	the	the	B-NP	DT	O	19	NMOD
19	activity	activity	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	several	several	B-NP	JJ	O	23	NMOD
22	transcription	transcription	I-NP	NN	B-protein	23	NMOD
23	factors	factor	I-NP	NNS	I-protein	20	PMOD
24	,	,	O	,	O	23	P
25	including	include	B-PP	VBG	O	23	NMOD
26	AP-1	AP-1	B-NP	NN	B-protein	35	NMOD
27	and	and	O	CC	O	35	NMOD
28	nuclear	nuclear	B-NP	JJ	B-protein	29	NMOD
29	factor-kappaB	factor-kappaB	I-NP	NN	I-protein	35	NMOD
30	(	(	O	(	I-protein	35	P
31	NF-kappaB	NF-kappaB	B-NP	NN	I-protein	35	NMOD
32	)	)	O	)	I-protein	35	P
33	/Rel	/Rel	B-NP	NN	I-protein	35	NMOD
34	family	family	I-NP	NN	I-protein	35	NMOD
35	members	member	I-NP	NNS	I-protein	42	NMOD
36	as	as	B-CONJP	RB	O	42	NMOD
37	well	well	I-CONJP	RB	O	36	DEP
38	as	as	I-CONJP	IN	O	36	DEP
39	an	an	B-NP	DT	O	42	NMOD
40	uncharacterized	uncharacterized	I-NP	JJ	B-protein	42	NMOD
41	transcription	transcription	I-NP	NN	I-protein	42	NMOD
42	factor	factor	I-NP	NN	I-protein	25	PMOD
43	called	call	B-VP	VBN	O	42	NMOD
44	CD28	CD28	B-NP	NN	B-protein	46	NMOD
45	response	response	I-NP	NN	O	46	NMOD
46	complex	complex	I-NP	NN	O	43	VMOD
47	.	.	O	.	O	3	P

1	While	While	B-SBAR	IN	O	0	ROOT
2	several	several	B-NP	JJ	O	3	NMOD
3	lines	line	I-NP	NNS	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	investigation	investigation	B-NP	NN	O	4	PMOD
6	have	have	B-VP	VBP	O	1	SBAR
7	suggested	suggest	I-VP	VBN	O	6	VC
8	that	that	B-SBAR	IN	O	7	VMOD
9	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	NN	B-protein	11	NMOD
10	family	family	I-NP	NN	I-protein	11	NMOD
11	members	member	I-NP	NNS	I-protein	12	SUB
12	make	make	B-VP	VBP	O	23	VMOD
13	up	up	B-PRT	RP	O	12	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	CD28	CD28	I-NP	NN	B-protein	16	NMOD
16	response	response	I-NP	NN	O	19	NMOD
17	complex	complex	I-NP	NN	O	19	NMOD
18	transcription	transcription	I-NP	NN	B-protein	19	NMOD
19	factor	factor	I-NP	NN	I-protein	22	NMOD
20	,	,	O	,	O	22	P
21	other	other	B-NP	JJ	O	22	NMOD
22	work	work	I-NP	NN	O	23	SUB
23	has	have	B-VP	VBZ	O	8	SBAR
24	not	not	I-VP	RB	O	23	VMOD
25	supported	support	I-VP	VBN	O	23	VC
26	this	this	B-NP	DT	O	27	NMOD
27	conclusion	conclusion	I-NP	NN	O	25	OBJ
28	.	.	O	.	O	1	P

1	Recent	Recent	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	CD28	CD28	I-NP	NN	B-DNA	8	NMOD
7	response	response	I-NP	NN	I-DNA	8	NMOD
8	element	element	I-NP	NN	I-DNA	12	SUB
9	(	(	O	(	O	10	P
10	CD28RE	CD28RE	B-NP	NN	B-DNA	8	NMOD
11	)	)	O	)	O	10	P
12	does	do	B-VP	VBZ	O	31	VMOD
13	not	not	I-VP	RB	O	12	VMOD
14	function	function	I-VP	VB	O	12	VC
15	independently	independently	B-ADVP	RB	O	14	VMOD
16	but	but	O	CC	O	12	VMOD
17	works	work	B-VP	VBZ	O	31	VMOD
18	instead	instead	B-ADVP	RB	O	17	VMOD
19	in	in	B-PP	IN	O	17	VMOD
20	conjunction	conjunction	B-NP	NN	O	19	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	27	NMOD
23	adjacent	adjacent	I-NP	JJ	B-DNA	27	NMOD
24	promoter	promoter	I-NP	NN	I-DNA	27	NMOD
25	proximal	proximal	I-NP	JJ	I-DNA	27	NMOD
26	AP-1-binding	AP-1-binding	I-NP	JJ	I-DNA	27	NMOD
27	site	site	I-NP	NN	I-DNA	21	PMOD
28	and	and	O	CC	O	31	VMOD
29	this	this	B-NP	DT	O	30	NMOD
30	hypothesis	hypothesis	I-NP	NN	O	31	SUB
31	is	be	B-VP	VBZ	O	4	SBAR
32	confirmed	confirm	I-VP	VBN	O	31	VC
33	here	here	B-ADVP	RB	O	32	VMOD
34	.	.	O	.	O	3	P

1	Also	Also	B-ADVP	RB	O	17	VMOD
2	in	in	B-PP	IN	O	1	AMOD
3	the	the	B-NP	DT	O	5	NMOD
4	current	current	I-NP	JJ	O	5	NMOD
5	study	study	I-NP	NN	O	2	PMOD
6	,	,	O	,	O	17	P
7	binding	binding	B-NP	NN	O	8	NMOD
8	activity	activity	I-NP	NN	O	17	SUB
9	to	to	B-PP	TO	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	CD28RE/AP-1	CD28RE/AP-1	I-NP	NN	B-DNA	12	NMOD
12	sequence	sequence	I-NP	NN	I-DNA	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	IL-2	IL-2	I-NP	NN	B-DNA	16	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
17	is	be	B-VP	VBZ	O	0	ROOT
18	evaluated	evaluate	I-VP	VBN	O	17	VC
19	.	.	O	.	O	17	P

1	Although	Although	B-SBAR	IN	O	18	VMOD
2	four	four	B-NP	CD	O	4	NMOD
3	specific	specific	I-NP	JJ	O	4	NMOD
4	complexes	complex	I-NP	NNS	O	5	SUB
5	can	can	B-VP	MD	O	1	SBAR
6	be	be	I-VP	VB	O	5	VC
7	detected	detect	I-VP	VBN	O	6	VC
8	binding	bind	B-VP	VBG	O	7	VMOD
9	to	to	B-PP	TO	O	8	VMOD
10	this	this	B-NP	DT	O	11	NMOD
11	sequence	sequence	I-NP	NN	O	9	PMOD
12	,	,	O	,	O	18	P
13	only	only	B-NP	RB	O	14	NMOD
14	one	one	I-NP	CD	O	18	SUB
15	of	of	B-PP	IN	O	14	NMOD
16	these	these	B-NP	DT	O	17	NMOD
17	complexes	complex	I-NP	NNS	O	15	PMOD
18	is	be	B-VP	VBZ	O	0	ROOT
19	specific	specific	B-ADJP	JJ	O	18	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	both	both	O	CC	O	28	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	CD28RE	CD28RE	I-NP	NN	B-DNA	28	NMOD
24	and	and	O	CC	O	28	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	adjacent	adjacent	I-NP	JJ	B-DNA	28	NMOD
27	AP-1	AP-1	I-NP	NN	I-DNA	28	NMOD
28	site	site	I-NP	NN	I-DNA	20	PMOD
29	.	.	O	.	O	18	P

1	Of	Of	B-PP	IN	O	11	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	NF-kappaB/Rel	NF-kappaB/Rel	I-NP	NN	B-protein	5	NMOD
4	family	family	I-NP	NN	I-protein	5	NMOD
5	members	member	I-NP	NNS	I-protein	1	PMOD
6	tested	test	B-VP	VBN	O	5	NMOD
7	,	,	O	,	O	11	P
8	this	this	B-NP	DT	O	10	NMOD
9	CD28RE/AP-1-specific	CD28RE/AP-1-specific	I-NP	JJ	B-protein	10	NMOD
10	complex	complex	I-NP	NN	I-protein	11	SUB
11	contains	contain	B-VP	VBZ	O	0	ROOT
12	predominantly	predominantly	B-NP	RB	O	13	NMOD
13	c-Rel	c-Rel	I-NP	NN	B-protein	11	OBJ
14	,	,	O	,	O	11	P
15	despite	despite	B-PP	IN	O	11	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	fact	fact	I-NP	NN	O	15	PMOD
18	that	that	B-SBAR	IN	O	17	NMOD
19	both	both	O	CC	O	22	NMOD
20	p50	p50	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	RelA	RelA	I-NP	NN	B-protein	23	SUB
23	can	can	B-VP	MD	O	18	SBAR
24	efficiently	efficiently	I-VP	RB	O	23	VMOD
25	bind	bind	I-VP	VB	O	23	VC
26	to	to	B-PP	TO	O	25	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	CD28RE	CD28RE	I-NP	NN	B-DNA	26	PMOD
29	.	.	O	.	O	11	P

1	c-Fos	c-Fos	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	c-Jun	c-Jun	I-NP	NN	B-protein	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	also	also	I-VP	RB	O	4	VMOD
6	found	find	I-VP	VBN	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	this	this	B-NP	DT	O	10	NMOD
9	CD28RE/AP-1-specific	CD28RE/AP-1-specific	I-NP	JJ	B-protein	10	NMOD
10	complex	complex	I-NP	NN	I-protein	7	PMOD
11	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	functional	functional	B-NP	JJ	O	6	NMOD
6	complexes	complex	I-NP	NNS	O	15	SUB
7	encompassing	encompass	B-VP	VBG	O	6	NMOD
8	both	both	O	CC	O	14	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	CD28RE	CD28RE	I-NP	NN	B-DNA	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	AP-1-binding	AP-1-binding	I-NP	JJ	B-DNA	14	NMOD
14	sites	site	I-NP	NNS	I-DNA	7	OBJ
15	influence	influence	B-VP	VBP	O	4	SBAR
16	IL-2	IL-2	B-NP	NN	B-DNA	18	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	18	NMOD
18	activity	activity	I-NP	NN	O	15	OBJ
19	in	in	B-PP	IN	O	15	VMOD
20	CD28-costimulated	CD28-costimulated	B-NP	JJ	B-cell_type	22	NMOD
21	T	T	I-NP	NN	I-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
23	.	.	O	.	O	3	P

1	c-Myb	c-Myb	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	Ets	Ets	I-NP	NN	B-protein	4	NMOD
4	proteins	protein	I-NP	NNS	I-protein	5	SUB
5	synergize	synergize	B-VP	VBP	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	overcome	overcome	I-VP	VB	O	5	VMOD
8	transcriptional	transcriptional	B-NP	JJ	O	9	NMOD
9	repression	repression	I-NP	NN	O	7	OBJ
10	by	by	B-PP	IN	O	7	VMOD
11	ZEB	ZEB	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	Zfh	Zfh	I-NP	NN	B-protein	3	NMOD
3	family	family	I-NP	NN	I-protein	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	zinc	zinc	B-NP	NN	B-protein	7	NMOD
6	finger/homeodomain	finger/homeodomain	I-NP	NN	I-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	4	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	first	first	I-VP	RB	O	8	VMOD
10	identified	identify	I-VP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	Drosophila	Drosophila	B-NP	FW	O	11	PMOD
13	where	where	B-ADVP	WRB	O	12	NMOD
14	it	it	B-NP	PRP	O	15	SUB
15	is	be	B-VP	VBZ	O	13	SBAR
16	required	require	I-VP	VBN	O	15	VC
17	for	for	B-PP	IN	O	16	VMOD
18	differentiation	differentiation	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	tissues	tissue	B-NP	NNS	O	19	PMOD
21	such	such	B-PP	JJ	O	22	PMOD
22	as	as	I-PP	IN	O	20	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	central	central	I-NP	JJ	O	26	NMOD
25	nervous	nervous	I-NP	JJ	O	26	NMOD
26	system	system	I-NP	NN	O	28	NMOD
27	and	and	I-NP	CC	O	28	NMOD
28	muscle	muscle	I-NP	NN	O	22	PMOD
29	.	.	O	.	O	8	P

1	ZEB	ZEB	B-NP	NN	B-protein	5	NMOD
2	,	,	O	,	O	5	P
3	a	a	B-NP	DT	O	5	NMOD
4	vertebrate	vertebrate	I-NP	JJ	O	5	NMOD
5	homolog	homolog	I-NP	NN	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	Zfh-1	Zfh-1	B-NP	NN	B-protein	6	PMOD
8	,	,	O	,	O	5	P
9	binds	bind	B-VP	VBZ	O	0	ROOT
10	a	a	B-NP	DT	O	11	NMOD
11	subset	subset	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	E	E	B-NP	NN	B-DNA	14	NMOD
14	boxes	box	I-NP	NNS	I-DNA	12	PMOD
15	and	and	O	CC	O	9	VMOD
16	blocks	block	B-VP	VBZ	O	9	VMOD
17	myogenesis	myogenesis	B-NP	NN	O	16	OBJ
18	through	through	B-PP	IN	O	16	VMOD
19	transcriptional	transcriptional	B-NP	JJ	O	20	NMOD
20	repression	repression	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	muscle	muscle	B-NP	NN	B-DNA	23	NMOD
23	genes	gene	I-NP	NNS	I-DNA	21	PMOD
24	.	.	O	.	O	9	P

1	We	We	B-NP	PRP	O	2	SUB
2	present	present	B-VP	VBP	O	0	ROOT
3	evidence	evidence	B-NP	NN	O	2	OBJ
4	here	here	B-ADVP	RB	O	2	VMOD
5	that	that	B-SBAR	IN	O	2	VMOD
6	ZEB	ZEB	B-NP	NN	B-protein	8	SUB
7	also	also	B-ADVP	RB	O	8	VMOD
8	has	have	B-VP	VBZ	O	5	SBAR
9	an	an	B-NP	DT	O	11	NMOD
10	important	important	I-NP	JJ	O	11	NMOD
11	role	role	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	8	VMOD
13	controlling	control	B-VP	VBG	O	12	PMOD
14	hematopoietic	hematopoietic	B-NP	JJ	B-DNA	16	NMOD
15	gene	gene	I-NP	NN	I-DNA	16	NMOD
16	transcription	transcription	I-NP	NN	O	13	OBJ
17	.	.	O	.	O	2	P

1	Two	Two	B-NP	CD	O	2	NMOD
2	families	family	I-NP	NNS	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	transcription	transcription	B-NP	NN	B-protein	5	NMOD
5	factors	factor	I-NP	NNS	I-protein	3	PMOD
6	that	that	B-NP	WDT	O	2	NMOD
7	are	be	B-VP	VBP	O	6	SBAR
8	required	require	I-VP	VBN	O	7	VC
9	for	for	B-PP	IN	O	8	VMOD
10	normal	normal	B-NP	JJ	O	11	NMOD
11	hematopoiesis	hematopoiesis	I-NP	NN	O	9	PMOD
12	are	be	B-VP	VBP	O	0	ROOT
13	c-Myb	c-Myb	B-NP	NN	B-protein	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	Ets	Ets	I-NP	NN	B-protein	12	PRD
16	.	.	O	.	O	12	P

1	These	These	B-NP	DT	O	2	NMOD
2	factors	factor	I-NP	NNS	O	3	SUB
3	act	act	B-VP	VBP	O	12	VMOD
4	synergistically	synergistically	B-ADVP	RB	O	3	VMOD
5	to	to	B-VP	TO	O	6	VMOD
6	activate	activate	I-VP	VB	O	3	VMOD
7	transcription	transcription	B-NP	NN	O	6	OBJ
8	,	,	O	,	O	12	P
9	and	and	O	CC	O	12	VMOD
10	this	this	B-NP	DT	O	11	NMOD
11	synergy	synergy	I-NP	NN	O	12	SUB
12	is	be	B-VP	VBZ	O	0	ROOT
13	required	require	I-VP	VBN	O	12	VC
14	for	for	B-PP	IN	O	13	VMOD
15	transcription	transcription	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	at	at	B-ADVP	IN	O	22	NMOD
18	least	least	I-ADVP	JJS	O	17	AMOD
19	several	several	B-NP	JJ	O	22	NMOD
20	important	important	I-NP	JJ	O	22	NMOD
21	hematopoietic	hematopoietic	I-NP	JJ	B-DNA	22	NMOD
22	genes	gene	I-NP	NNS	I-DNA	16	PMOD
23	.	.	O	.	O	12	P

1	ZEB	ZEB	B-NP	NN	B-protein	2	SUB
2	blocks	block	B-VP	VBZ	O	15	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	activity	activity	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	c-Myb	c-Myb	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	Ets	Ets	I-NP	NN	B-protein	5	PMOD
9	individually	individually	B-ADVP	RB	O	2	VMOD
10	,	,	O	,	O	15	P
11	but	but	O	CC	O	15	VMOD
12	together	together	B-ADVP	RB	O	11	DEP
13	the	the	B-NP	DT	O	14	NMOD
14	factors	factor	I-NP	NNS	O	15	SUB
15	synergize	synergize	B-VP	VBP	O	0	ROOT
16	to	to	I-VP	TO	O	17	VMOD
17	resist	resist	I-VP	VB	O	15	VMOD
18	this	this	B-NP	DT	O	19	NMOD
19	repression	repression	I-NP	NN	O	17	OBJ
20	.	.	O	.	O	15	P

1	Such	Such	B-NP	JJ	O	2	NMOD
2	repression	repression	I-NP	NN	O	3	SUB
3	imposes	impose	B-VP	VBZ	O	0	ROOT
4	a	a	B-NP	DT	O	5	NMOD
5	requirement	requirement	I-NP	NN	O	3	OBJ
6	for	for	B-PP	IN	O	5	NMOD
7	both	both	O	CC	O	10	NMOD
8	c-Myb	c-Myb	B-NP	NN	B-protein	10	NMOD
9	and	and	O	CC	O	10	NMOD
10	Ets	Ets	B-NP	NN	B-protein	6	PMOD
11	for	for	B-PP	IN	O	5	NMOD
12	transcriptional	transcriptional	B-NP	JJ	O	13	NMOD
13	activity	activity	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	3	P
15	providing	provide	B-VP	VBG	O	3	VMOD
16	one	one	B-NP	CD	O	17	NMOD
17	explanation	explanation	I-NP	NN	O	15	OBJ
18	for	for	B-PP	IN	O	17	NMOD
19	why	why	B-ADVP	WRB	O	18	PMOD
20	synergy	synergy	B-NP	NN	O	24	SUB
21	between	between	B-PP	IN	O	20	NMOD
22	these	these	B-NP	DT	O	23	NMOD
23	factors	factor	I-NP	NNS	O	21	PMOD
24	is	be	B-VP	VBZ	O	19	SBAR
25	important	important	B-ADJP	JJ	O	24	PRD
26	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	balance	balance	I-NP	NN	O	12	SUB
3	between	between	B-PP	IN	O	2	NMOD
4	repression	repression	B-NP	NN	O	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	ZEB	ZEB	B-NP	NN	B-protein	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	transcriptional	transcriptional	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	5	PMOD
10	by	by	B-PP	IN	O	2	NMOD
11	c-Myb/Ets	c-Myb/Ets	B-NP	NN	O	10	PMOD
12	provides	provide	B-VP	VBZ	O	0	ROOT
13	a	a	B-NP	DT	O	16	NMOD
14	flexible	flexible	I-NP	JJ	O	16	NMOD
15	regulatory	regulatory	I-NP	JJ	O	16	NMOD
16	mechanism	mechanism	I-NP	NN	O	12	OBJ
17	for	for	B-PP	IN	O	16	NMOD
18	controlling	control	B-VP	VBG	O	17	PMOD
19	gene	gene	B-NP	NN	O	20	NMOD
20	expression	expression	I-NP	NN	O	18	OBJ
21	in	in	B-PP	IN	O	20	NMOD
22	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
24	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	one	one	B-NP	CD	O	5	NMOD
5	target	target	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	this	this	B-NP	DT	O	9	NMOD
8	positive/negative	positive/negative	I-NP	JJ	O	9	NMOD
9	regulation	regulation	I-NP	NN	O	6	PMOD
10	in	in	B-ADVP	FW	O	9	NMOD
11	vivo	vivo	I-ADVP	FW	O	10	AMOD
12	is	be	B-VP	VBZ	O	3	SBAR
13	the	the	B-NP	DT	O	15	NMOD
14	alpha4	alpha4	I-NP	NN	B-protein	15	NMOD
15	integrin	integrin	I-NP	NN	I-protein	12	PRD
16	,	,	O	,	O	15	P
17	which	which	B-NP	WDT	O	15	NMOD
18	play	play	B-VP	VBP	O	17	SBAR
19	a	a	B-NP	DT	O	21	NMOD
20	key	key	I-NP	JJ	O	21	NMOD
21	role	role	I-NP	NN	O	18	OBJ
22	in	in	B-PP	IN	O	18	VMOD
23	normal	normal	B-NP	JJ	O	26	NMOD
24	hematopoiesis	hematopoiesis	I-NP	NN	O	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	function	function	I-NP	NN	O	22	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	mature	mature	B-NP	JJ	B-cell_type	29	NMOD
29	leukocytes	leukocyte	I-NP	NNS	I-cell_type	27	PMOD
30	.	.	O	.	O	2	P

1	GABP	GABP	B-NP	NN	B-protein	2	NMOD
2	factors	factor	I-NP	NNS	I-protein	3	SUB
3	bind	bind	B-VP	VBP	O	0	ROOT
4	to	to	B-PP	TO	O	3	VMOD
5	a	a	B-NP	DT	O	12	NMOD
6	distal	distal	I-NP	JJ	B-DNA	12	NMOD
7	interleukin	interleukin	I-NP	NN	I-DNA	12	NMOD
8	2	2	I-NP	CD	I-DNA	12	NMOD
9	(	(	O	(	I-DNA	12	P
10	IL-2	IL-2	B-NP	NN	I-DNA	12	NMOD
11	)	)	O	)	I-DNA	12	P
12	enhancer	enhancer	B-NP	NN	I-DNA	4	PMOD
13	and	and	O	CC	O	3	VMOD
14	contribute	contribute	B-VP	VBP	O	3	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	c-Raf-mediated	c-Raf-mediated	B-NP	JJ	O	17	NMOD
17	increase	increase	I-NP	NN	O	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	IL-2	IL-2	B-NP	NN	B-protein	20	NMOD
20	induction	induction	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	3	P

1	Triggering	Triggering	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	T-cell	T-cell	I-NP	NN	B-protein	6	NMOD
5	receptor-CD3	receptor-CD3	I-NP	NN	I-protein	6	NMOD
6	complex	complex	I-NP	NN	I-protein	2	PMOD
7	activates	activate	B-VP	VBZ	O	0	ROOT
8	two	two	B-NP	CD	O	11	NMOD
9	major	major	I-NP	JJ	O	11	NMOD
10	signal	signal	I-NP	NN	O	11	NMOD
11	cascades	cascade	I-NP	NNS	O	7	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	12	PMOD
15	,	,	O	,	O	28	P
16	(	(	B-LST	(	O	17	P
17	i	i	I-LST	LS	O	21	NMOD
18	)	)	O	)	O	17	P
19	Ca2+-dependent	Ca2+-dependent	B-NP	JJ	O	21	NMOD
20	signal	signal	I-NP	NN	O	21	NMOD
21	cascades	cascade	I-NP	NNS	O	28	NMOD
22	and	and	O	CC	O	28	NMOD
23	(	(	B-LST	(	O	24	P
24	ii	ii	I-LST	LS	O	28	NMOD
25	)	)	O	)	O	24	P
26	protein	protein	B-NP	NN	O	28	NMOD
27	kinase	kinase	I-NP	NN	O	28	NMOD
28	cascades	cascade	I-NP	NNS	O	7	VMOD
29	.	.	O	.	O	7	P

1	Both	Both	B-NP	DT	O	3	NMOD
2	signal	signal	I-NP	NN	O	3	NMOD
3	cascades	cascade	I-NP	NNS	O	4	SUB
4	contribute	contribute	B-VP	VBP	O	0	ROOT
5	to	to	B-PP	TO	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	induction	induction	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	15	NMOD
10	interleukin	interleukin	I-NP	NN	B-DNA	15	NMOD
11	2	2	I-NP	CD	I-DNA	10	NMOD
12	(	(	O	(	I-DNA	13	P
13	IL-2	IL-2	B-NP	NN	I-DNA	10	NMOD
14	)	)	O	)	I-DNA	13	P
15	gene	gene	B-NP	NN	I-DNA	8	PMOD
16	during	during	B-PP	IN	O	7	NMOD
17	T-cell	T-cell	B-NP	NN	O	18	NMOD
18	activation	activation	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	4	P

1	Prominent	Prominent	B-NP	JJ	O	4	NMOD
2	protein	protein	I-NP	NN	O	4	NMOD
3	kinase	kinase	I-NP	NN	O	4	NMOD
4	cascades	cascade	I-NP	NNS	O	5	SUB
5	are	be	B-VP	VBP	O	0	ROOT
6	those	those	B-NP	DT	O	5	PRD
7	that	that	B-NP	WDT	O	6	NMOD
8	activate	activate	B-VP	VBP	O	7	SBAR
9	mitogen-activated	mitogen-activated	B-NP	JJ	B-protein	14	NMOD
10	protein	protein	I-NP	NN	I-protein	14	NMOD
11	(	(	O	(	I-protein	14	P
12	MAP	MAP	B-NP	NN	I-protein	14	NMOD
13	)	)	O	)	I-protein	14	P
14	kinases	kinase	B-NP	NNS	I-protein	8	OBJ
15	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	c-Raf	c-Raf	B-NP	NN	B-protein	18	SUB
6	,	,	O	,	O	5	P
7	which	which	B-NP	WDT	O	5	NMOD
8	is	be	B-VP	VBZ	O	7	SBAR
9	at	at	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	helm	helm	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	16	NMOD
14	classic	classic	I-NP	JJ	O	16	NMOD
15	MAP-Erk	MAP-Erk	I-NP	NN	O	16	NMOD
16	cascade	cascade	I-NP	NN	O	12	PMOD
17	,	,	O	,	O	5	P
18	contributes	contribute	B-VP	VBZ	O	4	SBAR
19	to	to	B-PP	TO	O	18	VMOD
20	IL-2	IL-2	B-NP	NN	B-protein	21	NMOD
21	induction	induction	I-NP	NN	O	19	PMOD
22	through	through	B-PP	IN	O	18	VMOD
23	a	a	B-NP	DT	O	26	NMOD
24	distal	distal	I-NP	JJ	B-DNA	26	NMOD
25	enhancer	enhancer	I-NP	NN	I-DNA	26	NMOD
26	element	element	I-NP	NN	I-DNA	22	PMOD
27	spanning	span	B-VP	VBG	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	nucleotides	nucleotide	I-NP	NNS	O	27	OBJ
30	from	from	B-PP	IN	O	29	NMOD
31	positions	position	B-NP	NNS	O	30	PMOD
32	-502	-502	B-NP	CD	B-DNA	34	NMOD
33	to	to	B-PP	TO	I-DNA	34	NMOD
34	-413	-413	B-NP	CD	I-DNA	31	NMOD
35	in	in	B-PP	IN	O	27	VMOD
36	front	front	B-NP	NN	O	35	PMOD
37	of	of	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	41	NMOD
39	transcriptional	transcriptional	I-NP	JJ	B-DNA	41	NMOD
40	start	start	I-NP	NN	I-DNA	41	NMOD
41	site	site	I-NP	NN	I-DNA	37	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	the	the	B-NP	DT	O	45	NMOD
44	IL-2	IL-2	I-NP	NN	B-DNA	45	NMOD
45	gene	gene	I-NP	NN	I-DNA	42	PMOD
46	.	.	O	.	O	2	P

1	Induction	Induction	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	this	this	B-NP	DT	O	6	NMOD
4	distal	distal	I-NP	JJ	B-DNA	6	NMOD
5	IL-2	IL-2	I-NP	NN	I-DNA	6	NMOD
6	enhancer	enhancer	I-NP	NN	I-DNA	2	PMOD
7	differs	differ	B-VP	VBZ	O	0	ROOT
8	from	from	B-PP	IN	O	7	VMOD
9	induction	induction	B-NP	NN	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	proximal	proximal	I-NP	JJ	B-DNA	14	NMOD
13	IL-2	IL-2	I-NP	NN	I-DNA	14	NMOD
14	promoter-enhancer	promoter-enhancer	I-NP	NN	I-DNA	10	PMOD
15	,	,	O	,	O	7	P
16	since	since	B-SBAR	IN	O	7	VMOD
17	it	it	B-NP	PRP	O	18	SUB
18	is	be	B-VP	VBZ	O	16	SBAR
19	induced	induce	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	phorbol	phorbol	B-NP	NN	O	22	NMOD
22	esters	ester	I-NP	NNS	O	20	PMOD
23	alone	alone	B-ADVP	RB	O	22	NMOD
24	and	and	O	CC	O	22	NMOD
25	independent	independent	B-ADJP	JJ	O	22	NMOD
26	from	from	B-PP	IN	O	25	AMOD
27	Ca2+	Ca2+	B-NP	NN	O	28	NMOD
28	signals	signal	I-NP	NNS	O	26	PMOD
29	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	7	VMOD
2	DNA-protein	DNA-protein	B-NP	JJ	O	4	NMOD
3	binding	binding	I-NP	NN	O	4	NMOD
4	studies	study	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	detected	detect	B-VP	VBD	O	0	ROOT
8	the	the	B-NP	DT	O	9	NMOD
9	binding	binding	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	transcription	transcription	B-NP	NN	B-protein	12	NMOD
12	factors	factor	I-NP	NNS	I-protein	16	NMOD
13	GABP	GABP	B-NP	NN	B-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	16	NMOD
15	and	and	O	CC	I-protein	16	NMOD
16	-beta	-beta	B-NP	NN	I-protein	10	PMOD
17	to	to	B-PP	TO	O	9	NMOD
18	a	a	B-NP	DT	O	21	NMOD
19	dyad	dyad	I-NP	NN	B-DNA	21	NMOD
20	symmetry	symmetry	I-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	17	PMOD
22	(	(	O	(	O	23	P
23	DSE	DSE	B-NP	NN	B-DNA	21	NMOD
24	)	)	O	)	O	23	P
25	of	of	B-PP	IN	O	21	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	distal	distal	I-NP	JJ	B-DNA	28	NMOD
28	enhancer	enhancer	I-NP	NN	I-DNA	25	PMOD
29	,	,	O	,	O	21	P
30	which	which	B-NP	WDT	O	21	NMOD
31	is	be	B-VP	VBZ	O	30	SBAR
32	formed	form	I-VP	VBN	O	31	VC
33	by	by	B-PP	IN	O	32	VMOD
34	palindromic	palindromic	B-NP	JJ	B-DNA	36	NMOD
35	binding	bind	I-NP	VBG	I-DNA	36	NMOD
36	sites	site	I-NP	NNS	I-DNA	33	PMOD
37	of	of	B-PP	IN	O	36	NMOD
38	Ets-like	Ets-like	B-NP	JJ	B-protein	39	NMOD
39	factors	factor	I-NP	NNS	I-protein	37	PMOD
40	.	.	O	.	O	7	P

1	Introduction	Introduction	B-NP	NN	O	11	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	point	point	B-NP	NN	O	4	NMOD
4	mutations	mutation	I-NP	NNS	O	2	PMOD
5	suppressing	suppress	B-VP	VBG	O	4	NMOD
6	GABP	GABP	B-NP	NN	B-protein	7	NMOD
7	binding	binding	I-NP	NN	O	5	OBJ
8	to	to	B-PP	TO	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	DSE	DSE	I-NP	NN	B-DNA	8	PMOD
11	interfered	interfere	B-VP	VBD	O	0	ROOT
12	with	with	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	induction	induction	I-NP	NN	O	23	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	distal	distal	I-NP	JJ	B-DNA	18	NMOD
18	enhancer	enhancer	I-NP	NN	I-DNA	15	PMOD
19	and	and	O	CC	O	23	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	entire	entire	I-NP	JJ	O	23	NMOD
22	IL-2	IL-2	I-NP	NN	B-DNA	23	NMOD
23	promoter-enhancer	promoter-enhancer	I-NP	NN	I-DNA	12	PMOD
24	,	,	O	,	O	11	P
25	while	while	B-SBAR	IN	O	11	VMOD
26	overexpression	overexpression	B-NP	NN	O	31	SUB
27	of	of	B-PP	IN	O	26	NMOD
28	both	both	B-NP	DT	O	30	NMOD
29	GABP	GABP	I-NP	NN	B-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	27	PMOD
31	enhanced	enhance	B-VP	VBD	O	25	SBAR
32	the	the	B-NP	DT	O	35	NMOD
33	IL-2	IL-2	I-NP	NN	B-DNA	35	NMOD
34	promoter-enhancer	promoter-enhancer	I-NP	JJ	I-DNA	35	NMOD
35	induction	induction	I-NP	NN	O	31	OBJ
36	.	.	O	.	O	11	P

1	Overexpression	Overexpression	B-NP	NN	O	21	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	BXB	BXB	B-NP	NN	B-protein	8	NMOD
4	,	,	O	,	O	8	P
5	a	a	B-NP	DT	O	8	NMOD
6	constitutive	constitutive	I-NP	JJ	O	8	NMOD
7	active	active	I-NP	JJ	O	8	NMOD
8	version	version	I-NP	NN	O	2	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	c-Raf	c-Raf	B-NP	NN	B-protein	9	PMOD
11	,	,	B-PP	,	O	1	P
12	and	and	I-PP	CC	O	1	NMOD
13	of	of	B-PP	IN	O	12	PMOD
14	further	further	B-NP	JJ	O	15	NMOD
15	members	member	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	Ras-Raf-Erk	Ras-Raf-Erk	I-NP	NN	B-protein	20	NMOD
19	signal	signal	I-NP	NN	O	20	NMOD
20	cascade	cascade	I-NP	NN	O	16	PMOD
21	exerted	exert	B-VP	VBD	O	0	ROOT
22	an	an	B-NP	DT	O	23	NMOD
23	increase	increase	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	GABP-mediated	GABP-mediated	B-NP	JJ	B-DNA	27	NMOD
26	promoter-enhancer	promoter-enhancer	I-NP	JJ	I-DNA	27	NMOD
27	induction	induction	I-NP	NN	O	24	PMOD
28	.	.	O	.	O	21	P

1	In	In	B-PP	IN	O	0	ROOT
2	conjunction	conjunction	B-NP	NN	O	1	PMOD
3	with	with	B-PP	IN	O	2	NMOD
4	previously	previously	B-NP	RB	O	5	AMOD
5	published	publish	I-NP	VBN	O	6	NMOD
6	data	datum	I-NP	NNS	O	3	PMOD
7	on	on	B-PP	IN	O	6	NMOD
8	c-Raf-induced	c-Raf-induced	B-NP	JJ	O	9	NMOD
9	phosphorylation	phosphorylation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	GABP	GABP	B-NP	NN	B-protein	12	NMOD
12	factors	factor	I-NP	NNS	I-protein	16	NMOD
13	(	(	O	(	O	16	P
14	E.Flory	E.Flory	B-NP	NNP	O	16	NMOD
15	,	,	O	,	O	16	P
16	A	A	B-NP	NNP	O	10	PMOD
17	.	.	O	.	O	1	P

1	Hoffmeyer	Hoffmeyer	B-NP	NNP	O	8	NMOD
2	,	,	O	,	O	8	P
3	U.Smola	U.Smola	B-NP	NNP	O	8	NMOD
4	,	,	O	,	O	8	P
5	U.R.Rapp	U.R.Rapp	B-NP	NNP	O	8	NMOD
6	,	,	O	,	O	8	P
7	and	and	O	CC	O	8	NMOD
8	J.T.Bruder	J.T.Bruder	B-NP	NNP	O	19	NMOD
9	,	,	O	,	O	15	P
10	J.Virol.70	J.Virol.70	B-NP	NNP	O	15	NMOD
11	:	:	O	:	O	15	P
12	2260-	2260-	B-NP	CD	O	13	AMOD
13	2268	2268	I-NP	CD	O	15	NMOD
14	,	,	I-NP	,	O	15	P
15	1996	1996	I-NP	CD	O	8	NMOD
16	)	)	O	)	O	15	P
17	,	,	O	,	O	8	P
18	these	these	B-NP	DT	O	19	NMOD
19	results	result	I-NP	NNS	O	20	SUB
20	indicate	indicate	B-VP	VBP	O	0	ROOT
21	a	a	B-NP	DT	O	22	NMOD
22	contribution	contribution	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	GABP	GABP	B-NP	NN	B-protein	25	NMOD
25	factors	factor	I-NP	NNS	I-protein	23	PMOD
26	to	to	B-PP	TO	O	22	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	Raf-mediated	Raf-mediated	I-NP	JJ	O	29	NMOD
29	enhancement	enhancement	I-NP	NN	O	26	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	IL-2	IL-2	B-NP	NN	B-protein	32	NMOD
32	induction	induction	I-NP	NN	O	30	PMOD
33	during	during	B-PP	IN	O	32	NMOD
34	T-cell	T-cell	B-NP	NN	O	35	NMOD
35	activation	activation	I-NP	NN	O	33	PMOD
36	.	.	O	.	O	20	P

1	Genomic	Genomic	B-NP	JJ	O	2	NMOD
2	organization	organization	I-NP	NN	O	8	NMOD
3	,	,	O	,	O	8	P
4	sequence	sequence	B-NP	NN	O	8	NMOD
5	,	,	O	,	O	8	P
6	and	and	O	CC	O	8	NMOD
7	transcriptional	transcriptional	B-NP	JJ	O	8	NMOD
8	regulation	regulation	I-NP	NN	O	0	ROOT
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	human	human	I-NP	JJ	B-DNA	13	NMOD
12	eotaxin	eotaxin	I-NP	NN	I-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	9	PMOD
14	.	.	O	.	O	8	P

1	Eotaxin	Eotaxin	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	an	an	B-NP	DT	O	6	NMOD
4	eosinophil	eosinophil	I-NP	NN	B-protein	6	NMOD
5	specific	specific	I-NP	JJ	I-protein	4	AMOD
6	beta-chemokine	beta-chemokine	I-NP	NN	I-protein	2	PRD
7	assumed	assume	B-VP	VBN	O	6	NMOD
8	to	to	I-VP	TO	O	9	VMOD
9	be	be	I-VP	VB	O	7	VMOD
10	involved	involve	I-VP	VBN	O	9	VC
11	in	in	B-PP	IN	O	10	VMOD
12	eosinophilic	eosinophilic	B-NP	JJ	O	14	NMOD
13	inflammatory	inflammatory	I-NP	JJ	O	14	NMOD
14	diseases	disease	I-NP	NNS	O	11	PMOD
15	such	such	B-PP	JJ	O	16	PMOD
16	as	as	I-PP	IN	O	14	NMOD
17	atopic	atopic	B-NP	JJ	O	18	NMOD
18	dermatitis	dermatitis	I-NP	NN	O	26	NMOD
19	,	,	O	,	O	26	P
20	allergic	allergic	B-NP	JJ	O	21	NMOD
21	rhinitis	rhinitis	I-NP	NN	O	26	NMOD
22	,	,	O	,	O	26	P
23	asthma	asthma	B-NP	NN	O	26	NMOD
24	and	and	O	CC	O	26	NMOD
25	parasitic	parasitic	B-NP	JJ	O	26	NMOD
26	infections	infection	I-NP	NNS	O	16	PMOD
27	.	.	O	.	O	2	P

1	Its	Its	B-NP	PRP$	O	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	stimulus-	stimulus-	B-NP	NN	O	6	AMOD
5	and	and	O	CC	O	6	AMOD
6	cell-specific	cell-specific	B-ADJP	JJ	O	3	PRD
7	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	3	SUB
2	here	here	B-ADVP	RB	O	3	VMOD
3	describe	describe	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	genomic	genomic	I-NP	JJ	O	6	NMOD
6	organisation	organisation	I-NP	NN	O	19	NMOD
7	(	(	O	(	O	19	P
8	3	3	B-NP	CD	O	9	NMOD
9	exons	exon	I-NP	NNS	B-DNA	19	NMOD
10	of	of	B-PP	IN	O	9	NMOD
11	132	132	B-NP	CD	O	16	NMOD
12	,	,	I-NP	,	O	16	P
13	112	112	I-NP	CD	O	15	AMOD
14	and	and	I-NP	CC	O	15	AMOD
15	542	542	I-NP	CD	O	16	NMOD
16	bp	bp	I-NP	NN	O	10	PMOD
17	and	and	O	CC	O	19	NMOD
18	2	2	B-NP	CD	O	19	NMOD
19	introns	intron	I-NP	NNS	B-DNA	27	NMOD
20	of	of	B-PP	IN	O	19	NMOD
21	1211	1211	B-NP	CD	O	23	AMOD
22	and	and	I-NP	CC	O	23	AMOD
23	378	378	I-NP	CD	O	24	NMOD
24	bp	bp	I-NP	NN	O	20	PMOD
25	)	)	O	)	O	19	P
26	and	and	O	CC	O	27	NMOD
27	sequence	sequence	B-NP	NN	O	3	OBJ
28	including	include	B-PP	VBG	O	27	NMOD
29	3	3	B-NP	CD	O	30	NMOD
30	kb	kb	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	DNA	DNA	B-NP	NN	O	31	PMOD
33	from	from	B-PP	IN	O	30	NMOD
34	the	the	B-NP	DT	O	39	NMOD
35	immediate	immediate	I-NP	JJ	B-DNA	38	AMOD
36	5	5	I-NP	CD	I-DNA	38	AMOD
37	'	'	I-NP	SYM	I-DNA	38	AMOD
38	upstream	upstream	I-NP	JJ	I-DNA	39	NMOD
39	region	region	I-NP	NN	I-DNA	33	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	44	NMOD
42	human	human	I-NP	JJ	B-DNA	44	NMOD
43	eotaxin	eotaxin	I-NP	NN	I-DNA	44	NMOD
44	gene	gene	I-NP	NN	I-DNA	40	PMOD
45	.	.	O	.	O	3	P

1	Among	Among	B-PP	IN	O	19	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	regulatory	regulatory	I-NP	JJ	B-DNA	5	NMOD
4	promoter	promoter	I-NP	NN	I-DNA	5	NMOD
5	elements	element	I-NP	NNS	I-DNA	1	PMOD
6	potentially	potentially	B-VP	RB	O	7	VMOD
7	regulating	regulate	I-VP	VBG	O	5	NMOD
8	eotaxin	eotaxin	B-NP	NN	B-DNA	9	NMOD
9	gene	gene	I-NP	NN	I-DNA	10	NMOD
10	expression	expression	I-NP	NN	O	7	OBJ
11	and/or	and/or	O	CC	O	7	VMOD
12	mediating	mediate	B-VP	VBG	O	5	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	effects	effect	I-NP	NNS	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	anti-inflammatory	anti-inflammatory	B-NP	JJ	O	17	NMOD
17	drugs	drug	I-NP	NNS	O	15	PMOD
18	we	we	B-NP	PRP	O	19	SUB
19	identified	identify	B-VP	VBD	O	0	ROOT
20	consensus	consensus	B-NP	NN	B-DNA	21	NMOD
21	sequences	sequence	I-NP	NNS	I-DNA	19	OBJ
22	known	know	B-VP	VBN	O	21	NMOD
23	to	to	B-VP	TO	O	24	VMOD
24	interact	interact	I-VP	VB	O	22	VMOD
25	with	with	B-PP	IN	O	24	VMOD
26	nuclear	nuclear	B-NP	JJ	B-protein	27	NMOD
27	factors	factor	I-NP	NNS	I-protein	25	PMOD
28	like	like	B-PP	IN	O	24	VMOD
29	NF-IL6	NF-IL6	B-NP	NN	B-protein	34	NMOD
30	,	,	O	,	O	34	P
31	AP-1	AP-1	B-NP	NN	B-protein	34	NMOD
32	,	,	O	,	O	34	P
33	a	a	B-NP	DT	O	34	NMOD
34	NF-kappa-B	NF-kappa-B	I-NP	NN	B-DNA	37	NMOD
35	like	like	B-PP	IN	I-DNA	37	NMOD
36	consensus	consensus	B-NP	NN	I-DNA	37	NMOD
37	sequence	sequence	I-NP	NN	I-DNA	39	NMOD
38	and	and	I-NP	CC	O	39	NMOD
39	gamma-interferon-	gamma-interferon-	I-NP	NN	B-protein	45	NMOD
40	as	as	B-CONJP	RB	O	45	NMOD
41	well	well	I-CONJP	RB	O	40	DEP
42	as	as	I-CONJP	IN	O	40	DEP
43	glucocorticoid	glucocorticoid	B-NP	NN	B-DNA	45	NMOD
44	response	response	I-NP	NN	I-DNA	45	NMOD
45	elements	element	I-NP	NNS	I-DNA	28	PMOD
46	.	.	O	.	O	19	P

1	Dysregulation	Dysregulation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	monocytic	monocytic	B-NP	JJ	B-protein	6	NMOD
4	nuclear	nuclear	I-NP	JJ	I-protein	6	NMOD
5	factor-kappa	factor-kappa	I-NP	NN	I-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	oxidized	oxidize	B-NP	VBN	O	10	NMOD
9	low-density	low-density	I-NP	JJ	B-protein	10	NMOD
10	lipoprotein	lipoprotein	I-NP	NN	I-protein	7	PMOD
11	.	.	O	.	O	1	P

1	Nuclear	Nuclear	B-NP	JJ	B-protein	3	NMOD
2	factor-kappa	factor-kappa	I-NP	NN	I-protein	3	NMOD
3	B	B	I-NP	NN	I-protein	10	NMOD
4	(	(	O	(	O	6	P
5	NF-kappa	NF-kappa	B-NP	NN	B-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	3	NMOD
7	)	)	O	)	O	6	P
8	/Rel	/Rel	B-NP	NN	B-protein	10	NMOD
9	transcription	transcription	I-NP	NN	I-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	11	SUB
11	may	may	B-VP	MD	O	0	ROOT
12	be	be	I-VP	VB	O	11	VC
13	involved	involve	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	atherosclerosis	atherosclerosis	B-NP	NN	O	14	PMOD
16	,	,	O	,	O	11	P
17	as	as	B-SBAR	IN	O	11	VMOD
18	is	be	B-VP	VBZ	O	17	SBAR
19	suggested	suggest	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	presence	presence	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	activated	activate	B-NP	VBN	O	26	NMOD
25	NF-kappa	NF-kappa	I-NP	NN	B-protein	26	NMOD
26	B	B	I-NP	NN	I-protein	23	PMOD
27	in	in	B-PP	IN	O	22	NMOD
28	human	human	B-NP	JJ	O	30	NMOD
29	atherosclerotic	atherosclerotic	I-NP	JJ	O	30	NMOD
30	lesions	lesion	I-NP	NNS	O	27	PMOD
31	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	2	NMOD
2	aim	aim	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	present	present	I-NP	JJ	O	6	NMOD
6	study	study	I-NP	NN	O	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	to	to	B-VP	TO	O	9	VMOD
9	investigate	investigate	I-VP	VB	O	7	PRD
10	the	the	B-NP	DT	O	11	NMOD
11	effects	effect	I-NP	NNS	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	oxidized	oxidize	B-NP	VBN	B-protein	14	NMOD
14	LDL	LDL	I-NP	NN	I-protein	12	PMOD
15	(	(	O	(	O	16	P
16	oxLDL	oxLDL	B-NP	NN	B-protein	14	NMOD
17	)	)	O	)	O	16	P
18	on	on	B-PP	IN	O	11	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	NF-kappa	NF-kappa	I-NP	NN	B-protein	22	NMOD
21	B	B	I-NP	NN	I-protein	22	NMOD
22	system	system	I-NP	NN	O	18	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	human	human	B-NP	JJ	B-cell_line	27	NMOD
25	THP-1	THP-1	I-NP	NN	I-cell_line	27	NMOD
26	monocytic	monocytic	I-NP	JJ	I-cell_line	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_line	32	NMOD
28	as	as	B-CONJP	RB	O	32	NMOD
29	well	well	I-CONJP	RB	O	28	DEP
30	as	as	I-CONJP	IN	O	28	DEP
31	adherent	adherent	B-NP	JJ	B-cell_type	32	NMOD
32	monocytes	monocyte	I-NP	NNS	I-cell_type	23	PMOD
33	.	.	O	.	O	7	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	short-term	short-term	B-NP	JJ	O	6	NMOD
6	incubation	incubation	I-NP	NN	O	12	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	9	NMOD
9	cells	cell	I-NP	NNS	O	7	PMOD
10	with	with	B-PP	IN	O	6	NMOD
11	oxLDL	oxLDL	B-NP	NN	B-protein	10	PMOD
12	activated	activate	B-VP	VBD	I-protein	4	SBAR
13	p50/p65	p50/p65	B-NP	NN	I-protein	12	OBJ
14	containing	contain	B-VP	VBG	O	13	NMOD
15	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
16	B	B	I-NP	NN	I-protein	17	NMOD
17	dimers	dimer	I-NP	NNS	I-protein	14	OBJ
18	and	and	O	CC	O	12	VMOD
19	induced	induce	B-VP	VBD	O	12	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	expression	expression	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	target	target	I-NP	NN	B-DNA	26	NMOD
25	gene	gene	I-NP	NN	I-DNA	26	NMOD
26	IL-8	IL-8	I-NP	NN	B-protein	22	PMOD
27	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	activation	activation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	inhibited	inhibit	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	15	NMOD
10	antioxidant	antioxidant	I-NP	NN	O	15	NMOD
11	and	and	I-NP	CC	O	15	NMOD
12	H2O2	H2O2	I-NP	NN	O	15	NMOD
13	scavenger	scavenger	I-NP	NN	O	15	NMOD
14	pyrrolidine	pyrrolidine	I-NP	NN	O	15	NMOD
15	dithiocarbamate	dithiocarbamate	I-NP	NN	O	20	NMOD
16	and	and	O	CC	O	20	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	proteasome	proteasome	I-NP	NN	B-protein	20	NMOD
19	inhibitor	inhibitor	I-NP	NN	O	20	NMOD
20	PSI	PSI	I-NP	NN	O	8	PMOD
21	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	5	NMOD
2	oxLDL-induced	oxLDL-induced	I-NP	JJ	O	5	NMOD
3	NF-kappa	NF-kappa	I-NP	NN	B-protein	5	NMOD
4	B	B	I-NP	NN	I-protein	5	NMOD
5	activation	activation	I-NP	NN	O	6	SUB
6	was	be	B-VP	VBD	O	0	ROOT
7	accompanied	accompany	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	11	NMOD
10	initial	initial	I-NP	JJ	O	11	NMOD
11	depletion	depletion	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	I	I	B-NP	NN	B-protein	15	NMOD
14	kappa	kappa	I-NP	NN	I-protein	15	NMOD
15	B-alpha	B-alpha	I-NP	NN	I-protein	12	PMOD
16	followed	follow	B-VP	VBN	O	11	NMOD
17	by	by	B-PP	IN	O	16	VMOD
18	a	a	B-NP	DT	O	21	NMOD
19	slight	slight	I-NP	JJ	O	21	NMOD
20	transient	transient	I-NP	JJ	O	21	NMOD
21	increase	increase	I-NP	NN	O	17	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	level	level	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	this	this	B-NP	DT	O	28	NMOD
27	inhibitor	inhibitor	I-NP	NN	B-protein	28	NMOD
28	protein	protein	I-NP	NN	I-protein	25	PMOD
29	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	8	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	long-term	long-term	B-NP	JJ	O	5	NMOD
5	treatment	treatment	I-NP	NN	O	8	SUB
6	with	with	B-PP	IN	O	5	NMOD
7	oxLDL	oxLDL	B-NP	NN	B-protein	6	PMOD
8	prevented	prevent	B-VP	VBD	O	0	ROOT
9	the	the	B-NP	DT	O	11	NMOD
10	lipopolysaccharide-induced	lipopolysaccharide-induced	I-NP	JJ	O	11	NMOD
11	depletion	depletion	I-NP	NN	O	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	I	I	B-NP	NN	B-protein	15	NMOD
14	kappa	kappa	I-NP	NN	I-protein	15	NMOD
15	B-alpha	B-alpha	I-NP	NN	I-protein	12	PMOD
16	,	,	O	,	O	8	P
17	accompanied	accompany	B-VP	VBN	O	8	VMOD
18	by	by	B-PP	IN	O	17	VMOD
19	an	an	B-NP	DT	O	20	NMOD
20	inhibition	inhibition	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	both	both	O	CC	O	28	NMOD
23	NF-kappa	NF-kappa	B-NP	NN	B-protein	25	NMOD
24	B	B	I-NP	NN	I-protein	25	NMOD
25	activation	activation	I-NP	NN	O	28	NMOD
26	and	and	O	CC	O	28	NMOD
27	the	the	B-NP	DT	O	28	NMOD
28	expression	expression	I-NP	NN	O	21	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	tumor	tumor	B-NP	NN	B-protein	32	NMOD
31	necrosis	necrosis	I-NP	NN	I-protein	32	NMOD
32	factor-alpha	factor-alpha	I-NP	NN	I-protein	36	NMOD
33	and	and	O	CC	O	36	NMOD
34	interleukin-1	interleukin-1	B-NP	NN	B-DNA	36	NMOD
35	beta	beta	I-NP	NN	I-DNA	36	NMOD
36	genes	gene	I-NP	NNS	I-DNA	29	PMOD
37	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	provide	provide	B-VP	VBP	O	0	ROOT
4	additional	additional	B-NP	JJ	O	5	NMOD
5	evidence	evidence	I-NP	NN	O	3	OBJ
6	that	that	B-SBAR	IN	O	5	NMOD
7	oxLDL	oxLDL	B-NP	NN	B-protein	8	SUB
8	is	be	B-VP	VBZ	O	6	SBAR
9	a	a	B-NP	DT	O	11	NMOD
10	potent	potent	I-NP	JJ	O	11	NMOD
11	modulator	modulator	I-NP	NN	O	8	PRD
12	of	of	B-PP	IN	O	11	NMOD
13	gene	gene	B-NP	NN	O	14	NMOD
14	expression	expression	I-NP	NN	O	12	PMOD
15	and	and	O	CC	O	16	VMOD
16	suggest	suggest	B-VP	VBP	O	6	SBAR
17	that	that	B-SBAR	IN	O	16	VMOD
18	(	(	O	(	O	19	P
19	dys	dy	B-NP	NNS	O	21	NMOD
20	)	)	O	)	O	19	P
21	regulation	regulation	B-NP	NN	O	25	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	NF-kappa	NF-kappa	B-NP	NN	B-protein	24	NMOD
24	B/Rel	B/Rel	I-NP	NN	I-protein	22	PMOD
25	is	be	B-VP	VBZ	O	17	SBAR
26	likely	likely	B-ADJP	JJ	O	25	PRD
27	to	to	B-VP	TO	O	28	VMOD
28	play	play	I-VP	VB	O	26	AMOD
29	an	an	B-NP	DT	O	31	NMOD
30	important	important	I-NP	JJ	O	31	NMOD
31	role	role	I-NP	NN	O	28	OBJ
32	in	in	B-PP	IN	O	28	VMOD
33	atherogenesis	atherogenesis	B-NP	NN	O	32	PMOD
34	.	.	O	.	O	3	P

1	Suppression	Suppression	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	MHC	MHC	B-NP	NN	B-protein	6	NMOD
4	class	class	I-NP	NN	I-protein	6	NMOD
5	II	II	I-NP	CD	I-protein	6	NMOD
6	expression	expression	I-NP	NN	O	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	human	human	B-NP	JJ	B-DNA	12	NMOD
9	class	class	I-NP	NN	I-DNA	12	NMOD
10	II	II	I-NP	CD	I-DNA	12	NMOD
11	trans-activator	trans-activator	I-NP	NN	I-DNA	12	NMOD
12	constructs	construct	I-NP	NNS	I-DNA	7	PMOD
13	lacking	lack	B-VP	VBG	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	N-terminal	N-terminal	I-NP	JJ	B-protein	16	NMOD
16	domain	domain	I-NP	NN	I-protein	13	OBJ
17	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	4	NMOD
2	class	class	I-NP	NN	B-protein	4	NMOD
3	II	II	I-NP	CD	I-protein	4	NMOD
4	trans-activator	trans-activator	I-NP	NN	I-protein	8	SUB
5	(	(	O	(	O	6	P
6	CIITA	CIITA	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	14	NMOD
10	bi-	bi-	I-NP	JJ	B-protein	14	NMOD
11	or	or	I-NP	CC	I-protein	14	NMOD
12	multi-functional	multi-functional	I-NP	JJ	I-protein	14	NMOD
13	domain	domain	I-NP	NN	I-protein	14	NMOD
14	protein	protein	I-NP	NN	I-protein	8	PRD
15	which	which	B-NP	WDT	O	14	NMOD
16	plays	play	B-VP	VBZ	O	15	SBAR
17	a	a	B-NP	DT	O	19	NMOD
18	critical	critical	I-NP	JJ	O	19	NMOD
19	role	role	I-NP	NN	O	16	OBJ
20	in	in	B-PP	IN	O	16	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	expression	expression	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	MHC	MHC	B-NP	NN	B-DNA	27	NMOD
25	class	class	I-NP	NN	I-DNA	27	NMOD
26	II	II	B-NP	CD	I-DNA	27	NMOD
27	genes	gene	I-NP	NNS	I-DNA	23	PMOD
28	.	.	O	.	O	8	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	removal	removal	B-NP	NN	O	25	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	N-terminal	N-terminal	I-NP	JJ	B-protein	10	NMOD
8	151	151	I-NP	CD	I-protein	10	NMOD
9	amino	amino	I-NP	NN	I-protein	10	NMOD
10	acids	acid	I-NP	NNS	I-protein	5	PMOD
11	,	,	O	,	O	4	P
12	encompassing	encompass	B-VP	VBG	O	4	NMOD
13	all	all	B-NP	DT	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	acidic	acidic	I-NP	JJ	B-protein	17	NMOD
17	domain	domain	I-NP	NN	I-protein	14	PMOD
18	but	but	O	CC	O	12	VMOD
19	leaving	leave	B-VP	VBG	O	12	VMOD
20	intact	intact	B-ADJP	JJ	O	19	OBJ
21	the	the	B-NP	DT	O	23	NMOD
22	proline/serine/threonine-rich	proline/serine/threonine-rich	I-NP	JJ	B-protein	23	NMOD
23	domain	domain	I-NP	NN	I-protein	20	NMOD
24	,	,	O	,	O	4	P
25	results	result	B-VP	VBZ	O	3	SBAR
26	in	in	B-PP	IN	O	25	VMOD
27	a	a	B-NP	DT	O	29	NMOD
28	mutant	mutant	I-NP	JJ	B-protein	29	NMOD
29	protein	protein	I-NP	NN	I-protein	26	PMOD
30	with	with	B-PP	IN	O	29	NMOD
31	potent	potent	B-NP	JJ	O	33	NMOD
32	suppressive	suppressive	I-NP	JJ	O	33	NMOD
33	properties	property	I-NP	NNS	O	30	PMOD
34	for	for	B-PP	IN	O	33	NMOD
35	MHC	MHC	B-NP	NN	B-protein	38	NMOD
36	class	class	I-NP	NN	I-protein	38	NMOD
37	II	II	I-NP	CD	I-protein	38	NMOD
38	expression	expression	I-NP	NN	O	34	PMOD
39	.	.	O	.	O	2	P

1	HeLa	HeLa	B-NP	NN	B-cell_line	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_line	11	SUB
3	stably	stably	B-VP	RB	O	6	VMOD
4	or	or	I-VP	CC	O	3	AMOD
5	transiently	transiently	I-VP	RB	O	3	AMOD
6	transfected	transfecte	I-VP	VBN	O	2	NMOD
7	with	with	B-PP	IN	O	6	VMOD
8	mutant	mutant	B-NP	JJ	B-DNA	10	NMOD
9	CIITA	CIITA	I-NP	NN	I-DNA	10	NMOD
10	constructs	construct	I-NP	NNS	I-DNA	7	PMOD
11	showed	show	B-VP	VBD	O	0	ROOT
12	up	up	B-NP	RB	O	16	NMOD
13	to	to	I-NP	TO	O	12	AMOD
14	99	99	I-NP	CD	O	12	AMOD
15	%	%	I-NP	NN	O	16	NMOD
16	suppression	suppression	I-NP	NN	O	11	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	MHC	MHC	B-NP	NN	B-protein	21	NMOD
19	class	class	I-NP	NN	I-protein	21	NMOD
20	II	II	I-NP	CD	I-protein	21	NMOD
21	antigen	antigen	I-NP	NN	I-protein	22	NMOD
22	induction	induction	I-NP	NN	O	17	PMOD
23	by	by	B-PP	IN	O	11	VMOD
24	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	27	NMOD
25	and	and	O	CC	O	27	NMOD
26	marked	marked	B-NP	JJ	O	27	NMOD
27	suppression	suppression	I-NP	NN	O	23	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	HLA-DRA	HLA-DRA	B-NP	NN	B-RNA	30	NMOD
30	mRNA	mRNA	I-NP	NN	I-RNA	31	NMOD
31	expression	expression	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	11	P

1	Transient	Transient	B-NP	JJ	O	2	NMOD
2	transfection	transfection	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	7	NMOD
5	B	B	I-NP	NN	B-cell_line	7	NMOD
6	lymphoma	lymphoma	I-NP	NN	I-cell_line	7	NMOD
7	line	line	I-NP	NN	I-cell_line	3	PMOD
8	resulted	result	B-VP	VBD	O	0	ROOT
9	in	in	B-PP	IN	O	8	VMOD
10	up	up	B-NP	RB	O	14	NMOD
11	to	to	I-NP	TO	O	10	AMOD
12	89	89	I-NP	CD	O	10	AMOD
13	%	%	I-NP	NN	O	10	AMOD
14	reduction	reduction	I-NP	NN	O	25	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	constitutive	constitutive	B-NP	JJ	O	20	NMOD
17	MHC	MHC	I-NP	NN	B-protein	20	NMOD
18	class	class	I-NP	NN	I-protein	20	NMOD
19	II	II	I-NP	CD	I-protein	20	NMOD
20	expression	expression	I-NP	NN	O	15	PMOD
21	within	within	B-PP	IN	O	20	NMOD
22	5	5	B-NP	CD	O	23	NMOD
23	days	day	I-NP	NNS	O	21	PMOD
24	and	and	I-NP	CC	O	25	NMOD
25	suppression	suppression	I-NP	NN	O	9	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	HLA-DRA	HLA-DRA	B-NP	NN	B-RNA	28	NMOD
28	mRNA	mRNA	I-NP	NN	I-RNA	29	NMOD
29	synthesis	synthesis	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	8	P

1	CD30-dependent	CD30-dependent	B-NP	JJ	O	2	NMOD
2	degradation	degradation	I-NP	NN	O	6	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	TRAF2	TRAF2	B-NP	NN	B-protein	3	PMOD
5	:	:	O	:	O	2	P
6	implications	implication	B-NP	NNS	O	0	ROOT
7	for	for	B-PP	IN	O	6	NMOD
8	negative	negative	B-NP	JJ	O	9	NMOD
9	regulation	regulation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	TRAF	TRAF	B-NP	NN	B-protein	12	NMOD
12	signaling	signaling	I-NP	NN	O	15	NMOD
13	and	and	O	CC	O	15	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	control	control	I-NP	NN	O	10	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	cell	cell	B-NP	NN	O	18	NMOD
18	survival	survival	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	6	P

1	CD30	CD30	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	cell-surface	cell-surface	I-NP	JJ	B-protein	5	NMOD
5	receptor	receptor	I-NP	NN	I-protein	2	PRD
6	that	that	B-NP	WDT	O	5	NMOD
7	can	can	B-VP	MD	O	6	SBAR
8	augment	augment	I-VP	VB	O	7	VC
9	lymphocyte	lymphocyte	B-NP	NN	O	12	NMOD
10	activation	activation	B-NP	NN	O	12	NMOD
11	and	and	O	CC	O	12	NMOD
12	survival	survival	B-NP	NN	O	8	OBJ
13	through	through	B-PP	IN	O	8	VMOD
14	its	its	B-NP	PRP$	O	15	NMOD
15	ability	ability	I-NP	NN	O	13	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	induce	induce	I-VP	VB	O	15	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	transcription	transcription	I-NP	NN	B-protein	21	NMOD
20	factor	factor	I-NP	NN	I-protein	21	NMOD
21	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	17	OBJ
22	.	.	O	.	O	2	P

1	CD30	CD30	B-NP	NN	B-protein	5	VMOD
2	,	,	O	,	O	5	P
3	however	however	B-ADVP	RB	O	5	VMOD
4	,	,	O	,	O	5	P
5	has	have	B-VP	VBZ	O	0	ROOT
6	also	also	I-VP	RB	O	5	VMOD
7	been	be	I-VP	VBN	O	5	VC
8	implicated	implicate	I-VP	VBN	O	7	VC
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	induction	induction	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	apoptotic	apoptotic	B-NP	JJ	O	15	NMOD
14	cell	cell	I-NP	NN	O	15	NMOD
15	death	death	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	16	PMOD
18	.	.	O	.	O	5	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	one	one	B-NP	CD	O	13	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	effects	effect	I-NP	NNS	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	CD30	CD30	B-NP	NN	B-protein	12	NMOD
11	signal	signal	I-NP	NN	O	12	NMOD
12	transduction	transduction	I-NP	NN	O	9	PMOD
13	is	be	B-VP	VBZ	O	4	SBAR
14	to	to	B-VP	TO	O	15	VMOD
15	render	render	I-VP	VB	O	13	PRD
16	cells	cell	B-NP	NNS	O	15	OBJ
17	sensitive	sensitive	B-ADJP	JJ	O	16	NMOD
18	to	to	B-PP	TO	O	17	AMOD
19	apoptosis	apoptosis	B-NP	NN	O	18	PMOD
20	induced	induce	B-VP	VBN	O	19	NMOD
21	by	by	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	28	NMOD
23	type	type	I-NP	NN	B-protein	28	NMOD
24	1	1	I-NP	CD	I-protein	28	NMOD
25	tumor	tumor	I-NP	NN	I-protein	28	NMOD
26	necrosis	necrosis	I-NP	NN	I-protein	28	NMOD
27	factor	factor	I-NP	NN	I-protein	28	NMOD
28	receptor	receptor	I-NP	NN	I-protein	21	PMOD
29	(	(	O	(	O	30	P
30	TNFR1	TNFR1	B-NP	NN	B-protein	28	NMOD
31	)	)	O	)	O	30	P
32	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	sensitization	sensitization	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	dependent	dependent	B-ADJP	JJ	O	3	PRD
5	on	on	B-PP	IN	O	4	AMOD
6	the	the	B-NP	DT	O	8	NMOD
7	TRAF-binding	TRAF-binding	I-NP	JJ	B-DNA	8	NMOD
8	sites	site	I-NP	NNS	I-DNA	5	PMOD
9	within	within	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	CD30	CD30	I-NP	NN	B-protein	13	NMOD
12	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	13	NMOD
13	domain	domain	I-NP	NN	I-protein	9	PMOD
14	.	.	O	.	O	3	P

1	One	One	B-NP	CD	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	proteins	protein	I-NP	NNS	O	2	PMOD
5	that	that	B-NP	WDT	O	1	NMOD
6	binds	bind	B-VP	VBZ	O	5	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	these	these	B-NP	DT	O	9	NMOD
9	sites	site	I-NP	NNS	O	7	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	TRAF2	TRAF2	B-NP	NN	B-protein	16	NMOD
12	,	,	O	,	O	16	P
13	a	a	B-NP	DT	O	16	NMOD
14	signal	signal	I-NP	NN	B-protein	16	NMOD
15	transduction	transduction	I-NP	NN	I-protein	16	NMOD
16	molecule	molecule	I-NP	NN	I-protein	10	PRD
17	that	that	B-NP	WDT	O	16	NMOD
18	is	be	B-VP	VBZ	O	17	SBAR
19	also	also	I-VP	RB	O	18	VMOD
20	utilized	utilize	I-VP	VBN	O	18	VC
21	by	by	B-PP	IN	O	20	VMOD
22	TNFR1	TNFR1	B-NP	NN	B-protein	21	PMOD
23	to	to	B-VP	TO	O	24	VMOD
24	mediate	mediate	I-VP	VB	O	20	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	activation	activation	I-NP	NN	O	24	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	several	several	B-NP	JJ	O	30	NMOD
29	downstream	downstream	I-NP	JJ	O	30	NMOD
30	kinases	kinase	I-NP	NNS	O	33	NMOD
31	and	and	O	CC	O	33	NMOD
32	transcription	transcription	B-NP	NN	B-protein	33	NMOD
33	factors	factor	I-NP	NNS	I-protein	27	PMOD
34	.	.	O	.	O	10	P

1	During	During	B-PP	IN	O	7	VMOD
2	CD30	CD30	B-NP	NN	B-protein	4	NMOD
3	signal	signal	I-NP	NN	O	4	NMOD
4	transduction	transduction	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	found	find	B-VP	VBD	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	binding	binding	B-NP	NN	O	18	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	TRAF2	TRAF2	B-NP	NN	B-protein	10	PMOD
12	to	to	B-PP	TO	O	9	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	15	NMOD
15	domain	domain	I-NP	NN	I-protein	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	CD30	CD30	B-NP	NN	B-protein	16	PMOD
18	results	result	B-VP	VBZ	O	8	SBAR
19	in	in	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	rapid	rapid	I-NP	JJ	O	22	NMOD
22	depletion	depletion	I-NP	NN	O	29	NMOD
23	of	of	B-PP	IN	O	22	NMOD
24	TRAF2	TRAF2	B-NP	NN	B-protein	23	PMOD
25	and	and	O	CC	O	29	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	associated	associate	I-NP	VBN	O	29	NMOD
28	protein	protein	I-NP	NN	O	29	NMOD
29	TRAF1	TRAF1	I-NP	NN	B-protein	19	PMOD
30	by	by	B-PP	IN	O	29	NMOD
31	proteolysis	proteolysis	B-NP	NN	O	30	PMOD
32	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	5	NMOD
5	model	model	I-NP	NN	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	which	which	B-NP	WDT	O	6	PMOD
8	CD30	CD30	B-NP	NN	B-protein	6	PMOD
9	limits	limit	B-VP	VBZ	O	3	VMOD
10	its	its	B-NP	PRP$	O	12	NMOD
11	own	own	I-NP	JJ	O	12	NMOD
12	ability	ability	I-NP	NN	O	9	OBJ
13	to	to	B-VP	TO	O	14	VMOD
14	transduce	transduce	I-VP	VB	O	12	NMOD
15	cell	cell	B-NP	NN	O	17	NMOD
16	survival	survival	I-NP	NN	O	17	NMOD
17	signals	signal	I-NP	NNS	O	14	OBJ
18	through	through	B-PP	IN	O	14	VMOD
19	signal-coupled	signal-coupled	B-NP	JJ	O	20	NMOD
20	depletion	depletion	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	TRAF2	TRAF2	B-NP	NN	B-protein	21	PMOD
23	.	.	O	.	O	3	P

1	Depletion	Depletion	B-NP	NN	O	8	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	intracellular	intracellular	B-NP	JJ	O	4	NMOD
4	TRAF2	TRAF2	I-NP	NN	B-protein	2	PMOD
5	and	and	O	CC	O	8	NMOD
6	its	its	B-NP	PRP$	O	8	NMOD
7	coassociated	coassociate	I-NP	VBN	B-protein	8	NMOD
8	proteins	protein	I-NP	NNS	I-protein	10	SUB
9	also	also	B-ADVP	RB	O	10	VMOD
10	increased	increase	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	12	NMOD
12	sensitivity	sensitivity	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	cell	cell	I-NP	NN	O	13	PMOD
16	to	to	B-PP	TO	O	10	VMOD
17	undergoing	undergo	B-VP	VBG	O	16	PMOD
18	apoptosis	apoptosis	B-NP	NN	O	17	OBJ
19	during	during	B-PP	IN	O	10	VMOD
20	activation	activation	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	death-inducing	death-inducing	B-NP	JJ	B-protein	23	NMOD
23	receptors	receptor	I-NP	NNS	I-protein	21	PMOD
24	such	such	B-PP	JJ	O	25	PMOD
25	as	as	I-PP	IN	O	23	NMOD
26	TNFR1	TNFR1	B-NP	NN	B-protein	25	PMOD
27	.	.	O	.	O	10	P

1	Consistent	Consistent	B-ADJP	JJ	O	13	VMOD
2	with	with	B-PP	IN	O	1	AMOD
3	this	this	B-NP	DT	O	4	NMOD
4	hypothesis	hypothesis	I-NP	NN	O	2	PMOD
5	,	,	O	,	O	13	P
6	expression	expression	B-NP	NN	O	13	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	10	NMOD
9	dominant-negative	dominant-negative	I-NP	JJ	B-protein	10	NMOD
10	form	form	I-NP	NN	I-protein	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	TRAF2	TRAF2	B-NP	NN	B-protein	11	PMOD
13	was	be	B-VP	VBD	O	0	ROOT
14	found	find	I-VP	VBN	O	13	VC
15	to	to	I-VP	TO	O	16	VMOD
16	potentiate	potentiate	I-VP	VB	O	14	VMOD
17	TNFR1-mediated	TNFR1-mediated	B-NP	JJ	O	18	NMOD
18	death	death	I-NP	NN	O	16	OBJ
19	.	.	O	.	O	13	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	provide	provide	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	potential	potential	I-NP	JJ	O	6	NMOD
6	mechanism	mechanism	I-NP	NN	O	3	OBJ
7	through	through	B-PP	IN	O	6	NMOD
8	which	which	B-NP	WDT	O	7	PMOD
9	CD30	CD30	B-NP	NN	B-protein	16	NMOD
10	,	,	O	,	O	16	P
11	as	as	B-CONJP	RB	O	16	NMOD
12	well	well	I-CONJP	RB	O	11	DEP
13	as	as	I-CONJP	IN	O	11	DEP
14	other	other	B-NP	JJ	O	16	NMOD
15	TRAF-binding	TRAF-binding	I-NP	JJ	B-protein	16	NMOD
16	members	member	I-NP	NNS	I-protein	22	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	TNFR	TNFR	I-NP	NN	B-protein	20	NMOD
20	superfamily	superfamily	I-NP	NN	I-protein	17	PMOD
21	,	,	O	,	O	16	P
22	can	can	B-VP	MD	O	7	SBAR
23	negatively	negatively	I-VP	RB	O	22	VMOD
24	regulate	regulate	I-VP	VB	O	22	VC
25	cell	cell	B-NP	NN	O	26	NMOD
26	survival	survival	I-NP	NN	O	24	OBJ
27	.	.	O	.	O	3	P

1	TNFalpha	TNFalpha	B-NP	NN	B-protein	2	SUB
2	cooperates	cooperate	B-VP	VBZ	O	0	ROOT
3	with	with	B-PP	IN	O	2	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	protein	protein	I-NP	NN	B-protein	8	NMOD
6	kinase	kinase	I-NP	NN	I-protein	8	NMOD
7	A	A	I-NP	NN	I-protein	8	NMOD
8	pathway	pathway	I-NP	NN	O	3	PMOD
9	to	to	B-VP	TO	O	11	VMOD
10	synergistically	synergistically	I-VP	RB	O	11	VMOD
11	increase	increase	I-VP	VB	O	8	NMOD
12	HIV-1	HIV-1	B-NP	NN	B-DNA	14	NMOD
13	LTR	LTR	I-NP	NN	I-DNA	14	NMOD
14	transcription	transcription	I-NP	NN	O	11	OBJ
15	via	via	B-PP	IN	O	11	VMOD
16	downstream	downstream	B-NP	JJ	O	20	NMOD
17	TRE-like	TRE-like	I-NP	JJ	B-DNA	20	NMOD
18	cAMP	cAMP	I-NP	NN	I-DNA	20	NMOD
19	response	response	I-NP	NN	I-DNA	20	NMOD
20	elements	element	I-NP	NNS	I-DNA	15	PMOD
21	.	.	O	.	O	2	P

1	Activating	Activate	B-VP	VBG	B-protein	2	NMOD
2	protein-1	protein-1	B-NP	NN	I-protein	9	NMOD
3	(	(	O	(	O	4	P
4	AP-1	AP-1	B-NP	NN	B-protein	2	NMOD
5	)	)	O	)	O	4	P
6	binding	binding	B-NP	NN	O	9	NMOD
7	TPA	TPA	I-NP	NN	B-DNA	9	NMOD
8	responsive	responsive	I-NP	JJ	I-DNA	9	NMOD
9	elements	element	I-NP	NNS	I-DNA	13	SUB
10	(	(	O	(	O	11	P
11	TRE	TRE	B-NP	NN	B-DNA	9	NMOD
12	)	)	O	)	O	11	P
13	are	be	B-VP	VBP	O	0	ROOT
14	located	located	B-ADJP	JJ	O	13	PRD
15	downstream	downstream	B-PP	RB	O	16	PMOD
16	of	of	B-PP	IN	O	14	AMOD
17	the	the	B-NP	DT	O	20	NMOD
18	transcription	transcription	I-NP	NN	B-DNA	20	NMOD
19	initiation	initiation	I-NP	NN	I-DNA	20	NMOD
20	site	site	I-NP	NN	I-DNA	16	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	U5	U5	I-NP	NN	B-DNA	24	NMOD
24	region	region	I-NP	NN	I-DNA	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	30	NMOD
27	HIV-1	HIV-1	I-NP	NN	B-DNA	30	NMOD
28	long	long	I-NP	JJ	I-DNA	30	NMOD
29	terminal	terminal	I-NP	JJ	I-DNA	30	NMOD
30	repeat	repeat	I-NP	NN	I-DNA	25	PMOD
31	(	(	O	(	O	32	P
32	LTR	LTR	B-NP	NN	B-DNA	30	NMOD
33	)	)	O	)	O	32	P
34	.	.	O	.	O	13	P

1	These	These	B-NP	DT	O	4	NMOD
2	downstream	downstream	I-NP	JJ	B-DNA	4	NMOD
3	sequence	sequence	I-NP	NN	I-DNA	4	NMOD
4	elements	element	I-NP	NNS	I-DNA	7	NMOD
5	,	,	O	,	O	7	P
6	termed	term	B-NP	VBN	O	7	NMOD
7	DSE	DSE	I-NP	NN	B-DNA	9	SUB
8	,	,	O	,	O	7	P
9	can	can	B-VP	MD	O	0	ROOT
10	bind	bind	I-VP	VB	O	9	VC
11	both	both	O	CC	O	16	NMOD
12	AP-1	AP-1	B-NP	NN	B-protein	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	CREB/ATF	CREB/ATF	B-NP	NN	B-protein	16	NMOD
15	transcription	transcription	I-NP	NN	B-protein	16	NMOD
16	factors	factor	I-NP	NNS	I-protein	10	OBJ
17	.	.	O	.	O	9	P

1	Recently	Recently	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	DSE	DSE	I-NP	NN	B-DNA	8	SUB
8	are	be	B-VP	VBP	O	5	SBAR
9	also	also	B-ADVP	RB	O	8	VMOD
10	cAMP-responsive	cAMP-responsive	B-NP	JJ	B-DNA	11	NMOD
11	elements	element	I-NP	NNS	I-DNA	8	PRD
12	(	(	O	(	O	13	P
13	CRE	CRE	B-NP	NN	B-DNA	11	NMOD
14	)	)	O	)	O	13	P
15	,	,	O	,	O	8	P
16	since	since	B-SBAR	IN	O	8	VMOD
17	they	they	B-NP	PRP	O	18	SUB
18	mediated	mediate	B-VP	VBD	O	16	SBAR
19	activation	activation	B-NP	NN	O	20	NMOD
20	signals	signal	I-NP	NNS	O	18	OBJ
21	elicited	elicit	B-VP	VBN	O	20	NMOD
22	by	by	B-PP	IN	O	21	VMOD
23	cholera	cholera	B-NP	NN	B-protein	24	NMOD
24	toxin	toxin	I-NP	NN	I-protein	31	NMOD
25	(	(	O	(	O	26	P
26	Ctx	Ctx	B-NP	NN	B-protein	24	NMOD
27	)	)	O	)	O	26	P
28	,	,	O	,	O	31	P
29	a	a	B-NP	DT	O	31	NMOD
30	potent	potent	I-NP	JJ	O	31	NMOD
31	activator	activator	I-NP	NN	O	22	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	37	NMOD
34	cAMP-dependent	cAMP-dependent	I-NP	JJ	O	37	NMOD
35	protein	protein	I-NP	NN	B-protein	37	NMOD
36	kinase	kinase	I-NP	NN	I-protein	37	NMOD
37	A	A	I-NP	NN	I-protein	43	NMOD
38	(	(	O	(	O	39	P
39	PKA	PKA	B-NP	NN	B-protein	37	NMOD
40	)	)	O	)	O	39	P
41	signal	signal	B-NP	NN	O	43	NMOD
42	transduction	transduction	I-NP	NN	O	43	NMOD
43	pathway	pathway	I-NP	NN	O	32	PMOD
44	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	7	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	HIV-1	HIV-1	I-NP	NN	B-DNA	11	NMOD
11	DSE	DSE	I-NP	NN	I-DNA	12	SUB
12	can	can	B-VP	MD	O	8	SBAR
13	mediate	mediate	I-VP	VB	O	12	VC
14	the	the	B-NP	DT	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	synergy	synergy	I-NP	NN	O	13	OBJ
17	elicited	elicit	B-VP	VBN	O	16	NMOD
18	by	by	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	combination	combination	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	Ctx	Ctx	B-NP	NN	B-protein	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	TNFalpha	TNFalpha	I-NP	NN	B-protein	21	PMOD
25	.	.	O	.	O	7	P

1	Ctx	Ctx	B-NP	NN	B-protein	0	ROOT
2	combined	combine	B-VP	VBN	O	1	NMOD
3	with	with	B-PP	IN	O	2	VMOD
4	TNFalpha	TNFalpha	B-NP	NN	B-protein	6	NMOD
5	or	or	I-NP	CC	O	6	NMOD
6	IL-1beta	IL-1beta	I-NP	NN	B-protein	3	PMOD
7	to	to	B-VP	TO	O	8	VMOD
8	produce	produce	I-VP	VB	O	2	VMOD
9	a	a	B-NP	DT	O	11	NMOD
10	synergistic	synergistic	I-NP	JJ	O	11	NMOD
11	increase	increase	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	p24	p24	B-NP	NN	B-protein	15	NMOD
14	antigen	antigen	I-NP	NN	I-protein	15	NMOD
15	production	production	I-NP	NN	O	12	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	U1	U1	B-NP	NN	B-cell_line	19	NMOD
18	promonocytic	promonocytic	I-NP	JJ	I-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	16	PMOD
20	.	.	O	.	O	1	P

1	Transfection	Transfection	B-NP	NN	O	2	NMOD
2	studies	study	I-NP	NNS	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	LTR	LTR	B-NP	NN	B-DNA	6	NMOD
5	reporter	reporter	I-NP	NN	I-DNA	6	NMOD
6	constructs	construct	I-NP	NNS	I-DNA	3	PMOD
7	indicated	indicate	B-VP	VBD	O	24	VMOD
8	that	that	B-SBAR	IN	O	7	VMOD
9	mutation	mutation	B-NP	NN	O	14	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	DSE	DSE	I-NP	NN	B-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	10	PMOD
14	abrogated	abrogate	B-VP	VBD	O	8	SBAR
15	the	the	B-NP	DT	O	17	NMOD
16	LTR-mediated	LTR-mediated	I-NP	JJ	O	17	NMOD
17	synergy	synergy	I-NP	NN	O	14	OBJ
18	induced	induce	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	Ctx	Ctx	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	TNFalpha	TNFalpha	I-NP	NN	B-protein	19	PMOD
23	,	,	O	,	O	24	P
24	whereas	whereas	O	IN	O	39	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	synergy	synergy	I-NP	NN	O	32	SUB
27	induced	induce	B-VP	VBN	O	26	NMOD
28	by	by	B-PP	IN	O	27	VMOD
29	Ctx	Ctx	B-NP	NN	B-protein	31	NMOD
30	and	and	I-NP	CC	O	31	NMOD
31	IL-1beta	IL-1beta	I-NP	NN	B-protein	28	PMOD
32	was	be	B-VP	VBD	O	24	VMOD
33	unaffected	unaffected	B-ADJP	JJ	O	32	PRD
34	,	,	O	,	O	39	P
35	suggesting	suggest	B-VP	VBG	O	39	SUB
36	TNFalpha	TNFalpha	B-NP	NN	B-protein	38	NMOD
37	and	and	I-NP	CC	O	38	NMOD
38	IL-1beta	IL-1beta	I-NP	NN	B-protein	35	OBJ
39	cooperate	cooperate	B-VP	VBP	O	0	ROOT
40	differently	differently	B-ADVP	RB	O	39	VMOD
41	with	with	B-PP	IN	O	39	VMOD
42	the	the	B-NP	DT	O	45	NMOD
43	cAMP/PKA	cAMP/PKA	I-NP	NN	O	45	NMOD
44	activation	activation	I-NP	NN	O	45	NMOD
45	pathway	pathway	I-NP	NN	O	41	PMOD
46	to	to	B-VP	TO	O	47	VMOD
47	induce	induce	I-VP	VB	O	45	NMOD
48	HIV-1	HIV-1	B-NP	NN	O	49	NMOD
49	expression	expression	I-NP	NN	O	47	OBJ
50	in	in	B-PP	IN	O	47	VMOD
51	U1	U1	B-NP	NN	B-cell_line	52	NMOD
52	cells	cell	I-NP	NNS	I-cell_line	50	PMOD
53	.	.	O	.	O	39	P

1	Because	Because	B-SBAR	IN	O	10	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	DSE	DSE	I-NP	NN	B-DNA	4	SUB
4	are	be	B-VP	VBP	O	1	SBAR
5	also	also	B-ADVP	RB	O	4	VMOD
6	TRE	TRE	B-NP	NN	B-DNA	7	NMOD
7	sites	site	I-NP	NNS	I-DNA	4	PRD
8	,	,	O	,	O	10	P
9	we	we	B-NP	PRP	O	10	SUB
10	assessed	assess	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	12	NMOD
12	effect	effect	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	agonist	agonist	I-NP	NN	O	16	NMOD
16	combinations	combination	I-NP	NNS	O	13	PMOD
17	on	on	B-PP	IN	O	12	NMOD
18	AP-1-dependent	AP-1-dependent	B-NP	JJ	O	19	NMOD
19	transcription	transcription	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	10	P

1	TNFalpha	TNFalpha	B-NP	NN	B-protein	5	NMOD
2	as	as	B-CONJP	RB	O	5	NMOD
3	well	well	I-CONJP	RB	O	2	DEP
4	as	as	I-CONJP	IN	O	2	DEP
5	IL-1beta	IL-1beta	B-NP	NN	B-protein	6	SUB
6	cooperated	cooperate	B-VP	VBD	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	Ctx	Ctx	B-NP	NN	B-protein	7	PMOD
9	to	to	B-VP	TO	O	10	VMOD
10	produce	produce	I-VP	VB	O	6	VMOD
11	a	a	B-NP	DT	O	13	NMOD
12	synergistic	synergistic	I-NP	JJ	O	13	NMOD
13	activation	activation	I-NP	NN	O	10	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	AP-1-mediated	AP-1-mediated	B-NP	JJ	O	16	NMOD
16	transcription	transcription	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	6	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	9	NMOD
6	TRE-like	TRE-like	I-NP	JJ	B-DNA	9	NMOD
7	cAMP-responsive	cAMP-responsive	I-NP	JJ	I-DNA	9	NMOD
8	DSE	DSE	I-NP	NN	I-DNA	9	NMOD
9	sites	site	I-NP	NNS	I-DNA	14	SUB
10	within	within	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	5'-untranslated	5'-untranslated	I-NP	JJ	B-DNA	13	NMOD
13	leader	leader	I-NP	NN	I-DNA	10	PMOD
14	can	can	B-VP	MD	O	4	SBAR
15	mediate	mediate	I-VP	VB	O	14	VC
16	the	the	B-NP	DT	O	18	NMOD
17	transcriptional	transcriptional	I-NP	JJ	O	18	NMOD
18	cooperativity	cooperativity	I-NP	NN	O	15	OBJ
19	between	between	B-PP	IN	O	18	NMOD
20	TNFalpha	TNFalpha	B-NP	NN	B-protein	24	NMOD
21	and	and	O	CC	O	24	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	cAMP/PKA	cAMP/PKA	I-NP	NN	O	24	NMOD
24	pathway	pathway	I-NP	NN	O	19	PMOD
25	.	.	O	.	O	3	P

1	Since	Since	B-SBAR	IN	O	14	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	DSE	DSE	I-NP	NN	B-DNA	5	NMOD
4	and	and	I-NP	CC	O	5	NMOD
5	TRE	TRE	I-NP	NN	B-DNA	6	NMOD
6	sites	site	I-NP	NNS	I-DNA	7	SUB
7	can	can	B-VP	MD	O	1	SBAR
8	not	not	I-VP	RB	O	7	VMOD
9	bind	bind	I-VP	VB	O	7	VC
10	CREB/ATF	CREB/ATF	B-NP	NN	B-protein	11	NMOD
11	homodimers	homodimer	I-NP	NNS	I-protein	9	OBJ
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	propose	propose	B-VP	VBP	O	0	ROOT
15	a	a	B-NP	DT	O	16	NMOD
16	mechanism	mechanism	I-NP	NN	O	14	OBJ
17	in	in	B-PP	IN	O	16	NMOD
18	which	which	B-NP	WDT	O	17	PMOD
19	the	the	B-NP	DT	O	21	NMOD
20	HIV-1	HIV-1	I-NP	NN	B-DNA	21	NMOD
21	DSE	DSE	I-NP	NN	I-DNA	22	SUB
22	bind	bind	B-VP	VBP	O	17	SBAR
23	heterodimers	heterodimer	B-NP	NNS	B-protein	22	OBJ
24	composed	compose	B-VP	VBN	O	23	NMOD
25	of	of	B-PP	IN	O	24	VMOD
26	both	both	O	CC	O	30	NMOD
27	AP-1	AP-1	B-NP	NN	B-protein	30	NMOD
28	and	and	I-NP	CC	O	30	NMOD
29	CREB/ATF	CREB/ATF	I-NP	NN	B-protein	30	NMOD
30	proteins	protein	I-NP	NNS	I-protein	25	PMOD
31	.	.	O	.	O	14	P

1	Copyright	Copyright	B-NP	NN	O	0	ROOT
2	1997	1997	I-NP	CD	O	4	NMOD
3	Academic	Academic	I-NP	NNP	O	4	NMOD
4	Press	Press	I-NP	NNP	O	1	NMOD
5	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	5	NMOD
2	Epstein-Barr	Epstein-Barr	I-NP	JJ	B-protein	5	NMOD
3	virus	virus	I-NP	NN	I-protein	5	NMOD
4	oncogene	oncogene	I-NP	NN	I-protein	5	NMOD
5	product	product	I-NP	NN	I-protein	8	NMOD
6	latent	latent	I-NP	JJ	B-protein	8	NMOD
7	membrane	membrane	I-NP	NN	I-protein	8	NMOD
8	protein	protein	I-NP	NN	I-protein	10	SUB
9	1	1	I-NP	CD	I-protein	8	NMOD
10	engages	engage	B-VP	VBZ	O	0	ROOT
11	the	the	B-NP	DT	O	18	NMOD
12	tumor	tumor	I-NP	NN	B-protein	18	NMOD
13	necrosis	necrosis	I-NP	NN	I-protein	18	NMOD
14	factor	factor	I-NP	NN	I-protein	18	NMOD
15	receptor-associated	receptor-associated	I-NP	JJ	I-protein	18	NMOD
16	death	death	I-NP	NN	I-protein	18	NMOD
17	domain	domain	I-NP	NN	I-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	20	SUB
19	to	to	B-VP	TO	O	20	VMOD
20	mediate	mediate	I-VP	VB	O	10	VMOD
21	B	B	B-NP	NN	O	24	NMOD
22	lymphocyte	lymphocyte	I-NP	NN	O	24	NMOD
23	growth	growth	I-NP	NN	O	24	NMOD
24	transformation	transformation	I-NP	NN	O	20	OBJ
25	and	and	O	CC	O	10	VMOD
26	activate	activate	B-VP	VBP	O	10	VMOD
27	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	26	OBJ
28	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	6	NMOD
2	Epstein-Barr	Epstein-Barr	I-NP	JJ	B-protein	6	NMOD
3	virus	virus	I-NP	NN	I-protein	6	NMOD
4	latent	latent	I-NP	JJ	I-protein	6	NMOD
5	membrane	membrane	I-NP	NN	I-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	11	SUB
7	1	1	I-NP	CD	I-protein	6	NMOD
8	(	(	O	(	O	9	P
9	LMP1	LMP1	B-NP	NN	B-protein	6	NMOD
10	)	)	O	)	O	9	P
11	is	be	B-VP	VBZ	O	0	ROOT
12	essential	essential	B-ADJP	JJ	O	11	PRD
13	for	for	B-PP	IN	O	12	AMOD
14	the	the	B-NP	DT	O	15	NMOD
15	transformation	transformation	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	B	B	B-NP	NN	B-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD
19	into	into	B-PP	IN	O	15	NMOD
20	lymphoblastoid	lymphoblastoid	B-NP	JJ	B-cell_line	22	NMOD
21	cell	cell	I-NP	NN	I-cell_line	22	NMOD
22	lines	line	I-NP	NNS	I-cell_line	19	PMOD
23	.	.	O	.	O	11	P

1	Previous	Previous	B-NP	JJ	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	consistent	consistent	B-ADJP	JJ	O	3	PRD
5	with	with	B-PP	IN	O	4	AMOD
6	a	a	B-NP	DT	O	7	NMOD
7	model	model	I-NP	NN	O	5	PMOD
8	that	that	B-SBAR	IN	O	7	NMOD
9	LMP1	LMP1	B-NP	NN	B-protein	10	SUB
10	is	be	B-VP	VBZ	O	8	SBAR
11	a	a	B-NP	DT	O	14	NMOD
12	constitutively	constitutively	I-NP	RB	B-protein	13	AMOD
13	activated	activate	I-NP	VBN	I-protein	14	NMOD
14	receptor	receptor	I-NP	NN	I-protein	10	PRD
15	that	that	B-NP	WDT	O	14	NMOD
16	transduces	transduce	B-VP	VBZ	O	15	SBAR
17	signals	signal	B-NP	NNS	O	16	OBJ
18	for	for	B-PP	IN	O	17	NMOD
19	transformation	transformation	B-NP	NN	O	18	PMOD
20	through	through	B-PP	IN	O	16	VMOD
21	its	its	B-NP	PRP$	O	24	NMOD
22	carboxyl-terminal	carboxyl-terminal	I-NP	JJ	B-protein	24	NMOD
23	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	24	NMOD
24	tail	tail	I-NP	NN	I-protein	20	PMOD
25	.	.	O	.	O	3	P

1	One	One	B-NP	CD	O	4	NMOD
2	transformation	transformation	I-NP	NN	B-protein	4	NMOD
3	effector	effector	I-NP	NN	I-protein	4	NMOD
4	site	site	I-NP	NN	I-protein	22	SUB
5	(	(	O	(	O	6	P
6	TES1	TES1	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	,	,	O	,	O	4	P
9	located	located	B-ADJP	JJ	O	4	NMOD
10	within	within	B-PP	IN	O	9	AMOD
11	the	the	B-NP	DT	O	15	NMOD
12	membrane	membrane	I-NP	NN	B-protein	15	NMOD
13	proximal	proximal	I-NP	JJ	I-protein	15	NMOD
14	45	45	I-NP	CD	I-protein	15	NMOD
15	residues	residue	I-NP	NNS	I-protein	10	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	19	NMOD
19	tail	tail	I-NP	NN	I-protein	16	PMOD
20	,	,	O	,	O	4	P
21	constitutively	constitutively	B-VP	RB	O	22	VMOD
22	engages	engage	I-VP	VBZ	O	0	ROOT
23	tumor	tumor	B-NP	NN	B-protein	27	NMOD
24	necrosis	necrosis	I-NP	NN	I-protein	27	NMOD
25	factor	factor	I-NP	NN	I-protein	27	NMOD
26	receptor-associated	receptor-associated	I-NP	JJ	I-protein	27	NMOD
27	factors	factor	I-NP	NNS	I-protein	22	OBJ
28	.	.	O	.	O	22	P

1	Signals	Signal	B-NP	NNS	O	4	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	TES1	TES1	B-NP	NN	B-protein	2	PMOD
4	are	be	B-VP	VBP	O	33	VMOD
5	sufficient	sufficient	B-ADJP	JJ	O	4	PRD
6	to	to	B-VP	TO	O	7	VMOD
7	drive	drive	I-VP	VB	O	5	AMOD
8	initial	initial	B-NP	JJ	O	9	NMOD
9	proliferation	proliferation	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	infected	infected	B-NP	JJ	B-cell_type	14	NMOD
12	resting	rest	I-NP	VBG	I-cell_type	14	NMOD
13	B	B	I-NP	NN	I-cell_type	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD
15	,	,	O	,	O	33	P
16	but	but	O	CC	O	33	VMOD
17	most	most	B-NP	JJS	O	19	NMOD
18	lymphoblastoid	lymphoblastoid	I-NP	JJ	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	33	SUB
20	infected	infect	B-VP	VBN	O	19	NMOD
21	with	with	B-PP	IN	O	20	VMOD
22	a	a	B-NP	DT	O	23	NMOD
23	virus	virus	I-NP	NN	O	21	PMOD
24	that	that	B-NP	WDT	O	23	NMOD
25	does	do	B-VP	VBZ	O	24	SBAR
26	not	not	I-VP	RB	O	25	VMOD
27	express	express	I-VP	VB	O	25	VC
28	the	the	B-NP	DT	O	30	NMOD
29	155	155	I-NP	CD	B-protein	30	NMOD
30	residues	residue	I-NP	NNS	I-protein	27	OBJ
31	beyond	beyond	B-PP	IN	O	27	VMOD
32	TES1	TES1	B-NP	NN	B-protein	31	PMOD
33	fail	fail	B-VP	VBP	O	0	ROOT
34	to	to	I-VP	TO	O	35	VMOD
35	grow	grow	I-VP	VB	O	33	VMOD
36	as	as	B-PP	IN	O	35	VMOD
37	long-term	long-term	B-NP	JJ	B-cell_line	39	NMOD
38	cell	cell	I-NP	NN	I-cell_line	39	NMOD
39	lines	line	I-NP	NNS	I-cell_line	36	PMOD
40	.	.	O	.	O	33	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	find	find	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	mutating	mutate	B-VP	VBG	O	19	SUB
6	two	two	B-NP	CD	O	7	NMOD
7	tyrosines	tyrosine	I-NP	NNS	O	5	OBJ
8	to	to	B-PP	TO	O	5	VMOD
9	an	an	B-NP	DT	O	10	NMOD
10	isoleucine	isoleucine	I-NP	NN	O	8	PMOD
11	at	at	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	carboxyl	carboxyl	I-NP	NN	B-protein	14	NMOD
14	end	end	I-NP	NN	I-protein	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	18	NMOD
18	tail	tail	I-NP	NN	I-protein	15	PMOD
19	cripples	cripple	B-VP	VBZ	O	4	SBAR
20	the	the	B-NP	DT	O	21	NMOD
21	ability	ability	I-NP	NN	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	EBV	EBV	B-NP	NN	O	22	PMOD
24	to	to	B-VP	TO	O	25	VMOD
25	cause	cause	I-VP	VB	O	21	NMOD
26	lymphoblastoid	lymphoblastoid	B-NP	JJ	O	28	NMOD
27	cell	cell	I-NP	NN	O	28	NMOD
28	outgrowth	outgrowth	I-NP	NN	O	25	OBJ
29	,	,	O	,	O	19	P
30	thereby	thereby	B-VP	RB	O	31	VMOD
31	marking	mark	I-VP	VBG	O	19	VMOD
32	a	a	B-NP	DT	O	36	NMOD
33	second	second	I-NP	JJ	O	36	NMOD
34	transformation	transformation	I-NP	NN	B-protein	36	NMOD
35	effector	effector	I-NP	NN	I-protein	36	NMOD
36	site	site	I-NP	NN	I-protein	38	NMOD
37	,	,	O	,	O	38	P
38	TES2	TES2	B-NP	NN	B-protein	31	OBJ
39	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	4	NMOD
2	yeast	yeast	I-NP	NN	O	4	NMOD
3	two-hybrid	two-hybrid	I-NP	JJ	O	4	NMOD
4	screen	screen	I-NP	NN	O	5	SUB
5	identified	identify	B-VP	VBD	O	0	ROOT
6	TES2	TES2	B-NP	NN	B-protein	8	NMOD
7	interacting	interacting	I-NP	NN	I-protein	8	NMOD
8	proteins	protein	I-NP	NNS	I-protein	5	OBJ
9	,	,	O	,	O	8	P
10	including	include	B-PP	VBG	O	8	NMOD
11	the	the	B-NP	DT	O	18	NMOD
12	tumor	tumor	I-NP	NN	B-protein	18	NMOD
13	necrosis	necrosis	I-NP	NN	I-protein	18	NMOD
14	factor	factor	I-NP	NN	I-protein	18	NMOD
15	receptor-associated	receptor-associated	I-NP	JJ	I-protein	18	NMOD
16	death	death	I-NP	NN	I-protein	18	NMOD
17	domain	domain	I-NP	NN	I-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	10	PMOD
19	(	(	O	(	O	20	P
20	TRADD	TRADD	B-NP	NN	B-protein	18	NMOD
21	)	)	O	)	O	20	P
22	.	.	O	.	O	5	P

1	TRADD	TRADD	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	only	only	I-NP	JJ	O	5	NMOD
5	protein	protein	I-NP	NN	O	2	PRD
6	that	that	B-NP	WDT	O	5	NMOD
7	interacted	interact	B-VP	VBD	O	6	SBAR
8	with	with	B-PP	IN	O	7	VMOD
9	wild-type	wild-type	B-NP	JJ	B-protein	10	NMOD
10	TES2	TES2	I-NP	NN	I-protein	8	PMOD
11	and	and	B-PP	CC	O	8	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	with	with	I-PP	IN	O	8	PMOD
14	isoleucine-mutated	isoleucine-mutated	B-NP	JJ	B-protein	15	NMOD
15	TES2	TES2	I-NP	NN	I-protein	13	PMOD
16	.	.	O	.	O	2	P

1	TRADD	TRADD	B-NP	NN	B-protein	16	NMOD
2	associated	associate	B-VP	VBN	O	1	NMOD
3	with	with	B-PP	IN	O	2	VMOD
4	wild-type	wild-type	B-NP	JJ	B-protein	5	NMOD
5	LMP1	LMP1	I-NP	NN	I-protein	3	PMOD
6	but	but	B-PP	CC	O	3	PMOD
7	not	not	B-PP	RB	O	8	PMOD
8	with	with	I-PP	IN	O	3	PMOD
9	isoleucine-mutated	isoleucine-mutated	B-NP	JJ	O	10	NMOD
10	LMP1	LMP1	I-NP	NN	B-protein	8	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	mammalian	mammalian	B-NP	JJ	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	,	,	O	,	O	1	P
15	and	and	O	CC	O	16	NMOD
16	TRADD	TRADD	B-NP	NN	B-protein	0	ROOT
17	constitutively	constitutively	B-VP	RB	O	18	VMOD
18	associated	associate	I-VP	VBN	O	16	NMOD
19	with	with	B-PP	IN	O	18	VMOD
20	LMP1	LMP1	B-NP	NN	B-protein	19	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	EBV-transformed	EBV-transformed	B-NP	JJ	B-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	21	PMOD
24	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	9	VMOD
2	transfection	transfection	B-NP	NN	O	3	NMOD
3	assays	assay	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	9	P
5	TRADD	TRADD	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	TES2	TES2	I-NP	NN	B-protein	9	SUB
8	synergistically	synergistically	B-ADVP	RB	O	9	VMOD
9	mediated	mediate	B-VP	VBD	O	0	ROOT
10	high-level	high-level	B-NP	JJ	O	12	NMOD
11	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	12	NMOD
12	activation	activation	I-NP	NN	O	9	OBJ
13	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	LMP1	LMP1	B-NP	NN	B-protein	6	SUB
6	appropriates	appropriate	B-VP	VBZ	O	4	SBAR
7	TRADD	TRADD	B-NP	NN	B-protein	6	OBJ
8	to	to	B-VP	TO	O	9	VMOD
9	enable	enable	I-VP	VB	O	6	VMOD
10	efficient	efficient	B-NP	JJ	O	14	NMOD
11	long-term	long-term	I-NP	JJ	O	14	NMOD
12	lymphoblastoid	lymphoblastoid	I-NP	JJ	O	14	NMOD
13	cell	cell	I-NP	NN	O	14	NMOD
14	outgrowth	outgrowth	I-NP	NN	O	9	OBJ
15	.	.	O	.	O	3	P

1	High-level	High-level	B-NP	JJ	O	3	NMOD
2	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	3	NMOD
3	activation	activation	I-NP	NN	O	5	SUB
4	also	also	B-ADVP	RB	O	5	VMOD
5	appears	appear	B-VP	VBZ	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	be	be	I-VP	VB	O	5	VMOD
8	a	a	B-NP	DT	O	10	NMOD
9	critical	critical	I-NP	JJ	O	10	NMOD
10	component	component	I-NP	NN	O	7	PRD
11	of	of	B-PP	IN	O	10	NMOD
12	long-term	long-term	B-NP	JJ	O	13	NMOD
13	outgrowth	outgrowth	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	5	P

1	Transcription	Transcription	B-NP	NN	B-protein	3	NMOD
2	factor	factor	I-NP	NN	I-protein	3	NMOD
3	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	4	SUB
4	regulates	regulate	B-VP	VBZ	O	0	ROOT
5	inducible	inducible	B-NP	JJ	O	8	NMOD
6	Oct-2	Oct-2	I-NP	NN	B-DNA	8	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	NMOD
8	expression	expression	I-NP	NN	O	4	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	precursor	precursor	B-NP	NN	B-cell_type	12	NMOD
11	B	B	I-NP	NN	I-cell_type	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
13	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	POU	POU	I-NP	NN	B-protein	4	NMOD
3	transcription	transcription	I-NP	NN	I-protein	4	NMOD
4	factors	factor	I-NP	NNS	I-protein	8	SUB
5	Oct-1	Oct-1	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	Oct-2	Oct-2	I-NP	NN	B-protein	4	NMOD
8	regulate	regulate	B-VP	VBP	O	0	ROOT
9	the	the	B-NP	DT	O	10	NMOD
10	activity	activity	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	octamer-dependent	octamer-dependent	B-NP	JJ	B-DNA	13	NMOD
13	promoters	promoter	I-NP	NNS	I-DNA	11	PMOD
14	,	,	O	,	O	13	P
15	including	include	B-PP	VBG	O	13	NMOD
16	those	those	B-NP	DT	O	15	PMOD
17	that	that	B-NP	WDT	O	16	NMOD
18	direct	direct	B-VP	VBP	O	17	SBAR
19	transcription	transcription	B-NP	NN	O	18	OBJ
20	from	from	B-PP	IN	O	19	NMOD
21	rearranged	rearrange	B-NP	VBN	O	23	NMOD
22	immunoglobulin	immunoglobulin	I-NP	NN	B-DNA	23	NMOD
23	genes	gene	I-NP	NNS	I-DNA	20	PMOD
24	.	.	O	.	O	8	P

1	Unlike	Unlike	B-PP	IN	O	15	VMOD
2	Oct-1	Oct-1	B-NP	NN	B-protein	1	PMOD
3	,	,	O	,	O	1	P
4	which	which	B-NP	WDT	O	1	PMOD
5	is	be	B-VP	VBZ	O	4	SBAR
6	constitutively	constitutively	I-VP	RB	O	5	VMOD
7	expressed	express	I-VP	VBN	O	5	VC
8	in	in	B-PP	IN	O	7	VMOD
9	many	many	B-NP	JJ	O	11	NMOD
10	cell	cell	I-NP	NN	O	11	NMOD
11	types	type	I-NP	NNS	O	8	PMOD
12	,	,	O	,	O	15	P
13	Oct-2	Oct-2	B-NP	NN	B-protein	14	NMOD
14	expression	expression	I-NP	NN	O	15	SUB
15	is	be	B-VP	VBZ	O	0	ROOT
16	restricted	restrict	I-VP	VBN	O	15	VC
17	primarily	primarily	B-ADVP	RB	O	18	PMOD
18	to	to	B-PP	TO	O	16	VMOD
19	B	B	B-NP	NN	B-cell_type	20	NMOD
20	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	18	PMOD
21	and	and	O	CC	O	15	VMOD
22	can	can	B-VP	MD	O	15	VMOD
23	be	be	I-VP	VB	O	22	VC
24	induced	induce	I-VP	VBN	O	23	VC
25	in	in	B-PP	IN	O	24	VMOD
26	precursor	precursor	B-NP	NN	B-cell_type	28	NMOD
27	B	B	I-NP	NN	I-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	25	PMOD
29	by	by	B-PP	IN	O	24	VMOD
30	stimulation	stimulation	B-NP	NN	O	29	PMOD
31	with	with	B-PP	IN	O	30	NMOD
32	bacterial	bacterial	B-NP	JJ	O	33	NMOD
33	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	31	PMOD
34	(	(	O	(	O	35	P
35	LPS	LPS	B-NP	NN	O	33	NMOD
36	)	)	O	)	O	35	P
37	.	.	O	.	O	15	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	the	the	B-NP	DT	O	5	NMOD
4	precise	precise	I-NP	JJ	B-protein	5	NMOD
5	factors	factor	I-NP	NNS	I-protein	11	SUB
6	that	that	B-NP	WDT	O	5	NMOD
7	mediate	mediate	B-VP	VBP	O	6	SBAR
8	this	this	B-NP	DT	O	10	NMOD
9	induction	induction	I-NP	NN	O	10	NMOD
10	mechanism	mechanism	I-NP	NN	O	7	OBJ
11	remain	remain	B-VP	VBP	O	0	ROOT
12	unknown	unknown	B-ADJP	JJ	O	11	PRD
13	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	7	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	monitored	monitor	B-VP	VBD	O	0	ROOT
8	Oct-2	Oct-2	B-NP	NN	B-protein	9	NMOD
9	expression	expression	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	cells	cell	B-NP	NNS	O	10	PMOD
12	arrested	arrest	B-VP	VBN	O	11	NMOD
13	for	for	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	activation	activation	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	21	NMOD
18	,	,	O	,	O	21	P
19	an	an	B-NP	DT	O	21	NMOD
20	LPS-responsive	LPS-responsive	I-NP	JJ	B-protein	21	NMOD
21	member	member	I-NP	NN	I-protein	16	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	27	NMOD
24	Rel	Rel	I-NP	NN	B-protein	27	NMOD
25	transcription	transcription	I-NP	NN	I-protein	27	NMOD
26	factor	factor	I-NP	NN	I-protein	27	NMOD
27	family	family	I-NP	NN	I-protein	22	PMOD
28	.	.	O	.	O	7	P

1	Despite	Despite	B-PP	IN	O	16	VMOD
2	stimulation	stimulation	B-NP	NN	O	1	PMOD
3	with	with	B-PP	IN	O	2	NMOD
4	LPS	LPS	B-NP	NN	O	3	PMOD
5	,	,	O	,	O	16	P
6	disruption	disruption	B-NP	NN	O	16	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	11	NMOD
10	signaling	signaling	I-NP	NN	O	11	NMOD
11	pathway	pathway	I-NP	NN	O	7	PMOD
12	in	in	B-PP	IN	O	6	NMOD
13	precursor	precursor	B-NP	NN	B-cell_type	15	NMOD
14	B	B	I-NP	NN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	led	lead	B-VP	VBD	O	0	ROOT
17	to	to	B-PP	TO	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	loss	loss	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	inducible	inducible	B-NP	JJ	O	25	NMOD
22	Oct-2	Oct-2	I-NP	NN	B-protein	25	NMOD
23	DNA	DNA	I-NP	NN	O	25	NMOD
24	binding	binding	I-NP	NN	O	25	NMOD
25	activity	activity	I-NP	NN	O	20	PMOD
26	in	in	B-ADVP	FW	O	16	VMOD
27	vitro	vitro	I-ADVP	FW	O	26	AMOD
28	and	and	O	CC	O	16	VMOD
29	the	the	B-NP	DT	O	30	NMOD
30	suppression	suppression	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	Oct-2-directed	Oct-2-directed	B-NP	JJ	O	33	NMOD
33	transcription	transcription	I-NP	NN	O	31	PMOD
34	in	in	B-ADVP	FW	O	30	NMOD
35	vivo	vivo	I-ADVP	FW	O	34	AMOD
36	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	3	NMOD
2	biochemical	biochemical	I-NP	JJ	O	3	NMOD
3	defect	defect	I-NP	NN	O	4	SUB
4	correlated	correlate	B-VP	VBD	O	19	VMOD
5	with	with	B-PP	IN	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	specific	specific	I-NP	JJ	O	8	NMOD
8	block	block	I-NP	NN	O	5	PMOD
9	to	to	B-PP	TO	O	8	NMOD
10	Oct-2	Oct-2	B-NP	NN	B-DNA	12	NMOD
11	gene	gene	I-NP	NN	I-DNA	12	NMOD
12	expression	expression	I-NP	NN	O	9	PMOD
13	at	at	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	level	level	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	transcription	transcription	B-NP	NN	O	16	PMOD
18	,	,	O	,	O	19	P
19	whereas	whereas	O	IN	O	0	ROOT
20	the	the	B-NP	DT	O	21	NMOD
21	expression	expression	I-NP	NN	O	24	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	Oct-1	Oct-1	B-NP	NN	B-protein	22	PMOD
24	was	be	B-VP	VBD	O	19	VMOD
25	unaffected	unaffected	B-ADJP	JJ	O	24	PRD
26	.	.	O	.	O	19	P

1	The	The	B-NP	DT	O	2	NMOD
2	finding	finding	I-NP	NN	O	9	SUB
3	that	that	B-SBAR	IN	O	2	NMOD
4	Oct-2	Oct-2	B-NP	NN	B-protein	5	SUB
5	is	be	B-VP	VBZ	O	3	SBAR
6	under	under	B-PP	IN	O	5	VMOD
7	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	8	NMOD
8	control	control	I-NP	NN	O	6	PMOD
9	highlights	highlight	B-VP	VBZ	O	0	ROOT
10	an	an	B-NP	DT	O	13	NMOD
11	important	important	I-NP	JJ	O	13	NMOD
12	cross-talk	cross-talk	I-NP	NN	O	13	NMOD
13	mechanism	mechanism	I-NP	NN	O	9	OBJ
14	involving	involve	B-VP	VBG	O	13	NMOD
15	two	two	B-NP	CD	O	19	NMOD
16	distinct	distinct	I-NP	JJ	O	19	NMOD
17	transcription	transcription	I-NP	NN	B-protein	19	NMOD
18	factor	factor	I-NP	NN	I-protein	19	NMOD
19	families	family	I-NP	NNS	I-protein	14	OBJ
20	that	that	B-NP	WDT	O	19	NMOD
21	regulate	regulate	B-VP	VBP	O	20	SBAR
22	B	B	B-NP	NN	B-cell_type	24	NMOD
23	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	24	NMOD
24	function	function	I-NP	NN	O	21	OBJ
25	.	.	O	.	O	9	P

1	Paternal	Paternal	B-NP	JJ	O	2	NMOD
2	expression	expression	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	WT1	WT1	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	human	human	B-NP	JJ	B-cell_type	9	NMOD
7	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	lymphocytes	lymphocyte	I-NP	NNS	B-cell_type	5	PMOD
10	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	6	NMOD
2	Wilms	Wilms	I-NP	NNP	B-DNA	6	NMOD
3	'	'	B-NP	POS	I-DNA	6	NMOD
4	tumor	tumor	I-NP	NN	I-DNA	6	NMOD
5	suppressor	suppressor	I-NP	NN	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	10	SUB
7	(	(	O	(	O	8	P
8	WT1	WT1	B-NP	NN	B-DNA	6	NMOD
9	)	)	O	)	O	8	P
10	was	be	B-VP	VBD	O	0	ROOT
11	previously	previously	I-VP	RB	O	10	VMOD
12	identified	identify	I-VP	VBN	O	10	VC
13	as	as	B-PP	IN	O	12	VMOD
14	being	be	B-VP	VBG	O	13	PMOD
15	imprinted	imprint	I-VP	VBN	O	14	VC
16	,	,	O	,	O	12	P
17	with	with	B-PP	IN	O	12	VMOD
18	frequent	frequent	B-NP	JJ	O	20	NMOD
19	maternal	maternal	I-NP	JJ	O	20	NMOD
20	expression	expression	I-NP	NN	O	17	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	human	human	B-NP	JJ	O	23	NMOD
23	placentae	placentae	I-NP	NN	O	26	NMOD
24	and	and	O	CC	O	26	NMOD
25	fetal	fetal	B-NP	JJ	O	26	NMOD
26	brains	brain	I-NP	NNS	O	21	PMOD
27	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	examined	examine	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	allele-specific	allele-specific	I-NP	JJ	O	5	NMOD
5	expression	expression	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	WT1	WT1	B-NP	NN	B-protein	6	PMOD
8	in	in	B-PP	IN	O	5	NMOD
9	cultured	culture	B-NP	VBN	B-cell_line	11	NMOD
10	human	human	I-NP	JJ	I-cell_line	11	NMOD
11	fibroblasts	fibroblast	I-NP	NNS	I-cell_line	8	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	15	15	B-NP	CD	O	14	NMOD
14	individuals	individual	I-NP	NNS	O	12	PMOD
15	.	.	O	.	O	2	P

1	Seven	Seven	B-NP	CD	O	2	AMOD
2	of	of	B-PP	IN	O	16	VMOD
3	15	15	B-NP	CD	O	5	NMOD
4	fibroblast	fibroblast	I-NP	NN	B-cell_line	5	NMOD
5	lines	line	I-NP	NNS	I-cell_line	2	PMOD
6	were	be	B-VP	VBD	O	2	SBAR
7	heterozygous	heterozygous	B-ADJP	JJ	O	6	PRD
8	for	for	B-PP	IN	O	7	AMOD
9	polymorphic	polymorphic	B-NP	JJ	B-DNA	10	NMOD
10	alleles	allele	I-NP	NNS	I-DNA	8	PMOD
11	,	,	O	,	O	16	P
12	and	and	O	CC	O	15	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	expression	expression	I-NP	NN	O	15	NMOD
15	patterns	pattern	I-NP	NNS	O	16	SUB
16	were	be	B-VP	VBD	O	0	ROOT
17	variable	variable	B-ADJP	JJ	O	16	PRD
18	,	,	O	,	O	36	P
19	i.e.	i.e.	O	FW	O	36	NMOD
20	,	,	O	,	O	36	P
21	equal	equal	B-NP	JJ	O	25	AMOD
22	,	,	I-NP	,	O	25	P
23	unequal	unequal	I-NP	JJ	O	25	AMOD
24	or	or	I-NP	CC	O	25	AMOD
25	monoallelic	monoallelic	I-NP	JJ	O	27	NMOD
26	paternal	paternal	I-NP	JJ	O	27	NMOD
27	expression	expression	I-NP	NN	O	36	NMOD
28	in	in	B-PP	IN	O	27	NMOD
29	three	three	B-NP	CD	O	34	NMOD
30	,	,	I-NP	,	O	34	P
31	two	two	I-NP	CD	O	34	NMOD
32	and	and	I-NP	CC	O	34	NMOD
33	two	two	I-NP	CD	O	34	NMOD
34	cases	case	I-NP	NNS	O	28	PMOD
35	,	,	O	,	O	36	P
36	respectively	respectively	B-ADVP	RB	O	16	VMOD
37	.	.	O	.	O	16	P

1	Exclusive	Exclusive	B-NP	JJ	O	3	NMOD
2	paternal	paternal	I-NP	JJ	O	3	NMOD
3	expression	expression	I-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	WT1	WT1	B-NP	NN	B-protein	4	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	also	also	I-VP	RB	O	6	VMOD
8	shown	show	I-VP	VBN	O	6	VC
9	in	in	B-PP	IN	O	8	VMOD
10	non-cultured	non-cultured	B-NP	JJ	B-cell_type	12	NMOD
11	peripheral	peripheral	I-NP	JJ	I-cell_type	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	17	NMOD
15	latter	latter	I-NP	JJ	O	17	NMOD
16	two	two	I-NP	CD	O	17	NMOD
17	individuals	individual	I-NP	NNS	O	13	PMOD
18	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	allele-specific	allele-specific	I-NP	JJ	O	4	NMOD
3	expression	expression	I-NP	NN	O	4	NMOD
4	profiles	profile	I-NP	NNS	O	12	NMOD
5	of	of	B-PP	IN	O	4	NMOD
6	other	other	B-NP	JJ	O	8	NMOD
7	imprinted	imprinted	I-NP	JJ	B-DNA	8	NMOD
8	genes	gene	I-NP	NNS	I-DNA	5	PMOD
9	,	,	O	,	O	12	P
10	IGF2	IGF2	B-NP	NN	B-protein	12	NMOD
11	and	and	O	CC	O	12	NMOD
12	H19	H19	B-NP	NN	B-DNA	18	SUB
13	,	,	O	,	O	12	P
14	on	on	B-PP	IN	O	12	NMOD
15	human	human	B-NP	JJ	B-DNA	16	NMOD
16	chromosome	chromosome	I-NP	NN	I-DNA	14	PMOD
17	11	11	I-NP	CD	I-DNA	16	NMOD
18	were	be	B-VP	VBD	O	0	ROOT
19	constant	constant	B-ADJP	JJ	O	21	AMOD
20	and	and	I-ADJP	CC	O	21	AMOD
21	consistent	consistent	I-ADJP	JJ	O	18	PRD
22	with	with	B-PP	IN	O	21	AMOD
23	those	those	B-NP	DT	O	22	PMOD
24	in	in	B-PP	IN	O	23	NMOD
25	other	other	B-NP	JJ	O	26	NMOD
26	tissues	tissue	I-NP	NNS	O	24	PMOD
27	.	.	O	.	O	18	P

1	Our	Our	B-NP	PRP$	O	3	NMOD
2	unexpected	unexpected	I-NP	JJ	O	3	NMOD
3	observations	observation	I-NP	NNS	O	31	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	paternal	paternal	B-NP	JJ	O	7	AMOD
6	or	or	I-NP	CC	O	7	AMOD
7	biallelic	biallelic	I-NP	JJ	O	8	NMOD
8	expression	expression	I-NP	NN	O	4	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	WT1	WT1	B-NP	NN	B-protein	9	PMOD
11	in	in	B-PP	IN	O	3	NMOD
12	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	14	NMOD
13	and	and	I-NP	CC	O	14	NMOD
14	lymphocytes	lymphocyte	I-NP	NNS	B-cell_type	11	PMOD
15	,	,	O	,	O	3	P
16	together	together	B-ADVP	RB	O	3	NMOD
17	with	with	B-PP	IN	O	3	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	previous	previous	I-NP	JJ	O	20	NMOD
20	findings	finding	I-NP	NNS	O	17	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	maternal	maternal	B-NP	JJ	O	24	AMOD
23	or	or	I-NP	CC	O	24	AMOD
24	biallelic	biallelic	I-NP	JJ	O	25	NMOD
25	expression	expression	I-NP	NN	O	21	PMOD
26	in	in	B-PP	IN	O	20	NMOD
27	placentae	placenta	B-NP	NNS	O	29	NMOD
28	and	and	I-NP	CC	O	29	NMOD
29	brains	brain	I-NP	NNS	O	26	PMOD
30	,	,	O	,	O	3	P
31	suggest	suggest	B-VP	VBP	O	0	ROOT
32	that	that	B-SBAR	IN	O	31	VMOD
33	the	the	B-NP	DT	O	36	NMOD
34	allele-specific	allele-specific	I-NP	JJ	O	36	NMOD
35	regulatory	regulatory	I-NP	JJ	O	36	NMOD
36	system	system	I-NP	NN	O	39	SUB
37	of	of	B-PP	IN	O	36	NMOD
38	WT1	WT1	B-NP	NN	B-DNA	37	PMOD
39	is	be	B-VP	VBZ	O	32	SBAR
40	unique	unique	B-ADJP	JJ	O	39	PRD
41	and	and	O	CC	O	39	VMOD
42	may	may	B-VP	MD	O	39	VMOD
43	be	be	I-VP	VB	O	42	VC
44	controlled	control	I-VP	VBN	O	43	VC
45	by	by	B-PP	IN	O	44	VMOD
46	a	a	B-NP	DT	O	48	NMOD
47	putative	putative	I-NP	JJ	O	48	NMOD
48	tissue-	tissue-	I-NP	NN	O	51	NMOD
49	and	and	O	CC	O	51	NMOD
50	individual-specific	individual-specific	B-NP	JJ	O	51	NMOD
51	modifier	modifier	I-NP	NN	O	45	PMOD
52	.	.	O	.	O	31	P

1	Extinction	Extinction	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	5	NMOD
4	gene	gene	I-NP	NN	I-DNA	5	NMOD
5	expression	expression	I-NP	NN	O	2	PMOD
6	in	in	B-PP	IN	O	1	NMOD
7	B	B	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
9	upon	upon	B-PP	IN	O	1	NMOD
10	fusion	fusion	B-NP	NN	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	HeLa	HeLa	B-NP	NN	B-cell_line	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_line	11	PMOD
14	is	be	B-VP	VBZ	O	0	ROOT
15	preceded	precede	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	rapid	rapid	B-NP	JJ	O	19	NMOD
18	nuclear	nuclear	I-NP	JJ	O	19	NMOD
19	depletion	depletion	I-NP	NN	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	essential	essential	B-NP	JJ	B-protein	23	NMOD
22	transcription	transcription	I-NP	NN	I-protein	23	NMOD
23	factors	factor	I-NP	NNS	I-protein	20	PMOD
24	and	and	O	CC	O	14	VMOD
25	is	be	B-VP	VBZ	O	14	VMOD
26	accompanied	accompany	I-VP	VBN	O	25	VC
27	by	by	B-PP	IN	O	26	VMOD
28	widespread	widespread	B-NP	JJ	O	29	NMOD
29	inactivation	inactivation	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	genes	gene	B-NP	NNS	B-DNA	30	PMOD
32	expressed	express	B-VP	VBN	O	31	NMOD
33	in	in	B-PP	IN	O	32	VMOD
34	a	a	B-NP	DT	O	37	NMOD
35	B	B	I-NP	NN	O	37	NMOD
36	cell-specific	cell-specific	I-NP	JJ	O	35	AMOD
37	manner	manner	I-NP	NN	O	33	PMOD
38	.	.	O	.	O	14	P

1	When	When	B-ADVP	WRB	O	17	VMOD
2	immunoglobulin	immunoglobulin	B-NP	NN	B-protein	8	NMOD
3	(	(	O	(	O	4	P
4	Ig	Ig	B-NP	NN	O	2	NMOD
5	)	)	O	)	O	4	P
6	expressing	express	B-VP	VBG	O	8	NMOD
7	B	B	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	9	SUB
9	are	be	B-VP	VBP	O	1	SBAR
10	fused	fuse	I-VP	VBN	O	9	VC
11	with	with	B-PP	IN	O	10	VMOD
12	non-B	non-B	B-NP	JJ	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	,	,	O	,	O	17	P
15	Ig	Ig	B-NP	NN	B-protein	16	NMOD
16	expression	expression	I-NP	NN	O	17	SUB
17	is	be	B-VP	VBZ	O	0	ROOT
18	rapidly	rapidly	I-VP	RB	O	17	VMOD
19	suppressed	suppress	I-VP	VBN	O	17	VC
20	at	at	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	level	level	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	transcription	transcription	B-NP	NN	O	27	NMOD
25	,	,	O	,	O	27	P
26	a	a	B-NP	DT	O	27	NMOD
27	phenomenon	phenomenon	I-NP	NN	O	23	PMOD
28	termed	term	I-NP	VBN	O	27	NMOD
29	extinction	extinction	I-NP	NN	O	28	VMOD
30	.	.	O	.	O	17	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	fusion	fusion	B-NP	NN	O	19	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	HeLa	HeLa	B-NP	NN	B-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
9	with	with	B-PP	IN	O	5	NMOD
10	either	either	B-NP	CC	O	15	NMOD
11	diploid	diploid	I-NP	JJ	B-cell_type	15	NMOD
12	or	or	I-NP	CC	I-cell_type	15	NMOD
13	tetraploid	tetraploid	I-NP	JJ	I-cell_type	15	NMOD
14	B	B	I-NP	NN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
16	(	(	O	(	O	17	P
17	Daudi	Daudi	B-NP	NN	B-cell_line	15	NMOD
18	)	)	O	)	O	17	P
19	results	result	B-VP	VBZ	O	4	SBAR
20	in	in	B-PP	IN	O	19	VMOD
21	widespread	widespread	B-NP	JJ	O	22	NMOD
22	extinction	extinction	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	several	several	B-NP	JJ	O	28	NMOD
25	other	other	I-NP	JJ	O	28	NMOD
26	B	B	I-NP	NN	B-DNA	28	NMOD
27	cell-encoded	cell-encoded	I-NP	JJ	I-DNA	28	NMOD
28	genes	gene	I-NP	NNS	I-DNA	23	PMOD
29	that	that	B-NP	WDT	O	28	NMOD
30	are	be	B-VP	VBP	O	29	SBAR
31	expressed	express	I-VP	VBN	O	30	VC
32	in	in	B-PP	IN	O	31	VMOD
33	a	a	B-NP	DT	O	36	NMOD
34	B	B	I-NP	NN	O	36	NMOD
35	cell-specific	cell-specific	I-NP	JJ	O	34	AMOD
36	manner	manner	I-NP	NN	O	32	PMOD
37	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	16	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	16	P
4	expression	expression	B-NP	NN	O	16	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	B	B	B-NP	NN	B-DNA	8	NMOD
7	cell-expressed	cell-expressed	I-NP	JJ	I-DNA	8	NMOD
8	genes	gene	I-NP	NNS	I-DNA	5	PMOD
9	that	that	B-NP	WDT	O	8	NMOD
10	are	be	B-VP	VBP	O	9	SBAR
11	not	not	O	RB	O	10	VMOD
12	dependent	dependent	B-ADJP	JJ	O	10	VMOD
13	on	on	B-PP	IN	O	12	AMOD
14	cell-specific	cell-specific	B-NP	JJ	O	15	NMOD
15	controls	control	I-NP	NNS	O	13	PMOD
16	is	be	B-VP	VBZ	O	0	ROOT
17	unaffected	unaffected	B-ADJP	JJ	O	16	PRD
18	.	.	O	.	O	16	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	8	NMOD
5	molecular	molecular	I-NP	JJ	O	8	NMOD
6	mechanism	mechanism	I-NP	NN	O	8	NMOD
7	(	(	I-NP	(	O	8	P
8	s	s	I-NP	NNS	O	14	SUB
9	)	)	O	)	O	8	P
10	underlying	underlie	B-VP	VBG	O	8	NMOD
11	Ig	Ig	B-NP	NN	B-DNA	13	NMOD
12	gene	gene	I-NP	NN	I-DNA	13	NMOD
13	extinction	extinction	I-NP	NN	O	10	OBJ
14	can	can	B-VP	MD	O	3	SBAR
15	be	be	I-VP	VB	O	14	VC
16	explained	explain	I-VP	VBN	O	15	VC
17	,	,	O	,	O	16	P
18	at	at	B-ADVP	IN	O	20	PMOD
19	least	least	I-ADVP	JJS	O	18	AMOD
20	in	in	B-PP	IN	O	16	VMOD
21	part	part	B-NP	NN	O	20	PMOD
22	,	,	O	,	O	16	P
23	by	by	B-PP	IN	O	16	VMOD
24	a	a	B-NP	DT	O	25	NMOD
25	lack	lack	I-NP	NN	O	23	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	transcription	transcription	B-NP	NN	B-protein	28	NMOD
28	factors	factor	I-NP	NNS	I-protein	26	PMOD
29	that	that	B-NP	WDT	O	28	NMOD
30	are	be	B-VP	VBP	O	29	SBAR
31	essential	essential	B-ADJP	JJ	O	30	PRD
32	for	for	B-PP	IN	O	31	AMOD
33	Ig	Ig	B-NP	NN	B-DNA	35	NMOD
34	gene	gene	I-NP	NN	I-DNA	35	NMOD
35	transcription	transcription	I-NP	NN	O	32	PMOD
36	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	3	NMOD
2	transcription	transcription	I-NP	NN	B-protein	3	NMOD
3	factors	factor	I-NP	NNS	I-protein	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	either	either	O	CC	O	4	VMOD
6	not	not	O	RB	O	5	DEP
7	produced	produce	B-VP	VBN	O	5	DEP
8	due	due	B-ADJP	JJ	O	7	PRD
9	to	to	B-PP	TO	O	8	AMOD
10	block	block	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	transcription	transcription	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	their	their	B-NP	PRP$	O	16	NMOD
15	respective	respective	I-NP	JJ	O	16	NMOD
16	genes	gene	I-NP	NNS	O	26	SUB
17	(	(	O	(	O	26	P
18	Oct-2	Oct-2	B-NP	NN	B-protein	26	SUB
19	,	,	O	,	O	26	P
20	OBF-1	OBF-1	B-NP	NN	B-protein	26	SUB
21	,	,	O	,	O	22	P
22	PU.1	PU.1	B-NP	NN	B-protein	20	NMOD
23	)	)	O	)	O	22	P
24	,	,	O	,	O	20	P
25	or	or	O	CC	O	26	VMOD
26	are	be	B-VP	VBP	O	13	SBAR
27	rendered	render	I-VP	VBN	O	26	VC
28	inactive	inactive	O	JJ	O	27	VMOD
29	posttranslationally	posttranslationally	O	RB	O	28	AMOD
30	(	(	O	(	O	34	P
31	NF-kappa	NF-kappa	B-NP	NN	B-protein	32	NMOD
32	B	B	I-NP	NN	I-protein	34	NMOD
33	,	,	O	,	O	34	P
34	E47	E47	B-NP	NN	B-protein	29	NMOD
35	)	)	O	)	O	34	P
36	.	.	O	.	O	4	P

1	By	By	B-PP	IN	O	14	VMOD
2	isolating	isolate	B-VP	VBG	O	1	PMOD
3	Daudi	Daudi	B-NP	NN	B-cell_line	6	NMOD
4	x	x	B-NP	SYM	I-cell_line	6	NMOD
5	HeLa	HeLa	I-NP	NN	I-cell_line	6	NMOD
6	heterokaryons	heterokaryon	I-NP	NNS	I-cell_line	9	NMOD
7	a	a	B-NP	DT	O	9	NMOD
8	few	few	I-NP	JJ	O	9	NMOD
9	hours	hour	I-NP	NNS	O	2	OBJ
10	after	after	B-PP	IN	O	2	VMOD
11	fusion	fusion	B-NP	NN	O	10	PMOD
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	have	have	B-VP	VBP	O	0	ROOT
15	studied	study	I-VP	VBN	O	14	VC
16	the	the	B-NP	DT	O	18	NMOD
17	initial	initial	I-NP	JJ	O	18	NMOD
18	fate	fate	I-NP	NN	O	15	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	two	two	B-NP	CD	O	24	NMOD
21	B	B	I-NP	NN	B-protein	24	NMOD
22	cell-specific	cell-specific	I-NP	JJ	I-protein	21	AMOD
23	transcription	transcription	I-NP	NN	I-protein	24	NMOD
24	factors	factor	I-NP	NNS	I-protein	19	PMOD
25	involved	involve	B-VP	VBN	O	24	NMOD
26	in	in	B-PP	IN	O	25	VMOD
27	Ig	Ig	B-NP	NN	B-DNA	29	NMOD
28	gene	gene	I-NP	NN	I-DNA	29	NMOD
29	transcription	transcription	I-NP	NN	O	34	NMOD
30	,	,	O	,	O	34	P
31	Oct-2	Oct-2	B-NP	NN	B-protein	34	NMOD
32	and	and	O	CC	O	34	NMOD
33	NF-kappa	NF-kappa	B-NP	NN	B-protein	34	NMOD
34	B	B	I-NP	NN	I-protein	26	PMOD
35	.	.	O	.	O	14	P

1	This	This	B-NP	DT	O	2	NMOD
2	report	report	I-NP	NN	O	3	SUB
3	provides	provide	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	first	first	I-NP	JJ	O	6	NMOD
6	demonstration	demonstration	I-NP	NN	O	3	OBJ
7	that	that	B-NP	IN	O	6	NMOD
8	upon	upon	B-PP	IN	O	22	VMOD
9	fusion	fusion	B-NP	NN	O	8	PMOD
10	with	with	B-PP	IN	O	9	NMOD
11	HeLa	HeLa	B-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
13	,	,	O	,	O	22	P
14	the	the	B-NP	DT	O	16	NMOD
15	nuclear	nuclear	I-NP	JJ	O	16	NMOD
16	contents	content	I-NP	NNS	O	22	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	B	B	B-NP	NN	B-protein	21	NMOD
19	cell-expressed	cell-expressed	I-NP	JJ	I-protein	21	NMOD
20	transcription	transcription	I-NP	NN	I-protein	21	NMOD
21	factors	factor	I-NP	NNS	I-protein	17	PMOD
22	are	be	B-VP	VBP	O	7	SBAR
23	depleted	deplete	I-VP	VBN	O	22	VC
24	within	within	B-PP	IN	O	23	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	few	few	I-NP	JJ	O	27	NMOD
27	hours	hour	I-NP	NNS	O	24	PMOD
28	with	with	B-PP	IN	O	27	NMOD
29	kinetics	kinetic	B-NP	NNS	O	28	PMOD
30	that	that	B-NP	WDT	O	27	NMOD
31	are	be	B-VP	VBP	O	30	SBAR
32	as	as	B-PP	IN	O	31	PRD
33	fast	fast	B-ADJP	JJ	O	35	AMOD
34	or	or	I-ADJP	CC	O	35	AMOD
35	faster	fast	I-ADJP	JJR	O	32	PMOD
36	than	than	B-PP	IN	O	35	AMOD
37	that	that	B-NP	DT	O	36	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	Ig	Ig	B-NP	NN	B-DNA	41	NMOD
40	gene	gene	I-NP	NN	I-DNA	41	NMOD
41	extinction	extinction	I-NP	NN	O	38	PMOD
42	.	.	O	.	O	3	P

1	Thus	Thus	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	extinguishing	extinguishing	I-NP	NN	O	5	NMOD
5	mechanism	mechanism	I-NP	NN	O	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	effective	effective	B-ADJP	JJ	O	6	PRD
8	very	very	B-ADVP	RB	O	10	PMOD
9	early	early	I-ADVP	RB	O	8	AMOD
10	after	after	B-PP	IN	O	6	VMOD
11	fusion	fusion	B-NP	NN	O	10	PMOD
12	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	suggest	suggest	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	extinction	extinction	B-NP	NN	O	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	Ig	Ig	B-NP	NN	B-DNA	7	NMOD
7	genes	gene	I-NP	NNS	I-DNA	5	PMOD
8	is	be	B-VP	VBZ	O	3	SBAR
9	part	part	B-NP	NN	O	8	PRD
10	of	of	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	13	NMOD
12	global	global	I-NP	JJ	O	13	NMOD
13	mechanism	mechanism	I-NP	NN	O	10	PMOD
14	that	that	B-NP	WDT	O	13	NMOD
15	suppresses	suppress	B-VP	VBZ	O	14	SBAR
16	the	the	B-NP	DT	O	18	NMOD
17	differentiation	differentiation	I-NP	NN	O	18	NMOD
18	program	program	I-NP	NN	O	15	OBJ
19	foreign	foreign	B-ADJP	JJ	O	18	NMOD
20	to	to	B-PP	TO	O	19	AMOD
21	the	the	B-NP	DT	O	23	NMOD
22	HeLa	HeLa	I-NP	NN	B-cell_line	23	NMOD
23	phenotype	phenotype	I-NP	NN	I-cell_line	20	PMOD
24	.	.	O	.	O	2	P

1	Regulation	Regulation	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	Id3	Id3	B-NP	NN	B-protein	6	NMOD
4	cell	cell	I-NP	NN	O	6	NMOD
5	cycle	cycle	I-NP	NN	O	6	NMOD
6	function	function	I-NP	NN	O	2	PMOD
7	by	by	B-PP	IN	O	1	NMOD
8	Cdk-2-dependent	Cdk-2-dependent	B-NP	JJ	O	9	NMOD
9	phosphorylation	phosphorylation	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	2	NMOD
2	functions	function	I-NP	NNS	O	23	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	basic	basic	B-NP	JJ	B-protein	10	NMOD
5	helix-loop-helix	helix-loop-helix	I-NP	JJ	I-protein	7	AMOD
6	(	(	O	(	I-protein	7	P
7	bHLH	bHLH	B-ADJP	JJ	I-protein	4	AMOD
8	)	)	O	)	I-protein	7	P
9	transcription	transcription	B-NP	NN	I-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	3	PMOD
11	in	in	B-PP	IN	O	2	NMOD
12	activating	activate	B-VP	VBG	O	11	PMOD
13	differentiation-linked	differentiation-linked	B-NP	JJ	O	15	NMOD
14	gene	gene	I-NP	NN	O	15	NMOD
15	expression	expression	I-NP	NN	O	12	OBJ
16	and	and	B-PP	CC	O	11	PMOD
17	in	in	B-PP	IN	O	11	PMOD
18	inducing	induce	B-VP	VBG	O	17	PMOD
19	G1	G1	B-NP	NN	O	22	NMOD
20	cell	cell	I-NP	NN	O	22	NMOD
21	cycle	cycle	I-NP	NN	O	22	NMOD
22	arrest	arrest	I-NP	NN	O	18	OBJ
23	are	be	B-VP	VBP	O	0	ROOT
24	negatively	negatively	I-VP	RB	O	23	VMOD
25	regulated	regulate	I-VP	VBN	O	23	VC
26	by	by	B-PP	IN	O	25	VMOD
27	members	member	B-NP	NNS	O	26	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	31	NMOD
30	Id	Id	I-NP	NN	B-protein	31	NMOD
31	family	family	I-NP	NN	I-protein	28	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	HLH	HLH	B-NP	JJ	B-protein	34	NMOD
34	proteins	protein	I-NP	NNS	I-protein	32	PMOD
35	.	.	O	.	O	23	P

1	These	These	B-NP	DT	O	3	NMOD
2	bHLH	bHLH	I-NP	JJ	B-protein	3	NMOD
3	antagonists	antagonist	I-NP	NNS	I-protein	4	SUB
4	are	be	B-VP	VBP	O	14	VMOD
5	induced	induce	I-VP	VBN	O	4	VC
6	during	during	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	10	NMOD
8	mitogenic	mitogenic	I-NP	JJ	O	10	NMOD
9	signalling	signalling	I-NP	NN	O	10	NMOD
10	response	response	I-NP	NN	O	6	PMOD
11	,	,	O	,	O	14	P
12	and	and	O	CC	O	14	VMOD
13	they	they	B-NP	PRP	O	14	SUB
14	function	function	B-VP	VBP	O	0	ROOT
15	by	by	B-PP	IN	O	14	VMOD
16	sequestering	sequester	B-VP	VBG	O	15	PMOD
17	their	their	B-NP	PRP$	O	19	NMOD
18	bHLH	bHLH	I-NP	JJ	B-protein	19	NMOD
19	targets	target	I-NP	NNS	I-protein	16	OBJ
20	in	in	B-PP	IN	O	19	NMOD
21	inactive	inactive	B-NP	JJ	B-protein	22	NMOD
22	heterodimers	heterodimer	I-NP	NNS	I-protein	20	PMOD
23	that	that	B-NP	WDT	O	19	NMOD
24	are	be	B-VP	VBP	O	23	SBAR
25	unable	unable	B-ADJP	JJ	O	24	PRD
26	to	to	B-VP	TO	O	27	VMOD
27	bind	bind	I-VP	VB	O	25	AMOD
28	to	to	B-PP	TO	O	27	VMOD
29	specific	specific	B-NP	JJ	O	31	NMOD
30	gene	gene	I-NP	NN	O	31	NMOD
31	regulatory	regulatory	I-NP	JJ	O	28	PMOD
32	(	(	O	(	O	34	P
33	E	E	B-NP	NN	B-DNA	34	NMOD
34	box	box	I-NP	NN	I-DNA	31	NMOD
35	)	)	O	)	O	34	P
36	sequences	sequence	B-NP	NNS	O	31	NMOD
37	.	.	O	.	O	14	P

1	Recently	Recently	B-ADVP	RB	O	20	VMOD
2	,	,	O	,	O	20	P
3	cyclin	cyclin	B-NP	NN	B-protein	4	NMOD
4	E-Cdk2-	E-Cdk2-	I-NP	NN	I-protein	8	NMOD
5	and	and	O	CC	O	8	NMOD
6	cyclin	cyclin	B-NP	NN	O	8	NMOD
7	A-Cdk2-dependent	A-Cdk2-dependent	I-NP	JJ	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	20	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	14	NMOD
11	single	single	I-NP	JJ	O	14	NMOD
12	conserved	conserve	I-NP	VBN	O	14	NMOD
13	serine	serine	I-NP	NN	O	14	NMOD
14	residue	residue	I-NP	NN	O	9	PMOD
15	(	(	O	(	O	16	P
16	Ser5	Ser5	B-NP	NN	B-protein	14	NMOD
17	)	)	O	)	O	16	P
18	in	in	B-PP	IN	O	8	NMOD
19	Id2	Id2	B-NP	NN	B-protein	18	PMOD
20	has	have	B-VP	VBZ	O	37	VMOD
21	been	be	I-VP	VBN	O	20	VC
22	shown	show	I-VP	VBN	O	21	VC
23	to	to	I-VP	TO	O	24	VMOD
24	occur	occur	I-VP	VB	O	22	VMOD
25	during	during	B-PP	IN	O	24	VMOD
26	late	late	B-NP	JJ	O	29	NMOD
27	G1-to-S	G1-to-S	I-NP	JJ	O	29	NMOD
28	phase	phase	I-NP	NN	O	29	NMOD
29	transition	transition	I-NP	NN	O	25	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	cell	cell	I-NP	NN	O	33	NMOD
33	cycle	cycle	I-NP	NN	O	30	PMOD
34	,	,	O	,	O	37	P
35	and	and	O	CC	O	37	VMOD
36	this	this	B-NP	DT	O	37	SUB
37	neutralizes	neutralize	B-VP	VBZ	O	0	ROOT
38	the	the	B-NP	DT	O	39	NMOD
39	function	function	I-NP	NN	O	37	OBJ
40	of	of	B-PP	IN	O	39	NMOD
41	Id2	Id2	B-NP	NN	B-protein	40	PMOD
42	in	in	B-PP	IN	O	37	VMOD
43	abrogating	abrogate	B-VP	VBG	O	42	PMOD
44	E-box-dependent	E-box-dependent	B-NP	JJ	B-protein	46	NMOD
45	bHLH	bHLH	I-NP	JJ	I-protein	46	NMOD
46	homo-	homo-	I-NP	JJ	O	50	NMOD
47	or	or	I-NP	CC	O	48	AMOD
48	heterodimer	heterodimer	I-NP	NN	B-protein	50	NMOD
49	complex	complex	I-NP	NN	I-protein	50	NMOD
50	formation	formation	I-NP	NN	O	43	OBJ
51	in	in	B-ADVP	FW	O	37	VMOD
52	vitro	vitro	I-ADVP	FW	O	51	AMOD
53	(	(	O	(	O	66	P
54	E.Hara	E.Hara	B-NP	NNP	O	62	NMOD
55	,	,	O	,	O	62	P
56	M.Hall	M.Hall	B-NP	NNP	O	62	NMOD
57	,	,	O	,	O	62	P
58	and	and	O	CC	O	62	NMOD
59	G.Peters	G.Peters	B-NP	NNP	O	62	NMOD
60	,	,	O	,	O	62	P
61	EMBO	EMBO	B-NP	NNP	O	62	NMOD
62	J.16	J.16	I-NP	NNP	O	66	NMOD
63	:	:	O	:	O	66	P
64	332-342	332-342	B-NP	CD	O	66	NMOD
65	,	,	I-NP	,	O	66	P
66	1997	1997	I-NP	CD	O	37	VMOD
67	)	)	O	)	O	66	P
68	.	.	O	.	O	37	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	an	an	B-NP	DT	O	8	NMOD
6	analogous	analogous	I-NP	JJ	O	8	NMOD
7	cell-cycle-regulated	cell-cycle-regulated	I-NP	JJ	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	Id3	Id3	B-NP	NN	B-protein	9	PMOD
11	alters	alter	B-VP	VBZ	O	4	SBAR
12	the	the	B-NP	DT	O	13	NMOD
13	specificity	specificity	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	Id3	Id3	B-NP	NN	B-protein	14	PMOD
16	for	for	B-PP	IN	O	11	VMOD
17	abrogating	abrogate	B-VP	VBG	O	16	PMOD
18	both	both	O	CC	O	20	NMOD
19	E-box-dependent	E-box-dependent	B-NP	JJ	B-protein	20	NMOD
20	bHLH	bHLH	I-NP	JJ	I-protein	25	NMOD
21	homo-	homo-	I-NP	NN	O	25	NMOD
22	or	or	I-NP	CC	O	25	NMOD
23	heterodimer	heterodimer	I-NP	NN	B-protein	25	NMOD
24	complex	complex	I-NP	NN	I-protein	25	NMOD
25	formation	formation	I-NP	NN	O	17	OBJ
26	in	in	B-ADVP	FW	O	32	NMOD
27	vitro	vitro	I-ADVP	FW	O	26	AMOD
28	and	and	O	CC	O	26	AMOD
29	E-box-dependent	E-box-dependent	B-NP	JJ	B-DNA	32	NMOD
30	reporter	reporter	I-NP	NN	I-DNA	32	NMOD
31	gene	gene	I-NP	NN	I-DNA	32	NMOD
32	function	function	I-NP	NN	O	17	OBJ
33	in	in	B-ADVP	FW	O	32	NMOD
34	vivo	vivo	I-ADVP	FW	O	33	AMOD
35	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	16	VMOD
2	,	,	O	,	O	16	P
3	compared	compare	B-PP	VBN	O	16	SUB
4	with	with	B-PP	IN	O	3	VMOD
5	wild-type	wild-type	B-NP	JJ	B-protein	6	NMOD
6	Id3	Id3	I-NP	NN	I-protein	11	NMOD
7	,	,	O	,	O	11	P
8	an	an	B-NP	DT	O	11	NMOD
9	Id3	Id3	I-NP	NN	B-protein	11	NMOD
10	Asp5	Asp5	I-NP	NN	I-protein	11	NMOD
11	mutant	mutant	I-NP	NN	I-protein	4	PMOD
12	(	(	O	(	O	13	P
13	mimicking	mimic	B-VP	VBG	O	11	NMOD
14	phosphorylation	phosphorylation	B-NP	NN	O	13	OBJ
15	)	)	O	)	O	13	P
16	is	be	B-VP	VBZ	O	0	ROOT
17	unable	unable	B-ADJP	JJ	O	16	PRD
18	to	to	B-VP	TO	O	19	VMOD
19	promote	promote	I-VP	VB	O	17	AMOD
20	cell	cell	B-NP	NN	O	22	NMOD
21	cycle	cycle	I-NP	NN	O	22	NMOD
22	S	S	I-NP	NN	O	24	NMOD
23	phase	phase	I-NP	NN	O	24	NMOD
24	entry	entry	I-NP	NN	O	19	OBJ
25	in	in	B-PP	IN	O	24	NMOD
26	transfected	transfecte	B-NP	VBN	B-cell_line	27	NMOD
27	fibroblasts	fibroblast	I-NP	NNS	I-cell_line	25	PMOD
28	,	,	O	,	O	16	P
29	whereas	whereas	O	IN	O	16	VMOD
30	an	an	B-NP	DT	O	33	NMOD
31	Id3	Id3	I-NP	NN	B-protein	33	NMOD
32	Ala5	Ala5	I-NP	NN	I-protein	33	NMOD
33	mutant	mutant	I-NP	NN	I-protein	38	SUB
34	(	(	O	(	O	36	P
35	ablating	ablate	B-VP	VBG	O	36	NMOD
36	phosphorylation	phosphorylation	B-NP	NN	O	33	NMOD
37	)	)	O	)	O	36	P
38	displays	display	B-VP	VBZ	O	29	SBAR
39	an	an	B-NP	DT	O	40	NMOD
40	activity	activity	I-NP	NN	O	38	OBJ
41	significantly	significantly	B-ADJP	RB	O	42	AMOD
42	greater	great	I-ADJP	JJR	O	38	VMOD
43	than	than	B-PP	IN	O	42	AMOD
44	that	that	B-NP	DT	O	43	PMOD
45	of	of	B-PP	IN	O	44	NMOD
46	wild-type	wild-type	B-NP	JJ	B-protein	48	NMOD
47	Id3	Id3	I-NP	NN	I-protein	48	NMOD
48	protein	protein	I-NP	NN	I-protein	45	PMOD
49	.	.	O	.	O	16	P

1	Cdk2-dependent	Cdk2-dependent	B-NP	JJ	O	2	NMOD
2	phosphorylation	phosphorylation	I-NP	NN	O	4	SUB
3	therefore	therefore	B-ADVP	RB	O	4	VMOD
4	provides	provide	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	6	NMOD
6	switch	switch	I-NP	NN	O	4	OBJ
7	during	during	B-PP	IN	O	6	NMOD
8	late	late	B-NP	JJ	O	10	NMOD
9	G1-to-S	G1-to-S	I-NP	JJ	O	10	NMOD
10	phase	phase	I-NP	NN	O	7	PMOD
11	that	that	B-NP	IN	O	10	NMOD
12	both	both	O	CC	O	13	VMOD
13	nullifies	nullify	B-VP	VBZ	O	11	SBAR
14	an	an	B-NP	DT	O	20	NMOD
15	early	early	I-NP	JJ	O	20	NMOD
16	G1	G1	I-NP	NN	O	20	NMOD
17	cell	cell	I-NP	NN	O	20	NMOD
18	cycle	cycle	I-NP	NN	O	20	NMOD
19	regulatory	regulatory	I-NP	JJ	O	20	NMOD
20	function	function	I-NP	NN	O	13	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	Id3	Id3	B-NP	NN	B-protein	21	PMOD
23	and	and	O	CC	O	13	VMOD
24	modulates	modulate	B-VP	VBZ	O	11	SBAR
25	its	its	B-NP	PRP$	O	28	NMOD
26	target	target	I-NP	NN	O	28	NMOD
27	bHLH	bHLH	I-NP	JJ	O	28	NMOD
28	specificity	specificity	I-NP	NN	O	24	OBJ
29	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	4	SUB
3	also	also	B-ADVP	RB	O	4	VMOD
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	ability	ability	I-NP	NN	O	17	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	Id3	Id3	B-NP	NN	B-protein	8	PMOD
10	to	to	B-VP	TO	O	11	VMOD
11	promote	promote	I-VP	VB	O	7	NMOD
12	cell	cell	B-NP	NN	O	16	NMOD
13	cycle	cycle	I-NP	NN	O	16	NMOD
14	S	S	I-NP	NN	O	16	NMOD
15	phase	phase	I-NP	NN	O	16	NMOD
16	entry	entry	I-NP	NN	O	11	OBJ
17	is	be	B-VP	VBZ	O	5	SBAR
18	not	not	O	RB	O	17	VMOD
19	simply	simply	B-ADVP	RB	O	17	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	function	function	I-NP	NN	O	17	PRD
22	of	of	B-PP	IN	O	21	NMOD
23	its	its	B-NP	PRP$	O	24	NMOD
24	ability	ability	I-NP	NN	O	22	PMOD
25	to	to	B-VP	TO	O	26	VMOD
26	modulate	modulate	I-VP	VB	O	24	NMOD
27	bHLH	bHLH	B-NP	JJ	B-protein	30	NMOD
28	heterodimer-dependent	heterodimer-dependent	I-NP	JJ	O	30	NMOD
29	gene	gene	I-NP	NN	O	30	NMOD
30	expression	expression	I-NP	NN	O	26	OBJ
31	and	and	O	CC	O	26	VMOD
32	establish	establish	B-VP	VB	O	26	VMOD
33	a	a	B-NP	DT	O	36	NMOD
34	biologically	biologically	I-NP	RB	O	35	AMOD
35	important	important	I-NP	JJ	O	36	NMOD
36	mechanism	mechanism	I-NP	NN	O	32	OBJ
37	through	through	B-PP	IN	O	36	NMOD
38	which	which	B-NP	WDT	O	37	PMOD
39	Cdk2	Cdk2	B-NP	NN	B-protein	42	NMOD
40	and	and	I-NP	CC	O	42	NMOD
41	Id-bHLH	Id-bHLH	I-NP	JJ	O	42	NMOD
42	functions	function	I-NP	NNS	O	43	SUB
43	are	be	B-VP	VBP	O	37	SBAR
44	integrated	integrate	I-VP	VBN	O	43	VC
45	in	in	B-PP	IN	O	44	VMOD
46	the	the	B-NP	DT	O	47	NMOD
47	coordination	coordination	I-NP	NN	O	45	PMOD
48	of	of	B-PP	IN	O	47	NMOD
49	cell	cell	B-NP	NN	O	48	PMOD
50	proliferation	proliferation	I-NP	NN	O	49	NMOD
51	and	and	O	CC	O	49	NMOD
52	differentiation	differentiation	B-NP	NN	O	49	NMOD
53	.	.	O	.	O	4	P

1	Cytokine	Cytokine	B-NP	NN	B-protein	2	NMOD
2	rescue	rescue	I-NP	NN	O	5	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	glucocorticoid	glucocorticoid	B-NP	NN	O	3	PMOD
5	induced	induce	B-VP	VBD	O	0	ROOT
6	apoptosis	apoptosis	B-NP	NN	O	10	SUB
7	in	in	B-PP	IN	O	6	NMOD
8	T	T	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	is	be	B-VP	VBZ	O	5	VMOD
11	mediated	mediate	I-VP	VBN	O	10	VC
12	through	through	B-PP	IN	O	11	VMOD
13	inhibition	inhibition	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	3	SUB
2	previously	previously	B-ADVP	RB	O	3	VMOD
3	reported	report	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	23	DEP
5	dexamethasone	dexamethasone	B-NP	NN	O	12	NMOD
6	(	(	O	(	O	7	P
7	DEX	DEX	B-NP	NN	O	5	NMOD
8	)	)	O	)	O	7	P
9	,	,	O	,	O	12	P
10	a	a	B-NP	DT	O	12	NMOD
11	synthetic	synthetic	I-NP	JJ	O	12	NMOD
12	glucocorticoid	glucocorticoid	I-NP	NN	O	14	SUB
13	,	,	O	,	O	12	P
14	causes	cause	B-VP	VBZ	O	4	SBAR
15	apoptosis	apoptosis	B-NP	NN	O	14	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	mature	mature	B-NP	JJ	B-cell_line	20	NMOD
18	Th	Th	I-NP	NN	I-cell_line	20	NMOD
19	cell	cell	I-NP	NN	I-cell_line	20	NMOD
20	lines	line	I-NP	NNS	I-cell_line	16	PMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	DEP
23	that	that	B-SBAR	IN	O	3	VMOD
24	this	this	B-NP	DT	O	25	NMOD
25	induction	induction	I-NP	NN	O	29	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	cell	cell	B-NP	NN	O	28	NMOD
28	death	death	I-NP	NN	O	26	PMOD
29	is	be	B-VP	VBZ	O	23	SBAR
30	prevented	prevent	I-VP	VBN	O	29	VC
31	by	by	B-PP	IN	O	30	VMOD
32	specific	specific	B-NP	JJ	O	33	NMOD
33	cytokines	cytokine	I-NP	NNS	B-protein	31	PMOD
34	,	,	O	,	O	33	P
35	namely	namely	B-ADVP	RB	O	33	NMOD
36	,	,	O	,	O	30	P
37	by	by	B-PP	IN	O	30	VMOD
38	IL-2	IL-2	B-NP	NN	B-protein	37	PMOD
39	in	in	B-PP	IN	O	30	VMOD
40	Th1	Th1	B-NP	NN	B-cell_type	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_type	39	PMOD
42	and	and	B-PP	CC	O	39	PMOD
43	by	by	B-PP	IN	O	39	PMOD
44	IL-4	IL-4	B-NP	NN	B-protein	43	PMOD
45	in	in	B-PP	IN	O	30	VMOD
46	Th2	Th2	B-NP	NN	B-cell_type	47	NMOD
47	cells	cell	I-NP	NNS	I-cell_type	45	PMOD
48	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	this	this	B-NP	DT	O	7	NMOD
6	differential	differential	I-NP	JJ	O	7	NMOD
7	rescue	rescue	I-NP	NN	O	14	SUB
8	by	by	B-PP	IN	O	7	NMOD
9	specific	specific	B-NP	JJ	O	10	NMOD
10	cytokines	cytokine	I-NP	NNS	B-protein	8	PMOD
11	in	in	B-PP	IN	O	7	NMOD
12	Th	Th	B-NP	NN	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	correlates	correlate	B-VP	VBZ	O	4	SBAR
15	with	with	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	level	level	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	18	PMOD
20	that	that	B-NP	WDT	O	17	NMOD
21	is	be	B-VP	VBZ	O	20	SBAR
22	regulated	regulate	I-VP	VBN	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	DEX	DEX	B-NP	NN	O	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	cytokines	cytokine	I-NP	NNS	B-protein	23	PMOD
27	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	13	VMOD
2	both	both	B-NP	DT	O	4	NMOD
3	cell	cell	I-NP	NN	O	4	NMOD
4	types	type	I-NP	NNS	O	1	PMOD
5	the	the	B-NP	DT	O	7	NMOD
6	cellular	cellular	I-NP	JJ	O	7	NMOD
7	levels	level	I-NP	NNS	O	13	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	IkappaBalpha	IkappaBalpha	B-NP	NN	B-RNA	10	NMOD
10	mRNA	mRNA	I-NP	NN	I-RNA	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	protein	protein	I-NP	NN	O	8	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	evaluated	evaluate	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	DEX	DEX	B-NP	NN	O	17	NMOD
17	treatment	treatment	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	13	P

1	Interestingly	Interestingly	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	the	the	B-NP	DT	O	6	NMOD
4	DEX-mediated	DEX-mediated	I-NP	JJ	O	6	NMOD
5	IkappaBalpha	IkappaBalpha	I-NP	NN	B-protein	6	NMOD
6	induction	induction	I-NP	NN	O	7	SUB
7	was	be	B-VP	VBD	O	0	ROOT
8	completely	completely	I-VP	RB	O	9	VMOD
9	inhibited	inhibit	I-VP	VBN	O	7	VC
10	by	by	B-PP	IN	O	9	VMOD
11	IL-2	IL-2	B-NP	NN	B-protein	15	NMOD
12	,	,	O	,	O	15	P
13	but	but	O	CC	O	15	NMOD
14	not	not	O	RB	O	13	DEP
15	IL-4	IL-4	B-NP	NN	B-protein	10	PMOD
16	,	,	O	,	O	9	P
17	in	in	B-PP	IN	O	9	VMOD
18	Th1	Th1	B-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
20	,	,	O	,	O	9	P
21	while	while	B-SBAR	IN	O	9	VMOD
22	the	the	B-NP	DT	O	24	NMOD
23	reverse	reverse	I-NP	NN	O	24	NMOD
24	profile	profile	I-NP	NN	O	25	SUB
25	was	be	B-VP	VBD	O	21	SBAR
26	seen	see	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	Th2	Th2	B-NP	NN	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	27	PMOD
30	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	18	VMOD
2	both	both	B-NP	DT	O	4	NMOD
3	cell	cell	I-NP	NN	O	4	NMOD
4	types	type	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	18	P
6	the	the	B-NP	DT	O	7	NMOD
7	cytokine	cytokine	I-NP	NN	B-protein	18	SUB
8	that	that	B-NP	WDT	O	7	NMOD
9	inhibits	inhibit	B-VP	VBZ	O	8	SBAR
10	the	the	B-NP	DT	O	11	NMOD
11	induction	induction	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	12	PMOD
14	by	by	B-PP	IN	O	11	NMOD
15	DEX	DEX	B-NP	NN	O	14	PMOD
16	,	,	O	,	O	7	P
17	also	also	B-ADVP	RB	O	18	VMOD
18	rescues	rescue	B-VP	VBZ	O	0	ROOT
19	these	these	B-NP	DT	O	20	NMOD
20	cells	cell	I-NP	NNS	O	18	OBJ
21	from	from	B-PP	IN	O	18	VMOD
22	DEX-induced	DEX-induced	B-NP	JJ	O	23	NMOD
23	apoptosis	apoptosis	I-NP	NN	O	21	PMOD
24	,	,	O	,	O	18	P
25	although	although	B-SBAR	IN	O	18	VMOD
26	the	the	B-NP	DT	O	28	NMOD
27	rescue	rescue	I-NP	NN	O	28	NMOD
28	cytokine	cytokine	I-NP	NN	B-protein	29	SUB
29	is	be	B-VP	VBZ	O	25	SBAR
30	different	different	B-ADJP	JJ	O	29	PRD
31	in	in	B-PP	IN	O	30	AMOD
32	Th1	Th1	B-NP	NN	B-cell_type	35	NMOD
33	and	and	O	CC	I-cell_type	35	NMOD
34	Th2	Th2	B-NP	NN	I-cell_type	35	NMOD
35	cells	cell	I-NP	NNS	I-cell_type	31	PMOD
36	.	.	O	.	O	18	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	imply	imply	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	T	T	B-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	7	SUB
7	need	need	B-VP	VBP	O	4	SBAR
8	to	to	I-VP	TO	O	9	VMOD
9	maintain	maintain	I-VP	VB	O	7	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	certain	certain	I-NP	JJ	O	12	NMOD
12	level	level	I-NP	NN	O	9	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	activity	activity	I-NP	NN	O	13	PMOD
17	in	in	B-SBAR	IN	O	12	NMOD
18	order	order	O	NN	O	17	DEP
19	to	to	B-VP	TO	O	20	VMOD
20	survive	survive	I-VP	VB	O	38	VMOD
21	;	;	O	:	O	38	P
22	up-	up-	B-NP	NN	O	24	NMOD
23	or	or	I-NP	CC	O	24	NMOD
24	down-regulation	down-regulation	I-NP	NN	O	38	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	nuclear	nuclear	B-NP	JJ	B-protein	28	NMOD
27	NF	NF	I-NP	NN	I-protein	28	NMOD
28	kappaB	kappaB	I-NP	NN	I-protein	25	PMOD
29	through	through	B-PP	IN	O	24	NMOD
30	modulation	modulation	B-NP	NN	O	37	NMOD
31	of	of	B-PP	IN	O	30	NMOD
32	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	33	NMOD
33	expression	expression	I-NP	NN	O	31	PMOD
34	by	by	B-PP	IN	O	30	NMOD
35	cytokines	cytokine	B-NP	NNS	B-protein	34	PMOD
36	or	or	O	CC	O	37	NMOD
37	DEX	DEX	B-NP	NN	O	29	PMOD
38	may	may	B-VP	MD	O	17	SBAR
39	lead	lead	I-VP	VB	O	38	VC
40	to	to	B-PP	TO	O	39	VMOD
41	cell	cell	B-NP	NN	O	42	NMOD
42	survival	survival	I-NP	NN	O	45	NMOD
43	or	or	O	CC	O	45	NMOD
44	cell	cell	B-NP	NN	O	45	NMOD
45	death	death	I-NP	NN	O	40	PMOD
46	,	,	O	,	O	39	P
47	respectively	respectively	B-ADVP	RB	O	39	VMOD
48	.	.	O	.	O	3	P

1	Xenogeneic	Xenogeneic	B-NP	JJ	O	3	NMOD
2	human	human	I-NP	JJ	O	3	NMOD
3	serum	serum	I-NP	NN	O	4	SUB
4	promotes	promote	B-VP	VBZ	O	0	ROOT
5	leukocyte	leukocyte	B-NP	NN	O	6	NMOD
6	adhesion	adhesion	I-NP	NN	O	4	OBJ
7	to	to	B-PP	TO	O	6	NMOD
8	porcine	porcine	B-NP	JJ	O	9	NMOD
9	endothelium	endothelium	I-NP	NN	O	7	PMOD
10	under	under	B-PP	IN	O	9	NMOD
11	flow	flow	B-NP	NN	O	12	NMOD
12	conditions	condition	I-NP	NNS	O	10	PMOD
13	,	,	O	,	O	4	P
14	possibly	possibly	B-ADVP	RB	O	4	VMOD
15	through	through	B-PP	IN	O	4	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	activation	activation	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	23	NMOD
20	transcription	transcription	I-NP	NN	B-protein	23	NMOD
21	factor	factor	I-NP	NN	I-protein	23	NMOD
22	NF-kappa	NF-kappa	I-NP	NN	B-protein	23	NMOD
23	B	B	I-NP	NN	I-protein	18	PMOD
24	.	.	O	.	O	4	P

1	Endothelial	Endothelial	B-NP	JJ	B-cell_type	3	NMOD
2	cell	cell	I-NP	NN	I-cell_type	3	NMOD
3	activation	activation	I-NP	NN	O	6	NMOD
4	and	and	O	CC	O	6	NMOD
5	leukocyte	leukocyte	B-NP	NN	O	6	NMOD
6	infiltration	infiltration	I-NP	NN	O	7	SUB
7	are	be	B-VP	VBP	O	0	ROOT
8	a	a	B-NP	DT	O	10	NMOD
9	consistent	consistent	I-NP	JJ	O	10	NMOD
10	feature	feature	I-NP	NN	O	7	PRD
11	of	of	B-PP	IN	O	10	NMOD
12	discordant	discordant	B-NP	JJ	O	14	NMOD
13	xenograft	xenograft	I-NP	NN	O	14	NMOD
14	rejection	rejection	I-NP	NN	O	11	PMOD
15	.	.	O	.	O	7	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	evaluated	evaluate	B-VP	VBD	O	0	ROOT
4	whether	whether	B-SBAR	IN	O	3	VMOD
5	xenogeneic	xenogeneic	B-NP	JJ	O	6	NMOD
6	serum	serum	I-NP	NN	O	18	SUB
7	,	,	O	,	O	6	P
8	as	as	B-PP	IN	O	6	NMOD
9	a	a	B-NP	DT	O	10	NMOD
10	source	source	I-NP	NN	O	16	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	xenoreactive	xenoreactive	B-NP	JJ	B-protein	14	NMOD
13	natural	natural	I-NP	JJ	I-protein	14	NMOD
14	antibodies	antibody	I-NP	NNS	I-protein	11	PMOD
15	and	and	O	CC	O	16	NMOD
16	complement	complement	B-NP	NN	O	8	PMOD
17	,	,	O	,	O	6	P
18	induced	induce	B-VP	VBD	O	4	SBAR
19	endothelial	endothelial	B-NP	JJ	B-cell_type	21	NMOD
20	cell	cell	I-NP	NN	I-cell_type	21	NMOD
21	activation	activation	I-NP	NN	O	18	OBJ
22	with	with	B-PP	IN	O	21	NMOD
23	consequent	consequent	B-NP	JJ	O	25	NMOD
24	leukocyte	leukocyte	I-NP	NN	O	25	NMOD
25	adhesion	adhesion	I-NP	NN	O	22	PMOD
26	under	under	B-PP	IN	O	18	VMOD
27	flow	flow	B-NP	NN	O	28	NMOD
28	conditions	condition	I-NP	NNS	O	26	PMOD
29	.	.	O	.	O	3	P

1	Porcine	Porcine	B-NP	JJ	B-cell_line	4	NMOD
2	aortic	aortic	I-NP	JJ	I-cell_line	4	NMOD
3	endothelial	endothelial	I-NP	JJ	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	8	SUB
5	(	(	O	(	O	6	P
6	PAEC	PAEC	B-NP	NNS	B-cell_line	4	NMOD
7	)	)	O	)	O	6	P
8	were	be	B-VP	VBD	O	0	ROOT
9	incubated	incubate	I-VP	VBN	O	8	VC
10	for	for	B-PP	IN	O	9	VMOD
11	1	1	B-NP	CD	O	14	NMOD
12	hr	hr	I-NP	NN	O	14	NMOD
13	30	30	B-NP	CD	O	14	NMOD
14	min	min	I-NP	NN	O	17	NMOD
15	or	or	O	CC	O	17	NMOD
16	5	5	B-NP	CD	O	17	NMOD
17	hr	hr	I-NP	NN	O	10	PMOD
18	with	with	B-PP	IN	O	9	VMOD
19	10	10	B-NP	CD	O	20	AMOD
20	%	%	I-NP	NN	O	23	NMOD
21	homologous	homologous	I-NP	JJ	O	23	NMOD
22	porcine	porcine	I-NP	JJ	O	23	NMOD
23	serum	serum	I-NP	NN	O	32	NMOD
24	(	(	O	(	O	25	P
25	control	control	B-NP	NN	O	23	NMOD
26	)	)	O	)	O	25	P
27	or	or	O	CC	O	32	NMOD
28	10	10	B-NP	CD	O	29	AMOD
29	%	%	I-NP	NN	O	32	NMOD
30	xenogeneic	xenogeneic	I-NP	JJ	O	32	NMOD
31	human	human	I-NP	JJ	O	32	NMOD
32	serum	serum	I-NP	NN	O	18	PMOD
33	and	and	O	CC	O	9	VMOD
34	then	then	B-VP	RB	O	35	VMOD
35	perfused	perfuse	I-VP	VBN	O	9	VMOD
36	with	with	B-PP	IN	O	35	VMOD
37	total	total	B-NP	JJ	O	39	NMOD
38	human	human	I-NP	JJ	B-cell_type	39	NMOD
39	leukocytes	leukocyte	I-NP	NNS	I-cell_type	36	PMOD
40	in	in	B-PP	IN	O	39	NMOD
41	a	a	B-NP	DT	O	45	NMOD
42	parallel	parallel	I-NP	JJ	O	45	NMOD
43	plate	plate	I-NP	NN	O	45	NMOD
44	flow	flow	I-NP	NN	O	45	NMOD
45	chamber	chamber	I-NP	NN	O	40	PMOD
46	under	under	B-PP	IN	O	45	NMOD
47	laminar	laminar	B-NP	JJ	O	48	NMOD
48	flow	flow	I-NP	NN	O	46	PMOD
49	(	(	O	(	O	51	P
50	1.5	1.5	B-NP	CD	O	51	NMOD
51	dynes/cm2	dynes/cm2	I-NP	NN	O	48	NMOD
52	)	)	O	)	O	51	P
53	.	.	O	.	O	8	P

1	Adherent	Adherent	B-NP	JJ	B-cell_type	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_type	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	counted	count	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	digital	digital	B-NP	JJ	O	8	NMOD
7	image	image	I-NP	NN	O	8	NMOD
8	analysis	analysis	I-NP	NN	O	5	PMOD
9	.	.	O	.	O	3	P

1	Xenogeneic	Xenogeneic	B-NP	JJ	O	3	NMOD
2	human	human	I-NP	JJ	O	3	NMOD
3	serum	serum	I-NP	NN	O	10	SUB
4	significantly	significantly	B-ADVP	RB	O	10	VMOD
5	(	(	O	(	O	10	P
6	P	P	B-NP	NN	O	10	SUB
7	<	<	O	SYM	O	6	NMOD
8	0.01	0.01	B-NP	CD	O	7	AMOD
9	)	)	O	)	O	10	P
10	increased	increase	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	12	NMOD
12	number	number	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	adherent	adherent	B-NP	JJ	B-cell_type	15	NMOD
15	leukocytes	leukocyte	I-NP	NNS	I-cell_type	13	PMOD
16	as	as	B-PP	IN	O	10	VMOD
17	compared	compare	B-PP	VBN	O	16	SBAR
18	with	with	B-PP	IN	O	17	VMOD
19	porcine	porcine	B-NP	JJ	O	20	NMOD
20	serum	serum	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	10	P

1	A	A	B-NP	DT	O	4	NMOD
2	similar	similar	I-NP	JJ	O	4	NMOD
3	adhesive	adhesive	I-NP	JJ	O	4	NMOD
4	response	response	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	elicited	elicit	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	TNF	TNF	B-NP	NN	B-protein	9	NMOD
9	alpha	alpha	I-NP	NN	I-protein	15	NMOD
10	(	(	O	(	O	12	P
11	100	100	B-NP	CD	O	12	NMOD
12	U/ml	U/ml	I-NP	NN	O	9	NMOD
13	)	)	O	)	O	12	P
14	,	,	O	,	O	15	P
15	one	one	B-NP	CD	O	7	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	most	most	I-NP	RBS	O	19	AMOD
19	potent	potent	I-NP	JJ	O	20	NMOD
20	inducers	inducer	I-NP	NNS	O	16	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	endothelial	endothelial	B-NP	JJ	B-cell_type	25	NMOD
23	cell	cell	I-NP	NN	I-cell_type	25	NMOD
24	adhesive	adhesive	I-NP	JJ	O	25	NMOD
25	properties	property	I-NP	NNS	O	21	PMOD
26	,	,	O	,	O	15	P
27	here	here	B-ADVP	RB	O	28	VMOD
28	used	use	B-VP	VBN	O	15	NMOD
29	as	as	B-PP	IN	O	28	VMOD
30	positive	positive	B-NP	JJ	O	31	NMOD
31	control	control	I-NP	NN	O	29	PMOD
32	.	.	O	.	O	5	P

1	In	In	B-SBAR	IN	O	16	VMOD
2	order	order	O	NN	O	1	DEP
3	to	to	B-VP	TO	O	4	VMOD
4	elucidate	elucidate	I-VP	VB	O	1	SBAR
5	possible	possible	B-NP	JJ	O	6	NMOD
6	mechanisms	mechanism	I-NP	NNS	O	4	OBJ
7	underlying	underlie	B-VP	VBG	O	6	NMOD
8	endothelial	endothelial	B-NP	JJ	B-cell_type	10	NMOD
9	cell	cell	I-NP	NN	I-cell_type	10	NMOD
10	activation	activation	I-NP	NN	O	7	OBJ
11	by	by	B-PP	IN	O	7	VMOD
12	xenogeneic	xenogeneic	B-NP	JJ	O	13	NMOD
13	serum	serum	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	16	P
15	we	we	B-NP	PRP	O	16	SUB
16	focussed	focusse	B-VP	VBD	O	0	ROOT
17	on	on	B-PP	IN	O	16	VMOD
18	transcription	transcription	B-NP	NN	B-protein	21	NMOD
19	factor	factor	I-NP	NN	I-protein	21	NMOD
20	NF-kappa	NF-kappa	I-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	25	NMOD
22	,	,	O	,	O	25	P
23	a	a	B-NP	DT	O	25	NMOD
24	central	central	I-NP	JJ	O	25	NMOD
25	regulator	regulator	I-NP	NN	O	17	PMOD
26	for	for	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	28	NMOD
28	induction	induction	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	different	different	B-NP	JJ	O	31	NMOD
31	genes	gene	I-NP	NNS	O	29	PMOD
32	,	,	O	,	O	31	P
33	including	include	B-PP	VBG	O	31	NMOD
34	adhesive	adhesive	B-NP	JJ	B-protein	35	NMOD
35	molecules	molecule	I-NP	NNS	I-protein	37	NMOD
36	and	and	I-NP	CC	O	37	NMOD
37	chemoattractants	chemoattractant	I-NP	NNS	B-protein	33	PMOD
38	.	.	O	.	O	16	P

1	By	By	B-PP	IN	O	7	VMOD
2	confocal	confocal	B-NP	JJ	O	4	NMOD
3	fluorescence	fluorescence	I-NP	NN	O	4	NMOD
4	microscopy	microscopy	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	observed	observe	B-VP	VBD	O	0	ROOT
8	a	a	B-NP	DT	O	10	NMOD
9	positive	positive	I-NP	JJ	O	10	NMOD
10	staining	staining	I-NP	NN	O	7	OBJ
11	for	for	B-PP	IN	O	10	NMOD
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	11	PMOD
14	(	(	O	(	O	16	P
15	p65	p65	B-NP	NN	B-protein	16	NMOD
16	subunit	subunit	I-NP	NN	I-protein	13	NMOD
17	)	)	O	)	O	16	P
18	in	in	B-PP	IN	O	10	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	nuclei	nucleus	I-NP	NNS	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	PAEC	PAEC	B-NP	NNS	B-cell_line	21	PMOD
23	exposed	expose	B-VP	VBN	O	22	NMOD
24	for	for	B-PP	IN	O	23	VMOD
25	1	1	B-NP	CD	O	28	NMOD
26	hr	hr	I-NP	NN	O	28	NMOD
27	30	30	B-NP	CD	O	28	NMOD
28	min	min	I-NP	NN	O	24	PMOD
29	to	to	B-PP	TO	O	28	NMOD
30	human	human	B-NP	JJ	O	31	NMOD
31	serum	serum	I-NP	NN	O	29	PMOD
32	,	,	O	,	O	31	P
33	which	which	B-NP	WDT	O	31	NMOD
34	indicated	indicate	B-VP	VBD	O	33	SBAR
35	NF-kappa	NF-kappa	B-NP	NN	B-protein	37	NMOD
36	B	B	I-NP	NN	I-protein	37	NMOD
37	activation	activation	I-NP	NN	O	34	OBJ
38	in	in	B-PP	IN	O	37	NMOD
39	this	this	B-NP	DT	O	40	NMOD
40	setting	setting	I-NP	NN	O	38	PMOD
41	.	.	O	.	O	7	P

1	At	At	B-PP	IN	O	14	VMOD
2	variance	variance	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	14	P
4	in	in	B-PP	IN	O	14	VMOD
5	PAEC	PAEC	B-NP	NNS	B-cell_line	4	PMOD
6	incubated	incubate	B-VP	VBN	O	5	NMOD
7	with	with	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	homologous	homologous	I-NP	JJ	O	10	NMOD
10	serum	serum	I-NP	NN	O	7	PMOD
11	,	,	O	,	O	14	P
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	14	SUB
14	was	be	B-VP	VBD	O	0	ROOT
15	strictly	strictly	I-VP	RB	O	14	VMOD
16	localized	localize	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	20	NMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	cytoplasm	cytoplasm	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	14	P

1	Treatment	Treatment	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	PAEC	PAEC	B-NP	NNS	B-cell_line	2	PMOD
4	exposed	expose	B-VP	VBN	O	3	NMOD
5	to	to	B-PP	TO	O	4	VMOD
6	xenogeneic	xenogeneic	B-NP	JJ	O	7	NMOD
7	serum	serum	I-NP	NN	O	5	PMOD
8	with	with	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	NF-kappa	NF-kappa	I-NP	NN	B-protein	12	NMOD
11	B	B	I-NP	NN	I-protein	12	NMOD
12	inhibitors	inhibitor	I-NP	NNS	O	21	NMOD
13	pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	B-NP	NN	O	21	NMOD
14	(	(	O	(	O	18	P
15	PDTC	PDTC	B-NP	NN	O	18	NMOD
16	,	,	O	,	O	18	P
17	25	25	B-NP	CD	O	18	NMOD
18	microM	microM	I-NP	NN	O	13	NMOD
19	)	)	O	)	O	18	P
20	and	and	O	CC	O	21	NMOD
21	tosyl-phechloromethylketone	tosyl-phechloromethylketone	B-NP	NN	O	34	SUB
22	(	(	O	(	O	26	P
23	TPCK	TPCK	B-NP	NN	O	26	NMOD
24	,	,	O	,	O	26	P
25	25	25	B-NP	CD	O	26	NMOD
26	microM	microM	I-NP	NN	O	21	NMOD
27	)	)	O	)	O	26	P
28	significantly	significantly	B-ADVP	RB	O	34	VMOD
29	(	(	O	(	O	34	P
30	P	P	B-NP	NN	O	34	VMOD
31	<	<	O	SYM	O	30	NMOD
32	0.01	0.01	B-NP	CD	O	31	AMOD
33	)	)	O	)	O	34	P
34	reduced	reduce	B-VP	VBD	O	8	SBAR
35	leukocyte	leukocyte	B-NP	NN	O	36	NMOD
36	adhesion	adhesion	I-NP	NN	O	34	OBJ
37	in	in	B-PP	IN	O	34	VMOD
38	respect	respect	B-NP	NN	O	37	PMOD
39	to	to	B-PP	TO	O	37	PMOD
40	PAEC	PAEC	B-NP	NNS	B-cell_line	37	PMOD
41	treated	treat	B-VP	VBN	O	40	NMOD
42	with	with	B-PP	IN	O	41	VMOD
43	human	human	B-NP	JJ	O	44	NMOD
44	serum	serum	I-NP	NN	O	42	PMOD
45	alone	alone	B-ADVP	RB	O	44	NMOD
46	.	.	O	.	O	1	P

1	Findings	Finding	B-NP	NNS	O	13	SUB
2	that	that	B-SBAR	IN	O	1	NMOD
3	xenogeneic	xenogeneic	B-NP	JJ	O	4	NMOD
4	serum	serum	I-NP	NN	O	5	SUB
5	promotes	promote	B-VP	VBZ	O	2	SBAR
6	leukocyte-endothelium	leukocyte-endothelium	B-NP	NN	O	7	NMOD
7	interaction	interaction	I-NP	NN	O	5	OBJ
8	possibly	possibly	B-ADVP	RB	O	9	PMOD
9	through	through	B-PP	IN	O	5	VMOD
10	NF-kappa	NF-kappa	B-NP	NN	B-protein	12	NMOD
11	B	B	I-NP	NN	I-protein	12	NMOD
12	activation	activation	I-NP	NN	O	9	PMOD
13	might	might	B-VP	MD	O	0	ROOT
14	be	be	I-VP	VB	O	13	VC
15	relevant	relevant	B-ADJP	JJ	O	14	PRD
16	for	for	B-PP	IN	O	15	AMOD
17	designing	design	B-VP	VBG	O	16	PMOD
18	future	future	B-NP	JJ	O	20	NMOD
19	therapeutic	therapeutic	I-NP	JJ	O	20	NMOD
20	strategies	strategy	I-NP	NNS	O	17	OBJ
21	aimed	aim	B-VP	VBN	O	20	NMOD
22	at	at	B-PP	IN	O	21	VMOD
23	prolonging	prolong	B-VP	VBG	O	22	PMOD
24	xenograft	xenograft	B-NP	NN	O	25	NMOD
25	survival	survival	I-NP	NN	O	23	OBJ
26	.	.	O	.	O	13	P

1	IL-2-induced	IL-2-induced	B-NP	JJ	O	2	NMOD
2	growth	growth	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	CD8+	CD8+	B-NP	JJ	B-cell_type	9	NMOD
5	T	T	I-NP	NN	I-cell_type	9	NMOD
6	cell	cell	I-NP	NN	I-cell_type	9	NMOD
7	prolymphocytic	prolymphocytic	I-NP	JJ	I-cell_type	9	NMOD
8	leukemia	leukemia	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
10	mediated	mediate	B-VP	VBN	O	9	NMOD
11	by	by	B-PP	IN	O	10	VMOD
12	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	NMOD
13	induction	induction	I-NP	NN	O	18	NMOD
14	and	and	O	CC	O	18	NMOD
15	IL-2	IL-2	B-NP	NN	B-protein	18	NMOD
16	receptor	receptor	I-NP	NN	I-protein	18	NMOD
17	alpha	alpha	I-NP	NN	I-protein	18	NMOD
18	expression	expression	I-NP	NN	O	11	PMOD
19	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	binding	binding	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	interleukin-2	interleukin-2	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	6	P
6	IL-2	IL-2	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	to	to	B-PP	TO	O	2	NMOD
9	its	its	B-NP	PRP$	O	10	NMOD
10	receptor	receptor	I-NP	NN	O	8	PMOD
11	on	on	B-PP	IN	O	2	NMOD
12	normal	normal	B-NP	JJ	O	14	NMOD
13	T	T	I-NP	NN	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
15	induces	induce	B-VP	VBZ	O	0	ROOT
16	nuclear	nuclear	B-NP	JJ	O	17	NMOD
17	expression	expression	I-NP	NN	O	15	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	nuclear	nuclear	B-NP	JJ	B-protein	21	NMOD
20	factor	factor	I-NP	NN	I-protein	21	NMOD
21	kappaB	kappaB	I-NP	NN	I-protein	26	NMOD
22	(	(	O	(	O	23	P
23	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	21	NMOD
24	)	)	O	)	O	23	P
25	,	,	O	,	O	26	P
26	activation	activation	B-NP	NN	O	18	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	36	NMOD
29	IL-2	IL-2	I-NP	NN	B-DNA	36	NMOD
30	receptor	receptor	I-NP	NN	I-DNA	36	NMOD
31	(	(	O	(	I-DNA	36	P
32	IL-2R	IL-2R	B-NP	NN	I-DNA	36	NMOD
33	)	)	O	)	I-DNA	36	P
34	alpha	alpha	B-NP	NN	I-DNA	36	NMOD
35	chain	chain	I-NP	NN	I-DNA	36	NMOD
36	gene	gene	I-NP	NN	I-DNA	27	PMOD
37	,	,	O	,	O	40	P
38	and	and	O	CC	O	40	NMOD
39	cell	cell	B-NP	NN	O	40	NMOD
40	proliferation	proliferation	I-NP	NN	O	15	VMOD
41	.	.	O	.	O	15	P

1	In	In	B-PP	IN	O	24	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	24	P
6	the	the	B-NP	DT	O	7	NMOD
7	role	role	I-NP	NN	O	24	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	IL-2R	IL-2R	B-NP	NN	B-protein	10	NMOD
10	signaling	signaling	I-NP	NN	O	8	PMOD
11	in	in	B-PP	IN	O	7	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	growth	growth	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	CD8+	CD8+	B-NP	JJ	B-cell_line	23	NMOD
16	T	T	I-NP	NN	I-cell_line	23	NMOD
17	cell	cell	I-NP	NN	I-cell_line	23	NMOD
18	prolymphocytic	prolymphocytic	I-NP	JJ	I-cell_line	23	NMOD
19	leukemia	leukemia	I-NP	NN	I-cell_line	23	NMOD
20	(	(	I-NP	(	I-cell_line	23	P
21	T-PLL	T-PLL	I-NP	NN	I-cell_line	23	NMOD
22	)	)	I-NP	)	I-cell_line	23	P
23	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
24	has	have	B-VP	VBZ	O	0	ROOT
25	been	be	I-VP	VBN	O	24	VC
26	investigated	investigate	I-VP	VBN	O	25	VC
27	.	.	O	.	O	24	P

1	Flow	Flow	B-NP	NN	O	2	NMOD
2	cytometry	cytometry	I-NP	NN	O	3	SUB
3	revealed	reveal	B-VP	VBD	O	23	VMOD
4	that	that	B-SBAR	IN	O	3	VMOD
5	primary	primary	B-NP	JJ	B-cell_type	7	NMOD
6	leukemia	leukemia	I-NP	NN	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	14	SUB
8	from	from	B-PP	IN	O	7	NMOD
9	a	a	B-NP	DT	O	10	NMOD
10	patient	patient	I-NP	NN	O	8	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	CD8+	CD8+	B-NP	JJ	O	13	NMOD
13	T-PLL	T-PLL	I-NP	NN	O	11	PMOD
14	expressed	express	B-VP	VBD	O	4	SBAR
15	IL-2Ralpha	IL-2Ralpha	B-NP	NN	B-protein	17	NMOD
16	and	and	I-NP	CC	I-protein	17	NMOD
17	beta	beta	I-NP	NN	I-protein	18	NMOD
18	chains	chain	I-NP	NNS	I-protein	14	OBJ
19	,	,	O	,	O	23	P
20	and	and	O	CC	O	22	NMOD
21	the	the	B-NP	DT	O	22	NMOD
22	cells	cell	I-NP	NNS	O	23	SUB
23	showed	show	B-VP	VBD	O	0	ROOT
24	a	a	B-NP	DT	O	26	NMOD
25	proliferative	proliferative	I-NP	JJ	O	26	NMOD
26	response	response	I-NP	NN	O	29	NMOD
27	and	and	O	CC	O	29	NMOD
28	an	an	B-NP	DT	O	29	NMOD
29	increase	increase	I-NP	NN	O	23	OBJ
30	in	in	B-PP	IN	O	29	NMOD
31	IL-2Ralpha	IL-2Ralpha	B-NP	NN	B-protein	32	NMOD
32	expression	expression	I-NP	NN	O	30	PMOD
33	on	on	B-PP	IN	O	29	NMOD
34	culture	culture	B-NP	NN	O	33	PMOD
35	with	with	B-PP	IN	O	34	NMOD
36	exogeneous	exogeneous	B-NP	JJ	O	37	NMOD
37	IL-2	IL-2	I-NP	NN	B-protein	35	PMOD
38	.	.	O	.	O	23	P

1	Northern	Northern	B-NP	NN	O	3	NMOD
2	blot	blot	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	failed	fail	B-VP	VBD	O	0	ROOT
5	to	to	I-VP	TO	O	6	VMOD
6	detect	detect	I-VP	VB	O	4	VMOD
7	IL-2	IL-2	B-NP	NN	B-RNA	8	NMOD
8	mRNA	mRNA	I-NP	NN	I-RNA	6	OBJ
9	,	,	O	,	O	4	P
10	suggesting	suggest	B-VP	VBG	O	4	VMOD
11	that	that	B-SBAR	IN	O	10	VMOD
12	IL-2	IL-2	B-NP	NN	B-protein	13	SUB
13	may	may	B-VP	MD	O	11	SBAR
14	act	act	I-VP	VB	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	a	a	B-NP	DT	O	18	NMOD
17	paracrine	paracrine	I-NP	JJ	O	18	NMOD
18	manner	manner	I-NP	NN	O	15	PMOD
19	in	in	B-ADVP	FW	O	14	VMOD
20	vivo	vivo	I-ADVP	FW	O	19	AMOD
21	.	.	O	.	O	4	P

1	Electrophoretic	Electrophoretic	B-NP	JJ	O	3	NMOD
2	mobility-shift	mobility-shift	I-NP	JJ	O	3	NMOD
3	assays	assay	I-NP	NNS	O	4	SUB
4	revealed	reveal	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	recombinant	recombinant	B-NP	JJ	O	7	NMOD
7	IL-2	IL-2	I-NP	NN	B-protein	8	SUB
8	increased	increase	B-VP	VBD	O	24	VMOD
9	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	activity	activity	I-NP	NN	O	8	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	nuclear	nuclear	B-NP	JJ	O	14	NMOD
14	extracts	extract	I-NP	NNS	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	leukemia	leukemia	I-NP	NN	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	,	,	O	,	O	24	P
20	and	and	O	CC	O	23	NMOD
21	Northern	Northern	B-NP	NN	O	23	NMOD
22	blot	blot	I-NP	NN	O	23	NMOD
23	analysis	analysis	I-NP	NN	O	24	SUB
24	showed	show	B-VP	VBD	O	5	SBAR
25	that	that	B-SBAR	IN	O	24	VMOD
26	IL-2	IL-2	B-NP	NN	B-protein	27	SUB
27	increased	increase	B-VP	VBD	O	25	SBAR
28	the	the	B-NP	DT	O	29	NMOD
29	abundance	abundance	I-NP	NN	O	27	OBJ
30	of	of	B-PP	IN	O	29	NMOD
31	mRNAs	mRNA	B-NP	NNS	B-RNA	30	PMOD
32	encoding	encode	B-VP	VBG	O	31	NMOD
33	the	the	B-NP	DT	O	35	NMOD
34	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	35	NMOD
35	components	component	I-NP	NNS	O	38	NMOD
36	c-Rel	c-Rel	I-NP	NN	B-protein	38	NMOD
37	and	and	I-NP	CC	O	38	NMOD
38	KBF1	KBF1	I-NP	NN	B-protein	32	OBJ
39	in	in	B-PP	IN	O	32	VMOD
40	these	these	B-NP	DT	O	41	NMOD
41	cells	cell	I-NP	NNS	O	39	PMOD
42	.	.	O	.	O	4	P

1	IL-2	IL-2	B-NP	NN	B-protein	3	NMOD
2	binding	binding	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	IL-2	IL-2	B-NP	NN	B-protein	8	SUB
7	markedly	markedly	B-ADVP	RB	O	8	VMOD
8	increased	increase	B-VP	VBD	O	5	SBAR
9	the	the	B-NP	DT	O	10	NMOD
10	number	number	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	low	low	B-NP	JJ	O	11	PMOD
13	affinity	affinity	I-NP	NN	O	14	NMOD
14	IL-2Rs	IL-2R	I-NP	NNS	B-protein	12	NMOD
15	on	on	B-PP	IN	O	12	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	leukemia	leukemia	I-NP	NN	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	,	,	O	,	O	8	P
20	without	without	B-PP	IN	O	8	VMOD
21	an	an	B-NP	DT	O	22	NMOD
22	effect	effect	I-NP	NN	O	20	PMOD
23	on	on	B-PP	IN	O	8	VMOD
24	the	the	B-NP	DT	O	25	NMOD
25	number	number	I-NP	NN	O	23	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	high-affinity	high-affinity	B-NP	JJ	B-protein	28	NMOD
28	IL-2Rs	IL-2R	I-NP	NNS	I-protein	26	PMOD
29	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	22	DEP
5	IL-2	IL-2	B-NP	NN	B-protein	6	SUB
6	is	be	B-VP	VBZ	O	4	SBAR
7	capable	capable	B-ADJP	JJ	O	6	PRD
8	of	of	B-PP	IN	O	7	AMOD
9	inducing	induce	B-VP	VBG	O	8	PMOD
10	the	the	B-NP	DT	O	12	NMOD
11	nuclear	nuclear	I-NP	JJ	O	12	NMOD
12	expression	expression	I-NP	NN	O	9	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	PMOD
15	in	in	B-PP	IN	O	9	VMOD
16	primary	primary	B-NP	JJ	B-cell_line	19	NMOD
17	CD8+	CD8+	I-NP	JJ	I-cell_line	19	NMOD
18	T-PLL	T-PLL	I-NP	NN	I-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	15	PMOD
20	,	,	O	,	O	22	P
21	and	and	O	CC	O	22	DEP
22	that	that	B-SBAR	IN	O	3	VMOD
23	this	this	B-NP	DT	O	24	NMOD
24	effect	effect	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	22	SBAR
26	mediated	mediate	I-VP	VBN	O	25	VC
27	,	,	O	,	O	26	P
28	at	at	B-ADVP	IN	O	30	PMOD
29	least	least	I-ADVP	JJS	O	28	AMOD
30	in	in	B-PP	IN	O	26	VMOD
31	part	part	B-NP	NN	O	30	PMOD
32	,	,	O	,	O	26	P
33	at	at	B-PP	IN	O	26	VMOD
34	a	a	B-NP	DT	O	36	NMOD
35	pretranslational	pretranslational	I-NP	JJ	O	36	NMOD
36	level	level	I-NP	NN	O	33	PMOD
37	.	.	O	.	O	3	P

1	Molecular	Molecular	B-NP	JJ	O	4	NMOD
2	and	and	I-NP	CC	O	4	NMOD
3	cellular	cellular	I-NP	JJ	O	4	NMOD
4	analysis	analysis	I-NP	NN	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	human	human	B-NP	JJ	O	9	NMOD
7	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD
8	virus-induced	virus-induced	I-NP	JJ	O	9	NMOD
9	apoptosis	apoptosis	I-NP	NN	O	5	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	lymphoblastoid	lymphoblastoid	B-NP	JJ	B-protein	13	NMOD
12	T-cell-line-expressing	T-cell-line-expressing	I-NP	JJ	I-protein	13	NMOD
13	wild-type	wild-type	I-NP	JJ	I-protein	17	NMOD
14	and	and	I-NP	CC	I-protein	17	NMOD
15	mutated	mutate	I-NP	VBN	I-protein	17	NMOD
16	CD4	CD4	I-NP	NN	I-protein	17	NMOD
17	receptors	receptor	I-NP	NNS	I-protein	10	PMOD
18	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	previously	previously	I-VP	RB	O	2	VMOD
4	shown	show	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	presence	presence	I-NP	NN	O	13	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	CD4	CD4	I-NP	NN	B-protein	12	NMOD
11	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	12	NMOD
12	tail	tail	I-NP	NN	I-protein	8	PMOD
13	is	be	B-VP	VBZ	O	5	SBAR
14	critical	critical	B-ADJP	JJ	O	13	PRD
15	for	for	B-PP	IN	O	14	AMOD
16	human	human	B-NP	JJ	O	18	NMOD
17	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD
18	virus	virus	I-NP	NN	O	23	NMOD
19	(	(	O	(	O	20	P
20	HIV	HIV	B-NP	NN	O	18	NMOD
21	)	)	O	)	O	20	P
22	-induced	-induced	B-NP	JJ	O	23	NMOD
23	apoptosis	apoptosis	I-NP	NN	O	15	PMOD
24	(	(	O	(	O	36	P
25	J.Corbeil	J.Corbeil	B-NP	NNP	O	30	NMOD
26	,	,	O	,	O	30	P
27	M.Tremblay	M.Tremblay	B-NP	NNP	O	30	NMOD
28	,	,	O	,	O	30	P
29	and	and	O	CC	O	30	NMOD
30	D.D.Richman	D.D.Richman	B-NP	NNP	O	36	NMOD
31	,	,	O	,	O	36	P
32	J.Exp.Med.183	J.Exp.Med.183	B-NP	NNP	O	36	NMOD
33	:	:	O	:	O	36	P
34	39-48	39-48	B-NP	CD	O	36	NMOD
35	,	,	I-NP	,	O	36	P
36	1996	1996	I-NP	CD	O	4	VMOD
37	)	)	O	)	O	36	P
38	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	pursued	pursue	I-VP	VBN	O	2	VC
4	our	our	B-NP	PRP$	O	5	NMOD
5	investigation	investigation	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	role	role	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	CD4	CD4	I-NP	NN	B-protein	13	NMOD
12	transduction	transduction	I-NP	NN	O	13	NMOD
13	pathway	pathway	I-NP	NN	O	9	PMOD
14	in	in	B-PP	IN	O	8	NMOD
15	HIV-induced	HIV-induced	B-NP	JJ	O	16	NMOD
16	apoptosis	apoptosis	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	2	P

1	To	To	B-VP	TO	O	2	VMOD
2	do	do	I-VP	VB	O	14	VMOD
3	this	this	B-NP	DT	O	2	OBJ
4	,	,	O	,	O	14	P
5	wild-type	wild-type	B-NP	JJ	O	8	NMOD
6	and	and	I-NP	CC	O	8	NMOD
7	mutant	mutant	I-NP	JJ	O	8	NMOD
8	forms	form	I-NP	NNS	O	14	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	CD4	CD4	I-NP	NN	B-protein	13	NMOD
12	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	13	NMOD
13	tail	tail	I-NP	NN	I-protein	9	PMOD
14	were	be	B-VP	VBD	O	0	ROOT
15	stably	stably	I-VP	RB	O	14	VMOD
16	expressed	express	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	22	NMOD
19	lymphoblastoid	lymphoblastoid	I-NP	JJ	B-cell_line	21	NMOD
20	T-cell	T-cell	I-NP	NN	I-cell_line	21	NMOD
21	line	line	I-NP	NN	I-cell_line	22	NMOD
22	A2.01	A2.01	I-NP	NN	B-cell_line	17	PMOD
23	.	.	O	.	O	14	P

1	Apoptosis	Apoptosis	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	prevented	prevent	I-VP	VBN	O	2	VC
4	when	when	B-ADVP	WRB	O	3	VMOD
5	CD4	CD4	B-NP	NN	B-protein	10	SUB
6	truncated	truncate	B-VP	VBN	O	5	NMOD
7	at	at	B-PP	IN	O	6	VMOD
8	residue	residue	B-NP	NN	O	7	PMOD
9	402	402	I-NP	CD	O	8	NMOD
10	was	be	B-VP	VBD	O	4	SBAR
11	expressed	express	I-VP	VBN	O	10	VC
12	;	;	O	:	O	2	P
13	however	however	B-ADVP	RB	O	2	VMOD
14	,	,	O	,	O	2	P
15	cells	cell	B-NP	NNS	O	2	PRD
16	expressing	express	B-VP	VBG	O	15	NMOD
17	mutated	mutate	B-NP	VBN	B-protein	18	NMOD
18	receptors	receptor	I-NP	NNS	I-protein	16	OBJ
19	that	that	B-NP	WDT	O	18	NMOD
20	do	do	B-VP	VBP	O	19	SBAR
21	not	not	I-VP	RB	O	20	VMOD
22	associate	associate	I-VP	VB	O	20	VC
23	with	with	B-PP	IN	O	22	VMOD
24	p56	p56	B-NP	NN	B-protein	29	SUB
25	(	(	O	(	I-protein	26	P
26	lck	lck	B-NP	NN	I-protein	24	NMOD
27	)	)	O	)	I-protein	26	P
28	(	(	O	(	O	29	P
29	mutated	mutate	B-VP	VBN	O	23	PMOD
30	at	at	B-PP	IN	O	22	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	dicysteine	dicysteine	I-NP	NN	B-protein	33	NMOD
33	motif	motif	I-NP	NN	I-protein	30	PMOD
34	and	and	O	CC	O	22	VMOD
35	truncated	truncate	B-VP	VBN	O	22	VMOD
36	at	at	B-PP	IN	O	35	VMOD
37	residue	residue	B-NP	NN	O	36	PMOD
38	418	418	I-NP	CD	O	37	NMOD
39	)	)	O	)	O	35	P
40	but	but	O	CC	O	35	VMOD
41	which	which	B-NP	WDT	O	40	PMOD
42	conserved	conserve	B-VP	VBD	O	41	SBAR
43	proximal	proximal	B-NP	JJ	B-protein	44	NMOD
44	domains	domain	I-NP	NNS	I-protein	42	OBJ
45	of	of	B-PP	IN	O	44	NMOD
46	the	the	B-NP	DT	O	48	NMOD
47	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	48	NMOD
48	tail	tail	I-NP	NN	I-protein	45	PMOD
49	underwent	undergo	B-VP	VBD	O	41	SBAR
50	apoptosis	apoptosis	B-NP	NN	O	49	OBJ
51	like	like	B-PP	IN	O	49	VMOD
52	wild-	wild-	B-NP	JJ	B-protein	54	NMOD
53	type	type	I-NP	NN	I-protein	54	NMOD
54	CD4	CD4	I-NP	NN	I-protein	51	PMOD
55	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	differences	difference	I-NP	NNS	O	13	SUB
3	between	between	B-PP	IN	O	2	NMOD
4	wild-type	wild-type	B-NP	JJ	B-protein	7	NMOD
5	and	and	I-NP	CC	I-protein	6	AMOD
6	mutated	mutate	I-NP	VBN	I-protein	7	NMOD
7	receptors	receptor	I-NP	NNS	I-protein	3	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	induction	induction	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	apoptosis	apoptosis	B-NP	NN	O	11	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	not	not	O	RB	O	13	VMOD
15	related	related	B-ADJP	JJ	O	13	PRD
16	to	to	B-PP	TO	O	15	AMOD
17	levels	level	B-NP	NNS	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	p56	p56	B-NP	NN	B-protein	26	NMOD
20	(	(	O	(	I-protein	21	P
21	lck	lck	B-NP	NN	I-protein	19	NMOD
22	)	)	O	)	I-protein	21	P
23	or	or	O	CC	O	26	NMOD
24	NF-	NF-	B-NP	NF-	B-protein	26	NMOD
25	kappaB	kappaB	I-NP	NN	I-protein	26	NMOD
26	activation	activation	I-NP	NN	O	18	PMOD
27	.	.	O	.	O	13	P

1	Initial	Initial	B-NP	JJ	O	2	NMOD
2	signaling	signaling	I-NP	NN	O	7	SUB
3	through	through	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	CD4	CD4	I-NP	NN	B-protein	6	NMOD
6	receptor	receptor	I-NP	NN	I-protein	3	PMOD
7	played	play	B-VP	VBD	O	0	ROOT
8	a	a	B-NP	DT	O	10	NMOD
9	major	major	I-NP	JJ	O	10	NMOD
10	role	role	I-NP	NN	O	7	OBJ
11	in	in	B-PP	IN	O	7	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	sensitization	sensitization	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	HIV-infected	HIV-infected	B-NP	JJ	B-cell_type	17	NMOD
16	T	T	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
18	to	to	B-VP	TO	O	19	VMOD
19	undergo	undergo	I-VP	VB	O	13	NMOD
20	apoptosis	apoptosis	B-NP	NN	O	19	OBJ
21	.	.	O	.	O	7	P

1	Incubation	Incubation	B-NP	NN	O	27	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	HIV-infected	HIV-infected	B-NP	JJ	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	monoclonal	monoclonal	B-NP	JJ	B-protein	7	NMOD
7	antibody	antibody	I-NP	NN	I-protein	11	NMOD
8	(	(	O	(	O	9	P
9	MAb	MAb	B-NP	NN	B-protein	7	NMOD
10	)	)	O	)	O	9	P
11	13B8-2	13B8-2	B-NP	NN	O	5	PMOD
12	,	,	O	,	O	11	P
13	which	which	B-NP	WDT	O	11	NMOD
14	binds	bind	B-VP	VBZ	O	13	SBAR
15	to	to	B-PP	TO	O	14	VMOD
16	CD4	CD4	B-NP	NN	B-protein	15	PMOD
17	in	in	B-PP	IN	O	14	VMOD
18	a	a	B-NP	DT	O	19	NMOD
19	region	region	I-NP	NN	O	17	PMOD
20	critical	critical	B-ADJP	JJ	O	19	NMOD
21	for	for	B-PP	IN	O	20	AMOD
22	dimerization	dimerization	B-NP	NN	O	21	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	receptor	receptor	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	1	P
27	prevented	prevent	B-VP	VBD	O	0	ROOT
28	apoptosis	apoptosis	B-NP	NN	O	27	OBJ
29	without	without	B-PP	IN	O	27	VMOD
30	inhibiting	inhibit	B-VP	VBG	O	29	PMOD
31	HIV	HIV	B-NP	NN	O	32	NMOD
32	replication	replication	I-NP	NN	O	30	OBJ
33	.	.	O	.	O	27	P

1	Moreover	Moreover	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	apoptotic	apoptotic	I-NP	JJ	O	5	NMOD
5	process	process	I-NP	NN	O	6	SUB
6	was	be	B-VP	VBD	O	23	VMOD
7	not	not	O	RB	O	6	VMOD
8	related	related	B-ADJP	JJ	O	6	PRD
9	to	to	B-PP	TO	O	8	AMOD
10	Fas-Fas	Fas-Fas	B-NP	JJ	O	12	NMOD
11	ligand	ligand	I-NP	NN	O	12	NMOD
12	interaction	interaction	I-NP	NN	O	9	PMOD
13	;	;	O	:	O	6	P
14	however	however	B-ADVP	RB	O	23	VMOD
15	,	,	O	,	O	23	P
16	an	an	B-NP	DT	O	19	NMOD
17	antagonistic	antagonistic	I-NP	JJ	O	19	NMOD
18	anti-Fas	anti-Fas	I-NP	JJ	O	19	NMOD
19	MAb	MAb	I-NP	NN	O	23	SUB
20	(	(	O	(	O	21	P
21	ZB-4	ZB-4	B-NP	NN	B-protein	19	NMOD
22	)	)	O	)	O	21	P
23	enhanced	enhance	B-VP	VBD	O	0	ROOT
24	apoptosis	apoptosis	B-NP	NN	O	23	OBJ
25	in	in	B-PP	IN	O	24	NMOD
26	HIV-infected	HIV-infected	B-NP	JJ	B-cell_type	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_type	25	PMOD
28	without	without	B-PP	IN	O	23	VMOD
29	inducing	induce	B-VP	VBG	O	28	PMOD
30	apoptosis	apoptosis	B-NP	NN	O	29	OBJ
31	in	in	B-PP	IN	O	30	NMOD
32	uninfected	uninfected	B-NP	JJ	B-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD
34	.	.	O	.	O	23	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	CD4	CD4	B-NP	NN	B-protein	6	NMOD
6	signaling	signaling	I-NP	NN	O	7	SUB
7	mediates	mediate	B-VP	VBZ	O	4	SBAR
8	HIV-induced	HIV-induced	B-NP	JJ	O	9	NMOD
9	apoptosis	apoptosis	I-NP	NN	O	7	OBJ
10	by	by	B-PP	IN	O	7	VMOD
11	a	a	B-NP	DT	O	12	NMOD
12	mechanism	mechanism	I-NP	NN	O	10	PMOD
13	independent	independent	B-ADJP	JJ	O	12	NMOD
14	of	of	B-PP	IN	O	13	AMOD
15	Fas-Fas	Fas-Fas	B-NP	JJ	O	17	NMOD
16	ligand	ligand	I-NP	NN	O	17	NMOD
17	interaction	interaction	I-NP	NN	O	14	PMOD
18	,	,	O	,	O	7	P
19	does	do	B-VP	VBZ	O	7	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	require	require	I-VP	VB	O	19	VC
22	p56	p56	B-NP	NN	B-protein	26	NMOD
23	(	(	O	(	I-protein	24	P
24	lck	lck	B-NP	NN	I-protein	22	NMOD
25	)	)	O	)	I-protein	24	P
26	signaling	signaling	B-NP	NN	O	21	OBJ
27	,	,	O	,	O	3	P
28	and	and	O	CC	O	3	VMOD
29	may	may	B-VP	MD	O	3	VMOD
30	involve	involve	I-VP	VB	O	29	VC
31	a	a	B-NP	DT	O	33	NMOD
32	critical	critical	I-NP	JJ	O	33	NMOD
33	region	region	I-NP	NN	O	30	OBJ
34	for	for	B-PP	IN	O	33	NMOD
35	CD4	CD4	B-NP	NN	B-protein	36	NMOD
36	dimerization	dimerization	I-NP	NN	O	34	PMOD
37	.	.	O	.	O	3	P

1	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	4	SUB
2	only	only	B-ADVP	RB	O	3	VMOD
3	partially	partially	B-VP	RB	O	4	VMOD
4	mediates	mediate	I-VP	VBZ	O	0	ROOT
5	Epstein-Barr	Epstein-Barr	B-NP	JJ	B-protein	11	NMOD
6	virus	virus	I-NP	NN	I-protein	11	NMOD
7	latent	latent	I-NP	JJ	I-protein	11	NMOD
8	membrane	membrane	I-NP	NN	I-protein	11	NMOD
9	protein	protein	I-NP	NN	I-protein	11	NMOD
10	1	1	I-NP	CD	I-protein	11	NMOD
11	activation	activation	I-NP	NN	O	4	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	B	B	B-NP	NN	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	latent	latent	I-NP	JJ	B-protein	4	NMOD
3	membrane	membrane	I-NP	NN	I-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	15	SUB
5	1	1	I-NP	CD	I-protein	4	NMOD
6	(	(	O	(	O	7	P
7	LMP1	LMP1	B-NP	NN	B-protein	4	NMOD
8	)	)	O	)	O	7	P
9	of	of	B-PP	IN	O	4	NMOD
10	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	11	NMOD
11	virus	virus	I-NP	NN	O	9	PMOD
12	(	(	O	(	O	13	P
13	EBV	EBV	B-NP	NN	O	11	NMOD
14	)	)	O	)	O	13	P
15	is	be	B-VP	VBZ	O	0	ROOT
16	required	require	I-VP	VBN	O	15	VC
17	for	for	B-PP	IN	O	16	VMOD
18	EBV-induced	EBV-induced	B-NP	JJ	O	19	NMOD
19	immortalization	immortalization	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	human	human	B-NP	JJ	B-cell_type	23	NMOD
22	B	B	I-NP	NN	I-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
24	and	and	O	CC	O	15	VMOD
25	causes	cause	B-VP	VBZ	O	15	VMOD
26	tumorigenic	tumorigenic	B-NP	JJ	O	27	NMOD
27	transformation	transformation	I-NP	NN	O	25	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	cell	cell	B-NP	NN	B-cell_line	30	NMOD
30	lines	line	I-NP	NNS	I-cell_line	28	PMOD
31	.	.	O	.	O	15	P

1	LMP1	LMP1	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	induces	induce	B-VP	VBZ	O	0	ROOT
4	phenotypic	phenotypic	B-NP	JJ	O	5	NMOD
5	changes	change	I-NP	NNS	O	3	OBJ
6	resembling	resemble	B-VP	VBG	O	5	NMOD
7	B	B	B-NP	NN	O	9	NMOD
8	cell	cell	I-NP	NN	O	9	NMOD
9	activation	activation	I-NP	NN	O	6	OBJ
10	,	,	O	,	O	5	P
11	such	such	B-PP	JJ	O	12	PMOD
12	as	as	I-PP	IN	O	5	NMOD
13	cell	cell	B-NP	NN	O	15	NMOD
14	size	size	I-NP	NN	O	15	NMOD
15	increase	increase	I-NP	NN	O	17	NMOD
16	and	and	I-NP	CC	O	17	NMOD
17	up-regulation	up-regulation	I-NP	NN	O	12	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	cell	cell	B-NP	NN	B-protein	22	NMOD
20	surface	surface	I-NP	NN	I-protein	22	NMOD
21	activation	activation	I-NP	NN	I-protein	22	NMOD
22	markers	marker	I-NP	NNS	I-protein	18	PMOD
23	.	.	O	.	O	3	P

1	LMP1	LMP1	B-NP	NN	B-protein	2	SUB
2	contains	contain	B-VP	VBZ	O	0	ROOT
3	two	two	B-NP	CD	O	4	NMOD
4	domains	domain	I-NP	NNS	O	2	OBJ
5	that	that	B-NP	WDT	O	4	NMOD
6	activate	activate	B-VP	VBP	O	5	SBAR
7	the	the	B-NP	DT	O	10	NMOD
8	transcription	transcription	I-NP	NN	B-protein	10	NMOD
9	factor	factor	I-NP	NN	I-protein	10	NMOD
10	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	12	NMOD
11	,	,	O	,	O	12	P
12	one	one	B-NP	CD	O	6	OBJ
13	through	through	B-PP	IN	O	12	NMOD
14	interactions	interaction	B-NP	NNS	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	TRAF	TRAF	B-NP	NN	B-protein	17	NMOD
17	proteins	protein	I-NP	NNS	I-protein	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	other	other	I-NP	JJ	O	15	PMOD
21	with	with	B-PP	IN	O	14	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	TRADD	TRADD	I-NP	NN	B-protein	24	NMOD
24	protein	protein	I-NP	NN	I-protein	21	PMOD
25	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	purpose	purpose	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	present	present	I-NP	JJ	O	6	NMOD
6	study	study	I-NP	NN	O	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	to	to	B-VP	TO	O	9	VMOD
9	investigate	investigate	I-VP	VB	O	7	PRD
10	the	the	B-NP	DT	O	11	NMOD
11	importance	importance	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	14	NMOD
14	induction	induction	I-NP	NN	O	12	PMOD
15	in	in	B-PP	IN	O	11	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	up-regulation	up-regulation	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	23	NMOD
20	B	B	I-NP	NN	O	23	NMOD
21	cell	cell	I-NP	NN	O	23	NMOD
22	activation	activation	I-NP	NN	O	23	NMOD
23	markers	marker	I-NP	NNS	O	18	PMOD
24	ICAM-1	ICAM-1	I-NP	NN	B-protein	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	CD71	CD71	I-NP	NN	B-protein	23	NMOD
27	by	by	B-PP	IN	O	17	NMOD
28	LMP1	LMP1	B-NP	NN	B-protein	27	PMOD
29	.	.	O	.	O	7	P

1	This	This	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	shows	show	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	18	DEP
5	expression	expression	B-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	LMP1	LMP1	B-NP	NN	B-protein	6	PMOD
8	activates	activate	B-VP	VBZ	O	4	SBAR
9	transcription	transcription	B-NP	NN	O	8	OBJ
10	from	from	B-PP	IN	O	9	NMOD
11	p50/p65-	p50/p65-	B-NP	NN	B-DNA	15	NMOD
12	and	and	I-NP	CC	I-DNA	15	NMOD
13	c-Rel-	c-Rel-	I-NP	NN	I-DNA	15	NMOD
14	responsive	responsive	I-NP	JJ	I-DNA	15	NMOD
15	promoters	promoter	I-NP	NNS	I-DNA	10	PMOD
16	,	,	O	,	O	18	P
17	and	and	O	CC	O	18	DEP
18	that	that	B-SBAR	IN	O	3	VMOD
19	this	this	B-NP	DT	O	20	NMOD
20	activity	activity	I-NP	NN	O	21	SUB
21	can	can	B-VP	MD	O	18	SBAR
22	be	be	I-VP	VB	O	21	VC
23	completely	completely	I-VP	RB	O	24	VMOD
24	inhibited	inhibit	I-VP	VBN	O	22	VC
25	by	by	B-PP	IN	O	24	VMOD
26	expression	expression	B-NP	NN	O	25	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	a	a	B-NP	DT	O	32	NMOD
29	dominant	dominant	I-NP	JJ	B-protein	32	NMOD
30	inhibitory	inhibitory	I-NP	JJ	I-protein	32	NMOD
31	IkappaB	IkappaB	I-NP	NN	I-protein	32	NMOD
32	mutant	mutant	I-NP	NN	I-protein	27	PMOD
33	.	.	O	.	O	3	P

1	ICAM-1	ICAM-1	B-NP	NN	B-protein	3	NMOD
2	and	and	I-NP	CC	O	3	NMOD
3	CD71	CD71	I-NP	NN	B-protein	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	nevertheless	nevertheless	I-VP	RB	O	4	VMOD
6	up-regulated	up-regulate	I-VP	VBN	O	4	VC
7	by	by	B-PP	IN	O	6	VMOD
8	LMP1	LMP1	B-NP	NN	B-protein	7	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	primary	primary	B-NP	JJ	B-cell_type	12	NMOD
11	B	B	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	15	NMOD
13	and	and	O	CC	O	15	NMOD
14	cell	cell	B-NP	NN	B-cell_line	15	NMOD
15	lines	line	I-NP	NNS	I-cell_line	9	PMOD
16	expressing	express	B-VP	VBG	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	dominant	dominant	I-NP	JJ	B-protein	19	NMOD
19	IkappaB	IkappaB	I-NP	NN	I-protein	16	OBJ
20	.	.	O	.	O	4	P

1	Furthermore	Furthermore	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	LMP1-induced	LMP1-induced	B-NP	JJ	O	6	NMOD
4	cell	cell	I-NP	NN	O	6	NMOD
5	size	size	I-NP	NN	O	6	NMOD
6	increase	increase	I-NP	NN	O	11	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	primary	primary	B-NP	JJ	B-cell_type	10	NMOD
9	B	B	I-NP	NN	I-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	unaffected	unaffected	B-ADJP	JJ	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	IkappaB	IkappaB	B-NP	NN	B-protein	15	NMOD
15	expression	expression	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	11	P

1	It	It	B-NP	PRP	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	concluded	conclude	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	even	even	B-ADVP	RB	O	6	AMOD
6	when	when	I-ADVP	WRB	O	15	VMOD
7	LMP1	LMP1	B-NP	NN	B-protein	8	SUB
8	is	be	B-VP	VBZ	O	6	SBAR
9	unable	unable	B-ADJP	JJ	O	8	PRD
10	to	to	B-VP	TO	O	11	VMOD
11	activate	activate	I-VP	VB	O	9	AMOD
12	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	11	OBJ
13	,	,	O	,	O	15	P
14	it	it	B-NP	PRP	O	15	SUB
15	is	be	B-VP	VBZ	O	4	SBAR
16	still	still	B-ADVP	RB	O	15	VMOD
17	capable	capable	B-ADJP	JJ	O	15	PRD
18	of	of	B-PP	IN	O	17	AMOD
19	inducing	induce	B-VP	VBG	O	18	PMOD
20	certain	certain	B-NP	JJ	O	21	NMOD
21	characteristics	characteristic	I-NP	NNS	O	19	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	activated	activate	B-NP	VBN	B-cell_type	25	NMOD
24	B	B	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
26	,	,	O	,	O	15	P
27	strongly	strongly	B-VP	RB	O	28	VMOD
28	suggesting	suggest	I-VP	VBG	O	15	VMOD
29	that	that	B-SBAR	IN	O	28	VMOD
30	LMP1	LMP1	B-NP	NN	B-protein	31	SUB
31	can	can	B-VP	MD	O	29	SBAR
32	also	also	I-VP	RB	O	31	VMOD
33	activate	activate	I-VP	VB	O	31	VC
34	cells	cell	B-NP	NNS	O	33	OBJ
35	independently	independently	B-ADVP	RB	O	34	NMOD
36	of	of	B-PP	IN	O	35	AMOD
37	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	36	PMOD
38	.	.	O	.	O	2	P

1	Relationship	Relationship	B-NP	NN	O	0	ROOT
2	between	between	B-PP	IN	O	1	NMOD
3	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	5	NMOD
4	constitutive	constitutive	I-NP	JJ	O	5	NMOD
5	expression	expression	I-NP	NN	O	11	NMOD
6	,	,	O	,	O	11	P
7	TNFalpha	TNFalpha	B-NP	NN	B-protein	8	NMOD
8	synthesis	synthesis	I-NP	NN	O	11	NMOD
9	,	,	O	,	O	11	P
10	and	and	O	CC	O	11	NMOD
11	apoptosis	apoptosis	B-NP	NN	O	2	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	EBV-infected	EBV-infected	B-NP	JJ	B-cell_type	15	NMOD
14	lymphoblastoid	lymphoblastoid	I-NP	JJ	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	.	.	O	.	O	1	P

1	In	In	B-SBAR	IN	O	13	VMOD
2	order	order	O	NN	O	1	DEP
3	to	to	B-VP	TO	O	4	VMOD
4	understand	understand	I-VP	VB	O	13	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	role	role	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	7	PMOD
9	in	in	B-PP	IN	O	6	NMOD
10	EBV	EBV	B-NP	NN	O	11	NMOD
11	transformation	transformation	I-NP	NN	O	9	PMOD
12	we	we	B-NP	PRP	O	13	SUB
13	have	have	B-VP	VBP	O	0	ROOT
14	established	establish	I-VP	VBN	O	13	VC
15	stably	stably	B-NP	RB	O	16	AMOD
16	transfected	transfecte	I-NP	VBN	O	17	NMOD
17	IkappaBalpha	IkappaBalpha	I-NP	NN	B-protein	14	OBJ
18	into	into	B-PP	IN	O	14	VMOD
19	lymphoblastoid	lymphoblastoid	B-NP	JJ	B-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	18	PMOD
21	.	.	O	.	O	13	P

1	Two	Two	B-NP	CD	O	2	NMOD
2	clones	clone	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	obtained	obtain	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	which	which	B-NP	WDT	O	5	PMOD
7	the	the	B-NP	DT	O	8	NMOD
8	loss	loss	I-NP	NN	O	13	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	12	NMOD
11	binding	binding	I-NP	NN	O	12	NMOD
12	activity	activity	I-NP	NN	O	9	PMOD
13	correlated	correlate	B-VP	VBD	O	5	SBAR
14	with	with	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	17	NMOD
16	constitutive	constitutive	I-NP	JJ	O	17	NMOD
17	expression	expression	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	transgenic	transgenic	I-NP	JJ	O	21	NMOD
21	IkappaBalpha	IkappaBalpha	I-NP	NN	B-protein	18	PMOD
22	.	.	O	.	O	3	P

1	Protein	Protein	B-NP	NN	O	3	NMOD
2	latency	latency	I-NP	NN	O	3	NMOD
3	expression	expression	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	determined	determine	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	immunocytochemistry	immunocytochemistry	B-NP	NN	O	6	PMOD
8	.	.	O	.	O	4	P

1	Expression	Expression	B-NP	NN	O	7	NMOD
2	of	of	B-PP	IN	O	1	NMOD
3	surface	surface	B-NP	NN	B-protein	4	NMOD
4	markers	marker	I-NP	NNS	I-protein	2	PMOD
5	,	,	O	,	O	7	P
6	intracytoplasmic	intracytoplasmic	B-NP	JJ	O	7	NMOD
7	content	content	I-NP	NN	O	22	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	cytokines	cytokine	B-NP	NNS	B-protein	12	NMOD
10	cell	cell	I-NP	NN	O	12	NMOD
11	cycle	cycle	I-NP	NN	O	12	NMOD
12	analysis	analysis	I-NP	NN	O	8	PMOD
13	after	after	B-PP	IN	O	7	NMOD
14	BrdU	BrdU	B-NP	NN	B-protein	15	NMOD
15	incorporation	incorporation	I-NP	NN	O	18	NMOD
16	and	and	O	CC	O	18	NMOD
17	DNA	DNA	B-NP	NN	O	18	NMOD
18	staining	staining	I-NP	NN	O	13	PMOD
19	with	with	B-PP	IN	O	18	NMOD
20	propidium	propidium	B-NP	NN	O	21	NMOD
21	iodide	iodide	I-NP	NN	O	19	PMOD
22	were	be	B-VP	VBD	O	0	ROOT
23	studied	study	I-VP	VBN	O	22	VC
24	by	by	B-PP	IN	O	23	VMOD
25	flow	flow	B-NP	NN	O	26	NMOD
26	cytometry	cytometry	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	22	P

1	Percentage	Percentage	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	apoptotic	apoptotic	B-NP	JJ	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	was	be	B-VP	VBD	O	0	ROOT
6	determined	determine	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	in-situ	in-situ	B-NP	FW	O	9	NMOD
9	labelling	labelling	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	DNA	DNA	B-NP	NN	O	13	NMOD
12	strand	strand	I-NP	NN	O	13	NMOD
13	breaks	break	I-NP	NNS	O	10	PMOD
14	.	.	O	.	O	5	P

1	No	No	B-NP	DT	O	3	NMOD
2	significative	significative	I-NP	JJ	O	3	NMOD
3	changes	change	I-NP	NNS	O	13	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	EBV	EBV	B-NP	NN	O	6	NMOD
6	latency	latency	I-NP	NN	O	4	PMOD
7	nor	nor	B-PP	CC	O	4	PMOD
8	in	in	B-PP	IN	O	4	PMOD
9	cell	cell	B-NP	NN	B-protein	12	NMOD
10	surface	surface	I-NP	NN	I-protein	12	NMOD
11	marker	marker	I-NP	NN	I-protein	12	NMOD
12	expression	expression	I-NP	NN	O	8	PMOD
13	was	be	B-VP	VBD	O	0	ROOT
14	found	find	I-VP	VBN	O	13	VC
15	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	7	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	intracytoplasmic	intracytoplasmic	B-NP	JJ	O	6	NMOD
5	TNFalpha	TNFalpha	I-NP	NN	B-protein	6	NMOD
6	levels	level	I-NP	NNS	O	7	SUB
7	were	be	B-VP	VBD	O	0	ROOT
8	strongly	strongly	I-VP	RB	O	7	VMOD
9	reduced	reduce	I-VP	VBN	O	7	VC
10	in	in	B-PP	IN	O	9	VMOD
11	transfected	transfecte	B-NP	VBN	B-cell_line	12	NMOD
12	clones	clone	I-NP	NNS	I-cell_line	10	PMOD
13	.	.	O	.	O	7	P

1	Furthermore	Furthermore	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	30	30	B-NP	CD	O	4	NMOD
4	%	%	I-NP	NN	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	8	NMOD
7	transfected	transfecte	B-NP	VBN	O	8	NMOD
8	cells	cell	I-NP	NNS	O	5	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	apoptotic	apoptotic	B-ADJP	JJ	O	9	PRD
11	after	after	B-PP	IN	O	10	AMOD
12	8	8	B-NP	CD	O	13	NMOD
13	h	h	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	TNFalpha	TNFalpha	B-NP	NN	B-protein	16	NMOD
16	treatment	treatment	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	9	P

1	This	This	B-NP	DT	O	2	SUB
2	correlated	correlate	B-VP	VBD	O	0	ROOT
3	with	with	B-PP	IN	O	2	VMOD
4	a	a	B-NP	DT	O	6	NMOD
5	strong	strong	I-NP	JJ	O	6	NMOD
6	reduction	reduction	I-NP	NN	O	3	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	BrdU	BrdU	B-NP	NN	B-protein	9	NMOD
9	incorporation	incorporation	I-NP	NN	O	7	PMOD
10	after	after	B-PP	IN	O	6	NMOD
11	24	24	B-NP	CD	O	12	NMOD
12	h	h	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	TNFalpha	TNFalpha	B-NP	NN	B-protein	15	NMOD
15	treatment	treatment	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	2	P

1	No	No	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	seen	see	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	non	non	B-NP	JJ	B-cell_type	8	NMOD
7	transfected	transfecte	I-NP	VBN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
9	or	or	B-PP	CC	O	5	PMOD
10	with	with	B-PP	IN	O	5	PMOD
11	cells	cell	B-NP	NNS	O	10	PMOD
12	transfected	transfecte	B-VP	VBN	O	11	NMOD
13	with	with	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	16	NMOD
15	control	control	I-NP	NN	B-DNA	16	NMOD
16	plasmid	plasmid	I-NP	NN	I-DNA	13	PMOD
17	.	.	O	.	O	3	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	21	DEP
5	the	the	B-NP	DT	O	7	NMOD
6	TNFalpha	TNFalpha	I-NP	NN	B-DNA	7	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	SUB
8	could	could	B-VP	MD	O	4	SBAR
9	be	be	I-VP	VB	O	8	VC
10	one	one	B-NP	CD	O	9	PRD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	targets	target	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	14	PMOD
16	in	in	B-PP	IN	O	10	NMOD
17	EBV	EBV	B-NP	NN	B-cell_type	19	NMOD
18	infected	infected	I-NP	JJ	I-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	and	and	O	CC	O	21	DEP
21	that	that	B-SBAR	IN	O	3	VMOD
22	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	23	SUB
23	protects	protect	B-VP	VBZ	O	21	SBAR
24	EBV-infected	EBV-infected	B-NP	JJ	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	23	OBJ
26	from	from	B-PP	IN	O	23	VMOD
27	apoptosis	apoptosis	B-NP	NN	O	26	PMOD
28	induced	induce	B-VP	VBN	O	27	NMOD
29	by	by	B-PP	IN	O	28	VMOD
30	TNFalpha	TNFalpha	B-NP	NN	B-protein	29	PMOD
31	,	,	O	,	O	30	P
32	which	which	B-NP	WDT	O	30	NMOD
33	may	may	B-VP	MD	O	32	SBAR
34	favour	favour	I-VP	VB	O	33	VC
35	the	the	B-NP	DT	O	37	NMOD
36	proliferative	proliferative	I-NP	JJ	O	37	NMOD
37	effect	effect	I-NP	NN	O	34	OBJ
38	of	of	B-PP	IN	O	37	NMOD
39	this	this	B-NP	DT	O	40	NMOD
40	cytokine	cytokine	I-NP	NN	B-protein	38	PMOD
41	.	.	O	.	O	3	P

1	Uncoupling	Uncouple	B-VP	VBG	O	0	ROOT
2	activation-dependent	activation-dependent	B-NP	JJ	O	4	NMOD
3	HS1	HS1	I-NP	NN	B-protein	4	NMOD
4	phosphorylation	phosphorylation	I-NP	NN	O	1	OBJ
5	from	from	B-PP	IN	O	4	NMOD
6	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD
7	factor	factor	I-NP	NN	I-protein	13	NMOD
8	of	of	B-PP	IN	I-protein	7	NMOD
9	activated	activate	B-NP	VBN	I-protein	11	NMOD
10	T	T	I-NP	NN	I-protein	11	NMOD
11	cells	cell	I-NP	NNS	I-protein	8	PMOD
12	transcriptional	transcriptional	B-NP	JJ	O	13	NMOD
13	activation	activation	I-NP	NN	O	5	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	Jurkat	Jurkat	B-NP	NN	B-cell_line	17	NMOD
16	T	T	I-NP	NN	I-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
18	:	:	O	:	O	1	P
19	differential	differential	B-NP	JJ	O	20	NMOD
20	signaling	signaling	I-NP	NN	O	1	OBJ
21	through	through	B-PP	IN	O	20	NMOD
22	CD3	CD3	B-NP	NN	B-protein	26	NMOD
23	and	and	O	CC	O	26	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	costimulatory	costimulatory	I-NP	JJ	O	26	NMOD
26	receptors	receptor	I-NP	NNS	O	21	PMOD
27	CD2	CD2	I-NP	NN	B-protein	29	NMOD
28	and	and	I-NP	CC	O	29	NMOD
29	CD28	CD28	I-NP	NN	B-protein	26	NMOD
30	.	.	O	.	O	1	P

1	CD3	CD3	B-NP	NN	B-protein	6	NMOD
2	,	,	O	,	O	6	P
3	CD2	CD2	B-NP	NN	B-protein	6	NMOD
4	,	,	O	,	O	6	P
5	and	and	O	CC	O	6	NMOD
6	CD28	CD28	B-NP	NN	B-protein	7	SUB
7	are	be	B-VP	VBP	O	0	ROOT
8	functionally	functionally	B-NP	RB	O	9	AMOD
9	distinct	distinct	I-NP	JJ	O	10	NMOD
10	receptors	receptor	I-NP	NNS	O	7	PRD
11	on	on	B-PP	IN	O	10	NMOD
12	T	T	B-NP	NN	B-cell_type	13	NMOD
13	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	PMOD
14	.	.	O	.	O	7	P

1	Engagement	Engagement	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	any	any	B-NP	DT	O	2	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	these	these	B-NP	DT	O	6	NMOD
6	receptors	receptor	I-NP	NNS	O	4	PMOD
7	induces	induce	B-VP	VBZ	O	0	ROOT
8	the	the	B-NP	DT	O	11	NMOD
9	rapid	rapid	I-NP	JJ	O	11	NMOD
10	tyrosine	tyrosine	I-NP	NN	O	11	NMOD
11	phosphorylation	phosphorylation	I-NP	NN	O	7	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	15	NMOD
14	shared	shared	I-NP	JJ	O	15	NMOD
15	group	group	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	intracellular	intracellular	B-NP	JJ	B-protein	19	NMOD
18	signaling	signaling	I-NP	NN	I-protein	19	NMOD
19	proteins	protein	I-NP	NNS	I-protein	16	PMOD
20	,	,	O	,	O	19	P
21	including	include	B-PP	VBG	O	19	NMOD
22	Vav	Vav	B-NP	NN	B-protein	37	NMOD
23	,	,	O	,	O	37	P
24	Cbl	Cbl	B-NP	NN	B-protein	37	NMOD
25	,	,	O	,	O	37	P
26	p85	p85	B-NP	NN	B-protein	28	NMOD
27	phosphoinositide	phosphoinositide	I-NP	NN	I-protein	28	NMOD
28	3-kinase	3-kinase	I-NP	NN	I-protein	37	NMOD
29	,	,	O	,	O	37	P
30	and	and	O	CC	O	37	NMOD
31	the	the	B-NP	DT	O	34	NMOD
32	Src	Src	I-NP	NN	B-protein	34	NMOD
33	family	family	I-NP	NN	I-protein	34	NMOD
34	kinases	kinase	I-NP	NNS	I-protein	37	NMOD
35	Lck	Lck	I-NP	NN	B-protein	37	NMOD
36	and	and	I-NP	CC	O	37	NMOD
37	Fyn	Fyn	I-NP	NN	B-protein	21	PMOD
38	.	.	O	.	O	7	P

1	Ligation	Ligation	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	CD3	CD3	B-NP	NN	B-protein	2	PMOD
4	also	also	B-ADVP	RB	O	5	VMOD
5	induces	induce	B-VP	VBZ	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	tyrosine	tyrosine	I-NP	NN	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	HS1	HS1	B-NP	NN	B-protein	18	NMOD
11	,	,	O	,	O	18	P
12	a	a	B-NP	DT	O	18	NMOD
13	75-kDa	75-kDa	I-NP	JJ	B-protein	15	AMOD
14	hematopoietic	hematopoietic	I-NP	JJ	I-protein	15	AMOD
15	cell-specific	cell-specific	I-NP	JJ	I-protein	18	NMOD
16	intracellular	intracellular	I-NP	JJ	I-protein	18	NMOD
17	signaling	signaling	I-NP	NN	I-protein	18	NMOD
18	protein	protein	I-NP	NN	I-protein	9	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	unknown	unknown	B-NP	JJ	O	21	NMOD
21	function	function	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	examined	examine	I-VP	VBN	O	2	VC
4	changes	change	B-NP	NNS	O	3	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	HS1	HS1	B-NP	NN	B-protein	7	NMOD
7	phosphorylation	phosphorylation	I-NP	NN	O	5	PMOD
8	after	after	B-PP	IN	O	7	NMOD
9	differential	differential	B-NP	JJ	O	10	NMOD
10	stimulation	stimulation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	CD3	CD3	B-NP	NN	B-protein	17	NMOD
13	,	,	O	,	O	17	P
14	CD2	CD2	B-NP	NN	B-protein	17	NMOD
15	,	,	O	,	O	17	P
16	and	and	O	CC	O	17	NMOD
17	CD28	CD28	B-NP	NN	B-protein	11	PMOD
18	to	to	B-VP	TO	O	19	VMOD
19	elucidate	elucidate	I-VP	VB	O	10	NMOD
20	its	its	B-NP	PRP$	O	21	NMOD
21	role	role	I-NP	NN	O	19	OBJ
22	in	in	B-PP	IN	O	21	NMOD
23	T	T	B-NP	NN	B-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
25	and	and	O	CC	O	19	VMOD
26	to	to	B-VP	TO	O	28	VMOD
27	further	further	I-VP	RB	O	28	VMOD
28	delineate	delineate	I-VP	VB	O	19	VMOD
29	the	the	B-NP	DT	O	31	NMOD
30	signaling	signaling	I-NP	NN	O	31	NMOD
31	pathways	pathway	I-NP	NNS	O	28	OBJ
32	recruited	recruit	B-VP	VBN	O	31	NMOD
33	by	by	B-PP	IN	O	32	VMOD
34	these	these	B-NP	DT	O	35	NMOD
35	receptors	receptor	I-NP	NNS	O	33	PMOD
36	.	.	O	.	O	2	P

1	Unlike	Unlike	B-PP	IN	O	20	VMOD
2	ligation	ligation	B-NP	NN	O	1	PMOD
3	of	of	B-PP	IN	O	2	NMOD
4	CD3	CD3	B-NP	NN	B-protein	3	PMOD
5	,	,	O	,	O	20	P
6	stimulation	stimulation	B-NP	NN	O	20	SUB
7	with	with	B-PP	IN	O	6	NMOD
8	anti-CD28	anti-CD28	B-NP	JJ	B-protein	9	NMOD
9	mAb	mAb	I-NP	NN	I-protein	12	NMOD
10	or	or	I-NP	CC	O	12	NMOD
11	CHO	CHO	I-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	7	PMOD
13	expressing	express	B-VP	VBG	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	CD28	CD28	I-NP	NN	B-protein	16	NMOD
16	ligands	ligand	I-NP	NNS	I-protein	13	OBJ
17	CD80	CD80	I-NP	NN	B-protein	19	NMOD
18	or	or	I-NP	CC	O	19	NMOD
19	CD86	CD86	I-NP	NN	B-protein	16	NMOD
20	did	do	B-VP	VBD	O	0	ROOT
21	not	not	I-VP	RB	O	20	VMOD
22	lead	lead	I-VP	VB	O	20	VC
23	to	to	B-PP	TO	O	22	VMOD
24	tyrosine	tyrosine	B-NP	NN	O	25	NMOD
25	phosphorylation	phosphorylation	I-NP	NN	O	23	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	HS1	HS1	B-NP	NN	B-protein	26	PMOD
28	in	in	B-PP	IN	O	25	NMOD
29	Jurkat	Jurkat	B-NP	NN	B-cell_line	31	NMOD
30	T	T	I-NP	NN	I-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	28	PMOD
32	.	.	O	.	O	20	P

1	Additionally	Additionally	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	no	no	B-NP	DT	O	5	NMOD
4	tyrosine	tyrosine	I-NP	NN	O	5	NMOD
5	phosphorylation	phosphorylation	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	HS1	HS1	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	induced	induce	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	mitogenic	mitogenic	B-NP	JJ	B-cell_type	12	NMOD
12	pairs	pair	I-NP	NNS	I-cell_type	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	anti-CD2	anti-CD2	B-NP	JJ	B-protein	15	NMOD
15	mAbs	mAb	I-NP	NNS	I-protein	13	PMOD
16	capable	capable	B-ADJP	JJ	O	15	NMOD
17	of	of	B-PP	IN	O	16	AMOD
18	activating	activate	B-VP	VBG	O	17	PMOD
19	the	the	B-NP	DT	O	22	NMOD
20	transcription	transcription	I-NP	NN	B-protein	22	NMOD
21	factor	factor	I-NP	NN	I-protein	22	NMOD
22	NFAT	NFAT	I-NP	NN	B-protein	18	OBJ
23	(	(	O	(	O	25	P
24	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD
25	factor	factor	I-NP	NN	I-protein	22	NMOD
26	of	of	B-PP	IN	I-protein	25	NMOD
27	activated	activate	B-NP	VBN	I-protein	29	NMOD
28	T	T	I-NP	NN	I-protein	29	NMOD
29	cells	cell	I-NP	NNS	I-protein	26	PMOD
30	)	)	O	)	O	25	P
31	.	.	O	.	O	8	P

1	Costimulation	Costimulation	B-NP	NN	O	6	SUB
2	through	through	B-PP	IN	O	1	NMOD
3	CD28	CD28	B-NP	NN	B-protein	5	NMOD
4	and/or	and/or	O	CC	O	5	NMOD
5	CD2	CD2	B-NP	NN	B-protein	2	PMOD
6	did	do	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	modulate	modulate	I-VP	VB	O	6	VC
9	the	the	B-NP	DT	O	11	NMOD
10	CD3-dependent	CD3-dependent	I-NP	JJ	O	11	NMOD
11	phosphorylation	phosphorylation	I-NP	NN	O	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	HS1	HS1	B-NP	NN	B-protein	12	PMOD
14	.	.	O	.	O	6	P

1	In	In	B-NP	FW	O	2	AMOD
2	vivo	vivo	I-NP	FW	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	indicated	indicate	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	CD3-induced	CD3-induced	B-NP	JJ	O	8	NMOD
7	HSI	HSI	I-NP	NN	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	9	SUB
9	was	be	B-VP	VBD	O	5	SBAR
10	dependent	dependent	B-ADJP	JJ	O	9	PRD
11	upon	upon	B-PP	IN	O	10	AMOD
12	both	both	O	CC	O	17	NMOD
13	the	the	B-NP	DT	O	17	NMOD
14	Src	Src	I-NP	NN	B-protein	17	NMOD
15	family	family	I-NP	NN	I-protein	17	NMOD
16	tyrosine	tyrosine	I-NP	NN	I-protein	17	NMOD
17	kinase	kinase	I-NP	NN	I-protein	18	NMOD
18	Lck	Lck	I-NP	NN	B-protein	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	the	the	B-NP	DT	O	22	NMOD
21	tyrosine	tyrosine	I-NP	NN	B-protein	22	NMOD
22	phosphatase	phosphatase	I-NP	NN	I-protein	23	NMOD
23	CD45	CD45	I-NP	NN	B-protein	25	SUB
24	,	,	O	,	O	23	P
25	did	do	B-VP	VBD	O	11	SBAR
26	not	not	I-VP	RB	O	25	VMOD
27	require	require	I-VP	VB	O	25	VC
28	MEK1	MEK1	B-NP	NN	B-protein	30	NMOD
29	kinase	kinase	I-NP	NN	O	30	NMOD
30	activity	activity	I-NP	NN	O	27	OBJ
31	,	,	O	,	O	4	P
32	and	and	O	CC	O	4	VMOD
33	was	be	B-VP	VBD	O	4	VMOD
34	regulated	regulate	I-VP	VBN	O	33	VC
35	by	by	B-PP	IN	O	34	VMOD
36	protein	protein	B-NP	NN	B-protein	39	NMOD
37	kinase	kinase	I-NP	NN	I-protein	39	NMOD
38	C	C	I-NP	NN	I-protein	39	NMOD
39	activation	activation	I-NP	NN	O	35	PMOD
40	.	.	O	.	O	4	P

1	Thus	Thus	B-ADVP	RB	O	19	VMOD
2	,	,	O	,	O	19	P
3	although	although	B-SBAR	IN	O	19	VMOD
4	CD3	CD3	B-NP	NN	B-protein	9	NMOD
5	,	,	O	,	O	9	P
6	CD28	CD28	B-NP	NN	B-protein	9	NMOD
7	,	,	O	,	O	9	P
8	and	and	O	CC	O	9	NMOD
9	CD2	CD2	B-NP	NN	B-protein	10	SUB
10	activate	activate	B-VP	VBP	O	3	SBAR
11	many	many	B-NP	JJ	O	10	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	16	NMOD
14	same	same	I-NP	JJ	O	16	NMOD
15	signaling	signal	I-NP	VBG	B-protein	16	NMOD
16	molecules	molecule	I-NP	NNS	I-protein	12	PMOD
17	,	,	O	,	O	19	P
18	they	they	B-NP	PRP	O	19	SUB
19	differed	differ	B-VP	VBD	O	0	ROOT
20	in	in	B-PP	IN	O	19	VMOD
21	their	their	B-NP	PRP$	O	22	NMOD
22	capacity	capacity	I-NP	NN	O	20	PMOD
23	to	to	B-VP	TO	O	24	VMOD
24	induce	induce	I-VP	VB	O	19	VMOD
25	the	the	B-NP	DT	O	27	NMOD
26	tyrosine	tyrosine	I-NP	NN	O	27	NMOD
27	phosphorylation	phosphorylation	I-NP	NN	O	24	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	HSI	HSI	B-NP	NN	B-protein	28	PMOD
30	.	.	O	.	O	19	P

1	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	activation-dependent	activation-dependent	B-NP	JJ	O	5	NMOD
4	tyrosine	tyrosine	I-NP	NN	O	5	NMOD
5	phosphorylation	phosphorylation	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	HS1	HS1	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	required	require	I-VP	VBN	O	8	VC
11	for	for	B-PP	IN	O	10	VMOD
12	NFAT	NFAT	B-NP	NN	B-protein	14	NMOD
13	transcriptional	transcriptional	I-NP	JJ	O	14	NMOD
14	activation	activation	I-NP	NN	O	11	PMOD
15	.	.	O	.	O	8	P

1	IL-7	IL-7	B-NP	NN	B-protein	2	SUB
2	reconstitutes	reconstitute	B-VP	VBZ	O	0	ROOT
3	multiple	multiple	B-NP	JJ	O	4	NMOD
4	aspects	aspect	I-NP	NNS	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	v-Abl-mediated	v-Abl-mediated	B-NP	JJ	O	7	NMOD
7	signaling	signaling	I-NP	NN	O	5	PMOD
8	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanism	mechanism	I-NP	NN	O	13	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	early	early	B-NP	JJ	B-cell_type	7	NMOD
6	lymphoid	lymphoid	I-NP	JJ	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	8	SUB
8	are	be	B-VP	VBP	O	3	SBAR
9	selectively	selectively	I-VP	RB	O	8	VMOD
10	transformed	transform	I-VP	VBN	O	8	VC
11	by	by	B-PP	IN	O	10	VMOD
12	v-Abl	v-Abl	B-NP	NN	B-protein	11	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	currently	currently	B-ADJP	RB	O	13	VMOD
15	unknown	unknown	I-ADJP	JJ	O	13	PRD
16	.	.	O	.	O	13	P

1	Previous	Previous	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	shown	show	I-VP	VBN	O	3	VC
5	constitutive	constitutive	B-NP	JJ	O	6	NMOD
6	activation	activation	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	IL-4	IL-4	B-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	IL-7	IL-7	I-NP	NN	B-protein	12	NMOD
11	signaling	signaling	I-NP	NN	O	12	NMOD
12	pathways	pathway	I-NP	NNS	O	7	PMOD
13	,	,	O	,	O	4	P
14	as	as	B-SBAR	IN	O	4	VMOD
15	measured	measure	B-VP	VBN	O	14	SBAR
16	by	by	B-PP	IN	O	15	VMOD
17	activation	activation	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	Janus	Janus	B-NP	NN	B-protein	21	NMOD
20	protein	protein	I-NP	NN	I-protein	21	NMOD
21	kinase	kinase	I-NP	NN	I-protein	32	NMOD
22	(	(	O	(	O	23	P
23	JAK	JAK	B-NP	NN	B-protein	21	NMOD
24	)	)	O	)	O	23	P
25	1	1	B-NP	CD	O	21	NMOD
26	,	,	O	,	O	32	P
27	JAK3	JAK3	B-NP	NN	B-protein	32	NMOD
28	,	,	O	,	O	32	P
29	STAT5	STAT5	B-NP	NN	B-protein	32	NMOD
30	,	,	O	,	O	32	P
31	and	and	O	CC	O	32	NMOD
32	STAT6	STAT6	B-NP	NN	B-protein	18	PMOD
33	,	,	O	,	O	32	P
34	in	in	B-PP	IN	O	17	NMOD
35	pre-B	pre-B	B-NP	JJ	B-cell_type	36	NMOD
36	cells	cell	I-NP	NNS	I-cell_type	34	PMOD
37	transformed	transform	B-VP	VBN	O	36	NMOD
38	by	by	B-PP	IN	O	37	VMOD
39	v-Abl	v-Abl	B-NP	NN	B-protein	38	PMOD
40	.	.	O	.	O	3	P

1	To	To	B-VP	TO	O	2	VMOD
2	determine	determine	I-VP	VB	O	41	VMOD
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	activation	activation	B-NP	NN	O	12	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	these	these	B-NP	DT	O	9	NMOD
7	cytokine	cytokine	I-NP	NN	B-protein	9	NMOD
8	signaling	signaling	I-NP	NN	O	9	NMOD
9	pathways	pathway	I-NP	NNS	O	5	PMOD
10	by	by	B-PP	IN	O	4	NMOD
11	v-Abl	v-Abl	B-NP	NN	B-protein	10	PMOD
12	is	be	B-VP	VBZ	O	3	SBAR
13	important	important	B-ADJP	JJ	O	12	PRD
14	in	in	B-PP	IN	O	13	AMOD
15	the	the	B-NP	DT	O	17	NMOD
16	cellular	cellular	I-NP	JJ	O	17	NMOD
17	events	event	I-NP	NNS	O	14	PMOD
18	induced	induce	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	24	NMOD
21	Abelson	Abelson	I-NP	NN	O	24	NMOD
22	murine	murine	I-NP	JJ	O	24	NMOD
23	leukemia	leukemia	I-NP	NN	O	24	NMOD
24	virus	virus	I-NP	NN	O	19	PMOD
25	,	,	O	,	O	41	P
26	the	the	B-NP	DT	O	27	NMOD
27	effects	effect	I-NP	NNS	O	41	SUB
28	of	of	B-PP	IN	O	27	NMOD
29	IL-4	IL-4	B-NP	NN	B-protein	31	NMOD
30	and	and	I-NP	CC	O	31	NMOD
31	IL-7	IL-7	I-NP	NN	B-protein	28	PMOD
32	on	on	B-PP	IN	O	27	NMOD
33	pre-B	pre-B	B-NP	JJ	B-cell_type	34	NMOD
34	cells	cell	I-NP	NNS	I-cell_type	32	PMOD
35	transformed	transform	B-VP	VBN	O	34	NMOD
36	with	with	B-PP	IN	O	35	VMOD
37	a	a	B-NP	DT	O	40	NMOD
38	temperature-sensitive	temperature-sensitive	I-NP	JJ	B-protein	40	NMOD
39	v-Abl	v-Abl	I-NP	NN	I-protein	40	NMOD
40	mutant	mutant	I-NP	NN	I-protein	36	PMOD
41	were	be	B-VP	VBD	O	0	ROOT
42	examined	examine	I-VP	VBN	O	41	VC
43	.	.	O	.	O	41	P

1	Whereas	Whereas	B-SBAR	IN	O	10	VMOD
2	IL-4	IL-4	B-NP	NN	B-protein	3	SUB
3	had	have	B-VP	VBD	O	1	SBAR
4	little	little	B-NP	JJ	O	7	NMOD
5	or	or	I-NP	CC	O	7	NMOD
6	no	no	I-NP	DT	O	7	NMOD
7	effect	effect	I-NP	NN	O	3	OBJ
8	,	,	O	,	O	10	P
9	IL-7	IL-7	B-NP	NN	B-protein	10	SUB
10	delayed	delay	B-VP	VBD	O	0	ROOT
11	both	both	O	CC	O	17	NMOD
12	the	the	B-NP	DT	O	17	NMOD
13	apoptosis	apoptosis	I-NP	NN	O	17	NMOD
14	and	and	I-NP	CC	O	17	NMOD
15	cell	cell	I-NP	NN	O	17	NMOD
16	cycle	cycle	I-NP	NN	O	17	NMOD
17	arrest	arrest	I-NP	NN	O	10	OBJ
18	that	that	B-NP	WDT	O	17	NMOD
19	occur	occur	B-VP	VBP	O	18	SBAR
20	upon	upon	B-PP	IN	O	19	VMOD
21	v-Abl	v-Abl	B-NP	NN	B-protein	23	NMOD
22	kinase	kinase	I-NP	NN	O	23	NMOD
23	inactivation	inactivation	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	10	P

1	IL-7	IL-7	B-NP	NN	B-protein	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	delayed	delay	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	decreases	decrease	I-NP	NNS	O	3	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	levels	level	I-NP	NNS	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	c-Myc	c-Myc	B-NP	NN	B-protein	15	NMOD
11	,	,	O	,	O	15	P
12	Bcl-2	Bcl-2	B-NP	NN	B-protein	15	NMOD
13	,	,	O	,	O	15	P
14	and	and	O	CC	O	15	NMOD
15	Bcl-xL	Bcl-xL	B-NP	NN	B-protein	9	PMOD
16	that	that	B-NP	WDT	O	15	NMOD
17	occur	occur	B-VP	VBP	O	16	SBAR
18	upon	upon	B-PP	IN	O	17	VMOD
19	loss	loss	B-NP	NN	O	18	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	v-Abl	v-Abl	B-NP	NN	B-protein	23	NMOD
22	kinase	kinase	I-NP	NN	O	23	NMOD
23	activity	activity	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	3	P

1	IL-7	IL-7	B-NP	NN	B-protein	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	maintain	maintain	I-VP	VB	O	2	VC
5	v-Abl-mediated	v-Abl-mediated	B-NP	JJ	O	7	NMOD
6	differentiation	differentiation	I-NP	NN	O	7	NMOD
7	arrest	arrest	I-NP	NN	O	4	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	pre-B	pre-B	I-NP	JJ	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
12	,	,	O	,	O	4	P
13	as	as	B-PP	IN	O	4	VMOD
14	activation	activation	B-NP	NN	O	21	SUB
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	19	NMOD
17	and	and	I-NP	CC	O	19	NMOD
18	RAG	RAG	I-NP	NN	B-DNA	19	NMOD
19	gene	gene	I-NP	NN	I-DNA	20	NMOD
20	transcription	transcription	I-NP	NN	O	15	PMOD
21	was	be	B-VP	VBD	O	13	SBAR
22	unaffected	unaffected	B-ADJP	JJ	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	IL-7	IL-7	B-NP	NN	B-protein	23	PMOD
25	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	identify	identify	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	potential	potential	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	for	for	B-PP	IN	O	6	NMOD
8	IL-7	IL-7	B-NP	NN	B-protein	10	NMOD
9	signaling	signaling	I-NP	NN	O	10	NMOD
10	pathways	pathway	I-NP	NNS	O	7	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	transformation	transformation	B-NP	NN	O	11	PMOD
13	by	by	B-PP	IN	O	3	VMOD
14	v-Abl	v-Abl	B-NP	NN	B-protein	13	PMOD
15	while	while	B-SBAR	IN	O	3	VMOD
16	demonstrating	demonstrate	B-VP	VBG	O	15	SBAR
17	that	that	B-SBAR	IN	O	16	VMOD
18	a	a	B-NP	DT	O	19	NMOD
19	combination	combination	I-NP	NN	O	25	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	IL-4	IL-4	B-NP	NN	B-protein	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	IL-7	IL-7	I-NP	NN	B-protein	24	NMOD
24	signaling	signaling	I-NP	NN	O	20	PMOD
25	can	can	B-VP	MD	O	17	SBAR
26	not	not	I-VP	RB	O	25	VMOD
27	substitute	substitute	I-VP	VB	O	25	VC
28	for	for	B-PP	IN	O	27	VMOD
29	an	an	B-NP	DT	O	32	NMOD
30	active	active	I-NP	JJ	O	32	NMOD
31	v-Abl	v-Abl	I-NP	NN	B-protein	32	NMOD
32	kinase	kinase	I-NP	NN	O	28	PMOD
33	in	in	B-PP	IN	O	32	NMOD
34	transformed	transform	B-NP	VBN	B-cell_type	36	NMOD
35	pre-B	pre-B	I-NP	JJ	I-cell_type	36	NMOD
36	cells	cell	I-NP	NNS	I-cell_type	33	PMOD
37	.	.	O	.	O	3	P

1	p21ras	p21ras	B-NP	NN	B-protein	2	SUB
2	initiates	initiate	B-VP	VBZ	O	0	ROOT
3	Rac-1	Rac-1	B-NP	NN	B-protein	9	NMOD
4	but	but	B-NP	CC	O	9	NMOD
5	not	not	I-NP	RB	O	4	DEP
6	phosphatidyl	phosphatidyl	B-NP	NN	B-protein	9	NMOD
7	inositol	inositol	I-NP	NN	I-protein	9	NMOD
8	3	3	B-NP	CD	I-protein	9	NMOD
9	kinase/PKB	kinase/PKB	I-NP	NN	I-protein	13	NMOD
10	,	,	O	,	O	13	P
11	mediated	mediate	B-NP	VBN	O	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathways	pathway	I-NP	NNS	O	2	OBJ
14	in	in	B-PP	IN	O	13	NMOD
15	T	T	B-NP	NN	B-cell_type	16	NMOD
16	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	14	PMOD
17	.	.	O	.	O	2	P

1	p21ras	p21ras	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	activated	activate	I-VP	VBN	O	2	VC
4	by	by	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	9	NMOD
6	T	T	I-NP	NN	B-protein	9	NMOD
7	cell	cell	I-NP	NN	I-protein	9	NMOD
8	antigen	antigen	I-NP	NN	I-protein	9	NMOD
9	receptor	receptor	I-NP	NN	I-protein	4	PMOD
10	(	(	O	(	O	11	P
11	TCR	TCR	B-NP	NN	B-protein	9	NMOD
12	)	)	O	)	O	11	P
13	and	and	O	CC	O	2	VMOD
14	then	then	B-VP	RB	O	2	VMOD
15	co-ordinates	coordinate	I-VP	VBZ	O	2	VMOD
16	important	important	B-NP	JJ	O	18	NMOD
17	signaling	signaling	I-NP	NN	O	18	NMOD
18	pathways	pathway	I-NP	NNS	O	15	OBJ
19	for	for	B-PP	IN	O	18	NMOD
20	T	T	B-NP	NN	B-cell_type	22	NMOD
21	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	22	NMOD
22	activation	activation	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	2	P

1	Effector	Effector	B-NP	NN	O	2	NMOD
2	pathways	pathway	I-NP	NNS	O	12	SUB
3	for	for	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	8	NMOD
5	guanine	guanine	I-NP	NN	B-protein	8	NMOD
6	nucleotide	nucleotide	I-NP	NN	I-protein	8	NMOD
7	binding	binding	I-NP	NN	I-protein	8	NMOD
8	protein	protein	I-NP	NN	I-protein	3	PMOD
9	in	in	B-PP	IN	O	2	NMOD
10	T	T	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	are	be	B-VP	VBP	O	0	ROOT
13	mediated	mediate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	serine/threonine	serine/threonine	I-NP	NN	B-protein	18	NMOD
17	kinase	kinase	I-NP	NN	I-protein	18	NMOD
18	Raf-1	Raf-1	I-NP	NN	B-protein	23	NMOD
19	and	and	O	CC	O	23	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	Ras-related	Ras-related	I-NP	JJ	B-protein	23	NMOD
22	GTPase	GTPase	I-NP	NN	I-protein	23	NMOD
23	Rac-1	Rac-1	I-NP	NN	B-protein	14	PMOD
24	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	11	VMOD
2	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	1	PMOD
3	,	,	O	,	O	11	P
4	an	an	B-NP	DT	O	6	NMOD
5	important	important	I-NP	JJ	O	6	NMOD
6	effector	effector	I-NP	NN	O	11	SUB
7	for	for	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	Ras	Ras	I-NP	NN	B-DNA	10	NMOD
10	oncogene	oncogene	I-NP	NN	I-DNA	7	PMOD
11	is	be	B-VP	VBZ	O	0	ROOT
12	Phosphatidylinositol	Phosphatidylinositol	B-NP	NN	B-protein	13	NMOD
13	3-kinase	3-kinase	I-NP	NN	I-protein	11	PRD
14	(	(	O	(	O	16	P
15	PtdIns	PtdIns	B-NP	NN	B-protein	16	NMOD
16	3-kinase	3-kinase	I-NP	NN	I-protein	13	NMOD
17	)	)	O	)	O	16	P
18	.	.	O	.	O	11	P

1	Activation	Activation	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	this	this	B-NP	DT	O	5	NMOD
4	lipid	lipid	I-NP	NN	B-protein	5	NMOD
5	kinase	kinase	I-NP	NN	I-protein	2	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	able	able	B-ADJP	JJ	O	6	PRD
8	to	to	B-VP	TO	O	9	VMOD
9	induce	induce	I-VP	VB	O	7	AMOD
10	critical	critical	B-NP	JJ	O	13	NMOD
11	Rac-1	Rac-1	I-NP	NN	B-protein	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathways	pathway	I-NP	NNS	O	9	OBJ
14	and	and	O	CC	O	6	VMOD
15	can	can	B-VP	MD	O	6	VMOD
16	couple	couple	I-VP	VB	O	15	VC
17	p21ras	p21ras	B-NP	NN	B-protein	16	OBJ
18	to	to	B-PP	TO	O	16	VMOD
19	cell	cell	B-NP	NN	O	21	NMOD
20	survival	survival	I-NP	NN	O	21	NMOD
21	mechanisms	mechanism	I-NP	NNS	O	18	PMOD
22	via	via	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	serine/threonine	serine/threonine	I-NP	NN	B-protein	26	NMOD
25	kinase	kinase	I-NP	NN	I-protein	26	NMOD
26	Akt/PKB	Akt/PKB	I-NP	NN	I-protein	22	PMOD
27	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	PtdIns	PtdIns	B-NP	NN	B-protein	5	NMOD
5	3-kinase	3-kinase	I-NP	NN	I-protein	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	Ras	Ras	B-NP	NN	B-protein	8	NMOD
8	signaling	signaling	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	T	T	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	has	have	B-VP	VBZ	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	been	be	I-VP	VBN	O	12	VC
15	explored	explore	I-VP	VBN	O	14	VC
16	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	7	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	present	present	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	examined	examine	B-VP	VBD	O	0	ROOT
8	the	the	B-NP	DT	O	9	NMOD
9	ability	ability	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	PtdIns	PtdIns	B-NP	NN	B-protein	12	NMOD
12	3-kinase	3-kinase	I-NP	NN	I-protein	10	PMOD
13	to	to	B-VP	TO	O	14	VMOD
14	initiate	initiate	I-VP	VB	O	9	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	Rac-1	Rac-1	I-NP	NN	B-protein	18	NMOD
17	signaling	signaling	I-NP	NN	O	18	NMOD
18	pathways	pathway	I-NP	NNS	O	14	OBJ
19	important	important	B-ADJP	JJ	O	18	NMOD
20	for	for	B-PP	IN	O	19	AMOD
21	T	T	B-NP	NN	O	23	NMOD
22	cell	cell	I-NP	NN	O	23	NMOD
23	activation	activation	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	examined	examine	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	possibility	possibility	I-NP	NN	O	3	OBJ
6	that	that	B-SBAR	IN	O	5	NMOD
7	Akt/PKB	Akt/PKB	B-NP	NN	B-protein	8	SUB
8	is	be	B-VP	VBZ	O	6	SBAR
9	regulated	regulate	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	Ras	Ras	B-NP	NN	B-protein	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathways	pathway	I-NP	NNS	O	10	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	T	T	B-NP	NN	B-cell_type	16	NMOD
16	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	14	PMOD
17	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Ras	Ras	B-NP	NN	B-protein	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	initiate	initiate	I-VP	VB	O	6	VC
8	a	a	B-NP	DT	O	9	NMOD
9	Rac-1	Rac-1	I-NP	NN	B-protein	11	NMOD
10	mediated	mediate	I-NP	VBN	O	11	NMOD
11	pathway	pathway	I-NP	NN	O	7	OBJ
12	that	that	B-NP	WDT	O	11	NMOD
13	regulates	regulate	B-VP	VBZ	O	12	SBAR
14	the	the	B-NP	DT	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	function	function	I-NP	NN	O	13	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	AP-1	AP-1	B-NP	NN	B-protein	19	NMOD
19	complexes	complex	I-NP	NNS	I-protein	17	PMOD
20	.	.	O	.	O	3	P

1	PtdIns	PtdIns	B-NP	NN	B-protein	3	NMOD
2	3-kinase	3-kinase	I-NP	NN	I-protein	3	NMOD
3	signals	signal	I-NP	NNS	O	4	SUB
4	can	can	B-VP	MD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	mimic	mimic	I-VP	VB	O	4	VC
7	p21ras	p21ras	B-NP	NN	B-protein	6	OBJ
8	and	and	O	CC	O	6	VMOD
9	induce	induce	B-VP	VB	O	6	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	Rac	Rac	I-NP	NN	B-protein	13	NMOD
12	mediated	mediate	B-VP	VBN	O	13	NMOD
13	responses	response	B-NP	NNS	O	9	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	AP-1	AP-1	B-NP	NN	B-protein	17	NMOD
16	transcriptional	transcriptional	I-NP	JJ	O	17	NMOD
17	activation	activation	I-NP	NN	O	14	PMOD
18	.	.	O	.	O	4	P

1	Moreover	Moreover	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	neither	neither	O	CC	O	6	NMOD
4	TCR	TCR	B-NP	NN	B-protein	6	NMOD
5	or	or	I-NP	CC	O	6	NMOD
6	Ras	Ras	I-NP	NN	B-protein	7	NMOD
7	activation	activation	I-NP	NN	O	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	AP-1	AP-1	B-NP	NN	B-protein	8	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	dependent	dependent	B-ADJP	JJ	O	10	PRD
12	on	on	B-PP	IN	O	11	AMOD
13	PtdIns	PtdIns	B-NP	NN	B-protein	14	NMOD
14	3-kinase	3-kinase	I-NP	NN	I-protein	12	PMOD
15	.	.	O	.	O	10	P

1	PKB	PKB	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	activated	activate	I-VP	VBN	O	2	VC
4	in	in	B-PP	IN	O	3	VMOD
5	response	response	I-PP	NN	O	4	PMOD
6	to	to	I-PP	TO	O	5	NMOD
7	triggering	triggering	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	T	T	I-NP	NN	B-protein	13	NMOD
11	cell	cell	I-NP	NN	I-protein	13	NMOD
12	antigen	antigen	I-NP	NN	I-protein	13	NMOD
13	receptor	receptor	I-NP	NN	I-protein	8	PMOD
14	;	;	O	:	O	2	P
15	PtdIns	PtdIns	B-NP	NN	B-protein	17	NMOD
16	3-kinase	3-kinase	I-NP	NN	I-protein	17	NMOD
17	activity	activity	I-NP	NN	O	18	SUB
18	is	be	B-VP	VBZ	O	2	VMOD
19	both	both	I-VP	CC	O	18	VMOD
20	required	require	I-VP	VBN	O	19	VC
21	and	and	O	CC	O	20	VMOD
22	sufficient	sufficient	B-ADJP	JJ	O	21	PRD
23	for	for	B-PP	IN	O	22	AMOD
24	this	this	B-NP	DT	O	26	NMOD
25	TCR	TCR	I-NP	NN	B-protein	26	NMOD
26	response	response	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	p21ras	p21ras	B-NP	NN	B-protein	5	NMOD
5	signals	signal	I-NP	NNS	O	6	SUB
6	are	be	B-VP	VBP	O	16	VMOD
7	unable	unable	B-ADJP	JJ	O	6	PRD
8	to	to	B-VP	TO	O	9	VMOD
9	induce	induce	I-VP	VB	O	7	AMOD
10	Akt/PKB	Akt/PKB	B-NP	NN	B-protein	11	NMOD
11	activity	activity	I-NP	NN	O	9	OBJ
12	in	in	B-PP	IN	O	9	VMOD
13	T	T	B-NP	NN	B-cell_type	14	NMOD
14	cell	cell	I-NP	NN	I-cell_type	12	PMOD
15	nor	nor	O	CC	O	6	VMOD
16	is	be	B-VP	VBZ	O	0	ROOT
17	Ras	Ras	B-NP	NN	B-protein	18	NMOD
18	function	function	I-NP	NN	O	16	PRD
19	required	require	B-VP	VBN	O	18	NMOD
20	for	for	B-PP	IN	O	19	VMOD
21	Akt/PKB	Akt/PKB	B-NP	NN	B-protein	22	NMOD
22	activation	activation	I-NP	NN	O	20	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	response	response	B-NP	NN	O	23	PMOD
25	to	to	B-PP	TO	O	24	NMOD
26	the	the	B-NP	DT	O	27	NMOD
27	TCR	TCR	I-NP	NN	B-protein	25	PMOD
28	.	.	O	.	O	16	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	data	datum	I-NP	NNS	O	5	SUB
4	thus	thus	B-ADVP	RB	O	5	VMOD
5	highlight	highlight	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	PtdIns	PtdIns	B-NP	NN	B-protein	8	NMOD
8	3-kinase	3-kinase	I-NP	NN	I-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	Akt/PKB	Akt/PKB	I-NP	NN	B-protein	11	SUB
11	are	be	B-VP	VBP	O	6	SBAR
12	not	not	O	RB	O	11	VMOD
13	universal	universal	B-NP	JJ	O	16	NMOD
14	Ras	Ras	I-NP	NN	B-protein	16	NMOD
15	effector	effector	I-NP	NN	I-protein	16	NMOD
16	molecules	molecule	I-NP	NNS	I-protein	11	PRD
17	.	.	O	.	O	5	P

1	Ras	Ras	B-NP	NN	B-protein	2	SUB
2	can	can	B-VP	MD	O	0	ROOT
3	initiate	initiate	I-VP	VB	O	2	VC
4	Rac-1	Rac-1	B-NP	NN	B-protein	7	NMOD
5	regulated	regulated	I-NP	JJ	O	7	NMOD
6	signaling	signaling	I-NP	NN	O	7	NMOD
7	pathways	pathway	I-NP	NNS	O	3	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	context	context	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	T	T	B-NP	NN	B-protein	16	NMOD
13	cell	cell	I-NP	NN	I-protein	16	NMOD
14	antigen	antigen	I-NP	NN	I-protein	16	NMOD
15	receptor	receptor	I-NP	NN	I-protein	16	NMOD
16	function	function	I-NP	NN	O	11	PMOD
17	independently	independently	B-ADVP	RB	O	7	NMOD
18	of	of	B-PP	IN	O	17	AMOD
19	PtdIns	PtdIns	B-NP	NN	B-protein	21	NMOD
20	3-kinase	3-kinase	I-NP	NN	I-protein	21	NMOD
21	activity	activity	I-NP	NN	O	18	PMOD
22	.	.	O	.	O	2	P

1	Signal	Signal	B-NP	NN	O	3	NMOD
2	transduction	transduction	I-NP	NN	O	3	NMOD
3	abnormalities	abnormality	I-NP	NNS	O	17	NMOD
4	in	in	B-PP	IN	O	3	NMOD
5	T	T	B-NP	NN	B-cell_type	6	NMOD
6	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	4	PMOD
7	from	from	B-PP	IN	O	6	NMOD
8	patients	patient	B-NP	NNS	O	7	PMOD
9	with	with	B-PP	IN	O	8	NMOD
10	advanced	advance	B-NP	VBN	O	12	NMOD
11	renal	renal	I-NP	JJ	O	12	NMOD
12	carcinoma	carcinoma	I-NP	NN	O	9	PMOD
13	:	:	O	:	O	3	P
14	clinical	clinical	B-NP	JJ	O	15	NMOD
15	relevance	relevance	I-NP	NN	O	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	effects	effect	B-NP	NNS	O	0	ROOT
18	of	of	B-PP	IN	O	17	NMOD
19	cytokine	cytokine	B-NP	NN	B-protein	20	NMOD
20	therapy	therapy	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	17	P

1	Studies	Study	B-NP	NNS	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	demonstrated	demonstrate	I-VP	VBN	O	2	VC
4	abnormalities	abnormality	B-NP	NNS	O	3	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	CD3/T-cell	CD3/T-cell	I-NP	NN	B-protein	9	NMOD
8	antigen	antigen	I-NP	NN	I-protein	9	NMOD
9	receptor	receptor	I-NP	NN	I-protein	14	NMOD
10	(	(	O	(	O	11	P
11	TCR	TCR	B-NP	NN	B-protein	9	NMOD
12	)	)	O	)	O	11	P
13	and	and	O	CC	O	14	NMOD
14	pathways	pathway	B-NP	NNS	O	5	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	signal	signal	B-NP	NN	O	17	NMOD
17	transduction	transduction	I-NP	NN	O	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	T	T	B-NP	NN	B-cell_type	20	NMOD
20	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	18	PMOD
21	from	from	B-PP	IN	O	20	NMOD
22	animals	animal	B-NP	NNS	O	24	NMOD
23	and	and	O	CC	O	24	NMOD
24	patients	patient	B-NP	NNS	O	21	PMOD
25	with	with	B-PP	IN	O	24	NMOD
26	advanced	advanced	B-NP	JJ	O	27	NMOD
27	malignancy	malignancy	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	2	P

1	Diminished	Diminish	B-NP	VBN	O	2	NMOD
2	expression	expression	I-NP	NN	O	30	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	TCRzeta	TCRzeta	B-NP	NN	B-protein	3	PMOD
5	and	and	O	CC	O	6	NMOD
6	p56	p56	B-NP	NN	B-protein	4	NMOD
7	(	(	O	(	I-protein	8	P
8	lck	lck	B-NP	NN	I-protein	6	NMOD
9	)	)	O	)	I-protein	8	P
10	that	that	B-NP	WDT	O	2	NMOD
11	are	be	B-VP	VBP	O	10	SBAR
12	associated	associate	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	19	NMOD
15	TCR	TCR	I-NP	NN	B-protein	19	NMOD
16	and	and	O	CC	O	19	NMOD
17	reduced	reduce	B-NP	VBN	O	19	NMOD
18	nuclear	nuclear	I-NP	JJ	O	19	NMOD
19	localization	localization	I-NP	NN	O	13	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	RelA	RelA	B-NP	NN	B-protein	20	PMOD
22	containing	contain	B-VP	VBG	O	21	NMOD
23	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD
24	factor	factor	I-NP	NN	I-protein	25	NMOD
25	kappaB	kappaB	I-NP	NN	I-protein	29	NMOD
26	(	(	O	(	O	27	P
27	NFkappaB	NFkappaB	B-NP	NN	B-protein	25	NMOD
28	)	)	O	)	O	27	P
29	complexes	complex	B-NP	NNS	O	22	OBJ
30	have	have	B-VP	VBP	O	0	ROOT
31	been	be	I-VP	VBN	O	30	VC
32	noted	note	I-VP	VBN	O	31	VC
33	.	.	O	.	O	30	P

1	These	These	B-NP	DT	O	2	NMOD
2	defects	defect	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	been	be	I-VP	VBN	O	3	VC
5	described	describe	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	T	T	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
9	from	from	B-PP	IN	O	8	NMOD
10	patients	patient	B-NP	NNS	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	malignant	malignant	B-NP	JJ	O	13	NMOD
13	melanoma	melanoma	I-NP	NN	O	17	NMOD
14	,	,	O	,	O	17	P
15	renal	renal	B-NP	JJ	O	17	NMOD
16	cell	cell	I-NP	NN	O	17	NMOD
17	carcinoma	carcinoma	I-NP	NN	O	27	NMOD
18	(	(	O	(	O	19	P
19	RCC	RCC	B-NP	NN	O	17	NMOD
20	)	)	O	)	O	19	P
21	,	,	O	,	O	27	P
22	ovarian	ovarian	B-NP	JJ	O	23	NMOD
23	cancer	cancer	I-NP	NN	O	27	NMOD
24	,	,	O	,	O	27	P
25	and	and	O	CC	O	27	NMOD
26	colorectal	colorectal	B-NP	JJ	O	27	NMOD
27	cancer	cancer	I-NP	NN	O	11	PMOD
28	.	.	O	.	O	3	P

1	Preliminary	Preliminary	B-NP	JJ	O	2	NMOD
2	observations	observation	I-NP	NNS	O	4	SUB
3	also	also	B-ADVP	RB	O	4	VMOD
4	indicate	indicate	B-VP	VBP	O	0	ROOT
5	possible	possible	B-NP	JJ	O	6	NMOD
6	correlation	correlation	I-NP	NN	O	4	OBJ
7	with	with	B-PP	IN	O	6	NMOD
8	clinical	clinical	B-NP	JJ	O	9	NMOD
9	variables	variable	I-NP	NNS	O	7	PMOD
10	such	such	B-PP	JJ	O	11	PMOD
11	as	as	I-PP	IN	O	9	NMOD
12	stage	stage	B-NP	NN	O	11	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	selected	select	B-NP	VBN	O	15	NMOD
15	instances	instance	I-NP	NNS	O	13	PMOD
16	.	.	O	.	O	4	P

1	To	To	B-VP	TO	O	3	VMOD
2	further	further	I-VP	RB	O	3	VMOD
3	characterize	characterize	I-VP	VB	O	22	VMOD
4	altered	altered	B-NP	JJ	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	TCRzeta	TCRzeta	B-NP	NN	B-protein	16	NMOD
8	,	,	O	,	O	16	P
9	p56	p56	B-NP	NN	B-protein	16	NMOD
10	(	(	O	(	I-protein	11	P
11	lck	lck	B-NP	NN	I-protein	9	NMOD
12	)	)	O	)	I-protein	11	P
13	,	,	O	,	O	16	P
14	and	and	O	CC	O	16	NMOD
15	impaired	impaired	B-NP	JJ	O	16	NMOD
16	activation	activation	I-NP	NN	O	6	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	NFkappaB	NFkappaB	B-NP	NN	B-protein	17	PMOD
19	,	,	O	,	O	22	P
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	22	SUB
22	were	be	B-VP	VBD	O	34	VMOD
23	obtained	obtain	I-VP	VBN	O	22	VC
24	from	from	B-PP	IN	O	23	VMOD
25	65	65	B-NP	CD	O	26	NMOD
26	patients	patient	I-NP	NNS	O	24	PMOD
27	with	with	B-PP	IN	O	26	NMOD
28	RCC	RCC	B-NP	NN	O	27	PMOD
29	,	,	O	,	O	22	P
30	the	the	B-NP	DT	O	31	NMOD
31	majority	majority	I-NP	NN	O	34	SUB
32	of	of	B-PP	IN	O	31	NMOD
33	whom	whom	B-NP	WP	O	32	PMOD
34	were	be	B-VP	VBD	O	0	ROOT
35	receiving	receive	I-VP	VBG	O	34	VC
36	combination	combination	B-NP	NN	O	38	NMOD
37	cytokine	cytokine	I-NP	NN	B-protein	38	NMOD
38	therapy	therapy	I-NP	NN	O	35	OBJ
39	[	[	O	(	O	48	P
40	interleukin	interleukin	B-NP	NN	B-protein	42	NMOD
41	(	(	O	(	I-protein	42	P
42	IL	IL	B-NP	NN	I-protein	44	NMOD
43	)	)	O	)	I-protein	42	P
44	-2	-2	B-NP	CD	I-protein	48	NMOD
45	,	,	O	,	O	48	P
46	IFN	IFN	B-NP	NN	B-protein	48	NMOD
47	alpha-containing	alpha-containing	I-NP	JJ	O	48	NMOD
48	regimens	regimen	I-NP	NNS	O	53	NMOD
49	]	]	O	)	O	48	P
50	and	and	O	CC	O	53	NMOD
51	37	37	B-NP	CD	O	53	NMOD
52	control	control	I-NP	JJ	O	53	NMOD
53	individuals	individual	I-NP	NNS	O	34	PRD
54	.	.	O	.	O	34	P

1	In	In	B-PP	IN	O	15	VMOD
2	29	29	B-NP	CD	O	1	PMOD
3	of	of	B-PP	IN	O	2	NMOD
4	these	these	B-NP	DT	O	5	NMOD
5	patients	patient	I-NP	NNS	O	3	PMOD
6	,	,	O	,	O	15	P
7	levels	level	B-NP	NNS	O	15	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	TCRzeta	TCRzeta	B-NP	NN	B-protein	13	NMOD
10	and	and	O	CC	O	13	NMOD
11	p56	p56	B-NP	NN	B-protein	13	NMOD
12	(	(	O	(	I-protein	13	P
13	lck	lck	B-NP	NN	I-protein	8	PMOD
14	)	)	O	)	I-protein	13	P
15	were	be	B-VP	VBD	O	0	ROOT
16	determined	determine	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	Western	Western	B-NP	JJ	O	19	NMOD
19	blots	blot	I-NP	NNS	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	T-cell	T-cell	B-NP	NN	O	22	NMOD
22	lysates	lysate	I-NP	NNS	O	20	PMOD
23	and	and	O	CC	O	16	VMOD
24	semiquantitated	semiquantitate	B-VP	VBN	O	16	VMOD
25	using	use	B-VP	VBG	O	24	VMOD
26	densitometry	densitometry	B-NP	NN	O	25	OBJ
27	.	.	O	.	O	15	P

1	Relative	Relative	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	then	then	I-VP	RB	O	3	VMOD
5	correlated	correlate	I-VP	VBN	O	3	VC
6	with	with	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	8	NMOD
8	series	series	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	clinical	clinical	B-NP	JJ	O	11	NMOD
11	variables	variable	I-NP	NNS	O	9	PMOD
12	including	include	B-PP	VBG	O	11	NMOD
13	response	response	B-NP	NN	O	12	PMOD
14	to	to	B-PP	TO	O	13	NMOD
15	therapy	therapy	B-NP	NN	O	28	NMOD
16	,	,	O	,	O	28	P
17	performance	performance	B-NP	NN	O	18	NMOD
18	status	status	I-NP	NN	O	28	NMOD
19	,	,	O	,	O	28	P
20	survival	survival	B-NP	NN	O	28	NMOD
21	,	,	O	,	O	28	P
22	disease	disease	B-NP	NN	O	23	NMOD
23	sites	site	I-NP	NNS	O	28	NMOD
24	,	,	O	,	O	28	P
25	age	age	B-NP	NN	O	28	NMOD
26	,	,	O	,	O	28	P
27	and	and	O	CC	O	28	NMOD
28	others	other	B-NP	NNS	O	14	PMOD
29	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	22	VMOD
2	another	another	B-NP	DT	O	3	NMOD
3	group	group	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	28	28	B-NP	CD	O	6	NMOD
6	patients	patient	I-NP	NNS	O	4	PMOD
7	(	(	O	(	O	22	P
8	three	three	B-NP	CD	O	9	NMOD
9	individuals	individual	I-NP	NNS	O	22	VMOD
10	from	from	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	first	first	I-NP	JJ	O	13	NMOD
13	group	group	I-NP	NN	O	10	PMOD
14	)	)	O	)	O	9	P
15	,	,	O	,	O	22	P
16	the	the	B-NP	DT	O	17	NMOD
17	frequency	frequency	I-NP	NN	O	22	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	abnormal	abnormal	B-NP	JJ	O	21	NMOD
20	NFkappaB	NFkappaB	I-NP	NN	B-protein	21	NMOD
21	activation	activation	I-NP	NN	O	18	PMOD
22	was	be	B-VP	VBD	O	0	ROOT
23	studied	study	I-VP	VBN	O	22	VC
24	using	use	B-VP	VBG	O	23	VMOD
25	electrophoretic	electrophoretic	B-NP	JJ	O	28	NMOD
26	mobility	mobility	I-NP	NN	O	28	NMOD
27	shift	shift	I-NP	NN	O	28	NMOD
28	assays	assay	I-NP	NNS	O	24	OBJ
29	after	after	B-PP	IN	O	24	VMOD
30	activation	activation	B-NP	NN	O	29	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	T	T	B-NP	NN	B-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD
34	with	with	B-PP	IN	O	30	NMOD
35	phorbol	phorbol	B-NP	NN	O	37	NMOD
36	myristate	myristate	I-NP	NN	O	37	NMOD
37	acetate/ionomycin	acetate/ionomycin	I-NP	NN	O	41	NMOD
38	or	or	O	CC	O	41	NMOD
39	anti-CD3	anti-CD3	B-NP	JJ	B-protein	41	NMOD
40	monoclonal	monoclonal	I-NP	JJ	I-protein	41	NMOD
41	antibody	antibody	I-NP	NN	I-protein	34	PMOD
42	.	.	O	.	O	22	P

1	Changes	Change	B-NP	NNS	O	9	SUB
2	in	in	B-PP	IN	O	1	NMOD
3	these	these	B-NP	DT	O	5	NMOD
4	signaling	signal	I-NP	VBG	B-protein	5	NMOD
5	molecules	molecule	I-NP	NNS	I-protein	2	PMOD
6	during	during	B-PP	IN	O	1	NMOD
7	cytokine	cytokine	B-NP	NN	B-protein	8	NMOD
8	treatment	treatment	I-NP	NN	O	6	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	also	also	I-VP	RB	O	9	VMOD
11	investigated	investigate	I-VP	VBN	O	9	VC
12	.	.	O	.	O	9	P

1	TCRzeta	TCRzeta	B-NP	NN	B-protein	7	SUB
2	and	and	I-NP	CC	O	7	VMOD
3	p56	p56	I-NP	NN	B-protein	7	SUB
4	(	(	O	(	I-protein	5	P
5	lck	lck	B-NP	NN	I-protein	3	NMOD
6	)	)	O	)	I-protein	5	P
7	were	be	B-VP	VBD	O	26	VMOD
8	detected	detect	I-VP	VBN	O	7	VC
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	14	NMOD
11	peripheral	peripheral	I-NP	JJ	B-cell_type	14	NMOD
12	blood	blood	I-NP	NN	I-cell_type	14	NMOD
13	T	T	I-NP	NN	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
15	in	in	B-PP	IN	O	8	VMOD
16	27	27	B-NP	CD	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	29	29	B-NP	CD	O	19	NMOD
19	patients	patient	I-NP	NNS	O	17	PMOD
20	,	,	O	,	O	26	P
21	and	and	O	CC	O	26	VMOD
22	overall	overall	B-ADVP	RB	O	26	VMOD
23	,	,	O	,	O	26	P
24	reduced	reduce	B-NP	VBN	O	25	NMOD
25	levels	level	I-NP	NNS	O	26	SUB
26	were	be	B-VP	VBD	O	0	ROOT
27	noted	note	I-VP	VBN	O	26	VC
28	visually	visually	B-ADVP	RB	O	27	VMOD
29	in	in	B-PP	IN	O	27	VMOD
30	12	12	B-NP	CD	O	31	AMOD
31	of	of	B-PP	IN	O	29	PMOD
32	29	29	B-NP	CD	O	38	NMOD
33	(	(	O	(	O	35	P
34	41	41	B-NP	CD	O	35	NMOD
35	%	%	I-NP	NN	O	32	NMOD
36	)	)	O	)	O	35	P
37	and	and	O	CC	O	38	NMOD
38	13	13	B-NP	CD	O	29	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	29	29	B-NP	CD	O	45	NMOD
41	(	(	O	(	O	43	P
42	45	45	B-NP	CD	O	43	NMOD
43	%	%	I-NP	NN	O	40	NMOD
44	)	)	O	)	O	43	P
45	individuals	individual	B-NP	NNS	O	39	PMOD
46	,	,	O	,	O	38	P
47	respectively	respectively	B-ADVP	RB	O	38	NMOD
48	.	.	O	.	O	26	P

1	When	When	B-ADVP	WRB	O	41	VMOD
2	levels	level	B-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	1	SBAR
4	semiquantitated	semiquantitate	I-VP	VBN	O	3	VC
5	using	use	B-VP	VBG	O	4	VMOD
6	densitometry	densitometry	B-NP	NN	O	9	NMOD
7	,	,	O	,	O	9	P
8	significant	significant	B-NP	JJ	O	9	NMOD
9	decreases	decrease	I-NP	NNS	O	5	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	TCRzeta	TCRzeta	B-NP	NN	B-protein	29	NMOD
12	(	(	O	(	O	13	P
13	P	P	B-NP	NN	O	11	NMOD
14	=	=	B-VP	SYM	O	13	NMOD
15	0.029	0.029	B-NP	CD	O	14	AMOD
16	)	)	O	)	O	13	P
17	and	and	O	CC	O	29	NMOD
18	p56	p56	B-NP	NN	B-protein	29	NMOD
19	(	(	O	(	I-protein	20	P
20	lck	lck	B-NP	NN	I-protein	18	NMOD
21	)	)	O	)	I-protein	20	P
22	(	(	O	(	O	23	P
23	P	P	B-NP	NN	O	18	NMOD
24	=	=	B-VP	SYM	O	23	NMOD
25	0.029	0.029	B-NP	CD	O	24	AMOD
26	)	)	O	)	O	23	P
27	but	but	B-NP	CC	O	29	NMOD
28	not	not	I-NP	RB	O	27	DEP
29	CD3epsilon	CD3epsilon	B-NP	NN	B-protein	10	PMOD
30	(	(	O	(	O	31	P
31	P	P	B-NP	NN	O	29	NMOD
32	=	=	B-VP	SYM	O	31	NMOD
33	0.131	0.131	B-NP	CD	O	32	AMOD
34	)	)	O	)	O	31	P
35	,	,	O	,	O	29	P
36	compared	compare	B-PP	VBN	O	9	NMOD
37	with	with	B-PP	IN	O	36	VMOD
38	control	control	B-NP	NN	O	39	NMOD
39	levels	level	I-NP	NNS	O	37	PMOD
40	,	,	O	,	O	41	P
41	were	be	B-VP	VBD	O	0	ROOT
42	found	find	I-VP	VBN	O	41	VC
43	.	.	O	.	O	41	P

1	In	In	B-PP	IN	O	13	VMOD
2	patients	patient	B-NP	NNS	O	1	PMOD
3	treated	treat	B-VP	VBN	O	2	NMOD
4	with	with	B-PP	IN	O	3	VMOD
5	IL-2/IFN	IL-2/IFN	B-NP	NN	B-protein	7	NMOD
6	alpha-based	alpha-based	I-NP	JJ	O	7	NMOD
7	therapy	therapy	I-NP	NN	O	4	PMOD
8	,	,	O	,	O	13	P
9	relative	relative	B-NP	JJ	O	10	NMOD
10	levels	level	I-NP	NNS	O	13	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	TCRzeta	TCRzeta	B-NP	NN	B-protein	11	PMOD
13	increased	increase	B-VP	VBD	O	0	ROOT
14	significantly	significantly	B-ADVP	RB	O	13	VMOD
15	(	(	O	(	O	16	P
16	P	P	B-NP	NN	O	13	OBJ
17	=	=	B-VP	SYM	O	16	NMOD
18	0.002	0.002	B-NP	CD	O	17	AMOD
19	)	)	O	)	O	16	P
20	on	on	B-PP	IN	O	16	NMOD
21	day	day	B-NP	NN	O	20	PMOD
22	15	15	I-NP	CD	O	21	NMOD
23	of	of	B-PP	IN	O	21	NMOD
24	cycle	cycle	B-NP	NN	O	23	PMOD
25	one	one	I-NP	CD	O	24	NMOD
26	compared	compare	B-PP	VBN	O	13	VMOD
27	with	with	B-PP	IN	O	26	PMOD
28	the	the	B-NP	DT	O	29	NMOD
29	baseline	baseline	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	13	P

1	Correlations	Correlation	B-NP	NNS	O	33	VMOD
2	of	of	B-PP	IN	O	1	NMOD
3	TCRzeta	TCRzeta	B-NP	NN	B-protein	9	NMOD
4	or	or	O	CC	O	9	NMOD
5	p56	p56	B-NP	NN	B-protein	9	NMOD
6	(	(	O	(	I-protein	7	P
7	lck	lck	B-NP	NN	I-protein	5	NMOD
8	)	)	O	)	I-protein	7	P
9	levels	level	B-NP	NNS	O	2	PMOD
10	with	with	B-PP	IN	O	1	NMOD
11	response	response	B-NP	NN	O	14	NMOD
12	or	or	I-NP	CC	O	14	NMOD
13	disease	disease	I-NP	NN	O	14	NMOD
14	variables	variable	I-NP	NNS	O	10	PMOD
15	,	,	O	,	O	1	P
16	except	except	B-PP	IN	O	1	NMOD
17	for	for	B-PP	IN	O	16	PMOD
18	lower	low	B-NP	JJR	O	20	NMOD
19	TCRzeta	TCRzeta	I-NP	NN	B-protein	20	NMOD
20	levels	level	I-NP	NNS	O	17	PMOD
21	(	(	O	(	O	33	P
22	P	P	B-NP	NN	O	33	SUB
23	<	<	O	SYM	O	22	NMOD
24	0.001	0.001	B-NP	CD	O	23	AMOD
25	)	)	O	)	O	33	P
26	in	in	B-PP	IN	O	33	VMOD
27	the	the	I-PP	DT	O	26	PMOD
28	presence	presence	I-PP	NN	O	26	PMOD
29	of	of	I-PP	IN	O	26	PMOD
30	bone	bone	B-NP	NN	B-protein	31	NMOD
31	metastases	metastasis	I-NP	NNS	I-protein	26	PMOD
32	,	,	O	,	O	33	P
33	were	be	B-VP	VBD	O	0	ROOT
34	not	not	I-VP	RB	O	33	VMOD
35	found	find	I-VP	VBN	O	33	VC
36	.	.	O	.	O	33	P

1	Abnormal	Abnormal	B-NP	JJ	O	3	NMOD
2	NFkappaB	NFkappaB	I-NP	NN	B-protein	3	NMOD
3	activation	activation	I-NP	NN	O	14	SUB
4	after	after	B-PP	IN	O	3	NMOD
5	stimulation	stimulation	B-NP	NN	O	4	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	phorbol	phorbol	B-NP	NN	O	9	NMOD
8	myristate	myristate	I-NP	NN	O	9	NMOD
9	acetate/ionomycin	acetate/ionomycin	I-NP	NN	O	13	NMOD
10	and/or	and/or	O	CC	O	13	NMOD
11	anti-CD3	anti-CD3	B-NP	JJ	B-protein	13	NMOD
12	monoclonal	monoclonal	I-NP	JJ	I-protein	13	NMOD
13	antibody	antibody	I-NP	NN	I-protein	6	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	found	find	I-VP	VBN	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	59	59	B-NP	CD	O	18	NMOD
18	%	%	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	patients	patient	B-NP	NNS	O	19	PMOD
21	(	(	O	(	O	22	P
22	17	17	B-NP	CD	O	20	NMOD
23	of	of	B-PP	IN	O	22	NMOD
24	28	28	B-NP	CD	O	23	PMOD
25	)	)	O	)	O	22	P
26	and	and	O	CC	O	14	VMOD
27	was	be	B-VP	VBD	O	14	VMOD
28	not	not	I-VP	RB	O	27	VMOD
29	accounted	account	I-VP	VBN	O	27	VC
30	for	for	B-PP	IN	O	29	VMOD
31	by	by	B-PP	IN	O	30	PMOD
32	the	the	B-NP	DT	O	34	NMOD
33	advanced	advanced	I-NP	JJ	O	34	NMOD
34	age	age	I-NP	NN	O	31	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	study	study	I-NP	NN	O	38	NMOD
38	cohort	cohort	I-NP	NN	O	35	PMOD
39	.	.	O	.	O	14	P

1	Activation	Activation	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	NFkappaB	NFkappaB	B-NP	NN	B-protein	2	PMOD
4	in	in	B-PP	IN	O	1	NMOD
5	peripheral	peripheral	B-NP	JJ	B-cell_type	8	NMOD
6	blood	blood	I-NP	NN	I-cell_type	8	NMOD
7	T	T	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
9	was	be	B-VP	VBD	O	0	ROOT
10	inducible	inducible	B-ADJP	JJ	O	9	PRD
11	during	during	B-PP	IN	O	9	VMOD
12	cytokine	cytokine	B-NP	NN	B-protein	13	NMOD
13	therapy	therapy	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	four	four	B-NP	CD	O	14	PMOD
16	of	of	I-NP	IN	O	15	NMOD
17	six	six	I-NP	CD	O	18	NMOD
18	individuals	individual	I-NP	NNS	O	16	PMOD
19	who	who	B-NP	WP	O	13	NMOD
20	displayed	display	B-VP	VBD	O	19	SBAR
21	impaired	impaired	B-NP	JJ	O	23	NMOD
22	NFkappaB	NFkappaB	I-NP	NN	B-protein	23	NMOD
23	activity	activity	I-NP	NN	O	20	OBJ
24	prior	prior	B-ADVP	RB	O	25	PMOD
25	to	to	B-PP	TO	O	20	VMOD
26	therapy	therapy	B-NP	NN	O	25	PMOD
27	.	.	O	.	O	9	P

1	Moreover	Moreover	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	impaired	impaired	B-NP	JJ	O	4	NMOD
4	activation	activation	I-NP	NN	O	7	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	NFkappaB	NFkappaB	B-NP	NN	B-protein	5	PMOD
7	does	do	B-VP	VBZ	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	appear	appear	I-VP	VB	O	7	VC
10	linked	link	I-VP	VBN	O	9	VC
11	to	to	B-PP	TO	O	10	VMOD
12	a	a	B-NP	DT	O	13	NMOD
13	reduction	reduction	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	TCRzeta	TCRzeta	B-NP	NN	B-protein	16	NMOD
16	expression	expression	I-NP	NN	O	14	PMOD
17	,	,	O	,	O	10	P
18	because	because	B-SBAR	IN	O	10	VMOD
19	in	in	B-PP	IN	O	26	VMOD
20	five	five	B-NP	CD	O	21	NMOD
21	patients	patient	I-NP	NNS	O	19	PMOD
22	,	,	O	,	O	26	P
23	normal	normal	B-NP	JJ	O	25	NMOD
24	TCRzeta	TCRzeta	I-NP	NN	B-protein	25	NMOD
25	levels	level	I-NP	NNS	O	26	SUB
26	were	be	B-VP	VBD	O	18	SBAR
27	present	present	B-ADJP	JJ	O	26	PRD
28	although	although	B-SBAR	IN	O	26	VMOD
29	kappaB	kappaB	B-NP	NN	B-protein	30	NMOD
30	binding	binding	I-NP	NN	O	31	SUB
31	was	be	B-VP	VBD	O	28	SBAR
32	not	not	O	RB	O	31	VMOD
33	inducible	inducible	B-ADJP	JJ	O	31	PRD
34	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	14	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	majority	majority	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	patients	patient	B-NP	NNS	O	4	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	advanced	advance	B-NP	VBN	O	8	NMOD
8	RCC	RCC	I-NP	NN	O	6	PMOD
9	,	,	O	,	O	14	P
10	peripheral	peripheral	B-NP	JJ	B-cell_type	13	NMOD
11	blood	blood	I-NP	NN	I-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	14	SUB
14	express	express	B-VP	VBP	O	27	VMOD
15	TCRzeta	TCRzeta	B-NP	NN	B-protein	14	OBJ
16	and	and	O	CC	O	27	VMOD
17	p56	p56	B-NP	NN	B-protein	27	VMOD
18	(	(	O	(	I-protein	19	P
19	lck	lck	B-NP	NN	I-protein	17	NMOD
20	)	)	O	)	I-protein	19	P
21	,	,	O	,	O	27	P
22	and	and	O	CC	O	27	VMOD
23	in	in	B-PP	IN	O	27	VMOD
24	a	a	B-NP	DT	O	25	NMOD
25	subset	subset	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	27	P
27	reduced	reduce	B-VP	VBD	O	0	ROOT
28	levels	level	B-NP	NNS	O	27	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	these	these	B-NP	DT	O	33	NMOD
31	TCRzeta	TCRzeta	I-NP	NN	B-protein	33	NMOD
32	associated	associated	I-NP	JJ	I-protein	33	NMOD
33	molecules	molecule	I-NP	NNS	I-protein	29	PMOD
34	are	be	B-VP	VBP	O	27	VMOD
35	seen	see	I-VP	VBN	O	34	VC
36	that	that	B-NP	WDT	O	35	VMOD
37	may	may	B-VP	MD	O	36	SBAR
38	increase	increase	I-VP	VB	O	37	VC
39	during	during	B-PP	IN	O	38	VMOD
40	cytokine-based	cytokine-based	B-NP	JJ	O	41	NMOD
41	therapy	therapy	I-NP	NN	O	39	PMOD
42	.	.	O	.	O	27	P

1	Abnormal	Abnormal	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NFkappaB	NFkappaB	B-NP	NN	B-protein	3	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	also	also	B-ADVP	RB	O	5	VMOD
7	present	present	B-ADJP	JJ	O	5	PRD
8	in	in	B-PP	IN	O	7	AMOD
9	>	>	B-NP	JJR	O	11	NMOD
10	50	50	I-NP	CD	O	11	NMOD
11	%	%	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	patients	patient	B-NP	NNS	O	12	PMOD
14	and	and	O	CC	O	5	VMOD
15	may	may	B-VP	MD	O	5	VMOD
16	also	also	I-VP	RB	O	15	VMOD
17	revert	revert	I-VP	VB	O	15	VC
18	to	to	B-PP	TO	O	17	VMOD
19	normal	normal	B-ADJP	JJ	O	18	PMOD
20	during	during	B-PP	IN	O	17	VMOD
21	IL-2/IFN	IL-2/IFN	B-NP	NN	B-protein	23	NMOD
22	alpha-based	alpha-based	I-NP	JJ	O	23	NMOD
23	treatment	treatment	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	5	P

1	This	This	B-NP	DT	O	2	NMOD
2	alteration	alteration	I-NP	NN	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	NFkappaB	NFkappaB	B-NP	NN	B-protein	5	NMOD
5	activation	activation	I-NP	NN	O	3	PMOD
6	occurred	occur	B-VP	VBD	O	0	ROOT
7	in	in	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	presence	presence	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	normal	normal	B-NP	JJ	O	12	NMOD
12	expression	expression	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	TCRzeta-associated	TCRzeta-associated	B-NP	JJ	B-DNA	16	NMOD
15	signaling	signaling	I-NP	NN	I-DNA	16	NMOD
16	elements	element	I-NP	NNS	I-DNA	13	PMOD
17	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	clinical	clinical	I-NP	JJ	O	3	NMOD
3	significance	significance	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	these	these	B-NP	DT	O	6	NMOD
6	findings	finding	I-NP	NNS	O	4	PMOD
7	remains	remain	B-VP	VBZ	O	0	ROOT
8	unclear	unclear	B-ADJP	JJ	O	7	PRD
9	.	.	O	.	O	7	P

1	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	lysosomal	lysosomal	B-NP	JJ	B-protein	6	NMOD
5	acid	acid	I-NP	NN	I-protein	6	NMOD
6	lipase	lipase	I-NP	NN	I-protein	3	PMOD
7	in	in	B-PP	IN	O	2	NMOD
8	differentiating	differentiate	B-VP	VBG	B-cell_type	9	NMOD
9	monocytes	monocyte	B-NP	NNS	I-cell_type	7	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	mediated	mediate	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	transcription	transcription	B-NP	NN	B-protein	14	NMOD
14	factors	factor	I-NP	NNS	I-protein	12	PMOD
15	Sp1	Sp1	B-NP	NN	B-protein	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	AP-2	AP-2	B-NP	NN	B-protein	14	NMOD
18	.	.	O	.	O	10	P

1	Human	Human	B-NP	JJ	B-protein	4	NMOD
2	lysosomal	lysosomal	I-NP	JJ	I-protein	4	NMOD
3	acid	acid	I-NP	NN	I-protein	4	NMOD
4	lipase	lipase	I-NP	NN	I-protein	8	SUB
5	(	(	O	(	O	6	P
6	LAL	LAL	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	10	NMOD
10	hydrolase	hydrolase	I-NP	NN	B-protein	8	PRD
11	required	require	B-VP	VBN	O	10	NMOD
12	for	for	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	cleavage	cleavage	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	cholesteryl	cholesteryl	B-NP	NN	O	17	NMOD
17	esters	ester	I-NP	NNS	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	triglycerides	triglyceride	I-NP	NNS	O	15	PMOD
20	derived	derive	B-VP	VBN	O	19	NMOD
21	from	from	B-PP	IN	O	20	VMOD
22	plasma	plasma	B-NP	NN	B-protein	23	NMOD
23	lipoproteins	lipoprotein	I-NP	NNS	I-protein	21	PMOD
24	.	.	O	.	O	8	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	shown	show	I-VP	VBN	O	2	VC
4	here	here	B-ADVP	RB	O	3	VMOD
5	that	that	B-SBAR	IN	O	3	VMOD
6	during	during	B-PP	IN	O	16	VMOD
7	monocyte	monocyte	B-NP	NN	O	6	PMOD
8	to	to	B-PP	TO	O	7	NMOD
9	macrophage	macrophage	B-NP	NN	O	10	NMOD
10	differentiation	differentiation	I-NP	NN	O	8	PMOD
11	,	,	O	,	O	16	P
12	the	the	B-NP	DT	O	13	NMOD
13	expression	expression	I-NP	NN	O	16	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	LAL-mRNA	LAL-mRNA	B-NP	NN	B-RNA	14	PMOD
16	is	be	B-VP	VBZ	O	5	SBAR
17	induced	induce	I-VP	VBN	O	16	VC
18	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	2	NMOD
2	induction	induction	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	dependent	dependent	B-ADJP	JJ	O	3	PRD
5	on	on	B-PP	IN	O	4	AMOD
6	protein	protein	B-NP	NN	B-protein	8	NMOD
7	kinase	kinase	I-NP	NN	I-protein	8	NMOD
8	C	C	I-NP	NN	I-protein	12	NMOD
9	activity	activity	I-NP	NN	O	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	protein	protein	B-NP	NN	O	12	NMOD
12	synthesis	synthesis	I-NP	NN	O	5	PMOD
13	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	cell	cell	I-NP	NN	O	4	NMOD
3	type-specific	type-specific	I-NP	JJ	O	4	NMOD
4	increase	increase	I-NP	NN	O	8	SUB
5	in	in	B-PP	IN	O	4	NMOD
6	LAL	LAL	B-NP	NN	B-protein	7	NMOD
7	expression	expression	I-NP	NN	O	5	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	further	further	B-ADJP	RBR	O	8	VMOD
10	investigated	investigate	I-ADJP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	THP-1	THP-1	I-NP	NN	B-cell_line	15	NMOD
14	cell	cell	I-NP	NN	I-cell_line	15	NMOD
15	line	line	I-NP	NN	I-cell_line	11	PMOD
16	with	with	B-PP	IN	O	10	VMOD
17	respect	respect	B-NP	NN	O	16	PMOD
18	to	to	B-PP	TO	O	17	NMOD
19	transcriptional	transcriptional	B-NP	JJ	O	20	NMOD
20	regulation	regulation	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	7	NMOD
2	human	human	I-NP	JJ	B-cell_line	7	NMOD
3	monocytic	monocytic	I-NP	JJ	I-cell_line	7	NMOD
4	leukemia	leukemia	I-NP	NN	I-cell_line	7	NMOD
5	cell	cell	I-NP	NN	I-cell_line	7	NMOD
6	line	line	I-NP	NN	I-cell_line	7	NMOD
7	THP-1	THP-1	I-NP	NN	B-cell_line	8	SUB
8	differentiates	differentiate	B-VP	VBZ	O	0	ROOT
9	into	into	B-PP	IN	O	8	VMOD
10	macrophage-like	macrophage-like	B-NP	JJ	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	when	when	B-ADVP	WRB	O	8	VMOD
13	treated	treat	B-VP	VBN	O	12	SBAR
14	with	with	B-PP	IN	O	13	VMOD
15	phorbol	phorbol	B-NP	NN	O	16	NMOD
16	esters	ester	I-NP	NNS	O	14	PMOD
17	.	.	O	.	O	8	P

1	In	In	B-SBAR	IN	O	24	VMOD
2	order	order	O	NN	O	1	DEP
3	to	to	B-VP	TO	O	4	VMOD
4	determine	determine	I-VP	VB	O	1	SBAR
5	the	the	B-NP	DT	O	7	NMOD
6	cis-acting	cis-acting	I-NP	JJ	B-DNA	7	NMOD
7	elements	element	I-NP	NNS	I-DNA	4	OBJ
8	necessary	necessary	B-ADJP	JJ	O	7	NMOD
9	for	for	B-PP	IN	O	8	AMOD
10	both	both	O	CC	O	15	NMOD
11	basal	basal	B-NP	JJ	O	15	NMOD
12	and	and	O	CC	O	15	NMOD
13	phorbol	phorbol	B-NP	NN	O	15	NMOD
14	12-myristate-13	12-myristate-13	I-NP	NN	O	15	NMOD
15	acetate	acetate	I-NP	NN	O	21	NMOD
16	(	(	O	(	O	17	P
17	PMA	PMA	B-NP	NN	O	15	NMOD
18	)	)	O	)	O	17	P
19	-enhanced	-enhanced	B-NP	JJ	O	21	NMOD
20	promoter	promoter	I-NP	NN	O	21	NMOD
21	activity	activity	I-NP	NN	O	9	PMOD
22	,	,	O	,	O	24	P
23	we	we	B-NP	PRP	O	24	SUB
24	performed	perform	B-VP	VBD	O	0	ROOT
25	deletion	deletion	B-NP	NN	O	26	NMOD
26	analysis	analysis	I-NP	NN	O	30	NMOD
27	and	and	I-NP	CC	O	30	NMOD
28	reporter	reporter	I-NP	NN	O	30	NMOD
29	gene	gene	I-NP	NN	O	30	NMOD
30	assays	assay	I-NP	NNS	O	24	OBJ
31	.	.	O	.	O	24	P

1	A	A	B-NP	DT	O	4	NMOD
2	PMA	PMA	I-NP	NN	B-DNA	4	NMOD
3	responsive	responsive	I-NP	JJ	I-DNA	4	NMOD
4	element	element	I-NP	NN	I-DNA	5	SUB
5	has	have	B-VP	VBZ	O	0	ROOT
6	been	be	I-VP	VBN	O	5	VC
7	identified	identify	I-VP	VBN	O	6	VC
8	between	between	B-PP	IN	O	7	VMOD
9	-182	-182	B-NP	CD	B-DNA	10	NMOD
10	bp	bp	I-NP	NN	I-DNA	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	-107	-107	B-NP	CD	B-DNA	13	NMOD
13	bp	bp	I-NP	NN	I-DNA	8	PMOD
14	upstream	upstream	B-ADVP	RB	I-DNA	13	NMOD
15	of	of	B-PP	IN	O	13	NMOD
16	the	the	B-NP	DT	O	20	NMOD
17	major	major	I-NP	JJ	B-DNA	20	NMOD
18	transcription	transcription	I-NP	NN	I-DNA	20	NMOD
19	start	start	I-NP	NN	I-DNA	20	NMOD
20	site	site	I-NP	NN	I-DNA	15	PMOD
21	.	.	O	.	O	5	P

1	Gel	Gel	B-NP	NN	O	4	NMOD
2	mobility	mobility	I-NP	NN	O	4	NMOD
3	shift	shift	I-NP	NN	O	4	NMOD
4	assays	assay	I-NP	NNS	O	5	SUB
5	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	binding	binding	B-NP	NN	O	16	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	Sp1	Sp1	B-NP	NN	B-protein	11	NMOD
10	and	and	O	CC	O	11	NMOD
11	AP-2	AP-2	B-NP	NN	B-protein	8	PMOD
12	to	to	B-PP	TO	O	7	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	LAL	LAL	I-NP	NN	B-DNA	15	NMOD
15	promoter	promoter	I-NP	NN	I-DNA	12	PMOD
16	is	be	B-VP	VBZ	O	6	SBAR
17	increased	increase	I-VP	VBN	O	16	VC
18	by	by	B-PP	IN	O	17	VMOD
19	PMA	PMA	B-NP	NN	O	18	PMOD
20	in	in	B-PP	IN	O	17	VMOD
21	THP-1	THP-1	B-NP	NN	B-cell_line	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_line	20	PMOD
23	.	.	O	.	O	5	P

1	Co-transfections	Co-transfection	B-NP	NNS	O	10	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	expression	expression	B-NP	NN	O	4	NMOD
4	plasmids	plasmid	I-NP	NNS	O	2	PMOD
5	for	for	B-PP	IN	O	4	NMOD
6	Sp1	Sp1	B-NP	NN	B-protein	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	AP-2	AP-2	B-NP	NN	B-protein	5	PMOD
9	further	further	B-ADVP	RBR	O	10	VMOD
10	emphasized	emphasize	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	13	NMOD
12	important	important	I-NP	JJ	O	13	NMOD
13	role	role	I-NP	NN	O	10	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	these	these	B-NP	DT	O	17	NMOD
16	transcription	transcription	I-NP	NN	B-protein	17	NMOD
17	factors	factor	I-NP	NNS	I-protein	14	PMOD
18	in	in	B-PP	IN	O	13	NMOD
19	both	both	B-NP	CC	O	22	AMOD
20	basal	basal	I-NP	JJ	O	22	AMOD
21	and	and	I-NP	CC	O	22	AMOD
22	PMA-enhanced	PMA-enhanced	I-NP	JJ	O	24	NMOD
23	LAL	LAL	I-NP	NN	B-protein	24	NMOD
24	expression	expression	I-NP	NN	O	18	PMOD
25	.	.	O	.	O	10	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	differentiation	differentiation	B-NP	NN	O	7	NMOD
6	dependent	dependent	I-NP	JJ	O	7	NMOD
7	increase	increase	I-NP	NN	O	19	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	lysosomal	lysosomal	B-NP	JJ	B-protein	11	NMOD
10	acid	acid	I-NP	NN	I-protein	11	NMOD
11	lipase	lipase	I-NP	NN	I-protein	15	NMOD
12	(	(	O	(	O	13	P
13	LAL	LAL	B-NP	NN	B-protein	11	NMOD
14	)	)	O	)	O	13	P
15	expression	expression	B-NP	NN	O	8	PMOD
16	in	in	B-PP	IN	O	7	NMOD
17	THP-1	THP-1	B-NP	NN	B-cell_line	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_line	16	PMOD
19	is	be	B-VP	VBZ	O	4	SBAR
20	mediated	mediate	I-VP	VBN	O	19	VC
21	by	by	B-PP	IN	O	20	VMOD
22	a	a	B-NP	DT	O	24	NMOD
23	concerted	concerted	I-NP	JJ	O	24	NMOD
24	action	action	I-NP	NN	O	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	Sp1	Sp1	B-NP	NN	B-protein	28	NMOD
27	and	and	I-NP	CC	O	28	NMOD
28	AP-2	AP-2	I-NP	NN	B-protein	25	PMOD
29	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	3	NMOD
2	nongenomic	nongenomic	I-NP	JJ	O	3	NMOD
3	mechanism	mechanism	I-NP	NN	O	8	NMOD
4	for	for	B-PP	IN	O	3	NMOD
5	progesterone-mediated	progesterone-mediated	B-NP	JJ	O	6	NMOD
6	immunosuppression	immunosuppression	I-NP	NN	O	4	PMOD
7	:	:	O	:	O	3	P
8	inhibition	inhibition	B-NP	NN	O	18	NMOD
9	of	of	B-PP	IN	O	8	NMOD
10	K+	K+	B-NP	NN	B-protein	11	NMOD
11	channels	channel	I-NP	NNS	I-protein	9	PMOD
12	,	,	O	,	O	18	P
13	Ca2+	Ca2+	B-NP	NN	O	14	NMOD
14	signaling	signaling	I-NP	NN	O	18	NMOD
15	,	,	O	,	O	18	P
16	and	and	O	CC	O	18	NMOD
17	gene	gene	B-NP	NN	O	18	NMOD
18	expression	expression	I-NP	NN	O	0	ROOT
19	in	in	B-PP	IN	O	18	NMOD
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	19	PMOD
22	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanism	mechanism	I-NP	NN	O	15	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	progesterone	progesterone	B-NP	NN	O	6	SUB
6	causes	cause	B-VP	VBZ	O	3	SBAR
7	localized	localized	B-NP	JJ	O	8	NMOD
8	suppression	suppression	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	immune	immune	I-NP	JJ	O	12	NMOD
12	response	response	I-NP	NN	O	9	PMOD
13	during	during	B-PP	IN	O	6	VMOD
14	pregnancy	pregnancy	B-NP	NN	O	13	PMOD
15	has	have	B-VP	VBZ	O	0	ROOT
16	remained	remain	I-VP	VBN	O	15	VC
17	elusive	elusive	B-ADJP	JJ	O	16	PRD
18	.	.	O	.	O	15	P

1	Using	Use	B-VP	VBG	O	11	VMOD
2	human	human	B-NP	JJ	B-cell_type	4	NMOD
3	T	T	I-NP	NN	I-cell_type	4	NMOD
4	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	8	NMOD
5	and	and	O	CC	O	8	NMOD
6	T	T	B-NP	NN	B-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	lines	line	I-NP	NNS	I-cell_line	1	OBJ
9	,	,	O	,	O	11	P
10	we	we	B-NP	PRP	O	11	SUB
11	show	show	B-VP	VBP	O	0	ROOT
12	that	that	B-SBAR	IN	O	11	VMOD
13	progesterone	progesterone	B-NP	NN	O	25	SUB
14	,	,	O	,	O	13	P
15	at	at	B-PP	IN	O	13	NMOD
16	concentrations	concentration	B-NP	NNS	O	15	PMOD
17	found	find	B-VP	VBN	O	16	NMOD
18	in	in	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	placenta	placenta	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	13	P
22	rapidly	rapidly	B-ADVP	RB	O	25	VMOD
23	and	and	I-ADVP	CC	O	22	AMOD
24	reversibly	reversibly	B-VP	RB	O	22	AMOD
25	blocks	block	I-VP	VBZ	O	12	SBAR
26	voltage-gated	voltage-gated	B-NP	JJ	B-protein	30	NMOD
27	and	and	I-NP	CC	I-protein	30	NMOD
28	calcium-activated	calcium-activated	I-NP	JJ	I-protein	30	NMOD
29	K+	K+	I-NP	NN	I-protein	30	NMOD
30	channels	channel	I-NP	NNS	I-protein	34	NMOD
31	(	(	O	(	O	34	P
32	KV	KV	B-NP	NN	B-protein	34	NMOD
33	and	and	I-NP	CC	O	34	NMOD
34	KCa	KCa	I-NP	NN	B-protein	25	OBJ
35	,	,	O	,	O	25	P
36	respectively	respectively	B-ADVP	RB	O	25	VMOD
37	)	)	O	)	O	25	P
38	,	,	O	,	O	25	P
39	resulting	result	B-VP	VBG	O	25	VMOD
40	in	in	B-PP	IN	O	39	VMOD
41	depolarization	depolarization	B-NP	NN	O	40	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	the	the	B-NP	DT	O	45	NMOD
44	membrane	membrane	I-NP	NN	O	45	NMOD
45	potential	potential	I-NP	NN	O	42	PMOD
46	.	.	O	.	O	11	P

1	As	As	B-PP	IN	O	20	VMOD
2	a	a	B-NP	DT	O	3	NMOD
3	result	result	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	20	P
5	Ca2+	Ca2+	B-NP	NN	O	6	NMOD
6	signaling	signaling	I-NP	NN	O	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD
9	factor	factor	I-NP	NN	I-protein	19	NMOD
10	of	of	B-PP	IN	I-protein	9	NMOD
11	activated	activate	B-NP	VBN	I-protein	13	NMOD
12	T	T	I-NP	NN	I-protein	13	NMOD
13	cells	cell	I-NP	NNS	I-protein	10	PMOD
14	(	(	O	(	O	15	P
15	NF-AT	NF-AT	B-NP	NN	B-protein	9	NMOD
16	)	)	I-NP	)	O	15	P
17	-driven	-driven	I-NP	JJ	O	19	NMOD
18	gene	gene	I-NP	NN	O	19	NMOD
19	expression	expression	I-NP	NN	O	20	SUB
20	are	be	B-VP	VBP	O	0	ROOT
21	inhibited	inhibit	I-VP	VBN	O	20	VC
22	.	.	O	.	O	20	P

1	Progesterone	Progesterone	B-NP	NN	O	2	SUB
2	acts	act	B-VP	VBZ	O	0	ROOT
3	distally	distally	B-ADVP	RB	O	2	VMOD
4	to	to	B-PP	TO	O	2	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	initial	initial	I-NP	JJ	O	7	NMOD
7	steps	step	I-NP	NNS	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	T	T	B-NP	NN	B-protein	11	NMOD
10	cell	cell	I-NP	NN	I-protein	11	NMOD
11	receptor	receptor	I-NP	NN	I-protein	17	NMOD
12	(	(	I-NP	(	O	13	P
13	TCR	TCR	I-NP	NN	B-protein	11	NMOD
14	)	)	I-NP	)	O	13	P
15	-mediated	-mediated	I-NP	JJ	O	17	NMOD
16	signal	signal	I-NP	NN	O	17	NMOD
17	transduction	transduction	I-NP	NN	O	8	PMOD
18	,	,	O	,	O	2	P
19	since	since	B-SBAR	IN	O	2	VMOD
20	it	it	B-NP	PRP	O	21	SUB
21	blocks	block	B-VP	VBZ	O	19	SBAR
22	sustained	sustained	B-NP	JJ	O	24	NMOD
23	Ca2+	Ca2+	I-NP	NN	O	24	NMOD
24	signals	signal	I-NP	NNS	O	21	OBJ
25	after	after	B-PP	IN	O	21	VMOD
26	thapsigargin	thapsigargin	B-NP	NN	O	27	NMOD
27	stimulation	stimulation	I-NP	NN	O	25	PMOD
28	,	,	O	,	O	19	P
29	as	as	B-CONJP	RB	O	19	DEP
30	well	well	I-CONJP	RB	O	29	DEP
31	as	as	I-CONJP	IN	O	29	DEP
32	oscillatory	oscillatory	B-NP	JJ	O	34	NMOD
33	Ca2+	Ca2+	I-NP	NN	O	34	NMOD
34	signals	signal	I-NP	NNS	O	39	NMOD
35	,	,	O	,	O	39	P
36	but	but	O	CC	O	39	NMOD
37	not	not	O	RB	O	36	DEP
38	the	the	B-NP	DT	O	39	NMOD
39	Ca2+	Ca2+	I-NP	NN	O	19	DEP
40	transient	transient	B-ADJP	JJ	O	39	NMOD
41	after	after	B-PP	IN	O	40	AMOD
42	TCR	TCR	B-NP	NN	B-protein	43	NMOD
43	stimulation	stimulation	I-NP	NN	O	41	PMOD
44	.	.	O	.	O	2	P

1	K+	K+	B-NP	NN	O	3	NMOD
2	channel	channel	I-NP	NN	O	3	NMOD
3	blockade	blockade	I-NP	NN	O	6	SUB
4	by	by	B-PP	IN	O	3	NMOD
5	progesterone	progesterone	B-NP	NN	O	4	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	specific	specific	B-ADJP	JJ	O	6	PRD
8	;	;	O	:	O	6	VMOD
9	other	other	B-NP	JJ	O	11	NMOD
10	steroid	steroid	I-NP	NN	O	11	NMOD
11	hormones	hormone	I-NP	NNS	O	12	SUB
12	had	have	B-VP	VBD	O	8	SBAR
13	little	little	B-NP	JJ	O	16	NMOD
14	or	or	I-NP	CC	O	16	NMOD
15	no	no	I-NP	DT	O	16	NMOD
16	effect	effect	I-NP	NN	O	12	OBJ
17	,	,	O	,	O	12	P
18	although	although	B-SBAR	IN	O	12	VMOD
19	the	the	B-NP	DT	O	22	NMOD
20	progesterone	progesterone	I-NP	NN	O	22	NMOD
21	antagonist	antagonist	I-NP	NN	O	22	NMOD
22	RU	RU	I-NP	NN	O	25	SUB
23	486	486	I-NP	CD	O	22	NMOD
24	also	also	B-ADVP	RB	O	25	VMOD
25	blocked	block	B-VP	VBD	O	18	SBAR
26	KV	KV	B-NP	NN	B-protein	28	NMOD
27	and	and	I-NP	CC	O	28	NMOD
28	KCa	KCa	I-NP	NN	B-protein	29	NMOD
29	channels	channel	I-NP	NNS	O	25	OBJ
30	.	.	O	.	O	6	P

1	Progesterone	Progesterone	B-NP	NN	O	3	SUB
2	effectively	effectively	B-ADVP	RB	O	3	VMOD
3	blocked	block	B-VP	VBD	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	broad	broad	I-NP	JJ	O	6	NMOD
6	spectrum	spectrum	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	K+	K+	B-NP	NN	B-protein	9	NMOD
9	channels	channel	I-NP	NNS	I-protein	7	PMOD
10	,	,	O	,	O	3	P
11	reducing	reduce	B-VP	VBG	O	3	VMOD
12	both	both	O	CC	O	11	VMOD
13	Kv1.3	Kv1.3	B-NP	NN	B-protein	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	charybdotoxin-resistant	charybdotoxin-resistant	B-NP	JJ	B-protein	16	NMOD
16	components	component	I-NP	NNS	I-protein	12	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	KV	KV	B-NP	NN	B-protein	19	NMOD
19	current	current	I-NP	NN	O	22	NMOD
20	and	and	I-NP	CC	O	22	NMOD
21	KCa	KCa	I-NP	NN	B-protein	22	NMOD
22	current	current	I-NP	NN	O	17	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	T	T	B-NP	NN	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
26	,	,	O	,	O	16	P
27	as	as	B-CONJP	RB	O	30	VMOD
28	well	well	I-CONJP	RB	O	27	DEP
29	as	as	I-CONJP	IN	O	27	DEP
30	blocking	block	B-VP	VBG	O	16	NMOD
31	several	several	B-NP	JJ	O	30	OBJ
32	cloned	clone	I-NP	VBN	B-protein	34	NMOD
33	KV	KV	I-NP	NN	I-protein	34	NMOD
34	channels	channel	I-NP	NNS	I-protein	31	NMOD
35	expressed	express	B-VP	VBN	O	31	NMOD
36	in	in	B-PP	IN	O	35	VMOD
37	cell	cell	B-NP	NN	B-cell_line	38	NMOD
38	lines	line	I-NP	NNS	I-cell_line	36	PMOD
39	.	.	O	.	O	3	P

1	Progesterone	Progesterone	B-NP	NN	O	2	SUB
2	had	have	B-VP	VBD	O	0	ROOT
3	little	little	B-NP	JJ	O	6	NMOD
4	or	or	I-NP	CC	O	6	NMOD
5	no	no	I-NP	DT	O	6	NMOD
6	effect	effect	I-NP	NN	O	2	OBJ
7	on	on	B-PP	IN	O	2	VMOD
8	a	a	B-NP	DT	O	12	NMOD
9	cloned	clone	I-NP	VBN	B-protein	12	NMOD
10	voltage-gated	voltage-gated	I-NP	JJ	I-protein	12	NMOD
11	Na+	Na+	I-NP	NN	I-protein	12	NMOD
12	channel	channel	I-NP	NN	I-protein	18	NMOD
13	,	,	O	,	O	18	P
14	an	an	B-NP	DT	O	18	NMOD
15	inward	inward	I-NP	JJ	O	18	NMOD
16	rectifier	rectifier	I-NP	NN	O	18	NMOD
17	K+	K+	I-NP	NN	O	18	NMOD
18	channel	channel	I-NP	NN	O	7	PMOD
19	,	,	B-PP	,	O	7	P
20	or	or	I-PP	CC	O	7	PMOD
21	on	on	B-PP	IN	O	7	PMOD
22	lymphocyte	lymphocyte	B-NP	NN	B-protein	26	NMOD
23	Ca2+	Ca2+	I-NP	NN	I-protein	22	NMOD
24	and	and	I-NP	CC	I-protein	22	NMOD
25	Cl-	Cl-	I-NP	NN	I-protein	26	NMOD
26	channels	channel	I-NP	NNS	I-protein	21	PMOD
27	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	propose	propose	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	direct	direct	B-NP	JJ	O	5	NMOD
5	inhibition	inhibition	I-NP	NN	O	14	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	K+	K+	B-NP	NN	B-protein	8	NMOD
8	channels	channel	I-NP	NNS	I-protein	6	PMOD
9	in	in	B-PP	IN	O	5	NMOD
10	T	T	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	by	by	B-PP	IN	O	5	NMOD
13	progesterone	progesterone	B-NP	NN	O	12	PMOD
14	contributes	contribute	B-VP	VBZ	O	3	SBAR
15	to	to	B-PP	TO	O	14	VMOD
16	progesterone-induced	progesterone-induced	B-NP	JJ	O	17	NMOD
17	immunosuppression	immunosuppression	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	2	P

1	Role	Role	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	IKK1	IKK1	B-NP	NN	B-protein	5	NMOD
4	and	and	I-NP	CC	O	5	NMOD
5	IKK2	IKK2	I-NP	NN	B-protein	2	PMOD
6	in	in	B-PP	IN	O	1	NMOD
7	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	8	NMOD
8	signaling	signaling	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	human	human	B-NP	JJ	B-cell_type	12	NMOD
11	monocytic	monocytic	I-NP	JJ	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
13	.	.	O	.	O	1	P

1	Mononuclear	Mononuclear	B-NP	JJ	B-cell_type	2	NMOD
2	phagocytes	phagocyte	I-NP	NNS	I-cell_type	3	SUB
3	play	play	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	major	major	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	in	in	B-PP	IN	O	3	VMOD
8	immune	immune	B-NP	JJ	O	10	AMOD
9	and	and	I-NP	CC	O	10	AMOD
10	inflammatory	inflammatory	I-NP	JJ	O	11	NMOD
11	responses	response	I-NP	NNS	O	7	PMOD
12	.	.	O	.	O	3	P

1	Bacterial	Bacterial	B-NP	JJ	O	2	NMOD
2	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	6	SUB
3	(	(	O	(	O	4	P
4	LPS	LPS	B-NP	NN	O	2	NMOD
5	)	)	O	)	O	4	P
6	induces	induce	B-VP	VBZ	O	0	ROOT
7	monocytes	monocyte	B-NP	NNS	B-cell_type	9	SUB
8	to	to	B-VP	TO	O	9	VMOD
9	express	express	I-VP	VB	O	6	VMOD
10	a	a	B-NP	DT	O	11	NMOD
11	variety	variety	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	genes	gene	B-NP	NNS	O	12	PMOD
14	by	by	B-PP	IN	O	9	VMOD
15	activating	activate	B-VP	VBG	O	14	PMOD
16	the	the	B-NP	DT	O	20	NMOD
17	NF-kappaB/Rel	NF-kappaB/Rel	I-NP	NN	B-protein	20	NMOD
18	transcription	transcription	I-NP	NN	I-protein	20	NMOD
19	factor	factor	I-NP	NN	I-protein	20	NMOD
20	family	family	I-NP	NN	I-protein	15	OBJ
21	.	.	O	.	O	6	P

1	Recently	Recently	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	reported	report	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	tumor	tumor	I-NP	NN	B-protein	10	NMOD
9	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	15	NMOD
11	and	and	O	CC	O	15	NMOD
12	interleukin	interleukin	B-NP	NN	B-protein	15	NMOD
13	1	1	I-NP	CD	I-protein	15	NMOD
14	signaling	signaling	I-NP	NN	O	15	NMOD
15	pathways	pathway	I-NP	NNS	O	16	SUB
16	activate	activate	B-VP	VBP	O	6	SBAR
17	two	two	B-NP	CD	O	16	OBJ
18	kinases	kinase	I-NP	NNS	B-protein	22	NMOD
19	,	,	O	,	O	22	P
20	IKK1	IKK1	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	IKK2	IKK2	I-NP	NN	B-protein	16	OBJ
23	.	.	O	.	O	4	P

1	Phosphorylation	Phosphorylation	B-NP	NN	O	18	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	IkappaB	IkappaB	I-NP	NN	B-protein	6	NMOD
5	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	6	NMOD
6	inhibitors	inhibitor	I-NP	NNS	I-protein	13	NMOD
7	,	,	O	,	O	13	P
8	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	13	NMOD
9	,	,	O	,	O	13	P
10	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	13	NMOD
11	,	,	O	,	O	13	P
12	and	and	O	CC	O	13	NMOD
13	IkappaBepsilon	IkappaBepsilon	B-NP	NN	B-protein	2	PMOD
14	,	,	O	,	O	1	P
15	by	by	B-PP	IN	O	1	NMOD
16	these	these	B-NP	DT	O	17	NMOD
17	kinases	kinase	I-NP	NNS	B-protein	15	PMOD
18	triggers	trigger	B-VP	VBZ	O	0	ROOT
19	proteolytic	proteolytic	B-NP	JJ	O	20	NMOD
20	degradation	degradation	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	release	release	I-NP	NN	O	18	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	NN	B-protein	26	NMOD
26	proteins	protein	I-NP	NNS	I-protein	24	PMOD
27	into	into	B-PP	IN	O	18	VMOD
28	the	the	B-NP	DT	O	29	NMOD
29	nucleus	nucleus	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	18	P

1	At	At	B-PP	IN	O	12	VMOD
2	present	present	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	the	the	B-NP	DT	O	5	NMOD
5	role	role	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	IKKs	IKK	I-NP	NNS	B-protein	6	PMOD
9	in	in	B-PP	IN	O	5	NMOD
10	LPS	LPS	B-NP	NN	O	11	NMOD
11	signaling	signaling	I-NP	NN	O	9	PMOD
12	has	have	B-VP	VBZ	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	been	be	I-VP	VBN	O	12	VC
15	investigated	investigate	I-VP	VBN	O	14	VC
16	.	.	O	.	O	12	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	report	report	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	LPS	LPS	B-NP	NN	O	7	SUB
7	induces	induce	B-VP	VBZ	O	5	SBAR
8	IKK	IKK	B-NP	NN	B-protein	9	NMOD
9	activity	activity	I-NP	NN	O	7	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	B-cell_type	12	NMOD
12	monocytes	monocyte	I-NP	NNS	I-cell_type	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	THP-1	THP-1	B-NP	NN	B-cell_line	16	NMOD
15	monocytic	monocytic	I-NP	JJ	I-cell_line	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
17	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	kinetics	kinetic	I-NP	NNS	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	activation	activation	B-NP	NN	O	3	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	kinase	kinase	B-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	5	PMOD
8	in	in	B-PP	IN	O	4	NMOD
9	monocytic	monocytic	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	are	be	B-VP	VBP	O	0	ROOT
12	relatively	relatively	B-ADJP	RB	O	13	AMOD
13	slow	slow	I-ADJP	JJ	O	11	PRD
14	with	with	B-PP	IN	O	13	AMOD
15	maximal	maximal	B-NP	JJ	O	16	NMOD
16	activity	activity	I-NP	NN	O	14	PMOD
17	observed	observe	B-VP	VBN	O	16	NMOD
18	at	at	B-PP	IN	O	17	VMOD
19	60	60	B-NP	CD	O	20	NMOD
20	min	min	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	11	P
22	which	which	B-NP	WDT	O	11	VMOD
23	coincides	coincide	B-VP	VBZ	O	22	SBAR
24	with	with	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	degradation	degradation	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	IkappaBs	IkappaB	B-NP	NNS	B-protein	32	NMOD
29	and	and	O	CC	O	32	NMOD
30	the	the	B-NP	DT	O	32	NMOD
31	nuclear	nuclear	I-NP	JJ	O	32	NMOD
32	translocation	translocation	I-NP	NN	O	27	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	33	PMOD
35	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	24	VMOD
2	transfection	transfection	B-NP	NN	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	24	P
5	overexpression	overexpression	B-NP	NN	O	24	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	wild	wild	B-NP	JJ	B-protein	9	NMOD
8	type	type	I-NP	NN	I-protein	9	NMOD
9	IKK1	IKK1	I-NP	NN	I-protein	23	NMOD
10	,	,	O	,	O	23	P
11	a	a	B-NP	DT	O	15	NMOD
12	dominant	dominant	I-NP	JJ	B-protein	15	NMOD
13	negative	negative	I-NP	JJ	I-protein	15	NMOD
14	mutant	mutant	I-NP	JJ	I-protein	15	NMOD
15	IKK1	IKK1	I-NP	NN	I-protein	23	NMOD
16	(	(	O	(	O	17	P
17	K44M	K44M	B-NP	NN	B-protein	15	NMOD
18	)	)	O	)	O	17	P
19	,	,	O	,	O	23	P
20	or	or	O	CC	O	23	NMOD
21	wild	wild	B-NP	JJ	B-protein	23	NMOD
22	type	type	I-NP	NN	I-protein	23	NMOD
23	IKK2	IKK2	I-NP	NN	I-protein	6	PMOD
24	did	do	B-VP	VBD	O	0	ROOT
25	not	not	I-VP	RB	O	24	VMOD
26	affect	affect	I-VP	VB	O	24	VC
27	LPS-induced	LPS-induced	B-NP	JJ	O	29	NMOD
28	kappaB-dependent	kappaB-dependent	I-NP	JJ	O	29	NMOD
29	transcription	transcription	I-NP	NN	O	26	OBJ
30	in	in	B-PP	IN	O	29	NMOD
31	monocytic	monocytic	B-NP	JJ	B-cell_type	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_type	30	PMOD
33	.	.	O	.	O	24	P

1	In	In	B-PP	IN	O	10	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	a	a	B-NP	DT	O	7	NMOD
5	dominant	dominant	I-NP	JJ	B-protein	7	NMOD
6	negative	negative	I-NP	JJ	I-protein	7	NMOD
7	mutant	mutant	I-NP	NN	I-protein	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	IKK2	IKK2	B-NP	NN	B-protein	8	PMOD
10	inhibited	inhibit	B-VP	VBD	O	0	ROOT
11	LPS	LPS	B-NP	NN	O	12	NMOD
12	induction	induction	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	kappaB-dependent	kappaB-dependent	B-NP	JJ	O	15	NMOD
15	transcription	transcription	I-NP	NN	O	13	PMOD
16	in	in	B-PP	IN	O	12	NMOD
17	a	a	B-NP	DT	O	19	NMOD
18	dose-dependent	dose-dependent	I-NP	JJ	O	19	NMOD
19	manner	manner	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	10	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	LPS	LPS	B-NP	NN	O	6	NMOD
6	induction	induction	I-NP	NN	O	15	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	kappaB-dependent	kappaB-dependent	B-NP	JJ	O	10	NMOD
9	gene	gene	I-NP	NN	O	10	NMOD
10	expression	expression	I-NP	NN	O	7	PMOD
11	in	in	B-PP	IN	O	6	NMOD
12	human	human	B-NP	JJ	B-cell_type	14	NMOD
13	monocytic	monocytic	I-NP	JJ	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
15	requires	require	B-VP	VBZ	O	4	SBAR
16	activation	activation	B-NP	NN	O	15	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	IKK2	IKK2	B-NP	NN	B-protein	17	PMOD
19	.	.	O	.	O	3	P

1	Effects	Effect	B-NP	NNS	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	overexpression	overexpression	B-NP	NN	O	2	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	IL-1	IL-1	B-NP	NN	B-protein	7	NMOD
6	receptor-associated	receptor-associated	I-NP	JJ	I-protein	7	NMOD
7	kinase	kinase	I-NP	NN	I-protein	4	PMOD
8	on	on	B-PP	IN	O	1	NMOD
9	NFkappaB	NFkappaB	B-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	17	NMOD
11	,	,	O	,	O	17	P
12	IL-2	IL-2	B-NP	NN	B-protein	13	NMOD
13	production	production	I-NP	NN	O	17	NMOD
14	and	and	O	CC	O	17	NMOD
15	stress-activated	stress-activated	B-NP	JJ	B-protein	17	NMOD
16	protein	protein	I-NP	NN	I-protein	17	NMOD
17	kinases	kinase	I-NP	NNS	I-protein	8	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	24	NMOD
20	murine	murine	I-NP	JJ	B-cell_line	24	NMOD
21	T	T	I-NP	NN	I-cell_line	24	NMOD
22	cell	cell	I-NP	NN	I-cell_line	24	NMOD
23	line	line	I-NP	NN	I-cell_line	24	NMOD
24	EL4	EL4	I-NP	NN	I-cell_line	18	PMOD
25	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	4	NMOD
2	association	association	I-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	activation	activation	I-NP	NN	O	19	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	10	NMOD
7	IL-1	IL-1	I-NP	NN	B-protein	10	NMOD
8	receptor-associated	receptor-associated	I-NP	JJ	I-protein	10	NMOD
9	protein	protein	I-NP	NN	I-protein	10	NMOD
10	kinase	kinase	I-NP	NN	I-protein	5	PMOD
11	(	(	O	(	O	12	P
12	IRAK	IRAK	B-NP	NN	B-protein	10	NMOD
13	)	)	O	)	O	12	P
14	to	to	B-PP	TO	O	4	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	IL-1	IL-1	I-NP	NN	B-protein	18	NMOD
17	receptor	receptor	I-NP	NN	I-protein	18	NMOD
18	complex	complex	I-NP	NN	I-protein	14	PMOD
19	is	be	B-VP	VBZ	O	0	ROOT
20	one	one	B-NP	CD	O	19	PRD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	earliest	early	I-NP	JJS	O	24	NMOD
24	events	event	I-NP	NNS	O	21	PMOD
25	detectable	detectable	B-ADJP	JJ	O	24	NMOD
26	in	in	B-PP	IN	O	25	AMOD
27	IL-1	IL-1	B-NP	NN	B-protein	29	NMOD
28	signal	signal	I-NP	NN	O	29	NMOD
29	transduction	transduction	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	19	P

1	We	We	B-NP	PRP	O	2	SUB
2	generated	generate	B-VP	VBD	O	0	ROOT
3	permanent	permanent	B-NP	JJ	O	4	NMOD
4	clones	clone	I-NP	NNS	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	11	NMOD
7	murine	murine	I-NP	JJ	B-cell_line	11	NMOD
8	T	T	I-NP	NN	I-cell_line	11	NMOD
9	cell	cell	I-NP	NN	I-cell_line	11	NMOD
10	line	line	I-NP	NN	I-cell_line	11	NMOD
11	EL4	EL4	I-NP	NN	I-cell_line	5	PMOD
12	6.1	6.1	I-NP	CD	I-cell_line	11	NMOD
13	overexpressing	overexpresse	B-VP	VBG	O	11	NMOD
14	human	human	O	JJ	B-protein	18	NMOD
15	(	(	O	(	I-protein	18	P
16	h	h	B-NP	NN	I-protein	18	NMOD
17	)	)	O	)	I-protein	18	P
18	IRAK	IRAK	B-NP	NN	I-protein	13	OBJ
19	to	to	B-VP	TO	O	20	VMOD
20	evaluate	evaluate	I-VP	VB	O	2	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	role	role	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	this	this	B-NP	DT	O	25	NMOD
25	kinase	kinase	I-NP	NN	B-protein	23	PMOD
26	in	in	B-PP	IN	O	22	NMOD
27	IL-1	IL-1	B-NP	NN	B-protein	28	NMOD
28	signaling	signaling	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	2	P

1	Overexpression	Overexpression	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	hIRAK	hIRAK	B-NP	NN	B-protein	2	PMOD
4	enhanced	enhance	B-VP	VBD	O	13	VMOD
5	IL-1-stimulated	IL-1-stimulated	B-NP	JJ	O	6	NMOD
6	activation	activation	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	transcription	transcription	I-NP	NN	B-protein	11	NMOD
10	factor	factor	I-NP	NN	I-protein	11	NMOD
11	NFkappaB	NFkappaB	I-NP	NN	B-protein	7	PMOD
12	,	,	O	,	O	13	P
13	whereas	whereas	O	IN	O	0	ROOT
14	a	a	B-NP	DT	O	16	NMOD
15	truncated	truncate	I-NP	VBN	O	16	NMOD
16	form	form	I-NP	NN	O	21	SUB
17	(	(	O	(	O	18	P
18	N-IRAK	N-IRAK	B-NP	NN	B-protein	16	NMOD
19	)	)	O	)	O	18	P
20	specifically	specifically	B-ADVP	RB	O	21	VMOD
21	inhibited	inhibit	B-VP	VBD	O	13	VMOD
22	IL-1-dependent	IL-1-dependent	B-NP	JJ	O	24	NMOD
23	NFkappaB	NFkappaB	I-NP	NN	B-protein	24	NMOD
24	activity	activity	I-NP	NN	O	21	OBJ
25	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	12	VMOD
2	clones	clone	B-NP	NNS	O	1	PMOD
3	stably	stably	B-VP	RB	O	4	VMOD
4	overexpressing	overexpresse	I-VP	VBG	O	2	NMOD
5	hIRAK	hIRAK	B-NP	NN	B-protein	4	OBJ
6	a	a	B-NP	DT	O	9	NMOD
7	weak	weak	I-NP	JJ	O	9	NMOD
8	constitutive	constitutive	I-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	12	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	NFkappaB	NFkappaB	B-NP	NN	B-protein	10	PMOD
12	correlated	correlate	B-VP	VBD	O	0	ROOT
13	with	with	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	18	NMOD
15	low	low	I-NP	JJ	O	18	NMOD
16	basal	basal	I-NP	JJ	O	18	NMOD
17	IL-2	IL-2	I-NP	NN	B-protein	18	NMOD
18	production	production	I-NP	NN	O	13	PMOD
19	which	which	B-NP	WDT	O	18	NMOD
20	was	be	B-VP	VBD	O	19	SBAR
21	enhanced	enhance	I-VP	VBN	O	20	VC
22	in	in	B-PP	IN	O	21	VMOD
23	an	an	B-NP	DT	O	25	NMOD
24	IL-1-dependent	IL-1-dependent	I-NP	JJ	O	25	NMOD
25	manner	manner	I-NP	NN	O	22	PMOD
26	.	.	O	.	O	12	P

1	Compared	Compare	B-PP	VBN	O	14	VMOD
2	to	to	B-PP	TO	O	1	PMOD
3	the	the	B-NP	DT	O	6	NMOD
4	parental	parental	I-NP	JJ	B-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	line	line	I-NP	NN	I-cell_line	2	PMOD
7	the	the	B-NP	DT	O	9	NMOD
8	dose-response	dose-response	I-NP	JJ	O	9	NMOD
9	curve	curve	I-NP	NN	O	14	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	IL-1-induced	IL-1-induced	B-NP	JJ	O	13	NMOD
12	IL-2	IL-2	I-NP	NN	B-protein	13	NMOD
13	production	production	I-NP	NN	O	10	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	shifted	shift	I-VP	VBN	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	both	both	O	CC	O	20	NMOD
18	potency	potency	B-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	efficacy	efficacy	I-NP	NN	O	16	PMOD
21	.	.	O	.	O	14	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	IRAK	IRAK	B-NP	NN	B-protein	7	SUB
6	directly	directly	B-ADVP	RB	O	7	VMOD
7	triggers	trigger	B-VP	VBZ	O	4	SBAR
8	NFkappaB-mediated	NFkappaB-mediated	B-NP	JJ	B-DNA	10	NMOD
9	gene	gene	I-NP	NN	I-DNA	10	NMOD
10	expression	expression	I-NP	NN	O	7	OBJ
11	in	in	B-PP	IN	O	10	NMOD
12	EL4	EL4	B-NP	NN	B-cell_line	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_line	11	PMOD
14	.	.	O	.	O	3	P

1	Qualitatively	Qualitatively	B-NP	RB	O	2	AMOD
2	different	different	I-NP	JJ	O	3	NMOD
3	effects	effect	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	observed	observe	I-VP	VBN	O	4	VC
6	for	for	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	IL-1-induced	IL-1-induced	I-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	stress-activated	stress-activated	B-NP	JJ	B-protein	19	NMOD
12	protein	protein	I-NP	NN	I-protein	19	NMOD
13	(	(	O	(	I-protein	19	P
14	SAP	SAP	B-NP	NN	I-protein	16	NMOD
15	)	)	O	)	I-protein	16	P
16	kinases	kinase	B-NP	NNS	I-protein	19	NMOD
17	:	:	O	:	O	19	P
18	permanent	permanent	B-NP	JJ	O	19	NMOD
19	overexpression	overexpression	I-NP	NN	O	10	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	IRAK	IRAK	B-NP	NN	B-protein	20	PMOD
22	did	do	B-VP	VBD	O	4	VMOD
23	not	not	I-VP	RB	O	22	VMOD
24	affect	affect	I-VP	VB	O	22	VC
25	the	the	B-NP	DT	O	27	NMOD
26	dose	dose	I-NP	NN	O	27	NMOD
27	dependence	dependence	I-NP	NN	O	24	OBJ
28	but	but	O	CC	O	4	VMOD
29	prolonged	prolong	B-VP	VBD	O	4	VMOD
30	the	the	B-NP	DT	O	31	NMOD
31	kinetics	kinetic	I-NP	NNS	O	29	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	IL-1-induced	IL-1-induced	B-NP	JJ	O	34	NMOD
34	activation	activation	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	SAP	SAP	B-NP	NN	B-protein	37	NMOD
37	kinases	kinase	I-NP	NNS	I-protein	35	PMOD
38	,	,	O	,	O	4	P
39	suggesting	suggest	B-VP	VBG	O	4	VMOD
40	that	that	B-SBAR	IN	O	39	VMOD
41	this	this	B-NP	DT	O	43	NMOD
42	signaling	signaling	I-NP	NN	O	43	NMOD
43	branch	branch	I-NP	NN	O	44	SUB
44	may	may	B-VP	MD	O	40	SBAR
45	be	be	I-VP	VB	O	44	VC
46	regulated	regulate	I-VP	VBN	O	45	VC
47	by	by	B-PP	IN	O	46	VMOD
48	distinct	distinct	B-NP	JJ	O	49	NMOD
49	mechanisms	mechanism	I-NP	NNS	O	47	PMOD
50	.	.	O	.	O	4	P

1	Decreased	Decrease	B-NP	VBN	O	7	NMOD
2	IL-12	IL-12	I-NP	NN	B-protein	3	NMOD
3	production	production	I-NP	NN	O	7	NMOD
4	and	and	I-NP	CC	O	7	NMOD
5	Th1	Th1	I-NP	NN	O	7	NMOD
6	cell	cell	I-NP	NN	O	7	NMOD
7	development	development	I-NP	NN	O	0	ROOT
8	by	by	B-PP	IN	O	7	NMOD
9	acetyl	acetyl	B-NP	NN	O	12	NMOD
10	salicylic	salicylic	I-NP	JJ	O	12	NMOD
11	acid-mediated	acid-mediated	I-NP	JJ	O	12	NMOD
12	inhibition	inhibition	I-NP	NN	O	8	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	PMOD
15	.	.	O	.	O	7	P

1	IL-12	IL-12	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	6	NMOD
4	75-kDa	75-kDa	I-NP	JJ	B-protein	6	NMOD
5	heterodimeric	heterodimeric	I-NP	JJ	I-protein	6	NMOD
6	cytokine	cytokine	I-NP	NN	I-protein	2	PRD
7	composed	compose	B-VP	VBN	O	6	NMOD
8	of	of	B-PP	IN	O	7	VMOD
9	two	two	B-NP	CD	O	15	NMOD
10	covalently	covalently	I-NP	RB	O	11	AMOD
11	linked	link	I-NP	VBN	O	15	NMOD
12	p35	p35	I-NP	NN	B-protein	15	NMOD
13	and	and	I-NP	CC	O	15	NMOD
14	p40	p40	I-NP	NN	B-protein	15	NMOD
15	chains	chain	I-NP	NNS	I-protein	8	PMOD
16	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	3	NMOD
2	pro-inflammatory	pro-inflammatory	I-NP	JJ	B-protein	3	NMOD
3	cytokine	cytokine	I-NP	NN	I-protein	4	SUB
4	plays	play	B-VP	VBZ	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	prominent	prominent	I-NP	JJ	O	7	NMOD
7	role	role	I-NP	NN	O	4	OBJ
8	in	in	B-PP	IN	O	4	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	development	development	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	Th1	Th1	B-NP	NN	O	15	NMOD
13	cell-mediated	cell-mediated	I-NP	JJ	O	15	NMOD
14	immune	immune	I-NP	JJ	O	15	NMOD
15	responses	response	I-NP	NNS	O	11	PMOD
16	.	.	O	.	O	4	P

1	Th1	Th1	B-NP	NN	O	4	NMOD
2	cell-mediated	cell-mediated	I-NP	JJ	O	4	NMOD
3	immune	immune	I-NP	JJ	O	4	NMOD
4	responses	response	I-NP	NNS	O	5	SUB
5	have	have	B-VP	VBP	O	0	ROOT
6	been	be	I-VP	VBN	O	5	VC
7	implicated	implicate	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	pathogenesis	pathogenesis	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	chronic	chronic	B-NP	JJ	O	15	NMOD
13	inflammatory	inflammatory	I-NP	JJ	O	15	NMOD
14	autoimmune	autoimmune	I-NP	JJ	O	15	NMOD
15	diseases	disease	I-NP	NNS	O	11	PMOD
16	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	IL-12	IL-12	B-NP	NN	B-protein	4	SUB
4	appears	appear	B-VP	VBZ	O	0	ROOT
5	to	to	I-VP	TO	O	6	VMOD
6	be	be	I-VP	VB	O	4	VMOD
7	a	a	B-NP	DT	O	9	NMOD
8	critical	critical	I-NP	JJ	O	9	NMOD
9	factor	factor	I-NP	NN	O	6	PRD
10	in	in	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	generation	generation	I-NP	NN	O	14	NMOD
13	and	and	I-NP	CC	O	14	NMOD
14	maintenance	maintenance	I-NP	NN	O	10	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	chronic	chronic	B-NP	JJ	O	18	NMOD
17	inflammatory	inflammatory	I-NP	JJ	O	18	NMOD
18	conditions	condition	I-NP	NNS	O	15	PMOD
19	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	investigated	investigate	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	effects	effect	I-NP	NNS	O	18	NMOD
9	of	of	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	14	NMOD
11	commonly	commonly	I-NP	RB	O	12	AMOD
12	prescribed	prescribe	I-NP	VBN	O	14	NMOD
13	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	14	NMOD
14	drug	drug	I-NP	NN	O	9	PMOD
15	,	,	O	,	O	18	P
16	acetyl	acetyl	B-NP	NN	O	18	NMOD
17	salicylic	salicylic	I-NP	JJ	O	18	NMOD
18	acid	acid	I-NP	NN	O	6	OBJ
19	(	(	O	(	O	20	P
20	ASA	ASA	B-NP	NN	O	18	NMOD
21	)	)	O	)	O	20	P
22	,	,	O	,	O	6	P
23	on	on	B-PP	IN	O	6	VMOD
24	IL-12	IL-12	B-NP	NN	B-protein	25	NMOD
25	production	production	I-NP	NN	O	29	NMOD
26	and	and	O	CC	O	29	NMOD
27	Th1	Th1	B-NP	NN	O	29	NMOD
28	cell	cell	I-NP	NN	O	29	NMOD
29	development	development	I-NP	NN	O	23	PMOD
30	.	.	O	.	O	6	P

1	ASA	ASA	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	found	find	I-VP	VBN	O	2	VC
4	to	to	I-VP	TO	O	5	VMOD
5	inhibit	inhibit	I-VP	VB	O	3	VMOD
6	secretion	secretion	B-NP	NN	O	15	NMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	IL-12	IL-12	I-NP	NN	B-protein	10	NMOD
10	heterodimer	heterodimer	I-NP	NN	I-protein	7	PMOD
11	as	as	B-CONJP	RB	O	15	NMOD
12	well	well	I-CONJP	RB	O	11	DEP
13	as	as	I-CONJP	IN	O	11	DEP
14	p40	p40	B-NP	NN	B-protein	15	NMOD
15	monomer	monomer	I-NP	NN	I-protein	5	OBJ
16	by	by	B-PP	IN	O	15	NMOD
17	human	human	B-NP	JJ	B-cell_type	19	NMOD
18	monocytic	monocytic	I-NP	JJ	I-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
20	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	associated	associate	I-VP	VBN	O	2	VC
4	with	with	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	down-regulation	down-regulation	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	IL-12p40	IL-12p40	B-NP	NN	B-RNA	10	NMOD
9	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD
10	expression	expression	I-NP	NN	O	7	PMOD
11	.	.	O	.	O	2	P

1	Analysis	Analysis	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	p40	p40	I-NP	NN	B-DNA	9	NMOD
8	gene	gene	I-NP	NN	I-DNA	9	NMOD
9	promoter	promoter	I-NP	NN	I-DNA	5	PMOD
10	revealed	reveal	B-VP	VBD	O	0	ROOT
11	that	that	B-SBAR	IN	O	10	VMOD
12	ASA	ASA	B-NP	NN	O	13	SUB
13	inhibited	inhibit	B-VP	VBD	O	11	SBAR
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	15	NMOD
15	activation	activation	I-NP	NN	O	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	binding	binding	B-NP	NN	O	13	OBJ
18	to	to	B-PP	TO	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	p40-kappaB	p40-kappaB	I-NP	NN	B-DNA	21	NMOD
21	site	site	I-NP	NN	I-DNA	18	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	p40	p40	I-NP	NN	B-DNA	25	NMOD
25	promoter	promoter	I-NP	NN	I-DNA	22	PMOD
26	,	,	O	,	O	13	P
27	leading	lead	B-VP	VBG	O	13	VMOD
28	to	to	B-PP	TO	O	27	VMOD
29	transcriptional	transcriptional	B-NP	JJ	O	30	NMOD
30	repression	repression	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	p40	p40	I-NP	NN	B-DNA	34	NMOD
34	gene	gene	I-NP	NN	I-DNA	31	PMOD
35	.	.	O	.	O	10	P

1	Addition	Addition	B-NP	NN	O	25	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	ASA	ASA	B-NP	NN	O	2	PMOD
4	to	to	B-PP	TO	O	1	NMOD
5	an	an	B-NP	DT	O	12	NMOD
6	in	in	I-NP	FW	O	7	AMOD
7	vitro	vitro	I-NP	FW	O	12	NMOD
8	T	T	I-NP	NN	O	12	NMOD
9	helper	helper	I-NP	NN	O	12	NMOD
10	cell	cell	I-NP	NN	O	12	NMOD
11	differentiation	differentiation	I-NP	NN	O	12	NMOD
12	system	system	I-NP	NN	O	4	PMOD
13	,	,	O	,	O	1	P
14	at	at	B-PP	IN	O	1	NMOD
15	concentrations	concentration	B-NP	NNS	O	14	PMOD
16	compatible	compatible	B-ADJP	JJ	O	15	NMOD
17	with	with	B-PP	IN	O	16	AMOD
18	plasma	plasma	B-NP	NN	O	19	NMOD
19	levels	level	I-NP	NNS	O	17	PMOD
20	reached	reach	B-VP	VBN	O	19	NMOD
21	during	during	B-PP	IN	O	20	VMOD
22	anti-inflammatory	anti-inflammatory	B-NP	JJ	O	23	NMOD
23	therapy	therapy	I-NP	NN	O	21	PMOD
24	,	,	O	,	O	1	P
25	resulted	result	B-VP	VBD	O	0	ROOT
26	in	in	B-PP	IN	O	25	VMOD
27	reduced	reduce	B-NP	VBN	O	28	NMOD
28	development	development	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	Th1	Th1	B-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
32	.	.	O	.	O	25	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	inhibition	inhibition	I-NP	NN	O	12	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	9	NMOD
9	activation	activation	I-NP	NN	O	7	PMOD
10	by	by	B-PP	IN	O	6	NMOD
11	ASA	ASA	B-NP	NN	O	10	PMOD
12	leads	lead	B-VP	VBZ	O	4	SBAR
13	to	to	B-PP	TO	O	12	VMOD
14	down-regulation	down-regulation	B-NP	NN	O	19	NMOD
15	of	of	B-PP	IN	O	14	NMOD
16	IL-12	IL-12	B-NP	NN	B-protein	17	NMOD
17	production	production	I-NP	NN	O	15	PMOD
18	and	and	I-NP	CC	O	19	NMOD
19	inhibition	inhibition	I-NP	NN	O	13	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	Th1	Th1	B-NP	NN	O	23	NMOD
22	cell	cell	I-NP	NN	O	23	NMOD
23	development	development	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	3	P

1	Membrane-associated	Membrane-associated	B-NP	JJ	B-protein	2	NMOD
2	lymphotoxin	lymphotoxin	I-NP	NN	I-protein	7	SUB
3	on	on	B-PP	IN	O	2	NMOD
4	natural	natural	B-NP	JJ	B-cell_type	6	NMOD
5	killer	killer	I-NP	NN	I-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
7	activates	activate	B-VP	VBZ	O	0	ROOT
8	endothelial	endothelial	B-NP	JJ	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	OBJ
10	via	via	B-PP	IN	O	7	VMOD
11	an	an	B-NP	DT	O	13	NMOD
12	NF-kappaB-dependent	NF-kappaB-dependent	I-NP	JJ	O	13	NMOD
13	pathway	pathway	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	7	P

1	BACKGROUND	BACKGROUND	B-NP	NN	O	3	NMOD
2	:	:	O	:	O	1	P
3	Inhibition	Inhibition	B-NP	NN	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	complement	complement	B-NP	NN	O	4	PMOD
6	in	in	B-PP	IN	O	3	NMOD
7	small	small	B-NP	JJ	O	9	NMOD
8	animal	animal	I-NP	NN	O	9	NMOD
9	models	model	I-NP	NNS	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	xenotransplantation	xenotransplantation	B-NP	NN	O	10	PMOD
12	has	have	B-VP	VBZ	O	0	ROOT
13	demonstrated	demonstrate	I-VP	VBN	O	12	VC
14	graft	graft	B-NP	NN	O	15	NMOD
15	infiltration	infiltration	I-NP	NN	O	13	OBJ
16	with	with	B-PP	IN	O	15	NMOD
17	natural	natural	B-NP	JJ	B-cell_type	18	NMOD
18	killer	killer	I-NP	NN	I-cell_type	24	NMOD
19	(	(	O	(	I-cell_type	20	P
20	NK	NK	B-NP	NN	I-cell_type	18	NMOD
21	)	)	O	)	I-cell_type	20	P
22	cells	cell	B-NP	NNS	I-cell_type	18	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	monocytes	monocyte	I-NP	NNS	B-cell_type	16	PMOD
25	associated	associate	B-VP	VBN	O	24	NMOD
26	with	with	B-PP	IN	O	25	VMOD
27	endothelial	endothelial	B-NP	JJ	B-cell_type	28	NMOD
28	cell	cell	I-NP	NN	I-cell_type	26	PMOD
29	(	(	O	(	O	30	P
30	EC	EC	B-NP	NN	B-cell_type	28	NMOD
31	)	)	O	)	O	30	P
32	activation	activation	B-NP	NN	O	28	NMOD
33	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	previously	previously	I-VP	RB	O	2	VMOD
4	demonstrated	demonstrate	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	human	human	B-NP	JJ	B-cell_type	8	NMOD
7	NK	NK	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	9	SUB
9	activate	activate	B-VP	VBP	O	5	SBAR
10	porcine	porcine	B-NP	JJ	O	11	NMOD
11	EC	EC	I-NP	NN	B-cell_type	9	OBJ
12	in	in	B-ADVP	FW	O	9	VMOD
13	vitro	vitro	I-ADVP	FW	O	12	AMOD
14	,	,	O	,	O	9	P
15	which	which	B-NP	WDT	O	9	VMOD
16	results	result	B-VP	VBZ	O	15	SBAR
17	in	in	B-PP	IN	O	16	VMOD
18	adhesion	adhesion	B-NP	NN	B-protein	20	NMOD
19	molecule	molecule	I-NP	NN	I-protein	20	NMOD
20	expression	expression	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	cytokine	cytokine	B-NP	NN	B-protein	23	NMOD
23	secretion	secretion	I-NP	NN	O	17	PMOD
24	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	used	use	B-VP	VBD	O	0	ROOT
7	the	the	B-NP	DT	O	11	NMOD
8	NK	NK	I-NP	NN	B-cell_line	11	NMOD
9	cell	cell	I-NP	NN	I-cell_line	11	NMOD
10	line	line	I-NP	NN	I-cell_line	11	NMOD
11	NK92	NK92	I-NP	NN	I-cell_line	6	OBJ
12	to	to	B-VP	TO	O	13	VMOD
13	define	define	I-VP	VB	O	6	VMOD
14	the	the	B-NP	DT	O	18	NMOD
15	molecular	molecular	I-NP	JJ	O	17	AMOD
16	and	and	I-NP	CC	O	17	AMOD
17	cellular	cellular	I-NP	JJ	O	18	NMOD
18	basis	basis	I-NP	NN	O	13	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	NK	NK	B-NP	NN	O	23	NMOD
21	cell-mediated	cell-mediated	I-NP	JJ	O	20	AMOD
22	EC	EC	I-NP	NN	B-cell_type	23	NMOD
23	activation	activation	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	6	P

1	METHODS	METHODS	B-NP	NNS	O	3	NMOD
2	:	:	O	:	O	3	P
3	EC	EC	B-NP	NNS	B-cell_type	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	transfected	transfecte	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	either	either	O	CC	O	6	PMOD
8	reporter	reporter	B-NP	NN	B-DNA	9	NMOD
9	constructs	construct	I-NP	NNS	I-DNA	7	OBJ
10	containing	contain	B-VP	VBG	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	luciferase	luciferase	I-NP	NN	B-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	10	OBJ
14	driven	drive	B-VP	VBN	O	13	NMOD
15	either	either	B-PP	CC	O	16	PMOD
16	by	by	I-PP	IN	O	14	VMOD
17	E-selectin	E-selectin	B-NP	NN	B-protein	21	NMOD
18	or	or	O	CC	O	21	NMOD
19	interleukin	interleukin	B-NP	NN	B-DNA	21	NMOD
20	(	(	O	(	I-DNA	21	P
21	IL	IL	B-NP	NN	I-DNA	24	NMOD
22	)	)	O	)	I-DNA	21	P
23	-8	-8	B-NP	CD	I-DNA	21	NMOD
24	promoters	promoter	I-NP	NNS	I-DNA	29	NMOD
25	or	or	O	CC	O	29	NMOD
26	a	a	B-NP	DT	O	27	NMOD
27	synthetic	synthetic	I-NP	JJ	O	29	NMOD
28	NF-kappaB-dependent	NF-kappaB-dependent	I-NP	JJ	B-DNA	29	NMOD
29	promoter	promoter	I-NP	NN	I-DNA	16	PMOD
30	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	17	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	17	P
4	a	a	B-NP	DT	O	16	NMOD
5	dominant-negative	dominant-negative	I-NP	JJ	B-DNA	16	NMOD
6	mutant	mutant	I-NP	JJ	I-DNA	16	NMOD
7	tumor	tumor	I-NP	NN	I-DNA	16	NMOD
8	necrosis	necrosis	I-NP	NN	I-DNA	16	NMOD
9	factor	factor	I-NP	NN	I-DNA	16	NMOD
10	receptor	receptor	I-NP	NN	I-DNA	16	NMOD
11	I	I	I-NP	CD	I-DNA	16	NMOD
12	(	(	O	(	I-DNA	16	P
13	TNFRI	TNFRI	B-NP	NN	I-DNA	16	NMOD
14	)	)	O	)	I-DNA	16	P
15	expression	expression	B-NP	NN	I-DNA	16	NMOD
16	vector	vector	I-NP	NN	I-DNA	17	SUB
17	was	be	B-VP	VBD	O	0	ROOT
18	co-transfected	co-transfecte	I-VP	VBN	O	17	VC
19	in	in	B-PP	IN	O	18	VMOD
20	inhibition	inhibition	B-NP	NN	O	21	NMOD
21	studies	study	I-NP	NNS	O	19	PMOD
22	.	.	O	.	O	17	P

1	Forty-eight	Forty-eight	B-NP	CD	O	2	NMOD
2	hours	hour	I-NP	NNS	O	3	PMOD
3	after	after	B-PP	IN	O	7	VMOD
4	transfection	transfection	B-NP	NN	O	3	PMOD
5	,	,	O	,	O	7	P
6	EC	EC	B-NP	NN	B-cell_type	7	SUB
7	were	be	B-VP	VBD	O	0	ROOT
8	stimulated	stimulate	I-VP	VBN	O	7	VC
9	with	with	B-PP	IN	O	8	VMOD
10	NK	NK	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	16	NMOD
12	or	or	O	CC	O	16	NMOD
13	NK	NK	B-NP	NN	B-cell_type	16	NMOD
14	cell	cell	I-NP	NN	I-cell_type	16	NMOD
15	membrane	membrane	I-NP	NN	I-cell_type	16	NMOD
16	extracts	extract	I-NP	NNS	I-cell_type	9	PMOD
17	for	for	B-PP	IN	O	16	NMOD
18	7	7	B-NP	CD	O	19	NMOD
19	hr	hr	I-NP	NN	O	21	NMOD
20	and	and	I-NP	CC	O	21	NMOD
21	activation	activation	I-NP	NN	O	17	PMOD
22	was	be	B-VP	VBD	O	7	VMOD
23	measured	measure	I-VP	VBN	O	22	VC
24	by	by	B-PP	IN	O	23	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	luciferase	luciferase	I-NP	NN	B-protein	27	NMOD
27	assay	assay	I-NP	NN	O	24	PMOD
28	.	.	O	.	O	7	P

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT
2	:	:	O	:	O	1	P
3	Co-culture	Co-culture	B-NP	NN	O	10	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	NK	NK	B-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
7	with	with	B-PP	IN	O	3	NMOD
8	transfected	transfecte	B-NP	VBN	O	9	NMOD
9	EC	EC	I-NP	NN	B-cell_type	7	PMOD
10	enhanced	enhance	B-VP	VBD	O	1	NMOD
11	E-selectin	E-selectin	B-NP	NN	B-protein	18	NMOD
12	,	,	O	,	O	18	P
13	IL-8	IL-8	B-NP	NN	B-protein	18	NMOD
14	,	,	O	,	O	18	P
15	and	and	O	CC	O	18	NMOD
16	NF-kappaB-dependent	NF-kappaB-dependent	B-NP	JJ	B-DNA	18	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	18	NMOD
18	activity	activity	I-NP	NN	O	10	OBJ
19	.	.	O	.	O	10	P

1	NK	NK	B-NP	NN	O	4	NMOD
2	cell	cell	I-NP	NN	O	4	NMOD
3	membrane	membrane	I-NP	NN	O	4	NMOD
4	extracts	extract	I-NP	NNS	O	5	SUB
5	retained	retain	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	7	NMOD
7	capacity	capacity	I-NP	NN	O	5	OBJ
8	to	to	B-VP	TO	O	9	VMOD
9	activate	activate	I-VP	VB	O	7	NMOD
10	EC	EC	B-NP	NN	B-cell_type	9	OBJ
11	and	and	O	CC	O	5	VMOD
12	induced	induce	B-VP	VBD	O	5	VMOD
13	nuclear	nuclear	B-NP	JJ	O	14	NMOD
14	translocation	translocation	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	15	PMOD
17	(	(	O	(	O	20	P
18	p50	p50	B-NP	NN	B-protein	20	NMOD
19	and	and	O	CC	O	20	NMOD
20	p65	p65	B-NP	NN	B-protein	16	NMOD
21	)	)	O	)	O	20	P
22	.	.	O	.	O	5	P

1	Western	Western	B-NP	NN	O	2	NMOD
2	blotting	blotting	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NK	NK	B-NP	NN	B-cell_type	5	NMOD
5	cell	cell	I-NP	NN	I-cell_type	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	membrane	membrane	I-NP	NN	O	8	NMOD
8	extracts	extract	I-NP	NNS	O	3	PMOD
9	detected	detect	B-VP	VBD	O	0	ROOT
10	the	the	B-NP	DT	O	11	NMOD
11	presence	presence	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	Lymphotoxin-alpha	Lymphotoxin-alpha	B-NP	NN	B-protein	21	NMOD
14	(	(	O	(	O	15	P
15	LTalpha	LTalpha	B-NP	NN	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	but	but	B-NP	CC	O	21	NMOD
18	not	not	I-NP	RB	O	17	DEP
19	tumor	tumor	B-NP	NN	B-protein	21	NMOD
20	necrosis	necrosis	I-NP	NN	I-protein	21	NMOD
21	factor-alpha	factor-alpha	I-NP	NN	I-protein	12	PMOD
22	.	.	O	.	O	9	P

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	LTalpha	LTalpha	B-NP	NN	B-protein	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	secreted	secrete	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	NK	NK	B-NP	NN	B-cell_line	6	PMOD
8	:	:	O	:	I-cell_line	4	P
9	EC	EC	B-NP	NN	I-cell_line	10	NMOD
10	co-cultures	co-culture	I-NP	NNS	I-cell_line	4	PRD
11	.	.	O	.	O	4	P

1	Co-transfection	Co-transfection	B-NP	NN	O	6	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	dominant-negative	dominant-negative	B-NP	JJ	B-protein	5	NMOD
4	mutant	mutant	I-NP	JJ	I-protein	5	NMOD
5	TNFRI	TNFRI	I-NP	NN	I-protein	2	PMOD
6	inhibited	inhibit	B-VP	VBD	O	0	ROOT
7	EC	EC	B-NP	NN	B-cell_type	8	NMOD
8	activation	activation	I-NP	NN	O	6	OBJ
9	by	by	B-PP	IN	O	8	NMOD
10	NK	NK	B-NP	NN	B-cell_type	13	NMOD
11	cell	cell	I-NP	NN	I-cell_type	13	NMOD
12	membrane	membrane	I-NP	NN	O	13	NMOD
13	extracts	extract	I-NP	NNS	O	9	PMOD
14	and	and	B-PP	CC	O	6	VMOD
15	by	by	B-PP	IN	O	6	VMOD
16	NK	NK	B-NP	NN	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	by	by	B-PP	IN	O	6	VMOD
19	80	80	B-NP	CD	O	20	NMOD
20	%	%	I-NP	NN	O	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	47	47	B-NP	CD	O	23	NMOD
23	%	%	I-NP	NN	O	18	PMOD
24	,	,	O	,	O	6	P
25	respectively	respectively	B-ADVP	RB	O	6	VMOD
26	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	same	same	I-NP	JJ	O	3	NMOD
3	pattern	pattern	I-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	inhibition	inhibition	B-NP	NN	O	4	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	observed	observe	I-VP	VBN	O	6	VC
8	using	use	B-VP	VBG	O	7	VMOD
9	anti-human	anti-human	B-NP	JJ	O	11	NMOD
10	LT	LT	I-NP	NN	O	11	NMOD
11	sera	serum	I-NP	NNS	O	8	OBJ
12	.	.	O	.	O	6	P

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	8	NMOD
2	:	:	O	:	O	1	P
3	Human	Human	B-NP	JJ	O	8	NMOD
4	NK	NK	I-NP	NN	O	8	NMOD
5	cell	cell	I-NP	NN	O	8	NMOD
6	membrane-bound	membrane-bound	I-NP	JJ	O	8	NMOD
7	LT	LT	I-NP	NN	O	8	NMOD
8	signals	signal	I-NP	NNS	O	0	ROOT
9	across	across	B-PP	IN	O	8	NMOD
10	species	specie	B-NP	NNS	O	9	PMOD
11	via	via	B-PP	IN	O	10	NMOD
12	TNFRI	TNFRI	B-NP	NN	B-protein	11	PMOD
13	,	,	O	,	O	8	P
14	leading	lead	B-VP	VBG	O	8	NMOD
15	to	to	B-PP	TO	O	14	VMOD
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	NMOD
17	nuclear	nuclear	I-NP	JJ	O	18	NMOD
18	translocation	translocation	I-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	transcription	transcription	I-NP	NN	O	15	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	E-selectin	E-selectin	B-NP	NN	B-protein	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	IL-8	IL-8	I-NP	NN	B-protein	21	PMOD
25	,	,	O	,	O	24	P
26	which	which	B-NP	WDT	O	24	NMOD
27	results	result	B-VP	VBZ	O	26	SBAR
28	in	in	B-PP	IN	O	27	VMOD
29	EC	EC	B-NP	NN	B-cell_type	30	NMOD
30	activation	activation	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	discrepancy	discrepancy	I-NP	NN	O	17	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	degree	degree	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	inhibition	inhibition	B-NP	NN	O	6	PMOD
8	by	by	B-PP	IN	O	5	NMOD
9	membrane	membrane	B-NP	NN	O	10	NMOD
10	extracts	extract	I-NP	NNS	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	NK	NK	B-NP	NN	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
14	with	with	B-PP	IN	O	5	NMOD
15	mutant	mutant	B-NP	JJ	B-protein	16	NMOD
16	TNFRI	TNFRI	I-NP	NN	I-protein	14	PMOD
17	suggests	suggest	B-VP	VBZ	O	0	ROOT
18	that	that	B-SBAR	IN	O	17	VMOD
19	additional	additional	B-NP	JJ	O	20	NMOD
20	pathways	pathway	I-NP	NNS	O	21	SUB
21	are	be	B-VP	VBP	O	18	SBAR
22	utilized	utilize	I-VP	VBN	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	NK	NK	B-NP	NN	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
26	to	to	B-VP	TO	O	27	VMOD
27	activate	activate	I-VP	VB	O	21	VMOD
28	EC	EC	B-NP	NN	B-cell_type	27	OBJ
29	.	.	O	.	O	17	P

1	The	The	B-NP	DT	O	2	NMOD
2	involvement	involvement	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	multiple	multiple	B-NP	JJ	O	13	NMOD
5	tumor	tumor	I-NP	NN	B-protein	13	NMOD
6	necrosis	necrosis	I-NP	NN	I-protein	13	NMOD
7	factor	factor	I-NP	NN	I-protein	13	NMOD
8	receptor	receptor	I-NP	NN	I-protein	13	NMOD
9	(	(	I-NP	(	I-protein	13	P
10	TNFR	TNFR	I-NP	NN	I-protein	13	NMOD
11	)	)	I-NP	)	I-protein	13	P
12	-associated	-associated	I-NP	JJ	I-protein	13	NMOD
13	factors	factor	I-NP	NNS	I-protein	3	PMOD
14	in	in	B-PP	IN	O	2	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	signaling	signaling	I-NP	NN	O	17	NMOD
17	mechanisms	mechanism	I-NP	NNS	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	receptor	receptor	B-NP	NN	O	20	NMOD
20	activator	activator	I-NP	NN	O	25	NMOD
21	of	of	B-PP	IN	O	20	NMOD
22	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	21	PMOD
23	,	,	O	,	O	25	P
24	a	a	B-NP	DT	O	25	NMOD
25	member	member	I-NP	NN	O	18	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	TNFR	TNFR	I-NP	NN	B-protein	29	NMOD
29	superfamily	superfamily	I-NP	NN	I-protein	26	PMOD
30	.	.	O	.	O	2	P

1	Receptor	Receptor	B-NP	NN	O	2	NMOD
2	activator	activator	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	6	P
6	RANK	RANK	B-NP	NN	B-protein	4	NMOD
7	)	)	O	)	O	6	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	12	NMOD
10	recently	recently	I-NP	RB	O	11	AMOD
11	identified	identify	I-NP	VBN	O	12	NMOD
12	member	member	I-NP	NN	O	8	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	19	NMOD
15	tumor	tumor	I-NP	NN	B-protein	19	NMOD
16	necrosis	necrosis	I-NP	NN	I-protein	19	NMOD
17	factor	factor	I-NP	NN	I-protein	19	NMOD
18	receptor	receptor	I-NP	NN	I-protein	19	NMOD
19	superfamily	superfamily	I-NP	NN	I-protein	13	PMOD
20	and	and	O	CC	O	8	VMOD
21	is	be	B-VP	VBZ	O	8	VMOD
22	expressed	express	I-VP	VBN	O	21	VC
23	on	on	B-PP	IN	O	22	VMOD
24	activated	activate	B-NP	VBN	B-cell_type	26	NMOD
25	T	T	I-NP	NN	I-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	29	NMOD
27	and	and	O	CC	O	29	NMOD
28	dendritic	dendritic	B-NP	JJ	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
30	.	.	O	.	O	8	P

1	Its	Its	B-NP	PRP$	O	3	NMOD
2	cognate	cognate	I-NP	JJ	B-protein	3	NMOD
3	ligand	ligand	I-NP	NN	I-protein	7	SUB
4	(	(	O	(	O	5	P
5	RANKL	RANKL	B-NP	NN	B-protein	3	NMOD
6	)	)	O	)	O	5	P
7	plays	play	B-VP	VBZ	O	0	ROOT
8	significant	significant	B-NP	JJ	O	9	NMOD
9	roles	role	I-NP	NNS	O	7	OBJ
10	in	in	B-PP	IN	O	7	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	activation	activation	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	dendritic	dendritic	B-NP	JJ	O	16	NMOD
15	cell	cell	I-NP	NN	O	16	NMOD
16	function	function	I-NP	NN	O	19	NMOD
17	and	and	O	CC	O	19	NMOD
18	osteoclast	osteoclast	B-NP	NN	O	19	NMOD
19	differentiation	differentiation	I-NP	NN	O	13	PMOD
20	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	interaction	interaction	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	RANK	RANK	B-NP	NN	B-protein	6	PMOD
8	with	with	B-PP	IN	O	5	NMOD
9	tumor	tumor	B-NP	NN	B-protein	11	AMOD
10	necrosis	necrosis	I-NP	NN	I-protein	11	AMOD
11	factor	factor	I-NP	NN	I-protein	13	NMOD
12	receptor-associated	receptor-associated	I-NP	JJ	I-protein	13	NMOD
13	factors	factor	I-NP	NNS	I-protein	8	PMOD
14	(	(	O	(	O	15	P
15	TRAFs	TRAF	B-NP	NNS	B-protein	13	NMOD
16	)	)	O	)	O	15	P
17	1	1	B-NP	CD	O	26	NMOD
18	,	,	I-NP	,	O	26	P
19	2	2	I-NP	CD	O	26	NMOD
20	,	,	I-NP	,	O	26	P
21	3	3	I-NP	CD	O	26	NMOD
22	,	,	I-NP	,	O	26	P
23	5	5	I-NP	CD	O	26	NMOD
24	,	,	O	,	O	26	P
25	and	and	O	CC	O	26	NMOD
26	6	6	B-NP	CD	O	13	NMOD
27	both	both	O	CC	O	28	AMOD
28	in	in	B-ADVP	FW	O	26	NMOD
29	vitro	vitro	I-ADVP	FW	O	28	AMOD
30	and	and	O	CC	O	28	AMOD
31	in	in	B-PP	IN	O	28	AMOD
32	cells	cell	B-NP	NNS	O	31	PMOD
33	.	.	O	.	O	2	P

1	Mapping	Mapping	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	structural	structural	I-NP	JJ	O	5	NMOD
5	requirements	requirement	I-NP	NNS	O	2	PMOD
6	for	for	B-PP	IN	O	5	NMOD
7	TRAF/RANK	TRAF/RANK	B-NP	NN	B-protein	8	NMOD
8	interaction	interaction	I-NP	NN	O	6	PMOD
9	revealed	reveal	B-VP	VBD	O	0	ROOT
10	multiple	multiple	B-NP	JJ	O	13	NMOD
11	TRAF	TRAF	I-NP	NN	B-protein	13	NMOD
12	binding	binding	I-NP	NN	I-protein	13	NMOD
13	sites	site	I-NP	NNS	I-protein	9	OBJ
14	clustered	cluster	B-VP	VBN	O	13	NMOD
15	in	in	B-PP	IN	O	14	VMOD
16	two	two	B-NP	CD	O	18	NMOD
17	distinct	distinct	I-NP	JJ	O	18	NMOD
18	domains	domain	I-NP	NNS	O	15	PMOD
19	in	in	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	RANK	RANK	I-NP	NN	B-protein	23	NMOD
22	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	23	NMOD
23	tail	tail	I-NP	NN	I-protein	19	PMOD
24	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	4	NMOD
2	TRAF	TRAF	I-NP	NN	B-protein	4	NMOD
3	binding	binding	I-NP	NN	I-protein	4	NMOD
4	domains	domain	I-NP	NNS	I-protein	5	SUB
5	were	be	B-VP	VBD	O	0	ROOT
6	shown	show	I-VP	VBN	O	5	VC
7	to	to	I-VP	TO	O	8	VMOD
8	be	be	I-VP	VB	O	6	VMOD
9	functionally	functionally	B-ADJP	RB	O	10	AMOD
10	important	important	I-ADJP	JJ	O	8	PRD
11	for	for	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	14	NMOD
13	RANK-dependent	RANK-dependent	I-NP	JJ	O	14	NMOD
14	induction	induction	I-NP	NN	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	21	NMOD
17	and	and	O	CC	O	21	NMOD
18	c-Jun	c-Jun	B-NP	NN	B-protein	21	NMOD
19	NH2-terminal	NH2-terminal	I-NP	JJ	I-protein	21	NMOD
20	kinase	kinase	I-NP	NN	I-protein	21	NMOD
21	activities	activity	I-NP	NNS	O	15	PMOD
22	.	.	O	.	O	5	P

1	Site-directed	Site-directed	B-NP	JJ	O	2	NMOD
2	mutagenesis	mutagenesis	I-NP	NN	O	3	SUB
3	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	these	these	B-NP	DT	O	8	NMOD
6	TRAF	TRAF	I-NP	NN	B-protein	8	NMOD
7	binding	binding	I-NP	NN	I-protein	8	NMOD
8	sites	site	I-NP	NNS	I-protein	9	SUB
9	exhibited	exhibit	B-VP	VBD	O	4	SBAR
10	selective	selective	B-NP	JJ	O	11	NMOD
11	binding	binding	I-NP	NN	O	9	OBJ
12	for	for	B-PP	IN	O	11	NMOD
13	different	different	B-NP	JJ	O	15	NMOD
14	TRAF	TRAF	I-NP	NN	B-protein	15	NMOD
15	proteins	protein	I-NP	NNS	I-protein	12	PMOD
16	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	5	VMOD
2	particular	particular	B-NP	JJ	O	1	PMOD
3	,	,	O	,	O	5	P
4	TRAF6	TRAF6	B-NP	NN	B-protein	5	SUB
5	interacted	interact	B-VP	VBD	O	0	ROOT
6	with	with	B-PP	IN	O	5	VMOD
7	membrane-proximal	membrane-proximal	B-NP	JJ	B-protein	8	NMOD
8	determinants	determinant	I-NP	NNS	I-protein	6	PMOD
9	distinct	distinct	B-ADJP	JJ	O	8	NMOD
10	from	from	B-PP	IN	O	9	AMOD
11	those	those	B-NP	DT	O	21	NMOD
12	binding	bind	I-NP	VBG	O	21	NMOD
13	TRAFs	TRAF	I-NP	NNS	B-protein	21	NMOD
14	1	1	I-NP	CD	I-protein	21	NMOD
15	,	,	I-NP	,	I-protein	21	P
16	2	2	I-NP	CD	I-protein	21	NMOD
17	,	,	I-NP	,	I-protein	21	P
18	3	3	I-NP	CD	I-protein	21	NMOD
19	,	,	O	,	I-protein	21	P
20	and	and	O	CC	I-protein	21	NMOD
21	5	5	B-NP	CD	I-protein	10	PMOD
22	.	.	O	.	O	5	P

1	When	When	B-ADVP	WRB	O	13	VMOD
2	this	this	B-NP	DT	O	6	NMOD
3	membrane-proximal	membrane-proximal	I-NP	JJ	B-protein	6	NMOD
4	TRAF6	TRAF6	I-NP	NN	I-protein	6	NMOD
5	interaction	interaction	I-NP	NN	I-protein	6	NMOD
6	domain	domain	I-NP	NN	I-protein	7	SUB
7	was	be	B-VP	VBD	O	1	SBAR
8	deleted	delete	I-VP	VBN	O	7	VC
9	,	,	O	,	O	13	P
10	RANK-mediated	RANK-mediated	B-NP	JJ	O	12	NMOD
11	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	12	NMOD
12	signaling	signaling	I-NP	NN	O	13	SUB
13	was	be	B-VP	VBD	O	0	ROOT
14	completely	completely	I-VP	RB	O	13	VMOD
15	inhibited	inhibit	I-VP	VBN	O	13	VC
16	while	while	B-SBAR	IN	O	15	VMOD
17	c-Jun	c-Jun	B-NP	NN	B-protein	20	NMOD
18	NH2-terminal	NH2-terminal	I-NP	JJ	I-protein	20	NMOD
19	kinase	kinase	I-NP	NN	I-protein	20	NMOD
20	activation	activation	I-NP	NN	O	21	SUB
21	was	be	B-VP	VBD	O	16	SBAR
22	partially	partially	I-VP	RB	O	21	VMOD
23	inhibited	inhibit	I-VP	VBN	O	21	VC
24	.	.	O	.	O	13	P

1	An	An	B-NP	DT	O	4	NMOD
2	NH2-terminal	NH2-terminal	I-NP	JJ	B-protein	4	NMOD
3	truncation	truncation	I-NP	NN	I-protein	4	NMOD
4	mutant	mutant	I-NP	NN	I-protein	7	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	TRAF6	TRAF6	B-NP	NN	B-protein	5	PMOD
7	inhibited	inhibit	B-VP	VBD	O	0	ROOT
8	RANKL-mediated	RANKL-mediated	B-NP	JJ	O	10	NMOD
9	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	7	OBJ
11	,	,	O	,	O	7	P
12	but	but	O	CC	O	7	VMOD
13	failed	fail	B-VP	VBD	O	7	VMOD
14	to	to	I-VP	TO	O	15	VMOD
15	affect	affect	I-VP	VB	O	13	VMOD
16	constitutive	constitutive	B-NP	JJ	O	17	NMOD
17	signaling	signaling	I-NP	NN	O	15	OBJ
18	induced	induce	B-VP	VBN	O	17	NMOD
19	by	by	B-PP	IN	O	18	VMOD
20	receptor	receptor	B-NP	NN	O	21	NMOD
21	overexpression	overexpression	I-NP	NN	O	19	PMOD
22	,	,	O	,	O	7	P
23	revealing	reveal	B-VP	VBG	O	7	VMOD
24	a	a	B-NP	DT	O	26	NMOD
25	selective	selective	I-NP	JJ	O	26	NMOD
26	role	role	I-NP	NN	O	23	OBJ
27	for	for	B-PP	IN	O	26	NMOD
28	TRAF6	TRAF6	B-NP	NN	B-protein	27	PMOD
29	in	in	B-PP	IN	O	26	NMOD
30	ligand-induced	ligand-induced	B-NP	JJ	O	32	NMOD
31	activation	activation	I-NP	NN	O	32	NMOD
32	events	event	I-NP	NNS	O	29	PMOD
33	.	.	O	.	O	7	P

1	Regulation	Regulation	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	interleukin-1beta	interleukin-1beta	B-NP	NN	B-protein	4	NMOD
4	transcription	transcription	I-NP	NN	O	2	PMOD
5	by	by	B-PP	IN	O	1	NMOD
6	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	7	NMOD
7	virus	virus	I-NP	NN	O	5	PMOD
8	involves	involve	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	10	NMOD
10	number	number	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	latent	latent	B-NP	JJ	B-protein	13	NMOD
13	proteins	protein	I-NP	NNS	I-protein	11	PMOD
14	via	via	B-PP	IN	O	8	VMOD
15	their	their	B-NP	PRP$	O	16	NMOD
16	interaction	interaction	I-NP	NN	O	14	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	RBP	RBP	B-NP	NN	B-protein	17	PMOD
19	.	.	O	.	O	8	P

1	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	2	NMOD
2	virus	virus	I-NP	NN	O	6	SUB
3	(	(	O	(	O	4	P
4	EBV	EBV	B-NP	NN	O	2	NMOD
5	)	)	O	)	O	4	P
6	infects	infect	B-VP	VBZ	O	0	ROOT
7	B	B	B-NP	NN	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	6	OBJ
9	,	,	O	,	O	6	P
10	resulting	result	B-VP	VBG	O	6	VMOD
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	outgrowth	outgrowth	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	immortalised	immortalised	B-NP	JJ	B-cell_line	18	NMOD
16	lymphoblastoid	lymphoblastoid	I-NP	JJ	I-cell_line	18	NMOD
17	cell	cell	I-NP	NN	I-cell_line	18	NMOD
18	lines	line	I-NP	NNS	I-cell_line	14	PMOD
19	(	(	O	(	O	20	P
20	LCLs	LCL	B-NP	NNS	B-cell_line	18	NMOD
21	)	)	O	)	O	20	P
22	.	.	O	.	O	6	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
5	through	through	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	use	use	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	intracellular	intracellular	B-NP	JJ	O	10	NMOD
10	staining	staining	I-NP	NN	O	8	PMOD
11	that	that	B-NP	IN	O	10	NMOD
12	interleukin-1beta	interleukin-1beta	B-NP	NN	B-protein	16	SUB
13	(	(	O	(	O	14	P
14	IL-1beta	IL-1beta	B-NP	NN	B-protein	12	NMOD
15	)	)	O	)	O	14	P
16	is	be	B-VP	VBZ	O	11	SBAR
17	expressed	express	I-VP	VBN	O	16	VC
18	in	in	B-PP	IN	O	17	VMOD
19	LCLs	LCL	B-NP	NNS	B-cell_line	18	PMOD
20	and	and	O	CC	O	16	VMOD
21	investigate	investigate	B-VP	VB	O	16	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	influence	influence	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	individual	individual	I-NP	JJ	O	28	NMOD
27	latent	latent	I-NP	JJ	B-protein	28	NMOD
28	proteins	protein	I-NP	NNS	I-protein	24	PMOD
29	on	on	B-PP	IN	O	21	VMOD
30	the	the	B-NP	DT	O	31	NMOD
31	expression	expression	I-NP	NN	O	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	IL-1beta	IL-1beta	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	4	P

1	Using	Use	B-VP	VBG	O	5	VMOD
2	RT-PCR	RT-PCR	B-NP	NN	O	1	OBJ
3	,	,	O	,	O	5	P
4	IL-1beta	IL-1beta	B-NP	NN	B-protein	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	shown	show	I-VP	VBN	O	5	VC
7	to	to	I-VP	TO	O	8	VMOD
8	be	be	I-VP	VB	O	6	VMOD
9	up-regulated	up-regulate	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	EBV-transformed	EBV-transformed	B-NP	JJ	B-cell_line	12	NMOD
12	LCLs	LCL	I-NP	NNS	I-cell_line	10	PMOD
13	as	as	B-CONJP	RB	O	10	PMOD
14	well	well	I-CONJP	RB	O	13	DEP
15	as	as	I-CONJP	IN	O	13	DEP
16	in	in	B-PP	IN	O	10	PMOD
17	group	group	B-NP	NN	B-cell_line	21	NMOD
18	III	III	B-NP	CD	I-cell_line	21	NMOD
19	Burkitt	Burkitt	I-NP	NN	I-cell_line	20	NMOD
20	's	's	B-NP	POS	I-cell_line	21	NMOD
21	lymphoma	lymphoma	I-NP	NN	I-cell_line	26	NMOD
22	(	(	O	(	I-cell_line	23	P
23	BL	BL	B-NP	NN	I-cell_line	21	NMOD
24	)	)	O	)	I-cell_line	23	P
25	cell	cell	B-NP	NN	I-cell_line	26	NMOD
26	lines	line	I-NP	NNS	I-cell_line	16	PMOD
27	,	,	O	,	O	26	P
28	compared	compare	B-PP	VBN	O	26	NMOD
29	with	with	B-PP	IN	O	28	VMOD
30	group	group	B-NP	NN	B-cell_line	34	NMOD
31	I	I	I-NP	CD	I-cell_line	34	NMOD
32	BL	BL	I-NP	NN	I-cell_line	34	NMOD
33	cell	cell	I-NP	NN	I-cell_line	34	NMOD
34	lines	line	I-NP	NNS	I-cell_line	29	PMOD
35	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	up-regulation	up-regulation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	IL-1beta	IL-1beta	B-NP	NN	B-protein	5	NMOD
5	message	message	I-NP	NN	O	3	PMOD
6	could	could	B-VP	MD	O	0	ROOT
7	be	be	I-VP	VB	O	6	VC
8	mediated	mediate	I-VP	VBN	O	7	VC
9	by	by	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	13	NMOD
11	latent	latent	I-NP	JJ	B-protein	13	NMOD
12	membrane	membrane	I-NP	NN	I-protein	13	NMOD
13	protein-1	protein-1	I-NP	NN	I-protein	17	NMOD
14	,	,	O	,	O	17	P
15	EBV	EBV	B-NP	NN	B-protein	17	NMOD
16	nuclear	nuclear	I-NP	JJ	I-protein	17	NMOD
17	proteins	protein	I-NP	NNS	I-protein	26	NMOD
18	2	2	I-NP	CD	I-protein	17	NMOD
19	,	,	I-NP	,	O	17	P
20	3	3	I-NP	CD	O	17	NMOD
21	,	,	I-NP	,	O	26	P
22	4	4	I-NP	CD	O	26	NMOD
23	,	,	O	,	O	26	P
24	and	and	O	CC	O	26	NMOD
25	6	6	B-NP	CD	O	26	NMOD
26	genes	gene	I-NP	NNS	O	9	PMOD
27	.	.	O	.	O	6	P

1	Electrophoretic	Electrophoretic	B-NP	JJ	O	4	NMOD
2	mobility	mobility	I-NP	NN	O	4	NMOD
3	shift	shift	I-NP	NN	O	4	NMOD
4	assays	assay	I-NP	NNS	O	8	SUB
5	(	(	O	(	O	6	P
6	EMSAs	EMSA	B-NP	NNS	O	4	NMOD
7	)	)	O	)	O	6	P
8	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	-300	-300	I-NP	CD	B-DNA	12	NMOD
12	region	region	I-NP	NN	I-DNA	29	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	IL-1beta	IL-1beta	I-NP	NN	B-DNA	16	NMOD
16	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
17	,	,	O	,	O	12	P
18	which	which	B-NP	WDT	O	12	NMOD
19	contains	contain	B-VP	VBZ	O	18	SBAR
20	a	a	B-NP	DT	O	27	NMOD
21	nuclear	nuclear	I-NP	JJ	B-DNA	27	NMOD
22	factor-kappaB	factor-kappaB	I-NP	NN	I-DNA	27	NMOD
23	(	(	O	(	I-DNA	24	P
24	NF-kappaB	NF-kappaB	B-NP	NN	I-DNA	22	NMOD
25	)	)	O	)	I-DNA	24	P
26	binding	binding	B-NP	NN	I-DNA	27	NMOD
27	site	site	I-NP	NN	I-DNA	19	OBJ
28	,	,	O	,	O	12	P
29	contained	contain	B-VP	VBD	O	9	SBAR
30	a	a	B-NP	DT	O	34	NMOD
31	functional	functional	I-NP	JJ	B-DNA	34	NMOD
32	RBP	RBP	I-NP	NN	I-DNA	34	NMOD
33	binding	binding	I-NP	NN	I-DNA	34	NMOD
34	site	site	I-NP	NN	I-DNA	29	OBJ
35	.	.	O	.	O	8	P

1	Binding	Binding	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	RBP	RBP	B-NP	NN	B-protein	2	PMOD
4	to	to	B-PP	TO	O	1	NMOD
5	this	this	B-NP	DT	O	6	NMOD
6	site	site	I-NP	NN	O	4	PMOD
7	could	could	B-VP	MD	O	0	ROOT
8	be	be	I-VP	VB	O	7	VC
9	inhibited	inhibit	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	addition	addition	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	EBV	EBV	B-NP	NN	B-protein	15	NMOD
14	nuclear	nuclear	I-NP	JJ	I-protein	15	NMOD
15	proteins	protein	I-NP	NNS	I-protein	12	PMOD
16	3	3	B-NP	CD	I-protein	15	NMOD
17	and	and	I-NP	CC	I-protein	15	NMOD
18	6	6	I-NP	CD	I-protein	15	NMOD
19	,	,	O	,	O	9	P
20	suggesting	suggest	B-VP	VBG	O	9	VMOD
21	that	that	B-SBAR	IN	O	20	VMOD
22	these	these	B-NP	DT	O	23	NMOD
23	proteins	protein	I-NP	NNS	O	24	SUB
24	displace	displace	B-VP	VBP	O	21	SBAR
25	RBP	RBP	B-NP	NN	B-protein	24	OBJ
26	from	from	B-PP	IN	O	24	VMOD
27	its	its	B-NP	PRP$	O	29	NMOD
28	recognition	recognition	I-NP	NN	B-DNA	29	NMOD
29	sequence	sequence	I-NP	NN	I-DNA	26	PMOD
30	,	,	O	,	O	24	P
31	removing	remove	B-VP	VBG	O	24	VMOD
32	transcriptional	transcriptional	B-NP	JJ	O	33	NMOD
33	repression	repression	I-NP	NN	O	31	OBJ
34	and	and	O	CC	O	24	VMOD
35	allowing	allow	B-VP	VBG	O	24	VMOD
36	gene	gene	B-NP	NN	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	39	SUB
38	to	to	B-VP	TO	O	39	VMOD
39	occur	occur	I-VP	VB	O	35	VMOD
40	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	16	VMOD
2	group	group	B-NP	NN	B-cell_line	5	NMOD
3	I	I	I-NP	CD	I-cell_line	5	NMOD
4	BL	BL	I-NP	NN	I-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
6	,	,	O	,	O	16	P
7	containing	contain	B-VP	VBG	O	16	VMOD
8	low	low	B-NP	JJ	O	9	NMOD
9	levels	level	I-NP	NNS	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	PMOD
12	,	,	O	,	O	16	P
13	only	only	B-NP	RB	O	15	NMOD
14	RBP	RBP	I-NP	NN	B-protein	15	NMOD
15	binding	binding	I-NP	NN	O	16	SUB
16	was	be	B-VP	VBD	O	21	VMOD
17	observed	observe	I-VP	VBN	O	16	VC
18	in	in	B-PP	IN	O	17	VMOD
19	EMSAs	EMSA	B-NP	NNS	O	18	PMOD
20	,	,	O	,	O	21	P
21	whereas	whereas	O	IN	O	0	ROOT
22	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	23	NMOD
23	binding	binding	I-NP	NN	O	24	SUB
24	could	could	B-VP	MD	O	21	VMOD
25	be	be	I-VP	VB	O	24	VC
26	demonstrated	demonstrate	I-VP	VBN	O	25	VC
27	in	in	B-PP	IN	O	26	VMOD
28	EBV-transformed	EBV-transformed	B-NP	JJ	B-cell_line	31	NMOD
29	B	B	I-NP	NN	I-cell_line	31	NMOD
30	cell	cell	I-NP	NN	I-cell_line	31	NMOD
31	lines	line	I-NP	NNS	I-cell_line	27	PMOD
32	containing	contain	B-VP	VBG	O	31	NMOD
33	high	high	B-NP	JJ	O	34	NMOD
34	levels	level	I-NP	NNS	O	32	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	activated	activate	B-NP	VBN	O	37	NMOD
37	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	35	PMOD
38	.	.	O	.	O	21	P

1	In	In	B-PP	IN	O	10	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	the	the	B-NP	DT	O	5	NMOD
5	expression	expression	I-NP	NN	O	10	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	latent	latent	B-NP	JJ	B-protein	9	NMOD
8	membrane	membrane	I-NP	NN	I-protein	9	NMOD
9	protein-1	protein-1	I-NP	NN	I-protein	6	PMOD
10	led	lead	B-VP	VBD	O	0	ROOT
11	to	to	B-PP	TO	O	10	VMOD
12	activation	activation	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	PMOD
15	that	that	B-NP	WDT	O	10	VMOD
16	was	be	B-VP	VBD	O	15	SBAR
17	capable	capable	B-ADJP	JJ	O	16	PRD
18	of	of	B-PP	IN	O	17	AMOD
19	binding	bind	B-VP	VBG	O	18	PMOD
20	the	the	B-NP	DT	O	22	NMOD
21	IL-1beta	IL-1beta	I-NP	NN	B-DNA	22	NMOD
22	promoter	promoter	I-NP	NN	I-DNA	19	OBJ
23	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	EBV	EBV	B-NP	NN	O	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	up-regulate	up-regulate	I-VP	VB	O	6	VC
8	IL-1beta	IL-1beta	B-NP	NN	B-protein	9	NMOD
9	expression	expression	I-NP	NN	O	7	OBJ
10	,	,	O	,	O	7	P
11	possibly	possibly	B-ADVP	RB	O	12	PMOD
12	by	by	B-PP	IN	O	7	VMOD
13	using	use	B-VP	VBG	O	12	PMOD
14	RBP	RBP	B-NP	NN	B-protein	19	NMOD
15	,	,	O	,	O	19	P
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	19	NMOD
17	,	,	O	,	O	19	P
18	or	or	O	CC	O	19	NMOD
19	both	both	B-NP	DT	O	13	OBJ
20	.	.	O	.	O	3	P

1	Copyright	Copyright	B-NP	NN	O	0	ROOT
2	1998	1998	I-NP	CD	O	4	NMOD
3	Academic	Academic	I-NP	NNP	O	4	NMOD
4	Press	Press	I-NP	NNP	O	1	NMOD
5	.	.	O	.	O	4	P

1	Characterization	Characterization	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	human	human	I-NP	JJ	B-DNA	6	NMOD
5	elk-1	elk-1	I-NP	NN	I-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	2	PMOD
7	.	.	O	.	O	1	P

1	Potential	Potential	B-NP	JJ	O	2	NMOD
2	role	role	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	7	NMOD
5	downstream	downstream	I-NP	JJ	B-DNA	7	NMOD
6	intronic	intronic	I-NP	JJ	I-DNA	7	NMOD
7	sequence	sequence	I-NP	NN	I-DNA	3	PMOD
8	for	for	B-PP	IN	O	2	NMOD
9	elk-1	elk-1	B-NP	NN	B-DNA	11	NMOD
10	gene	gene	I-NP	NN	I-DNA	11	NMOD
11	expression	expression	I-NP	NN	O	8	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	monocytes	monocyte	B-NP	NNS	B-cell_type	12	PMOD
14	.	.	O	.	O	2	P

1	To	To	B-VP	TO	O	2	VMOD
2	characterize	characterize	I-VP	VB	O	9	VMOD
3	the	the	B-NP	DT	O	6	NMOD
4	human	human	I-NP	JJ	B-DNA	6	NMOD
5	elk-1	elk-1	I-NP	NN	I-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	2	OBJ
7	,	,	O	,	O	9	P
8	we	we	B-NP	PRP	O	9	SUB
9	mapped	map	B-VP	VBD	O	0	ROOT
10	the	the	B-NP	DT	O	13	NMOD
11	transcriptional	transcriptional	I-NP	JJ	B-DNA	13	NMOD
12	start	start	I-NP	NN	I-DNA	13	NMOD
13	site	site	I-NP	NN	I-DNA	9	OBJ
14	and	and	O	CC	O	9	VMOD
15	isolated	isolate	B-VP	VBN	O	9	VMOD
16	elk-1-specific	elk-1-specific	B-NP	JJ	B-cell_line	19	NMOD
17	genomic	genomic	I-NP	JJ	I-cell_line	19	NMOD
18	phage	phage	I-NP	NN	I-cell_line	19	NMOD
19	clones	clone	I-NP	NNS	I-cell_line	15	OBJ
20	that	that	B-NP	WDT	O	19	NMOD
21	contained	contain	B-VP	VBD	O	20	SBAR
22	extensive	extensive	B-NP	JJ	O	26	NMOD
23	upstream	upstream	I-NP	JJ	B-DNA	25	AMOD
24	and	and	I-NP	CC	I-DNA	25	AMOD
25	downstream	downstream	I-NP	JJ	I-DNA	26	NMOD
26	sequences	sequence	I-NP	NNS	I-DNA	21	OBJ
27	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	3	NMOD
2	TATA-like	TATA-like	I-NP	JJ	B-DNA	3	NMOD
3	motif	motif	I-NP	NN	I-DNA	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	identified	identify	I-VP	VBN	O	4	VC
6	immediately	immediately	B-ADVP	RB	O	5	VMOD
7	upstream	upstream	B-ADVP	RB	O	6	AMOD
8	of	of	B-PP	IN	O	7	AMOD
9	the	the	B-NP	DT	O	12	NMOD
10	transcriptional	transcriptional	I-NP	JJ	B-DNA	12	NMOD
11	start	start	I-NP	NN	I-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	8	PMOD
13	.	.	O	.	O	4	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	analyses	analysis	I-NP	NNS	O	30	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	DNA	DNA	B-NP	NN	B-DNA	5	NMOD
5	fragments	fragment	I-NP	NNS	I-DNA	3	PMOD
6	containing	contain	B-VP	VBG	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	TATA	TATA	I-NP	NN	B-DNA	9	NMOD
9	element	element	I-NP	NN	I-DNA	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	the	the	B-NP	DT	O	12	NMOD
12	identification	identification	I-NP	NN	O	6	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	18	NMOD
15	DNase	DNase	I-NP	NN	B-DNA	18	NMOD
16	I-hypersensitive	I-hypersensitive	I-NP	JJ	I-DNA	18	NMOD
17	chromatin	chromatin	I-NP	NN	I-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	13	PMOD
19	(	(	O	(	O	20	P
20	HS	HS	B-NP	NN	B-DNA	18	NMOD
21	1	1	I-NP	CD	I-DNA	20	NMOD
22	)	)	O	)	O	20	P
23	in	in	B-PP	IN	O	18	NMOD
24	close	close	B-NP	JJ	O	25	NMOD
25	proximity	proximity	I-NP	NN	O	23	PMOD
26	to	to	B-PP	TO	O	25	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	TATA	TATA	I-NP	NN	B-DNA	29	NMOD
29	box	box	I-NP	NN	I-DNA	26	PMOD
30	suggest	suggest	B-VP	VBP	O	0	ROOT
31	that	that	B-SBAR	IN	O	30	VMOD
32	the	the	B-NP	DT	O	35	NMOD
33	identified	identify	I-NP	VBN	O	35	NMOD
34	TATA	TATA	I-NP	NN	B-DNA	35	NMOD
35	motif	motif	I-NP	NN	I-DNA	36	SUB
36	is	be	B-VP	VBZ	O	31	SBAR
37	important	important	B-ADJP	JJ	O	36	PRD
38	for	for	B-PP	IN	O	37	AMOD
39	elk-1	elk-1	B-NP	NN	B-DNA	40	NMOD
40	transcription	transcription	I-NP	NN	O	38	PMOD
41	in	in	B-ADVP	FW	O	36	VMOD
42	vivo	vivo	I-ADVP	FW	O	41	AMOD
43	.	.	O	.	O	30	P

1	Sequences	Sequence	B-NP	NNS	O	9	SUB
2	upstream	upstream	B-ADVP	RB	O	1	NMOD
3	and	and	I-ADVP	CC	O	2	AMOD
4	downstream	downstream	I-ADVP	RB	O	2	AMOD
5	from	from	B-PP	IN	O	2	AMOD
6	the	the	B-NP	DT	O	8	NMOD
7	TATA	TATA	I-NP	NN	B-DNA	8	NMOD
8	box	box	I-NP	NN	I-DNA	5	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	found	find	I-VP	VBN	O	9	VC
11	to	to	I-VP	TO	O	12	VMOD
12	contribute	contribute	I-VP	VB	O	10	VMOD
13	to	to	B-PP	TO	O	12	VMOD
14	elk-1	elk-1	B-NP	NN	B-DNA	16	NMOD
15	promoter	promoter	I-NP	NN	I-DNA	16	NMOD
16	activity	activity	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	4	NMOD
2	second	second	I-NP	JJ	O	4	NMOD
3	hypersensitive	hypersensitive	I-NP	JJ	O	4	NMOD
4	site	site	I-NP	NN	O	9	SUB
5	(	(	O	(	O	6	P
6	HS	HS	B-NP	NN	B-DNA	4	NMOD
7	2	2	I-NP	CD	I-DNA	6	NMOD
8	)	)	O	)	O	6	P
9	was	be	B-VP	VBD	O	0	ROOT
10	identified	identify	I-VP	VBN	O	9	VC
11	within	within	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	first	first	I-NP	JJ	B-DNA	14	NMOD
14	intron	intron	I-NP	NN	I-DNA	11	PMOD
15	in	in	B-PP	IN	O	14	NMOD
16	pre-monocytic	pre-monocytic	B-NP	JJ	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	,	,	O	,	O	17	P
19	which	which	B-NP	WDT	O	17	NMOD
20	express	express	B-VP	VBP	O	19	SBAR
21	Elk-1	Elk-1	B-NP	NN	B-protein	20	OBJ
22	only	only	B-ADVP	RB	O	20	VMOD
23	when	when	B-ADVP	WRB	O	20	VMOD
24	differentiating	differentiate	B-VP	VBG	O	23	SBAR
25	to	to	B-PP	TO	O	24	VMOD
26	monocytes	monocyte	B-NP	NNS	B-cell_type	25	PMOD
27	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	18	VMOD
2	a	a	B-NP	DT	O	3	NMOD
3	variety	variety	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	other	other	B-NP	JJ	O	7	NMOD
6	cell	cell	I-NP	NN	O	7	NMOD
7	types	type	I-NP	NNS	O	4	PMOD
8	,	,	O	,	O	7	P
9	which	which	B-NP	WDT	O	7	NMOD
10	display	display	B-VP	VBP	O	9	SBAR
11	a	a	B-NP	DT	O	14	NMOD
12	constitutive	constitutive	I-NP	JJ	O	14	NMOD
13	Elk-1	Elk-1	I-NP	NN	B-protein	14	NMOD
14	expression	expression	I-NP	NN	O	10	OBJ
15	,	,	O	,	O	18	P
16	HS	HS	B-NP	NN	B-DNA	18	SUB
17	2	2	I-NP	CD	I-DNA	16	NMOD
18	did	do	B-VP	VBD	O	0	ROOT
19	not	not	I-VP	RB	O	18	VMOD
20	exist	exist	I-VP	VB	O	18	VC
21	,	,	O	,	O	20	P
22	suggesting	suggest	B-VP	VBG	O	20	VMOD
23	that	that	B-SBAR	IN	O	22	VMOD
24	inducibility	inducibility	B-NP	NN	O	28	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	elk-1	elk-1	B-NP	NN	B-DNA	27	NMOD
27	expression	expression	I-NP	NN	O	25	PMOD
28	is	be	B-VP	VBZ	O	23	SBAR
29	associated	associate	I-VP	VBN	O	28	VC
30	with	with	B-PP	IN	O	29	VMOD
31	the	the	B-NP	DT	O	32	NMOD
32	presence	presence	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	HS	HS	B-NP	NN	B-protein	33	PMOD
35	2	2	I-NP	CD	I-protein	34	NMOD
36	.	.	O	.	O	18	P

1	Egr-1	Egr-1	B-NP	NN	B-protein	6	NMOD
2	and	and	O	CC	O	6	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	serum	serum	I-NP	NN	B-protein	6	NMOD
5	response	response	I-NP	NN	I-protein	6	NMOD
6	factor	factor	I-NP	NN	I-protein	7	SUB
7	were	be	B-VP	VBD	O	0	ROOT
8	found	find	I-VP	VBN	O	7	VC
9	to	to	I-VP	TO	O	10	VMOD
10	interact	interact	I-VP	VB	O	8	VMOD
11	specifically	specifically	B-ADVP	RB	O	10	VMOD
12	with	with	B-PP	IN	O	10	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	intronic	intronic	I-NP	JJ	B-DNA	15	NMOD
15	sequence	sequence	I-NP	NN	I-DNA	12	PMOD
16	at	at	B-PP	IN	O	10	VMOD
17	+265	+265	B-NP	CD	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	+448	+448	I-NP	CD	O	16	PMOD
20	,	,	O	,	O	10	P
21	respectively	respectively	B-ADVP	RB	O	10	VMOD
22	.	.	O	.	O	7	P

1	Because	Because	B-SBAR	IN	O	19	VMOD
2	Egr-1	Egr-1	B-NP	NN	B-RNA	6	NMOD
3	mRNA	mRNA	I-NP	NN	I-RNA	6	NMOD
4	and	and	I-NP	CC	O	6	NMOD
5	protein	protein	I-NP	NN	O	6	NMOD
6	levels	level	I-NP	NNS	O	7	SUB
7	were	be	B-VP	VBD	O	1	SBAR
8	observed	observe	I-VP	VBN	O	7	VC
9	to	to	I-VP	TO	O	10	VMOD
10	increase	increase	I-VP	VB	O	8	VMOD
11	significantly	significantly	B-ADVP	RB	O	10	VMOD
12	before	before	B-PP	IN	O	10	VMOD
13	induction	induction	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	elk-1	elk-1	B-NP	NN	B-DNA	16	NMOD
16	expression	expression	I-NP	NN	O	14	PMOD
17	,	,	O	,	O	19	P
18	we	we	B-NP	PRP	O	19	SUB
19	propose	propose	B-VP	VBP	O	0	ROOT
20	that	that	B-SBAR	IN	O	19	VMOD
21	Egr-1	Egr-1	B-NP	NN	B-protein	22	SUB
22	is	be	B-VP	VBZ	O	20	SBAR
23	important	important	B-ADJP	JJ	O	22	PRD
24	for	for	B-PP	IN	O	23	AMOD
25	the	the	B-NP	DT	O	26	NMOD
26	regulation	regulation	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	elk-1	elk-1	B-NP	NN	B-DNA	29	NMOD
29	transcription	transcription	I-NP	NN	O	27	PMOD
30	in	in	B-PP	IN	O	26	NMOD
31	differentiating	differentiate	B-VP	VBG	B-cell_type	32	NMOD
32	monocytes	monocyte	B-NP	NNS	I-cell_type	30	PMOD
33	.	.	O	.	O	19	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	association	association	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	Nmi	Nmi	B-NP	NN	B-protein	3	PMOD
5	with	with	B-PP	IN	O	2	NMOD
6	Stat5	Stat5	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	Stat1	Stat1	I-NP	NN	B-protein	5	PMOD
9	in	in	B-PP	IN	O	2	NMOD
10	IL-2-	IL-2-	B-NP	NN	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	IFNgamma-mediated	IFNgamma-mediated	B-NP	JJ	O	13	NMOD
13	signaling	signaling	I-NP	NN	O	9	PMOD
14	.	.	O	.	O	2	P

1	Using	Use	B-VP	VBG	O	17	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	coiled-coil	coiled-coil	I-NP	JJ	B-DNA	4	NMOD
4	region	region	I-NP	NN	I-DNA	1	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	Stat5b	Stat5b	B-NP	NN	B-protein	5	PMOD
7	as	as	B-PP	IN	O	1	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	bait	bait	I-NP	NN	O	7	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	14	NMOD
12	yeast	yeast	I-NP	NN	O	14	NMOD
13	two-hybrid	two-hybrid	I-NP	JJ	O	14	NMOD
14	screen	screen	I-NP	NN	O	10	PMOD
15	,	,	O	,	O	17	P
16	we	we	B-NP	PRP	O	17	SUB
17	identified	identify	B-VP	VBD	O	0	ROOT
18	the	the	B-NP	DT	O	19	NMOD
19	association	association	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	Nmi	Nmi	B-NP	NN	B-protein	24	NMOD
22	,	,	O	,	O	24	P
23	a	a	B-NP	DT	O	24	NMOD
24	protein	protein	I-NP	NN	O	20	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	unknown	unknown	B-NP	JJ	O	27	NMOD
27	function	function	I-NP	NN	O	25	PMOD
28	previously	previously	B-VP	RB	O	29	VMOD
29	reported	report	I-VP	VBN	O	24	NMOD
30	as	as	B-PP	IN	O	29	VMOD
31	an	an	B-NP	DT	O	33	NMOD
32	N-Myc	N-Myc	I-NP	NN	B-protein	33	NMOD
33	interactor	interactor	I-NP	NN	I-protein	30	PMOD
34	.	.	O	.	O	17	P

1	We	We	B-NP	PRP	O	3	SUB
2	further	further	B-ADVP	RB	O	3	VMOD
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Nmi	Nmi	B-NP	NN	B-protein	6	SUB
6	interacts	interact	B-VP	VBZ	O	4	SBAR
7	with	with	B-PP	IN	O	6	VMOD
8	all	all	B-NP	DT	O	9	NMOD
9	STATs	STAT	I-NP	NNS	B-protein	7	PMOD
10	except	except	B-PP	IN	O	9	NMOD
11	Stat2	Stat2	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	evaluated	evaluate	B-VP	VBD	O	0	ROOT
3	two	two	B-NP	CD	O	5	NMOD
4	cytokine	cytokine	I-NP	NN	B-protein	5	NMOD
5	systems	system	I-NP	NNS	O	9	NMOD
6	,	,	O	,	O	9	P
7	IL-2	IL-2	B-NP	NN	B-protein	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	IFNgamma	IFNgamma	B-NP	NN	B-protein	2	OBJ
10	,	,	O	,	O	2	P
11	and	and	O	CC	O	2	VMOD
12	demonstrate	demonstrate	B-VP	VBP	O	2	VMOD
13	that	that	B-SBAR	IN	O	12	VMOD
14	Nmi	Nmi	B-NP	NN	B-protein	15	SUB
15	augments	augment	B-VP	VBZ	O	13	SBAR
16	STAT-mediated	STAT-mediated	B-NP	JJ	O	17	NMOD
17	transcription	transcription	I-NP	NN	O	15	OBJ
18	in	in	B-PP	IN	O	15	VMOD
19	response	response	B-NP	NN	O	18	PMOD
20	to	to	B-PP	TO	O	18	PMOD
21	these	these	B-NP	DT	O	22	NMOD
22	cytokines	cytokine	I-NP	NNS	B-protein	18	PMOD
23	.	.	O	.	O	2	P

1	Interestingly	Interestingly	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	Nmi	Nmi	B-NP	NN	B-protein	4	SUB
4	lacks	lack	B-VP	VBZ	O	14	VMOD
5	an	an	B-NP	DT	O	9	NMOD
6	intrinsic	intrinsic	I-NP	JJ	O	9	NMOD
7	transcriptional	transcriptional	I-NP	JJ	B-protein	9	NMOD
8	activation	activation	I-NP	NN	I-protein	9	NMOD
9	domain	domain	I-NP	NN	I-protein	4	OBJ
10	;	;	O	:	O	4	P
11	instead	instead	B-ADVP	RB	O	4	VMOD
12	,	,	O	,	O	14	P
13	Nmi	Nmi	B-NP	NN	B-protein	14	SUB
14	enhances	enhance	B-VP	VBZ	O	0	ROOT
15	the	the	B-NP	DT	O	16	NMOD
16	association	association	I-NP	NN	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	CBP/p300	CBP/p300	B-NP	NN	B-protein	20	NMOD
19	coactivator	coactivator	I-NP	NN	I-protein	20	NMOD
20	proteins	protein	I-NP	NNS	I-protein	17	PMOD
21	with	with	B-PP	IN	O	16	NMOD
22	Stat1	Stat1	B-NP	NN	B-protein	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	Stat5	Stat5	I-NP	NN	B-protein	21	PMOD
25	,	,	O	,	O	14	P
26	and	and	O	CC	O	14	VMOD
27	together	together	B-ADVP	RB	O	14	VMOD
28	with	with	B-PP	IN	O	14	VMOD
29	CBP/p300	CBP/p300	B-NP	NN	B-protein	28	PMOD
30	can	can	B-VP	MD	O	14	VMOD
31	augment	augment	I-VP	VB	O	30	VC
32	IL-2-	IL-2-	B-NP	NN	O	35	NMOD
33	and	and	O	CC	O	35	NMOD
34	IFNgamma-dependent	IFNgamma-dependent	B-NP	JJ	O	35	NMOD
35	transcription	transcription	I-NP	NN	O	31	OBJ
36	.	.	O	.	O	14	P

1	Therefore	Therefore	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	our	our	B-NP	PRP$	O	4	NMOD
4	data	datum	I-NP	NNS	O	7	SUB
5	not	not	B-CONJP	RB	O	7	VMOD
6	only	only	I-CONJP	RB	O	5	DEP
7	reveal	reveal	B-VP	VBP	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	Nmi	Nmi	B-NP	NN	B-protein	10	SUB
10	can	can	B-VP	MD	O	8	SBAR
11	potentiate	potentiate	I-VP	VB	O	10	VC
12	STAT-dependent	STAT-dependent	B-NP	JJ	O	13	NMOD
13	transcription	transcription	I-NP	NN	O	11	OBJ
14	,	,	O	,	O	11	P
15	but	but	B-CONJP	CC	O	11	VMOD
16	also	also	I-CONJP	RB	O	15	DEP
17	suggest	suggest	B-VP	VBP	O	11	VMOD
18	that	that	B-SBAR	IN	O	17	VMOD
19	it	it	B-NP	PRP	O	20	SUB
20	can	can	B-VP	MD	O	18	SBAR
21	augment	augment	I-VP	VB	O	20	VC
22	coactivator	coactivator	B-NP	NN	O	24	NMOD
23	protein	protein	I-NP	NN	O	24	NMOD
24	recruitment	recruitment	I-NP	NN	O	21	OBJ
25	to	to	B-PP	TO	O	21	VMOD
26	at	at	B-ADVP	IN	O	29	NMOD
27	least	least	I-ADVP	JJS	O	26	AMOD
28	some	some	B-NP	DT	O	29	NMOD
29	members	member	I-NP	NNS	O	25	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	a	a	B-NP	DT	O	32	NMOD
32	group	group	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	sequence-specific	sequence-specific	B-NP	JJ	B-protein	36	NMOD
35	transcription	transcription	I-NP	NN	I-protein	36	NMOD
36	factors	factor	I-NP	NNS	I-protein	33	PMOD
37	.	.	O	.	O	7	P

